_unit_id,_golden,_unit_state,_trusted_judgments,_last_judgment_at,comment_box,verify_relationship,verify_relationship:confidence,orig__golden,chemical_id,chemical_name,disease_id,disease_name,form_sentence,original_job_id,pmid,relation_pair_id,sentence_id,uniq_id,verify_relationship_gold,verify_relationship_gold_reason770955372,TRUE,golden,9,,"

'5-HT6 receptors' and not just '5-HT'





",yes_direct,0.4463,TRUE,D012701,"<span class=""chemical"">5-HT</span>",D011605,"<span class=""disease"">psychotic disorders</span>","These animal models were considered to reflect the positive symptoms of schizophrenia, and the above evidence suggests that altered <span class=""chemical"">5-HT</span>6 receptors are involved in the pathophysiology of <span class=""disease"">psychotic disorders</span>.",762850,20705401,20705401_D012701_D011605,20705401_4,bcv_easy_68_sent_dev_set_762850,no_relation,"The receptors to 5-HT6 are related to psychotic disorders, not 5-HT itself."770955373,TRUE,golden,11,,"









",no_relation,0.9181,TRUE,D010396,"<span class=""chemical"">D-penicillamine</span>",D012594,"<span class=""disease"">localized scleroderma</span>","Case reports of 11 patients with severe, extensive <span class=""disease"">localized scleroderma</span> who were treated with <span class=""chemical"">D-penicillamine</span> are summarized in this article.",762850,2334179,2334179_D010396_D012594,2334179_3,bcv_easy_2399_sent_dev_set_762850,no_relation,D-penicillamine was used to treat the patients.770955374,TRUE,golden,12,,"










",no_relation,1,TRUE,D015016,"<span class=""chemical"">yohimbine</span>",D019964,"<span class=""disease"">affective disorders</span>","METHOD: Six patients with either obsessive compulsive disorder, trichotillomania, anxiety, or <span class=""disease"">affective disorders</span> who suffered sexual side effects after treatment with serotonin reuptake blockers were given <span class=""chemical"">yohimbine</span> on a p.r.n. basis in an open clinical trial.",762850,1535072,1535072_D015016_D019964,1535072_4,bcv_easy_642_sent_dev_set_762850,no_relation,"The sentence says the affective disorders were caused by ""serotonin reuptake blockers"". Yohimbine was used to try and treat the patients."770955375,TRUE,golden,11,,"









",no_relation,1,TRUE,D002118,"<span class=""chemical"">calcium</span>",D013035,"<span class=""disease"">muscle spasms</span>","While severe hypokalemia may cause muscle weakness, severe hypomagnesemia is associated with <span class=""disease"">muscle spasms</span> and tetany which cannot be corrected by potassium and <span class=""chemical"">calcium</span> supplementation alone (1,2).",762850,8492347,8492347_D002118_D013035,8492347_2,bcv_easy_1271_sent_dev_set_762850,no_relation,The sentence says calcium supplementation cannot be used to treat muscle spasms and tetany.770955376,TRUE,golden,9,,"







",no_relation,0.8905,TRUE,D064730,"<span class=""chemical"">dexrazoxane</span>",D006402,"<span class=""disease"">hematologic toxicity</span>","Clinical trials in patients with brain metastases combining <span class=""chemical"">dexrazoxane</span> and high doses of etoposide is ongoing with the aim of improving efficacy without aggravating <span class=""disease"">hematologic toxicity</span>.",762850,15897593,15897593_D064730_D006402,15897593_8,bcv_easy_2793_sent_dev_set_762850,no_relation,Dexrazoxane is being used to try and make the patients better without making hematologic toxicity worse. The sentence does not say that dexrazoxane causes hematologic toxicity.770955377,TRUE,golden,15,,"













",no_relation,1,TRUE,D003404,"<span class=""chemical"">creatinine</span>",D006973,"<span class=""disease"">hypertension</span>","We used time-to-event analysis to identify potential predictors of decrease in renal function including age, baseline ejection fraction, baseline <span class=""chemical"">creatinine</span>, low systolic blood pressure (<100 mm Hg), history of <span class=""disease"">hypertension</span>, diabetes, and use of antiplatelet, diuretic, and beta-blocker therapy.",762850,10539815,10539815_D003404_D006973,10539815_7,bcv_easy_306_sent_dev_set_762850,no_relation,Creatinine and hypertension were studied as potential predictors of decreased renal (kidney) function.770955378,TRUE,golden,14,,"












",no_relation,1,TRUE,C071741,"<span class=""chemical"">remifentanil</span>",D010146,"<span class=""disease"">pain</span>","CONCLUSIONS: During induction of anaesthesia with TCI of propofol and <span class=""chemical"">remifentanil</span>, a significant reduction in propofol infusion <span class=""disease"">pain</span> was achieved without significant complications by prior administration of <span class=""chemical"">remifentanil</span> at a target Ce of 4 ng ml(-1).",762850,18006530,18006530_C071741_D010146,18006530_11,bcv_easy_2437_sent_dev_set_762850,no_relation,Remifentanil reduces the pain caused by propofol.770955379,TRUE,golden,11,,"









",yes_direct,0.828,TRUE,C012052,"<span class=""chemical"">amisulpride</span>",D006973,"<span class=""disease"">hypertensive</span>","CONCLUSIONS: As of March 24, 2005, this is the first reported case of <span class=""chemical"">amisulpride</span>- and tiapride-induced <span class=""disease"">hypertensive</span> crisis in a patient with pheochromocytoma.",762850,15811908,15811908_C012052_D006973,15811908_7,bcv_easy_808_sent_dev_set_762850,yes_direct,This sentence talks about the first case of amisulpride induced hypertensive crisis.770955380,TRUE,golden,10,,"








",yes_direct,0.6143,TRUE,D002211,"<span class=""chemical"">capsaicin</span>",D010146,"<span class=""disease"">painful</span>","A small amount of <span class=""chemical"">capsaicin</span> was administered subcutaneously in the right forehead to evoke a burning <span class=""disease"">painful</span> sensation in the first division of the trigeminal nerve.",762850,9514561,9514561_D002211_D010146,9514561_4,bcv_easy_2013_sent_dev_set_762850,yes_direct,"Capsaicin (the chemical that makes chilis spicy), when put under your skin, causes pain."770955381,TRUE,golden,16,,"














",no_relation,1,TRUE,D003630,"<span class=""chemical"">daunorubicin</span>",D000163,"<span class=""disease"">AIDS</span>","We report a non-randomized Phase II clinical trial to assess the efficacy and safety of liposomal <span class=""chemical"">daunorubicin</span> (DaunoXome) in the treatment of <span class=""disease"">AIDS</span> related Kaposi's sarcoma.",762850,8305357,8305357_D003630_D000163,8305357_1,bcv_easy_125_sent_dev_set_762850,no_relation,Daunorubicin is being studied as a way to treat AIDS related Kaposi's sarcoma.770955382,TRUE,golden,10,,"








",no_relation,1,TRUE,D000241,"<span class=""chemical"">adenosine</span>",D059787|D059350,"<span class=""disease"">acute and chronic pain</span>","BACKGROUND: Preclinical studies of intrathecal <span class=""chemical"">adenosine</span> suggest it may be effective in the treatment of <span class=""disease"">acute and chronic pain</span> in humans, and preliminary studies in volunteers and patients with a Swedish formulation of <span class=""chemical"">adenosine</span> suggests it may be effective in hypersensitivity states but not with acute noxious stimulation.",762850,11752998,11752998_D000241_D059787|D059350,11752998_1,bcv_easy_3089_sent_dev_set_762850,no_relation,Adenosine might be able to treat acute and chronic pain.770955383,TRUE,golden,9,,"







",yes_direct,0.8953,TRUE,D010830,"<span class=""chemical"">eserine</span>",D015878,"<span class=""disease"">mydriasis</span>","On the other hand, <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions evoked by carbachol and <span class=""chemical"">eserine</span> were not significantly changed by calcium chloride.",762850,6892185,6892185_D010830_D015878,6892185_3,bcv_easy_1548_sent_dev_set_762850,yes_direct,Eserine and carbachol cause mydriasis.770955384,TRUE,golden,12,,"










",no_relation,1,TRUE,C084178,"<span class=""chemical"">telmisartan</span>",D006973,"<span class=""disease"">hypertension</span>","Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of <span class=""chemical"">telmisartan</span> and amlodipine versus amlodipine monotherapy in Indian adults with stage II <span class=""disease"">hypertension</span>.",762850,18201582,18201582_C084178_D006973,18201582_0,bcv_easy_2744_sent_dev_set_762850,no_relation,Telmisartan is being used in patients with stage II hypertension. It seems it is being tested as a treatment.770955385,TRUE,golden,10,,"








",yes_direct,0.6858,TRUE,D004329,"<span class=""chemical"">droperidol</span>",D004342,"<span class=""disease"">drug allergies</span>","We report the case of a previously healthy 19-year-old man with no known <span class=""disease"">drug allergies</span> in whom angioedema with significant tongue swelling and protrusion developed within 10 minutes of the administration of a single IV dose of <span class=""chemical"">droperidol</span>.",762850,8599504,8599504_D004329_D004342,8599504_2,bcv_easy_1324_sent_dev_set_762850,no_relation,"Droperidol causes angioedema and tongue swelling, but the patient had no prior drug allergies."770955386,TRUE,golden,11,,"









",yes_direct,0.63,TRUE,D006493,"<span class=""chemical"">heparin</span>",D006470,"<span class=""disease"">hemorrhage</span>","Clinical manifestations of this disorder include <span class=""disease"">hemorrhage</span> or, more frequently, thromboembolic events in patients receiving <span class=""chemical"">heparin</span>.",762850,6615052,6615052_D006493_D006470,6615052_2,bcv_easy_3021_sent_dev_set_762850,yes_direct,"The sentence does not follow the ""[chemical]-induced [other disease] causes [highlighted disease]"" structure, so  heparin-induced [other disease] causes hemorrhage is wrong. Patients developed hemorrhage after receiving heparin, so the correct choice is ""heparin directly contributes to or causes hemorrhage."""770955387,TRUE,golden,14,,"












",yes_direct,1,TRUE,D014700,"<span class=""chemical"">Verapamil</span>",D001281,"<span class=""disease"">AF</span>","RESULTS: <span class=""chemical"">Verapamil</span> caused <span class=""disease"">AF</span> promotion in six dogs, increasing mean duration of <span class=""disease"">AF</span> induced by burst pacing, from 8+/-4 s (mean+/-S.E.) to 95+/-39 s (P<0.01 vs. control) at a loading dose of 0.1 mg/kg and 228+/-101 s (P<0.0005 vs. control) at a dose of 0.2 mg/kg.",762850,11282081,11282081_D014700_D001281,11282081_6,bcv_easy_1715_sent_dev_set_762850,yes_direct,770955388,TRUE,golden,20,,"


















",yes_direct,1,TRUE,D004298,"<span class=""chemical"">dopamine</span>",D002389,"<span class=""disease"">catatonia</span>","In the pinealectomized chick, pretreatment with <span class=""chemical"">dopamine</span> increased the duration of <span class=""disease"">catatonia</span> (DOC) after ketamine, but pretreatment with norepinephrine did not.",762850,6540303,6540303_D004298_D002389,6540303_2,bcv_easy_967_sent_dev_set_762850,yes_direct,"Dopamine made the duration of catatonia longer, which means dopamine made catatonia worse."770955389,TRUE,golden,11,,"









",yes_direct,0.7389,TRUE,D000082,"<span class=""chemical"">acetaminophen</span>",D064420,"<span class=""disease"">toxicity</span>","To further our understanding of the mechanism of CS cytoprotection, we examined in rats and mice the protective abilities of CS and the non-hydrolyzable ether form of CS, gamma-cholesteryloxybutyric acid, tris salt (CSE) against <span class=""chemical"">acetaminophen</span>-, adriamycin-, carbon tetrachloride-, chloroform- and galactosamine-induced <span class=""disease"">toxicity</span>.",762850,9067481,9067481_D000082_D064420,9067481_2,bcv_easy_2720_sent_dev_set_762850,yes_direct,"Five chemicals, including acetaminophen, induced (caused) toxicity."770955390,TRUE,golden,8,,"






",yes_direct,1,TRUE,D016861,"<span class=""chemical"">cyclooxygenase inhibitors</span>",D020521,"<span class=""disease"">stroke</span>","Randomised clinical trials and observational studies have shown an increased risk of myocardial infarction, <span class=""disease"">stroke</span>, hypertension and heart failure during treatment with <span class=""chemical"">cyclooxygenase inhibitors</span>.",762850,16586083,16586083_D016861_D020521,16586083_1,bcv_easy_291_sent_dev_set_762850,yes_direct,Cyclooxygenase inhibitors cause four diseases including stroke.770955391,TRUE,golden,14,,"












",no_relation,0.9297,TRUE,D000109,"<span class=""chemical"">acetylcholine</span>",D023921,"<span class=""disease"">coronary artery stenosis</span>","Coronary spasm was induced by intracoronary injection of <span class=""chemical"">acetylcholine</span>, and no fixed <span class=""disease"">coronary artery stenosis</span> was documented on angiograms in all patients.",762850,11078231,11078231_D000109_D023921,11078231_6,bcv_easy_1807_sent_dev_set_762850,no_relation,No fixed coronary artery stenosis was observed in patients who were injected with acetylcholine.770955392,TRUE,golden,10,,"








",yes_direct,0.6957,TRUE,D014147,"<span class=""chemical"">tramadol</span>",D006212,"<span class=""disease"">hallucinations</span>","Fifty-six days after initiation of the treatment the patient presented <span class=""disease"">hallucinations</span> that only stopped after the withdrawal of psycho-active drugs and <span class=""chemical"">tramadol</span>.",762850,8766220,8766220_D014147_D006212,8766220_3,bcv_easy_1658_sent_dev_set_762850,yes_direct,The hallucinations only went away after psycho-active drugs and tramadol were taken away.770955393,TRUE,golden,14,,"












",yes_direct,1,TRUE,D000638,"<span class=""chemical"">Amiodarone</span>",D011014,"<span class=""disease"">pneumonitis</span>","<span class=""chemical"">Amiodarone</span> is an effective antiarrhythmic agent whose utility is limited by many side-effects, the most problematic being <span class=""disease"">pneumonitis</span>.",762850,1595783,1595783_D000638_D011014,1595783_1,bcv_easy_3183_sent_dev_set_762850,yes_direct,Pneumonitis is a side effect of amiodarone.770955394,TRUE,golden,14,,"












",no_relation,1,TRUE,D017374,"<span class=""chemical"">paroxetine</span>",D059350,"<span class=""disease"">chronic pain</span>","This drug was initiated in association with <span class=""chemical"">paroxetine</span> and dosulepine hydrochloride in a tetraparetic patient with <span class=""disease"">chronic pain</span>.",762850,8766220,8766220_D017374_D059350,8766220_2,bcv_easy_1657_sent_dev_set_762850,no_relation,"A patient with chronic pain was given paroxetine, but the sentence does not say paroxetine caused the pain."770955395,TRUE,golden,5,,"



",yes_direct,1,TRUE,D002945,"<span class=""chemical"">cisplatin</span>",D058186,"<span class=""disease"">acute renal injury</span>","The nephroprotective effect of coenzyme Q10 was investigated in mice with <span class=""disease"">acute renal injury</span> induced by a single i.p. injection of <span class=""chemical"">cisplatin</span> (5 mg/kg).",762850,20510337,20510337_D002945_D058186,20510337_1,bcv_easy_1046_sent_dev_set_762850,yes_direct,Acute renal injury was induced by cisplatin injection.770955396,TRUE,golden,14,,"












",yes_direct,1,TRUE,D010878,"<span class=""chemical"">piperacillin</span>",D006311,"<span class=""disease"">Ototoxicity</span>","<span class=""disease"">Ototoxicity</span> occurred in four (9.5%) of 42 netilmicin and <span class=""chemical"">piperacillin</span> and in 12 (22%) of 54 tobramycin and <span class=""chemical"">piperacillin</span>-treated patients.",762850,3535719,3535719_D010878_D006311,3535719_4,bcv_easy_773_sent_dev_set_762850,yes_direct,Some of the patients receiving piperacillin developed ototoxicity.770955397,TRUE,golden,12,,"










",no_relation,0.8426,TRUE,D010665,"<span class=""chemical"">PPA</span>",D006973,"<span class=""disease"">hypertensive</span>","These results suggest that <span class=""chemical"">PPA</span>/caffeine can lead to cerebral hemorrhage in previously <span class=""disease"">hypertensive</span> animals when administered in greater than the allowed dosage.",762850,6695415,6695415_D010665_D006973,6695415_6,bcv_easy_1498_sent_dev_set_762850,no_relation,"The ""previously"" implies that the animals already had hypertension before they were given PPA."770955398,TRUE,golden,13,,"











",no_relation,0.5225,TRUE,D000666,"<span class=""chemical"">amphotericin B</span>",D007008,"<span class=""disease"">hypokalemia</span>","Spironolactone: is it a novel drug for the prevention of <span class=""chemical"">amphotericin B</span>-related <span class=""disease"">hypokalemia</span> in cancer patients?",762850,11868798,11868798_D000666_D007008,11868798_0,bcv_easy_1118_sent_dev_set_762850,yes_direct,770955399,TRUE,golden,10,,"
'was assessed' could mean that they reached the conclution either way.







",no_relation,0.7009,TRUE,C034753,"<span class=""chemical"">benzylacyclouridine/BAU</span>",D007970,"<span class=""disease"">leukopenia</span>","Because of the clinical toxicities associated with chronic Urd administration, the ability of <span class=""chemical"">benzylacyclouridine</span> (<span class=""chemical"">BAU</span>) to effect, in vivo, AZT-induced anemia and <span class=""disease"">leukopenia</span> was assessed.",762850,2257294,2257294_C034753_D007970,2257294_2,bcv_easy_2854_sent_dev_set_762850,no_relation,"Leukopenia was caused by ""AZT""."770955400,TRUE,golden,9,,"







",yes_direct,0.7841,TRUE,D002083,"<span class=""chemical"">BHA</span>",D010212,"<span class=""disease"">squamous cell papilloma</span>","In groups given 2% <span class=""chemical"">BHA</span>, although marked hyperplastic changes of the forestomach epithelium were observed in all animals, co-administration of 0.25% RA significantly (P less than 0.05) increased the incidence of forestomach tumors (<span class=""disease"">squamous cell papilloma</span> and carcinoma) to 60% (9/15, 2 rats with carcinoma) from 15% (3/20, one rat with carcinoma) in the group given RA-free water.",762850,3131282,3131282_D002083_D010212,3131282_3,bcv_easy_24_sent_dev_set_762850,yes_direct,"Giving BHA together with RA caused squamous cell papillomas. Remember if a chemical only works in combination with other chemicals, then the correct choice is that the chemical can cause the disease."770955401,TRUE,golden,11,,"









",no_relation,0.911,TRUE,D013835,"<span class=""chemical"">TPP</span>",D014899,"<span class=""disease"">Wernicke's encephalopathy</span>","We found that the above-mentioned patient and one of the diabetic kindreds with no history of <span class=""disease"">Wernicke's encephalopathy</span> had abnormal transketolase as determined by its Km for <span class=""chemical"">TPP</span>.",762850,3762968,3762968_D013835_D014899,3762968_3,bcv_easy_1369_sent_dev_set_762850,no_relation,770955402,TRUE,golden,10,,"








",no_relation,0.5825,TRUE,D004110,"<span class=""chemical"">diltiazem</span>",D062787,"<span class=""disease"">overdose</span>","It should be considered early in cases of cardiac arrest after <span class=""chemical"">diltiazem</span> <span class=""disease"">overdose</span>.",762850,12101159,12101159_D004110_D062787,12101159_8,bcv_easy_834_sent_dev_set_762850,yes_direct,You can overdose on the drug diltiazem.770955403,TRUE,golden,14,,"












",yes_direct,1,TRUE,D012110,"<span class=""chemical"">Reserpine</span>",D014202,"<span class=""disease"">tremor</span>","<span class=""chemical"">Reserpine</span> also produced <span class=""disease"">tremor</span> and catalepsy, which are signs suggestive of Parkinson's disease.",762850,11999899,11999899_D012110_D014202,11999899_4,bcv_easy_2175_sent_dev_set_762850,yes_direct,770955404,TRUE,golden,9,,"







",no_relation,0.785,TRUE,C018370,"<span class=""chemical"">PREGS</span>",D000647,"<span class=""disease"">amnesia</span>","The memory-enhancing effects of <span class=""chemical"">PREGS</span> and its analogs were tested in the passive avoidance task using the model of scopolamine-induced <span class=""disease"">amnesia</span>.",762850,11860495,11860495_C018370_D000647,11860495_7,bcv_easy_3086_sent_dev_set_762850,no_relation,The amnesia was caused by scopolamine.770955405,TRUE,golden,14,,"












",no_relation,1,TRUE,D001590,"<span class=""chemical"">benztropine</span>",D010302,"<span class=""disease"">parkinsonism</span>","In a 12-week controlled study ethopropazine was compared to <span class=""chemical"">benztropine</span> in the treatment of <span class=""disease"">parkinsonism</span> induced by fluphenazine enanthate in 60 schizophrenic outpatients.",762850,33969,33969_D001590_D010302,33969_1,bcv_easy_2138_sent_dev_set_762850,no_relation,Benztropine is being studied as a treatment for parkinsonism.770955406,TRUE,golden,9,,"







",no_relation,0.8881,TRUE,D015119,"<span class=""chemical"">epsilon-aminocaproic acid</span>",D012851,"<span class=""disease"">cerebral sinus thrombosis</span>","Although increased risk of thromboembolic disease has been reported during treatment with <span class=""chemical"">epsilon-aminocaproic acid</span>, <span class=""disease"">cerebral sinus thrombosis</span> has not been previously described.",762850,2339463,2339463_D015119_D012851,2339463_3,bcv_easy_43_sent_dev_set_762850,no_relation,"The sentence says no known cases of epsilon-aminocaproic acid causing cerebral sinus thrombosis existed before. Although we might want to say that this sentence is reporting the first case, the relation between epsilon-aminocaproic acid and cerebral sinus thrombosis is not explicit here."770955407,TRUE,golden,12,,"










",no_relation,1,TRUE,D010878,"<span class=""chemical"">piperacillin sodium</span>",D007239,"<span class=""disease"">infections</span>","We prospectively compared the efficacy and safety of netilmicin sulfate or tobramycin sulfate in conjunction with <span class=""chemical"">piperacillin sodium</span> in 118 immunocompromised patients with presumed severe <span class=""disease"">infections</span>.",762850,3535719,3535719_D010878_D007239,3535719_1,bcv_easy_768_sent_dev_set_762850,no_relation,The text seems to say that piperacillin sodium was being tested as a treatment.770955408,TRUE,golden,13,,"











",yes_direct,0.8612,TRUE,D004317,"<span class=""chemical"">ADR/adriamycin</span>",D002318,"<span class=""disease"">cardiovascular toxicity</span>","The use of <span class=""chemical"">adriamycin</span> (<span class=""chemical"">ADR</span>) in cancer chemotherapy has been limited due to its cumulative <span class=""disease"">cardiovascular toxicity</span>.",762850,9952311,9952311_D004317_D002318,9952311_1,bcv_easy_1186_sent_dev_set_762850,yes_direct,770955409,TRUE,golden,10,,"








",yes_direct,0.6912,TRUE,D013467,"<span class=""chemical"">sulindac</span>",D007681,"<span class=""disease"">renal papillary necrosis/RPN</span>","A 31-year-old man with rheumatoid arthritis, who had previously been treated with <span class=""chemical"">sulindac</span>, fenoprofen calcium, high dose salicylates and gold salts, developed <span class=""disease"">renal papillary necrosis</span> (<span class=""disease"">RPN</span>) 4 months after institution of naproxen therapy.",762850,6699841,6699841_D013467_D007681,6699841_1,bcv_easy_840_sent_dev_set_762850,no_relation,"The patient developed renal papillary necrosis only after starting naproxen therapy. The sentence says the man was ""previously treated with sulindac"", which implies that sulindac was not taken at the same time as naproxen."770955410,TRUE,golden,4,,"


",yes_direct,0.7687,TRUE,D010862,"<span class=""chemical"">pilocarpine</span>",D012640,"<span class=""disease"">seizures</span>","Steroids with the 3-hydroxy group in the alpha-position and 5-H in the alpha- or beta-configurations were highly effective in protecting against <span class=""chemical"">pilocarpine</span> (416 mg/kg, s.c.)-induced limbic motor <span class=""disease"">seizures</span> and status epilepticus (ED50 values, 7.0-18.7 mg/kg, i.p.).",762850,9121607,9121607_D010862_D012640,9121607_2,bcv_easy_2104_sent_dev_set_762850,yes_direct,770955411,TRUE,golden,16,,"














",no_relation,0.9386,TRUE,D000082,"<span class=""chemical"">paracetamol</span>",D006525,"<span class=""disease"">viral hepatitis</span>","Acid protease (cathepsin D) activity was increased about tenfold in patients who died and nearly fourfold in those who survived fulminant hepatic failure after <span class=""chemical"">paracetamol</span> overdose, whereas activities were increased equally in patients with fulminant hepatic failure due to <span class=""disease"">viral hepatitis</span> whether or not they survived.",762850,7007443,7007443_D000082_D006525,7007443_2,bcv_easy_1359_sent_dev_set_762850,no_relation,Paracetamol overdose causes fulminant hepatic (liver) failure. The text does not say what caused the viral hepatitis.770955412,TRUE,golden,9,,"







",no_relation,0.5319,TRUE,D016202,"<span class=""chemical"">NMDA/N-methyl-D-aspartate</span>",D012559,"<span class=""disease"">schizophrenia</span>","The glutamatergic <span class=""chemical"">N-methyl-D-aspartate</span> (<span class=""chemical"">NMDA</span>) receptor has been implicated in the pathophysiology of <span class=""disease"">schizophrenia</span>.",762850,20727411,20727411_D016202_D012559,20727411_1,bcv_easy_2627_sent_dev_set_762850,no_relation,"The NMDA receptor is involved in schizophrenia, not the chemical NMDA."770955413,TRUE,golden,14,,"












",no_relation,0.935,TRUE,D010396,"<span class=""chemical"">D-penicillamine</span>",D008105,"<span class=""disease"">primary biliary cirrhosis</span>","A case of polymyositis in a patient with <span class=""disease"">primary biliary cirrhosis</span> treated with <span class=""chemical"">D-penicillamine</span>.",762850,8268147,8268147_D010396_D008105,8268147_0,bcv_easy_2535_sent_dev_set_762850,no_relation,D-penicillamine seems to have been used to treat primary biliary cirrhosis.770955414,TRUE,golden,23,,"





















",yes_direct,0.8279,TRUE,D011692,"<span class=""chemical"">puromycin aminonucleoside/PAN</span>",D058186,"<span class=""disease"">Acute experimental models of renal damage</span>","<span class=""disease"">Acute experimental models of renal damage</span> to the proximal tubular, glomerular, and papillary regions of the rat were produced by administration of hexachloro-1:3-butadiene (HCBD), <span class=""chemical"">puromycin aminonucleoside</span> (<span class=""chemical"">PAN</span>), and 2-bromoethylamine (BEA), respectively.",762850,3653576,3653576_D011692_D058186,3653576_1,bcv_easy_1663_sent_dev_set_762850,yes_direct,Three chemicals all produced acute experimental models of renal damage.770955415,TRUE,golden,18,,"
















",yes_direct,0.9467,TRUE,D013619,"<span class=""chemical"">Tacrine</span>",D012640,"<span class=""disease"">seizures</span>","<span class=""chemical"">Tacrine</span>, administered in LiCl pre-treated rats, induces electrocorticographic <span class=""disease"">seizures</span> and delayed hippocampal damage.",762850,19944736,19944736_D013619_D012640,19944736_3,bcv_easy_1618_sent_dev_set_762850,yes_direct,770955416,TRUE,golden,4,,"


",no_relation,0.768,TRUE,D020123,"<span class=""chemical"">sirolimus</span>",D011565,"<span class=""disease"">psoriasis</span>","Activated peripheral blood T cells from patients with <span class=""disease"">psoriasis</span> tended to exhibit greater spontaneous or dexamethasone-induced apoptosis than did normal T cells, particularly in the presence of <span class=""chemical"">sirolimus</span>.",762850,10328196,10328196_D020123_D011565,10328196_4,bcv_easy_3112_sent_dev_set_762850,no_relation,"Sirolimus made T cells undergo apoptosis (cell death) faster, but sirolimus is not stated to have caused psoriasis."770955417,TRUE,golden,12,,"










",no_relation,1,TRUE,C107135,"<span class=""chemical"">everolimus</span>",D009190,"<span class=""disease"">MDS/myelodysplastic syndrome</span>","We report on a combination of <span class=""chemical"">everolimus</span> and tacrolimus in 24 patients (median age, 62 years) with either <span class=""disease"">myelodysplastic syndrome</span> (<span class=""disease"">MDS</span>; n = 17) or acute myeloid leukemia (AML; n = 7) undergoing intensive conditioning followed by HSCT from related (n = 4) or unrelated (n = 20) donors.",762850,19135948,19135948_C107135_D009190,19135948_3,bcv_easy_161_sent_dev_set_762850,no_relation,"Everolimus was used in patients with myelodysplastic syndrome, but the text does not say everolimus caused MDS."770955418,TRUE,golden,3,,"

",yes_direct,1,TRUE,D013390,"<span class=""chemical"">succinylcholine</span>",D063806,"<span class=""disease"">myalgia</span>","In conclusion, there is no evidence for an inflammatory origin of <span class=""chemical"">succinylcholine</span>-associated <span class=""disease"">myalgia</span>.",762850,12760988,12760988_D013390_D063806,12760988_9,bcv_easy_3068_sent_dev_set_762850,yes_direct,"The sentence says that there is no evidence for an ""inflammatory origin"" of myalgia caused by succinylcholine. This does not mean that succinylcholine cannot cause myalgia."770955419,TRUE,golden,7,,"





",no_relation,0.7214,TRUE,D000809,"<span class=""chemical"">angiotensin</span>",D009404,"<span class=""disease"">NS/nephrotic syndrome</span>","Plasma concentration and urine excretion of the renin-<span class=""chemical"">angiotensin</span> system proteins are altered in rats with <span class=""disease"">nephrotic syndrome</span> (<span class=""disease"">NS</span>).",762850,9154656,9154656_D000809_D009404,9154656_1,bcv_easy_2019_sent_dev_set_762850,no_relation,The renin-angiotensin system protein levels were different in rats with nephrotic syndrome.770955420,TRUE,golden,8,,"






",no_relation,1,TRUE,C024224,"<span class=""chemical"">naloxazone</span>",D007035,"<span class=""disease"">hypothermia</span>","Pretreatment with <span class=""chemical"">naloxazone</span> significantly blocked morphine analgesia, catalepsy and <span class=""disease"">hypothermia</span> at a dose which completely eliminated high-affinity binding in brain membranes.",762850,6308526,6308526_C024224_D007035,6308526_2,bcv_easy_2753_sent_dev_set_762850,no_relation,Naloxazone made hypothermia better.770955421,TRUE,golden,9,,"







",no_relation,0.7725,TRUE,C005618,"<span class=""chemical"">benzoylecgonine</span>",D003693,"<span class=""disease"">EDDs</span>","<span class=""disease"">EDDs</span> had concentrations of cocaine and <span class=""chemical"">benzoylecgonine</span> in autopsy blood that were similar to those for controls.",762850,8988571,8988571_C005618_D003693,8988571_5,bcv_easy_3013_sent_dev_set_762850,no_relation,770955422,TRUE,golden,7,,"





",no_relation,1,TRUE,D008625,"<span class=""chemical"">Tiopronin</span>",D001172,"<span class=""disease"">RA</span>","Compared to healthy controls a lower DR5 frequency was observed in patients with <span class=""disease"">RA</span> except for the <span class=""chemical"">Tiopronin</span> related nephritis group.",762850,3084782,3084782_D008625_D001172,3084782_3,bcv_easy_3042_sent_dev_set_762850,no_relation,770955423,TRUE,golden,15,,"













",no_relation,0.804,TRUE,D008094,"<span class=""chemical"">lithium</span>",D014262,"<span class=""disease"">tricuspid regurgitation</span>","A newborn with massive <span class=""disease"">tricuspid regurgitation</span>, atrial flutter, congestive heart failure, and a high serum <span class=""chemical"">lithium</span> level is described.",762850,6794356,6794356_D008094_D014262,6794356_1,bcv_easy_2_sent_dev_set_762850,no_relation,"Although the newborn had both tricuspid regurgitation and high blood lithium levels, the sentence does not say that the lithium is what caused the tricuspid regurgitation."770955424,TRUE,golden,12,,"










",yes_direct,1,TRUE,C020976,"<span class=""chemical"">azelastine</span>",D013651,"<span class=""disease"">altered taste perception</span>","Drowsiness and <span class=""disease"">altered taste perception</span> were increased significantly over placebo only in the high-dose <span class=""chemical"">azelastine</span> group.",762850,3057041,3057041_C020976_D013651,3057041_13,bcv_easy_974_sent_dev_set_762850,yes_direct,Azelastine caused drowsiness and altered taste perception whereas the placebo (no chemical given) did not.770955425,TRUE,golden,10,,"








",yes_direct,0.8018,TRUE,D011433,"<span class=""chemical"">propranolol</span>",D011928,"<span class=""disease"">Raynaud's phenomenon</span>","Other adverse reactions significantly linked with active drugs include impaired glucose tolerance in men and women and gout in men, associated with bendrofluazide treatment, and <span class=""disease"">Raynaud's phenomenon</span> and dyspnoea in men and women taking <span class=""chemical"">propranolol</span>.",762850,6115999,6115999_D011433_D011928,6115999_5,bcv_easy_864_sent_dev_set_762850,yes_direct,Raynaud's phenomenon is given as an example of an adverse reaction linked with drugs (in this case propranolol).770955426,TRUE,golden,14,,"












",yes_direct,0.722,TRUE,D004837,"<span class=""chemical"">adrenaline</span>",D001919,"<span class=""disease"">bradycardia</span>","Intravenous pretreatment of the rats with diazepam, although causing no change in the <span class=""chemical"">adrenaline</span>-induced pressor effect, did enhance the <span class=""chemical"">adrenaline</span>-induced reflex <span class=""disease"">bradycardia</span>.",762850,2894433,2894433_D004837_D001919,2894433_4,bcv_easy_2376_sent_dev_set_762850,yes_direct,770955427,TRUE,golden,11,,"









",no_relation,0.5457,TRUE,D000431,"<span class=""chemical"">alcohol</span>",D000437,"<span class=""disease"">alcohol abuse</span>","The patient had a history of <span class=""disease"">alcohol abuse</span>; <span class=""chemical"">alcohol</span> intake as well as withdrawal can also cause seizures.",762850,11573852,11573852_D000431_D000437,11573852_6,bcv_easy_102_sent_dev_set_762850,no_relation,Alcohol is mentioned as something that might cause seizures. The sentence does not say that alcohol causes alcohol abuse!770955428,TRUE,golden,16,,"














",yes_direct,0.9383,TRUE,C047426,"<span class=""chemical"">venlafaxine</span>",D020230,"<span class=""disease"">Serotonin syndrome</span>","<span class=""disease"">Serotonin syndrome</span> from <span class=""chemical"">venlafaxine</span>-tranylcypromine interaction.",762850,8888541,8888541_C047426_D020230,8888541_0,bcv_easy_2054_sent_dev_set_762850,yes_direct,770955429,TRUE,golden,16,,"














",no_relation,1,TRUE,D013438,"<span class=""chemical"">thiol</span>",D008175,"<span class=""disease"">lung cancer</span>","The protective effect of oral administration of the <span class=""chemical"">thiol</span> compound sodium 2-mercaptoethane sulphonate (MESNA) against urothelial toxicity induced by ifosfamide (IF) was tested in a group of 45 patients with inoperable <span class=""disease"">lung cancer</span> under treatment with IF (2250 mg/m2 on days 2-5) as part of a polychemotherapy regimen repeated in a 4-week cycle.",762850,6402369,6402369_D013438_D008175,6402369_1,bcv_easy_3143_sent_dev_set_762850,no_relation,"The subject of the sentence is sodium 2-mercaptoethane sulphonate, not thiol."770955430,TRUE,golden,14,,"












",no_relation,0.6576,TRUE,D006493,"<span class=""chemical"">heparin</span>",D013923,"<span class=""disease"">thromboembolism</span>","MEASUREMENTS: Platelet counts, onset of objectively determined <span class=""disease"">thromboembolism</span>, results of <span class=""chemical"">heparin</span>-induced platelet factor 4 antibody tests, and outcomes.",762850,11827497,11827497_D006493_D013923,11827497_7,bcv_easy_2916_sent_dev_set_762850,no_relation,The sentence lists some things that were measured.770955431,TRUE,golden,10,,"








",no_relation,0.8034,TRUE,D007980,"<span class=""chemical"">L-dihydroxyphenylalanine</span>",D020258,"<span class=""disease"">neurotoxicity</span>","Here we show that the recently reported ability of <span class=""chemical"">L-dihydroxyphenylalanine</span> to reverse the protective effect of alpha-methyl-para-tyrosine on METH-induced DA <span class=""disease"">neurotoxicity</span> is also confounded by drug effects on body temperature.",762850,20533999,20533999_D007980_D020258,20533999_3,bcv_easy_2637_sent_dev_set_762850,no_relation,"Neurotoxicity was induced by ""METH""."770955432,TRUE,golden,13,,"











",yes_direct,1,TRUE,D017963,"<span class=""chemical"">azithromycin</span>",D006606,"<span class=""disease"">hiccups</span>","Possible <span class=""chemical"">azithromycin</span>-associated <span class=""disease"">hiccups</span>.",762850,15985056,15985056_D017963_D006606,15985056_0,bcv_easy_545_sent_dev_set_762850,yes_direct,"The sentence suggests that azithromycin likely causes hiccups through the use of ""possible""."770955433,TRUE,golden,12,,"










",no_relation,0.8347,TRUE,D015632,"<span class=""chemical"">MPTP</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","Compound 1 is a potent A(2A)/A(1) receptor antagonist in vitro (A(2A) K(i) = 4.1 nM; A(1) K(i) = 17.0 nM) that has excellent activity, after oral administration, across a number of animal models of <span class=""disease"">Parkinson's disease</span> including mouse and rat models of haloperidol-induced catalepsy, mouse model of reserpine-induced akinesia, rat 6-hydroxydopamine (6-OHDA) lesion model of drug-induced rotation, and <span class=""chemical"">MPTP</span>-treated non-human primate model.",762850,20973483,20973483_D015632_D010300,20973483_3,bcv_easy_265_sent_dev_set_762850,no_relation,770955434,TRUE,golden,17,,"















",no_relation,0.7156,TRUE,D016642,"<span class=""chemical"">bupropion</span>",D012892,"<span class=""disease"">sleep deprivation</span>","This case report describes a generalized seizure associated with sustained-release <span class=""chemical"">bupropion</span> use and <span class=""disease"">sleep deprivation</span>.",762850,12745515,12745515_D016642_D012892,12745515_1,bcv_easy_2004_sent_dev_set_762850,no_relation,"The sentence says bupropion causes seizure and sleep deprivation causes seizure, but does not say bupropion causes sleep deprivation."770955435,TRUE,golden,7,,"





",yes_direct,0.8519,TRUE,D011034,"<span class=""chemical"">epipodophyllotoxin</span>",D066126,"<span class=""disease"">cardiac toxicity</span>","PURPOSE: The anthracyclines daunorubicin and doxorubicin and the <span class=""chemical"">epipodophyllotoxin</span> etoposide are potent DNA cleavage-enhancing drugs that are widely used in clinical oncology; however, myelosuppression and <span class=""disease"">cardiac toxicity</span> limit their use.",762850,15897593,15897593_D011034_D066126,15897593_1,bcv_easy_2770_sent_dev_set_762850,no_relation,"The chemical ""etoposide"" is a kind of ""epipodophyllotoxin"". The sentence says that etoposide causes cardiac toxicity, but the sentence does not say all epipodophyllotoxins cause cardiac toxicity!"770955436,TRUE,golden,9,,"







",yes_direct,1,TRUE,D002110,"<span class=""chemical"">caffeine</span>",D001145,"<span class=""disease"">ventricular arrhythmias</span>","Although intravenous <span class=""chemical"">caffeine</span> is generally well tolerated, the clinician should be aware of the potential for unpredictable and serious <span class=""disease"">ventricular arrhythmias</span>.",762850,18997632,18997632_D002110_D001145,18997632_4,bcv_easy_368_sent_dev_set_762850,yes_direct,Serious ventricular arrhythmias can result from taking caffeine.770955437,TRUE,golden,10,,"








",yes_direct,0.8918,TRUE,D008790,"<span class=""chemical"">metoprolol</span>",D006327,"<span class=""disease"">heart block</span>","A seventy-eight-year-old woman presented with complete <span class=""disease"">heart block</span> and refractory hypotension two days after a therapeutic dose of sustained-release verapamil with concomitant use of <span class=""chemical"">metoprolol</span>.",762850,7785794,7785794_D008790_D006327,7785794_1,bcv_easy_2230_sent_dev_set_762850,yes_direct,The woman developed a heart block after taking two chemicals together (verapamil and metoprolol).770955438,TRUE,golden,9,,"







",yes_direct,1,TRUE,D004317,"<span class=""chemical"">doxorubicin</span>",D006333,"<span class=""disease"">cardiac failure</span>","One of the patients developed <span class=""disease"">cardiac failure</span> after 30 mg m-2 MMC and only 150 mg m-2 <span class=""chemical"">doxorubicin</span>.",762850,3137399,3137399_D004317_D006333,3137399_7,bcv_easy_2589_sent_dev_set_762850,yes_direct,770955439,TRUE,golden,10,,"








",no_relation,0.902,TRUE,D018818,"<span class=""chemical"">fenoldopam</span>",D009369,"<span class=""disease"">tumor</span>","Arteritis induced in rats by vasodilators, <span class=""chemical"">fenoldopam</span> and theophylline, was examined immunohistochemically for expressions of inducible type of nitric oxide synthase (iNOS), basic fibroblast growth factor (bFGF) and <span class=""disease"">tumor</span> growth factor-beta1 (TGF-beta1).",762850,12180796,12180796_D018818_D009369,12180796_1,bcv_easy_1109_sent_dev_set_762850,no_relation,"Some rats which had been given fenoldopam were examined for a kind of protein (""tumor growth factor-beta1""). Here the word ""tumor"" is not being used to refer to the disease, but is rather part of the name of a protein (""tumor growth factor-beta1"")."770955440,TRUE,golden,12,,"










",yes_direct,0.5113,TRUE,D005047,"<span class=""chemical"">etoposide</span>",D066126,"<span class=""disease"">cardiac toxicity</span>","PURPOSE: The anthracyclines daunorubicin and doxorubicin and the epipodophyllotoxin <span class=""chemical"">etoposide</span> are potent DNA cleavage-enhancing drugs that are widely used in clinical oncology; however, myelosuppression and <span class=""disease"">cardiac toxicity</span> limit their use.",762850,15897593,15897593_D005047_D066126,15897593_1,bcv_easy_2774_sent_dev_set_762850,yes_direct,770955441,TRUE,golden,13,,"











",yes_direct,0.9282,TRUE,D008874,"<span class=""chemical"">midazolam</span>",D006606,"<span class=""disease"">hiccups</span>","Corticosteroids (dexamethasone and methylprednisolone), benzodiazepines (<span class=""chemical"">midazolam</span>) and general anaesthesia have been the specific agents mentioned most frequently in the literature as being associated with the development of <span class=""disease"">hiccups</span>.",762850,15985056,15985056_D008874_D006606,15985056_7,bcv_easy_554_sent_dev_set_762850,yes_direct,"""Benzodiazepines"" are a category of chemicals. Midazolam is mentioned as a specific example of a ""benzodiazepine"" that is known to cause hiccups."770955442,TRUE,golden,9,,"







",yes_direct,1,TRUE,D008775,"<span class=""chemical"">methylprednisolone</span>",D006323,"<span class=""disease"">asystole</span>","We report a case of hypotension, bradycardia, and <span class=""disease"">asystole</span> after intravenous administration of high-dose <span class=""chemical"">methylprednisolone</span> in a 73-year-old patient who underwent electrocardiographic (ECG) monitoring throughout the episode.",762850,10074612,10074612_D008775_D006323,10074612_1,bcv_easy_1727_sent_dev_set_762850,yes_direct,Methylprednisolone caused three different diseases in this patient.770955443,TRUE,golden,11,,"









",no_relation,0.8172,TRUE,D005045,"<span class=""chemical"">etomidate</span>",D009207,"<span class=""disease"">myoclonus</span>","Remifentanil pretreatment reduces <span class=""disease"">myoclonus</span> after <span class=""chemical"">etomidate</span>.",762850,16563323,16563323_D005045_D009207,16563323_0,bcv_easy_523_sent_dev_set_762850,yes_direct,Remifentanil makes myoclonus caused by etomidate better.770955444,TRUE,golden,13,,"











",yes_direct,1,TRUE,C045645,"<span class=""chemical"">CLZ</span>",D006261,"<span class=""disease"">headache</span>","Seven out of 12 subjects experienced <span class=""disease"">headache</span> of a short duration accompanying facial flush in one and nausea in one, especially after ingestion of <span class=""chemical"">CLZ</span>.",762850,7596955,7596955_C045645_D006261,7596955_6,bcv_easy_202_sent_dev_set_762850,yes_direct,Eating CLZ caused headaches in 7 of 12 patients.770955445,TRUE,golden,8,,"






",yes_direct,1,TRUE,C037663,"<span class=""chemical"">ropivacaine</span>",D012640,"<span class=""disease"">seizures</span>","The cumulative doses of levobupivacaine and <span class=""chemical"">ropivacaine</span> that produced <span class=""disease"">seizures</span> were similar and were larger than those of bupivacaine.",762850,11524350,11524350_C037663_D012640,11524350_9,bcv_easy_1454_sent_dev_set_762850,yes_direct,770955446,TRUE,golden,13,,"











",no_relation,1,TRUE,D013739,"<span class=""chemical"">testosterone</span>",D006966,"<span class=""disease"">hyperprolactinemia</span>","Serum <span class=""chemical"">testosterone</span> concentration increased with pubertal status but was not affected by <span class=""disease"">hyperprolactinemia</span>.",762850,20331935,20331935_D013739_D006966,20331935_7,bcv_easy_1924_sent_dev_set_762850,no_relation,770955447,TRUE,golden,15,,"













",no_relation,0.9384,TRUE,D002794,"<span class=""chemical"">choline</span>",D000544,"<span class=""disease"">AD/Alzheimer's disease</span>","The <span class=""chemical"">choline</span> acetyltransferase (ChAT) activator, which enhances cholinergic transmission via an augmentation of the enzymatic production of acetylcholine (ACh), is an important factor in the treatment of <span class=""disease"">Alzheimer's disease</span> (<span class=""disease"">AD</span>).",762850,16428827,16428827_D002794_D000544,16428827_1,bcv_easy_539_sent_dev_set_762850,no_relation,"The ""choline acetyltransferase activator"" (a protein) and not ""choline"" itself is important to treating Alzheimer's disease."770955448,TRUE,golden,2,,"
",yes_direct,1,TRUE,D004967,"<span class=""chemical"">oestrogen</span>",D005705,"<span class=""disease"">gallbladder disease</span>","Long-term <span class=""chemical"">oestrogen</span>-only HT significantly increased the risk of venous thrombo-embolism, stroke and <span class=""disease"">gallbladder disease</span> (after one to two years, three years and seven years' use respectively), but did not significantly increase the risk of breast cancer.",762850,19370593,19370593_D004967_D005705,19370593_11,bcv_easy_175_sent_dev_set_762850,yes_direct,Oestrogen increased the risk of gallbladder disease.770955449,TRUE,golden,6,,"




",yes_direct,0.8284,TRUE,D002738,"<span class=""chemical"">chloroquine</span>",D015354,"<span class=""disease"">deterioration of vision</span>","A 27-year old African woman with history of regular <span class=""chemical"">chloroquine</span> ingestion presented with progressive <span class=""disease"">deterioration of vision</span>, easy fatiguability, dyspnoea, dizziness progressing to syncopal attacks.",762850,1628552,1628552_D002738_D015354,1628552_1,bcv_easy_1438_sent_dev_set_762850,yes_direct,770955450,TRUE,golden,12,,"










",no_relation,1,TRUE,D013629,"<span class=""chemical"">tamoxifen</span>",D001943,"<span class=""disease"">breast cancer</span>","INTERPRETATION: Although this preliminary analysis has low power, in this cohort of women at low-to-normal risk of <span class=""disease"">breast cancer</span>, the postulated protective effects of <span class=""chemical"">tamoxifen</span> are not yet apparent.",762850,9672273,9672273_D013629_D001943,9672273_15,bcv_easy_595_sent_dev_set_762850,no_relation,Tamoxifen's protective (beneficial) effects on breast cancer are not yet clear according to this sentence.770955451,TRUE,golden,21,,"



















",no_relation,1,TRUE,D011188,"<span class=""chemical"">potassium</span>",D007008,"<span class=""disease"">hypokalemia</span>","In conclusion we found that thiazide diuretics cause <span class=""disease"">hypokalemia</span> and depletion of body <span class=""chemical"">potassium</span>.",762850,6942642,6942642_D011188_D007008,6942642_11,bcv_easy_998_sent_dev_set_762850,no_relation,"Hypokalemia is caused by ""thiazide diuretics""."770955452,FALSE,golden,1,,,yes_direct,1,TRUE,D010830,"<span class=""chemical"">eserine</span>",D015878,"<span class=""disease"">mydriasis</span>","The effect of calcium chloride injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions produced by carbachol and <span class=""chemical"">eserine</span> injected similarly was investigated.",762850,6892185,6892185_D010830_D015878,6892185_1,bcv_easy_1540_sent_dev_set_762850,no_relation,770955453,TRUE,golden,13,,"











",no_relation,1,TRUE,D012293,"<span class=""chemical"">rifampin</span>",D014376,"<span class=""disease"">tuberculosis</span>","Light chain proteinuria and cellular mediated immunity in <span class=""chemical"">rifampin</span> treated patients with <span class=""disease"">tuberculosis</span>.",762850,804391,804391_D012293_D014376,804391_0,bcv_easy_3185_sent_dev_set_762850,no_relation,"Rifampin was given to patients with tuberculosis, but the sentence does not say rifampin caused their tuberculosis."770955454,TRUE,golden,9,,"







",no_relation,1,TRUE,D006024,"<span class=""chemical"">glycopyrronium</span>",D001919,"<span class=""disease"">bradycardias</span>","Use of <span class=""chemical"">glycopyrronium</span> 5 micrograms kg-1 provided greater cardiovascular stability and, given 1 min before the edrophonium, was sufficient to minimize early, edrophonium-induced <span class=""disease"">bradycardias</span>.",762850,2917114,2917114_D006024_D001919,2917114_4,bcv_easy_39_sent_dev_set_762850,no_relation,Glycopyrronium had a beneficial effect on bradycardias.770955455,TRUE,golden,16,,"














",no_relation,1,TRUE,D002998,"<span class=""chemical"">clonazepam</span>",D009207,"<span class=""disease"">myoclonic jerks</span>","Of the benzodiazepines, <span class=""chemical"">clonazepam</span> (0.1-0.3 mg/kg) was found to be several fold more potent than diazepam (0.3-3 mg/kg) in blocking the <span class=""disease"">myoclonic jerks</span>.",762850,6118280,6118280_D002998_D009207,6118280_6,bcv_easy_1583_sent_dev_set_762850,no_relation,Clonazepam blocked myoclonic jerks.770955456,TRUE,golden,11,,"









",yes_direct,0.554,TRUE,D004317,"<span class=""chemical"">doxorubicin</span>",D009202,"<span class=""disease"">cardiomyopathy</span>","Dose-effect and structure-function relationships in <span class=""chemical"">doxorubicin</span> <span class=""disease"">cardiomyopathy</span>.",762850,7282516,7282516_D004317_D009202,7282516_0,bcv_easy_705_sent_dev_set_762850,yes_direct,"The ""dose-effect"" and ""structure-function relationships"" refer to that between doxorubicin and cardiomyopathy. Therefore we can conclude that different doses of doxorubicin have different effects on cardiomyopathy, and that therefore doxorubicin causes cardiomyopathy."770955457,TRUE,golden,11,,"









",yes_direct,0.8184,TRUE,D003024,"<span class=""chemical"">clozapine</span>",D013981,"<span class=""disease"">tic-like symptoms</span>","However, there are two case reports that show <span class=""disease"">tic-like symptoms</span>, including motor and phonic variants, occurring during treatment with quetiapine or <span class=""chemical"">clozapine</span>.",762850,16225977,16225977_D003024_D013981,16225977_2,bcv_easy_2976_sent_dev_set_762850,yes_direct,Two reports showed that tic-like symptoms arose during clozapine treatment.770955458,TRUE,golden,9,,"







",no_relation,1,TRUE,C059896,"<span class=""chemical"">SC-48334</span>",D007153,"<span class=""disease"">immunodeficiency</span>","The mean <span class=""chemical"">SC-48334</span> steady-state trough level (4.04 +/- 0.99 micrograms/ml) was below the in vitro inhibitory concentration for human <span class=""disease"">immunodeficiency</span> virus (HIV).",762850,7905523,7905523_C059896_D007153,7905523_5,bcv_easy_2126_sent_dev_set_762850,no_relation,"SC-48334 concentration was not high enough to inhibit ""human immunodeficiency virus"". Immunodeficiency is not discussed as a disease here. It is part of ""human immunodeficiency virus""."770955459,TRUE,golden,8,,"






",yes_direct,0.8908,TRUE,D010389,"<span class=""chemical"">pemoline</span>",D062787,"<span class=""disease"">overdose</span>","The possibility of choreoathetoid movements should be considered in patients presenting after <span class=""chemical"">pemoline</span> <span class=""disease"">overdose</span>.",762850,9022662,9022662_D010389_D062787,9022662_13,bcv_easy_330_sent_dev_set_762850,yes_direct,770955460,TRUE,golden,10,,"








",yes_direct,1,TRUE,C033457,"<span class=""chemical"">Quinidine phenylethylbarbiturate</span>",D056486,"<span class=""disease"">hepatitis</span>","<span class=""chemical"">Quinidine phenylethylbarbiturate</span>-induced fulminant <span class=""disease"">hepatitis</span> in a pregnant woman. A case report.",762850,3411101,3411101_C033457_D056486,3411101_0,bcv_easy_2695_sent_dev_set_762850,yes_direct,Induced means caused.770955461,TRUE,golden,5,,"



",no_relation,0.8179,TRUE,D000255,"<span class=""chemical"">ATP</span>",D009765,"<span class=""disease"">obese</span>","In conclusion, HFD-induced <span class=""disease"">obese</span> rats are highly sensitized to doxorubicin-induced cardiotoxicity by substantially downregulating cardiac mitochondrial <span class=""chemical"">ATP</span> generation, increasing oxidative stress and downregulating the JAK/STAT3 pathway.",762850,18674790,18674790_D000255_D009765,18674790_9,bcv_easy_491_sent_dev_set_762850,no_relation,770955462,TRUE,golden,9,,"







",yes_direct,0.897,TRUE,D017374,"<span class=""chemical"">paroxetine</span>",D009459,"<span class=""disease"">neuroleptic malignant syndrome</span>","Possible <span class=""disease"">neuroleptic malignant syndrome</span> related to concomitant treatment with <span class=""chemical"">paroxetine</span> and alprazolam.",762850,16720068,16720068_D017374_D009459,16720068_0,bcv_easy_276_sent_dev_set_762850,yes_direct,The sentence says that treatment with paroxetine and alprazolam possibly causes neuroleptic malignant syndrome.770955463,TRUE,golden,7,,"





",no_relation,0.7103,TRUE,D003520,"<span class=""chemical"">Cyclophosphamide</span>",D059265,"<span class=""disease"">visceral pain</span>","<span class=""chemical"">Cyclophosphamide</span>-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of <span class=""disease"">visceral pain</span>.",762850,10840460,10840460_D003520_D059265,10840460_0,bcv_easy_2866_sent_dev_set_762850,no_relation,770955464,TRUE,golden,11,,"









",no_relation,0.8362,TRUE,D005680,"<span class=""chemical"">gamma-aminobutyric acid/GABA</span>",D007022,"<span class=""disease"">hypotension</span>","High doses of isoniazid increase <span class=""disease"">hypotension</span> induced by vasodilators and change the accompanying reflex tachycardia to bradycardia, an interaction attributed to decreased synthesis of brain <span class=""chemical"">gamma-aminobutyric acid</span> (<span class=""chemical"">GABA</span>).",762850,9915601,9915601_D005680_D007022,9915601_1,bcv_easy_1197_sent_dev_set_762850,no_relation,"Hypotension is caused by ""vasodilators"" (chemicals that make blood vessels wider) and made worse by the chemical ""isoniazid""."770955465,TRUE,golden,12,,"










",yes_direct,0.7582,TRUE,D000319,"<span class=""chemical"">beta-adrenergic blocking drugs</span>",D001919,"<span class=""disease"">bradycardia</span>","Three patients with ischaemic heart disease developed profound cardiac failure, hypotension and <span class=""disease"">bradycardia</span> during combined therapy with verapamil and <span class=""chemical"">beta-adrenergic blocking drugs</span>.",762850,6127992,6127992_D000319_D001919,6127992_1,bcv_easy_851_sent_dev_set_762850,yes_direct,770955466,TRUE,golden,10,,"








",no_relation,1,TRUE,D010068,"<span class=""chemical"">oxacillin</span>",D013203|D016470,"<span class=""disease"">Staphylococcus aureus bacteremia</span>","A 67-year-old man who was treated with <span class=""chemical"">oxacillin</span> for one week because of <span class=""disease"">Staphylococcus aureus bacteremia</span>, developed renal failure and diffuse, symmetric, palpable purpuric lesions on his feet.",762850,11337188,11337188_D010068_D013203|D016470,11337188_1,bcv_easy_2749_sent_dev_set_762850,no_relation,Oxacillin was used to treat staphylococcus aureus bacteremia.770955467,TRUE,golden,13,,"








Gold thiosulphate though, not just gold... but right still


",yes_direct,0.6089,TRUE,D006046,"<span class=""chemical"">gold</span>",D003872,"<span class=""disease"">dermatitis</span>","A strong association has been found between nephritis and <span class=""disease"">dermatitis</span> due to Tiopronin (a D-Penicillamine like compound) and class I antigens B35-Cw4, and between <span class=""disease"">dermatitis</span> due to <span class=""chemical"">gold</span> thiosulphate and B35.",762850,3084782,3084782_D006046_D003872,3084782_2,bcv_easy_3040_sent_dev_set_762850,no_relation,"""Gold"" is part of ""gold thiosulphate"", which is a very different chemical than ""gold""! Dermatitis is caused by ""gold thiosulphate"", not ""gold""."770955468,TRUE,golden,12,,"










",no_relation,0.7384,TRUE,D008094,"<span class=""chemical"">Li</span>",D001480,"<span class=""disease"">EPS</span>","Similarly, <span class=""disease"">EPS</span>-related adverse events with QTP + <span class=""chemical"">Li</span>/DVP (21.4%) were no different than with PBO + <span class=""chemical"">Li</span>/DVP (19.2%).",762850,17042884,17042884_D008094_D001480,17042884_7,bcv_easy_227_sent_dev_set_762850,no_relation,The EPS related events are no different when chemical QTP is given and when PBO is given. The sentence does not contain enough information to say that lithium (Li) causes EPS related adverse events.770955469,TRUE,golden,8,,"






",yes_direct,0.8714,TRUE,D012110,"<span class=""chemical"">reserpine</span>",D014202,"<span class=""disease"">tremor</span>","Pretreatment with <span class=""chemical"">reserpine</span> (1 mg/kg) 24 h before the observation test produced increases in vacuous chewing movements and tongue protrusion, as well as increases in <span class=""disease"">tremor</span> and catalepsy, whereas MK-801 (0.1 mg/kg) injection 90 min before the test reversed the effects of <span class=""chemical"">reserpine</span>.",762850,11999899,11999899_D012110_D014202,11999899_10,bcv_easy_2190_sent_dev_set_762850,yes_direct,Giving reserpine 24 hours prior caused tremor.770955470,TRUE,golden,12,,"










",no_relation,1,TRUE,D014810,"<span class=""chemical"">Vitamin E</span>",D009203,"<span class=""disease"">MI</span>","The heart tissue antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, glutathione transferase and glutathione reductase activities, non-enzymic antioxidants such as cerruloplasmin, Vitamin C, <span class=""chemical"">Vitamin E</span> and glutathione levels were altered in <span class=""disease"">MI</span> rats.",762850,16584858,16584858_D014810_D009203,16584858_5,bcv_easy_514_sent_dev_set_762850,no_relation,Vitamin E levels were changed in MI rats.770955471,TRUE,golden,9,,"







",no_relation,1,TRUE,D005839,"<span class=""chemical"">gentamicin</span>",D009956,"<span class=""disease"">tubular necrosis</span>","In Group II, P did not prevent <span class=""chemical"">gentamicin</span>-ARF (maximal decrease in CCr at day 9.89%, P less than 0.001; peak lysozymuria, 1863 +/- 321 micrograms/day; and <span class=""disease"">tubular necrosis</span> score, 3.9 +/- 0.1).",762850,2709684,2709684_D005839_D009956,2709684_8,bcv_easy_2614_sent_dev_set_762850,no_relation,"The ""tubular necrosis score"" was a measurement used to quantify whether ""P"" prevented ""gentamicin-ARF"". The text never says ""gentamicin"" is related to ""tubular necrosis""."770955473,TRUE,golden,8,,"






",yes_direct,0.7612,TRUE,D043343,"<span class=""chemical"">TP</span>",D011471,"<span class=""disease"">prostate cancer</span>","In L-W rats, <span class=""chemical"">TP</span> acted as a tumor enhancement agent, with primary emphasis on the development of <span class=""disease"">prostate cancer</span>.",762850,3461217,3461217_D043343_D011471,3461217_4,bcv_easy_3155_sent_dev_set_762850,yes_direct,"TP enhances tumors, especially the development of prostate cancer. Therefore we can conclude that TP can cause prostate cancer."770955474,TRUE,golden,9,,"







",yes_direct,0.5827,TRUE,D010672,"<span class=""chemical"">phenytoin</span>",D011605,"<span class=""disease"">psychosis</span>","The case of a nonepileptic patient who developed <span class=""disease"">psychosis</span> following <span class=""chemical"">phenytoin</span> treatment for trigeminal neuralgia is described.",760841,14698717,14698717_D010672_D011605,,bcv_easy_3152_sent_train_set_revised_760841,yes_direct,The patient developed psychosis after receiving phenytoin.770955475,TRUE,golden,10,,"








",no_relation,1,TRUE,D001379,"<span class=""chemical"">azathioprine</span>",D009369,"<span class=""disease"">cancers</span>","There have been several long-term studies of patients with rheumatoid arthritis treated with <span class=""chemical"">azathioprine</span> and cyclophosphamide and the incidence of most of the common <span class=""disease"">cancers</span> is not increased.",760841,3970039,3970039_D001379_D009369,,bcv_easy_2200_sent_train_set_revised_760841,no_relation,Azathioprine had no effect on cancer prevalence in the patients.770955476,TRUE,golden,9,,"







",no_relation,1,TRUE,D011433,"<span class=""chemical"">propranolol</span>",D016584,"<span class=""disease"">panic disorders</span>","The effects of oral doses of diazepam (single dose of 10 mg and a median dose of 30 mg/day for 2 weeks) and <span class=""chemical"">propranolol</span> (single dose of 80 mg and a median dose of 240 mg/day for 2 weeks) on psychological performance of patients with <span class=""disease"">panic disorders</span> and agoraphobia were investigated in a double-blind, randomized and crossover design.",760841,6387529,6387529_D011433_D016584,,bcv_easy_174_sent_train_set_revised_760841,no_relation,The sentence says that the effects of diazepam and propranolol on patients was investigated. The sentence does not state what the effect was.770955477,TRUE,golden,13,,"











",yes_direct,0.4668,TRUE,D004837,"<span class=""chemical"">adrenaline</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","An increase in blood pressure, accompanied by <span class=""disease"">atrial fibrillation</span>, agitation, incomprehensible shouts and loss of consciousness, was observed in an elderly, ASA classification group II, cardiovascularly medicated male, 12 min after performance of axillary block with mepivacaine 850 mg containing <span class=""chemical"">adrenaline</span> 0.225 mg, for correction of Dupuytren's contracture.",760841,9698967,9698967_D004837_D001281,,bcv_easy_762_sent_train_set_revised_760841,yes_direct,Giving mepivacaine and adrenaline together caused the male patient to experience atrial fibrillation.770955478,TRUE,golden,10,,"








",yes_direct,0.9,TRUE,D007654,"<span class=""chemical"">ketoconazole</span>",D006973,"<span class=""disease"">hypertension</span>","In both cases normal plasma and urinary free cortisol levels had been achieved following <span class=""chemical"">ketoconazole</span> therapy, yet continuous blood pressure monitoring demonstrated <span class=""disease"">hypertension</span> 31 (patient 1) and 52 weeks (patient 2) after treatment.",760841,2632720,2632720_D007654_D006973,,bcv_easy_58_sent_train_set_revised_760841,yes_direct,Long-term patient monitoring showed that both patients had hypertension after receiving ketoconazole therapy.770955479,TRUE,golden,11,,"









",no_relation,0.9065,TRUE,D002945,"<span class=""chemical"">cisplatin</span>",D064420,"<span class=""disease"">toxicity</span>","We initiated a phase I/II trial to determine the response and <span class=""disease"">toxicity</span> of escalating paclitaxel doses combined with fixed-dose <span class=""chemical"">cisplatin</span> with granulocyte colony-stimulating factor support in patients with untreated locally advanced inoperable head and neck carcinoma.",760841,8643971,8643971_D002945_D064420,,bcv_easy_2217_sent_train_set_revised_760841,no_relation,"The sentence says that the response and toxicity of paclitaxel with cisplatin was studied, but does not say what the result was."770955480,TRUE,golden,13,,"











",no_relation,1,TRUE,D012964,"<span class=""chemical"">na</span>",D012640,"<span class=""disease"">Seizure</span>","METHODS: Cholinergic convulsant sensitivity was examined in alcohol-<span class=""chemical"">na</span>  ve Withdrawal <span class=""disease"">Seizure</span>-Prone (WSP) and-Resistant (WSR) mice.",760841,12198388,12198388_D012964_D012640,,bcv_easy_847_sent_train_set_revised_760841,no_relation,"""na"" does not represent a chemical in this context. There seems to be an error with ""alcohol-na ve"" since ""ve"" is not a word."770955481,TRUE,golden,8,,"






",yes_direct,0.7679,TRUE,D014031,"<span class=""chemical"">tobramycin sulfate</span>",D006311,"<span class=""disease"">ototoxicity</span>","Gentamicin sulfate and <span class=""chemical"">tobramycin sulfate</span> continue to demonstrate <span class=""disease"">ototoxicity</span> and nephrotoxicity in both animal and clinical studies.",760841,7420681,7420681_D014031_D006311,,bcv_easy_2055_sent_train_set_revised_760841,yes_direct,Tobramycin sulfate causes ototoxicity in animals and humans.770955482,TRUE,golden,9,,"







",no_relation,0.8969,TRUE,D014700,"<span class=""chemical"">Verapamil</span>",D006973,"<span class=""disease"">hypertensive</span>","<span class=""chemical"">Verapamil</span> withdrawal as a possible cause of myocardial infarction in a <span class=""disease"">hypertensive</span> woman with a normal coronary angiogram.",760841,3173179,3173179_D014700_D006973,,bcv_easy_1910_sent_train_set_revised_760841,no_relation,"Verapamil was used by a woman with hypertension, but the sentence does not say that verapamil causes hypertension."770955483,TRUE,golden,12,,"










",yes_direct,0.9164,TRUE,D002110,"<span class=""chemical"">caffeine</span>",D014693,"<span class=""disease"">ventricular fibrillation</span>","We describe a 25-year-old woman with pre-existing mitral valve prolapse who developed intractable <span class=""disease"">ventricular fibrillation</span> after consuming a ""natural energy"" guarana health drink containing a high concentration of <span class=""chemical"">caffeine</span>.",760841,11419773,11419773_D002110_D014693,,bcv_easy_298_sent_train_set_revised_760841,yes_direct,She developed ventricular fibrillation after consuming the health drink containing caffeine.770955484,TRUE,golden,9,,"







",yes_direct,0.5372,TRUE,D000082,"<span class=""chemical"">acetaminophen</span>",D007676,"<span class=""disease"">ESRD</span>","The possibility that habitual use of <span class=""chemical"">acetaminophen</span> alone increases the risk of <span class=""disease"">ESRD</span> has not been clearly demonstrated, but cannot be dismissed.",760841,8669433,8669433_D000082_D007676,,bcv_easy_698_sent_train_set_revised_760841,no_relation,"The sentence says that it is not known whether acetaminophen causes ESRD, but that it is also not impossible. Therefore we do not know whether acetaminophen causes ESRD, and therefore the answer is that ""the sentence does not say that acetaminophen contributes to or causes ESRD""."770955485,TRUE,golden,13,,"











",yes_indirect,0.7891,TRUE,D010862,"<span class=""chemical"">pilocarpine</span>",D002544,"<span class=""disease"">Infarcts in substantia nigra pars reticulata</span>","<span class=""disease"">Infarcts in substantia nigra pars reticulata</span> were evoked by prolonged <span class=""chemical"">pilocarpine</span>-induced status epilepticus.",760841,8410052,8410052_D010862_D002544,,bcv_easy_229_sent_train_set_revised_760841,yes_indirect,"This sentence follows the structure of ""[chemical]-induced [other disease] causes [highlighted disease]"". Status epilepticus is what is actually causing ""infarcts in substantia nigra pars reticulata""."770955486,TRUE,golden,15,,"













",no_relation,0.8156,TRUE,D000628,"<span class=""chemical"">aminophylline</span>",D012131,"<span class=""disease"">respiratory failure</span>","The effects of <span class=""chemical"">aminophylline</span> on the ventricular fibrillation threshold during normal acid-base conditions and during <span class=""disease"">respiratory failure</span> were studied in anesthetized open chest dogs.",760841,234669,234669_D000628_D012131,,bcv_easy_2792_sent_train_set_revised_760841,no_relation,"The sentence says that the effects were studied, but does not say if there were any effects."770955487,TRUE,golden,14,,"












",no_relation,1,TRUE,C027260,"<span class=""chemical"">4'-0-tetrahydropyranyladriamycin/Pirarubicin</span>",D009369,"<span class=""disease"">tumors</span>","A Phase I study of intravenous (IV) bolus <span class=""chemical"">4'-0-tetrahydropyranyladriamycin</span> (<span class=""chemical"">Pirarubicin</span>) was done in 55 patients in good performance status with refractory <span class=""disease"">tumors</span>.",760841,2224762,2224762_C027260_D009369,,bcv_easy_2221_sent_train_set_revised_760841,no_relation,"The study of Pirarubicin was done in patients with existing tumors, but there is no stated link between Pirarubicin and tumors."770955488,TRUE,golden,15,,"













",yes_direct,0.547,TRUE,C558899,"<span class=""chemical"">lopinavir/ritonavir</span>",D001919,"<span class=""disease"">bradycardia</span>","One of the twins developed complete heart block and dilated cardiomyopathy related to <span class=""chemical"">lopinavir/ritonavir</span> therapy, a boosted protease-inhibitor agent, while the other twin developed mild <span class=""disease"">bradycardia</span>.",760841,19820426,19820426_C558899_D001919,,bcv_easy_1711_sent_train_set_revised_760841,yes_direct,The second twin developed bradycardia as a result of lopinavir/ritonavir.770955489,TRUE,golden,10,,"








",no_relation,0.8957,TRUE,D011346,"<span class=""chemical"">prochlorperazine</span>",D017109,"<span class=""disease"">akathisia</span>","Intravenous administration of <span class=""chemical"">prochlorperazine</span> by 15-minute infusion versus 2-minute bolus does not affect the incidence of <span class=""disease"">akathisia</span>: a prospective, randomized, controlled trial.",760841,11679859,11679859_D011346_D017109,,bcv_easy_834_sent_train_set_revised_760841,no_relation,Prochlorperazine has no effect on akathisia.770955490,TRUE,golden,14,,"












",yes_direct,0.7179,TRUE,D005283,"<span class=""chemical"">Fentanyl</span>",D001919,"<span class=""disease"">bradycardia</span>","<span class=""chemical"">Fentanyl</span> did reduce minor intraoperative movement but had no sevoflurane-sparing effect and increased respiratory depression, hypotension and <span class=""disease"">bradycardia</span>.",760841,18544179,18544179_D005283_D001919,,bcv_easy_2375_sent_train_set_revised_760841,yes_direct,Fentanyl increased bradycardia.770955491,TRUE,golden,10,,"








",no_relation,1,TRUE,D003042,"<span class=""chemical"">cocaine</span>",D005921,"<span class=""disease"">glomerulonephritis</span>","These 13 included cases of malignant hypertension, thrombotic microangiopathy, lupus nephritis, Henoch-Schonlein nephritis, crescentic <span class=""disease"">glomerulonephritis</span>, and <span class=""chemical"">cocaine</span>-related acute renal failure.",760841,11391224,11391224_D003042_D005921,,bcv_easy_814_sent_train_set_revised_760841,no_relation,"Cocaine is causing ""acute renal failure"", not glomerulonephritis."770955492,TRUE,golden,4,,"


",no_relation,1,TRUE,D015740,"<span class=""chemical"">CGRP</span>",D008881,"<span class=""disease"">migraine</span>","Plasma <span class=""chemical"">CGRP</span> concentration increased significantly (P<0.01) during the <span class=""disease"">migraine</span> attack and returned to baseline after the cessation of the <span class=""disease"">migraine</span>.",760841,14659530,14659530_D015740_D008881,,bcv_easy_349_sent_train_set_revised_760841,no_relation,"Here ""CGRP"" is part of ""Plasma CGRP concentration"". The migraine seemed to cause the increase in CGRP levels, and not the other way around."770955493,TRUE,golden,13,,"











",yes_direct,1,TRUE,C106791,"<span class=""chemical"">telithromycin</span>",D056486,"<span class=""disease"">toxic hepatitis/hepatitis</span>","Based on a score of 8 on the Naranjo adverse drug reaction probability scale, <span class=""chemical"">telithromycin</span> was the probable cause of acute <span class=""disease"">hepatitis</span> in this patient, and pathological findings suggested drug-induced <span class=""disease"">toxic hepatitis</span>.",760841,17919553,17919553_C106791_D056486,,bcv_easy_2550_sent_train_set_revised_760841,yes_direct,Telithromycin was the likely cause of hepatitis in the patient.770955494,TRUE,golden,8,,"






",no_relation,0.8783,TRUE,D001920,"<span class=""chemical"">bradykinin</span>",D006973,"<span class=""disease"">hypertension</span>","Role of activation of <span class=""chemical"">bradykinin</span> B2 receptors in disruption of the blood-brain barrier during acute <span class=""disease"">hypertension</span>.",760841,8955532,8955532_D001920_D006973,,bcv_easy_1892_sent_train_set_revised_760841,no_relation,"Here ""bradykinin"" is part of ""bradykinin B2 receptors"", because the activated receptors are disrupting the blood-brain barrier somehow."770955495,TRUE,golden,10,,"








",yes_direct,0.6119,TRUE,D013390,"<span class=""chemical"">suxamethonium</span>",D001919,"<span class=""disease"">bradycardia</span>","Comparison of i.v. glycopyrrolate and atropine in the prevention of <span class=""disease"">bradycardia</span> and arrhythmias following repeated doses of <span class=""chemical"">suxamethonium</span> in children.",760841,6466532,6466532_D013390_D001919,,bcv_easy_3049_sent_train_set_revised_760841,yes_direct,"Suxamethonium causes bradycardia, and the sentence says two other chemicals (glycopyrrolate and atropine) are being used to try and prevent the bradycardia."770955496,TRUE,golden,16,,"














",no_relation,0.8239,TRUE,C060802,"<span class=""chemical"">fangchinoline</span>",D013927,"<span class=""disease"">thrombosis</span>","Effects of tetrandrine and <span class=""chemical"">fangchinoline</span> on experimental <span class=""disease"">thrombosis</span> in mice and human platelet aggregation.",760841,10193204,10193204_C060802_D013927,,bcv_easy_253_sent_train_set_revised_760841,no_relation,"The sentence is a fragment, and does not explicitly say that negative effects of fangchinoline exist, rather that the effects were tested."770955497,TRUE,golden,15,,"













",yes_direct,0.9457,TRUE,D004164,"<span class=""chemical"">bisphosphonate</span>",D058186,"<span class=""disease"">acute renal failure</span>","Massive proteinuria and <span class=""disease"">acute renal failure</span> after oral <span class=""chemical"">bisphosphonate</span> (alendronate) administration in a patient with focal segmental glomerulosclerosis.",760841,18754075,18754075_D004164_D058186,,bcv_easy_1641_sent_train_set_revised_760841,yes_direct,Patient developed acute renal failure after taking bisphosphonate.770955498,TRUE,golden,9,,"







",yes_direct,1,TRUE,D000082,"<span class=""chemical"">acetaminophen</span>",D007676,"<span class=""disease"">chronic renal failure/ESRD</span>","However, three case control studies, one each in North Carolina, northern Maryland, and West Berlin, Germany, showed that habitual use of <span class=""chemical"">acetaminophen</span> is also associated with <span class=""disease"">chronic renal failure</span> and <span class=""disease"">ESRD</span>, with a relative risk in the range of 2 to 4.",760841,8669433,8669433_D000082_D007676,,bcv_easy_695_sent_train_set_revised_760841,yes_direct,Habitual use of acetaminophen causes chronic renal failure.770955499,TRUE,golden,11,,"









",no_relation,1,TRUE,D009569,"<span class=""chemical"">NO</span>",D009437,"<span class=""disease"">neuropathic pain</span>","Therefore, concomitant administration of small doses of bradykinin receptor antagonists and <span class=""chemical"">NO</span> synthase inhibitors can be effective in alleviation of <span class=""disease"">neuropathic pain</span>, even in hospital care.",760841,19300402,19300402_D009569_D009437,,bcv_easy_2907_sent_train_set_revised_760841,no_relation,"The sentence says small doses of ""NO synthase inhibitors"" (a category of chemicals) removes neuropathic pain."770955500,TRUE,golden,14,,"












",no_relation,0.9245,TRUE,D003520,"<span class=""chemical"">cyclophosphamide</span>",D006973,"<span class=""disease"">hypertension</span>","Analysis was performed on 61 women with chemotherapy-responsive metastatic breast cancer receiving 96-h infusional <span class=""chemical"">cyclophosphamide</span> as part of a triple sequential high-dose regimen to assess association between presence of peritransplant congestive heart failure (CHF) and the following pretreatment characteristics: presence of electrocardiogram (EKG) abnormalities, age, <span class=""disease"">hypertension</span>, prior cardiac history, smoking, diabetes mellitus, prior use of anthracyclines, and left-sided chest irradiation.",760841,15325671,15325671_D003520_D006973,,bcv_easy_2919_sent_train_set_revised_760841,no_relation,"An analysis was done to see if congestive heart failure had anything to do with some pretreatment characteristics, including hypertension. The sentence never says what the conclusions of the analysis were, or whether cyclophosphamide causes hypertension."770955501,TRUE,golden,10,,"








",no_relation,0.918,TRUE,C524754,"<span class=""chemical"">maltolyl p-coumarate</span>",D009410,"<span class=""disease"">neuronal death</span>","Taking these in vitro and in vivo results together, our study suggests that <span class=""chemical"">maltolyl p-coumarate</span> is a potentially effective candidate against Alzheimer's disease that is characterized by wide spread <span class=""disease"">neuronal death</span> and progressive decline of cognitive function.",760841,17600377,17600377_C524754_D009410,,bcv_easy_1560_sent_train_set_revised_760841,no_relation,"Maltolyl p-coumarate is treating Alzheimer's disease, and not causing one of the symptoms (""neuronal death"") of Alzheimer's disease."770955502,TRUE,golden,11,,"




it's 'nicotinic acetylcholine receptors' and not acetylcholine.




",yes_direct,0.5251,TRUE,D000109,"<span class=""chemical"">acetylcholine</span>",D014202,"<span class=""disease"">tremors</span>","Binding of nicotine to nicotinic <span class=""chemical"">acetylcholine</span> receptors (nAChRs) elicits a series of dose-dependent behaviors that go from altered exploration, sedation, and <span class=""disease"">tremors</span>, to seizures and death.",760841,15275829,15275829_D000109_D014202,,bcv_easy_1512_sent_train_set_revised_760841,no_relation,"Here ""acetylcholine"" is part of ""nicotinic acetylcholine receptors"". Nicotine binding to these receptors causes tremors, but acetylcholine itself does not."770955503,TRUE,golden,11,,"









",no_relation,1,TRUE,D012964,"<span class=""chemical"">na</span>",D006509,"<span class=""disease"">HBV infected/HBV mono-infected</span>","Thirty-five lamivudine-<span class=""chemical"">na</span>  ve <span class=""disease"">HBV infected</span> patients with or without HIV co-infection were studied: 15 chronic <span class=""disease"">HBV mono-infected</span> patients and 20 HBV-HIV co-infected patients.",760841,17854040,17854040_D012964_D006509,,bcv_easy_1578_sent_train_set_revised_760841,no_relation,"""na"" is not being used as a chemical in this context, because ""ve"" is not a word. There seems to be a missing letter between ""na"" and ""ve""."770955504,TRUE,golden,14,,"












",yes_direct,0.8613,TRUE,D004837,"<span class=""chemical"">epinephrine/EP</span>",D013927,"<span class=""disease"">thrombosis</span>","The present study was undertaken to investigate the effects of TET and FAN on the experimental <span class=""disease"">thrombosis</span> induced by collagen plus <span class=""chemical"">epinephrine</span> (<span class=""chemical"">EP</span>) in mice, and platelet aggregation and blood coagulation in vitro.",760841,10193204,10193204_D004837_D013927,,bcv_easy_262_sent_train_set_revised_760841,yes_direct,"Thrombosis was ""induced by"" (caused by) collagen and epinephrine."770955505,TRUE,golden,14,,"












",no_relation,0.7929,TRUE,D006854,"<span class=""chemical"">hydrocortisone</span>",D009202,"<span class=""disease"">myocardial injury</span>","Effects of acetylsalicylic acid, dipyridamole, and <span class=""chemical"">hydrocortisone</span> on epinephrine-induced <span class=""disease"">myocardial injury</span> in dogs.",760841,983936,983936_D006854_D009202,,bcv_easy_1098_sent_train_set_revised_760841,no_relation,"Myocardial injury is caused by ""epinephrine"". We do not know what the effect of hydrocortisone on myocardial injury is."770955506,TRUE,golden,11,,"









",no_relation,0.8137,TRUE,D002784,"<span class=""chemical"">cholesterol</span>",D003072,"<span class=""disease"">cognitive dysfunctions</span>","Therefore, DCE may prove to be a useful remedy for the management of <span class=""disease"">cognitive dysfunctions</span> on account of its multifarious beneficial effects such as, memory improving property, <span class=""chemical"">cholesterol</span> lowering property and anticholinesterase activity.",760841,16755009,16755009_D002784_D003072,,bcv_easy_978_sent_train_set_revised_760841,no_relation,"The sentence lists some ""beneficial effects"" of DCE, such as ""cholesterol lowering property"". The sentence does not say cholesterol causes cognitive dysfunctions."770955507,TRUE,golden,8,,"






",no_relation,0.8756,TRUE,D012964,"<span class=""chemical"">sodium</span>",D016055,"<span class=""disease"">volume retention</span>","Doxorubicin-induced nephropathy leads to epithelial <span class=""chemical"">sodium</span> channel (ENaC)-dependent <span class=""disease"">volume retention</span> and renal fibrosis.",760841,18768591,18768591_D012964_D016055,,bcv_easy_1653_sent_train_set_revised_760841,no_relation,"The sentence says nephropathy caused by doxorubicin leads to volume retention that is dependent on ""epithelial sodium channels"", a kind of protein. It does not say sodium causes volume retention."770955508,TRUE,golden,16,,"














",yes_indirect,0.5817,TRUE,D002945,"<span class=""chemical"">cisplatin</span>",D028361,"<span class=""disease"">mitochondrial toxicity</span>","In conclusion <span class=""disease"">mitochondrial toxicity</span> is an early common event both in paclitaxel and <span class=""chemical"">cisplatin</span> induced neurotoxicity.",760841,18809400,18809400_D002945_D028361,,bcv_easy_2259_sent_train_set_revised_760841,yes_indirect,"This sentence follows the ""[chemical]-induced [other disease] causes [highlighted disease]"" structure. Therefore the correct answer is ""cisplatin-induced [neurotoxicity] causes mitochondrial toxicity""."770955509,TRUE,golden,7,,"





",no_relation,1,TRUE,D009020,"<span class=""chemical"">morphine</span>",D059787,"<span class=""disease"">acute pain</span>","Enhancement of <span class=""chemical"">morphine</span> antinociception by dextromethorphan was seen in both males and females in the <span class=""disease"">acute pain</span> models, with the magnitude of this effect being greater in males.",760841,18221780,18221780_D009020_D059787,,bcv_easy_1595_sent_train_set_revised_760841,no_relation,The effect was enhanced by dextromethorphan in a model of acute pain. The sentence does not say morphine causes acute pain. Fun fact: morphine is actually a very strong painkiller that is similar to opium and heroin.770955510,TRUE,golden,9,,"







",no_relation,0.7793,TRUE,D016202,"<span class=""chemical"">NMDA</span>",D059787,"<span class=""disease"">acute pain</span>","These findings demonstrate a sexually-dimorphic interaction between <span class=""chemical"">NMDA</span> antagonists and morphine in a persistent pain model that can be distinguished from those observed in <span class=""disease"">acute pain</span> models.",760841,18221780,18221780_D016202_D059787,,bcv_easy_1597_sent_train_set_revised_760841,no_relation,"""NMDA antagonists"" are interacting with morphine. The study is done in a ""acute pain"" model, but the sentence does not say that NMDA causes acute pain."770955511,TRUE,golden,10,,"








",yes_direct,0.9053,TRUE,D000431,"<span class=""chemical"">alcohol</span>",D005483,"<span class=""disease"">flushing of the face</span>","In less than 1 hour after the ingestion of <span class=""chemical"">alcohol</span>, he developed malaise with <span class=""disease"">flushing of the face</span>, tachycardia, and dyspnea.",760841,19657887,19657887_D000431_D005483,,bcv_easy_1805_sent_train_set_revised_760841,yes_direct,Ingesting alcohol causes your face to flush (but you already knew that!).770955512,TRUE,golden,6,,"




",no_relation,0.8397,TRUE,D004298,"<span class=""chemical"">dopamine</span>",D001919,"<span class=""disease"">bradycardia</span>","They suggest that, in normal conscious rats, the central tachycardia of bromocriptine appears to predominate and to mask the <span class=""disease"">bradycardia</span> of this agonist at peripheral <span class=""chemical"">dopamine</span> D2 receptors.",760841,10721819,10721819_D004298_D001919,,bcv_easy_1391_sent_train_set_revised_760841,no_relation,"Here ""dopamine"" is part of ""dopamine D2 receptors"", which is a kind of protein."770955513,TRUE,golden,14,,"












",no_relation,1,TRUE,D006220,"<span class=""chemical"">haloperidol</span>",D011595,"<span class=""disease"">psychomotor agitation</span>","RESULTS: For the 60 patients who completed phase A, standard-dose <span class=""chemical"">haloperidol</span> was efficacious and superior to both low-dose <span class=""chemical"">haloperidol</span> and placebo for scores on the Brief Psychiatric Rating Scale psychosis factor and on <span class=""disease"">psychomotor agitation</span>.",760841,9812111,9812111_D006220_D011595,,bcv_easy_2042_sent_train_set_revised_760841,no_relation,Haloperidol seemed to have a positive effect on psychomotor agitation.770955514,TRUE,golden,12,,"










",no_relation,0.9264,TRUE,D005283,"<span class=""chemical"">fentanyl</span>",D010149,"<span class=""disease"">postoperative pain</span>","CONCLUSION: As <span class=""chemical"">fentanyl</span> exacerbated postoperative nausea and vomiting without an improvement in <span class=""disease"">postoperative pain</span> and also had adverse cardiorespiratory effects, it appears to be an unnecessary and possibly detrimental supplement to sevoflurane in day surgery.",760841,18544179,18544179_D005283_D010149,,bcv_easy_2381_sent_train_set_revised_760841,no_relation,"Fentanyl made postoperative nausea and vomiting worse, but did not improve postoperative pain. The sentence does not say that fentanyl originally caused the postoperative pain!"770955515,TRUE,golden,13,,"











",yes_direct,1,TRUE,D009582,"<span class=""chemical"">Nitrofurantoins</span>",D000853,"<span class=""disease"">anophthalmia</span>","<span class=""chemical"">Nitrofurantoins</span> were associated with <span class=""disease"">anophthalmia</span> or microphthalmos (AOR = 3.7; 95% CI, 1.1-12.2), hypoplastic left heart syndrome (AOR = 4.2; 95% CI, 1.9-9.1), atrial septal defects (AOR = 1.9; 95% CI, 1.1-3.4), and cleft lip with cleft palate (AOR = 2.1; 95% CI, 1.2-3.9).",760841,19884587,19884587_D009582_D000853,,bcv_easy_2185_sent_train_set_revised_760841,yes_direct,Nitrofurantoins cause anophthalmia.770955516,TRUE,golden,10,,"








",no_relation,1,TRUE,D004177,"<span class=""chemical"">metamizol</span>",D059350,"<span class=""disease"">chronic pain</span>","These findings show a significant interaction between morphine and <span class=""chemical"">metamizol</span> in chronically treated rats, suggesting that this combination could be useful for the treatment of <span class=""disease"">chronic pain</span>.",760841,12063090,12063090_D004177_D059350,,bcv_easy_1462_sent_train_set_revised_760841,no_relation,Metamizol is said to be useful for treating chronic pain.770955517,TRUE,golden,11,,"









",yes_indirect,0.5533,TRUE,D007608,"<span class=""chemical"">kainic acid</span>",D001930,"<span class=""disease"">hippocampal injury</span>","Estrogens protect ovariectomized rats from <span class=""disease"">hippocampal injury</span> induced by <span class=""chemical"">kainic acid</span>-induced status epilepticus (SE).",760841,12757899,12757899_D007608_D001930,,bcv_easy_1482_sent_train_set_revised_760841,yes_indirect,"This follows the ""[chemical]-induced [other disease] caused [highlighted disease]"" format, so the correct answer is ""kainic acid-induced [status epilepticus] causes hippocampal injury""."770955518,TRUE,golden,12,,"










",yes_direct,1,TRUE,D008775,"<span class=""chemical"">methylprednisolone</span>",D020250,"<span class=""disease"">nausea, vomiting</span>","CONCLUSIONS: The administration of <span class=""chemical"">methylprednisolone</span> and gentamicin in the posterior sub-Tenon's space was related to a high incidence of side effects including <span class=""disease"">nausea, vomiting</span>, and headache.",760841,17466854,17466854_D008775_D020250,,bcv_easy_1538_sent_train_set_revised_760841,yes_direct,Methylprednisolone causes nausea and vomiting as a side effect.770955519,TRUE,golden,9,,"






Only in this patient with hypersensitivity.
",yes_direct,0.789,TRUE,D002220,"<span class=""chemical"">carbamazepine</span>",D051437,"<span class=""disease"">renal failure</span>","We report a patient in whom hypersensitivity to <span class=""chemical"">carbamazepine</span> presented with generalized erythroderma, a severe leukemoid reaction, eosinophilia, hyponatremia, and <span class=""disease"">renal failure</span>.",760841,2522601,2522601_D002220_D051437,,bcv_easy_1930_sent_train_set_revised_760841,yes_direct,Carbamazepine caused many diseases in this patient.770955520,TRUE,golden,9,,"







",yes_direct,1,TRUE,D019386,"<span class=""chemical"">alendronate</span>",D011507,"<span class=""disease"">proteinuria</span>","Massive <span class=""disease"">proteinuria</span> and acute renal failure after oral bisphosphonate (<span class=""chemical"">alendronate</span>) administration in a patient with focal segmental glomerulosclerosis.",760841,18754075,18754075_D019386_D011507,,bcv_easy_1645_sent_train_set_revised_760841,yes_direct,Patient developed proteinuria after taking alendronate.770955521,TRUE,golden,13,,"











",yes_direct,1,TRUE,D002443,"<span class=""chemical"">ceftriaxone</span>",D056486,"<span class=""disease"">hepatitis</span>","Acute <span class=""disease"">hepatitis</span>, autoimmune hemolytic anemia, and erythroblastocytopenia induced by <span class=""chemical"">ceftriaxone</span>.",760841,9625142,9625142_D002443_D056486,,bcv_easy_241_sent_train_set_revised_760841,yes_direct,Induced means caused by.770955522,TRUE,golden,11,,"









",no_relation,1,TRUE,D009568,"<span class=""chemical"">nitrendipine</span>",D006978,"<span class=""disease"">renovascular hypertension</span>","The effect of a 6-week treatment with the calcium channel blocker <span class=""chemical"">nitrendipine</span> or the angiotensin converting enzyme inhibitor enalapril on blood pressure, albuminuria, renal hemodynamics, and morphology of the nonclipped kidney was studied in rats with two-kidney, one clip <span class=""disease"">renovascular hypertension</span>.",760841,1639466,1639466_D009568_D006978,,bcv_easy_3086_sent_train_set_revised_760841,no_relation,The sentence gives no conclusion regarding the result of the study.770955523,TRUE,golden,11,,"









",no_relation,1,TRUE,C030852,"<span class=""chemical"">vinorelbine</span>",D002289,"<span class=""disease"">nonsmall cell lung carcinoma</span>","Gemcitabine plus <span class=""chemical"">vinorelbine</span> in <span class=""disease"">nonsmall cell lung carcinoma</span> patients age 70 years or older or patients who cannot receive cisplatin. Oncopaz Cooperative Group.",760841,10526274,10526274_C030852_D002289,,bcv_easy_269_sent_train_set_revised_760841,no_relation,"The sentence says vinorelbine was used in patients with lung carcinoma, but does not say whether vinorelbine is treating or causing the cancer."770955524,TRUE,golden,16,,"














",yes_direct,0.9364,TRUE,D005283,"<span class=""chemical"">fentanyl</span>",D016055,"<span class=""disease"">retention of urine</span>","Bladder <span class=""disease"">retention of urine</span> as a result of continuous intravenous infusion of <span class=""chemical"">fentanyl</span>: 2 case reports.",760841,11581460,11581460_D005283_D016055,,bcv_easy_299_sent_train_set_revised_760841,yes_direct,Using fentanyl caused retention or urine.770955525,TRUE,golden,7,,"





",yes_direct,0.8569,TRUE,D018817,"<span class=""chemical"">MDMA</span>",D003072,"<span class=""disease"">impaired social and emotional judgement processes</span>","<span class=""chemical"">MDMA</span> polydrug users show process-specific central executive impairments coupled with <span class=""disease"">impaired social and emotional judgement processes</span>.",760841,16574712,16574712_D018817_D003072,,bcv_easy_371_sent_train_set_revised_760841,yes_direct,People who take MDMA (and other drugs) develop impaired social and emotional judgement processes.770955526,TRUE,golden,7,,"





",yes_direct,0.8665,TRUE,D007980,"<span class=""chemical"">Levodopa</span>",D004421,"<span class=""disease"">dystonia</span>","<span class=""chemical"">Levodopa</span>-induced oromandibular <span class=""disease"">dystonia</span> in progressive supranuclear palsy.",761593,12691807,12691807_D007980_D004421,12691807_0,bcv_easy_330_sent_work_dev_set_761593,yes_direct,770955527,TRUE,golden,8,,"






",yes_direct,0.8818,TRUE,D008619,"<span class=""chemical"">mepivacaine</span>",D009135,"<span class=""disease"">muscle damage</span>","In addition to <span class=""disease"">muscle damage</span>, severe damage was also seen in harderian glands, especially after exposure to <span class=""chemical"">mepivacaine</span> and lidocaine plus epinephrine.",761593,4038130,4038130_D008619_D009135,4038130_5,bcv_easy_395_sent_work_dev_set_761593,yes_direct,770955528,TRUE,golden,6,,"




",yes_direct,0.8451,TRUE,D004917,"<span class=""chemical"">erythromycin</span>",D008133,"<span class=""disease"">Prolongation of QT interval</span>","<span class=""disease"">Prolongation of QT interval</span>, torsades de pointes, and sudden cardiac death have been reported after concomitant administration with <span class=""chemical"">erythromycin</span> or azole antifungal agents, but not with other CYP3A4 inhibitors.",761593,9545159,9545159_D004917_D008133,9545159_2,bcv_easy_258_sent_work_dev_set_761593,yes_direct,770955529,TRUE,golden,10,,"








",yes_direct,1,TRUE,D002217,"<span class=""chemical"">carbachol</span>",D014202,"<span class=""disease"">tremor</span>","It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions caused by <span class=""chemical"">carbachol</span> and eserine.",761593,6892185,6892185_D002217_D014202,6892185_4,bcv_easy_1055_sent_work_dev_set_761593,yes_direct,770955530,TRUE,golden,9,,"







",yes_direct,0.9007,TRUE,D017035,"<span class=""chemical"">pravastatin</span>",D009220,"<span class=""disease"">inflammatory myopathy</span>","A case of acute <span class=""disease"">inflammatory myopathy</span> associated with the use of <span class=""chemical"">pravastatin</span>, a new hydrophilic 3-hydroxy-3 methylglutaril coenzyme A reductase inhibitor, is reported.",761593,7604176,7604176_D017035_D009220,7604176_1,bcv_easy_809_sent_work_dev_set_761593,yes_direct,770955531,TRUE,golden,13,,"











",yes_direct,1,TRUE,D002119,"<span class=""chemical"">calcium carbon-ate</span>",D053040,"<span class=""disease"">nephrolithiasis</span>","One case of acute hypercalcaemia and two of recurrent <span class=""disease"">nephrolithiasis</span> are reported in patients who had regularly consumed large amounts of <span class=""chemical"">calcium carbon-ate</span>-sodium bicarbonate powders for more than 20 years.",761593,625456,625456_D002119_D053040,625456_1,bcv_easy_48_sent_work_dev_set_761593,yes_direct,770955532,TRUE,golden,9,,"







",yes_direct,1,TRUE,D004317,"<span class=""chemical"">adriamycin</span>",D015470,"<span class=""disease"">acute myeloblastic leukemia</span>","1 of the 10 monkeys developed <span class=""disease"">acute myeloblastic leukemia</span> after receiving 324 mg/m2 of <span class=""chemical"">adriamycin</span>; the 10th monkey is alive and well 26 months after the last dose of drug.",761593,6769133,6769133_D004317_D015470,6769133_4,bcv_easy_941_sent_work_dev_set_761593,yes_direct,770955533,TRUE,golden,16,,"














",yes_direct,0.8778,TRUE,D001971,"<span class=""chemical"">bromocriptine</span>",D011605,"<span class=""disease"">psychosis</span>","Two multigravida patients with no prior psychiatric history were seen with postpartum <span class=""disease"">psychosis</span>, having received <span class=""chemical"">bromocriptine</span> for inhibition of lactation.",761593,3686155,3686155_D001971_D011605,3686155_1,bcv_easy_558_sent_work_dev_set_761593,yes_direct,770955534,TRUE,golden,11,,"









",yes_direct,0.5612,TRUE,D006221,"<span class=""chemical"">halothane</span>",D056486,"<span class=""disease"">hepatitis</span>","This supports and extends previous evidence for a mechanism by which enflurane and/or isoflurane could produce a hypersensitivity condition similar to that of <span class=""chemical"">halothane</span> <span class=""disease"">hepatitis</span> either alone or subsequent to <span class=""chemical"">halothane</span> administration.",761593,7647582,7647582_D006221_D056486,7647582_8,bcv_easy_919_sent_work_dev_set_761593,yes_direct,770955535,TRUE,golden,14,,"












",yes_direct,0.7288,TRUE,D003520,"<span class=""chemical"">Cyclophosphamide</span>",D001749,"<span class=""disease"">bladder tumor</span>","CONCLUSIONS: <span class=""chemical"">Cyclophosphamide</span> associated <span class=""disease"">bladder tumor</span> is an aggressive disease.",761593,8911359,8911359_D003520_D001749,8911359_7,bcv_easy_436_sent_work_dev_set_761593,yes_direct,770955536,TRUE,golden,7,,"





",yes_direct,1,TRUE,D008713,"<span class=""chemical"">methimazole</span>",D011537,"<span class=""disease"">itching</span>","A 43-year-old woman had severe jaundice and <span class=""disease"">itching</span> 1 month after receiving <span class=""chemical"">methimazole</span> (10 mg tid) and propranolol (20 mg tid) for treatment of hyperthyroidism.",761593,14982270,14982270_D008713_D011537,14982270_2,bcv_easy_546_sent_work_dev_set_761593,yes_direct,770955537,TRUE,golden,16,,"














",yes_direct,0.8075,TRUE,D010830,"<span class=""chemical"">eserine</span>",D014202,"<span class=""disease"">tremor</span>","On the other hand, mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions evoked by carbachol and <span class=""chemical"">eserine</span> were not significantly changed by calcium chloride.",761593,6892185,6892185_D010830_D014202,6892185_3,bcv_easy_1051_sent_work_dev_set_761593,yes_direct,770955538,TRUE,golden,14,,"




That's a no-brainer.







",yes_direct,0.7941,TRUE,D011441,"<span class=""chemical"">PTU/propylthiouracil</span>",D014657,"<span class=""disease"">vasculitis</span>","The diagnosis of <span class=""chemical"">propylthiouracil</span> (<span class=""chemical"">PTU</span>)-associated <span class=""disease"">vasculitis</span> was made by observation of consistent clinical features, the detection of elevated ANA and ANCA in the blood, and the observed clinical resolution of symptoms following withdrawal of <span class=""chemical"">PTU</span>.",761593,16418614,16418614_D011441_D014657,16418614_4,bcv_easy_94_sent_work_dev_set_761593,yes_direct,770955539,TRUE,golden,7,,"





",yes_direct,0.5738,TRUE,D004837,"<span class=""chemical"">epinephrine</span>",D017202,"<span class=""disease"">myocardial ischemia</span>","The role of <span class=""chemical"">epinephrine</span> in eliciting <span class=""disease"">myocardial ischemia</span> was examined in patients with coronary artery disease.",761593,3413271,3413271_D004837_D017202,3413271_1,bcv_easy_848_sent_work_dev_set_761593,yes_direct,770955540,TRUE,golden,10,,"








",yes_direct,0.7043,TRUE,C047781,"<span class=""chemical"">Lamotrigine</span>",D009207,"<span class=""disease"">myoclonus</span>","<span class=""chemical"">Lamotrigine</span> associated with exacerbation or de novo <span class=""disease"">myoclonus</span> in idiopathic generalized epilepsies.",761593,16157917,16157917_C047781_D009207,16157917_0,bcv_easy_1005_sent_work_dev_set_761593,yes_direct,770955541,TRUE,golden,8,,"






",yes_direct,1,TRUE,D002110,"<span class=""chemical"">caffeine</span>",D017180,"<span class=""disease"">ventricular tachycardia</span>","We describe a patient with no previous history of cardiac disease or arrhythmia who developed sustained bigeminy and 2 brief runs of <span class=""disease"">ventricular tachycardia</span> after <span class=""chemical"">caffeine</span> administration.",761593,18997632,18997632_D002110_D017180,18997632_3,bcv_easy_122_sent_work_dev_set_761593,yes_direct,770955542,TRUE,golden,12,,"










",yes_direct,0.9256,TRUE,D014700,"<span class=""chemical"">verapamil</span>",D007022,"<span class=""disease"">hypotension</span>","Three patients with ischaemic heart disease developed profound cardiac failure, <span class=""disease"">hypotension</span> and bradycardia during combined therapy with <span class=""chemical"">verapamil</span> and beta-adrenergic blocking drugs.",761593,6127992,6127992_D014700_D007022,6127992_1,bcv_easy_469_sent_work_dev_set_761593,yes_direct,770955543,TRUE,golden,10,,"








",yes_direct,1,TRUE,D005473,"<span class=""chemical"">fluoxetine</span>",D062788,"<span class=""disease"">adenomyosis</span>","Histological studies revealed 11 cases of <span class=""disease"">adenomyosis</span>, all within the noncastrated group receiving <span class=""chemical"">fluoxetine</span>.",761593,9098464,9098464_D005473_D062788,9098464_8,bcv_easy_1036_sent_work_dev_set_761593,yes_direct,770955544,TRUE,golden,11,,"









",yes_direct,0.8453,TRUE,D004656,"<span class=""chemical"">enalapril</span>",D051437,"<span class=""disease"">decreased renal function</span>","Older age was associated with a greater risk of developing <span class=""disease"">decreased renal function</span> in both groups, but significantly more so in the <span class=""chemical"">enalapril</span> group (<span class=""chemical"">enalapril</span>: risk ratio [RR] 1.42 per 10 years, 95% confidence interval [CI] 1.32-1.52 with <span class=""chemical"">enalapril</span>; placebo: RR 1.18, 95% CI 1.12-1.25).",761593,10539815,10539815_D004656_D051437,10539815_10,bcv_easy_765_sent_work_dev_set_761593,yes_direct,770955545,TRUE,golden,12,,"










",yes_direct,0.828,TRUE,D017693,"<span class=""chemical"">sodium bicarbonate</span>",D006934,"<span class=""disease"">hypercalcaemia</span>","One case of acute <span class=""disease"">hypercalcaemia</span> and two of recurrent nephrolithiasis are reported in patients who had regularly consumed large amounts of calcium carbon-ate-<span class=""chemical"">sodium bicarbonate</span> powders for more than 20 years.",761593,625456,625456_D017693_D006934,625456_1,bcv_easy_49_sent_work_dev_set_761593,yes_direct,770955546,TRUE,golden,13,,"











",yes_direct,0.7819,TRUE,C014282,"<span class=""chemical"">cirazoline</span>",D001919,"<span class=""disease"">bradycardia</span>","Both the pressor and <span class=""disease"">bradycardia</span> effects of <span class=""chemical"">cirazoline</span> were abolished in chronic prazosin treated SHR (n = 4) as compared to the untreated SHR (n = 4).",761593,1355091,1355091_C014282_D001919,1355091_15,bcv_easy_1079_sent_work_dev_set_761593,yes_direct,770955547,TRUE,golden,13,,"











",yes_direct,0.7762,TRUE,D000583,"<span class=""chemical"">amikacin</span>",D007674,"<span class=""disease"">nephrotoxicity</span>","To evaluate <span class=""chemical"">amikacin</span>-associated <span class=""disease"">nephrotoxicity</span> in an adult hematology/oncology population, a prospective, randomized, open-label trial was conducted at a university-affiliated medical center.",761593,18356633,18356633_D000583_D007674,18356633_3,bcv_easy_698_sent_work_dev_set_761593,yes_direct,770955548,TRUE,golden,6,,"




",yes_direct,0.6826,TRUE,D010042,"<span class=""chemical"">ouabain</span>",D001145,"<span class=""disease"">arrhythmia</span>","This study was designed to evaluate the effects of pilocarpine and explore the underlying ionic mechanism, using both aconitine-induced rat and <span class=""chemical"">ouabain</span>-induced guinea pig <span class=""disease"">arrhythmia</span> models.",761593,19721134,19721134_D010042_D001145,19721134_1,bcv_easy_34_sent_work_dev_set_761593,yes_direct,"Two animal models were used in this study. One was a rat model where arrhythmia was induced by ""aconitine"". The second was a guinea pig model induced by ""ouabain""."770955549,TRUE,golden,8,,"






",yes_direct,1,TRUE,C019248,"<span class=""chemical"">Pamidronate</span>",D006996,"<span class=""disease"">hypocalcemia</span>","<span class=""chemical"">Pamidronate</span> treatment is associated with considerable risk for <span class=""disease"">hypocalcemia</span>, even in cases of initially severe hypercalcemia.",761593,16006300,16006300_C019248_D006996,16006300_11,bcv_easy_709_sent_work_dev_set_761593,yes_direct,770955550,TRUE,golden,10,,"








",yes_direct,0.9015,TRUE,D004977,"<span class=""chemical"">ethambutol</span>",D009901,"<span class=""disease"">Bilateral optic neuropathy</span>","<span class=""disease"">Bilateral optic neuropathy</span> due to combined <span class=""chemical"">ethambutol</span> and isoniazid treatment.",761593,384871,384871_D004977_D009901,384871_0,bcv_easy_570_sent_work_dev_set_761593,yes_direct,770955551,TRUE,golden,12,,"










",yes_direct,0.9252,TRUE,D002110,"<span class=""chemical"">caffeine</span>",D017180,"<span class=""disease"">ventricular tachycardia</span>","A case of <span class=""disease"">ventricular tachycardia</span> related to <span class=""chemical"">caffeine</span> pretreatment.",761593,18997632,18997632_D002110_D017180,18997632_0,bcv_easy_119_sent_work_dev_set_761593,yes_direct,770955552,TRUE,golden,14,,"












",no_relation,0.5434,TRUE,D008727,"<span class=""chemical"">methotrexate</span>",D056784,"<span class=""disease"">leukoencephalopathy</span>","BACKGROUND: A transient <span class=""disease"">leukoencephalopathy</span> mimicking cerebrovascular accident has been described as a complication of chemotherapy, most commonly in recipients of intrathecal <span class=""chemical"">methotrexate</span> for childhood leukaemia.",761593,17682013,17682013_D008727_D056784,17682013_1,bcv_easy_779_sent_work_dev_set_761593,yes_direct,770955553,TRUE,golden,17,,"















",yes_direct,0.8845,TRUE,C534628,"<span class=""chemical"">SCH 23390</span>",D002375,"<span class=""disease"">catalepsy</span>","D-1 agonist SKF 38393 or D-2 agonist quinpirole decreased the <span class=""disease"">catalepsy</span> induced by fluphenazine, <span class=""chemical"">SCH 23390</span> or sulpiride.",761593,1687392,1687392_C534628_D002375,1687392_8,bcv_easy_861_sent_work_dev_set_761593,yes_direct,770955554,TRUE,golden,13,,"











",yes_direct,0.7746,TRUE,D003630,"<span class=""chemical"">daunorubicin</span>",D015431,"<span class=""disease"">weight loss</span>","RESULTS: Nontoxic doses of dexrazoxane reduced myelosuppression and <span class=""disease"">weight loss</span> from <span class=""chemical"">daunorubicin</span> and etoposide in mice and antagonized their antiproliferative effects in the colony assay; however, dexrazoxane neither reduced myelosuppression, <span class=""disease"">weight loss</span>, nor the in vitro cytotoxicity from doxorubicin.",761593,15897593,15897593_D003630_D015431,15897593_5,bcv_easy_983_sent_work_dev_set_761593,yes_direct,770955555,TRUE,golden,9,,"







",yes_direct,0.6644,TRUE,D009020,"<span class=""chemical"">morphine</span>",D002375,"<span class=""disease"">cataleptic</span>","Pre-treatment with ketamine produced cross-tolerance to <span class=""chemical"">morphine</span>, whereas pretreatment with <span class=""chemical"">morphine</span> did not induce cross-tolerance to ketamine but rather augmented the <span class=""disease"">cataleptic</span> response; this augmentation was attributed to residual <span class=""chemical"">morphine</span> in the brain.",761593,2716967,2716967_D009020_D002375,2716967_2,bcv_easy_740_sent_work_dev_set_761593,yes_direct,770955556,TRUE,golden,12,,"










",yes_direct,1,TRUE,C033457,"<span class=""chemical"">Quinidine phenylethylbarbiturate</span>",D056486,"<span class=""disease"">hepatitis</span>","<span class=""chemical"">Quinidine phenylethylbarbiturate</span>-induced fulminant <span class=""disease"">hepatitis</span> in a pregnant woman. A case report.",761593,3411101,3411101_C033457_D056486,3411101_0,bcv_easy_1215_sent_work_dev_set_761593,yes_direct,770955557,TRUE,golden,11,,"









",yes_direct,0.8171,TRUE,D015742,"<span class=""chemical"">propofol</span>",D010146,"<span class=""disease"">pain</span>","We hypothesized that <span class=""chemical"">propofol</span> infusion <span class=""disease"">pain</span> might be prevented by infusing remifentanil before starting the <span class=""chemical"">propofol</span> infusion in a clinical setting where target-controlled infusions (TCI) of both drugs were used.",761593,18006530,18006530_D015742_D010146,18006530_2,bcv_easy_5_sent_work_dev_set_761593,yes_direct,770955558,TRUE,golden,17,,"















",yes_direct,0.767,TRUE,D013619,"<span class=""chemical"">Tacrine</span>",D001930,"<span class=""disease"">hippocampal damage</span>","<span class=""chemical"">Tacrine</span>, administered in LiCl pre-treated rats, induces electrocorticographic seizures and delayed <span class=""disease"">hippocampal damage</span>.",761593,19944736,19944736_D013619_D001930,19944736_3,bcv_easy_630_sent_work_dev_set_761593,yes_direct,770955559,TRUE,golden,9,,"







",yes_direct,1,TRUE,D009543,"<span class=""chemical"">nifedipine/Adalat</span>",D013684,"<span class=""disease"">telangiectasia</span>","Five months after starting <span class=""chemical"">nifedipine</span> (<span class=""chemical"">Adalat</span>), two patients developed photodistributed facial <span class=""disease"">telangiectasia</span>, which became more noticeable with time.",761593,8251368,8251368_D009543_D013684,8251368_1,bcv_easy_453_sent_work_dev_set_761593,yes_direct,770955560,TRUE,golden,7,,"





",yes_direct,0.5931,TRUE,D014859,"<span class=""chemical"">warfarin</span>",D018366,"<span class=""disease"">LV Cutaneous lesions</span>","The results of skin lesion biopsies were available in 3 patients, confirming <span class=""disease"">LV Cutaneous lesions</span> resolved in all patients after <span class=""chemical"">warfarin</span> was discontinued.",761593,16047871,16047871_D014859_D018366,16047871_5,bcv_easy_1184_sent_work_dev_set_761593,yes_direct,770955561,TRUE,golden,7,,"





",yes_direct,1,TRUE,D004837,"<span class=""chemical"">epinephrine</span>",D017202,"<span class=""disease"">myocardial ischemia</span>","Both <span class=""chemical"">epinephrine</span> and exercise produced <span class=""disease"">myocardial ischemia</span> as evidenced by ST segment depression and angina.",761593,3413271,3413271_D004837_D017202,3413271_3,bcv_easy_852_sent_work_dev_set_761593,yes_direct,770955562,TRUE,golden,11,,"


'Involved' being the key word.






",yes_direct,1,TRUE,D009569,"<span class=""chemical"">nitric oxide/NO</span>",D020326,"<span class=""disease"">migraine without aura</span>","In recent years, increasing evidence has suggested that the messenger molecule <span class=""chemical"">nitric oxide</span> (<span class=""chemical"">NO</span>) is involved in pain mechanisms of <span class=""disease"">migraine without aura</span>.",761593,10524660,10524660_D009569_D020326,10524660_2,bcv_easy_603_sent_work_dev_set_761593,yes_direct,770955563,TRUE,golden,12,,"










",yes_direct,1,TRUE,D001971,"<span class=""chemical"">bromocriptine</span>",D011605,"<span class=""disease"">psychosis</span>","These cases demonstrate that <span class=""chemical"">bromocriptine</span> may cause <span class=""disease"">psychosis</span> even when given in low doses.",761593,3686155,3686155_D001971_D011605,3686155_3,bcv_easy_561_sent_work_dev_set_761593,yes_direct,770955564,TRUE,golden,11,,"









",yes_direct,1,TRUE,C092292,"<span class=""chemical"">ziprasidone</span>",D009459,"<span class=""disease"">NMS</span>","This case is the earliest (second day of treatment) <span class=""disease"">NMS</span> due to <span class=""chemical"">ziprasidone</span> reported in the literature.",761593,17366349,17366349_C092292_D009459,17366349_5,bcv_easy_57_sent_work_dev_set_761593,yes_direct,770955565,TRUE,golden,9,,"







",yes_direct,1,TRUE,D003915,"<span class=""chemical"">DM</span>",D003072,"<span class=""disease"">cognitive deterioration</span>","This report describes a case of <span class=""disease"">cognitive deterioration</span> resulting from prolonged use of <span class=""chemical"">DM</span>.",761593,7803371,7803371_D003915_D003072,7803371_7,bcv_easy_1243_sent_work_dev_set_761593,yes_direct,770955566,TRUE,golden,9,,"







",yes_direct,1,TRUE,D016861,"<span class=""chemical"">cyclooxygenase inhibitors</span>",D006973,"<span class=""disease"">hypertension</span>","Randomised clinical trials and observational studies have shown an increased risk of myocardial infarction, stroke, <span class=""disease"">hypertension</span> and heart failure during treatment with <span class=""chemical"">cyclooxygenase inhibitors</span>.",761593,16586083,16586083_D016861_D006973,16586083_1,bcv_easy_1148_sent_work_dev_set_761593,yes_direct,770955567,TRUE,golden,5,,"



",yes_direct,1,TRUE,D002217,"<span class=""chemical"">carbachol</span>",D004830,"<span class=""disease"">clonic-tonic convulsions</span>","The effect of calcium chloride injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> produced by <span class=""chemical"">carbachol</span> and eserine injected similarly was investigated.",761593,6892185,6892185_D002217_D004830,6892185_1,bcv_easy_1038_sent_work_dev_set_761593,yes_direct,770955568,TRUE,golden,12,,"










",yes_direct,0.9119,TRUE,D007649,"<span class=""chemical"">ketamine</span>",D002375,"<span class=""disease"">catalepsy</span>","Previous studies demonstrated that both <span class=""chemical"">ketamine</span> and morphine induced analgesia and <span class=""disease"">catalepsy</span> in the rat.",761593,2716967,2716967_D007649_D002375,2716967_1,bcv_easy_736_sent_work_dev_set_761593,yes_direct,770955569,TRUE,golden,10,,"








",yes_direct,0.8979,TRUE,D010830,"<span class=""chemical"">eserine</span>",D015878,"<span class=""disease"">mydriasis</span>","It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions caused by carbachol and <span class=""chemical"">eserine</span>.",761593,6892185,6892185_D010830_D015878,6892185_4,bcv_easy_1058_sent_work_dev_set_761593,yes_direct,770955570,TRUE,golden,3,,"

",yes_direct,1,TRUE,D014147,"<span class=""chemical"">tramadol</span>",D006212,"<span class=""disease"">hallucinations</span>","Nightmares and <span class=""disease"">hallucinations</span> after long-term intake of <span class=""chemical"">tramadol</span> combined with antidepressants.",761593,8766220,8766220_D014147_D006212,8766220_0,bcv_easy_96_sent_work_dev_set_761593,yes_direct,770955571,TRUE,golden,11,,"









",yes_direct,0.9124,TRUE,D000638,"<span class=""chemical"">amiodarone</span>",D008103,"<span class=""disease"">cirrhosis of the liver</span>","It is concluded that solid evidence exists of hepatic injury due to <span class=""chemical"">amiodarone</span> treatment, including steatosis, alterations resembling alcoholic hepatitis, cholestatic hepatitis and micronodular <span class=""disease"">cirrhosis of the liver</span>.",761593,3962737,3962737_D000638_D008103,3962737_4,bcv_easy_289_sent_work_dev_set_761593,yes_direct,770955572,TRUE,golden,14,,"












",yes_direct,0.6423,TRUE,D001556,"<span class=""chemical"">alpha-benzene hexachloride</span>",D006528,"<span class=""disease"">hepatomas</span>","Peroxisomes in <span class=""disease"">hepatomas</span> and hyperplastic preneoplastic liver lesions induced in mice by 500 ppm <span class=""chemical"">alpha-benzene hexachloride</span> were examined histochemically and electron microscopically.",761593,85485,85485_D001556_D006528,85485_1,bcv_easy_379_sent_work_dev_set_761593,yes_direct,770955573,TRUE,golden,6,,"




",yes_direct,1,TRUE,D005283,"<span class=""chemical"">fentanyl</span>",D009127,"<span class=""disease"">rigidity</span>","Post-operative <span class=""disease"">rigidity</span> after <span class=""chemical"">fentanyl</span> administration.",761593,3780697,3780697_D005283_D009127,3780697_0,bcv_easy_785_sent_work_dev_set_761593,yes_direct,770955574,TRUE,golden,6,,"




",yes_direct,0.8478,TRUE,D005472,"<span class=""chemical"">5-fluorouracil</span>",D056784,"<span class=""disease"">leukoencephalopathy</span>","RESULTS: We identified 27 reports of toxic <span class=""disease"">leukoencephalopathy</span> in patients treated with methotrexate (intrathecal, systemic), <span class=""chemical"">5-fluorouracil</span> and its derivative carmofur, and capecitabine.",761593,17682013,17682013_D005472_D056784,17682013_6,bcv_easy_783_sent_work_dev_set_761593,yes_direct,770955575,TRUE,golden,10,,"








",yes_direct,0.8045,TRUE,D010830,"<span class=""chemical"">eserine</span>",D014202,"<span class=""disease"">tremor</span>","The effect of calcium chloride injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions produced by carbachol and <span class=""chemical"">eserine</span> injected similarly was investigated.",761593,6892185,6892185_D010830_D014202,6892185_1,bcv_easy_1041_sent_work_dev_set_761593,yes_direct,770955576,TRUE,golden,13,,"











",yes_direct,1,TRUE,D012293,"<span class=""chemical"">rifampicin</span>",D058186,"<span class=""disease"">Acute renal failure</span>","<span class=""disease"">Acute renal failure</span> subsequent to the administration of <span class=""chemical"">rifampicin</span>. A follow-up study of cases reported earlier.",761593,982002,982002_D012293_D058186,982002_0,bcv_easy_335_sent_work_dev_set_761593,yes_direct,770955577,TRUE,golden,5,,"



",yes_direct,1,TRUE,D010830,"<span class=""chemical"">eserine</span>",D014202,"<span class=""disease"">tremor</span>","It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions caused by carbachol and <span class=""chemical"">eserine</span>.",761593,6892185,6892185_D010830_D014202,6892185_4,bcv_easy_1059_sent_work_dev_set_761593,yes_direct,770955578,TRUE,golden,15,,"













",yes_direct,1,TRUE,D003276,"<span class=""chemical"">oral contraceptives</span>",D008113,"<span class=""disease"">liver tumors</span>","Etiologic factors in the pathogenesis of <span class=""disease"">liver tumors</span> associated with <span class=""chemical"">oral contraceptives</span>.",761593,188339,188339_D003276_D008113,188339_0,bcv_easy_421_sent_work_dev_set_761593,yes_direct,770955579,TRUE,golden,8,,"






",yes_direct,1,TRUE,D004737,"<span class=""chemical"">enflurane</span>",D056486,"<span class=""disease"">hepatic injury</span>","Two halogenated anesthetics, <span class=""chemical"">enflurane</span> and isoflurane, have been associated with an allergic-type <span class=""disease"">hepatic injury</span> both alone and following previous exposure to halothane.",761593,7647582,7647582_D004737_D056486,7647582_1,bcv_easy_910_sent_work_dev_set_761593,yes_direct,770955580,TRUE,golden,13,,"











",yes_direct,1,TRUE,D003975,"<span class=""chemical"">diazepam</span>",D001259,"<span class=""disease"">incoordination</span>","Both verapamil (10 mg/kg i.p.) and NH4Ac pretreatment enhanced morphine analgesia- and <span class=""chemical"">diazepam</span>-induced muscular <span class=""disease"">incoordination</span> and antagonized amphetamine-induced motor activity, and neither verapamil nor NH4Ac affected the convulsant action of metrazol.",761593,6323692,6323692_D003975_D001259,6323692_7,bcv_easy_372_sent_work_dev_set_761593,yes_direct,770955581,TRUE,golden,14,,"












",yes_direct,0.9314,TRUE,D004837,"<span class=""chemical"">epinephrine</span>",D017202,"<span class=""disease"">myocardial ischemia</span>","However, the mechanisms of <span class=""disease"">myocardial ischemia</span> induced by <span class=""chemical"">epinephrine</span> were significantly different from those of exercise.",761593,3413271,3413271_D004837_D017202,3413271_4,bcv_easy_853_sent_work_dev_set_761593,yes_direct,770955582,TRUE,golden,7,,"





",yes_direct,1,TRUE,D007649,"<span class=""chemical"">Ketamine</span>",D011605,"<span class=""disease"">psychosis</span>","<span class=""chemical"">Ketamine</span> elicited <span class=""disease"">psychosis</span> like psychopathology.",761593,20727411,20727411_D007649_D011605,20727411_7,bcv_easy_225_sent_work_dev_set_761593,yes_direct,770955583,TRUE,golden,8,,"






",yes_direct,1,TRUE,D015215,"<span class=""chemical"">AZT</span>",D002311,"<span class=""disease"">cardiac dilation</span>","In contrast, <span class=""chemical"">AZT</span>-treated FasL Tg mice developed <span class=""disease"">cardiac dilation</span> and depressed cardiac function in a dose-dependent manner, with concomitant inflammatory infiltration of both ventricles.",761593,17943461,17943461_D015215_D002311,17943461_6,bcv_easy_503_sent_work_dev_set_761593,yes_direct,770955584,TRUE,golden,10,,"








",yes_direct,0.9194,TRUE,D010068,"<span class=""chemical"">oxacillin</span>",D018366,"<span class=""disease"">Cutaneous leucocytoclastic vasculitis</span>","<span class=""disease"">Cutaneous leucocytoclastic vasculitis</span> associated with <span class=""chemical"">oxacillin</span>.",761593,11337188,11337188_D010068_D018366,11337188_0,bcv_easy_301_sent_work_dev_set_761593,yes_direct,770955585,TRUE,golden,10,,"








",yes_direct,0.726,TRUE,D004317,"<span class=""chemical"">doxorubicin/DXR/Adriamycin</span>",D009202,"<span class=""disease"">cardiomyopathy/myocardial disease/CM</span>","The <span class=""disease"">cardiomyopathy</span> (<span class=""disease"">CM</span>) produced by the anticancer drug <span class=""chemical"">doxorubicin</span> (<span class=""chemical"">DXR</span>) (<span class=""chemical"">Adriamycin</span>) provides a unique opportunity to analyze dose-effect and structure-function relationships during development of <span class=""disease"">myocardial disease</span>.",761593,7282516,7282516_D004317_D009202,7282516_1,bcv_easy_59_sent_work_dev_set_761593,yes_direct,770955586,TRUE,golden,8,,"






",yes_direct,1,TRUE,D003915,"<span class=""chemical"">dextromethorphan</span>",D003072,"<span class=""disease"">Cognitive deterioration</span>","<span class=""disease"">Cognitive deterioration</span> from long-term abuse of <span class=""chemical"">dextromethorphan</span>: a case report.",761593,7803371,7803371_D003915_D003072,7803371_0,bcv_easy_1242_sent_work_dev_set_761593,yes_direct,770955587,TRUE,golden,18,,"
















",yes_direct,0.8436,TRUE,C047426,"<span class=""chemical"">venlafaxine</span>",D020230,"<span class=""disease"">Serotonin syndrome</span>","<span class=""disease"">Serotonin syndrome</span> from <span class=""chemical"">venlafaxine</span>-tranylcypromine interaction.",761593,8888541,8888541_C047426_D020230,8888541_0,bcv_easy_1101_sent_work_dev_set_761593,yes_direct,770955588,TRUE,golden,12,,"










",yes_direct,0.9201,TRUE,D009288,"<span class=""chemical"">naproxen</span>",D007681,"<span class=""disease"">renal papillary necrosis/RPN</span>","A 31-year-old man with rheumatoid arthritis, who had previously been treated with sulindac, fenoprofen calcium, high dose salicylates and gold salts, developed <span class=""disease"">renal papillary necrosis</span> (<span class=""disease"">RPN</span>) 4 months after institution of <span class=""chemical"">naproxen</span> therapy.",761593,6699841,6699841_D009288_D007681,6699841_1,bcv_easy_1253_sent_work_dev_set_761593,yes_direct,770955589,TRUE,golden,12,,"







'Hypomania-like syndrome' and not just 'Hypomania'


",yes_direct,0.9178,TRUE,C076029,"<span class=""chemical"">olanzapine</span>",D001714,"<span class=""disease"">Hypomania</span>","<span class=""disease"">Hypomania</span>-like syndrome induced by <span class=""chemical"">olanzapine</span>.",761593,10565806,10565806_C076029_D001714,10565806_0,bcv_easy_126_sent_work_dev_set_761593,yes_direct,770955590,TRUE,golden,12,,"










",yes_direct,1,TRUE,D000728,"<span class=""chemical"">androgen</span>",D020181,"<span class=""disease"">obstructive sleep apnea syndrome</span>","Development of the <span class=""disease"">obstructive sleep apnea syndrome</span> must be considered a possible side effect of <span class=""chemical"">androgen</span> therapy.",761593,6732043,6732043_D000728_D020181,6732043_7,bcv_easy_1161_sent_work_dev_set_761593,yes_direct,770955591,TRUE,golden,14,,"












",yes_direct,1,TRUE,D005473,"<span class=""chemical"">fluoxetine hydrochloride</span>",D006966,"<span class=""disease"">hyperprolactinemia</span>","A murine model of adenomyosis: the effects of <span class=""disease"">hyperprolactinemia</span> induced by <span class=""chemical"">fluoxetine hydrochloride</span>, a selective serotonin reuptake inhibitor, on adenomyosis induction in Wistar albino rats.",761593,9098464,9098464_D005473_D006966,9098464_0,bcv_easy_1031_sent_work_dev_set_761593,yes_direct,770955592,TRUE,golden,11,,"









",yes_direct,0.6438,TRUE,D018967,"<span class=""chemical"">Risperidone</span>",D010468,"<span class=""disease"">visual disturbances</span>","<span class=""chemical"">Risperidone</span>-associated, benign transient <span class=""disease"">visual disturbances</span> in schizophrenic patients with a past history of LSD abuse.",761593,12013711,12013711_D018967_D010468,12013711_0,bcv_easy_149_sent_work_dev_set_761593,yes_direct,770955593,TRUE,golden,11,,"









",yes_direct,0.8349,TRUE,D005283,"<span class=""chemical"">fentanyl</span>",D009127,"<span class=""disease"">rigidity</span>","A case of thoraco-abdominal <span class=""disease"">rigidity</span> leading to respiratory failure is described in the post-operative period in an elderly patient who received a moderate dose of <span class=""chemical"">fentanyl</span>.",761593,3780697,3780697_D005283_D009127,3780697_1,bcv_easy_787_sent_work_dev_set_761593,yes_direct,770955594,TRUE,golden,13,,"











",yes_direct,0.8484,TRUE,D013619,"<span class=""chemical"">Tacrine</span>",D012640,"<span class=""disease"">seizures</span>","<span class=""chemical"">Tacrine</span>, administered in LiCl pre-treated rats, induces electrocorticographic <span class=""disease"">seizures</span> and delayed hippocampal damage.",761593,19944736,19944736_D013619_D012640,19944736_3,bcv_easy_629_sent_work_dev_set_761593,yes_direct,770955595,TRUE,golden,15,,"













",yes_direct,1,TRUE,D004837,"<span class=""chemical"">epinephrine</span>",D017202,"<span class=""disease"">myocardial ischemia</span>","Mechanisms of <span class=""disease"">myocardial ischemia</span> induced by <span class=""chemical"">epinephrine</span>: comparison with exercise-induced ischemia.",761593,3413271,3413271_D004837_D017202,3413271_0,bcv_easy_846_sent_work_dev_set_761593,yes_direct,770955596,TRUE,golden,11,,"






This is true.


",yes_direct,0.8178,TRUE,D004977,"<span class=""chemical"">Ethambutol</span>",D014786,"<span class=""disease"">visual loss</span>","INTRODUCTION: <span class=""chemical"">Ethambutol</span> is used in the treatment of tuberculosis, which is still prevalent in Southeast Asia, and can be associated with permanent <span class=""disease"">visual loss</span>.",761593,16710500,16710500_D004977_D014786,16710500_1,bcv_easy_339_sent_work_dev_set_761593,yes_direct,770955597,TRUE,golden,7,,"





",yes_direct,0.8546,TRUE,D005047,"<span class=""chemical"">Etoposide</span>",D009203,"<span class=""disease"">myocardial infarction</span>","<span class=""chemical"">Etoposide</span>-related <span class=""disease"">myocardial infarction</span>.",761593,7619765,7619765_D005047_D009203,7619765_0,bcv_easy_552_sent_work_dev_set_761593,yes_direct,770955598,TRUE,golden,13,,"











",yes_direct,0.6961,TRUE,D014191,"<span class=""chemical"">tranylcypromine</span>",D020230,"<span class=""disease"">serotonin syndrome</span>","We report a venlafaxine-MAOI interaction that resulted in the <span class=""disease"">serotonin syndrome</span> in a 23-y-old male who was taking <span class=""chemical"">tranylcypromine</span> for depression.",761593,8888541,8888541_D014191_D020230,8888541_4,bcv_easy_1109_sent_work_dev_set_761593,yes_direct,770955599,TRUE,golden,14,,"












",yes_direct,0.8545,TRUE,D018817,"<span class=""chemical"">MDMA</span>",D008569,"<span class=""disease"">impaired memory functioning/memory impairments</span>","While the use of <span class=""chemical"">MDMA</span> in quantities that may be considered ""moderate"" is not associated with <span class=""disease"">impaired memory functioning</span>, heavy use of <span class=""chemical"">MDMA</span> use may lead to long lasting <span class=""disease"">memory impairments</span>.",761593,16574713,16574713_D018817_D008569,16574713_10,bcv_easy_317_sent_work_dev_set_761593,yes_direct,770955600,TRUE,golden,12,,"










",yes_direct,0.9193,TRUE,D008012,"<span class=""chemical"">lidocaine</span>",D012640,"<span class=""disease"">seizures</span>","Chronic carbamazepine inhibits the development of local anesthetic <span class=""disease"">seizures</span> kindled by cocaine and <span class=""chemical"">lidocaine</span>.",761593,2790457,2790457_D008012_D012640,2790457_0,bcv_easy_682_sent_work_dev_set_761593,yes_direct,770955601,TRUE,golden,7,,"





",yes_direct,1,TRUE,D008625,"<span class=""chemical"">Tiopronin</span>",D009393,"<span class=""disease"">nephritis</span>","A strong association has been found between <span class=""disease"">nephritis</span> and dermatitis due to <span class=""chemical"">Tiopronin</span> (a D-Penicillamine like compound) and class I antigens B35-Cw4, and between dermatitis due to gold thiosulphate and B35.",761593,3084782,3084782_D008625_D009393,3084782_2,bcv_easy_670_sent_work_dev_set_761593,yes_direct,770955602,TRUE,golden,15,,"













",yes_direct,0.8652,TRUE,D000643,"<span class=""chemical"">NH4CL</span>",D003128,"<span class=""disease"">coma</span>","Ammonia <span class=""disease"">coma</span> was produced in rats within 10 to 15 minutes of an intraperitonealinjection of 1.7 mmol <span class=""chemical"">NH4CL</span>.",761593,761833,761833_D000643_D003128,761833_1,bcv_easy_457_sent_work_dev_set_761593,yes_direct,770955603,TRUE,golden,8,,"






",yes_direct,1,TRUE,D017963,"<span class=""chemical"">azithromycin</span>",D006606,"<span class=""disease"">hiccups</span>","Possible <span class=""chemical"">azithromycin</span>-associated <span class=""disease"">hiccups</span>.",761593,15985056,15985056_D017963_D006606,15985056_0,bcv_easy_815_sent_work_dev_set_761593,yes_direct,770955604,TRUE,golden,8,,"






",yes_direct,0.7541,TRUE,D013390,"<span class=""chemical"">succinylcholine</span>",D001049,"<span class=""disease"">apnoea</span>","Fifteen patients demonstrating unexpected prolonged <span class=""disease"">apnoea</span> lasting several hours after <span class=""chemical"">succinylcholine</span> have been treated by a new preparation of human serum cholinesterase.",761593,871943,871943_D013390_D001049,871943_1,bcv_easy_207_sent_work_dev_set_761593,yes_direct,770955605,TRUE,golden,9,,"







",yes_direct,1,TRUE,D000319,"<span class=""chemical"">beta-adrenergic blocking drugs</span>",D006333,"<span class=""disease"">cardiac failure</span>","Three patients with ischaemic heart disease developed profound <span class=""disease"">cardiac failure</span>, hypotension and bradycardia during combined therapy with verapamil and <span class=""chemical"">beta-adrenergic blocking drugs</span>.",761593,6127992,6127992_D000319_D006333,6127992_1,bcv_easy_471_sent_work_dev_set_761593,yes_direct,770955606,TRUE,golden,15,,"













",yes_direct,0.8676,TRUE,C047426,"<span class=""chemical"">venlafaxine</span>",D020230,"<span class=""disease"">serotonin syndrome</span>","We report a <span class=""chemical"">venlafaxine</span>-MAOI interaction that resulted in the <span class=""disease"">serotonin syndrome</span> in a 23-y-old male who was taking tranylcypromine for depression.",761593,8888541,8888541_C047426_D020230,8888541_4,bcv_easy_1110_sent_work_dev_set_761593,yes_direct,770955607,TRUE,golden,13,,"











",yes_direct,0.9231,TRUE,D006220,"<span class=""chemical"">Haloperidol</span>",D003072,"<span class=""disease"">cognitive impairment</span>","CONCLUSION: <span class=""chemical"">Haloperidol</span> produced a clear profile of <span class=""disease"">cognitive impairment</span> that was not worsened by concomitant sertraline administration.",761593,8617710,8617710_D006220_D003072,8617710_11,bcv_easy_1194_sent_work_dev_set_761593,yes_direct,770955608,TRUE,golden,9,,"







",yes_direct,1,TRUE,D010830,"<span class=""chemical"">eserine</span>",D004830,"<span class=""disease"">clonic-tonic convulsions</span>","It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> caused by carbachol and <span class=""chemical"">eserine</span>.",761593,6892185,6892185_D010830_D004830,6892185_4,bcv_easy_1061_sent_work_dev_set_761593,yes_direct,770955609,TRUE,golden,10,,"








",yes_direct,1,TRUE,D004917,"<span class=""chemical"">erythromycin</span>",D016171,"<span class=""disease"">torsades de pointes</span>","Prolongation of QT interval, <span class=""disease"">torsades de pointes</span>, and sudden cardiac death have been reported after concomitant administration with <span class=""chemical"">erythromycin</span> or azole antifungal agents, but not with other CYP3A4 inhibitors.",761593,9545159,9545159_D004917_D016171,9545159_2,bcv_easy_259_sent_work_dev_set_761593,yes_direct,770955610,TRUE,golden,10,,"








",yes_direct,0.901,TRUE,D004041,"<span class=""chemical"">fat</span>",D009765,"<span class=""disease"">obesity</span>","In the current study, we investigated whether a physiological intervention by feeding 40% high <span class=""chemical"">fat</span> diet (HFD), which induces <span class=""disease"">obesity</span> in male Sprague-Dawley rats (250-275 g), sensitizes to doxorubicin-induced cardiotoxicity.",761593,18674790,18674790_D004041_D009765,18674790_4,bcv_easy_871_sent_work_dev_set_761593,yes_direct,770955611,TRUE,golden,7,,"





",yes_direct,1,TRUE,D001971,"<span class=""chemical"">Bromocriptine</span>",D011605,"<span class=""disease"">psychosis</span>","<span class=""chemical"">Bromocriptine</span> given in high doses has been associated with <span class=""disease"">psychosis</span> in patients receiving the drug for Parkinson's disease.",761593,3686155,3686155_D001971_D011605,3686155_2,bcv_easy_559_sent_work_dev_set_761593,yes_direct,770955612,TRUE,golden,11,,"









",yes_direct,0.8318,TRUE,D007538,"<span class=""chemical"">isoniazid</span>",D009901,"<span class=""disease"">Bilateral optic neuropathy</span>","<span class=""disease"">Bilateral optic neuropathy</span> due to combined ethambutol and <span class=""chemical"">isoniazid</span> treatment.",761593,384871,384871_D007538_D009901,384871_0,bcv_easy_569_sent_work_dev_set_761593,yes_direct,770955613,TRUE,golden,11,,"









",yes_direct,0.914,TRUE,D004917,"<span class=""chemical"">erythromycin</span>",D016757,"<span class=""disease"">sudden cardiac death</span>","Prolongation of QT interval, torsades de pointes, and <span class=""disease"">sudden cardiac death</span> have been reported after concomitant administration with <span class=""chemical"">erythromycin</span> or azole antifungal agents, but not with other CYP3A4 inhibitors.",761593,9545159,9545159_D004917_D016757,9545159_2,bcv_easy_257_sent_work_dev_set_761593,yes_direct,770955614,TRUE,golden,5,,"



",yes_direct,0.63,TRUE,D016685,"<span class=""chemical"">Mitomycin C</span>",D006463,"<span class=""disease"">Hemolytic Uremic Syndrome/HUS</span>","<span class=""chemical"">Mitomycin C</span> associated <span class=""disease"">Hemolytic Uremic Syndrome</span> (<span class=""disease"">HUS</span>) is a potentially fatal but uncommon condition that is not yet widely recognised.",761593,3108839,3108839_D016685_D006463,3108839_1,bcv_easy_798_sent_work_dev_set_761593,yes_direct,770955615,TRUE,golden,8,,"






",yes_direct,1,TRUE,D008775,"<span class=""chemical"">methylprednisolone</span>",D006323,"<span class=""disease"">asystole</span>","Hypotension, bradycardia, and <span class=""disease"">asystole</span> after high-dose intravenous <span class=""chemical"">methylprednisolone</span> in a monitored patient.",761593,10074612,10074612_D008775_D006323,10074612_0,bcv_easy_1085_sent_work_dev_set_761593,yes_direct,770955616,TRUE,golden,12,,"










",yes_direct,0.9258,TRUE,D014635,"<span class=""chemical"">sodium valproate/VPA</span>",D007177,"<span class=""disease"">SIADH/syndrome of inappropriate secretion of antidiuretic hormone</span>","We report the case of a 62-year-old man who was administered <span class=""chemical"">sodium valproate</span> (<span class=""chemical"">VPA</span>) and who subsequently developed the <span class=""disease"">syndrome of inappropriate secretion of antidiuretic hormone</span> (<span class=""disease"">SIADH</span>).",761593,11195262,11195262_D014635_D007177,11195262_1,bcv_easy_159_sent_work_dev_set_761593,yes_direct,770955617,TRUE,golden,7,,"





",yes_direct,0.8723,TRUE,D014700,"<span class=""chemical"">verapamil</span>",D001919,"<span class=""disease"">bradycardia</span>","Three patients with ischaemic heart disease developed profound cardiac failure, hypotension and <span class=""disease"">bradycardia</span> during combined therapy with <span class=""chemical"">verapamil</span> and beta-adrenergic blocking drugs.",761593,6127992,6127992_D014700_D001919,6127992_1,bcv_easy_476_sent_work_dev_set_761593,yes_direct,770955618,TRUE,golden,11,,"









",yes_direct,1,TRUE,D001556,"<span class=""chemical"">alpha-benzene hexachloride</span>",D006528,"<span class=""disease"">hepatoma</span>","Changes in peroxisomes in preneoplastic liver and <span class=""disease"">hepatoma</span> of mice induced by <span class=""chemical"">alpha-benzene hexachloride</span>.",761593,85485,85485_D001556_D006528,85485_0,bcv_easy_378_sent_work_dev_set_761593,yes_direct,770955619,TRUE,golden,9,,"







",yes_direct,0.8949,TRUE,D013866,"<span class=""chemical"">6-thioguanine</span>",D006504,"<span class=""disease"">veno-occlusive disease of the liver</span>","Clinically reversible <span class=""disease"">veno-occlusive disease of the liver</span> developed in a 23-year-old man with acute lymphocytic leukemia after 10 months of maintenance therapy with <span class=""chemical"">6-thioguanine</span>.",761593,7053705,7053705_D013866_D006504,7053705_1,bcv_easy_1213_sent_work_dev_set_761593,yes_direct,770955620,TRUE,golden,10,,"








",yes_direct,1,TRUE,D010672,"<span class=""chemical"">diphenylhydantoin/DPH</span>",D002526,"<span class=""disease"">cerebellar dysfunction</span>","Among the common side effects of <span class=""chemical"">diphenylhydantoin</span> (<span class=""chemical"">DPH</span>) overdose, the most frequently encountered neurological signs are those of <span class=""disease"">cerebellar dysfunction</span>.",761593,430165,430165_D010672_D002526,430165_1,bcv_easy_592_sent_work_dev_set_761593,yes_direct,770955621,TRUE,golden,11,,"









",yes_direct,0.823,TRUE,C092292,"<span class=""chemical"">ziprasidone</span>",D009459,"<span class=""disease"">NMS</span>","Although conventional neuroleptics are more frequently associated with <span class=""disease"">NMS</span>, atypical antipsychotic drugs like <span class=""chemical"">ziprasidone</span> may also be a cause.",761593,17366349,17366349_C092292_D009459,17366349_3,bcv_easy_54_sent_work_dev_set_761593,yes_direct,770955622,TRUE,golden,10,,"








",yes_direct,0.9096,TRUE,D004317,"<span class=""chemical"">doxorubicin</span>",D006331,"<span class=""disease"">cardiac dysfunction</span>","A LD(10) dose (8 mg <span class=""chemical"">doxorubicin</span>/kg, ip) administered on day 43 of the HFD feeding regimen led to higher cardiotoxicity, <span class=""disease"">cardiac dysfunction</span>, lipid peroxidation, and 80% mortality in the obese (OB) rats in the absence of any significant renal or hepatic toxicity.",761593,18674790,18674790_D004317_D006331,18674790_5,bcv_easy_875_sent_work_dev_set_761593,yes_direct,770955623,TRUE,golden,11,,"









",yes_direct,1,TRUE,D010672,"<span class=""chemical"">DPH</span>",D010291,"<span class=""disease"">hemiparesis</span>","Two patients are presented who suffered progressive <span class=""disease"">hemiparesis</span> due to <span class=""chemical"">DPH</span> overdose.",761593,430165,430165_D010672_D010291,430165_3,bcv_easy_595_sent_work_dev_set_761593,yes_direct,770955624,TRUE,golden,12,,"










",yes_direct,0.92,TRUE,C092292,"<span class=""chemical"">ziprasidone</span>",D009459,"<span class=""disease"">NMS</span>","The patient is a 24-year-old male with a history of schizophrenia who developed signs and symptoms of <span class=""disease"">NMS</span> after 2 days of treatment with an 80-mg/day dose of orally administrated <span class=""chemical"">ziprasidone</span>.",761593,17366349,17366349_C092292_D009459,17366349_4,bcv_easy_55_sent_work_dev_set_761593,yes_direct,770955625,TRUE,golden,14,,"












",yes_direct,1,TRUE,D007530,"<span class=""chemical"">Isoflurane</span>",D002779|D056486,"<span class=""disease"">cholestatic hepatitis</span>","CONCLUSIONS: <span class=""chemical"">Isoflurane</span>, a common anesthetic agent, can cause severe <span class=""disease"">cholestatic hepatitis</span>.",761593,11847945,11847945_D007530_D002779|D056486,11847945_9,bcv_easy_118_sent_work_dev_set_761593,yes_direct,770955626,TRUE,golden,7,,"





",yes_direct,1,TRUE,D000728,"<span class=""chemical"">androgen</span>",D020181,"<span class=""disease"">obstructive sleep apnea</span>","A rechallenge with <span class=""chemical"">androgen</span> produced symptoms of <span class=""disease"">obstructive sleep apnea</span> that abated upon withdrawal of the hormone.",761593,6732043,6732043_D000728_D020181,6732043_3,bcv_easy_1159_sent_work_dev_set_761593,yes_direct,770955627,TRUE,golden,12,,"










",yes_direct,1,TRUE,D016861,"<span class=""chemical"">cyclooxygenase inhibitors</span>",D009203,"<span class=""disease"">myocardial infarction</span>","Randomised clinical trials and observational studies have shown an increased risk of <span class=""disease"">myocardial infarction</span>, stroke, hypertension and heart failure during treatment with <span class=""chemical"">cyclooxygenase inhibitors</span>.",761593,16586083,16586083_D016861_D009203,16586083_1,bcv_easy_1149_sent_work_dev_set_761593,yes_direct,770955628,TRUE,golden,12,,"










",yes_direct,0.8455,TRUE,D010830,"<span class=""chemical"">eserine</span>",D015878,"<span class=""disease"">mydriasis</span>","On the other hand, <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions evoked by carbachol and <span class=""chemical"">eserine</span> were not significantly changed by calcium chloride.",761593,6892185,6892185_D010830_D015878,6892185_3,bcv_easy_1050_sent_work_dev_set_761593,yes_direct,770955629,TRUE,golden,8,,"






",yes_direct,1,TRUE,D011718,"<span class=""chemical"">pyrazinamide</span>",D000857,"<span class=""disease"">dysosmia</span>","Recurrent <span class=""disease"">dysosmia</span> induced by <span class=""chemical"">pyrazinamide</span>.",761593,19674115,19674115_D011718_D000857,19674115_0,bcv_easy_665_sent_work_dev_set_761593,yes_direct,770955630,TRUE,golden,8,,"






",yes_direct,1,TRUE,D002701,"<span class=""chemical"">chloramphenicol</span>",D000741,"<span class=""disease"">aplastic anemia</span>","This was the second report of fatal <span class=""disease"">aplastic anemia</span> after topical treatment with <span class=""chemical"">chloramphenicol</span> for ocular conditions, although two cases of reversible bone marrow hypoplasia have also been reported.",761593,7072798,7072798_D002701_D000741,7072798_4,bcv_easy_177_sent_work_dev_set_761593,yes_direct,770955631,TRUE,golden,9,,"







",yes_direct,1,TRUE,D010634,"<span class=""chemical"">PB</span>",D008107,"<span class=""disease"">liver damage</span>","Our findings illustrate that <span class=""chemical"">PB</span> may be associated with chronic <span class=""disease"">liver damage</span>, which may lead to more serious and deleterious consequences.",761593,17574447,17574447_D010634_D008107,17574447_5,bcv_easy_1208_sent_work_dev_set_761593,yes_direct,770955632,TRUE,golden,13,,"











",yes_direct,0.6918,TRUE,D014191,"<span class=""chemical"">tranylcypromine</span>",D020230,"<span class=""disease"">Serotonin syndrome</span>","<span class=""disease"">Serotonin syndrome</span> from venlafaxine-<span class=""chemical"">tranylcypromine</span> interaction.",761593,8888541,8888541_D014191_D020230,8888541_0,bcv_easy_1100_sent_work_dev_set_761593,yes_direct,770955633,TRUE,golden,9,,"







",yes_direct,0.6596,TRUE,D005476,"<span class=""chemical"">fluphenazine</span>",D002375,"<span class=""disease"">catalepsy</span>","Dopamine antagonist <span class=""chemical"">fluphenazine</span>, D-1 antagonist SCH 23390 or D-2 antagonist sulpiride induced <span class=""disease"">catalepsy</span>.",761593,1687392,1687392_D005476_D002375,1687392_4,bcv_easy_858_sent_work_dev_set_761593,yes_direct,770955634,TRUE,golden,8,,"






",yes_direct,1,TRUE,D011718,"<span class=""chemical"">pyrazinamide</span>",D000857,"<span class=""disease"">olfactory disorder</span>","We report a case of reversible <span class=""disease"">olfactory disorder</span> related to <span class=""chemical"">pyrazinamide</span> in a woman, with a positive rechallenge.",761593,19674115,19674115_D011718_D000857,19674115_3,bcv_easy_668_sent_work_dev_set_761593,yes_direct,770955635,TRUE,golden,13,,"











",yes_direct,1,TRUE,D010665,"<span class=""chemical"">Phenylpropanolamine/Dexatrim</span>",D009203,"<span class=""disease"">myocardial infarction</span>","Case report: <span class=""chemical"">Dexatrim</span> (<span class=""chemical"">Phenylpropanolamine</span>) as a cause of <span class=""disease"">myocardial infarction</span>.",761593,12734532,12734532_D010665_D009203,12734532_0,bcv_easy_598_sent_work_dev_set_761593,yes_direct,770955636,TRUE,golden,13,,"











",yes_direct,0.9274,TRUE,D002217,"<span class=""chemical"">carbachol</span>",D004830,"<span class=""disease"">clonic-tonic convulsions</span>","On the other hand, mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> evoked by <span class=""chemical"">carbachol</span> and eserine were not significantly changed by calcium chloride.",761593,6892185,6892185_D002217_D004830,6892185_3,bcv_easy_1048_sent_work_dev_set_761593,yes_direct,770955637,TRUE,golden,12,,"







Oral Contraception is not a Chemical.


",yes_direct,0.9191,TRUE,D003276,"<span class=""chemical"">oral contraception</span>",D002819,"<span class=""disease"">Chorea</span>","<span class=""disease"">Chorea</span> associated with <span class=""chemical"">oral contraception</span>.",761593,3123611,3123611_D003276_D002819,3123611_0,bcv_easy_388_sent_work_dev_set_761593,yes_direct,770955638,TRUE,golden,13,,"











",yes_direct,0.9267,TRUE,D018967,"<span class=""chemical"">risperidone</span>",D010468,"<span class=""disease"">visual disturbances</span>","They both reported short episodes of transient <span class=""disease"">visual disturbances</span>, which appeared immediately after starting treatment with <span class=""chemical"">risperidone</span>.",761593,12013711,12013711_D018967_D010468,12013711_2,bcv_easy_155_sent_work_dev_set_761593,yes_direct,770955639,TRUE,golden,12,,"










",yes_direct,0.842,TRUE,C047781,"<span class=""chemical"">LTG</span>",D009207,"<span class=""disease"">MJ</span>","In three patients, <span class=""chemical"">LTG</span> exacerbated <span class=""disease"">MJ</span> in a dose-dependent manner with early aggravation during titration.",761593,16157917,16157917_C047781_D009207,16157917_2,bcv_easy_1008_sent_work_dev_set_761593,yes_direct,770955640,TRUE,golden,11,,"









",yes_direct,0.8167,TRUE,C047781,"<span class=""chemical"">LTG</span>",D009207,"<span class=""disease"">myoclonic status/MJ</span>","In two patients, <span class=""chemical"">LTG</span> exacerbated <span class=""disease"">MJ</span> in a delayed but more severe manner, with <span class=""disease"">myoclonic status</span> that only ceased after <span class=""chemical"">LTG</span> withdrawal.",761593,16157917,16157917_C047781_D009207,16157917_4,bcv_easy_1010_sent_work_dev_set_761593,yes_direct,770955641,TRUE,golden,8,,"






",yes_direct,1,TRUE,D003520,"<span class=""chemical"">Cyclophosphamide</span>",D001749,"<span class=""disease"">bladder cancer</span>","<span class=""chemical"">Cyclophosphamide</span> associated <span class=""disease"">bladder cancer</span>--a highly aggressive disease: analysis of 12 cases.",761593,8911359,8911359_D003520_D001749,8911359_0,bcv_easy_433_sent_work_dev_set_761593,yes_direct,770955642,TRUE,golden,17,,"















",yes_direct,0.8799,TRUE,D002217,"<span class=""chemical"">carbachol</span>",D014202,"<span class=""disease"">tremor</span>","The effect of calcium chloride injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions produced by <span class=""chemical"">carbachol</span> and eserine injected similarly was investigated.",761593,6892185,6892185_D002217_D014202,6892185_1,bcv_easy_1037_sent_work_dev_set_761593,yes_direct,770955643,TRUE,golden,9,,"







",yes_direct,0.8824,TRUE,D010396,"<span class=""chemical"">D-penicillamine</span>",D017285,"<span class=""disease"">polymyositis</span>","We report a patient with primary biliary cirrhosis, who developed <span class=""disease"">polymyositis</span> while receiving <span class=""chemical"">D-penicillamine</span> therapy.",761593,8268147,8268147_D010396_D017285,8268147_3,bcv_easy_837_sent_work_dev_set_761593,yes_direct,770955644,TRUE,golden,10,,"








",yes_direct,0.9049,TRUE,D002701,"<span class=""chemical"">chloramphenicol</span>",D000741,"<span class=""disease"">aplastic anemia</span>","A 73-year-old woman died of <span class=""disease"">aplastic anemia</span> less than two months after undergoing cataract extraction and beginning topical therapy with <span class=""chemical"">chloramphenicol</span>.",761593,7072798,7072798_D002701_D000741,7072798_1,bcv_easy_174_sent_work_dev_set_761593,yes_direct,770955645,TRUE,golden,11,,"









",yes_direct,1,TRUE,D001393,"<span class=""chemical"">azole</span>",D016757,"<span class=""disease"">sudden cardiac death</span>","Prolongation of QT interval, torsades de pointes, and <span class=""disease"">sudden cardiac death</span> have been reported after concomitant administration with erythromycin or <span class=""chemical"">azole</span> antifungal agents, but not with other CYP3A4 inhibitors.",761593,9545159,9545159_D001393_D016757,9545159_2,bcv_easy_260_sent_work_dev_set_761593,yes_direct,770955646,TRUE,golden,10,,"








",yes_direct,0.6087,TRUE,D008094,"<span class=""chemical"">lithium</span>",D054537,"<span class=""disease"">atrioventricular (AV) block</span>","In the present case, complete <span class=""disease"">atrioventricular (AV) block</span> with syncopal attacks developed secondary to <span class=""chemical"">lithium</span> therapy, necessitating permanent pacemaker implantation.",761593,18441470,18441470_D008094_D054537,18441470_2,bcv_easy_531_sent_work_dev_set_761593,yes_direct,770955647,TRUE,golden,6,,"




",yes_direct,1,TRUE,D003907,"<span class=""chemical"">dexamethasone</span>",D009422,"<span class=""disease"">neurological dysfunctions</span>","After <span class=""chemical"">dexamethasone</span> treatment, children showed a higher rate of minor <span class=""disease"">neurological dysfunctions</span>.",761593,15814210,15814210_D003907_D009422,15814210_11,bcv_easy_1259_sent_work_dev_set_761593,yes_direct,770955648,TRUE,golden,4,,"


",yes_direct,1,TRUE,D016861,"<span class=""chemical"">cyclooxygenase inhibitors</span>",D006333,"<span class=""disease"">heart failure</span>","Randomised clinical trials and observational studies have shown an increased risk of myocardial infarction, stroke, hypertension and <span class=""disease"">heart failure</span> during treatment with <span class=""chemical"">cyclooxygenase inhibitors</span>.",761593,16586083,16586083_D016861_D006333,16586083_1,bcv_easy_1146_sent_work_dev_set_761593,yes_direct,770955649,TRUE,golden,10,,"








",yes_direct,0.8996,TRUE,D005839,"<span class=""chemical"">gentamicin</span>",D058186,"<span class=""disease"">acute renal failure</span>","In this study we postulated that during <span class=""disease"">acute renal failure</span> induced by <span class=""chemical"">gentamicin</span> the transient or dynamic response of blood vessels could be affected, and that antioxidants can prevent the changes in dynamic responses of blood vessels.",761593,19893084,19893084_D005839_D058186,19893084_1,bcv_easy_324_sent_work_dev_set_761593,yes_direct,770955650,TRUE,golden,9,,"







",yes_direct,0.785,TRUE,D000324,"<span class=""chemical"">ACTH</span>",D004421,"<span class=""disease"">dystonia</span>","A <span class=""disease"">dystonia</span>-like syndrome after neuropeptide (MSH/<span class=""chemical"">ACTH</span>) stimulation of the rat locus ceruleus.",761593,2840807,2840807_D000324_D004421,2840807_0,bcv_easy_492_sent_work_dev_set_761593,yes_direct,770955651,TRUE,golden,16,,"














",yes_direct,0.8124,TRUE,D000728,"<span class=""chemical"">androgens</span>",D020181,"<span class=""disease"">syndrome of obstructive sleep apnea</span>","We documented airway occlusion during sleep and an abnormally high supraglottic resistance while awake in a 54-yr-old woman who had developed physical changes and the <span class=""disease"">syndrome of obstructive sleep apnea</span> while being administered exogenous <span class=""chemical"">androgens</span>.",761593,6732043,6732043_D000728_D020181,6732043_1,bcv_easy_1158_sent_work_dev_set_761593,yes_direct,770955652,TRUE,golden,11,,"









",yes_direct,0.8239,TRUE,D006220,"<span class=""chemical"">haloperidol</span>",D003072,"<span class=""disease"">Impairment of cognitive function</span>","RESULTS: <span class=""disease"">Impairment of cognitive function</span> was observed 6 to 8 hours after administration of <span class=""chemical"">haloperidol</span> on Day 2 but was not evident 23 hours after dosing.",761593,8617710,8617710_D006220_D003072,8617710_5,bcv_easy_1193_sent_work_dev_set_761593,yes_direct,770955653,TRUE,golden,11,,"









",yes_direct,1,TRUE,D008094,"<span class=""chemical"">lithium</span>",D012804,"<span class=""disease"">Sinus node dysfunction</span>","<span class=""disease"">Sinus node dysfunction</span> has been reported most frequently among the adverse cardiovascular effects of <span class=""chemical"">lithium</span>.",761593,18441470,18441470_D008094_D012804,18441470_1,bcv_easy_530_sent_work_dev_set_761593,yes_direct,770955654,TRUE,golden,8,,"






",yes_direct,0.8828,TRUE,D014635,"<span class=""chemical"">sodium valproate</span>",D007177,"<span class=""disease"">syndrome of inappropriate secretion of antidiuretic hormone</span>","Contribution of <span class=""chemical"">sodium valproate</span> to the <span class=""disease"">syndrome of inappropriate secretion of antidiuretic hormone</span>.",761593,11195262,11195262_D014635_D007177,11195262_0,bcv_easy_158_sent_work_dev_set_761593,yes_direct,770955655,TRUE,golden,9,,"







",yes_direct,0.8951,TRUE,D008012,"<span class=""chemical"">lidocaine</span>",D009135,"<span class=""disease"">muscle damage</span>","In addition to <span class=""disease"">muscle damage</span>, severe damage was also seen in harderian glands, especially after exposure to mepivacaine and <span class=""chemical"">lidocaine</span> plus epinephrine.",761593,4038130,4038130_D008012_D009135,4038130_5,bcv_easy_397_sent_work_dev_set_761593,yes_direct,770955656,TRUE,golden,7,,"





",yes_direct,0.8684,TRUE,D010396,"<span class=""chemical"">D-penicillamine</span>",D005921,"<span class=""disease"">glomerulonephritis/RPGN</span>","A 67-year-old woman with rheumatoid arthritis presented rapidly progressive <span class=""disease"">glomerulonephritis</span> (<span class=""disease"">RPGN</span>) after 5 months of <span class=""chemical"">D-penicillamine</span> (250 mg/day) treatment.",761593,8267029,8267029_D010396_D005921,8267029_1,bcv_easy_499_sent_work_dev_set_761593,yes_direct,770955657,TRUE,golden,12,,"










",yes_direct,1,TRUE,D014700,"<span class=""chemical"">verapamil</span>",D006333,"<span class=""disease"">cardiac failure</span>","Three patients with ischaemic heart disease developed profound <span class=""disease"">cardiac failure</span>, hypotension and bradycardia during combined therapy with <span class=""chemical"">verapamil</span> and beta-adrenergic blocking drugs.",761593,6127992,6127992_D014700_D006333,6127992_1,bcv_easy_473_sent_work_dev_set_761593,yes_direct,770955658,TRUE,golden,8,,"






",yes_direct,1,TRUE,D007530,"<span class=""chemical"">isoflurane</span>",D002779|D056486,"<span class=""disease"">cholestatic hepatitis</span>","Acute <span class=""disease"">cholestatic hepatitis</span> after exposure to <span class=""chemical"">isoflurane</span>.",761593,11847945,11847945_D007530_D002779|D056486,11847945_0,bcv_easy_115_sent_work_dev_set_761593,yes_direct,770955659,TRUE,golden,5,,"



",yes_direct,1,TRUE,D015119,"<span class=""chemical"">epsilon-aminocaproic acid</span>",D020225|D020227,"<span class=""disease"">sagittal and left transverse sinus thrombosis</span>","We describe a 42-year-old woman who developed superior <span class=""disease"">sagittal and left transverse sinus thrombosis</span> associated with prolonged <span class=""chemical"">epsilon-aminocaproic acid</span> therapy for menorrhagia.",761593,2339463,2339463_D015119_D020225|D020227,2339463_1,bcv_easy_209_sent_work_dev_set_761593,yes_direct,770955660,TRUE,golden,12,,"










",yes_direct,0.8399,TRUE,D002217,"<span class=""chemical"">carbachol</span>",D015878,"<span class=""disease"">mydriasis</span>","It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions caused by <span class=""chemical"">carbachol</span> and eserine.",761593,6892185,6892185_D002217_D015878,6892185_4,bcv_easy_1060_sent_work_dev_set_761593,yes_direct,770955661,TRUE,golden,9,,"







",yes_direct,0.903,TRUE,D014640,"<span class=""chemical"">vancomycin</span>",D006311,"<span class=""disease"">ototoxicity</span>","Thrombophlebitis occurred only with infusion through peripheral cannulae; nephrotoxicity and <span class=""disease"">ototoxicity</span> were confined to patients receiving an aminoglycoside plus <span class=""chemical"">vancomycin</span>.",761593,3934126,3934126_D014640_D006311,3934126_5,bcv_easy_1144_sent_work_dev_set_761593,yes_direct,770955662,TRUE,golden,9,,"







",yes_direct,1,TRUE,D002752,"<span class=""chemical"">chlorthalidone</span>",D018879,"<span class=""disease"">ventricular ectopic beats</span>","Compared to amiloride treatment, the <span class=""chemical"">chlorthalidone</span> phase was associated with an increased frequency of <span class=""disease"">ventricular ectopic beats</span> (24-hour Holter monitoring) and a higher Lown grading, increased upslope and duration of the monophasic action potential, prolonged ventricular effective refractory period, and increased electrical instability during programmed ventricular stimulation.",761593,3732088,3732088_D002752_D018879,3732088_6,bcv_easy_23_sent_work_dev_set_761593,yes_direct,770955663,TRUE,golden,11,,"





Side effect



",yes_direct,1,TRUE,D002927,"<span class=""chemical"">cimetidine</span>",D007172,"<span class=""disease"">impotence</span>","Sixty percent of the males developed breast changes or <span class=""disease"">impotence</span> while taking <span class=""chemical"">cimetidine</span> and in all cases these changes disappeared when <span class=""chemical"">cimetidine</span> was replaced by ranitidine.",761593,6150641,6150641_D002927_D007172,6150641_6,bcv_easy_326_sent_work_dev_set_761593,yes_direct,770955664,TRUE,golden,9,,"







",yes_direct,0.8917,TRUE,D016685,"<span class=""chemical"">MMC</span>",D006333,"<span class=""disease"">cardiac failure</span>","One of the patients developed <span class=""disease"">cardiac failure</span> after 30 mg m-2 <span class=""chemical"">MMC</span> and only 150 mg m-2 doxorubicin.",761593,3137399,3137399_D016685_D006333,3137399_7,bcv_easy_1200_sent_work_dev_set_761593,yes_direct,770955665,TRUE,golden,10,,"








",yes_direct,1,TRUE,D009288,"<span class=""chemical"">naproxen</span>",D007681,"<span class=""disease"">Renal papillary necrosis</span>","<span class=""disease"">Renal papillary necrosis</span> due to <span class=""chemical"">naproxen</span>.",761593,6699841,6699841_D009288_D007681,6699841_0,bcv_easy_1244_sent_work_dev_set_761593,yes_direct,770955666,TRUE,golden,13,,"











",yes_direct,1,TRUE,C019248,"<span class=""chemical"">pamidronate</span>",D006996,"<span class=""disease"">hypocalcemia</span>","The 2 patients with the higher serum calcium concentrations received <span class=""chemical"">pamidronate</span> intravenously (60 and 30 mg, respectively), which caused severe <span class=""disease"">hypocalcemia</span>.",761593,16006300,16006300_C019248_D006996,16006300_6,bcv_easy_707_sent_work_dev_set_761593,yes_direct,770955667,TRUE,golden,13,,"











",yes_direct,1,TRUE,D000638,"<span class=""chemical"">amiodarone</span>",D056486,"<span class=""disease"">hepatic injury</span>","It is concluded that solid evidence exists of <span class=""disease"">hepatic injury</span> due to <span class=""chemical"">amiodarone</span> treatment, including steatosis, alterations resembling alcoholic hepatitis, cholestatic hepatitis and micronodular cirrhosis of the liver.",761593,3962737,3962737_D000638_D056486,3962737_4,bcv_easy_292_sent_work_dev_set_761593,yes_direct,770955668,TRUE,golden,13,,"











",yes_direct,0.7661,TRUE,D009074,"<span class=""chemical"">MSH</span>",D004421,"<span class=""disease"">dystonia</span>","A <span class=""disease"">dystonia</span>-like syndrome after neuropeptide (<span class=""chemical"">MSH</span>/ACTH) stimulation of the rat locus ceruleus.",761593,2840807,2840807_D009074_D004421,2840807_0,bcv_easy_493_sent_work_dev_set_761593,yes_direct,770955669,TRUE,golden,12,,"










",yes_direct,0.7497,TRUE,D004456,"<span class=""chemical"">echothiophate iodide</span>",D018908,"<span class=""disease"">muscle weakness</span>","A patient developed a severe cholinergic syndrome from the use of <span class=""chemical"">echothiophate iodide</span> ophthalmic drops, presented with profound <span class=""disease"">muscle weakness</span> and was initially given the diagnosis of myasthenia gravis.",761593,7650771,7650771_D004456_D018908,7650771_1,bcv_easy_1165_sent_work_dev_set_761593,yes_direct,770955670,TRUE,golden,6,,"




",yes_direct,1,TRUE,D002217,"<span class=""chemical"">carbachol</span>",D004830,"<span class=""disease"">clonic-tonic convulsions</span>","It is apparent that calcium chloride can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> caused by <span class=""chemical"">carbachol</span> and eserine.",761593,6892185,6892185_D002217_D004830,6892185_4,bcv_easy_1056_sent_work_dev_set_761593,yes_direct,770955671,TRUE,golden,9,,"







",yes_direct,1,TRUE,D010068,"<span class=""chemical"">oxacillin</span>",D051437,"<span class=""disease"">renal failure</span>","A 67-year-old man who was treated with <span class=""chemical"">oxacillin</span> for one week because of Staphylococcus aureus bacteremia, developed <span class=""disease"">renal failure</span> and diffuse, symmetric, palpable purpuric lesions on his feet.",761593,11337188,11337188_D010068_D051437,11337188_1,bcv_easy_302_sent_work_dev_set_761593,yes_direct,770955672,TRUE,golden,14,,"












",yes_direct,0.9314,TRUE,D013874,"<span class=""chemical"">thiopental</span>",D012133,"<span class=""disease"">respiratory paralysis</span>","GABA involvement in naloxone induced reversal of <span class=""disease"">respiratory paralysis</span> produced by <span class=""chemical"">thiopental</span>.",761593,2893236,2893236_D013874_D012133,2893236_0,bcv_easy_438_sent_work_dev_set_761593,yes_direct,770955673,TRUE,golden,7,,"





",yes_direct,1,TRUE,D008775,"<span class=""chemical"">methylprednisolone</span>",D001919,"<span class=""disease"">bradycardia</span>","We report a case of hypotension, <span class=""disease"">bradycardia</span>, and asystole after intravenous administration of high-dose <span class=""chemical"">methylprednisolone</span> in a 73-year-old patient who underwent electrocardiographic (ECG) monitoring throughout the episode.",761593,10074612,10074612_D008775_D001919,10074612_1,bcv_easy_1089_sent_work_dev_set_761593,yes_direct,770955674,TRUE,golden,8,,"






",yes_direct,0.8784,TRUE,D011692,"<span class=""chemical"">PAN</span>",D034141,"<span class=""disease"">hypoalbuminemia</span>","After 7 days, <span class=""chemical"">PAN</span> treatment induced significant proteinuria, <span class=""disease"">hypoalbuminemia</span>, decreased urinary sodium excretion, and extensive ascites.",761593,15075188,15075188_D011692_D034141,15075188_5,bcv_easy_1094_sent_work_dev_set_761593,yes_direct,770955675,TRUE,golden,17,,"















",yes_direct,0.8432,TRUE,C017367,"<span class=""chemical"">carmofur</span>",D056784,"<span class=""disease"">leukoencephalopathy</span>","RESULTS: We identified 27 reports of toxic <span class=""disease"">leukoencephalopathy</span> in patients treated with methotrexate (intrathecal, systemic), 5-fluorouracil and its derivative <span class=""chemical"">carmofur</span>, and capecitabine.",761593,17682013,17682013_C017367_D056784,17682013_6,bcv_easy_782_sent_work_dev_set_761593,yes_direct,770955676,TRUE,golden,5,,"



",yes_direct,1,TRUE,D017693,"<span class=""chemical"">sodium bicarbonate</span>",D053040,"<span class=""disease"">nephrolithiasis</span>","One case of acute hypercalcaemia and two of recurrent <span class=""disease"">nephrolithiasis</span> are reported in patients who had regularly consumed large amounts of calcium carbon-ate-<span class=""chemical"">sodium bicarbonate</span> powders for more than 20 years.",761593,625456,625456_D017693_D053040,625456_1,bcv_easy_51_sent_work_dev_set_761593,yes_direct,770955677,TRUE,golden,11,,"









",yes_direct,1,TRUE,D005476,"<span class=""chemical"">fluphenazine</span>",D002375,"<span class=""disease"">catalepsy</span>","D-1 agonist SKF 38393 or D-2 agonist quinpirole decreased the <span class=""disease"">catalepsy</span> induced by <span class=""chemical"">fluphenazine</span>, SCH 23390 or sulpiride.",761593,1687392,1687392_D005476_D002375,1687392_8,bcv_easy_862_sent_work_dev_set_761593,yes_direct,770955678,TRUE,golden,11,,"









",yes_direct,1,TRUE,D005047,"<span class=""chemical"">etoposide</span>",D009203,"<span class=""disease"">myocardial infarction</span>","The occurrence of a <span class=""disease"">myocardial infarction</span> is reported after chemotherapy containing <span class=""chemical"">etoposide</span>, in a man with no risk factors for coronary heart disease.",761593,7619765,7619765_D005047_D009203,7619765_1,bcv_easy_554_sent_work_dev_set_761593,yes_direct,770955679,TRUE,golden,15,,"













",yes_direct,0.9387,TRUE,D010068,"<span class=""chemical"">Oxacillin</span>",D018366,"<span class=""disease"">leucocytoclastic vasculitis</span>","<span class=""chemical"">Oxacillin</span> should be included among the drugs that can cause <span class=""disease"">leucocytoclastic vasculitis</span>.",761593,11337188,11337188_D010068_D018366,11337188_10,bcv_easy_305_sent_work_dev_set_761593,yes_direct,770955680,TRUE,golden,8,,"






",yes_direct,0.7597,TRUE,D010396,"<span class=""chemical"">Penicillamine</span>",D005921,"<span class=""disease"">glomerulonephritis</span>","<span class=""chemical"">Penicillamine</span>-induced rapidly progressive <span class=""disease"">glomerulonephritis</span> in a patient with rheumatoid arthritis.",761593,8267029,8267029_D010396_D005921,8267029_0,bcv_easy_496_sent_work_dev_set_761593,yes_direct,770955681,TRUE,golden,7,,"





",yes_direct,1,TRUE,D016685,"<span class=""chemical"">Mitomycin C</span>",D006463,"<span class=""disease"">hemolytic uremic syndrome</span>","<span class=""chemical"">Mitomycin C</span> associated <span class=""disease"">hemolytic uremic syndrome</span>.",761593,3108839,3108839_D016685_D006463,3108839_0,bcv_easy_797_sent_work_dev_set_761593,yes_direct,770955682,TRUE,golden,8,,"






",yes_direct,1,TRUE,D002217,"<span class=""chemical"">carbachol</span>",D015878,"<span class=""disease"">mydriasis</span>","The effect of calcium chloride injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions produced by <span class=""chemical"">carbachol</span> and eserine injected similarly was investigated.",761593,6892185,6892185_D002217_D015878,6892185_1,bcv_easy_1042_sent_work_dev_set_761593,yes_direct,770955683,TRUE,golden,17,,"















",yes_direct,0.9463,TRUE,D005473,"<span class=""chemical"">Fluoxetine</span>",D006966,"<span class=""disease"">hyperprolactinemia</span>","DESIGN: <span class=""chemical"">Fluoxetine</span>, a serotonin reuptake inhibitor, was given to Wistar Albino rats for 98 days to produce <span class=""disease"">hyperprolactinemia</span>.",761593,9098464,9098464_D005473_D006966,9098464_2,bcv_easy_1034_sent_work_dev_set_761593,yes_direct,770955684,TRUE,golden,9,,"







",no_relation,0.5549,TRUE,C056299,"<span class=""chemical"">Abbott-53693</span>",D001919,"<span class=""disease"">bradycardia</span>","On the other hand, the pressor effects of <span class=""chemical"">Abbott-53693</span> were similar in both groups of SHR, but the accompanying <span class=""disease"">bradycardia</span> was greater in SHR with chronic prazosin treatment than without such treatment.",761593,1355091,1355091_C056299_D001919,1355091_16,bcv_easy_1081_sent_work_dev_set_761593,yes_direct,770955685,TRUE,golden,7,,"





",yes_direct,1,TRUE,D001971,"<span class=""chemical"">bromocriptine</span>",D011605,"<span class=""disease"">psychosis</span>","Postpartum <span class=""disease"">psychosis</span> induced by <span class=""chemical"">bromocriptine</span>.",761593,3686155,3686155_D001971_D011605,3686155_0,bcv_easy_555_sent_work_dev_set_761593,yes_direct,770955686,TRUE,golden,14,,"












",yes_direct,0.9354,TRUE,D004317,"<span class=""chemical"">doxorubicin</span>",D006333,"<span class=""disease"">cardiac failure</span>","One of the patients developed <span class=""disease"">cardiac failure</span> after 30 mg m-2 MMC and only 150 mg m-2 <span class=""chemical"">doxorubicin</span>.",761593,3137399,3137399_D004317_D006333,3137399_7,bcv_easy_1199_sent_work_dev_set_761593,yes_direct,770955687,TRUE,golden,10,,"








",yes_direct,1,TRUE,D008727,"<span class=""chemical"">methotrexate</span>",D056784,"<span class=""disease"">leukoencephalopathy</span>","RESULTS: We identified 27 reports of toxic <span class=""disease"">leukoencephalopathy</span> in patients treated with <span class=""chemical"">methotrexate</span> (intrathecal, systemic), 5-fluorouracil and its derivative carmofur, and capecitabine.",761593,17682013,17682013_D008727_D056784,17682013_6,bcv_easy_781_sent_work_dev_set_761593,yes_direct,770955688,TRUE,golden,10,,"








",yes_direct,1,TRUE,D013866,"<span class=""chemical"">6-thioguanine</span>",D006504,"<span class=""disease"">Hepatic veno-occlusive disease</span>","<span class=""disease"">Hepatic veno-occlusive disease</span> caused by <span class=""chemical"">6-thioguanine</span>.",761593,7053705,7053705_D013866_D006504,7053705_0,bcv_easy_1211_sent_work_dev_set_761593,yes_direct,770955689,TRUE,golden,13,,"











",yes_direct,1,TRUE,D015742,"<span class=""chemical"">propofol</span>",D010146,"<span class=""disease"">pain</span>","Remifentanil-related complications were assessed during the remifentanil infusion, and <span class=""disease"">pain</span> caused by <span class=""chemical"">propofol</span> was evaluated using a four-point scale during the <span class=""chemical"">propofol</span> infusion.",761593,18006530,18006530_D015742_D010146,18006530_6,bcv_easy_8_sent_work_dev_set_761593,yes_direct,770955690,TRUE,golden,9,,"







",yes_direct,0.8914,TRUE,D007530,"<span class=""chemical"">isoflurane</span>",D002779|D056486,"<span class=""disease"">cholestatic hepatitis</span>","OBJECTIVE: To report a case of acute <span class=""disease"">cholestatic hepatitis</span> following exposure to the inhalational anesthetic <span class=""chemical"">isoflurane</span>.",761593,11847945,11847945_D007530_D002779|D056486,11847945_1,bcv_easy_116_sent_work_dev_set_761593,yes_direct,770955691,TRUE,golden,14,,"












",yes_direct,0.9276,TRUE,D002217,"<span class=""chemical"">carbachol</span>",D014202,"<span class=""disease"">tremor</span>","On the other hand, mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions evoked by <span class=""chemical"">carbachol</span> and eserine were not significantly changed by calcium chloride.",761593,6892185,6892185_D002217_D014202,6892185_3,bcv_easy_1047_sent_work_dev_set_761593,yes_direct,770955692,TRUE,golden,8,,"






",yes_direct,0.7587,TRUE,D017963,"<span class=""chemical"">azithromycin</span>",D006606,"<span class=""disease"">hiccups</span>","CASE SUMMARY: A 76-year-old man presented with persistent <span class=""disease"">hiccups</span> after beginning <span class=""chemical"">azithromycin</span> for the treatment of pharyngitis.",761593,15985056,15985056_D017963_D006606,15985056_2,bcv_easy_817_sent_work_dev_set_761593,yes_direct,770955693,TRUE,golden,17,,"















",yes_direct,0.8899,TRUE,D015632,"<span class=""chemical"">MPTP</span>",D020734,"<span class=""disease"">parkinsonian</span>","A group of four monkeys was rendered <span class=""disease"">parkinsonian</span> with the toxin <span class=""chemical"">MPTP</span>.",761593,8106150,8106150_D015632_D020734,8106150_1,bcv_easy_1113_sent_work_dev_set_761593,yes_direct,770955694,TRUE,golden,7,,"





",yes_direct,1,TRUE,D002217,"<span class=""chemical"">carbachol</span>",D015878,"<span class=""disease"">mydriasis</span>","On the other hand, <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions evoked by <span class=""chemical"">carbachol</span> and eserine were not significantly changed by calcium chloride.",761593,6892185,6892185_D002217_D015878,6892185_3,bcv_easy_1052_sent_work_dev_set_761593,yes_direct,770955695,TRUE,golden,14,,"












",yes_direct,0.859,TRUE,D003276,"<span class=""chemical"">Oral Contraceptives</span>",D008113,"<span class=""disease"">Liver Tumors</span>","The Registry for <span class=""disease"">Liver Tumors</span> Associated with <span class=""chemical"">Oral Contraceptives</span> at the University of California, Irvine, has clearly identified 27 cases.",761593,188339,188339_D003276_D008113,188339_2,bcv_easy_424_sent_work_dev_set_761593,yes_direct,770955696,TRUE,golden,10,,"








",yes_direct,1,TRUE,D004298,"<span class=""chemical"">dopamine</span>",D002389,"<span class=""disease"">catatonia</span>","In the pinealectomized chick, pretreatment with <span class=""chemical"">dopamine</span> increased the duration of <span class=""disease"">catatonia</span> (DOC) after ketamine, but pretreatment with norepinephrine did not.",761593,6540303,6540303_D004298_D002389,6540303_2,bcv_easy_485_sent_work_dev_set_761593,yes_direct,770955697,TRUE,golden,11,,"









",yes_direct,0.8262,TRUE,D005472,"<span class=""chemical"">5-FU/5-fluorouracil</span>",D002637,"<span class=""disease"">chest pain</span>","We report a case of a patient with colon carcinoma and liver metastasis who presented <span class=""disease"">chest pain</span> after <span class=""chemical"">5-fluorouracil</span> (<span class=""chemical"">5-FU</span>) administration.",761593,3952818,3952818_D005472_D002637,3952818_1,bcv_easy_997_sent_work_dev_set_761593,yes_direct,770955698,TRUE,golden,6,,"




",yes_direct,0.8466,TRUE,D014635,"<span class=""chemical"">VPA</span>",D007177,"<span class=""disease"">SIADH</span>","We consider this episode of <span class=""disease"">SIADH</span> to be the result of a combination of factors including a weakness of the central nervous system and the long-term administration of <span class=""chemical"">VPA</span>.",761593,11195262,11195262_D014635_D007177,11195262_4,bcv_easy_162_sent_work_dev_set_761593,yes_direct,770955699,TRUE,golden,9,,"







",yes_direct,1,TRUE,D013629,"<span class=""chemical"">tamoxifen</span>",D015228,"<span class=""disease"">hypertriglyceridaemia</span>","Compared with the placebo group, there was a significantly increased risk of vascular events and <span class=""disease"">hypertriglyceridaemia</span> among women on <span class=""chemical"">tamoxifen</span>.",761593,9672273,9672273_D013629_D015228,9672273_14,bcv_easy_313_sent_work_dev_set_761593,yes_direct,770955700,TRUE,golden,9,,"







",yes_direct,0.7775,TRUE,D008012,"<span class=""chemical"">lidocaine</span>",D012640,"<span class=""disease"">seizures</span>","Chronic oral CBZ inhibited the development of both <span class=""chemical"">lidocaine</span>- and cocaine-induced <span class=""disease"">seizures</span>, but had little effect on the fully developed local anesthetic <span class=""disease"">seizures</span>.",761593,2790457,2790457_D008012_D012640,2790457_2,bcv_easy_685_sent_work_dev_set_761593,yes_direct,770955701,TRUE,golden,11,,"









",yes_direct,0.7269,TRUE,D008094,"<span class=""chemical"">Lithium</span>",D011141,"<span class=""disease"">polyuria</span>","<span class=""chemical"">Lithium</span> induced nephrogenic diabetes insipidus is considered to be reversible on cessation of therapy but <span class=""disease"">polyuria</span> persisted in this patient for ten years after <span class=""chemical"">lithium</span> was stopped.",761593,9226773,9226773_D008094_D011141,9226773_4,bcv_easy_200_sent_work_dev_set_761593,yes_direct,770955702,TRUE,golden,18,,"
















",yes_direct,0.838,TRUE,D009543,"<span class=""chemical"">nifedipine</span>",D013684,"<span class=""disease"">telangiectasia</span>","Photodistributed <span class=""chemical"">nifedipine</span>-induced facial <span class=""disease"">telangiectasia</span>.",761593,8251368,8251368_D009543_D013684,8251368_0,bcv_easy_452_sent_work_dev_set_761593,yes_direct,770955703,TRUE,golden,12,,"










",yes_direct,0.7515,TRUE,D004656,"<span class=""chemical"">enalapril</span>",D051437,"<span class=""disease"">decreased renal function</span>","Diuretic therapy was likewise associated with a greater risk of <span class=""disease"">decreased renal function</span> in the <span class=""chemical"">enalapril</span> group (RR 1.89, 95% CI 1.70-2.08) than in the placebo group (RR 1.35, 95% CI 1.09-1.66).",761593,10539815,10539815_D004656_D051437,10539815_11,bcv_easy_767_sent_work_dev_set_761593,yes_direct,770955704,TRUE,golden,8,,"






",yes_direct,1,TRUE,D016861,"<span class=""chemical"">cyclooxygenase inhibitors</span>",D020521,"<span class=""disease"">stroke</span>","Randomised clinical trials and observational studies have shown an increased risk of myocardial infarction, <span class=""disease"">stroke</span>, hypertension and heart failure during treatment with <span class=""chemical"">cyclooxygenase inhibitors</span>.",761593,16586083,16586083_D016861_D020521,16586083_1,bcv_easy_1147_sent_work_dev_set_761593,yes_direct,770955705,TRUE,golden,8,,"






",yes_direct,1,TRUE,D005996,"<span class=""chemical"">Glyceryl trinitrate</span>",D020326,"<span class=""disease"">migraine without aura</span>","<span class=""chemical"">Glyceryl trinitrate</span> induces attacks of <span class=""disease"">migraine without aura</span> in sufferers of migraine with aura.",761593,10524660,10524660_D005996_D020326,10524660_0,bcv_easy_601_sent_work_dev_set_761593,yes_direct,770955706,TRUE,golden,9,,"







",yes_direct,1,TRUE,D014282,"<span class=""chemical"">trihexyphenidyl hydrochloride</span>",D001919,"<span class=""disease"">Bradycardia</span>","<span class=""disease"">Bradycardia</span> due to <span class=""chemical"">trihexyphenidyl hydrochloride</span>.",761593,3769769,3769769_D014282_D001919,3769769_0,bcv_easy_250_sent_work_dev_set_761593,yes_direct,770955707,TRUE,golden,14,,"












",yes_direct,0.9313,TRUE,D016685,"<span class=""chemical"">mitomycin C</span>",D051437,"<span class=""disease"">renal failure</span>","It consists of microangiopathic hemolytic anemia, thrombocytopenia and progressive <span class=""disease"">renal failure</span> associated with <span class=""chemical"">mitomycin C</span> treatment and affects about 10% of patients treated with this agent.",761593,3108839,3108839_D016685_D051437,3108839_2,bcv_easy_800_sent_work_dev_set_761593,yes_direct,770955708,TRUE,golden,16,,"














",yes_direct,0.7553,TRUE,D011441,"<span class=""chemical"">PTU</span>",D014657,"<span class=""disease"">vasculitis</span>","<span class=""chemical"">PTU</span>-associated <span class=""disease"">vasculitis</span> in a girl with Turner Syndrome and Graves' disease.",761593,16418614,16418614_D011441_D014657,16418614_0,bcv_easy_93_sent_work_dev_set_761593,yes_direct,770955709,TRUE,golden,4,,"


",yes_direct,1,TRUE,D000638,"<span class=""chemical"">amiodarone</span>",D002779|D056486,"<span class=""disease"">cholestatic hepatitis</span>","It is concluded that solid evidence exists of hepatic injury due to <span class=""chemical"">amiodarone</span> treatment, including steatosis, alterations resembling alcoholic hepatitis, <span class=""disease"">cholestatic hepatitis</span> and micronodular cirrhosis of the liver.",761593,3962737,3962737_D000638_D002779|D056486,3962737_4,bcv_easy_293_sent_work_dev_set_761593,yes_direct,770955710,TRUE,golden,12,,"










",yes_direct,0.7552,TRUE,D004317,"<span class=""chemical"">ADR</span>",D028361,"<span class=""disease"">mitochondrial structural and functional impairment</span>","Knowing that heart mitochondria represent almost 40% of heart muscle by weight, we conclude that the deteriorating effects of <span class=""chemical"">ADR</span> on cardiovascular function involve <span class=""disease"">mitochondrial structural and functional impairment</span>.",761593,9952311,9952311_D004317_D028361,9952311_8,bcv_easy_796_sent_work_dev_set_761593,yes_direct,770955711,TRUE,golden,11,,"









",yes_direct,1,TRUE,D007069,"<span class=""chemical"">ifosfamide</span>",D001002,"<span class=""disease"">anuria</span>","We strongly suspect that this lethal <span class=""disease"">anuria</span> was mainly due to <span class=""chemical"">ifosfamide</span>, occurring in a patient having received previous cisplatin chemotherapy and with poor kidney perfusion due to transient hypotension.",761593,2320800,2320800_D007069_D001002,2320800_6,bcv_easy_411_sent_work_dev_set_761593,yes_direct,770955712,TRUE,golden,12,,"










",yes_direct,0.9227,TRUE,D000319,"<span class=""chemical"">beta-adrenergic blocking drugs</span>",D001919,"<span class=""disease"">bradycardia</span>","Three patients with ischaemic heart disease developed profound cardiac failure, hypotension and <span class=""disease"">bradycardia</span> during combined therapy with verapamil and <span class=""chemical"">beta-adrenergic blocking drugs</span>.",761593,6127992,6127992_D000319_D001919,6127992_1,bcv_easy_472_sent_work_dev_set_761593,yes_direct,770955713,TRUE,golden,10,,"








",yes_direct,1,TRUE,D008775,"<span class=""chemical"">methylprednisolone</span>",D006323,"<span class=""disease"">asystole</span>","We report a case of hypotension, bradycardia, and <span class=""disease"">asystole</span> after intravenous administration of high-dose <span class=""chemical"">methylprednisolone</span> in a 73-year-old patient who underwent electrocardiographic (ECG) monitoring throughout the episode.",761593,10074612,10074612_D008775_D006323,10074612_1,bcv_easy_1088_sent_work_dev_set_761593,yes_direct,770955714,TRUE,golden,12,,"










",yes_direct,0.9191,TRUE,D000082,"<span class=""chemical"">paracetamol</span>",D017114,"<span class=""disease"">fulminant hepatic failure</span>","Acid protease (cathepsin D) activity was increased about tenfold in patients who died and nearly fourfold in those who survived <span class=""disease"">fulminant hepatic failure</span> after <span class=""chemical"">paracetamol</span> overdose, whereas activities were increased equally in patients with <span class=""disease"">fulminant hepatic failure</span> due to viral hepatitis whether or not they survived.",761593,7007443,7007443_D000082_D017114,7007443_2,bcv_easy_342_sent_work_dev_set_761593,yes_direct,770955715,TRUE,golden,9,,"







",yes_direct,0.8965,TRUE,D001393,"<span class=""chemical"">azole</span>",D008133,"<span class=""disease"">Prolongation of QT interval</span>","<span class=""disease"">Prolongation of QT interval</span>, torsades de pointes, and sudden cardiac death have been reported after concomitant administration with erythromycin or <span class=""chemical"">azole</span> antifungal agents, but not with other CYP3A4 inhibitors.",761593,9545159,9545159_D001393_D008133,9545159_2,bcv_easy_255_sent_work_dev_set_761593,yes_direct,770955716,TRUE,golden,10,,"








",yes_direct,1,TRUE,D000420,"<span class=""chemical"">Salbutamol</span>",D013617,"<span class=""disease"">SIAT</span>","CONCLUSION: <span class=""chemical"">Salbutamol</span> is presented here as a possible trigger for <span class=""disease"">SIAT</span>.",761593,20552622,20552622_D000420_D013617,20552622_10,bcv_easy_45_sent_work_dev_set_761593,yes_direct,770955717,TRUE,golden,11,,"









",yes_direct,1,TRUE,C092292,"<span class=""chemical"">ziprasidone</span>",D009459,"<span class=""disease"">Neuroleptic malignant syndrome</span>","<span class=""disease"">Neuroleptic malignant syndrome</span> induced by <span class=""chemical"">ziprasidone</span> on the second day of treatment.",761593,17366349,17366349_C092292_D009459,17366349_0,bcv_easy_52_sent_work_dev_set_761593,yes_direct,770955718,TRUE,golden,18,,"
















",yes_direct,0.8874,TRUE,D007069,"<span class=""chemical"">ifosfamide</span>",D001002,"<span class=""disease"">anuria</span>","A sixty-year-old woman with advanced breast cancer, previously treated with cisplatin, developed an irreversible lethal renal failure with <span class=""disease"">anuria</span>, the day after 5 g/m2 bolus <span class=""chemical"">ifosfamide</span>.",761593,2320800,2320800_D007069_D001002,2320800_1,bcv_easy_404_sent_work_dev_set_761593,yes_direct,770955719,TRUE,golden,14,,"












",yes_direct,0.929,TRUE,D013874,"<span class=""chemical"">thiopental</span>",D012133,"<span class=""disease"">respiratory paralysis</span>","These data suggest naloxone reverses <span class=""disease"">respiratory paralysis</span> produced by <span class=""chemical"">thiopental</span> and involves GABA in its action.",761593,2893236,2893236_D013874_D012133,2893236_7,bcv_easy_449_sent_work_dev_set_761593,yes_direct,770955720,TRUE,golden,9,,"







",no_relation,0.6479,TRUE,C056299,"<span class=""chemical"">Abbott-53693</span>",D001919,"<span class=""disease"">bradycardia</span>","The pressor responses and <span class=""disease"">bradycardia</span> to the alpha 1-agonist cirazoline (0.6 and 2 micrograms kg-1 i.v.), the alpha 2-agonist <span class=""chemical"">Abbott-53693</span> (1 and 3 micrograms kg-1 i.v.), and noradrenaline (0.1 and 1.0 micrograms kg-1 i.v.) were determined in conscious SHR with and without chronic prazosin pretreatment.",761593,1355091,1355091_C056299_D001919,1355091_14,bcv_easy_1074_sent_work_dev_set_761593,yes_direct,770955721,TRUE,golden,13,,"











",yes_direct,0.9274,TRUE,D000319,"<span class=""chemical"">beta-adrenergic blocking drugs</span>",D007022,"<span class=""disease"">hypotension</span>","Three patients with ischaemic heart disease developed profound cardiac failure, <span class=""disease"">hypotension</span> and bradycardia during combined therapy with verapamil and <span class=""chemical"">beta-adrenergic blocking drugs</span>.",761593,6127992,6127992_D000319_D007022,6127992_1,bcv_easy_474_sent_work_dev_set_761593,yes_direct,770955722,TRUE,golden,13,,"











",yes_direct,1,TRUE,D004977,"<span class=""chemical"">ethambutol</span>",D009901,"<span class=""disease"">optic neuropathy</span>","CLINICAL PICTURE: Three patients with <span class=""chemical"">ethambutol</span>-associated toxic <span class=""disease"">optic neuropathy</span> are described.",761593,16710500,16710500_D004977_D009901,16710500_3,bcv_easy_340_sent_work_dev_set_761593,yes_direct,770955723,TRUE,golden,13,,"











",yes_direct,0.7758,TRUE,D002110,"<span class=""chemical"">caffeine</span>",D018879,"<span class=""disease"">ventricular ectopy</span>","Intravenous <span class=""chemical"">caffeine</span> is commonly used to improve seizure duration and quality in such patients and is generally well tolerated aside from occasional reports of relatively benign <span class=""disease"">ventricular ectopy</span>.",761593,18997632,18997632_D002110_D018879,18997632_2,bcv_easy_120_sent_work_dev_set_761593,yes_direct,770955724,TRUE,golden,11,,"





'Induced' being the key term.



",yes_direct,1,TRUE,D009627,"<span class=""chemical"">nomifensine</span>",D006948,"<span class=""disease"">hyperactivity</span>","The <span class=""disease"">hyperactivity</span> induced by <span class=""chemical"">nomifensine</span> in mice remained unaffected by fluvoxamine.",761593,2576810,2576810_D009627_D006948,2576810_3,bcv_easy_1178_sent_work_dev_set_761593,yes_direct,770955725,TRUE,golden,13,,"











",yes_direct,1,TRUE,D010396,"<span class=""chemical"">D-penicillamine</span>",D017285,"<span class=""disease"">Polymyositis</span>","<span class=""disease"">Polymyositis</span>/dermatomyositis can develop as one of the autoimmune complications of <span class=""chemical"">D-penicillamine</span> treatment, but its exact pathogenesis remains unclear.",761593,8268147,8268147_D010396_D017285,8268147_2,bcv_easy_836_sent_work_dev_set_761593,yes_direct,770955726,TRUE,golden,8,,"






",no_relation,1,TRUE,D007660,"<span class=""chemical"">Ketoprofen</span>",D013345,"<span class=""disease"">SAH</span>","<span class=""chemical"">Ketoprofen</span> but not acetaminophen impaired platelet function in patients with <span class=""disease"">SAH</span>.",761593,10414674,10414674_D007660_D013345,10414674_11,bcv_easy_901_sent_work_dev_set_761593,no_relation,770955727,TRUE,golden,10,,"








",no_relation,0.9061,TRUE,C012655,"<span class=""chemical"">nimesulide</span>",D014581,"<span class=""disease"">urticaria</span>","In this study we investigated tolerability and reliability of <span class=""chemical"">nimesulide</span> and paracetamol in a very large number of patients with an exclusive well-documented history of NSAID-induced <span class=""disease"">urticaria</span>/angioedema.",761593,11694026,11694026_C012655_D014581,11694026_2,bcv_easy_641_sent_work_dev_set_761593,no_relation,770955728,TRUE,golden,18,,"
















",no_relation,0.7843,TRUE,D000082,"<span class=""chemical"">paracetamol</span>",D001744,"<span class=""disease"">bladder calculi</span>","Additionally, 20 to 25% of <span class=""chemical"">paracetamol</span>-treated rats developed hyperplasia of the bladder epithelium, which was not coincident with the presence of <span class=""disease"">bladder calculi</span>.",761593,4090988,4090988_D000082_D001744,4090988_6,bcv_easy_282_sent_work_dev_set_761593,no_relation,770955729,TRUE,golden,11,,"
'Reduced' is the key word.








",no_relation,1,TRUE,D010830,"<span class=""chemical"">physostigmine</span>",D004409,"<span class=""disease"">dyskinetic</span>","Several drugs, including clonidine, <span class=""chemical"">physostigmine</span>, methysergide, 5-MDOT, propranolol, and MK-801, markedly reduced the <span class=""disease"">dyskinetic</span> movements but at the cost of a return of parkinsonian symptomatology.",761593,8106150,8106150_D010830_D004409,8106150_5,bcv_easy_1121_sent_work_dev_set_761593,no_relation,770955730,TRUE,golden,11,,"









",no_relation,1,TRUE,D004317,"<span class=""chemical"">doxorubicin</span>",D001943,"<span class=""disease"">breast cancer</span>","Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated <span class=""chemical"">doxorubicin</span> and cyclophosphamide compared with conventional <span class=""chemical"">doxorubicin</span> and cyclophosphamide in a randomized, multicenter trial of metastatic <span class=""disease"">breast cancer</span>.",761593,11230490,11230490_D004317_D001943,11230490_0,bcv_easy_130_sent_work_dev_set_761593,no_relation,770955731,TRUE,golden,8,,"






",no_relation,1,TRUE,D014147,"<span class=""chemical"">Tramadol</span>",D009369,"<span class=""disease"">cancer</span>","<span class=""chemical"">Tramadol</span> is a weak opioid with effects on adrenergic and serotonergic neurotransmission that is used to treat <span class=""disease"">cancer</span> pain and chronic non malignant pain.",761593,8766220,8766220_D014147_D009369,8766220_1,bcv_easy_98_sent_work_dev_set_761593,no_relation,770955732,TRUE,golden,11,,"









",no_relation,1,TRUE,D004008,"<span class=""chemical"">diclofenac sodium</span>",D001172,"<span class=""disease"">rheumatoid arthritis</span>","Gastrointestinal tolerability of etoricoxib in <span class=""disease"">rheumatoid arthritis</span> patients: results of the etoricoxib vs <span class=""chemical"">diclofenac sodium</span> gastrointestinal tolerability and effectiveness trial (EDGE-II).",761593,17965424,17965424_D004008_D001172,17965424_0,bcv_easy_924_sent_work_dev_set_761593,no_relation,770955733,TRUE,golden,12,,"










",no_relation,1,TRUE,D011188,"<span class=""chemical"">potassium</span>",D003327,"<span class=""disease"">coronary disease</span>","Diuretics, <span class=""chemical"">potassium</span> and arrhythmias in hypertensive <span class=""disease"">coronary disease</span>.",761593,3732088,3732088_D011188_D003327,3732088_0,bcv_easy_13_sent_work_dev_set_761593,no_relation,770955734,TRUE,golden,13,,"











",no_relation,0.925,TRUE,C422649,"<span class=""chemical"">etoricoxib</span>",D001172,"<span class=""disease"">RA</span>","PATIENTS AND METHODS: A total of 4086 patients (mean age 60.8 years) diagnosed with <span class=""disease"">RA</span> were enrolled and received <span class=""chemical"">etoricoxib</span> 90 mg daily (n = 2032) or diclofenac 75 mg twice daily (n = 2054).",761593,17965424,17965424_C422649_D001172,17965424_2,bcv_easy_927_sent_work_dev_set_761593,no_relation,770955735,TRUE,golden,13,,"











",no_relation,1,TRUE,C004742,"<span class=""chemical"">daidzein</span>",D000647,"<span class=""disease"">amnesia</span>","Administration of <span class=""chemical"">daidzein</span> (4.5 mg/kg body weight) to mice was shown significantly to reverse scopolamine-induced <span class=""disease"">amnesia</span>, according to the results of a Y-maze test.",761593,16428827,16428827_C004742_D000647,16428827_5,bcv_easy_66_sent_work_dev_set_761593,no_relation,770955736,TRUE,golden,17,,"















",no_relation,0.95,TRUE,D015647,"<span class=""chemical"">SKF 38393</span>",D002375,"<span class=""disease"">catalepsy</span>","D-1 agonist <span class=""chemical"">SKF 38393</span> or D-2 agonist quinpirole decreased the <span class=""disease"">catalepsy</span> induced by fluphenazine, SCH 23390 or sulpiride.",761593,1687392,1687392_D015647_D002375,1687392_8,bcv_easy_863_sent_work_dev_set_761593,no_relation,770955737,TRUE,golden,17,,"















",no_relation,1,TRUE,D003520,"<span class=""chemical"">cyclophosphamide</span>",D001943,"<span class=""disease"">MBC</span>","PATIENTS AND METHODS: Two hundred ninety-seven patients with <span class=""disease"">MBC</span> and no prior chemotherapy for metastatic disease were randomized to receive either 60 mg/m(2) of Myocet (M) or conventional doxorubicin (A), in combination with 600 mg/m(2) of <span class=""chemical"">cyclophosphamide</span> (C), every 3 weeks until disease progression or unacceptable toxicity.",761593,11230490,11230490_D003520_D001943,11230490_2,bcv_easy_140_sent_work_dev_set_761593,no_relation,770955738,TRUE,golden,14,,"












",no_relation,1,TRUE,D015215,"<span class=""chemical"">AZT</span>",D000163,"<span class=""disease"">AIDS</span>","We have used a murine model of <span class=""disease"">AIDS</span>, infection of female C57BL/6 mice with LP-BM5 murine leukaemia (MuLV) virus, to determine if <span class=""chemical"">AZT</span>-induced anaemia is due, in part, to decreased responsiveness of erythropoietic precursors (BFU-e) to erythropoietin (EPO).",761593,2004015,2004015_D015215_D000163,2004015_2,bcv_easy_215_sent_work_dev_set_761593,no_relation,770955739,TRUE,golden,9,,"







",no_relation,1,TRUE,D007660,"<span class=""chemical"">ketoprofen</span>",D013345,"<span class=""disease"">aneurysmal subarachnoid hemorrhage/SAH</span>","Patients with <span class=""disease"">aneurysmal subarachnoid hemorrhage</span> (<span class=""disease"">SAH</span>) were randomized to receive either <span class=""chemical"">ketoprofen</span>, 100 mg, three times a day (<span class=""chemical"">ketoprofen</span> group, n = 9) or a weak NSAID, acetaminophen, 1 g, three times a day (acetaminophen group, n = 9) starting immediately after the diagnosis of aneurysmal <span class=""disease"">SAH</span>.",761593,10414674,10414674_D007660_D013345,10414674_3,bcv_easy_894_sent_work_dev_set_761593,no_relation,770955740,TRUE,golden,11,,"









",no_relation,1,TRUE,C065179,"<span class=""chemical"">Atorvastatin</span>",D006973,"<span class=""disease"">hypertension</span>","<span class=""chemical"">Atorvastatin</span> prevented and reversed dexamethasone-induced <span class=""disease"">hypertension</span> in the rat.",761593,16820346,16820346_C065179_D006973,16820346_0,bcv_easy_69_sent_work_dev_set_761593,no_relation,770955741,TRUE,golden,13,,"











",no_relation,0.9322,TRUE,D000082,"<span class=""chemical"">paracetamol</span>",D006525,"<span class=""disease"">viral hepatitis</span>","Acid protease (cathepsin D) activity was increased about tenfold in patients who died and nearly fourfold in those who survived fulminant hepatic failure after <span class=""chemical"">paracetamol</span> overdose, whereas activities were increased equally in patients with fulminant hepatic failure due to <span class=""disease"">viral hepatitis</span> whether or not they survived.",761593,7007443,7007443_D000082_D006525,7007443_2,bcv_easy_344_sent_work_dev_set_761593,no_relation,770955742,TRUE,golden,8,,"






",no_relation,1,TRUE,D002118,"<span class=""chemical"">calcium</span>",D003866,"<span class=""disease"">depression</span>","Addition of excess <span class=""chemical"">calcium</span> reversed the <span class=""disease"">depression</span> in both tissues, but <span class=""chemical"">calcium</span>-independent catecholamine release by acetaldehyde was not blocked by NH4Ac.",761593,6323692,6323692_D002118_D003866,6323692_4,bcv_easy_364_sent_work_dev_set_761593,no_relation,770955743,TRUE,golden,13,,"











",no_relation,1,TRUE,D005680,"<span class=""chemical"">GABA</span>",D012133,"<span class=""disease"">respiratory paralysis</span>","Naloxone (2.5 mg/kg, i.v.) reversed <span class=""disease"">respiratory paralysis</span>, glutamate and <span class=""chemical"">GABA</span> levels to control values in brain stem and cortex with no changes in caudate or cerebellum.",761593,2893236,2893236_D005680_D012133,2893236_6,bcv_easy_446_sent_work_dev_set_761593,no_relation,770955744,TRUE,golden,9,,"







",no_relation,1,TRUE,D017311,"<span class=""chemical"">amlodipine</span>",D006973,"<span class=""disease"">hypertension</span>","OBJECTIVE: The aim of this study was to evaluate the efficacy and tolerability of a new fixed-dose combination (FDC) of telmisartan 40 mg + <span class=""chemical"">amlodipine</span> 5 mg (T+A) compared with <span class=""chemical"">amlodipine</span> 5-mg monotherapy (A) in adult Indian patients with stage II <span class=""disease"">hypertension</span>.",761593,18201582,18201582_D017311_D006973,18201582_1,bcv_easy_888_sent_work_dev_set_761593,no_relation,770955745,TRUE,golden,14,,"












",no_relation,0.942,TRUE,D001058,"<span class=""chemical"">Apomorphine</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","<span class=""chemical"">Apomorphine</span> was the first dopaminergic drug ever used to treat symptoms of <span class=""disease"">Parkinson's disease</span>.",761593,11009181,11009181_D001058_D010300,11009181_1,bcv_easy_190_sent_work_dev_set_761593,no_relation,770955746,TRUE,golden,13,,"











",no_relation,0.8457,TRUE,C012655,"<span class=""chemical"">nimesulide</span>",D014581,"<span class=""disease"">urticaria</span>","A single-placebo-controlled oral challenge procedure with <span class=""chemical"">nimesulide</span> or paracetamol was applied to 829 patients with a history of NSAID-induced <span class=""disease"">urticaria</span>/angioedema.",761593,11694026,11694026_C012655_D014581,11694026_4,bcv_easy_645_sent_work_dev_set_761593,no_relation,770955747,TRUE,golden,12,,"










",no_relation,1,TRUE,D011224,"<span class=""chemical"">prazosin</span>",D001919,"<span class=""disease"">bradycardia</span>","The pressor responses and <span class=""disease"">bradycardia</span> to the alpha 1-agonist cirazoline (0.6 and 2 micrograms kg-1 i.v.), the alpha 2-agonist Abbott-53693 (1 and 3 micrograms kg-1 i.v.), and noradrenaline (0.1 and 1.0 micrograms kg-1 i.v.) were determined in conscious SHR with and without chronic <span class=""chemical"">prazosin</span> pretreatment.",761593,1355091,1355091_D011224_D001919,1355091_14,bcv_easy_1075_sent_work_dev_set_761593,no_relation,770955748,TRUE,golden,9,,"







",no_relation,0.8909,TRUE,D002216,"<span class=""chemical"">captopril</span>",D011507,"<span class=""disease"">proteinuria</span>","Also, <span class=""chemical"">captopril</span> treatment failed to potentiate or facilitate development of massive <span class=""disease"">proteinuria</span> invoked by puromycin aminonucleoside in SHR.",761593,6454943,6454943_D002216_D011507,6454943_4,bcv_easy_589_sent_work_dev_set_761593,no_relation,770955749,TRUE,golden,11,,"









",no_relation,1,TRUE,D002220,"<span class=""chemical"">CBZ</span>",D012640,"<span class=""disease"">seizure</span>","Chronic <span class=""chemical"">CBZ</span> also decreased the incidence of <span class=""disease"">seizure</span>-related mortality in the cocaine-injected rats.",761593,2790457,2790457_D002220_D012640,2790457_3,bcv_easy_686_sent_work_dev_set_761593,no_relation,770955750,TRUE,golden,13,,"











",no_relation,1,TRUE,D012964,"<span class=""chemical"">sodium</span>",D034141,"<span class=""disease"">hypoalbuminemia</span>","After 7 days, PAN treatment induced significant proteinuria, <span class=""disease"">hypoalbuminemia</span>, decreased urinary <span class=""chemical"">sodium</span> excretion, and extensive ascites.",761593,15075188,15075188_D012964_D034141,15075188_5,bcv_easy_1097_sent_work_dev_set_761593,no_relation,770955751,TRUE,golden,18,,"
















",no_relation,1,TRUE,D012254,"<span class=""chemical"">ribavirin</span>",D000257,"<span class=""disease"">adenovirus disease</span>","Although intravenous <span class=""chemical"">ribavirin</span> was not effective for all children with severe <span class=""disease"">adenovirus disease</span> in this series or in the literature, therapy is unlikely to be of benefit if begun late in the course of the infection.",761593,12093990,12093990_D012254_D000257,12093990_23,bcv_easy_246_sent_work_dev_set_761593,no_relation,770955752,TRUE,golden,17,,"















",no_relation,0.8878,TRUE,D013629,"<span class=""chemical"">tamoxifen</span>",D001943,"<span class=""disease"">breast cancer</span>","INTERPRETATION: Although this preliminary analysis has low power, in this cohort of women at low-to-normal risk of <span class=""disease"">breast cancer</span>, the postulated protective effects of <span class=""chemical"">tamoxifen</span> are not yet apparent.",761593,9672273,9672273_D013629_D001943,9672273_15,bcv_easy_314_sent_work_dev_set_761593,no_relation,770955753,TRUE,golden,6,,"




",no_relation,1,TRUE,D007980,"<span class=""chemical"">L-dopa</span>",D003128,"<span class=""disease"">coma</span>","Bilateral nephrectomy eliminated the beneficial effect of <span class=""chemical"">L-dopa</span> on blood and brain ammonia and the ammonia <span class=""disease"">coma</span> was not prevented.",761593,761833,761833_D007980_D003128,761833_5,bcv_easy_463_sent_work_dev_set_761593,no_relation,770955754,TRUE,golden,10,,"








",no_relation,0.831,TRUE,D009020,"<span class=""chemical"">Morphine</span>",D001523,"<span class=""disease"">behavioral disorders</span>","<span class=""chemical"">Morphine</span> dose-dependently reversed these <span class=""disease"">behavioral disorders</span>.",761593,10840460,10840460_D009020_D001523,10840460_11,bcv_easy_320_sent_work_dev_set_761593,no_relation,770955755,TRUE,golden,11,,"









",no_relation,1,TRUE,D008687,"<span class=""chemical"">metformin</span>",D014652,"<span class=""disease"">vascular dysfunction</span>","The antidiabetic drug <span class=""chemical"">metformin</span> can diminish apoptosis induced by oxidative stress in endothelial cells and prevent <span class=""disease"">vascular dysfunction</span> even in nondiabetic patients.",761593,20164825,20164825_D008687_D014652,20164825_1,bcv_easy_268_sent_work_dev_set_761593,no_relation,770955756,TRUE,golden,15,,"













",no_relation,0.9285,TRUE,D017374,"<span class=""chemical"">paroxetine</span>",D059350,"<span class=""disease"">chronic pain</span>","This drug was initiated in association with <span class=""chemical"">paroxetine</span> and dosulepine hydrochloride in a tetraparetic patient with <span class=""disease"">chronic pain</span>.",761593,8766220,8766220_D017374_D059350,8766220_2,bcv_easy_100_sent_work_dev_set_761593,no_relation,770955757,TRUE,golden,9,,"





Used as treatment.

",no_relation,1,TRUE,D003520,"<span class=""chemical"">cyclophosphamide</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","CONCLUSION: Myocet improves the therapeutic index of doxorubicin by significantly reducing <span class=""disease"">cardiotoxicity</span> and grade 4 neutropenia and provides comparable antitumor efficacy, when used in combination with <span class=""chemical"">cyclophosphamide</span> as first-line therapy for MBC.",761593,11230490,11230490_D003520_D066126,11230490_9,bcv_easy_142_sent_work_dev_set_761593,no_relation,770955758,TRUE,golden,8,,"






",no_relation,1,TRUE,C032151,"<span class=""chemical"">cibenzoline</span>",D001145,"<span class=""disease"">ventricular arrhythmias</span>","Antiarrhythmic plasma concentrations of <span class=""chemical"">cibenzoline</span> on canine <span class=""disease"">ventricular arrhythmias</span>.",761593,2435991,2435991_C032151_D001145,2435991_0,bcv_easy_425_sent_work_dev_set_761593,no_relation,770955759,TRUE,golden,17,,"















",no_relation,1,TRUE,D002220,"<span class=""chemical"">CBZ</span>",D012640,"<span class=""disease"">seizures</span>","Repeated i.p. injection of <span class=""chemical"">CBZ</span> (15 mg/kg) also was without effect on the development of lidocaine- or cocaine-kindled <span class=""disease"">seizures</span>.",761593,2790457,2790457_D002220_D012640,2790457_5,bcv_easy_689_sent_work_dev_set_761593,no_relation,770955760,TRUE,golden,13,,"











",no_relation,0.8526,TRUE,D011224,"<span class=""chemical"">prazosin</span>",D009127,"<span class=""disease"">muscular rigidity</span>","Such an induced <span class=""disease"">muscular rigidity</span> by the narcotic agent was significantly antagonized or even reduced by prior electrolytic lesions of the locus coeruleus or pretreatment with the alpha-adrenoceptor blocker, <span class=""chemical"">prazosin</span>.",761593,2564649,2564649_D011224_D009127,2564649_4,bcv_easy_1162_sent_work_dev_set_761593,no_relation,770955761,TRUE,golden,5,,"



",no_relation,0.7829,TRUE,D010433,"<span class=""chemical"">metrazol</span>",D000699,"<span class=""disease"">analgesia</span>","Both verapamil (10 mg/kg i.p.) and NH4Ac pretreatment enhanced morphine <span class=""disease"">analgesia</span>- and diazepam-induced muscular incoordination and antagonized amphetamine-induced motor activity, and neither verapamil nor NH4Ac affected the convulsant action of <span class=""chemical"">metrazol</span>.",761593,6323692,6323692_D010433_D000699,6323692_7,bcv_easy_376_sent_work_dev_set_761593,no_relation,770955762,TRUE,golden,9,,"







",no_relation,1,TRUE,D001262,"<span class=""chemical"">atenolol</span>",D001145,"<span class=""disease"">arrhythmia</span>","The <span class=""disease"">arrhythmia</span> resolved after therapy with <span class=""chemical"">atenolol</span>, but recurred a year later.",761593,20552622,20552622_D001262_D001145,20552622_3,bcv_easy_43_sent_work_dev_set_761593,no_relation,770955763,TRUE,golden,10,,"








",no_relation,1,TRUE,D006493,"<span class=""chemical"">Unfractionated heparin sodium/UFH</span>",D013927,"<span class=""disease"">thrombosis</span>","BACKGROUND: <span class=""chemical"">Unfractionated heparin sodium</span> (<span class=""chemical"">UFH</span>) or low-molecular weight heparin (LMWH) is used in anticoagulant protocols at several institutions to prevent <span class=""disease"">thrombosis</span> after liver transplantation.",761593,18589141,18589141_D006493_D013927,18589141_1,bcv_easy_491_sent_work_dev_set_761593,no_relation,770955764,TRUE,golden,15,,"













",no_relation,1,TRUE,D008687,"<span class=""chemical"">metformin</span>",D007674,"<span class=""disease"">nephrotoxicity</span>","Thus, our study suggests that pleiotropic effects of <span class=""chemical"">metformin</span> can lessen gentamicin <span class=""disease"">nephrotoxicity</span> and improve mitochondrial homeostasis.",761593,20164825,20164825_D008687_D007674,20164825_10,bcv_easy_273_sent_work_dev_set_761593,no_relation,770955765,TRUE,golden,10,,"








",no_relation,1,TRUE,D004052,"<span class=""chemical"">diethylnitrosamine</span>",D063646,"<span class=""disease"">carcinogenic</span>","Anti-<span class=""disease"">carcinogenic</span> action of phenobarbital given simultaneously with <span class=""chemical"">diethylnitrosamine</span> in the rat.",761593,3780814,3780814_D004052_D063646,3780814_0,bcv_easy_712_sent_work_dev_set_761593,no_relation,770955766,TRUE,golden,13,,"











",no_relation,0.8558,TRUE,D000086,"<span class=""chemical"">acetazolamide</span>",D007674,"<span class=""disease"">renal impairment</span>","Acute confusion induced by <span class=""chemical"">acetazolamide</span> is a well known adverse drug reaction in patients with <span class=""disease"">renal impairment</span>.",761593,10692744,10692744_D000086_D007674,10692744_1,bcv_easy_989_sent_work_dev_set_761593,no_relation,770955767,TRUE,golden,13,,"











",no_relation,0.921,TRUE,D004298,"<span class=""chemical"">dopamine</span>",D003128,"<span class=""disease"">coma</span>","Thus, the reduction in blood and brain ammonia and the prevention of ammonia <span class=""disease"">coma</span> after L-dopa, can be accounted for by the peripheral effect of <span class=""chemical"">dopamine</span> on renal function rather than its central action.",761593,761833,761833_D004298_D003128,761833_6,bcv_easy_465_sent_work_dev_set_761593,no_relation,770955768,TRUE,golden,13,,"











",no_relation,1,TRUE,D012254,"<span class=""chemical"">ribavirin</span>",D006482,"<span class=""disease"">infection with hemorrhagic fever viruses</span>","Intravenous <span class=""chemical"">ribavirin</span> is the treatment of choice for <span class=""disease"">infection with hemorrhagic fever viruses</span>.",761593,12093990,12093990_D012254_D006482,12093990_8,bcv_easy_238_sent_work_dev_set_761593,no_relation,770955769,TRUE,golden,15,,"













",no_relation,0.8116,TRUE,D015725,"<span class=""chemical"">fluconazole</span>",D001145,"<span class=""disease"">ventricular arrhythmias</span>","Serial electrocardiographic monitoring may be considered when <span class=""chemical"">fluconazole</span> is administered in patients who are at risk for <span class=""disease"">ventricular arrhythmias</span>.",761593,11302406,11302406_D015725_D001145,11302406_7,bcv_easy_544_sent_work_dev_set_761593,no_relation,770955770,TRUE,golden,9,,"







",no_relation,1,TRUE,D000082,"<span class=""chemical"">acetaminophen</span>",D013345,"<span class=""disease"">SAH</span>","Ketoprofen but not <span class=""chemical"">acetaminophen</span> impaired platelet function in patients with <span class=""disease"">SAH</span>.",761593,10414674,10414674_D000082_D013345,10414674_11,bcv_easy_902_sent_work_dev_set_761593,no_relation,770955771,TRUE,golden,15,,"













",no_relation,1,TRUE,D017035,"<span class=""chemical"">pravastatin</span>",D006937,"<span class=""disease"">hypercholesterolemia</span>","He assumed <span class=""chemical"">pravastatin</span> (20 mg/day) because of <span class=""disease"">hypercholesterolemia</span>.",761593,7604176,7604176_D017035_D006937,7604176_3,bcv_easy_810_sent_work_dev_set_761593,no_relation,770955772,TRUE,golden,9,,"







",no_relation,1,TRUE,D013792,"<span class=""chemical"">thalidomide</span>",D002292,"<span class=""disease"">renal cell carcinoma</span>","CONCLUSION: These results are consistent with a low level of activity of <span class=""chemical"">thalidomide</span> in <span class=""disease"">renal cell carcinoma</span>.",761593,12448656,12448656_D013792_D002292,12448656_9,bcv_easy_386_sent_work_dev_set_761593,no_relation,770955773,TRUE,golden,8,,"






",no_relation,1,TRUE,C018370,"<span class=""chemical"">pregnenolone sulphate</span>",D000647,"<span class=""disease"">amnesic</span>","Steroid structure and pharmacological properties determine the anti-<span class=""disease"">amnesic</span> effects of <span class=""chemical"">pregnenolone sulphate</span> in the passive avoidance task in rats.",761593,11860495,11860495_C018370_D000647,11860495_0,bcv_easy_1227_sent_work_dev_set_761593,no_relation,770955774,TRUE,golden,16,,"














",no_relation,1,TRUE,D007980,"<span class=""chemical"">levodopa</span>",D010300,"<span class=""disease"">idiopathic Parkinson's disease</span>","Tiapride, a substituted benzamide derivative closely related to metoclopramide, reduced <span class=""chemical"">levodopa</span>-induced peak dose involuntary movements in 16 patients with <span class=""disease"">idiopathic Parkinson's disease</span>.",761593,458486,458486_D007980_D010300,458486_1,bcv_easy_109_sent_work_dev_set_761593,no_relation,770955775,TRUE,golden,11,,"









",no_relation,0.9171,TRUE,D014269,"<span class=""chemical"">trifluoroacetyl</span>",D056486,"<span class=""disease"">hepatitis</span>","An antibody response to a protein-bound biotransformation product (<span class=""chemical"">trifluoroacetyl</span> adduct) has been detected on halothane <span class=""disease"">hepatitis</span> patients.",761593,7647582,7647582_D014269_D056486,7647582_3,bcv_easy_913_sent_work_dev_set_761593,no_relation,770955776,TRUE,golden,10,,"








",no_relation,1,TRUE,D003520,"<span class=""chemical"">cyclophosphamide</span>",D007674,"<span class=""disease"">renal involvement</span>","Since 1989, she had been suffering from systemic lupus erythematosus (SLE) with <span class=""disease"">renal involvement</span> and undergone periods of treatment with azathioprine and <span class=""chemical"">cyclophosphamide</span>.",761593,12739036,12739036_D003520_D007674,12739036_2,bcv_easy_296_sent_work_dev_set_761593,no_relation,770955777,TRUE,golden,5,,"



",no_relation,0.8033,TRUE,D004052,"<span class=""chemical"">diethylnitrosamine/DEN</span>",D063646,"<span class=""disease"">carcinogenesis</span>","The present work has been planned in order to elucidate the effect of phenobarbital (PB: 15 mg per rat of ingested dose) on <span class=""disease"">carcinogenesis</span> when it is administered simultaneously with <span class=""chemical"">diethylnitrosamine</span> (<span class=""chemical"">DEN</span>: 10 mg/kg/day).",761593,3780814,3780814_D004052_D063646,3780814_1,bcv_easy_714_sent_work_dev_set_761593,no_relation,770955778,TRUE,golden,12,,"










",no_relation,1,TRUE,D005492,"<span class=""chemical"">folic acid</span>",D064420,"<span class=""disease"">toxicity</span>","This observation prompted a Phase I clinical study of lometrexol given with <span class=""chemical"">folic acid</span> supplementation which has confirmed that the <span class=""disease"">toxicity</span> of lometrexol can be markedly reduced by <span class=""chemical"">folic acid</span> supplementation.",761593,8958188,8958188_D005492_D064420,8958188_5,bcv_easy_185_sent_work_dev_set_761593,no_relation,770955779,TRUE,golden,10,,"








",no_relation,0.9061,TRUE,C095756,"<span class=""chemical"">AIDA</span>",D009127,"<span class=""disease"">muscle rigidity</span>","<span class=""chemical"">AIDA</span> in doses of 7.5-15 microg/0.5 microl diminished the haloperidol-induced <span class=""disease"">muscle rigidity</span>.",761593,12231232,12231232_C095756_D009127,12231232_4,bcv_easy_479_sent_work_dev_set_761593,no_relation,770955780,TRUE,golden,12,,"










",no_relation,1,TRUE,C507346,"<span class=""chemical"">AMN082</span>",D018476,"<span class=""disease"">akinetic</span>","In a more complex task commonly used to evaluate major <span class=""disease"">akinetic</span> symptoms of PD patients, 5 mg/kg <span class=""chemical"">AMN082</span> reverses the increased reaction time to respond to a cue of bilateral 6-OHDA-lesioned rats.",761593,19940105,19940105_C507346_D018476,19940105_6,bcv_easy_1238_sent_work_dev_set_761593,no_relation,770955781,TRUE,golden,6,,"




",no_relation,0.6858,TRUE,D006046,"<span class=""chemical"">gold</span>",D009393,"<span class=""disease"">nephritis</span>","A strong association has been found between <span class=""disease"">nephritis</span> and dermatitis due to Tiopronin (a D-Penicillamine like compound) and class I antigens B35-Cw4, and between dermatitis due to <span class=""chemical"">gold</span> thiosulphate and B35.",761593,3084782,3084782_D006046_D009393,3084782_2,bcv_easy_674_sent_work_dev_set_761593,no_relation,770955782,TRUE,golden,5,,"



",no_relation,1,TRUE,D007649,"<span class=""chemical"">Ketamine</span>",D012559,"<span class=""disease"">schizophrenia</span>","<span class=""chemical"">Ketamine</span> induces activation changes in healthy subjects similar to those observed in patients with <span class=""disease"">schizophrenia</span>, particularly in frontal and temporal brain regions.",761593,20727411,20727411_D007649_D012559,20727411_10,bcv_easy_226_sent_work_dev_set_761593,no_relation,770955783,TRUE,golden,9,,"







",no_relation,1,TRUE,D010634,"<span class=""chemical"">PB</span>",D009369,"<span class=""disease"">tumor</span>","In DEN + <span class=""chemical"">PB</span> treated rats, the survival was prolonged and the <span class=""disease"">tumor</span> incidence decreased as compared with the results obtained by DEN alone.",761593,3780814,3780814_D010634_D009369,3780814_6,bcv_easy_720_sent_work_dev_set_761593,no_relation,770955784,TRUE,golden,14,,"












",no_relation,0.933,TRUE,D007650,"<span class=""chemical"">Ketanserin</span>",D009127,"<span class=""disease"">muscle rigidity</span>","<span class=""chemical"">Ketanserin</span> pretreatment reverses alfentanil-induced <span class=""disease"">muscle rigidity</span>.",761593,3115150,3115150_D007650_D009127,3115150_0,bcv_easy_228_sent_work_dev_set_761593,no_relation,770955785,TRUE,golden,15,,"













",no_relation,0.9383,TRUE,D009270,"<span class=""chemical"">Naloxone</span>",D012133,"<span class=""disease"">respiratory paralysis</span>","<span class=""chemical"">Naloxone</span> (2.5 mg/kg, i.v.) reversed <span class=""disease"">respiratory paralysis</span>, glutamate and GABA levels to control values in brain stem and cortex with no changes in caudate or cerebellum.",761593,2893236,2893236_D009270_D012133,2893236_6,bcv_easy_447_sent_work_dev_set_761593,no_relation,770955786,TRUE,golden,9,,"







",no_relation,0.7794,TRUE,D001379,"<span class=""chemical"">azathioprine</span>",D007674,"<span class=""disease"">renal involvement</span>","Since 1989, she had been suffering from systemic lupus erythematosus (SLE) with <span class=""disease"">renal involvement</span> and undergone periods of treatment with <span class=""chemical"">azathioprine</span> and cyclophosphamide.",761593,12739036,12739036_D001379_D007674,12739036_2,bcv_easy_297_sent_work_dev_set_761593,no_relation,770955787,TRUE,golden,6,,"




",no_relation,0.8321,TRUE,D014031,"<span class=""chemical"">tobramicyn</span>",D064420,"<span class=""disease"">toxicity</span>","OBJECTIVE: To evaluate the effect of dosage regimen (once-daily vs. twice-daily) of <span class=""chemical"">tobramicyn</span> on steady-state serum concentrations and <span class=""disease"">toxicity</span>.",761593,9875685,9875685_D014031_D064420,9875685_1,bcv_easy_1026_sent_work_dev_set_761593,no_relation,770955788,TRUE,golden,10,,"








",no_relation,1,TRUE,D005492,"<span class=""chemical"">folic acid</span>",D064420,"<span class=""disease"">toxicity</span>","Preclinical murine studies demonstrated that the <span class=""disease"">toxicity</span> of lometrexol can be prevented by low dose <span class=""chemical"">folic acid</span> administration, i.e. for 7 days prior to and 7 days following a single bolus dose.",761593,8958188,8958188_D005492_D064420,8958188_4,bcv_easy_183_sent_work_dev_set_761593,no_relation,770955789,TRUE,golden,13,,"











",no_relation,0.9328,TRUE,D002216,"<span class=""chemical"">captopril</span>",D006973,"<span class=""disease"">hypertensive</span>","Contribution of the sympathetic nervous system to salt-sensitivity in lifetime <span class=""chemical"">captopril</span>-treated spontaneously <span class=""disease"">hypertensive</span> rats.",761593,8586822,8586822_D002216_D006973,8586822_0,bcv_easy_1188_sent_work_dev_set_761593,no_relation,770955790,TRUE,golden,16,,"














",no_relation,0.8813,TRUE,D013467,"<span class=""chemical"">sulindac</span>",D001172,"<span class=""disease"">rheumatoid arthritis</span>","A 31-year-old man with <span class=""disease"">rheumatoid arthritis</span>, who had previously been treated with <span class=""chemical"">sulindac</span>, fenoprofen calcium, high dose salicylates and gold salts, developed renal papillary necrosis (RPN) 4 months after institution of naproxen therapy.",761593,6699841,6699841_D013467_D001172,6699841_1,bcv_easy_1250_sent_work_dev_set_761593,no_relation,770955791,TRUE,golden,14,,"












",no_relation,0.9308,TRUE,D000638,"<span class=""chemical"">amiodarone</span>",D017180,"<span class=""disease"">VT</span>","Six percent of the patients had a nonfatal recurrence of <span class=""disease"">VT</span> and were successfully managed by continuing <span class=""chemical"">amiodarone</span> at a higher dose or by the addition of a conventional antiarrhythmic drug.",761593,6637851,6637851_D000638_D017180,6637851_4,bcv_easy_1018_sent_work_dev_set_761593,no_relation,770955792,TRUE,golden,10,,"








",no_relation,1,TRUE,D014635,"<span class=""chemical"">VPA</span>",D004830,"<span class=""disease"">tonic-clonic convulsions</span>","He had been taking <span class=""chemical"">VPA</span> for treatment of idiopathic generalized <span class=""disease"">tonic-clonic convulsions</span> since he was 56 years old.",761593,11195262,11195262_D014635_D004830,11195262_2,bcv_easy_160_sent_work_dev_set_761593,no_relation,770955793,TRUE,golden,9,,"







",no_relation,1,TRUE,D000617,"<span class=""chemical"">aminoglycoside</span>",D006402|D009369,"<span class=""disease"">hematologic/oncologic disorder</span>","Forty patients with a diagnosis consistent with a <span class=""disease"">hematologic/oncologic disorder</span> that required treatment with an <span class=""chemical"">aminoglycoside</span> were randomized to either conventional or extended-interval amikacin.",761593,18356633,18356633_D000617_D006402|D009369,18356633_4,bcv_easy_699_sent_work_dev_set_761593,no_relation,770955794,TRUE,golden,7,,"





",no_relation,0.8507,TRUE,D003630,"<span class=""chemical"">daunorubicin</span>",D001855,"<span class=""disease"">myelosuppression</span>","RESULTS: Nontoxic doses of dexrazoxane reduced <span class=""disease"">myelosuppression</span> and weight loss from <span class=""chemical"">daunorubicin</span> and etoposide in mice and antagonized their antiproliferative effects in the colony assay; however, dexrazoxane neither reduced <span class=""disease"">myelosuppression</span>, weight loss, nor the in vitro cytotoxicity from doxorubicin.",761593,15897593,15897593_D003630_D001855,15897593_5,bcv_easy_977_sent_work_dev_set_761593,yes_direct,Daunorubicin causes weight loss and myelosuppression. Dexrazoxane made the myelosuppression and weight loss better.770955795,TRUE,golden,10,,"








",no_relation,1,TRUE,D064730,"<span class=""chemical"">dexrazoxane</span>",D009362,"<span class=""disease"">metastases</span>","Clinical trials in patients with brain <span class=""disease"">metastases</span> combining <span class=""chemical"">dexrazoxane</span> and high doses of etoposide is ongoing with the aim of improving efficacy without aggravating hematologic toxicity.",761593,15897593,15897593_D064730_D009362,15897593_8,bcv_easy_985_sent_work_dev_set_761593,no_relation,770955796,TRUE,golden,12,,"










",no_relation,0.5919,TRUE,D002122,"<span class=""chemical"">calcium chloride</span>",D014202,"<span class=""disease"">tremor</span>","The effect of <span class=""chemical"">calcium chloride</span> injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), mydriasis, <span class=""disease"">tremor</span> and clonic-tonic convulsions produced by carbachol and eserine injected similarly was investigated.",761593,6892185,6892185_D002122_D014202,6892185_1,bcv_easy_1044_sent_work_dev_set_761593,no_relation,770955797,TRUE,golden,14,,"












",no_relation,1,TRUE,D000583,"<span class=""chemical"">Amikacin</span>",D009503,"<span class=""disease"">febrile neutropenia</span>","<span class=""chemical"">Amikacin</span> is an aminoglycoside commonly used to provide empirical double gram-negative treatment for <span class=""disease"">febrile neutropenia</span> and other suspected infections.",761593,18356633,18356633_D000583_D009503,18356633_1,bcv_easy_694_sent_work_dev_set_761593,no_relation,770955798,TRUE,golden,11,,"





Used as treatment.



",no_relation,0.9104,TRUE,D014282,"<span class=""chemical"">trihexyphenidyl hydrochloride</span>",D012559,"<span class=""disease"">schizophrenic</span>","A chronic <span class=""disease"">schizophrenic</span> patient was treated with an anticholinergic drug, <span class=""chemical"">trihexyphenidyl hydrochloride</span>.",761593,3769769,3769769_D014282_D012559,3769769_1,bcv_easy_251_sent_work_dev_set_761593,no_relation,770955799,FALSE,golden,2,,"
",yes_direct,1,TRUE,D002122,"<span class=""chemical"">calcium chloride</span>",D004830,"<span class=""disease"">clonic-tonic convulsions</span>","The effect of <span class=""chemical"">calcium chloride</span> injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> produced by carbachol and eserine injected similarly was investigated.",761593,6892185,6892185_D002122_D004830,6892185_1,bcv_easy_1045_sent_work_dev_set_761593,no_relation,770955800,TRUE,golden,10,,"








",no_relation,1,TRUE,D003520,"<span class=""chemical"">cyclophosphamide</span>",D008180,"<span class=""disease"">systemic lupus erythematosus/SLE</span>","Since 1989, she had been suffering from <span class=""disease"">systemic lupus erythematosus</span> (<span class=""disease"">SLE</span>) with renal involvement and undergone periods of treatment with azathioprine and <span class=""chemical"">cyclophosphamide</span>.",761593,12739036,12739036_D003520_D008180,12739036_2,bcv_easy_295_sent_work_dev_set_761593,no_relation,770955801,TRUE,golden,9,,"







",no_relation,0.6702,TRUE,D005557,"<span class=""chemical"">formalin</span>",D010146,"<span class=""disease"">pain</span>","Their ester prodrugs 6 and 8 were orally active in three models of <span class=""disease"">pain</span>: reversal of <span class=""chemical"">formalin</span>-induced paw licking, carrageenan-induced thermal hyperalgesia, and capsaicin-induced mechanical hyperalgesia.",761593,15974569,15974569_D005557_D010146,15974569_2,bcv_easy_420_sent_work_dev_set_761593,no_relation,770955802,TRUE,golden,9,,"







",no_relation,0.5529,TRUE,D002110,"<span class=""chemical"">caffeine</span>",D006331,"<span class=""disease"">cardiac disease</span>","We describe a patient with no previous history of <span class=""disease"">cardiac disease</span> or arrhythmia who developed sustained bigeminy and 2 brief runs of ventricular tachycardia after <span class=""chemical"">caffeine</span> administration.",761593,18997632,18997632_D002110_D006331,18997632_3,bcv_easy_124_sent_work_dev_set_761593,no_relation,770955803,TRUE,golden,15,,"













",no_relation,1,TRUE,C400082,"<span class=""chemical"">bortezomib</span>",D009101,"<span class=""disease"">MM</span>","The results suggest that <span class=""chemical"">bortezomib</span> in combination with cyclophosphamide at 900 mg/m(2) and dexamethasone is an effective induction treatment for patients with newly diagnosed <span class=""disease"">MM</span> that warrants further investigation.",761593,19274460,19274460_C400082_D009101,19274460_8,bcv_easy_578_sent_work_dev_set_761593,no_relation,770955804,TRUE,golden,17,,"















",no_relation,1,TRUE,D007980,"<span class=""chemical"">L-dopa</span>",D003128,"<span class=""disease"">coma</span>","This <span class=""disease"">coma</span> was prevented with 1.68 mmol <span class=""chemical"">L-dopa</span> given by gastric intubation 15 minutes before the ammonium salt injection.",761593,761833,761833_D007980_D003128,761833_2,bcv_easy_460_sent_work_dev_set_761593,no_relation,770955805,TRUE,golden,14,,"












",no_relation,1,TRUE,D011899,"<span class=""chemical"">ranitidine</span>",D007172,"<span class=""disease"">impotence</span>","Sixty percent of the males developed breast changes or <span class=""disease"">impotence</span> while taking cimetidine and in all cases these changes disappeared when cimetidine was replaced by <span class=""chemical"">ranitidine</span>.",761593,6150641,6150641_D011899_D007172,6150641_6,bcv_easy_325_sent_work_dev_set_761593,no_relation,770955806,TRUE,golden,9,,"







",no_relation,0.8937,TRUE,D005996,"<span class=""chemical"">Glyceryl trinitrate</span>",D020325,"<span class=""disease"">migraine with aura</span>","<span class=""chemical"">Glyceryl trinitrate</span> induces attacks of migraine without aura in sufferers of <span class=""disease"">migraine with aura</span>.",761593,10524660,10524660_D005996_D020325,10524660_0,bcv_easy_600_sent_work_dev_set_761593,no_relation,770955807,TRUE,golden,10,,"








",no_relation,1,TRUE,C018370,"<span class=""chemical"">PREGS</span>",D000647,"<span class=""disease"">amnesic</span>","Moreover, <span class=""chemical"">PREGS</span> is able to reverse the <span class=""disease"">amnesic</span>-like effects of NMDAR and GABA(A)R ligands.",761593,11860495,11860495_C018370_D000647,11860495_4,bcv_easy_1229_sent_work_dev_set_761593,no_relation,770955808,TRUE,golden,10,,"








",no_relation,0.6116,TRUE,D005472,"<span class=""chemical"">5-FU/5-fluorouracil</span>",D009362,"<span class=""disease"">metastasis</span>","We report a case of a patient with colon carcinoma and liver <span class=""disease"">metastasis</span> who presented chest pain after <span class=""chemical"">5-fluorouracil</span> (<span class=""chemical"">5-FU</span>) administration.",761593,3952818,3952818_D005472_D009362,3952818_1,bcv_easy_996_sent_work_dev_set_761593,no_relation,770955809,TRUE,golden,9,,"







",no_relation,1,TRUE,D002122,"<span class=""chemical"">calcium chloride</span>",D015878,"<span class=""disease"">mydriasis</span>","On the other hand, <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions evoked by carbachol and eserine were not significantly changed by <span class=""chemical"">calcium chloride</span>.",761593,6892185,6892185_D002122_D015878,6892185_3,bcv_easy_1049_sent_work_dev_set_761593,no_relation,770955810,TRUE,golden,13,,"











",no_relation,1,TRUE,D003520,"<span class=""chemical"">cyclophosphamide</span>",D001943,"<span class=""disease"">breast cancer</span>","Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and <span class=""chemical"">cyclophosphamide</span> compared with conventional doxorubicin and <span class=""chemical"">cyclophosphamide</span> in a randomized, multicenter trial of metastatic <span class=""disease"">breast cancer</span>.",761593,11230490,11230490_D003520_D001943,11230490_0,bcv_easy_131_sent_work_dev_set_761593,no_relation,770955811,TRUE,golden,10,,"al simplificar las palabras es mas entendible para uno que no es medico en este tipo de tarea...thanksss








",no_relation,1,TRUE,D000638,"<span class=""chemical"">Amiodarone</span>",D017180,"<span class=""disease"">VT/ventricular tachycardia</span>","<span class=""chemical"">Amiodarone</span> was administered to 154 patients who had sustained, symptomatic <span class=""disease"">ventricular tachycardia</span> (<span class=""disease"">VT</span>) (n = 118) or a cardiac arrest (n = 36) and who were refractory to conventional antiarrhythmic drugs.",761593,6637851,6637851_D000638_D017180,6637851_1,bcv_easy_1014_sent_work_dev_set_761593,no_relation,770955812,TRUE,golden,12,,"










",no_relation,1,TRUE,C047781,"<span class=""chemical"">LTG/lamotrigine</span>",C562694,"<span class=""disease"">IGE/idiopathic generalized epilepsies</span>","Five patients with <span class=""disease"">idiopathic generalized epilepsies</span> (<span class=""disease"">IGE</span>) treated with <span class=""chemical"">lamotrigine</span> (<span class=""chemical"">LTG</span>) experienced exacerbation or de novo appearance of myoclonic jerks (MJ).",761593,16157917,16157917_C047781_C562694,16157917_1,bcv_easy_1006_sent_work_dev_set_761593,no_relation,770955813,TRUE,golden,12,,"










",no_relation,0.831,TRUE,D008713,"<span class=""chemical"">methimazole</span>",D006980,"<span class=""disease"">hyperthyroidism</span>","A 43-year-old woman had severe jaundice and itching 1 month after receiving <span class=""chemical"">methimazole</span> (10 mg tid) and propranolol (20 mg tid) for treatment of <span class=""disease"">hyperthyroidism</span>.",761593,14982270,14982270_D008713_D006980,14982270_2,bcv_easy_550_sent_work_dev_set_761593,no_relation,770955814,TRUE,golden,5,,"



",no_relation,0.8017,TRUE,C004742,"<span class=""chemical"">Daidzein</span>",D000647,"<span class=""disease"">amnesia</span>","<span class=""chemical"">Daidzein</span> activates choline acetyltransferase from MC-IXC cells and improves drug-induced <span class=""disease"">amnesia</span>.",761593,16428827,16428827_C004742_D000647,16428827_0,bcv_easy_62_sent_work_dev_set_761593,no_relation,770955815,TRUE,golden,13,,"











",no_relation,1,TRUE,D005557,"<span class=""chemical"">formalin</span>",D006930,"<span class=""disease"">thermal hyperalgesia/mechanical hyperalgesia</span>","Their ester prodrugs 6 and 8 were orally active in three models of pain: reversal of <span class=""chemical"">formalin</span>-induced paw licking, carrageenan-induced <span class=""disease"">thermal hyperalgesia</span>, and capsaicin-induced <span class=""disease"">mechanical hyperalgesia</span>.",761593,15974569,15974569_D005557_D006930,15974569_2,bcv_easy_419_sent_work_dev_set_761593,no_relation,770955816,TRUE,golden,8,,"






",no_relation,1,TRUE,D020117,"<span class=""chemical"">Cisapride</span>",D015835,"<span class=""disease"">gastrointestinal motility disorders</span>","<span class=""chemical"">Cisapride</span>, a cytochrome P450 3A4 (CYP3A4) substrate, is widely prescribed for the treatment of <span class=""disease"">gastrointestinal motility disorders</span>.",761593,9545159,9545159_D020117_D015835,9545159_1,bcv_easy_254_sent_work_dev_set_761593,no_relation,770955817,TRUE,golden,10,,"








",no_relation,0.8957,TRUE,D015215,"<span class=""chemical"">AZT</span>",D000163,"<span class=""disease"">AIDS</span>","<span class=""chemical"">AZT</span> has induced a macrocytic anemia in <span class=""disease"">AIDS</span> patients on long term <span class=""chemical"">AZT</span> therapy.",761593,9209318,9209318_D015215_D000163,9209318_1,bcv_easy_906_sent_work_dev_set_761593,no_relation,770955818,TRUE,golden,8,,"






",no_relation,1,TRUE,D013835,"<span class=""chemical"">thiamine pyrophosphate/TPP</span>",D003920,"<span class=""disease"">diabetic</span>","We studied a thiamine-dependent enzyme, transketolase, from fibroblasts of a <span class=""disease"">diabetic</span> patient who developed Wernicke's encephalopathy when treated with tolazamide, in order to delineate if this patient also had transketolase abnormality [high Km for <span class=""chemical"">thiamine pyrophosphate</span> (<span class=""chemical"">TPP</span>)], as previously reported in postalcoholic Wernicke-Korsakoff syndrome.",761593,3762968,3762968_D013835_D003920,3762968_1,bcv_easy_729_sent_work_dev_set_761593,no_relation,770955819,TRUE,golden,11,,"









",no_relation,0.5445,TRUE,C009166,"<span class=""chemical"">retinyl acetate</span>",D013274,"<span class=""disease"">forestomach carcinogenesis</span>","Co-carcinogenic effect of <span class=""chemical"">retinyl acetate</span> on <span class=""disease"">forestomach carcinogenesis</span> of male F344 rats induced with butylated hydroxyanisole.",761593,3131282,3131282_C009166_D013274,3131282_0,bcv_easy_347_sent_work_dev_set_761593,no_relation,770955820,TRUE,golden,6,,"




",no_relation,1,TRUE,C097949,"<span class=""chemical"">1,25-dihydroxyvitamin D</span>",D058186,"<span class=""disease"">acute renal insufficiency</span>","RESULTS: The 3 patients had <span class=""disease"">acute renal insufficiency</span>, relative metabolic alkalosis, and low parathyroid hormone (PTH), PTH-related peptide, and <span class=""chemical"">1,25-dihydroxyvitamin D</span> concentrations.",761593,16006300,16006300_C097949_D058186,16006300_3,bcv_easy_705_sent_work_dev_set_761593,no_relation,770955821,TRUE,golden,9,,"







",no_relation,1,TRUE,C071741,"<span class=""chemical"">Remifentanil</span>",D010146,"<span class=""disease"">pain</span>","<span class=""chemical"">Remifentanil</span>-related complications were assessed during the <span class=""chemical"">remifentanil</span> infusion, and <span class=""disease"">pain</span> caused by propofol was evaluated using a four-point scale during the propofol infusion.",761593,18006530,18006530_C071741_D010146,18006530_6,bcv_easy_9_sent_work_dev_set_761593,no_relation,770955822,TRUE,golden,12,,"










",no_relation,1,TRUE,D000617,"<span class=""chemical"">aminoglycoside</span>",D009503,"<span class=""disease"">febrile neutropenia</span>","Amikacin is an <span class=""chemical"">aminoglycoside</span> commonly used to provide empirical double gram-negative treatment for <span class=""disease"">febrile neutropenia</span> and other suspected infections.",761593,18356633,18356633_D000617_D009503,18356633_1,bcv_easy_695_sent_work_dev_set_761593,no_relation,770955823,TRUE,golden,17,,"















",no_relation,1,TRUE,D002122,"<span class=""chemical"">calcium chloride</span>",D004830,"<span class=""disease"">clonic-tonic convulsions</span>","On the other hand, mydriasis, tremor and <span class=""disease"">clonic-tonic convulsions</span> evoked by carbachol and eserine were not significantly changed by <span class=""chemical"">calcium chloride</span>.",761593,6892185,6892185_D002122_D004830,6892185_3,bcv_easy_1054_sent_work_dev_set_761593,no_relation,770955824,TRUE,golden,9,,"







",no_relation,0.8932,TRUE,D008687,"<span class=""chemical"">Metformin</span>",D058186,"<span class=""disease"">acute renal failure</span>","<span class=""chemical"">Metformin</span> treatment fully blocked gentamicin-mediated <span class=""disease"">acute renal failure</span>.",761593,20164825,20164825_D008687_D058186,20164825_4,bcv_easy_271_sent_work_dev_set_761593,no_relation,770955825,TRUE,golden,8,,"






",no_relation,1,TRUE,C037689,"<span class=""chemical"">benzamide</span>",D010300,"<span class=""disease"">idiopathic Parkinson's disease</span>","Tiapride, a substituted <span class=""chemical"">benzamide</span> derivative closely related to metoclopramide, reduced levodopa-induced peak dose involuntary movements in 16 patients with <span class=""disease"">idiopathic Parkinson's disease</span>.",761593,458486,458486_C037689_D010300,458486_1,bcv_easy_103_sent_work_dev_set_761593,no_relation,770955826,TRUE,golden,10,,"








",no_relation,1,TRUE,D006046,"<span class=""chemical"">gold</span>",D001172,"<span class=""disease"">rheumatoid arthritis</span>","A 31-year-old man with <span class=""disease"">rheumatoid arthritis</span>, who had previously been treated with sulindac, fenoprofen calcium, high dose salicylates and <span class=""chemical"">gold</span> salts, developed renal papillary necrosis (RPN) 4 months after institution of naproxen therapy.",761593,6699841,6699841_D006046_D001172,6699841_1,bcv_easy_1245_sent_work_dev_set_761593,no_relation,770955827,TRUE,golden,11,,"









",no_relation,1,TRUE,D018967,"<span class=""chemical"">risperidone</span>",D001480,"<span class=""disease"">EPS</span>","Two schizophrenic patients, who had a prior history of LSD abuse and who had previously developed <span class=""disease"">EPS</span> with classic antipsychotics, were successfully treated with <span class=""chemical"">risperidone</span>.",761593,12013711,12013711_D018967_D001480,12013711_1,bcv_easy_151_sent_work_dev_set_761593,no_relation,770955828,TRUE,golden,12,,"










",no_relation,0.9206,TRUE,D002752,"<span class=""chemical"">chlorthalidone</span>",D003324,"<span class=""disease"">coronary artery disease</span>","Thus, myocardial electrical excitability was measured in patients with mild essential hypertension and known <span class=""disease"">coronary artery disease</span> after 8 weeks of treatment with a potassium-conserving diuretic (amiloride) and a similar period on a potassium-losing diuretic (<span class=""chemical"">chlorthalidone</span>) in a randomised study.",761593,3732088,3732088_D002752_D003324,3732088_3,bcv_easy_20_sent_work_dev_set_761593,no_relation,770955829,TRUE,golden,9,,"







",no_relation,0.8848,TRUE,D003345,"<span class=""chemical"">corticosterone</span>",D009422,"<span class=""disease"">neuropathy</span>","Although low concentrations (less than or equal to 50 ppm) of <span class=""chemical"">corticosterone</span> had beneficial effects on TOTP-induced <span class=""disease"">neuropathy</span>, greater than or equal to 200 ppm exacerbated clinical signs in chickens given either TOTP or DFP.",761593,3961813,3961813_D003345_D009422,3961813_3,bcv_easy_520_sent_work_dev_set_761593,no_relation,770955830,TRUE,golden,11,,"









",no_relation,1,TRUE,D009543,"<span class=""chemical"">nifedipine</span>",D000788,"<span class=""disease"">Prinzmetal's angina</span>","Clinical electrocardiographic evolution was similar to that observed in <span class=""disease"">Prinzmetal's angina</span>, and chest pain promptly resolved with <span class=""chemical"">nifedipine</span>.",761593,3952818,3952818_D009543_D000788,3952818_2,bcv_easy_999_sent_work_dev_set_761593,no_relation,770955831,TRUE,golden,7,,"





",no_relation,1,TRUE,C507346,"<span class=""chemical"">AMN082</span>",D010300,"<span class=""disease"">PD</span>","In a more complex task commonly used to evaluate major akinetic symptoms of <span class=""disease"">PD</span> patients, 5 mg/kg <span class=""chemical"">AMN082</span> reverses the increased reaction time to respond to a cue of bilateral 6-OHDA-lesioned rats.",761593,19940105,19940105_C507346_D010300,19940105_6,bcv_easy_1239_sent_work_dev_set_761593,no_relation,770955832,TRUE,golden,9,,"







",no_relation,0.8851,TRUE,C422649,"<span class=""chemical"">etoricoxib</span>",D005767,"<span class=""disease"">GI AEs</span>","The cumulative discontinuation rate due to <span class=""disease"">GI AEs</span> was significantly lower with <span class=""chemical"">etoricoxib</span> than diclofenac (5.2 vs 8.5 events per 100 patient-years, respectively; hazard ratio 0.62 (95% CI: 0.47, 0.81; p<or=0.001)).",761593,17965424,17965424_C422649_D005767,17965424_8,bcv_easy_930_sent_work_dev_set_761593,no_relation,770955833,TRUE,golden,5,,"



",no_relation,1,TRUE,D009599,"<span class=""chemical"">nitroprusside</span>",D007511,"<span class=""disease"">ischemia</span>","Increased plasma malondialdehyde was also recorded in two other groups of animals subjected to the same experimental model, one receiving 20 mg/kg b.w. of the cyclooxygenase inhibitor acetylsalicylate intravenously immediately before <span class=""disease"">ischemia</span>, the other receiving 650 micrograms/kg b.w. of the hypotensive drug <span class=""chemical"">nitroprusside</span> at a flow rate of 103 microliters/min intravenously during <span class=""disease"">ischemia</span>, although in this latter group malondialdehyde was significantly higher.",761593,7710775,7710775_D009599_D007511,7710775_6,bcv_easy_950_sent_work_dev_set_761593,no_relation,770955834,TRUE,golden,10,,"






'Reduced cardiotoxicity' being the key term.

",no_relation,1,TRUE,D004317,"<span class=""chemical"">doxorubicin</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","Reduced <span class=""disease"">cardiotoxicity</span> and preserved antitumor efficacy of liposome-encapsulated <span class=""chemical"">doxorubicin</span> and cyclophosphamide compared with conventional <span class=""chemical"">doxorubicin</span> and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer.",761593,11230490,11230490_D004317_D066126,11230490_0,bcv_easy_132_sent_work_dev_set_761593,no_relation,770955835,TRUE,golden,17,,"















",no_relation,0.9361,TRUE,D001262,"<span class=""chemical"">atenolol</span>",D001145,"<span class=""disease"">arrhythmia</span>","After stopping the beta-agonist, and after a week with the <span class=""chemical"">atenolol</span>, the <span class=""disease"">arrhythmia</span> disappeared.",761593,20552622,20552622_D001262_D001145,20552622_5,bcv_easy_44_sent_work_dev_set_761593,no_relation,770955836,TRUE,golden,9,,"







",no_relation,1,TRUE,D007980,"<span class=""chemical"">L-dopa</span>",D020734,"<span class=""disease"">parkinsonian</span>","We have studied the regional cerebral blood flow (rCBF) changes induced by the execution of a finger-to-thumb opposition motor task in the supplementary and primary motor cortex of two groups of <span class=""disease"">parkinsonian</span> patients on <span class=""chemical"">L-dopa</span> medication, the first one without <span class=""chemical"">L-dopa</span> induced dyskinesia (n = 23) and the other with moderate peak-dose dyskinesia (n = 15), and of a group of 14 normal subjects.",761593,9549528,9549528_D007980_D020734,9549528_1,bcv_easy_891_sent_work_dev_set_761593,no_relation,770955837,TRUE,golden,6,,"




",no_relation,1,TRUE,D064704,"<span class=""chemical"">levofloxacin</span>",D012852,"<span class=""disease"">sinusitis</span>","PURPOSE: To evaluate the efficacy and safety of <span class=""chemical"">levofloxacin</span> (500 mg orally once daily for 10 to 14 days) in treating adult outpatients with acute bacterial <span class=""disease"">sinusitis</span>.",761593,9564988,9564988_D064704_D012852,9564988_1,bcv_easy_679_sent_work_dev_set_761593,no_relation,770955838,TRUE,golden,7,,"





",no_relation,1,TRUE,D002945,"<span class=""chemical"">cisplatin</span>",D001943,"<span class=""disease"">breast cancer</span>","A sixty-year-old woman with advanced <span class=""disease"">breast cancer</span>, previously treated with <span class=""chemical"">cisplatin</span>, developed an irreversible lethal renal failure with anuria, the day after 5 g/m2 bolus ifosfamide.",761593,2320800,2320800_D002945_D001943,2320800_1,bcv_easy_407_sent_work_dev_set_761593,no_relation,770955839,TRUE,golden,10,,"








",no_relation,0.8068,TRUE,D063325,"<span class=""chemical"">Tiapride</span>",D004409,"<span class=""disease"">involuntary movements</span>","<span class=""chemical"">Tiapride</span>, a substituted benzamide derivative closely related to metoclopramide, reduced levodopa-induced peak dose <span class=""disease"">involuntary movements</span> in 16 patients with idiopathic Parkinson's disease.",761593,458486,458486_D063325_D004409,458486_1,bcv_easy_108_sent_work_dev_set_761593,no_relation,770955840,TRUE,golden,11,,"






Used as treatment.


",no_relation,1,TRUE,D003520,"<span class=""chemical"">cyclophosphamide</span>",D009101,"<span class=""disease"">myeloma</span>","DSMM XI study: dose definition for intravenous <span class=""chemical"">cyclophosphamide</span> in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed <span class=""disease"">myeloma</span>.",761593,19274460,19274460_D003520_D009101,19274460_0,bcv_easy_573_sent_work_dev_set_761593,no_relation,770955841,TRUE,golden,11,,"









",no_relation,0.9202,TRUE,D018698,"<span class=""chemical"">glutamate</span>",D020336,"<span class=""disease"">spastic paraparesis</span>","These data indicate that IT morphine induces <span class=""disease"">spastic paraparesis</span> with a concomitant increase in CSF <span class=""chemical"">glutamate</span>, which is involved in NMDA receptor activation.",761593,15673851,15673851_D018698_D020336,15673851_9,bcv_easy_88_sent_work_dev_set_761593,no_relation,770955842,TRUE,golden,10,,"








",no_relation,1,TRUE,D008790,"<span class=""chemical"">metoprolol</span>",D017202,"<span class=""disease"">myocardial ischemia</span>","CONCLUSION: During dobutamine stress testing, <span class=""chemical"">metoprolol</span> attenuates or eliminates evidence of <span class=""disease"">myocardial ischemia</span>.",761593,11079278,11079278_D008790_D017202,11079278_12,bcv_easy_1187_sent_work_dev_set_761593,no_relation,770955843,TRUE,golden,9,,"







",no_relation,1,TRUE,D012254,"<span class=""chemical"">ribavirin</span>",D007239,"<span class=""disease"">infection</span>","Although intravenous <span class=""chemical"">ribavirin</span> was not effective for all children with severe adenovirus disease in this series or in the literature, therapy is unlikely to be of benefit if begun late in the course of the <span class=""disease"">infection</span>.",761593,12093990,12093990_D012254_D007239,12093990_23,bcv_easy_247_sent_work_dev_set_761593,no_relation,770955844,TRUE,golden,10,,"








",no_relation,0.71,TRUE,D007980,"<span class=""chemical"">Levodopa</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","<span class=""chemical"">Levodopa</span>-induced dyskinesias have been reported in <span class=""disease"">Parkinson's disease</span> and multiple system atrophy.",761593,12691807,12691807_D007980_D010300,12691807_1,bcv_easy_333_sent_work_dev_set_761593,no_relation,770955845,TRUE,golden,12,,"










",no_relation,1,TRUE,C032151,"<span class=""chemical"">Cibenzoline</span>",D001145,"<span class=""disease"">arrhythmias</span>","<span class=""chemical"">Cibenzoline</span> suppressed all the <span class=""disease"">arrhythmias</span>, and the minimum effective plasma concentrations for <span class=""disease"">arrhythmias</span> induced by 24-h coronary ligation, 48-h coronary ligation, digitalis, and adrenaline were 1.9 +/- 0.9 (by 8 mg/kg i.v.), 1.6 +/- 0.5 (by 8 mg/kg i.v.), 0.6 +/- 0.2 (by 2 mg/kg i.v.), and 3.5 +/- 1.3 (by 5 mg/kg i.v.) micrograms/ml, respectively (mean +/- SDM, n = 6-7).",761593,2435991,2435991_C032151_D001145,2435991_2,bcv_easy_429_sent_work_dev_set_761593,no_relation,770955846,TRUE,golden,10,,"








",no_relation,1,TRUE,D007660,"<span class=""chemical"">ketoprofen</span>",D017542,"<span class=""disease"">aneurysmal</span>","Patients with aneurysmal subarachnoid hemorrhage (SAH) were randomized to receive either <span class=""chemical"">ketoprofen</span>, 100 mg, three times a day (<span class=""chemical"">ketoprofen</span> group, n = 9) or a weak NSAID, acetaminophen, 1 g, three times a day (acetaminophen group, n = 9) starting immediately after the diagnosis of <span class=""disease"">aneurysmal</span> SAH.",761593,10414674,10414674_D007660_D017542,10414674_3,bcv_easy_893_sent_work_dev_set_761593,no_relation,770955847,TRUE,golden,8,,"






",no_relation,0.8757,TRUE,D008687,"<span class=""chemical"">Metformin</span>",D007674,"<span class=""disease"">nephropathy</span>","<span class=""chemical"">Metformin</span> prevents experimental gentamicin-induced <span class=""disease"">nephropathy</span> by a mitochondria-dependent pathway.",761593,20164825,20164825_D008687_D007674,20164825_0,bcv_easy_267_sent_work_dev_set_761593,no_relation,770955848,TRUE,golden,11,,"









",no_relation,0.9049,TRUE,D020117,"<span class=""chemical"">cisapride</span>",D006973,"<span class=""disease"">hypertension</span>","A possible drug interaction occurred in a 45-year-old woman who was taking <span class=""chemical"">cisapride</span> for gastroesophageal reflux disorder and diltiazem, an agent that has inhibitory effect on CYP3A4, for <span class=""disease"">hypertension</span>.",761593,9545159,9545159_D020117_D006973,9545159_3,bcv_easy_262_sent_work_dev_set_761593,no_relation,770955849,TRUE,golden,10,,"








",no_relation,0.7972,TRUE,D002939,"<span class=""chemical"">ciprofloxacin</span>",D009369,"<span class=""disease"">cancer</span>","Five patients with <span class=""disease"">cancer</span> who developed acute renal failure that followed treatment with <span class=""chemical"">ciprofloxacin</span> are described and an additional 15 cases reported in the literature are reviewed.",761593,8494478,8494478_D002939_D009369,8494478_2,bcv_easy_845_sent_work_dev_set_761593,no_relation,770955850,TRUE,golden,19,,"

















",no_relation,1,TRUE,D016291,"<span class=""chemical"">MK-801</span>",D004409,"<span class=""disease"">dyskinetic</span>","Several drugs, including clonidine, physostigmine, methysergide, 5-MDOT, propranolol, and <span class=""chemical"">MK-801</span>, markedly reduced the <span class=""disease"">dyskinetic</span> movements but at the cost of a return of parkinsonian symptomatology.",761593,8106150,8106150_D016291_D004409,8106150_5,bcv_easy_1120_sent_work_dev_set_761593,no_relation,770955851,TRUE,golden,12,,"










",no_relation,0.7402,TRUE,D004317,"<span class=""chemical"">doxorubicin</span>",D009765,"<span class=""disease"">obese</span>","In conclusion, HFD-induced <span class=""disease"">obese</span> rats are highly sensitized to <span class=""chemical"">doxorubicin</span>-induced cardiotoxicity by substantially downregulating cardiac mitochondrial ATP generation, increasing oxidative stress and downregulating the JAK/STAT3 pathway.",761593,18674790,18674790_D004317_D009765,18674790_9,bcv_easy_883_sent_work_dev_set_761593,no_relation,770955852,TRUE,golden,9,,"







",no_relation,1,TRUE,D002927,"<span class=""chemical"">cimetidine</span>",D056486|D006402,"<span class=""disease"">hepatic or hematologic toxicity</span>","Treatment with high doses of <span class=""chemical"">cimetidine</span> (one to 60 months; median, 11 months) or ranitidine (two to 31 months; median, 14 months) was not associated with <span class=""disease"">hepatic or hematologic toxicity</span> or alterations of serum gastrin concentrations, but ranitidine therapy was associated with a significantly lower serum creatinine level than seen with <span class=""chemical"">cimetidine</span> therapy.",761593,6150641,6150641_D002927_D056486|D006402,6150641_7,bcv_easy_327_sent_work_dev_set_761593,no_relation,770955853,TRUE,golden,7,,"





",no_relation,1,TRUE,D014147,"<span class=""chemical"">Tramadol</span>",D010146,"<span class=""disease"">pain</span>","<span class=""chemical"">Tramadol</span> is a weak opioid with effects on adrenergic and serotonergic neurotransmission that is used to treat cancer <span class=""disease"">pain</span> and chronic non malignant <span class=""disease"">pain</span>.",761593,8766220,8766220_D014147_D010146,8766220_1,bcv_easy_97_sent_work_dev_set_761593,no_relation,770955854,TRUE,golden,8,,"






",no_relation,1,TRUE,D015647,"<span class=""chemical"">SKF 38393</span>",D002375,"<span class=""disease"">catalepsy</span>","Combination of <span class=""chemical"">SKF 38393</span> with quinpirole did not cause potentiated inhibitory effect on <span class=""disease"">catalepsy</span> induced by dopamine antagonists.",761593,1687392,1687392_D015647_D002375,1687392_10,bcv_easy_867_sent_work_dev_set_761593,no_relation,770955855,TRUE,golden,8,,"






",no_relation,0.8784,TRUE,D000082,"<span class=""chemical"">paracetamol</span>",D014581,"<span class=""disease"">urticaria</span>","Taken together, our results confirm the good tolerability of nimesulide and <span class=""chemical"">paracetamol</span> in patients who experienced <span class=""disease"">urticaria</span>/angioedema caused by NSAIDs.",761593,11694026,11694026_D000082_D014581,11694026_8,bcv_easy_648_sent_work_dev_set_761593,no_relation,770955856,TRUE,golden,14,,"












",no_relation,0.925,TRUE,D005492,"<span class=""chemical"">folic acid</span>",D064420,"<span class=""disease"">toxicity</span>","Associated studies demonstrated that lometrexol plasma pharmacokinetics were not altered by <span class=""chemical"">folic acid</span> administration indicating that supplementation is unlikely to reduce <span class=""disease"">toxicity</span> by enhancing lometrexol plasma clearance.",761593,8958188,8958188_D005492_D064420,8958188_8,bcv_easy_188_sent_work_dev_set_761593,no_relation,770955857,TRUE,golden,7,,"





",no_relation,1,TRUE,D004317,"<span class=""chemical"">Doxorubicin</span>",D009765,"<span class=""disease"">OB</span>","<span class=""chemical"">Doxorubicin</span> toxicokinetics studies revealed no change in accumulation of <span class=""chemical"">doxorubicin</span> and doxorubicinol (toxic metabolite) in the normal diet-fed (ND) and <span class=""disease"">OB</span> hearts.",761593,18674790,18674790_D004317_D009765,18674790_6,bcv_easy_878_sent_work_dev_set_761593,no_relation,770955858,TRUE,golden,19,,"

















",no_relation,1,TRUE,C053571,"<span class=""chemical"">iopentol</span>",D014693,"<span class=""disease"">ventricular fibrillation</span>","Frequencies of <span class=""disease"">ventricular fibrillation</span> were significantly lower (p less than 0.05) after <span class=""chemical"">iopentol</span> (0%) and iohexol (3%) than after metrizoate (22%).",761593,2980315,2980315_C053571_D014693,2980315_3,bcv_easy_167_sent_work_dev_set_761593,no_relation,770955859,TRUE,golden,8,,"






",no_relation,1,TRUE,D064730,"<span class=""chemical"">dexrazoxane</span>",D015431,"<span class=""disease"">weight loss</span>","RESULTS: Nontoxic doses of <span class=""chemical"">dexrazoxane</span> reduced myelosuppression and <span class=""disease"">weight loss</span> from daunorubicin and etoposide in mice and antagonized their antiproliferative effects in the colony assay; however, <span class=""chemical"">dexrazoxane</span> neither reduced myelosuppression, <span class=""disease"">weight loss</span>, nor the in vitro cytotoxicity from doxorubicin.",761593,15897593,15897593_D064730_D015431,15897593_5,bcv_easy_976_sent_work_dev_set_761593,no_relation,770955860,TRUE,golden,10,,"








",no_relation,1,TRUE,D008774,"<span class=""chemical"">methylphenidate</span>",D000544,"<span class=""disease"">Alzheimer's disease</span>","An 82-year-old man with treatment-resistant depression and early <span class=""disease"">Alzheimer's disease</span> was started on <span class=""chemical"">methylphenidate</span>.",761593,12907924,12907924_D008774_D000544,12907924_1,bcv_easy_399_sent_work_dev_set_761593,no_relation,770955861,TRUE,golden,12,,"










",no_relation,1,TRUE,D004656,"<span class=""chemical"">enalapril</span>",D018487,"<span class=""disease"">Left Ventricular Dysfunction</span>","METHOD: We analyzed data from the Studies of <span class=""disease"">Left Ventricular Dysfunction</span> (SOLVD), a randomized, double-blind, placebo-controlled trial of <span class=""chemical"">enalapril</span> for the treatment of CHF.",761593,10539815,10539815_D004656_D018487,10539815_4,bcv_easy_753_sent_work_dev_set_761593,no_relation,770955862,TRUE,golden,10,,"








",no_relation,1,TRUE,C400082,"<span class=""chemical"">bortezomib</span>",D009101,"<span class=""disease"">MM/multiple myeloma</span>","A clinical trial was initiated to evaluate the recommended dose of cyclophosphamide in combination with <span class=""chemical"">bortezomib</span> and dexamethasone as induction treatment before stem cell transplantation for younger patients with newly diagnosed <span class=""disease"">multiple myeloma</span> (<span class=""disease"">MM</span>).",761593,19274460,19274460_C400082_D009101,19274460_1,bcv_easy_575_sent_work_dev_set_761593,no_relation,770955863,TRUE,golden,13,,"











",no_relation,0.855,TRUE,D009288,"<span class=""chemical"">naproxen</span>",D001172,"<span class=""disease"">rheumatoid arthritis</span>","A 31-year-old man with <span class=""disease"">rheumatoid arthritis</span>, who had previously been treated with sulindac, fenoprofen calcium, high dose salicylates and gold salts, developed renal papillary necrosis (RPN) 4 months after institution of <span class=""chemical"">naproxen</span> therapy.",761593,6699841,6699841_D009288_D001172,6699841_1,bcv_easy_1254_sent_work_dev_set_761593,no_relation,770955864,TRUE,golden,10,,"








",no_relation,1,TRUE,D013629,"<span class=""chemical"">tamoxifen</span>",D001943,"<span class=""disease"">breast cancer</span>","METHODS: In October, 1992, we started a double-blind placebo-controlled, randomised trial of <span class=""chemical"">tamoxifen</span> in women (mainly in Italy) who did not have <span class=""disease"">breast cancer</span> and who had had a hysterectomy.",761593,9672273,9672273_D013629_D001943,9672273_3,bcv_easy_309_sent_work_dev_set_761593,no_relation,770955865,TRUE,golden,15,,"













",no_relation,0.8645,TRUE,D004008,"<span class=""chemical"">diclofenac</span>",D004487,"<span class=""disease"">oedema</span>","The incidence of discontinuations for hypertension-related and <span class=""disease"">oedema</span>-related AEs were significantly higher with etoricoxib (2.5% and 1.1% respectively) compared with <span class=""chemical"">diclofenac</span> (1.5% and 0.4% respectively; p<0.001 for hypertension and p<0.01 for <span class=""disease"">oedema</span>).",761593,17965424,17965424_D004008_D004487,17965424_9,bcv_easy_931_sent_work_dev_set_761593,no_relation,770955866,TRUE,golden,7,,"





",no_relation,1,TRUE,D001379,"<span class=""chemical"">azathioprine</span>",D008180,"<span class=""disease"">systemic lupus erythematosus/SLE</span>","Since 1989, she had been suffering from <span class=""disease"">systemic lupus erythematosus</span> (<span class=""disease"">SLE</span>) with renal involvement and undergone periods of treatment with <span class=""chemical"">azathioprine</span> and cyclophosphamide.",761593,12739036,12739036_D001379_D008180,12739036_2,bcv_easy_298_sent_work_dev_set_761593,no_relation,770955867,TRUE,golden,9,,"







",no_relation,0.889,TRUE,D008238,"<span class=""chemical"">LSD</span>",D001480,"<span class=""disease"">EPS</span>","Two schizophrenic patients, who had a prior history of <span class=""chemical"">LSD</span> abuse and who had previously developed <span class=""disease"">EPS</span> with classic antipsychotics, were successfully treated with risperidone.",761593,12013711,12013711_D008238_D001480,12013711_1,bcv_easy_153_sent_work_dev_set_761593,no_relation,770955868,TRUE,golden,8,,"






",no_relation,1,TRUE,D004317,"<span class=""chemical"">ADR/adriamycin</span>",D009369,"<span class=""disease"">cancer</span>","The use of <span class=""chemical"">adriamycin</span> (<span class=""chemical"">ADR</span>) in <span class=""disease"">cancer</span> chemotherapy has been limited due to its cumulative cardiovascular toxicity.",761593,9952311,9952311_D004317_D009369,9952311_1,bcv_easy_792_sent_work_dev_set_761593,no_relation,770955869,TRUE,golden,12,,"








'produced by carbachol' being the key term.

",no_relation,0.6808,TRUE,D002122,"<span class=""chemical"">calcium chloride</span>",D015878,"<span class=""disease"">mydriasis</span>","The effect of <span class=""chemical"">calcium chloride</span> injected into the cerebral ventricles of group-housed unanaesthetized cats upon vocalization (rage, hissing and snarling), fighting (attack with paws and claws, defense with paws and claws and biting), <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions produced by carbachol and eserine injected similarly was investigated.",761593,6892185,6892185_D002122_D015878,6892185_1,bcv_easy_1039_sent_work_dev_set_761593,no_relation,770955870,TRUE,golden,10,,"








",no_relation,1,TRUE,D009270,"<span class=""chemical"">naloxone</span>",D002375,"<span class=""disease"">catalepsy</span>","While the mutual potentiation, antagonism and tolerance suggest common mechanisms for the induced <span class=""disease"">catalepsy</span>, differences in latency, rigidity and behavior, asymmetry of cross-tolerance and a widely-different ID50 for <span class=""chemical"">naloxone</span> would argue against an action at a single opioid site.",761593,2716967,2716967_D009270_D002375,2716967_9,bcv_easy_744_sent_work_dev_set_761593,no_relation,770955871,TRUE,golden,17,,"















",no_relation,0.8921,TRUE,D015119,"<span class=""chemical"">epsilon-aminocaproic acid</span>",D008595,"<span class=""disease"">menorrhagia</span>","We describe a 42-year-old woman who developed superior sagittal and left transverse sinus thrombosis associated with prolonged <span class=""chemical"">epsilon-aminocaproic acid</span> therapy for <span class=""disease"">menorrhagia</span>.",761593,2339463,2339463_D015119_D008595,2339463_1,bcv_easy_210_sent_work_dev_set_761593,no_relation,770955872,TRUE,golden,4,,"


",no_relation,1,TRUE,D013467,"<span class=""chemical"">sulindac</span>",D007674,"<span class=""disease"">renal toxicity</span>","We review previous reports linking RPN to antiinflammatory drug use and discuss possible advantages of <span class=""chemical"">sulindac</span> in patients who have experienced <span class=""disease"">renal toxicity</span> from other antiinflammatory agents.",761593,6699841,6699841_D013467_D007674,6699841_4,bcv_easy_1255_sent_work_dev_set_761593,no_relation,770955873,TRUE,golden,11,,"









",no_relation,0.8275,TRUE,D009270,"<span class=""chemical"">naloxone</span>",D012133,"<span class=""disease"">respiratory paralysis</span>","GABA involvement in <span class=""chemical"">naloxone</span> induced reversal of <span class=""disease"">respiratory paralysis</span> produced by thiopental.",761593,2893236,2893236_D009270_D012133,2893236_0,bcv_easy_439_sent_work_dev_set_761593,no_relation,770955874,TRUE,golden,12,,"










",no_relation,0.7534,TRUE,D002794,"<span class=""chemical"">choline</span>",D000647,"<span class=""disease"">amnesia</span>","Daidzein activates <span class=""chemical"">choline</span> acetyltransferase from MC-IXC cells and improves drug-induced <span class=""disease"">amnesia</span>.",761593,16428827,16428827_D002794_D000647,16428827_0,bcv_easy_61_sent_work_dev_set_761593,no_relation,770955875,TRUE,golden,9,,"







",yes_direct,0.5603,TRUE,D017373,"<span class=""chemical"">CPA/cyproterone acetate</span>",D054556,"<span class=""disease"">venous thromboembolism/VTE</span>","OBJECTIVE: To achieve absolute risk estimates of <span class=""disease"">venous thromboembolism</span> (<span class=""disease"">VTE</span>) among women on <span class=""chemical"">cyproterone acetate</span> plus ethinylestradiol (<span class=""chemical"">CPA</span>/EE), and among women on combined oral contraceptives (COCs).",761593,12851669,12851669_D017373_D054556,12851669_1,bcv_easy_656_sent_work_dev_set_761593,no_relation,770955876,TRUE,golden,11,,"









",no_relation,1,TRUE,D000662,"<span class=""chemical"">amphetamines</span>",D012640,"<span class=""disease"">seizure</span>","CONCLUSIONS: During this study period, routine plasma screening for cocaine and <span class=""chemical"">amphetamines</span> in adult <span class=""disease"">seizure</span> patients had a low yield.",761593,11185967,11185967_D000662_D012640,11185967_8,bcv_easy_568_sent_work_dev_set_761593,no_relation,770955877,TRUE,golden,16,,"




Used as treatment.









",no_relation,1,TRUE,D000638,"<span class=""chemical"">amiodarone</span>",D014693,"<span class=""disease"">ventricular fibrillation/VF</span>","Sixty-nine percent of patients continued treatment with <span class=""chemical"">amiodarone</span> and had no recurrence of symptomatic VT or <span class=""disease"">ventricular fibrillation</span> (<span class=""disease"">VF</span>) over a follow-up of 6 to 52 months (mean +/- standard deviation 14.2 +/- 8.2).",761593,6637851,6637851_D000638_D014693,6637851_3,bcv_easy_1017_sent_work_dev_set_761593,no_relation,770955878,TRUE,golden,8,,"






",no_relation,1,TRUE,D002701,"<span class=""chemical"">chloramphenicol</span>",D002386,"<span class=""disease"">cataract</span>","A 73-year-old woman died of aplastic anemia less than two months after undergoing <span class=""disease"">cataract</span> extraction and beginning topical therapy with <span class=""chemical"">chloramphenicol</span>.",761593,7072798,7072798_D002701_D002386,7072798_1,bcv_easy_173_sent_work_dev_set_761593,no_relation,770955879,TRUE,golden,12,,"










",no_relation,0.9234,TRUE,D007530,"<span class=""chemical"">isoflurane</span>",D004342,"<span class=""disease"">hypersensitivity</span>","This study was performed to determine cross-reactivity between enflurane and <span class=""chemical"">isoflurane</span> with the <span class=""disease"">hypersensitivity</span> induced by halothane.",761593,7647582,7647582_D007530_D004342,7647582_4,bcv_easy_915_sent_work_dev_set_761593,no_relation,770955880,TRUE,golden,13,,"











",no_relation,1,TRUE,D004656,"<span class=""chemical"">enalapril</span>",D006333,"<span class=""disease"">CHF</span>","METHOD: We analyzed data from the Studies of Left Ventricular Dysfunction (SOLVD), a randomized, double-blind, placebo-controlled trial of <span class=""chemical"">enalapril</span> for the treatment of <span class=""disease"">CHF</span>.",761593,10539815,10539815_D004656_D006333,10539815_4,bcv_easy_754_sent_work_dev_set_761593,no_relation,770955881,TRUE,golden,16,,"














",no_relation,0.8881,TRUE,D009270,"<span class=""chemical"">naloxone</span>",D012133,"<span class=""disease"">respiratory paralysis</span>","These data suggest <span class=""chemical"">naloxone</span> reverses <span class=""disease"">respiratory paralysis</span> produced by thiopental and involves GABA in its action.",761593,2893236,2893236_D009270_D012133,2893236_7,bcv_easy_451_sent_work_dev_set_761593,no_relation,770955882,TRUE,golden,11,,"









",no_relation,1,TRUE,D011441,"<span class=""chemical"">PTU</span>",D014424,"<span class=""disease"">Turner Syndrome</span>","<span class=""chemical"">PTU</span>-associated vasculitis in a girl with <span class=""disease"">Turner Syndrome</span> and Graves' disease.",761593,16418614,16418614_D011441_D014424,16418614_0,bcv_easy_92_sent_work_dev_set_761593,no_relation,770955883,TRUE,golden,11,,"









",no_relation,1,TRUE,C065179,"<span class=""chemical"">atorvastatin</span>",D006973,"<span class=""disease"">hypertension</span>","Thus, <span class=""chemical"">atorvastatin</span> prevented and reversed dexamethasone-induced <span class=""disease"">hypertension</span> in the rat.",761593,16820346,16820346_C065179_D006973,16820346_7,bcv_easy_73_sent_work_dev_set_761593,no_relation,770955884,TRUE,golden,11,,"









",no_relation,0.8259,TRUE,D002216,"<span class=""chemical"">captopril</span>",D011507,"<span class=""disease"">proteinuria</span>","Effect of <span class=""chemical"">captopril</span> on pre-existing and aminonucleoside-induced <span class=""disease"">proteinuria</span> in spontaneously hypertensive rats.",761593,6454943,6454943_D002216_D011507,6454943_0,bcv_easy_582_sent_work_dev_set_761593,no_relation,770955885,TRUE,golden,6,,"




",no_relation,0.8368,TRUE,C059262,"<span class=""chemical"">cidofovir</span>",D000257,"<span class=""disease"">adenovirus infection</span>","The use of <span class=""chemical"">cidofovir</span> in severe <span class=""disease"">adenovirus infection</span> has been limited by adverse effects, the most significant of which is nephrotoxicity.",761593,12093990,12093990_C059262_D000257,12093990_10,bcv_easy_241_sent_work_dev_set_761593,no_relation,770955886,TRUE,golden,11,,"









",no_relation,1,TRUE,D004308,"<span class=""chemical"">dosulepine hydrochloride</span>",D059350,"<span class=""disease"">chronic pain</span>","This drug was initiated in association with paroxetine and <span class=""chemical"">dosulepine hydrochloride</span> in a tetraparetic patient with <span class=""disease"">chronic pain</span>.",761593,8766220,8766220_D004308_D059350,8766220_2,bcv_easy_99_sent_work_dev_set_761593,no_relation,770955887,TRUE,golden,9,,"







",no_relation,1,TRUE,D000109,"<span class=""chemical"">ACh/acetylcholine</span>",D000544,"<span class=""disease"">AD/Alzheimer's disease</span>","The choline acetyltransferase (ChAT) activator, which enhances cholinergic transmission via an augmentation of the enzymatic production of <span class=""chemical"">acetylcholine</span> (<span class=""chemical"">ACh</span>), is an important factor in the treatment of <span class=""disease"">Alzheimer's disease</span> (<span class=""disease"">AD</span>).",761593,16428827,16428827_D000109_D000544,16428827_1,bcv_easy_64_sent_work_dev_set_761593,no_relation,770955888,TRUE,golden,11,,"









",no_relation,1,TRUE,D013629,"<span class=""chemical"">tamoxifen</span>",D001943,"<span class=""disease"">breast cancer</span>","There is a statistically significant reduction of <span class=""disease"">breast cancer</span> among women receiving <span class=""chemical"">tamoxifen</span> who also used hormone-replacement therapy during the trial: among 390 women on such therapy and allocated to placebo, we found eight cases of <span class=""disease"">breast cancer</span> compared with one case among 362 women allocated to <span class=""chemical"">tamoxifen</span>.",761593,9672273,9672273_D013629_D001943,9672273_13,bcv_easy_311_sent_work_dev_set_761593,no_relation,770955889,TRUE,golden,9,,"







",no_relation,1,TRUE,D004052,"<span class=""chemical"">DEN</span>",D009369,"<span class=""disease"">tumor</span>","In <span class=""chemical"">DEN</span> + PB treated rats, the survival was prolonged and the <span class=""disease"">tumor</span> incidence decreased as compared with the results obtained by <span class=""chemical"">DEN</span> alone.",761593,3780814,3780814_D004052_D009369,3780814_6,bcv_easy_719_sent_work_dev_set_761593,no_relation,770955890,TRUE,golden,8,,"






",no_relation,1,TRUE,D013629,"<span class=""chemical"">tamoxifen</span>",D001943,"<span class=""disease"">breast cancer</span>","Prevention of <span class=""disease"">breast cancer</span> with <span class=""chemical"">tamoxifen</span>: preliminary findings from the Italian randomised trial among hysterectomised women. Italian <span class=""chemical"">Tamoxifen</span> Prevention Study.",761593,9672273,9672273_D013629_D001943,9672273_0,bcv_easy_306_sent_work_dev_set_761593,no_relation,770955891,TRUE,golden,7,,"





",no_relation,0.8579,TRUE,C012655,"<span class=""chemical"">nimesulide</span>",D014581,"<span class=""disease"">urticaria</span>","Tolerability of <span class=""chemical"">nimesulide</span> and paracetamol in patients with NSAID-induced <span class=""disease"">urticaria</span>/angioedema.",761593,11694026,11694026_C012655_D014581,11694026_0,bcv_easy_637_sent_work_dev_set_761593,no_relation,770955892,TRUE,golden,8,,"






",no_relation,1,TRUE,D000638,"<span class=""chemical"">amiodarone</span>",D017180,"<span class=""disease"">VT</span>","Sixty-nine percent of patients continued treatment with <span class=""chemical"">amiodarone</span> and had no recurrence of symptomatic <span class=""disease"">VT</span> or ventricular fibrillation (VF) over a follow-up of 6 to 52 months (mean +/- standard deviation 14.2 +/- 8.2).",761593,6637851,6637851_D000638_D017180,6637851_3,bcv_easy_1016_sent_work_dev_set_761593,no_relation,770955893,TRUE,golden,17,,"















",no_relation,1,TRUE,D001058,"<span class=""chemical"">Apomorphine</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","<span class=""chemical"">Apomorphine</span>: an underutilized therapy for <span class=""disease"">Parkinson's disease</span>.",761593,11009181,11009181_D001058_D010300,11009181_0,bcv_easy_189_sent_work_dev_set_761593,no_relation,770955894,TRUE,golden,10,,"








",no_relation,1,TRUE,D014443,"<span class=""chemical"">tyrosine</span>",D009410,"<span class=""disease"">degeneration of dopaminergic neurons</span>","To demonstrate the relationship between peripheral iron overload and dopaminergic neuron loss in rat substantia nigra (SN), in the present study we used fast cyclic voltammetry, <span class=""chemical"">tyrosine</span> hydroxylase (TH) immunohistochemistry, Perls' iron staining, and high performance liquid chromatography-electrochemical detection to study the <span class=""disease"">degeneration of dopaminergic neurons</span> and increased iron content in the SN of iron dextran overloaded animals.",761593,17490790,17490790_D014443_D009410,17490790_2,bcv_easy_776_sent_work_dev_set_761593,no_relation,770955895,TRUE,golden,13,,"











",no_relation,1,TRUE,D002216,"<span class=""chemical"">captopril</span>",D011507,"<span class=""disease"">proteinuria</span>","Oral administration of <span class=""chemical"">captopril</span> at 100 mg/kg for 14 days failed to aggravate <span class=""disease"">proteinuria</span> pre-existing in SHR.",761593,6454943,6454943_D002216_D011507,6454943_3,bcv_easy_588_sent_work_dev_set_761593,no_relation,770955896,TRUE,golden,6,,"




",no_relation,0.8487,TRUE,D013835,"<span class=""chemical"">thiamine pyrophosphate/TPP</span>",D014899,"<span class=""disease"">Wernicke's encephalopathy</span>","We studied a thiamine-dependent enzyme, transketolase, from fibroblasts of a diabetic patient who developed <span class=""disease"">Wernicke's encephalopathy</span> when treated with tolazamide, in order to delineate if this patient also had transketolase abnormality [high Km for <span class=""chemical"">thiamine pyrophosphate</span> (<span class=""chemical"">TPP</span>)], as previously reported in postalcoholic Wernicke-Korsakoff syndrome.",761593,3762968,3762968_D013835_D014899,3762968_1,bcv_easy_723_sent_work_dev_set_761593,no_relation,770955897,TRUE,golden,12,,"










",no_relation,0.9189,TRUE,D003975,"<span class=""chemical"">Diazepam</span>",D006212,"<span class=""disease"">hallucinations</span>","<span class=""chemical"">Diazepam</span>, unless contraindicated or risky, remains the only necessary complementary drug to ketamine as it buffers its cardiovascular response and decreases the duration and intensity of operative and postoperative <span class=""disease"">hallucinations</span>.",761593,12091028,12091028_D003975_D006212,12091028_5,bcv_easy_991_sent_work_dev_set_761593,no_relation,770955898,TRUE,golden,18,,"












'Correction' being the key term.



",no_relation,1,TRUE,D008687,"<span class=""chemical"">metformin</span>",D007674,"<span class=""disease"">kidney dysfunction</span>","These in vivo markers of <span class=""disease"">kidney dysfunction</span> and their correction by <span class=""chemical"">metformin</span> were complemented by in vitro studies of mitochondrial function.",761593,20164825,20164825_D008687_D007674,20164825_7,bcv_easy_272_sent_work_dev_set_761593,no_relation,770955899,TRUE,golden,10,,"




Used as treatment.



",no_relation,0.9044,TRUE,D013629,"<span class=""chemical"">Tamoxifen</span>",D001943,"<span class=""disease"">breast cancer</span>","BACKGROUND: <span class=""chemical"">Tamoxifen</span> is a candidate chemopreventive agent in <span class=""disease"">breast cancer</span>, although the drug may be associated with the development of endometrial cancer.",761593,9672273,9672273_D013629_D001943,9672273_1,bcv_easy_308_sent_work_dev_set_761593,no_relation,770955900,TRUE,golden,13,,"











",no_relation,0.7779,TRUE,D012254,"<span class=""chemical"">ribavirin</span>",D000257,"<span class=""disease"">adenovirus disease</span>","DESIGN/METHODS: We retrospectively reviewed the medical records of 5 children treated with intravenous <span class=""chemical"">ribavirin</span> for documented severe <span class=""disease"">adenovirus disease</span>.",761593,12093990,12093990_D012254_D000257,12093990_12,bcv_easy_243_sent_work_dev_set_761593,no_relation,770955901,TRUE,golden,10,,"








",no_relation,0.9075,TRUE,D014191,"<span class=""chemical"">tranylcypromine</span>",D003866,"<span class=""disease"">depression</span>","We report a venlafaxine-MAOI interaction that resulted in the serotonin syndrome in a 23-y-old male who was taking <span class=""chemical"">tranylcypromine</span> for <span class=""disease"">depression</span>.",761593,8888541,8888541_D014191_D003866,8888541_4,bcv_easy_1107_sent_work_dev_set_761593,no_relation,770955902,TRUE,golden,11,,"









",no_relation,1,TRUE,D004656,"<span class=""chemical"">enalapril</span>",D003920,"<span class=""disease"">diabetes</span>","By multivariate analysis, in both the placebo and <span class=""chemical"">enalapril</span> groups older age, diuretic therapy, and <span class=""disease"">diabetes</span> were associated with decreased renal function, whereas beta-blocker therapy and higher ejection fraction were renoprotective.",761593,10539815,10539815_D004656_D003920,10539815_9,bcv_easy_761_sent_work_dev_set_761593,no_relation,770955903,TRUE,golden,13,,"











",no_relation,0.7182,TRUE,D010396,"<span class=""chemical"">D-penicillamine</span>",D001172,"<span class=""disease"">rheumatoid arthritis</span>","A 67-year-old woman with <span class=""disease"">rheumatoid arthritis</span> presented rapidly progressive glomerulonephritis (RPGN) after 5 months of <span class=""chemical"">D-penicillamine</span> (250 mg/day) treatment.",761593,8267029,8267029_D010396_D001172,8267029_1,bcv_easy_498_sent_work_dev_set_761593,no_relation,770955904,TRUE,golden,14,,"












",no_relation,1,TRUE,D002122,"<span class=""chemical"">calcium chloride</span>",D015878,"<span class=""disease"">mydriasis</span>","It is apparent that <span class=""chemical"">calcium chloride</span> can ""dissociate"" vocalization and fighting from autonomic and motor phenomena such as <span class=""disease"">mydriasis</span>, tremor and clonic-tonic convulsions caused by carbachol and eserine.",761593,6892185,6892185_D002122_D015878,6892185_4,bcv_easy_1057_sent_work_dev_set_761593,no_relation,770955905,TRUE,golden,15,,"













",no_relation,1,TRUE,D014635,"<span class=""chemical"">Valproate</span>",D006423,"<span class=""disease"">homonymous hemianopsia</span>","Complications were observed in two patients: one had a left <span class=""disease"">homonymous hemianopsia</span> after pallidotomy and another one developed left hemiballistic movements 3 days after subthalamotomy which partly improved within 1 month with <span class=""chemical"">Valproate</span> 1000 mg/day.",761593,19234905,19234905_D014635_D006423,19234905_10,bcv_easy_201_sent_work_dev_set_761593,no_relation,770955906,TRUE,golden,11,,"









",no_relation,1,TRUE,D015215,"<span class=""chemical"">azidothymidine</span>",C565469,"<span class=""disease"">immunodeficient</span>","Sensitivity of erythroid progenitor colonies to erythropoietin in <span class=""chemical"">azidothymidine</span> treated <span class=""disease"">immunodeficient</span> mice.",761593,2004015,2004015_D015215_C565469,2004015_0,bcv_easy_213_sent_work_dev_set_761593,no_relation,770955907,TRUE,golden,9,,"







",no_relation,0.8964,TRUE,D009270,"<span class=""chemical"">naloxone</span>",D007022,"<span class=""disease"">hypotension</span>","Our experience demonstrates a possible role of <span class=""chemical"">naloxone</span> in the reversal of <span class=""disease"">hypotension</span> resulting from captopril.",761593,1928887,1928887_D009270_D007022,1928887_5,bcv_easy_514_sent_work_dev_set_761593,no_relation,770955908,TRUE,golden,13,,"











",no_relation,0.6245,TRUE,D000617,"<span class=""chemical"">aminoglycoside</span>",D013924,"<span class=""disease"">Thrombophlebitis</span>","<span class=""disease"">Thrombophlebitis</span> occurred only with infusion through peripheral cannulae; nephrotoxicity and ototoxicity were confined to patients receiving an <span class=""chemical"">aminoglycoside</span> plus vancomycin.",761593,3934126,3934126_D000617_D013924,3934126_5,bcv_easy_1143_sent_work_dev_set_761593,no_relation,770955909,TRUE,golden,8,,"






",no_relation,0.8679,TRUE,D008727,"<span class=""chemical"">methotrexate</span>",D007938,"<span class=""disease"">leukaemia</span>","BACKGROUND: A transient leukoencephalopathy mimicking cerebrovascular accident has been described as a complication of chemotherapy, most commonly in recipients of intrathecal <span class=""chemical"">methotrexate</span> for childhood <span class=""disease"">leukaemia</span>.",761593,17682013,17682013_D008727_D007938,17682013_1,bcv_easy_780_sent_work_dev_set_761593,no_relation,770955910,TRUE,golden,17,,"















",no_relation,1,TRUE,D013999,"<span class=""chemical"">timolol</span>",D007008,"<span class=""disease"">hypokalemia</span>","The beta adrenergic blocking drug, <span class=""chemical"">timolol</span>, tended to correct the <span class=""disease"">hypokalemia</span> of short-term bendrofluazide treatment in 6 healthy male subjects and although the effect was small it was significant.",761593,326460,326460_D013999_D007008,326460_1,bcv_easy_394_sent_work_dev_set_761593,no_relation,770955911,TRUE,golden,9,,"







",no_relation,1,TRUE,D004110,"<span class=""chemical"">diltiazem</span>",D005764,"<span class=""disease"">gastroesophageal reflux disorder</span>","A possible drug interaction occurred in a 45-year-old woman who was taking cisapride for <span class=""disease"">gastroesophageal reflux disorder</span> and <span class=""chemical"">diltiazem</span>, an agent that has inhibitory effect on CYP3A4, for hypertension.",761593,9545159,9545159_D004110_D005764,9545159_3,bcv_easy_264_sent_work_dev_set_761593,no_relation,770955912,TRUE,golden,9,,"







",no_relation,1,TRUE,D009270,"<span class=""chemical"">naloxone</span>",D012133,"<span class=""disease"">respiratory paralysis</span>","In this study <span class=""chemical"">naloxone</span> reversed <span class=""disease"">respiratory paralysis</span> induced by thiopental in rats.",761593,2893236,2893236_D009270_D012133,2893236_2,bcv_easy_441_sent_work_dev_set_761593,no_relation,770955913,TRUE,golden,10,,"








",no_relation,0.8003,TRUE,D005680,"<span class=""chemical"">GABA</span>",D012133,"<span class=""disease"">respiratory paralysis</span>","These data suggest naloxone reverses <span class=""disease"">respiratory paralysis</span> produced by thiopental and involves <span class=""chemical"">GABA</span> in its action.",761593,2893236,2893236_D005680_D012133,2893236_7,bcv_easy_450_sent_work_dev_set_761593,no_relation,770955914,TRUE,golden,11,,"









",no_relation,1,TRUE,D015742,"<span class=""chemical"">propofol</span>",D008305,"<span class=""disease"">malignant hyperthermia</span>","Anesthesia was continued uneventfully with <span class=""chemical"">propofol</span> infusion while all facilities were available to detect and treat <span class=""disease"">malignant hyperthermia</span>.",761593,15893386,15893386_D015742_D008305,15893386_4,bcv_easy_1225_sent_work_dev_set_761593,no_relation,770955915,TRUE,golden,10,,"








",no_relation,0.899,TRUE,C422649,"<span class=""chemical"">Etoricoxib</span>",D005767,"<span class=""disease"">GI AEs</span>","CONCLUSIONS: <span class=""chemical"">Etoricoxib</span> 90 mg demonstrated a significantly lower risk for discontinuing treatment due to <span class=""disease"">GI AEs</span> compared with diclofenac 150 mg.",761593,17965424,17965424_C422649_D005767,17965424_11,bcv_easy_936_sent_work_dev_set_761593,no_relation,770955916,TRUE,golden,15,,"













",no_relation,0.8851,TRUE,D008094,"<span class=""chemical"">lithium</span>",D001714,"<span class=""disease"">bipolar disorder</span>","PATIENTS: One hundred and one patients (28 men and 73 women) with <span class=""disease"">bipolar disorder</span> receiving <span class=""chemical"">lithium</span> maintenance therapy ranging from 1 year's to 32 years' duration.",761593,10354657,10354657_D008094_D001714,10354657_5,bcv_easy_1132_sent_work_dev_set_761593,no_relation,770955917,TRUE,golden,8,,"






",no_relation,0.8892,TRUE,D008774,"<span class=""chemical"">methylphenidate</span>",D061218,"<span class=""disease"">treatment-resistant depression</span>","An 82-year-old man with <span class=""disease"">treatment-resistant depression</span> and early Alzheimer's disease was started on <span class=""chemical"">methylphenidate</span>.",761593,12907924,12907924_D008774_D061218,12907924_1,bcv_easy_398_sent_work_dev_set_761593,no_relation,770955918,TRUE,golden,4,,"


",no_relation,1,TRUE,D011224,"<span class=""chemical"">prazosin</span>",D001919,"<span class=""disease"">bradycardia</span>","Furthermore, the <span class=""disease"">bradycardia</span> that accompanied the noradrenaline-induced pressor effect in SHR was similar with and without chronic <span class=""chemical"">prazosin</span> treatment despite a 47-71% reduction of the pressor effect in chronic alpha 1-receptor blocked SHR.(ABSTRACT TRUNCATED AT 400 WORDS)",761593,1355091,1355091_D011224_D001919,1355091_17,bcv_easy_1082_sent_work_dev_set_761593,no_relation,770955919,TRUE,golden,15,,"













",no_relation,0.8748,TRUE,D007980,"<span class=""chemical"">levodopa</span>",D018476,"<span class=""disease"">bradykinesia</span>","Pallidal stimulation improves <span class=""disease"">bradykinesia</span> and rigidity to a minor extent; however, its strength seems to be in improving <span class=""chemical"">levodopa</span>-induced dyskinesias.",761593,15096016,15096016_D007980_D018476,15096016_6,bcv_easy_842_sent_work_dev_set_761593,no_relation,770955920,TRUE,golden,9,,"







",no_relation,0.8941,TRUE,D010396,"<span class=""chemical"">Penicillamine</span>",D001172,"<span class=""disease"">rheumatoid arthritis</span>","<span class=""chemical"">Penicillamine</span>-induced rapidly progressive glomerulonephritis in a patient with <span class=""disease"">rheumatoid arthritis</span>.",761593,8267029,8267029_D010396_D001172,8267029_0,bcv_easy_497_sent_work_dev_set_761593,no_relation,770955921,TRUE,golden,10,,"








",no_relation,1,TRUE,D002118,"<span class=""chemical"">calcium</span>",D003329,"<span class=""disease"">coronary spasm</span>","These data suggest that <span class=""disease"">coronary spasm</span> may be the cause of cardiotoxicity due to 5-FU, and that <span class=""chemical"">calcium</span> antagonists may probably be used in the prevention or treatment of 5-FU cardiotoxicity.",761593,3952818,3952818_D002118_D003329,3952818_3,bcv_easy_1002_sent_work_dev_set_761593,no_relation,770955922,TRUE,golden,11,,"









",no_relation,1,TRUE,C018824,"<span class=""chemical"">NH4Ac</span>",D003866,"<span class=""disease"">depression</span>","Addition of excess calcium reversed the <span class=""disease"">depression</span> in both tissues, but calcium-independent catecholamine release by acetaldehyde was not blocked by <span class=""chemical"">NH4Ac</span>.",761593,6323692,6323692_C018824_D003866,6323692_4,bcv_easy_362_sent_work_dev_set_761593,no_relation,770955923,TRUE,golden,11,,"









",no_relation,1,TRUE,D009705,"<span class=""chemical"">nucleosides</span>",D002545,"<span class=""disease"">cerebral ischemia</span>","Time dependence of plasma malondialdehyde, oxypurines, and <span class=""chemical"">nucleosides</span> during incomplete <span class=""disease"">cerebral ischemia</span> in the rat.",761593,7710775,7710775_D009705_D002545,7710775_0,bcv_easy_944_sent_work_dev_set_761593,no_relation,770955924,TRUE,golden,17,,"















",no_relation,0.944,TRUE,D008784,"<span class=""chemical"">methysergide</span>",D004409,"<span class=""disease"">dyskinetic</span>","Several drugs, including clonidine, physostigmine, <span class=""chemical"">methysergide</span>, 5-MDOT, propranolol, and MK-801, markedly reduced the <span class=""disease"">dyskinetic</span> movements but at the cost of a return of parkinsonian symptomatology.",761593,8106150,8106150_D008784_D004409,8106150_5,bcv_easy_1116_sent_work_dev_set_761593,no_relation,770955925,TRUE,golden,12,,"










",no_relation,1,TRUE,D011899,"<span class=""chemical"">ranitidine</span>",D056486|D006402,"<span class=""disease"">hepatic or hematologic toxicity</span>","Treatment with high doses of cimetidine (one to 60 months; median, 11 months) or <span class=""chemical"">ranitidine</span> (two to 31 months; median, 14 months) was not associated with <span class=""disease"">hepatic or hematologic toxicity</span> or alterations of serum gastrin concentrations, but <span class=""chemical"">ranitidine</span> therapy was associated with a significantly lower serum creatinine level than seen with cimetidine therapy.",761593,6150641,6150641_D011899_D056486|D006402,6150641_7,bcv_easy_328_sent_work_dev_set_761593,no_relation,770955926,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D016047,"<span class=""chemical"">2',3'-dideoxycytidine</span>",D000744,"<span class=""disease"">immunodeficiency</span>","Novel mutation in the human <span class=""disease"">immunodeficiency</span> virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and <span class=""chemical"">2',3'-dideoxycytidine</span>.",,1279198,1279198_D016047_D000744,1279198_0,bcv_sentence_task_befree_0,,770955927,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,1,,D016049,"<span class=""chemical"">2',3'-dideoxyinosine</span>",D000744,"<span class=""disease"">immunodeficiency</span>","Novel mutation in the human <span class=""disease"">immunodeficiency</span> virus type 1 reverse transcriptase gene that encodes cross-resistance to <span class=""chemical"">2',3'-dideoxyinosine</span> and 2',3'-dideoxycytidine.",,1279198,1279198_D016049_D000744,1279198_0,bcv_sentence_task_befree_1,,770955928,FALSE,finalized,5,8/14/15 20:43,"



",no_relation,1,,D016047,"<span class=""chemical"">ddC/2',3'-dideoxycytidine</span>",D000744,"<span class=""disease"">immunodeficiency</span>","We have used the technique of in vitro selection to generate variants of human <span class=""disease"">immunodeficiency</span> virus type 1 (HIV-1) that are resistant to 2',3'-dideoxyinosine (ddI) and cross-resistant to <span class=""chemical"">2',3'-dideoxycytidine</span> (<span class=""chemical"">ddC</span>).",,1279198,1279198_D016047_D000744,1279198_1,bcv_sentence_task_befree_2,,770955929,FALSE,finalized,5,8/14/15 23:18,"


It's 'human immunodeficiency virus type 1' and not just 'Inmunodeficiency'
",no_relation,1,,D016049,"<span class=""chemical"">ddI/2',3'-dideoxyinosine</span>",D000744,"<span class=""disease"">immunodeficiency</span>","We have used the technique of in vitro selection to generate variants of human <span class=""disease"">immunodeficiency</span> virus type 1 (HIV-1) that are resistant to <span class=""chemical"">2',3'-dideoxyinosine</span> (<span class=""chemical"">ddI</span>) and cross-resistant to 2',3'-dideoxycytidine (ddC).",,1279198,1279198_D016049_D000744,1279198_1,bcv_sentence_task_befree_3,,770955930,FALSE,finalized,5,8/14/15 22:53,"



",no_relation,0.7893,,D008274,"<span class=""chemical"">magnesium</span>",D009135,"<span class=""disease"">muscle damage</span>","This study examined the effect of <span class=""chemical"">magnesium</span> supplementation on muscle <span class=""chemical"">magnesium</span> content, on running performance during a 42-km marathon footrace, and on <span class=""disease"">muscle damage</span> and the rate of recovery of muscle function following the race.",,1299490,1299490_D008274_D009135,1299490_1,bcv_sentence_task_befree_4,,770955931,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,D008274,"<span class=""chemical"">magnesium</span>",D009135,"<span class=""disease"">muscle damage</span>","Extra <span class=""chemical"">magnesium</span> ingestion also had no influence on the extent of <span class=""disease"">muscle damage</span> or the rate of recovery of muscle function.",,1299490,1299490_D008274_D009135,1299490_4,bcv_sentence_task_befree_5,,770955932,FALSE,finalized,5,8/15/15 1:57,"



",no_relation,1,,D008274,"<span class=""chemical"">magnesium</span>",D009135,"<span class=""disease"">muscle damage</span>","Thus, <span class=""chemical"">magnesium</span> supplementation in <span class=""chemical"">magnesium</span>-replete subjects did not enhance performance or increase resistance to <span class=""disease"">muscle damage</span> during the race, or the rate of recovery of muscle function following the race.",,1299490,1299490_D008274_D009135,1299490_6,bcv_sentence_task_befree_6,,770955933,FALSE,finalized,5,8/15/15 1:53,"



",yes_direct,0.5999,,D004837,"<span class=""chemical"">epinephrine</span>",D011655,"<span class=""disease"">pulmonary thromboembolism</span>","Compound 7e, which has a comparable level of TXA2 synthase (IC50 1.2 microM) and human platelet cAMP PDE (IC50 6.4 microM) inhibitory activities, was found to be orally bioavailable with a long duration of action and offered effective protection against mortality in a collagen-<span class=""chemical"">epinephrine</span>-induced <span class=""disease"">pulmonary thromboembolism</span> model in mice.",,1311763,1311763_D004837_D011655,1311763_8,bcv_sentence_task_befree_7,,770955934,FALSE,finalized,5,8/15/15 1:38,"



",no_relation,1,,D000242,"<span class=""chemical"">cAMP</span>",D011655,"<span class=""disease"">pulmonary thromboembolism</span>","Compound 7e, which has a comparable level of TXA2 synthase (IC50 1.2 microM) and human platelet <span class=""chemical"">cAMP</span> PDE (IC50 6.4 microM) inhibitory activities, was found to be orally bioavailable with a long duration of action and offered effective protection against mortality in a collagen-epinephrine-induced <span class=""disease"">pulmonary thromboembolism</span> model in mice.",,1311763,1311763_D000242_D011655,1311763_8,bcv_sentence_task_befree_8,,770955935,FALSE,finalized,5,8/14/15 20:42,"



",no_relation,1,,D016190,"<span class=""chemical"">carboplatin</span>",D002289,"<span class=""disease"">non-small-cell lung cancer</span>","Intensive etoposide and <span class=""chemical"">carboplatin</span> chemotherapy for advanced <span class=""disease"">non-small-cell lung cancer</span>.",,1326224,1326224_D016190_D002289,1326224_0,bcv_sentence_task_befree_9,,770955936,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,D016190,"<span class=""chemical"">carboplatin</span>",D007938,"<span class=""disease"">Leukemia</span>","From April 2 to July 9, 1989, Cancer and <span class=""disease"">Leukemia</span> Group B (CALGB) conducted a Phase II study of etoposide and <span class=""chemical"">carboplatin</span> in advanced (AJC Stage IIIb-IV) non-small-cell lung cancer (NSCLC) patients whose performance status (PS) was 0-2.",,1326224,1326224_D016190_D007938,1326224_2,bcv_sentence_task_befree_10,,770955937,FALSE,finalized,5,8/14/15 20:19,"



",no_relation,1,,D005047,"<span class=""chemical"">etoposide</span>",D009369,"<span class=""disease"">Cancer</span>","From April 2 to July 9, 1989, <span class=""disease"">Cancer</span> and Leukemia Group B (CALGB) conducted a Phase II study of <span class=""chemical"">etoposide</span> and carboplatin in advanced (AJC Stage IIIb-IV) non-small-cell lung cancer (NSCLC) patients whose performance status (PS) was 0-2.",,1326224,1326224_D005047_D009369,1326224_2,bcv_sentence_task_befree_11,,770955938,FALSE,finalized,5,8/14/15 20:38,"



",no_relation,1,,D016190,"<span class=""chemical"">carboplatin</span>",D009369,"<span class=""disease"">Cancer</span>","From April 2 to July 9, 1989, <span class=""disease"">Cancer</span> and Leukemia Group B (CALGB) conducted a Phase II study of etoposide and <span class=""chemical"">carboplatin</span> in advanced (AJC Stage IIIb-IV) non-small-cell lung cancer (NSCLC) patients whose performance status (PS) was 0-2.",,1326224,1326224_D016190_D009369,1326224_2,bcv_sentence_task_befree_12,,770955939,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,1,,D005047,"<span class=""chemical"">etoposide</span>",D007938,"<span class=""disease"">Leukemia</span>","From April 2 to July 9, 1989, Cancer and <span class=""disease"">Leukemia</span> Group B (CALGB) conducted a Phase II study of <span class=""chemical"">etoposide</span> and carboplatin in advanced (AJC Stage IIIb-IV) non-small-cell lung cancer (NSCLC) patients whose performance status (PS) was 0-2.",,1326224,1326224_D005047_D007938,1326224_2,bcv_sentence_task_befree_13,,770955940,FALSE,finalized,5,8/14/15 20:34,"



",no_relation,1,,D016190,"<span class=""chemical"">carboplatin</span>",D002289,"<span class=""disease"">non-small-cell lung cancer/NSCLC</span>","From April 2 to July 9, 1989, Cancer and Leukemia Group B (CALGB) conducted a Phase II study of etoposide and <span class=""chemical"">carboplatin</span> in advanced (AJC Stage IIIb-IV) <span class=""disease"">non-small-cell lung cancer</span> (<span class=""disease"">NSCLC</span>) patients whose performance status (PS) was 0-2.",,1326224,1326224_D016190_D002289,1326224_2,bcv_sentence_task_befree_14,,770955941,FALSE,finalized,5,8/14/15 20:41,"



",no_relation,1,,D005047,"<span class=""chemical"">etoposide</span>",D002289,"<span class=""disease"">non-small-cell lung cancer/NSCLC</span>","From April 2 to July 9, 1989, Cancer and Leukemia Group B (CALGB) conducted a Phase II study of <span class=""chemical"">etoposide</span> and carboplatin in advanced (AJC Stage IIIb-IV) <span class=""disease"">non-small-cell lung cancer</span> (<span class=""disease"">NSCLC</span>) patients whose performance status (PS) was 0-2.",,1326224,1326224_D005047_D002289,1326224_2,bcv_sentence_task_befree_15,,770955942,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,1,,D002784,"<span class=""chemical"">cholesterol</span>",D007673,"<span class=""disease"">glomerular diseases</span>","After a baseline control period of 8 weeks on their usual diets, 20 untreated patients with chronic <span class=""disease"">glomerular diseases</span>, stable long-lasting severe proteinuria (5.9 [SD 3.4] g/24 h) and hyperlipidaemia (mean serum <span class=""chemical"">cholesterol</span> 8.69 [3.34] mmol/l) ate a vegetarian soy diet for 8 weeks.",,1349366,1349366_D002784_D007673,1349366_3,bcv_sentence_task_befree_16,,770955943,FALSE,finalized,5,8/14/15 21:02,"



",no_relation,1,,D002784,"<span class=""chemical"">cholesterol</span>",D011507,"<span class=""disease"">proteinuria</span>","After a baseline control period of 8 weeks on their usual diets, 20 untreated patients with chronic glomerular diseases, stable long-lasting severe <span class=""disease"">proteinuria</span> (5.9 [SD 3.4] g/24 h) and hyperlipidaemia (mean serum <span class=""chemical"">cholesterol</span> 8.69 [3.34] mmol/l) ate a vegetarian soy diet for 8 weeks.",,1349366,1349366_D002784_D011507,1349366_3,bcv_sentence_task_befree_17,,770955944,FALSE,finalized,5,8/15/15 1:58,"



",yes_direct,0.5819,,D017258,"<span class=""chemical"">medroxyprogesterone acetate</span>",D002769,"<span class=""disease"">Cholelithiasis</span>","<span class=""disease"">Cholelithiasis</span> associated with <span class=""chemical"">medroxyprogesterone acetate</span> therapy in men.",,1385654,1385654_D017258_D002769,1385654_0,bcv_sentence_task_befree_18,,770955945,FALSE,finalized,5,8/15/15 0:20,"



",yes_direct,0.8042,,D017258,"<span class=""chemical"">medroxyprogesterone acetate/MPA</span>",D002769,"<span class=""disease"">cholelithiasis</span>","Five out of forty-five adult men, 50 years of age or less, who had received, for at least six months, <span class=""chemical"">medroxyprogesterone acetate</span> (<span class=""chemical"">MPA</span>, Depo Provera) IM, 200-400 mg/week, for prevention of sex-offending or genital-mutilating behavior developed symptomatic <span class=""disease"">cholelithiasis</span>.",,1385654,1385654_D017258_D002769,1385654_1,bcv_sentence_task_befree_19,,770955946,FALSE,finalized,5,8/15/15 0:09,"


The stone had high cholesterol, but it wasn't caused by it.
",yes_direct,0.5893,,D002784,"<span class=""chemical"">cholesterol</span>",D042882,"<span class=""disease"">Gallstones</span>","<span class=""disease"">Gallstones</span> recovered from two patients were found to have very high <span class=""chemical"">cholesterol</span> content, suggesting they were formed in <span class=""chemical"">cholesterol</span> supersaturated bile.",,1385654,1385654_D002784_D042882,1385654_3,bcv_sentence_task_befree_20,,770955947,FALSE,finalized,5,8/14/15 22:19,"



",yes_direct,0.7987,,D011374,"<span class=""chemical"">progesterone</span>",D005705,"<span class=""disease"">gallbladder disease</span>","These findings are consistent with the increased incidence of <span class=""disease"">gallbladder disease</span> related to high-<span class=""chemical"">progesterone</span> states and suggest that MPA may be a causative agent in cholelithiasis.",,1385654,1385654_D011374_D005705,1385654_4,bcv_sentence_task_befree_21,,770955948,FALSE,finalized,5,8/14/15 22:24,"



",no_relation,1,,D011374,"<span class=""chemical"">progesterone</span>",D002769,"<span class=""disease"">cholelithiasis</span>","These findings are consistent with the increased incidence of gallbladder disease related to high-<span class=""chemical"">progesterone</span> states and suggest that MPA may be a causative agent in <span class=""disease"">cholelithiasis</span>.",,1385654,1385654_D011374_D002769,1385654_4,bcv_sentence_task_befree_22,,770955949,FALSE,finalized,5,8/15/15 0:15,"



",yes_direct,1,,D017258,"<span class=""chemical"">MPA</span>",D002769,"<span class=""disease"">cholelithiasis</span>","These findings are consistent with the increased incidence of gallbladder disease related to high-progesterone states and suggest that <span class=""chemical"">MPA</span> may be a causative agent in <span class=""disease"">cholelithiasis</span>.",,1385654,1385654_D017258_D002769,1385654_4,bcv_sentence_task_befree_23,,770955950,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,0.5996,,D017258,"<span class=""chemical"">MPA</span>",D005705,"<span class=""disease"">gallbladder disease</span>","These findings are consistent with the increased incidence of <span class=""disease"">gallbladder disease</span> related to high-progesterone states and suggest that <span class=""chemical"">MPA</span> may be a causative agent in cholelithiasis.",,1385654,1385654_D017258_D005705,1385654_4,bcv_sentence_task_befree_24,,770955951,FALSE,finalized,5,8/14/15 23:24,"



",no_relation,1,,D008727,"<span class=""chemical"">methotrexate</span>",D001172,"<span class=""disease"">rheumatoid arthritis</span>","Accelerated nodulosis during low dose <span class=""chemical"">methotrexate</span> therapy for <span class=""disease"">rheumatoid arthritis</span>.",,1404122,1404122_D008727_D001172,1404122_0,bcv_sentence_task_befree_25,,770955952,FALSE,finalized,5,8/14/15 20:17,"



",yes_direct,0.8267,,D008727,"<span class=""chemical"">methotrexate</span>",D003072,"<span class=""disease"">Accelerated nodulosis</span>","<span class=""disease"">Accelerated nodulosis</span> during low dose <span class=""chemical"">methotrexate</span> therapy for rheumatoid arthritis.",,1404122,1404122_D008727_D003072,1404122_0,bcv_sentence_task_befree_26,,770955953,FALSE,finalized,5,8/15/15 2:22,"



",no_relation,1,,D008727,"<span class=""chemical"">methotrexate/MTX</span>",D001172,"<span class=""disease"">rheumatoid arthritis/RA</span>","To obtain information on the occurrence of accelerated nodulosis during <span class=""chemical"">methotrexate</span> (<span class=""chemical"">MTX</span>) for <span class=""disease"">rheumatoid arthritis</span> (<span class=""disease"">RA</span>), localization, size and presence in heart and lungs of these nodules, predisposing factors, relationship with other extraarticular manifestations (EAM) and their histological features.",,1404122,1404122_D008727_D001172,1404122_2,bcv_sentence_task_befree_27,,770955954,FALSE,finalized,5,8/14/15 20:25,"



",yes_direct,1,,D008727,"<span class=""chemical"">MTX</span>",D003072,"<span class=""disease"">Accelerated nodulosis</span>","<span class=""disease"">Accelerated nodulosis</span> occurred exclusively during treatment with <span class=""chemical"">MTX</span> in our double blind study.",,1404122,1404122_D008727_D003072,1404122_7,bcv_sentence_task_befree_28,,770955955,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,D008727,"<span class=""chemical"">MTX</span>",D001172,"<span class=""disease"">RA</span>","Accelerated nodulosis during <span class=""chemical"">MTX</span> for <span class=""disease"">RA</span> is not rare, and occurs despite good clinical response of polyarthritis.",,1404122,1404122_D008727_D001172,1404122_18,bcv_sentence_task_befree_29,,770955956,FALSE,finalized,5,8/14/15 20:55,"



",yes_direct,1,,D008727,"<span class=""chemical"">MTX</span>",D003072,"<span class=""disease"">Accelerated nodulosis</span>","<span class=""disease"">Accelerated nodulosis</span> during <span class=""chemical"">MTX</span> for RA is not rare, and occurs despite good clinical response of polyarthritis.",,1404122,1404122_D008727_D003072,1404122_18,bcv_sentence_task_befree_30,,770955957,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,D008727,"<span class=""chemical"">MTX</span>",D001168,"<span class=""disease"">polyarthritis</span>","Accelerated nodulosis during <span class=""chemical"">MTX</span> for RA is not rare, and occurs despite good clinical response of <span class=""disease"">polyarthritis</span>.",,1404122,1404122_D008727_D001168,1404122_18,bcv_sentence_task_befree_31,,770955958,FALSE,finalized,5,8/15/15 1:23,"



",no_relation,1,,D009705,"<span class=""chemical"">nucleoside</span>",D015658,"<span class=""disease"">human immunodeficiency virus</span>","The objective of this study was to determine the population pharmacokinetic parameters and the extent of absorption of 2',3'-dideoxyinosine, a <span class=""chemical"">nucleoside</span> analog with activity against <span class=""disease"">human immunodeficiency virus</span> in vitro and in vivo, after oral and intravenous administration through the use of NON-linear Mixed Effects Modeling.",,1416828,1416828_D009705_D015658,1416828_1,bcv_sentence_task_befree_32,,770955959,FALSE,finalized,5,8/14/15 23:38,"



",no_relation,1,,D016049,"<span class=""chemical"">2',3'-dideoxyinosine</span>",D015658,"<span class=""disease"">human immunodeficiency virus</span>","The objective of this study was to determine the population pharmacokinetic parameters and the extent of absorption of <span class=""chemical"">2',3'-dideoxyinosine</span>, a nucleoside analog with activity against <span class=""disease"">human immunodeficiency virus</span> in vitro and in vivo, after oral and intravenous administration through the use of NON-linear Mixed Effects Modeling.",,1416828,1416828_D016049_D015658,1416828_1,bcv_sentence_task_befree_33,,770955960,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,0.8055,,D001839,"<span class=""chemical"">Bombesin</span>",D015408,"<span class=""disease"">gastrinoma</span>","<span class=""chemical"">Bombesin</span>, the equivalent of the mammalian gastrin-releasing peptide, has trophic effects on normal and neoplastic tissues of the gastrointestinal tract; the effects of gut hormones on the growth of <span class=""disease"">gastrinoma</span> are not known.",,1455308,1455308_D001839_D015408,1455308_2,bcv_sentence_task_befree_34,,770955961,FALSE,finalized,5,8/14/15 20:17,"



",yes_direct,1,,D001839,"<span class=""chemical"">Bombesin</span>",D009369,"<span class=""disease"">tumors</span>","<span class=""chemical"">Bombesin</span> significantly stimulated growth of PT <span class=""disease"">tumors</span> from day 18 until mice were sacrificed (day 28).",,1455308,1455308_D001839_D009369,1455308_9,bcv_sentence_task_befree_35,,770955962,FALSE,finalized,5,8/14/15 20:56,"



",yes_direct,0.613,,D001839,"<span class=""chemical"">bombesin</span>",D015408,"<span class=""disease"">gastrinoma</span>","We have demonstrated for the first time that <span class=""chemical"">bombesin</span> is a trophic hormone for <span class=""disease"">gastrinoma</span>.",,1455308,1455308_D001839_D015408,1455308_11,bcv_sentence_task_befree_36,,770955963,FALSE,finalized,5,8/15/15 0:35,"



",no_relation,1,,D020280,"<span class=""chemical"">sertraline</span>",D003866,"<span class=""disease"">depression</span>","One hundred patients with major <span class=""disease"">depression</span> who had discontinued fluoxetine because of side effects were enrolled in a multicenter, open, 8-week study of <span class=""chemical"">sertraline</span>.",,1480728,1480728_D020280_D003866,1480728_1,bcv_sentence_task_befree_37,,770955964,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,0.7864,,D005473,"<span class=""chemical"">fluoxetine</span>",D003866,"<span class=""disease"">depression</span>","One hundred patients with major <span class=""disease"">depression</span> who had discontinued <span class=""chemical"">fluoxetine</span> because of side effects were enrolled in a multicenter, open, 8-week study of sertraline.",,1480728,1480728_D005473_D003866,1480728_1,bcv_sentence_task_befree_38,,770955965,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,0.5925,,D020280,"<span class=""chemical"">sertraline</span>",D003866,"<span class=""disease"">Depressive symptoms</span>","The maximum daily dose of <span class=""chemical"">sertraline</span> was 200 mg. <span class=""disease"">Depressive symptoms</span> and adverse events were assessed weekly.",,1480728,1480728_D020280_D003866,1480728_4,bcv_sentence_task_befree_39,,770955966,FALSE,finalized,5,8/14/15 20:43,"



",no_relation,0.8112,,D020280,"<span class=""chemical"">sertraline</span>",D003866,"<span class=""disease"">depression</span>","Of 91 evaluable patients, 69 <span class=""chemical"">sertraline</span>-treated patients (75.8%) experienced significant improvement in <span class=""disease"">depression</span>.",,1480728,1480728_D020280_D003866,1480728_6,bcv_sentence_task_befree_40,,770955967,FALSE,finalized,5,8/14/15 20:29,"



",no_relation,0.8114,,D007069,"<span class=""chemical"">ifosfamide</span>",D009369,"<span class=""disease"">tumors</span>","Current studies of <span class=""chemical"">ifosfamide</span> for pediatric solid <span class=""disease"">tumors</span> and leukemia in the United States.",,1485174,1485174_D007069_D009369,1485174_0,bcv_sentence_task_befree_41,,770955968,FALSE,finalized,5,8/14/15 20:17,"



",no_relation,1,,D007069,"<span class=""chemical"">ifosfamide</span>",D007938,"<span class=""disease"">leukemia</span>","Current studies of <span class=""chemical"">ifosfamide</span> for pediatric solid tumors and <span class=""disease"">leukemia</span> in the United States.",,1485174,1485174_D007069_D007938,1485174_0,bcv_sentence_task_befree_42,,770955969,FALSE,finalized,5,8/15/15 1:09,"



",no_relation,1,,D007069,"<span class=""chemical"">ifosfamide</span>",D016609,"<span class=""disease"">malignancies</span>","This paper reviews current approaches to the use of <span class=""chemical"">ifosfamide</span>/mesna alone or in combination with other agents or modalities in the treatment of pediatric <span class=""disease"">malignancies</span>.",,1485174,1485174_D007069_D016609,1485174_1,bcv_sentence_task_befree_43,,770955970,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,D015080,"<span class=""chemical"">mesna</span>",D016609,"<span class=""disease"">malignancies</span>","This paper reviews current approaches to the use of ifosfamide/<span class=""chemical"">mesna</span> alone or in combination with other agents or modalities in the treatment of pediatric <span class=""disease"">malignancies</span>.",,1485174,1485174_D015080_D016609,1485174_1,bcv_sentence_task_befree_44,,770955971,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D016609,"<span class=""disease"">malignancies</span>","Randomized trials to determine the relative efficacy of ifosfamide and <span class=""chemical"">cyclophosphamide</span> in various childhood <span class=""disease"">malignancies</span> are under way.",,1485174,1485174_D003520_D016609,1485174_4,bcv_sentence_task_befree_45,,770955972,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,1,,D007069,"<span class=""chemical"">ifosfamide</span>",D016609,"<span class=""disease"">malignancies</span>","Randomized trials to determine the relative efficacy of <span class=""chemical"">ifosfamide</span> and cyclophosphamide in various childhood <span class=""disease"">malignancies</span> are under way.",,1485174,1485174_D007069_D016609,1485174_4,bcv_sentence_task_befree_46,,770955973,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,0.8005,,D007069,"<span class=""chemical"">ifosfamide</span>",D001749,"<span class=""disease"">bladder cancer</span>","The long-term consequences of <span class=""chemical"">ifosfamide</span> in survivors of childhood cancer, in terms of development of <span class=""disease"">bladder cancer</span> or other malignancies thought to be associated with alkylating agents, are not known, and will only be determined through follow-up studies of adult survivors.",,1485174,1485174_D007069_D001749,1485174_5,bcv_sentence_task_befree_47,,770955974,FALSE,finalized,5,8/15/15 2:04,"



",no_relation,0.8065,,D007069,"<span class=""chemical"">ifosfamide</span>",D009369,"<span class=""disease"">cancer</span>","The long-term consequences of <span class=""chemical"">ifosfamide</span> in survivors of childhood <span class=""disease"">cancer</span>, in terms of development of bladder cancer or other malignancies thought to be associated with alkylating agents, are not known, and will only be determined through follow-up studies of adult survivors.",,1485174,1485174_D007069_D009369,1485174_5,bcv_sentence_task_befree_48,,770955975,FALSE,finalized,5,8/14/15 20:38,"



",no_relation,0.7925,,D007069,"<span class=""chemical"">ifosfamide</span>",D016609,"<span class=""disease"">malignancies</span>","The long-term consequences of <span class=""chemical"">ifosfamide</span> in survivors of childhood cancer, in terms of development of bladder cancer or other <span class=""disease"">malignancies</span> thought to be associated with alkylating agents, are not known, and will only be determined through follow-up studies of adult survivors.",,1485174,1485174_D007069_D016609,1485174_5,bcv_sentence_task_befree_49,,770955976,FALSE,finalized,5,8/14/15 20:23,"



",no_relation,0.5917,,D007069,"<span class=""chemical"">Ifosfamide</span>",D064420,"<span class=""disease"">toxicity</span>","<span class=""chemical"">Ifosfamide</span>'s future role in pediatric oncology will depend on evaluation of its therapeutic benefits against long-term <span class=""disease"">toxicity</span>.",,1485174,1485174_D007069_D064420,1485174_6,bcv_sentence_task_befree_50,,770955977,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,D010844,"<span class=""chemical"">OK-432</span>",D009369,"<span class=""disease"">tumor</span>","Thirty KE of <span class=""chemical"">OK-432</span> was injected into the <span class=""disease"">tumor</span> per week (total 90-KE) and 5 KE of <span class=""chemical"">OK-432</span> was inoculated into the intracutaneous space per week (total 125 KE).",,1498496,1498496_D010844_D009369,1498496_2,bcv_sentence_task_befree_51,,770955978,FALSE,finalized,5,8/14/15 22:07,"



",no_relation,1,,C062940,"<span class=""chemical"">RP 59500</span>",D012174,"<span class=""disease"">RP</span>","The in vitro antistaphylococcal activity of <span class=""chemical""></span><span class=""disease"">RP</span> 59500, a new streptogramin, was comparable to those of vancomycin and teicoplanin against Staphylococcus aureus, and <span class=""disease"">RP</span> 59500 was the most active agent against coagulase-negative staphylococci.",,1503448,1503448_C062940_D012174,1503448_1,bcv_sentence_task_befree_52,,770955979,FALSE,finalized,5,8/14/15 20:05,"



",no_relation,1,,D014640,"<span class=""chemical"">vancomycin</span>",D012174,"<span class=""disease"">RP</span>","The in vitro antistaphylococcal activity of <span class=""disease"">RP</span> 59500, a new streptogramin, was comparable to those of <span class=""chemical"">vancomycin</span> and teicoplanin against Staphylococcus aureus, and <span class=""disease"">RP</span> 59500 was the most active agent against coagulase-negative staphylococci.",,1503448,1503448_D014640_D012174,1503448_1,bcv_sentence_task_befree_53,,770955980,FALSE,finalized,5,8/14/15 22:14,"



",no_relation,1,,D008550,"<span class=""chemical"">melatonin</span>",D009369,"<span class=""disease"">tumor</span>","While the in vivo <span class=""disease"">tumor</span>-inhibiting activity of <span class=""chemical"">melatonin</span> is established, observations on its in vitro effects have been contradictory.",,1542489,1542489_D008550_D009369,1542489_2,bcv_sentence_task_befree_54,,770955981,FALSE,finalized,5,8/14/15 20:29,"



",no_relation,1,,D008550,"<span class=""chemical"">melatonin</span>",D009369,"<span class=""disease"">cancer</span>","The effect of this substance was investigated on six human <span class=""disease"">cancer</span> cell lines and compared to the activity of a partially purified, <span class=""chemical"">melatonin</span>-free low molecular weight pineal extract (UMO5R).",,1542489,1542489_D008550_D009369,1542489_3,bcv_sentence_task_befree_55,,770955982,FALSE,finalized,5,8/14/15 23:16,"



",no_relation,1,,D008550,"<span class=""chemical"">melatonin</span>",D009369,"<span class=""disease"">tumor</span>","It is therefore concluded that a direct inhibiting action on <span class=""disease"">tumor</span> cells is not a general physiological role of <span class=""chemical"">melatonin</span> as opposed to UMO5R.",,1542489,1542489_D008550_D009369,1542489_5,bcv_sentence_task_befree_56,,770955983,FALSE,finalized,5,8/14/15 23:53,"



",no_relation,0.7932,,D015649,"<span class=""chemical"">pentostatin</span>",D007943,"<span class=""disease"">hairy cell leukemia</span>","Similar to interferon alpha, <span class=""chemical"">pentostatin</span> is highly effective in <span class=""disease"">hairy cell leukemia</span> and moderately active in other chronic lymphoid malignancies.",,1564958,1564958_D015649_D007943,1564958_1,bcv_sentence_task_befree_57,,770955984,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,D015649,"<span class=""chemical"">pentostatin</span>",D007945,"<span class=""disease"">lymphoid malignancies</span>","Similar to interferon alpha, <span class=""chemical"">pentostatin</span> is highly effective in hairy cell leukemia and moderately active in other chronic <span class=""disease"">lymphoid malignancies</span>.",,1564958,1564958_D015649_D007945,1564958_1,bcv_sentence_task_befree_58,,770955985,FALSE,finalized,5,8/15/15 0:35,"



",no_relation,1,,D015649,"<span class=""chemical"">pentostatin</span>",D015451,"<span class=""disease"">chronic leukemias</span>","In ten patients with hairy cell leukemia (HCL) and seven patients with other B-cell <span class=""disease"">chronic leukemias</span> (BCL), we have studied the intracellular 2',5'-oligoadenylate synthetase (2,5OAS) activity of the mononuclear cells before, 4 h, 24 h, and 48 h after <span class=""chemical"">pentostatin</span> administration.",,1564958,1564958_D015649_D015451,1564958_2,bcv_sentence_task_befree_59,,770955986,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,1,,D015649,"<span class=""chemical"">pentostatin</span>",D007943,"<span class=""disease"">HCL/hairy cell leukemia</span>","In ten patients with <span class=""disease"">hairy cell leukemia</span> (<span class=""disease"">HCL</span>) and seven patients with other B-cell chronic leukemias (BCL), we have studied the intracellular 2',5'-oligoadenylate synthetase (2,5OAS) activity of the mononuclear cells before, 4 h, 24 h, and 48 h after <span class=""chemical"">pentostatin</span> administration.",,1564958,1564958_D015649_D007943,1564958_2,bcv_sentence_task_befree_60,,770955987,FALSE,finalized,5,8/14/15 20:29,"



",no_relation,1,,C023505,"<span class=""chemical"">2',5'-oligoadenylate</span>",D007943,"<span class=""disease"">HCL/hairy cell leukemia</span>","In ten patients with <span class=""disease"">hairy cell leukemia</span> (<span class=""disease"">HCL</span>) and seven patients with other B-cell chronic leukemias (BCL), we have studied the intracellular <span class=""chemical"">2',5'-oligoadenylate</span> synthetase (2,5OAS) activity of the mononuclear cells before, 4 h, 24 h, and 48 h after pentostatin administration.",,1564958,1564958_C023505_D007943,1564958_2,bcv_sentence_task_befree_61,,770955988,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,1,,C023505,"<span class=""chemical"">2',5'-oligoadenylate</span>",D015451,"<span class=""disease"">chronic leukemias</span>","In ten patients with hairy cell leukemia (HCL) and seven patients with other B-cell <span class=""disease"">chronic leukemias</span> (BCL), we have studied the intracellular <span class=""chemical"">2',5'-oligoadenylate</span> synthetase (2,5OAS) activity of the mononuclear cells before, 4 h, 24 h, and 48 h after pentostatin administration.",,1564958,1564958_C023505_D015451,1564958_2,bcv_sentence_task_befree_62,,770955989,FALSE,finalized,5,8/15/15 1:17,"



",no_relation,1,,D015649,"<span class=""chemical"">pentostatin</span>",D007943,"<span class=""disease"">HCL</span>","Eleven patients (eight with <span class=""disease"">HCL</span> and two with BCL) responded to <span class=""chemical"">pentostatin</span>.",,1564958,1564958_D015649_D007943,1564958_5,bcv_sentence_task_befree_63,,770955990,FALSE,finalized,5,8/15/15 1:45,"



",yes_direct,0.3992,,D015649,"<span class=""chemical"">pentostatin</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Thus, response to <span class=""chemical"">pentostatin</span> correlates with induction of 2,5OAS directly and the 2',5'-oligoadenylate system seems to be involved in <span class=""disease"">cytotoxicity</span>.",,1564958,1564958_D015649_D004487,1564958_11,bcv_sentence_task_befree_64,,770955991,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,0.7854,,D007213,"<span class=""chemical"">indomethacin</span>",D020521,"<span class=""disease"">stroke</span>","Using Doppler technology, we determined cardiac output, <span class=""disease"">stroke</span> volume, and total peripheral resistance before and after three 25-mg doses of <span class=""chemical"">indomethacin</span>.",,1565345,1565345_D007213_D020521,1565345_5,bcv_sentence_task_befree_65,,770955992,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,0.7922,,D007213,"<span class=""chemical"">indomethacin</span>",D020521,"<span class=""disease"">stroke</span>","Although blood pressure did not change, peripheral resistance rose and <span class=""disease"">stroke</span> volume fell following <span class=""chemical"">indomethacin</span> administration.",,1565345,1565345_D007213_D020521,1565345_6,bcv_sentence_task_befree_66,,770955993,FALSE,finalized,5,8/15/15 1:39,"



",yes_direct,0.5911,,D000666,"<span class=""chemical"">amphotericin B</span>",D064420,"<span class=""disease"">toxicity</span>","Double-blind randomized study of the effect of infusion rates on <span class=""disease"">toxicity</span> of <span class=""chemical"">amphotericin B</span>.",,1590686,1590686_D000666_D064420,1590686_0,bcv_sentence_task_befree_67,,770955994,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,0.5894,,D000666,"<span class=""chemical"">amphotericin B</span>",D008172,"<span class=""disease"">fungal infection</span>","Results of a double-blind randomized non-crossover study of rapid (45 min) versus slow (4 h) infusion of <span class=""chemical"">amphotericin B</span> administered to 20 patients with proven or suspected <span class=""disease"">fungal infection</span> are reported.",,1590686,1590686_D000666_D008172,1590686_1,bcv_sentence_task_befree_68,,770955995,FALSE,finalized,5,8/14/15 22:23,"



",yes_direct,0.5742,,D008614,"<span class=""chemical"">meperidine</span>",D064420,"<span class=""disease"">Toxicity</span>","<span class=""disease"">Toxicity</span> was higher in the rapid infusion group than it was in the slow infusion group (mean total 7-day chill score, 173 +/- 276 versus 20 +/- 30 [P less than 0.01]; mean total 7-day dosage of <span class=""chemical"">meperidine</span> required to abate rigors, 180 +/- 133 versus 58 +/- 78 mg [P less than 0.05]; and mean maximum total 7-day pulse rise, 225 +/- 64 versus 135 +/- 56 beats per min [P less than 0.02], respectively).",,1590686,1590686_D008614_D064420,1590686_2,bcv_sentence_task_befree_69,,770955996,FALSE,finalized,5,8/14/15 20:21,"



",yes_direct,1,,D000666,"<span class=""chemical"">amphotericin B</span>",D009325,"<span class=""disease"">nausea</span>","When analyzed on a daily basis, the mean chill score, meperidine dosage, and pulse rise were also higher; and in addition, <span class=""disease"">nausea</span> and vomiting (5 of 11 patients who received a rapid infusion versus 0 of 9 patients who received a slow infusion [P less than 0.01]) appeared to be more common in those who received <span class=""chemical"">amphotericin B</span> rapidly.",,1590686,1590686_D000666_D009325,1590686_3,bcv_sentence_task_befree_70,,770955997,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,0.6072,,D000666,"<span class=""chemical"">amphotericin B</span>",D014839,"<span class=""disease"">vomiting</span>","When analyzed on a daily basis, the mean chill score, meperidine dosage, and pulse rise were also higher; and in addition, nausea and <span class=""disease"">vomiting</span> (5 of 11 patients who received a rapid infusion versus 0 of 9 patients who received a slow infusion [P less than 0.01]) appeared to be more common in those who received <span class=""chemical"">amphotericin B</span> rapidly.",,1590686,1590686_D000666_D014839,1590686_3,bcv_sentence_task_befree_71,,770955998,FALSE,finalized,5,8/15/15 1:23,"



",no_relation,0.5906,,D008614,"<span class=""chemical"">meperidine</span>",D009325,"<span class=""disease"">nausea</span>","When analyzed on a daily basis, the mean chill score, <span class=""chemical"">meperidine</span> dosage, and pulse rise were also higher; and in addition, <span class=""disease"">nausea</span> and vomiting (5 of 11 patients who received a rapid infusion versus 0 of 9 patients who received a slow infusion [P less than 0.01]) appeared to be more common in those who received amphotericin B rapidly.",,1590686,1590686_D008614_D009325,1590686_3,bcv_sentence_task_befree_72,,770955999,FALSE,finalized,5,8/14/15 22:24,"



",yes_direct,0.5938,,D008614,"<span class=""chemical"">meperidine</span>",D014839,"<span class=""disease"">vomiting</span>","When analyzed on a daily basis, the mean chill score, <span class=""chemical"">meperidine</span> dosage, and pulse rise were also higher; and in addition, nausea and <span class=""disease"">vomiting</span> (5 of 11 patients who received a rapid infusion versus 0 of 9 patients who received a slow infusion [P less than 0.01]) appeared to be more common in those who received amphotericin B rapidly.",,1590686,1590686_D008614_D014839,1590686_3,bcv_sentence_task_befree_73,,770956000,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,0.8087,,D008788,"<span class=""chemical"">metolazone</span>",D001997,"<span class=""disease"">bronchopulmonary dysplasia</span>","Addition of <span class=""chemical"">metolazone</span> to overcome tolerance to furosemide in infants with <span class=""disease"">bronchopulmonary dysplasia</span>.",,1593359,1593359_D008788_D001997,1593359_0,bcv_sentence_task_befree_74,,770956001,FALSE,finalized,5,8/14/15 20:34,"



",no_relation,1,,D005665,"<span class=""chemical"">furosemide</span>",D001997,"<span class=""disease"">bronchopulmonary dysplasia</span>","Addition of metolazone to overcome tolerance to <span class=""chemical"">furosemide</span> in infants with <span class=""disease"">bronchopulmonary dysplasia</span>.",,1593359,1593359_D005665_D001997,1593359_0,bcv_sentence_task_befree_75,,770956002,FALSE,finalized,5,8/14/15 23:30,"


The disease is a pre-existing condition.
",no_relation,1,,D012964,"<span class=""chemical"">sodium</span>",D001997,"<span class=""disease"">bronchopulmonary dysplasia</span>","We conclude that the administration of metolazone with furosemide enhances diuresis, natriuresis, and chloruresis and overcomes the rapid development of tolerance to furosemide in infants with <span class=""disease"">bronchopulmonary dysplasia</span> by blocking the compensatory increase in renal <span class=""chemical"">sodium</span> and chloride absorption.",,1593359,1593359_D012964_D001997,1593359_12,bcv_sentence_task_befree_76,,770956003,FALSE,finalized,5,8/15/15 1:14,"



",no_relation,1,,D008788,"<span class=""chemical"">metolazone</span>",D001997,"<span class=""disease"">bronchopulmonary dysplasia</span>","We conclude that the administration of <span class=""chemical"">metolazone</span> with furosemide enhances diuresis, natriuresis, and chloruresis and overcomes the rapid development of tolerance to furosemide in infants with <span class=""disease"">bronchopulmonary dysplasia</span> by blocking the compensatory increase in renal sodium and chloride absorption.",,1593359,1593359_D008788_D001997,1593359_12,bcv_sentence_task_befree_77,,770956004,FALSE,finalized,5,8/14/15 23:45,"



Disease is a pre-existing condition.",no_relation,1,,D005665,"<span class=""chemical"">furosemide</span>",D001997,"<span class=""disease"">bronchopulmonary dysplasia</span>","We conclude that the administration of metolazone with <span class=""chemical"">furosemide</span> enhances diuresis, natriuresis, and chloruresis and overcomes the rapid development of tolerance to <span class=""chemical"">furosemide</span> in infants with <span class=""disease"">bronchopulmonary dysplasia</span> by blocking the compensatory increase in renal sodium and chloride absorption.",,1593359,1593359_D005665_D001997,1593359_12,bcv_sentence_task_befree_78,,770956005,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D002712,"<span class=""chemical"">chloride</span>",D001997,"<span class=""disease"">bronchopulmonary dysplasia</span>","We conclude that the administration of metolazone with furosemide enhances diuresis, natriuresis, and chloruresis and overcomes the rapid development of tolerance to furosemide in infants with <span class=""disease"">bronchopulmonary dysplasia</span> by blocking the compensatory increase in renal sodium and <span class=""chemical"">chloride</span> absorption.",,1593359,1593359_D002712_D001997,1593359_12,bcv_sentence_task_befree_79,,770956006,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,1,,D013256,"<span class=""chemical"">steroids</span>",D006509,"<span class=""disease"">hepatitis B</span>","We report two <span class=""disease"">hepatitis B</span> virus (HBV) carriers who had liver failure after withdrawal of corticosteroids (<span class=""chemical"">steroids</span>) administered for treatment of serious asthmatic attacks.",,1600269,1600269_D013256_D006509,1600269_1,bcv_sentence_task_befree_80,,770956007,FALSE,finalized,5,8/15/15 1:49,"



",yes_direct,0.6112,,D013256,"<span class=""chemical"">steroids</span>",D017093,"<span class=""disease"">liver failure</span>","We report two hepatitis B virus (HBV) carriers who had <span class=""disease"">liver failure</span> after withdrawal of corticosteroids (<span class=""chemical"">steroids</span>) administered for treatment of serious asthmatic attacks.",,1600269,1600269_D013256_D017093,1600269_1,bcv_sentence_task_befree_81,,770956008,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,0.5787,,D000305,"<span class=""chemical"">corticosteroids</span>",D017093,"<span class=""disease"">liver failure</span>","We report two hepatitis B virus (HBV) carriers who had <span class=""disease"">liver failure</span> after withdrawal of <span class=""chemical"">corticosteroids</span> (steroids) administered for treatment of serious asthmatic attacks.",,1600269,1600269_D000305_D017093,1600269_1,bcv_sentence_task_befree_82,,770956009,FALSE,finalized,5,8/14/15 20:28,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D006509,"<span class=""disease"">hepatitis B</span>","We report two <span class=""disease"">hepatitis B</span> virus (HBV) carriers who had liver failure after withdrawal of <span class=""chemical"">corticosteroids</span> (steroids) administered for treatment of serious asthmatic attacks.",,1600269,1600269_D000305_D006509,1600269_1,bcv_sentence_task_befree_83,,770956010,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,D013256,"<span class=""chemical"">steroids</span>",D013224,"<span class=""disease"">asthmatic</span>","We report two hepatitis B virus (HBV) carriers who had liver failure after withdrawal of corticosteroids (<span class=""chemical"">steroids</span>) administered for treatment of serious <span class=""disease"">asthmatic</span> attacks.",,1600269,1600269_D013256_D013224,1600269_1,bcv_sentence_task_befree_84,,770956011,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D013224,"<span class=""disease"">asthmatic</span>","We report two hepatitis B virus (HBV) carriers who had liver failure after withdrawal of <span class=""chemical"">corticosteroids</span> (steroids) administered for treatment of serious <span class=""disease"">asthmatic</span> attacks.",,1600269,1600269_D000305_D013224,1600269_1,bcv_sentence_task_befree_85,,770956012,FALSE,finalized,5,8/14/15 23:59,"



",no_relation,0.5969,,D013256,"<span class=""chemical"">steroid</span>",D017093,"<span class=""disease"">liver failure</span>","Liver functions deteriorated 1 to 2 wk after withdrawal of the <span class=""chemical"">steroid</span> therapy and <span class=""disease"">liver failure</span> occurred.",,1600269,1600269_D013256_D017093,1600269_2,bcv_sentence_task_befree_86,,770956013,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D013256,"<span class=""chemical"">Steroid</span>",D017093,"<span class=""disease"">liver failure</span>","<span class=""chemical"">Steroid</span> readministration and intensive therapy for <span class=""disease"">liver failure</span> did not prevent death.",,1600269,1600269_D013256_D017093,1600269_3,bcv_sentence_task_befree_87,,770956014,FALSE,finalized,5,8/14/15 20:52,"



",no_relation,1,,D013256,"<span class=""chemical"">Steroid</span>",D003643,"<span class=""disease"">death</span>","<span class=""chemical"">Steroid</span> readministration and intensive therapy for liver failure did not prevent <span class=""disease"">death</span>.",,1600269,1600269_D013256_D003643,1600269_3,bcv_sentence_task_befree_88,,770956015,FALSE,finalized,5,8/14/15 21:46,"



",no_relation,0.7904,,D013256,"<span class=""chemical"">steroid</span>",D008107,"<span class=""disease"">liver disease</span>","An excessive immune response provoked by <span class=""chemical"">steroid</span> withdrawal and decreased reserve capacity due to underlying chronic <span class=""disease"">liver disease</span> were thought to be factors in the liver failure.",,1600269,1600269_D013256_D008107,1600269_4,bcv_sentence_task_befree_89,,770956016,FALSE,finalized,5,8/14/15 20:24,"



",no_relation,0.6153,,D013256,"<span class=""chemical"">steroid</span>",D017093,"<span class=""disease"">liver failure</span>","An excessive immune response provoked by <span class=""chemical"">steroid</span> withdrawal and decreased reserve capacity due to underlying chronic liver disease were thought to be factors in the <span class=""disease"">liver failure</span>.",,1600269,1600269_D013256_D017093,1600269_4,bcv_sentence_task_befree_90,,770956017,FALSE,finalized,5,8/14/15 20:43,"



",no_relation,1,,D013256,"<span class=""chemical"">steroids</span>",D006509,"<span class=""disease"">HBV infection</span>","Caution must be exercised in the administration of <span class=""chemical"">steroids</span> to patients with underlying chronic <span class=""disease"">HBV infection</span> to prevent exacerbation of hepatitis.",,1600269,1600269_D013256_D006509,1600269_5,bcv_sentence_task_befree_91,,770956018,FALSE,finalized,5,8/14/15 20:38,"



",yes_direct,0.8009,,D013256,"<span class=""chemical"">steroids</span>",D006505,"<span class=""disease"">hepatitis</span>","Caution must be exercised in the administration of <span class=""chemical"">steroids</span> to patients with underlying chronic HBV infection to prevent exacerbation of <span class=""disease"">hepatitis</span>.",,1600269,1600269_D013256_D006505,1600269_5,bcv_sentence_task_befree_92,,770956019,FALSE,finalized,5,8/14/15 20:06,"



",no_relation,1,,D013256,"<span class=""chemical"">steroids</span>",D017093,"<span class=""disease"">liver failure</span>","Prompt readministration of <span class=""chemical"">steroids</span> is indicated if evidence of <span class=""disease"">liver failure</span> develops.",,1600269,1600269_D013256_D017093,1600269_6,bcv_sentence_task_befree_93,,770956020,FALSE,finalized,5,8/14/15 22:31,"



",no_relation,1,,D008715,"<span class=""chemical"">methionine</span>",D055752,"<span class=""disease"">SCLC</span>","In summary, BN analogues which lack a C-terminal <span class=""chemical"">methionine</span> may function as useful <span class=""disease"">SCLC</span> BN receptor antagonists.",,1646997,1646997_D008715_D055752,1646997_6,bcv_sentence_task_befree_94,,770956021,FALSE,finalized,5,8/14/15 23:21,"



",no_relation,0.7925,,D001839,"<span class=""chemical"">BN</span>",D055752,"<span class=""disease"">SCLC</span>","In summary, <span class=""chemical"">BN</span> analogues which lack a C-terminal methionine may function as useful <span class=""disease"">SCLC</span> BN receptor antagonists.",,1646997,1646997_D001839_D055752,1646997_6,bcv_sentence_task_befree_95,,770956022,FALSE,finalized,5,8/14/15 20:38,"



",no_relation,0.824,,D013629,"<span class=""chemical"">tamoxifen</span>",D009447,"<span class=""disease"">neuroblastoma</span>","Non-myelotoxic antitumour effects of L-dopa, buthionine sulphoximine and <span class=""chemical"">tamoxifen</span> on <span class=""disease"">neuroblastoma</span> cells in vitro and in vivo.",,1653780,1653780_D013629_D009447,1653780_0,bcv_sentence_task_befree_96,,770956023,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,1,,D007980,"<span class=""chemical"">L-dopa</span>",D008545,"<span class=""disease"">melanoma</span>","The effects of three non-myelotoxic cancer drugs on the growth of neuroblastoma cells were investigated in vitro and in vivo: dihydroxyphenylalanine (<span class=""chemical"">L-dopa</span>, a drug with selective toxicity for <span class=""disease"">melanoma</span> cells), DL-buthionine sulphoximine (BSO, a drug with radiosensitizing effects), and tamoxifen (a drug used in the treatment of human mammary carcinoma).",,1653780,1653780_D007980_D008545,1653780_1,bcv_sentence_task_befree_97,,770956024,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D008545,"<span class=""disease"">melanoma</span>","The effects of three non-myelotoxic cancer drugs on the growth of neuroblastoma cells were investigated in vitro and in vivo: dihydroxyphenylalanine (L-dopa, a drug with selective toxicity for <span class=""disease"">melanoma</span> cells), DL-buthionine sulphoximine (BSO, a drug with radiosensitizing effects), and <span class=""chemical"">tamoxifen</span> (a drug used in the treatment of human mammary carcinoma).",,1653780,1653780_D013629_D008545,1653780_1,bcv_sentence_task_befree_98,,770956025,FALSE,finalized,5,8/14/15 20:49,"



",yes_direct,0.5949,,D004295,"<span class=""chemical"">dihydroxyphenylalanine</span>",D064420,"<span class=""disease"">toxicity</span>","The effects of three non-myelotoxic cancer drugs on the growth of neuroblastoma cells were investigated in vitro and in vivo: <span class=""chemical"">dihydroxyphenylalanine</span> (L-dopa, a drug with selective <span class=""disease"">toxicity</span> for melanoma cells), DL-buthionine sulphoximine (BSO, a drug with radiosensitizing effects), and tamoxifen (a drug used in the treatment of human mammary carcinoma).",,1653780,1653780_D004295_D064420,1653780_1,bcv_sentence_task_befree_99,,770956026,FALSE,finalized,5,8/14/15 23:45,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D064420,"<span class=""disease"">toxicity</span>","The effects of three non-myelotoxic cancer drugs on the growth of neuroblastoma cells were investigated in vitro and in vivo: dihydroxyphenylalanine (L-dopa, a drug with selective <span class=""disease"">toxicity</span> for melanoma cells), DL-buthionine sulphoximine (BSO, a drug with radiosensitizing effects), and <span class=""chemical"">tamoxifen</span> (a drug used in the treatment of human mammary carcinoma).",,1653780,1653780_D013629_D064420,1653780_1,bcv_sentence_task_befree_100,,770956027,FALSE,finalized,5,8/14/15 22:31,"



",no_relation,1,,D004295,"<span class=""chemical"">dihydroxyphenylalanine</span>",D001943,"<span class=""disease"">human mammary carcinoma</span>","The effects of three non-myelotoxic cancer drugs on the growth of neuroblastoma cells were investigated in vitro and in vivo: <span class=""chemical"">dihydroxyphenylalanine</span> (L-dopa, a drug with selective toxicity for melanoma cells), DL-buthionine sulphoximine (BSO, a drug with radiosensitizing effects), and tamoxifen (a drug used in the treatment of <span class=""disease"">human mammary carcinoma</span>).",,1653780,1653780_D004295_D001943,1653780_1,bcv_sentence_task_befree_101,,770956028,FALSE,finalized,5,8/14/15 20:06,"



",no_relation,1,,D007980,"<span class=""chemical"">L-dopa</span>",D001943,"<span class=""disease"">human mammary carcinoma</span>","The effects of three non-myelotoxic cancer drugs on the growth of neuroblastoma cells were investigated in vitro and in vivo: dihydroxyphenylalanine (<span class=""chemical"">L-dopa</span>, a drug with selective toxicity for melanoma cells), DL-buthionine sulphoximine (BSO, a drug with radiosensitizing effects), and tamoxifen (a drug used in the treatment of <span class=""disease"">human mammary carcinoma</span>).",,1653780,1653780_D007980_D001943,1653780_1,bcv_sentence_task_befree_102,,770956029,FALSE,finalized,5,8/15/15 0:11,"



",no_relation,1,,D007980,"<span class=""chemical"">L-dopa</span>",D009447,"<span class=""disease"">neuroblastoma</span>","The effects of three non-myelotoxic cancer drugs on the growth of <span class=""disease"">neuroblastoma</span> cells were investigated in vitro and in vivo: dihydroxyphenylalanine (<span class=""chemical"">L-dopa</span>, a drug with selective toxicity for melanoma cells), DL-buthionine sulphoximine (BSO, a drug with radiosensitizing effects), and tamoxifen (a drug used in the treatment of human mammary carcinoma).",,1653780,1653780_D007980_D009447,1653780_1,bcv_sentence_task_befree_103,,770956030,FALSE,finalized,5,8/14/15 22:15,"



",no_relation,0.5749,,D007980,"<span class=""chemical"">L-dopa</span>",D064420,"<span class=""disease"">toxicity</span>","The effects of three non-myelotoxic cancer drugs on the growth of neuroblastoma cells were investigated in vitro and in vivo: dihydroxyphenylalanine (<span class=""chemical"">L-dopa</span>, a drug with selective <span class=""disease"">toxicity</span> for melanoma cells), DL-buthionine sulphoximine (BSO, a drug with radiosensitizing effects), and tamoxifen (a drug used in the treatment of human mammary carcinoma).",,1653780,1653780_D007980_D064420,1653780_1,bcv_sentence_task_befree_104,,770956031,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D009447,"<span class=""disease"">neuroblastoma</span>","The effects of three non-myelotoxic cancer drugs on the growth of <span class=""disease"">neuroblastoma</span> cells were investigated in vitro and in vivo: dihydroxyphenylalanine (L-dopa, a drug with selective toxicity for melanoma cells), DL-buthionine sulphoximine (BSO, a drug with radiosensitizing effects), and <span class=""chemical"">tamoxifen</span> (a drug used in the treatment of human mammary carcinoma).",,1653780,1653780_D013629_D009447,1653780_1,bcv_sentence_task_befree_105,,770956032,FALSE,finalized,5,8/15/15 0:07,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D001943,"<span class=""disease"">human mammary carcinoma</span>","The effects of three non-myelotoxic cancer drugs on the growth of neuroblastoma cells were investigated in vitro and in vivo: dihydroxyphenylalanine (L-dopa, a drug with selective toxicity for melanoma cells), DL-buthionine sulphoximine (BSO, a drug with radiosensitizing effects), and <span class=""chemical"">tamoxifen</span> (a drug used in the treatment of <span class=""disease"">human mammary carcinoma</span>).",,1653780,1653780_D013629_D001943,1653780_1,bcv_sentence_task_befree_106,,770956033,FALSE,finalized,5,8/14/15 20:54,"



",no_relation,1,,D004295,"<span class=""chemical"">dihydroxyphenylalanine</span>",D009447,"<span class=""disease"">neuroblastoma</span>","The effects of three non-myelotoxic cancer drugs on the growth of <span class=""disease"">neuroblastoma</span> cells were investigated in vitro and in vivo: <span class=""chemical"">dihydroxyphenylalanine</span> (L-dopa, a drug with selective toxicity for melanoma cells), DL-buthionine sulphoximine (BSO, a drug with radiosensitizing effects), and tamoxifen (a drug used in the treatment of human mammary carcinoma).",,1653780,1653780_D004295_D009447,1653780_1,bcv_sentence_task_befree_107,,770956034,FALSE,finalized,5,8/14/15 23:16,"



",no_relation,0.8046,,D004295,"<span class=""chemical"">dihydroxyphenylalanine</span>",D008545,"<span class=""disease"">melanoma</span>","The effects of three non-myelotoxic cancer drugs on the growth of neuroblastoma cells were investigated in vitro and in vivo: <span class=""chemical"">dihydroxyphenylalanine</span> (L-dopa, a drug with selective toxicity for <span class=""disease"">melanoma</span> cells), DL-buthionine sulphoximine (BSO, a drug with radiosensitizing effects), and tamoxifen (a drug used in the treatment of human mammary carcinoma).",,1653780,1653780_D004295_D008545,1653780_1,bcv_sentence_task_befree_108,,770956035,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,1,,D004298,"<span class=""chemical"">dopamine</span>",D009369,"<span class=""disease"">neuroblastoma tumours</span>","The growth of <span class=""disease"">neuroblastoma tumours</span> was inhibited by different mechanisms: L-dopa and its metabolite <span class=""chemical"">dopamine</span> reduced the activity of tyrosinase, BSO reduced glutathione levels, and L-dopa and tamoxifen raised cAMP concentrations.",,1653780,1653780_D004298_D009369,1653780_5,bcv_sentence_task_befree_109,,770956036,FALSE,finalized,5,8/14/15 22:52,"



",no_relation,1,,D005978,"<span class=""chemical"">glutathione</span>",D009369,"<span class=""disease"">neuroblastoma tumours</span>","The growth of <span class=""disease"">neuroblastoma tumours</span> was inhibited by different mechanisms: L-dopa and its metabolite dopamine reduced the activity of tyrosinase, BSO reduced <span class=""chemical"">glutathione</span> levels, and L-dopa and tamoxifen raised cAMP concentrations.",,1653780,1653780_D005978_D009369,1653780_5,bcv_sentence_task_befree_110,,770956037,FALSE,finalized,5,8/14/15 20:32,"



",no_relation,0.7976,,D000242,"<span class=""chemical"">cAMP</span>",D009369,"<span class=""disease"">neuroblastoma tumours</span>","The growth of <span class=""disease"">neuroblastoma tumours</span> was inhibited by different mechanisms: L-dopa and its metabolite dopamine reduced the activity of tyrosinase, BSO reduced glutathione levels, and L-dopa and tamoxifen raised <span class=""chemical"">cAMP</span> concentrations.",,1653780,1653780_D000242_D009369,1653780_5,bcv_sentence_task_befree_111,,770956038,FALSE,finalized,5,8/15/15 0:44,"



",no_relation,1,,D007980,"<span class=""chemical"">L-dopa</span>",D009369,"<span class=""disease"">neuroblastoma tumours</span>","The growth of <span class=""disease"">neuroblastoma tumours</span> was inhibited by different mechanisms: <span class=""chemical"">L-dopa</span> and its metabolite dopamine reduced the activity of tyrosinase, BSO reduced glutathione levels, and <span class=""chemical"">L-dopa</span> and tamoxifen raised cAMP concentrations.",,1653780,1653780_D007980_D009369,1653780_5,bcv_sentence_task_befree_112,,770956039,FALSE,finalized,5,8/15/15 0:42,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">neuroblastoma tumours</span>","The growth of <span class=""disease"">neuroblastoma tumours</span> was inhibited by different mechanisms: L-dopa and its metabolite dopamine reduced the activity of tyrosinase, BSO reduced glutathione levels, and L-dopa and <span class=""chemical"">tamoxifen</span> raised cAMP concentrations.",,1653780,1653780_D013629_D009369,1653780_5,bcv_sentence_task_befree_113,,770956040,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,D016210,"<span class=""chemical"">methacholine</span>",D013224,"<span class=""disease"">asthmatic</span>","Ten <span class=""disease"">asthmatic</span> subjects were studied on three occasions after bronchial challenges with aerosolized PAF, <span class=""chemical"">methacholine</span>, or isotonic saline.",,1661723,1661723_D016210_D013224,1661723_3,bcv_sentence_task_befree_114,,770956041,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",C531854,"<span class=""disease"">retinoic acid/RA</span>","We have investigated the effect of <span class=""disease"">retinoic acid</span> (<span class=""disease"">RA</span>) and retinyl acetate (RAc) on the production of reactive <span class=""chemical"">oxygen</span> metabolites and the release of lysosomal enzymes by human polymorphonuclear leukocytes (PMN).",,1667243,1667243_D010100_C531854,1667243_2,bcv_sentence_task_befree_115,,770956042,FALSE,finalized,5,8/15/15 0:12,"



",no_relation,1,,C009166,"<span class=""chemical"">retinyl acetate</span>",C531854,"<span class=""disease"">retinoic acid/RA</span>","We have investigated the effect of <span class=""disease"">retinoic acid</span> (<span class=""disease"">RA</span>) and <span class=""chemical"">retinyl acetate</span> (RAc) on the production of reactive oxygen metabolites and the release of lysosomal enzymes by human polymorphonuclear leukocytes (PMN).",,1667243,1667243_C009166_C531854,1667243_2,bcv_sentence_task_befree_116,,770956043,FALSE,finalized,5,8/15/15 0:10,"



",no_relation,1,,D014212,"<span class=""chemical"">retinoic acid</span>",C531854,"<span class=""disease"">retinoic acid/RA</span>","We have investigated the effect of <span class=""chemical""></span><span class=""disease"">retinoic acid</span> (<span class=""disease"">RA</span>) and retinyl acetate (RAc) on the production of reactive oxygen metabolites and the release of lysosomal enzymes by human polymorphonuclear leukocytes (PMN).",,1667243,1667243_D014212_C531854,1667243_2,bcv_sentence_task_befree_117,,770956044,FALSE,finalized,5,8/15/15 1:39,"



",no_relation,1,,D000001,"<span class=""chemical"">A23187</span>",C531854,"<span class=""disease"">RA</span>","Incubation of PMN with RAc or <span class=""disease"">RA</span> (1-100 microM) caused a dose-dependent inhibition (upto 90%) in O2- production and chemiluminescence induced by phorbol myristate acetate (PMA), N-formyl-methionyl-leucyl-phenylanaline (fMLP), opsonized zymosan or ionophore <span class=""chemical"">A23187</span>.",,1667243,1667243_D000001_C531854,1667243_3,bcv_sentence_task_befree_118,,770956045,FALSE,finalized,5,8/15/15 1:50,"



",no_relation,1,,D013481,"<span class=""chemical"">O2</span>",C531854,"<span class=""disease"">RA</span>","Incubation of PMN with RAc or <span class=""disease"">RA</span> (1-100 microM) caused a dose-dependent inhibition (upto 90%) in <span class=""chemical"">O2</span>- production and chemiluminescence induced by phorbol myristate acetate (PMA), N-formyl-methionyl-leucyl-phenylanaline (fMLP), opsonized zymosan or ionophore A23187.",,1667243,1667243_D013481_C531854,1667243_3,bcv_sentence_task_befree_119,,770956046,FALSE,finalized,5,8/15/15 2:25,"



",no_relation,0.6306,,D013755,"<span class=""chemical"">phorbol myristate acetate/PMA</span>",C531854,"<span class=""disease"">RA</span>","Incubation of PMN with RAc or <span class=""disease"">RA</span> (1-100 microM) caused a dose-dependent inhibition (upto 90%) in O2- production and chemiluminescence induced by <span class=""chemical"">phorbol myristate acetate</span> (<span class=""chemical"">PMA</span>), N-formyl-methionyl-leucyl-phenylanaline (fMLP), opsonized zymosan or ionophore A23187.",,1667243,1667243_D013755_C531854,1667243_3,bcv_sentence_task_befree_120,,770956047,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,0.8049,,D012176,"<span class=""chemical"">retinoids</span>",C531854,"<span class=""disease"">RA</span>","Both <span class=""chemical"">retinoids</span> (1-100 microM) also inhibited, in a dose-dependent way, degranulation induced by fMLP (upto 85% at the highest concentration of <span class=""disease"">RA</span>).",,1667243,1667243_D012176_C531854,1667243_4,bcv_sentence_task_befree_121,,770956048,FALSE,finalized,5,8/14/15 20:05,"



",no_relation,1,,D015215,"<span class=""chemical"">zidovudine</span>",D000163,"<span class=""disease"">AIDS</span>","Surrogate markers for survival in patients with <span class=""disease"">AIDS</span> and <span class=""disease"">AIDS</span> related complex treated with <span class=""chemical"">zidovudine</span>.",,1671651,1671651_D015215_D000163,1671651_0,bcv_sentence_task_befree_122,,770956049,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,D015215,"<span class=""chemical"">zidovudine</span>",D000163,"<span class=""disease"">AIDS</span>","To determine whether early effects of <span class=""chemical"">zidovudine</span> treatment on CD4+ lymphocyte count and concentrations of beta 2 microglobulin, neopterin, or HIV p24 antigen or antibody are correlated with survival in patients with <span class=""disease"">AIDS</span> or <span class=""disease"">AIDS</span> related complex.",,1671651,1671651_D015215_D000163,1671651_1,bcv_sentence_task_befree_123,,770956050,FALSE,finalized,5,8/15/15 1:29,"



",no_relation,1,,D019798,"<span class=""chemical"">neopterin</span>",D000163,"<span class=""disease"">AIDS</span>","To determine whether early effects of zidovudine treatment on CD4+ lymphocyte count and concentrations of beta 2 microglobulin, <span class=""chemical"">neopterin</span>, or HIV p24 antigen or antibody are correlated with survival in patients with <span class=""disease"">AIDS</span> or <span class=""disease"">AIDS</span> related complex.",,1671651,1671651_D019798_D000163,1671651_1,bcv_sentence_task_befree_124,,770956051,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D019798,"<span class=""chemical"">neopterin</span>",D000163,"<span class=""disease"">AIDS</span>","The pretreatment characteristics that independently predicted poor survival were determined using a multivariate proportional hazards model: a diagnosis of <span class=""disease"">AIDS</span> (v <span class=""disease"">AIDS</span> related complex), age over 45 years, and the logarithm of serum <span class=""chemical"">neopterin</span> concentration.",,1671651,1671651_D019798_D000163,1671651_8,bcv_sentence_task_befree_125,,770956052,FALSE,finalized,5,8/14/15 20:38,"



",no_relation,1,,D049971,"<span class=""chemical"">Thiazide</span>",D006973,"<span class=""disease"">hypertensive/hypertension</span>","<span class=""chemical"">Thiazide</span> diuretics remain the drugs of first choice for treating <span class=""disease"">hypertension</span> in the African-American <span class=""disease"">hypertensive</span>.",,1687447,1687447_D049971_D006973,1687447_4,bcv_sentence_task_befree_126,,770956053,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,0.8137,,D002118,"<span class=""chemical"">calcium</span>",D054144,"<span class=""disease"">diastolic dysfunction</span>","The <span class=""chemical"">calcium</span> channel blockers (CCBs) are attractive alternatives to thiazides in patients uncontrolled by or intolerant of thiazides or who have specific indications for these agents (eg, angina, severe <span class=""disease"">diastolic dysfunction</span>).",,1687447,1687447_D002118_D054144,1687447_5,bcv_sentence_task_befree_127,,770956054,FALSE,finalized,5,8/15/15 1:22,"



",no_relation,0.7992,,D049971,"<span class=""chemical"">thiazides</span>",D017566,"<span class=""disease"">angina</span>","The calcium channel blockers (CCBs) are attractive alternatives to <span class=""chemical"">thiazides</span> in patients uncontrolled by or intolerant of <span class=""chemical"">thiazides</span> or who have specific indications for these agents (eg, <span class=""disease"">angina</span>, severe diastolic dysfunction).",,1687447,1687447_D049971_D017566,1687447_5,bcv_sentence_task_befree_128,,770956055,FALSE,finalized,5,8/14/15 20:55,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D017566,"<span class=""disease"">angina</span>","The <span class=""chemical"">calcium</span> channel blockers (CCBs) are attractive alternatives to thiazides in patients uncontrolled by or intolerant of thiazides or who have specific indications for these agents (eg, <span class=""disease"">angina</span>, severe diastolic dysfunction).",,1687447,1687447_D002118_D017566,1687447_5,bcv_sentence_task_befree_129,,770956056,FALSE,finalized,5,8/15/15 1:11,"



",no_relation,1,,D049971,"<span class=""chemical"">thiazides</span>",D054144,"<span class=""disease"">diastolic dysfunction</span>","The calcium channel blockers (CCBs) are attractive alternatives to <span class=""chemical"">thiazides</span> in patients uncontrolled by or intolerant of <span class=""chemical"">thiazides</span> or who have specific indications for these agents (eg, angina, severe <span class=""disease"">diastolic dysfunction</span>).",,1687447,1687447_D049971_D054144,1687447_5,bcv_sentence_task_befree_130,,770956057,FALSE,finalized,5,8/15/15 2:34,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D006525,"<span class=""disease"">viral hepatitis</span>","These include: the requirement for improved enzymological screening, despite the introduction of a test for hepatitis C; the imbalance between the popularity of ""unexplained chronic aminotransferase elevations"" and efforts to solve the inherent problems; the inadequate attempts to use the metabolic changes in the hepatocytes to improve diagnosis, prognosis, and pathophysiological understanding of viral liver diseases; the remarkable investigations into the 2'-5'-oligoadenylate synthetase for better control of interferon therapy in chronic <span class=""disease"">viral hepatitis</span>; the use of enzymes as markers of etiology, particularly for the detection of <span class=""chemical"">alcohol</span> induced liver diseases; the continuing preference for the aminotransferases in this scenario although the ratios of aspartate aminotransferase over alanine aminotransferase, or of mitochondrial aspartate aminotransferase over total aspartate aminotransferase activity, largely depend on the severity and intralobular localization of damage and the stage of the liver disease.",,1701367,1701367_D000431_D006525,1701367_2,bcv_sentence_task_befree_131,,770956058,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,0.6061,,D000431,"<span class=""chemical"">alcohol</span>",D006526,"<span class=""disease"">hepatitis C</span>","These include: the requirement for improved enzymological screening, despite the introduction of a test for <span class=""disease"">hepatitis C</span>; the imbalance between the popularity of ""unexplained chronic aminotransferase elevations"" and efforts to solve the inherent problems; the inadequate attempts to use the metabolic changes in the hepatocytes to improve diagnosis, prognosis, and pathophysiological understanding of viral liver diseases; the remarkable investigations into the 2'-5'-oligoadenylate synthetase for better control of interferon therapy in chronic viral hepatitis; the use of enzymes as markers of etiology, particularly for the detection of <span class=""chemical"">alcohol</span> induced liver diseases; the continuing preference for the aminotransferases in this scenario although the ratios of aspartate aminotransferase over alanine aminotransferase, or of mitochondrial aspartate aminotransferase over total aspartate aminotransferase activity, largely depend on the severity and intralobular localization of damage and the stage of the liver disease.",,1701367,1701367_D000431_D006526,1701367_2,bcv_sentence_task_befree_132,,770956059,FALSE,finalized,5,8/15/15 1:45,"



",yes_direct,1,,D000431,"<span class=""chemical"">alcohol</span>",D008107,"<span class=""disease"">liver diseases/liver disease</span>","These include: the requirement for improved enzymological screening, despite the introduction of a test for hepatitis C; the imbalance between the popularity of ""unexplained chronic aminotransferase elevations"" and efforts to solve the inherent problems; the inadequate attempts to use the metabolic changes in the hepatocytes to improve diagnosis, prognosis, and pathophysiological understanding of viral <span class=""disease"">liver diseases</span>; the remarkable investigations into the 2'-5'-oligoadenylate synthetase for better control of interferon therapy in chronic viral hepatitis; the use of enzymes as markers of etiology, particularly for the detection of <span class=""chemical"">alcohol</span> induced <span class=""disease"">liver diseases</span>; the continuing preference for the aminotransferases in this scenario although the ratios of aspartate aminotransferase over alanine aminotransferase, or of mitochondrial aspartate aminotransferase over total aspartate aminotransferase activity, largely depend on the severity and intralobular localization of damage and the stage of the <span class=""disease"">liver disease</span>.",,1701367,1701367_D000431_D008107,1701367_2,bcv_sentence_task_befree_133,,770956060,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,D000409,"<span class=""chemical"">alanine</span>",D006526,"<span class=""disease"">hepatitis C</span>","These include: the requirement for improved enzymological screening, despite the introduction of a test for <span class=""disease"">hepatitis C</span>; the imbalance between the popularity of ""unexplained chronic aminotransferase elevations"" and efforts to solve the inherent problems; the inadequate attempts to use the metabolic changes in the hepatocytes to improve diagnosis, prognosis, and pathophysiological understanding of viral liver diseases; the remarkable investigations into the 2'-5'-oligoadenylate synthetase for better control of interferon therapy in chronic viral hepatitis; the use of enzymes as markers of etiology, particularly for the detection of alcohol induced liver diseases; the continuing preference for the aminotransferases in this scenario although the ratios of aspartate aminotransferase over <span class=""chemical"">alanine</span> aminotransferase, or of mitochondrial aspartate aminotransferase over total aspartate aminotransferase activity, largely depend on the severity and intralobular localization of damage and the stage of the liver disease.",,1701367,1701367_D000409_D006526,1701367_2,bcv_sentence_task_befree_134,,770956061,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,1,,D001224,"<span class=""chemical"">aspartate</span>",D006525,"<span class=""disease"">viral hepatitis</span>","These include: the requirement for improved enzymological screening, despite the introduction of a test for hepatitis C; the imbalance between the popularity of ""unexplained chronic aminotransferase elevations"" and efforts to solve the inherent problems; the inadequate attempts to use the metabolic changes in the hepatocytes to improve diagnosis, prognosis, and pathophysiological understanding of viral liver diseases; the remarkable investigations into the 2'-5'-oligoadenylate synthetase for better control of interferon therapy in chronic <span class=""disease"">viral hepatitis</span>; the use of enzymes as markers of etiology, particularly for the detection of alcohol induced liver diseases; the continuing preference for the aminotransferases in this scenario although the ratios of <span class=""chemical"">aspartate</span> aminotransferase over alanine aminotransferase, or of mitochondrial <span class=""chemical"">aspartate</span> aminotransferase over total <span class=""chemical"">aspartate</span> aminotransferase activity, largely depend on the severity and intralobular localization of damage and the stage of the liver disease.",,1701367,1701367_D001224_D006525,1701367_2,bcv_sentence_task_befree_135,,770956062,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,D000409,"<span class=""chemical"">alanine</span>",D006525,"<span class=""disease"">viral hepatitis</span>","These include: the requirement for improved enzymological screening, despite the introduction of a test for hepatitis C; the imbalance between the popularity of ""unexplained chronic aminotransferase elevations"" and efforts to solve the inherent problems; the inadequate attempts to use the metabolic changes in the hepatocytes to improve diagnosis, prognosis, and pathophysiological understanding of viral liver diseases; the remarkable investigations into the 2'-5'-oligoadenylate synthetase for better control of interferon therapy in chronic <span class=""disease"">viral hepatitis</span>; the use of enzymes as markers of etiology, particularly for the detection of alcohol induced liver diseases; the continuing preference for the aminotransferases in this scenario although the ratios of aspartate aminotransferase over <span class=""chemical"">alanine</span> aminotransferase, or of mitochondrial aspartate aminotransferase over total aspartate aminotransferase activity, largely depend on the severity and intralobular localization of damage and the stage of the liver disease.",,1701367,1701367_D000409_D006525,1701367_2,bcv_sentence_task_befree_136,,770956063,FALSE,finalized,5,8/14/15 20:21,"



",no_relation,1,,D000409,"<span class=""chemical"">alanine</span>",D008107,"<span class=""disease"">liver diseases/liver disease</span>","These include: the requirement for improved enzymological screening, despite the introduction of a test for hepatitis C; the imbalance between the popularity of ""unexplained chronic aminotransferase elevations"" and efforts to solve the inherent problems; the inadequate attempts to use the metabolic changes in the hepatocytes to improve diagnosis, prognosis, and pathophysiological understanding of viral <span class=""disease"">liver diseases</span>; the remarkable investigations into the 2'-5'-oligoadenylate synthetase for better control of interferon therapy in chronic viral hepatitis; the use of enzymes as markers of etiology, particularly for the detection of alcohol induced <span class=""disease"">liver diseases</span>; the continuing preference for the aminotransferases in this scenario although the ratios of aspartate aminotransferase over <span class=""chemical"">alanine</span> aminotransferase, or of mitochondrial aspartate aminotransferase over total aspartate aminotransferase activity, largely depend on the severity and intralobular localization of damage and the stage of the <span class=""disease"">liver disease</span>.",,1701367,1701367_D000409_D008107,1701367_2,bcv_sentence_task_befree_137,,770956064,FALSE,finalized,5,8/14/15 20:43,"



",no_relation,1,,D001224,"<span class=""chemical"">aspartate</span>",D006526,"<span class=""disease"">hepatitis C</span>","These include: the requirement for improved enzymological screening, despite the introduction of a test for <span class=""disease"">hepatitis C</span>; the imbalance between the popularity of ""unexplained chronic aminotransferase elevations"" and efforts to solve the inherent problems; the inadequate attempts to use the metabolic changes in the hepatocytes to improve diagnosis, prognosis, and pathophysiological understanding of viral liver diseases; the remarkable investigations into the 2'-5'-oligoadenylate synthetase for better control of interferon therapy in chronic viral hepatitis; the use of enzymes as markers of etiology, particularly for the detection of alcohol induced liver diseases; the continuing preference for the aminotransferases in this scenario although the ratios of <span class=""chemical"">aspartate</span> aminotransferase over alanine aminotransferase, or of mitochondrial <span class=""chemical"">aspartate</span> aminotransferase over total <span class=""chemical"">aspartate</span> aminotransferase activity, largely depend on the severity and intralobular localization of damage and the stage of the liver disease.",,1701367,1701367_D001224_D006526,1701367_2,bcv_sentence_task_befree_138,,770956065,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,1,,D001224,"<span class=""chemical"">aspartate</span>",D008107,"<span class=""disease"">liver diseases/liver disease</span>","These include: the requirement for improved enzymological screening, despite the introduction of a test for hepatitis C; the imbalance between the popularity of ""unexplained chronic aminotransferase elevations"" and efforts to solve the inherent problems; the inadequate attempts to use the metabolic changes in the hepatocytes to improve diagnosis, prognosis, and pathophysiological understanding of viral <span class=""disease"">liver diseases</span>; the remarkable investigations into the 2'-5'-oligoadenylate synthetase for better control of interferon therapy in chronic viral hepatitis; the use of enzymes as markers of etiology, particularly for the detection of alcohol induced <span class=""disease"">liver diseases</span>; the continuing preference for the aminotransferases in this scenario although the ratios of <span class=""chemical"">aspartate</span> aminotransferase over alanine aminotransferase, or of mitochondrial <span class=""chemical"">aspartate</span> aminotransferase over total <span class=""chemical"">aspartate</span> aminotransferase activity, largely depend on the severity and intralobular localization of damage and the stage of the <span class=""disease"">liver disease</span>.",,1701367,1701367_D001224_D008107,1701367_2,bcv_sentence_task_befree_139,,770956066,FALSE,finalized,5,8/15/15 1:09,"



",no_relation,1,,D010426,"<span class=""chemical"">PPS</span>",D009369,"<span class=""disease"">tumor</span>","Daily intraperitoneal injections of <span class=""chemical"">PPS</span> were tolerated well by athymic nude mice and prevented growth of subcutaneous SW-13/K-fgf <span class=""disease"">tumor</span> xenografts.",,1708834,1708834_D010426_D009369,1708834_9,bcv_sentence_task_befree_140,,770956067,FALSE,finalized,5,8/14/15 23:34,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D015267,"<span class=""disease"">granulomatosis</span>","The course of Wegener <span class=""disease"">granulomatosis</span> has been dramatically improved by daily treatment with <span class=""chemical"">cyclophosphamide</span> and glucocorticoids.",,1739240,1739240_D003520_D015267,1739240_16,bcv_sentence_task_befree_141,,770956068,FALSE,finalized,5,8/14/15 23:40,"



",yes_direct,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D064420,"<span class=""disease"">toxicity</span>","Despite continued therapeutic success with <span class=""chemical"">cyclophosphamide</span>, our long-term follow-up of patients with Wegener granulomatosis has led to increasing concerns about <span class=""disease"">toxicity</span> resulting from prolonged <span class=""chemical"">cyclophosphamide</span> therapy and has encouraged investigation of other therapeutic regimens.",,1739240,1739240_D003520_D064420,1739240_19,bcv_sentence_task_befree_142,,770956069,FALSE,finalized,5,8/14/15 20:56,"



",no_relation,0.6112,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D015267,"<span class=""disease"">granulomatosis</span>","Despite continued therapeutic success with <span class=""chemical"">cyclophosphamide</span>, our long-term follow-up of patients with Wegener <span class=""disease"">granulomatosis</span> has led to increasing concerns about toxicity resulting from prolonged <span class=""chemical"">cyclophosphamide</span> therapy and has encouraged investigation of other therapeutic regimens.",,1739240,1739240_D003520_D015267,1739240_19,bcv_sentence_task_befree_143,,770956070,FALSE,finalized,5,8/14/15 20:41,"



",no_relation,1,,D000596,"<span class=""chemical"">amino acid</span>",D016638,"<span class=""disease"">critically ill</span>","The effect of fuel source on <span class=""chemical"">amino acid</span> metabolism in <span class=""disease"">critically ill</span> patients.",,1740940,1740940_D000596_D016638,1740940_0,bcv_sentence_task_befree_144,,770956071,FALSE,finalized,5,8/15/15 0:39,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D016638,"<span class=""disease"">critically ill</span>","While <span class=""chemical"">glucose</span> has been proved to have nitrogen sparing properties in postoperative patients, <span class=""disease"">critically ill</span> patients tolerate <span class=""chemical"">glucose</span> loads poorly and fat appears to be an obligatory fuel in sepsis.",,1740940,1740940_D005947_D016638,1740940_2,bcv_sentence_task_befree_145,,770956072,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,1,,D009584,"<span class=""chemical"">nitrogen</span>",D016638,"<span class=""disease"">critically ill</span>","While glucose has been proved to have <span class=""chemical"">nitrogen</span> sparing properties in postoperative patients, <span class=""disease"">critically ill</span> patients tolerate glucose loads poorly and fat appears to be an obligatory fuel in sepsis.",,1740940,1740940_D009584_D016638,1740940_2,bcv_sentence_task_befree_146,,770956073,FALSE,finalized,5,8/15/15 2:09,"



",no_relation,0.8263,,D005947,"<span class=""chemical"">glucose</span>",D018805,"<span class=""disease"">sepsis</span>","While <span class=""chemical"">glucose</span> has been proved to have nitrogen sparing properties in postoperative patients, critically ill patients tolerate <span class=""chemical"">glucose</span> loads poorly and fat appears to be an obligatory fuel in <span class=""disease"">sepsis</span>.",,1740940,1740940_D005947_D018805,1740940_2,bcv_sentence_task_befree_147,,770956074,FALSE,finalized,5,8/14/15 20:27,"



",no_relation,0.795,,D009584,"<span class=""chemical"">nitrogen</span>",D018805,"<span class=""disease"">sepsis</span>","While glucose has been proved to have <span class=""chemical"">nitrogen</span> sparing properties in postoperative patients, critically ill patients tolerate glucose loads poorly and fat appears to be an obligatory fuel in <span class=""disease"">sepsis</span>.",,1740940,1740940_D009584_D018805,1740940_2,bcv_sentence_task_befree_148,,770956075,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,0.8091,,D005947,"<span class=""chemical"">glucose</span>",D018149,"<span class=""disease"">glucose intolerance</span>","Four patients on the G regimen were withdrawn due to <span class=""chemical""></span><span class=""disease"">glucose</span> intolerance while none of the patients on GF developed <span class=""chemical""></span><span class=""disease"">glucose</span> intolerance or hyperlipidaemia.",,1740940,1740940_D005947_D018149,1740940_14,bcv_sentence_task_befree_149,,770956076,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,D006493,"<span class=""chemical"">Heparin</span>",D006620,"<span class=""disease"">fractured hip</span>","<span class=""chemical"">Heparin</span> and graduated compression stockings in patients undergoing <span class=""disease"">fractured hip</span> surgery.",,1761997,1761997_D006493_D006620,1761997_0,bcv_sentence_task_befree_150,,770956077,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,D006493,"<span class=""chemical"">heparin</span>",D006620,"<span class=""disease"">fractured hip</span>","This study confirms that therapy with <span class=""chemical"">heparin</span> and graduated compression stockings is effective, inexpensive, and convenient for the prevention of venous thrombosis in <span class=""disease"">fractured hip</span> patients and is associated with a low bleeding risk.",,1761997,1761997_D006493_D006620,1761997_9,bcv_sentence_task_befree_151,,770956078,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,0.8107,,D006493,"<span class=""chemical"">heparin</span>",D006470,"<span class=""disease"">bleeding</span>","This study confirms that therapy with <span class=""chemical"">heparin</span> and graduated compression stockings is effective, inexpensive, and convenient for the prevention of venous thrombosis in fractured hip patients and is associated with a low <span class=""disease"">bleeding</span> risk.",,1761997,1761997_D006493_D006470,1761997_9,bcv_sentence_task_befree_152,,770956079,FALSE,finalized,5,8/15/15 0:12,"



",no_relation,1,,D006493,"<span class=""chemical"">heparin</span>",D019851,"<span class=""disease"">venous thrombosis</span>","This study confirms that therapy with <span class=""chemical"">heparin</span> and graduated compression stockings is effective, inexpensive, and convenient for the prevention of <span class=""disease"">venous thrombosis</span> in fractured hip patients and is associated with a low bleeding risk.",,1761997,1761997_D006493_D019851,1761997_9,bcv_sentence_task_befree_153,,770956080,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,0.8339,,D004176,"<span class=""chemical"">dipyridamole</span>",D001778,"<span class=""disease"">hemorrheologic and blood coagulation</span>","Effect of buflomedil, <span class=""chemical"">dipyridamole</span> and indobufene on <span class=""disease"">hemorrheologic and blood coagulation</span> parameters in patients who underwent vascular surgery for severe atherosclerosis.",,1770324,1770324_D004176_D001778,1770324_0,bcv_sentence_task_befree_154,,770956081,FALSE,finalized,5,8/14/15 20:34,"



",no_relation,0.8034,,D004176,"<span class=""chemical"">dipyridamole</span>",D050197,"<span class=""disease"">atherosclerosis</span>","Effect of buflomedil, <span class=""chemical"">dipyridamole</span> and indobufene on hemorrheologic and blood coagulation parameters in patients who underwent vascular surgery for severe <span class=""disease"">atherosclerosis</span>.",,1770324,1770324_D004176_D050197,1770324_0,bcv_sentence_task_befree_155,,770956082,FALSE,finalized,5,8/15/15 0:52,"



",no_relation,0.7933,,D016572,"<span class=""chemical"">cyclosporin A</span>",D011565,"<span class=""disease"">psoriasis</span>","Soluble IL-2 receptor and CD25 cells in <span class=""disease"">psoriasis</span>: effects of <span class=""chemical"">cyclosporin A</span> and PUVA therapy.",,1864010,1864010_D016572_D011565,1864010_0,bcv_sentence_task_befree_156,,770956083,FALSE,finalized,5,8/14/15 20:33,"



",no_relation,0.7893,,D016572,"<span class=""chemical"">cyclosporin A/CsA</span>",D011565,"<span class=""disease"">psoriasis</span>","A study was conducted to quantify soluble IL-2 receptor (sIL-2R) levels in sera of 57 chronic plaque <span class=""disease"">psoriasis</span> patients and correlate these measurements with disease activity and the number of IL-2R-positive (CD25+) lymphocytes in lesional biopsies of 11 <span class=""chemical"">cyclosporin A</span> (<span class=""chemical"">CsA</span>) and 13 psoralen plus ultraviolet radiation (PUVA) treated patients.",,1864010,1864010_D016572_D011565,1864010_1,bcv_sentence_task_befree_157,,770956084,FALSE,finalized,5,8/14/15 20:55,"



",no_relation,1,,D013256,"<span class=""chemical"">steroids</span>",D004487,"<span class=""disease"">edema</span>","Many facial plastic surgeons use perioperative <span class=""chemical"">steroids</span> to reduce postoperative <span class=""disease"">edema</span> and morbidity.",,1910730,1910730_D013256_D004487,1910730_2,bcv_sentence_task_befree_158,,770956085,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,1,,D013256,"<span class=""chemical"">steroids</span>",D004487,"<span class=""disease"">edema</span>","We found significantly less postoperative eyelid and paranasal <span class=""disease"">edema</span> in those patients receiving <span class=""chemical"">steroids</span>.",,1910730,1910730_D013256_D004487,1910730_5,bcv_sentence_task_befree_159,,770956086,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,0.8117,,D013256,"<span class=""chemical"">steroids</span>",D004487,"<span class=""disease"">edema</span>","In addition, trends toward less ecchymosis, less intranasal <span class=""disease"">edema</span>, and less discomfort in the patients receiving <span class=""chemical"">steroids</span> were noted.",,1910730,1910730_D013256_D004487,1910730_6,bcv_sentence_task_befree_160,,770956087,FALSE,finalized,5,8/15/15 2:19,"



",no_relation,1,,D004077,"<span class=""chemical"">digoxin</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","Our data indicate that patients who develop spontaneous postoperative <span class=""disease"">atrial fibrillation</span> should be treated with <span class=""chemical"">digoxin</span> for 3 weeks following operation and then drug therapy may be discontinued indefinitely.",,1910852,1910852_D004077_D001281,1910852_7,bcv_sentence_task_befree_161,,770956088,FALSE,finalized,5,8/14/15 23:56,"



",no_relation,1,,D002511,"<span class=""chemical"">cephalosporins</span>",D044504,"<span class=""disease"">neutropenic</span>","Third-generation <span class=""chemical"">cephalosporins</span> are an important part of the therapeutic armamentarium for the empiric management of <span class=""disease"">neutropenic</span> patients.",,1918211,1918211_D002511_D044504,1918211_5,bcv_sentence_task_befree_162,,770956089,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,1,,D002443,"<span class=""chemical"">ceftriaxone</span>",D044504,"<span class=""disease"">neutropenic</span>","But even when combined with an aminoglycoside, <span class=""chemical"">ceftriaxone</span> would not be a good choice for <span class=""disease"">neutropenic</span> patients.",,1918211,1918211_D002443_D044504,1918211_8,bcv_sentence_task_befree_163,,770956090,FALSE,finalized,5,8/15/15 1:20,"



",no_relation,1,,D000617,"<span class=""chemical"">aminoglycoside</span>",D044504,"<span class=""disease"">neutropenic</span>","But even when combined with an <span class=""chemical"">aminoglycoside</span>, ceftriaxone would not be a good choice for <span class=""disease"">neutropenic</span> patients.",,1918211,1918211_D000617_D044504,1918211_8,bcv_sentence_task_befree_164,,770956091,FALSE,finalized,5,8/14/15 22:55,"



",no_relation,0.8031,,D005947,"<span class=""chemical"">glucose</span>",D003929,"<span class=""disease"">diabetes</span>","Effect of Konjac food on blood <span class=""chemical"">glucose</span> level in patients with <span class=""disease"">diabetes</span>.",,1966003,1966003_D005947_D003929,1966003_0,bcv_sentence_task_befree_165,,770956092,FALSE,finalized,5,8/14/15 20:53,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D006402,"<span class=""disease"">blood glucose</span>","Effect of Konjac food on <span class=""disease"">blood </span><span class=""chemical"">glucose</span> level in patients with diabetes.",,1966003,1966003_D005947_D006402,1966003_0,bcv_sentence_task_befree_166,,770956093,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D006402,"<span class=""disease"">blood glucose</span>","The data analyzed by multiple F test indicate that the fasting <span class=""disease"">blood </span><span class=""chemical"">glucose</span> (FBG) and the 2-h postprandial <span class=""disease"">blood </span><span class=""chemical"">glucose</span> (PBG) on the 30th and the 65th days after the food was ingested were significantly reduced (P = 0.001, P less than 0.001, respectively), as was the glycosylated hemoglobin level at the end of the trial (P less than 0.05).",,1966003,1966003_D005947_D006402,1966003_2,bcv_sentence_task_befree_167,,770956094,FALSE,finalized,5,8/14/15 20:28,"



",no_relation,0.8047,,D009553,"<span class=""chemical"">Nimodipine</span>",D014581,"<span class=""disease"">urticaria</span>","<span class=""chemical"">Nimodipine</span> versus terfenadine in the treatment of physical stimulus-induced <span class=""disease"">urticaria</span>.",,1968727,1968727_D009553_D014581,1968727_0,bcv_sentence_task_befree_168,,770956095,FALSE,finalized,5,8/14/15 22:01,"



",no_relation,1,,D016593,"<span class=""chemical"">terfenadine</span>",D014581,"<span class=""disease"">urticaria</span>","Nimodipine versus <span class=""chemical"">terfenadine</span> in the treatment of physical stimulus-induced <span class=""disease"">urticaria</span>.",,1968727,1968727_D016593_D014581,1968727_0,bcv_sentence_task_befree_169,,770956096,FALSE,finalized,5,8/14/15 20:06,"



",no_relation,0.6024,,C038806,"<span class=""chemical"">dihydropyridine</span>",D014581,"<span class=""disease"">urticaria</span>","The present study was aimed at testing the therapeutic effects and side effects of nimodipine therapy, a new <span class=""chemical"">dihydropyridine</span> anti-calcium derivative for physical stimulus-induced <span class=""disease"">urticaria</span>, in comparison with a standard H1-antihistamine therapy.",,1968727,1968727_C038806_D014581,1968727_4,bcv_sentence_task_befree_170,,770956097,FALSE,finalized,5,8/15/15 0:34,"



",no_relation,1,,D009553,"<span class=""chemical"">nimodipine</span>",D014581,"<span class=""disease"">urticaria</span>","The present study was aimed at testing the therapeutic effects and side effects of <span class=""chemical"">nimodipine</span> therapy, a new dihydropyridine anti-calcium derivative for physical stimulus-induced <span class=""disease"">urticaria</span>, in comparison with a standard H1-antihistamine therapy.",,1968727,1968727_D009553_D014581,1968727_4,bcv_sentence_task_befree_171,,770956098,FALSE,finalized,5,8/15/15 2:42,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D014581,"<span class=""disease"">urticaria</span>","The present study was aimed at testing the therapeutic effects and side effects of nimodipine therapy, a new dihydropyridine anti-<span class=""chemical"">calcium</span> derivative for physical stimulus-induced <span class=""disease"">urticaria</span>, in comparison with a standard H1-antihistamine therapy.",,1968727,1968727_D002118_D014581,1968727_4,bcv_sentence_task_befree_172,,770956099,FALSE,finalized,5,8/15/15 0:51,"



",no_relation,1,,D009553,"<span class=""chemical"">nimodipine</span>",D014581,"<span class=""disease"">urticaria</span>","The study was done in 32 outpatients who had physical stimulus-induced <span class=""disease"">urticaria</span>: 20 patients received <span class=""chemical"">nimodipine</span> three times a day in a daily dose of 180 mg, 12 patients were treated with terfenadine in a dose of 120 mg.",,1968727,1968727_D009553_D014581,1968727_5,bcv_sentence_task_befree_173,,770956100,FALSE,finalized,5,8/15/15 0:45,"



",no_relation,0.8075,,D016593,"<span class=""chemical"">terfenadine</span>",D014581,"<span class=""disease"">urticaria</span>","The study was done in 32 outpatients who had physical stimulus-induced <span class=""disease"">urticaria</span>: 20 patients received nimodipine three times a day in a daily dose of 180 mg, 12 patients were treated with <span class=""chemical"">terfenadine</span> in a dose of 120 mg.",,1968727,1968727_D016593_D014581,1968727_5,bcv_sentence_task_befree_174,,770956101,FALSE,finalized,5,8/14/15 20:45,"



",yes_direct,0.615,,D017640,"<span class=""chemical"">silicate</span>",D008171,"<span class=""disease"">lung disease</span>","Hypothesis: is <span class=""disease"">lung disease</span> after <span class=""chemical"">silicate</span> inhalation caused by oxidant generation?",,1977006,1977006_D017640_D008171,1977006_0,bcv_sentence_task_befree_175,,770956102,FALSE,finalized,5,8/15/15 1:59,"



",yes_direct,1,,D017640,"<span class=""chemical"">silicate</span>",D008171,"<span class=""disease"">lung disease</span>","Inhaled <span class=""chemical"">silicate</span> dusts may cause <span class=""disease"">lung disease</span> through their surface coordination of iron with subsequent oxidant generation via the Fenton reaction.",,1977006,1977006_D017640_D008171,1977006_1,bcv_sentence_task_befree_176,,770956103,FALSE,finalized,5,8/14/15 20:40,"



",yes_direct,0.7903,,D007501,"<span class=""chemical"">iron</span>",D008171,"<span class=""disease"">lung disease</span>","Inhaled silicate dusts may cause <span class=""disease"">lung disease</span> through their surface coordination of <span class=""chemical"">iron</span> with subsequent oxidant generation via the Fenton reaction.",,1977006,1977006_D007501_D008171,1977006_1,bcv_sentence_task_befree_177,,770956104,FALSE,finalized,5,8/14/15 20:38,"



",yes_direct,0.6123,,D017640,"<span class=""chemical"">silicate</span>",D014376,"<span class=""disease"">tuberculosis</span>","The increased incidence of <span class=""disease"">tuberculosis</span> observed among <span class=""chemical"">silicate</span> workers could be explained by accumulation of iron complexed by dust particles in the lung and made available to dormant mycobacteria as a virulence factor.",,1977006,1977006_D017640_D014376,1977006_3,bcv_sentence_task_befree_178,,770956105,FALSE,finalized,5,8/14/15 22:39,"



",yes_direct,1,,D007501,"<span class=""chemical"">iron</span>",D014376,"<span class=""disease"">tuberculosis</span>","The increased incidence of <span class=""disease"">tuberculosis</span> observed among silicate workers could be explained by accumulation of <span class=""chemical"">iron</span> complexed by dust particles in the lung and made available to dormant mycobacteria as a virulence factor.",,1977006,1977006_D007501_D014376,1977006_3,bcv_sentence_task_befree_179,,770956106,FALSE,finalized,5,8/14/15 20:06,"



",no_relation,0.8082,,D002118,"<span class=""chemical"">calcium</span>",D006973,"<span class=""disease"">hypertension</span>","Effect of a <span class=""chemical"">calcium</span>-entry blocker, nicardipine, on intrarenal hemodynamics in essential <span class=""disease"">hypertension</span>.",,1986570,1986570_D002118_D006973,1986570_0,bcv_sentence_task_befree_180,,770956107,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,0.7898,,D009529,"<span class=""chemical"">nicardipine</span>",D006973,"<span class=""disease"">hypertension</span>","Effect of a calcium-entry blocker, <span class=""chemical"">nicardipine</span>, on intrarenal hemodynamics in essential <span class=""disease"">hypertension</span>.",,1986570,1986570_D009529_D006973,1986570_0,bcv_sentence_task_befree_181,,770956108,FALSE,finalized,5,8/15/15 1:58,"



",no_relation,0.8089,,D002118,"<span class=""chemical"">calcium</span>",D006973,"<span class=""disease"">hypertension</span>","The effects of a <span class=""chemical"">calcium</span>-entry blocker, nicardipine, on intrarenal hemodynamics were studied in essential <span class=""disease"">hypertension</span>.",,1986570,1986570_D002118_D006973,1986570_1,bcv_sentence_task_befree_182,,770956109,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,0.8302,,D009529,"<span class=""chemical"">nicardipine</span>",D006973,"<span class=""disease"">hypertension</span>","The effects of a calcium-entry blocker, <span class=""chemical"">nicardipine</span>, on intrarenal hemodynamics were studied in essential <span class=""disease"">hypertension</span>.",,1986570,1986570_D009529_D006973,1986570_1,bcv_sentence_task_befree_183,,770956110,FALSE,finalized,5,8/15/15 2:06,"



",no_relation,1,,D012964,"<span class=""chemical"">sodium</span>",D006973,"<span class=""disease"">hypertension</span>","A 4-week study was performed in eight patients with essential <span class=""disease"">hypertension</span> who were given a regular <span class=""chemical"">sodium</span> diet in the first and third weeks, and a <span class=""chemical"">sodium</span>-restricted diet in the second and fourth weeks.",,1986570,1986570_D012964_D006973,1986570_2,bcv_sentence_task_befree_184,,770956111,FALSE,finalized,5,8/14/15 20:16,"



",no_relation,1,,D002118,"<span class=""chemical"">Ca</span>",D006973,"<span class=""disease"">hypertension</span>","This <span class=""chemical"">Ca</span>-entry blocker worked to normalize intrarenal hemodynamics in essential <span class=""disease"">hypertension</span> by dilating afferent arterioles alone.",,1986570,1986570_D002118_D006973,1986570_9,bcv_sentence_task_befree_185,,770956112,FALSE,finalized,5,8/14/15 20:05,"



",yes_direct,0.5928,,D003345,"<span class=""chemical"">corticosterone</span>",D006994,"<span class=""disease"">hypoaldosteronism</span>","Severe <span class=""disease"">hypoaldosteronism</span> due to <span class=""chemical"">corticosterone</span> methyl oxidase type II deficiency in two boys: metabolic and gas chromatography-mass spectrometry studies.",,2044581,2044581_D003345_D006994,2044581_0,bcv_sentence_task_befree_186,,770956113,FALSE,finalized,5,8/15/15 1:45,"



",no_relation,0.6394,,D003345,"<span class=""chemical"">corticosterone</span>",D007020,"<span class=""disease"">II deficiency</span>","Severe hypoaldosteronism due to <span class=""chemical"">corticosterone</span> methyl oxidase type <span class=""disease"">II deficiency</span> in two boys: metabolic and gas chromatography-mass spectrometry studies.",,2044581,2044581_D003345_D007020,2044581_0,bcv_sentence_task_befree_187,,770956114,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,0.8205,,D000450,"<span class=""chemical"">aldosterone</span>",D019282,"<span class=""disease"">wasting</span>","Infection-triggered, life-threatening salt-loss and hyperkalaemia developed in two male infants with <span class=""disease"">wasting</span>, inappropriately low plasma <span class=""chemical"">aldosterone</span> concentrations and elevated plasma renin activity.",,2044581,2044581_D000450_D019282,2044581_1,bcv_sentence_task_befree_188,,770956115,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,D013256,"<span class=""chemical"">Steroid</span>",D014456,"<span class=""disease"">ulcer</span>","<span class=""chemical"">Steroid</span> therapy and duodenal <span class=""disease"">ulcer</span> in infants.",,2051278,2051278_D013256_D014456,2051278_0,bcv_sentence_task_befree_189,,770956116,FALSE,finalized,5,8/14/15 20:53,"



",yes_direct,1,,D013256,"<span class=""chemical"">steroid</span>",D014456,"<span class=""disease"">ulcer</span>","Two infants with acute life-threatening complications of duodenal <span class=""disease"">ulcer</span> following <span class=""chemical"">steroid</span> administration are described.",,2051278,2051278_D013256_D014456,2051278_1,bcv_sentence_task_befree_190,,770956117,FALSE,finalized,5,8/14/15 22:19,"



",yes_direct,0.8132,,D013256,"<span class=""chemical"">steroid</span>",D014456,"<span class=""disease"">ulcer disease/ulcer</span>","Although the possible association between <span class=""chemical"">steroid</span> therapy and peptic <span class=""disease"">ulcer disease</span> is well known, the need for <span class=""disease"">ulcer</span> prophylaxis during such therapy in infants is not unanimously accepted.",,2051278,2051278_D013256_D014456,2051278_2,bcv_sentence_task_befree_191,,770956118,FALSE,finalized,5,8/14/15 20:23,"



",yes_direct,0.6308,,D000617,"<span class=""chemical"">aminoglycoside</span>",D064420,"<span class=""disease"">toxicity</span>","Haemofiltration is indicated particularly for <span class=""chemical"">aminoglycoside</span> <span class=""disease"">toxicity</span>.",,2056948,2056948_D000617_D064420,2056948_4,bcv_sentence_task_befree_192,,770956119,FALSE,finalized,5,8/15/15 0:17,"



",yes_direct,1,,D008727,"<span class=""chemical"">methotrexate</span>",D010198,"<span class=""disease"">pancytopenia</span>","Severe <span class=""disease"">pancytopenia</span> in a patient taking low dose <span class=""chemical"">methotrexate</span> and probenecid.",,2066953,2066953_D008727_D010198,2066953_0,bcv_sentence_task_befree_193,,770956120,FALSE,finalized,5,8/14/15 20:23,"



",yes_direct,1,,D011339,"<span class=""chemical"">probenecid</span>",D010198,"<span class=""disease"">pancytopenia</span>","Severe <span class=""disease"">pancytopenia</span> in a patient taking low dose methotrexate and <span class=""chemical"">probenecid</span>.",,2066953,2066953_D011339_D010198,2066953_0,bcv_sentence_task_befree_194,,770956121,FALSE,finalized,5,8/15/15 0:23,"



",no_relation,1,,D008727,"<span class=""chemical"">methotrexate/MTX</span>",D001172,"<span class=""disease"">rheumatoid arthritis</span>","A patient with <span class=""disease"">rheumatoid arthritis</span> developed life-threatening pancytopenia resulting from low dose oral <span class=""chemical"">methotrexate</span> (<span class=""chemical"">MTX</span>) toxicity potentiated by probenecid.",,2066953,2066953_D008727_D001172,2066953_1,bcv_sentence_task_befree_195,,770956122,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,0.5891,,D008727,"<span class=""chemical"">methotrexate/MTX</span>",D064420,"<span class=""disease"">toxicity</span>","A patient with rheumatoid arthritis developed life-threatening pancytopenia resulting from low dose oral <span class=""chemical"">methotrexate</span> (<span class=""chemical"">MTX</span>) <span class=""disease"">toxicity</span> potentiated by probenecid.",,2066953,2066953_D008727_D064420,2066953_1,bcv_sentence_task_befree_196,,770956123,FALSE,finalized,5,8/15/15 1:19,"



",yes_direct,0.7919,,D011339,"<span class=""chemical"">probenecid</span>",D010198,"<span class=""disease"">pancytopenia</span>","A patient with rheumatoid arthritis developed life-threatening <span class=""disease"">pancytopenia</span> resulting from low dose oral methotrexate (MTX) toxicity potentiated by <span class=""chemical"">probenecid</span>.",,2066953,2066953_D011339_D010198,2066953_1,bcv_sentence_task_befree_197,,770956124,FALSE,finalized,5,8/15/15 0:42,"



",yes_direct,1,,D011339,"<span class=""chemical"">probenecid</span>",D064420,"<span class=""disease"">toxicity</span>","A patient with rheumatoid arthritis developed life-threatening pancytopenia resulting from low dose oral methotrexate (MTX) <span class=""disease"">toxicity</span> potentiated by <span class=""chemical"">probenecid</span>.",,2066953,2066953_D011339_D064420,2066953_1,bcv_sentence_task_befree_198,,770956125,FALSE,finalized,5,8/14/15 20:50,"



",yes_direct,0.7792,,D008727,"<span class=""chemical"">methotrexate/MTX</span>",D010198,"<span class=""disease"">pancytopenia</span>","A patient with rheumatoid arthritis developed life-threatening <span class=""disease"">pancytopenia</span> resulting from low dose oral <span class=""chemical"">methotrexate</span> (<span class=""chemical"">MTX</span>) toxicity potentiated by probenecid.",,2066953,2066953_D008727_D010198,2066953_1,bcv_sentence_task_befree_199,,770956126,FALSE,finalized,5,8/15/15 1:51,"



",no_relation,0.6151,,D011339,"<span class=""chemical"">probenecid</span>",D001172,"<span class=""disease"">rheumatoid arthritis</span>","A patient with <span class=""disease"">rheumatoid arthritis</span> developed life-threatening pancytopenia resulting from low dose oral methotrexate (MTX) toxicity potentiated by <span class=""chemical"">probenecid</span>.",,2066953,2066953_D011339_D001172,2066953_1,bcv_sentence_task_befree_200,,770956127,FALSE,finalized,5,8/14/15 20:26,"



",yes_direct,0.6087,,D008727,"<span class=""chemical"">MTX</span>",D064420,"<span class=""disease"">toxicity</span>","Clinically significant drug interactions are not frequently cited as risk factors for <span class=""chemical"">MTX</span> hematologic <span class=""disease"">toxicity</span>.",,2066953,2066953_D008727_D064420,2066953_2,bcv_sentence_task_befree_201,,770956128,FALSE,finalized,5,8/14/15 20:17,"



",no_relation,1,,D015738,"<span class=""chemical"">Famotidine</span>",D005764,"<span class=""disease"">reflux oesophagitis</span>","<span class=""chemical"">Famotidine</span> in the management of acid-<span class=""disease"">reflux oesophagitis</span>: a multicentre study.",,2083926,2083926_D015738_D005764,2083926_0,bcv_sentence_task_befree_202,,770956129,FALSE,finalized,5,8/14/15 23:30,"


Probably used as treatment.
",no_relation,1,,D015738,"<span class=""chemical"">famotidine</span>",D005764,"<span class=""disease"">reflux oesophagitis/gastro-oesophageal reflux</span>","In this study, we tested the response to treatment with <span class=""chemical"">famotidine</span> for 8 weeks in patients with <span class=""disease"">reflux oesophagitis</span>, taking into consideration, however, only cases with pathological <span class=""disease"">gastro-oesophageal reflux</span> of the acidic type.",,2083926,2083926_D015738_D005764,2083926_2,bcv_sentence_task_befree_203,,770956130,FALSE,finalized,5,8/15/15 1:19,"



",no_relation,1,,D009257,"<span class=""chemical"">naftidrofuryl</span>",D057066,"<span class=""disease"">normal tension glaucoma</span>","Double-blind study in the treatment of <span class=""disease"">normal tension glaucoma</span> with <span class=""chemical"">naftidrofuryl</span>.",,2089356,2089356_D009257_D057066,2089356_0,bcv_sentence_task_befree_204,,770956131,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,D009257,"<span class=""chemical"">naftidrofuryl</span>",D006311,"<span class=""disease"">visual acuity and the visual field</span>","The administration of 2 x 200 mg/day of <span class=""chemical"">naftidrofuryl</span> during 6 weeks to 12 patients with normal tension glaucoma has shown an improvement of the <span class=""disease"">visual acuity and the visual field</span> compared with a 6-week period of placebo administration, with a double-blind study method.",,2089356,2089356_D009257_D006311,2089356_3,bcv_sentence_task_befree_205,,770956132,FALSE,finalized,5,8/14/15 23:57,"

'Improvement' being the key term.

",no_relation,1,,D009257,"<span class=""chemical"">naftidrofuryl</span>",D057066,"<span class=""disease"">normal tension glaucoma</span>","The administration of 2 x 200 mg/day of <span class=""chemical"">naftidrofuryl</span> during 6 weeks to 12 patients with <span class=""disease"">normal tension glaucoma</span> has shown an improvement of the visual acuity and the visual field compared with a 6-week period of placebo administration, with a double-blind study method.",,2089356,2089356_D009257_D057066,2089356_3,bcv_sentence_task_befree_206,,770956133,FALSE,finalized,5,8/14/15 23:17,"



",no_relation,1,,D009257,"<span class=""chemical"">naftidrofuryl</span>",D007022,"<span class=""disease"">hypotensive</span>","It suggested that <span class=""chemical"">naftidrofuryl</span> might be administered as a useful complement to conventional <span class=""disease"">hypotensive</span> therapy, since it acts positively on the glaucomatous optic nerve damage.",,2089356,2089356_D009257_D007022,2089356_4,bcv_sentence_task_befree_207,,770956134,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,1,,D009257,"<span class=""chemical"">naftidrofuryl</span>",D006177,"<span class=""disease"">optic nerve damage</span>","It suggested that <span class=""chemical"">naftidrofuryl</span> might be administered as a useful complement to conventional hypotensive therapy, since it acts positively on the glaucomatous <span class=""disease"">optic nerve damage</span>.",,2089356,2089356_D009257_D006177,2089356_4,bcv_sentence_task_befree_208,,770956135,FALSE,finalized,5,8/14/15 22:04,"



",no_relation,1,,D011464,"<span class=""chemical"">prostacyclin</span>",D009503,"<span class=""disease"">neutropenia</span>","Effects of <span class=""chemical"">prostacyclin</span> on bronchoconstriction and <span class=""disease"">neutropenia</span> induced by inhaled platelet-activating factor in man.",,2109002,2109002_D011464_D009503,2109002_0,bcv_sentence_task_befree_209,,770956136,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,0.7957,,D011464,"<span class=""chemical"">PGI2</span>",C566800,"<span class=""disease"">platelet aggregation</span>","Ex vivo <span class=""disease"">platelet aggregation</span> to PAF (10(-9) to 10(-7) mol/L) was significantly inhibited by <span class=""chemical"">PGI2</span>.",,2109002,2109002_D011464_C566800,2109002_7,bcv_sentence_task_befree_210,,770956137,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,0.5935,,D011464,"<span class=""chemical"">PGI2</span>",C566800,"<span class=""disease"">platelet aggregation</span>","Thus, <span class=""chemical"">PGI2</span> does not influence PAF-induced bronchoconstriction in man despite causing marked inhibition of ex vivo PAF-induced <span class=""disease"">platelet aggregation</span> and preventing the fall of neutrophils.",,2109002,2109002_D011464_C566800,2109002_9,bcv_sentence_task_befree_211,,770956138,FALSE,finalized,5,8/14/15 23:40,"



",no_relation,1,,D017334,"<span class=""chemical"">teicoplanin</span>",D018805,"<span class=""disease"">septicaemia</span>","A comparative efficacy and safety study of <span class=""chemical"">teicoplanin</span> plus aztreonam versus gentamicin plus piperacillin in haematology oncology patients with clinically diagnosed <span class=""disease"">septicaemia</span>.",,2149049,2149049_D017334_D018805,2149049_0,bcv_sentence_task_befree_212,,770956139,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,0.7929,,D001398,"<span class=""chemical"">aztreonam</span>",D018805,"<span class=""disease"">septicaemia</span>","A comparative efficacy and safety study of teicoplanin plus <span class=""chemical"">aztreonam</span> versus gentamicin plus piperacillin in haematology oncology patients with clinically diagnosed <span class=""disease"">septicaemia</span>.",,2149049,2149049_D001398_D018805,2149049_0,bcv_sentence_task_befree_213,,770956140,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,1,,D005839,"<span class=""chemical"">gentamicin</span>",D018805,"<span class=""disease"">septicaemia</span>","A comparative efficacy and safety study of teicoplanin plus aztreonam versus <span class=""chemical"">gentamicin</span> plus piperacillin in haematology oncology patients with clinically diagnosed <span class=""disease"">septicaemia</span>.",,2149049,2149049_D005839_D018805,2149049_0,bcv_sentence_task_befree_214,,770956141,FALSE,finalized,5,8/15/15 0:14,"



",no_relation,1,,D010878,"<span class=""chemical"">piperacillin</span>",D018805,"<span class=""disease"">septicaemia</span>","A comparative efficacy and safety study of teicoplanin plus aztreonam versus gentamicin plus <span class=""chemical"">piperacillin</span> in haematology oncology patients with clinically diagnosed <span class=""disease"">septicaemia</span>.",,2149049,2149049_D010878_D018805,2149049_0,bcv_sentence_task_befree_215,,770956142,FALSE,finalized,5,8/15/15 1:23,"



",no_relation,0.7979,,D001398,"<span class=""chemical"">aztreonam</span>",D018805,"<span class=""disease"">septicaemia</span>","A randomized comparative evaluation of teicoplanin plus <span class=""chemical"">aztreonam</span> versus gentamicin plus piperacillin in leukaemic patients with a clinical diagnosis of <span class=""disease"">septicaemia</span> was undertaken.",,2149049,2149049_D001398_D018805,2149049_3,bcv_sentence_task_befree_216,,770956143,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,D005839,"<span class=""chemical"">gentamicin</span>",D018805,"<span class=""disease"">septicaemia</span>","A randomized comparative evaluation of teicoplanin plus aztreonam versus <span class=""chemical"">gentamicin</span> plus piperacillin in leukaemic patients with a clinical diagnosis of <span class=""disease"">septicaemia</span> was undertaken.",,2149049,2149049_D005839_D018805,2149049_3,bcv_sentence_task_befree_217,,770956144,FALSE,finalized,5,8/14/15 22:02,"



",no_relation,1,,D010878,"<span class=""chemical"">piperacillin</span>",D018805,"<span class=""disease"">septicaemia</span>","A randomized comparative evaluation of teicoplanin plus aztreonam versus gentamicin plus <span class=""chemical"">piperacillin</span> in leukaemic patients with a clinical diagnosis of <span class=""disease"">septicaemia</span> was undertaken.",,2149049,2149049_D010878_D018805,2149049_3,bcv_sentence_task_befree_218,,770956145,FALSE,finalized,5,8/14/15 20:23,"



",no_relation,1,,C029063,"<span class=""chemical"">fructose 1,6-diphosphate</span>",D016491,"<span class=""disease"">peripheral vascular disease</span>","Effect of <span class=""chemical"">fructose 1,6-diphosphate</span> on exercise capacity in patients with <span class=""disease"">peripheral vascular disease</span>.",,2172175,2172175_C029063_D016491,2172175_0,bcv_sentence_task_befree_219,,770956146,FALSE,finalized,5,8/15/15 2:30,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D016491,"<span class=""disease"">peripheral vascular disease</span>","The present study was undertaken to determine whether FDP could enhance <span class=""chemical"">oxygen</span> supply and thus improve exercise performance in patients with <span class=""disease"">peripheral vascular disease</span>.",,2172175,2172175_D010100_D016491,2172175_3,bcv_sentence_task_befree_220,,770956147,FALSE,finalized,5,8/15/15 1:00,"



",no_relation,1,,D019794,"<span class=""chemical"">2,3 diphosphoglycerate</span>",D007383,"<span class=""disease"">claudication or peak exercise</span>","No differences were observed in heart rate, blood pressure, gas exchange data, time to the onset of <span class=""disease"">claudication or peak exercise</span>, or lactate and <span class=""chemical"">2,3 diphosphoglycerate</span> levels.",,2172175,2172175_D019794_D007383,2172175_6,bcv_sentence_task_befree_221,,770956148,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D019344,"<span class=""chemical"">lactate</span>",D007383,"<span class=""disease"">claudication or peak exercise</span>","No differences were observed in heart rate, blood pressure, gas exchange data, time to the onset of <span class=""disease"">claudication or peak exercise</span>, or <span class=""chemical"">lactate</span> and 2,3 diphosphoglycerate levels.",,2172175,2172175_D019344_D007383,2172175_6,bcv_sentence_task_befree_222,,770956149,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,C029063,"<span class=""chemical"">FDP</span>",D000860,"<span class=""disease"">hypoxic</span>","In contrast to previous studies performed among patients with peripheral vascular disease and other studies using more severe <span class=""disease"">hypoxic</span> conditions, <span class=""chemical"">FDP</span> did not affect the respiratory gas exchange or exercise capacity of patients with exertional claudication.",,2172175,2172175_C029063_D000860,2172175_7,bcv_sentence_task_befree_223,,770956150,FALSE,finalized,5,8/14/15 22:24,"



",no_relation,1,,C029063,"<span class=""chemical"">FDP</span>",D007383,"<span class=""disease"">exertional claudication</span>","In contrast to previous studies performed among patients with peripheral vascular disease and other studies using more severe hypoxic conditions, <span class=""chemical"">FDP</span> did not affect the respiratory gas exchange or exercise capacity of patients with <span class=""disease"">exertional claudication</span>.",,2172175,2172175_C029063_D007383,2172175_7,bcv_sentence_task_befree_224,,770956151,FALSE,finalized,5,8/14/15 20:43,"



",no_relation,1,,C029063,"<span class=""chemical"">FDP</span>",D016491,"<span class=""disease"">peripheral vascular disease</span>","In contrast to previous studies performed among patients with <span class=""disease"">peripheral vascular disease</span> and other studies using more severe hypoxic conditions, <span class=""chemical"">FDP</span> did not affect the respiratory gas exchange or exercise capacity of patients with exertional claudication.",,2172175,2172175_C029063_D016491,2172175_7,bcv_sentence_task_befree_225,,770956152,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D006820,"<span class=""chemical"">sodium hyaluronate/SH</span>",D065306,"<span class=""disease"">cornea</span>","The aim of the present study was to quantify in man the distribution and clearance of two aqueous <span class=""chemical"">sodium hyaluronate</span> (<span class=""chemical"">SH</span>) solutions of 0.125% and 0.250% after the administration of 25 microliters onto the <span class=""disease"">cornea</span>.",,2176168,2176168_D006820_D065306,2176168_1,bcv_sentence_task_befree_226,,770956153,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,D006820,"<span class=""chemical"">SH</span>",D065306,"<span class=""disease"">cornea</span>","Actually, 53% of the radiolabelled 0.250% <span class=""chemical"">SH</span> solution remained on the <span class=""disease"">cornea</span> as compared with 30% for the 0.125% <span class=""chemical"">SH</span> solution and 18.3% for the PB solution.",,2176168,2176168_D006820_D065306,2176168_8,bcv_sentence_task_befree_227,,770956154,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,1,,D007213,"<span class=""chemical"">indomethacin</span>",D006831,"<span class=""disease"">polyhydramnios</span>","Maternal <span class=""chemical"">indomethacin</span> therapy in the treatment of <span class=""disease"">polyhydramnios</span>.",,2187352,2187352_D007213_D006831,2187352_0,bcv_sentence_task_befree_228,,770956155,FALSE,finalized,5,8/15/15 1:10,"



",no_relation,1,,D007213,"<span class=""chemical"">indomethacin</span>",D006831,"<span class=""disease"">polyhydramnios</span>","Fifteen patients with <span class=""disease"">polyhydramnios</span> and clinical symptoms related to excess amniotic fluid volume were treated with <span class=""chemical"">indomethacin</span> therapy that was started at a mean gestational age of 27.4 +/- 2.79 weeks and discontinued at a mean gestational age of 32.9 +/- 1.83 weeks.",,2187352,2187352_D007213_D006831,2187352_1,bcv_sentence_task_befree_229,,770956156,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D007559,"<span class=""chemical"">ivermectin</span>",D005128,"<span class=""disease"">ocular onchocercal disease</span>","Community trials were started to address questions concerning the safety of <span class=""chemical"">ivermectin</span> during large scale treatment, its potential for transmission control, its effect in preventing <span class=""disease"">ocular onchocercal disease</span>, its acceptability and the organization of large scale treatment.",,2198750,2198750_D007559_D005128,2198750_1,bcv_sentence_task_befree_230,,770956157,FALSE,finalized,5,8/14/15 20:23,"



",no_relation,1,,D007559,"<span class=""chemical"">ivermectin</span>",D009855,"<span class=""disease"">Onchocerciasis</span>","A summary is presented of the major, latest results on the short-term epidemiological impact of large scale <span class=""chemical"">ivermectin</span> treatment, as observed in eight community trials undertaken in the <span class=""disease"">Onchocerciasis</span> Control Programme in West Africa (OCP).",,2198750,2198750_D007559_D009855,2198750_2,bcv_sentence_task_befree_231,,770956158,FALSE,finalized,5,8/14/15 22:29,"



",no_relation,1,,D007559,"<span class=""chemical"">Ivermectin</span>",D007239,"<span class=""disease"">infection</span>","<span class=""chemical"">Ivermectin</span> treatment appears to be the most appropriate method for control of recrudescence of <span class=""disease"">infection</span> in an area where the parasite reservoir has been virtually eliminated by vector control, such as in the core area of the OCP.",,2198750,2198750_D007559_D007239,2198750_9,bcv_sentence_task_befree_232,,770956159,FALSE,finalized,5,8/14/15 22:03,"



",no_relation,1,,D002784,"<span class=""chemical"">cholesterol</span>",D003929,"<span class=""disease"">diabetic</span>","The aim of this study was to examine the effect of Max EPA (a commercially available fish oil preparation) on serum <span class=""chemical"">cholesterol</span> lipoproteins and apolipoproteins in insulin-dependent <span class=""disease"">diabetic</span> (IDDM) men with dosages that were likely to be acceptable to patients.",,2201495,2201495_D002784_D003929,2201495_1,bcv_sentence_task_befree_233,,770956160,FALSE,finalized,5,8/15/15 1:02,"



",no_relation,1,,D002784,"<span class=""chemical"">cholesterol</span>",D003922,"<span class=""disease"">IDDM</span>","The aim of this study was to examine the effect of Max EPA (a commercially available fish oil preparation) on serum <span class=""chemical"">cholesterol</span> lipoproteins and apolipoproteins in insulin-dependent diabetic (<span class=""disease"">IDDM</span>) men with dosages that were likely to be acceptable to patients.",,2201495,2201495_D002784_D003922,2201495_1,bcv_sentence_task_befree_234,,770956161,FALSE,finalized,5,8/14/15 20:49,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D010024,"<span class=""disease"">osteoporosis</span>","Aging is characterized, besides other changes, by a progressive increase in <span class=""chemical"">calcium</span> content in the arterial wall, which is enhanced by diabetes mellitus, <span class=""disease"">osteoporosis</span>, arterial hypertension, and tabagism.",,2226675,2226675_D002118_D010024,2226675_1,bcv_sentence_task_befree_235,,770956162,FALSE,finalized,5,8/15/15 0:57,"



",no_relation,0.8374,,D002118,"<span class=""chemical"">calcium</span>",D003920,"<span class=""disease"">diabetes mellitus</span>","Aging is characterized, besides other changes, by a progressive increase in <span class=""chemical"">calcium</span> content in the arterial wall, which is enhanced by <span class=""disease"">diabetes mellitus</span>, osteoporosis, arterial hypertension, and tabagism.",,2226675,2226675_D002118_D003920,2226675_1,bcv_sentence_task_befree_236,,770956163,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D065627,"<span class=""disease"">arterial hypertension</span>","Aging is characterized, besides other changes, by a progressive increase in <span class=""chemical"">calcium</span> content in the arterial wall, which is enhanced by diabetes mellitus, osteoporosis, <span class=""disease"">arterial hypertension</span>, and tabagism.",,2226675,2226675_D002118_D065627,2226675_1,bcv_sentence_task_befree_237,,770956164,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",C562794,"<span class=""disease"">hypocalcemizing</span>","In order to study the role of <span class=""chemical"">calcium</span> ions in the pathogenesis of the vasoconstrictive lesions caused by ""acute"" smoking, the author has studied the peripheral vascular effects of the <span class=""chemical"">calcium</span>-channel antagonist nifedipine, a dihydropyridine derivative, and calcitonin, a <span class=""disease"">hypocalcemizing</span> hormone which possess vasoactive actions on 12 elderly regular smokers (mean age 65.8 years).",,2226675,2226675_D002118_C562794,2226675_3,bcv_sentence_task_befree_238,,770956165,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,C038806,"<span class=""chemical"">dihydropyridine</span>",C562794,"<span class=""disease"">hypocalcemizing</span>","In order to study the role of calcium ions in the pathogenesis of the vasoconstrictive lesions caused by ""acute"" smoking, the author has studied the peripheral vascular effects of the calcium-channel antagonist nifedipine, a <span class=""chemical"">dihydropyridine</span> derivative, and calcitonin, a <span class=""disease"">hypocalcemizing</span> hormone which possess vasoactive actions on 12 elderly regular smokers (mean age 65.8 years).",,2226675,2226675_C038806_C562794,2226675_3,bcv_sentence_task_befree_239,,770956166,FALSE,finalized,5,8/15/15 0:11,"



",no_relation,1,,D009543,"<span class=""chemical"">nifedipine</span>",C562794,"<span class=""disease"">hypocalcemizing</span>","In order to study the role of calcium ions in the pathogenesis of the vasoconstrictive lesions caused by ""acute"" smoking, the author has studied the peripheral vascular effects of the calcium-channel antagonist <span class=""chemical"">nifedipine</span>, a dihydropyridine derivative, and calcitonin, a <span class=""disease"">hypocalcemizing</span> hormone which possess vasoactive actions on 12 elderly regular smokers (mean age 65.8 years).",,2226675,2226675_D009543_C562794,2226675_3,bcv_sentence_task_befree_240,,770956167,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,0.6321,,D002116,"<span class=""chemical"">calcitonin</span>",C562794,"<span class=""disease"">hypocalcemizing</span>","In order to study the role of calcium ions in the pathogenesis of the vasoconstrictive lesions caused by ""acute"" smoking, the author has studied the peripheral vascular effects of the calcium-channel antagonist nifedipine, a dihydropyridine derivative, and <span class=""chemical"">calcitonin</span>, a <span class=""disease"">hypocalcemizing</span> hormone which possess vasoactive actions on 12 elderly regular smokers (mean age 65.8 years).",,2226675,2226675_D002116_C562794,2226675_3,bcv_sentence_task_befree_241,,770956168,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,0.803,,D010100,"<span class=""chemical"">oxygen</span>",D009202,"<span class=""disease"">myocardial dysfunction</span>","The ""stunned myocardium"" is a syndrome of reversible <span class=""disease"">myocardial dysfunction</span> that may be mediated by <span class=""chemical"">oxygen</span>-derived free radicals.",,2252128,2252128_D010100_D009202,2252128_1,bcv_sentence_task_befree_242,,770956169,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D017682,"<span class=""disease"">stunned myocardium</span>","The ""<span class=""disease"">stunned myocardium</span>"" is a syndrome of reversible myocardial dysfunction that may be mediated by <span class=""chemical"">oxygen</span>-derived free radicals.",,2252128,2252128_D010100_D017682,2252128_1,bcv_sentence_task_befree_243,,770956170,FALSE,finalized,5,8/14/15 20:28,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D017682,"<span class=""disease"">stunned myocardium</span>","These data suggest that <span class=""chemical"">oxygen</span>-derived free radicals may not cause the <span class=""disease"">stunned myocardium</span> seen in neonates undergoing extracorporeal membrane oxygenation.",,2252128,2252128_D010100_D017682,2252128_6,bcv_sentence_task_befree_244,,770956171,FALSE,finalized,5,8/14/15 21:44,"



",no_relation,0.8204,,C092985,"<span class=""chemical"">calcium pidolate</span>",D010024,"<span class=""disease"">involutional osteoporosis</span>","Effect of <span class=""chemical"">calcium pidolate</span> on biochemical and hormonal parameters in <span class=""disease"">involutional osteoporosis</span>.",,2255262,2255262_C092985_D010024,2255262_0,bcv_sentence_task_befree_245,,770956172,FALSE,finalized,5,8/14/15 22:02,"



",no_relation,1,,C092985,"<span class=""chemical"">calcium pidolate</span>",D010024,"<span class=""disease"">involutional osteoporosis</span>","The purpose of this study was to determine the value of <span class=""chemical"">calcium pidolate</span> in the treatment of <span class=""disease"">involutional osteoporosis</span>.",,2255262,2255262_C092985_D010024,2255262_1,bcv_sentence_task_befree_246,,770956173,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D010024,"<span class=""disease"">involutional osteoporosis</span>","We accordingly treated one group of 10 women suffering from <span class=""disease"">involutional osteoporosis</span> with the equivalent of 1 g elemental <span class=""chemical"">calcium</span> and administered a placebo to a second group of 10 osteoporotic women whose mean age and body surface area were comparable.",,2255262,2255262_D002118_D010024,2255262_3,bcv_sentence_task_befree_247,,770956174,FALSE,finalized,5,8/14/15 20:06,"



",no_relation,1,,D015725,"<span class=""chemical"">fluconazole</span>",D002177,"<span class=""disease"">candidiasis</span>","Clinical trials and reports support the use of <span class=""chemical"">fluconazole</span> in treatment of <span class=""disease"">candidiasis</span>, particularly oropharyngeal and esophageal infections in immunocompromised hosts.",,2260347,2260347_D015725_D002177,2260347_8,bcv_sentence_task_befree_248,,770956175,FALSE,finalized,5,8/14/15 20:05,"



",no_relation,1,,D015725,"<span class=""chemical"">fluconazole</span>",D007239,"<span class=""disease"">infections</span>","Clinical trials and reports support the use of <span class=""chemical"">fluconazole</span> in treatment of candidiasis, particularly oropharyngeal and esophageal <span class=""disease"">infections</span> in immunocompromised hosts.",,2260347,2260347_D015725_D007239,2260347_8,bcv_sentence_task_befree_249,,770956176,FALSE,finalized,5,8/14/15 20:34,"



",no_relation,1,,D015725,"<span class=""chemical"">Fluconazole</span>",D016919,"<span class=""disease"">cryptococcal meningitis</span>","<span class=""chemical"">Fluconazole</span> is also approved for initial and suppressive therapy of <span class=""disease"">cryptococcal meningitis</span>.",,2260347,2260347_D015725_D016919,2260347_9,bcv_sentence_task_befree_250,,770956177,FALSE,finalized,5,8/14/15 20:25,"



",no_relation,0.6057,,D002395,"<span class=""chemical"">catecholamines</span>",D005334,"<span class=""disease"">hyperthermia</span>","Urinary <span class=""chemical"">catecholamines</span> in <span class=""disease"">hyperthermia</span>-related deaths.",,2279717,2279717_D002395_D005334,2279717_0,bcv_sentence_task_befree_251,,770956178,FALSE,finalized,5,8/14/15 20:41,"



",yes_direct,0.5723,,D002395,"<span class=""chemical"">catecholamines</span>",D003643,"<span class=""disease"">deaths</span>","Urinary <span class=""chemical"">catecholamines</span> in hyperthermia-related <span class=""disease"">deaths</span>.",,2279717,2279717_D002395_D003643,2279717_0,bcv_sentence_task_befree_252,,770956179,FALSE,finalized,5,8/14/15 23:25,"


'hyperthermia-related deaths' 'urinary noradrenaline (NA) concentrations' and 'rapid violent deaths' :)
",yes_direct,0.587,,D009638,"<span class=""chemical"">noradrenaline</span>",D003643,"<span class=""disease"">deaths</span>","A group of five hyperthermia-related <span class=""disease"">deaths</span> is presented in which urinary <span class=""chemical"">noradrenaline</span> (NA) concentrations were elevated (172.1 +/- 119.4 ng/ml) compared with a control group of rapid violent <span class=""disease"">deaths</span> (43.7 +/- 26.1 ng/ml).",,2279717,2279717_D009638_D003643,2279717_1,bcv_sentence_task_befree_253,,770956180,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,0.6065,,D009638,"<span class=""chemical"">noradrenaline</span>",D005334,"<span class=""disease"">hyperthermia</span>","A group of five <span class=""disease"">hyperthermia</span>-related deaths is presented in which urinary <span class=""chemical"">noradrenaline</span> (NA) concentrations were elevated (172.1 +/- 119.4 ng/ml) compared with a control group of rapid violent deaths (43.7 +/- 26.1 ng/ml).",,2279717,2279717_D009638_D005334,2279717_1,bcv_sentence_task_befree_254,,770956181,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,1,,D004837,"<span class=""chemical"">adrenaline</span>",D005334,"<span class=""disease"">hyperthermia</span>","Urinary <span class=""chemical"">adrenaline</span> (A) concentrations were not elevated in the <span class=""disease"">hyperthermia</span> cases, nor were there any significant differences in urinary dopamine (DA) concentrations between the two groups.",,2279717,2279717_D004837_D005334,2279717_2,bcv_sentence_task_befree_255,,770956182,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,D004298,"<span class=""chemical"">dopamine</span>",D005334,"<span class=""disease"">hyperthermia</span>","Urinary adrenaline (A) concentrations were not elevated in the <span class=""disease"">hyperthermia</span> cases, nor were there any significant differences in urinary <span class=""chemical"">dopamine</span> (DA) concentrations between the two groups.",,2279717,2279717_D004298_D005334,2279717_2,bcv_sentence_task_befree_256,,770956183,FALSE,finalized,5,8/15/15 1:22,"



",yes_direct,0.7836,,D000431,"<span class=""chemical"">ethanol</span>",D005334,"<span class=""disease"">hyperthermia</span>","All except one of the <span class=""disease"">hyperthermia</span> victims were under the influence of <span class=""chemical"">ethanol</span>.",,2279717,2279717_D000431_D005334,2279717_3,bcv_sentence_task_befree_257,,770956184,FALSE,finalized,5,8/15/15 2:27,"



",no_relation,0.8194,,D000431,"<span class=""chemical"">ethanol</span>",D005334,"<span class=""disease"">hyperthermia</span>","It is suggested that a combination of heat stress and <span class=""chemical"">ethanol</span> consumption was responsible for the elevated urinary NA in the <span class=""disease"">hyperthermia</span> cases, reflecting increased sympathetic nervous system activity.",,2279717,2279717_D000431_D005334,2279717_4,bcv_sentence_task_befree_258,,770956185,FALSE,finalized,5,8/14/15 23:29,"



",no_relation,1,,D013015,"<span class=""chemical"">sotalol</span>",D054141,"<span class=""disease"">flutter</span>","One hundred nine patients with recurrent episodes of symptomatic atrial fibrillation or <span class=""disease"">flutter</span>, or both, who had failed one to five previous antiarrhythmic drug trials were treated with propafenone and, subsequently, <span class=""chemical"">sotalol</span> if atrial fibrillation recurred.",,2303641,2303641_D013015_D054141,2303641_1,bcv_sentence_task_befree_259,,770956186,FALSE,finalized,5,8/14/15 22:47,"



",no_relation,1,,D011405,"<span class=""chemical"">propafenone</span>",D054141,"<span class=""disease"">flutter</span>","One hundred nine patients with recurrent episodes of symptomatic atrial fibrillation or <span class=""disease"">flutter</span>, or both, who had failed one to five previous antiarrhythmic drug trials were treated with <span class=""chemical"">propafenone</span> and, subsequently, sotalol if atrial fibrillation recurred.",,2303641,2303641_D011405_D054141,2303641_1,bcv_sentence_task_befree_260,,770956187,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,1,,D011405,"<span class=""chemical"">propafenone</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","One hundred nine patients with recurrent episodes of symptomatic <span class=""disease"">atrial fibrillation</span> or flutter, or both, who had failed one to five previous antiarrhythmic drug trials were treated with <span class=""chemical"">propafenone</span> and, subsequently, sotalol if <span class=""disease"">atrial fibrillation</span> recurred.",,2303641,2303641_D011405_D001281,2303641_1,bcv_sentence_task_befree_261,,770956188,FALSE,finalized,5,8/14/15 20:31,"



",no_relation,1,,D013015,"<span class=""chemical"">sotalol</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","One hundred nine patients with recurrent episodes of symptomatic <span class=""disease"">atrial fibrillation</span> or flutter, or both, who had failed one to five previous antiarrhythmic drug trials were treated with propafenone and, subsequently, <span class=""chemical"">sotalol</span> if <span class=""disease"">atrial fibrillation</span> recurred.",,2303641,2303641_D013015_D001281,2303641_1,bcv_sentence_task_befree_262,,770956189,FALSE,finalized,5,8/15/15 1:28,"



",no_relation,1,,D013015,"<span class=""chemical"">sotalol</span>",D001145,"<span class=""disease"">arrhythmia</span>","The percent of patients free of recurrent symptomatic <span class=""disease"">arrhythmia</span> at 6 months was 39% for propafenone and 50% for <span class=""chemical"">sotalol</span>.",,2303641,2303641_D013015_D001145,2303641_6,bcv_sentence_task_befree_263,,770956190,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,0.7968,,D011405,"<span class=""chemical"">propafenone</span>",D001145,"<span class=""disease"">arrhythmia</span>","The percent of patients free of recurrent symptomatic <span class=""disease"">arrhythmia</span> at 6 months was 39% for <span class=""chemical"">propafenone</span> and 50% for sotalol.",,2303641,2303641_D011405_D001145,2303641_6,bcv_sentence_task_befree_264,,770956191,FALSE,finalized,5,8/14/15 20:52,"



",no_relation,1,,C050504,"<span class=""chemical"">Tianeptine</span>",D007022,"<span class=""disease"">orthostatic hypotension</span>","<span class=""chemical"">Tianeptine</span> did not produce <span class=""disease"">orthostatic hypotension</span> or increase heart rate.",,2306747,2306747_C050504_D007022,2306747_5,bcv_sentence_task_befree_265,,770956192,FALSE,finalized,5,8/15/15 2:00,"



",yes_direct,0.6165,,C050504,"<span class=""chemical"">tianeptine</span>",D064420,"<span class=""disease"">cardiac toxicity</span>","The present study suggests that <span class=""chemical"">tianeptine</span> is a tricyclic antidepressant endowed with less <span class=""disease"">cardiac toxicity</span> than classical tricyclic antidepressants.",,2306747,2306747_C050504_D064420,2306747_9,bcv_sentence_task_befree_266,,770956193,FALSE,finalized,5,8/14/15 20:33,"



""An underappreciated relationship""...  hm, puzzling and unorthodox  qualification.",no_relation,0.7895,,D000305,"<span class=""chemical"">corticosteroid</span>",D004241,"<span class=""disease"">colonic diverticula</span>","An underappreciated relationship is that of perforation of <span class=""disease"">colonic diverticula</span> and <span class=""chemical"">corticosteroid</span> therapy.",,2353866,2353866_D000305_D004241,2353866_3,bcv_sentence_task_befree_267,,770956194,FALSE,finalized,5,8/15/15 0:58,"



",yes_direct,1,,D000305,"<span class=""chemical"">corticosteroid</span>",D004241,"<span class=""disease"">colonic diverticula</span>","This report describes the course of three patients who developed perforations of <span class=""disease"">colonic diverticula</span> that were temporally related to <span class=""chemical"">corticosteroid</span> use.",,2353866,2353866_D000305_D004241,2353866_4,bcv_sentence_task_befree_268,,770956195,FALSE,finalized,5,8/14/15 20:16,"



",no_relation,1,,D000667,"<span class=""chemical"">ampicillin</span>",D011704,"<span class=""disease"">pyelonephritis</span>","Therefore, we conclude that a limited-spectrum cephalosporin is more appropriate than <span class=""chemical"">ampicillin</span> for empirical therapy of <span class=""disease"">pyelonephritis</span> in pregnancy.",,2371028,2371028_D000667_D011704,2371028_7,bcv_sentence_task_befree_269,,770956196,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,1,,D002511,"<span class=""chemical"">cephalosporin</span>",D011704,"<span class=""disease"">pyelonephritis</span>","Therefore, we conclude that a limited-spectrum <span class=""chemical"">cephalosporin</span> is more appropriate than ampicillin for empirical therapy of <span class=""disease"">pyelonephritis</span> in pregnancy.",,2371028,2371028_D002511_D011704,2371028_7,bcv_sentence_task_befree_270,,770956197,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D000617,"<span class=""chemical"">aminoglycoside</span>",D011552,"<span class=""disease"">Pseudomonas aeruginosa</span>","Mortality due to left-sided endocarditis caused by <span class=""disease"">Pseudomonas aeruginosa</span> remains high despite the therapeutic regimen of high doses of an <span class=""chemical"">aminoglycoside</span> plus a beta-lactam antibiotic.",,2385771,2385771_D000617_D011552,2385771_1,bcv_sentence_task_befree_271,,770956198,FALSE,finalized,5,8/14/15 20:17,"



",no_relation,1,,D000617,"<span class=""chemical"">aminoglycoside</span>",D004696,"<span class=""disease"">endocarditis</span>","Mortality due to left-sided <span class=""disease"">endocarditis</span> caused by Pseudomonas aeruginosa remains high despite the therapeutic regimen of high doses of an <span class=""chemical"">aminoglycoside</span> plus a beta-lactam antibiotic.",,2385771,2385771_D000617_D004696,2385771_1,bcv_sentence_task_befree_272,,770956199,FALSE,finalized,5,8/14/15 22:24,"



",no_relation,1,,D015525,"<span class=""chemical"">omega-3 fatty acids</span>",D009369,"<span class=""disease"">pancreatic cancer</span>","No association was found between <span class=""disease"">pancreatic cancer</span> risk and the intake of total fat, saturated fat, cholesterol, <span class=""chemical"">omega-3 fatty acids</span>, or vitamins A and C. There was an unexpected inverse association between calcium intake and <span class=""disease"">pancreatic cancer</span> risk in these data.",,2389747,2389747_D015525_D009369,2389747_9,bcv_sentence_task_befree_273,,770956200,FALSE,finalized,5,8/15/15 0:24,"



",no_relation,0.8119,,D002118,"<span class=""chemical"">calcium</span>",D009369,"<span class=""disease"">pancreatic cancer</span>","No association was found between <span class=""disease"">pancreatic cancer</span> risk and the intake of total fat, saturated fat, cholesterol, omega-3 fatty acids, or vitamins A and C. There was an unexpected inverse association between <span class=""chemical"">calcium</span> intake and <span class=""disease"">pancreatic cancer</span> risk in these data.",,2389747,2389747_D002118_D009369,2389747_9,bcv_sentence_task_befree_274,,770956201,FALSE,finalized,5,8/14/15 20:05,"



",no_relation,1,,D002784,"<span class=""chemical"">cholesterol</span>",D009369,"<span class=""disease"">pancreatic cancer</span>","No association was found between <span class=""disease"">pancreatic cancer</span> risk and the intake of total fat, saturated fat, <span class=""chemical"">cholesterol</span>, omega-3 fatty acids, or vitamins A and C. There was an unexpected inverse association between calcium intake and <span class=""disease"">pancreatic cancer</span> risk in these data.",,2389747,2389747_D002784_D009369,2389747_9,bcv_sentence_task_befree_275,,770956202,FALSE,finalized,5,8/14/15 22:16,"



",yes_direct,0.814,,D009532,"<span class=""chemical"">Nickel</span>",D003872,"<span class=""disease"">dermatitis</span>","<span class=""chemical"">Nickel</span> <span class=""disease"">dermatitis</span>.",,2406062,2406062_D009532_D003872,2406062_0,bcv_sentence_task_befree_276,,770956203,FALSE,finalized,5,8/15/15 2:00,"



",yes_direct,0.7991,,D009532,"<span class=""chemical"">nickel</span>",D004342,"<span class=""disease"">hypersensitivity</span>","It has been claimed that there is such a high correlation between a positive history of <span class=""chemical"">nickel</span> <span class=""disease"">hypersensitivity</span> and patch-test results that testing is unnecessary if there is a history of <span class=""disease"">hypersensitivity</span>.",,2406062,2406062_D009532_D004342,2406062_3,bcv_sentence_task_befree_277,,770956204,FALSE,finalized,5,8/14/15 23:39,"



",no_relation,0.5832,,D009532,"<span class=""chemical"">Nickel</span>",D004342,"<span class=""disease"">hypersensitivity</span>","<span class=""chemical"">Nickel</span> <span class=""disease"">hypersensitivity</span> itself is not a serious health problem for the individual.",,2406062,2406062_D009532_D004342,2406062_5,bcv_sentence_task_befree_278,,770956205,FALSE,finalized,5,8/14/15 20:50,"



",yes_direct,0.5894,,D009532,"<span class=""chemical"">nickel</span>",D004342,"<span class=""disease"">hypersensitivity</span>","It seems important to introduce safe methods of ear piercing (a primary source of <span class=""chemical"">nickel</span> <span class=""disease"">hypersensitivity</span>) and to spread information about the health hazard potential of the seemingly harmless sensitivity to <span class=""chemical"">nickel</span>.",,2406062,2406062_D009532_D004342,2406062_9,bcv_sentence_task_befree_279,,770956206,FALSE,finalized,5,8/14/15 20:58,"



",no_relation,1,,D006221,"<span class=""chemical"">halothane</span>",D008107,"<span class=""disease"">liver disease</span>","Of the 28 overt icteric hepatitis cases, 13 (2.8%) were thought to be true overt icteric posttransfusion hepatitis because the icterus was caused by other reasons in the other 15 cases (seven neonatal jaundice, four hemolytic anemia, one radiation hepatitis, one <span class=""chemical"">halothane</span>-induced hepatitis; two other cases were excluded because chronic <span class=""disease"">liver disease</span> was diagnosed by imaging procedures despite serum ALTs in the normal range before transfusion).",,7506644,7506644_D006221_D008107,7506644_4,bcv_sentence_task_befree_280,,770956207,FALSE,finalized,5,8/14/15 22:31,"



The first highlighting is erroneous (""hepatitis because the icterus""); it should be just ""hepatitis"" which in this case is directly induced by halothane.",no_relation,0.791,,D006221,"<span class=""chemical"">halothane</span>",D007565,"<span class=""disease"">jaundice/hepatitis because the icterus</span>","Of the 28 overt icteric hepatitis cases, 13 (2.8%) were thought to be true overt icteric posttransfusion <span class=""disease"">hepatitis because the icterus</span> was caused by other reasons in the other 15 cases (seven neonatal <span class=""disease"">jaundice</span>, four hemolytic anemia, one radiation hepatitis, one <span class=""chemical"">halothane</span>-induced hepatitis; two other cases were excluded because chronic liver disease was diagnosed by imaging procedures despite serum ALTs in the normal range before transfusion).",,7506644,7506644_D006221_D007565,7506644_4,bcv_sentence_task_befree_281,,770956208,FALSE,finalized,5,8/14/15 20:49,"



",yes_direct,0.5905,,D006221,"<span class=""chemical"">halothane</span>",D006505,"<span class=""disease"">hepatitis</span>","Of the 28 overt icteric <span class=""disease"">hepatitis</span> cases, 13 (2.8%) were thought to be true overt icteric posttransfusion hepatitis because the icterus was caused by other reasons in the other 15 cases (seven neonatal jaundice, four hemolytic anemia, one radiation <span class=""disease"">hepatitis</span>, one <span class=""chemical"">halothane</span>-induced <span class=""disease"">hepatitis</span>; two other cases were excluded because chronic liver disease was diagnosed by imaging procedures despite serum ALTs in the normal range before transfusion).",,7506644,7506644_D006221_D006505,7506644_4,bcv_sentence_task_befree_282,,770956209,FALSE,finalized,5,8/14/15 20:52,"



",no_relation,1,,D006221,"<span class=""chemical"">halothane</span>",D000743,"<span class=""disease"">hemolytic anemia</span>","Of the 28 overt icteric hepatitis cases, 13 (2.8%) were thought to be true overt icteric posttransfusion hepatitis because the icterus was caused by other reasons in the other 15 cases (seven neonatal jaundice, four <span class=""disease"">hemolytic anemia</span>, one radiation hepatitis, one <span class=""chemical"">halothane</span>-induced hepatitis; two other cases were excluded because chronic liver disease was diagnosed by imaging procedures despite serum ALTs in the normal range before transfusion).",,7506644,7506644_D006221_D000743,7506644_4,bcv_sentence_task_befree_283,,770956210,FALSE,finalized,5,8/15/15 1:57,"



",no_relation,0.8288,,D016729,"<span class=""chemical"">leuprolide</span>",D011470,"<span class=""disease"">prostatic hyperplasia</span>","Safety, side effects and patient acceptance of the luteinizing hormone releasing hormone agonist <span class=""chemical"">leuprolide</span> in treatment of benign <span class=""disease"">prostatic hyperplasia</span>.",,7516978,7516978_D016729_D011470,7516978_0,bcv_sentence_task_befree_284,,770956211,FALSE,finalized,5,8/14/15 23:23,"


Used as treatment.
",no_relation,1,,D016729,"<span class=""chemical"">leuprolide</span>",D011470,"<span class=""disease"">prostatic hyperplasia</span>","The luteinizing hormone releasing hormone agonist <span class=""chemical"">leuprolide</span> was investigated in a double-blind, randomized, placebo-controlled study comprising 50 evaluable patients with moderate to severe symptoms resulting from benign <span class=""disease"">prostatic hyperplasia</span>.",,7516978,7516978_D016729_D011470,7516978_1,bcv_sentence_task_befree_285,,770956212,FALSE,finalized,5,8/15/15 1:47,"



",yes_direct,1,,D016729,"<span class=""chemical"">leuprolide</span>",D015430,"<span class=""disease"">weight gain</span>","Of 26 patients receiving <span class=""chemical"">leuprolide</span> 5 had a <span class=""disease"">weight gain</span> of more than 3 kg.",,7516978,7516978_D016729_D015430,7516978_6,bcv_sentence_task_befree_286,,770956213,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,D017265,"<span class=""chemical"">procaterol</span>",D013224,"<span class=""disease"">asthmatic</span>","Effect of <span class=""chemical"">procaterol</span>, a beta 2-adrenoceptor agonist, on skin whealing response caused by inflammatory mediators in <span class=""disease"">asthmatic</span> children.",,7544228,7544228_D017265_D013224,7544228_0,bcv_sentence_task_befree_287,,770956214,FALSE,finalized,5,8/14/15 21:50,"



",no_relation,1,,D001920,"<span class=""chemical"">bradykinin</span>",D013224,"<span class=""disease"">asthmatic</span>","We examined the effect of procaterol, a beta 2-adrenoceptor agonist, on skin whealing responses to histamine, platelet-activating factor (PAF), substance P, or <span class=""chemical"">bradykinin</span> in eight <span class=""disease"">asthmatic</span> children in a double-blind, randomized, cross-over study.",,7544228,7544228_D001920_D013224,7544228_3,bcv_sentence_task_befree_288,,770956215,FALSE,finalized,5,8/15/15 0:07,"



",no_relation,1,,D017265,"<span class=""chemical"">procaterol</span>",D013224,"<span class=""disease"">asthmatic</span>","We examined the effect of <span class=""chemical"">procaterol</span>, a beta 2-adrenoceptor agonist, on skin whealing responses to histamine, platelet-activating factor (PAF), substance P, or bradykinin in eight <span class=""disease"">asthmatic</span> children in a double-blind, randomized, cross-over study.",,7544228,7544228_D017265_D013224,7544228_3,bcv_sentence_task_befree_289,,770956216,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D006632,"<span class=""chemical"">histamine</span>",D013224,"<span class=""disease"">asthmatic</span>","We examined the effect of procaterol, a beta 2-adrenoceptor agonist, on skin whealing responses to <span class=""chemical"">histamine</span>, platelet-activating factor (PAF), substance P, or bradykinin in eight <span class=""disease"">asthmatic</span> children in a double-blind, randomized, cross-over study.",,7544228,7544228_D006632_D013224,7544228_3,bcv_sentence_task_befree_290,,770956217,FALSE,finalized,5,8/14/15 20:34,"



",no_relation,1,,D002939,"<span class=""chemical"">Ciprofloxacin</span>",D002771,"<span class=""disease"">cholera</span>","<span class=""chemical"">Ciprofloxacin</span> for the treatment of <span class=""disease"">cholera</span>: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults.",,7548496,7548496_D002939_D002771,7548496_0,bcv_sentence_task_befree_291,,770956218,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,D002939,"<span class=""chemical"">ciprofloxacin</span>",D002771,"<span class=""disease"">cholera</span>","We conducted a randomized, double-blind clinical trial to compare <span class=""chemical"">ciprofloxacin</span> (250 mg once a day for 3 days) with tetracycline (500 mg four times a day for 3 days) in terms of efficacy and safety in the treatment of moderate-to-severe <span class=""disease"">cholera</span> in Peruvian adults.",,7548496,7548496_D002939_D002771,7548496_1,bcv_sentence_task_befree_292,,770956219,FALSE,finalized,5,8/14/15 20:34,"



",no_relation,1,,D013752,"<span class=""chemical"">tetracycline</span>",D002771,"<span class=""disease"">cholera</span>","We conducted a randomized, double-blind clinical trial to compare ciprofloxacin (250 mg once a day for 3 days) with <span class=""chemical"">tetracycline</span> (500 mg four times a day for 3 days) in terms of efficacy and safety in the treatment of moderate-to-severe <span class=""disease"">cholera</span> in Peruvian adults.",,7548496,7548496_D013752_D002771,7548496_1,bcv_sentence_task_befree_293,,770956220,FALSE,finalized,5,8/15/15 1:13,"



",no_relation,1,,D002939,"<span class=""chemical"">ciprofloxacin</span>",D002771,"<span class=""disease"">cholera</span>","We conclude that <span class=""chemical"">ciprofloxacin</span> given once a day is as effective as the standard tetracycline regimen for the treatment of <span class=""disease"">cholera</span> in adults.",,7548496,7548496_D002939_D002771,7548496_6,bcv_sentence_task_befree_294,,770956221,FALSE,finalized,5,8/15/15 1:26,"



",no_relation,1,,D013752,"<span class=""chemical"">tetracycline</span>",D002771,"<span class=""disease"">cholera</span>","We conclude that ciprofloxacin given once a day is as effective as the standard <span class=""chemical"">tetracycline</span> regimen for the treatment of <span class=""disease"">cholera</span> in adults.",,7548496,7548496_D013752_D002771,7548496_6,bcv_sentence_task_befree_295,,770956222,FALSE,finalized,5,8/15/15 0:01,"



",no_relation,1,,D003894,"<span class=""chemical"">desmopressin</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","An open, in-patient incremental safety and efficacy study of <span class=""chemical"">desmopressin</span> in women with <span class=""disease"">multiple sclerosis</span> and nocturia.",,7551881,7551881_D003894_D009103,7551881_0,bcv_sentence_task_befree_296,,770956223,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,0.8042,,D003894,"<span class=""chemical"">desmopressin</span>",D053158,"<span class=""disease"">nocturia</span>","An open, in-patient incremental safety and efficacy study of <span class=""chemical"">desmopressin</span> in women with multiple sclerosis and <span class=""disease"">nocturia</span>.",,7551881,7551881_D003894_D053158,7551881_0,bcv_sentence_task_befree_297,,770956224,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,1,,D003894,"<span class=""chemical"">desmopressin</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","To examine the safety and efficacy of <span class=""chemical"">desmopressin</span> in three doses given to women with <span class=""disease"">multiple sclerosis</span> to treat nocturia with or without enuresis.",,7551881,7551881_D003894_D009103,7551881_1,bcv_sentence_task_befree_298,,770956225,FALSE,finalized,5,8/14/15 20:19,"



",no_relation,1,,D003894,"<span class=""chemical"">desmopressin</span>",D053158,"<span class=""disease"">nocturia</span>","To examine the safety and efficacy of <span class=""chemical"">desmopressin</span> in three doses given to women with multiple sclerosis to treat <span class=""disease"">nocturia</span> with or without enuresis.",,7551881,7551881_D003894_D053158,7551881_1,bcv_sentence_task_befree_299,,770956226,FALSE,finalized,5,8/15/15 0:32,"


Used as treatment of another disease.
",no_relation,1,,D003894,"<span class=""chemical"">desmopressin</span>",D004775,"<span class=""disease"">enuresis</span>","To examine the safety and efficacy of <span class=""chemical"">desmopressin</span> in three doses given to women with multiple sclerosis to treat nocturia with or without <span class=""disease"">enuresis</span>.",,7551881,7551881_D003894_D004775,7551881_1,bcv_sentence_task_befree_300,,770956227,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,C080985,"<span class=""chemical"">Batimastat</span>",D009369,"<span class=""disease"">cancer</span>","<span class=""chemical"">Batimastat</span> (BB-94) is the first inhibitor of this class to enter clinical trial in <span class=""disease"">cancer</span> patients.",,7572350,7572350_C080985_D009369,7572350_6,bcv_sentence_task_befree_301,,770956228,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,1,,C080985,"<span class=""chemical"">batimastat</span>",D001201,"<span class=""disease"">malignant ascites</span>","In a phase I/II trial in patients with <span class=""disease"">malignant ascites</span> <span class=""chemical"">batimastat</span> was well tolerated and there were preliminary signs of efficacy.",,7572350,7572350_C080985_D001201,7572350_7,bcv_sentence_task_befree_302,,770956229,FALSE,finalized,5,8/14/15 20:48,"



",no_relation,0.6013,,D005280,"<span class=""chemical"">fenoterol</span>",D004417,"<span class=""disease"">breathlessness</span>","The response to regular inhaled <span class=""chemical"">fenoterol</span> and ipratropium bromide by metered dose inhaler (MDI) and large volume spacer, and to regular nebulized salbutamol and ipratropium bromide was assessed by home peak flow recordings, spirometry and two subjective scores: (a) rating of <span class=""disease"">breathlessness</span> on a simple four-point scale, and (b) activity score of the St George's Respiratory Questionnaire.",,7597269,7597269_D005280_D004417,7597269_7,bcv_sentence_task_befree_303,,770956230,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,0.7932,,D009241,"<span class=""chemical"">ipratropium bromide</span>",D004417,"<span class=""disease"">breathlessness</span>","The response to regular inhaled fenoterol and <span class=""chemical"">ipratropium bromide</span> by metered dose inhaler (MDI) and large volume spacer, and to regular nebulized salbutamol and <span class=""chemical"">ipratropium bromide</span> was assessed by home peak flow recordings, spirometry and two subjective scores: (a) rating of <span class=""disease"">breathlessness</span> on a simple four-point scale, and (b) activity score of the St George's Respiratory Questionnaire.",,7597269,7597269_D009241_D004417,7597269_7,bcv_sentence_task_befree_304,,770956231,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,1,,D000420,"<span class=""chemical"">salbutamol</span>",D004417,"<span class=""disease"">breathlessness</span>","The response to regular inhaled fenoterol and ipratropium bromide by metered dose inhaler (MDI) and large volume spacer, and to regular nebulized <span class=""chemical"">salbutamol</span> and ipratropium bromide was assessed by home peak flow recordings, spirometry and two subjective scores: (a) rating of <span class=""disease"">breathlessness</span> on a simple four-point scale, and (b) activity score of the St George's Respiratory Questionnaire.",,7597269,7597269_D000420_D004417,7597269_7,bcv_sentence_task_befree_305,,770956232,FALSE,finalized,5,8/15/15 0:28,"



",no_relation,0.5904,,D000728,"<span class=""chemical"">androgen</span>",D011471,"<span class=""disease"">prostate cancer</span>","Maximum <span class=""chemical"">androgen</span> blockade in advanced <span class=""disease"">prostate cancer</span>: an overview of 22 randomised trials with 3283 deaths in 5710 patients.",,7630245,7630245_D000728_D011471,7630245_0,bcv_sentence_task_befree_306,,770956233,FALSE,finalized,5,8/14/15 20:57,"



",no_relation,1,,D005485,"<span class=""chemical"">flutamide</span>",D011471,"<span class=""disease"">prostate cancer</span>","A systematic overview, or meta-analysis, of the randomised evidence on maximum androgen blockade (MAB) in advanced <span class=""disease"">prostate cancer</span> identified 25 trials that compared conventional castration (surgical or medical) versus MAB (castration plus prolonged use of an antiandrogen such as <span class=""chemical"">flutamide</span>, cyproterone acetate, or nilutamide).",,7630245,7630245_D005485_D011471,7630245_2,bcv_sentence_task_befree_307,,770956234,FALSE,finalized,5,8/15/15 1:09,"



",no_relation,1,,D017373,"<span class=""chemical"">cyproterone acetate</span>",D011471,"<span class=""disease"">prostate cancer</span>","A systematic overview, or meta-analysis, of the randomised evidence on maximum androgen blockade (MAB) in advanced <span class=""disease"">prostate cancer</span> identified 25 trials that compared conventional castration (surgical or medical) versus MAB (castration plus prolonged use of an antiandrogen such as flutamide, <span class=""chemical"">cyproterone acetate</span>, or nilutamide).",,7630245,7630245_D017373_D011471,7630245_2,bcv_sentence_task_befree_308,,770956235,FALSE,finalized,5,8/14/15 20:33,"



",no_relation,1,,C021277,"<span class=""chemical"">nilutamide</span>",D011471,"<span class=""disease"">prostate cancer</span>","A systematic overview, or meta-analysis, of the randomised evidence on maximum androgen blockade (MAB) in advanced <span class=""disease"">prostate cancer</span> identified 25 trials that compared conventional castration (surgical or medical) versus MAB (castration plus prolonged use of an antiandrogen such as flutamide, cyproterone acetate, or <span class=""chemical"">nilutamide</span>).",,7630245,7630245_C021277_D011471,7630245_2,bcv_sentence_task_befree_309,,770956236,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,0.5897,,D002996,"<span class=""chemical"">CC/clomiphene citrate</span>",D016471,"<span class=""disease"">ovarian hyperstimulation</span>","Controlled <span class=""disease"">ovarian hyperstimulation</span> was achieved using three types of ovarian stimulation protocols: <span class=""chemical"">clomiphene citrate</span> (<span class=""chemical"">CC</span>) and hMG (n = 35). hMG alone (n = 35) or GnRH agonist and FSH and hMG (n = 30).",,7641902,7641902_D002996_D016471,7641902_5,bcv_sentence_task_befree_310,,770956237,FALSE,finalized,5,8/15/15 0:33,"



",no_relation,1,,C040791,"<span class=""chemical"">8-hydroxydeoxyguanosine</span>",D009369,"<span class=""disease"">cancer</span>","Determination of urinary <span class=""chemical"">8-hydroxydeoxyguanosine</span> by automated coupled-column high performance liquid chromatography: a powerful technique for assaying in vivo oxidative DNA damage in <span class=""disease"">cancer</span> patients.",,7646926,7646926_C040791_D009369,7646926_0,bcv_sentence_task_befree_311,,770956238,FALSE,finalized,5,8/14/15 20:45,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",D009369,"<span class=""disease"">cancer</span>","Normal healthy individuals were found to excrete 14.9 +/- 7.8 nmol 8OHdG/24 h, or 1.11 +/- 0.62 mumol 8OHdG per mol <span class=""chemical"">creatinine</span>, in their urine, whereas increased levels of 8OHdG were found in 24 h collections from a variety of <span class=""disease"">cancer</span> patients, both in samples taken before onset of oncological therapy (1.84 +/- 1.12 mumol/mol <span class=""chemical"">creatinine</span>, P < 0.01 versus healthy individuals) and after therapy onset (2.18 +/- 1.44 mumol/mol <span class=""chemical"">creatinine</span>, P < 0.001 versus healthy individuals).",,7646926,7646926_D003404_D009369,7646926_6,bcv_sentence_task_befree_312,,770956239,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,C040791,"<span class=""chemical"">8OHdG</span>",D009369,"<span class=""disease"">cancer</span>","Normal healthy individuals were found to excrete 14.9 +/- 7.8 nmol <span class=""chemical"">8OHdG</span>/24 h, or 1.11 +/- 0.62 mumol <span class=""chemical"">8OHdG</span> per mol creatinine, in their urine, whereas increased levels of <span class=""chemical"">8OHdG</span> were found in 24 h collections from a variety of <span class=""disease"">cancer</span> patients, both in samples taken before onset of oncological therapy (1.84 +/- 1.12 mumol/mol creatinine, P < 0.01 versus healthy individuals) and after therapy onset (2.18 +/- 1.44 mumol/mol creatinine, P < 0.001 versus healthy individuals).",,7646926,7646926_C040791_D009369,7646926_6,bcv_sentence_task_befree_313,,770956240,FALSE,finalized,5,8/14/15 20:16,"



",no_relation,0.8167,,D003404,"<span class=""chemical"">creatinine</span>",D009369,"<span class=""disease"">cancer</span>","Moreover, mean values of 8OHdG in random urinary samples from <span class=""disease"">cancer</span> patients were significantly higher than from healthy individuals (2.42 +/- 2.28 versus 1.19 +/- 0.48 mumol/mol <span class=""chemical"">creatinine</span>, P < 0.001), both in samples taken before therapy onset (1.91 +/- 0.96, P < 0.001 versus healthy individuals) and after (2.57 +/- 2.46, P < 0.001 versus healthy individuals).",,7646926,7646926_D003404_D009369,7646926_7,bcv_sentence_task_befree_314,,770956241,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,C040791,"<span class=""chemical"">8OHdG</span>",D009369,"<span class=""disease"">cancer</span>","Moreover, mean values of <span class=""chemical"">8OHdG</span> in random urinary samples from <span class=""disease"">cancer</span> patients were significantly higher than from healthy individuals (2.42 +/- 2.28 versus 1.19 +/- 0.48 mumol/mol creatinine, P < 0.001), both in samples taken before therapy onset (1.91 +/- 0.96, P < 0.001 versus healthy individuals) and after (2.57 +/- 2.46, P < 0.001 versus healthy individuals).",,7646926,7646926_C040791_D009369,7646926_7,bcv_sentence_task_befree_315,,770956242,FALSE,finalized,5,8/14/15 22:19,"



",yes_direct,0.5973,,D019796,"<span class=""chemical"">U-46619</span>",C566800,"<span class=""disease"">platelet aggregation</span>","In human platelets in vitro, daltroban (10 nM-100 microM; n = 6 per group) concentration-dependently induced shape change, attaining at 50 microM, a maximum amplitude of 0.83 +/- 0.09 mV representing 46.4 +/- 4.8% of that evoked by <span class=""chemical"">U-46619</span> (1.78 +/- 0.20 mV at 0.2 microM; n = 9); and inhibited <span class=""chemical"">U-46619</span>-induced <span class=""disease"">platelet aggregation</span> with an IC50 of 77 (41-161)nM.",,7647979,7647979_D019796_C566800,7647979_4,bcv_sentence_task_befree_316,,770956243,FALSE,finalized,5,8/15/15 1:29,"



",no_relation,0.5876,,D019796,"<span class=""chemical"">U-46619</span>",C566800,"<span class=""disease"">platelet aggregation</span>","SQ 29,548 (10 nM-100 microM; n = 6 per group) failed to evoke any platelet shape change, but potently inhibited <span class=""chemical"">U-46619</span>-induced <span class=""disease"">platelet aggregation</span> with an IC50 < 10 nM.",,7647979,7647979_D019796_C566800,7647979_5,bcv_sentence_task_befree_317,,770956244,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,D005467,"<span class=""chemical"">floxuridine</span>",D009369,"<span class=""disease"">tumour</span>","Effect of aberrant hepatic arterial anatomy on <span class=""disease"">tumour</span> response to hepatic artery infusion of <span class=""chemical"">floxuridine</span> for colorectal liver metastases.",,7648164,7648164_D005467_D009369,7648164_0,bcv_sentence_task_befree_318,,770956245,FALSE,finalized,5,8/14/15 23:27,"



",no_relation,0.8014,,D005467,"<span class=""chemical"">floxuridine</span>",D009362,"<span class=""disease"">metastases</span>","Effect of aberrant hepatic arterial anatomy on tumour response to hepatic artery infusion of <span class=""chemical"">floxuridine</span> for colorectal liver <span class=""disease"">metastases</span>.",,7648164,7648164_D005467_D009362,7648164_0,bcv_sentence_task_befree_319,,770956246,FALSE,finalized,5,8/15/15 1:16,"



",yes_direct,0.5933,,D005467,"<span class=""chemical"">floxuridine</span>",D009369,"<span class=""disease"">tumour</span>","The effect of variation in hepatic artery anatomy on <span class=""disease"">tumour</span> response to regional <span class=""chemical"">floxuridine</span> (FUdR) was studied.",,7648164,7648164_D005467_D009369,7648164_2,bcv_sentence_task_befree_320,,770956247,FALSE,finalized,5,8/14/15 23:44,"



",no_relation,1,,D020280,"<span class=""chemical"">sertraline</span>",D003866,"<span class=""disease"">depression</span>","Outpatients receiving fluoxetine were switched to <span class=""chemical"">sertraline</span> therapy without a loss of control of <span class=""disease"">depression</span> and without substantial adverse effects.",,7656119,7656119_D020280_D003866,7656119_10,bcv_sentence_task_befree_321,,770956248,FALSE,finalized,5,8/14/15 23:42,"



'without a loss of control of depression' being the key term.",no_relation,1,,D005473,"<span class=""chemical"">fluoxetine</span>",D003866,"<span class=""disease"">depression</span>","Outpatients receiving <span class=""chemical"">fluoxetine</span> were switched to sertraline therapy without a loss of control of <span class=""disease"">depression</span> and without substantial adverse effects.",,7656119,7656119_D005473_D003866,7656119_10,bcv_sentence_task_befree_322,,770956249,FALSE,finalized,5,8/14/15 23:16,"


It's a suspected connection.
",yes_direct,0.6101,,D007980,"<span class=""chemical"">levodopa</span>",D001008,"<span class=""disease"">anxiety</span>","Dose-response relationship of <span class=""chemical"">levodopa</span> with mood and <span class=""disease"">anxiety</span> in fluctuating Parkinson's disease: a double-blind, placebo-controlled study.",,7675241,7675241_D007980_D001008,7675241_0,bcv_sentence_task_befree_323,,770956250,FALSE,finalized,5,8/14/15 23:24,"



",no_relation,0.8103,,D007980,"<span class=""chemical"">levodopa</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","Dose-response relationship of <span class=""chemical"">levodopa</span> with mood and anxiety in fluctuating <span class=""disease"">Parkinson's disease</span>: a double-blind, placebo-controlled study.",,7675241,7675241_D007980_D010300,7675241_0,bcv_sentence_task_befree_324,,770956251,FALSE,finalized,5,8/15/15 0:22,"



",no_relation,1,,D007980,"<span class=""chemical"">levodopa</span>",D001008,"<span class=""disease"">anxiety</span>","We investigated the effect of <span class=""chemical"">levodopa</span> on mood and <span class=""disease"">anxiety</span> in eight Parkinson's disease patients with motor fluctuations.",,7675241,7675241_D007980_D001008,7675241_1,bcv_sentence_task_befree_325,,770956252,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,1,,D007980,"<span class=""chemical"">levodopa</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","We investigated the effect of <span class=""chemical"">levodopa</span> on mood and anxiety in eight <span class=""disease"">Parkinson's disease</span> patients with motor fluctuations.",,7675241,7675241_D007980_D010300,7675241_1,bcv_sentence_task_befree_326,,770956253,FALSE,finalized,5,8/15/15 1:13,"



",yes_direct,1,,D007980,"<span class=""chemical"">levodopa</span>",D001008,"<span class=""disease"">anxiety</span>","We conclude that mood and <span class=""disease"">anxiety</span> fluctuations related to <span class=""chemical"">levodopa</span> dosing are robust pharmacologic, and not placebo, effects.",,7675241,7675241_D007980_D001008,7675241_6,bcv_sentence_task_befree_327,,770956254,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,D015311,"<span class=""chemical"">cefmetazole</span>",D016063,"<span class=""disease"">surgical incision</span>","Administration of <span class=""chemical"">cefmetazole</span> immediately prior to <span class=""disease"">surgical incision</span> should be effective prophylaxis for surgical wound infections.",,7694975,7694975_D015311_D016063,7694975_8,bcv_sentence_task_befree_328,,770956255,FALSE,finalized,5,8/14/15 20:32,"



",no_relation,1,,D015311,"<span class=""chemical"">cefmetazole</span>",D007239,"<span class=""disease"">infections</span>","Administration of <span class=""chemical"">cefmetazole</span> immediately prior to surgical incision should be effective prophylaxis for surgical wound <span class=""disease"">infections</span>.",,7694975,7694975_D015311_D007239,7694975_8,bcv_sentence_task_befree_329,,770956256,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D018170,"<span class=""chemical"">sumatriptan</span>",D008881,"<span class=""disease"">migraine</span>","Since the vasoconstrictor response of <span class=""chemical"">sumatriptan</span> is reproducible outside the <span class=""disease"">migraine</span> attack, this action appears to be a direct vascular effect and not indirectly mediated via neural mechanisms.",,7697699,7697699_D018170_D008881,7697699_5,bcv_sentence_task_befree_330,,770956257,FALSE,finalized,5,8/14/15 20:53,"



",no_relation,1,,D018170,"<span class=""chemical"">sumatriptan</span>",D008881,"<span class=""disease"">migraine</span>","This finding is further supported by the clinical observation that <span class=""chemical"">sumatriptan</span> reduces the plasma levels of calcitonin gene-related peptide which are raised during a <span class=""disease"">migraine</span> attack.",,7697699,7697699_D018170_D008881,7697699_12,bcv_sentence_task_befree_331,,770956258,FALSE,finalized,5,8/15/15 2:15,"



",yes_direct,0.8018,,D015127,"<span class=""chemical"">DMBA</span>",D001943,"<span class=""disease"">mammary carcinoma</span>","Vorozole, like ovariectomy, almost completely reduces tumor growth in the <span class=""chemical"">DMBA</span>-induced <span class=""disease"">mammary carcinoma</span> model in the rat.",,7726994,7726994_D015127_D001943,7726994_6,bcv_sentence_task_befree_332,,770956259,FALSE,finalized,5,8/14/15 22:50,"



",no_relation,1,,C060523,"<span class=""chemical"">Vorozole</span>",D009369,"<span class=""disease"">tumor</span>","<span class=""chemical"">Vorozole</span>, like ovariectomy, almost completely reduces <span class=""disease"">tumor</span> growth in the DMBA-induced mammary carcinoma model in the rat.",,7726994,7726994_C060523_D009369,7726994_6,bcv_sentence_task_befree_333,,770956260,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,C060523,"<span class=""chemical"">Vorozole</span>",D001943,"<span class=""disease"">mammary carcinoma</span>","<span class=""chemical"">Vorozole</span>, like ovariectomy, almost completely reduces tumor growth in the DMBA-induced <span class=""disease"">mammary carcinoma</span> model in the rat.",,7726994,7726994_C060523_D001943,7726994_6,bcv_sentence_task_befree_334,,770956261,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,0.6016,,D015127,"<span class=""chemical"">DMBA</span>",D009369,"<span class=""disease"">tumor</span>","Vorozole, like ovariectomy, almost completely reduces <span class=""disease"">tumor</span> growth in the <span class=""chemical"">DMBA</span>-induced mammary carcinoma model in the rat.",,7726994,7726994_D015127_D009369,7726994_6,bcv_sentence_task_befree_335,,770956262,FALSE,finalized,5,8/14/15 20:57,"
al simplificar las palabras es mas entendible para uno que no es medico en este tipo de tarea...thanksss


",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D013224,"<span class=""disease"">asthmatic</span>","Both <span class=""disease"">asthmatic</span> and nonasthmatic patients who received a thiobarbiturate for induction had a greater incidence of wheezing than did patients receiving <span class=""chemical"">propofol</span>.",,7741285,7741285_D015742_D013224,7741285_9,bcv_sentence_task_befree_336,,770956263,FALSE,finalized,5,8/15/15 0:28,"



",no_relation,0.7987,,C029684,"<span class=""chemical"">thiobarbiturate</span>",D013224,"<span class=""disease"">asthmatic</span>","Both <span class=""disease"">asthmatic</span> and nonasthmatic patients who received a <span class=""chemical"">thiobarbiturate</span> for induction had a greater incidence of wheezing than did patients receiving propofol.",,7741285,7741285_C029684_D013224,7741285_9,bcv_sentence_task_befree_337,,770956264,FALSE,finalized,5,8/14/15 22:11,"



",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D013224,"<span class=""disease"">asthmatic</span>","In <span class=""disease"">asthmatic</span> patients, 45% (23, 67) (mean and 95% confidence interval) who received a thiobarbiturate, 26% (8, 44) who received an oxybarbiturate, and none (0, 17) who received <span class=""chemical"">propofol</span> wheezed after intubation.",,7741285,7741285_D015742_D013224,7741285_10,bcv_sentence_task_befree_338,,770956265,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,C029684,"<span class=""chemical"">thiobarbiturate</span>",D013224,"<span class=""disease"">asthmatic</span>","In <span class=""disease"">asthmatic</span> patients, 45% (23, 67) (mean and 95% confidence interval) who received a <span class=""chemical"">thiobarbiturate</span>, 26% (8, 44) who received an oxybarbiturate, and none (0, 17) who received propofol wheezed after intubation.",,7741285,7741285_C029684_D013224,7741285_10,bcv_sentence_task_befree_339,,770956266,FALSE,finalized,5,8/14/15 23:05,"
Beneficial


",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D001249,"<span class=""disease"">asthma</span>","This study suggests that <span class=""chemical"">propofol</span> should be considered for induction of anesthesia in patients, particularly those with <span class=""disease"">asthma</span>, who require timely intubation.",,7741285,7741285_D015742_D001249,7741285_12,bcv_sentence_task_befree_340,,770956267,FALSE,finalized,5,8/15/15 2:39,"



",no_relation,1,,D014859,"<span class=""chemical"">coumadin</span>",D020521,"<span class=""disease"">cardioembolic stroke</span>","A comparative study of <span class=""chemical"">coumadin</span> and aspirin for primary <span class=""disease"">cardioembolic stroke</span> and thromboembolic preventions of chronic rheumatic mitral stenosis with atrial fibrillation.",,7798824,7798824_D014859_D020521,7798824_0,bcv_sentence_task_befree_341,,770956268,FALSE,finalized,5,8/15/15 0:03,"


Used as a preventive measure.
",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D008946,"<span class=""disease"">rheumatic mitral stenosis</span>","A comparative study of coumadin and <span class=""chemical"">aspirin</span> for primary cardioembolic stroke and thromboembolic preventions of chronic <span class=""disease"">rheumatic mitral stenosis</span> with atrial fibrillation.",,7798824,7798824_D001241_D008946,7798824_0,bcv_sentence_task_befree_342,,770956269,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,D014859,"<span class=""chemical"">coumadin</span>",D013923,"<span class=""disease"">thromboembolic</span>","A comparative study of <span class=""chemical"">coumadin</span> and aspirin for primary cardioembolic stroke and <span class=""disease"">thromboembolic</span> preventions of chronic rheumatic mitral stenosis with atrial fibrillation.",,7798824,7798824_D014859_D013923,7798824_0,bcv_sentence_task_befree_343,,770956270,FALSE,finalized,5,8/14/15 22:14,"



",no_relation,1,,D014859,"<span class=""chemical"">coumadin</span>",D008946,"<span class=""disease"">rheumatic mitral stenosis</span>","A comparative study of <span class=""chemical"">coumadin</span> and aspirin for primary cardioembolic stroke and thromboembolic preventions of chronic <span class=""disease"">rheumatic mitral stenosis</span> with atrial fibrillation.",,7798824,7798824_D014859_D008946,7798824_0,bcv_sentence_task_befree_344,,770956271,FALSE,finalized,5,8/14/15 20:33,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","A comparative study of coumadin and <span class=""chemical"">aspirin</span> for primary cardioembolic stroke and thromboembolic preventions of chronic rheumatic mitral stenosis with <span class=""disease"">atrial fibrillation</span>.",,7798824,7798824_D001241_D001281,7798824_0,bcv_sentence_task_befree_345,,770956272,FALSE,finalized,5,8/15/15 2:23,"



",no_relation,1,,D014859,"<span class=""chemical"">coumadin</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","A comparative study of <span class=""chemical"">coumadin</span> and aspirin for primary cardioembolic stroke and thromboembolic preventions of chronic rheumatic mitral stenosis with <span class=""disease"">atrial fibrillation</span>.",,7798824,7798824_D014859_D001281,7798824_0,bcv_sentence_task_befree_346,,770956273,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D013923,"<span class=""disease"">thromboembolic</span>","A comparative study of coumadin and <span class=""chemical"">aspirin</span> for primary cardioembolic stroke and <span class=""disease"">thromboembolic</span> preventions of chronic rheumatic mitral stenosis with atrial fibrillation.",,7798824,7798824_D001241_D013923,7798824_0,bcv_sentence_task_befree_347,,770956274,FALSE,finalized,5,8/15/15 1:00,"



",no_relation,0.7976,,D001241,"<span class=""chemical"">aspirin</span>",D020521,"<span class=""disease"">cardioembolic stroke</span>","A comparative study of coumadin and <span class=""chemical"">aspirin</span> for primary <span class=""disease"">cardioembolic stroke</span> and thromboembolic preventions of chronic rheumatic mitral stenosis with atrial fibrillation.",,7798824,7798824_D001241_D020521,7798824_0,bcv_sentence_task_befree_348,,770956275,FALSE,finalized,5,8/14/15 20:25,"



",no_relation,1,,D014859,"<span class=""chemical"">coumadin</span>",D020521,"<span class=""disease"">cardioembolic stroke</span>","The comparative study of the efficacy of <span class=""chemical"">coumadin</span> and aspirin in primary <span class=""disease"">cardioembolic stroke</span> prevention of chronic rheumatic heart disease (mitral stenosis) with atrial fibrillation was conducted at Siriraj Hospital, Mahidol University, Bangkok, Thailand.",,7798824,7798824_D014859_D020521,7798824_1,bcv_sentence_task_befree_349,,770956276,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D008946,"<span class=""disease"">mitral stenosis</span>","The comparative study of the efficacy of coumadin and <span class=""chemical"">aspirin</span> in primary cardioembolic stroke prevention of chronic rheumatic heart disease (<span class=""disease"">mitral stenosis</span>) with atrial fibrillation was conducted at Siriraj Hospital, Mahidol University, Bangkok, Thailand.",,7798824,7798824_D001241_D008946,7798824_1,bcv_sentence_task_befree_350,,770956277,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,1,,D014859,"<span class=""chemical"">coumadin</span>",D008946,"<span class=""disease"">mitral stenosis</span>","The comparative study of the efficacy of <span class=""chemical"">coumadin</span> and aspirin in primary cardioembolic stroke prevention of chronic rheumatic heart disease (<span class=""disease"">mitral stenosis</span>) with atrial fibrillation was conducted at Siriraj Hospital, Mahidol University, Bangkok, Thailand.",,7798824,7798824_D014859_D008946,7798824_1,bcv_sentence_task_befree_351,,770956278,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","The comparative study of the efficacy of coumadin and <span class=""chemical"">aspirin</span> in primary cardioembolic stroke prevention of chronic rheumatic heart disease (mitral stenosis) with <span class=""disease"">atrial fibrillation</span> was conducted at Siriraj Hospital, Mahidol University, Bangkok, Thailand.",,7798824,7798824_D001241_D001281,7798824_1,bcv_sentence_task_befree_352,,770956279,FALSE,finalized,5,8/14/15 20:45,"



",no_relation,1,,D014859,"<span class=""chemical"">coumadin</span>",D012214,"<span class=""disease"">rheumatic heart disease</span>","The comparative study of the efficacy of <span class=""chemical"">coumadin</span> and aspirin in primary cardioembolic stroke prevention of chronic <span class=""disease"">rheumatic heart disease</span> (mitral stenosis) with atrial fibrillation was conducted at Siriraj Hospital, Mahidol University, Bangkok, Thailand.",,7798824,7798824_D014859_D012214,7798824_1,bcv_sentence_task_befree_353,,770956280,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,1,,D014859,"<span class=""chemical"">coumadin</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","The comparative study of the efficacy of <span class=""chemical"">coumadin</span> and aspirin in primary cardioembolic stroke prevention of chronic rheumatic heart disease (mitral stenosis) with <span class=""disease"">atrial fibrillation</span> was conducted at Siriraj Hospital, Mahidol University, Bangkok, Thailand.",,7798824,7798824_D014859_D001281,7798824_1,bcv_sentence_task_befree_354,,770956281,FALSE,finalized,5,8/14/15 20:17,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D020521,"<span class=""disease"">cardioembolic stroke</span>","The comparative study of the efficacy of coumadin and <span class=""chemical"">aspirin</span> in primary <span class=""disease"">cardioembolic stroke</span> prevention of chronic rheumatic heart disease (mitral stenosis) with atrial fibrillation was conducted at Siriraj Hospital, Mahidol University, Bangkok, Thailand.",,7798824,7798824_D001241_D020521,7798824_1,bcv_sentence_task_befree_355,,770956282,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D012214,"<span class=""disease"">rheumatic heart disease</span>","The comparative study of the efficacy of coumadin and <span class=""chemical"">aspirin</span> in primary cardioembolic stroke prevention of chronic <span class=""disease"">rheumatic heart disease</span> (mitral stenosis) with atrial fibrillation was conducted at Siriraj Hospital, Mahidol University, Bangkok, Thailand.",,7798824,7798824_D001241_D012214,7798824_1,bcv_sentence_task_befree_356,,770956283,FALSE,finalized,5,8/15/15 2:14,"



",no_relation,1,,D014859,"<span class=""chemical"">coumadin</span>",D020521,"<span class=""disease"">cardioembolic stroke</span>","There were three patients with nonfatal <span class=""disease"">cardioembolic stroke</span> in the aspirin group but none in the <span class=""chemical"">coumadin</span> group after three years of follow-up.",,7798824,7798824_D014859_D020521,7798824_7,bcv_sentence_task_befree_357,,770956284,FALSE,finalized,5,8/14/15 20:42,"



",no_relation,0.5988,,D001241,"<span class=""chemical"">aspirin</span>",D020521,"<span class=""disease"">cardioembolic stroke</span>","There were three patients with nonfatal <span class=""disease"">cardioembolic stroke</span> in the <span class=""chemical"">aspirin</span> group but none in the coumadin group after three years of follow-up.",,7798824,7798824_D001241_D020521,7798824_7,bcv_sentence_task_befree_358,,770956285,FALSE,finalized,5,8/15/15 2:01,"



",yes_direct,0.8012,,D014859,"<span class=""chemical"">coumadin</span>",D006470,"<span class=""disease"">bleeding</span>","The complications in <span class=""chemical"">coumadin</span> group were minor <span class=""disease"">bleeding</span> over the thigh in one patient and generalised ecchymosis over the whole body in one other.",,7798824,7798824_D014859_D006470,7798824_10,bcv_sentence_task_befree_359,,770956286,FALSE,finalized,5,8/14/15 22:07,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D006470,"<span class=""disease"">bleeding</span>","In the <span class=""chemical"">aspirin</span> group, the complication was gastrointestional symptoms, mainly epigastric pain, but no frank <span class=""disease"">bleeding</span> was observed.",,7798824,7798824_D001241_D006470,7798824_11,bcv_sentence_task_befree_360,,770956287,FALSE,finalized,5,8/14/15 20:28,"



",yes_direct,1,,D001241,"<span class=""chemical"">aspirin</span>",D010146,"<span class=""disease"">epigastric pain</span>","In the <span class=""chemical"">aspirin</span> group, the complication was gastrointestional symptoms, mainly <span class=""disease"">epigastric pain</span>, but no frank bleeding was observed.",,7798824,7798824_D001241_D010146,7798824_11,bcv_sentence_task_befree_361,,770956288,FALSE,finalized,5,8/15/15 1:09,"



",no_relation,1,,D014859,"<span class=""chemical"">coumadin</span>",D020521,"<span class=""disease"">cardioembolic stroke</span>","Primary prevention of <span class=""disease"">cardioembolic stroke</span> in chronic rheumatic heart disease was found to be more effective with <span class=""chemical"">coumadin</span> than aspirin.",,7798824,7798824_D014859_D020521,7798824_12,bcv_sentence_task_befree_362,,770956289,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,D014859,"<span class=""chemical"">coumadin</span>",D012214,"<span class=""disease"">rheumatic heart disease</span>","Primary prevention of cardioembolic stroke in chronic <span class=""disease"">rheumatic heart disease</span> was found to be more effective with <span class=""chemical"">coumadin</span> than aspirin.",,7798824,7798824_D014859_D012214,7798824_12,bcv_sentence_task_befree_363,,770956290,FALSE,finalized,5,8/14/15 20:10,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D020521,"<span class=""disease"">cardioembolic stroke</span>","Primary prevention of <span class=""disease"">cardioembolic stroke</span> in chronic rheumatic heart disease was found to be more effective with coumadin than <span class=""chemical"">aspirin</span>.",,7798824,7798824_D001241_D020521,7798824_12,bcv_sentence_task_befree_364,,770956291,FALSE,finalized,5,8/15/15 1:48,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D012214,"<span class=""disease"">rheumatic heart disease</span>","Primary prevention of cardioembolic stroke in chronic <span class=""disease"">rheumatic heart disease</span> was found to be more effective with coumadin than <span class=""chemical"">aspirin</span>.",,7798824,7798824_D001241_D012214,7798824_12,bcv_sentence_task_befree_365,,770956292,FALSE,finalized,5,8/14/15 22:39,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D004617,"<span class=""disease"">cardiac embolism</span>","Our study does not support the use of <span class=""chemical"">aspirin</span> in primary prevention of <span class=""disease"">cardiac embolism</span> in chronic rheumatic heart disease.",,7798824,7798824_D001241_D004617,7798824_13,bcv_sentence_task_befree_366,,770956293,FALSE,finalized,5,8/14/15 23:28,"



",no_relation,0.8197,,D001241,"<span class=""chemical"">aspirin</span>",D012214,"<span class=""disease"">rheumatic heart disease</span>","Our study does not support the use of <span class=""chemical"">aspirin</span> in primary prevention of cardiac embolism in chronic <span class=""disease"">rheumatic heart disease</span>.",,7798824,7798824_D001241_D012214,7798824_13,bcv_sentence_task_befree_367,,770956294,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D015215,"<span class=""chemical"">AZT</span>",D015658,"<span class=""disease"">HIV infection</span>","A mathematical model of CD4+ lymphocyte depletion in <span class=""disease"">HIV infection</span> is used to simulate and analyse the effect of <span class=""chemical"">AZT</span> treatment.",,7805931,7805931_D015215_D015658,7805931_1,bcv_sentence_task_befree_368,,770956295,FALSE,finalized,5,8/15/15 1:48,"



",no_relation,1,,D015215,"<span class=""chemical"">AZT</span>",D007239,"<span class=""disease"">infection</span>","Interestingly, the survival prolongation is greater, if the treatment is started at five than at two years after the <span class=""disease"">infection</span> and there is no striking increase in survival time if a dose of <span class=""chemical"">AZT</span> inhibiting 75% of HIV proliferation is used instead of a lower one inducing 25% inhibition only.",,7805931,7805931_D015215_D007239,7805931_7,bcv_sentence_task_befree_369,,770956296,FALSE,finalized,5,8/15/15 0:41,"



",yes_direct,0.6159,,D005907,"<span class=""chemical"">gliclazide</span>",D003925,"<span class=""disease"">diabetic vascular disease</span>","From hemobiology to vascular disease: a review of the potential of <span class=""chemical"">gliclazide</span> to influence the pathogenesis of <span class=""disease"">diabetic vascular disease</span>.",,7833498,7833498_D005907_D003925,7833498_0,bcv_sentence_task_befree_370,,770956297,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,0.6228,,D005907,"<span class=""chemical"">gliclazide</span>",D014652,"<span class=""disease"">vascular disease</span>","From hemobiology to <span class=""disease"">vascular disease</span>: a review of the potential of <span class=""chemical"">gliclazide</span> to influence the pathogenesis of diabetic vascular disease.",,7833498,7833498_D005907_D014652,7833498_0,bcv_sentence_task_befree_371,,770956298,FALSE,finalized,5,8/14/15 23:53,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003929,"<span class=""disease"">diabetes</span>","The process of vascular damage is accelerated by <span class=""disease"">diabetes</span>, often due to co-existing disease and aging, although it is not clear that improvement in long-term glycemic control by lowering blood <span class=""chemical"">glucose</span> levels to near to the nondiabetic state reduces the development of small and large vessel disease.",,7833498,7833498_D005947_D003929,7833498_9,bcv_sentence_task_befree_372,,770956299,FALSE,finalized,5,8/14/15 20:34,"



",no_relation,0.7911,,D005947,"<span class=""chemical"">glucose</span>",D006177,"<span class=""disease"">vascular damage</span>","The process of <span class=""disease"">vascular damage</span> is accelerated by diabetes, often due to co-existing disease and aging, although it is not clear that improvement in long-term glycemic control by lowering blood <span class=""chemical"">glucose</span> levels to near to the nondiabetic state reduces the development of small and large vessel disease.",,7833498,7833498_D005947_D006177,7833498_9,bcv_sentence_task_befree_373,,770956300,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,0.8225,,D016718,"<span class=""chemical"">arachidonic acid</span>",D003925,"<span class=""disease"">diabetic vascular disease</span>","Increased oxidative stress due to excess free-radical activity may be central to <span class=""disease"">diabetic vascular disease</span> as endothelial cell damage, lipoprotein oxidation, modification of both platelet reactivity and <span class=""chemical"">arachidonic acid</span> cascade are all properties of free radicals and their reaction products lipid peroxides.",,7833498,7833498_D016718_D003925,7833498_11,bcv_sentence_task_befree_374,,770956301,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,0.5954,,D010545,"<span class=""chemical"">peroxides</span>",D003925,"<span class=""disease"">diabetic vascular disease</span>","Increased oxidative stress due to excess free-radical activity may be central to <span class=""disease"">diabetic vascular disease</span> as endothelial cell damage, lipoprotein oxidation, modification of both platelet reactivity and arachidonic acid cascade are all properties of free radicals and their reaction products lipid <span class=""chemical"">peroxides</span>.",,7833498,7833498_D010545_D003925,7833498_11,bcv_sentence_task_befree_375,,770956302,FALSE,finalized,5,8/15/15 0:28,"



",no_relation,0.5953,,C077908,"<span class=""chemical"">BW2258U89</span>",D055752,"<span class=""disease"">small cell lung cancer</span>","<span class=""chemical"">BW2258U89</span>: a GRP receptor antagonist which inhibits <span class=""disease"">small cell lung cancer</span> growth.",,7869832,7869832_C077908_D055752,7869832_0,bcv_sentence_task_befree_376,,770956303,FALSE,finalized,5,8/14/15 20:16,"



",no_relation,0.8167,,D005755,"<span class=""chemical"">gastrin</span>",D055752,"<span class=""disease"">SCLC/small cell lung cancer</span>","The ability of reduced peptide bond analogues of <span class=""chemical"">gastrin</span> releasing peptide (GRP) to antagonize <span class=""disease"">small cell lung cancer</span> (<span class=""disease"">SCLC</span>) GRP receptors was investigated.",,7869832,7869832_D005755_D055752,7869832_1,bcv_sentence_task_befree_377,,770956304,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,D001279,"<span class=""chemical"">atracurium</span>",D003866,"<span class=""disease"">depression</span>","Once the adductor pollicis response has returned to normal values after a single intubating dose of <span class=""chemical"">atracurium</span> or vecuronium, the risk of residual <span class=""disease"">depression</span> of the TH of the geniohyoid muscle, one of the principal muscles contributing to airway patency, appears unlikely.",,7879933,7879933_D001279_D003866,7879933_9,bcv_sentence_task_befree_378,,770956305,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D014673,"<span class=""chemical"">vecuronium</span>",D003866,"<span class=""disease"">depression</span>","Once the adductor pollicis response has returned to normal values after a single intubating dose of atracurium or <span class=""chemical"">vecuronium</span>, the risk of residual <span class=""disease"">depression</span> of the TH of the geniohyoid muscle, one of the principal muscles contributing to airway patency, appears unlikely.",,7879933,7879933_D014673_D003866,7879933_9,bcv_sentence_task_befree_379,,770956306,FALSE,finalized,5,8/14/15 20:19,"



",yes_direct,0.7919,,D010416,"<span class=""chemical"">pentachlorophenol</span>",D011041,"<span class=""disease"">poisoning</span>","Human <span class=""chemical"">pentachlorophenol</span> <span class=""disease"">poisoning</span>.",,7904464,7904464_D010416_D011041,7904464_0,bcv_sentence_task_befree_380,,770956307,FALSE,finalized,5,8/14/15 20:48,"



",yes_direct,1,,D010416,"<span class=""chemical"">PCP</span>",D011041,"<span class=""disease"">Chronic poisoning</span>","<span class=""disease"">Chronic poisoning</span> occurs mainly in sawmill workers or people living in log homes treated with <span class=""chemical"">PCP</span>-containing wood protecting formulations.",,7904464,7904464_D010416_D011041,7904464_4,bcv_sentence_task_befree_381,,770956308,FALSE,finalized,5,8/14/15 20:32,"



",yes_direct,0.6209,,D010416,"<span class=""chemical"">PCP</span>",D011041,"<span class=""disease"">poisoning</span>","The clinical features of acute and chronic <span class=""chemical"">PCP</span> <span class=""disease"">poisoning</span> can be classified systematically into effects on the skin, metabolism (fever), the haematopoietic tissue, the respiratory system, the central and peripheral nervous system, the kidney and the gastrointestinal tract.",,7904464,7904464_D010416_D011041,7904464_6,bcv_sentence_task_befree_382,,770956309,FALSE,finalized,5,8/14/15 20:28,"



",yes_direct,1,,D010416,"<span class=""chemical"">PCP</span>",D012509,"<span class=""disease"">sarcoma</span>","Although <span class=""chemical"">PCP</span> is not classified as a human carcinogen, some epidemiological observations suggest that exposure to chlorophenols in general and <span class=""chemical"">PCP</span> solutions in particular may result in an increased risk for certain malignant disorders such as nasal carcinoma and soft tissue <span class=""disease"">sarcoma</span>.",,7904464,7904464_D010416_D012509,7904464_7,bcv_sentence_task_befree_383,,770956310,FALSE,finalized,5,8/14/15 20:33,"



",yes_direct,1,,D002733,"<span class=""chemical"">chlorophenols</span>",D009668,"<span class=""disease"">nasal carcinoma</span>","Although PCP is not classified as a human carcinogen, some epidemiological observations suggest that exposure to <span class=""chemical"">chlorophenols</span> in general and PCP solutions in particular may result in an increased risk for certain malignant disorders such as <span class=""disease"">nasal carcinoma</span> and soft tissue sarcoma.",,7904464,7904464_D002733_D009668,7904464_7,bcv_sentence_task_befree_384,,770956311,FALSE,finalized,5,8/14/15 20:40,"



",yes_direct,1,,D010416,"<span class=""chemical"">PCP</span>",D009668,"<span class=""disease"">nasal carcinoma</span>","Although <span class=""chemical"">PCP</span> is not classified as a human carcinogen, some epidemiological observations suggest that exposure to chlorophenols in general and <span class=""chemical"">PCP</span> solutions in particular may result in an increased risk for certain malignant disorders such as <span class=""disease"">nasal carcinoma</span> and soft tissue sarcoma.",,7904464,7904464_D010416_D009668,7904464_7,bcv_sentence_task_befree_385,,770956312,FALSE,finalized,5,8/14/15 23:56,"



",yes_direct,1,,D002733,"<span class=""chemical"">chlorophenols</span>",D012509,"<span class=""disease"">sarcoma</span>","Although PCP is not classified as a human carcinogen, some epidemiological observations suggest that exposure to <span class=""chemical"">chlorophenols</span> in general and PCP solutions in particular may result in an increased risk for certain malignant disorders such as nasal carcinoma and soft tissue <span class=""disease"">sarcoma</span>.",,7904464,7904464_D002733_D012509,7904464_7,bcv_sentence_task_befree_386,,770956313,FALSE,finalized,5,8/14/15 23:02,"


PCP overdose causes poisoning and not on its own.
",no_relation,0.5704,,D010416,"<span class=""chemical"">PCP</span>",D011041,"<span class=""disease"">poisoning</span>","No specific antidote exists for the treatment of (acute) <span class=""chemical"">PCP</span> <span class=""disease"">poisoning</span>.",,7904464,7904464_D010416_D011041,7904464_9,bcv_sentence_task_befree_387,,770956314,FALSE,finalized,5,8/14/15 21:49,"



",no_relation,1,,D000242,"<span class=""chemical"">cAMP</span>",D001249,"<span class=""disease"">asthma</span>","A variety of drugs known to act via increasing intracellular <span class=""chemical"">cAMP</span> are used in the treatment of <span class=""disease"">asthma</span>.",,7908546,7908546_D000242_D001249,7908546_1,bcv_sentence_task_befree_388,,770956315,FALSE,finalized,5,8/15/15 2:11,"



",no_relation,0.8372,,C041226,"<span class=""chemical"">terazosin</span>",D006973,"<span class=""disease"">hypertension</span>","Alpha 1-blockade for the treatment of <span class=""disease"">hypertension</span>: a megastudy of <span class=""chemical"">terazosin</span> in 2214 clinical practice settings.",,7923316,7923316_C041226_D006973,7923316_0,bcv_sentence_task_befree_389,,770956316,FALSE,finalized,5,8/15/15 1:09,"



",no_relation,1,,C041226,"<span class=""chemical"">terazosin</span>",D006973,"<span class=""disease"">hypertension</span>","The purpose of this study was to evaluate the effects of the alpha 1-blocking agent <span class=""chemical"">terazosin</span> on blood pressure (BP) and blood lipids in a large, variant population of patients with <span class=""disease"">hypertension</span>.",,7923316,7923316_C041226_D006973,7923316_1,bcv_sentence_task_befree_390,,770956317,FALSE,finalized,5,8/14/15 20:21,"



",no_relation,1,,C041226,"<span class=""chemical"">terazosin</span>",D006973,"<span class=""disease"">hypertension</span>","A total of 16,917 patients with <span class=""disease"">hypertension</span> were evaluated at 2214 primary and community care facilities; 7808 of these patients had not been treated previously for <span class=""disease"">hypertension</span>; 3928 were switched to <span class=""chemical"">terazosin</span> from another antihypertensive agent; and 5181 received <span class=""chemical"">terazosin</span> in addition to an agent that had not controlled their <span class=""disease"">hypertension</span>.",,7923316,7923316_C041226_D006973,7923316_2,bcv_sentence_task_befree_391,,770956318,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,D002784,"<span class=""chemical"">cholesterol</span>",D006949,"<span class=""disease"">hyperlipidemia</span>","The greatest reductions in blood <span class=""chemical"">cholesterol</span> (-9.2%) were observed among patients with <span class=""disease"">hyperlipidemia</span> (total <span class=""chemical"">cholesterol</span> > or = 240 mg/dL).",,7923316,7923316_D002784_D006949,7923316_8,bcv_sentence_task_befree_392,,770956319,FALSE,finalized,5,8/15/15 1:11,"



",no_relation,1,,C041226,"<span class=""chemical"">Terazosin</span>",D004194,"<span class=""disease"">concomitant diseases</span>","<span class=""chemical"">Terazosin</span> maintained its antihypertensive efficacy and was well tolerated by patients with a variety of <span class=""disease"">concomitant diseases</span>, including congestive heart failure, peripheral vascular disease, chronic obstructive pulmonary disease, benign prostatic hyperplasia, diabetes, and obesity.",,7923316,7923316_C041226_D004194,7923316_9,bcv_sentence_task_befree_393,,770956320,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,0.6035,,C041226,"<span class=""chemical"">Terazosin</span>",D006333,"<span class=""disease"">congestive heart failure</span>","<span class=""chemical"">Terazosin</span> maintained its antihypertensive efficacy and was well tolerated by patients with a variety of concomitant diseases, including <span class=""disease"">congestive heart failure</span>, peripheral vascular disease, chronic obstructive pulmonary disease, benign prostatic hyperplasia, diabetes, and obesity.",,7923316,7923316_C041226_D006333,7923316_9,bcv_sentence_task_befree_394,,770956321,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,1,,C041226,"<span class=""chemical"">Terazosin</span>",D029424,"<span class=""disease"">chronic obstructive pulmonary disease</span>","<span class=""chemical"">Terazosin</span> maintained its antihypertensive efficacy and was well tolerated by patients with a variety of concomitant diseases, including congestive heart failure, peripheral vascular disease, <span class=""disease"">chronic obstructive pulmonary disease</span>, benign prostatic hyperplasia, diabetes, and obesity.",,7923316,7923316_C041226_D029424,7923316_9,bcv_sentence_task_befree_395,,770956322,FALSE,finalized,5,8/14/15 20:49,"



",no_relation,1,,C041226,"<span class=""chemical"">Terazosin</span>",D016491,"<span class=""disease"">peripheral vascular disease</span>","<span class=""chemical"">Terazosin</span> maintained its antihypertensive efficacy and was well tolerated by patients with a variety of concomitant diseases, including congestive heart failure, <span class=""disease"">peripheral vascular disease</span>, chronic obstructive pulmonary disease, benign prostatic hyperplasia, diabetes, and obesity.",,7923316,7923316_C041226_D016491,7923316_9,bcv_sentence_task_befree_396,,770956323,FALSE,finalized,5,8/15/15 2:04,"



",no_relation,1,,C041226,"<span class=""chemical"">Terazosin</span>",D011470,"<span class=""disease"">prostatic hyperplasia</span>","<span class=""chemical"">Terazosin</span> maintained its antihypertensive efficacy and was well tolerated by patients with a variety of concomitant diseases, including congestive heart failure, peripheral vascular disease, chronic obstructive pulmonary disease, benign <span class=""disease"">prostatic hyperplasia</span>, diabetes, and obesity.",,7923316,7923316_C041226_D011470,7923316_9,bcv_sentence_task_befree_397,,770956324,FALSE,finalized,5,8/15/15 1:08,"



",no_relation,1,,C041226,"<span class=""chemical"">Terazosin</span>",D009765,"<span class=""disease"">obesity</span>","<span class=""chemical"">Terazosin</span> maintained its antihypertensive efficacy and was well tolerated by patients with a variety of concomitant diseases, including congestive heart failure, peripheral vascular disease, chronic obstructive pulmonary disease, benign prostatic hyperplasia, diabetes, and <span class=""disease"">obesity</span>.",,7923316,7923316_C041226_D009765,7923316_9,bcv_sentence_task_befree_398,,770956325,FALSE,finalized,5,8/14/15 20:50,"



",no_relation,1,,C041226,"<span class=""chemical"">Terazosin</span>",D003929,"<span class=""disease"">diabetes</span>","<span class=""chemical"">Terazosin</span> maintained its antihypertensive efficacy and was well tolerated by patients with a variety of concomitant diseases, including congestive heart failure, peripheral vascular disease, chronic obstructive pulmonary disease, benign prostatic hyperplasia, <span class=""disease"">diabetes</span>, and obesity.",,7923316,7923316_C041226_D003929,7923316_9,bcv_sentence_task_befree_399,,770956326,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,1,,C041226,"<span class=""chemical"">terazosin</span>",D006973,"<span class=""disease"">hypertension</span>","These data demonstrate the usefulness of <span class=""chemical"">terazosin</span> as monotherapy or add-on therapy for treatment of <span class=""disease"">hypertension</span>.",,7923316,7923316_C041226_D006973,7923316_13,bcv_sentence_task_befree_400,,770956327,FALSE,finalized,5,8/15/15 1:58,"



",yes_direct,0.6209,,D002330,"<span class=""chemical"">carmustine</span>",D064420,"<span class=""disease"">Ocular toxicity</span>","<span class=""disease"">Ocular toxicity</span> of systemic chemotherapy with megadoses of <span class=""chemical"">carmustine</span> and mitomycin.",,7944163,7944163_D002330_D064420,7944163_0,bcv_sentence_task_befree_401,,770956328,FALSE,finalized,5,8/15/15 0:26,"



",yes_direct,0.6139,,D016685,"<span class=""chemical"">mitomycin</span>",D064420,"<span class=""disease"">Ocular toxicity</span>","<span class=""disease"">Ocular toxicity</span> of systemic chemotherapy with megadoses of carmustine and <span class=""chemical"">mitomycin</span>.",,7944163,7944163_D016685_D064420,7944163_0,bcv_sentence_task_befree_402,,770956329,FALSE,finalized,5,8/15/15 2:22,"



",yes_direct,0.6116,,D002330,"<span class=""chemical"">carmustine</span>",D064420,"<span class=""disease"">ocular toxicity</span>","In this article, we discuss the <span class=""disease"">ocular toxicity</span> in six patients with advanced nonpretreated colorectal cancer who received megadoses of <span class=""chemical"">carmustine</span> and mitomycin with the support of autologous bone marrow transplantation.",,7944163,7944163_D002330_D064420,7944163_2,bcv_sentence_task_befree_403,,770956330,FALSE,finalized,5,8/14/15 23:12,"



",no_relation,0.6118,,D016685,"<span class=""chemical"">mitomycin</span>",D015179,"<span class=""disease"">colorectal cancer</span>","In this article, we discuss the ocular toxicity in six patients with advanced nonpretreated <span class=""disease"">colorectal cancer</span> who received megadoses of carmustine and <span class=""chemical"">mitomycin</span> with the support of autologous bone marrow transplantation.",,7944163,7944163_D016685_D015179,7944163_2,bcv_sentence_task_befree_404,,770956331,FALSE,finalized,5,8/14/15 23:13,"



Its a mere discussion on whether mitomycin contributes to ocular toxicity, on basis of six patients which concluded in negative effect, so mitomycin don't contribute or causes cular toxicity.",no_relation,0.7997,,D016685,"<span class=""chemical"">mitomycin</span>",D064420,"<span class=""disease"">ocular toxicity</span>","In this article, we discuss the <span class=""disease"">ocular toxicity</span> in six patients with advanced nonpretreated colorectal cancer who received megadoses of carmustine and <span class=""chemical"">mitomycin</span> with the support of autologous bone marrow transplantation.",,7944163,7944163_D016685_D064420,7944163_2,bcv_sentence_task_befree_405,,770956332,FALSE,finalized,5,8/15/15 1:11,"



",no_relation,0.8,,D002330,"<span class=""chemical"">carmustine</span>",D015179,"<span class=""disease"">colorectal cancer</span>","In this article, we discuss the ocular toxicity in six patients with advanced nonpretreated <span class=""disease"">colorectal cancer</span> who received megadoses of <span class=""chemical"">carmustine</span> and mitomycin with the support of autologous bone marrow transplantation.",,7944163,7944163_D002330_D015179,7944163_2,bcv_sentence_task_befree_406,,770956333,FALSE,finalized,5,8/14/15 20:23,"



",no_relation,1,,D005978,"<span class=""chemical"">glutathione</span>",D007511,"<span class=""disease"">ischemic renal injury</span>","Previous reports have suggested beneficial effects of exogenous <span class=""chemical"">glutathione</span> for preservation of renal function after <span class=""disease"">ischemic renal injury</span>.",,7952483,7952483_D005978_D007511,7952483_2,bcv_sentence_task_befree_407,,770956334,FALSE,finalized,5,8/15/15 1:43,"



",no_relation,1,,D005047,"<span class=""chemical"">etoposide</span>",D002289,"<span class=""disease"">non-small-cell lung cancer/NSCLC</span>","Patients with <span class=""disease"">non-small-cell lung cancer</span> (<span class=""disease"">NSCLC</span>) were treated with ICE chemotherapy (ifosfamide 2000 mg/m2, days 1-3; carboplatin 300 mg/m2, day 1; <span class=""chemical"">etoposide</span> 75 mg/m2, days 1-3) intravenously (i.v.) during the first 3 d of a maximum of four 28 d treatment cycles.",,7986706,7986706_D005047_D002289,7986706_1,bcv_sentence_task_befree_408,,770956335,FALSE,finalized,5,8/14/15 23:58,"



Used as treatment.",no_relation,1,,D016190,"<span class=""chemical"">carboplatin</span>",D002289,"<span class=""disease"">non-small-cell lung cancer/NSCLC</span>","Patients with <span class=""disease"">non-small-cell lung cancer</span> (<span class=""disease"">NSCLC</span>) were treated with ICE chemotherapy (ifosfamide 2000 mg/m2, days 1-3; <span class=""chemical"">carboplatin</span> 300 mg/m2, day 1; etoposide 75 mg/m2, days 1-3) intravenously (i.v.) during the first 3 d of a maximum of four 28 d treatment cycles.",,7986706,7986706_D016190_D002289,7986706_1,bcv_sentence_task_befree_409,,770956336,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,1,,D007069,"<span class=""chemical"">ifosfamide</span>",D002289,"<span class=""disease"">non-small-cell lung cancer/NSCLC</span>","Patients with <span class=""disease"">non-small-cell lung cancer</span> (<span class=""disease"">NSCLC</span>) were treated with ICE chemotherapy (<span class=""chemical"">ifosfamide</span> 2000 mg/m2, days 1-3; carboplatin 300 mg/m2, day 1; etoposide 75 mg/m2, days 1-3) intravenously (i.v.) during the first 3 d of a maximum of four 28 d treatment cycles.",,7986706,7986706_D007069_D002289,7986706_1,bcv_sentence_task_befree_410,,770956337,FALSE,finalized,5,8/14/15 20:22,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D016638,"<span class=""disease"">critically ill</span>","Elevation of systemic <span class=""chemical"">oxygen</span> delivery in the treatment of <span class=""disease"">critically ill</span> patients.",,7993413,7993413_D010100_D016638,7993413_0,bcv_sentence_task_befree_411,,770956338,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D016638,"<span class=""disease"">critically ill</span>","Elevation of systemic <span class=""chemical"">oxygen</span> delivery and consumption has been associated with an improved outcome in <span class=""disease"">critically ill</span> patients.",,7993413,7993413_D010100_D016638,7993413_1,bcv_sentence_task_befree_412,,770956339,FALSE,finalized,5,8/14/15 20:19,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D016638,"<span class=""disease"">critically ill</span>","The use of dobutamine to boost the cardiac index and systemic <span class=""chemical"">oxygen</span> delivery failed to improve the outcome in this heterogeneous group of <span class=""disease"">critically ill</span> patients.",,7993413,7993413_D010100_D016638,7993413_12,bcv_sentence_task_befree_413,,770956340,FALSE,finalized,5,8/14/15 20:56,"



",no_relation,1,,D004280,"<span class=""chemical"">dobutamine</span>",D016638,"<span class=""disease"">critically ill</span>","The use of <span class=""chemical"">dobutamine</span> to boost the cardiac index and systemic oxygen delivery failed to improve the outcome in this heterogeneous group of <span class=""disease"">critically ill</span> patients.",,7993413,7993413_D004280_D016638,7993413_12,bcv_sentence_task_befree_414,,770956341,FALSE,finalized,5,8/15/15 0:11,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D018222,"<span class=""disease"">aggressive</span>","Contrary to what might have been expected, our results suggest that in some cases <span class=""disease"">aggressive</span> efforts to increase <span class=""chemical"">oxygen</span> consumption may have been detrimental.",,7993413,7993413_D010100_D018222,7993413_13,bcv_sentence_task_befree_415,,770956342,FALSE,finalized,5,8/15/15 1:42,"



",no_relation,1,,D017035,"<span class=""chemical"">pravastatin</span>",D006937,"<span class=""disease"">hypercholesterolemia</span>","A multinational study of the effects of low-dose <span class=""chemical"">pravastatin</span> in patients with non-insulin-dependent diabetes mellitus and <span class=""disease"">hypercholesterolemia</span>.",,8001304,8001304_D017035_D006937,8001304_0,bcv_sentence_task_befree_416,,770956343,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D017035,"<span class=""chemical"">pravastatin</span>",D003924,"<span class=""disease"">non-insulin-dependent diabetes mellitus</span>","A multinational study of the effects of low-dose <span class=""chemical"">pravastatin</span> in patients with <span class=""disease"">non-insulin-dependent diabetes mellitus</span> and hypercholesterolemia.",,8001304,8001304_D017035_D003924,8001304_0,bcv_sentence_task_befree_417,,770956344,FALSE,finalized,5,8/14/15 20:28,"



",no_relation,1,,D017035,"<span class=""chemical"">pravastatin</span>",D006937,"<span class=""disease"">hypercholesterolemia</span>","This multinational, 16-week, randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of low-dose <span class=""chemical"">pravastatin</span> in 325 patients with non-insulin-dependent diabetes mellitus (NIDDM) and <span class=""disease"">hypercholesterolemia</span> [serum total cholesterol concentrations of 5.2-7.8 mmol/l (200 to 300 mg/dl)].",,8001304,8001304_D017035_D006937,8001304_2,bcv_sentence_task_befree_418,,770956345,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D017035,"<span class=""chemical"">pravastatin</span>",D003924,"<span class=""disease"">non-insulin-dependent diabetes mellitus/NIDDM</span>","This multinational, 16-week, randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of low-dose <span class=""chemical"">pravastatin</span> in 325 patients with <span class=""disease"">non-insulin-dependent diabetes mellitus</span> (<span class=""disease"">NIDDM</span>) and hypercholesterolemia [serum total cholesterol concentrations of 5.2-7.8 mmol/l (200 to 300 mg/dl)].",,8001304,8001304_D017035_D003924,8001304_2,bcv_sentence_task_befree_419,,770956346,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,0.7917,,D002784,"<span class=""chemical"">cholesterol</span>",D006937,"<span class=""disease"">hypercholesterolemia</span>","This multinational, 16-week, randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of low-dose pravastatin in 325 patients with non-insulin-dependent diabetes mellitus (NIDDM) and <span class=""disease"">hypercholesterolemia</span> [serum total <span class=""chemical"">cholesterol</span> concentrations of 5.2-7.8 mmol/l (200 to 300 mg/dl)].",,8001304,8001304_D002784_D006937,8001304_2,bcv_sentence_task_befree_420,,770956347,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,1,,D002784,"<span class=""chemical"">cholesterol</span>",D003924,"<span class=""disease"">non-insulin-dependent diabetes mellitus/NIDDM</span>","This multinational, 16-week, randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of low-dose pravastatin in 325 patients with <span class=""disease"">non-insulin-dependent diabetes mellitus</span> (<span class=""disease"">NIDDM</span>) and hypercholesterolemia [serum total <span class=""chemical"">cholesterol</span> concentrations of 5.2-7.8 mmol/l (200 to 300 mg/dl)].",,8001304,8001304_D002784_D003924,8001304_2,bcv_sentence_task_befree_421,,770956348,FALSE,finalized,5,8/14/15 22:10,"



",yes_direct,0.5844,,D017035,"<span class=""chemical"">pravastatin</span>",D007757,"<span class=""disease"">laboratory test abnormalities</span>","Adverse events and <span class=""disease"">laboratory test abnormalities</span> were similar among patients treated with <span class=""chemical"">pravastatin</span> or placebo.",,8001304,8001304_D017035_D007757,8001304_6,bcv_sentence_task_befree_422,,770956349,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,D017035,"<span class=""chemical"">pravastatin</span>",D006937,"<span class=""disease"">hypercholesterolemia</span>","The results of this study demonstrate that low-dose <span class=""chemical"">pravastatin</span> is effective and well tolerated for lowering elevated cholesterol concentrations during short-term treatment of patients with NIDDM and <span class=""disease"">hypercholesterolemia</span>.",,8001304,8001304_D017035_D006937,8001304_8,bcv_sentence_task_befree_423,,770956350,FALSE,finalized,5,8/14/15 20:52,"



",no_relation,1,,D017035,"<span class=""chemical"">pravastatin</span>",D003924,"<span class=""disease"">NIDDM</span>","The results of this study demonstrate that low-dose <span class=""chemical"">pravastatin</span> is effective and well tolerated for lowering elevated cholesterol concentrations during short-term treatment of patients with <span class=""disease"">NIDDM</span> and hypercholesterolemia.",,8001304,8001304_D017035_D003924,8001304_8,bcv_sentence_task_befree_424,,770956351,FALSE,finalized,5,8/14/15 21:59,"



",no_relation,0.599,,D002784,"<span class=""chemical"">cholesterol</span>",D006937,"<span class=""disease"">hypercholesterolemia</span>","The results of this study demonstrate that low-dose pravastatin is effective and well tolerated for lowering elevated <span class=""chemical"">cholesterol</span> concentrations during short-term treatment of patients with NIDDM and <span class=""disease"">hypercholesterolemia</span>.",,8001304,8001304_D002784_D006937,8001304_8,bcv_sentence_task_befree_425,,770956352,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,0.804,,D002784,"<span class=""chemical"">cholesterol</span>",D003924,"<span class=""disease"">NIDDM</span>","The results of this study demonstrate that low-dose pravastatin is effective and well tolerated for lowering elevated <span class=""chemical"">cholesterol</span> concentrations during short-term treatment of patients with <span class=""disease"">NIDDM</span> and hypercholesterolemia.",,8001304,8001304_D002784_D003924,8001304_8,bcv_sentence_task_befree_426,,770956353,FALSE,finalized,5,8/14/15 20:23,"



",no_relation,1,,D012176,"<span class=""chemical"">Retinoids</span>",D015473,"<span class=""disease"">acute promyelocytic leukemia</span>","<span class=""chemical"">Retinoids</span> can differentiate leukemic cell lines in vitro and induce clinically complete remissions in patients with <span class=""disease"">acute promyelocytic leukemia</span>.",,8025272,8025272_D012176_D015473,8025272_3,bcv_sentence_task_befree_427,,770956354,FALSE,finalized,5,8/14/15 23:37,"



",no_relation,1,,D000242,"<span class=""chemical"">cAMP</span>",D006463,"<span class=""disease"">cholera toxin</span>","Potent <span class=""chemical"">cAMP</span> inducers like <span class=""disease"">cholera toxin</span> are also growth promoters for neonatal melanocytes but only transient growth stimulators for cells derived from adults.",,8054689,8054689_D000242_D006463,8054689_3,bcv_sentence_task_befree_428,,770956355,FALSE,finalized,5,8/15/15 0:04,"



",no_relation,1,,D010703,"<span class=""chemical"">phorbol esters</span>",D006463,"<span class=""disease"">cholera toxin</span>","The simultaneous addition of <span class=""chemical"">phorbol esters</span> and <span class=""disease"">cholera toxin</span> did not prevent cells from reaching terminal differentiation.",,8054689,8054689_D010703_D006463,8054689_7,bcv_sentence_task_befree_429,,770956356,FALSE,finalized,5,8/15/15 1:26,"



",no_relation,0.8088,,D010703,"<span class=""chemical"">phorbol esters</span>",D020151,"<span class=""disease"">PKC/protein kinase C</span>","Identified targets for <span class=""chemical"">phorbol esters</span> are <span class=""disease"">protein kinase C</span> (<span class=""disease"">PKC</span>) and the mitogen-activated kinases (MAPKs), also called extracellular signal-regulated kinases (ERKs).",,8054689,8054689_D010703_D020151,8054689_8,bcv_sentence_task_befree_430,,770956357,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,0.8174,,D015282,"<span class=""chemical"">octreotide</span>",D012891,"<span class=""disease"">sleep apnea</span>","Effect of <span class=""chemical"">octreotide</span>, a somatostatin analog, on <span class=""disease"">sleep apnea</span> in patients with acromegaly.",,8067645,8067645_D015282_D012891,8067645_0,bcv_sentence_task_befree_431,,770956358,FALSE,finalized,5,8/14/15 20:21,"



",no_relation,1,,D015282,"<span class=""chemical"">octreotide</span>",D000172,"<span class=""disease"">acromegaly</span>","Effect of <span class=""chemical"">octreotide</span>, a somatostatin analog, on sleep apnea in patients with <span class=""disease"">acromegaly</span>.",,8067645,8067645_D015282_D000172,8067645_0,bcv_sentence_task_befree_432,,770956359,FALSE,finalized,5,8/14/15 22:13,"



",no_relation,1,,D013004,"<span class=""chemical"">somatostatin</span>",D000172,"<span class=""disease"">acromegaly</span>","Effect of octreotide, a <span class=""chemical"">somatostatin</span> analog, on sleep apnea in patients with <span class=""disease"">acromegaly</span>.",,8067645,8067645_D013004_D000172,8067645_0,bcv_sentence_task_befree_433,,770956360,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,0.8042,,D013004,"<span class=""chemical"">somatostatin</span>",D012891,"<span class=""disease"">sleep apnea</span>","Effect of octreotide, a <span class=""chemical"">somatostatin</span> analog, on <span class=""disease"">sleep apnea</span> in patients with acromegaly.",,8067645,8067645_D013004_D012891,8067645_0,bcv_sentence_task_befree_434,,770956361,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,1,,D015282,"<span class=""chemical"">octreotide</span>",D012891,"<span class=""disease"">sleep apnea</span>","To determine the effects of <span class=""chemical"">octreotide</span>, a somatostatin analog, on the severity of <span class=""disease"">sleep apnea</span> and on growth hormone levels in patients with acromegaly.",,8067645,8067645_D015282_D012891,8067645_1,bcv_sentence_task_befree_435,,770956362,FALSE,finalized,5,8/15/15 0:12,"



",no_relation,1,,D015282,"<span class=""chemical"">octreotide</span>",D000172,"<span class=""disease"">acromegaly</span>","To determine the effects of <span class=""chemical"">octreotide</span>, a somatostatin analog, on the severity of sleep apnea and on growth hormone levels in patients with <span class=""disease"">acromegaly</span>.",,8067645,8067645_D015282_D000172,8067645_1,bcv_sentence_task_befree_436,,770956363,FALSE,finalized,5,8/14/15 20:20,"



",no_relation,1,,D013004,"<span class=""chemical"">somatostatin</span>",D000172,"<span class=""disease"">acromegaly</span>","To determine the effects of octreotide, a <span class=""chemical"">somatostatin</span> analog, on the severity of sleep apnea and on growth hormone levels in patients with <span class=""disease"">acromegaly</span>.",,8067645,8067645_D013004_D000172,8067645_1,bcv_sentence_task_befree_437,,770956364,FALSE,finalized,5,8/14/15 20:41,"



",no_relation,1,,D013004,"<span class=""chemical"">somatostatin</span>",D012891,"<span class=""disease"">sleep apnea</span>","To determine the effects of octreotide, a <span class=""chemical"">somatostatin</span> analog, on the severity of <span class=""disease"">sleep apnea</span> and on growth hormone levels in patients with acromegaly.",,8067645,8067645_D013004_D012891,8067645_1,bcv_sentence_task_befree_438,,770956365,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D012893,"<span class=""disease"">sleepiness improved</span>","Indices of <span class=""chemical"">oxygen</span> desaturation, sleep quality, and subjective <span class=""disease"">sleepiness improved</span> after 6 months of octreotide.",,8067645,8067645_D010100_D012893,8067645_8,bcv_sentence_task_befree_439,,770956366,FALSE,finalized,5,8/15/15 1:57,"



",yes_direct,0.6083,,D015282,"<span class=""chemical"">octreotide</span>",D012893,"<span class=""disease"">sleepiness improved</span>","Indices of oxygen desaturation, sleep quality, and subjective <span class=""disease"">sleepiness improved</span> after 6 months of <span class=""chemical"">octreotide</span>.",,8067645,8067645_D015282_D012893,8067645_8,bcv_sentence_task_befree_440,,770956367,FALSE,finalized,5,8/15/15 1:02,"



",no_relation,0.8059,,D015282,"<span class=""chemical"">octreotide</span>",D012891,"<span class=""disease"">sleep apnea</span>","Improvement in indices of <span class=""disease"">sleep apnea</span> severity occurs in association with <span class=""chemical"">octreotide</span> treatment in patients with <span class=""disease"">sleep apnea</span> and acromegaly.",,8067645,8067645_D015282_D012891,8067645_12,bcv_sentence_task_befree_441,,770956368,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,1,,D015282,"<span class=""chemical"">octreotide</span>",D000172,"<span class=""disease"">acromegaly</span>","Improvement in indices of sleep apnea severity occurs in association with <span class=""chemical"">octreotide</span> treatment in patients with sleep apnea and <span class=""disease"">acromegaly</span>.",,8067645,8067645_D015282_D000172,8067645_12,bcv_sentence_task_befree_442,,770956369,FALSE,finalized,5,8/14/15 21:45,"



",no_relation,1,,D015251,"<span class=""chemical"">Epirubicin</span>",D006528,"<span class=""disease"">Epirubicin in hepatocellular carcinoma</span>","<span class=""chemical""></span><span class=""disease"">Epirubicin</span> in hepatocellular carcinoma: pharmacokinetics and clinical activity.",,8070007,8070007_D015251_D006528,8070007_0,bcv_sentence_task_befree_443,,770956370,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,D015251,"<span class=""chemical"">epirubicin</span>",D006528,"<span class=""disease"">HCC/hepatocellular carcinoma</span>","The pharmacokinetics and clinical activity of <span class=""chemical"">epirubicin</span> were investigated in 16 patients with <span class=""disease"">hepatocellular carcinoma</span> (<span class=""disease"">HCC</span>) who received <span class=""chemical"">epirubicin</span> at 75 mg/m2; the drug was given intravenously to 7 patients and via the hepatic artery to 9 patients (7 of whom also underwent embolisation).",,8070007,8070007_D015251_D006528,8070007_1,bcv_sentence_task_befree_444,,770956371,FALSE,finalized,5,8/15/15 2:32,"



",no_relation,1,,D015251,"<span class=""chemical"">epirubicin</span>",D006528,"<span class=""disease"">HCC</span>","However, at this dose and schedule, <span class=""chemical"">epirubicin</span> has only modest activity against <span class=""disease"">HCC</span>.",,8070007,8070007_D015251_D006528,8070007_9,bcv_sentence_task_befree_445,,770956372,FALSE,finalized,5,8/14/15 20:32,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D006935,"<span class=""disease"">hypercapnia</span>","Therefore, the nonsteroidal anti-inflammatory drugs and <span class=""chemical"">aspirin</span>, which inhibit cyclooxygenase, might be expected to reduce cerebral blood flow and the response to <span class=""disease"">hypercapnia</span>.",,8073456,8073456_D001241_D006935,8073456_2,bcv_sentence_task_befree_446,,770956373,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,D005472,"<span class=""chemical"">5-fluorouracil</span>",D009369,"<span class=""disease"">tumor</span>","Recombinant human interferon alpha-2a increases <span class=""chemical"">5-fluorouracil</span> efficacy by elevating fluorouridine concentration in <span class=""disease"">tumor</span> tissue.",,8074466,8074466_D005472_D009369,8074466_0,bcv_sentence_task_befree_447,,770956374,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU/5-fluorouracil</span>",D002277,"<span class=""disease"">carcinoma</span>","The modulating effect of recombinant human interferon alpha (IFN-alpha) on the antitumor efficacy of <span class=""chemical"">5-fluorouracil</span> (<span class=""chemical"">5-FU</span>) against human <span class=""disease"">carcinoma</span> cell lines was investigated in vitro and in vivo.",,8074466,8074466_D005472_D002277,8074466_1,bcv_sentence_task_befree_448,,770956375,FALSE,finalized,5,8/14/15 20:22,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D009369,"<span class=""disease"">colon tumor</span>","<span class=""chemical"">5-FU</span>, fluorouridine (FUR) or fluoro-5'-deoxyuridine (FUdR) were tested against cultured human <span class=""disease"">colon tumor</span> C-1 cells with or without IFN-alpha.",,8074466,8074466_D005472_D009369,8074466_2,bcv_sentence_task_befree_449,,770956376,FALSE,finalized,5,8/14/15 22:08,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D003108,"<span class=""disease"">colon carcinoma</span>","The in vivo antitumor activity of <span class=""chemical"">5-FU</span> with or without IFN-alpha was assessed using Co-4, a human <span class=""disease"">colon carcinoma</span> xenograft, in nude mice.",,8074466,8074466_D005472_D003108,8074466_4,bcv_sentence_task_befree_450,,770956377,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D015431,"<span class=""disease"">weight loss</span>","A synergistic effect of <span class=""chemical"">5-FU</span> and IFN-alpha was observed on Co-4 in nude mice, and this in vivo synergism was obtained without any increment of thymidylate synthetase inhibition or side effects in terms of death rate and body <span class=""disease"">weight loss</span>.",,8074466,8074466_D005472_D015431,8074466_6,bcv_sentence_task_befree_451,,770956378,FALSE,finalized,5,8/14/15 20:10,"



",no_relation,0.5891,,D005472,"<span class=""chemical"">5-FU</span>",D009369,"<span class=""disease"">tumor</span>","The intratumoral concentration of FUR was significantly increased by the addition of IFN-alpha in Co-4 <span class=""disease"">tumor</span> tissue treated with <span class=""chemical"">5-FU</span>.",,8074466,8074466_D005472_D009369,8074466_7,bcv_sentence_task_befree_452,,770956379,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D009369,"<span class=""disease"">target tumor</span>","These results suggest that the mechanism of the combined effect of <span class=""chemical"">5-FU</span> and IFN-alpha is not related to enhancement of thymidylate synthetase inhibition, but to an increase of FUR concentration in the <span class=""disease"">target tumor</span> tissue.",,8074466,8074466_D005472_D009369,8074466_8,bcv_sentence_task_befree_453,,770956380,FALSE,finalized,5,8/15/15 1:15,"



",yes_direct,0.4054,,D006861,"<span class=""chemical"">H2O2</span>",D005921,"<span class=""disease"">glomerulonephritis</span>","Brouwer et al. reported pauci-immune <span class=""disease"">glomerulonephritis</span> in rats immunized with human MPO followed by perfusion of kidneys with lysosomal enzyme extract combined with <span class=""chemical"">H2O2</span>, and suggested that this could serve as a model of ANCA-induced disease.",,8082301,8082301_D006861_D005921,8082301_3,bcv_sentence_task_befree_454,,770956381,FALSE,finalized,5,8/14/15 20:43,"



",yes_direct,0.6139,,D006861,"<span class=""chemical"">H2O2</span>",D004108,"<span class=""disease"">Pathological lesions</span>","<span class=""disease"">Pathological lesions</span> and deposits of IgG, C3, and MPO were found in immunized rats perfused with MPO + <span class=""chemical"">H2O2</span> with or without neutral protease, or MPO alone, in both rat strains and on both day 4 and day 10.",,8082301,8082301_D006861_D004108,8082301_8,bcv_sentence_task_befree_455,,770956382,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,C071192,"<span class=""chemical"">entacapone</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","Effect of <span class=""chemical"">entacapone</span>, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with <span class=""disease"">Parkinson's disease</span>.",,8112370,8112370_C071192_D010300,8112370_0,bcv_sentence_task_befree_456,,770956383,FALSE,finalized,5,8/14/15 20:29,"



",no_relation,1,,D007980,"<span class=""chemical"">levodopa</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of <span class=""chemical"">levodopa</span> and on cardiovascular responses in patients with <span class=""disease"">Parkinson's disease</span>.",,8112370,8112370_D007980_D010300,8112370_0,bcv_sentence_task_befree_457,,770956384,FALSE,finalized,5,8/14/15 20:17,"



",no_relation,1,,C034221,"<span class=""chemical"">catechol</span>",D020734,"<span class=""disease"">parkinsonian</span>","In an open, randomised, cross-over study we investigated the effect of a single 200 mg oral dose of entacapone, a novel <span class=""chemical"">catechol</span>-O-methyltransferase (COMT) inhibitor, on the pharmacokinetics and metabolism of levodopa/carbidopa, and on the cardiovascular responses (blood pressure and pulse rate variation to standard stimuli) in eight <span class=""disease"">parkinsonian</span> patients.",,8112370,8112370_C034221_D020734,8112370_1,bcv_sentence_task_befree_458,,770956385,FALSE,finalized,5,8/14/15 23:47,"



",no_relation,1,,D007980,"<span class=""chemical"">levodopa</span>",D020734,"<span class=""disease"">parkinsonian</span>","In an open, randomised, cross-over study we investigated the effect of a single 200 mg oral dose of entacapone, a novel catechol-O-methyltransferase (COMT) inhibitor, on the pharmacokinetics and metabolism of <span class=""chemical"">levodopa</span>/carbidopa, and on the cardiovascular responses (blood pressure and pulse rate variation to standard stimuli) in eight <span class=""disease"">parkinsonian</span> patients.",,8112370,8112370_D007980_D020734,8112370_1,bcv_sentence_task_befree_459,,770956386,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,D002230,"<span class=""chemical"">carbidopa</span>",D020734,"<span class=""disease"">parkinsonian</span>","In an open, randomised, cross-over study we investigated the effect of a single 200 mg oral dose of entacapone, a novel catechol-O-methyltransferase (COMT) inhibitor, on the pharmacokinetics and metabolism of levodopa/<span class=""chemical"">carbidopa</span>, and on the cardiovascular responses (blood pressure and pulse rate variation to standard stimuli) in eight <span class=""disease"">parkinsonian</span> patients.",,8112370,8112370_D002230_D020734,8112370_1,bcv_sentence_task_befree_460,,770956387,FALSE,finalized,5,8/15/15 0:06,"



",no_relation,1,,C071192,"<span class=""chemical"">entacapone</span>",D020734,"<span class=""disease"">parkinsonian</span>","In an open, randomised, cross-over study we investigated the effect of a single 200 mg oral dose of <span class=""chemical"">entacapone</span>, a novel catechol-O-methyltransferase (COMT) inhibitor, on the pharmacokinetics and metabolism of levodopa/carbidopa, and on the cardiovascular responses (blood pressure and pulse rate variation to standard stimuli) in eight <span class=""disease"">parkinsonian</span> patients.",,8112370,8112370_C071192_D020734,8112370_1,bcv_sentence_task_befree_461,,770956388,FALSE,finalized,5,8/15/15 0:10,"



",yes_direct,1,,D000431,"<span class=""chemical"">alcohol</span>",D006177,"<span class=""disease"">brain damage</span>","Because drinking patterns can include periods of <span class=""chemical"">alcohol</span> consumption followed by abstinence, binge drinking may enhance the possibility of <span class=""disease"">brain damage</span>.",,8123218,8123218_D000431_D006177,8123218_2,bcv_sentence_task_befree_462,,770956389,FALSE,finalized,5,8/15/15 0:02,"



",yes_direct,1,,D016202,"<span class=""chemical"">NMDA</span>",D006177,"<span class=""disease"">brain damage</span>","<span class=""chemical"">NMDA</span>-mediated mechanisms and glucocorticoid actions on the hippocampus are associated with <span class=""disease"">brain damage</span>.",,8123218,8123218_D016202_D006177,8123218_4,bcv_sentence_task_befree_463,,770956390,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,1,,D016202,"<span class=""chemical"">NMDA</span>",D000437,"<span class=""disease"">alcoholism</span>","Therapeutic adjuncts for treating ethanol withdrawal, including <span class=""chemical"">NMDA</span>, calcium, and glucocorticoid antagonists, may eventually prove useful in preventing further brain damage in <span class=""disease"">alcoholism</span>.",,8123218,8123218_D016202_D000437,8123218_6,bcv_sentence_task_befree_464,,770956391,FALSE,finalized,5,8/14/15 23:18,"



",no_relation,0.7844,,D000431,"<span class=""chemical"">ethanol</span>",D006177,"<span class=""disease"">brain damage</span>","Therapeutic adjuncts for treating <span class=""chemical"">ethanol</span> withdrawal, including NMDA, calcium, and glucocorticoid antagonists, may eventually prove useful in preventing further <span class=""disease"">brain damage</span> in alcoholism.",,8123218,8123218_D000431_D006177,8123218_6,bcv_sentence_task_befree_465,,770956392,FALSE,finalized,5,8/14/15 20:31,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",D000437,"<span class=""disease"">alcoholism</span>","Therapeutic adjuncts for treating <span class=""chemical"">ethanol</span> withdrawal, including NMDA, calcium, and glucocorticoid antagonists, may eventually prove useful in preventing further brain damage in <span class=""disease"">alcoholism</span>.",,8123218,8123218_D000431_D000437,8123218_6,bcv_sentence_task_befree_466,,770956393,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D006177,"<span class=""disease"">brain damage</span>","Therapeutic adjuncts for treating ethanol withdrawal, including NMDA, <span class=""chemical"">calcium</span>, and glucocorticoid antagonists, may eventually prove useful in preventing further <span class=""disease"">brain damage</span> in alcoholism.",,8123218,8123218_D002118_D006177,8123218_6,bcv_sentence_task_befree_467,,770956394,FALSE,finalized,5,8/14/15 23:33,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D000437,"<span class=""disease"">alcoholism</span>","Therapeutic adjuncts for treating ethanol withdrawal, including NMDA, <span class=""chemical"">calcium</span>, and glucocorticoid antagonists, may eventually prove useful in preventing further brain damage in <span class=""disease"">alcoholism</span>.",,8123218,8123218_D002118_D000437,8123218_6,bcv_sentence_task_befree_468,,770956395,FALSE,finalized,5,8/14/15 20:53,"



",no_relation,1,,D016202,"<span class=""chemical"">NMDA</span>",D006177,"<span class=""disease"">brain damage</span>","Therapeutic adjuncts for treating ethanol withdrawal, including <span class=""chemical"">NMDA</span>, calcium, and glucocorticoid antagonists, may eventually prove useful in preventing further <span class=""disease"">brain damage</span> in alcoholism.",,8123218,8123218_D016202_D006177,8123218_6,bcv_sentence_task_befree_469,,770956396,FALSE,finalized,5,8/14/15 20:55,"



",no_relation,1,,C022192,"<span class=""chemical"">alinidine</span>",D009203,"<span class=""disease"">AMI</span>","We investigated prospectively the arrhythmia incidence in 244 patients with <span class=""disease"">AMI</span> receiving alteplase and a double-blind randomized adjunctive therapy with intravenous atenolol, <span class=""chemical"">alinidine</span>, or placebo.",,8124790,8124790_C022192_D009203,8124790_2,bcv_sentence_task_befree_470,,770956397,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,D001262,"<span class=""chemical"">atenolol</span>",D009203,"<span class=""disease"">AMI</span>","We investigated prospectively the arrhythmia incidence in 244 patients with <span class=""disease"">AMI</span> receiving alteplase and a double-blind randomized adjunctive therapy with intravenous <span class=""chemical"">atenolol</span>, alinidine, or placebo.",,8124790,8124790_D001262_D009203,8124790_2,bcv_sentence_task_befree_471,,770956398,FALSE,finalized,5,8/14/15 23:38,"



",no_relation,0.6059,,C022192,"<span class=""chemical"">alinidine</span>",D001145,"<span class=""disease"">arrhythmia</span>","We investigated prospectively the <span class=""disease"">arrhythmia</span> incidence in 244 patients with AMI receiving alteplase and a double-blind randomized adjunctive therapy with intravenous atenolol, <span class=""chemical"">alinidine</span>, or placebo.",,8124790,8124790_C022192_D001145,8124790_2,bcv_sentence_task_befree_472,,770956399,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,0.803,,D001262,"<span class=""chemical"">atenolol</span>",D001145,"<span class=""disease"">arrhythmia</span>","We investigated prospectively the <span class=""disease"">arrhythmia</span> incidence in 244 patients with AMI receiving alteplase and a double-blind randomized adjunctive therapy with intravenous <span class=""chemical"">atenolol</span>, alinidine, or placebo.",,8124790,8124790_D001262_D001145,8124790_2,bcv_sentence_task_befree_473,,770956400,FALSE,finalized,5,8/14/15 20:30,"



",no_relation,1,,C022192,"<span class=""chemical"">alinidine</span>",D054537,"<span class=""disease"">atrioventricular block</span>","Atenolol and <span class=""chemical"">alinidine</span> significantly decreased the basic heart rate without causing more sinus arrest or higher-degree <span class=""disease"">atrioventricular block</span>.",,8124790,8124790_C022192_D054537,8124790_6,bcv_sentence_task_befree_474,,770956401,FALSE,finalized,5,8/15/15 1:24,"



",no_relation,1,,D001262,"<span class=""chemical"">Atenolol</span>",D054537,"<span class=""disease"">atrioventricular block</span>","<span class=""chemical"">Atenolol</span> and alinidine significantly decreased the basic heart rate without causing more sinus arrest or higher-degree <span class=""disease"">atrioventricular block</span>.",,8124790,8124790_D001262_D054537,8124790_6,bcv_sentence_task_befree_475,,770956402,FALSE,finalized,5,8/14/15 23:34,"



",no_relation,1,,D001262,"<span class=""chemical"">Atenolol</span>",D054138,"<span class=""disease"">sinus arrest</span>","<span class=""chemical"">Atenolol</span> and alinidine significantly decreased the basic heart rate without causing more <span class=""disease"">sinus arrest</span> or higher-degree atrioventricular block.",,8124790,8124790_D001262_D054138,8124790_6,bcv_sentence_task_befree_476,,770956403,FALSE,finalized,5,8/14/15 22:29,"



",no_relation,1,,C022192,"<span class=""chemical"">alinidine</span>",D054138,"<span class=""disease"">sinus arrest</span>","Atenolol and <span class=""chemical"">alinidine</span> significantly decreased the basic heart rate without causing more <span class=""disease"">sinus arrest</span> or higher-degree atrioventricular block.",,8124790,8124790_C022192_D054138,8124790_6,bcv_sentence_task_befree_477,,770956404,FALSE,finalized,5,8/14/15 20:22,"



",no_relation,0.6182,,D001262,"<span class=""chemical"">atenolol</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","The prevalence of <span class=""disease"">atrial fibrillation</span> in alinidine patients was lower than in the <span class=""chemical"">atenolol</span> patients (P = .007) but not lower than in placebo patients (P = .11).",,8124790,8124790_D001262_D001281,8124790_7,bcv_sentence_task_befree_478,,770956405,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,0.6027,,C022192,"<span class=""chemical"">alinidine</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","The prevalence of <span class=""disease"">atrial fibrillation</span> in <span class=""chemical"">alinidine</span> patients was lower than in the atenolol patients (P = .007) but not lower than in placebo patients (P = .11).",,8124790,8124790_C022192_D001281,8124790_7,bcv_sentence_task_befree_479,,770956406,FALSE,finalized,5,8/14/15 22:14,"



",no_relation,0.8217,,D013498,"<span class=""chemical"">Suramin</span>",D009369,"<span class=""disease"">metastatic cancer</span>","<span class=""chemical"">Suramin</span> and serum insulin-like growth factor levels in <span class=""disease"">metastatic cancer</span> patients.",,8135485,8135485_D013498_D009369,8135485_0,bcv_sentence_task_befree_480,,770956407,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,D013498,"<span class=""chemical"">Suramin</span>",D009369,"<span class=""disease"">tumors</span>","<span class=""chemical"">Suramin</span>, a polysulphonated naphthylurea, inhibits the activity of several growth factors in in vitro experiments and clinical responses have been reported in human solid <span class=""disease"">tumors</span>.",,8135485,8135485_D013498_D009369,8135485_1,bcv_sentence_task_befree_481,,770956408,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,1,,D013498,"<span class=""chemical"">suramin</span>",D008175,"<span class=""disease"">lung cancer</span>","We decided to investigate the relationship between <span class=""chemical"">suramin</span> treatment and serum levels of insulin-like growth factor I (IGF-I) and II (IGF-II) in advanced breast, prostate and <span class=""disease"">lung cancer</span> patients.",,8135485,8135485_D013498_D008175,8135485_2,bcv_sentence_task_befree_482,,770956409,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,1,,D013498,"<span class=""chemical"">suramin</span>",C564816,"<span class=""disease"">IGF</span>","We decided to investigate the relationship between <span class=""chemical"">suramin</span> treatment and serum levels of insulin-like growth factor I (<span class=""disease"">IGF</span>-I) and II (<span class=""disease"">IGF</span>-II) in advanced breast, prostate and lung cancer patients.",,8135485,8135485_D013498_C564816,8135485_2,bcv_sentence_task_befree_483,,770956410,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,1,,D013498,"<span class=""chemical"">suramin</span>",C564816,"<span class=""disease"">IGF</span>","A significant decline of <span class=""disease"">IGF</span>-I and <span class=""disease"">IGF</span>-II serum levels was demonstrated in <span class=""chemical"">suramin</span> treated patients.",,8135485,8135485_D013498_C564816,8135485_4,bcv_sentence_task_befree_484,,770956411,FALSE,finalized,5,8/14/15 23:19,"



",yes_direct,0.6052,,D013498,"<span class=""chemical"">suramin</span>",C564816,"<span class=""disease"">IGF</span>","Our results suggest that <span class=""chemical"">suramin</span>-induced <span class=""disease"">IGF</span> suppression could be one of the possible mechanisms of <span class=""chemical"">suramin</span> action.",,8135485,8135485_D013498_C564816,8135485_5,bcv_sentence_task_befree_485,,770956412,FALSE,finalized,5,8/14/15 20:29,"



",no_relation,0.6199,,D006513,"<span class=""chemical"">HBeAg</span>",D012075,"<span class=""disease"">Remission</span>","<span class=""disease"">Remission</span> occurred within 6 months of clearing the antigen (<span class=""chemical"">HBeAg</span>) in the majority of cases.",,8142208,8142208_D006513_D012075,8142208_7,bcv_sentence_task_befree_486,,770956413,FALSE,finalized,5,8/14/15 20:57,"



",no_relation,1,,D006513,"<span class=""chemical"">HBeAg</span>",D011507,"<span class=""disease"">proteinuria</span>","One had a reduction of <span class=""disease"">proteinuria</span> but remained <span class=""chemical"">HBeAg</span> positive.",,8142208,8142208_D006513_D011507,8142208_11,bcv_sentence_task_befree_487,,770956414,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,D014807,"<span class=""chemical"">vitamin D</span>",D051436,"<span class=""disease"">chronic renal diseases</span>","The influence of UV irradiation on <span class=""chemical"">vitamin D</span> metabolism in children with <span class=""disease"">chronic renal diseases</span>.",,8175280,8175280_D014807_D051436,8175280_0,bcv_sentence_task_befree_488,,770956415,FALSE,finalized,5,8/14/15 23:38,"



",yes_direct,0.6118,,D014807,"<span class=""chemical"">vitamin D</span>",D002114,"<span class=""disease"">calcinosis</span>","One can obtain the same results also by oral <span class=""chemical"">vitamin D</span> therapy, although we have to point out the danger of <span class=""disease"">calcinosis</span> and stone formation which the author could frequently demonstrate, but never after UV treatment.",,8175280,8175280_D014807_D002114,8175280_5,bcv_sentence_task_befree_489,,770956416,FALSE,finalized,5,8/14/15 23:47,"



",no_relation,1,,D010716,"<span class=""chemical"">phosphatidylinositol</span>",D009101,"<span class=""disease"">MM</span>","The <span class=""disease"">MM</span> cell lines contained significantly more hormone-stimulated <span class=""chemical"">phosphatidylinositol</span> 3-kinase (PI 3-kinase) activity than the B-lymphoblastoid cell lines.",,8205537,8205537_D010716_D009101,8205537_10,bcv_sentence_task_befree_490,,770956417,FALSE,finalized,5,8/15/15 0:42,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D009101,"<span class=""disease"">MM</span>","Hormone-responsive <span class=""chemical"">glucose</span> metabolism was also greater in the <span class=""disease"">MM</span> cell lines.",,8205537,8205537_D005947_D009101,8205537_12,bcv_sentence_task_befree_491,,770956418,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D013755,"<span class=""chemical"">phorbol myristate acetate/PMA</span>",D000163,"<span class=""disease"">AIDS/ARC/acquired immunodeficiency syndrome/AIDS-related complex</span>","Peripheral blood mononuclear cells from patients with the <span class=""disease"">acquired immunodeficiency syndrome</span> (<span class=""disease"">AIDS</span>), <span class=""disease"">AIDS-related complex</span> (<span class=""disease"">ARC</span>), and heterosexual controls were stimulated with anti-CD3 monoclonal antibody, <span class=""chemical"">phorbol myristate acetate</span> (<span class=""chemical"">PMA</span>), or both and 3H thymidine incorporation and IL-2 receptor (IL-2R alpha; CD25; Tac antigen) expression were measured.",,8209399,8209399_D013755_D000163,8209399_1,bcv_sentence_task_befree_492,,770956419,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D013755,"<span class=""chemical"">PMA</span>",D000163,"<span class=""disease"">AIDS/ARC</span>","A significantly reduced DNA synthesis and CD25 expression was observed in both <span class=""disease"">AIDS</span> and <span class=""disease"">ARC</span> upon stimulation with anti-CD3 or <span class=""chemical"">PMA</span>.",,8209399,8209399_D013755_D000163,8209399_3,bcv_sentence_task_befree_493,,770956420,FALSE,finalized,5,8/14/15 23:45,"


It's 'anti-CD3 plus PMA stimulation' and not just 'PMA'
",no_relation,1,,D013755,"<span class=""chemical"">PMA</span>",D000163,"<span class=""disease"">AIDS/ARC</span>","Although, a significant synergism was observed with anti-CD3 plus <span class=""chemical"">PMA</span> stimulation in both <span class=""disease"">AIDS</span> and <span class=""disease"">ARC</span>, and the responses were normalized to the levels of anti-CD3 or <span class=""chemical"">PMA</span> response in normal control, the levels were significantly lower than those observed with anti-CD3 plus <span class=""chemical"">PMA</span> in controls.",,8209399,8209399_D013755_D000163,8209399_4,bcv_sentence_task_befree_494,,770956421,FALSE,finalized,5,8/15/15 0:39,"



",no_relation,0.7975,,D005947,"<span class=""chemical"">glucose</span>",D003924,"<span class=""disease"">NIDDM</span>","The rationale for combining insulin and oral drug therapy derives from a better understanding of the pathophysiology of <span class=""disease"">NIDDM</span> and of the mechanisms of action of the oral drugs available: 1) type 2 diabetic patients are both insulin-deficient and insulin-resistant, thus requiring quite high doses of exogenous insulin; 2) peripheral insulin delivery leads to hyperinsulinaemia which could play a role in the pathogenesis of late diabetic complications; 3) sulphonylureas stimulate insulin release directly into the portal vein and could also potentiate peripheral insulin action; and 4) metformin (by improving <span class=""chemical"">glucose</span> metabolism and insulin sensitivity) and alpha-glucosidase inhibitors (by slowing down the digestion of complex carbohydrates and sucrose) are able to reduce the amounts of insulin needed to control postprandial hyperglycaemia.",,8212978,8212978_D005947_D003924,8212978_6,bcv_sentence_task_befree_495,,770956422,FALSE,finalized,5,8/14/15 20:16,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D003924,"<span class=""disease"">NIDDM</span>","The rationale for combining insulin and oral drug therapy derives from a better understanding of the pathophysiology of <span class=""disease"">NIDDM</span> and of the mechanisms of action of the oral drugs available: 1) type 2 diabetic patients are both insulin-deficient and insulin-resistant, thus requiring quite high doses of exogenous insulin; 2) peripheral insulin delivery leads to hyperinsulinaemia which could play a role in the pathogenesis of late diabetic complications; 3) sulphonylureas stimulate insulin release directly into the portal vein and could also potentiate peripheral insulin action; and 4) <span class=""chemical"">metformin</span> (by improving glucose metabolism and insulin sensitivity) and alpha-glucosidase inhibitors (by slowing down the digestion of complex carbohydrates and sucrose) are able to reduce the amounts of insulin needed to control postprandial hyperglycaemia.",,8212978,8212978_D008687_D003924,8212978_6,bcv_sentence_task_befree_496,,770956423,FALSE,finalized,5,8/14/15 20:28,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003929,"<span class=""disease"">diabetic</span>","The rationale for combining insulin and oral drug therapy derives from a better understanding of the pathophysiology of NIDDM and of the mechanisms of action of the oral drugs available: 1) type 2 <span class=""disease"">diabetic</span> patients are both insulin-deficient and insulin-resistant, thus requiring quite high doses of exogenous insulin; 2) peripheral insulin delivery leads to hyperinsulinaemia which could play a role in the pathogenesis of late <span class=""disease"">diabetic</span> complications; 3) sulphonylureas stimulate insulin release directly into the portal vein and could also potentiate peripheral insulin action; and 4) metformin (by improving <span class=""chemical"">glucose</span> metabolism and insulin sensitivity) and alpha-glucosidase inhibitors (by slowing down the digestion of complex carbohydrates and sucrose) are able to reduce the amounts of insulin needed to control postprandial hyperglycaemia.",,8212978,8212978_D005947_D003929,8212978_6,bcv_sentence_task_befree_497,,770956424,FALSE,finalized,5,8/14/15 23:48,"



",no_relation,0.788,,D002241,"<span class=""chemical"">carbohydrates</span>",D003929,"<span class=""disease"">diabetic</span>","The rationale for combining insulin and oral drug therapy derives from a better understanding of the pathophysiology of NIDDM and of the mechanisms of action of the oral drugs available: 1) type 2 <span class=""disease"">diabetic</span> patients are both insulin-deficient and insulin-resistant, thus requiring quite high doses of exogenous insulin; 2) peripheral insulin delivery leads to hyperinsulinaemia which could play a role in the pathogenesis of late <span class=""disease"">diabetic</span> complications; 3) sulphonylureas stimulate insulin release directly into the portal vein and could also potentiate peripheral insulin action; and 4) metformin (by improving glucose metabolism and insulin sensitivity) and alpha-glucosidase inhibitors (by slowing down the digestion of complex <span class=""chemical"">carbohydrates</span> and sucrose) are able to reduce the amounts of insulin needed to control postprandial hyperglycaemia.",,8212978,8212978_D002241_D003929,8212978_6,bcv_sentence_task_befree_498,,770956425,FALSE,finalized,5,8/14/15 20:10,"



",no_relation,1,,D013395,"<span class=""chemical"">sucrose</span>",D003929,"<span class=""disease"">diabetic</span>","The rationale for combining insulin and oral drug therapy derives from a better understanding of the pathophysiology of NIDDM and of the mechanisms of action of the oral drugs available: 1) type 2 <span class=""disease"">diabetic</span> patients are both insulin-deficient and insulin-resistant, thus requiring quite high doses of exogenous insulin; 2) peripheral insulin delivery leads to hyperinsulinaemia which could play a role in the pathogenesis of late <span class=""disease"">diabetic</span> complications; 3) sulphonylureas stimulate insulin release directly into the portal vein and could also potentiate peripheral insulin action; and 4) metformin (by improving glucose metabolism and insulin sensitivity) and alpha-glucosidase inhibitors (by slowing down the digestion of complex carbohydrates and <span class=""chemical"">sucrose</span>) are able to reduce the amounts of insulin needed to control postprandial hyperglycaemia.",,8212978,8212978_D013395_D003929,8212978_6,bcv_sentence_task_befree_499,,770956426,FALSE,finalized,5,8/15/15 2:39,"



",no_relation,1,,D013395,"<span class=""chemical"">sucrose</span>",D003924,"<span class=""disease"">NIDDM</span>","The rationale for combining insulin and oral drug therapy derives from a better understanding of the pathophysiology of <span class=""disease"">NIDDM</span> and of the mechanisms of action of the oral drugs available: 1) type 2 diabetic patients are both insulin-deficient and insulin-resistant, thus requiring quite high doses of exogenous insulin; 2) peripheral insulin delivery leads to hyperinsulinaemia which could play a role in the pathogenesis of late diabetic complications; 3) sulphonylureas stimulate insulin release directly into the portal vein and could also potentiate peripheral insulin action; and 4) metformin (by improving glucose metabolism and insulin sensitivity) and alpha-glucosidase inhibitors (by slowing down the digestion of complex carbohydrates and <span class=""chemical"">sucrose</span>) are able to reduce the amounts of insulin needed to control postprandial hyperglycaemia.",,8212978,8212978_D013395_D003924,8212978_6,bcv_sentence_task_befree_500,,770956427,FALSE,finalized,5,8/15/15 2:03,"



",no_relation,1,,D002241,"<span class=""chemical"">carbohydrates</span>",D003924,"<span class=""disease"">NIDDM</span>","The rationale for combining insulin and oral drug therapy derives from a better understanding of the pathophysiology of <span class=""disease"">NIDDM</span> and of the mechanisms of action of the oral drugs available: 1) type 2 diabetic patients are both insulin-deficient and insulin-resistant, thus requiring quite high doses of exogenous insulin; 2) peripheral insulin delivery leads to hyperinsulinaemia which could play a role in the pathogenesis of late diabetic complications; 3) sulphonylureas stimulate insulin release directly into the portal vein and could also potentiate peripheral insulin action; and 4) metformin (by improving glucose metabolism and insulin sensitivity) and alpha-glucosidase inhibitors (by slowing down the digestion of complex <span class=""chemical"">carbohydrates</span> and sucrose) are able to reduce the amounts of insulin needed to control postprandial hyperglycaemia.",,8212978,8212978_D002241_D003924,8212978_6,bcv_sentence_task_befree_501,,770956428,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D003929,"<span class=""disease"">diabetic</span>","The rationale for combining insulin and oral drug therapy derives from a better understanding of the pathophysiology of NIDDM and of the mechanisms of action of the oral drugs available: 1) type 2 <span class=""disease"">diabetic</span> patients are both insulin-deficient and insulin-resistant, thus requiring quite high doses of exogenous insulin; 2) peripheral insulin delivery leads to hyperinsulinaemia which could play a role in the pathogenesis of late <span class=""disease"">diabetic</span> complications; 3) sulphonylureas stimulate insulin release directly into the portal vein and could also potentiate peripheral insulin action; and 4) <span class=""chemical"">metformin</span> (by improving glucose metabolism and insulin sensitivity) and alpha-glucosidase inhibitors (by slowing down the digestion of complex carbohydrates and sucrose) are able to reduce the amounts of insulin needed to control postprandial hyperglycaemia.",,8212978,8212978_D008687_D003929,8212978_6,bcv_sentence_task_befree_502,,770956429,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003924,"<span class=""disease"">NIDDM</span>","Numerous studies have shown that a combination of insulin and sulphonylurea is more effective than insulin alone in the treatment of patients with <span class=""disease"">NIDDM</span> after secondary failure to oral drugs, leading to better <span class=""chemical"">glucose</span> profiles and/or decreased insulin needs.",,8212978,8212978_D005947_D003924,8212978_7,bcv_sentence_task_befree_503,,770956430,FALSE,finalized,5,8/15/15 1:26,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D009765,"<span class=""disease"">obesity</span>","Preliminary results suggested that insulin-<span class=""chemical"">metformin</span> (when <span class=""disease"">obesity</span> is present) or insulin-acarbose (when post-prandial hyperglycaemia occurs) combinations might offer some favourable features for the treatment of NIDDM patients although these therapeutical approaches still require adequate evaluation in further controlled studies.",,8212978,8212978_D008687_D009765,8212978_9,bcv_sentence_task_befree_504,,770956431,FALSE,finalized,5,8/14/15 23:16,"



",no_relation,1,,D020909,"<span class=""chemical"">acarbose</span>",D009765,"<span class=""disease"">obesity</span>","Preliminary results suggested that insulin-metformin (when <span class=""disease"">obesity</span> is present) or insulin-<span class=""chemical"">acarbose</span> (when post-prandial hyperglycaemia occurs) combinations might offer some favourable features for the treatment of NIDDM patients although these therapeutical approaches still require adequate evaluation in further controlled studies.",,8212978,8212978_D020909_D009765,8212978_9,bcv_sentence_task_befree_505,,770956432,FALSE,finalized,5,8/15/15 0:51,"



",no_relation,1,,D020909,"<span class=""chemical"">acarbose</span>",D003924,"<span class=""disease"">NIDDM</span>","Preliminary results suggested that insulin-metformin (when obesity is present) or insulin-<span class=""chemical"">acarbose</span> (when post-prandial hyperglycaemia occurs) combinations might offer some favourable features for the treatment of <span class=""disease"">NIDDM</span> patients although these therapeutical approaches still require adequate evaluation in further controlled studies.",,8212978,8212978_D020909_D003924,8212978_9,bcv_sentence_task_befree_506,,770956433,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D003924,"<span class=""disease"">NIDDM</span>","Preliminary results suggested that insulin-<span class=""chemical"">metformin</span> (when obesity is present) or insulin-acarbose (when post-prandial hyperglycaemia occurs) combinations might offer some favourable features for the treatment of <span class=""disease"">NIDDM</span> patients although these therapeutical approaches still require adequate evaluation in further controlled studies.",,8212978,8212978_D008687_D003924,8212978_9,bcv_sentence_task_befree_507,,770956434,FALSE,finalized,5,8/15/15 0:07,"



",no_relation,1,,D000212,"<span class=""chemical"">acyclovir</span>",D020804,"<span class=""disease"">varicella-zoster virus infections</span>","Previous studies in immunocompetent hosts and normal adults have demonstrated the value of intravenous <span class=""chemical"">acyclovir</span> in the treatment of <span class=""disease"">varicella-zoster virus infections</span>.",,8245900,8245900_D000212_D020804,8245900_2,bcv_sentence_task_befree_508,,770956435,FALSE,finalized,5,8/14/15 20:16,"



",no_relation,1,,D000212,"<span class=""chemical"">acyclovir</span>",D002644,"<span class=""disease"">varicella</span>","Oral <span class=""chemical"">acyclovir</span> has also shown efficacy in both normal adults with zoster (shingles) and immunocompetent children with <span class=""disease"">varicella</span>.",,8245900,8245900_D000212_D002644,8245900_3,bcv_sentence_task_befree_509,,770956436,FALSE,finalized,5,8/14/15 20:13,"



",no_relation,1,,D000212,"<span class=""chemical"">acyclovir</span>",D006562,"<span class=""disease"">shingles</span>","Oral <span class=""chemical"">acyclovir</span> has also shown efficacy in both normal adults with zoster (<span class=""disease"">shingles</span>) and immunocompetent children with varicella.",,8245900,8245900_D000212_D006562,8245900_3,bcv_sentence_task_befree_510,,770956437,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,1,,D000212,"<span class=""chemical"">acyclovir</span>",D002644,"<span class=""disease"">varicella</span>","A recently completed double-blind placebo-controlled study of oral <span class=""chemical"">acyclovir</span> in immunocompetent adults with uncomplicated <span class=""disease"">varicella</span> also demonstrated efficacy.",,8245900,8245900_D000212_D002644,8245900_4,bcv_sentence_task_befree_511,,770956438,FALSE,finalized,5,8/15/15 2:31,"



",no_relation,1,,D000212,"<span class=""chemical"">acyclovir</span>",D002644,"<span class=""disease"">varicella pneumonia/varicella</span>","Adults with complicated <span class=""disease"">varicella</span> (usually symptomatic <span class=""disease"">varicella pneumonia</span>) should receive intravenous <span class=""chemical"">acyclovir</span>.",,8245900,8245900_D000212_D002644,8245900_8,bcv_sentence_task_befree_512,,770956439,FALSE,finalized,5,8/15/15 1:27,"



",no_relation,1,,C031368,"<span class=""chemical"">brovavir</span>",D002644,"<span class=""disease"">varicella</span>","Several new agents for <span class=""disease"">varicella</span>-zoster therapy are being evaluated; <span class=""chemical"">brovavir</span> is a new agent currently being compared to placebo in the treatment of adult <span class=""disease"">varicella</span>.",,8245900,8245900_C031368_D002644,8245900_9,bcv_sentence_task_befree_513,,770956440,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,0.793,,D000082,"<span class=""chemical"">paracetamol</span>",D001172,"<span class=""disease"">rheumatoid arthritis</span>","Additive effect of combined naproxen and <span class=""chemical"">paracetamol</span> in <span class=""disease"">rheumatoid arthritis</span>.",,8252318,8252318_D000082_D001172,8252318_0,bcv_sentence_task_befree_514,,770956441,FALSE,finalized,5,8/14/15 23:19,"



",no_relation,0.626,,D009288,"<span class=""chemical"">naproxen</span>",D001172,"<span class=""disease"">rheumatoid arthritis</span>","Additive effect of combined <span class=""chemical"">naproxen</span> and paracetamol in <span class=""disease"">rheumatoid arthritis</span>.",,8252318,8252318_D009288_D001172,8252318_0,bcv_sentence_task_befree_515,,770956442,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,1,,D000082,"<span class=""chemical"">paracetamol/acetaminophen</span>",D001172,"<span class=""disease"">RA</span>","The clinical effect and plasma naproxen levels were studied in 20 patients with <span class=""disease"">RA</span> receiving three doses of naproxen and two naproxen doses combined with <span class=""chemical"">paracetamol</span> (<span class=""chemical"">acetaminophen</span>) in a randomized, double-blind, comparison in five 2-wk treatment periods.",,8252318,8252318_D000082_D001172,8252318_1,bcv_sentence_task_befree_516,,770956443,FALSE,finalized,5,8/15/15 0:35,"



",no_relation,1,,D009288,"<span class=""chemical"">naproxen</span>",D001172,"<span class=""disease"">RA</span>","The clinical effect and plasma <span class=""chemical"">naproxen</span> levels were studied in 20 patients with <span class=""disease"">RA</span> receiving three doses of <span class=""chemical"">naproxen</span> and two <span class=""chemical"">naproxen</span> doses combined with paracetamol (acetaminophen) in a randomized, double-blind, comparison in five 2-wk treatment periods.",,8252318,8252318_D009288_D001172,8252318_1,bcv_sentence_task_befree_517,,770956444,FALSE,finalized,5,8/15/15 1:02,"



",no_relation,0.818,,D000082,"<span class=""chemical"">paracetamol</span>",D001172,"<span class=""disease"">RA</span>","The results show that the clinical effect of naproxen in <span class=""disease"">RA</span> may be significantly increased by concomitant <span class=""chemical"">paracetamol</span> administration.",,8252318,8252318_D000082_D001172,8252318_6,bcv_sentence_task_befree_518,,770956445,FALSE,finalized,5,8/14/15 23:37,"



",no_relation,1,,D009288,"<span class=""chemical"">naproxen</span>",D001172,"<span class=""disease"">RA</span>","The results show that the clinical effect of <span class=""chemical"">naproxen</span> in <span class=""disease"">RA</span> may be significantly increased by concomitant paracetamol administration.",,8252318,8252318_D009288_D001172,8252318_6,bcv_sentence_task_befree_519,,770956446,FALSE,finalized,5,8/15/15 2:06,"



",no_relation,1,,D003401,"<span class=""chemical"">creatine</span>",D009203,"<span class=""disease"">acute myocardial infarction</span>","The latter complex, <span class=""chemical"">creatine</span> kinase and cardiac troponin T, were measured in peripheral venous blood samples serially drawn in 39 patients with <span class=""disease"">acute myocardial infarction</span>.",,8259712,8259712_D003401_D009203,8259712_2,bcv_sentence_task_befree_520,,770956447,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,D003401,"<span class=""chemical"">Creatine</span>",D009202,"<span class=""disease"">myocardial tissue injury</span>","<span class=""chemical"">Creatine</span> kinase activities and cardiac troponin T concentrations were used as markers of <span class=""disease"">myocardial tissue injury</span>.",,8259712,8259712_D003401_D009202,8259712_4,bcv_sentence_task_befree_521,,770956448,FALSE,finalized,5,8/15/15 0:59,"



",yes_direct,0.6029,,D009638,"<span class=""chemical"">norepinephrine</span>",D006323,"<span class=""disease"">asystole</span>","A 36-year-old male who experienced postexercise bradycardia and <span class=""disease"">asystole</span> had higher basal plasma <span class=""chemical"">norepinephrine</span> (120 versus 68 +/- 6 pg/ml) and epinephrine (18 versus less than 10 pg/ml) but a similar vagal tone (vagal tone index of 5.44 versus 5.81 +/- 1.00 U) when compared with 6 closely matched subjects who underwent an uneventful stress test.",,8261477,8261477_D009638_D006323,8261477_2,bcv_sentence_task_befree_522,,770956449,FALSE,finalized,5,8/14/15 20:23,"



",no_relation,0.7838,,D004837,"<span class=""chemical"">epinephrine</span>",D006323,"<span class=""disease"">asystole</span>","A 36-year-old male who experienced postexercise bradycardia and <span class=""disease"">asystole</span> had higher basal plasma norepinephrine (120 versus 68 +/- 6 pg/ml) and <span class=""chemical"">epinephrine</span> (18 versus less than 10 pg/ml) but a similar vagal tone (vagal tone index of 5.44 versus 5.81 +/- 1.00 U) when compared with 6 closely matched subjects who underwent an uneventful stress test.",,8261477,8261477_D004837_D006323,8261477_2,bcv_sentence_task_befree_523,,770956450,FALSE,finalized,5,8/14/15 21:55,"



",no_relation,0.4181,,D009638,"<span class=""chemical"">norepinephrine</span>",D001919,"<span class=""disease"">bradycardia</span>","A 36-year-old male who experienced postexercise <span class=""disease"">bradycardia</span> and asystole had higher basal plasma <span class=""chemical"">norepinephrine</span> (120 versus 68 +/- 6 pg/ml) and epinephrine (18 versus less than 10 pg/ml) but a similar vagal tone (vagal tone index of 5.44 versus 5.81 +/- 1.00 U) when compared with 6 closely matched subjects who underwent an uneventful stress test.",,8261477,8261477_D009638_D001919,8261477_2,bcv_sentence_task_befree_524,,770956451,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,0.5815,,D004837,"<span class=""chemical"">epinephrine</span>",D001919,"<span class=""disease"">bradycardia</span>","A 36-year-old male who experienced postexercise <span class=""disease"">bradycardia</span> and asystole had higher basal plasma norepinephrine (120 versus 68 +/- 6 pg/ml) and <span class=""chemical"">epinephrine</span> (18 versus less than 10 pg/ml) but a similar vagal tone (vagal tone index of 5.44 versus 5.81 +/- 1.00 U) when compared with 6 closely matched subjects who underwent an uneventful stress test.",,8261477,8261477_D004837_D001919,8261477_2,bcv_sentence_task_befree_525,,770956452,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,0.806,,D011092,"<span class=""chemical"">Polyethylene glycol</span>",D002292,"<span class=""disease"">renal cell carcinoma</span>","<span class=""chemical"">Polyethylene glycol</span> conjugated interleukin-2: clinical and immunologic effects in patients with advanced <span class=""disease"">renal cell carcinoma</span>.",,8262734,8262734_D011092_D002292,8262734_0,bcv_sentence_task_befree_526,,770956453,FALSE,finalized,5,8/15/15 1:31,"



",no_relation,1,,C028210,"<span class=""chemical"">monomethoxypolyethylene glycol</span>",D002292,"<span class=""disease"">renal cell carcinoma</span>","Recombinant interleukin-2 (rIL-2) modified with <span class=""chemical"">monomethoxypolyethylene glycol</span> (PEG IL-2) was utilized in patients with metastatic <span class=""disease"">renal cell carcinoma</span> in two separate multi-institutional trials.",,8262734,8262734_C028210_D002292,8262734_1,bcv_sentence_task_befree_527,,770956454,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,D000728,"<span class=""chemical"">Androgens</span>",D011471,"<span class=""disease"">prostate cancer</span>","<span class=""chemical"">Androgens</span> regulate proliferation of human <span class=""disease"">prostate cancer</span> cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor.",,8263129,8263129_D000728_D011471,8263129_0,bcv_sentence_task_befree_528,,770956455,FALSE,finalized,5,8/15/15 1:49,"



",yes_direct,0.8154,,D000728,"<span class=""chemical"">Androgens</span>",D011471,"<span class=""disease"">prostate cancers</span>","<span class=""chemical"">Androgens</span> affect growth of the prostate gland and many <span class=""disease"">prostate cancers</span>.",,8263129,8263129_D000728_D011471,8263129_1,bcv_sentence_task_befree_529,,770956456,FALSE,finalized,5,8/15/15 2:04,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D011471,"<span class=""disease"">prostate cancer</span>","We examined the effects of 5 alpha-dihydrotestosterone (DHT) and <span class=""chemical"">testosterone</span> (T), EGF, and EGF-alpha on cell proliferation and 3H-thymidine incorporation in an androgen-dependent human <span class=""disease"">prostate cancer</span> cell line, ALVA101, in serum-free medium.",,8263129,8263129_D013739_D011471,8263129_3,bcv_sentence_task_befree_530,,770956457,FALSE,finalized,5,8/14/15 20:42,"



",no_relation,0.7906,,D000728,"<span class=""chemical"">androgen</span>",D011471,"<span class=""disease"">prostate cancer</span>","We examined the effects of 5 alpha-dihydrotestosterone (DHT) and testosterone (T), EGF, and EGF-alpha on cell proliferation and 3H-thymidine incorporation in an <span class=""chemical"">androgen</span>-dependent human <span class=""disease"">prostate cancer</span> cell line, ALVA101, in serum-free medium.",,8263129,8263129_D000728_D011471,8263129_3,bcv_sentence_task_befree_531,,770956458,FALSE,finalized,5,8/14/15 20:53,"



",no_relation,1,,D013196,"<span class=""chemical"">5 alpha-dihydrotestosterone</span>",D011471,"<span class=""disease"">prostate cancer</span>","We examined the effects of <span class=""chemical"">5 alpha-dihydrotestosterone</span> (DHT) and testosterone (T), EGF, and EGF-alpha on cell proliferation and 3H-thymidine incorporation in an androgen-dependent human <span class=""disease"">prostate cancer</span> cell line, ALVA101, in serum-free medium.",,8263129,8263129_D013196_D011471,8263129_3,bcv_sentence_task_befree_532,,770956459,FALSE,finalized,5,8/15/15 1:58,"



",no_relation,1,,C055305,"<span class=""chemical"">ginsenoside Rh2</span>",D009369,"<span class=""disease"">ovarian cancer</span>","Inhibitory effects by oral administration of <span class=""chemical"">ginsenoside Rh2</span> on the growth of human <span class=""disease"">ovarian cancer</span> cells in nude mice.",,8270603,8270603_C055305_D009369,8270603_0,bcv_sentence_task_befree_533,,770956460,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin/cis-diamminedichloroplatinum(II)</span>",D009369,"<span class=""disease"">tumor</span>","After 7 days of <span class=""disease"">tumor</span> inoculation 2 mg/kg <span class=""chemical"">cis-diamminedichloroplatinum(II)</span> (<span class=""chemical"">cisplatin</span>) was administered intraperitoneally once a week for 5 weeks.",,8270603,8270603_D002945_D009369,8270603_5,bcv_sentence_task_befree_534,,770956461,FALSE,finalized,5,8/14/15 20:44,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",D009369,"<span class=""disease"">tumor</span>","Rh2 was dissolved in absolute <span class=""chemical"">ethanol</span>, adjusted with distilled water to 1, 15, and 120 microM, and 0.4 ml of each concentration was administered orally by canula every day for 90 days, from the next day of <span class=""disease"">tumor</span> inoculation.",,8270603,8270603_D000431_D009369,8270603_7,bcv_sentence_task_befree_535,,770956462,FALSE,finalized,5,8/15/15 0:30,"



",no_relation,0.8103,,D000431,"<span class=""chemical"">ethanol</span>",D009369,"<span class=""disease"">tumor</span>","On days 56 and 63 after <span class=""disease"">tumor</span> inoculation, the <span class=""disease"">tumor</span> volumes in all groups treated with Rh2 were significantly less than those in an <span class=""chemical"">ethanol</span>-treated control group and also in cisplatin treated group.",,8270603,8270603_D000431_D009369,8270603_9,bcv_sentence_task_befree_536,,770956463,FALSE,finalized,5,8/14/15 23:24,"



",no_relation,0.8103,,D002945,"<span class=""chemical"">cisplatin</span>",D009369,"<span class=""disease"">tumor</span>","On days 56 and 63 after <span class=""disease"">tumor</span> inoculation, the <span class=""disease"">tumor</span> volumes in all groups treated with Rh2 were significantly less than those in an ethanol-treated control group and also in <span class=""chemical"">cisplatin</span> treated group.",,8270603,8270603_D002945_D009369,8270603_9,bcv_sentence_task_befree_537,,770956464,FALSE,finalized,5,8/14/15 23:40,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D009369,"<span class=""disease"">tumor</span>","After 70 days, the <span class=""disease"">tumor</span> growth in nude mice treated with 15 microM and 120 microM Rh2 was significantly inhibited compared to that in a <span class=""chemical"">cisplatin</span> treated group as well as a control group.",,8270603,8270603_D002945_D009369,8270603_10,bcv_sentence_task_befree_538,,770956465,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,1,,D005473,"<span class=""chemical"">fluoxetine</span>",D009771,"<span class=""disease"">compulsive behavior disorder</span>","Diagnosis and <span class=""chemical"">fluoxetine</span> treatment of <span class=""disease"">compulsive behavior disorder</span> of adults with mental retardation.",,8292312,8292312_D005473_D009771,8292312_0,bcv_sentence_task_befree_539,,770956466,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,D005473,"<span class=""chemical"">fluoxetine</span>",D008607,"<span class=""disease"">mental retardation</span>","Diagnosis and <span class=""chemical"">fluoxetine</span> treatment of compulsive behavior disorder of adults with <span class=""disease"">mental retardation</span>.",,8292312,8292312_D005473_D008607,8292312_0,bcv_sentence_task_befree_540,,770956467,FALSE,finalized,5,8/15/15 2:47,"



",no_relation,1,,D005473,"<span class=""chemical"">fluoxetine</span>",D009771,"<span class=""disease"">compulsive behavior disorder</span>","The behavior disorders of 10 subjects who met criteria for <span class=""disease"">compulsive behavior disorder</span> and 6 subjects who did not (comparison subjects) were treated using the medication <span class=""chemical"">fluoxetine</span>.",,8292312,8292312_D005473_D009771,8292312_2,bcv_sentence_task_befree_541,,770956468,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D005473,"<span class=""chemical"">fluoxetine</span>",D009771,"<span class=""disease"">compulsive behavior disorder</span>","Seven of the 10 subjects with <span class=""disease"">compulsive behavior disorder</span> responded favorably to <span class=""chemical"">fluoxetine</span> treatment; none of the comparison subjects responded favorably to this medication.",,8292312,8292312_D005473_D009771,8292312_4,bcv_sentence_task_befree_542,,770956469,FALSE,finalized,5,8/15/15 0:42,"



",yes_direct,0.5798,,D005473,"<span class=""chemical"">fluoxetine</span>",D009771,"<span class=""disease"">compulsive behaviors</span>","Further, there appeared to be a relation between manifest motor stereotypies, <span class=""disease"">compulsive behaviors</span>, and response to <span class=""chemical"">fluoxetine</span>.",,8292312,8292312_D005473_D009771,8292312_5,bcv_sentence_task_befree_543,,770956470,FALSE,finalized,5,8/15/15 1:20,"



",no_relation,0.7865,,D003891,"<span class=""chemical"">desipramine</span>",D061218,"<span class=""disease"">desipramine-refractory depression</span>","Characteristics of <span class=""chemical""></span><span class=""disease"">desipramine</span>-refractory depression.",,8294386,8294386_D003891_D061218,8294386_0,bcv_sentence_task_befree_544,,770956471,FALSE,finalized,5,8/14/15 20:20,"



",no_relation,1,,D003891,"<span class=""chemical"">desipramine</span>",D003865,"<span class=""disease"">major depression</span>","To determine the predictors of <span class=""chemical"">desipramine</span>-refractory depression, the authors examined the outcome in patients with <span class=""disease"">major depression</span> who were admitted to a general hospital and treated with <span class=""chemical"">desipramine</span> adjusted to an adequate blood level.",,8294386,8294386_D003891_D003865,8294386_1,bcv_sentence_task_befree_545,,770956472,FALSE,finalized,5,8/14/15 20:13,"



",no_relation,0.5955,,D003891,"<span class=""chemical"">desipramine</span>",D061218,"<span class=""disease"">desipramine-refractory depression</span>","To determine the predictors of <span class=""chemical""></span><span class=""disease"">desipramine</span>-refractory depression, the authors examined the outcome in patients with major depression who were admitted to a general hospital and treated with <span class=""chemical"">desipramine</span> adjusted to an adequate blood level.",,8294386,8294386_D003891_D061218,8294386_1,bcv_sentence_task_befree_546,,770956473,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,D003891,"<span class=""chemical"">desipramine</span>",D003866,"<span class=""disease"">Depression</span>","Outcome was assessed with the Yale <span class=""disease"">Depression</span> Inventory after a 4-week <span class=""chemical"">desipramine</span> trial in which 24-hour plasma concentrations were used to rapidly achieve a therapeutic <span class=""chemical"">desipramine</span> level.",,8294386,8294386_D003891_D003866,8294386_3,bcv_sentence_task_befree_547,,770956474,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,0.6027,,D003891,"<span class=""chemical"">desipramine</span>",D003866,"<span class=""disease"">depressive episode/depression</span>","Poor response to a therapeutic <span class=""chemical"">desipramine</span> trial, which occurred in 15 of 50 patients, was significantly associated with definite personality disorder, prior treatment failure, near delusional status, age < or = 35 years, duration of <span class=""disease"">depressive episode</span>, recurrence of <span class=""disease"">depression</span>, dysthymia, and secondary <span class=""disease"">depression</span>.",,8294386,8294386_D003891_D003866,8294386_4,bcv_sentence_task_befree_548,,770956475,FALSE,finalized,5,8/15/15 0:19,"



",no_relation,0.62,,D003891,"<span class=""chemical"">desipramine</span>",D010554,"<span class=""disease"">personality disorder</span>","Poor response to a therapeutic <span class=""chemical"">desipramine</span> trial, which occurred in 15 of 50 patients, was significantly associated with definite <span class=""disease"">personality disorder</span>, prior treatment failure, near delusional status, age < or = 35 years, duration of depressive episode, recurrence of depression, dysthymia, and secondary depression.",,8294386,8294386_D003891_D010554,8294386_4,bcv_sentence_task_befree_549,,770956476,FALSE,finalized,5,8/15/15 0:51,"



",no_relation,1,,C071363,"<span class=""chemical"">RC-3095</span>",D009369,"<span class=""disease"">breast cancer</span>","Inhibitory effect of bombesin/gastrin-releasing peptide antagonist <span class=""chemical"">RC-3095</span> and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human <span class=""disease"">breast cancer</span> xenografts in athymic nude mice.",,8313327,8313327_C071363_D009369,8313327_0,bcv_sentence_task_befree_550,,770956477,FALSE,finalized,5,8/15/15 1:16,"



",yes_direct,0.5989,,C062876,"<span class=""chemical"">SB-75</span>",D009369,"<span class=""disease"">breast cancer</span>","Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist <span class=""chemical"">SB-75</span> on the growth of MCF-7 MIII human <span class=""disease"">breast cancer</span> xenografts in athymic nude mice.",,8313327,8313327_C062876_D009369,8313327_0,bcv_sentence_task_befree_551,,770956478,FALSE,finalized,5,8/15/15 1:44,"



",no_relation,0.8335,,D001839,"<span class=""chemical"">bombesin</span>",D009369,"<span class=""disease"">breast cancer</span>","Inhibitory effect of <span class=""chemical"">bombesin</span>/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human <span class=""disease"">breast cancer</span> xenografts in athymic nude mice.",,8313327,8313327_D001839_D009369,8313327_0,bcv_sentence_task_befree_552,,770956479,FALSE,finalized,5,8/14/15 22:17,"



",yes_direct,0.6062,,D004967,"<span class=""chemical"">estrogen</span>",D009369,"<span class=""disease"">breast cancers</span>","However, only about 30% of <span class=""disease"">breast cancers</span> are <span class=""chemical"">estrogen</span>-dependent and can be treated by hormonal manipulation.",,8313327,8313327_D004967_D009369,8313327_2,bcv_sentence_task_befree_553,,770956480,FALSE,finalized,5,8/14/15 23:08,"



",yes_direct,1,,D001839,"<span class=""chemical"">bombesin</span>",D009369,"<span class=""disease"">cancers</span>","Various studies suggest that <span class=""chemical"">bombesin</span> or gastrin-releasing peptide acts as an autocrine growth factor and may play a role in the initiation and progression of some <span class=""disease"">cancers</span>, including that of the breast.",,8313327,8313327_D001839_D009369,8313327_4,bcv_sentence_task_befree_554,,770956481,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,D001839,"<span class=""chemical"">bombesin</span>",D009369,"<span class=""disease"">breast cancer</span>","Female athymic nude mice bearing xenografts of the MCF-7 MIII human <span class=""disease"">breast cancer</span> cell line were treated for 7 weeks with <span class=""chemical"">bombesin</span>/gastrin-releasing peptide antagonist (D-Tpi6, Leu13 psi[CH2NH]-Leu14) bombesin(6-14) (RC-3095) injected subcutaneously daily at a dose of 20 micrograms and luteinizing hormone-releasing hormone antagonist SB-75 (Cetrorelix) administered biweekly in the form of microgranules releasing 45 micrograms/day.",,8313327,8313327_D001839_D009369,8313327_5,bcv_sentence_task_befree_555,,770956482,FALSE,finalized,5,8/14/15 23:21,"


'Inhibition' being the key term.
",no_relation,1,,C062876,"<span class=""chemical"">SB-75</span>",D009369,"<span class=""disease"">tumor</span>","After 2 weeks of treatment, a significant inhibition of <span class=""disease"">tumor</span> volume was observed in the groups treated with RC-3095 alone or in combination with <span class=""chemical"">SB-75</span> but not in those treated with <span class=""chemical"">SB-75</span> as a single agent.",,8313327,8313327_C062876_D009369,8313327_6,bcv_sentence_task_befree_556,,770956483,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,C024352,"<span class=""chemical"">Fludarabine</span>",D008258,"<span class=""disease"">macroglobulinemia</span>","<span class=""chemical"">Fludarabine</span> therapy in Waldenstrm's <span class=""disease"">macroglobulinemia</span>.",,8328496,8328496_C024352_D008258,8328496_0,bcv_sentence_task_befree_557,,770956484,FALSE,finalized,5,8/14/15 20:45,"



",no_relation,1,,C024352,"<span class=""chemical"">fludarabine</span>",D008258,"<span class=""disease"">macroglobulinemia</span>","To assess the response rate, remission duration, and survival of patients with Waldenstrm's <span class=""disease"">macroglobulinemia</span> treated with the adenine nucleoside analogue <span class=""chemical"">fludarabine</span>.",,8328496,8328496_C024352_D008258,8328496_1,bcv_sentence_task_befree_558,,770956485,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,C024352,"<span class=""chemical"">fludarabine</span>",D008258,"<span class=""disease"">macroglobulinemia</span>","Twenty-eight patients with Waldenstrm's <span class=""disease"">macroglobulinemia</span>, of whom only 2 were previously untreated, received <span class=""chemical"">fludarabine</span> at a dose of 20 to 30 mg/m2 intravenously daily for 5 days (20 patients) or 30 mg/m2 intravenously daily for 3 days (8 patients).",,8328496,8328496_C024352_D008258,8328496_2,bcv_sentence_task_befree_559,,770956486,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,1,,C024352,"<span class=""chemical"">Fludarabine</span>",D008258,"<span class=""disease"">macroglobulinemia</span>","<span class=""chemical"">Fludarabine</span> is an effective salvage agent for the treatment of patients with resistant Waldenstrm's <span class=""disease"">macroglobulinemia</span>.",,8328496,8328496_C024352_D008258,8328496_9,bcv_sentence_task_befree_560,,770956487,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,1,,D000617,"<span class=""chemical"">aminoglycoside</span>",D059413,"<span class=""disease"">intraabdominal infections</span>","Effect of peritoneal fluid pH on outcome of <span class=""chemical"">aminoglycoside</span> treatment of <span class=""disease"">intraabdominal infections</span>.",,8337887,8337887_D000617_D059413,8337887_0,bcv_sentence_task_befree_561,,770956488,FALSE,finalized,5,8/14/15 23:08,"



",no_relation,1,,D002981,"<span class=""chemical"">clindamycin</span>",D059413,"<span class=""disease"">intraabdominal infection</span>","Netilmicin and <span class=""chemical"">clindamycin</span> were administered to 47 patients with an <span class=""disease"">intraabdominal infection</span> who underwent emergency laparotomy.",,8337887,8337887_D002981_D059413,8337887_1,bcv_sentence_task_befree_562,,770956489,FALSE,finalized,5,8/15/15 0:33,"



",no_relation,1,,D009428,"<span class=""chemical"">Netilmicin</span>",D059413,"<span class=""disease"">intraabdominal infection</span>","<span class=""chemical"">Netilmicin</span> and clindamycin were administered to 47 patients with an <span class=""disease"">intraabdominal infection</span> who underwent emergency laparotomy.",,8337887,8337887_D009428_D059413,8337887_1,bcv_sentence_task_befree_563,,770956490,FALSE,finalized,5,8/14/15 21:00,"



",no_relation,1,,D000617,"<span class=""chemical"">aminoglycoside</span>",D004927,"<span class=""disease"">Escherichia</span>","Reduction of pH antagonized <span class=""chemical"">aminoglycoside</span> activity in vitro against clinical isolates of <span class=""disease"">Escherichia</span> coli.",,8337887,8337887_D000617_D004927,8337887_8,bcv_sentence_task_befree_564,,770956491,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroid</span>",D000402,"<span class=""disease"">obstructive airways disease</span>","Although most patients with <span class=""disease"">obstructive airways disease</span> show some amelioration with long-term inhaled <span class=""chemical"">corticosteroid</span> therapy, the extent of improvement may vary considerably between patients.",,8339808,8339808_D000305_D000402,8339808_2,bcv_sentence_task_befree_565,,770956492,FALSE,finalized,5,8/14/15 20:16,"



",no_relation,1,,D020682,"<span class=""chemical"">cefixime</span>",D006069,"<span class=""disease"">gonorrhea</span>","Single-dose oral treatment with <span class=""chemical"">cefixime</span> (Suprax) or a quinolone appears to be effective, safe, and practical for patients with uncomplicated <span class=""disease"">gonorrhea</span>.",,8341619,8341619_D020682_D006069,8341619_6,bcv_sentence_task_befree_566,,770956493,FALSE,finalized,5,8/14/15 20:25,"



",no_relation,1,,D002443,"<span class=""chemical"">Rocephin/ceftriaxone sodium</span>",D007239,"<span class=""disease"">infections</span>","Because disseminated <span class=""disease"">infections</span> can be fatal, hospitalization and treatment with intravenous antibiotics such as <span class=""chemical"">ceftriaxone sodium</span> (<span class=""chemical"">Rocephin</span>) or cefotaxime sodium (Claforan) are required.",,8341619,8341619_D002443_D007239,8341619_8,bcv_sentence_task_befree_567,,770956494,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,D002439,"<span class=""chemical"">cefotaxime sodium</span>",D007239,"<span class=""disease"">infections</span>","Because disseminated <span class=""disease"">infections</span> can be fatal, hospitalization and treatment with intravenous antibiotics such as ceftriaxone sodium (Rocephin) or <span class=""chemical"">cefotaxime sodium</span> (Claforan) are required.",,8341619,8341619_D002439_D007239,8341619_8,bcv_sentence_task_befree_568,,770956495,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,0.8017,,D004298,"<span class=""chemical"">dopamine</span>",D012559,"<span class=""disease"">schizophrenic</span>","Homovanillic acid (HVA), an oxidative metabolite of <span class=""chemical"">dopamine</span>, has been shown in a number of studies to reflect severity of symptoms and to predict response to neuroleptic treatment in <span class=""disease"">schizophrenic</span> patients.",,8341767,8341767_D004298_D012559,8341767_1,bcv_sentence_task_befree_569,,770956496,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,D006719,"<span class=""chemical"">HVA/Homovanillic acid</span>",D012559,"<span class=""disease"">schizophrenic</span>","<span class=""chemical"">Homovanillic acid</span> (<span class=""chemical"">HVA</span>), an oxidative metabolite of dopamine, has been shown in a number of studies to reflect severity of symptoms and to predict response to neuroleptic treatment in <span class=""disease"">schizophrenic</span> patients.",,8341767,8341767_D006719_D012559,8341767_1,bcv_sentence_task_befree_570,,770956497,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,1,,D004298,"<span class=""chemical"">dopamine</span>",D009207,"<span class=""disease"">drug action</span>","However, administration of <span class=""chemical"">dopamine</span> postsynaptic antagonists should be expected to increase synaptic <span class=""chemical"">dopamine</span> availability, thereby increasing HVA concentrations, according to traditional models of <span class=""disease"">drug action</span>.",,8341767,8341767_D004298_D009207,8341767_4,bcv_sentence_task_befree_571,,770956498,FALSE,finalized,5,8/14/15 20:23,"



",no_relation,1,,D006719,"<span class=""chemical"">HVA</span>",D009207,"<span class=""disease"">drug action</span>","However, administration of dopamine postsynaptic antagonists should be expected to increase synaptic dopamine availability, thereby increasing <span class=""chemical"">HVA</span> concentrations, according to traditional models of <span class=""disease"">drug action</span>.",,8341767,8341767_D006719_D009207,8341767_4,bcv_sentence_task_befree_572,,770956499,FALSE,finalized,5,8/14/15 20:29,"



",yes_direct,1,,D002104,"<span class=""chemical"">cadmium</span>",D042882,"<span class=""disease"">renal stones</span>","Incidence of <span class=""disease"">renal stones</span> among <span class=""chemical"">cadmium</span> exposed battery workers.",,8343420,8343420_D002104_D042882,8343420_0,bcv_sentence_task_befree_573,,770956500,FALSE,finalized,5,8/14/15 23:34,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",D011507,"<span class=""disease"">proteinuria</span>","The IRRs were 1.0, 1.6 [95% confidence interval (95% CI) 0.7-3.4], and 3.0 (95% CI 1.3-6.8) respectively. beta 2 Microglobulin measurements were available for 33 workers who formed stones; 13 of these workers had tubular <span class=""disease"">proteinuria</span> (beta 2 microglobulin > or = 34 micrograms/mmole <span class=""chemical"">creatinine</span>)--that is, a prevalence of 39%.",,8343420,8343420_D003404_D011507,8343420_8,bcv_sentence_task_befree_574,,770956501,FALSE,finalized,5,8/14/15 20:43,"



",no_relation,0.7936,,D013004,"<span class=""chemical"">somatostatin</span>",D007027,"<span class=""disease"">hypothalamic</span>","To clarify the pathogenesis underlying these alterations, in six obese patients (3 males and 3 females, age 20-44 yrs, BMI = 42.1 +/- 2.2) on unrestricted diet we studied the effect of 8 day GHRH pretreatment (1 micrograms/kg iv each day) on the acute somatotropic response to the neurohormone administered both alone and combined with arginine (ARG, 0.5 g/kg iv infused from 0 to 30 min) which likely inhibits the release of <span class=""disease"">hypothalamic</span> <span class=""chemical"">somatostatin</span>.",,8344645,8344645_D013004_D007027,8344645_3,bcv_sentence_task_befree_575,,770956502,FALSE,finalized,5,8/14/15 20:45,"



",no_relation,0.7956,,D013004,"<span class=""chemical"">somatostatin</span>",D009765,"<span class=""disease"">obese</span>","To clarify the pathogenesis underlying these alterations, in six <span class=""disease"">obese</span> patients (3 males and 3 females, age 20-44 yrs, BMI = 42.1 +/- 2.2) on unrestricted diet we studied the effect of 8 day GHRH pretreatment (1 micrograms/kg iv each day) on the acute somatotropic response to the neurohormone administered both alone and combined with arginine (ARG, 0.5 g/kg iv infused from 0 to 30 min) which likely inhibits the release of hypothalamic <span class=""chemical"">somatostatin</span>.",,8344645,8344645_D013004_D009765,8344645_3,bcv_sentence_task_befree_576,,770956503,FALSE,finalized,5,8/15/15 2:06,"



",no_relation,0.6272,,D000728,"<span class=""chemical"">androgens</span>",D011471,"<span class=""disease"">prostatic cancer</span>","Although all <span class=""chemical"">androgens</span> have an effect on prostatic cells, it is believed that dihydrotestosterone (DHT) is the active metabolite primarily utilized by <span class=""disease"">prostatic cancer</span> cells for growth and division.",,8358057,8358057_D000728_D011471,8358057_2,bcv_sentence_task_befree_577,,770956504,FALSE,finalized,5,8/14/15 20:57,"



",yes_direct,1,,D013196,"<span class=""chemical"">dihydrotestosterone/DHT</span>",D011471,"<span class=""disease"">prostatic cancer</span>","Although all androgens have an effect on prostatic cells, it is believed that <span class=""chemical"">dihydrotestosterone</span> (<span class=""chemical"">DHT</span>) is the active metabolite primarily utilized by <span class=""disease"">prostatic cancer</span> cells for growth and division.",,8358057,8358057_D013196_D011471,8358057_2,bcv_sentence_task_befree_578,,770956505,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,0.803,,D013196,"<span class=""chemical"">DHT</span>",D011471,"<span class=""disease"">prostatic cancer</span>","Hormonal therapies are therefore designed to lower tissue levels of <span class=""chemical"">DHT</span> or prevent its binding to receptors on <span class=""disease"">prostatic cancer</span> cells.",,8358057,8358057_D013196_D011471,8358057_3,bcv_sentence_task_befree_579,,770956506,FALSE,finalized,5,8/14/15 20:28,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D006521,"<span class=""disease"">chronic viral hepatitis</span>","The effect of long-term treatment with recombinant interferon-alpha 2b (IFN-alpha 2b) on luteinizing hormone (LH), <span class=""chemical"">testosterone</span>, free <span class=""chemical"">testosterone</span>, and sex hormone-binding globulin (SHBG) was evaluated in 7 male patients suffering from <span class=""disease"">chronic viral hepatitis</span>.",,8366286,8366286_D013739_D006521,8366286_1,bcv_sentence_task_befree_580,,770956507,FALSE,finalized,5,8/14/15 22:12,"



",no_relation,1,,D005047,"<span class=""chemical"">etoposide</span>",D064420,"<span class=""disease"">toxicity</span>","Although the optimal chemotherapy regimen for combined-modality treatment has not yet been established, use of cisplatin and <span class=""chemical"">etoposide</span> combinations, which do not promote pulmonary, cardiac, or esophageal <span class=""disease"">toxicity</span>, have been particularly appropriate in patients with small-cell lung cancer.",,8380135,8380135_D005047_D064420,8380135_7,bcv_sentence_task_befree_581,,770956508,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D008175,"<span class=""disease"">lung cancer</span>","Although the optimal chemotherapy regimen for combined-modality treatment has not yet been established, use of <span class=""chemical"">cisplatin</span> and etoposide combinations, which do not promote pulmonary, cardiac, or esophageal toxicity, have been particularly appropriate in patients with small-cell <span class=""disease"">lung cancer</span>.",,8380135,8380135_D002945_D008175,8380135_7,bcv_sentence_task_befree_582,,770956509,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,D005047,"<span class=""chemical"">etoposide</span>",D008175,"<span class=""disease"">lung cancer</span>","Although the optimal chemotherapy regimen for combined-modality treatment has not yet been established, use of cisplatin and <span class=""chemical"">etoposide</span> combinations, which do not promote pulmonary, cardiac, or esophageal toxicity, have been particularly appropriate in patients with small-cell <span class=""disease"">lung cancer</span>.",,8380135,8380135_D005047_D008175,8380135_7,bcv_sentence_task_befree_583,,770956510,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D064420,"<span class=""disease"">toxicity</span>","Although the optimal chemotherapy regimen for combined-modality treatment has not yet been established, use of <span class=""chemical"">cisplatin</span> and etoposide combinations, which do not promote pulmonary, cardiac, or esophageal <span class=""disease"">toxicity</span>, have been particularly appropriate in patients with small-cell lung cancer.",,8380135,8380135_D002945_D064420,8380135_7,bcv_sentence_task_befree_584,,770956511,FALSE,finalized,5,8/15/15 1:51,"



",no_relation,1,,D017963,"<span class=""chemical"">azithromycin</span>",D002690,"<span class=""disease"">Chlamydia trachomatis infected</span>","In-vitro activity of <span class=""chemical"">azithromycin</span> on <span class=""disease"">Chlamydia trachomatis infected</span>, polarized human endometrial epithelial cells.",,8383102,8383102_D017963_D002690,8383102_0,bcv_sentence_task_befree_585,,770956512,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D017963,"<span class=""chemical"">azithromycin</span>",D002690,"<span class=""disease"">Chlamydia trachomatis infected</span>","The in-vitro activity of <span class=""chemical"">azithromycin</span> on <span class=""disease"">Chlamydia trachomatis infected</span> human endometrial epithelial cells, both primary and transformed cells growing in a polarized and non-polarized orientation, was analyzed.",,8383102,8383102_D017963_D002690,8383102_1,bcv_sentence_task_befree_586,,770956513,FALSE,finalized,5,8/14/15 23:53,"



",no_relation,1,,C059499,"<span class=""chemical"">9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine</span>",D015658,"<span class=""disease"">human immunodeficiency virus (HIV) replication</span>","<span class=""chemical"">9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine</span> (PMEDAP), a potent inhibitor of <span class=""disease"">human immunodeficiency virus (HIV) replication</span>, was evaluated for its activity against human cytomegalovirus (HCMV) in vitro, and murine cytomegalovirus (MCMV) and rat CMV (RCMV) in vivo.",,8395382,8395382_C059499_D015658,8395382_1,bcv_sentence_task_befree_587,,770956514,FALSE,finalized,5,8/14/15 21:23,"



",no_relation,0.5766,,D006495,"<span class=""chemical"">LMWH</span>",D013927,"<span class=""disease"">thrombosis</span>","There were 21 cases of <span class=""disease"">thrombosis</span> in the group without prophylaxis (16.5%) and only six cases of <span class=""disease"">thrombosis</span> (4.8%) with <span class=""chemical"">LMWH</span>.",,8395716,8395716_D006495_D013927,8395716_6,bcv_sentence_task_befree_588,,770956515,FALSE,finalized,5,8/14/15 23:24,"



",no_relation,0.8067,,D004967,"<span class=""chemical"">Oestrogen</span>",D016889,"<span class=""disease"">endometrial cancer</span>","<span class=""chemical"">Oestrogen</span> replacement treatment and the risk of <span class=""disease"">endometrial cancer</span>: an assessment of the role of covariates.",,8398274,8398274_D004967_D016889,8398274_0,bcv_sentence_task_befree_589,,770956516,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,0.8187,,D004967,"<span class=""chemical"">oestrogen</span>",D016889,"<span class=""disease"">endometrial cancer</span>","The relationship between <span class=""chemical"">oestrogen</span> replacement treatment and the risk of <span class=""disease"">endometrial cancer</span> was analysed in a case-control study of 158 histologically confirmed incident cases below the age of 75 and 468 controls in hospital for acute, non-neoplastic, non-hormone-related conditions conducted in the Swiss Canton of Vaud in 1988-1992.",,8398274,8398274_D004967_D016889,8398274_1,bcv_sentence_task_befree_590,,770956517,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,0.5934,,D004967,"<span class=""chemical"">oestrogen</span>",D016889,"<span class=""disease"">endometrial cancer</span>","Thus, this study confirms the presence of a strong association between <span class=""chemical"">oestrogen</span> replacement treatment and <span class=""disease"">endometrial cancer</span> risk, since in the late 1980s or early 1990s about 25% of cases could be attributed to <span class=""chemical"">oestrogen</span> replacement treatment in this Swiss population.",,8398274,8398274_D004967_D016889,8398274_8,bcv_sentence_task_befree_591,,770956518,FALSE,finalized,5,8/14/15 20:31,"



",yes_direct,0.5923,,D004967,"<span class=""chemical"">oestrogen</span>",D009765,"<span class=""disease"">obesity</span>","Further, it confirms the presence of significant negative interactions of <span class=""chemical"">oestrogen</span> use with <span class=""disease"">obesity</span>, and, possibly, with OC as well.",,8398274,8398274_D004967_D009765,8398274_9,bcv_sentence_task_befree_592,,770956519,FALSE,finalized,5,8/14/15 20:49,"



",no_relation,0.825,,D017835,"<span class=""chemical"">Nedocromil sodium</span>",D001986,"<span class=""disease"">bronchospasm</span>","<span class=""chemical"">Nedocromil sodium</span> in the prevention of exercise-induced <span class=""disease"">bronchospasm</span> in athletes with asthma.",,8412049,8412049_D017835_D001986,8412049_0,bcv_sentence_task_befree_593,,770956520,FALSE,finalized,5,8/15/15 2:14,"



",no_relation,1,,D017835,"<span class=""chemical"">Nedocromil sodium</span>",D001249,"<span class=""disease"">asthma</span>","<span class=""chemical"">Nedocromil sodium</span> in the prevention of exercise-induced bronchospasm in athletes with <span class=""disease"">asthma</span>.",,8412049,8412049_D017835_D001249,8412049_0,bcv_sentence_task_befree_594,,770956521,FALSE,finalized,5,8/14/15 20:48,"



",no_relation,0.8173,,D012964,"<span class=""chemical"">sodium</span>",D001986,"<span class=""disease"">bronchospasm</span>","The aim of this study was to determine the efficacy of nedocromil <span class=""chemical"">sodium</span> in the prevention of exercise-induced <span class=""disease"">bronchospasm</span> (EIB) in 13 top athletes affected by bronchial asthma.",,8412049,8412049_D012964_D001986,8412049_1,bcv_sentence_task_befree_595,,770956522,FALSE,finalized,5,8/14/15 23:57,"

It's 'nedocromil sodium' and not just 'Na'

",no_relation,1,,D012964,"<span class=""chemical"">sodium</span>",D001249,"<span class=""disease"">bronchial asthma</span>","The aim of this study was to determine the efficacy of nedocromil <span class=""chemical"">sodium</span> in the prevention of exercise-induced bronchospasm (EIB) in 13 top athletes affected by <span class=""disease"">bronchial asthma</span>.",,8412049,8412049_D012964_D001249,8412049_1,bcv_sentence_task_befree_596,,770956523,FALSE,finalized,5,8/15/15 0:46,"



",no_relation,0.8081,,D012964,"<span class=""chemical"">sodium</span>",D016535,"<span class=""disease"">bronchial hyperreactivity</span>","In conclusion, the effect of nedocromil <span class=""chemical"">sodium</span> in the prevention of EIB may be dose-dependent in relation to the degree of <span class=""disease"">bronchial hyperreactivity</span> or to interference of other factors.",,8412049,8412049_D012964_D016535,8412049_5,bcv_sentence_task_befree_597,,770956524,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,0.8065,,D013420,"<span class=""chemical"">sulfamethoxazole</span>",D014890,"<span class=""disease"">Wegener's granulomatosis</span>","Long-term <span class=""chemical"">sulfamethoxazole</span>-trimethoprim in <span class=""disease"">Wegener's granulomatosis</span>.",,8417733,8417733_D013420_D014890,8417733_0,bcv_sentence_task_befree_598,,770956525,FALSE,finalized,5,8/14/15 20:27,"



",no_relation,0.8123,,D014295,"<span class=""chemical"">trimethoprim</span>",D014890,"<span class=""disease"">Wegener's granulomatosis</span>","Long-term sulfamethoxazole-<span class=""chemical"">trimethoprim</span> in <span class=""disease"">Wegener's granulomatosis</span>.",,8417733,8417733_D014295_D014890,8417733_0,bcv_sentence_task_befree_599,,770956526,FALSE,finalized,5,8/14/15 20:56,"



",no_relation,1,,D013420,"<span class=""chemical"">sulfamethoxazole</span>",D014890,"<span class=""disease"">Wegener's granulomatosis</span>","Since 1985, a number of reports have highlighted the effectiveness of a short course of <span class=""chemical"">sulfamethoxazole</span>-trimethoprim as an adjuvant to immunosuppressive drugs in the treatment of <span class=""disease"">Wegener's granulomatosis</span>.",,8417733,8417733_D013420_D014890,8417733_1,bcv_sentence_task_befree_600,,770956527,FALSE,finalized,5,8/14/15 23:27,"



",no_relation,1,,D014295,"<span class=""chemical"">trimethoprim</span>",D014890,"<span class=""disease"">Wegener's granulomatosis</span>","Since 1985, a number of reports have highlighted the effectiveness of a short course of sulfamethoxazole-<span class=""chemical"">trimethoprim</span> as an adjuvant to immunosuppressive drugs in the treatment of <span class=""disease"">Wegener's granulomatosis</span>.",,8417733,8417733_D014295_D014890,8417733_1,bcv_sentence_task_befree_601,,770956528,FALSE,finalized,5,8/14/15 20:48,"



",no_relation,1,,D013420,"<span class=""chemical"">sulfamethoxazole</span>",D014890,"<span class=""disease"">Wegener's granulomatosis</span>","We report our experience with long-term <span class=""chemical"">sulfamethoxazole</span>-trimethoprim therapy in patients with <span class=""disease"">Wegener's granulomatosis</span>.",,8417733,8417733_D013420_D014890,8417733_2,bcv_sentence_task_befree_602,,770956529,FALSE,finalized,5,8/14/15 21:51,"



",no_relation,1,,D014295,"<span class=""chemical"">trimethoprim</span>",D014890,"<span class=""disease"">Wegener's granulomatosis</span>","We report our experience with long-term sulfamethoxazole-<span class=""chemical"">trimethoprim</span> therapy in patients with <span class=""disease"">Wegener's granulomatosis</span>.",,8417733,8417733_D014295_D014890,8417733_2,bcv_sentence_task_befree_603,,770956530,FALSE,finalized,5,8/15/15 2:24,"



",no_relation,1,,D013420,"<span class=""chemical"">sulfamethoxazole</span>",D014890,"<span class=""disease"">Wegener's granulomatosis</span>","We describe recent advances in the pathogenesis of <span class=""disease"">Wegener's granulomatosis</span>, suggest a complementary mechanism of action of <span class=""chemical"">sulfamethoxazole</span>-trimethoprim, and advocate long-term <span class=""chemical"">sulfamethoxazole</span>-trimethoprim therapy as a treatment option in <span class=""disease"">Wegener's granulomatosis</span>.",,8417733,8417733_D013420_D014890,8417733_3,bcv_sentence_task_befree_604,,770956531,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D014295,"<span class=""chemical"">trimethoprim</span>",D014890,"<span class=""disease"">Wegener's granulomatosis</span>","We describe recent advances in the pathogenesis of <span class=""disease"">Wegener's granulomatosis</span>, suggest a complementary mechanism of action of sulfamethoxazole-<span class=""chemical"">trimethoprim</span>, and advocate long-term sulfamethoxazole-<span class=""chemical"">trimethoprim</span> therapy as a treatment option in <span class=""disease"">Wegener's granulomatosis</span>.",,8417733,8417733_D014295_D014890,8417733_3,bcv_sentence_task_befree_605,,770956532,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,1,,D002511,"<span class=""chemical"">cephalosporin</span>",D008581,"<span class=""disease"">meningitis</span>","Dilemmas in diagnosis and management of <span class=""chemical"">cephalosporin</span>-resistant Streptococcus pneumoniae <span class=""disease"">meningitis</span>.",,8451095,8451095_D002511_D008581,8451095_0,bcv_sentence_task_befree_606,,770956533,FALSE,finalized,5,8/14/15 21:45,"



",no_relation,1,,D002443,"<span class=""chemical"">ceftriaxone</span>",D008581,"<span class=""disease"">meningitis</span>","We recently managed an infant with <span class=""disease"">meningitis</span> caused by Streptococcus pneumoniae in whom <span class=""chemical"">ceftriaxone</span> failed to sterilize the cerebrospinal fluid after 6 days of therapy.",,8451095,8451095_D002443_D008581,8451095_1,bcv_sentence_task_befree_607,,770956534,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,0.8063,,D002443,"<span class=""chemical"">ceftriaxone</span>",D008581,"<span class=""disease"">meningitis</span>","Furthermore <span class=""chemical"">ceftriaxone</span> therapy of <span class=""disease"">meningitis</span> induced with this strain in a rabbit model was ineffective.",,8451095,8451095_D002443_D008581,8451095_3,bcv_sentence_task_befree_608,,770956535,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,D002511,"<span class=""chemical"">cephalosporin/cephalosporins</span>",D008581,"<span class=""disease"">meningitis</span>","The definition of <span class=""chemical"">cephalosporin</span> resistance for pneumococci requires modification and further studies of the antibiotic management of <span class=""disease"">meningitis</span> caused by such strains are needed because resistance to <span class=""chemical"">cephalosporins</span> is increasing and the extended spectrum <span class=""chemical"">cephalosporins</span> may be ineffective as sole therapy.",,8451095,8451095_D002511_D008581,8451095_6,bcv_sentence_task_befree_609,,770956536,FALSE,finalized,5,8/15/15 0:15,"



",yes_direct,0.6051,,C011272,"<span class=""chemical"">4-hydroperoxycyclophosphamide</span>",D002869,"<span class=""disease"">Chromosome abnormalities</span>","<span class=""disease"">Chromosome abnormalities</span> in patients treated with <span class=""chemical"">4-hydroperoxycyclophosphamide</span>-purged autologous bone marrow transplantation.",,8453599,8453599_C011272_D002869,8453599_0,bcv_sentence_task_befree_610,,770956537,FALSE,finalized,5,8/14/15 23:56,"



",no_relation,1,,D002066,"<span class=""chemical"">busulfan</span>",D015470,"<span class=""disease"">ANLL</span>","<span class=""disease"">ANLL</span> patients received <span class=""chemical"">busulfan</span> and cytoxan, and the others received cytoxan and total body irradiation as their preparative regimen before transplant.",,8453599,8453599_D002066_D015470,8453599_4,bcv_sentence_task_befree_611,,770956538,FALSE,finalized,5,8/14/15 21:59,"



",no_relation,1,,C011272,"<span class=""chemical"">4-hydroperoxycyclophosphamide/4-HC</span>",D009369,"<span class=""disease"">tumor</span>","BM was purged ex vivo with <span class=""chemical"">4-hydroperoxycyclophosphamide</span> (<span class=""chemical"">4-HC</span>) at 30-100 micrograms/ml before reinfusion to kill <span class=""disease"">tumor</span> cells.",,8453599,8453599_C011272_D009369,8453599_5,bcv_sentence_task_befree_612,,770956539,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,1,,C011272,"<span class=""chemical"">4-HC</span>",D009369,"<span class=""disease"">tumor</span>","Our data suggest that clonal abnormalities observed posttransplant are best explained by clinical relapse of <span class=""disease"">tumor</span> and that ex vivo marrow purging with <span class=""chemical"">4-HC</span> is not likely to induce clonal chromosome abnormalities in normal cells.",,8453599,8453599_C011272_D009369,8453599_12,bcv_sentence_task_befree_613,,770956540,FALSE,finalized,5,8/15/15 0:06,"



",no_relation,0.5804,,C011272,"<span class=""chemical"">4-HC</span>",D001855,"<span class=""disease"">marrow purging</span>","Our data suggest that clonal abnormalities observed posttransplant are best explained by clinical relapse of tumor and that ex vivo <span class=""disease"">marrow purging</span> with <span class=""chemical"">4-HC</span> is not likely to induce clonal chromosome abnormalities in normal cells.",,8453599,8453599_C011272_D001855,8453599_12,bcv_sentence_task_befree_614,,770956541,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,1,,C011272,"<span class=""chemical"">4-HC</span>",C580365,"<span class=""disease"">clonal abnormalities</span>","Our data suggest that <span class=""disease"">clonal abnormalities</span> observed posttransplant are best explained by clinical relapse of tumor and that ex vivo marrow purging with <span class=""chemical"">4-HC</span> is not likely to induce clonal chromosome abnormalities in normal cells.",,8453599,8453599_C011272_C580365,8453599_12,bcv_sentence_task_befree_615,,770956542,FALSE,finalized,5,8/14/15 20:58,"



",no_relation,1,,C011272,"<span class=""chemical"">4-HC</span>",D002869,"<span class=""disease"">clonal chromosome abnormalities</span>","Our data suggest that clonal abnormalities observed posttransplant are best explained by clinical relapse of tumor and that ex vivo marrow purging with <span class=""chemical"">4-HC</span> is not likely to induce <span class=""disease"">clonal chromosome abnormalities</span> in normal cells.",,8453599,8453599_C011272_D002869,8453599_12,bcv_sentence_task_befree_616,,770956543,FALSE,finalized,5,8/14/15 20:16,"



",no_relation,1,,D024841,"<span class=""chemical"">Fluoroquinolone</span>",D007239,"<span class=""disease"">infection</span>","<span class=""chemical"">Fluoroquinolone</span> antimicrobials meet Joint Commission criteria for targeting for DUE: the drugs are used in populations at high risk for adverse drug reactions, quality assurance or <span class=""disease"">infection</span> control committees target them for DUE, the drugs are costly, they may be suspected or known to be used inappropriately, and they are prescribed frequently.",,8474940,8474940_D024841_D007239,8474940_3,bcv_sentence_task_befree_617,,770956544,FALSE,finalized,5,8/15/15 1:39,"



",no_relation,0.8129,,D024841,"<span class=""chemical"">fluoroquinolone</span>",D007239,"<span class=""disease"">infections</span>","Suggested criteria include use in patients who would otherwise be candidates for oral <span class=""chemical"">fluoroquinolone</span> therapy (for which published criteria exist) but who cannot use the oral route of administration due to gastrointestinal conditions predisposing to malabsorption or unavailability of the oral route; for severe <span class=""disease"">infections</span> due to gram-negative pathogens; as a replacement for aminoglycosides when ototoxicity or nephrotoxicity is a substantial risk; targeting to resistant pathogens (i.e., not as empiric therapy); and targeting to therapeutic use only (not for prophylaxis).",,8474940,8474940_D024841_D007239,8474940_5,bcv_sentence_task_befree_618,,770956545,FALSE,finalized,5,8/15/15 0:22,"



",no_relation,1,,D024841,"<span class=""chemical"">fluoroquinolone</span>",C564013,"<span class=""disease"">ototoxicity</span>","Suggested criteria include use in patients who would otherwise be candidates for oral <span class=""chemical"">fluoroquinolone</span> therapy (for which published criteria exist) but who cannot use the oral route of administration due to gastrointestinal conditions predisposing to malabsorption or unavailability of the oral route; for severe infections due to gram-negative pathogens; as a replacement for aminoglycosides when <span class=""disease"">ototoxicity</span> or nephrotoxicity is a substantial risk; targeting to resistant pathogens (i.e., not as empiric therapy); and targeting to therapeutic use only (not for prophylaxis).",,8474940,8474940_D024841_C564013,8474940_5,bcv_sentence_task_befree_619,,770956546,FALSE,finalized,5,8/14/15 20:22,"



",yes_direct,0.5857,,D000617,"<span class=""chemical"">aminoglycosides</span>",C564013,"<span class=""disease"">ototoxicity</span>","Suggested criteria include use in patients who would otherwise be candidates for oral fluoroquinolone therapy (for which published criteria exist) but who cannot use the oral route of administration due to gastrointestinal conditions predisposing to malabsorption or unavailability of the oral route; for severe infections due to gram-negative pathogens; as a replacement for <span class=""chemical"">aminoglycosides</span> when <span class=""disease"">ototoxicity</span> or nephrotoxicity is a substantial risk; targeting to resistant pathogens (i.e., not as empiric therapy); and targeting to therapeutic use only (not for prophylaxis).",,8474940,8474940_D000617_C564013,8474940_5,bcv_sentence_task_befree_620,,770956547,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,0.809,,D000617,"<span class=""chemical"">aminoglycosides</span>",D007239,"<span class=""disease"">infections</span>","Suggested criteria include use in patients who would otherwise be candidates for oral fluoroquinolone therapy (for which published criteria exist) but who cannot use the oral route of administration due to gastrointestinal conditions predisposing to malabsorption or unavailability of the oral route; for severe <span class=""disease"">infections</span> due to gram-negative pathogens; as a replacement for <span class=""chemical"">aminoglycosides</span> when ototoxicity or nephrotoxicity is a substantial risk; targeting to resistant pathogens (i.e., not as empiric therapy); and targeting to therapeutic use only (not for prophylaxis).",,8474940,8474940_D000617_D007239,8474940_5,bcv_sentence_task_befree_621,,770956548,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D000783,"<span class=""disease"">aneurysm</span>","This series represents a minimum number of cases for this period and illustrates an association of <span class=""disease"">aneurysm</span>-risk with prolonged fever; improved defervescence with the combination of intravenous gamma-globulin (IVGG) and <span class=""chemical"">aspirin</span> compared with <span class=""chemical"">aspirin</span> alone; and a more severe disease process in the very young.",,8489792,8489792_D001241_D000783,8489792_7,bcv_sentence_task_befree_622,,770956549,FALSE,finalized,5,8/14/15 20:28,"



",no_relation,0.6021,,D001241,"<span class=""chemical"">aspirin</span>",D005334,"<span class=""disease"">fever</span>","This series represents a minimum number of cases for this period and illustrates an association of aneurysm-risk with prolonged <span class=""disease"">fever</span>; improved defervescence with the combination of intravenous gamma-globulin (IVGG) and <span class=""chemical"">aspirin</span> compared with <span class=""chemical"">aspirin</span> alone; and a more severe disease process in the very young.",,8489792,8489792_D001241_D005334,8489792_7,bcv_sentence_task_befree_623,,770956550,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,1,,D003613,"<span class=""chemical"">danazol</span>",D004715,"<span class=""disease"">endometriosis</span>","Vaginal patterns during <span class=""chemical"">danazol</span> and buserelin acetate therapy for <span class=""disease"">endometriosis</span>: structural and ultrastructural study.",,8495764,8495764_D003613_D004715,8495764_0,bcv_sentence_task_befree_624,,770956551,FALSE,finalized,5,8/14/15 20:17,"



",no_relation,1,,D002064,"<span class=""chemical"">buserelin acetate</span>",D004715,"<span class=""disease"">endometriosis</span>","Vaginal patterns during danazol and <span class=""chemical"">buserelin acetate</span> therapy for <span class=""disease"">endometriosis</span>: structural and ultrastructural study.",,8495764,8495764_D002064_D004715,8495764_0,bcv_sentence_task_befree_625,,770956552,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,1,,D003613,"<span class=""chemical"">danazol</span>",D004715,"<span class=""disease"">endometriosis</span>","To evaluate histologic and ultrastructural changes of the vaginal mucosa in patients given buserelin acetate or <span class=""chemical"">danazol</span> treatment for <span class=""disease"">endometriosis</span>.",,8495764,8495764_D003613_D004715,8495764_1,bcv_sentence_task_befree_626,,770956553,FALSE,finalized,5,8/14/15 22:29,"



",no_relation,1,,D002064,"<span class=""chemical"">buserelin acetate</span>",D004715,"<span class=""disease"">endometriosis</span>","To evaluate histologic and ultrastructural changes of the vaginal mucosa in patients given <span class=""chemical"">buserelin acetate</span> or danazol treatment for <span class=""disease"">endometriosis</span>.",,8495764,8495764_D002064_D004715,8495764_1,bcv_sentence_task_befree_627,,770956554,FALSE,finalized,5,8/15/15 1:13,"



",no_relation,0.8078,,D002064,"<span class=""chemical"">buserelin acetate</span>",D007246,"<span class=""disease"">Infertile</span>","<span class=""disease"">Infertile</span> women with endometriosis randomized to receive <span class=""chemical"">buserelin acetate</span> or danazol and undergoing vaginal biopsies during treatment were selected.",,8495764,8495764_D002064_D007246,8495764_4,bcv_sentence_task_befree_628,,770956555,FALSE,finalized,5,8/15/15 0:29,"



",no_relation,1,,D003613,"<span class=""chemical"">danazol</span>",D004715,"<span class=""disease"">endometriosis</span>","Infertile women with <span class=""disease"">endometriosis</span> randomized to receive buserelin acetate or <span class=""chemical"">danazol</span> and undergoing vaginal biopsies during treatment were selected.",,8495764,8495764_D003613_D004715,8495764_4,bcv_sentence_task_befree_629,,770956556,FALSE,finalized,5,8/15/15 1:26,"



",no_relation,1,,D002064,"<span class=""chemical"">buserelin acetate</span>",D004715,"<span class=""disease"">endometriosis</span>","Infertile women with <span class=""disease"">endometriosis</span> randomized to receive <span class=""chemical"">buserelin acetate</span> or danazol and undergoing vaginal biopsies during treatment were selected.",,8495764,8495764_D002064_D004715,8495764_4,bcv_sentence_task_befree_630,,770956557,FALSE,finalized,5,8/14/15 20:16,"



",no_relation,1,,D003613,"<span class=""chemical"">danazol</span>",D007246,"<span class=""disease"">Infertile</span>","<span class=""disease"">Infertile</span> women with endometriosis randomized to receive buserelin acetate or <span class=""chemical"">danazol</span> and undergoing vaginal biopsies during treatment were selected.",,8495764,8495764_D003613_D007246,8495764_4,bcv_sentence_task_befree_631,,770956558,FALSE,finalized,5,8/14/15 23:32,"



",no_relation,0.7945,,D003613,"<span class=""chemical"">danazol</span>",D004715,"<span class=""disease"">endometriosis</span>","Vaginal mucosa undergoes constant and well-defined modifications during both buserelin acetate and <span class=""chemical"">danazol</span> treatment for <span class=""disease"">endometriosis</span>.",,8495764,8495764_D003613_D004715,8495764_11,bcv_sentence_task_befree_632,,770956559,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,1,,D002064,"<span class=""chemical"">buserelin acetate</span>",D004715,"<span class=""disease"">endometriosis</span>","Vaginal mucosa undergoes constant and well-defined modifications during both <span class=""chemical"">buserelin acetate</span> and danazol treatment for <span class=""disease"">endometriosis</span>.",,8495764,8495764_D002064_D004715,8495764_11,bcv_sentence_task_befree_633,,770956560,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,D007741,"<span class=""chemical"">labetalol</span>",D002637,"<span class=""disease"">chest pain</span>","Although <span class=""chemical"">labetalol</span> is sometimes given to patients with cocaine-associated <span class=""disease"">chest pain</span>, its influence on cocaine-induced coronary vasoconstriction is unknown.",,8506886,8506886_D007741_D002637,8506886_1,bcv_sentence_task_befree_634,,770956561,FALSE,finalized,5,8/14/15 23:31,"



",yes_direct,0.8066,,D003042,"<span class=""chemical"">cocaine</span>",D002637,"<span class=""disease"">chest pain</span>","Although labetalol is sometimes given to patients with <span class=""chemical"">cocaine</span>-associated <span class=""disease"">chest pain</span>, its influence on <span class=""chemical"">cocaine</span>-induced coronary vasoconstriction is unknown.",,8506886,8506886_D003042_D002637,8506886_1,bcv_sentence_task_befree_635,,770956562,FALSE,finalized,5,8/14/15 23:28,"



",yes_direct,0.5858,,D003042,"<span class=""chemical"">cocaine</span>",D002637,"<span class=""disease"">chest pain</span>","In 15 patients (7 men, 8 women, aged 40 to 79 years) undergoing catheterization for <span class=""disease"">chest pain</span>, heart rate, mean arterial pressure, and coronary arterial area (by computer-assisted quantitative angiography) were measured (1) at baseline, (2) 15 minutes after intranasal <span class=""chemical"">cocaine</span>, 2 mg/kg, then (3) 5 minutes after intravenous saline (n = 6) or labetalol, 0.25 mg/kg (n = 9).",,8506886,8506886_D003042_D002637,8506886_2,bcv_sentence_task_befree_636,,770956563,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D007741,"<span class=""chemical"">labetalol</span>",D002637,"<span class=""disease"">chest pain</span>","In 15 patients (7 men, 8 women, aged 40 to 79 years) undergoing catheterization for <span class=""disease"">chest pain</span>, heart rate, mean arterial pressure, and coronary arterial area (by computer-assisted quantitative angiography) were measured (1) at baseline, (2) 15 minutes after intranasal cocaine, 2 mg/kg, then (3) 5 minutes after intravenous saline (n = 6) or <span class=""chemical"">labetalol</span>, 0.25 mg/kg (n = 9).",,8506886,8506886_D007741_D002637,8506886_2,bcv_sentence_task_befree_637,,770956564,FALSE,finalized,5,8/14/15 20:26,"



",no_relation,1,,D013793,"<span class=""chemical"">thallium</span>",D002037,"<span class=""disease"">left bundle branch block</span>","Twelve patients with exercise-induced ST-segment elevation without prior myocardial infarction, electrocardiographic evidence of left ventricular hypertrophy or <span class=""disease"">left bundle branch block</span> underwent <span class=""chemical"">thallium</span>-201 tomography immediately after exercise and 4 hours later.",,8517412,8517412_D013793_D002037,8517412_1,bcv_sentence_task_befree_638,,770956565,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,1,,D013793,"<span class=""chemical"">thallium</span>",D006984,"<span class=""disease"">ventricular hypertrophy</span>","Twelve patients with exercise-induced ST-segment elevation without prior myocardial infarction, electrocardiographic evidence of left <span class=""disease"">ventricular hypertrophy</span> or left bundle branch block underwent <span class=""chemical"">thallium</span>-201 tomography immediately after exercise and 4 hours later.",,8517412,8517412_D013793_D006984,8517412_1,bcv_sentence_task_befree_639,,770956566,FALSE,finalized,5,8/15/15 1:21,"



",no_relation,1,,D013793,"<span class=""chemical"">thallium</span>",D009203,"<span class=""disease"">myocardial infarction</span>","Twelve patients with exercise-induced ST-segment elevation without prior <span class=""disease"">myocardial infarction</span>, electrocardiographic evidence of left ventricular hypertrophy or left bundle branch block underwent <span class=""chemical"">thallium</span>-201 tomography immediately after exercise and 4 hours later.",,8517412,8517412_D013793_D009203,8517412_1,bcv_sentence_task_befree_640,,770956567,FALSE,finalized,5,8/14/15 20:17,"



",no_relation,1,,D004986,"<span class=""chemical"">ether</span>",D005910,"<span class=""disease"">glioma</span>","Effects of structural modifications of <span class=""chemical"">ether</span> lipids on antiproliferative activity against human <span class=""disease"">glioma</span> cell lines.",,8517654,8517654_D004986_D005910,8517654_0,bcv_sentence_task_befree_641,,770956568,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,1,,D004986,"<span class=""chemical"">ether</span>",D005910,"<span class=""disease"">glioma</span>","The effect of structural modifications of <span class=""chemical"">ether</span> lipids on antiproliferative activity was studied in four human <span class=""disease"">glioma</span> cell lines.",,8517654,8517654_D004986_D005910,8517654_1,bcv_sentence_task_befree_642,,770956569,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,1,,D011034,"<span class=""chemical"">podophyllotoxin</span>",D003218,"<span class=""disease"">condylomata</span>","To evaluate the clinical efficacy of a 0.15% and a 0.3% cream formulation of <span class=""chemical"">podophyllotoxin</span> in comparison with the 0.5% solution in the treatment of <span class=""disease"">condylomata</span> acuminata and to compare the treatment modalities regarding side effects.",,8566979,8566979_D011034_D003218,8566979_1,bcv_sentence_task_befree_643,,770956570,FALSE,finalized,5,8/14/15 22:52,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D008171,"<span class=""disease"">chronic lung disease</span>","We studied pulmonary protein oxidation and its association with the development of <span class=""disease"">chronic lung disease</span> in 61 newborn infants (mean gestational age 31.1 +/- 4.0, range 24-41 weeks) requiring intensive care with <span class=""chemical"">oxygen</span> therapy.",,8580630,8580630_D010100_D008171,8580630_2,bcv_sentence_task_befree_644,,770956571,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D001997,"<span class=""disease"">bronchopulmonary dysplasia</span>","In multiple regression analysis explaining <span class=""disease"">bronchopulmonary dysplasia</span>, using gestational age, inspired <span class=""chemical"">oxygen</span> on days 1-3 and protein carbonylation on day 3 as independent variables, only protein carbonylation remained significant.",,8580630,8580630_D010100_D001997,8580630_7,bcv_sentence_task_befree_645,,770956572,FALSE,finalized,5,8/14/15 22:25,"



",no_relation,1,,D000111,"<span class=""chemical"">N-acetylcysteine</span>",C565846,"<span class=""disease"">toxicosis</span>","Comparison of <span class=""chemical"">N-acetylcysteine</span> and methylene blue, alone or in combination, for treatment of acetaminophen <span class=""disease"">toxicosis</span> in cats.",,8585668,8585668_D000111_C565846,8585668_0,bcv_sentence_task_befree_646,,770956573,FALSE,finalized,5,8/15/15 1:51,"



",no_relation,1,,D008751,"<span class=""chemical"">methylene blue</span>",C565846,"<span class=""disease"">toxicosis</span>","Comparison of N-acetylcysteine and <span class=""chemical"">methylene blue</span>, alone or in combination, for treatment of acetaminophen <span class=""disease"">toxicosis</span> in cats.",,8585668,8585668_D008751_C565846,8585668_0,bcv_sentence_task_befree_647,,770956574,FALSE,finalized,5,8/14/15 20:58,"



",no_relation,0.591,,D000082,"<span class=""chemical"">acetaminophen</span>",C565846,"<span class=""disease"">toxicosis</span>","Comparison of N-acetylcysteine and methylene blue, alone or in combination, for treatment of <span class=""chemical"">acetaminophen</span> <span class=""disease"">toxicosis</span> in cats.",,8585668,8585668_D000082_C565846,8585668_0,bcv_sentence_task_befree_648,,770956575,FALSE,finalized,5,8/15/15 1:33,"



",yes_direct,1,,D000082,"<span class=""chemical"">Acetaminophen</span>",D011041,"<span class=""disease"">poisoning</span>","<span class=""chemical"">Acetaminophen</span> is widely used in human beings for analgesic purposes, but is one of the most frequent causes of <span class=""disease"">poisoning</span> in cats.",,8585668,8585668_D000082_D011041,8585668_1,bcv_sentence_task_befree_649,,770956576,FALSE,finalized,5,8/15/15 2:18,"



",yes_direct,1,,D000082,"<span class=""chemical"">Acetaminophen</span>",D008708,"<span class=""disease"">methemoglobinemia</span>","<span class=""chemical"">Acetaminophen</span>-poisoned cats develop <span class=""disease"">methemoglobinemia</span> and sometimes hepatic failure.",,8585668,8585668_D000082_D008708,8585668_2,bcv_sentence_task_befree_650,,770956577,FALSE,finalized,5,8/14/15 20:17,"



",yes_direct,1,,D000082,"<span class=""chemical"">Acetaminophen</span>",D017093,"<span class=""disease"">hepatic failure</span>","<span class=""chemical"">Acetaminophen</span>-poisoned cats develop methemoglobinemia and sometimes <span class=""disease"">hepatic failure</span>.",,8585668,8585668_D000082_D017093,8585668_2,bcv_sentence_task_befree_651,,770956578,FALSE,finalized,5,8/14/15 20:13,"



",no_relation,1,,D000111,"<span class=""chemical"">NAC/N-acetylcysteine</span>",D008708,"<span class=""disease"">methemoglobinemia</span>","To determine the benefit of using methylene blue, a treatment for <span class=""disease"">methemoglobinemia</span>, along with <span class=""chemical"">N-acetylcysteine</span> (<span class=""chemical"">NAC</span>), the recommended treatment for acetaminophen-poisoned cats, groups of 3 male and 3 female cats each were given methylene blue <span class=""chemical"">NAC</span>, or both after administration of acetaminophen (120 mg/kg of body weight, PO).",,8585668,8585668_D000111_D008708,8585668_3,bcv_sentence_task_befree_652,,770956579,FALSE,finalized,5,8/15/15 0:24,"



",no_relation,1,,D008751,"<span class=""chemical"">methylene blue</span>",D008708,"<span class=""disease"">methemoglobinemia</span>","To determine the benefit of using <span class=""chemical"">methylene blue</span>, a treatment for <span class=""disease"">methemoglobinemia</span>, along with N-acetylcysteine (NAC), the recommended treatment for acetaminophen-poisoned cats, groups of 3 male and 3 female cats each were given methylene blue NAC, or both after administration of acetaminophen (120 mg/kg of body weight, PO).",,8585668,8585668_D008751_D008708,8585668_3,bcv_sentence_task_befree_653,,770956580,FALSE,finalized,5,8/14/15 21:53,"



",no_relation,1,,D000082,"<span class=""chemical"">acetaminophen</span>",D008708,"<span class=""disease"">methemoglobinemia</span>","To determine the benefit of using methylene blue, a treatment for <span class=""disease"">methemoglobinemia</span>, along with N-acetylcysteine (NAC), the recommended treatment for <span class=""chemical"">acetaminophen</span>-poisoned cats, groups of 3 male and 3 female cats each were given methylene blue NAC, or both after administration of <span class=""chemical"">acetaminophen</span> (120 mg/kg of body weight, PO).",,8585668,8585668_D000082_D008708,8585668_3,bcv_sentence_task_befree_654,,770956581,FALSE,finalized,5,8/15/15 1:58,"



",yes_direct,0.5873,,D000111,"<span class=""chemical"">NAC</span>",C565846,"<span class=""disease"">toxicosis</span>","Male cats seemed more susceptible than female cats to acetaminophen <span class=""disease"">toxicosis</span>, because 3 males died of hepatic failure (2 cats given acetaminophen/methylene blue and 1 given acetaminophen/<span class=""chemical"">NAC</span>/methylene blue).",,8585668,8585668_D000111_C565846,8585668_4,bcv_sentence_task_befree_655,,770956582,FALSE,finalized,5,8/15/15 2:02,"



",yes_direct,1,,D008751,"<span class=""chemical"">methylene blue</span>",C565846,"<span class=""disease"">toxicosis</span>","Male cats seemed more susceptible than female cats to acetaminophen <span class=""disease"">toxicosis</span>, because 3 males died of hepatic failure (2 cats given acetaminophen/<span class=""chemical"">methylene blue</span> and 1 given acetaminophen/NAC/<span class=""chemical"">methylene blue</span>).",,8585668,8585668_D008751_C565846,8585668_4,bcv_sentence_task_befree_656,,770956583,FALSE,finalized,5,8/15/15 1:18,"



",yes_direct,1,,D000082,"<span class=""chemical"">acetaminophen</span>",C565846,"<span class=""disease"">toxicosis</span>","Male cats seemed more susceptible than female cats to <span class=""chemical"">acetaminophen</span> <span class=""disease"">toxicosis</span>, because 3 males died of hepatic failure (2 cats given <span class=""chemical"">acetaminophen</span>/methylene blue and 1 given <span class=""chemical"">acetaminophen</span>/NAC/methylene blue).",,8585668,8585668_D000082_C565846,8585668_4,bcv_sentence_task_befree_657,,770956584,FALSE,finalized,5,8/15/15 1:35,"



",yes_direct,0.7851,,D008751,"<span class=""chemical"">methylene blue</span>",D017093,"<span class=""disease"">hepatic failure</span>","Male cats seemed more susceptible than female cats to acetaminophen toxicosis, because 3 males died of <span class=""disease"">hepatic failure</span> (2 cats given acetaminophen/<span class=""chemical"">methylene blue</span> and 1 given acetaminophen/NAC/<span class=""chemical"">methylene blue</span>).",,8585668,8585668_D008751_D017093,8585668_4,bcv_sentence_task_befree_658,,770956585,FALSE,finalized,5,8/14/15 20:10,"



",yes_direct,0.8224,,D000111,"<span class=""chemical"">NAC</span>",D017093,"<span class=""disease"">hepatic failure</span>","Male cats seemed more susceptible than female cats to acetaminophen toxicosis, because 3 males died of <span class=""disease"">hepatic failure</span> (2 cats given acetaminophen/methylene blue and 1 given acetaminophen/<span class=""chemical"">NAC</span>/methylene blue).",,8585668,8585668_D000111_D017093,8585668_4,bcv_sentence_task_befree_659,,770956586,FALSE,finalized,5,8/14/15 20:27,"



",yes_direct,1,,D000082,"<span class=""chemical"">acetaminophen</span>",D017093,"<span class=""disease"">hepatic failure</span>","Male cats seemed more susceptible than female cats to <span class=""chemical"">acetaminophen</span> toxicosis, because 3 males died of <span class=""disease"">hepatic failure</span> (2 cats given <span class=""chemical"">acetaminophen</span>/methylene blue and 1 given <span class=""chemical"">acetaminophen</span>/NAC/methylene blue).",,8585668,8585668_D000082_D017093,8585668_4,bcv_sentence_task_befree_660,,770956587,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,D016685,"<span class=""chemical"">mitomycin C</span>",D009369,"<span class=""disease"">Tumor</span>","Reductase enzyme expression across the National Cancer Institute <span class=""disease"">Tumor</span> cell line panel: correlation with sensitivity to <span class=""chemical"">mitomycin C</span> and EO9.",,8614004,8614004_D016685_D009369,8614004_0,bcv_sentence_task_befree_661,,770956588,FALSE,finalized,5,8/14/15 20:48,"



",no_relation,1,,D010710,"<span class=""chemical"">phosphate</span>",D009369,"<span class=""disease"">tumor</span>","We measured expression levels of three different reductase enzymes-DT-diaphorase [NAD(P)H (i.e., reduced nicotinamide adenine dinucleotide, with or without <span class=""chemical"">phosphate</span>): quinone oxidoreductase]; NADPH:cytochrome P-450 reductase; and NADH (i.e., reduced nicotinamide adenine dinucleotide): cytochrome-b5 reductase- in 69 cell lines (most of the National Cancer Institute [NCI] human <span class=""disease"">tumor</span> cell panel) to see if relationships could be established between the activities of these enzymes and cellular sensitivities to the bioreductive compounds mitomycin C and EO9.",,8614004,8614004_D010710_D009369,8614004_4,bcv_sentence_task_befree_662,,770956589,FALSE,finalized,5,8/14/15 20:27,"



",no_relation,1,,D009249,"<span class=""chemical"">NADPH/NAD(P)H</span>",D009369,"<span class=""disease"">tumor</span>","We measured expression levels of three different reductase enzymes-DT-diaphorase [<span class=""chemical"">NAD(P)H</span> (i.e., reduced nicotinamide adenine dinucleotide, with or without phosphate): quinone oxidoreductase]; <span class=""chemical"">NADPH</span>:cytochrome P-450 reductase; and NADH (i.e., reduced nicotinamide adenine dinucleotide): cytochrome-b5 reductase- in 69 cell lines (most of the National Cancer Institute [NCI] human <span class=""disease"">tumor</span> cell panel) to see if relationships could be established between the activities of these enzymes and cellular sensitivities to the bioreductive compounds mitomycin C and EO9.",,8614004,8614004_D009249_D009369,8614004_4,bcv_sentence_task_befree_663,,770956590,FALSE,finalized,5,8/15/15 1:23,"



",no_relation,1,,D016685,"<span class=""chemical"">mitomycin C</span>",D009369,"<span class=""disease"">tumor</span>","We measured expression levels of three different reductase enzymes-DT-diaphorase [NAD(P)H (i.e., reduced nicotinamide adenine dinucleotide, with or without phosphate): quinone oxidoreductase]; NADPH:cytochrome P-450 reductase; and NADH (i.e., reduced nicotinamide adenine dinucleotide): cytochrome-b5 reductase- in 69 cell lines (most of the National Cancer Institute [NCI] human <span class=""disease"">tumor</span> cell panel) to see if relationships could be established between the activities of these enzymes and cellular sensitivities to the bioreductive compounds <span class=""chemical"">mitomycin C</span> and EO9.",,8614004,8614004_D016685_D009369,8614004_4,bcv_sentence_task_befree_664,,770956591,FALSE,finalized,5,8/14/15 23:32,"



",no_relation,1,,D009243,"<span class=""chemical"">nicotinamide adenine dinucleotide/NADH</span>",D009369,"<span class=""disease"">tumor</span>","We measured expression levels of three different reductase enzymes-DT-diaphorase [NAD(P)H (i.e., reduced <span class=""chemical"">nicotinamide adenine dinucleotide</span>, with or without phosphate): quinone oxidoreductase]; NADPH:cytochrome P-450 reductase; and <span class=""chemical"">NADH</span> (i.e., reduced nicotinamide adenine dinucleotide): cytochrome-b5 reductase- in 69 cell lines (most of the National Cancer Institute [NCI] human <span class=""disease"">tumor</span> cell panel) to see if relationships could be established between the activities of these enzymes and cellular sensitivities to the bioreductive compounds mitomycin C and EO9.",,8614004,8614004_D009243_D009369,8614004_4,bcv_sentence_task_befree_665,,770956592,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,0.7989,,C004532,"<span class=""chemical"">quinone</span>",D009369,"<span class=""disease"">tumor</span>","We measured expression levels of three different reductase enzymes-DT-diaphorase [NAD(P)H (i.e., reduced nicotinamide adenine dinucleotide, with or without phosphate): <span class=""chemical"">quinone</span> oxidoreductase]; NADPH:cytochrome P-450 reductase; and NADH (i.e., reduced nicotinamide adenine dinucleotide): cytochrome-b5 reductase- in 69 cell lines (most of the National Cancer Institute [NCI] human <span class=""disease"">tumor</span> cell panel) to see if relationships could be established between the activities of these enzymes and cellular sensitivities to the bioreductive compounds mitomycin C and EO9.",,8614004,8614004_C004532_D009369,8614004_4,bcv_sentence_task_befree_666,,770956593,FALSE,finalized,5,8/14/15 23:20,"



",no_relation,0.5682,,D006493,"<span class=""chemical"">heparin</span>",D006470,"<span class=""disease"">haemorrhagic</span>","The use of heparin for extracorporeal therapies has been problematical due to <span class=""disease"">haemorrhagic</span> complications; as a consequence, heparinase I from Flavobacterium heparinum is used for the determination of plasma heparin and for elimination of <span class=""chemical"">heparin</span> from circulation.",,8615834,8615834_D006493_D006470,8615834_1,bcv_sentence_task_befree_667,,770956594,FALSE,finalized,5,8/15/15 1:13,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">breast cancer</span>","Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of <span class=""chemical"">tamoxifen</span> and toremifene on plasma lipid levels in postmenopausal women with node-positive <span class=""disease"">breast cancer</span>.",,8636753,8636753_D013629_D009369,8636753_0,bcv_sentence_task_befree_668,,770956595,FALSE,finalized,5,8/15/15 2:08,"



",no_relation,1,,D017312,"<span class=""chemical"">toremifene</span>",D009369,"<span class=""disease"">breast cancer</span>","Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and <span class=""chemical"">toremifene</span> on plasma lipid levels in postmenopausal women with node-positive <span class=""disease"">breast cancer</span>.",,8636753,8636753_D017312_D009369,8636753_0,bcv_sentence_task_befree_669,,770956596,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">breast cancer</span>","Forty-nine postmenopausal patients with node-positive <span class=""disease"">breast cancer</span> were randomized in a trial that compared the effects of <span class=""chemical"">tamoxifen</span> and toremifene on serum lipoproteins.",,8636753,8636753_D013629_D009369,8636753_2,bcv_sentence_task_befree_670,,770956597,FALSE,finalized,5,8/14/15 20:17,"



",no_relation,1,,D017312,"<span class=""chemical"">toremifene</span>",D009369,"<span class=""disease"">breast cancer</span>","Forty-nine postmenopausal patients with node-positive <span class=""disease"">breast cancer</span> were randomized in a trial that compared the effects of tamoxifen and <span class=""chemical"">toremifene</span> on serum lipoproteins.",,8636753,8636753_D017312_D009369,8636753_2,bcv_sentence_task_befree_671,,770956598,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,D017312,"<span class=""chemical"">toremifene</span>",D003327,"<span class=""disease"">CHD/coronary heart disease</span>","These results provide positive evidence that <span class=""chemical"">toremifene</span> has antiatherogenic properties with potency to improve all lipoproteins that are associated with increased <span class=""disease"">coronary heart disease</span> (<span class=""disease"">CHD</span>) risk.",,8636753,8636753_D017312_D003327,8636753_11,bcv_sentence_task_befree_672,,770956599,FALSE,finalized,5,8/14/15 20:32,"



",no_relation,1,,D000666,"<span class=""chemical"">amphotericin B</span>",D058387,"<span class=""disease"">candidemia</span>","During a comparative trial of <span class=""chemical"">amphotericin B</span> vs. fluconazole for treatment of <span class=""disease"">candidemia</span> in nonneutropenic patients, data on the management of intravascular catheters were collected.",,8645855,8645855_D000666_D058387,8645855_2,bcv_sentence_task_befree_673,,770956600,FALSE,finalized,5,8/14/15 20:21,"



",no_relation,1,,D015725,"<span class=""chemical"">fluconazole</span>",D058387,"<span class=""disease"">candidemia</span>","During a comparative trial of amphotericin B vs. <span class=""chemical"">fluconazole</span> for treatment of <span class=""disease"">candidemia</span> in nonneutropenic patients, data on the management of intravascular catheters were collected.",,8645855,8645855_D015725_D058387,8645855_2,bcv_sentence_task_befree_674,,770956601,FALSE,finalized,5,8/15/15 1:53,"



",no_relation,1,,D016898,"<span class=""chemical"">interferon-alpha</span>",D006509,"<span class=""disease"">hepatitis B</span>","We investigated the long-term effect of <span class=""chemical"">interferon-alpha</span> treatment in patients with chronic <span class=""disease"">hepatitis B</span> with regard to the response status during treatment.",,8686350,8686350_D016898_D006509,8686350_1,bcv_sentence_task_befree_675,,770956602,FALSE,finalized,5,8/14/15 20:27,"



",yes_direct,0.5789,,D016898,"<span class=""chemical"">interferon-alpha</span>",D006509,"<span class=""disease"">hepatitis B</span>","97 patients with chronic <span class=""disease"">hepatitis B</span>, including 18 patients with active cirrhosis Child A, were followed for 12-110 months (mean: 40.5 months) after <span class=""chemical"">interferon-alpha</span> treatment.",,8686350,8686350_D016898_D006509,8686350_2,bcv_sentence_task_befree_676,,770956603,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,0.8048,,D016898,"<span class=""chemical"">interferon-alpha</span>",D005355,"<span class=""disease"">cirrhosis</span>","97 patients with chronic hepatitis B, including 18 patients with active <span class=""disease"">cirrhosis</span> Child A, were followed for 12-110 months (mean: 40.5 months) after <span class=""chemical"">interferon-alpha</span> treatment.",,8686350,8686350_D016898_D005355,8686350_2,bcv_sentence_task_befree_677,,770956604,FALSE,finalized,5,8/15/15 1:50,"



",no_relation,1,,D006513,"<span class=""chemical"">HBeAg</span>",D005355,"<span class=""disease"">cirrhosis</span>","Thus, in patients without apparent <span class=""disease"">cirrhosis</span> interferon-alpha treatment has a considerable long-term effect with regard to the enhanced rate of HBsAg and <span class=""chemical"">HBeAg</span> clearance during prolonged follow-up.",,8686350,8686350_D006513_D005355,8686350_12,bcv_sentence_task_befree_678,,770956605,FALSE,finalized,5,8/15/15 2:14,"



",no_relation,0.8082,,D007649,"<span class=""chemical"">ketamine</span>",D010146,"<span class=""disease"">terminal cancer pain</span>","Intrathecal <span class=""chemical"">ketamine</span> reduces morphine requirements in patients with <span class=""disease"">terminal cancer pain</span>.",,8697554,8697554_D007649_D010146,8697554_0,bcv_sentence_task_befree_679,,770956606,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D010146,"<span class=""disease"">terminal cancer pain</span>","Intrathecal ketamine reduces <span class=""chemical"">morphine</span> requirements in patients with <span class=""disease"">terminal cancer pain</span>.",,8697554,8697554_D009020_D010146,8697554_0,bcv_sentence_task_befree_680,,770956607,FALSE,finalized,5,8/15/15 2:33,"



",no_relation,1,,D007649,"<span class=""chemical"">Ketamine</span>",D010146,"<span class=""disease"">pain</span>","<span class=""chemical"">Ketamine</span> has been administered epidurally and intrathecally for operative and post-operative <span class=""disease"">pain</span> control.",,8697554,8697554_D007649_D010146,8697554_1,bcv_sentence_task_befree_681,,770956608,FALSE,finalized,5,8/14/15 20:25,"



",yes_direct,1,,D009020,"<span class=""chemical"">morphine</span>",D000699,"<span class=""disease"">analgesia</span>","Animal studies showed potentiation of <span class=""disease"">analgesia</span> induced by ketamine and <span class=""chemical"">morphine</span>.",,8697554,8697554_D009020_D000699,8697554_2,bcv_sentence_task_befree_682,,770956609,FALSE,finalized,5,8/15/15 1:42,"



",yes_direct,0.5764,,D007649,"<span class=""chemical"">ketamine</span>",D000699,"<span class=""disease"">analgesia</span>","Animal studies showed potentiation of <span class=""disease"">analgesia</span> induced by <span class=""chemical"">ketamine</span> and morphine.",,8697554,8697554_D007649_D000699,8697554_2,bcv_sentence_task_befree_683,,770956610,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D007649,"<span class=""chemical"">ketamine</span>",D010146,"<span class=""disease"">cancer pain</span>","We hypothesized that intrathecal <span class=""chemical"">ketamine</span> would potentiate the effects of intrathecal morphine in the treatment of <span class=""disease"">cancer pain</span>.",,8697554,8697554_D007649_D010146,8697554_3,bcv_sentence_task_befree_684,,770956611,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D010146,"<span class=""disease"">cancer pain</span>","We hypothesized that intrathecal ketamine would potentiate the effects of intrathecal <span class=""chemical"">morphine</span> in the treatment of <span class=""disease"">cancer pain</span>.",,8697554,8697554_D009020_D010146,8697554_3,bcv_sentence_task_befree_685,,770956612,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,1,,D007649,"<span class=""chemical"">ketamine</span>",D010146,"<span class=""disease"">terminal cancer pain</span>","A double blind, cross over study was designed to evaluate the effect of <span class=""chemical"">ketamine</span> on spinal morphine analgesia in <span class=""disease"">terminal cancer pain</span> patients.",,8697554,8697554_D007649_D010146,8697554_4,bcv_sentence_task_befree_686,,770956613,FALSE,finalized,5,8/14/15 22:27,"



",yes_direct,0.616,,D009020,"<span class=""chemical"">morphine</span>",D000699,"<span class=""disease"">analgesia</span>","A double blind, cross over study was designed to evaluate the effect of ketamine on spinal <span class=""chemical"">morphine</span> <span class=""disease"">analgesia</span> in terminal cancer pain patients.",,8697554,8697554_D009020_D000699,8697554_4,bcv_sentence_task_befree_687,,770956614,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D010146,"<span class=""disease"">terminal cancer pain</span>","A double blind, cross over study was designed to evaluate the effect of ketamine on spinal <span class=""chemical"">morphine</span> analgesia in <span class=""disease"">terminal cancer pain</span> patients.",,8697554,8697554_D009020_D010146,8697554_4,bcv_sentence_task_befree_688,,770956615,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,0.7963,,D007649,"<span class=""chemical"">ketamine</span>",D000699,"<span class=""disease"">analgesia</span>","A double blind, cross over study was designed to evaluate the effect of <span class=""chemical"">ketamine</span> on spinal morphine <span class=""disease"">analgesia</span> in terminal cancer pain patients.",,8697554,8697554_D007649_D000699,8697554_4,bcv_sentence_task_befree_689,,770956616,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D010146,"<span class=""disease"">pain</span>","The dose of <span class=""chemical"">morphine</span> was titrated upwards until acceptable <span class=""disease"">pain</span> relief was achieved, defined by numeric rating scales (0-10) < or = 3, and the rescue dose of <span class=""chemical"">morphine</span> was less than 5 mg after each intrathecal administration for two days.",,8697554,8697554_D009020_D010146,8697554_6,bcv_sentence_task_befree_690,,770956617,FALSE,finalized,5,8/14/15 20:10,"



",no_relation,1,,D011188,"<span class=""chemical"">K</span>",D010146,"<span class=""disease"">Pain</span>","<span class=""disease"">Pain</span> scales were decreased to 2.2 +/- 0.17 (P < 0.05) in phase M and 1.95 +/- 0.20 (P < 0.05) in phase M + <span class=""chemical"">K</span> after the effective dose of morphine had been reached.",,8697554,8697554_D011188_D010146,8697554_10,bcv_sentence_task_befree_691,,770956618,FALSE,finalized,5,8/15/15 2:29,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D010146,"<span class=""disease"">Pain</span>","<span class=""disease"">Pain</span> scales were decreased to 2.2 +/- 0.17 (P < 0.05) in phase M and 1.95 +/- 0.20 (P < 0.05) in phase M + K after the effective dose of <span class=""chemical"">morphine</span> had been reached.",,8697554,8697554_D009020_D010146,8697554_10,bcv_sentence_task_befree_692,,770956619,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D010431,"<span class=""chemical"">Pentoxifylline</span>",D013927,"<span class=""disease"">thrombosis</span>","<span class=""chemical"">Pentoxifylline</span>: a potential treatment for <span class=""disease"">thrombosis</span> associated with abnormal tissue factor expression by monocytes and endothelial cells.",,8699848,8699848_D010431_D013927,8699848_0,bcv_sentence_task_befree_693,,770956620,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,D010431,"<span class=""chemical"">pentoxifylline/PTX</span>",D009336,"<span class=""disease"">necrosis</span>","In vitro, <span class=""chemical"">pentoxifylline</span> (<span class=""chemical"">PTX</span>) inhibits monocyte production of TF in response to endotoxin, as well as endothelial cell production of TF in response to tumor <span class=""disease"">necrosis</span> factor-alpha (TNF-alpha).",,8699848,8699848_D010431_D009336,8699848_5,bcv_sentence_task_befree_694,,770956621,FALSE,finalized,5,8/15/15 1:37,"



",no_relation,1,,C047781,"<span class=""chemical"">Lamotrigine</span>",D020189,"<span class=""disease"">nocturnal myoclonus syndrome/NMS</span>","<span class=""chemical"">Lamotrigine</span> in the treatment of <span class=""disease"">nocturnal myoclonus syndrome</span> (<span class=""disease"">NMS</span>): two case reports.",,8739847,8739847_C047781_D020189,8739847_0,bcv_sentence_task_befree_695,,770956622,FALSE,finalized,5,8/15/15 2:03,"



",no_relation,0.7879,,D004298,"<span class=""chemical"">dopamine</span>",D020189,"<span class=""disease"">nocturnal myoclonus syndrome/NMS</span>","In previous investigations we found an increase of D2 <span class=""chemical"">dopamine</span> receptors in the striatum of patients with <span class=""disease"">nocturnal myoclonus syndrome</span> (<span class=""disease"">NMS</span>) after treatment with dopamimetics.",,8739847,8739847_D004298_D020189,8739847_1,bcv_sentence_task_befree_696,,770956623,FALSE,finalized,5,8/14/15 20:19,"



",no_relation,1,,D018698,"<span class=""chemical"">glutamate</span>",D020189,"<span class=""disease"">NMS</span>","The <span class=""chemical"">glutamate</span> release inhibitor lamotrigine was tested in up to now two <span class=""disease"">NMS</span> patients.",,8739847,8739847_D018698_D020189,8739847_3,bcv_sentence_task_befree_697,,770956624,FALSE,finalized,5,8/14/15 23:19,"


Used as treatment.
",no_relation,1,,C047781,"<span class=""chemical"">lamotrigine</span>",D020189,"<span class=""disease"">NMS</span>","The glutamate release inhibitor <span class=""chemical"">lamotrigine</span> was tested in up to now two <span class=""disease"">NMS</span> patients.",,8739847,8739847_C047781_D020189,8739847_3,bcv_sentence_task_befree_698,,770956625,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,0.7997,,D013619,"<span class=""chemical"">tacrine</span>",D000544,"<span class=""disease"">Alzheimer's amyloid</span>","Amyloidogenic processing of <span class=""disease"">Alzheimer's amyloid</span> precursor protein in vitro and its modulation by metal ions and <span class=""chemical"">tacrine</span>.",,8761343,8761343_D013619_D000544,8761343_0,bcv_sentence_task_befree_699,,770956626,FALSE,finalized,5,8/14/15 20:42,"



",no_relation,0.8087,,D013619,"<span class=""chemical"">tacrine</span>",D000544,"<span class=""disease"">AD</span>","In addition, zinc or <span class=""chemical"">tacrine</span> treatment of <span class=""disease"">AD</span> patients with high dosage or in the long term may have effects on the process of amyloidogensis.",,8761343,8761343_D013619_D000544,8761343_7,bcv_sentence_task_befree_700,,770956627,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,1,,D015032,"<span class=""chemical"">zinc</span>",D000544,"<span class=""disease"">AD</span>","In addition, <span class=""chemical"">zinc</span> or tacrine treatment of <span class=""disease"">AD</span> patients with high dosage or in the long term may have effects on the process of amyloidogensis.",,8761343,8761343_D015032_D000544,8761343_7,bcv_sentence_task_befree_701,,770956628,FALSE,finalized,5,8/14/15 20:16,"



",yes_direct,1,,D004317,"<span class=""chemical"">adriamycin</span>",D064420,"<span class=""disease"">acute cardiac toxicity</span>","The protective role of manganese superoxide dismutase against <span class=""chemical"">adriamycin</span>-induced <span class=""disease"">acute cardiac toxicity</span> in transgenic mice.",,8787689,8787689_D004317_D064420,8787689_0,bcv_sentence_task_befree_702,,770956629,FALSE,finalized,5,8/15/15 2:27,"



",yes_direct,1,,D004317,"<span class=""chemical"">ADR/Adriamycin</span>",D064420,"<span class=""disease"">cardiac toxicity</span>","<span class=""chemical"">Adriamycin</span> (<span class=""chemical"">ADR</span>) is a potent anticancer drug known to cause severe <span class=""disease"">cardiac toxicity</span>.",,8787689,8787689_D004317_D064420,8787689_1,bcv_sentence_task_befree_703,,770956630,FALSE,finalized,5,8/14/15 22:19,"



",yes_direct,0.5907,,D004317,"<span class=""chemical"">ADR</span>",D064420,"<span class=""disease"">cardiac toxicity</span>","Although ADR generates free radicals, the role of free radicals in the development of <span class=""disease"">cardiac toxicity</span> and the intracellular target for <span class=""chemical"">ADR</span>-induced <span class=""disease"">cardiac toxicity</span> are still not well understood.",,8787689,8787689_D004317_D064420,8787689_2,bcv_sentence_task_befree_704,,770956631,FALSE,finalized,5,8/15/15 1:02,"



",yes_direct,0.6124,,D004317,"<span class=""chemical"">ADR</span>",D006177,"<span class=""disease"">mitochondrial damage</span>","Electron microscopy revealed dose-dependent ultrastructural alterations with marked <span class=""disease"">mitochondrial damage</span> in nontransgenic mice treated with <span class=""chemical"">ADR</span>, but not in the transgenic littermates.",,8787689,8787689_D004317_D006177,8787689_6,bcv_sentence_task_befree_705,,770956632,FALSE,finalized,5,8/14/15 22:07,"



",yes_direct,0.8068,,D004317,"<span class=""chemical"">ADR</span>",D064420,"<span class=""disease"">toxicity</span>","These results support a major role for free radical generation in <span class=""chemical"">ADR</span> <span class=""disease"">toxicity</span> as well as suggesting mitochondria as the critical site of cardiac injury.",,8787689,8787689_D004317_D064420,8787689_8,bcv_sentence_task_befree_706,,770956633,FALSE,finalized,5,8/15/15 1:14,"



",no_relation,0.7839,,D004317,"<span class=""chemical"">ADR</span>",D014947,"<span class=""disease"">cardiac injury</span>","These results support a major role for free radical generation in <span class=""chemical"">ADR</span> toxicity as well as suggesting mitochondria as the critical site of <span class=""disease"">cardiac injury</span>.",,8787689,8787689_D004317_D014947,8787689_8,bcv_sentence_task_befree_707,,770956634,FALSE,finalized,5,8/14/15 23:01,"



",yes_direct,1,,D012701,"<span class=""chemical"">5-HT</span>",D018229,"<span class=""disease"">contractions</span>","Ketanserin (10-1000 nM) antagonized part of the <span class=""chemical"">5-HT</span>-induced <span class=""disease"">contractions</span>.",,8789380,8789380_D012701_D018229,8789380_7,bcv_sentence_task_befree_708,,770956635,FALSE,finalized,5,8/14/15 22:04,"



",no_relation,0.8188,,D007650,"<span class=""chemical"">Ketanserin</span>",D018229,"<span class=""disease"">contractions</span>","<span class=""chemical"">Ketanserin</span> (10-1000 nM) antagonized part of the 5-HT-induced <span class=""disease"">contractions</span>.",,8789380,8789380_D007650_D018229,8789380_7,bcv_sentence_task_befree_709,,770956636,FALSE,finalized,5,8/14/15 22:43,"



",yes_direct,0.7944,,D012701,"<span class=""chemical"">5-HT</span>",D018229,"<span class=""disease"">contractions</span>","Ketanserin-resistant components of <span class=""chemical"">5-HT</span>-induced <span class=""disease"">contractions</span> were found with -log EC50, M of 6.9 and f1 of 0.17 (100 nM ketanserin) and -log EC50, M of 6.4 and f1 of 0.20 (1000 nM ketanserin).",,8789380,8789380_D012701_D018229,8789380_8,bcv_sentence_task_befree_710,,770956637,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,0.6231,,D007650,"<span class=""chemical"">Ketanserin</span>",D018229,"<span class=""disease"">contractions</span>","<span class=""chemical"">Ketanserin</span>-resistant components of 5-HT-induced <span class=""disease"">contractions</span> were found with -log EC50, M of 6.9 and f1 of 0.17 (100 nM <span class=""chemical"">ketanserin</span>) and -log EC50, M of 6.4 and f1 of 0.20 (1000 nM <span class=""chemical"">ketanserin</span>).",,8789380,8789380_D007650_D018229,8789380_8,bcv_sentence_task_befree_711,,770956638,FALSE,finalized,5,8/15/15 0:15,"



",yes_direct,1,,D012701,"<span class=""chemical"">5-HT</span>",D018229,"<span class=""disease"">contractions</span>","In rings with endothelial function attenuated by enzymatic treatment, <span class=""chemical"">5-HT</span> caused <span class=""disease"">contractions</span> with a -log EC50, M of 7.2 that were partially blocked by ketanserin.",,8789380,8789380_D012701_D018229,8789380_10,bcv_sentence_task_befree_712,,770956639,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,1,,D007650,"<span class=""chemical"">ketanserin</span>",D018229,"<span class=""disease"">contractions</span>","In rings with endothelial function attenuated by enzymatic treatment, 5-HT caused <span class=""disease"">contractions</span> with a -log EC50, M of 7.2 that were partially blocked by <span class=""chemical"">ketanserin</span>.",,8789380,8789380_D007650_D018229,8789380_10,bcv_sentence_task_befree_713,,770956640,FALSE,finalized,5,8/14/15 20:13,"


al simplificar las palabras es mas entendible para uno que no es medico en este tipo de tarea...thanksss
",yes_direct,0.7972,,D012701,"<span class=""chemical"">5-HT</span>",D018229,"<span class=""disease"">contractions</span>","Ketanserin-resistant components of <span class=""chemical"">5-HT</span>-induced <span class=""disease"">contractions</span> were found with -log EC50, M 7.4 and f1 of 0.16 (100 nM ketanserin) and -log EC50, M of 7.5 and f1 of 0.14 (1000 nM ketanserin).",,8789380,8789380_D012701_D018229,8789380_11,bcv_sentence_task_befree_714,,770956641,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,0.4106,,D007650,"<span class=""chemical"">Ketanserin</span>",D018229,"<span class=""disease"">contractions</span>","<span class=""chemical"">Ketanserin</span>-resistant components of 5-HT-induced <span class=""disease"">contractions</span> were found with -log EC50, M 7.4 and f1 of 0.16 (100 nM <span class=""chemical"">ketanserin</span>) and -log EC50, M of 7.5 and f1 of 0.14 (1000 nM <span class=""chemical"">ketanserin</span>).",,8789380,8789380_D007650_D018229,8789380_11,bcv_sentence_task_befree_715,,770956642,FALSE,finalized,5,8/15/15 0:17,"



",yes_direct,1,,D018170,"<span class=""chemical"">sumatriptan</span>",D018229,"<span class=""disease"">contractions</span>","In rings with intact endothelium the 5-HT1-like-selective agonist, <span class=""chemical"">sumatriptan</span>, caused small <span class=""disease"">contractions</span> with a -log EC50, M of 6.5 and intrinsic activity of 0.21 with respect to 5-HT that were resistant to blockade by 1000 nM ketanserin but antagonized by 100 nM methiothepin.",,8789380,8789380_D018170_D018229,8789380_15,bcv_sentence_task_befree_716,,770956643,FALSE,finalized,5,8/14/15 23:01,"



",no_relation,1,,D012701,"<span class=""chemical"">5-HT</span>",D018229,"<span class=""disease"">contractions</span>","In rings with intact endothelium the 5-HT1-like-selective agonist, sumatriptan, caused small <span class=""disease"">contractions</span> with a -log EC50, M of 6.5 and intrinsic activity of 0.21 with respect to <span class=""chemical"">5-HT</span> that were resistant to blockade by 1000 nM ketanserin but antagonized by 100 nM methiothepin.",,8789380,8789380_D012701_D018229,8789380_15,bcv_sentence_task_befree_717,,770956644,FALSE,finalized,5,8/15/15 0:01,"



",no_relation,1,,D008719,"<span class=""chemical"">methiothepin</span>",D018229,"<span class=""disease"">contractions</span>","In rings with intact endothelium the 5-HT1-like-selective agonist, sumatriptan, caused small <span class=""disease"">contractions</span> with a -log EC50, M of 6.5 and intrinsic activity of 0.21 with respect to 5-HT that were resistant to blockade by 1000 nM ketanserin but antagonized by 100 nM <span class=""chemical"">methiothepin</span>.",,8789380,8789380_D008719_D018229,8789380_15,bcv_sentence_task_befree_718,,770956645,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,1,,D007650,"<span class=""chemical"">ketanserin</span>",D018229,"<span class=""disease"">contractions</span>","In rings with intact endothelium the 5-HT1-like-selective agonist, sumatriptan, caused small <span class=""disease"">contractions</span> with a -log EC50, M of 6.5 and intrinsic activity of 0.21 with respect to 5-HT that were resistant to blockade by 1000 nM <span class=""chemical"">ketanserin</span> but antagonized by 100 nM methiothepin.",,8789380,8789380_D007650_D018229,8789380_15,bcv_sentence_task_befree_719,,770956646,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,1,,D006919,"<span class=""chemical"">hydroxyzine</span>",D065631,"<span class=""disease"">allergic rhinitis</span>","Fifteen subjects with <span class=""disease"">allergic rhinitis</span> were tested before and 2-2.5 h after administration of diphenhydramine, <span class=""chemical"">hydroxyzine</span>, or placebo in a double-blind, single-dose, three-way crossover study.",,8792380,8792380_D006919_D065631,8792380_4,bcv_sentence_task_befree_720,,770956647,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,0.8026,,D004155,"<span class=""chemical"">diphenhydramine</span>",D065631,"<span class=""disease"">allergic rhinitis</span>","Fifteen subjects with <span class=""disease"">allergic rhinitis</span> were tested before and 2-2.5 h after administration of <span class=""chemical"">diphenhydramine</span>, hydroxyzine, or placebo in a double-blind, single-dose, three-way crossover study.",,8792380,8792380_D004155_D065631,8792380_4,bcv_sentence_task_befree_721,,770956648,FALSE,finalized,5,8/14/15 20:29,"



",yes_direct,1,,D006919,"<span class=""chemical"">hydroxyzine</span>",D002493,"<span class=""disease"">CNS dysfunction</span>","In children, diphenhydramine and <span class=""chemical"">hydroxyzine</span> are effective H1-receptor antagonists, but both these medications cause <span class=""disease"">CNS dysfunction</span>, as evidenced by increased P300 latency, a measure of cognitive function, and by increased subjective somnolence.",,8792380,8792380_D006919_D002493,8792380_11,bcv_sentence_task_befree_722,,770956649,FALSE,finalized,5,8/14/15 20:31,"



",yes_direct,1,,D004155,"<span class=""chemical"">diphenhydramine</span>",D002493,"<span class=""disease"">CNS dysfunction</span>","In children, <span class=""chemical"">diphenhydramine</span> and hydroxyzine are effective H1-receptor antagonists, but both these medications cause <span class=""disease"">CNS dysfunction</span>, as evidenced by increased P300 latency, a measure of cognitive function, and by increased subjective somnolence.",,8792380,8792380_D004155_D002493,8792380_11,bcv_sentence_task_befree_723,,770956650,FALSE,finalized,5,8/14/15 22:07,"



",no_relation,1,,D006854,"<span class=""chemical"">cortisol</span>",D007027,"<span class=""disease"">hypothalamic</span>","Three months after the head injury, the hormonal evaluation of the <span class=""disease"">hypothalamic</span>-pituitary axis by means of insulin stress test with the simultaneous administration of TRH and GnRH resulted in reduced responses of GH, <span class=""chemical"">cortisol</span>, TSH, FSH, and LH with low baseline serum concentrations of free T4 and testosterone.",,8796342,8796342_D006854_D007027,8796342_5,bcv_sentence_task_befree_724,,770956651,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,D006854,"<span class=""chemical"">cortisol</span>",D006259,"<span class=""disease"">head injury</span>","Three months after the <span class=""disease"">head injury</span>, the hormonal evaluation of the hypothalamic-pituitary axis by means of insulin stress test with the simultaneous administration of TRH and GnRH resulted in reduced responses of GH, <span class=""chemical"">cortisol</span>, TSH, FSH, and LH with low baseline serum concentrations of free T4 and testosterone.",,8796342,8796342_D006854_D006259,8796342_5,bcv_sentence_task_befree_725,,770956652,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D006259,"<span class=""disease"">head injury</span>","Three months after the <span class=""disease"">head injury</span>, the hormonal evaluation of the hypothalamic-pituitary axis by means of insulin stress test with the simultaneous administration of TRH and GnRH resulted in reduced responses of GH, cortisol, TSH, FSH, and LH with low baseline serum concentrations of free T4 and <span class=""chemical"">testosterone</span>.",,8796342,8796342_D013739_D006259,8796342_5,bcv_sentence_task_befree_726,,770956653,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,1,,D007987,"<span class=""chemical"">GnRH</span>",D007027,"<span class=""disease"">hypothalamic</span>","Three months after the head injury, the hormonal evaluation of the <span class=""disease"">hypothalamic</span>-pituitary axis by means of insulin stress test with the simultaneous administration of TRH and <span class=""chemical"">GnRH</span> resulted in reduced responses of GH, cortisol, TSH, FSH, and LH with low baseline serum concentrations of free T4 and testosterone.",,8796342,8796342_D007987_D007027,8796342_5,bcv_sentence_task_befree_727,,770956654,FALSE,finalized,5,8/14/15 20:30,"



",no_relation,1,,D007987,"<span class=""chemical"">GnRH</span>",D006259,"<span class=""disease"">head injury</span>","Three months after the <span class=""disease"">head injury</span>, the hormonal evaluation of the hypothalamic-pituitary axis by means of insulin stress test with the simultaneous administration of TRH and <span class=""chemical"">GnRH</span> resulted in reduced responses of GH, cortisol, TSH, FSH, and LH with low baseline serum concentrations of free T4 and testosterone.",,8796342,8796342_D007987_D006259,8796342_5,bcv_sentence_task_befree_728,,770956655,FALSE,finalized,5,8/14/15 20:22,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D007027,"<span class=""disease"">hypothalamic</span>","Three months after the head injury, the hormonal evaluation of the <span class=""disease"">hypothalamic</span>-pituitary axis by means of insulin stress test with the simultaneous administration of TRH and GnRH resulted in reduced responses of GH, cortisol, TSH, FSH, and LH with low baseline serum concentrations of free T4 and <span class=""chemical"">testosterone</span>.",,8796342,8796342_D013739_D007027,8796342_5,bcv_sentence_task_befree_729,,770956656,FALSE,finalized,5,8/15/15 0:04,"



",no_relation,1,,D003000,"<span class=""chemical"">clonidine</span>",D007003,"<span class=""disease"">hypoglycemia</span>","However, GH response was reduced both to insulin-induced <span class=""disease"">hypoglycemia</span>, <span class=""chemical"">clonidine</span> and GHRH tests.",,8796342,8796342_D003000_D007003,8796342_9,bcv_sentence_task_befree_730,,770956657,FALSE,finalized,5,8/15/15 1:02,"



",no_relation,1,,D019319,"<span class=""chemical"">okadaic acid</span>",C531854,"<span class=""disease"">okadaic acid/OA</span>","Human (6.2 +/- 4.5 x 10(-2) mU/10(6) sperm) and monkey (4.3 +/- 0.8 x 10(-2) mU/10(6) sperm) sonicates contained activity tentatively identified as PP1 on the basis of inhibition profiles in <span class=""chemical""></span><span class=""disease"">okadaic acid</span> (<span class=""disease"">OA</span>) and CA.",,8835396,8835396_D019319_C531854,8835396_7,bcv_sentence_task_befree_731,,770956658,FALSE,finalized,5,8/14/15 20:23,"



",no_relation,1,,D013752,"<span class=""chemical"">tetracycline</span>",D007239,"<span class=""disease"">infection</span>","The recommended management of this <span class=""disease"">infection</span> consists of drainage and antimicrobial therapy with <span class=""chemical"">tetracycline</span>, clindamycin, or a fluoroquinolone.",,8852981,8852981_D013752_D007239,8852981_5,bcv_sentence_task_befree_732,,770956659,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,D024841,"<span class=""chemical"">fluoroquinolone</span>",D007239,"<span class=""disease"">infection</span>","The recommended management of this <span class=""disease"">infection</span> consists of drainage and antimicrobial therapy with tetracycline, clindamycin, or a <span class=""chemical"">fluoroquinolone</span>.",,8852981,8852981_D024841_D007239,8852981_5,bcv_sentence_task_befree_733,,770956660,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,D002981,"<span class=""chemical"">clindamycin</span>",D007239,"<span class=""disease"">infection</span>","The recommended management of this <span class=""disease"">infection</span> consists of drainage and antimicrobial therapy with tetracycline, <span class=""chemical"">clindamycin</span>, or a fluoroquinolone.",,8852981,8852981_D002981_D007239,8852981_5,bcv_sentence_task_befree_734,,770956661,FALSE,finalized,5,8/14/15 20:16,"



",no_relation,1,,D004744,"<span class=""chemical"">[Met5]enkephalin</span>",D009369,"<span class=""disease"">colon cancer</span>","Opioid growth factor (<span class=""chemical"">[Met5]enkephalin</span>) prevents the incidence and retards the growth of human <span class=""disease"">colon cancer</span>.",,8853403,8853403_D004744_D009369,8853403_0,bcv_sentence_task_befree_735,,770956662,FALSE,finalized,5,8/15/15 2:19,"



",no_relation,1,,D004744,"<span class=""chemical"">[Met5]enkephalin</span>",D009369,"<span class=""disease"">colon cancer</span>","Daily administration of the native opioid growth factor (OGF), <span class=""chemical"">[Met5]enkephalin</span>, at dosages of 0.5, 5, or 25 mg/kg prevented the occurrence of human <span class=""disease"">colon cancer</span> HT-29 xenografts in nude mice.",,8853403,8853403_D004744_D009369,8853403_3,bcv_sentence_task_befree_736,,770956663,FALSE,finalized,5,8/14/15 20:13,"



",no_relation,1,,D016210,"<span class=""chemical"">methacholine</span>",D001249,"<span class=""disease"">asthma</span>","To evaluate the effects of age, height and prechallenge respiratory system resistance (Rrs) on bronchial responsiveness to <span class=""chemical"">methacholine</span> inhalation (BRm) as measured by the oscillation technique in children with mild <span class=""disease"">asthma</span>, we studied BRm in 92 atopic children aged from 8 to 13 years (mean +/- SD, 10.5 +/- 1.7 years).",,8856797,8856797_D016210_D001249,8856797_1,bcv_sentence_task_befree_737,,770956664,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,0.8035,,D008727,"<span class=""chemical"">methotrexate</span>",D000799,"<span class=""disease"">angioedema</span>","A 68-year-old woman with a 5 yr history of chronic recurrent urticarial vasculitis with <span class=""disease"">angioedema</span>, refractory to conventional treatment including glucocorticosteroids, H1 and H2 blockers, nonsteroidal antiinflammatory agents, <span class=""chemical"">methotrexate</span>, hydroxychloroquine, dapsone, azathioprine, intravenous gamma globulin, and plasma exchange, was successfully treated with interferon alpha 2a.",,8882052,8882052_D008727_D000799,8882052_1,bcv_sentence_task_befree_738,,770956665,FALSE,finalized,5,8/14/15 22:35,"



",no_relation,1,,D003622,"<span class=""chemical"">dapsone</span>",D000799,"<span class=""disease"">angioedema</span>","A 68-year-old woman with a 5 yr history of chronic recurrent urticarial vasculitis with <span class=""disease"">angioedema</span>, refractory to conventional treatment including glucocorticosteroids, H1 and H2 blockers, nonsteroidal antiinflammatory agents, methotrexate, hydroxychloroquine, <span class=""chemical"">dapsone</span>, azathioprine, intravenous gamma globulin, and plasma exchange, was successfully treated with interferon alpha 2a.",,8882052,8882052_D003622_D000799,8882052_1,bcv_sentence_task_befree_739,,770956666,FALSE,finalized,5,8/14/15 23:53,"



",no_relation,1,,D006886,"<span class=""chemical"">hydroxychloroquine</span>",D000799,"<span class=""disease"">angioedema</span>","A 68-year-old woman with a 5 yr history of chronic recurrent urticarial vasculitis with <span class=""disease"">angioedema</span>, refractory to conventional treatment including glucocorticosteroids, H1 and H2 blockers, nonsteroidal antiinflammatory agents, methotrexate, <span class=""chemical"">hydroxychloroquine</span>, dapsone, azathioprine, intravenous gamma globulin, and plasma exchange, was successfully treated with interferon alpha 2a.",,8882052,8882052_D006886_D000799,8882052_1,bcv_sentence_task_befree_740,,770956667,FALSE,finalized,5,8/14/15 23:48,"

Used as a failed treatment.

",no_relation,1,,D006886,"<span class=""chemical"">hydroxychloroquine</span>",D014657,"<span class=""disease"">urticarial vasculitis</span>","A 68-year-old woman with a 5 yr history of chronic recurrent <span class=""disease"">urticarial vasculitis</span> with angioedema, refractory to conventional treatment including glucocorticosteroids, H1 and H2 blockers, nonsteroidal antiinflammatory agents, methotrexate, <span class=""chemical"">hydroxychloroquine</span>, dapsone, azathioprine, intravenous gamma globulin, and plasma exchange, was successfully treated with interferon alpha 2a.",,8882052,8882052_D006886_D014657,8882052_1,bcv_sentence_task_befree_741,,770956668,FALSE,finalized,5,8/15/15 1:43,"



",no_relation,1,,D008727,"<span class=""chemical"">methotrexate</span>",D014657,"<span class=""disease"">urticarial vasculitis</span>","A 68-year-old woman with a 5 yr history of chronic recurrent <span class=""disease"">urticarial vasculitis</span> with angioedema, refractory to conventional treatment including glucocorticosteroids, H1 and H2 blockers, nonsteroidal antiinflammatory agents, <span class=""chemical"">methotrexate</span>, hydroxychloroquine, dapsone, azathioprine, intravenous gamma globulin, and plasma exchange, was successfully treated with interferon alpha 2a.",,8882052,8882052_D008727_D014657,8882052_1,bcv_sentence_task_befree_742,,770956669,FALSE,finalized,5,8/14/15 20:58,"



",no_relation,0.7857,,D003622,"<span class=""chemical"">dapsone</span>",D014657,"<span class=""disease"">urticarial vasculitis</span>","A 68-year-old woman with a 5 yr history of chronic recurrent <span class=""disease"">urticarial vasculitis</span> with angioedema, refractory to conventional treatment including glucocorticosteroids, H1 and H2 blockers, nonsteroidal antiinflammatory agents, methotrexate, hydroxychloroquine, <span class=""chemical"">dapsone</span>, azathioprine, intravenous gamma globulin, and plasma exchange, was successfully treated with interferon alpha 2a.",,8882052,8882052_D003622_D014657,8882052_1,bcv_sentence_task_befree_743,,770956670,FALSE,finalized,5,8/14/15 20:50,"



",no_relation,1,,D001379,"<span class=""chemical"">azathioprine</span>",D000799,"<span class=""disease"">angioedema</span>","A 68-year-old woman with a 5 yr history of chronic recurrent urticarial vasculitis with <span class=""disease"">angioedema</span>, refractory to conventional treatment including glucocorticosteroids, H1 and H2 blockers, nonsteroidal antiinflammatory agents, methotrexate, hydroxychloroquine, dapsone, <span class=""chemical"">azathioprine</span>, intravenous gamma globulin, and plasma exchange, was successfully treated with interferon alpha 2a.",,8882052,8882052_D001379_D000799,8882052_1,bcv_sentence_task_befree_744,,770956671,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,0.7941,,D001379,"<span class=""chemical"">azathioprine</span>",D014657,"<span class=""disease"">urticarial vasculitis</span>","A 68-year-old woman with a 5 yr history of chronic recurrent <span class=""disease"">urticarial vasculitis</span> with angioedema, refractory to conventional treatment including glucocorticosteroids, H1 and H2 blockers, nonsteroidal antiinflammatory agents, methotrexate, hydroxychloroquine, dapsone, <span class=""chemical"">azathioprine</span>, intravenous gamma globulin, and plasma exchange, was successfully treated with interferon alpha 2a.",,8882052,8882052_D001379_D014657,8882052_1,bcv_sentence_task_befree_745,,770956672,FALSE,finalized,5,8/15/15 2:07,"



",no_relation,1,,D005978,"<span class=""chemical"">glutathione</span>",C535575,"<span class=""disease"">head and neck squamous carcinoma</span>","Chemosensitivity of <span class=""disease"">head and neck squamous carcinoma</span> cell lines is not primarily correlated with <span class=""chemical"">glutathione</span> level but is modified by <span class=""chemical"">glutathione</span> depletion.",,8898974,8898974_D005978_C535575,8898974_0,bcv_sentence_task_befree_746,,770956674,FALSE,finalized,5,8/14/15 23:21,"



",no_relation,1,,D010984,"<span class=""chemical"">platinum</span>",D009369,"<span class=""disease"">tumor</span>","On the basis of this interaction with both endogenous and synthetic substances, glutathione and the key enzyme for its conjugation, glutathione S-transferase, appear to be critical determinants in <span class=""disease"">tumor</span> cell resistance to several antineoplastic drugs, e.g. <span class=""chemical"">platinum</span> analogs.",,8898974,8898974_D010984_D009369,8898974_2,bcv_sentence_task_befree_747,,770956675,FALSE,finalized,5,8/15/15 2:20,"



",no_relation,1,,D005978,"<span class=""chemical"">glutathione</span>",D009369,"<span class=""disease"">tumor</span>","On the basis of this interaction with both endogenous and synthetic substances, <span class=""chemical"">glutathione</span> and the key enzyme for its conjugation, <span class=""chemical"">glutathione</span> S-transferase, appear to be critical determinants in <span class=""disease"">tumor</span> cell resistance to several antineoplastic drugs, e.g. platinum analogs.",,8898974,8898974_D005978_D009369,8898974_2,bcv_sentence_task_befree_748,,770956676,FALSE,finalized,5,8/14/15 20:45,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D006258,"<span class=""disease"">head and neck cancer</span>","In ten established <span class=""disease"">head and neck cancer</span> cell lines (UM-SCC 10A, 10B, 11B, 14A, 14B, 14C, and 22B, HLac79, 8029NA, and 8029DDP4) chemosensitivity to <span class=""chemical"">cisplatin</span>, carboplatin, 5-fluorouracil, and bleomycin, as well as cellular glutathione content and activity of glutathione S-transferase were determined.",,8898974,8898974_D002945_D006258,8898974_3,bcv_sentence_task_befree_749,,770956677,FALSE,finalized,5,8/14/15 20:52,"



",no_relation,1,,D001761,"<span class=""chemical"">bleomycin</span>",D006258,"<span class=""disease"">head and neck cancer</span>","In ten established <span class=""disease"">head and neck cancer</span> cell lines (UM-SCC 10A, 10B, 11B, 14A, 14B, 14C, and 22B, HLac79, 8029NA, and 8029DDP4) chemosensitivity to cisplatin, carboplatin, 5-fluorouracil, and <span class=""chemical"">bleomycin</span>, as well as cellular glutathione content and activity of glutathione S-transferase were determined.",,8898974,8898974_D001761_D006258,8898974_3,bcv_sentence_task_befree_750,,770956678,FALSE,finalized,5,8/14/15 23:33,"



",no_relation,1,,D005472,"<span class=""chemical"">5-fluorouracil</span>",D006258,"<span class=""disease"">head and neck cancer</span>","In ten established <span class=""disease"">head and neck cancer</span> cell lines (UM-SCC 10A, 10B, 11B, 14A, 14B, 14C, and 22B, HLac79, 8029NA, and 8029DDP4) chemosensitivity to cisplatin, carboplatin, <span class=""chemical"">5-fluorouracil</span>, and bleomycin, as well as cellular glutathione content and activity of glutathione S-transferase were determined.",,8898974,8898974_D005472_D006258,8898974_3,bcv_sentence_task_befree_751,,770956679,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,0.8022,,D016190,"<span class=""chemical"">carboplatin</span>",D006258,"<span class=""disease"">head and neck cancer</span>","In ten established <span class=""disease"">head and neck cancer</span> cell lines (UM-SCC 10A, 10B, 11B, 14A, 14B, 14C, and 22B, HLac79, 8029NA, and 8029DDP4) chemosensitivity to cisplatin, <span class=""chemical"">carboplatin</span>, 5-fluorouracil, and bleomycin, as well as cellular glutathione content and activity of glutathione S-transferase were determined.",,8898974,8898974_D016190_D006258,8898974_3,bcv_sentence_task_befree_752,,770956680,FALSE,finalized,5,8/14/15 20:27,"



",no_relation,1,,D005978,"<span class=""chemical"">glutathione</span>",D006258,"<span class=""disease"">head and neck cancer</span>","In ten established <span class=""disease"">head and neck cancer</span> cell lines (UM-SCC 10A, 10B, 11B, 14A, 14B, 14C, and 22B, HLac79, 8029NA, and 8029DDP4) chemosensitivity to cisplatin, carboplatin, 5-fluorouracil, and bleomycin, as well as cellular <span class=""chemical"">glutathione</span> content and activity of <span class=""chemical"">glutathione</span> S-transferase were determined.",,8898974,8898974_D005978_D006258,8898974_3,bcv_sentence_task_befree_753,,770956681,FALSE,finalized,5,8/14/15 23:57,"



",no_relation,1,,D005978,"<span class=""chemical"">glutathione</span>",D009369,"<span class=""disease"">tumor</span>","The results revealed no correlation between the sensitivity of <span class=""disease"">tumor</span> cells to any of the drugs tested and the level of <span class=""chemical"">glutathione</span> or the activity of <span class=""chemical"">glutathione</span> S-transferase.",,8898974,8898974_D005978_D009369,8898974_4,bcv_sentence_task_befree_754,,770956682,FALSE,finalized,5,8/14/15 23:48,"



",no_relation,1,,D005978,"<span class=""chemical"">glutathione</span>",C537866,"<span class=""disease"">cross-resistance</span>","However, the cisplatin-resistant subpopulation 8029DDP4 showed the highest <span class=""chemical"">glutathione</span> level and marked <span class=""disease"">cross-resistance</span> to bleomycin.",,8898974,8898974_D005978_C537866,8898974_5,bcv_sentence_task_befree_755,,770956683,FALSE,finalized,5,8/15/15 0:39,"



",no_relation,1,,D001761,"<span class=""chemical"">bleomycin</span>",C537866,"<span class=""disease"">cross-resistance</span>","However, the cisplatin-resistant subpopulation 8029DDP4 showed the highest glutathione level and marked <span class=""disease"">cross-resistance</span> to <span class=""chemical"">bleomycin</span>.",,8898974,8898974_D001761_C537866,8898974_5,bcv_sentence_task_befree_756,,770956684,FALSE,finalized,5,8/15/15 0:08,"



",no_relation,0.8135,,D002945,"<span class=""chemical"">cisplatin</span>",C537866,"<span class=""disease"">cross-resistance</span>","However, the <span class=""chemical"">cisplatin</span>-resistant subpopulation 8029DDP4 showed the highest glutathione level and marked <span class=""disease"">cross-resistance</span> to bleomycin.",,8898974,8898974_D002945_C537866,8898974_5,bcv_sentence_task_befree_757,,770956685,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D005978,"<span class=""chemical"">glutathione</span>",D002277,"<span class=""disease"">carcinoma</span>","These results suggest that the level of <span class=""chemical"">glutathione</span> or the activity of <span class=""chemical"">glutathione</span> S-transferase is not a suitable parameter for the assessment of chemosensitivity in head and neck squamous-cell <span class=""disease"">carcinoma</span> lines.",,8898974,8898974_D005978_D002277,8898974_7,bcv_sentence_task_befree_758,,770956686,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,1,,C047340,"<span class=""chemical"">Levocabastine</span>",D003231,"<span class=""disease"">conjunctivitis</span>","<span class=""chemical"">Levocabastine</span> is a selective topical H1 antagonist, effective in the treatment of seasonal allergic rhinitis and <span class=""disease"">conjunctivitis</span>.",,8911706,8911706_C047340_D003231,8911706_1,bcv_sentence_task_befree_759,,770956687,FALSE,finalized,5,8/14/15 20:27,"



",no_relation,1,,C047340,"<span class=""chemical"">Levocabastine</span>",D006255,"<span class=""disease"">seasonal allergic rhinitis</span>","<span class=""chemical"">Levocabastine</span> is a selective topical H1 antagonist, effective in the treatment of <span class=""disease"">seasonal allergic rhinitis</span> and conjunctivitis.",,8911706,8911706_C047340_D006255,8911706_1,bcv_sentence_task_befree_760,,770956688,FALSE,finalized,5,8/15/15 2:07,"



",no_relation,0.8239,,C066304,"<span class=""chemical"">sertindole</span>",D012559,"<span class=""disease"">schizophrenia</span>","A randomized, controlled, dose-ranging trial of <span class=""chemical"">sertindole</span> in patients with <span class=""disease"">schizophrenia</span>.",,8935813,8935813_C066304_D012559,8935813_0,bcv_sentence_task_befree_761,,770956689,FALSE,finalized,5,8/14/15 22:12,"



",no_relation,1,,C066304,"<span class=""chemical"">sertindole</span>",D012559,"<span class=""disease"">schizophrenic</span>","This 40-day randomized, placebo-controlled, dose-ranging multicenter study was designed to assess the effect of <span class=""chemical"">sertindole</span> on previously neuroleptic-responsive, hospitalized <span class=""disease"">schizophrenic</span> patients (n = 205).",,8935813,8935813_C066304_D012559,8935813_2,bcv_sentence_task_befree_762,,770956690,FALSE,finalized,5,8/15/15 0:45,"



",no_relation,1,,C066304,"<span class=""chemical"">sertindole</span>",D001480,"<span class=""disease"">EPS</span>","<span class=""disease"">EPS</span>-related events were comparable in the placebo and <span class=""chemical"">sertindole</span> groups.",,8935813,8935813_C066304_D001480,8935813_8,bcv_sentence_task_befree_763,,770956691,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,1,,D000241,"<span class=""chemical"">adenosine</span>",C566351,"<span class=""disease"">various disorders</span>","Recent data support the evidence that <span class=""chemical"">adenosine</span> A2 receptor properties may prove useful in future drug development, and selective manipulation of receptor-associated biologic effects might be relevant in the treatment of <span class=""disease"">various disorders</span>, including psychiatric diseases, hypoxia/ischemia, inflammation or erythrocytosis.",,8940747,8940747_D000241_C566351,8940747_4,bcv_sentence_task_befree_764,,770956692,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,D000241,"<span class=""chemical"">adenosine</span>",D000860,"<span class=""disease"">hypoxia</span>","Recent data support the evidence that <span class=""chemical"">adenosine</span> A2 receptor properties may prove useful in future drug development, and selective manipulation of receptor-associated biologic effects might be relevant in the treatment of various disorders, including psychiatric diseases, <span class=""disease"">hypoxia</span>/ischemia, inflammation or erythrocytosis.",,8940747,8940747_D000241_D000860,8940747_4,bcv_sentence_task_befree_765,,770956693,FALSE,finalized,5,8/15/15 2:32,"



",no_relation,1,,D000241,"<span class=""chemical"">adenosine</span>",D001523,"<span class=""disease"">psychiatric diseases</span>","Recent data support the evidence that <span class=""chemical"">adenosine</span> A2 receptor properties may prove useful in future drug development, and selective manipulation of receptor-associated biologic effects might be relevant in the treatment of various disorders, including <span class=""disease"">psychiatric diseases</span>, hypoxia/ischemia, inflammation or erythrocytosis.",,8940747,8940747_D000241_D001523,8940747_4,bcv_sentence_task_befree_766,,770956694,FALSE,finalized,5,8/15/15 1:28,"



",no_relation,1,,D000241,"<span class=""chemical"">adenosine</span>",D007511,"<span class=""disease"">ischemia</span>","Recent data support the evidence that <span class=""chemical"">adenosine</span> A2 receptor properties may prove useful in future drug development, and selective manipulation of receptor-associated biologic effects might be relevant in the treatment of various disorders, including psychiatric diseases, hypoxia/<span class=""disease"">ischemia</span>, inflammation or erythrocytosis.",,8940747,8940747_D000241_D007511,8940747_4,bcv_sentence_task_befree_767,,770956695,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,D000241,"<span class=""chemical"">adenosine</span>",D007249,"<span class=""disease"">inflammation</span>","Recent data support the evidence that <span class=""chemical"">adenosine</span> A2 receptor properties may prove useful in future drug development, and selective manipulation of receptor-associated biologic effects might be relevant in the treatment of various disorders, including psychiatric diseases, hypoxia/ischemia, <span class=""disease"">inflammation</span> or erythrocytosis.",,8940747,8940747_D000241_D007249,8940747_4,bcv_sentence_task_befree_768,,770956696,FALSE,finalized,5,8/15/15 1:14,"



",no_relation,1,,D018698,"<span class=""chemical"">Glutamine</span>",D009369,"<span class=""disease"">cancer</span>","<span class=""chemical"">Glutamine</span>, <span class=""disease"">cancer</span>, and its therapy.",,8942537,8942537_D018698_D009369,8942537_1,bcv_sentence_task_befree_769,,770956697,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D018698,"<span class=""chemical"">glutamine</span>",D009369,"<span class=""disease"">tumor/cancer</span>","This overview on <span class=""chemical"">glutamine</span>, <span class=""disease"">cancer</span> and its therapy discusses some of the in vitro and in vivo work on <span class=""chemical"">glutamine</span> and <span class=""disease"">tumor</span> growth, and summarizes animal and human data on the potential benefits of <span class=""chemical"">glutamine</span> in the <span class=""disease"">tumor</span>-bearing host receiving radiation or chemotherapy.",,8942537,8942537_D018698_D009369,8942537_2,bcv_sentence_task_befree_770,,770956698,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,0.6202,,D018698,"<span class=""chemical"">glutamine</span>",D002100,"<span class=""disease"">cachexia</span>","A tumor can act as a ""<span class=""chemical"">glutamine</span> trap,"" depleting host <span class=""chemical"">glutamine</span> stores and resulting in <span class=""disease"">cachexia</span>.",,8942537,8942537_D018698_D002100,8942537_4,bcv_sentence_task_befree_771,,770956699,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,1,,D018698,"<span class=""chemical"">glutamine</span>",D009369,"<span class=""disease"">tumor</span>","A <span class=""disease"">tumor</span> can act as a ""<span class=""chemical"">glutamine</span> trap,"" depleting host <span class=""chemical"">glutamine</span> stores and resulting in cachexia.",,8942537,8942537_D018698_D009369,8942537_4,bcv_sentence_task_befree_772,,770956700,FALSE,finalized,5,8/15/15 0:57,"



",no_relation,0.5787,,D018698,"<span class=""chemical"">glutamine</span>",D019966,"<span class=""disease"">dependence</span>","In vitro evidence of the <span class=""disease"">dependence</span> of tumor growth on <span class=""chemical"">glutamine</span> has deterred its use in the clinic setting.",,8942537,8942537_D018698_D019966,8942537_5,bcv_sentence_task_befree_773,,770956701,FALSE,finalized,5,8/15/15 0:47,"



",yes_direct,0.8076,,D018698,"<span class=""chemical"">glutamine</span>",D009369,"<span class=""disease"">tumor</span>","In vitro evidence of the dependence of <span class=""disease"">tumor</span> growth on <span class=""chemical"">glutamine</span> has deterred its use in the clinic setting.",,8942537,8942537_D018698_D009369,8942537_5,bcv_sentence_task_befree_774,,770956702,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,D018698,"<span class=""chemical"">glutamine</span>",D009369,"<span class=""disease"">tumor</span>","Data from a variety of investigations studying <span class=""chemical"">glutamine</span>'s interaction with the <span class=""disease"">tumor</span>-bearing host receiving radiation or chemotherapy were compiled and summarized.",,8942537,8942537_D018698_D009369,8942537_6,bcv_sentence_task_befree_775,,770956703,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,D018698,"<span class=""chemical"">glutamine</span>",D009369,"<span class=""disease"">tumors</span>","A large body of evidence in vivo suggests that supplemental <span class=""chemical"">glutamine</span> does not make <span class=""disease"">tumors</span> grow but in fact results in decreased growth through stimulation of the immune system.",,8942537,8942537_D018698_D009369,8942537_7,bcv_sentence_task_befree_776,,770956704,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,1,,D018698,"<span class=""chemical"">glutamine</span>",D009369,"<span class=""disease"">tumor</span>","When given with radiation or chemotherapy, <span class=""chemical"">glutamine</span> protects the host and actually increases the selectivity of therapy for the <span class=""disease"">tumor</span>.",,8942537,8942537_D018698_D009369,8942537_8,bcv_sentence_task_befree_777,,770956705,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,1,,D002166,"<span class=""chemical"">camptothecin</span>",D008228,"<span class=""disease"">non-Hodgkin's lymphoma</span>","The <span class=""chemical"">camptothecin</span> derivative irinotecan (CPT-11) has been shown to possess antitumor activity in phase II trials for patients with carcinoma of the lung, cervix, ovary, colon, or rectum and for patients with <span class=""disease"">non-Hodgkin's lymphoma</span>.",,8996518,8996518_D002166_D008228,8996518_2,bcv_sentence_task_befree_778,,770956706,FALSE,finalized,5,8/14/15 20:58,"



",no_relation,1,,C051890,"<span class=""chemical"">irinotecan</span>",D008171,"<span class=""disease"">carcinoma of the lung</span>","The camptothecin derivative <span class=""chemical"">irinotecan</span> (CPT-11) has been shown to possess antitumor activity in phase II trials for patients with <span class=""disease"">carcinoma of the lung</span>, cervix, ovary, colon, or rectum and for patients with non-Hodgkin's lymphoma.",,8996518,8996518_C051890_D008171,8996518_2,bcv_sentence_task_befree_779,,770956707,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,1,,D002166,"<span class=""chemical"">camptothecin</span>",D008171,"<span class=""disease"">carcinoma of the lung</span>","The <span class=""chemical"">camptothecin</span> derivative irinotecan (CPT-11) has been shown to possess antitumor activity in phase II trials for patients with <span class=""disease"">carcinoma of the lung</span>, cervix, ovary, colon, or rectum and for patients with non-Hodgkin's lymphoma.",,8996518,8996518_D002166_D008171,8996518_2,bcv_sentence_task_befree_780,,770956708,FALSE,finalized,5,8/14/15 23:59,"



",no_relation,1,,C051890,"<span class=""chemical"">irinotecan</span>",D008228,"<span class=""disease"">non-Hodgkin's lymphoma</span>","The camptothecin derivative <span class=""chemical"">irinotecan</span> (CPT-11) has been shown to possess antitumor activity in phase II trials for patients with carcinoma of the lung, cervix, ovary, colon, or rectum and for patients with <span class=""disease"">non-Hodgkin's lymphoma</span>.",,8996518,8996518_C051890_D008228,8996518_2,bcv_sentence_task_befree_781,,770956709,FALSE,finalized,5,8/14/15 20:45,"



",no_relation,1,,D002066,"<span class=""chemical"">busulfan</span>",D005910,"<span class=""disease"">gliomas</span>","Tumors included childhood high-grade <span class=""disease"">gliomas</span> (D-212 MG, D-456 MG), adult high-grade <span class=""disease"">gliomas</span> (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to <span class=""chemical"">busulfan</span> (D-456 MG (BR)), cyclophosphamide (TE-671 CR), procarbazine (D-245 MG (PR)) or melphalan (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D002066_D005910,8996518_4,bcv_sentence_task_befree_782,,770956710,FALSE,finalized,5,8/14/15 22:29,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D005910,"<span class=""disease"">gliomas</span>","Tumors included childhood high-grade <span class=""disease"">gliomas</span> (D-212 MG, D-456 MG), adult high-grade <span class=""disease"">gliomas</span> (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to busulfan (D-456 MG (BR)), <span class=""chemical"">cyclophosphamide</span> (TE-671 CR), procarbazine (D-245 MG (PR)) or melphalan (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D003520_D005910,8996518_4,bcv_sentence_task_befree_783,,770956711,FALSE,finalized,5,8/14/15 23:38,"

Used as a useless treatment

",no_relation,1,,D011344,"<span class=""chemical"">procarbazine</span>",D012208,"<span class=""disease"">rhabdomyosarcoma</span>","Tumors included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a <span class=""disease"">rhabdomyosarcoma</span> (TE-671), as well as sublines with demonstrated resistance to busulfan (D-456 MG (BR)), cyclophosphamide (TE-671 CR), <span class=""chemical"">procarbazine</span> (D-245 MG (PR)) or melphalan (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D011344_D012208,8996518_4,bcv_sentence_task_befree_784,,770956712,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,1,,D008558,"<span class=""chemical"">melphalan</span>",D012208,"<span class=""disease"">rhabdomyosarcoma</span>","Tumors included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a <span class=""disease"">rhabdomyosarcoma</span> (TE-671), as well as sublines with demonstrated resistance to busulfan (D-456 MG (BR)), cyclophosphamide (TE-671 CR), procarbazine (D-245 MG (PR)) or <span class=""chemical"">melphalan</span> (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D008558_D012208,8996518_4,bcv_sentence_task_befree_785,,770956713,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,0.8136,,D011344,"<span class=""chemical"">procarbazine</span>",D009369,"<span class=""disease"">Tumors</span>","<span class=""disease"">Tumors</span> included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to busulfan (D-456 MG (BR)), cyclophosphamide (TE-671 CR), <span class=""chemical"">procarbazine</span> (D-245 MG (PR)) or melphalan (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D011344_D009369,8996518_4,bcv_sentence_task_befree_786,,770956714,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,D008558,"<span class=""chemical"">melphalan</span>",D009369,"<span class=""disease"">Tumors</span>","<span class=""disease"">Tumors</span> included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to busulfan (D-456 MG (BR)), cyclophosphamide (TE-671 CR), procarbazine (D-245 MG (PR)) or <span class=""chemical"">melphalan</span> (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D008558_D009369,8996518_4,bcv_sentence_task_befree_787,,770956715,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,D002066,"<span class=""chemical"">busulfan</span>",D008527,"<span class=""disease"">medulloblastomas</span>","Tumors included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), <span class=""disease"">medulloblastomas</span> (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to <span class=""chemical"">busulfan</span> (D-456 MG (BR)), cyclophosphamide (TE-671 CR), procarbazine (D-245 MG (PR)) or melphalan (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D002066_D008527,8996518_4,bcv_sentence_task_befree_788,,770956716,FALSE,finalized,5,8/14/15 20:34,"



",no_relation,1,,D002066,"<span class=""chemical"">busulfan</span>",D004806,"<span class=""disease"">ependymomas</span>","Tumors included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), <span class=""disease"">ependymomas</span> (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to <span class=""chemical"">busulfan</span> (D-456 MG (BR)), cyclophosphamide (TE-671 CR), procarbazine (D-245 MG (PR)) or melphalan (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D002066_D004806,8996518_4,bcv_sentence_task_befree_789,,770956717,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,1,,D008558,"<span class=""chemical"">melphalan</span>",D004806,"<span class=""disease"">ependymomas</span>","Tumors included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), <span class=""disease"">ependymomas</span> (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to busulfan (D-456 MG (BR)), cyclophosphamide (TE-671 CR), procarbazine (D-245 MG (PR)) or <span class=""chemical"">melphalan</span> (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D008558_D004806,8996518_4,bcv_sentence_task_befree_790,,770956718,FALSE,finalized,5,8/14/15 21:46,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D012208,"<span class=""disease"">rhabdomyosarcoma</span>","Tumors included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a <span class=""disease"">rhabdomyosarcoma</span> (TE-671), as well as sublines with demonstrated resistance to busulfan (D-456 MG (BR)), <span class=""chemical"">cyclophosphamide</span> (TE-671 CR), procarbazine (D-245 MG (PR)) or melphalan (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D003520_D012208,8996518_4,bcv_sentence_task_befree_791,,770956719,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,D002066,"<span class=""chemical"">busulfan</span>",D009369,"<span class=""disease"">Tumors</span>","<span class=""disease"">Tumors</span> included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to <span class=""chemical"">busulfan</span> (D-456 MG (BR)), cyclophosphamide (TE-671 CR), procarbazine (D-245 MG (PR)) or melphalan (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D002066_D009369,8996518_4,bcv_sentence_task_befree_792,,770956720,FALSE,finalized,5,8/14/15 20:58,"



",no_relation,1,,D011344,"<span class=""chemical"">procarbazine</span>",D005910,"<span class=""disease"">gliomas</span>","Tumors included childhood high-grade <span class=""disease"">gliomas</span> (D-212 MG, D-456 MG), adult high-grade <span class=""disease"">gliomas</span> (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to busulfan (D-456 MG (BR)), cyclophosphamide (TE-671 CR), <span class=""chemical"">procarbazine</span> (D-245 MG (PR)) or melphalan (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D011344_D005910,8996518_4,bcv_sentence_task_befree_793,,770956721,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,1,,D008558,"<span class=""chemical"">melphalan</span>",D005910,"<span class=""disease"">gliomas</span>","Tumors included childhood high-grade <span class=""disease"">gliomas</span> (D-212 MG, D-456 MG), adult high-grade <span class=""disease"">gliomas</span> (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to busulfan (D-456 MG (BR)), cyclophosphamide (TE-671 CR), procarbazine (D-245 MG (PR)) or <span class=""chemical"">melphalan</span> (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D008558_D005910,8996518_4,bcv_sentence_task_befree_794,,770956722,FALSE,finalized,5,8/14/15 20:31,"



",no_relation,1,,D011344,"<span class=""chemical"">procarbazine</span>",D008527,"<span class=""disease"">medulloblastomas</span>","Tumors included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), <span class=""disease"">medulloblastomas</span> (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to busulfan (D-456 MG (BR)), cyclophosphamide (TE-671 CR), <span class=""chemical"">procarbazine</span> (D-245 MG (PR)) or melphalan (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D011344_D008527,8996518_4,bcv_sentence_task_befree_795,,770956723,FALSE,finalized,5,8/15/15 2:09,"



",no_relation,1,,D002066,"<span class=""chemical"">busulfan</span>",D012208,"<span class=""disease"">rhabdomyosarcoma</span>","Tumors included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a <span class=""disease"">rhabdomyosarcoma</span> (TE-671), as well as sublines with demonstrated resistance to <span class=""chemical"">busulfan</span> (D-456 MG (BR)), cyclophosphamide (TE-671 CR), procarbazine (D-245 MG (PR)) or melphalan (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D002066_D012208,8996518_4,bcv_sentence_task_befree_796,,770956724,FALSE,finalized,5,8/14/15 23:49,"



",no_relation,1,,D011344,"<span class=""chemical"">procarbazine</span>",D004806,"<span class=""disease"">ependymomas</span>","Tumors included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), <span class=""disease"">ependymomas</span> (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to busulfan (D-456 MG (BR)), cyclophosphamide (TE-671 CR), <span class=""chemical"">procarbazine</span> (D-245 MG (PR)) or melphalan (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D011344_D004806,8996518_4,bcv_sentence_task_befree_797,,770956725,FALSE,finalized,5,8/14/15 20:48,"
al simplificar las palabras es mas entendible para uno que no es medico en este tipo de tarea...thanksss


",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D008527,"<span class=""disease"">medulloblastomas</span>","Tumors included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), <span class=""disease"">medulloblastomas</span> (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to busulfan (D-456 MG (BR)), <span class=""chemical"">cyclophosphamide</span> (TE-671 CR), procarbazine (D-245 MG (PR)) or melphalan (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D003520_D008527,8996518_4,bcv_sentence_task_befree_798,,770956726,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,1,,D008558,"<span class=""chemical"">melphalan</span>",D008527,"<span class=""disease"">medulloblastomas</span>","Tumors included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), <span class=""disease"">medulloblastomas</span> (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to busulfan (D-456 MG (BR)), cyclophosphamide (TE-671 CR), procarbazine (D-245 MG (PR)) or <span class=""chemical"">melphalan</span> (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D008558_D008527,8996518_4,bcv_sentence_task_befree_799,,770956727,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D009369,"<span class=""disease"">Tumors</span>","<span class=""disease"">Tumors</span> included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), ependymomas (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to busulfan (D-456 MG (BR)), <span class=""chemical"">cyclophosphamide</span> (TE-671 CR), procarbazine (D-245 MG (PR)) or melphalan (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D003520_D009369,8996518_4,bcv_sentence_task_befree_800,,770956728,FALSE,finalized,5,8/15/15 0:23,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D004806,"<span class=""disease"">ependymomas</span>","Tumors included childhood high-grade gliomas (D-212 MG, D-456 MG), adult high-grade gliomas (D-54 MG, D-245 MG), medulloblastomas (D341 Med, D487 Med), <span class=""disease"">ependymomas</span> (D528 EP, D612 EP), and a rhabdomyosarcoma (TE-671), as well as sublines with demonstrated resistance to busulfan (D-456 MG (BR)), <span class=""chemical"">cyclophosphamide</span> (TE-671 CR), procarbazine (D-245 MG (PR)) or melphalan (TE-671 MR), growing subcutaneously and intracranially in athymic nude mice.",,8996518,8996518_D003520_D004806,8996518_4,bcv_sentence_task_befree_801,,770956729,FALSE,finalized,5,8/15/15 0:49,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D009369,"<span class=""disease"">tumor</span>","CPT-11 produced statistically significant (P < 0.001) growth delays in all subcutaneous xenografts tested, including those resistant to busulfan, <span class=""chemical"">cyclophosphamide</span>, procarbazine, and melphalan, with growth delays ranging from 21.3 days in D487 Med to 90+ days in several <span class=""disease"">tumor</span> lines.",,8996518,8996518_D003520_D009369,8996518_6,bcv_sentence_task_befree_802,,770956730,FALSE,finalized,5,8/15/15 1:24,"



",no_relation,1,,D002066,"<span class=""chemical"">busulfan</span>",D009369,"<span class=""disease"">tumor</span>","CPT-11 produced statistically significant (P < 0.001) growth delays in all subcutaneous xenografts tested, including those resistant to <span class=""chemical"">busulfan</span>, cyclophosphamide, procarbazine, and melphalan, with growth delays ranging from 21.3 days in D487 Med to 90+ days in several <span class=""disease"">tumor</span> lines.",,8996518,8996518_D002066_D009369,8996518_6,bcv_sentence_task_befree_803,,770956731,FALSE,finalized,5,8/14/15 22:49,"



",no_relation,1,,C051890,"<span class=""chemical"">CPT-11</span>",D009369,"<span class=""disease"">tumor</span>","<span class=""chemical"">CPT-11</span> produced statistically significant (P < 0.001) growth delays in all subcutaneous xenografts tested, including those resistant to busulfan, cyclophosphamide, procarbazine, and melphalan, with growth delays ranging from 21.3 days in D487 Med to 90+ days in several <span class=""disease"">tumor</span> lines.",,8996518,8996518_C051890_D009369,8996518_6,bcv_sentence_task_befree_804,,770956732,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,1,,D011344,"<span class=""chemical"">procarbazine</span>",D009369,"<span class=""disease"">tumor</span>","CPT-11 produced statistically significant (P < 0.001) growth delays in all subcutaneous xenografts tested, including those resistant to busulfan, cyclophosphamide, <span class=""chemical"">procarbazine</span>, and melphalan, with growth delays ranging from 21.3 days in D487 Med to 90+ days in several <span class=""disease"">tumor</span> lines.",,8996518,8996518_D011344_D009369,8996518_6,bcv_sentence_task_befree_805,,770956733,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,1,,D013806,"<span class=""chemical"">theophylline</span>",D003680,"<span class=""disease"">impaired or difficult deglutition</span>","Microcapsules of <span class=""chemical"">theophylline</span>, administered as a suspension in water, proved to be a suitable dosage form for a clientele with <span class=""disease"">impaired or difficult deglutition</span>.",,8996853,8996853_D013806_D003680,8996853_2,bcv_sentence_task_befree_806,,770956734,FALSE,finalized,5,8/14/15 20:41,"



",no_relation,1,,D013806,"<span class=""chemical"">theophylline</span>",D001249,"<span class=""disease"">asthma</span>","Maximum serum levels of 9.6 micrograms/ml and 10.0 micrograms/ml were attained 6.6 and 6.1 hours after dosing of T1 and T2, coinciding perfectly with the time of the critical morning dip at 2-4 a.m. With a nocturnal excess of 15.5% (T1) and 17.9% (T2) this circadian-tailored asymmetric dosage regimen proved to take into account the chronopathology of <span class=""disease"">asthma</span> and the chronopharmacokinetics of <span class=""chemical"">theophylline</span> sustained-release preparations.",,8996853,8996853_D013806_D001249,8996853_6,bcv_sentence_task_befree_807,,770956735,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,0.5984,,D001285,"<span class=""chemical"">atropine</span>",D015835,"<span class=""disease"">colonic motility</span>","Effect of cholecystokinin octapeptide and <span class=""chemical"">atropine</span> on human <span class=""disease"">colonic motility</span>, tone, and transit.",,9009112,9009112_D001285_D015835,9009112_0,bcv_sentence_task_befree_808,,770956736,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,1,,D001285,"<span class=""chemical"">Atropine</span>",D015835,"<span class=""disease"">colonic motility</span>","<span class=""chemical"">Atropine</span> was used as control to demonstrate responsiveness of selected parameters of <span class=""disease"">colonic motility</span>.",,9009112,9009112_D001285_D015835,9009112_4,bcv_sentence_task_befree_809,,770956737,FALSE,finalized,5,8/14/15 20:42,"



",no_relation,0.6081,,D015016,"<span class=""chemical"">yohimbine</span>",D013313,"<span class=""disease"">posttraumatic stress disorder</span>","Positron emission tomography measurement of cerebral metabolic correlates of <span class=""chemical"">yohimbine</span> administration in combat-related <span class=""disease"">posttraumatic stress disorder</span>.",,9075465,9075465_D015016_D013313,9075465_0,bcv_sentence_task_befree_810,,770956738,FALSE,finalized,5,8/14/15 20:39,"



",no_relation,0.591,,D009638,"<span class=""chemical"">norepinephrine</span>",D001008,"<span class=""disease"">anxiety</span>","We have previously reported an increase in symptoms of <span class=""disease"">anxiety</span> in patients with posttraumatic stress disorder (PTSD) following administration of the beta 2-antagonist yohimbine, which stimulates brain <span class=""chemical"">norepinephrine</span> release.",,9075465,9075465_D009638_D001008,9075465_1,bcv_sentence_task_befree_811,,770956739,FALSE,finalized,5,8/14/15 20:38,"



",yes_direct,0.5908,,D015016,"<span class=""chemical"">yohimbine</span>",D013313,"<span class=""disease"">posttraumatic stress disorder/PTSD</span>","We have previously reported an increase in symptoms of anxiety in patients with <span class=""disease"">posttraumatic stress disorder</span> (<span class=""disease"">PTSD</span>) following administration of the beta 2-antagonist <span class=""chemical"">yohimbine</span>, which stimulates brain norepinephrine release.",,9075465,9075465_D015016_D013313,9075465_1,bcv_sentence_task_befree_812,,770956740,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,0.5893,,D009638,"<span class=""chemical"">norepinephrine</span>",D013313,"<span class=""disease"">posttraumatic stress disorder/PTSD</span>","We have previously reported an increase in symptoms of anxiety in patients with <span class=""disease"">posttraumatic stress disorder</span> (<span class=""disease"">PTSD</span>) following administration of the beta 2-antagonist yohimbine, which stimulates brain <span class=""chemical"">norepinephrine</span> release.",,9075465,9075465_D009638_D013313,9075465_1,bcv_sentence_task_befree_813,,770956741,FALSE,finalized,5,8/15/15 0:27,"



",yes_direct,1,,D015016,"<span class=""chemical"">yohimbine</span>",D001008,"<span class=""disease"">anxiety</span>","We have previously reported an increase in symptoms of <span class=""disease"">anxiety</span> in patients with posttraumatic stress disorder (PTSD) following administration of the beta 2-antagonist <span class=""chemical"">yohimbine</span>, which stimulates brain norepinephrine release.",,9075465,9075465_D015016_D001008,9075465_1,bcv_sentence_task_befree_814,,770956742,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,D015016,"<span class=""chemical"">yohimbine</span>",D013313,"<span class=""disease"">PTSD</span>","We used positron emission tomography and fludeoxyglucose F 18 to measure brain metabolism in Vietnam combat veterans with <span class=""disease"">PTSD</span> (n = 10) and healthy age-matched control subjects (n = 10), following administration of <span class=""chemical"">yohimbine</span> (0.4 mg/kg) or placebo in a randomized, double-blind fashion.",,9075465,9075465_D015016_D013313,9075465_3,bcv_sentence_task_befree_815,,770956743,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,0.6319,,D015016,"<span class=""chemical"">Yohimbine</span>",D013313,"<span class=""disease"">PTSD</span>","<span class=""chemical"">Yohimbine</span> resulted in a significant increase in anxiety in the patients with <span class=""disease"">PTSD</span>, but not in healthy subjects.",,9075465,9075465_D015016_D013313,9075465_4,bcv_sentence_task_befree_816,,770956744,FALSE,finalized,5,8/14/15 22:23,"



Only in PTSD patients, making the third option also technically correct.",yes_direct,1,,D015016,"<span class=""chemical"">Yohimbine</span>",D001008,"<span class=""disease"">anxiety</span>","<span class=""chemical"">Yohimbine</span> resulted in a significant increase in <span class=""disease"">anxiety</span> in the patients with PTSD, but not in healthy subjects.",,9075465,9075465_D015016_D001008,9075465_4,bcv_sentence_task_befree_817,,770956745,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,1,,D015016,"<span class=""chemical"">yohimbine</span>",D013313,"<span class=""disease"">PTSD</span>","There was a significant difference in brain metabolic response to <span class=""chemical"">yohimbine</span> in patients with <span class=""disease"">PTSD</span> compared with healthy subjects in prefrontal, temporal, parietal, and orbitofrontal cortexes.",,9075465,9075465_D015016_D013313,9075465_5,bcv_sentence_task_befree_818,,770956746,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,D015016,"<span class=""chemical"">yohimbine</span>",D013313,"<span class=""disease"">PTSD</span>","Metabolism tended to decrease in patients with <span class=""disease"">PTSD</span> and increase in healthy subjects following administration of <span class=""chemical"">yohimbine</span>.",,9075465,9075465_D015016_D013313,9075465_6,bcv_sentence_task_befree_819,,770956747,FALSE,finalized,5,8/14/15 20:42,"



",no_relation,0.8077,,D015016,"<span class=""chemical"">yohimbine</span>",D013313,"<span class=""disease"">PTSD</span>","These findings are consistent with our previous hypothesis of enhanced norepinephrine release in the brain with <span class=""chemical"">yohimbine</span> in patients with <span class=""disease"">PTSD</span>.",,9075465,9075465_D015016_D013313,9075465_7,bcv_sentence_task_befree_820,,770956748,FALSE,finalized,5,8/15/15 0:39,"



",no_relation,0.8198,,D009638,"<span class=""chemical"">norepinephrine</span>",D013313,"<span class=""disease"">PTSD</span>","These findings are consistent with our previous hypothesis of enhanced <span class=""chemical"">norepinephrine</span> release in the brain with yohimbine in patients with <span class=""disease"">PTSD</span>.",,9075465,9075465_D009638_D013313,9075465_7,bcv_sentence_task_befree_821,,770956749,FALSE,finalized,5,8/14/15 22:04,"



",no_relation,1,,D002701,"<span class=""chemical"">chloramphenicol</span>",D014435,"<span class=""disease"">typhoid fever</span>","In 28 children, with bacteriologically and/or serologically diagnosed <span class=""disease"">typhoid fever</span> treated at KEM Hospital, Bombay in 1991, initially one of the three recommended drugs (viz. <span class=""chemical"">chloramphenicol</span>, amoxycillin or co-trimoxazole) was given for 7 days for defervescence to occur.",,9136240,9136240_D002701_D014435,9136240_1,bcv_sentence_task_befree_822,,770956750,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,D000658,"<span class=""chemical"">amoxycillin</span>",D014435,"<span class=""disease"">typhoid fever</span>","In 28 children, with bacteriologically and/or serologically diagnosed <span class=""disease"">typhoid fever</span> treated at KEM Hospital, Bombay in 1991, initially one of the three recommended drugs (viz. chloramphenicol, <span class=""chemical"">amoxycillin</span> or co-trimoxazole) was given for 7 days for defervescence to occur.",,9136240,9136240_D000658_D014435,9136240_1,bcv_sentence_task_befree_823,,770956751,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,0.6092,,D015662,"<span class=""chemical"">co-trimoxazole</span>",D014435,"<span class=""disease"">typhoid hepatitis</span>","There were no major complications, except 2 cases with <span class=""disease"">typhoid hepatitis</span> who responded to choramphenicol and <span class=""chemical"">co-trimoxazole</span>, respectively.",,9136240,9136240_D015662_D014435,9136240_7,bcv_sentence_task_befree_824,,770956752,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,1,,D014700,"<span class=""chemical"">verapamil</span>",D006973,"<span class=""disease"">hypertension</span>","Once-daily fixed dose combinations of <span class=""chemical"">verapamil</span> and trandolapril in black patients with mild to moderate <span class=""disease"">hypertension</span>: a new choice for first line treatment.",,9147707,9147707_D014700_D006973,9147707_0,bcv_sentence_task_befree_825,,770956753,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,C052035,"<span class=""chemical"">trandolapril</span>",D006973,"<span class=""disease"">hypertension</span>","Once-daily fixed dose combinations of verapamil and <span class=""chemical"">trandolapril</span> in black patients with mild to moderate <span class=""disease"">hypertension</span>: a new choice for first line treatment.",,9147707,9147707_C052035_D006973,9147707_0,bcv_sentence_task_befree_826,,770956754,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D006973,"<span class=""disease"">hypertension</span>","Using ambulatory blood pressure (BP) monitoring, a potent ACE-inhibitor/<span class=""chemical"">calcium</span> channel blocker combination was tested in 21 Black patients (age 52 +/- 10 years; 10 males, 11 females) with mild to moderate <span class=""disease"">hypertension</span> (mean 12-hour daytime diastolic BP > or = 90 mmHg and < or = 114 mmHg).",,9147707,9147707_D002118_D006973,9147707_1,bcv_sentence_task_befree_827,,770956755,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,0.5907,,D001971,"<span class=""chemical"">bromocriptine</span>",D000236,"<span class=""disease"">adenoma</span>","Transformation of a human mixed GH-PRL <span class=""disease"">adenoma</span> cell population in response to long-term <span class=""chemical"">bromocriptine</span> treatment.",,9151080,9151080_D001971_D000236,9151080_0,bcv_sentence_task_befree_828,,770956756,FALSE,finalized,5,8/14/15 20:46,"



",no_relation,1,,D010431,"<span class=""chemical"">Pentoxifylline</span>",D008288,"<span class=""disease"">malaria</span>","<span class=""chemical"">Pentoxifylline</span> and the two analogues HWA138 and HWA448, at concentrations exceeding 60 micrograms/ml, inhibited <span class=""disease"">malaria</span> antigen or lipopolysaccharide (LPS) induced TNF-alpha and IL-1 alpha secretion, but not IL-6 secretion, from human peripheral blood mononuclear cells in vitro.",,9160101,9160101_D010431_D008288,9160101_1,bcv_sentence_task_befree_829,,770956757,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,0.7852,,D010431,"<span class=""chemical"">pentoxifylline</span>",D064420,"<span class=""disease"">toxicity</span>","The <span class=""chemical"">pentoxifylline</span> analogues may have lower <span class=""disease"">toxicity</span> than <span class=""chemical"">pentoxifylline</span> itself and may therefore be useful in future treatment of diseases induced by endotoxic substances.",,9160101,9160101_D010431_D064420,9160101_8,bcv_sentence_task_befree_830,,770956758,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,D010431,"<span class=""chemical"">pentoxifylline</span>",D012772,"<span class=""disease"">endotoxic</span>","The <span class=""chemical"">pentoxifylline</span> analogues may have lower toxicity than <span class=""chemical"">pentoxifylline</span> itself and may therefore be useful in future treatment of diseases induced by <span class=""disease"">endotoxic</span> substances.",,9160101,9160101_D010431_D012772,9160101_8,bcv_sentence_task_befree_831,,770956759,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,1,,D010431,"<span class=""chemical"">pentoxifylline</span>",D004194,"<span class=""disease"">diseases</span>","The <span class=""chemical"">pentoxifylline</span> analogues may have lower toxicity than <span class=""chemical"">pentoxifylline</span> itself and may therefore be useful in future treatment of <span class=""disease"">diseases</span> induced by endotoxic substances.",,9160101,9160101_D010431_D004194,9160101_8,bcv_sentence_task_befree_832,,770956760,FALSE,finalized,5,8/15/15 1:20,"



",no_relation,0.4218,,D020106,"<span class=""chemical"">acrylamide</span>",D001167,"<span class=""disease"">neuropathy</span>","The increase in the rate of tubulin polymerization by <span class=""chemical"">acrylamide</span> and carbon disulfide treatment may alter the rate of transport of axonal constituents, including neurofilament, and contribute toward their accumulation in the focal swellings observed in this <span class=""disease"">neuropathy</span>.",,9165488,9165488_D020106_D001167,9165488_10,bcv_sentence_task_befree_833,,770956761,FALSE,finalized,5,8/14/15 20:49,"



",no_relation,0.7961,,D002246,"<span class=""chemical"">carbon disulfide</span>",D001167,"<span class=""disease"">neuropathy</span>","The increase in the rate of tubulin polymerization by acrylamide and <span class=""chemical"">carbon disulfide</span> treatment may alter the rate of transport of axonal constituents, including neurofilament, and contribute toward their accumulation in the focal swellings observed in this <span class=""disease"">neuropathy</span>.",,9165488,9165488_D002246_D001167,9165488_10,bcv_sentence_task_befree_834,,770956762,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,1,,D018967,"<span class=""chemical"">risperidone</span>",D012559,"<span class=""disease"">schizophrenia</span>","Does <span class=""chemical"">risperidone</span> improve verbal working memory in treatment-resistant <span class=""disease"">schizophrenia</span>?",,9167507,9167507_D018967_D012559,9167507_0,bcv_sentence_task_befree_835,,770956763,FALSE,finalized,5,8/15/15 2:29,"



",no_relation,1,,D006220,"<span class=""chemical"">haloperidol</span>",D012559,"<span class=""disease"">schizophrenic</span>","Verbal working memory of 59 treatment-resistant <span class=""disease"">schizophrenic</span> patients was assessed as part of a randomized, double-blind comparison of treatment with risperidone and <span class=""chemical"">haloperidol</span>.",,9167507,9167507_D006220_D012559,9167507_4,bcv_sentence_task_befree_836,,770956764,FALSE,finalized,5,8/14/15 20:38,"



",no_relation,1,,D018967,"<span class=""chemical"">risperidone</span>",D012559,"<span class=""disease"">schizophrenic</span>","Verbal working memory of 59 treatment-resistant <span class=""disease"">schizophrenic</span> patients was assessed as part of a randomized, double-blind comparison of treatment with <span class=""chemical"">risperidone</span> and haloperidol.",,9167507,9167507_D018967_D012559,9167507_4,bcv_sentence_task_befree_837,,770956765,FALSE,finalized,5,8/15/15 0:04,"



",no_relation,0.8032,,D001590,"<span class=""chemical"">benztropine</span>",D000341,"<span class=""disease"">psychotic symptoms</span>","The treatment effect remained significant after the effects of <span class=""chemical"">benztropine</span> cotreatment, change in <span class=""disease"">psychotic symptoms</span>, and change in negative symptoms were controlled.",,9167507,9167507_D001590_D000341,9167507_7,bcv_sentence_task_befree_838,,770956766,FALSE,finalized,5,8/14/15 23:54,"



",no_relation,1,,D012828,"<span class=""chemical"">silicone</span>",D009216,"<span class=""disease"">myopia</span>","We investigated the efficacy, safety, and stability of correction achieved with a <span class=""chemical"">silicone</span> posterior chamber intraocular lens used to correct high <span class=""disease"">myopia</span> in phakic eyes.",,9183752,9183752_D012828_D009216,9183752_1,bcv_sentence_task_befree_839,,770956767,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,1,,D012828,"<span class=""chemical"">silicone</span>",D009216,"<span class=""disease"">myopia</span>","A <span class=""chemical"">silicone</span> posterior chamber plate-style intraocular lens (Chiron, Adatomed) was implanted in 38 consecutive phakic eyes with high <span class=""disease"">myopia</span> (-7.00 to -28.00 diopters (D) over a period of 21 months.",,9183752,9183752_D012828_D009216,9183752_2,bcv_sentence_task_befree_840,,770956768,FALSE,finalized,5,8/15/15 0:46,"



",no_relation,1,,D000804,"<span class=""chemical"">angiotensin II</span>",D006333,"<span class=""disease"">heart failure</span>","Effects of <span class=""chemical"">angiotensin II</span> receptor blockade on N-terminal proatrial natriuretic factor plasma levels in chronic <span class=""disease"">heart failure</span>.",,9220306,9220306_D000804_D006333,9220306_0,bcv_sentence_task_befree_841,,770956769,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,1,,D000804,"<span class=""chemical"">angiotensin II</span>",D006333,"<span class=""disease"">heart failure</span>","This double-blind, placebo-controlled study investigated whether 12 weeks of treatment with the <span class=""chemical"">angiotensin II</span> receptor blocker losartan influenced N-terminal proANF plasma levels in 129 chronic <span class=""disease"">heart failure</span> patients.",,9220306,9220306_D000804_D006333,9220306_3,bcv_sentence_task_befree_842,,770956770,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D019808,"<span class=""chemical"">losartan</span>",D006333,"<span class=""disease"">heart failure</span>","This double-blind, placebo-controlled study investigated whether 12 weeks of treatment with the angiotensin II receptor blocker <span class=""chemical"">losartan</span> influenced N-terminal proANF plasma levels in 129 chronic <span class=""disease"">heart failure</span> patients.",,9220306,9220306_D019808_D006333,9220306_3,bcv_sentence_task_befree_843,,770956771,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,1,,D017035,"<span class=""chemical"">pravastatin</span>",D006937,"<span class=""disease"">hypercholesterolemia</span>","Most recently, a positive effect of cholesterol-lowering drugs (<span class=""chemical"">pravastatin</span>, lovastatin) on NPT has been observed in middle-aged males with chronic <span class=""disease"">hypercholesterolemia</span>.",,9226599,9226599_D017035_D006937,9226599_6,bcv_sentence_task_befree_844,,770956772,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,1,,D008148,"<span class=""chemical"">lovastatin</span>",D006937,"<span class=""disease"">hypercholesterolemia</span>","Most recently, a positive effect of cholesterol-lowering drugs (pravastatin, <span class=""chemical"">lovastatin</span>) on NPT has been observed in middle-aged males with chronic <span class=""disease"">hypercholesterolemia</span>.",,9226599,9226599_D008148_D006937,9226599_6,bcv_sentence_task_befree_845,,770956773,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D002784,"<span class=""chemical"">cholesterol</span>",D006937,"<span class=""disease"">hypercholesterolemia</span>","Most recently, a positive effect of <span class=""chemical"">cholesterol</span>-lowering drugs (pravastatin, lovastatin) on NPT has been observed in middle-aged males with chronic <span class=""disease"">hypercholesterolemia</span>.",,9226599,9226599_D002784_D006937,9226599_6,bcv_sentence_task_befree_846,,770956774,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,D017964,"<span class=""chemical"">Itraconazole</span>",D009062,"<span class=""disease"">oral candidosis</span>","<span class=""chemical"">Itraconazole</span> for treatment of <span class=""disease"">oral candidosis</span> in pediatric cancer patients.",,9240009,9240009_D017964_D009062,9240009_0,bcv_sentence_task_befree_847,,770956775,FALSE,finalized,5,8/14/15 21:46,"



",no_relation,1,,D017964,"<span class=""chemical"">Itraconazole</span>",D009369,"<span class=""disease"">pediatric cancer</span>","<span class=""chemical"">Itraconazole</span> for treatment of oral candidosis in <span class=""disease"">pediatric cancer</span> patients.",,9240009,9240009_D017964_D009369,9240009_0,bcv_sentence_task_befree_848,,770956776,FALSE,finalized,5,8/14/15 20:46,"



",no_relation,1,,D017964,"<span class=""chemical"">itraconazole</span>",D009062,"<span class=""disease"">oral candidosis</span>","The aim of this study is to evaluate the efficacy and side effects of <span class=""chemical"">itraconazole</span> on treatment of <span class=""disease"">oral candidosis</span>.",,9240009,9240009_D017964_D009062,9240009_3,bcv_sentence_task_befree_849,,770956777,FALSE,finalized,5,8/14/15 20:44,"



",no_relation,1,,D017964,"<span class=""chemical"">itraconazole</span>",D009062,"<span class=""disease"">oral candidosis</span>","Fourteen children with malignancy undergoing chemotherapy received <span class=""chemical"">itraconazole</span> 100-200 mg/day for 10 days to treat <span class=""disease"">oral candidosis</span>.",,9240009,9240009_D017964_D009062,9240009_4,bcv_sentence_task_befree_850,,770956778,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,1,,D017964,"<span class=""chemical"">itraconazole</span>",D016609,"<span class=""disease"">malignancy</span>","Fourteen children with <span class=""disease"">malignancy</span> undergoing chemotherapy received <span class=""chemical"">itraconazole</span> 100-200 mg/day for 10 days to treat oral candidosis.",,9240009,9240009_D017964_D016609,9240009_4,bcv_sentence_task_befree_851,,770956779,FALSE,finalized,5,8/14/15 20:42,"



",no_relation,1,,D005363,"<span class=""chemical"">psoralen</span>",D011565,"<span class=""disease"">psoriasis</span>","p53 mutation in squamous cell carcinomas from <span class=""disease"">psoriasis</span> patients treated with <span class=""chemical"">psoralen</span> + UVA (PUVA).",,9242514,9242514_D005363_D011565,9242514_0,bcv_sentence_task_befree_852,,770956780,FALSE,finalized,5,8/14/15 20:41,"



",no_relation,0.5988,,D005363,"<span class=""chemical"">psoralen</span>",D002294,"<span class=""disease"">squamous cell carcinomas</span>","p53 mutation in <span class=""disease"">squamous cell carcinomas</span> from psoriasis patients treated with <span class=""chemical"">psoralen</span> + UVA (PUVA).",,9242514,9242514_D005363_D002294,9242514_0,bcv_sentence_task_befree_853,,770956781,FALSE,finalized,5,8/14/15 21:00,"



",yes_direct,1,,D011803,"<span class=""chemical"">quinine</span>",D034381,"<span class=""disease"">hearing loss</span>","Reversible <span class=""disease"">hearing loss</span> is a known complication following the administration of <span class=""chemical"">quinine</span>, salicylates and other nonsteroidal anti-inflammatory drugs, and erythromycin.",,9270425,9270425_D011803_D034381,9270425_2,bcv_sentence_task_befree_854,,770956782,FALSE,finalized,5,8/14/15 20:48,"



",yes_direct,1,,D012459,"<span class=""chemical"">salicylates</span>",D034381,"<span class=""disease"">hearing loss</span>","Reversible <span class=""disease"">hearing loss</span> is a known complication following the administration of quinine, <span class=""chemical"">salicylates</span> and other nonsteroidal anti-inflammatory drugs, and erythromycin.",,9270425,9270425_D012459_D034381,9270425_2,bcv_sentence_task_befree_855,,770956783,FALSE,finalized,5,8/14/15 20:44,"



",yes_direct,1,,D004917,"<span class=""chemical"">erythromycin</span>",D034381,"<span class=""disease"">hearing loss</span>","Reversible <span class=""disease"">hearing loss</span> is a known complication following the administration of quinine, salicylates and other nonsteroidal anti-inflammatory drugs, and <span class=""chemical"">erythromycin</span>.",,9270425,9270425_D004917_D034381,9270425_2,bcv_sentence_task_befree_856,,770956784,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,1,,D004298,"<span class=""chemical"">dopamine</span>",D012559,"<span class=""disease"">schizophrenia</span>","Review the role of <span class=""chemical"">dopamine</span> D4 receptors in <span class=""disease"">schizophrenia</span> and antipsychotic action.",,9278187,9278187_D004298_D012559,9278187_0,bcv_sentence_task_befree_857,,770956785,FALSE,finalized,5,8/14/15 20:49,"



",yes_direct,0.8022,,D004298,"<span class=""chemical"">dopamine</span>",D012559,"<span class=""disease"">schizophrenia</span>","For the past 20 years the most enduring explanation for <span class=""disease"">schizophrenia</span> has been the <span class=""chemical"">dopamine</span> hypothesis, which proposes that the dopaminergic system is overactive in this widespread disease.",,9278187,9278187_D004298_D012559,9278187_1,bcv_sentence_task_befree_858,,770956786,FALSE,finalized,5,8/14/15 21:23,"



",no_relation,0.6062,,D004298,"<span class=""chemical"">dopamine</span>",D059350,"<span class=""disease"">widespread disease</span>","For the past 20 years the most enduring explanation for schizophrenia has been the <span class=""chemical"">dopamine</span> hypothesis, which proposes that the dopaminergic system is overactive in this <span class=""disease"">widespread disease</span>.",,9278187,9278187_D004298_D059350,9278187_1,bcv_sentence_task_befree_859,,770956787,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,0.5915,,D004298,"<span class=""chemical"">dopamine</span>",D012559,"<span class=""disease"">schizophrenic</span>","Classically, the D2 receptor formed the core of the <span class=""chemical"">dopamine</span> hypothesis since there was considerable evidence for elevations of D2 receptor levels in the brains of <span class=""disease"">schizophrenic</span> patients, and because these receptors served as the primary target in mediating antipsychotic effects of most neuroleptics.",,9278187,9278187_D004298_D012559,9278187_2,bcv_sentence_task_befree_860,,770956788,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,0.8075,,D003024,"<span class=""chemical"">clozapine</span>",D012559,"<span class=""disease"">schizophrenia</span>","The existence of these D4 polymorphisms raises the possibility that structural variations of this receptor may be associated with an increased susceptibility to <span class=""disease"">schizophrenia</span>, or observed variations in individual response to <span class=""chemical"">clozapine</span> treatment.",,9278187,9278187_D003024_D012559,9278187_8,bcv_sentence_task_befree_861,,770956789,FALSE,finalized,5,8/14/15 20:49,"



",no_relation,0.8209,,D003024,"<span class=""chemical"">clozapine</span>",D012559,"<span class=""disease"">schizophrenia</span>","Furthermore, no association was evident between the polymorphic forms of D4 and susceptibility to <span class=""disease"">schizophrenia</span>, or variable <span class=""chemical"">clozapine</span> response.",,9278187,9278187_D003024_D012559,9278187_10,bcv_sentence_task_befree_862,,770956790,FALSE,finalized,5,8/14/15 23:32,"



",no_relation,1,,D004298,"<span class=""chemical"">dopamine</span>",D012559,"<span class=""disease"">schizophrenia</span>","The observations which support the idea that D4 might serve as a target for clozapine have significantly modified and extended our understanding of mechanisms underlying atypical antipsychotic treatment of <span class=""disease"">schizophrenia</span>, as well as the <span class=""chemical"">dopamine</span> hypothesis for <span class=""disease"">schizophrenia</span>.",,9278187,9278187_D004298_D012559,9278187_12,bcv_sentence_task_befree_863,,770956791,FALSE,finalized,5,8/15/15 2:14,"



",no_relation,1,,D003024,"<span class=""chemical"">clozapine</span>",D012559,"<span class=""disease"">schizophrenia</span>","The observations which support the idea that D4 might serve as a target for <span class=""chemical"">clozapine</span> have significantly modified and extended our understanding of mechanisms underlying atypical antipsychotic treatment of <span class=""disease"">schizophrenia</span>, as well as the dopamine hypothesis for <span class=""disease"">schizophrenia</span>.",,9278187,9278187_D003024_D012559,9278187_12,bcv_sentence_task_befree_864,,770956792,FALSE,finalized,5,8/14/15 22:01,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D001008,"<span class=""disease"">anxiety</span>","There was no difference in pain intensity after the initial assessment, <span class=""chemical"">morphine</span> usage, mood, <span class=""disease"">anxiety</span>, and depression at any other measurement period.",,9338905,9338905_D009020_D001008,9338905_9,bcv_sentence_task_befree_865,,770956793,FALSE,finalized,5,8/14/15 20:43,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D010146,"<span class=""disease"">pain</span>","There was no difference in <span class=""disease"">pain</span> intensity after the initial assessment, <span class=""chemical"">morphine</span> usage, mood, anxiety, and depression at any other measurement period.",,9338905,9338905_D009020_D010146,9338905_9,bcv_sentence_task_befree_866,,770956794,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D003866,"<span class=""disease"">depression</span>","There was no difference in pain intensity after the initial assessment, <span class=""chemical"">morphine</span> usage, mood, anxiety, and <span class=""disease"">depression</span> at any other measurement period.",,9338905,9338905_D009020_D003866,9338905_9,bcv_sentence_task_befree_867,,770956795,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,1,,D002129,"<span class=""chemical"">calcium oxalate</span>",D000138,"<span class=""disease"">acidosis</span>","Ingestion of ethylene glycol, either accidentally or in a suicide attempt, is characterized by severe <span class=""disease"">acidosis</span>, <span class=""chemical"">calcium oxalate</span> crystal formation and deposition, and a wide variety of end organ effects that may be fatal.",,9348055,9348055_D002129_D000138,9348055_2,bcv_sentence_task_befree_868,,770956796,FALSE,finalized,5,8/15/15 2:31,"



",yes_direct,1,,D019855,"<span class=""chemical"">ethylene glycol</span>",D000138,"<span class=""disease"">acidosis</span>","Ingestion of <span class=""chemical"">ethylene glycol</span>, either accidentally or in a suicide attempt, is characterized by severe <span class=""disease"">acidosis</span>, calcium oxalate crystal formation and deposition, and a wide variety of end organ effects that may be fatal.",,9348055,9348055_D019855_D000138,9348055_2,bcv_sentence_task_befree_869,,770956797,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,0.5816,,D019855,"<span class=""chemical"">ethylene glycol</span>",D064420,"<span class=""disease"">toxicity</span>","A comprehensive review of the literature on the pathology and pathophysiology of <span class=""chemical"">ethylene glycol</span> <span class=""disease"">toxicity</span> on each organ system is provided, along with information on diagnosis and current treatment recommendations.",,9348055,9348055_D019855_D064420,9348055_4,bcv_sentence_task_befree_870,,770956798,FALSE,finalized,5,8/15/15 1:26,"



",no_relation,1,,D003401,"<span class=""chemical"">creatine</span>",D009203,"<span class=""disease"">myocardial infarction</span>","By measuring <span class=""chemical"">creatine</span> kinase (CK) MB levels preoperatively, at entry to the intensive care unit (ICU), and every 12 h for 48 h; and by obtaining serial 12-lead electrocardiograms (ECG) (preoperatively; 2, 4, 12, 24, and 48 h after ICU admission, 8:00 AM the morning after surgery; and 5 min pre- and postextubation), <span class=""disease"">myocardial infarction</span> was identified.",,9356086,9356086_D003401_D009203,9356086_6,bcv_sentence_task_befree_871,,770956799,FALSE,finalized,5,8/14/15 21:47,"



",yes_direct,0.5896,,D015742,"<span class=""chemical"">propofol</span>",D017202,"<span class=""disease"">myocardial ischemia</span>","This randomized study of patients after coronary artery bypass surgery examined whether light (versus heavy) sedation with <span class=""chemical"">propofol</span> in the intensive care unit was associated with an increased degree of <span class=""disease"">myocardial ischemia</span>.",,9356086,9356086_D015742_D017202,9356086_16,bcv_sentence_task_befree_872,,770956800,FALSE,finalized,5,8/14/15 23:00,"



",no_relation,1,,D005996,"<span class=""chemical"">glyceryl trinitrate</span>",D005401,"<span class=""disease"">chronic anal fissure</span>","A sample of 24 consecutive patients with <span class=""disease"">chronic anal fissure</span> was randomly allocated to treatment with sphincterotomy or local <span class=""chemical"">glyceryl trinitrate</span>.",,9369106,9369106_D005996_D005401,9369106_2,bcv_sentence_task_befree_873,,770956801,FALSE,finalized,5,8/15/15 1:39,"



",no_relation,1,,D005996,"<span class=""chemical"">glyceryl trinitrate</span>",D005401,"<span class=""disease"">chronic anal fissure</span>","Local application of <span class=""chemical"">glyceryl trinitrate</span> can avoid surgery in more than 80 percent of patients with <span class=""disease"">chronic anal fissure</span>.",,9369106,9369106_D005996_D005401,9369106_6,bcv_sentence_task_befree_874,,770956802,FALSE,finalized,5,8/15/15 0:34,"



",no_relation,0.7917,,D017258,"<span class=""chemical"">medroxyprogesterone acetate</span>",D009336,"<span class=""disease"">necrosis</span>","Effect of high-dose <span class=""chemical"">medroxyprogesterone acetate</span> on tumor <span class=""disease"">necrosis</span> factor-alpha release in patients with chemotherapy-induced neutropenia.",,9373794,9373794_D017258_D009336,9373794_0,bcv_sentence_task_befree_875,,770956803,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,0.8324,,D017258,"<span class=""chemical"">medroxyprogesterone acetate</span>",D009369,"<span class=""disease"">tumor</span>","Effect of high-dose <span class=""chemical"">medroxyprogesterone acetate</span> on <span class=""disease"">tumor</span> necrosis factor-alpha release in patients with chemotherapy-induced neutropenia.",,9373794,9373794_D017258_D009369,9373794_0,bcv_sentence_task_befree_876,,770956804,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,1,,D017258,"<span class=""chemical"">medroxyprogesterone acetate</span>",D009503,"<span class=""disease"">neutropenia</span>","Effect of high-dose <span class=""chemical"">medroxyprogesterone acetate</span> on tumor necrosis factor-alpha release in patients with chemotherapy-induced <span class=""disease"">neutropenia</span>.",,9373794,9373794_D017258_D009503,9373794_0,bcv_sentence_task_befree_877,,770956805,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,D017258,"<span class=""chemical"">medroxyprogesterone acetate/MPA</span>",D009336,"<span class=""disease"">necrosis</span>","The aim of the study was to investigate the effects of high-dose <span class=""chemical"">medroxyprogesterone acetate</span> (<span class=""chemical"">MPA</span>) on the tumor <span class=""disease"">necrosis</span> factor-alpha (TNF-alpha) release in patients with chemotherapy-induced neutropenia.",,9373794,9373794_D017258_D009336,9373794_1,bcv_sentence_task_befree_878,,770956806,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,D017258,"<span class=""chemical"">medroxyprogesterone acetate/MPA</span>",D009369,"<span class=""disease"">tumor</span>","The aim of the study was to investigate the effects of high-dose <span class=""chemical"">medroxyprogesterone acetate</span> (<span class=""chemical"">MPA</span>) on the <span class=""disease"">tumor</span> necrosis factor-alpha (TNF-alpha) release in patients with chemotherapy-induced neutropenia.",,9373794,9373794_D017258_D009369,9373794_1,bcv_sentence_task_befree_879,,770956807,FALSE,finalized,5,8/15/15 2:33,"



",no_relation,0.8087,,D017258,"<span class=""chemical"">medroxyprogesterone acetate/MPA</span>",D009503,"<span class=""disease"">neutropenia</span>","The aim of the study was to investigate the effects of high-dose <span class=""chemical"">medroxyprogesterone acetate</span> (<span class=""chemical"">MPA</span>) on the tumor necrosis factor-alpha (TNF-alpha) release in patients with chemotherapy-induced <span class=""disease"">neutropenia</span>.",,9373794,9373794_D017258_D009503,9373794_1,bcv_sentence_task_befree_880,,770956808,FALSE,finalized,5,8/14/15 23:49,"



",no_relation,1,,D005664,"<span class=""chemical"">furazolidone</span>",D000163,"<span class=""disease"">AIDS</span>","Enterocytozoon bieneusi in <span class=""disease"">AIDS</span>: symptomatic relief and parasite changes after <span class=""chemical"">furazolidone</span>.",,9378811,9378811_D005664_D000163,9378811_0,bcv_sentence_task_befree_881,,770956809,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,D005664,"<span class=""chemical"">furazolidone</span>",D000163,"<span class=""disease"">AIDS</span>","To investigate changes in morphology of the developmental stages of Enterocytozoon bieneusi and symptomatic relief observed in <span class=""disease"">AIDS</span> patients after treatment with <span class=""chemical"">furazolidone</span>.",,9378811,9378811_D005664_D000163,9378811_1,bcv_sentence_task_befree_882,,770956810,FALSE,finalized,5,8/15/15 2:14,"



",no_relation,1,,D005664,"<span class=""chemical"">furazolidone</span>",D000163,"<span class=""disease"">AIDS</span>","Six <span class=""disease"">AIDS</span> patients with symptomatic E bieneusi infection of the small intestine were treated with a course of <span class=""chemical"">furazolidone</span>.",,9378811,9378811_D005664_D000163,9378811_2,bcv_sentence_task_befree_883,,770956811,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,D005664,"<span class=""chemical"">furazolidone</span>",D007410,"<span class=""disease"">intestinal infection</span>","The clinical benefit seen after treatment with <span class=""chemical"">furazolidone</span> in six AIDS patients with E bieneusi <span class=""disease"">intestinal infection</span> may be due to damage to the developmental stages causing a partial inhibition to reproduction of the parasite.",,9378811,9378811_D005664_D007410,9378811_7,bcv_sentence_task_befree_884,,770956812,FALSE,finalized,5,8/14/15 22:24,"



",no_relation,1,,D005664,"<span class=""chemical"">furazolidone</span>",D000163,"<span class=""disease"">AIDS</span>","The clinical benefit seen after treatment with <span class=""chemical"">furazolidone</span> in six <span class=""disease"">AIDS</span> patients with E bieneusi intestinal infection may be due to damage to the developmental stages causing a partial inhibition to reproduction of the parasite.",,9378811,9378811_D005664_D000163,9378811_7,bcv_sentence_task_befree_885,,770956813,FALSE,finalized,5,8/14/15 20:36,"



",no_relation,0.6201,,D005557,"<span class=""chemical"">formaldehyde</span>",D009369,"<span class=""disease"">tumor</span>","Data for one of the most extensively studied chemicals, the weakly genotoxic carcinogen <span class=""chemical"">formaldehyde</span>, support the contention that the concentration-response relationship for <span class=""disease"">tumor</span> incidence is a function of <span class=""chemical"">formaldehyde</span>-induced target cell proliferation, in addition to other factors including target cell population size.",,9385388,9385388_D005557_D009369,9385388_4,bcv_sentence_task_befree_886,,770956814,FALSE,finalized,5,8/14/15 22:35,"



",no_relation,0.6076,,D007200,"<span class=""chemical"">Indoxyl sulfate</span>",D051437,"<span class=""disease"">renal failure</span>","<span class=""chemical"">Indoxyl sulfate</span> and progression of <span class=""disease"">renal failure</span>: effects of a low-protein diet and oral sorbent on <span class=""chemical"">indoxyl sulfate</span> production in uremic rats and undialyzed uremic patients.",,9387112,9387112_D007200_D051437,9387112_0,bcv_sentence_task_befree_887,,770956815,FALSE,finalized,5,8/14/15 20:41,"



",yes_direct,0.8122,,D007200,"<span class=""chemical"">indoxyl sulfate</span>",D007673,"<span class=""disease"">glomerular sclerosis</span>","We have previously demonstrated that <span class=""chemical"">indoxyl sulfate</span> is a stimulating factor for the progression of <span class=""disease"">glomerular sclerosis</span> in uremic rats.",,9387112,9387112_D007200_D007673,9387112_1,bcv_sentence_task_befree_888,,770956816,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,0.7904,,D007200,"<span class=""chemical"">indoxyl sulfate</span>",D007673,"<span class=""disease"">glomerular sclerosis</span>","In conclusion, a low-protein diet or AST-120 reduced the serum and urine levels of <span class=""chemical"">indoxyl sulfate</span>, a stimulating factor for <span class=""disease"">glomerular sclerosis</span>, in both uremic rats and undialyzed uremic patients.",,9387112,9387112_D007200_D007673,9387112_8,bcv_sentence_task_befree_889,,770956817,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,D002045,"<span class=""chemical"">bupivacaine</span>",D007021,"<span class=""disease"">hypospadias</span>","Ninety boys, aged 13-53 months, undergoing repair of <span class=""disease"">hypospadias</span>, were allocated randomly to receive 0.8 ml kg-1 of one of three solutions into the caudal extradural space: group B received <span class=""chemical"">bupivacaine</span> 2 mg kg-1, group T received tramadol 2 mg kg-1 in 0.9% saline and group BT a mixture of both.",,9389843,9389843_D002045_D007021,9389843_1,bcv_sentence_task_befree_890,,770956818,FALSE,finalized,5,8/15/15 1:51,"



",no_relation,1,,D014147,"<span class=""chemical"">tramadol</span>",D007021,"<span class=""disease"">hypospadias</span>","Ninety boys, aged 13-53 months, undergoing repair of <span class=""disease"">hypospadias</span>, were allocated randomly to receive 0.8 ml kg-1 of one of three solutions into the caudal extradural space: group B received bupivacaine 2 mg kg-1, group T received <span class=""chemical"">tramadol</span> 2 mg kg-1 in 0.9% saline and group BT a mixture of both.",,9389843,9389843_D014147_D007021,9389843_1,bcv_sentence_task_befree_891,,770956819,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,0.6173,,D016559,"<span class=""chemical"">FK506</span>",D006259,"<span class=""disease"">sciatic-nerve crush injury</span>","This review focuses on studies showing that systemic administration of <span class=""chemical"">FK506</span> dose-dependently speeds nerve regeneration and functional recovery in rats following a <span class=""disease"">sciatic-nerve crush injury</span>.",,9457703,9457703_D016559_D006259,9457703_7,bcv_sentence_task_befree_892,,770956820,FALSE,finalized,5,8/14/15 20:36,"



",no_relation,0.8066,,D014640,"<span class=""chemical"">vancomycin</span>",D007239,"<span class=""disease"">infection</span>","In order to determine the extent of <span class=""chemical"">vancomycin</span> resistant enterococcus (VRE) colonisation within a paediatric oncology unit, the risk factors for the acquisition of the organism, the molecular epidemiology of the isolates and the impact of <span class=""disease"">infection</span> control measures, extensive patient and environmental surveillance was undertaken with identification, antibiotic susceptibility testing and pulsed-field gel electrophoresis (PFGE) of all VRE isolates.",,9461358,9461358_D014640_D007239,9461358_1,bcv_sentence_task_befree_893,,770956821,FALSE,finalized,5,8/15/15 1:33,"



",no_relation,1,,D000583,"<span class=""chemical"">amikacin</span>",D009503,"<span class=""disease"">neutropenia</span>","Following comparison of the 14 cases with 41 controls matched for age (+/- 4 years) and cohabitation on the oncology unit, risk factors for colonisation with VRE included duration of <span class=""disease"">neutropenia</span>, (OR, 3.72; 95% CI, 1.0-13.1), and antibiotic therapy, (OR, 4.07; 95% CI, 1.08-15.3), the number of antibiotic agents received, (OR, 8.4; 95% CI, 1.34-34.3) and the duration of therapy with <span class=""chemical"">amikacin</span>, (OR, 10.7; 95% CI, 1.4-81.5), ceftazidime, (OR, 11.5; 95% CI, 2.2 59.9) or teicoplanin, (OR, 12.3; 95% CI, 2.25-67.4).",,9461358,9461358_D000583_D009503,9461358_7,bcv_sentence_task_befree_894,,770956822,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,0.8197,,D002442,"<span class=""chemical"">ceftazidime</span>",D009503,"<span class=""disease"">neutropenia</span>","Following comparison of the 14 cases with 41 controls matched for age (+/- 4 years) and cohabitation on the oncology unit, risk factors for colonisation with VRE included duration of <span class=""disease"">neutropenia</span>, (OR, 3.72; 95% CI, 1.0-13.1), and antibiotic therapy, (OR, 4.07; 95% CI, 1.08-15.3), the number of antibiotic agents received, (OR, 8.4; 95% CI, 1.34-34.3) and the duration of therapy with amikacin, (OR, 10.7; 95% CI, 1.4-81.5), <span class=""chemical"">ceftazidime</span>, (OR, 11.5; 95% CI, 2.2 59.9) or teicoplanin, (OR, 12.3; 95% CI, 2.25-67.4).",,9461358,9461358_D002442_D009503,9461358_7,bcv_sentence_task_befree_895,,770956823,FALSE,finalized,5,8/14/15 20:41,"



",no_relation,0.805,,D000583,"<span class=""chemical"">amikacin</span>",D009503,"<span class=""disease"">neutropenia</span>","Risk factors for VRE colonization in paediatric oncology patients included duration of <span class=""disease"">neutropenia</span>, duration of any antibiotic therapy, exposure to ceftazidime, <span class=""chemical"">amikacin</span> or teicoplanin and the number of antibiotics used.",,9461358,9461358_D000583_D009503,9461358_10,bcv_sentence_task_befree_896,,770956824,FALSE,finalized,5,8/15/15 1:24,"



",no_relation,1,,D017334,"<span class=""chemical"">teicoplanin</span>",D009503,"<span class=""disease"">neutropenia</span>","Risk factors for VRE colonization in paediatric oncology patients included duration of <span class=""disease"">neutropenia</span>, duration of any antibiotic therapy, exposure to ceftazidime, amikacin or <span class=""chemical"">teicoplanin</span> and the number of antibiotics used.",,9461358,9461358_D017334_D009503,9461358_10,bcv_sentence_task_befree_897,,770956825,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,0.8108,,D002442,"<span class=""chemical"">ceftazidime</span>",D009503,"<span class=""disease"">neutropenia</span>","Risk factors for VRE colonization in paediatric oncology patients included duration of <span class=""disease"">neutropenia</span>, duration of any antibiotic therapy, exposure to <span class=""chemical"">ceftazidime</span>, amikacin or teicoplanin and the number of antibiotics used.",,9461358,9461358_D002442_D009503,9461358_10,bcv_sentence_task_befree_898,,770956826,FALSE,finalized,5,8/15/15 0:29,"



",yes_direct,0.8139,,D000431,"<span class=""chemical"">alcohol</span>",D015356,"<span class=""disease"">septal branch occlusion</span>","As an alternative nonsurgical procedure for reducing the left ventricular outflow tract (LVOT) gradient, PTSMA by <span class=""chemical"">alcohol</span>-induced <span class=""disease"">septal branch occlusion</span> was introduced.",,9462563,9462563_D000431_D015356,9462563_3,bcv_sentence_task_befree_899,,770956827,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,D003401,"<span class=""chemical"">creatine</span>",D017566,"<span class=""disease"">angina</span>","All patients had <span class=""disease"">angina</span> pectoris for 24 h. The maximal <span class=""chemical"">creatine</span> kinase increase was 780 +/- 436 U/liter (range 305 to 1,810) after 11.1 +/- 6.0 h (range 4 to 24).",,9462563,9462563_D003401_D017566,9462563_8,bcv_sentence_task_befree_900,,770956828,FALSE,finalized,5,8/15/15 2:03,"



",no_relation,1,,D005045,"<span class=""chemical"">etomidate</span>",D055090,"<span class=""disease"">trachea</span>","The effect of propofol and <span class=""chemical"">etomidate</span> was also studied on both [Ca2+]i increase measured by microspectrofluorimetry in isolated myocytes and isometric contraction in the rat <span class=""disease"">trachea</span>.",,9477050,9477050_D005045_D055090,9477050_4,bcv_sentence_task_befree_901,,770956829,FALSE,finalized,5,8/14/15 22:02,"



",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D055090,"<span class=""disease"">trachea</span>","The effect of <span class=""chemical"">propofol</span> and etomidate was also studied on both [Ca2+]i increase measured by microspectrofluorimetry in isolated myocytes and isometric contraction in the rat <span class=""disease"">trachea</span>.",,9477050,9477050_D015742_D055090,9477050_4,bcv_sentence_task_befree_902,,770956830,FALSE,finalized,5,8/15/15 1:40,"



",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D013224,"<span class=""disease"">asthmatic</span>","Whereas thiopental contracts human isolated bronchi, <span class=""chemical"">propofol</span> and etomidate reduce histamine-induced contraction in human isolated airway smooth muscle that were either not sensitized or passively sensitized with <span class=""disease"">asthmatic</span> serum.",,9477050,9477050_D015742_D013224,9477050_10,bcv_sentence_task_befree_903,,770956831,FALSE,finalized,5,8/15/15 0:34,"



",no_relation,1,,D013874,"<span class=""chemical"">thiopental</span>",D013224,"<span class=""disease"">asthmatic</span>","Whereas <span class=""chemical"">thiopental</span> contracts human isolated bronchi, propofol and etomidate reduce histamine-induced contraction in human isolated airway smooth muscle that were either not sensitized or passively sensitized with <span class=""disease"">asthmatic</span> serum.",,9477050,9477050_D013874_D013224,9477050_10,bcv_sentence_task_befree_904,,770956832,FALSE,finalized,5,8/14/15 20:42,"



",no_relation,0.6129,,D006632,"<span class=""chemical"">histamine</span>",D013224,"<span class=""disease"">asthmatic</span>","Whereas thiopental contracts human isolated bronchi, propofol and etomidate reduce <span class=""chemical"">histamine</span>-induced contraction in human isolated airway smooth muscle that were either not sensitized or passively sensitized with <span class=""disease"">asthmatic</span> serum.",,9477050,9477050_D006632_D013224,9477050_10,bcv_sentence_task_befree_905,,770956833,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,D005045,"<span class=""chemical"">etomidate</span>",D013224,"<span class=""disease"">asthmatic</span>","Whereas thiopental contracts human isolated bronchi, propofol and <span class=""chemical"">etomidate</span> reduce histamine-induced contraction in human isolated airway smooth muscle that were either not sensitized or passively sensitized with <span class=""disease"">asthmatic</span> serum.",,9477050,9477050_D005045_D013224,9477050_10,bcv_sentence_task_befree_906,,770956834,FALSE,finalized,5,8/14/15 21:51,"



",yes_direct,1,,C010745,"<span class=""chemical"">maltitol</span>",D005414,"<span class=""disease"">flatulence</span>","Relative to ingestion of sucrose, 30 g <span class=""chemical"">maltitol</span> caused no significant difference in symptoms, but 40 g resulted in more mild borborygmi (P < 0.05) and mild <span class=""disease"">flatulence</span> (P < 0.01) but not moderate or severe symptoms.",,9482768,9482768_C010745_D005414,9482768_6,bcv_sentence_task_befree_907,,770956835,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,0.5922,,D013395,"<span class=""chemical"">sucrose</span>",D005414,"<span class=""disease"">flatulence</span>","Relative to ingestion of <span class=""chemical"">sucrose</span>, 30 g maltitol caused no significant difference in symptoms, but 40 g resulted in more mild borborygmi (P < 0.05) and mild <span class=""disease"">flatulence</span> (P < 0.01) but not moderate or severe symptoms.",,9482768,9482768_D013395_D005414,9482768_6,bcv_sentence_task_befree_908,,770956836,FALSE,finalized,5,8/15/15 1:43,"



",no_relation,1,,D013256,"<span class=""chemical"">Steroid</span>",D009135,"<span class=""disease"">myopathy</span>","<span class=""chemical"">Steroid</span>-responsive <span class=""disease"">myopathy</span> with deficient chondroitin sulfate C in skeletal muscle connective tissue.",,9484390,9484390_D013256_D009135,9484390_0,bcv_sentence_task_befree_909,,770956837,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,0.7888,,D002809,"<span class=""chemical"">chondroitin sulfate C</span>",D009135,"<span class=""disease"">myopathy</span>","Steroid-responsive <span class=""disease"">myopathy</span> with deficient <span class=""chemical"">chondroitin sulfate C</span> in skeletal muscle connective tissue.",,9484390,9484390_D002809_D009135,9484390_0,bcv_sentence_task_befree_910,,770956838,FALSE,finalized,5,8/15/15 1:31,"



",no_relation,1,,D002809,"<span class=""chemical"">chondroitin sulfate</span>",D001284,"<span class=""disease"">atrophy</span>","A muscle biopsy showed only a moderate degree of type 2 <span class=""disease"">atrophy</span>, but immunocytochemistry showed absence of <span class=""chemical"">chondroitin sulfate</span> C glycosaminoglycan in the endomysium.",,9484390,9484390_D002809_D001284,9484390_2,bcv_sentence_task_befree_911,,770956839,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,0.6,,D004128,"<span class=""chemical"">N-nitrosodimethylamine</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Heterologous expression of rat P450 2E1 in a mammalian cell line: in situ metabolism and <span class=""disease"">cytotoxicity</span> of <span class=""chemical"">N-nitrosodimethylamine</span>.",,9498284,9498284_D004128_D004487,9498284_0,bcv_sentence_task_befree_912,,770956840,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,1,,C010238,"<span class=""chemical"">4-methylpyrazole</span>",D064420,"<span class=""disease"">toxicity</span>","Inhibitors of P450 2E1 activity such as ethanol, <span class=""chemical"">4-methylpyrazole</span>, and isoniazid caused a 90% decrease in the methylation of cellular macromolecules and also completely protected the cells against NDMA-mediated <span class=""disease"">toxicity</span>.",,9498284,9498284_C010238_D064420,9498284_7,bcv_sentence_task_befree_913,,770956841,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",D064420,"<span class=""disease"">toxicity</span>","Inhibitors of P450 2E1 activity such as <span class=""chemical"">ethanol</span>, 4-methylpyrazole, and isoniazid caused a 90% decrease in the methylation of cellular macromolecules and also completely protected the cells against NDMA-mediated <span class=""disease"">toxicity</span>.",,9498284,9498284_D000431_D064420,9498284_7,bcv_sentence_task_befree_914,,770956842,FALSE,finalized,5,8/14/15 22:02,"



",no_relation,1,,D007538,"<span class=""chemical"">isoniazid</span>",D064420,"<span class=""disease"">toxicity</span>","Inhibitors of P450 2E1 activity such as ethanol, 4-methylpyrazole, and <span class=""chemical"">isoniazid</span> caused a 90% decrease in the methylation of cellular macromolecules and also completely protected the cells against NDMA-mediated <span class=""disease"">toxicity</span>.",,9498284,9498284_D007538_D064420,9498284_7,bcv_sentence_task_befree_915,,770956843,FALSE,finalized,5,8/14/15 20:51,"



",yes_direct,0.5884,,D004128,"<span class=""chemical"">NDMA</span>",D064420,"<span class=""disease"">toxicity</span>","Inhibitors of P450 2E1 activity such as ethanol, 4-methylpyrazole, and isoniazid caused a 90% decrease in the methylation of cellular macromolecules and also completely protected the cells against <span class=""chemical"">NDMA</span>-mediated <span class=""disease"">toxicity</span>.",,9498284,9498284_D004128_D064420,9498284_7,bcv_sentence_task_befree_916,,770956844,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,C029217,"<span class=""chemical"">N-t-butyl-alpha-phenylnitrone</span>",D004487,"<span class=""disease"">cytotoxicity</span>","The <span class=""disease"">cytotoxicity</span> due to exposure to NDMA was partially inhibited by antioxidants such as N-acetylcysteine, ascorbic acid, butylated hydroxyanisole and <span class=""chemical"">N-t-butyl-alpha-phenylnitrone</span> but was not potentiated upon glutathione depletion.",,9498284,9498284_C029217_D004487,9498284_8,bcv_sentence_task_befree_917,,770956845,FALSE,finalized,5,8/15/15 2:07,"



",no_relation,0.8248,,D002083,"<span class=""chemical"">butylated hydroxyanisole</span>",D004487,"<span class=""disease"">cytotoxicity</span>","The <span class=""disease"">cytotoxicity</span> due to exposure to NDMA was partially inhibited by antioxidants such as N-acetylcysteine, ascorbic acid, <span class=""chemical"">butylated hydroxyanisole</span> and N-t-butyl-alpha-phenylnitrone but was not potentiated upon glutathione depletion.",,9498284,9498284_D002083_D004487,9498284_8,bcv_sentence_task_befree_918,,770956846,FALSE,finalized,5,8/15/15 0:01,"



",no_relation,1,,D000111,"<span class=""chemical"">N-acetylcysteine</span>",D004487,"<span class=""disease"">cytotoxicity</span>","The <span class=""disease"">cytotoxicity</span> due to exposure to NDMA was partially inhibited by antioxidants such as <span class=""chemical"">N-acetylcysteine</span>, ascorbic acid, butylated hydroxyanisole and N-t-butyl-alpha-phenylnitrone but was not potentiated upon glutathione depletion.",,9498284,9498284_D000111_D004487,9498284_8,bcv_sentence_task_befree_919,,770956847,FALSE,finalized,5,8/14/15 23:52,"



",no_relation,1,,D001205,"<span class=""chemical"">ascorbic acid</span>",D004487,"<span class=""disease"">cytotoxicity</span>","The <span class=""disease"">cytotoxicity</span> due to exposure to NDMA was partially inhibited by antioxidants such as N-acetylcysteine, <span class=""chemical"">ascorbic acid</span>, butylated hydroxyanisole and N-t-butyl-alpha-phenylnitrone but was not potentiated upon glutathione depletion.",,9498284,9498284_D001205_D004487,9498284_8,bcv_sentence_task_befree_920,,770956848,FALSE,finalized,5,8/14/15 20:45,"



",yes_direct,0.8218,,D004128,"<span class=""chemical"">NDMA</span>",D004487,"<span class=""disease"">cytotoxicity</span>","The <span class=""disease"">cytotoxicity</span> due to exposure to <span class=""chemical"">NDMA</span> was partially inhibited by antioxidants such as N-acetylcysteine, ascorbic acid, butylated hydroxyanisole and N-t-butyl-alpha-phenylnitrone but was not potentiated upon glutathione depletion.",,9498284,9498284_D004128_D004487,9498284_8,bcv_sentence_task_befree_921,,770956849,FALSE,finalized,5,8/14/15 23:49,"



",no_relation,1,,D005978,"<span class=""chemical"">glutathione</span>",D004487,"<span class=""disease"">cytotoxicity</span>","The <span class=""disease"">cytotoxicity</span> due to exposure to NDMA was partially inhibited by antioxidants such as N-acetylcysteine, ascorbic acid, butylated hydroxyanisole and N-t-butyl-alpha-phenylnitrone but was not potentiated upon <span class=""chemical"">glutathione</span> depletion.",,9498284,9498284_D005978_D004487,9498284_8,bcv_sentence_task_befree_922,,770956850,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,1,,D004128,"<span class=""chemical"">NDMA</span>",D063646,"<span class=""disease"">carcinogenesis</span>","These results document the ability of rat P450 2E1 to metabolize <span class=""chemical"">NDMA</span> to toxic reactive intermediates and demonstrate that this cell line provides a useful model for studying the mechanisms of metabolism-mediated toxicity and <span class=""disease"">carcinogenesis</span>.",,9498284,9498284_D004128_D063646,9498284_9,bcv_sentence_task_befree_923,,770956851,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,0.8074,,D004128,"<span class=""chemical"">NDMA</span>",D064420,"<span class=""disease"">toxicity</span>","These results document the ability of rat P450 2E1 to metabolize <span class=""chemical"">NDMA</span> to toxic reactive intermediates and demonstrate that this cell line provides a useful model for studying the mechanisms of metabolism-mediated <span class=""disease"">toxicity</span> and carcinogenesis.",,9498284,9498284_D004128_D064420,9498284_9,bcv_sentence_task_befree_924,,770956852,FALSE,finalized,5,8/15/15 1:43,"



",no_relation,1,,D008775,"<span class=""chemical"">methylprednisolone</span>",D008180,"<span class=""disease"">lupus</span>","Survival was even more prolonged when bindarit (0.5% medicated diet) was combined with a low dose of <span class=""chemical"">methylprednisolone</span> (1.5 mg/kg i.p.), which that only partially modifies proteinuria and survival of <span class=""disease"">lupus</span> mice, in an additional group of animals (N = 16).",,9507220,9507220_D008775_D008180,9507220_10,bcv_sentence_task_befree_925,,770956853,FALSE,finalized,5,8/15/15 1:50,"



",no_relation,1,,D008775,"<span class=""chemical"">methylprednisolone</span>",D011507,"<span class=""disease"">proteinuria</span>","Survival was even more prolonged when bindarit (0.5% medicated diet) was combined with a low dose of <span class=""chemical"">methylprednisolone</span> (1.5 mg/kg i.p.), which that only partially modifies <span class=""disease"">proteinuria</span> and survival of lupus mice, in an additional group of animals (N = 16).",,9507220,9507220_D008775_D011507,9507220_10,bcv_sentence_task_befree_926,,770956854,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",D008180,"<span class=""disease"">lupus</span>","Studies are needed to establish whether bindarit may function as a <span class=""chemical"">steroid</span> sparing drug in human <span class=""disease"">lupus</span>.",,9507220,9507220_D013256_D008180,9507220_12,bcv_sentence_task_befree_927,,770956855,FALSE,finalized,5,8/14/15 23:18,"



",no_relation,1,,D000617,"<span class=""chemical"">aminoglycosides</span>",D005600,"<span class=""disease"">tubular marker proteins</span>","In order to assess the nephrotoxic potential of antibiotics, various <span class=""chemical"">aminoglycosides</span> and cephalosporins were tested for their potency to alter the excretion of <span class=""disease"">tubular marker proteins</span> (and brush border antigens) or to change the normal pattern of serumproteinuria as analyzed by SDS polyacrylamidgel gradient electrophoresis.",,9562231,9562231_D000617_D005600,9562231_1,bcv_sentence_task_befree_928,,770956856,FALSE,finalized,5,8/14/15 20:41,"



",no_relation,0.7959,,D002511,"<span class=""chemical"">cephalosporins</span>",D005600,"<span class=""disease"">tubular marker proteins</span>","In order to assess the nephrotoxic potential of antibiotics, various aminoglycosides and <span class=""chemical"">cephalosporins</span> were tested for their potency to alter the excretion of <span class=""disease"">tubular marker proteins</span> (and brush border antigens) or to change the normal pattern of serumproteinuria as analyzed by SDS polyacrylamidgel gradient electrophoresis.",,9562231,9562231_D002511_D005600,9562231_1,bcv_sentence_task_befree_929,,770956857,FALSE,finalized,5,8/14/15 21:02,"



",no_relation,0.7975,,D000617,"<span class=""chemical"">aminoglycosides/aminoglycoside</span>",D005600,"<span class=""disease"">tubular marker proteins</span>","Excretion of <span class=""disease"">tubular marker proteins</span> was enhanced under combined administration of cephalosporins and <span class=""chemical"">aminoglycosides</span> mainly due to the <span class=""chemical"">aminoglycoside</span> component.",,9562231,9562231_D000617_D005600,9562231_4,bcv_sentence_task_befree_930,,770956858,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,0.7893,,D002511,"<span class=""chemical"">cephalosporins</span>",D005600,"<span class=""disease"">tubular marker proteins</span>","Excretion of <span class=""disease"">tubular marker proteins</span> was enhanced under combined administration of <span class=""chemical"">cephalosporins</span> and aminoglycosides mainly due to the aminoglycoside component.",,9562231,9562231_D002511_D005600,9562231_4,bcv_sentence_task_befree_931,,770956859,FALSE,finalized,5,8/15/15 0:14,"



",yes_direct,1,,C007027,"<span class=""chemical"">Chloroxylenol</span>",D003872,"<span class=""disease"">dermatitis</span>","<span class=""chemical"">Chloroxylenol</span> causing hand <span class=""disease"">dermatitis</span> in a plumber.",,9601902,9601902_C007027_D003872,9601902_0,bcv_sentence_task_befree_932,,770956860,FALSE,finalized,5,8/14/15 21:50,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D010146,"<span class=""disease"">pain</span>","Aural canal (core) and skin surface (15 sites) temperatures; <span class=""chemical"">oxygen</span> consumption; <span class=""disease"">pain</span> visual analogue score; and concentrations of epinephrine, norepinephrine, glucose, cortisol, lactate, and free fatty acids in plasma were measured before epidural blockade, 30 min after epidural blockade, at the end of surgery, and for 4 h after surgery.",,9605680,9605680_D010100_D010146,9605680_8,bcv_sentence_task_befree_933,,770956861,FALSE,finalized,5,8/14/15 23:59,"



",no_relation,1,,D004837,"<span class=""chemical"">epinephrine</span>",D010146,"<span class=""disease"">pain</span>","Aural canal (core) and skin surface (15 sites) temperatures; oxygen consumption; <span class=""disease"">pain</span> visual analogue score; and concentrations of <span class=""chemical"">epinephrine</span>, norepinephrine, glucose, cortisol, lactate, and free fatty acids in plasma were measured before epidural blockade, 30 min after epidural blockade, at the end of surgery, and for 4 h after surgery.",,9605680,9605680_D004837_D010146,9605680_8,bcv_sentence_task_befree_934,,770956862,FALSE,finalized,5,8/14/15 20:45,"



",no_relation,1,,D009638,"<span class=""chemical"">norepinephrine</span>",D010146,"<span class=""disease"">pain</span>","Aural canal (core) and skin surface (15 sites) temperatures; oxygen consumption; <span class=""disease"">pain</span> visual analogue score; and concentrations of epinephrine, <span class=""chemical"">norepinephrine</span>, glucose, cortisol, lactate, and free fatty acids in plasma were measured before epidural blockade, 30 min after epidural blockade, at the end of surgery, and for 4 h after surgery.",,9605680,9605680_D009638_D010146,9605680_8,bcv_sentence_task_befree_935,,770956863,FALSE,finalized,5,8/15/15 1:29,"



",no_relation,1,,D019344,"<span class=""chemical"">lactate</span>",D010146,"<span class=""disease"">pain</span>","Aural canal (core) and skin surface (15 sites) temperatures; oxygen consumption; <span class=""disease"">pain</span> visual analogue score; and concentrations of epinephrine, norepinephrine, glucose, cortisol, <span class=""chemical"">lactate</span>, and free fatty acids in plasma were measured before epidural blockade, 30 min after epidural blockade, at the end of surgery, and for 4 h after surgery.",,9605680,9605680_D019344_D010146,9605680_8,bcv_sentence_task_befree_936,,770956864,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D005230,"<span class=""chemical"">free fatty acids</span>",D010146,"<span class=""disease"">pain</span>","Aural canal (core) and skin surface (15 sites) temperatures; oxygen consumption; <span class=""disease"">pain</span> visual analogue score; and concentrations of epinephrine, norepinephrine, glucose, cortisol, lactate, and <span class=""chemical"">free fatty acids</span> in plasma were measured before epidural blockade, 30 min after epidural blockade, at the end of surgery, and for 4 h after surgery.",,9605680,9605680_D005230_D010146,9605680_8,bcv_sentence_task_befree_937,,770956865,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D010146,"<span class=""disease"">pain</span>","Aural canal (core) and skin surface (15 sites) temperatures; oxygen consumption; <span class=""disease"">pain</span> visual analogue score; and concentrations of epinephrine, norepinephrine, <span class=""chemical"">glucose</span>, cortisol, lactate, and free fatty acids in plasma were measured before epidural blockade, 30 min after epidural blockade, at the end of surgery, and for 4 h after surgery.",,9605680,9605680_D005947_D010146,9605680_8,bcv_sentence_task_befree_938,,770956866,FALSE,finalized,5,8/14/15 22:12,"



",no_relation,1,,D006854,"<span class=""chemical"">cortisol</span>",D010146,"<span class=""disease"">pain</span>","Aural canal (core) and skin surface (15 sites) temperatures; oxygen consumption; <span class=""disease"">pain</span> visual analogue score; and concentrations of epinephrine, norepinephrine, glucose, <span class=""chemical"">cortisol</span>, lactate, and free fatty acids in plasma were measured before epidural blockade, 30 min after epidural blockade, at the end of surgery, and for 4 h after surgery.",,9605680,9605680_D006854_D010146,9605680_8,bcv_sentence_task_befree_939,,770956867,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D010146,"<span class=""disease"">pain</span>","During recovery, there was no difference between the two groups for norepinephrine concentrations in plasma, body weight-adjusted <span class=""chemical"">oxygen</span> consumption, <span class=""disease"">pain</span> visual analogue score, and metabolites.",,9605680,9605680_D010100_D010146,9605680_12,bcv_sentence_task_befree_940,,770956868,FALSE,finalized,5,8/15/15 0:33,"



",no_relation,1,,D009638,"<span class=""chemical"">norepinephrine</span>",D010146,"<span class=""disease"">pain</span>","During recovery, there was no difference between the two groups for <span class=""chemical"">norepinephrine</span> concentrations in plasma, body weight-adjusted oxygen consumption, <span class=""disease"">pain</span> visual analogue score, and metabolites.",,9605680,9605680_D009638_D010146,9605680_12,bcv_sentence_task_befree_941,,770956869,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,1,,D004298,"<span class=""chemical"">dopamine</span>",D004421,"<span class=""disease"">dystonia</span>","It has been suggested that tardive cervical <span class=""disease"">dystonia</span> may be clinically indistinguishable from the idiopathic form and that the diagnosis rests solely on documenting an exposure to <span class=""chemical"">dopamine</span> antagonist medications.",,9613742,9613742_D004298_D004421,9613742_1,bcv_sentence_task_befree_942,,770956870,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,0.8018,,D004298,"<span class=""chemical"">dopamine</span>",D004421,"<span class=""disease"">dystonia</span>","These differences may help to distinguish them in the clinical setting, improve diagnostic accuracy, and support the existence of a causal relationship between exposure to <span class=""chemical"">dopamine</span> antagonist medications and chronic <span class=""disease"">dystonia</span>.",,9613742,9613742_D004298_D004421,9613742_10,bcv_sentence_task_befree_943,,770956871,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,1,,C002939,"<span class=""chemical"">L-ornithine-L-aspartate</span>",D006521,"<span class=""disease"">chronic hepatic encephalopathy</span>","Oral <span class=""chemical"">L-ornithine-L-aspartate</span> therapy of <span class=""disease"">chronic hepatic encephalopathy</span>: results of a placebo-controlled double-blind study.",,9625322,9625322_C002939_D006521,9625322_0,bcv_sentence_task_befree_944,,770956872,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,C002939,"<span class=""chemical"">L-ornithine-L-aspartate</span>",D005355,"<span class=""disease"">cirrhosis</span>","Therefore, the therapeutic efficacy of oral <span class=""chemical"">L-ornithine-L-aspartate</span>, which improves impaired ammonia detoxification, was investigated in patients with <span class=""disease"">cirrhosis</span>, hyperammonemia and stable, overt, chronic hepatic encephalopathy, and in subclinical hepatic encephalopathy in a randomized, double-blind, placebo-controlled clinical trial.",,9625322,9625322_C002939_D005355,9625322_2,bcv_sentence_task_befree_945,,770956873,FALSE,finalized,5,8/14/15 20:46,"



",no_relation,1,,C002939,"<span class=""chemical"">L-ornithine-L-aspartate</span>",D022124,"<span class=""disease"">hyperammonemia</span>","Therefore, the therapeutic efficacy of oral <span class=""chemical"">L-ornithine-L-aspartate</span>, which improves impaired ammonia detoxification, was investigated in patients with cirrhosis, <span class=""disease"">hyperammonemia</span> and stable, overt, chronic hepatic encephalopathy, and in subclinical hepatic encephalopathy in a randomized, double-blind, placebo-controlled clinical trial.",,9625322,9625322_C002939_D022124,9625322_2,bcv_sentence_task_befree_946,,770956874,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,1,,C002939,"<span class=""chemical"">L-ornithine-L-aspartate</span>",D006521,"<span class=""disease"">chronic hepatic encephalopathy</span>","Therefore, the therapeutic efficacy of oral <span class=""chemical"">L-ornithine-L-aspartate</span>, which improves impaired ammonia detoxification, was investigated in patients with cirrhosis, hyperammonemia and stable, overt, <span class=""disease"">chronic hepatic encephalopathy</span>, and in subclinical hepatic encephalopathy in a randomized, double-blind, placebo-controlled clinical trial.",,9625322,9625322_C002939_D006521,9625322_2,bcv_sentence_task_befree_947,,770956875,FALSE,finalized,5,8/14/15 23:40,"



",no_relation,0.8031,,C002939,"<span class=""chemical"">L-ornithine-L-aspartate</span>",C538320,"<span class=""disease"">impaired ammonia detoxification</span>","Therefore, the therapeutic efficacy of oral <span class=""chemical"">L-ornithine-L-aspartate</span>, which improves <span class=""disease"">impaired ammonia detoxification</span>, was investigated in patients with cirrhosis, hyperammonemia and stable, overt, chronic hepatic encephalopathy, and in subclinical hepatic encephalopathy in a randomized, double-blind, placebo-controlled clinical trial.",,9625322,9625322_C002939_C538320,9625322_2,bcv_sentence_task_befree_948,,770956876,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,C002939,"<span class=""chemical"">L-ornithine-L-aspartate</span>",D006501,"<span class=""disease"">hepatic encephalopathy</span>","Therefore, the therapeutic efficacy of oral <span class=""chemical"">L-ornithine-L-aspartate</span>, which improves impaired ammonia detoxification, was investigated in patients with cirrhosis, hyperammonemia and stable, overt, chronic hepatic encephalopathy, and in subclinical <span class=""disease"">hepatic encephalopathy</span> in a randomized, double-blind, placebo-controlled clinical trial.",,9625322,9625322_C002939_D006501,9625322_2,bcv_sentence_task_befree_949,,770956877,FALSE,finalized,5,8/14/15 20:39,"



",no_relation,1,,D000641,"<span class=""chemical"">ammonia</span>",D005355,"<span class=""disease"">cirrhosis</span>","Therefore, the therapeutic efficacy of oral L-ornithine-L-aspartate, which improves impaired <span class=""chemical"">ammonia</span> detoxification, was investigated in patients with <span class=""disease"">cirrhosis</span>, hyperammonemia and stable, overt, chronic hepatic encephalopathy, and in subclinical hepatic encephalopathy in a randomized, double-blind, placebo-controlled clinical trial.",,9625322,9625322_D000641_D005355,9625322_2,bcv_sentence_task_befree_950,,770956878,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,1,,D000641,"<span class=""chemical"">ammonia</span>",D006521,"<span class=""disease"">chronic hepatic encephalopathy</span>","Therefore, the therapeutic efficacy of oral L-ornithine-L-aspartate, which improves impaired <span class=""chemical"">ammonia</span> detoxification, was investigated in patients with cirrhosis, hyperammonemia and stable, overt, <span class=""disease"">chronic hepatic encephalopathy</span>, and in subclinical hepatic encephalopathy in a randomized, double-blind, placebo-controlled clinical trial.",,9625322,9625322_D000641_D006521,9625322_2,bcv_sentence_task_befree_951,,770956879,FALSE,finalized,5,8/15/15 0:10,"



",no_relation,1,,D000641,"<span class=""chemical"">ammonia</span>",D006501,"<span class=""disease"">hepatic encephalopathy</span>","Therefore, the therapeutic efficacy of oral L-ornithine-L-aspartate, which improves impaired <span class=""chemical"">ammonia</span> detoxification, was investigated in patients with cirrhosis, hyperammonemia and stable, overt, chronic hepatic encephalopathy, and in subclinical <span class=""disease"">hepatic encephalopathy</span> in a randomized, double-blind, placebo-controlled clinical trial.",,9625322,9625322_D000641_D006501,9625322_2,bcv_sentence_task_befree_952,,770956880,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,D000641,"<span class=""chemical"">ammonia</span>",C538320,"<span class=""disease"">impaired ammonia detoxification</span>","Therefore, the therapeutic efficacy of oral L-ornithine-L-aspartate, which improves <span class=""disease"">impaired </span><span class=""chemical"">ammonia</span> detoxification, was investigated in patients with cirrhosis, hyperammonemia and stable, overt, chronic hepatic encephalopathy, and in subclinical hepatic encephalopathy in a randomized, double-blind, placebo-controlled clinical trial.",,9625322,9625322_D000641_C538320,9625322_2,bcv_sentence_task_befree_953,,770956881,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,D000641,"<span class=""chemical"">ammonia</span>",D022124,"<span class=""disease"">hyperammonemia</span>","Therefore, the therapeutic efficacy of oral L-ornithine-L-aspartate, which improves impaired <span class=""chemical"">ammonia</span> detoxification, was investigated in patients with cirrhosis, <span class=""disease"">hyperammonemia</span> and stable, overt, chronic hepatic encephalopathy, and in subclinical hepatic encephalopathy in a randomized, double-blind, placebo-controlled clinical trial.",,9625322,9625322_D000641_D022124,9625322_2,bcv_sentence_task_befree_954,,770956882,FALSE,finalized,5,8/15/15 2:19,"



",no_relation,1,,D000641,"<span class=""chemical"">ammonia</span>",D001925,"<span class=""disease"">Encephalopathy</span>","Efficacy variables were: fasting and postprandial <span class=""chemical"">ammonia</span> concentration, Number-Connection-Test time, mental state grades, and a Portosystemic <span class=""disease"">Encephalopathy</span> Index.",,9625322,9625322_D000641_D001925,9625322_5,bcv_sentence_task_befree_955,,770956883,FALSE,finalized,5,8/14/15 20:43,"



",no_relation,1,,C002939,"<span class=""chemical"">L-ornithine-L-aspartate</span>",D006501,"<span class=""disease"">hepatic encephalopathy</span>","Analyses were based on the total study sample of 32 placebo- and 34 <span class=""chemical"">L-ornithine-L-aspartate</span>-treated patients as well as on the subgroup samples in the overt (20 placebo- and 23 L-ornithine-L-aspartate-treated) and subclinical <span class=""disease"">hepatic encephalopathy</span> (12 placebo- and 11 <span class=""chemical"">L-ornithine-L-aspartate</span>-treated) patients.",,9625322,9625322_C002939_D006501,9625322_6,bcv_sentence_task_befree_956,,770956884,FALSE,finalized,5,8/14/15 23:38,"



",no_relation,1,,C002939,"<span class=""chemical"">L-ornithine-L-aspartate</span>",D001925,"<span class=""disease"">Encephalopathy</span>","Also, the mental state grade (p<0.05) and the Portosystemic <span class=""disease"">Encephalopathy</span> Index (p<0.01), improved to a much greater degree in the <span class=""chemical"">L-ornithine-L-aspartate</span> group than in the placebo group.",,9625322,9625322_C002939_D001925,9625322_8,bcv_sentence_task_befree_957,,770956885,FALSE,finalized,5,8/15/15 1:38,"



",no_relation,1,,C002939,"<span class=""chemical"">L-ornithine-L-aspartate</span>",D005355,"<span class=""disease"">cirrhosis</span>","Oral <span class=""chemical"">L-ornithine-L-aspartate</span> is a safe, well-tolerated treatment with a good compliance rate and a beneficial therapeutic effect in patients with <span class=""disease"">cirrhosis</span> and stable, overt, chronic hepatic encephalopathy.",,9625322,9625322_C002939_D005355,9625322_10,bcv_sentence_task_befree_958,,770956886,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,C002939,"<span class=""chemical"">L-ornithine-L-aspartate</span>",D006521,"<span class=""disease"">chronic hepatic encephalopathy</span>","Oral <span class=""chemical"">L-ornithine-L-aspartate</span> is a safe, well-tolerated treatment with a good compliance rate and a beneficial therapeutic effect in patients with cirrhosis and stable, overt, <span class=""disease"">chronic hepatic encephalopathy</span>.",,9625322,9625322_C002939_D006521,9625322_10,bcv_sentence_task_befree_959,,770956887,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,D013256,"<span class=""chemical"">steroids</span>",D019106,"<span class=""disease"">aggressive postoperative diuresis</span>","A protocol emphasizing preoperative placement of the intra-aortic balloon pump, reduced CPB time, early extubation, perioperative <span class=""chemical"">steroids</span>, thyroid hormone, and <span class=""disease"">aggressive postoperative diuresis</span> was used.",,9635268,9635268_D013256_D019106,9635268_4,bcv_sentence_task_befree_960,,770956888,FALSE,finalized,5,8/14/15 22:12,"



",no_relation,0.808,,D010100,"<span class=""chemical"">oxygen</span>",D000787,"<span class=""disease"">angina pectoris</span>","From a therapeutic point of view, <span class=""disease"">angina pectoris</span> is best thought of as an imbalance between <span class=""chemical"">oxygen</span> supply and demand.",,9642483,9642483_D010100_D000787,9642483_1,bcv_sentence_task_befree_961,,770956889,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,0.8189,,D010100,"<span class=""chemical"">oxygen</span>",D007022,"<span class=""disease"">decreasing heart rate</span>","Reduction of <span class=""chemical"">oxygen</span> demand is accomplished by <span class=""disease"">decreasing heart rate</span>, blood pressure, heart size, and left ventricular mass.",,9642483,9642483_D010100_D007022,9642483_5,bcv_sentence_task_befree_962,,770956890,FALSE,finalized,5,8/14/15 23:37,"

Used as treatment.

",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D000787,"<span class=""disease"">angina pectoris</span>","Together with reduction of risk factors, this combination therapy plus <span class=""chemical"">aspirin</span> provides optimal management of patients with <span class=""disease"">angina pectoris</span>.",,9642483,9642483_D001241_D000787,9642483_8,bcv_sentence_task_befree_963,,770956891,FALSE,finalized,5,8/14/15 23:16,"



",no_relation,1,,D000596,"<span class=""chemical"">amino acid</span>",D005355,"<span class=""disease"">cirrhosis</span>","Effects of branched-chain <span class=""chemical"">amino acid</span>-enriched nutrient mixture on natural killer cell activity in viral <span class=""disease"">cirrhosis</span>.",,9689432,9689432_D000596_D005355,9689432_0,bcv_sentence_task_befree_964,,770956892,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,D000596,"<span class=""chemical"">amino acid</span>",D005355,"<span class=""disease"">cirrhosis</span>","A controlled study was performed in 18 viral <span class=""disease"">cirrhosis</span> patients to evaluate whether immune function, as indicated by natural killer (NK) cell activity, was improved by a branched-chain <span class=""chemical"">amino acid</span>-enriched nutrient mixture (nutrient-mixture), Aminoleban EN.",,9689432,9689432_D000596_D005355,9689432_1,bcv_sentence_task_befree_965,,770956893,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,D001663,"<span class=""chemical"">bilirubin</span>",D008103,"<span class=""disease"">liver cirrhosis</span>","Laboratory data, indicating severity of <span class=""disease"">liver cirrhosis</span>, such as total <span class=""chemical"">bilirubin</span> and albumin, showed better values (p < 0.01, p < 0.05 respectively), and baseline NK cell activity was low (8.7 +/- 7.2% vs 33.3 +/- 13.0%, p < 0.05) in the affected group than unaffected group.",,9689432,9689432_D001663_D008103,9689432_7,bcv_sentence_task_befree_966,,770956894,FALSE,finalized,5,8/14/15 22:03,"



",no_relation,1,,D000596,"<span class=""chemical"">amino acid</span>",D008103,"<span class=""disease"">liver cirrhosis</span>","These results suggest that the branched-chain <span class=""chemical"">amino acid</span>-enriched nutrient mixture increases NK cell activity moderately in patients who have compensated <span class=""disease"">liver cirrhosis</span> and shows lower values of baseline NK cell activity.",,9689432,9689432_D000596_D008103,9689432_11,bcv_sentence_task_befree_967,,770956895,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,0.8087,,D001241,"<span class=""chemical"">aspirin</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","Cardioversion of patients with nonvalvular <span class=""disease"">atrial fibrillation</span> followed by the use of <span class=""chemical"">aspirin</span> alone or with amiodarone has a reasonable marginal cost-effectiveness ratio.",,9701102,9701102_D001241_D001281,9701102_13,bcv_sentence_task_befree_968,,770956896,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,0.6212,,D000638,"<span class=""chemical"">amiodarone</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","Cardioversion of patients with nonvalvular <span class=""disease"">atrial fibrillation</span> followed by the use of aspirin alone or with <span class=""chemical"">amiodarone</span> has a reasonable marginal cost-effectiveness ratio.",,9701102,9701102_D000638_D001281,9701102_13,bcv_sentence_task_befree_969,,770956897,FALSE,finalized,5,8/15/15 0:41,"



",no_relation,0.794,,D001241,"<span class=""chemical"">aspirin</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","Finally, for patients who are bothered little by symptoms of <span class=""disease"">atrial fibrillation</span>, cardioversion followed by either <span class=""chemical"">aspirin</span> or warfarin without subsequent antiarrhythmic therapy is the treatment of choice.",,9701102,9701102_D001241_D001281,9701102_15,bcv_sentence_task_befree_970,,770956898,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,1,,D014859,"<span class=""chemical"">warfarin</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","Finally, for patients who are bothered little by symptoms of <span class=""disease"">atrial fibrillation</span>, cardioversion followed by either aspirin or <span class=""chemical"">warfarin</span> without subsequent antiarrhythmic therapy is the treatment of choice.",,9701102,9701102_D014859_D001281,9701102_15,bcv_sentence_task_befree_971,,770956899,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,1,,D013739,"<span class=""chemical"">Testosterone</span>",D008594,"<span class=""disease"">surgical menopause</span>","<span class=""chemical"">Testosterone</span> deficiency in menopausal women is more common than appreciated, particularly in patients on hormone replacement or with <span class=""disease"">surgical menopause</span>.",,9711681,9711681_D013739_D008594,9711681_2,bcv_sentence_task_befree_972,,770956900,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,1,,D013739,"<span class=""chemical"">Testosterone</span>",D003677,"<span class=""disease"">Testosterone deficiency</span>","<span class=""chemical""></span><span class=""disease"">Testosterone</span> deficiency in menopausal women is more common than appreciated, particularly in patients on hormone replacement or with surgical menopause.",,9711681,9711681_D013739_D003677,9711681_2,bcv_sentence_task_befree_973,,770956901,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D010024,"<span class=""disease"">osteoporosis</span>","Epidemiologic and clinical studies suggest that magnesium may reduce the frequency of sudden death, that sodium contributes to the occurrence of hypertension, and that <span class=""chemical"">calcium</span> may help prevent <span class=""disease"">osteoporosis</span>.",,9727819,9727819_D002118_D010024,9727819_7,bcv_sentence_task_befree_974,,770956902,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D003645,"<span class=""disease"">sudden death</span>","Epidemiologic and clinical studies suggest that magnesium may reduce the frequency of <span class=""disease"">sudden death</span>, that sodium contributes to the occurrence of hypertension, and that <span class=""chemical"">calcium</span> may help prevent osteoporosis.",,9727819,9727819_D002118_D003645,9727819_7,bcv_sentence_task_befree_975,,770956903,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D006973,"<span class=""disease"">hypertension</span>","Epidemiologic and clinical studies suggest that magnesium may reduce the frequency of sudden death, that sodium contributes to the occurrence of <span class=""disease"">hypertension</span>, and that <span class=""chemical"">calcium</span> may help prevent osteoporosis.",,9727819,9727819_D002118_D006973,9727819_7,bcv_sentence_task_befree_976,,770956904,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,1,,D012964,"<span class=""chemical"">sodium</span>",D010024,"<span class=""disease"">osteoporosis</span>","Epidemiologic and clinical studies suggest that magnesium may reduce the frequency of sudden death, that <span class=""chemical"">sodium</span> contributes to the occurrence of hypertension, and that calcium may help prevent <span class=""disease"">osteoporosis</span>.",,9727819,9727819_D012964_D010024,9727819_7,bcv_sentence_task_befree_977,,770956905,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,D012964,"<span class=""chemical"">sodium</span>",D003645,"<span class=""disease"">sudden death</span>","Epidemiologic and clinical studies suggest that magnesium may reduce the frequency of <span class=""disease"">sudden death</span>, that <span class=""chemical"">sodium</span> contributes to the occurrence of hypertension, and that calcium may help prevent osteoporosis.",,9727819,9727819_D012964_D003645,9727819_7,bcv_sentence_task_befree_978,,770956906,FALSE,finalized,5,8/14/15 23:47,"



",no_relation,1,,D008274,"<span class=""chemical"">magnesium</span>",D003645,"<span class=""disease"">sudden death</span>","Epidemiologic and clinical studies suggest that <span class=""chemical"">magnesium</span> may reduce the frequency of <span class=""disease"">sudden death</span>, that sodium contributes to the occurrence of hypertension, and that calcium may help prevent osteoporosis.",,9727819,9727819_D008274_D003645,9727819_7,bcv_sentence_task_befree_979,,770956907,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,D008274,"<span class=""chemical"">magnesium</span>",D010024,"<span class=""disease"">osteoporosis</span>","Epidemiologic and clinical studies suggest that <span class=""chemical"">magnesium</span> may reduce the frequency of sudden death, that sodium contributes to the occurrence of hypertension, and that calcium may help prevent <span class=""disease"">osteoporosis</span>.",,9727819,9727819_D008274_D010024,9727819_7,bcv_sentence_task_befree_980,,770956908,FALSE,finalized,5,8/14/15 23:08,"



",no_relation,1,,D008274,"<span class=""chemical"">magnesium</span>",D006973,"<span class=""disease"">hypertension</span>","Epidemiologic and clinical studies suggest that <span class=""chemical"">magnesium</span> may reduce the frequency of sudden death, that sodium contributes to the occurrence of <span class=""disease"">hypertension</span>, and that calcium may help prevent osteoporosis.",,9727819,9727819_D008274_D006973,9727819_7,bcv_sentence_task_befree_981,,770956909,FALSE,finalized,5,8/14/15 23:36,"



",yes_direct,1,,D012964,"<span class=""chemical"">sodium</span>",D006973,"<span class=""disease"">hypertension</span>","Epidemiologic and clinical studies suggest that magnesium may reduce the frequency of sudden death, that <span class=""chemical"">sodium</span> contributes to the occurrence of <span class=""disease"">hypertension</span>, and that calcium may help prevent osteoporosis.",,9727819,9727819_D012964_D006973,9727819_7,bcv_sentence_task_befree_982,,770956910,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,0.8047,,D000431,"<span class=""chemical"">alcohol</span>",D002318,"<span class=""disease"">cardiovascular disease</span>","In the presence of <span class=""disease"">cardiovascular disease</span>, however, even such small quantities of <span class=""chemical"">alcohol</span> might result in transient unfavorable hemodynamic changes.",,9751945,9751945_D000431_D002318,9751945_3,bcv_sentence_task_befree_983,,770956911,FALSE,finalized,5,8/14/15 20:39,"



",yes_direct,1,,D000431,"<span class=""chemical"">alcohol</span>",D003645,"<span class=""disease"">sudden death</span>","Moreover, <span class=""chemical"">alcohol</span> abuse can produce cardiac arrhythmias, hypertension, cardiomyopathy, stroke, and even <span class=""disease"">sudden death</span>.",,9751945,9751945_D000431_D003645,9751945_4,bcv_sentence_task_befree_984,,770956912,FALSE,finalized,5,8/14/15 23:10,"



",yes_direct,1,,D000431,"<span class=""chemical"">alcohol</span>",D020521,"<span class=""disease"">stroke</span>","Moreover, <span class=""chemical"">alcohol</span> abuse can produce cardiac arrhythmias, hypertension, cardiomyopathy, <span class=""disease"">stroke</span>, and even sudden death.",,9751945,9751945_D000431_D020521,9751945_4,bcv_sentence_task_befree_985,,770956913,FALSE,finalized,5,8/15/15 1:14,"



",yes_direct,1,,D000431,"<span class=""chemical"">alcohol</span>",D006973,"<span class=""disease"">hypertension</span>","Moreover, <span class=""chemical"">alcohol</span> abuse can produce cardiac arrhythmias, <span class=""disease"">hypertension</span>, cardiomyopathy, stroke, and even sudden death.",,9751945,9751945_D000431_D006973,9751945_4,bcv_sentence_task_befree_986,,770956914,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D000437,"<span class=""disease"">alcohol abuse</span>","Moreover, <span class=""chemical""></span><span class=""disease"">alcohol</span> abuse can produce cardiac arrhythmias, hypertension, cardiomyopathy, stroke, and even sudden death.",,9751945,9751945_D000431_D000437,9751945_4,bcv_sentence_task_befree_987,,770956915,FALSE,finalized,5,8/14/15 22:29,"



",yes_direct,1,,D000431,"<span class=""chemical"">alcohol</span>",D009202,"<span class=""disease"">cardiomyopathy</span>","Moreover, <span class=""chemical"">alcohol</span> abuse can produce cardiac arrhythmias, hypertension, <span class=""disease"">cardiomyopathy</span>, stroke, and even sudden death.",,9751945,9751945_D000431_D009202,9751945_4,bcv_sentence_task_befree_988,,770956916,FALSE,finalized,5,8/14/15 22:20,"



",yes_direct,1,,D000431,"<span class=""chemical"">alcohol</span>",D001145,"<span class=""disease"">cardiac arrhythmias</span>","Moreover, <span class=""chemical"">alcohol</span> abuse can produce <span class=""disease"">cardiac arrhythmias</span>, hypertension, cardiomyopathy, stroke, and even sudden death.",,9751945,9751945_D000431_D001145,9751945_4,bcv_sentence_task_befree_989,,770956917,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D014652,"<span class=""disease"">vascular diseases</span>","In contrast, moderate <span class=""chemical"">alcohol</span> use produces changes that have an overall favorable effect on atherosclerotic-related <span class=""disease"">vascular diseases</span>.",,9751945,9751945_D000431_D014652,9751945_5,bcv_sentence_task_befree_990,,770956918,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D050197,"<span class=""disease"">atherosclerosis</span>","Because cardiovascular disease due to <span class=""disease"">atherosclerosis</span> is the leading cause of death in Western society, this desirable effect of <span class=""chemical"">alcohol</span> use outweighs its detrimental actions, resulting in favorable findings in population studies.",,9751945,9751945_D000431_D050197,9751945_6,bcv_sentence_task_befree_991,,770956919,FALSE,finalized,5,8/14/15 20:42,"



",no_relation,0.8087,,D000431,"<span class=""chemical"">alcohol</span>",D002318,"<span class=""disease"">cardiovascular disease</span>","Because <span class=""disease"">cardiovascular disease</span> due to atherosclerosis is the leading cause of death in Western society, this desirable effect of <span class=""chemical"">alcohol</span> use outweighs its detrimental actions, resulting in favorable findings in population studies.",,9751945,9751945_D000431_D002318,9751945_6,bcv_sentence_task_befree_992,,770956920,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,0.817,,D000431,"<span class=""chemical"">alcohol</span>",D003643,"<span class=""disease"">death</span>","Because cardiovascular disease due to atherosclerosis is the leading cause of <span class=""disease"">death</span> in Western society, this desirable effect of <span class=""chemical"">alcohol</span> use outweighs its detrimental actions, resulting in favorable findings in population studies.",,9751945,9751945_D000431_D003643,9751945_6,bcv_sentence_task_befree_993,,770956921,FALSE,finalized,5,8/14/15 21:02,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003920,"<span class=""disease"">diabetes mellitus</span>","Cross-sectional analysis of data for 1567 participants in The Gubbio Population Study (677 men and 890 women), aged 45 to 64 years, without macroalbuminuria, without <span class=""disease"">diabetes mellitus</span>, and with fasting plasma <span class=""chemical"">glucose</span> levels of less than 7.8 mmol/L (140 mg/ dL).",,9759691,9759691_D005947_D003920,9759691_3,bcv_sentence_task_befree_994,,770956922,FALSE,finalized,5,8/14/15 22:09,"



",yes_direct,0.5908,,C043562,"<span class=""chemical"">flavone</span>",C538231,"<span class=""disease"">A549 lung adenocarcinoma</span>","Promoter activation and following induction of the p21/WAF1 gene by <span class=""chemical"">flavone</span> is involved in G1 phase arrest in <span class=""disease"">A549 lung adenocarcinoma</span> cells.",,9804172,9804172_C043562_C538231,9804172_0,bcv_sentence_task_befree_995,,770956923,FALSE,finalized,5,8/15/15 2:30,"



",no_relation,0.8255,,C043562,"<span class=""chemical"">Flavone</span>",D009369,"<span class=""disease"">cancer</span>","<span class=""chemical"">Flavone</span> is a well known flavonoid, and many of its derivatives have been shown to have anti-proliferative effects on several <span class=""disease"">cancer</span> cells.",,9804172,9804172_C043562_D009369,9804172_3,bcv_sentence_task_befree_996,,770956924,FALSE,finalized,5,8/14/15 21:02,"



",no_relation,1,,C043562,"<span class=""chemical"">flavone</span>",C538231,"<span class=""disease"">lung adenocarcinoma</span>","We report here that <span class=""chemical"">flavone</span> can effectively inhibit the cell growth of human <span class=""disease"">lung adenocarcinoma</span> A549 cells in a dose-dependent manner, and 100 microM <span class=""chemical"">flavone</span> causes cell cycle arrest at the G1 phase.",,9804172,9804172_C043562_C538231,9804172_4,bcv_sentence_task_befree_997,,770956925,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,C043562,"<span class=""chemical"">flavone</span>",D012175,"<span class=""disease"">RB/retinoblastoma</span>","As a mechanism underlying the cell cycle arrest, <span class=""chemical"">flavone</span> markedly increases the mRNA and protein levels of a universal inhibitor of cyclin-dependent kinase, p21/WAF1, and inhibits phosphorylation of <span class=""disease"">retinoblastoma</span> (<span class=""disease"">RB</span>) protein.",,9804172,9804172_C043562_D012175,9804172_5,bcv_sentence_task_befree_998,,770956926,FALSE,finalized,5,8/14/15 23:54,"



",no_relation,1,,C043562,"<span class=""chemical"">flavone</span>",D012175,"<span class=""disease"">RB</span>","These results suggest that the G1 phase arrest by <span class=""chemical"">flavone</span> is due to p53-independent transcriptional induction of the p21/WAF1 gene and the subsequent dephosphorylation of <span class=""disease"">RB</span> protein.",,9804172,9804172_C043562_D012175,9804172_8,bcv_sentence_task_befree_999,,770956927,FALSE,finalized,5,8/14/15 20:43,"



",yes_direct,0.8035,,D020123,"<span class=""chemical"">sirolimus</span>",D064420,"<span class=""disease"">toxicities</span>","After a phase I trial in stable renal transplant recipients documented that cyclosporine and <span class=""chemical"">sirolimus</span> have few overlapping <span class=""disease"">toxicities</span>, we conducted an open-label, single-center, phase I/II dose-escalation trial to examine the safety and efficacy of this drug combination.",,9808489,9808489_D020123_D064420,9808489_2,bcv_sentence_task_befree_1000,,770956928,FALSE,finalized,5,8/15/15 1:53,"



",no_relation,0.6175,,D016572,"<span class=""chemical"">cyclosporine</span>",D064420,"<span class=""disease"">toxicities</span>","After a phase I trial in stable renal transplant recipients documented that <span class=""chemical"">cyclosporine</span> and sirolimus have few overlapping <span class=""disease"">toxicities</span>, we conducted an open-label, single-center, phase I/II dose-escalation trial to examine the safety and efficacy of this drug combination.",,9808489,9808489_D016572_D064420,9808489_2,bcv_sentence_task_befree_1001,,770956929,FALSE,finalized,5,8/15/15 0:29,"



",no_relation,1,,D020123,"<span class=""chemical"">sirolimus</span>",D006973,"<span class=""disease"">hypertensive</span>","Although <span class=""chemical"">sirolimus</span>-treated patients displayed comparatively lower platelet and white blood cell counts and higher levels of serum cholesterol and triglycerides, <span class=""chemical"">sirolimus</span> did not augment the nephrotoxic or <span class=""disease"">hypertensive</span> proclivities of cyclosporine.",,9808489,9808489_D020123_D006973,9808489_7,bcv_sentence_task_befree_1002,,770956930,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,D014280,"<span class=""chemical"">triglycerides</span>",D006973,"<span class=""disease"">hypertensive</span>","Although sirolimus-treated patients displayed comparatively lower platelet and white blood cell counts and higher levels of serum cholesterol and <span class=""chemical"">triglycerides</span>, sirolimus did not augment the nephrotoxic or <span class=""disease"">hypertensive</span> proclivities of cyclosporine.",,9808489,9808489_D014280_D006973,9808489_7,bcv_sentence_task_befree_1003,,770956931,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,D002784,"<span class=""chemical"">cholesterol</span>",D006973,"<span class=""disease"">hypertensive</span>","Although sirolimus-treated patients displayed comparatively lower platelet and white blood cell counts and higher levels of serum <span class=""chemical"">cholesterol</span> and triglycerides, sirolimus did not augment the nephrotoxic or <span class=""disease"">hypertensive</span> proclivities of cyclosporine.",,9808489,9808489_D002784_D006973,9808489_7,bcv_sentence_task_befree_1004,,770956932,FALSE,finalized,5,8/14/15 23:37,"



",no_relation,0.7947,,D016572,"<span class=""chemical"">cyclosporine</span>",D006973,"<span class=""disease"">hypertensive</span>","Although sirolimus-treated patients displayed comparatively lower platelet and white blood cell counts and higher levels of serum cholesterol and triglycerides, sirolimus did not augment the nephrotoxic or <span class=""disease"">hypertensive</span> proclivities of <span class=""chemical"">cyclosporine</span>.",,9808489,9808489_D016572_D006973,9808489_7,bcv_sentence_task_befree_1005,,770956933,FALSE,finalized,5,8/14/15 20:53,"



",no_relation,0.8145,,D004967,"<span class=""chemical"">estrogens</span>",D009369,"<span class=""disease"">breast cancer</span>","Profound suppression of plasma <span class=""chemical"">estrogens</span> by megestrol acetate in postmenopausal <span class=""disease"">breast cancer</span> patients.",,9816328,9816328_D004967_D009369,9816328_0,bcv_sentence_task_befree_1006,,770956934,FALSE,finalized,5,8/15/15 1:58,"



",no_relation,1,,D019290,"<span class=""chemical"">megestrol acetate</span>",D009369,"<span class=""disease"">breast cancer</span>","Profound suppression of plasma estrogens by <span class=""chemical"">megestrol acetate</span> in postmenopausal <span class=""disease"">breast cancer</span> patients.",,9816328,9816328_D019290_D009369,9816328_0,bcv_sentence_task_befree_1007,,770956935,FALSE,finalized,5,8/14/15 20:44,"



",no_relation,0.7939,,D006854,"<span class=""chemical"">cortisol</span>",D009369,"<span class=""disease"">breast cancer</span>","Twelve postmenopausal women suffering from advanced <span class=""disease"">breast cancer</span> had plasma estrogens, androgens, <span class=""chemical"">cortisol</span>, and gonadotropins determined before therapy and during treatment with megestrol acetate (MA) in oral doses escalated from 40 to 160 mg.",,9816328,9816328_D006854_D009369,9816328_1,bcv_sentence_task_befree_1008,,770956936,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogens</span>",D009369,"<span class=""disease"">breast cancer</span>","Twelve postmenopausal women suffering from advanced <span class=""disease"">breast cancer</span> had plasma <span class=""chemical"">estrogens</span>, androgens, cortisol, and gonadotropins determined before therapy and during treatment with megestrol acetate (MA) in oral doses escalated from 40 to 160 mg.",,9816328,9816328_D004967_D009369,9816328_1,bcv_sentence_task_befree_1009,,770956937,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,0.8101,,D000728,"<span class=""chemical"">androgens</span>",D009369,"<span class=""disease"">breast cancer</span>","Twelve postmenopausal women suffering from advanced <span class=""disease"">breast cancer</span> had plasma estrogens, <span class=""chemical"">androgens</span>, cortisol, and gonadotropins determined before therapy and during treatment with megestrol acetate (MA) in oral doses escalated from 40 to 160 mg.",,9816328,9816328_D000728_D009369,9816328_1,bcv_sentence_task_befree_1010,,770956938,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,1,,D019290,"<span class=""chemical"">megestrol acetate</span>",D009369,"<span class=""disease"">breast cancer</span>","Twelve postmenopausal women suffering from advanced <span class=""disease"">breast cancer</span> had plasma estrogens, androgens, cortisol, and gonadotropins determined before therapy and during treatment with <span class=""chemical"">megestrol acetate</span> (MA) in oral doses escalated from 40 to 160 mg.",,9816328,9816328_D019290_D009369,9816328_1,bcv_sentence_task_befree_1011,,770956939,FALSE,finalized,5,8/15/15 1:41,"



",no_relation,1,,D000728,"<span class=""chemical"">androgens</span>",D009369,"<span class=""disease"">breast cancer</span>","Our findings indicate that MA causes profound suppression of adrenal steroid production but in addition suppresses ovarian secretion of <span class=""chemical"">androgens</span> in postmenopausal <span class=""disease"">breast cancer</span> patients.",,9816328,9816328_D000728_D009369,9816328_6,bcv_sentence_task_befree_1012,,770956940,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",D009369,"<span class=""disease"">breast cancer</span>","Our findings indicate that MA causes profound suppression of adrenal <span class=""chemical"">steroid</span> production but in addition suppresses ovarian secretion of androgens in postmenopausal <span class=""disease"">breast cancer</span> patients.",,9816328,9816328_D013256_D009369,9816328_6,bcv_sentence_task_befree_1013,,770956941,FALSE,finalized,5,8/14/15 23:39,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogens</span>",D009369,"<span class=""disease"">breast cancer</span>","The reduction in plasma <span class=""chemical"">estrogens</span> is comparable to values obtained with commonly used aromatase inhibitors and may be responsible for its antitumor effects in <span class=""disease"">breast cancer</span>.",,9816328,9816328_D004967_D009369,9816328_7,bcv_sentence_task_befree_1014,,770956942,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,D008274,"<span class=""chemical"">Mg/magnesium</span>",D018476,"<span class=""disease"">hypokinesia</span>","The aim of this study was to evaluate the effect of <span class=""chemical"">magnesium</span> (<span class=""chemical"">Mg</span>) loading (10.0 mg <span class=""chemical"">Mg</span>/kg body wt) and daily <span class=""chemical"">Mg</span> supplements (5.0 mg <span class=""chemical"">Mg</span>/kg body wt) on <span class=""chemical"">Mg</span> deficiency shown by increased and not by decreased serum <span class=""chemical"">Mg</span> concentration during <span class=""disease"">hypokinesia</span> (decreased km number/d).",,9823441,9823441_D008274_D018476,9823441_1,bcv_sentence_task_befree_1015,,770956943,FALSE,finalized,5,8/14/15 23:41,"



",no_relation,1,,D008274,"<span class=""chemical"">Mg</span>",D014717,"<span class=""disease"">SACS</span>","The SHKS and <span class=""disease"">SACS</span> groups took daily 5.0 mg elemental <span class=""chemical"">Mg</span>/kg body wt and subjected to <span class=""chemical"">Mg</span> loading (10.0 mg <span class=""chemical"">Mg</span>/kg body wt).",,9823441,9823441_D008274_D014717,9823441_12,bcv_sentence_task_befree_1016,,770956944,FALSE,finalized,5,8/14/15 22:11,"



",no_relation,1,,D008274,"<span class=""chemical"">Mg</span>",C536231,"<span class=""disease"">hypokinetic</span>","During the prehypokinetic and <span class=""disease"">hypokinetic</span> periods, excretion of <span class=""chemical"">Mg</span> in feces and urine, concentration of <span class=""chemical"">Mg</span> in serum, and <span class=""chemical"">Mg</span> balance were measured.",,9823441,9823441_D008274_C536231,9823441_14,bcv_sentence_task_befree_1017,,770956945,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,D008274,"<span class=""chemical"">Mg</span>",D014717,"<span class=""disease"">SACS</span>","In both SHKS and UHKS groups, fecal <span class=""chemical"">Mg</span> loss, urinary excretion of electrolytes, and serum concentrations of electrolytes increased significantly (p < or = 0.05) when compared with the <span class=""disease"">SACS</span> and UACS groups.",,9823441,9823441_D008274_D014717,9823441_16,bcv_sentence_task_befree_1018,,770956946,FALSE,finalized,5,8/15/15 2:14,"



",no_relation,1,,D008274,"<span class=""chemical"">Mg</span>",D014717,"<span class=""disease"">SACS</span>","During <span class=""chemical"">Mg</span> loading tests, urinary and fecal <span class=""chemical"">Mg</span> excretion was also greater in the SHKS and UHKS groups than in the <span class=""disease"">SACS</span> and UACS groups.",,9823441,9823441_D008274_D014717,9823441_17,bcv_sentence_task_befree_1019,,770956947,FALSE,finalized,5,8/14/15 22:08,"



",no_relation,1,,D008274,"<span class=""chemical"">Mg</span>",D014717,"<span class=""disease"">SACS</span>","Throughout the study, <span class=""chemical"">Mg</span> balance was negative in the SHKS and UHKS groups, whereas in the <span class=""disease"">SACS</span> and UACS groups, <span class=""chemical"">Mg</span> balance was positive.",,9823441,9823441_D008274_D014717,9823441_18,bcv_sentence_task_befree_1020,,770956948,FALSE,finalized,5,8/14/15 20:45,"



",no_relation,0.8207,,D008274,"<span class=""chemical"">Mg</span>",D018476,"<span class=""disease"">HK</span>","It was concluded that significant losses of <span class=""chemical"">Mg</span> occurred in the presence of negative <span class=""chemical"">Mg</span> balance and <span class=""chemical"">Mg</span> deficiency in endurance-trained subjects during prolonged exposure to <span class=""disease"">HK</span>, daily mg supplements, and <span class=""chemical"">Mg</span> loading tests.",,9823441,9823441_D008274_D018476,9823441_19,bcv_sentence_task_befree_1021,,770956949,FALSE,finalized,5,8/14/15 23:50,"



",yes_direct,0.815,,D017367,"<span class=""chemical"">SSRI</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","Management of <span class=""chemical"">SSRI</span>-induced <span class=""disease"">sexual dysfunction</span>.",,9825088,9825088_D017367_D012735,9825088_0,bcv_sentence_task_befree_1022,,770956950,FALSE,finalized,5,8/14/15 20:38,"



",yes_direct,0.5968,,D012701,"<span class=""chemical"">serotonin</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","To describe the occurrence and management of <span class=""disease"">sexual dysfunction</span> induced by selective <span class=""chemical"">serotonin</span>-reuptake inhibitors (SSRIs), to provide an overview of <span class=""disease"">sexual dysfunction</span>, reports of SSRI-induced <span class=""disease"">sexual dysfunction</span>, and management strategies.",,9825088,9825088_D012701_D012735,9825088_1,bcv_sentence_task_befree_1023,,770956951,FALSE,finalized,5,8/14/15 20:40,"



",yes_direct,0.7994,,D017367,"<span class=""chemical"">SSRI</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","To describe the occurrence and management of <span class=""disease"">sexual dysfunction</span> induced by selective serotonin-reuptake inhibitors (SSRIs), to provide an overview of <span class=""disease"">sexual dysfunction</span>, reports of <span class=""chemical"">SSRI</span>-induced <span class=""disease"">sexual dysfunction</span>, and management strategies.",,9825088,9825088_D017367_D012735,9825088_1,bcv_sentence_task_befree_1024,,770956952,FALSE,finalized,5,8/14/15 20:46,"



",no_relation,0.7897,,C051752,"<span class=""chemical"">nefazodone</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","Indexing terms included <span class=""disease"">sexual dysfunction</span>, antidepressants, selective serotonergic reuptake inhibitors, fluoxetine, sertraline, paroxetine, fluvoxamine, clomipramine, buspirone, <span class=""chemical"">nefazodone</span>, bupropion, cyproheptadine, amantadine, yohimbine, and central nervous system stimulants.",,9825088,9825088_C051752_D012735,9825088_3,bcv_sentence_task_befree_1025,,770956953,FALSE,finalized,5,8/15/15 0:49,"



",no_relation,1,,D005473,"<span class=""chemical"">fluoxetine</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","Indexing terms included <span class=""disease"">sexual dysfunction</span>, antidepressants, selective serotonergic reuptake inhibitors, <span class=""chemical"">fluoxetine</span>, sertraline, paroxetine, fluvoxamine, clomipramine, buspirone, nefazodone, bupropion, cyproheptadine, amantadine, yohimbine, and central nervous system stimulants.",,9825088,9825088_D005473_D012735,9825088_3,bcv_sentence_task_befree_1026,,770956954,FALSE,finalized,5,8/14/15 21:55,"



",no_relation,0.7899,,D016642,"<span class=""chemical"">bupropion</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","Indexing terms included <span class=""disease"">sexual dysfunction</span>, antidepressants, selective serotonergic reuptake inhibitors, fluoxetine, sertraline, paroxetine, fluvoxamine, clomipramine, buspirone, nefazodone, <span class=""chemical"">bupropion</span>, cyproheptadine, amantadine, yohimbine, and central nervous system stimulants.",,9825088,9825088_D016642_D012735,9825088_3,bcv_sentence_task_befree_1027,,770956955,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D003533,"<span class=""chemical"">cyproheptadine</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","Indexing terms included <span class=""disease"">sexual dysfunction</span>, antidepressants, selective serotonergic reuptake inhibitors, fluoxetine, sertraline, paroxetine, fluvoxamine, clomipramine, buspirone, nefazodone, bupropion, <span class=""chemical"">cyproheptadine</span>, amantadine, yohimbine, and central nervous system stimulants.",,9825088,9825088_D003533_D012735,9825088_3,bcv_sentence_task_befree_1028,,770956956,FALSE,finalized,5,8/15/15 2:31,"



",no_relation,0.7938,,D015016,"<span class=""chemical"">yohimbine</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","Indexing terms included <span class=""disease"">sexual dysfunction</span>, antidepressants, selective serotonergic reuptake inhibitors, fluoxetine, sertraline, paroxetine, fluvoxamine, clomipramine, buspirone, nefazodone, bupropion, cyproheptadine, amantadine, <span class=""chemical"">yohimbine</span>, and central nervous system stimulants.",,9825088,9825088_D015016_D012735,9825088_3,bcv_sentence_task_befree_1029,,770956957,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,D002997,"<span class=""chemical"">clomipramine</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","Indexing terms included <span class=""disease"">sexual dysfunction</span>, antidepressants, selective serotonergic reuptake inhibitors, fluoxetine, sertraline, paroxetine, fluvoxamine, <span class=""chemical"">clomipramine</span>, buspirone, nefazodone, bupropion, cyproheptadine, amantadine, yohimbine, and central nervous system stimulants.",,9825088,9825088_D002997_D012735,9825088_3,bcv_sentence_task_befree_1030,,770956958,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,D020280,"<span class=""chemical"">sertraline</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","Indexing terms included <span class=""disease"">sexual dysfunction</span>, antidepressants, selective serotonergic reuptake inhibitors, fluoxetine, <span class=""chemical"">sertraline</span>, paroxetine, fluvoxamine, clomipramine, buspirone, nefazodone, bupropion, cyproheptadine, amantadine, yohimbine, and central nervous system stimulants.",,9825088,9825088_D020280_D012735,9825088_3,bcv_sentence_task_befree_1031,,770956959,FALSE,finalized,5,8/15/15 1:58,"



",no_relation,1,,D000547,"<span class=""chemical"">amantadine</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","Indexing terms included <span class=""disease"">sexual dysfunction</span>, antidepressants, selective serotonergic reuptake inhibitors, fluoxetine, sertraline, paroxetine, fluvoxamine, clomipramine, buspirone, nefazodone, bupropion, cyproheptadine, <span class=""chemical"">amantadine</span>, yohimbine, and central nervous system stimulants.",,9825088,9825088_D000547_D012735,9825088_3,bcv_sentence_task_befree_1032,,770956960,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D002065,"<span class=""chemical"">buspirone</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","Indexing terms included <span class=""disease"">sexual dysfunction</span>, antidepressants, selective serotonergic reuptake inhibitors, fluoxetine, sertraline, paroxetine, fluvoxamine, clomipramine, <span class=""chemical"">buspirone</span>, nefazodone, bupropion, cyproheptadine, amantadine, yohimbine, and central nervous system stimulants.",,9825088,9825088_D002065_D012735,9825088_3,bcv_sentence_task_befree_1033,,770956961,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,0.7996,,D017374,"<span class=""chemical"">paroxetine</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","Indexing terms included <span class=""disease"">sexual dysfunction</span>, antidepressants, selective serotonergic reuptake inhibitors, fluoxetine, sertraline, <span class=""chemical"">paroxetine</span>, fluvoxamine, clomipramine, buspirone, nefazodone, bupropion, cyproheptadine, amantadine, yohimbine, and central nervous system stimulants.",,9825088,9825088_D017374_D012735,9825088_3,bcv_sentence_task_befree_1034,,770956962,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,0.7899,,D016666,"<span class=""chemical"">fluvoxamine</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","Indexing terms included <span class=""disease"">sexual dysfunction</span>, antidepressants, selective serotonergic reuptake inhibitors, fluoxetine, sertraline, paroxetine, <span class=""chemical"">fluvoxamine</span>, clomipramine, buspirone, nefazodone, bupropion, cyproheptadine, amantadine, yohimbine, and central nervous system stimulants.",,9825088,9825088_D016666_D012735,9825088_3,bcv_sentence_task_befree_1035,,770956963,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,0.5815,,D017367,"<span class=""chemical"">SSRI</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","There are no controlled studies describing <span class=""chemical"">SSRI</span>-induced <span class=""disease"">sexual dysfunction</span> or its management.",,9825088,9825088_D017367_D012735,9825088_4,bcv_sentence_task_befree_1036,,770956964,FALSE,finalized,5,8/14/15 22:00,"



",yes_direct,0.8106,,D005473,"<span class=""chemical"">fluoxetine</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","SSRI-induced <span class=""disease"">sexual dysfunction</span> is described with <span class=""chemical"">fluoxetine</span>, paroxetine, sertraline, and fluvoxamine for 3-24 weeks of therapy.",,9825088,9825088_D005473_D012735,9825088_6,bcv_sentence_task_befree_1037,,770956965,FALSE,finalized,5,8/14/15 22:19,"



",yes_direct,0.7906,,D017374,"<span class=""chemical"">paroxetine</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","SSRI-induced <span class=""disease"">sexual dysfunction</span> is described with fluoxetine, <span class=""chemical"">paroxetine</span>, sertraline, and fluvoxamine for 3-24 weeks of therapy.",,9825088,9825088_D017374_D012735,9825088_6,bcv_sentence_task_befree_1038,,770956966,FALSE,finalized,5,8/15/15 0:04,"



",no_relation,0.5885,,D016666,"<span class=""chemical"">fluvoxamine</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","SSRI-induced <span class=""disease"">sexual dysfunction</span> is described with fluoxetine, paroxetine, sertraline, and <span class=""chemical"">fluvoxamine</span> for 3-24 weeks of therapy.",,9825088,9825088_D016666_D012735,9825088_6,bcv_sentence_task_befree_1039,,770956967,FALSE,finalized,5,8/15/15 0:12,"



",yes_direct,0.7997,,D020280,"<span class=""chemical"">sertraline</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","SSRI-induced <span class=""disease"">sexual dysfunction</span> is described with fluoxetine, paroxetine, <span class=""chemical"">sertraline</span>, and fluvoxamine for 3-24 weeks of therapy.",,9825088,9825088_D020280_D012735,9825088_6,bcv_sentence_task_befree_1040,,770956968,FALSE,finalized,5,8/14/15 21:36,"



",yes_direct,1,,D017367,"<span class=""chemical"">SSRI</span>",D012735,"<span class=""disease"">sexual dysfunction</span>","<span class=""chemical"">SSRI</span>-induced <span class=""disease"">sexual dysfunction</span> is described with fluoxetine, paroxetine, sertraline, and fluvoxamine for 3-24 weeks of therapy.",,9825088,9825088_D017367_D012735,9825088_6,bcv_sentence_task_befree_1041,,770956969,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,0.6084,,D012701,"<span class=""chemical"">serotonin</span>",D009771,"<span class=""disease"">obsessive-compulsive disorder</span>","Role of <span class=""chemical"">serotonin</span> in <span class=""disease"">obsessive-compulsive disorder</span>.",,9829022,9829022_D012701_D009771,9829022_0,bcv_sentence_task_befree_1042,,770956970,FALSE,finalized,5,8/14/15 20:51,"



",yes_direct,0.41,,D012701,"<span class=""chemical"">Serotonin</span>",D009771,"<span class=""disease"">obsessive-compulsive disorder/OCD</span>","<span class=""chemical"">Serotonin</span> may play a role in the pathophysiology of <span class=""disease"">obsessive-compulsive disorder</span> (<span class=""disease"">OCD</span>) because of the anti-obsessional effect of selective <span class=""chemical"">serotonin</span> reuptake inhibitors (SSRIs).",,9829022,9829022_D012701_D009771,9829022_1,bcv_sentence_task_befree_1043,,770956971,FALSE,finalized,5,8/14/15 21:46,"



",no_relation,1,,D006719,"<span class=""chemical"">homovanillic acid</span>",D009771,"<span class=""disease"">OCD</span>","In most of the <span class=""disease"">OCD</span> cases analysed, CSF 5-hydroxyindoleacetic acid and <span class=""chemical"">homovanillic acid</span> concentrations do not significantly differ from age-corrected controls.",,9829022,9829022_D006719_D009771,9829022_3,bcv_sentence_task_befree_1044,,770956972,FALSE,finalized,5,8/15/15 0:08,"



",no_relation,0.7866,,D013004,"<span class=""chemical"">somatostatin</span>",D009771,"<span class=""disease"">OCD</span>","Abnormalities in CSF arginine vasopressin, corticotropin-releasing hormone, oxytocin and <span class=""chemical"">somatostatin</span> levels have been reported in <span class=""disease"">OCD</span>.",,9829022,9829022_D013004_D009771,9829022_5,bcv_sentence_task_befree_1045,,770956973,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,0.8103,,D001127,"<span class=""chemical"">arginine vasopressin</span>",D009771,"<span class=""disease"">OCD</span>","Abnormalities in CSF <span class=""chemical"">arginine vasopressin</span>, corticotropin-releasing hormone, oxytocin and somatostatin levels have been reported in <span class=""disease"">OCD</span>.",,9829022,9829022_D001127_D009771,9829022_5,bcv_sentence_task_befree_1046,,770956974,FALSE,finalized,5,8/15/15 2:47,"



",no_relation,1,,D010121,"<span class=""chemical"">oxytocin</span>",D009771,"<span class=""disease"">OCD</span>","Abnormalities in CSF arginine vasopressin, corticotropin-releasing hormone, <span class=""chemical"">oxytocin</span> and somatostatin levels have been reported in <span class=""disease"">OCD</span>.",,9829022,9829022_D010121_D009771,9829022_5,bcv_sentence_task_befree_1047,,770956975,FALSE,finalized,5,8/14/15 23:32,"



",no_relation,1,,D002997,"<span class=""chemical"">clomipramine</span>",D002869,"<span class=""disease"">neuropeptide abnormalities</span>","Long-term treatment with high-doses of <span class=""chemical"">clomipramine</span>, fluvoxamine, and fluoxetine tend to correct these <span class=""disease"">neuropeptide abnormalities</span>.",,9829022,9829022_D002997_D002869,9829022_6,bcv_sentence_task_befree_1048,,770956976,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,1,,D005473,"<span class=""chemical"">fluoxetine</span>",D002869,"<span class=""disease"">neuropeptide abnormalities</span>","Long-term treatment with high-doses of clomipramine, fluvoxamine, and <span class=""chemical"">fluoxetine</span> tend to correct these <span class=""disease"">neuropeptide abnormalities</span>.",,9829022,9829022_D005473_D002869,9829022_6,bcv_sentence_task_befree_1049,,770956977,FALSE,finalized,5,8/14/15 20:43,"



",no_relation,1,,D016666,"<span class=""chemical"">fluvoxamine</span>",D002869,"<span class=""disease"">neuropeptide abnormalities</span>","Long-term treatment with high-doses of clomipramine, <span class=""chemical"">fluvoxamine</span>, and fluoxetine tend to correct these <span class=""disease"">neuropeptide abnormalities</span>.",,9829022,9829022_D016666_D002869,9829022_6,bcv_sentence_task_befree_1050,,770956978,FALSE,finalized,5,8/15/15 0:04,"



",no_relation,0.8209,,D012701,"<span class=""chemical"">serotonin</span>",D009771,"<span class=""disease"">OCD</span>","We hypothesise that continuous treatment with SSRIs alters <span class=""chemical"">serotonin</span> turnover and neuropeptide expression patterns in <span class=""disease"">OCD</span>-entertaining functional forebrain/midbrain circuits.",,9829022,9829022_D012701_D009771,9829022_7,bcv_sentence_task_befree_1051,,770956979,FALSE,finalized,5,8/15/15 2:07,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D007676,"<span class=""disease"">ESRD/end-stage renal disease</span>","The study included 20 <span class=""disease"">end-stage renal disease</span> (<span class=""disease"">ESRD</span>) patients, performing chronic peritoneal or home hemodialysis, with <span class=""chemical"">iron</span> deficiency defined as ferritin < 100 ng/mL and/or an <span class=""chemical"">iron</span> saturation < 20%.",,9848632,9848632_D007501_D007676,9848632_4,bcv_sentence_task_befree_1052,,770956980,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D018798,"<span class=""disease"">iron deficiency</span>","The study included 20 end-stage renal disease (ESRD) patients, performing chronic peritoneal or home hemodialysis, with <span class=""chemical""></span><span class=""disease"">iron</span> deficiency defined as ferritin < 100 ng/mL and/or an <span class=""chemical"">iron</span> saturation < 20%.",,9848632,9848632_D007501_D018798,9848632_4,bcv_sentence_task_befree_1053,,770956981,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D007676,"<span class=""disease"">ESRD</span>","Total dose <span class=""chemical"">iron</span> is a safe and effective means of restoring <span class=""chemical"">iron</span> and erythropoietic response in <span class=""disease"">ESRD</span> patients weighing more than 50 kg who receive their renal replacement therapy at home.",,9848632,9848632_D007501_D007676,9848632_18,bcv_sentence_task_befree_1054,,770956982,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,D008751,"<span class=""chemical"">Methylene blue</span>",D008708,"<span class=""disease"">methemoglobinemia</span>","<span class=""chemical"">Methylene blue</span> by intraosseous infusion for <span class=""disease"">methemoglobinemia</span>.",,9867898,9867898_D008751_D008708,9867898_0,bcv_sentence_task_befree_1055,,770956983,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,1,,D008751,"<span class=""chemical"">methylene blue</span>",D008708,"<span class=""disease"">methemoglobinemia</span>","Intraosseous administration of standard intravenous doses of <span class=""chemical"">methylene blue</span> rapidly terminated the effects of acquired <span class=""disease"">methemoglobinemia</span>.",,9867898,9867898_D008751_D008708,9867898_11,bcv_sentence_task_befree_1056,,770956984,FALSE,finalized,5,8/14/15 23:18,"



",no_relation,1,,D010406,"<span class=""chemical"">penicillin</span>",D000039,"<span class=""disease"">peritonsillar abscess</span>","These results suggest that intravenous <span class=""chemical"">penicillin</span> remains an excellent choice for therapy in cases of <span class=""disease"">peritonsillar abscess</span> requiring parenteral antibiotics after drainage.",,9914550,9914550_D010406_D000039,9914550_9,bcv_sentence_task_befree_1057,,770956985,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,0.5878,,D002725,"<span class=""chemical"">chloroform</span>",D006177,"<span class=""disease"">hepatic damage</span>","The contribution of drug-induced <span class=""disease"">hepatic damage</span> to postoperative hepatic dysfunction has remained unsettled since <span class=""chemical"">chloroform</span> was first incriminated during the nineteenth century.",,9921434,9921434_D002725_D006177,9921434_4,bcv_sentence_task_befree_1058,,770956986,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,0.5968,,D002725,"<span class=""chemical"">chloroform</span>",D006505,"<span class=""disease"">hepatic dysfunction</span>","The contribution of drug-induced hepatic damage to postoperative <span class=""disease"">hepatic dysfunction</span> has remained unsettled since <span class=""chemical"">chloroform</span> was first incriminated during the nineteenth century.",,9921434,9921434_D002725_D006505,9921434_4,bcv_sentence_task_befree_1059,,770956987,FALSE,finalized,5,8/15/15 2:14,"



",yes_direct,0.8072,,D002725,"<span class=""chemical"">chloroform</span>",D011041,"<span class=""disease"">poisoning</span>","The drug was condemned in 1912, without any attempt being made to determine the incidence of the so-called delayed <span class=""chemical"">chloroform</span> <span class=""disease"">poisoning</span>, with the result that the drug is still in use and the <span class=""chemical"">chloroform</span> controversy remains unsettled to this day.",,9921434,9921434_D002725_D011041,9921434_5,bcv_sentence_task_befree_1060,,770956988,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,0.7771,,D002725,"<span class=""chemical"">chloroform</span>",D009336,"<span class=""disease"">necrosis</span>","Babior and Davidson noted that it was the first drug implicated in hepatic <span class=""disease"">necrosis</span>--presumably with the exception of <span class=""chemical"">chloroform</span>--the first report appearing in 1922.",,9921434,9921434_D002725_D009336,9921434_8,bcv_sentence_task_befree_1061,,770956989,FALSE,finalized,5,8/15/15 1:23,"



",no_relation,0.7793,,D006221,"<span class=""chemical"">halothane</span>",D006505,"<span class=""disease"">hepatitis</span>","Just as we have conducted the definitive retrospective hypothesis-testing study--the National Halothane Study--demanded by the ""<span class=""chemical"">halothane</span> <span class=""disease"">hepatitis</span>"" controversy, so must we now move to the final stage of epidemiological investigation (experimental epidemiology) by investigating the effects of multiple administrations of the drug.",,9921434,9921434_D006221_D006505,9921434_18,bcv_sentence_task_befree_1062,,770956990,FALSE,finalized,5,8/14/15 22:08,"



",no_relation,0.7981,,D017239,"<span class=""chemical"">Paclitaxel</span>",D009369,"<span class=""disease"">tumor</span>","<span class=""chemical"">Paclitaxel</span> is preferentially cytotoxic to human cervical <span class=""disease"">tumor</span> cells with low Raf-1 kinase activity: implications for <span class=""chemical"">paclitaxel</span>-based chemoradiation regimens.",,9925253,9925253_D017239_D009369,9925253_0,bcv_sentence_task_befree_1063,,770956991,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,0.6068,,D017239,"<span class=""chemical"">paclitaxel</span>",D009369,"<span class=""disease"">tumor</span>","Low Raf- kinase activity has been reported to be associated with radioresistance in epithelial <span class=""disease"">tumor</span> cell lines and with <span class=""chemical"">paclitaxel</span> sensitivity in cervical <span class=""disease"">tumor</span> cells.",,9925253,9925253_D017239_D009369,9925253_1,bcv_sentence_task_befree_1064,,770956992,FALSE,finalized,5,8/15/15 1:33,"



",no_relation,1,,D017239,"<span class=""chemical"">Paclitaxel</span>",D009369,"<span class=""disease"">tumors</span>","<span class=""chemical"">Paclitaxel</span> might thus be effective in eliminating radioresistant clones from cervical <span class=""disease"">tumors</span>, even in the absence of synergistic interaction between these therapeutic modalities.",,9925253,9925253_D017239_D009369,9925253_2,bcv_sentence_task_befree_1065,,770956993,FALSE,finalized,5,8/15/15 2:20,"



",no_relation,0.7929,,D017239,"<span class=""chemical"">paclitaxel</span>",D009369,"<span class=""disease"">tumor</span>","We thus established the relationship between Raf-1 kinase activity and radiosensitivity in human cervical <span class=""disease"">tumor</span> cells and determined if <span class=""chemical"">paclitaxel</span> is preferentially cytotoxic to radio-resistant <span class=""disease"">tumor</span> clones.",,9925253,9925253_D017239_D009369,9925253_3,bcv_sentence_task_befree_1066,,770956994,FALSE,finalized,5,8/15/15 2:16,"



",no_relation,1,,D017239,"<span class=""chemical"">paclitaxel</span>",D009369,"<span class=""disease"">tumor</span>","We established and contrasted the radiation and <span class=""chemical"">paclitaxel</span> sensitivity of 12 human cervical <span class=""disease"">tumor</span> clones that exhibited a wide range of Raf-1 kinase activity.",,9925253,9925253_D017239_D009369,9925253_4,bcv_sentence_task_befree_1067,,770956995,FALSE,finalized,5,8/14/15 22:52,"



",no_relation,1,,D017239,"<span class=""chemical"">Paclitaxel</span>",D009369,"<span class=""disease"">tumor</span>","<span class=""chemical"">Paclitaxel</span> was preferentially cytotoxic to radioresistant <span class=""disease"">tumor</span> clones, with the level of <span class=""chemical"">paclitaxel</span>-induced cytotoxicity being significantly (P = 0.0016) influenced by Raf-1 kinase activity levels.",,9925253,9925253_D017239_D009369,9925253_6,bcv_sentence_task_befree_1068,,770956996,FALSE,finalized,5,8/14/15 20:41,"



",yes_direct,1,,D017239,"<span class=""chemical"">Paclitaxel</span>",D004487,"<span class=""disease"">cytotoxicity</span>","<span class=""chemical"">Paclitaxel</span> was preferentially cytotoxic to radioresistant tumor clones, with the level of <span class=""chemical"">paclitaxel</span>-induced <span class=""disease"">cytotoxicity</span> being significantly (P = 0.0016) influenced by Raf-1 kinase activity levels.",,9925253,9925253_D017239_D004487,9925253_6,bcv_sentence_task_befree_1069,,770956997,FALSE,finalized,5,8/14/15 21:53,"



",no_relation,0.7893,,D017239,"<span class=""chemical"">paclitaxel</span>",D009369,"<span class=""disease"">tumor</span>","Our in vitro data indicate that there are marked, but completely opposite, Raf-1 kinase dependencies of radiation and <span class=""chemical"">paclitaxel</span> cytotoxicity in cervical <span class=""disease"">tumor</span> cells.",,9925253,9925253_D017239_D009369,9925253_7,bcv_sentence_task_befree_1070,,770956998,FALSE,finalized,5,8/14/15 21:02,"



",no_relation,0.7975,,D017239,"<span class=""chemical"">paclitaxel</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Our in vitro data indicate that there are marked, but completely opposite, Raf-1 kinase dependencies of radiation and <span class=""chemical"">paclitaxel</span> <span class=""disease"">cytotoxicity</span> in cervical tumor cells.",,9925253,9925253_D017239_D004487,9925253_7,bcv_sentence_task_befree_1071,,770956999,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,D017239,"<span class=""chemical"">paclitaxel</span>",D065309,"<span class=""disease"">squamous cell carcinoma of the cervix</span>","The use of combined <span class=""chemical"">paclitaxel</span> and radiotherapy treatment may thus lead to higher local control rates for <span class=""disease"">squamous cell carcinoma of the cervix</span>.",,9925253,9925253_D017239_D065309,9925253_8,bcv_sentence_task_befree_1072,,770957000,FALSE,finalized,5,8/15/15 1:00,"



",no_relation,1,,D017239,"<span class=""chemical"">paclitaxel</span>",D009369,"<span class=""disease"">tumor</span>","Circumstantially, our data suggest that the greatest therapeutic gains might accrue if <span class=""chemical"">paclitaxel</span> was administered when there is the greatest proportion of <span class=""disease"">tumor</span> clones with low Raf-1 kinase activity.",,9925253,9925253_D017239_D009369,9925253_9,bcv_sentence_task_befree_1073,,770957001,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,D005978,"<span class=""chemical"">glutathione</span>",D009369,"<span class=""disease"">tumor</span>","Molecular mechanism of the regulation of <span class=""chemical"">glutathione</span> synthesis by <span class=""disease"">tumor</span> necrosis factor-alpha and dexamethasone in human alveolar epithelial cells.",,9988757,9988757_D005978_D009369,9988757_0,bcv_sentence_task_befree_1074,,770957002,FALSE,finalized,5,8/14/15 21:02,"



",no_relation,1,,D003907,"<span class=""chemical"">dexamethasone</span>",D009336,"<span class=""disease"">necrosis</span>","Molecular mechanism of the regulation of glutathione synthesis by tumor <span class=""disease"">necrosis</span> factor-alpha and <span class=""chemical"">dexamethasone</span> in human alveolar epithelial cells.",,9988757,9988757_D003907_D009336,9988757_0,bcv_sentence_task_befree_1075,,770957003,FALSE,finalized,5,8/15/15 0:35,"



",no_relation,1,,D005978,"<span class=""chemical"">glutathione</span>",D009336,"<span class=""disease"">necrosis</span>","Molecular mechanism of the regulation of <span class=""chemical"">glutathione</span> synthesis by tumor <span class=""disease"">necrosis</span> factor-alpha and dexamethasone in human alveolar epithelial cells.",,9988757,9988757_D005978_D009336,9988757_0,bcv_sentence_task_befree_1076,,770957004,FALSE,finalized,5,8/14/15 20:42,"



",no_relation,1,,D003907,"<span class=""chemical"">dexamethasone</span>",D009369,"<span class=""disease"">tumor</span>","Molecular mechanism of the regulation of glutathione synthesis by <span class=""disease"">tumor</span> necrosis factor-alpha and <span class=""chemical"">dexamethasone</span> in human alveolar epithelial cells.",,9988757,9988757_D003907_D009369,9988757_0,bcv_sentence_task_befree_1077,,770957005,FALSE,finalized,5,8/14/15 20:44,"



",no_relation,0.8302,,D005978,"<span class=""chemical"">GSH</span>",D009369,"<span class=""disease"">tumor</span>","We studied the regulation of <span class=""chemical"">GSH</span> synthesis in response to the pro-inflammatory cytokine <span class=""disease"">tumor</span> necrosis factor-alpha (TNF-alpha) and the anti-inflammatory agent dexamethasone in human alveolar epithelial cells (A549).",,9988757,9988757_D005978_D009369,9988757_2,bcv_sentence_task_befree_1078,,770957006,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,D003907,"<span class=""chemical"">dexamethasone</span>",D009336,"<span class=""disease"">necrosis</span>","We studied the regulation of GSH synthesis in response to the pro-inflammatory cytokine tumor <span class=""disease"">necrosis</span> factor-alpha (TNF-alpha) and the anti-inflammatory agent <span class=""chemical"">dexamethasone</span> in human alveolar epithelial cells (A549).",,9988757,9988757_D003907_D009336,9988757_2,bcv_sentence_task_befree_1079,,770957007,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,0.7996,,D005978,"<span class=""chemical"">GSH</span>",D009336,"<span class=""disease"">necrosis</span>","We studied the regulation of <span class=""chemical"">GSH</span> synthesis in response to the pro-inflammatory cytokine tumor <span class=""disease"">necrosis</span> factor-alpha (TNF-alpha) and the anti-inflammatory agent dexamethasone in human alveolar epithelial cells (A549).",,9988757,9988757_D005978_D009336,9988757_2,bcv_sentence_task_befree_1080,,770957008,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,D003907,"<span class=""chemical"">dexamethasone</span>",D009369,"<span class=""disease"">tumor</span>","We studied the regulation of GSH synthesis in response to the pro-inflammatory cytokine <span class=""disease"">tumor</span> necrosis factor-alpha (TNF-alpha) and the anti-inflammatory agent <span class=""chemical"">dexamethasone</span> in human alveolar epithelial cells (A549).",,9988757,9988757_D003907_D009369,9988757_2,bcv_sentence_task_befree_1081,,770957009,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,D011241,"<span class=""chemical"">prednisone</span>",D006333,"<span class=""disease"">heart failure</span>","The 2 patients with active inflammation received <span class=""chemical"">prednisone</span> (1 mg. kg-1. d-1 for 4 weeks followed by 0.33 mg. kg-1. d-1 for 5 months) and azathioprine (2 mg. kg-1. d-1 for 5 months) in addition to conventional drug therapy for <span class=""disease"">heart failure</span>.",,10077512,10077512_D011241_D006333,10077512_6,bcv_sentence_task_befree_1082,,770957010,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,D001379,"<span class=""chemical"">azathioprine</span>",D006333,"<span class=""disease"">heart failure</span>","The 2 patients with active inflammation received prednisone (1 mg. kg-1. d-1 for 4 weeks followed by 0.33 mg. kg-1. d-1 for 5 months) and <span class=""chemical"">azathioprine</span> (2 mg. kg-1. d-1 for 5 months) in addition to conventional drug therapy for <span class=""disease"">heart failure</span>.",,10077512,10077512_D001379_D006333,10077512_6,bcv_sentence_task_befree_1083,,770957011,FALSE,finalized,5,8/15/15 1:23,"



",no_relation,1,,D011241,"<span class=""chemical"">prednisone</span>",D007249,"<span class=""disease"">inflammation</span>","The 2 patients with active <span class=""disease"">inflammation</span> received <span class=""chemical"">prednisone</span> (1 mg. kg-1. d-1 for 4 weeks followed by 0.33 mg. kg-1. d-1 for 5 months) and azathioprine (2 mg. kg-1. d-1 for 5 months) in addition to conventional drug therapy for heart failure.",,10077512,10077512_D011241_D007249,10077512_6,bcv_sentence_task_befree_1084,,770957012,FALSE,finalized,5,8/14/15 20:49,"



",no_relation,1,,D001379,"<span class=""chemical"">azathioprine</span>",D007249,"<span class=""disease"">inflammation</span>","The 2 patients with active <span class=""disease"">inflammation</span> received prednisone (1 mg. kg-1. d-1 for 4 weeks followed by 0.33 mg. kg-1. d-1 for 5 months) and <span class=""chemical"">azathioprine</span> (2 mg. kg-1. d-1 for 5 months) in addition to conventional drug therapy for heart failure.",,10077512,10077512_D001379_D007249,10077512_6,bcv_sentence_task_befree_1085,,770957013,FALSE,finalized,5,8/14/15 23:45,"



",no_relation,1,,D019797,"<span class=""chemical"">MIBG</span>",D009369,"<span class=""disease"">Carcinoid tumours/breast cancer</span>","<span class=""disease"">Carcinoid tumours</span> presenting as <span class=""disease"">breast cancer</span>: the utility of radionuclide imaging with 123I-<span class=""chemical"">MIBG</span> and 111In-DTPA pentetreotide.",,10197087,10197087_D019797_D009369,10197087_0,bcv_sentence_task_befree_1086,,770957014,FALSE,finalized,5,8/15/15 1:44,"



",no_relation,1,,C081788,"<span class=""chemical"">pentetreotide</span>",D009369,"<span class=""disease"">Carcinoid tumours/breast cancer</span>","<span class=""disease"">Carcinoid tumours</span> presenting as <span class=""disease"">breast cancer</span>: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA <span class=""chemical"">pentetreotide</span>.",,10197087,10197087_C081788_D009369,10197087_0,bcv_sentence_task_befree_1087,,770957015,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,1,,D019793,"<span class=""chemical"">fluorescein</span>",D001237,"<span class=""disease"">asphyxia</span>","Superfusion of PAF over the cortex induced a dose-dependent increase in leukocyte adherence to cerebral venules and leakage of <span class=""chemical"">fluorescein</span>; with 1 micromol/L PAF, the magnitude of adherence and BBB breakdown was similar to that seen during reoxygenation after 9 minutes of <span class=""disease"">asphyxia</span>.",,10197511,10197511_D019793_D001237,10197511_4,bcv_sentence_task_befree_1088,,770957016,FALSE,finalized,5,8/14/15 23:17,"



",no_relation,1,,D013134,"<span class=""chemical"">spiperone</span>",D012559,"<span class=""disease"">schizophrenia</span>","3H-<span class=""chemical"">spiperone</span> binding to lymphocytes in neuroleptic-naive-<span class=""disease"">schizophrenia</span> and the effect of neuroleptic treatment.",,10202608,10202608_D013134_D012559,10202608_0,bcv_sentence_task_befree_1089,,770957017,FALSE,finalized,5,8/14/15 20:46,"



",no_relation,0.5871,,D013134,"<span class=""chemical"">spiperone</span>",D012559,"<span class=""disease"">schizophrenic/schizophrenia</span>","The aim of this study was to determine whether <span class=""chemical"">spiperone</span> binding to lymphocytes could serve as a biological marker of susceptibility to <span class=""disease"">schizophrenia</span> and <span class=""disease"">schizophrenic</span> spectrum disorders or as a measure of response to neuroleptic treatment.",,10202608,10202608_D013134_D012559,10202608_1,bcv_sentence_task_befree_1090,,770957018,FALSE,finalized,5,8/15/15 0:19,"



",no_relation,1,,D013134,"<span class=""chemical"">spiperone</span>",D012569,"<span class=""disease"">schizotypal personality disorder</span>","Lymphocyte <span class=""chemical"">spiperone</span> binding parameters (Bmax, KD) were assessed in 13 patients with schizophrenia and 4 patients with <span class=""disease"">schizotypal personality disorder</span>, all neuroleptic naive, and in 19 age- and sex-matched control subjects.",,10202608,10202608_D013134_D012569,10202608_2,bcv_sentence_task_befree_1091,,770957019,FALSE,finalized,5,8/15/15 0:51,"



",no_relation,0.8121,,D013134,"<span class=""chemical"">spiperone</span>",D012559,"<span class=""disease"">schizophrenia</span>","Lymphocyte <span class=""chemical"">spiperone</span> binding parameters (Bmax, KD) were assessed in 13 patients with <span class=""disease"">schizophrenia</span> and 4 patients with schizotypal personality disorder, all neuroleptic naive, and in 19 age- and sex-matched control subjects.",,10202608,10202608_D013134_D012559,10202608_2,bcv_sentence_task_befree_1092,,770957020,FALSE,finalized,5,8/14/15 23:33,"



",no_relation,1,,D003609,"<span class=""chemical"">actinomycin</span>",D004828,"<span class=""disease"">localized disease</span>","Seven patients had <span class=""disease"">localized disease</span> (stage I/II) and the six surviving patients received chemotherapy with vincristine and <span class=""chemical"">actinomycin</span>; no patient received radiotherapy.",,10212915,10212915_D003609_D004828,10212915_6,bcv_sentence_task_befree_1093,,770957021,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,1,,D014750,"<span class=""chemical"">vincristine</span>",D004828,"<span class=""disease"">localized disease</span>","Seven patients had <span class=""disease"">localized disease</span> (stage I/II) and the six surviving patients received chemotherapy with <span class=""chemical"">vincristine</span> and actinomycin; no patient received radiotherapy.",,10212915,10212915_D014750_D004828,10212915_6,bcv_sentence_task_befree_1094,,770957022,FALSE,finalized,5,8/14/15 20:36,"



",yes_direct,0.6225,,D000109,"<span class=""chemical"">ACh/acetylcholine</span>",D000544,"<span class=""disease"">AD/Alzheimer's disease</span>","<span class=""disease"">Alzheimer's disease</span> (<span class=""disease"">AD</span>) is associated with a deficiency of <span class=""chemical"">acetylcholine</span> (<span class=""chemical"">ACh</span>) in the forebrain that correlates with brain pathology and cognitive dysfunction.",,10332937,10332937_D000109_D000544,10332937_1,bcv_sentence_task_befree_1095,,770957023,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,0.5987,,D000109,"<span class=""chemical"">ACh/acetylcholine</span>",D004108,"<span class=""disease"">brain pathology</span>","Alzheimer's disease (AD) is associated with a deficiency of <span class=""chemical"">acetylcholine</span> (<span class=""chemical"">ACh</span>) in the forebrain that correlates with <span class=""disease"">brain pathology</span> and cognitive dysfunction.",,10332937,10332937_D000109_D004108,10332937_1,bcv_sentence_task_befree_1096,,770957024,FALSE,finalized,5,8/14/15 22:02,"



",no_relation,0.4057,,D000109,"<span class=""chemical"">ACh/acetylcholine</span>",D003072,"<span class=""disease"">cognitive dysfunction</span>","Alzheimer's disease (AD) is associated with a deficiency of <span class=""chemical"">acetylcholine</span> (<span class=""chemical"">ACh</span>) in the forebrain that correlates with brain pathology and <span class=""disease"">cognitive dysfunction</span>.",,10332937,10332937_D000109_D003072,10332937_1,bcv_sentence_task_befree_1097,,770957025,FALSE,finalized,5,8/15/15 0:11,"



",no_relation,1,,C076946,"<span class=""chemical"">Donepezil</span>",C535860,"<span class=""disease"">HCI</span>","<span class=""chemical"">Donepezil</span> <span class=""disease"">HCI</span> represents a new chemical class of AChE inhibitors, the piperidines.",,10332937,10332937_C076946_C535860,10332937_4,bcv_sentence_task_befree_1098,,770957026,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,D010880,"<span class=""chemical"">piperidines</span>",C535860,"<span class=""disease"">HCI</span>","Donepezil <span class=""disease"">HCI</span> represents a new chemical class of AChE inhibitors, the <span class=""chemical"">piperidines</span>.",,10332937,10332937_D010880_C535860,10332937_4,bcv_sentence_task_befree_1099,,770957027,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,C076946,"<span class=""chemical"">donepezil</span>",D000544,"<span class=""disease"">AD</span>","In clinical trials, <span class=""chemical"">donepezil</span> has been shown to improve significantly cognition and global function in patients with mild to moderately severe <span class=""disease"">AD</span>, and has demonstrated an excellent tolerability and safety profile.",,10332937,10332937_C076946_D000544,10332937_5,bcv_sentence_task_befree_1100,,770957028,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,C076946,"<span class=""chemical"">donepezil</span>",D000544,"<span class=""disease"">AD</span>","These benefits, as well as a simple, once-daily dosing regimen, make <span class=""chemical"">donepezil</span> a viable therapeutic option for <span class=""disease"">AD</span> patients.",,10332937,10332937_C076946_D000544,10332937_6,bcv_sentence_task_befree_1101,,770957029,FALSE,finalized,5,8/15/15 1:40,"



",no_relation,1,,D000728,"<span class=""chemical"">androgen</span>",D011471,"<span class=""disease"">prostate cancer</span>","Effect of total <span class=""chemical"">androgen</span> ablation on pathologic stage and resection limit status of <span class=""disease"">prostate cancer</span>.",,10337657,10337657_D000728_D011471,10337657_0,bcv_sentence_task_befree_1102,,770957030,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,D000728,"<span class=""chemical"">androgen</span>",D011471,"<span class=""disease"">PCa/prostate cancer</span>","We undertook the present analysis to evaluate the effect of NHT on pathologic stage of <span class=""disease"">PCa</span> and resection limit status in patients with <span class=""disease"">prostate cancer</span> and treated with total <span class=""chemical"">androgen</span> ablation either for three or six months before RP.",,10337657,10337657_D000728_D011471,10337657_6,bcv_sentence_task_befree_1103,,770957031,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,0.8139,,D000728,"<span class=""chemical"">androgen</span>",D009369,"<span class=""disease"">tumours</span>","114 patients were clinical stage B whereas 41 were clinical stage C. After three months of total <span class=""chemical"">androgen</span> ablation, pathological stage B was more prevalent among patients with clinical B <span class=""disease"">tumours</span>, compared with untreated patients (57% in treated patients vs. 36% in untreated).",,10337657,10337657_D000728_D009369,10337657_12,bcv_sentence_task_befree_1104,,770957032,FALSE,finalized,5,8/14/15 23:16,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D009369,"<span class=""disease"">tumors</span>","Northern and Western blots and <span class=""chemical"">tyrosine</span> phosphorylation analysis showed that the HGF receptor was overexpressed and functional in all five <span class=""disease"">tumors</span>, as well as in two additional <span class=""disease"">tumors</span>.",,10359528,10359528_D014443_D009369,10359528_5,bcv_sentence_task_befree_1105,,770957033,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,D002857,"<span class=""chemical"">chromium</span>",D003872,"<span class=""disease"">dermatitis</span>","Therapeutic review: is ascorbic acid of value in <span class=""chemical"">chromium</span> poisoning and chromium <span class=""disease"">dermatitis</span>?",,10382555,10382555_D002857_D003872,10382555_0,bcv_sentence_task_befree_1106,,770957034,FALSE,finalized,5,8/14/15 20:36,"



",yes_direct,0.602,,D002857,"<span class=""chemical"">chromium</span>",D011041,"<span class=""disease"">poisoning</span>","Therapeutic review: is ascorbic acid of value in <span class=""chemical"">chromium</span> <span class=""disease"">poisoning</span> and chromium dermatitis?",,10382555,10382555_D002857_D011041,10382555_0,bcv_sentence_task_befree_1107,,770957035,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,0.8053,,D001205,"<span class=""chemical"">ascorbic acid</span>",D003872,"<span class=""disease"">dermatitis</span>","Therapeutic review: is <span class=""chemical"">ascorbic acid</span> of value in chromium poisoning and chromium <span class=""disease"">dermatitis</span>?",,10382555,10382555_D001205_D003872,10382555_0,bcv_sentence_task_befree_1108,,770957036,FALSE,finalized,5,8/14/15 23:27,"



",no_relation,1,,D001205,"<span class=""chemical"">ascorbic acid</span>",D011041,"<span class=""disease"">poisoning</span>","Therapeutic review: is <span class=""chemical"">ascorbic acid</span> of value in chromium <span class=""disease"">poisoning</span> and chromium dermatitis?",,10382555,10382555_D001205_D011041,10382555_0,bcv_sentence_task_befree_1109,,770957037,FALSE,finalized,5,8/15/15 2:21,"



",yes_direct,1,,C074702,"<span class=""chemical"">chromium(VI)</span>",D014456,"<span class=""disease"">ulcers</span>","Repeated topical exposure to <span class=""chemical"">chromium(VI)</span> may cause an allergic contact dermatitis or the formation of chrome <span class=""disease"">ulcers</span>.",,10382555,10382555_C074702_D014456,10382555_1,bcv_sentence_task_befree_1110,,770957038,FALSE,finalized,5,8/14/15 22:23,"



'May' could make the third option right as well.",yes_direct,1,,C074702,"<span class=""chemical"">chromium(VI)</span>",D011695,"<span class=""disease"">allergic</span>","Repeated topical exposure to <span class=""chemical"">chromium(VI)</span> may cause an <span class=""disease"">allergic</span> contact dermatitis or the formation of chrome ulcers.",,10382555,10382555_C074702_D011695,10382555_1,bcv_sentence_task_befree_1111,,770957039,FALSE,finalized,5,8/15/15 0:33,"



",yes_direct,1,,C074702,"<span class=""chemical"">chromium(VI)</span>",D003872,"<span class=""disease"">dermatitis</span>","Repeated topical exposure to <span class=""chemical"">chromium(VI)</span> may cause an allergic contact <span class=""disease"">dermatitis</span> or the formation of chrome ulcers.",,10382555,10382555_C074702_D003872,10382555_1,bcv_sentence_task_befree_1112,,770957040,FALSE,finalized,5,8/15/15 2:10,"



",yes_direct,1,,C074702,"<span class=""chemical"">chromium(VI)</span>",D002056,"<span class=""disease"">skin burns</span>","Systemic toxicity may occur following the ingestion of a <span class=""chemical"">chromium(VI)</span> salt, from <span class=""chemical"">chromium(VI)</span>-induced <span class=""disease"">skin burns</span>, or from inhalation of <span class=""chemical"">chromium(VI)</span> occurring occupationally.",,10382555,10382555_C074702_D002056,10382555_2,bcv_sentence_task_befree_1113,,770957041,FALSE,finalized,5,8/14/15 20:43,"



",yes_direct,1,,C074702,"<span class=""chemical"">chromium(VI)</span>",D064420,"<span class=""disease"">toxicity</span>","Systemic <span class=""disease"">toxicity</span> may occur following the ingestion of a <span class=""chemical"">chromium(VI)</span> salt, from <span class=""chemical"">chromium(VI)</span>-induced skin burns, or from inhalation of <span class=""chemical"">chromium(VI)</span> occurring occupationally.",,10382555,10382555_C074702_D064420,10382555_2,bcv_sentence_task_befree_1114,,770957042,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,0.5975,,C074702,"<span class=""chemical"">chromium(VI)</span>",D011041,"<span class=""disease"">poisoning</span>","The administration of exogenous ascorbic acid has been advocated therefore in the treatment of systemic chromium <span class=""disease"">poisoning</span> and chromium dermatitis to enhance the extracellular reduction of <span class=""chemical"">chromium(VI)</span> to the less bioavailable chromium(III).",,10382555,10382555_C074702_D011041,10382555_5,bcv_sentence_task_befree_1115,,770957043,FALSE,finalized,5,8/14/15 23:18,"



",no_relation,1,,D001205,"<span class=""chemical"">ascorbic acid</span>",D003872,"<span class=""disease"">dermatitis</span>","The administration of exogenous <span class=""chemical"">ascorbic acid</span> has been advocated therefore in the treatment of systemic chromium poisoning and chromium <span class=""disease"">dermatitis</span> to enhance the extracellular reduction of chromium(VI) to the less bioavailable chromium(III).",,10382555,10382555_D001205_D003872,10382555_5,bcv_sentence_task_befree_1116,,770957044,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,1,,D001205,"<span class=""chemical"">ascorbic acid</span>",D011041,"<span class=""disease"">poisoning</span>","The administration of exogenous <span class=""chemical"">ascorbic acid</span> has been advocated therefore in the treatment of systemic chromium <span class=""disease"">poisoning</span> and chromium dermatitis to enhance the extracellular reduction of chromium(VI) to the less bioavailable chromium(III).",,10382555,10382555_D001205_D011041,10382555_5,bcv_sentence_task_befree_1117,,770957045,FALSE,finalized,5,8/15/15 0:45,"



",no_relation,0.6099,,D002857,"<span class=""chemical"">chromium</span>",D003872,"<span class=""disease"">dermatitis</span>","The administration of exogenous ascorbic acid has been advocated therefore in the treatment of systemic <span class=""chemical"">chromium</span> poisoning and chromium <span class=""disease"">dermatitis</span> to enhance the extracellular reduction of chromium(VI) to the less bioavailable chromium(III).",,10382555,10382555_D002857_D003872,10382555_5,bcv_sentence_task_befree_1118,,770957046,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,0.5914,,D002857,"<span class=""chemical"">chromium</span>",D011041,"<span class=""disease"">poisoning</span>","The administration of exogenous ascorbic acid has been advocated therefore in the treatment of systemic <span class=""chemical"">chromium</span> <span class=""disease"">poisoning</span> and chromium dermatitis to enhance the extracellular reduction of chromium(VI) to the less bioavailable chromium(III).",,10382555,10382555_D002857_D011041,10382555_5,bcv_sentence_task_befree_1119,,770957047,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,1,,C074702,"<span class=""chemical"">chromium(VI)</span>",D003872,"<span class=""disease"">dermatitis</span>","The administration of exogenous ascorbic acid has been advocated therefore in the treatment of systemic chromium poisoning and chromium <span class=""disease"">dermatitis</span> to enhance the extracellular reduction of <span class=""chemical"">chromium(VI)</span> to the less bioavailable chromium(III).",,10382555,10382555_C074702_D003872,10382555_5,bcv_sentence_task_befree_1120,,770957048,FALSE,finalized,5,8/15/15 0:15,"



",yes_direct,0.7805,,D001205,"<span class=""chemical"">ascorbic acid</span>",D064420,"<span class=""disease"">toxicity</span>","However, the administration of parenteral <span class=""chemical"">ascorbic acid</span> more than 2 hours after parenteral chromate in these experimental studies did not protect against renal damage, and parenteral <span class=""chemical"">ascorbic acid</span> given 3 hours postparenteral chromate increased <span class=""disease"">toxicity</span>.",,10382555,10382555_D001205_D064420,10382555_9,bcv_sentence_task_befree_1121,,770957049,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,1,,D001205,"<span class=""chemical"">ascorbic acid</span>",D006177,"<span class=""disease"">renal damage</span>","However, the administration of parenteral <span class=""chemical"">ascorbic acid</span> more than 2 hours after parenteral chromate in these experimental studies did not protect against <span class=""disease"">renal damage</span>, and parenteral <span class=""chemical"">ascorbic acid</span> given 3 hours postparenteral chromate increased toxicity.",,10382555,10382555_D001205_D006177,10382555_9,bcv_sentence_task_befree_1122,,770957050,FALSE,finalized,5,8/15/15 2:57,"



",yes_direct,0.5978,,D002857,"<span class=""chemical"">chromium</span>",D011041,"<span class=""disease"">poisoning</span>","In addition, there is no confirmed clinical evidence that the administration of ascorbic acid lessens morbidity or mortality in systemic <span class=""chemical"">chromium</span> <span class=""disease"">poisoning</span>.",,10382555,10382555_D002857_D011041,10382555_10,bcv_sentence_task_befree_1123,,770957051,FALSE,finalized,5,8/14/15 23:57,"

It's 'chromium poisoning' and not just 'poisoning'

",no_relation,1,,D001205,"<span class=""chemical"">ascorbic acid</span>",D011041,"<span class=""disease"">poisoning</span>","In addition, there is no confirmed clinical evidence that the administration of <span class=""chemical"">ascorbic acid</span> lessens morbidity or mortality in systemic chromium <span class=""disease"">poisoning</span>.",,10382555,10382555_D001205_D011041,10382555_10,bcv_sentence_task_befree_1124,,770957052,FALSE,finalized,5,8/14/15 20:54,"



",no_relation,1,,D001205,"<span class=""chemical"">ascorbic acid</span>",D014456,"<span class=""disease"">ulcers</span>","Topical 10% <span class=""chemical"">ascorbic acid</span> has been claimed to reduce significantly the healing time of experimentally induced chrome <span class=""disease"">ulcers</span> in guinea pigs.",,10382555,10382555_D001205_D014456,10382555_12,bcv_sentence_task_befree_1125,,770957053,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,1,,D001205,"<span class=""chemical"">ascorbic acid</span>",D003872,"<span class=""disease"">dermatitis</span>","Several case reports suggest that topical <span class=""chemical"">ascorbic acid</span> is effective in the management of chromium <span class=""disease"">dermatitis</span> but this has not been confirmed in controlled clinical trials and, moreover, the practical difficulties of frequent application are likely to limit its usefulness.",,10382555,10382555_D001205_D003872,10382555_14,bcv_sentence_task_befree_1126,,770957054,FALSE,finalized,5,8/14/15 23:19,"



",no_relation,1,,D001205,"<span class=""chemical"">ascorbic acid</span>",D064420,"<span class=""disease"">toxicity</span>","Based on experimental studies, substantial amounts of <span class=""chemical"">ascorbic acid</span> would need to be administered, preferably parenterally, soon after exposure to prevent systemic <span class=""disease"">toxicity</span> from chromium(VI) in humans.",,10382555,10382555_D001205_D064420,10382555_15,bcv_sentence_task_befree_1127,,770957055,FALSE,finalized,5,8/14/15 20:36,"



",yes_direct,1,,C074702,"<span class=""chemical"">chromium(VI)</span>",D064420,"<span class=""disease"">toxicity</span>","Based on experimental studies, substantial amounts of ascorbic acid would need to be administered, preferably parenterally, soon after exposure to prevent systemic <span class=""disease"">toxicity</span> from <span class=""chemical"">chromium(VI)</span> in humans.",,10382555,10382555_C074702_D064420,10382555_15,bcv_sentence_task_befree_1128,,770957056,FALSE,finalized,5,8/14/15 20:39,"



",no_relation,0.6043,,D001205,"<span class=""chemical"">ascorbic acid</span>",D051437,"<span class=""disease"">renal failure</span>","However, as <span class=""chemical"">ascorbic acid</span> is a metabolic precursor of oxalate, the administration of <span class=""chemical"">ascorbic acid</span> in high dose could lead to acute oxalate nephropathy, particularly in the presence of <span class=""disease"">renal failure</span>.",,10382555,10382555_D001205_D051437,10382555_16,bcv_sentence_task_befree_1129,,770957057,FALSE,finalized,5,8/15/15 1:52,"



",yes_direct,1,,D001205,"<span class=""chemical"">ascorbic acid</span>",D000208,"<span class=""disease"">acute oxalate nephropathy</span>","However, as <span class=""chemical"">ascorbic acid</span> is a metabolic precursor of oxalate, the administration of <span class=""chemical"">ascorbic acid</span> in high dose could lead to <span class=""disease"">acute oxalate nephropathy</span>, particularly in the presence of renal failure.",,10382555,10382555_D001205_D000208,10382555_16,bcv_sentence_task_befree_1130,,770957058,FALSE,finalized,5,8/14/15 20:45,"



",yes_direct,0.6032,,D002857,"<span class=""chemical"">chromium</span>",D011041,"<span class=""disease"">poisoning</span>","While smaller doses of ascorbic acid (e.g., 10 g intravenously) are not toxic, such doses probably will not reduce the mortality from systemic <span class=""chemical"">chromium</span> <span class=""disease"">poisoning</span>.",,10382555,10382555_D002857_D011041,10382555_17,bcv_sentence_task_befree_1131,,770957059,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,D001205,"<span class=""chemical"">ascorbic acid</span>",D011041,"<span class=""disease"">poisoning</span>","While smaller doses of <span class=""chemical"">ascorbic acid</span> (e.g., 10 g intravenously) are not toxic, such doses probably will not reduce the mortality from systemic chromium <span class=""disease"">poisoning</span>.",,10382555,10382555_D001205_D011041,10382555_17,bcv_sentence_task_befree_1132,,770957060,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,D001205,"<span class=""chemical"">ascorbic acid</span>",D064420,"<span class=""disease"">toxicity</span>","There is currently insufficient evidence to advocate the use of <span class=""chemical"">ascorbic acid</span> in the management of systemic chromium <span class=""disease"">toxicity</span>.",,10382555,10382555_D001205_D064420,10382555_18,bcv_sentence_task_befree_1133,,770957061,FALSE,finalized,5,8/14/15 22:22,"



",yes_direct,0.8003,,D002857,"<span class=""chemical"">chromium</span>",D064420,"<span class=""disease"">toxicity</span>","There is currently insufficient evidence to advocate the use of ascorbic acid in the management of systemic <span class=""chemical"">chromium</span> <span class=""disease"">toxicity</span>.",,10382555,10382555_D002857_D064420,10382555_18,bcv_sentence_task_befree_1134,,770957062,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,0.8136,,D002784,"<span class=""chemical"">cholesterol</span>",D007511,"<span class=""disease"">ischemic</span>","Acute <span class=""disease"">ischemic</span> events during the treatment period and a persistently elevated serum <span class=""chemical"">cholesterol</span> thereafter are observations of particular concern in these patients, and the underlying basic mechanisms are unknown to date.",,10383804,10383804_D002784_D007511,10383804_2,bcv_sentence_task_befree_1135,,770957063,FALSE,finalized,5,8/15/15 1:43,"



",no_relation,1,,D005047,"<span class=""chemical"">etoposide</span>",D009369,"<span class=""disease"">testicular cancer</span>","To evaluate <span class=""chemical"">etoposide</span>, which is part of the standard treatment for <span class=""disease"">testicular cancer</span>, as a potential cause of atherogenesis in an experimental model.",,10383804,10383804_D005047_D009369,10383804_3,bcv_sentence_task_befree_1136,,770957064,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,D019787,"<span class=""chemical"">linoleic acid</span>",D009369,"<span class=""disease"">tumor/cancer</span>","Conjugated <span class=""chemical"">linoleic acid</span> inhibits the growth of a number of human <span class=""disease"">cancer</span> cell lines and suppresses chemically-induced <span class=""disease"">tumor</span> development at a number of sites in animal models.",,10386321,10386321_D019787_D009369,10386321_3,bcv_sentence_task_befree_1137,,770957065,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,0.8198,,D019787,"<span class=""chemical"">linoleic acid</span>",D009369,"<span class=""disease"">tumors</span>","As little as 0.1% of dietary conjugated <span class=""chemical"">linoleic acid</span> inhibits the development of rat mammary <span class=""disease"">tumors</span>, independent of the amount and type of fat in the diet.",,10386321,10386321_D019787_D009369,10386321_4,bcv_sentence_task_befree_1138,,770957066,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,0.8026,,D013110,"<span class=""chemical"">sphingosine</span>",D063646,"<span class=""disease"">suppression of carcinogenesis</span>","Sphingomyelin, through its metabolites ceramide and <span class=""chemical"">sphingosine</span>, participates in multiple antiproliferative pathways associated with <span class=""disease"">suppression of carcinogenesis</span>.",,10386321,10386321_D013110_D063646,10386321_5,bcv_sentence_task_befree_1139,,770957067,FALSE,finalized,5,8/14/15 20:39,"



",no_relation,0.8138,,C105791,"<span class=""chemical"">auristatin PE</span>",D008258,"<span class=""disease"">Waldenstrom's macroglobulinemia</span>","A new tubulin polymerization inhibitor, <span class=""chemical"">auristatin PE</span>, induces tumor regression in a human <span class=""disease"">Waldenstrom's macroglobulinemia</span> xenograft model.",,10402249,10402249_C105791_D008258,10402249_0,bcv_sentence_task_befree_1140,,770957068,FALSE,finalized,5,8/14/15 20:42,"



",no_relation,0.7976,,C105791,"<span class=""chemical"">auristatin PE</span>",D009369,"<span class=""disease"">tumor</span>","A new tubulin polymerization inhibitor, <span class=""chemical"">auristatin PE</span>, induces <span class=""disease"">tumor</span> regression in a human Waldenstrom's macroglobulinemia xenograft model.",,10402249,10402249_C105791_D009369,10402249_0,bcv_sentence_task_befree_1141,,770957069,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,1,,C105791,"<span class=""chemical"">auristatin PE</span>",D009369,"<span class=""disease"">tumor</span>","In this study, we investigated the anti-<span class=""disease"">tumor</span> effects of <span class=""chemical"">auristatin PE</span> (a structural modification of the marine, shell-less mollusk peptide constituent dolastatin 10).",,10402249,10402249_C105791_D009369,10402249_3,bcv_sentence_task_befree_1142,,770957070,FALSE,finalized,5,8/15/15 0:28,"



",no_relation,1,,C105791,"<span class=""chemical"">Auristatin PE</span>",D008258,"<span class=""disease"">WM</span>","<span class=""chemical"">Auristatin PE</span> or dolastatin 10 were added to triplicate wells and cell count and viability were assessed after 24, 48 and 72 h. Results showed that both agents were active against WSU-<span class=""disease"">WM</span>, and were able to induce complete growth inhibition at 100 pg/ml.",,10402249,10402249_C105791_D008258,10402249_5,bcv_sentence_task_befree_1143,,770957071,FALSE,finalized,5,8/14/15 20:49,"



",no_relation,1,,C105791,"<span class=""chemical"">auristatin PE</span>",D009369,"<span class=""disease"">Tumor</span>","<span class=""disease"">Tumor</span> growth inhibition (T/C), <span class=""disease"">tumor</span> growth delay (T-C), and log10 kill for <span class=""chemical"">auristatin PE</span> and dolastatin 10 were 0%, 18 days, 2.83 and 67%, 2 days, 0.06, respectively.",,10402249,10402249_C105791_D009369,10402249_9,bcv_sentence_task_befree_1144,,770957072,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,0.805,,C105791,"<span class=""chemical"">auristatin PE</span>",D009369,"<span class=""disease"">tumor</span>","The activity of <span class=""chemical"">auristatin PE</span> should be evaluated in other <span class=""disease"">tumor</span> types and in clinical trials.",,10402249,10402249_C105791_D009369,10402249_15,bcv_sentence_task_befree_1145,,770957073,FALSE,finalized,5,8/14/15 23:09,"



",no_relation,1,,D014810,"<span class=""chemical"">vitamin E</span>",D002386,"<span class=""disease"">cataract</span>","The role of past intake of <span class=""chemical"">vitamin E</span> in early <span class=""disease"">cataract</span> changes.",,10420210,10420210_D014810_D002386,10420210_0,bcv_sentence_task_befree_1146,,770957074,FALSE,finalized,5,8/14/15 22:51,"



",no_relation,1,,D014810,"<span class=""chemical"">vitamin E</span>",D002386,"<span class=""disease"">cataract</span>","We examined the association between prior supplementation of <span class=""chemical"">vitamin E</span> and early <span class=""disease"">cataract</span> changes in volunteers currently enrolled in the cross-sectional VECAT study.",,10420210,10420210_D014810_D002386,10420210_1,bcv_sentence_task_befree_1147,,770957075,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,1,,D014810,"<span class=""chemical"">Vitamin E</span>",D002386,"<span class=""disease"">Cataract</span>","The <span class=""chemical"">Vitamin E</span> and <span class=""disease"">Cataract</span> Prevention Study (VECAT) is a clinical trial currently in progress, designed to assess the affect of <span class=""chemical"">vitamin E</span> supplementation on the development and progression of <span class=""disease"">cataract</span> and age-related macular degeneration.",,10420210,10420210_D014810_D002386,10420210_2,bcv_sentence_task_befree_1148,,770957076,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,0.8178,,D014810,"<span class=""chemical"">Vitamin E</span>",D008268,"<span class=""disease"">macular degeneration</span>","The <span class=""chemical"">Vitamin E</span> and Cataract Prevention Study (VECAT) is a clinical trial currently in progress, designed to assess the affect of <span class=""chemical"">vitamin E</span> supplementation on the development and progression of cataract and age-related <span class=""disease"">macular degeneration</span>.",,10420210,10420210_D014810_D008268,10420210_2,bcv_sentence_task_befree_1149,,770957077,FALSE,finalized,5,8/14/15 20:44,"



",no_relation,1,,D014810,"<span class=""chemical"">vitamin E</span>",D003318,"<span class=""disease"">nuclear opacity/NO</span>","The levels of <span class=""disease"">nuclear opacity</span> (<span class=""disease"">NO</span>) were not statistically different between those who reported intake and those with no prior <span class=""chemical"">vitamin E</span> supplementation.",,10420210,10420210_D014810_D003318,10420210_8,bcv_sentence_task_befree_1150,,770957078,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,1,,D014810,"<span class=""chemical"">vitamin E</span>",D002386,"<span class=""disease"">cataracts</span>","Prior <span class=""chemical"">vitamin E</span> supplementation may protect VECAT participants from developing at least early cortical <span class=""disease"">cataracts</span>.",,10420210,10420210_D014810_D002386,10420210_9,bcv_sentence_task_befree_1151,,770957079,FALSE,finalized,5,8/14/15 23:32,"



",no_relation,1,,D000109,"<span class=""chemical"">acetylcholine</span>",D055090,"<span class=""disease"">trachea</span>","Modulation of <span class=""chemical"">acetylcholine</span> release from parasympathetic nerves innervating guinea-pig and human <span class=""disease"">trachea</span> by endomorphin-1 and -2.",,10422636,10422636_D000109_D055090,10422636_0,bcv_sentence_task_befree_1152,,770957080,FALSE,finalized,5,8/14/15 20:40,"



",no_relation,1,,D009270,"<span class=""chemical"">naloxone</span>",D055090,"<span class=""disease"">trachea</span>","Endomorphin-1 and -2 (mu-opioid receptor agonists) produced a concentration-dependent and <span class=""chemical"">naloxone</span>-sensitive inhibition of cholinergic contractile responses in guinea-pig <span class=""disease"">trachea</span> (at 10 microM, 46.1 +/- 8.0% and 33.8 +/- 8.6%, respectively).",,10422636,10422636_D009270_D055090,10422636_1,bcv_sentence_task_befree_1153,,770957081,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,D000109,"<span class=""chemical"">acetylcholine</span>",D055090,"<span class=""disease"">trachea</span>","Endomorphin-1 and -2 also inhibited electrically-evoked <span class=""chemical"">acetylcholine</span> release from cholinergic nerves innervating guinea-pig (at 0.1 microM, 41.8 +/- 10.9%; at 1 microM 60.1 +/- 6.3%, respectively) and human <span class=""disease"">trachea</span> (at 10 microM, 76.2 +/- 18.1%, and 77.7 +/- 14.3%, respectively).",,10422636,10422636_D000109_D055090,10422636_2,bcv_sentence_task_befree_1154,,770957082,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,D009270,"<span class=""chemical"">Naloxone</span>",D055090,"<span class=""disease"">trachea</span>","<span class=""chemical"">Naloxone</span> prevented the inhibition by endomorphin-1 and -2 in both guinea-pig and human <span class=""disease"">trachea</span>, suggesting that these peptides can inhibit cholinergic, parasympathetic neurotransmission to the airways via the activation of classical opioid receptors.",,10422636,10422636_D009270_D055090,10422636_3,bcv_sentence_task_befree_1155,,770957083,FALSE,finalized,5,8/14/15 20:49,"



",yes_direct,1,,D016595,"<span class=""chemical"">misoprostol</span>",D005316,"<span class=""disease"">fetal distress</span>","Some trials also indicate increased frequencies of meconium passage, neonatal acidemia, and cesarean delivery for <span class=""disease"">fetal distress</span> in women receiving higher doses of <span class=""chemical"">misoprostol</span>.",,10454679,10454679_D016595_D005316,10454679_6,bcv_sentence_task_befree_1156,,770957084,FALSE,finalized,5,8/14/15 22:01,"



",yes_direct,1,,D016595,"<span class=""chemical"">misoprostol</span>",C537358,"<span class=""disease"">acidemia</span>","Some trials also indicate increased frequencies of meconium passage, neonatal <span class=""disease"">acidemia</span>, and cesarean delivery for fetal distress in women receiving higher doses of <span class=""chemical"">misoprostol</span>.",,10454679,10454679_D016595_C537358,10454679_6,bcv_sentence_task_befree_1157,,770957085,FALSE,finalized,5,8/14/15 22:02,"



",no_relation,1,,D009569,"<span class=""chemical"">nitric oxide</span>",D001249,"<span class=""disease"">asthma</span>","Circadian variation in exhaled <span class=""chemical"">nitric oxide</span> in nocturnal <span class=""disease"">asthma</span>.",,10461936,10461936_D009569_D001249,10461936_0,bcv_sentence_task_befree_1158,,770957086,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D009569,"<span class=""chemical"">nitric oxide</span>",D007249,"<span class=""disease"">inflammation</span>","Because exhaled <span class=""chemical"">nitric oxide</span> (ENO) measurement appears to be a noninvasive marker of airway <span class=""disease"">inflammation</span>, we examined the hypothesis that ENO would increase at night.",,10461936,10461936_D009569_D007249,10461936_2,bcv_sentence_task_befree_1159,,770957087,FALSE,finalized,5,8/14/15 21:25,"



",yes_direct,0.5946,,D009569,"<span class=""chemical"">nitric oxide</span>",D001249,"<span class=""disease"">asthma</span>","The significant decrease in ENO in nocturnal <span class=""disease"">asthma</span> may reflect an important chronobiological defect in the endogenous production and/or increased disposition of <span class=""chemical"">nitric oxide</span>, which in view of its bronchodilator action, could play a role in nocturnal exacerbations of <span class=""disease"">asthma</span>.",,10461936,10461936_D009569_D001249,10461936_9,bcv_sentence_task_befree_1160,,770957088,FALSE,finalized,5,8/15/15 0:28,"



",no_relation,1,,D016572,"<span class=""chemical"">cyclosporin</span>",C536463,"<span class=""disease"">neurological involvement</span>","We describe a case of Cogan's syndrome with <span class=""disease"">neurological involvement</span> in which early treatment with combination therapy (prednisolone and <span class=""chemical"">cyclosporin</span>) failed to bring ear inflammation under control.",,10464564,10464564_D016572_C536463,10464564_4,bcv_sentence_task_befree_1161,,770957089,FALSE,finalized,5,8/14/15 20:44,"



",no_relation,1,,D011239,"<span class=""chemical"">prednisolone</span>",C536463,"<span class=""disease"">neurological involvement</span>","We describe a case of Cogan's syndrome with <span class=""disease"">neurological involvement</span> in which early treatment with combination therapy (<span class=""chemical"">prednisolone</span> and cyclosporin) failed to bring ear inflammation under control.",,10464564,10464564_D011239_C536463,10464564_4,bcv_sentence_task_befree_1162,,770957090,FALSE,finalized,5,8/14/15 20:49,"



",no_relation,1,,D016572,"<span class=""chemical"">cyclosporin</span>",D055952,"<span class=""disease"">Cogan's syndrome</span>","We describe a case of <span class=""disease"">Cogan's syndrome</span> with neurological involvement in which early treatment with combination therapy (prednisolone and <span class=""chemical"">cyclosporin</span>) failed to bring ear inflammation under control.",,10464564,10464564_D016572_D055952,10464564_4,bcv_sentence_task_befree_1163,,770957091,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,0.7894,,D011239,"<span class=""chemical"">prednisolone</span>",D007249,"<span class=""disease"">inflammation</span>","We describe a case of Cogan's syndrome with neurological involvement in which early treatment with combination therapy (<span class=""chemical"">prednisolone</span> and cyclosporin) failed to bring ear <span class=""disease"">inflammation</span> under control.",,10464564,10464564_D011239_D007249,10464564_4,bcv_sentence_task_befree_1164,,770957092,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,1,,D011239,"<span class=""chemical"">prednisolone</span>",D055952,"<span class=""disease"">Cogan's syndrome</span>","We describe a case of <span class=""disease"">Cogan's syndrome</span> with neurological involvement in which early treatment with combination therapy (<span class=""chemical"">prednisolone</span> and cyclosporin) failed to bring ear inflammation under control.",,10464564,10464564_D011239_D055952,10464564_4,bcv_sentence_task_befree_1165,,770957093,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,D016572,"<span class=""chemical"">cyclosporin</span>",D007249,"<span class=""disease"">inflammation</span>","We describe a case of Cogan's syndrome with neurological involvement in which early treatment with combination therapy (prednisolone and <span class=""chemical"">cyclosporin</span>) failed to bring ear <span class=""disease"">inflammation</span> under control.",,10464564,10464564_D016572_D007249,10464564_4,bcv_sentence_task_befree_1166,,770957094,FALSE,finalized,5,8/14/15 23:29,"



",no_relation,0.8008,,D013739,"<span class=""chemical"">testosterone</span>",D010024,"<span class=""disease"">osteoporosis</span>","The effects of <span class=""chemical"">testosterone</span> on <span class=""disease"">osteoporosis</span> in men.",,10468898,10468898_D013739_D010024,10468898_0,bcv_sentence_task_befree_1167,,770957095,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,0.7987,,D013739,"<span class=""chemical"">testosterone</span>",D010024,"<span class=""disease"">osteoporosis</span>","Although the pathogenesis of <span class=""disease"">osteoporosis</span> in men is multi-factorial, <span class=""chemical"">testosterone</span> is known to play an important role in the maintenance of the male skeleton.",,10468898,10468898_D013739_D010024,10468898_1,bcv_sentence_task_befree_1168,,770957096,FALSE,finalized,5,8/14/15 20:39,"



",no_relation,1,,D013739,"<span class=""chemical"">Testosterone</span>",D010024,"<span class=""disease"">hypogonadal osteoporosis</span>","<span class=""chemical"">Testosterone</span> replacement therapy improves bone density in men with <span class=""disease"">hypogonadal osteoporosis</span>, particularly if the epiphyses are still open.",,10468898,10468898_D013739_D010024,10468898_3,bcv_sentence_task_befree_1169,,770957097,FALSE,finalized,5,8/15/15 2:25,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",C537700,"<span class=""disease"">idiopathic osteoporosis</span>","There is no well-established treatment for <span class=""disease"">idiopathic osteoporosis</span> in men, but <span class=""chemical"">testosterone</span> supplementation may prove to be useful.",,10468898,10468898_D013739_C537700,10468898_4,bcv_sentence_task_befree_1170,,770957098,FALSE,finalized,5,8/14/15 22:51,"



",no_relation,1,,D009569,"<span class=""chemical"">nitric oxide</span>",D018496,"<span class=""disease"">hyperoxia</span>","Effects of exogenous <span class=""chemical"">nitric oxide</span> and <span class=""disease"">hyperoxia</span> on lung fibroblast viability and DNA fragmentation.",,10471386,10471386_D009569_D018496,10471386_0,bcv_sentence_task_befree_1171,,770957099,FALSE,finalized,5,8/14/15 20:43,"



",no_relation,1,,D009569,"<span class=""chemical"">NO</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Primary cultures of normal human lung fibroblasts were exposed for 4 h to room air (RA), 80% oxygen, <span class=""chemical"">NO</span> (at either 20 or 50 ppm) blended with RA, or <span class=""chemical"">NO</span> blended with 80% O(2), then incubated for 24 to 72 h. Cell viability was determined by fluorescence viability/<span class=""disease"">cytotoxicity</span> assay and DNA fragmentation by TUNEL assay.",,10471386,10471386_D009569_D004487,10471386_4,bcv_sentence_task_befree_1172,,770957100,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Primary cultures of normal human lung fibroblasts were exposed for 4 h to room air (RA), 80% <span class=""chemical"">oxygen</span>, NO (at either 20 or 50 ppm) blended with RA, or NO blended with 80% O(2), then incubated for 24 to 72 h. Cell viability was determined by fluorescence viability/<span class=""disease"">cytotoxicity</span> assay and DNA fragmentation by TUNEL assay.",,10471386,10471386_D010100_D004487,10471386_4,bcv_sentence_task_befree_1173,,770957101,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,D013481,"<span class=""chemical"">O(2)</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Primary cultures of normal human lung fibroblasts were exposed for 4 h to room air (RA), 80% oxygen, NO (at either 20 or 50 ppm) blended with RA, or NO blended with 80% <span class=""chemical"">O(2)</span>, then incubated for 24 to 72 h. Cell viability was determined by fluorescence viability/<span class=""disease"">cytotoxicity</span> assay and DNA fragmentation by TUNEL assay.",,10471386,10471386_D013481_D004487,10471386_4,bcv_sentence_task_befree_1174,,770957102,FALSE,finalized,5,8/14/15 22:51,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D011020,"<span class=""disease"">pneumocystis pneumonia</span>","The clinical picture was consistent with <span class=""disease"">pneumocystis pneumonia</span>, and antibiotic therapy with <span class=""chemical"">corticosteroids</span> was initiated.",,10498175,10498175_D000305_D011020,10498175_2,bcv_sentence_task_befree_1175,,770957103,FALSE,finalized,5,8/15/15 0:47,"



",yes_direct,0.8059,,D013256,"<span class=""chemical"">steroids</span>",D003453,"<span class=""disease"">cryptococcosis</span>","Sudden, rapid deterioration and death are rare consequences of disseminated <span class=""disease"">cryptococcosis</span>, and <span class=""chemical"">steroids</span> may worsen the course of the disease.",,10498175,10498175_D013256_D003453,10498175_5,bcv_sentence_task_befree_1176,,770957104,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,0.8283,,D013256,"<span class=""chemical"">steroids</span>",D003643,"<span class=""disease"">death</span>","Sudden, rapid deterioration and <span class=""disease"">death</span> are rare consequences of disseminated cryptococcosis, and <span class=""chemical"">steroids</span> may worsen the course of the disease.",,10498175,10498175_D013256_D003643,10498175_5,bcv_sentence_task_befree_1177,,770957105,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,D008874,"<span class=""chemical"">Midazolam</span>",D013226,"<span class=""disease"">status epilepticus</span>","<span class=""chemical"">Midazolam</span> treatment of acute and refractory <span class=""disease"">status epilepticus</span>.",,10516875,10516875_D008874_D013226,10516875_0,bcv_sentence_task_befree_1178,,770957106,FALSE,finalized,5,8/14/15 22:18,"



",yes_direct,1,,D001463,"<span class=""chemical"">barbiturates</span>",D012131,"<span class=""disease"">respiratory depression</span>","Refractory GCSE is often difficult to treat, and traditional therapy with <span class=""chemical"">barbiturates</span> induces hypotension and <span class=""disease"">respiratory depression</span> and prolongs recovery.",,10516875,10516875_D001463_D012131,10516875_3,bcv_sentence_task_befree_1179,,770957107,FALSE,finalized,5,8/14/15 23:17,"



",yes_direct,1,,D001463,"<span class=""chemical"">barbiturates</span>",D007022,"<span class=""disease"">hypotension</span>","Refractory GCSE is often difficult to treat, and traditional therapy with <span class=""chemical"">barbiturates</span> induces <span class=""disease"">hypotension</span> and respiratory depression and prolongs recovery.",,10516875,10516875_D001463_D007022,10516875_3,bcv_sentence_task_befree_1180,,770957108,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,D001463,"<span class=""chemical"">barbiturates</span>",D013226,"<span class=""disease"">GCSE</span>","Refractory <span class=""disease"">GCSE</span> is often difficult to treat, and traditional therapy with <span class=""chemical"">barbiturates</span> induces hypotension and respiratory depression and prolongs recovery.",,10516875,10516875_D001463_D013226,10516875_3,bcv_sentence_task_befree_1181,,770957109,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,D008874,"<span class=""chemical"">Midazolam</span>",D013226,"<span class=""disease"">GCSE</span>","<span class=""chemical"">Midazolam</span> is particularly useful for treating acute <span class=""disease"">GCSE</span> because it has an imidazole ring that is open at low pH, allowing it to be dissolved in aqueous solution for intramuscular injection, but closed at physiologic pH, increasing lipophilicity and rendering good intramuscular absorption, brain penetration, and fast onset of action.",,10516875,10516875_D008874_D013226,10516875_4,bcv_sentence_task_befree_1182,,770957110,FALSE,finalized,5,8/14/15 23:52,"



",no_relation,1,,C029899,"<span class=""chemical"">imidazole</span>",D013226,"<span class=""disease"">GCSE</span>","Midazolam is particularly useful for treating acute <span class=""disease"">GCSE</span> because it has an <span class=""chemical"">imidazole</span> ring that is open at low pH, allowing it to be dissolved in aqueous solution for intramuscular injection, but closed at physiologic pH, increasing lipophilicity and rendering good intramuscular absorption, brain penetration, and fast onset of action.",,10516875,10516875_C029899_D013226,10516875_4,bcv_sentence_task_befree_1183,,770957111,FALSE,finalized,5,8/15/15 0:23,"


Another ambiguous one. The [chemical] does induce less [disease]. Does it mean it causes the disease? Probably, but how much?
",yes_direct,0.7985,,D008874,"<span class=""chemical"">midazolam</span>",D007022,"<span class=""disease"">less hypotension</span>","For refractory GCSE, continuous i.v. <span class=""chemical"">midazolam</span> infusion at 0.1-0.6 mg/kg/hr after a 0.2 mg/kg i.v. bolus is effective and has advantages over traditional therapies because it induces <span class=""disease"">less hypotension</span> and cardiorespiratory depression and can be easily titrated.",,10516875,10516875_D008874_D007022,10516875_7,bcv_sentence_task_befree_1184,,770957112,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,D008874,"<span class=""chemical"">midazolam</span>",D013226,"<span class=""disease"">GCSE</span>","For refractory <span class=""disease"">GCSE</span>, continuous i.v. <span class=""chemical"">midazolam</span> infusion at 0.1-0.6 mg/kg/hr after a 0.2 mg/kg i.v. bolus is effective and has advantages over traditional therapies because it induces less hypotension and cardiorespiratory depression and can be easily titrated.",,10516875,10516875_D008874_D013226,10516875_7,bcv_sentence_task_befree_1185,,770957113,FALSE,finalized,5,8/14/15 20:45,"



",no_relation,0.8101,,D008874,"<span class=""chemical"">midazolam</span>",D003866,"<span class=""disease"">cardiorespiratory depression</span>","For refractory GCSE, continuous i.v. <span class=""chemical"">midazolam</span> infusion at 0.1-0.6 mg/kg/hr after a 0.2 mg/kg i.v. bolus is effective and has advantages over traditional therapies because it induces less hypotension and <span class=""disease"">cardiorespiratory depression</span> and can be easily titrated.",,10516875,10516875_D008874_D003866,10516875_7,bcv_sentence_task_befree_1186,,770957114,FALSE,finalized,5,8/14/15 22:24,"



",no_relation,1,,D015474,"<span class=""chemical"">13-cis-retinoic acid</span>",D009447,"<span class=""disease"">high-risk neuroblastoma</span>","Treatment of <span class=""disease"">high-risk neuroblastoma</span> with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and <span class=""chemical"">13-cis-retinoic acid</span>.",,10519894,10519894_D015474_D009447,10519894_0,bcv_sentence_task_befree_1187,,770957115,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,C041359,"<span class=""chemical"">terbinafine</span>",D014008,"<span class=""disease"">tinea pedis</span>","Effectiveness of treatment of severe <span class=""disease"">tinea pedis</span> with 1% <span class=""chemical"">terbinafine</span> cream in members of the Japanese self-defense forces.",,10546490,10546490_C041359_D014008,10546490_0,bcv_sentence_task_befree_1188,,770957116,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,C041359,"<span class=""chemical"">terbinafine</span>",D014008,"<span class=""disease"">tinea pedis</span>","A clinical study was conducted to determine the efficacy of <span class=""chemical"">terbinafine</span> cream in severe cases of <span class=""disease"">tinea pedis</span>.",,10546490,10546490_C041359_D014008,10546490_1,bcv_sentence_task_befree_1189,,770957117,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,C041359,"<span class=""chemical"">terbinafine</span>",D014008,"<span class=""disease"">tinea pedis</span>","These results suggested that <span class=""chemical"">terbinafine</span> cream is a beneficial topical antifungal cream for severe <span class=""disease"">tinea pedis</span>.",,10546490,10546490_C041359_D014008,10546490_7,bcv_sentence_task_befree_1190,,770957118,FALSE,finalized,5,8/14/15 20:53,"



",yes_direct,1,,D020748,"<span class=""chemical"">mibefradil</span>",D064420,"<span class=""disease"">Tacrolimus toxicity</span>","<span class=""disease"">Tacrolimus toxicity</span> due to drug interaction with <span class=""chemical"">mibefradil</span> in a patient after liver transplantation.",,10549098,10549098_D020748_D064420,10549098_0,bcv_sentence_task_befree_1191,,770957119,FALSE,finalized,5,8/15/15 1:19,"



",yes_direct,0.4119,,D016559,"<span class=""chemical"">Tacrolimus</span>",D064420,"<span class=""disease"">Tacrolimus toxicity</span>","<span class=""chemical""></span><span class=""disease"">Tacrolimus</span> toxicity due to drug interaction with mibefradil in a patient after liver transplantation.",,10549098,10549098_D016559_D064420,10549098_0,bcv_sentence_task_befree_1192,,770957120,FALSE,finalized,5,8/14/15 20:53,"



",no_relation,1,,D016572,"<span class=""chemical"">cyclosporin A</span>",D011565,"<span class=""disease"">psoriasis</span>","Effects of <span class=""chemical"">cyclosporin A</span> on immune activation markers in patients with active <span class=""disease"">psoriasis</span>.",,10559581,10559581_D016572_D011565,10559581_0,bcv_sentence_task_befree_1193,,770957121,FALSE,finalized,5,8/15/15 1:02,"



",no_relation,1,,D016572,"<span class=""chemical"">cyclosporin A/CsA</span>",D011565,"<span class=""disease"">psoriasis</span>","The objective of this work was to investigate the presence of cellular and soluble activation molecules in the blood of patients with <span class=""disease"">psoriasis</span>, not responding to local treatment and to study the effect of <span class=""chemical"">cyclosporin A</span> (<span class=""chemical"">CsA</span>) on these markers.",,10559581,10559581_D016572_D011565,10559581_2,bcv_sentence_task_befree_1194,,770957122,FALSE,finalized,5,8/15/15 1:20,"



",no_relation,1,,D016572,"<span class=""chemical"">CsA</span>",D011565,"<span class=""disease"">psoriasis</span>","Although there is evidence for systemic immune activation in <span class=""disease"">psoriasis</span>, sIL-2R is the most consistently increased activation marker, related to the Th1 immune response, that may be used as a marker for monitoring disease activity and response to treatment with <span class=""chemical"">CsA</span> in psoriatic patients.",,10559581,10559581_D016572_D011565,10559581_9,bcv_sentence_task_befree_1195,,770957123,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,D013004,"<span class=""chemical"">somatostatin</span>",D006470,"<span class=""disease"">bleeding</span>","The efficacy of <span class=""chemical"">somatostatin</span> and octreotide have been widely studied in the control of <span class=""disease"">bleeding</span> from oesophageal varices.",,10567788,10567788_D013004_D006470,10567788_2,bcv_sentence_task_befree_1196,,770957124,FALSE,finalized,5,8/14/15 23:48,"



",no_relation,1,,D015282,"<span class=""chemical"">octreotide</span>",D006470,"<span class=""disease"">bleeding</span>","The efficacy of somatostatin and <span class=""chemical"">octreotide</span> have been widely studied in the control of <span class=""disease"">bleeding</span> from oesophageal varices.",,10567788,10567788_D015282_D006470,10567788_2,bcv_sentence_task_befree_1197,,770957125,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,1,,D013004,"<span class=""chemical"">somatostatin</span>",D006470,"<span class=""disease"">bleeding/haemorrhage</span>","Results from recent studies have indicated that <span class=""chemical"">somatostatin</span> is an effective treatment for the control of non-variceal UGI <span class=""disease"">bleeding</span> in high-risk patients, i.e. those in whom <span class=""disease"">haemorrhage</span> does not cease spontaneously or is likely to recur.",,10567788,10567788_D013004_D006470,10567788_6,bcv_sentence_task_befree_1198,,770957126,FALSE,finalized,5,8/14/15 20:48,"



",no_relation,1,,D013004,"<span class=""chemical"">somatostatin</span>",D006470,"<span class=""disease"">bleeding</span>","The efficacy of <span class=""chemical"">somatostatin</span> in controlling <span class=""disease"">bleeding</span> in patients with non-variceal UGI <span class=""disease"">bleeding</span> at high risk of mortality upon admission, or rebleeding following endoscopy, coupled with an excellent safety and tolerability profile, suggests it may be a valuable therapeutic option in the management of non-variceal <span class=""disease"">bleeding</span>.",,10567788,10567788_D013004_D006470,10567788_8,bcv_sentence_task_befree_1199,,770957127,FALSE,finalized,5,8/14/15 22:18,"



",no_relation,0.8058,,D014280,"<span class=""chemical"">triglycerides</span>",D006973,"<span class=""disease"">Hypertensive</span>","<span class=""disease"">Hypertensive</span> patients with microalbuminuria manifest greater levels of blood pressure, particularly at night, and higher serum levels of cholesterol, <span class=""chemical"">triglycerides</span>, and uric acid than patients with normal UAE.",,10585306,10585306_D014280_D006973,10585306_3,bcv_sentence_task_befree_1200,,770957128,FALSE,finalized,5,8/14/15 20:50,"



",no_relation,1,,D002784,"<span class=""chemical"">cholesterol</span>",D006973,"<span class=""disease"">Hypertensive</span>","<span class=""disease"">Hypertensive</span> patients with microalbuminuria manifest greater levels of blood pressure, particularly at night, and higher serum levels of <span class=""chemical"">cholesterol</span>, triglycerides, and uric acid than patients with normal UAE.",,10585306,10585306_D002784_D006973,10585306_3,bcv_sentence_task_befree_1201,,770957129,FALSE,finalized,5,8/15/15 1:40,"



",no_relation,1,,D014527,"<span class=""chemical"">uric acid</span>",D006973,"<span class=""disease"">Hypertensive</span>","<span class=""disease"">Hypertensive</span> patients with microalbuminuria manifest greater levels of blood pressure, particularly at night, and higher serum levels of cholesterol, triglycerides, and <span class=""chemical"">uric acid</span> than patients with normal UAE.",,10585306,10585306_D014527_D006973,10585306_3,bcv_sentence_task_befree_1202,,770957130,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,1,,C023036,"<span class=""chemical"">perfluorooctanoic acid</span>",D006528,"<span class=""disease"">hepatoma</span>","Effects of the rodent peroxisome proliferator and hepatocarcinogen, <span class=""chemical"">perfluorooctanoic acid</span>, on apoptosis in human <span class=""disease"">hepatoma</span> HepG2 cells.",,10590214,10590214_C023036_D006528,10590214_0,bcv_sentence_task_befree_1203,,770957131,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,1,,C023036,"<span class=""chemical"">PFOA</span>",D018197,"<span class=""disease"">hepatoblastoma</span>","In the present study we demonstrate that treatment of human <span class=""disease"">hepatoblastoma</span> HepG2 cells with <span class=""chemical"">PFOA</span> induces apoptosis, as well as perturbs the cell cycle.",,10590214,10590214_C023036_D018197,10590214_2,bcv_sentence_task_befree_1204,,770957132,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,1,,D011419,"<span class=""chemical"">propidium iodide</span>",D012892,"<span class=""disease"">typical nucleosomal fragmentation</span>","This apoptosis was characterized by electron microscopy, which revealed <span class=""disease"">typical nucleosomal fragmentation</span> (also observed as a 'DNA ladder' upon electrophoresis on agarose) and was quantitated using <span class=""chemical"">propidium iodide</span> staining of cellular DNA and the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay.",,10590214,10590214_D011419_D012892,10590214_3,bcv_sentence_task_befree_1205,,770957133,FALSE,finalized,5,8/14/15 20:57,"



",yes_direct,0.8026,,C023036,"<span class=""chemical"">PFOA</span>",D009336,"<span class=""disease"">necrosis</span>","These findings indicate that in the presence of high concentrations of <span class=""chemical"">PFOA</span> for long times, HepG2 cells undergo primary and secondary <span class=""disease"">necrosis</span>.",,10590214,10590214_C023036_D009336,10590214_5,bcv_sentence_task_befree_1206,,770957134,FALSE,finalized,5,8/14/15 21:57,"



",no_relation,1,,D007294,"<span class=""chemical"">inositol</span>",D016736,"<span class=""disease"">APS</span>","These data suggest that a strategy for development of therapeutic agents for <span class=""disease"">APS</span> may be based on the use of small cyclic, organic oligoanions such as <span class=""chemical"">inositol</span> derivatives to act as ligands for lysine residues at the PL binding site of beta 2GPI.",,10624568,10624568_D007294_D016736,10624568_9,bcv_sentence_task_befree_1207,,770957135,FALSE,finalized,5,8/14/15 21:02,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",C536227,"<span class=""disease"">hematopoiesis</span>","A retrospective study was conducted to quantitate plasma levels of 5 cytokines regulating <span class=""disease"">hematopoiesis</span>, namely, 2 stimulatory fms-like <span class=""chemical"">tyrosine</span> kinase (FLT3-L) and stem cell factor (SCF) and 3 inhibitory growth factors tumor necrosis factor-alpha (TNFalpha), tumor growth factor-beta, and macrophage inflammatory protein (MIP-1alpha), by immunoassay in 43 patients enrolled in clinical trials at Garden State Cancer Center in Belleville, New Jersey.",,10640965,10640965_D014443_C536227,10640965_7,bcv_sentence_task_befree_1208,,770957136,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D009336,"<span class=""disease"">necrosis</span>","A retrospective study was conducted to quantitate plasma levels of 5 cytokines regulating hematopoiesis, namely, 2 stimulatory fms-like <span class=""chemical"">tyrosine</span> kinase (FLT3-L) and stem cell factor (SCF) and 3 inhibitory growth factors tumor <span class=""disease"">necrosis</span> factor-alpha (TNFalpha), tumor growth factor-beta, and macrophage inflammatory protein (MIP-1alpha), by immunoassay in 43 patients enrolled in clinical trials at Garden State Cancer Center in Belleville, New Jersey.",,10640965,10640965_D014443_D009336,10640965_7,bcv_sentence_task_befree_1209,,770957137,FALSE,finalized,5,8/14/15 21:06,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D009369,"<span class=""disease"">tumor</span>","A retrospective study was conducted to quantitate plasma levels of 5 cytokines regulating hematopoiesis, namely, 2 stimulatory fms-like <span class=""chemical"">tyrosine</span> kinase (FLT3-L) and stem cell factor (SCF) and 3 inhibitory growth factors <span class=""disease"">tumor</span> necrosis factor-alpha (TNFalpha), <span class=""disease"">tumor</span> growth factor-beta, and macrophage inflammatory protein (MIP-1alpha), by immunoassay in 43 patients enrolled in clinical trials at Garden State Cancer Center in Belleville, New Jersey.",,10640965,10640965_D014443_D009369,10640965_7,bcv_sentence_task_befree_1210,,770957138,FALSE,finalized,5,8/15/15 1:03,"



",yes_indirect,0.4119,,D017953,"<span class=""chemical"">isocyanates</span>",D001249,"<span class=""disease"">asthma</span>","Animal studies have suggested that skin exposure to <span class=""chemical"">isocyanates</span> may be an important risk factor for respiratory sensitization leading to <span class=""disease"">asthma</span>.",,10642416,10642416_D017953_D001249,10642416_2,bcv_sentence_task_befree_1211,,770957139,FALSE,finalized,5,8/15/15 1:02,"



",no_relation,1,,D013256,"<span class=""chemical"">steroids</span>",D006177,"<span class=""disease"">structural damage</span>","Following <span class=""chemical"">steroids</span> and hydroxyurea administration, the lesions on MRI disappeared, suggesting that the pathogenetic mechanism was reversible and did not cause significant <span class=""disease"">structural damage</span>.",,10646028,10646028_D013256_D006177,10646028_2,bcv_sentence_task_befree_1212,,770957140,FALSE,finalized,5,8/14/15 23:56,"



",no_relation,1,,D006918,"<span class=""chemical"">hydroxyurea</span>",D006177,"<span class=""disease"">structural damage</span>","Following steroids and <span class=""chemical"">hydroxyurea</span> administration, the lesions on MRI disappeared, suggesting that the pathogenetic mechanism was reversible and did not cause significant <span class=""disease"">structural damage</span>.",,10646028,10646028_D006918_D006177,10646028_2,bcv_sentence_task_befree_1213,,770957141,FALSE,finalized,5,8/15/15 2:31,"



",no_relation,1,,C071315,"<span class=""chemical"">Ramosetron</span>",D020250,"<span class=""disease"">postoperative nausea and vomiting</span>","<span class=""chemical"">Ramosetron</span> for preventing <span class=""disease"">postoperative nausea and vomiting</span> in women undergoing gynecological surgery.",,10648342,10648342_C071315_D020250,10648342_0,bcv_sentence_task_befree_1214,,770957142,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,C071315,"<span class=""chemical"">ramosetron</span>",D020250,"<span class=""disease"">PONV/prevention of postoperative nausea and vomiting</span>","In a prospective, randomized, double-blinded, placebo-controlled trial, we evaluated the efficacy of <span class=""chemical"">ramosetron</span> at three different doses (0.15, 0.3, and 0.6 mg) for the <span class=""disease"">prevention of postoperative nausea and vomiting</span> (<span class=""disease"">PONV</span>) after gynecological surgery.",,10648342,10648342_C071315_D020250,10648342_1,bcv_sentence_task_befree_1215,,770957143,FALSE,finalized,5,8/14/15 20:53,"



",no_relation,1,,C071315,"<span class=""chemical"">ramosetron</span>",D020250,"<span class=""disease"">PONV</span>","In conclusion, <span class=""chemical"">ramosetron</span> 0.3 mg is an effective antiemetic for preventing <span class=""disease"">PONV</span> during 0-48 h after anesthesia in female patients undergoing gynecological surgery.",,10648342,10648342_C071315_D020250,10648342_8,bcv_sentence_task_befree_1216,,770957144,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,1,,C071315,"<span class=""chemical"">ramosetron</span>",D020250,"<span class=""disease"">postoperative nausea and vomiting</span>","This randomized, double-blinded, placebo-controlled trial in 120 women found the effective dose of <span class=""chemical"">ramosetron</span> for preventing <span class=""disease"">postoperative nausea and vomiting</span> after gynecological surgery to be 0.3 mg.",,10648342,10648342_C071315_D020250,10648342_10,bcv_sentence_task_befree_1217,,770957145,FALSE,finalized,5,8/14/15 21:00,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D001249,"<span class=""disease"">bronchial asthma</span>","Study of fluticasone propionate efficacy in the treatment of patients with <span class=""disease"">bronchial asthma</span> not controlled by other inhaled <span class=""chemical"">corticosteroids</span>.",,10660975,10660975_D000305_D001249,10660975_0,bcv_sentence_task_befree_1218,,770957146,FALSE,finalized,5,8/15/15 0:00,"



",no_relation,1,,C065382,"<span class=""chemical"">fluticasone propionate</span>",D001249,"<span class=""disease"">bronchial asthma</span>","Study of <span class=""chemical"">fluticasone propionate</span> efficacy in the treatment of patients with <span class=""disease"">bronchial asthma</span> not controlled by other inhaled corticosteroids.",,10660975,10660975_C065382_D001249,10660975_0,bcv_sentence_task_befree_1219,,770957147,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,0.8156,,D000305,"<span class=""chemical"">corticosteroids</span>",D001249,"<span class=""disease"">bronchial asthma/BA</span>","The aim of the study was to test the fluticasone propionate (FP) efficacy in the treatment of patients with <span class=""disease"">bronchial asthma</span> (<span class=""disease"">BA</span>), not controlled by high doses (more than 1 mg) of other inhaled <span class=""chemical"">corticosteroids</span>.",,10660975,10660975_D000305_D001249,10660975_1,bcv_sentence_task_befree_1220,,770957148,FALSE,finalized,5,8/14/15 20:57,"



",no_relation,1,,C065382,"<span class=""chemical"">fluticasone propionate</span>",D001249,"<span class=""disease"">bronchial asthma/BA</span>","The aim of the study was to test the <span class=""chemical"">fluticasone propionate</span> (FP) efficacy in the treatment of patients with <span class=""disease"">bronchial asthma</span> (<span class=""disease"">BA</span>), not controlled by high doses (more than 1 mg) of other inhaled corticosteroids.",,10660975,10660975_C065382_D001249,10660975_1,bcv_sentence_task_befree_1221,,770957149,FALSE,finalized,5,8/15/15 1:31,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D001249,"<span class=""disease"">BA</span>","Our results demonstrate improved efficacy of FP vs high doses of other inhaled <span class=""chemical"">corticosteroids</span> in the treatment of moderate persistent and severe forms of <span class=""disease"">BA</span>.",,10660975,10660975_D000305_D001249,10660975_14,bcv_sentence_task_befree_1222,,770957150,FALSE,finalized,5,8/14/15 21:00,"



",no_relation,0.598,,D002110,"<span class=""chemical"">Caffeine</span>",D007040,"<span class=""disease"">hypoventilation</span>","<span class=""chemical"">Caffeine</span> can affect velocity in the middle cerebral artery during hyperventilation, <span class=""disease"">hypoventilation</span>, and thinking: a transcranial Doppler study.",,10666980,10666980_D002110_D007040,10666980_0,bcv_sentence_task_befree_1223,,770957151,FALSE,finalized,5,8/15/15 1:04,"



",no_relation,1,,D002110,"<span class=""chemical"">caffeine</span>",D007040,"<span class=""disease"">hypoventilation</span>","Time-course analyses showed that VMCA (1) followed a triphasic pattern to increase over baselines during <span class=""disease"">hypoventilation</span> regardless of <span class=""chemical"">caffeine</span> condition, (2) slowed below baselines during hyperventilation (with the degree of slowing attenuated under <span class=""chemical"">caffeine</span>), and (3) increased over baselines during all cognitive activities (ranges 3.8-6.9%).",,10666980,10666980_D002110_D007040,10666980_5,bcv_sentence_task_befree_1224,,770957152,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,1,,D000242,"<span class=""chemical"">cAMP</span>",D020335,"<span class=""disease"">hypotonic challenge</span>","A <span class=""disease"">hypotonic challenge</span>, but not <span class=""chemical"">cAMP</span> stimulation, was found to induce release of ATP measured by the luciferin-luciferase assay from both the murine mammary carcinoma cell line C127i and C127 cells stably transfected with the cDNA for human cystic fibrosis transmembrane conductance regulator (CFTR) protein (C127/CFTR).",,10673540,10673540_D000242_D020335,10673540_2,bcv_sentence_task_befree_1225,,770957153,FALSE,finalized,5,8/14/15 22:03,"



",no_relation,1,,D000242,"<span class=""chemical"">cAMP</span>",D002277,"<span class=""disease"">carcinoma</span>","A hypotonic challenge, but not <span class=""chemical"">cAMP</span> stimulation, was found to induce release of ATP measured by the luciferin-luciferase assay from both the murine mammary <span class=""disease"">carcinoma</span> cell line C127i and C127 cells stably transfected with the cDNA for human cystic fibrosis transmembrane conductance regulator (CFTR) protein (C127/CFTR).",,10673540,10673540_D000242_D002277,10673540_2,bcv_sentence_task_befree_1226,,770957154,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,0.8065,,D000255,"<span class=""chemical"">ATP</span>",D020335,"<span class=""disease"">hypotonic challenge</span>","A <span class=""disease"">hypotonic challenge</span>, but not cAMP stimulation, was found to induce release of <span class=""chemical"">ATP</span> measured by the luciferin-luciferase assay from both the murine mammary carcinoma cell line C127i and C127 cells stably transfected with the cDNA for human cystic fibrosis transmembrane conductance regulator (CFTR) protein (C127/CFTR).",,10673540,10673540_D000255_D020335,10673540_2,bcv_sentence_task_befree_1227,,770957155,FALSE,finalized,5,8/15/15 2:03,"



",no_relation,1,,D000255,"<span class=""chemical"">ATP</span>",D002277,"<span class=""disease"">carcinoma</span>","A hypotonic challenge, but not cAMP stimulation, was found to induce release of <span class=""chemical"">ATP</span> measured by the luciferin-luciferase assay from both the murine mammary <span class=""disease"">carcinoma</span> cell line C127i and C127 cells stably transfected with the cDNA for human cystic fibrosis transmembrane conductance regulator (CFTR) protein (C127/CFTR).",,10673540,10673540_D000255_D002277,10673540_2,bcv_sentence_task_befree_1228,,770957156,FALSE,finalized,5,8/14/15 20:56,"



",no_relation,1,,D000255,"<span class=""chemical"">ATP</span>",D020335,"<span class=""disease"">hypotonic</span>","CFTR expression augmented swelling-induced <span class=""chemical"">ATP</span> release by 10-20 times under <span class=""disease"">hypotonic</span> conditions (< or = 80 % osmolality).",,10673540,10673540_D000255_D020335,10673540_3,bcv_sentence_task_befree_1229,,770957157,FALSE,finalized,5,8/14/15 21:51,"



",no_relation,1,,D020849,"<span class=""chemical"">Raloxifene</span>",D014082,"<span class=""disease"">Fracture</span>","Two randomized, double-blind, placebo-controlled trials in 11 US clinical research centers for the <span class=""disease"">Fracture</span> Intervention Trial and 180 centers in the United States and other countries for the Multiple Outcomes of <span class=""chemical"">Raloxifene</span> Evaluation Trial.",,10714731,10714731_D020849_D014082,10714731_4,bcv_sentence_task_befree_1230,,770957158,FALSE,finalized,5,8/15/15 2:26,"



",no_relation,1,,D020849,"<span class=""chemical"">Raloxifene/raloxifene hydrochloride</span>",D014082,"<span class=""disease"">Fracture</span>","Postmenopausal women with low BMD assigned to treatment with 5 mg/d of alendronate sodium in the <span class=""disease"">Fracture</span> intervention Trial who completed 2 years of BMD monitoring and adhered to study medication (n = 2634), and postmenopausal women with osteoporosis assigned to treatment with 60 or 120 mg/d of <span class=""chemical"">raloxifene hydrochloride</span> in the Multiple Outcomes of <span class=""chemical"">Raloxifene</span> Evaluation trial who similarly completed 2 years of monitoring while adhering to study medication (n = 3954).",,10714731,10714731_D020849_D014082,10714731_5,bcv_sentence_task_befree_1231,,770957159,FALSE,finalized,5,8/15/15 2:09,"



",no_relation,1,,D020849,"<span class=""chemical"">Raloxifene/raloxifene hydrochloride</span>",D010024,"<span class=""disease"">BMD/osteoporosis</span>","Postmenopausal women with low <span class=""disease"">BMD</span> assigned to treatment with 5 mg/d of alendronate sodium in the Fracture intervention Trial who completed 2 years of <span class=""disease"">BMD</span> monitoring and adhered to study medication (n = 2634), and postmenopausal women with <span class=""disease"">osteoporosis</span> assigned to treatment with 60 or 120 mg/d of <span class=""chemical"">raloxifene hydrochloride</span> in the Multiple Outcomes of <span class=""chemical"">Raloxifene</span> Evaluation trial who similarly completed 2 years of monitoring while adhering to study medication (n = 3954).",,10714731,10714731_D020849_D010024,10714731_5,bcv_sentence_task_befree_1232,,770957160,FALSE,finalized,5,8/15/15 2:01,"



",no_relation,1,,D019386,"<span class=""chemical"">alendronate sodium</span>",D010024,"<span class=""disease"">BMD/osteoporosis</span>","Postmenopausal women with low <span class=""disease"">BMD</span> assigned to treatment with 5 mg/d of <span class=""chemical"">alendronate sodium</span> in the Fracture intervention Trial who completed 2 years of <span class=""disease"">BMD</span> monitoring and adhered to study medication (n = 2634), and postmenopausal women with <span class=""disease"">osteoporosis</span> assigned to treatment with 60 or 120 mg/d of raloxifene hydrochloride in the Multiple Outcomes of Raloxifene Evaluation trial who similarly completed 2 years of monitoring while adhering to study medication (n = 3954).",,10714731,10714731_D019386_D010024,10714731_5,bcv_sentence_task_befree_1233,,770957161,FALSE,finalized,5,8/15/15 1:44,"



",no_relation,1,,D019386,"<span class=""chemical"">alendronate sodium</span>",D014082,"<span class=""disease"">Fracture</span>","Postmenopausal women with low BMD assigned to treatment with 5 mg/d of <span class=""chemical"">alendronate sodium</span> in the <span class=""disease"">Fracture</span> intervention Trial who completed 2 years of BMD monitoring and adhered to study medication (n = 2634), and postmenopausal women with osteoporosis assigned to treatment with 60 or 120 mg/d of raloxifene hydrochloride in the Multiple Outcomes of Raloxifene Evaluation trial who similarly completed 2 years of monitoring while adhering to study medication (n = 3954).",,10714731,10714731_D019386_D014082,10714731_5,bcv_sentence_task_befree_1234,,770957162,FALSE,finalized,5,8/14/15 20:56,"



",no_relation,0.5971,,D019386,"<span class=""chemical"">alendronate</span>",D010024,"<span class=""disease"">BMD</span>","Specifically, among women taking <span class=""chemical"">alendronate</span> whose hip <span class=""disease"">BMD</span> decreased by more than 4% during the first year, 83% (95% confidence interval [CI], 82%-84%)had increases in hip <span class=""disease"">BMD</span> during the second year, with an overall mean increase of 4.7%.",,10714731,10714731_D019386_D010024,10714731_8,bcv_sentence_task_befree_1235,,770957163,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,0.789,,D020849,"<span class=""chemical"">raloxifene</span>",D010024,"<span class=""disease"">BMD</span>","Our data suggest that most women who lose <span class=""disease"">BMD</span> during the first year of treatment with alendronate or <span class=""chemical"">raloxifene</span> will gain <span class=""disease"">BMD</span> if the same treatment is continued for a second year.",,10714731,10714731_D020849_D010024,10714731_11,bcv_sentence_task_befree_1236,,770957164,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,0.8064,,D019386,"<span class=""chemical"">alendronate</span>",D010024,"<span class=""disease"">BMD</span>","Our data suggest that most women who lose <span class=""disease"">BMD</span> during the first year of treatment with <span class=""chemical"">alendronate</span> or raloxifene will gain <span class=""disease"">BMD</span> if the same treatment is continued for a second year.",,10714731,10714731_D019386_D010024,10714731_11,bcv_sentence_task_befree_1237,,770957165,FALSE,finalized,5,8/15/15 1:49,"



",yes_direct,1,,D005472,"<span class=""chemical"">5-fluorouracil</span>",D007767,"<span class=""disease"">excessive lacrimation</span>","Ocular side effects of systemic <span class=""chemical"">5-fluorouracil</span> therapy include <span class=""disease"">excessive lacrimation</span> which often resolves on cessation of therapy.",,10726804,10726804_D005472_D007767,10726804_1,bcv_sentence_task_befree_1238,,770957166,FALSE,finalized,5,8/14/15 20:57,"



",yes_direct,1,,D005472,"<span class=""chemical"">5-fluorouracil</span>",D003251,"<span class=""disease"">stenosis</span>","Severe <span class=""disease"">stenosis</span> of puncta and canaliculi may be associated with prolonged systemic <span class=""chemical"">5-fluorouracil</span> therapy.",,10726804,10726804_D005472_D003251,10726804_5,bcv_sentence_task_befree_1239,,770957167,FALSE,finalized,5,8/14/15 22:20,"



",yes_direct,1,,D005472,"<span class=""chemical"">5-fluorouracil</span>",D064420,"<span class=""disease"">ocular toxicity</span>","It is important for both the oncologist and ophthalmologist to be aware of the potential <span class=""disease"">ocular toxicity</span> of <span class=""chemical"">5-fluorouracil</span>.",,10726804,10726804_D005472_D064420,10726804_6,bcv_sentence_task_befree_1240,,770957168,FALSE,finalized,5,8/14/15 20:56,"



",no_relation,1,,D002857,"<span class=""chemical"">Cr</span>",D009369,"<span class=""disease"">tumor</span>","In our improved model, <span class=""disease"">tumor</span> angiogenesis is determined by measuring the blood volume in an area of skin held in contact with a <span class=""disease"">tumor</span> cell-containing chamber, using 51<span class=""chemical"">Cr</span>-labeled red blood cells (RBC).",,10757446,10757446_D002857_D009369,10757446_2,bcv_sentence_task_befree_1241,,770957169,FALSE,finalized,5,8/14/15 21:23,"



",no_relation,1,,D002857,"<span class=""chemical"">Cr</span>",D016510,"<span class=""disease"">angiogenesis</span>","In our improved model, tumor <span class=""disease"">angiogenesis</span> is determined by measuring the blood volume in an area of skin held in contact with a tumor cell-containing chamber, using 51<span class=""chemical"">Cr</span>-labeled red blood cells (RBC).",,10757446,10757446_D002857_D016510,10757446_2,bcv_sentence_task_befree_1242,,770957170,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,C005066,"<span class=""chemical"">borrelidin</span>",D016510,"<span class=""disease"">angiogenesis</span>","Using the improved model, it was confirmed that TNP-470, a well-known inhibitor, and <span class=""chemical"">borrelidin</span>, an antibiotic from Streptomyces rochei, significantly inhibited the WiDr cell-induced <span class=""disease"">angiogenesis</span>.",,10757446,10757446_C005066_D016510,10757446_6,bcv_sentence_task_befree_1243,,770957171,FALSE,finalized,5,8/14/15 22:24,"



",no_relation,0.7891,,C005066,"<span class=""chemical"">Borrelidin</span>",D016510,"<span class=""disease"">angiogenesis</span>","<span class=""chemical"">Borrelidin</span> also inhibited spontaneous lung metastasis of B16-BL6 melanoma at the same dose that inhibited <span class=""disease"">angiogenesis</span>.",,10757446,10757446_C005066_D016510,10757446_7,bcv_sentence_task_befree_1244,,770957172,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,0.8037,,C005066,"<span class=""chemical"">Borrelidin</span>",D008545,"<span class=""disease"">melanoma</span>","<span class=""chemical"">Borrelidin</span> also inhibited spontaneous lung metastasis of B16-BL6 <span class=""disease"">melanoma</span> at the same dose that inhibited angiogenesis.",,10757446,10757446_C005066_D008545,10757446_7,bcv_sentence_task_befree_1245,,770957173,FALSE,finalized,5,8/14/15 20:55,"



",no_relation,0.8019,,D020123,"<span class=""chemical"">rapamycin</span>",C580075,"<span class=""disease"">AML</span>","While inhibition of p70S6-kinase with <span class=""chemical"">rapamycin</span> did not increase drug-induced apoptosis, PI3-kinase inhibition resulted in notable dephosphorylation of PKB, suggesting that the PI3-kinase/PKB survival pathway may play a major role in chemoresistance in <span class=""disease"">AML</span>.",,10764145,10764145_D020123_C580075,10764145_6,bcv_sentence_task_befree_1246,,770957174,FALSE,finalized,5,8/14/15 20:57,"



",no_relation,1,,C014347,"<span class=""chemical"">5-azadeoxycytidine/5-aza-dC</span>",D011218,"<span class=""disease"">PWS</span>","Furthermore, treatment of <span class=""disease"">PWS</span> cells with the DNA methyltransferase inhibitor <span class=""chemical"">5-azadeoxycytidine</span> (<span class=""chemical"">5-aza-dC</span>) induced demethylation of the SNURF-SNRPN CpG island and restoration of gene expression on the maternal allele.",,10775525,10775525_C014347_D011218,10775525_4,bcv_sentence_task_befree_1247,,770957175,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,D059808,"<span class=""chemical"">polyphenols</span>",D009369,"<span class=""disease"">Cancer</span>","<span class=""disease"">Cancer</span> chemoprevention by tea <span class=""chemical"">polyphenols</span>.",,10786933,10786933_D059808_D009369,10786933_0,bcv_sentence_task_befree_1248,,770957176,FALSE,finalized,5,8/14/15 23:22,"

'Against' being the key term.

",no_relation,0.7879,,D059808,"<span class=""chemical"">polyphenol</span>",D063646,"<span class=""disease"">carcinogenesis</span>","The inhibitory effects of tea against <span class=""disease"">carcinogenesis</span> have been attributed to the biologic activities of the <span class=""chemical"">polyphenol</span> fraction in tea.",,10786933,10786933_D059808_D063646,10786933_3,bcv_sentence_task_befree_1249,,770957177,FALSE,finalized,5,8/14/15 23:18,"



",no_relation,1,,D059808,"<span class=""chemical"">polyphenols</span>",D009369,"<span class=""disease"">tumor</span>","This review summarizes experimental data on chemopreventive effects of tea <span class=""chemical"">polyphenols</span> in various <span class=""disease"">tumor</span> bioassay systems.",,10786933,10786933_D059808_D009369,10786933_4,bcv_sentence_task_befree_1250,,770957178,FALSE,finalized,5,8/14/15 20:57,"



",no_relation,1,,C045651,"<span class=""chemical"">(-)-epigallocatechin-3-gallate/EGCG</span>",D063646,"<span class=""disease"">carcinogenesis</span>","Many laboratory studies have demonstrated the inhibitory effects of green tea polyphenols, especially <span class=""chemical"">(-)-epigallocatechin-3-gallate</span> (<span class=""chemical"">EGCG</span>), on <span class=""disease"">carcinogenesis</span> in animals models.",,10786933,10786933_C045651_D063646,10786933_5,bcv_sentence_task_befree_1251,,770957179,FALSE,finalized,5,8/14/15 22:42,"



",no_relation,1,,D059808,"<span class=""chemical"">polyphenols</span>",D063646,"<span class=""disease"">carcinogenesis</span>","Many laboratory studies have demonstrated the inhibitory effects of green tea <span class=""chemical"">polyphenols</span>, especially (-)-epigallocatechin-3-gallate (EGCG), on <span class=""disease"">carcinogenesis</span> in animals models.",,10786933,10786933_D059808_D063646,10786933_5,bcv_sentence_task_befree_1252,,770957180,FALSE,finalized,5,8/14/15 20:53,"



",no_relation,0.8133,,D059808,"<span class=""chemical"">polyphenols</span>",D009369,"<span class=""disease"">skin tumor</span>","The majority of these studies have been conducted in mouse <span class=""disease"">skin tumor</span> models, where tea <span class=""chemical"">polyphenols</span> were used either as oral feeding in drinking water or in direct local application.",,10786933,10786933_D059808_D009369,10786933_6,bcv_sentence_task_befree_1253,,770957181,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,0.8241,,D059808,"<span class=""chemical"">polyphenols</span>",D009369,"<span class=""disease"">tumor</span>","Most studies used 12-O-tetradecanoylphorbol-13-acetate (TPA) or ultraviolet (UV) radiation as the <span class=""disease"">tumor</span> promoter and found anticarcinogenic effects caused by green tea <span class=""chemical"">polyphenols</span>.",,10786933,10786933_D059808_D009369,10786933_7,bcv_sentence_task_befree_1254,,770957182,FALSE,finalized,5,8/14/15 23:33,"



",no_relation,0.7967,,C554292|D013755,"<span class=""chemical"">12-O-tetradecanoylphorbol-13-acetate/TPA</span>",D009369,"<span class=""disease"">tumor</span>","Most studies used <span class=""chemical"">12-O-tetradecanoylphorbol-13-acetate</span> (<span class=""chemical"">TPA</span>) or ultraviolet (UV) radiation as the <span class=""disease"">tumor</span> promoter and found anticarcinogenic effects caused by green tea polyphenols.",,10786933,10786933_C554292|D013755_D009369,10786933_7,bcv_sentence_task_befree_1255,,770957183,FALSE,finalized,5,8/14/15 20:54,"



",no_relation,1,,D002110,"<span class=""chemical"">Caffeine</span>",D063646,"<span class=""disease"">tumorigenesis</span>","<span class=""chemical"">Caffeine</span> in tea was also important for tea to prevent <span class=""disease"">tumorigenesis</span>.",,10786933,10786933_D002110_D063646,10786933_10,bcv_sentence_task_befree_1256,,770957184,FALSE,finalized,5,8/14/15 20:57,"



",no_relation,0.6,,D059808,"<span class=""chemical"">polyphenols</span>",D009369,"<span class=""disease"">cancer</span>","The molecular mechanisms of the <span class=""disease"">cancer</span> chemopreventive effects of tea <span class=""chemical"">polyphenols</span> are not completely understood.",,10786933,10786933_D059808_D009369,10786933_11,bcv_sentence_task_befree_1257,,770957185,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,0.6086,,D059808,"<span class=""chemical"">polyphenols</span>",D009369,"<span class=""disease"">tumor</span>","They are most likely related to the mechanisms of biochemical actions of tea <span class=""chemical"">polyphenols</span>, which include antioxidative activities, modulation of xenobiotic metabolite enzymes and inhibition of <span class=""disease"">tumor</span> promotion.",,10786933,10786933_D059808_D009369,10786933_12,bcv_sentence_task_befree_1258,,770957186,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,0.8044,,D059808,"<span class=""chemical"">polyphenols</span>",D009369,"<span class=""disease"">cancer</span>","In addition, we have also proposed that tea <span class=""chemical"">polyphenols</span> function as <span class=""disease"">cancer</span> chemopreventive agents through modulation of mitotic signal transduction.",,10786933,10786933_D059808_D009369,10786933_13,bcv_sentence_task_befree_1259,,770957187,FALSE,finalized,5,8/15/15 2:22,"



",no_relation,1,,D005472,"<span class=""chemical"">5-fluorouracil</span>",D003108,"<span class=""disease"">colon carcinoma</span>","Relation between thymidylate synthase expression and survival in <span class=""disease"">colon carcinoma</span>, and determination of appropriate application of <span class=""chemical"">5-fluorouracil</span> by immunohistochemical method.",,10791849,10791849_D005472_D003108,10791849_0,bcv_sentence_task_befree_1260,,770957188,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU/5-fluorouracil</span>",D015179,"<span class=""disease"">colorectal carcinoma</span>","Thymidylate synthase (TS) is regarded as a parameter of <span class=""chemical"">5-fluorouracil</span> (<span class=""chemical"">5-FU</span>) chemosensitivity for <span class=""disease"">colorectal carcinoma</span>.",,10791849,10791849_D005472_D015179,10791849_1,bcv_sentence_task_befree_1261,,770957189,FALSE,finalized,5,8/15/15 0:52,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU/5-fluorouracil</span>",D020159,"<span class=""disease"">Thymidylate synthase/TS</span>","<span class=""disease"">Thymidylate synthase</span> (<span class=""disease"">TS</span>) is regarded as a parameter of <span class=""chemical"">5-fluorouracil</span> (<span class=""chemical"">5-FU</span>) chemosensitivity for colorectal carcinoma.",,10791849,10791849_D005472_D020159,10791849_1,bcv_sentence_task_befree_1262,,770957190,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D015179,"<span class=""disease"">colorectal carcinoma</span>","Recent researchers indicate that the chemosensitivity of <span class=""chemical"">5-FU</span> for <span class=""disease"">colorectal carcinoma</span> with low expression of TS is better than tumors with high expression of TS.",,10791849,10791849_D005472_D015179,10791849_2,bcv_sentence_task_befree_1263,,770957191,FALSE,finalized,5,8/15/15 1:17,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D009369,"<span class=""disease"">tumors</span>","Recent researchers indicate that the chemosensitivity of <span class=""chemical"">5-FU</span> for colorectal carcinoma with low expression of TS is better than <span class=""disease"">tumors</span> with high expression of TS.",,10791849,10791849_D005472_D009369,10791849_2,bcv_sentence_task_befree_1264,,770957192,FALSE,finalized,5,8/15/15 2:57,"



",no_relation,0.808,,D005472,"<span class=""chemical"">5-FU</span>",D020159,"<span class=""disease"">TS</span>","Recent researchers indicate that the chemosensitivity of <span class=""chemical"">5-FU</span> for colorectal carcinoma with low expression of <span class=""disease"">TS</span> is better than tumors with high expression of <span class=""disease"">TS</span>.",,10791849,10791849_D005472_D020159,10791849_2,bcv_sentence_task_befree_1265,,770957193,FALSE,finalized,5,8/14/15 23:38,"

Used as treatment.

",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D003108,"<span class=""disease"">colon carcinoma</span>","TS, itself, may be a prognostic factor for <span class=""disease"">colon carcinoma</span>; and <span class=""chemical"">5-FU</span> adjuvant chemotherapy may be appropriate for <span class=""disease"">colon carcinoma</span> with high expression of TS.",,10791849,10791849_D005472_D003108,10791849_11,bcv_sentence_task_befree_1266,,770957194,FALSE,finalized,5,8/14/15 23:24,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D020159,"<span class=""disease"">TS</span>","<span class=""disease"">TS</span>, itself, may be a prognostic factor for colon carcinoma; and <span class=""chemical"">5-FU</span> adjuvant chemotherapy may be appropriate for colon carcinoma with high expression of <span class=""disease"">TS</span>.",,10791849,10791849_D005472_D020159,10791849_11,bcv_sentence_task_befree_1267,,770957195,FALSE,finalized,5,8/14/15 21:00,"



",no_relation,1,,D013256,"<span class=""chemical"">steroids</span>",D001987,"<span class=""disease"">bronchiectasis</span>","Inhaled <span class=""chemical"">steroids</span> for <span class=""disease"">bronchiectasis</span>.",,10796575,10796575_D013256_D001987,10796575_0,bcv_sentence_task_befree_1268,,770957196,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroid</span>",D001987,"<span class=""disease"">bronchiectasis</span>","The Cochrane Airways Group RCT register and Cochrane Controlled Clinical Trials Register were searched using the following search terms; <span class=""disease"">bronchiectasis</span> AND [<span class=""chemical"">corticosteroid</span>* OR beclomethasone OR budesonide OR fluticasone OR triamcinolone OR flunisolide].",,10796575,10796575_D000305_D001987,10796575_4,bcv_sentence_task_befree_1269,,770957197,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,1,,C065382,"<span class=""chemical"">fluticasone</span>",D001987,"<span class=""disease"">bronchiectasis</span>","The Cochrane Airways Group RCT register and Cochrane Controlled Clinical Trials Register were searched using the following search terms; <span class=""disease"">bronchiectasis</span> AND [corticosteroid* OR beclomethasone OR budesonide OR <span class=""chemical"">fluticasone</span> OR triamcinolone OR flunisolide].",,10796575,10796575_C065382_D001987,10796575_4,bcv_sentence_task_befree_1270,,770957198,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,1,,D014221,"<span class=""chemical"">triamcinolone</span>",D001987,"<span class=""disease"">bronchiectasis</span>","The Cochrane Airways Group RCT register and Cochrane Controlled Clinical Trials Register were searched using the following search terms; <span class=""disease"">bronchiectasis</span> AND [corticosteroid* OR beclomethasone OR budesonide OR fluticasone OR <span class=""chemical"">triamcinolone</span> OR flunisolide].",,10796575,10796575_D014221_D001987,10796575_4,bcv_sentence_task_befree_1271,,770957199,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,C007734,"<span class=""chemical"">flunisolide</span>",D001987,"<span class=""disease"">bronchiectasis</span>","The Cochrane Airways Group RCT register and Cochrane Controlled Clinical Trials Register were searched using the following search terms; <span class=""disease"">bronchiectasis</span> AND [corticosteroid* OR beclomethasone OR budesonide OR fluticasone OR triamcinolone OR <span class=""chemical"">flunisolide</span>].",,10796575,10796575_C007734_D001987,10796575_4,bcv_sentence_task_befree_1272,,770957200,FALSE,finalized,5,8/14/15 20:55,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D001987,"<span class=""disease"">bronchiectasis</span>","In <span class=""disease"">bronchiectasis</span>, regular use of inhaled <span class=""chemical"">corticosteroids</span> may improve lung function.",,10796575,10796575_D000305_D001987,10796575_14,bcv_sentence_task_befree_1273,,770957201,FALSE,finalized,5,8/15/15 0:54,"



",yes_direct,0.8233,,D000305,"<span class=""chemical"">corticosteroids</span>",D002386,"<span class=""disease"">cataract</span>","Risk of <span class=""disease"">cataract</span> among users of intranasal <span class=""chemical"">corticosteroids</span>.",,10808171,10808171_D000305_D002386,10808171_0,bcv_sentence_task_befree_1274,,770957202,FALSE,finalized,5,8/14/15 23:53,"



",yes_direct,1,,D000305,"<span class=""chemical"">corticosteroid/corticosteroids</span>",D002386,"<span class=""disease"">cataract</span>","Oral <span class=""chemical"">corticosteroid</span> users are at increased risk of <span class=""disease"">cataract</span>, but the risk among intranasal <span class=""chemical"">corticosteroids</span> users is unknown.",,10808171,10808171_D000305_D002386,10808171_1,bcv_sentence_task_befree_1275,,770957203,FALSE,finalized,5,8/14/15 23:57,"

It's 'intranasal steroids' and not just 'Steroids'

",no_relation,0.6194,,D013256,"<span class=""chemical"">steroids</span>",D002386,"<span class=""disease"">cataract</span>","Our purpose was to describe the risk of <span class=""disease"">cataract</span> among users of intranasal <span class=""chemical"">steroids</span>.",,10808171,10808171_D013256_D002386,10808171_2,bcv_sentence_task_befree_1276,,770957204,FALSE,finalized,5,8/14/15 20:57,"



",yes_direct,0.6114,,D013256,"<span class=""chemical"">steroids</span>",D002386,"<span class=""disease"">cataract</span>","A retrospective observational cohort study of <span class=""disease"">cataract</span> incidence was conducted among users of oral and intranasal <span class=""chemical"">steroids</span> identified from the United Kingdom-based General Practice Research Database with a nested case-control analysis to control for confounding factors.",,10808171,10808171_D013256_D002386,10808171_3,bcv_sentence_task_befree_1277,,770957205,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,0.8256,,D000305,"<span class=""chemical"">corticosteroids</span>",D002386,"<span class=""disease"">cataract</span>","The incidence rate of <span class=""disease"">cataract</span> (1.0/1000 person-years) among users of intranasal <span class=""chemical"">corticosteroids</span> was similar to the incidence rate among nonusers.",,10808171,10808171_D000305_D002386,10808171_8,bcv_sentence_task_befree_1278,,770957206,FALSE,finalized,5,8/14/15 21:47,"



",yes_direct,1,,D000305,"<span class=""chemical"">corticosteroid</span>",D002386,"<span class=""disease"">cataract</span>","However, oral <span class=""chemical"">corticosteroid</span> users were at higher risk of <span class=""disease"">cataract</span> (2.2/1000 person-years).",,10808171,10808171_D000305_D002386,10808171_9,bcv_sentence_task_befree_1279,,770957207,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D002386,"<span class=""disease"">Cataract</span>","<span class=""disease"">Cataract</span> risk did not increase with the number of prior prescriptions for intranasal <span class=""chemical"">corticosteroids</span>.",,10808171,10808171_D000305_D002386,10808171_11,bcv_sentence_task_befree_1280,,770957208,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D002386,"<span class=""disease"">cataracts</span>","The use of intranasal <span class=""chemical"">corticosteroids</span> was not associated with an increased risk of <span class=""disease"">cataracts</span> in this study population.",,10808171,10808171_D000305_D002386,10808171_12,bcv_sentence_task_befree_1281,,770957209,FALSE,finalized,5,8/14/15 23:49,"



",no_relation,0.5956,,D014443,"<span class=""chemical"">tyrosine</span>",D003929,"<span class=""disease"">diabetes</span>","Expression of pancreatic islet MHC class I, insulin, and ICA 512 <span class=""chemical"">tyrosine</span> phosphatase in low-dose streptozotocin-induced <span class=""disease"">diabetes</span> in mice.",,10820150,10820150_D014443_D003929,10820150_0,bcv_sentence_task_befree_1282,,770957210,FALSE,finalized,5,8/14/15 21:06,"



",yes_direct,0.8054,,D013311,"<span class=""chemical"">streptozotocin</span>",D003929,"<span class=""disease"">diabetes</span>","Expression of pancreatic islet MHC class I, insulin, and ICA 512 tyrosine phosphatase in low-dose <span class=""chemical"">streptozotocin</span>-induced <span class=""disease"">diabetes</span> in mice.",,10820150,10820150_D013311_D003929,10820150_0,bcv_sentence_task_befree_1283,,770957211,FALSE,finalized,5,8/14/15 22:39,"



",yes_direct,0.6053,,D013311,"<span class=""chemical"">streptozotocin</span>",D003920,"<span class=""disease"">diabetes mellitus</span>","Activated immune cells contribute to the development of <span class=""disease"">diabetes mellitus</span> in multiple low-dose <span class=""chemical"">streptozotocin</span>-treated mice.",,10820150,10820150_D013311_D003920,10820150_1,bcv_sentence_task_befree_1284,,770957212,FALSE,finalized,5,8/14/15 20:53,"



",no_relation,0.7983,,D004967,"<span class=""chemical"">oestrogen</span>",D009369,"<span class=""disease"">breast cancer</span>","Effect of transforming growth factor beta 2 on <span class=""chemical"">oestrogen</span> metabolism in the MCF-7 <span class=""disease"">breast cancer</span> cell line.",,10823131,10823131_D004967_D009369,10823131_0,bcv_sentence_task_befree_1285,,770957213,FALSE,finalized,5,8/15/15 1:32,"



",yes_direct,0.6079,,D004967,"<span class=""chemical"">oestrogens</span>",D009369,"<span class=""disease"">breast cancer</span>","In addition, <span class=""chemical"">oestrogens</span> play an important role in <span class=""disease"">breast cancer</span> development, and oestrone sulphate (E1S) might be the main source of active <span class=""chemical"">oestrogens</span> in the breast.",,10823131,10823131_D004967_D009369,10823131_3,bcv_sentence_task_befree_1286,,770957214,FALSE,finalized,5,8/15/15 0:55,"



",yes_direct,0.402,,C017296,"<span class=""chemical"">oestrone sulphate</span>",D009369,"<span class=""disease"">breast cancer</span>","In addition, oestrogens play an important role in <span class=""disease"">breast cancer</span> development, and <span class=""chemical"">oestrone sulphate</span> (E1S) might be the main source of active oestrogens in the breast.",,10823131,10823131_C017296_D009369,10823131_3,bcv_sentence_task_befree_1287,,770957215,FALSE,finalized,5,8/15/15 2:07,"



",no_relation,1,,D004967,"<span class=""chemical"">oestrogen</span>",D009369,"<span class=""disease"">breast cancer</span>","The aim of this study was to assess the effect of TGF-beta 2 on <span class=""chemical"">oestrogen</span> synthesis in an attempt to understand the mechanism by which TGF-beta 2 may exert a protective effect in <span class=""disease"">breast cancer</span>.",,10823131,10823131_D004967_D009369,10823131_4,bcv_sentence_task_befree_1288,,770957216,FALSE,finalized,5,8/14/15 23:16,"



",yes_direct,0.5712,,D004967,"<span class=""chemical"">oestrogens</span>",D009369,"<span class=""disease"">breast cancer</span>","In conclusion, TGF-beta 2 might exert a protective role in <span class=""disease"">breast cancer</span> by reducing the amount of active <span class=""chemical"">oestrogens</span> present in the breast.",,10823131,10823131_D004967_D009369,10823131_7,bcv_sentence_task_befree_1289,,770957217,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,1,,C076029,"<span class=""chemical"">olanzapine</span>",D012559,"<span class=""disease"">schizophrenia</span>","Differential efficacy of <span class=""chemical"">olanzapine</span> for deficit and nondeficit negative symptoms in <span class=""disease"">schizophrenia</span>.",,10831481,10831481_C076029_D012559,10831481_0,bcv_sentence_task_befree_1290,,770957218,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,1,,C076029,"<span class=""chemical"">olanzapine</span>",D009461,"<span class=""disease"">deficit syndrome</span>","The authors examined the effects of <span class=""chemical"">olanzapine</span> on primary and secondary negative symptoms for patients with severe negative symptoms who did or did not have the <span class=""disease"">deficit syndrome</span>.",,10831481,10831481_C076029_D009461,10831481_3,bcv_sentence_task_befree_1291,,770957219,FALSE,finalized,5,8/15/15 1:19,"



",no_relation,1,,C076029,"<span class=""chemical"">olanzapine</span>",D009461,"<span class=""disease"">deficit syndrome</span>","Thirty-nine outpatients with schizophrenia and severe negative symptoms were assessed for the presence of the <span class=""disease"">deficit syndrome</span> and entered into a 12-week, open-label study of <span class=""chemical"">olanzapine</span>.",,10831481,10831481_C076029_D009461,10831481_4,bcv_sentence_task_befree_1292,,770957220,FALSE,finalized,5,8/14/15 21:00,"



",no_relation,1,,C076029,"<span class=""chemical"">olanzapine</span>",D012559,"<span class=""disease"">schizophrenia</span>","Thirty-nine outpatients with <span class=""disease"">schizophrenia</span> and severe negative symptoms were assessed for the presence of the deficit syndrome and entered into a 12-week, open-label study of <span class=""chemical"">olanzapine</span>.",,10831481,10831481_C076029_D012559,10831481_4,bcv_sentence_task_befree_1293,,770957221,FALSE,finalized,5,8/14/15 22:02,"



",no_relation,0.8076,,C076029,"<span class=""chemical"">olanzapine</span>",D012559,"<span class=""disease"">schizophrenia</span>","The results of this study suggest that <span class=""chemical"">olanzapine</span> is efficacious for secondary negative symptoms in <span class=""disease"">schizophrenia</span> but fail to support the contention that <span class=""chemical"">olanzapine</span> has a direct beneficial effect on primary negative symptoms.",,10831481,10831481_C076029_D012559,10831481_9,bcv_sentence_task_befree_1294,,770957222,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,0.7928,,D020888,"<span class=""chemical"">vigabatrin</span>",D004827,"<span class=""disease"">epilepsy</span>","Visual impairment in children with <span class=""disease"">epilepsy</span> treated with <span class=""chemical"">vigabatrin</span>.",,10894216,10894216_D020888_D004827,10894216_0,bcv_sentence_task_befree_1295,,770957223,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,0.5941,,D020888,"<span class=""chemical"">vigabatrin</span>",D006311,"<span class=""disease"">Visual impairment</span>","<span class=""disease"">Visual impairment</span> in children with epilepsy treated with <span class=""chemical"">vigabatrin</span>.",,10894216,10894216_D020888_D006311,10894216_0,bcv_sentence_task_befree_1296,,770957224,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,0.7957,,D020888,"<span class=""chemical"">Vigabatrin</span>",D012640,"<span class=""disease"">seizures</span>","<span class=""chemical"">Vigabatrin</span> is an anti-epileptic drug particularly useful for drug-resistant partial <span class=""disease"">seizures</span> and infantile spasms.",,10894216,10894216_D020888_D012640,10894216_1,bcv_sentence_task_befree_1297,,770957225,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,1,,D020888,"<span class=""chemical"">Vigabatrin</span>",D004827,"<span class=""disease"">epileptic</span>","<span class=""chemical"">Vigabatrin</span> is an anti-<span class=""disease"">epileptic</span> drug particularly useful for drug-resistant partial seizures and infantile spasms.",,10894216,10894216_D020888_D004827,10894216_1,bcv_sentence_task_befree_1298,,770957226,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,1,,D020888,"<span class=""chemical"">Vigabatrin</span>",D013035,"<span class=""disease"">spasms</span>","<span class=""chemical"">Vigabatrin</span> is an anti-epileptic drug particularly useful for drug-resistant partial seizures and infantile <span class=""disease"">spasms</span>.",,10894216,10894216_D020888_D013035,10894216_1,bcv_sentence_task_befree_1299,,770957227,FALSE,finalized,5,8/14/15 23:14,"



",yes_direct,0.6074,,D020888,"<span class=""chemical"">vigabatrin</span>",D006311,"<span class=""disease"">visual field constriction/VFC</span>","Recently, <span class=""chemical"">vigabatrin</span>-induced <span class=""disease"">visual field constriction</span> (<span class=""disease"">VFC</span>) and abnormal ocular electrophysiological studies were reported.",,10894216,10894216_D020888_D006311,10894216_2,bcv_sentence_task_befree_1300,,770957228,FALSE,finalized,5,8/14/15 20:53,"



",yes_direct,0.8214,,D020888,"<span class=""chemical"">vigabatrin</span>",D006311,"<span class=""disease"">VFC</span>","In summary, over half of the children treated with <span class=""chemical"">vigabatrin</span> demonstrated <span class=""disease"">VFC</span> or abnormal ocular electrophysiological studies.",,10894216,10894216_D020888_D006311,10894216_9,bcv_sentence_task_befree_1301,,770957229,FALSE,finalized,5,8/15/15 1:45,"



",yes_direct,0.579,,D020888,"<span class=""chemical"">vigabatrin</span>",D064420,"<span class=""disease"">toxicity</span>","Perimetry seemed to be the most sensitive modality for identifying <span class=""chemical"">vigabatrin</span> <span class=""disease"">toxicity</span>.",,10894216,10894216_D020888_D064420,10894216_10,bcv_sentence_task_befree_1302,,770957230,FALSE,finalized,5,8/15/15 0:02,"



",no_relation,0.5964,,D020888,"<span class=""chemical"">vigabatrin</span>",D012640,"<span class=""disease"">seizures</span>","Although the incidence of <span class=""chemical"">vigabatrin</span>-induced VFC is worrisome, in the context of intractable <span class=""disease"">seizures</span> or infantile spasms, therapeutic benefits must be weighed against risks.",,10894216,10894216_D020888_D012640,10894216_12,bcv_sentence_task_befree_1303,,770957231,FALSE,finalized,5,8/14/15 21:00,"



",yes_direct,0.6106,,D020888,"<span class=""chemical"">vigabatrin</span>",D006311,"<span class=""disease"">VFC</span>","Although the incidence of <span class=""chemical"">vigabatrin</span>-induced <span class=""disease"">VFC</span> is worrisome, in the context of intractable seizures or infantile spasms, therapeutic benefits must be weighed against risks.",,10894216,10894216_D020888_D006311,10894216_12,bcv_sentence_task_befree_1304,,770957232,FALSE,finalized,5,8/15/15 1:51,"



",no_relation,0.6194,,D020888,"<span class=""chemical"">vigabatrin</span>",D013035,"<span class=""disease"">spasms</span>","Although the incidence of <span class=""chemical"">vigabatrin</span>-induced VFC is worrisome, in the context of intractable seizures or infantile <span class=""disease"">spasms</span>, therapeutic benefits must be weighed against risks.",,10894216,10894216_D020888_D013035,10894216_12,bcv_sentence_task_befree_1305,,770957233,FALSE,finalized,5,8/15/15 2:42,"



",no_relation,0.805,,D010622,"<span class=""chemical"">PCP</span>",D010623,"<span class=""disease"">PCP</span>","Primary or secondary P. carinii pneumonia prophylaxis was discontinued in 43 patients: 1 first episode of <span class=""chemical""></span><span class=""disease"">PCP</span> occurred after 2 months but no other episode was recorded after a median follow-up of 16 months.",,10896967,10896967_D010622_D010623,10896967_6,bcv_sentence_task_befree_1306,,770957234,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,1,,D010622,"<span class=""chemical"">PCP</span>",D011014,"<span class=""disease"">pneumonia</span>","Primary or secondary P. carinii <span class=""disease"">pneumonia</span> prophylaxis was discontinued in 43 patients: 1 first episode of <span class=""chemical"">PCP</span> occurred after 2 months but no other episode was recorded after a median follow-up of 16 months.",,10896967,10896967_D010622_D011014,10896967_6,bcv_sentence_task_befree_1307,,770957235,FALSE,finalized,5,8/14/15 22:02,"



",no_relation,1,,D005641,"<span class=""chemical"">tegafur</span>",D064420,"<span class=""disease"">toxicity</span>","This study set out to evaluate, in patients with metastatic colorectal carcinoma, the efficacy and <span class=""disease"">toxicity</span> of S-1, which contains <span class=""chemical"">tegafur</span>, 5-chloro-2,4-dihydroxypyridine (CDHP) and potassium oxonate, based on a biochemical modulation of 5-fluorouracil (5-FU) targeted at inhibition of dihydropyrimidine dehydrogenase (DPD).",,10901361,10901361_D005641_D064420,10901361_2,bcv_sentence_task_befree_1308,,770957236,FALSE,finalized,5,8/14/15 23:50,"


No toxicity is actaully claimed.
",no_relation,0.7952,,C104201,"<span class=""chemical"">5-chloro-2,4-dihydroxypyridine</span>",D064420,"<span class=""disease"">toxicity</span>","This study set out to evaluate, in patients with metastatic colorectal carcinoma, the efficacy and <span class=""disease"">toxicity</span> of S-1, which contains tegafur, <span class=""chemical"">5-chloro-2,4-dihydroxypyridine</span> (CDHP) and potassium oxonate, based on a biochemical modulation of 5-fluorouracil (5-FU) targeted at inhibition of dihydropyrimidine dehydrogenase (DPD).",,10901361,10901361_C104201_D064420,10901361_2,bcv_sentence_task_befree_1309,,770957237,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,0.602,,C489337,"<span class=""chemical"">potassium oxonate</span>",D064420,"<span class=""disease"">toxicity</span>","This study set out to evaluate, in patients with metastatic colorectal carcinoma, the efficacy and <span class=""disease"">toxicity</span> of S-1, which contains tegafur, 5-chloro-2,4-dihydroxypyridine (CDHP) and <span class=""chemical"">potassium oxonate</span>, based on a biochemical modulation of 5-fluorouracil (5-FU) targeted at inhibition of dihydropyrimidine dehydrogenase (DPD).",,10901361,10901361_C489337_D064420,10901361_2,bcv_sentence_task_befree_1310,,770957238,FALSE,finalized,5,8/14/15 20:57,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU/5-fluorouracil</span>",D064420,"<span class=""disease"">toxicity</span>","This study set out to evaluate, in patients with metastatic colorectal carcinoma, the efficacy and <span class=""disease"">toxicity</span> of S-1, which contains tegafur, 5-chloro-2,4-dihydroxypyridine (CDHP) and potassium oxonate, based on a biochemical modulation of <span class=""chemical"">5-fluorouracil</span> (<span class=""chemical"">5-FU</span>) targeted at inhibition of dihydropyrimidine dehydrogenase (DPD).",,10901361,10901361_D005472_D064420,10901361_2,bcv_sentence_task_befree_1311,,770957239,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU/5-fluorouracil</span>",D015179,"<span class=""disease"">colorectal carcinoma</span>","This study set out to evaluate, in patients with metastatic <span class=""disease"">colorectal carcinoma</span>, the efficacy and toxicity of S-1, which contains tegafur, 5-chloro-2,4-dihydroxypyridine (CDHP) and potassium oxonate, based on a biochemical modulation of <span class=""chemical"">5-fluorouracil</span> (<span class=""chemical"">5-FU</span>) targeted at inhibition of dihydropyrimidine dehydrogenase (DPD).",,10901361,10901361_D005472_D015179,10901361_2,bcv_sentence_task_befree_1312,,770957240,FALSE,finalized,5,8/14/15 23:48,"



Used as possible treatment.",no_relation,1,,C104201,"<span class=""chemical"">5-chloro-2,4-dihydroxypyridine</span>",D015179,"<span class=""disease"">colorectal carcinoma</span>","This study set out to evaluate, in patients with metastatic <span class=""disease"">colorectal carcinoma</span>, the efficacy and toxicity of S-1, which contains tegafur, <span class=""chemical"">5-chloro-2,4-dihydroxypyridine</span> (CDHP) and potassium oxonate, based on a biochemical modulation of 5-fluorouracil (5-FU) targeted at inhibition of dihydropyrimidine dehydrogenase (DPD).",,10901361,10901361_C104201_D015179,10901361_2,bcv_sentence_task_befree_1313,,770957241,FALSE,finalized,5,8/15/15 2:14,"



",no_relation,1,,C489337,"<span class=""chemical"">potassium oxonate</span>",D015179,"<span class=""disease"">colorectal carcinoma</span>","This study set out to evaluate, in patients with metastatic <span class=""disease"">colorectal carcinoma</span>, the efficacy and toxicity of S-1, which contains tegafur, 5-chloro-2,4-dihydroxypyridine (CDHP) and <span class=""chemical"">potassium oxonate</span>, based on a biochemical modulation of 5-fluorouracil (5-FU) targeted at inhibition of dihydropyrimidine dehydrogenase (DPD).",,10901361,10901361_C489337_D015179,10901361_2,bcv_sentence_task_befree_1314,,770957242,FALSE,finalized,5,8/15/15 0:04,"



",no_relation,0.6111,,D005641,"<span class=""chemical"">tegafur</span>",D015179,"<span class=""disease"">colorectal carcinoma</span>","This study set out to evaluate, in patients with metastatic <span class=""disease"">colorectal carcinoma</span>, the efficacy and toxicity of S-1, which contains <span class=""chemical"">tegafur</span>, 5-chloro-2,4-dihydroxypyridine (CDHP) and potassium oxonate, based on a biochemical modulation of 5-fluorouracil (5-FU) targeted at inhibition of dihydropyrimidine dehydrogenase (DPD).",,10901361,10901361_D005641_D015179,10901361_2,bcv_sentence_task_befree_1315,,770957243,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,D002955,"<span class=""chemical"">leucovorin</span>",D064420,"<span class=""disease"">toxicity</span>","None of the 53 patients treated as outpatients required hospitalization due to adverse reactions: These results suggest that S-1 achieves similar responses to those of infusional 5-FU plus <span class=""chemical"">leucovorin</span> and shows the potential of another biochemical modulation with easily manageable <span class=""disease"">toxicity</span>.",,10901361,10901361_D002955_D064420,10901361_11,bcv_sentence_task_befree_1316,,770957244,FALSE,finalized,5,8/14/15 20:53,"



",no_relation,0.7979,,D005472,"<span class=""chemical"">5-FU</span>",D064420,"<span class=""disease"">toxicity</span>","None of the 53 patients treated as outpatients required hospitalization due to adverse reactions: These results suggest that S-1 achieves similar responses to those of infusional <span class=""chemical"">5-FU</span> plus leucovorin and shows the potential of another biochemical modulation with easily manageable <span class=""disease"">toxicity</span>.",,10901361,10901361_D005472_D064420,10901361_11,bcv_sentence_task_befree_1317,,770957245,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,D010862,"<span class=""chemical"">pilocarpine</span>",D009798,"<span class=""disease"">ocular hypertension</span>","The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and <span class=""chemical"">pilocarpine</span> 2% t.i.d. in patients with open-angle glaucoma or <span class=""disease"">ocular hypertension</span>. a 6-month, randomized, multicenter study.",,10901475,10901475_D010862_D009798,10901475_0,bcv_sentence_task_befree_1318,,770957246,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,1,,D010862,"<span class=""chemical"">pilocarpine</span>",D005902,"<span class=""disease"">open-angle glaucoma</span>","The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and <span class=""chemical"">pilocarpine</span> 2% t.i.d. in patients with <span class=""disease"">open-angle glaucoma</span> or ocular hypertension. a 6-month, randomized, multicenter study.",,10901475,10901475_D010862_D005902,10901475_0,bcv_sentence_task_befree_1319,,770957247,FALSE,finalized,5,8/15/15 0:45,"



",no_relation,1,,D010862,"<span class=""chemical"">pilocarpine</span>",D009798,"<span class=""disease"">ocular hypertension</span>","To compare the additional intraocular pressure-lowering effect of latanoprost 0.005% administered once daily with that of <span class=""chemical"">pilocarpine</span> 2% administered three times daily in patients with primary open-angle glaucoma or <span class=""disease"">ocular hypertension</span> currently on monotherapy with timolol 0.5% twice daily.",,10901475,10901475_D010862_D009798,10901475_2,bcv_sentence_task_befree_1320,,770957248,FALSE,finalized,5,8/14/15 23:51,"



",no_relation,1,,D013999,"<span class=""chemical"">timolol</span>",D005902,"<span class=""disease"">open-angle glaucoma</span>","To compare the additional intraocular pressure-lowering effect of latanoprost 0.005% administered once daily with that of pilocarpine 2% administered three times daily in patients with primary <span class=""disease"">open-angle glaucoma</span> or ocular hypertension currently on monotherapy with <span class=""chemical"">timolol</span> 0.5% twice daily.",,10901475,10901475_D013999_D005902,10901475_2,bcv_sentence_task_befree_1321,,770957249,FALSE,finalized,5,8/15/15 0:11,"



",no_relation,1,,D013999,"<span class=""chemical"">timolol</span>",D009798,"<span class=""disease"">ocular hypertension</span>","To compare the additional intraocular pressure-lowering effect of latanoprost 0.005% administered once daily with that of pilocarpine 2% administered three times daily in patients with primary open-angle glaucoma or <span class=""disease"">ocular hypertension</span> currently on monotherapy with <span class=""chemical"">timolol</span> 0.5% twice daily.",,10901475,10901475_D013999_D009798,10901475_2,bcv_sentence_task_befree_1322,,770957250,FALSE,finalized,5,8/14/15 23:10,"



",no_relation,1,,D010862,"<span class=""chemical"">pilocarpine</span>",D005902,"<span class=""disease"">open-angle glaucoma</span>","To compare the additional intraocular pressure-lowering effect of latanoprost 0.005% administered once daily with that of <span class=""chemical"">pilocarpine</span> 2% administered three times daily in patients with primary <span class=""disease"">open-angle glaucoma</span> or ocular hypertension currently on monotherapy with timolol 0.5% twice daily.",,10901475,10901475_D010862_D005902,10901475_2,bcv_sentence_task_befree_1323,,770957251,FALSE,finalized,5,8/15/15 2:08,"



",no_relation,1,,C031356,"<span class=""chemical"">OH</span>",C562750,"<span class=""disease"">POAG</span>","In a 6-month, multicenter, randomized, open-label study 242 patients with <span class=""disease"">POAG</span> or <span class=""chemical"">OH</span> whose IOP was not controlled with timolol 0.5% b.i.d. were enrolled.",,10901475,10901475_C031356_C562750,10901475_3,bcv_sentence_task_befree_1324,,770957252,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,1,,D013999,"<span class=""chemical"">timolol</span>",C562750,"<span class=""disease"">POAG</span>","In a 6-month, multicenter, randomized, open-label study 242 patients with <span class=""disease"">POAG</span> or OH whose IOP was not controlled with <span class=""chemical"">timolol</span> 0.5% b.i.d. were enrolled.",,10901475,10901475_D013999_C562750,10901475_3,bcv_sentence_task_befree_1325,,770957253,FALSE,finalized,5,8/15/15 1:29,"



",no_relation,0.827,,C012629,"<span class=""chemical"">formoterol fumarate</span>",D013224,"<span class=""disease"">asthmatic</span>","Bronchodilatation effects of dry powder <span class=""chemical"">formoterol fumarate</span> in <span class=""disease"">asthmatic</span> patients.",,10904569,10904569_C012629_D013224,10904569_0,bcv_sentence_task_befree_1326,,770957254,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,1,,C012629,"<span class=""chemical"">formoterol fumarate</span>",D013224,"<span class=""disease"">asthmatic</span>","Ten <span class=""disease"">asthmatic</span> patients were enrolled in our study of the effects of dry powder <span class=""chemical"">formoterol fumarate</span>.",,10904569,10904569_C012629_D013224,10904569_1,bcv_sentence_task_befree_1327,,770957255,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,0.7914,,D011241,"<span class=""chemical"">Prednisone</span>",D020773,"<span class=""disease"">daily headache</span>","<span class=""chemical"">Prednisone</span> as initial treatment of analgesic-induced <span class=""disease"">daily headache</span>.",,10961766,10961766_D011241_D020773,10961766_0,bcv_sentence_task_befree_1328,,770957256,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,0.808,,D011241,"<span class=""chemical"">prednisone</span>",D020773,"<span class=""disease"">daily headache</span>","This study aimed to analyse the possibility of using a short course of oral <span class=""chemical"">prednisone</span> for detoxifying patients with chronic <span class=""disease"">daily headache</span> due to medication overuse in an out-patient setting.",,10961766,10961766_D011241_D020773,10961766_2,bcv_sentence_task_befree_1329,,770957257,FALSE,finalized,5,8/14/15 20:53,"



",no_relation,1,,D011241,"<span class=""chemical"">prednisone</span>",D006261,"<span class=""disease"">rebound headaches</span>","This study demonstrates that it is possible to detoxify patients suffering from <span class=""disease"">rebound headaches</span>, using oral <span class=""chemical"">prednisone</span> during the first days of withdrawal, in an out-patient setting.",,10961766,10961766_D011241_D006261,10961766_10,bcv_sentence_task_befree_1330,,770957258,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,1,,D017963,"<span class=""chemical"">Azithromycin</span>",D001991,"<span class=""disease"">bronchitis</span>","<span class=""chemical"">Azithromycin</span> versus pivampicillin in the treatment of acute exacerbations of chronic <span class=""disease"">bronchitis</span>: a single-blind, double-dummy, multicentre study.",,10983860,10983860_D017963_D001991,10983860_0,bcv_sentence_task_befree_1331,,770957259,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,1,,D010917,"<span class=""chemical"">pivampicillin</span>",D001991,"<span class=""disease"">bronchitis</span>","Azithromycin versus <span class=""chemical"">pivampicillin</span> in the treatment of acute exacerbations of chronic <span class=""disease"">bronchitis</span>: a single-blind, double-dummy, multicentre study.",,10983860,10983860_D010917_D001991,10983860_0,bcv_sentence_task_befree_1332,,770957260,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,1,,D017963,"<span class=""chemical"">azithromycin</span>",D001991,"<span class=""disease"">bronchitis</span>","This single-blind, double-dummy, multicentre study compared oral <span class=""chemical"">azithromycin</span>, administered as tablets, 500 mg once daily for 3 days, versus oral pivampicillin, 700 mg twice daily for 10 days, in adults with acute exacerbations of chronic <span class=""disease"">bronchitis</span> (not needing parenteral antibiotic therapy, hospitalization or oxygen support).",,10983860,10983860_D017963_D001991,10983860_1,bcv_sentence_task_befree_1333,,770957261,FALSE,finalized,5,8/15/15 1:29,"



",no_relation,0.7956,,D010917,"<span class=""chemical"">pivampicillin</span>",D001991,"<span class=""disease"">bronchitis</span>","This single-blind, double-dummy, multicentre study compared oral azithromycin, administered as tablets, 500 mg once daily for 3 days, versus oral <span class=""chemical"">pivampicillin</span>, 700 mg twice daily for 10 days, in adults with acute exacerbations of chronic <span class=""disease"">bronchitis</span> (not needing parenteral antibiotic therapy, hospitalization or oxygen support).",,10983860,10983860_D010917_D001991,10983860_1,bcv_sentence_task_befree_1334,,770957262,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,0.8068,,D010100,"<span class=""chemical"">oxygen</span>",D001991,"<span class=""disease"">bronchitis</span>","This single-blind, double-dummy, multicentre study compared oral azithromycin, administered as tablets, 500 mg once daily for 3 days, versus oral pivampicillin, 700 mg twice daily for 10 days, in adults with acute exacerbations of chronic <span class=""disease"">bronchitis</span> (not needing parenteral antibiotic therapy, hospitalization or <span class=""chemical"">oxygen</span> support).",,10983860,10983860_D010100_D001991,10983860_1,bcv_sentence_task_befree_1335,,770957263,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,D017963,"<span class=""chemical"">azithromycin</span>",D001991,"<span class=""disease"">bronchitis</span>","This oral <span class=""chemical"">azithromycin</span> regime is an effective treatment for acute exacerbations of chronic <span class=""disease"">bronchitis</span>, similar in efficacy to the longer pivampicillin regime and may offer superior patient compliance.",,10983860,10983860_D017963_D001991,10983860_6,bcv_sentence_task_befree_1336,,770957264,FALSE,finalized,5,8/14/15 20:58,"



",no_relation,1,,D010917,"<span class=""chemical"">pivampicillin</span>",D001991,"<span class=""disease"">bronchitis</span>","This oral azithromycin regime is an effective treatment for acute exacerbations of chronic <span class=""disease"">bronchitis</span>, similar in efficacy to the longer <span class=""chemical"">pivampicillin</span> regime and may offer superior patient compliance.",,10983860,10983860_D010917_D001991,10983860_6,bcv_sentence_task_befree_1337,,770957265,FALSE,finalized,5,8/14/15 20:57,"



",yes_direct,0.5991,,D008727,"<span class=""chemical"">methotrexate</span>",D015212,"<span class=""disease"">IBD</span>","There were four cases of NHL in our <span class=""disease"">IBD</span> cohort (SIR 31.2; 95% CI 2.0-85; p=0.0001), all of whom had received immunosuppressive therapy: azathioprine (n=2), <span class=""chemical"">methotrexate</span> (n=1), and <span class=""chemical"">methotrexate</span> and cyclosporin (n=1).",,10986211,10986211_D008727_D015212,10986211_6,bcv_sentence_task_befree_1338,,770957266,FALSE,finalized,5,8/14/15 22:24,"



",no_relation,0.5774,,D016572,"<span class=""chemical"">cyclosporin</span>",D008228,"<span class=""disease"">NHL</span>","There were four cases of <span class=""disease"">NHL</span> in our IBD cohort (SIR 31.2; 95% CI 2.0-85; p=0.0001), all of whom had received immunosuppressive therapy: azathioprine (n=2), methotrexate (n=1), and methotrexate and <span class=""chemical"">cyclosporin</span> (n=1).",,10986211,10986211_D016572_D008228,10986211_6,bcv_sentence_task_befree_1339,,770957267,FALSE,finalized,5,8/15/15 2:57,"



",no_relation,0.784,,D001379,"<span class=""chemical"">azathioprine</span>",D008228,"<span class=""disease"">NHL</span>","There were four cases of <span class=""disease"">NHL</span> in our IBD cohort (SIR 31.2; 95% CI 2.0-85; p=0.0001), all of whom had received immunosuppressive therapy: <span class=""chemical"">azathioprine</span> (n=2), methotrexate (n=1), and methotrexate and cyclosporin (n=1).",,10986211,10986211_D001379_D008228,10986211_6,bcv_sentence_task_befree_1340,,770957268,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,0.5976,,D008727,"<span class=""chemical"">methotrexate</span>",D008228,"<span class=""disease"">NHL</span>","There were four cases of <span class=""disease"">NHL</span> in our IBD cohort (SIR 31.2; 95% CI 2.0-85; p=0.0001), all of whom had received immunosuppressive therapy: azathioprine (n=2), <span class=""chemical"">methotrexate</span> (n=1), and <span class=""chemical"">methotrexate</span> and cyclosporin (n=1).",,10986211,10986211_D008727_D008228,10986211_6,bcv_sentence_task_befree_1341,,770957269,FALSE,finalized,5,8/14/15 21:06,"



",yes_direct,0.6236,,D001379,"<span class=""chemical"">azathioprine</span>",D015212,"<span class=""disease"">IBD</span>","There were four cases of NHL in our <span class=""disease"">IBD</span> cohort (SIR 31.2; 95% CI 2.0-85; p=0.0001), all of whom had received immunosuppressive therapy: <span class=""chemical"">azathioprine</span> (n=2), methotrexate (n=1), and methotrexate and cyclosporin (n=1).",,10986211,10986211_D001379_D015212,10986211_6,bcv_sentence_task_befree_1342,,770957270,FALSE,finalized,5,8/15/15 1:45,"



",no_relation,0.8062,,D016572,"<span class=""chemical"">cyclosporin</span>",D015212,"<span class=""disease"">IBD</span>","There were four cases of NHL in our <span class=""disease"">IBD</span> cohort (SIR 31.2; 95% CI 2.0-85; p=0.0001), all of whom had received immunosuppressive therapy: azathioprine (n=2), methotrexate (n=1), and methotrexate and <span class=""chemical"">cyclosporin</span> (n=1).",,10986211,10986211_D016572_D015212,10986211_6,bcv_sentence_task_befree_1343,,770957271,FALSE,finalized,5,8/15/15 0:22,"



",no_relation,1,,C085665,"<span class=""chemical"">Zaleplon</span>",D007319,"<span class=""disease"">insomnia</span>","<span class=""chemical"">Zaleplon</span> - a review of a novel sedative hypnotic used in the treatment of <span class=""disease"">insomnia</span>.",,11060714,11060714_C085665_D007319,11060714_0,bcv_sentence_task_befree_1344,,770957272,FALSE,finalized,5,8/14/15 21:00,"



",yes_direct,0.8034,,D013331,"<span class=""chemical"">strychnine</span>",D012640,"<span class=""disease"">convulsions</span>","The compound is also reported to be active against <span class=""disease"">convulsions</span> induced by bicuculline, picrotoxin and <span class=""chemical"">strychnine</span>.",,11060714,11060714_D013331_D012640,11060714_8,bcv_sentence_task_befree_1345,,770957273,FALSE,finalized,5,8/14/15 20:58,"



",yes_direct,1,,D010852,"<span class=""chemical"">picrotoxin</span>",D012640,"<span class=""disease"">convulsions</span>","The compound is also reported to be active against <span class=""disease"">convulsions</span> induced by bicuculline, <span class=""chemical"">picrotoxin</span> and strychnine.",,11060714,11060714_D010852_D012640,11060714_8,bcv_sentence_task_befree_1346,,770957274,FALSE,finalized,5,8/15/15 1:03,"



",yes_direct,1,,D001640,"<span class=""chemical"">bicuculline</span>",D012640,"<span class=""disease"">convulsions</span>","The compound is also reported to be active against <span class=""disease"">convulsions</span> induced by <span class=""chemical"">bicuculline</span>, picrotoxin and strychnine.",,11060714,11060714_D001640_D012640,11060714_8,bcv_sentence_task_befree_1347,,770957275,FALSE,finalized,5,8/14/15 20:57,"



",yes_direct,1,,C085665,"<span class=""chemical"">zaleplon</span>",D012893,"<span class=""disease"">reduction in sleep latency</span>","Results from Phase II/III studies suggest that <span class=""chemical"">zaleplon</span> (5 - 20 mg) produces a dose-dependent <span class=""disease"">reduction in sleep latency</span> in patients suffering from primary insomnia.",,11060714,11060714_C085665_D012893,11060714_18,bcv_sentence_task_befree_1348,,770957276,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,0.8125,,C085665,"<span class=""chemical"">zaleplon</span>",D007319,"<span class=""disease"">primary insomnia</span>","Results from Phase II/III studies suggest that <span class=""chemical"">zaleplon</span> (5 - 20 mg) produces a dose-dependent reduction in sleep latency in patients suffering from <span class=""disease"">primary insomnia</span>.",,11060714,11060714_C085665_D007319,11060714_18,bcv_sentence_task_befree_1349,,770957277,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,0.8178,,D014229,"<span class=""chemical"">triazolam</span>",D019966,"<span class=""disease"">drug abuse</span>","The clinical efficacy of zaleplon persists for at least four weeks at doses of 10 mg and 20 mg. Studies in patients with a history of <span class=""disease"">drug abuse</span> suggest that the abuse potential of zaleplon (at doses above the therapeutic dose range) is similar to that seen with the benzodiazepine <span class=""chemical"">triazolam</span>.",,11060714,11060714_D014229_D019966,11060714_19,bcv_sentence_task_befree_1350,,770957278,FALSE,finalized,5,8/14/15 22:56,"



",no_relation,0.6286,,D001569,"<span class=""chemical"">benzodiazepine</span>",D019966,"<span class=""disease"">drug abuse</span>","The clinical efficacy of zaleplon persists for at least four weeks at doses of 10 mg and 20 mg. Studies in patients with a history of <span class=""disease"">drug abuse</span> suggest that the abuse potential of zaleplon (at doses above the therapeutic dose range) is similar to that seen with the <span class=""chemical"">benzodiazepine</span> triazolam.",,11060714,11060714_D001569_D019966,11060714_19,bcv_sentence_task_befree_1351,,770957279,FALSE,finalized,5,8/14/15 22:18,"



",no_relation,0.5763,,C085665,"<span class=""chemical"">zaleplon</span>",D019966,"<span class=""disease"">drug abuse</span>","The clinical efficacy of zaleplon persists for at least four weeks at doses of 10 mg and 20 mg. Studies in patients with a history of <span class=""disease"">drug abuse</span> suggest that the abuse potential of <span class=""chemical"">zaleplon</span> (at doses above the therapeutic dose range) is similar to that seen with the benzodiazepine triazolam.",,11060714,11060714_C085665_D019966,11060714_19,bcv_sentence_task_befree_1352,,770957280,FALSE,finalized,5,8/15/15 1:47,"



",yes_direct,0.8095,,D000109,"<span class=""chemical"">acetylcholine</span>",D013035,"<span class=""disease"">spasm</span>","Major complications during <span class=""disease"">spasm</span> provocation tests with an intracoronary injection of <span class=""chemical"">acetylcholine</span>.",,11078314,11078314_D000109_D013035,11078314_0,bcv_sentence_task_befree_1353,,770957281,FALSE,finalized,5,8/14/15 20:57,"



",yes_direct,1,,D000109,"<span class=""chemical"">acetylcholine</span>",D013035,"<span class=""disease"">spasm</span>","The <span class=""disease"">spasm</span> provocation test using <span class=""chemical"">acetylcholine</span> should be performed carefully, although it is considered a safe and reliable method.",,11078314,11078314_D000109_D013035,11078314_3,bcv_sentence_task_befree_1354,,770957282,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D003876,"<span class=""disease"">atopic dermatitis</span>","The number of patients with <span class=""disease"">atopic dermatitis</span> who refuse to use topical <span class=""chemical"">corticosteroids</span> because of personal fears seems to be increasing.",,11096196,11096196_D000305_D003876,11096196_1,bcv_sentence_task_befree_1355,,770957283,FALSE,finalized,5,8/14/15 20:54,"



",no_relation,1,,D004656,"<span class=""chemical"">enalapril</span>",D006333,"<span class=""disease"">congestive heart failure</span>","Outcome of patients with <span class=""disease"">congestive heart failure</span> treated with standard versus high doses of <span class=""chemical"">enalapril</span>: a multicenter study.",,11127445,11127445_D004656_D006333,11127445_0,bcv_sentence_task_befree_1356,,770957284,FALSE,finalized,5,8/14/15 20:57,"



",no_relation,0.8123,,D004656,"<span class=""chemical"">enalapril</span>",D006333,"<span class=""disease"">CHF/congestive heart failure</span>","We sought to prospectively and randomly compare survival with clinical and hemodynamic variables in patients with <span class=""disease"">congestive heart failure</span> (<span class=""disease"">CHF</span>) treated with standard versus high doses of <span class=""chemical"">enalapril</span>.",,11127445,11127445_D004656_D006333,11127445_2,bcv_sentence_task_befree_1357,,770957285,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,D000809,"<span class=""chemical"">Angiotensin</span>",D006333,"<span class=""disease"">CHF</span>","<span class=""chemical"">Angiotensin</span>-converting enzyme (ACE) inhibitors produce hemodynamic and symptomatic benefits in patients with <span class=""disease"">CHF</span>, but there is still controversy about the optimal dose in this clinical setting.",,11127445,11127445_D000809_D006333,11127445_3,bcv_sentence_task_befree_1358,,770957286,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,D004656,"<span class=""chemical"">enalapril</span>",D006333,"<span class=""disease"">CHF</span>","Two hundred and forty-eight patients with advanced <span class=""disease"">CHF</span> (age 56.3+/-12 years) were randomized to receive a maximal tolerated dose of <span class=""chemical"">enalapril</span>, up to 20 mg/day in group 1 (mean dose achieved 17.9+/-4.3 mg/day, n = 122) and 60 mg/day in group 2 (mean dose achieved 42+/-19.3 mg/day, n = 126).",,11127445,11127445_D004656_D006333,11127445_4,bcv_sentence_task_befree_1359,,770957287,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D000961,"<span class=""chemical"">antithymocyte globulin</span>",D000741,"<span class=""disease"">aplastic anemia</span>","Four patients with <span class=""disease"">aplastic anemia</span> received intravenous <span class=""chemical"">antithymocyte globulin</span> (ATG) or antilymphocyte globulin (ALG).",,11144443,11144443_D000961_D000741,11144443_12,bcv_sentence_task_befree_1360,,770957288,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,0.8138,,D000961,"<span class=""chemical"">ATG</span>",D000741,"<span class=""disease"">aplastic anemia</span>","Four did not receive <span class=""chemical"">ATG</span>/ALG, two had <span class=""disease"">aplastic anemia</span>, and two had bone marrow suppression.",,11144443,11144443_D000961_D000741,11144443_15,bcv_sentence_task_befree_1361,,770957289,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,0.8043,,D000961,"<span class=""chemical"">ATG</span>",D001855,"<span class=""disease"">bone marrow suppression</span>","Four did not receive <span class=""chemical"">ATG</span>/ALG, two had aplastic anemia, and two had <span class=""disease"">bone marrow suppression</span>.",,11144443,11144443_D000961_D001855,11144443_15,bcv_sentence_task_befree_1362,,770957290,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,D016572,"<span class=""chemical"">cyclosporine</span>",D064420,"<span class=""disease"">toxicity</span>","Although one large randomized study has demonstrated a proven survival advantage without increased <span class=""disease"">toxicity</span> using <span class=""chemical"">cyclosporine</span>, the inconsistent results with other modulators raise doubt as to the utility and overall strategy of using drug efflux blockers in patients with established Pgp overexpression.",,11148681,11148681_D016572_D064420,11148681_8,bcv_sentence_task_befree_1363,,770957291,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,1,,D014807,"<span class=""chemical"">vitamin D</span>",D009369,"<span class=""disease"">breast cancer</span>","Interactions of <span class=""chemical"">vitamin D</span> analogue CB1093, TNFalpha and ceramide on <span class=""disease"">breast cancer</span> cell apoptosis.",,11165041,11165041_D014807_D009369,11165041_0,bcv_sentence_task_befree_1364,,770957292,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,0.807,,C103436,"<span class=""chemical"">CB1093</span>",D009369,"<span class=""disease"">breast cancer</span>","Interactions of vitamin D analogue <span class=""chemical"">CB1093</span>, TNFalpha and ceramide on <span class=""disease"">breast cancer</span> cell apoptosis.",,11165041,11165041_C103436_D009369,11165041_0,bcv_sentence_task_befree_1365,,770957293,FALSE,finalized,5,8/14/15 21:08,"



",no_relation,0.8255,,D014807,"<span class=""chemical"">vitamin D</span>",D009369,"<span class=""disease"">tumour</span>","Mechanisms by which <span class=""chemical"">vitamin D</span> analogues promote apoptosis in <span class=""disease"">tumour</span> cells are unclear.",,11165041,11165041_D014807_D009369,11165041_1,bcv_sentence_task_befree_1366,,770957294,FALSE,finalized,5,8/15/15 1:44,"



",no_relation,1,,D014807,"<span class=""chemical"">vitamin D</span>",D009369,"<span class=""disease"">breast cancer</span>","In this study we have examined possible interactions between the synthetic <span class=""chemical"">vitamin D</span> analogue CB1093 and two other known mediators of apoptosis, TNFalpha and ceramide, in MCF-7, T47D and Hs578T <span class=""disease"">breast cancer</span> cells.",,11165041,11165041_D014807_D009369,11165041_2,bcv_sentence_task_befree_1367,,770957295,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,0.8065,,C103436,"<span class=""chemical"">CB1093</span>",D009369,"<span class=""disease"">breast cancer</span>","In this study we have examined possible interactions between the synthetic vitamin D analogue <span class=""chemical"">CB1093</span> and two other known mediators of apoptosis, TNFalpha and ceramide, in MCF-7, T47D and Hs578T <span class=""disease"">breast cancer</span> cells.",,11165041,11165041_C103436_D009369,11165041_2,bcv_sentence_task_befree_1368,,770957296,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,1,,D014807,"<span class=""chemical"">vitamin D</span>",D009369,"<span class=""disease"">breast cancer</span>","These results indicate that CB1093 potentiates responsiveness of <span class=""disease"">breast cancer</span> cells to TNFalpha and suggest that ceramide and/or cPLA(2) might be involved as downstream effectors in <span class=""chemical"">vitamin D</span>-mediated caspase-independent cell death.",,11165041,11165041_D014807_D009369,11165041_10,bcv_sentence_task_befree_1369,,770957297,FALSE,finalized,5,8/14/15 21:00,"



",yes_direct,0.6309,,C103436,"<span class=""chemical"">CB1093</span>",D009369,"<span class=""disease"">breast cancer</span>","These results indicate that <span class=""chemical"">CB1093</span> potentiates responsiveness of <span class=""disease"">breast cancer</span> cells to TNFalpha and suggest that ceramide and/or cPLA(2) might be involved as downstream effectors in vitamin D-mediated caspase-independent cell death.",,11165041,11165041_C103436_D009369,11165041_10,bcv_sentence_task_befree_1370,,770957298,FALSE,finalized,5,8/15/15 2:01,"



",no_relation,1,,D002701,"<span class=""chemical"">chloramphenicol</span>",D007239,"<span class=""disease"">infections</span>","Sometimes penicillin G and <span class=""chemical"">chloramphenicol</span> were used successfully in some anaerobic <span class=""disease"">infections</span>.",,11178339,11178339_D002701_D007239,11178339_2,bcv_sentence_task_befree_1371,,770957299,FALSE,finalized,5,8/14/15 20:58,"



",no_relation,1,,D010400,"<span class=""chemical"">penicillin G</span>",D007239,"<span class=""disease"">infections</span>","Sometimes <span class=""chemical"">penicillin G</span> and chloramphenicol were used successfully in some anaerobic <span class=""disease"">infections</span>.",,11178339,11178339_D010400_D007239,11178339_2,bcv_sentence_task_befree_1372,,770957300,FALSE,finalized,5,8/14/15 23:31,"



",no_relation,1,,D007501,"<span class=""chemical"">Iron</span>",D001265,"<span class=""disease"">athletes</span>","<span class=""chemical"">Iron</span> status in female endurance <span class=""disease"">athletes</span> and in non-<span class=""disease"">athletes</span>.",,11183845,11183845_D007501_D001265,11183845_0,bcv_sentence_task_befree_1373,,770957301,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,1,,D007501,"<span class=""chemical"">Iron</span>",D001265,"<span class=""disease"">athletes</span>","<span class=""chemical"">Iron</span> status was studied in 126 female endurance <span class=""disease"">athletes</span> and 52 control subjects, all aged 16-20 years.",,11183845,11183845_D007501_D001265,11183845_1,bcv_sentence_task_befree_1374,,770957302,FALSE,finalized,5,8/14/15 23:19,"


Iron cures iron-deficiency.
",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D018798,"<span class=""disease"">iron deficiency</span>","The study aimed at identifying factors responsible for <span class=""chemical""></span><span class=""disease"">iron</span> deficiency.",,11183845,11183845_D007501_D018798,11183845_2,bcv_sentence_task_befree_1375,,770957303,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,0.8,,D007501,"<span class=""chemical"">iron</span>",D000740,"<span class=""disease"">anemia</span>","Twenty-six percent of athletes and 50% of controls had latent <span class=""chemical"">iron</span>-deficiency without <span class=""disease"">anemia</span> symptoms.",,11183845,11183845_D007501_D000740,11183845_3,bcv_sentence_task_befree_1376,,770957304,FALSE,finalized,5,8/15/15 0:46,"
Athletes is not a Disease.


",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D001265,"<span class=""disease"">athletes</span>","Twenty-six percent of <span class=""disease"">athletes</span> and 50% of controls had latent <span class=""chemical"">iron</span>-deficiency without anemia symptoms.",,11183845,11183845_D007501_D001265,11183845_3,bcv_sentence_task_befree_1377,,770957305,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D018798,"<span class=""disease"">iron-deficiency</span>","Twenty-six percent of athletes and 50% of controls had latent <span class=""chemical""></span><span class=""disease"">iron</span>-deficiency without anemia symptoms.",,11183845,11183845_D007501_D018798,11183845_3,bcv_sentence_task_befree_1378,,770957306,FALSE,finalized,5,8/14/15 23:14,"



",yes_direct,0.5925,,D007501,"<span class=""chemical"">iron</span>",D018798,"<span class=""disease"">iron deficiency</span>","A too low intake of <span class=""chemical"">iron</span> (especially heme <span class=""chemical"">iron</span>: 0.3 mg daily), and of nutrients influencing <span class=""chemical"">iron</span> metabolism, were identified as main causes of <span class=""chemical""></span><span class=""disease"">iron</span> deficiency in control subjects.",,11183845,11183845_D007501_D018798,11183845_4,bcv_sentence_task_befree_1379,,770957307,FALSE,finalized,5,8/14/15 20:58,"



",no_relation,0.619,,D006418,"<span class=""chemical"">heme</span>",D018798,"<span class=""disease"">iron deficiency</span>","A too low intake of iron (especially <span class=""chemical"">heme</span> iron: 0.3 mg daily), and of nutrients influencing iron metabolism, were identified as main causes of <span class=""disease"">iron deficiency</span> in control subjects.",,11183845,11183845_D006418_D018798,11183845_4,bcv_sentence_task_befree_1380,,770957308,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D018798,"<span class=""disease"">iron deficiency</span>","In athletes, whose <span class=""chemical"">iron</span> intake was sufficient (14.6 mg), the principal cause of <span class=""chemical""></span><span class=""disease"">iron</span> deficiency were blood losses due to menstruation.",,11183845,11183845_D007501_D018798,11183845_5,bcv_sentence_task_befree_1381,,770957309,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D001265,"<span class=""disease"">athletes</span>","In <span class=""disease"">athletes</span>, whose <span class=""chemical"">iron</span> intake was sufficient (14.6 mg), the principal cause of <span class=""chemical"">iron</span> deficiency were blood losses due to menstruation.",,11183845,11183845_D007501_D001265,11183845_5,bcv_sentence_task_befree_1382,,770957310,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D019106,"<span class=""disease"">blood losses</span>","In athletes, whose <span class=""chemical"">iron</span> intake was sufficient (14.6 mg), the principal cause of <span class=""chemical"">iron</span> deficiency were <span class=""disease"">blood losses</span> due to menstruation.",,11183845,11183845_D007501_D019106,11183845_5,bcv_sentence_task_befree_1383,,770957311,FALSE,finalized,5,8/15/15 1:39,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D018798,"<span class=""disease"">iron deficiency</span>","High level of physical activity, expressed as training volume and experience, did not adversely affect <span class=""chemical"">iron</span> stores, as these were higher than in control subjects and the incidence of <span class=""chemical""></span><span class=""disease"">iron</span> deficiency was much lower than in the control group.",,11183845,11183845_D007501_D018798,11183845_6,bcv_sentence_task_befree_1384,,770957312,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D001265,"<span class=""disease"">athletes</span>","It was concluded that an increased intake of <span class=""chemical"">iron</span> and of dietary factors involved in <span class=""chemical"">iron</span> metabolism prevented possible exercise-induced losses of <span class=""chemical"">iron</span> in young <span class=""disease"">athletes</span>.",,11183845,11183845_D007501_D001265,11183845_7,bcv_sentence_task_befree_1385,,770957313,FALSE,finalized,5,8/15/15 0:12,"



",yes_direct,1,,D004155,"<span class=""chemical"">diphenhydramine</span>",D064420,"<span class=""disease"">toxicity</span>","Dose-dependent <span class=""disease"">toxicity</span> of <span class=""chemical"">diphenhydramine</span> overdose.",,11204550,11204550_D004155_D064420,11204550_0,bcv_sentence_task_befree_1386,,770957314,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,0.5773,,D004155,"<span class=""chemical"">diphenhydramine</span>",D062787,"<span class=""disease"">overdose</span>","Dose-dependent toxicity of <span class=""chemical"">diphenhydramine</span> <span class=""disease"">overdose</span>.",,11204550,11204550_D004155_D062787,11204550_0,bcv_sentence_task_befree_1387,,770957315,FALSE,finalized,5,8/14/15 23:08,"



",no_relation,0.8143,,D004155,"<span class=""chemical"">Diphenhydramine/DPHM</span>",D062787,"<span class=""disease"">overdose</span>","<span class=""chemical"">Diphenhydramine</span> (<span class=""chemical"">DPHM</span>) <span class=""disease"">overdose</span> is a frequent cause of acute poisoning.",,11204550,11204550_D004155_D062787,11204550_1,bcv_sentence_task_befree_1388,,770957316,FALSE,finalized,5,8/14/15 21:02,"



",yes_direct,1,,D004155,"<span class=""chemical"">Diphenhydramine/DPHM</span>",D011041,"<span class=""disease"">poisoning</span>","<span class=""chemical"">Diphenhydramine</span> (<span class=""chemical"">DPHM</span>) overdose is a frequent cause of acute <span class=""disease"">poisoning</span>.",,11204550,11204550_D004155_D011041,11204550_1,bcv_sentence_task_befree_1389,,770957317,FALSE,finalized,5,8/14/15 21:08,"



",no_relation,0.5971,,D004155,"<span class=""chemical"">DPHM</span>",D064420,"<span class=""disease"">toxicity</span>","Although its clinical features are well known, information about the dose-dependent <span class=""disease"">toxicity</span> of <span class=""chemical"">DPHM</span> is still scarce.",,11204550,11204550_D004155_D064420,11204550_2,bcv_sentence_task_befree_1390,,770957318,FALSE,finalized,5,8/14/15 21:00,"



",no_relation,0.5825,,D004155,"<span class=""chemical"">DPHM</span>",D064420,"<span class=""disease"">toxicity</span>","The objective of this study was to investigate the dose-dependent <span class=""disease"">toxicity</span> of <span class=""chemical"">DPHM</span> in patients with acute <span class=""chemical"">DPHM</span> poisoning.",,11204550,11204550_D004155_D064420,11204550_3,bcv_sentence_task_befree_1391,,770957319,FALSE,finalized,5,8/14/15 23:02,"



",yes_direct,0.6121,,D004155,"<span class=""chemical"">DPHM</span>",D011041,"<span class=""disease"">poisoning</span>","The objective of this study was to investigate the dose-dependent toxicity of <span class=""chemical"">DPHM</span> in patients with acute <span class=""chemical"">DPHM</span> <span class=""disease"">poisoning</span>.",,11204550,11204550_D004155_D011041,11204550_3,bcv_sentence_task_befree_1392,,770957320,FALSE,finalized,5,8/15/15 2:25,"



",yes_direct,0.7873,,D004155,"<span class=""chemical"">DPHM</span>",D064420,"<span class=""disease"">toxicity</span>","These data demonstrate a clear dose-dependent acute <span class=""disease"">toxicity</span> of <span class=""chemical"">DPHM</span>.",,11204550,11204550_D004155_D064420,11204550_11,bcv_sentence_task_befree_1393,,770957321,FALSE,finalized,5,8/14/15 21:08,"



",yes_direct,0.6046,,D004155,"<span class=""chemical"">DPHM</span>",D062787,"<span class=""disease"">overdose</span>","Thus, the results contribute to the data basis required for a cost effective management of patients with <span class=""chemical"">DPHM</span> <span class=""disease"">overdose</span>.",,11204550,11204550_D004155_D062787,11204550_13,bcv_sentence_task_befree_1394,,770957322,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,C089995,"<span class=""chemical"">Glatiramer acetate</span>",D009103,"<span class=""disease"">MS</span>","<span class=""chemical"">Glatiramer acetate</span> is a drug recently approved for the treatment of <span class=""disease"">MS</span>. We therefore investigated the effect of <span class=""chemical"">glatiramer acetate</span> on RANTES expression in glial cells in vitro.",,11223159,11223159_C089995_D009103,11223159_2,bcv_sentence_task_befree_1395,,770957323,FALSE,finalized,5,8/15/15 0:52,"



",no_relation,0.812,,C089995,"<span class=""chemical"">glatiramer acetate</span>",D004194,"<span class=""disease"">diseases</span>","Our results suggest that <span class=""chemical"">glatiramer acetate</span> may inhibit IL-1beta-stimulated RANTES expression in human glial cells by blocking NF-kappaB activation, thus identifying part of the molecular basis for its anti-inflammatory and immunosuppressive effects in demyelinating <span class=""disease"">diseases</span>.",,11223159,11223159_C089995_D004194,11223159_9,bcv_sentence_task_befree_1396,,770957324,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D002289,"<span class=""disease"">non-small-cell lung cancer</span>","Duration of chemotherapy in advanced <span class=""disease"">non-small-cell lung cancer</span>: a randomized trial of three versus six courses of mitomycin, vinblastine, and <span class=""chemical"">cisplatin</span>.",,11230476,11230476_D002945_D002289,11230476_0,bcv_sentence_task_befree_1397,,770957325,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,D016685,"<span class=""chemical"">mitomycin</span>",D002289,"<span class=""disease"">non-small-cell lung cancer</span>","Duration of chemotherapy in advanced <span class=""disease"">non-small-cell lung cancer</span>: a randomized trial of three versus six courses of <span class=""chemical"">mitomycin</span>, vinblastine, and cisplatin.",,11230476,11230476_D016685_D002289,11230476_0,bcv_sentence_task_befree_1398,,770957326,FALSE,finalized,5,8/15/15 1:33,"



",no_relation,1,,D014747,"<span class=""chemical"">vinblastine</span>",D002289,"<span class=""disease"">non-small-cell lung cancer</span>","Duration of chemotherapy in advanced <span class=""disease"">non-small-cell lung cancer</span>: a randomized trial of three versus six courses of mitomycin, <span class=""chemical"">vinblastine</span>, and cisplatin.",,11230476,11230476_D014747_D002289,11230476_0,bcv_sentence_task_befree_1399,,770957327,FALSE,finalized,5,8/15/15 1:39,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D002289,"<span class=""disease"">NSCLC</span>","Patients with stage IIIb or IV <span class=""disease"">NSCLC</span> were randomized at start of treatment to receive either three or six courses of mitomycin 8 mg/m(2) (courses 1, 2, 4, and 6), vinblastine 6 mg/m(2), and <span class=""chemical"">cisplatin</span> 50 mg/m(2) (MVP) every 21 days.",,11230476,11230476_D002945_D002289,11230476_3,bcv_sentence_task_befree_1400,,770957328,FALSE,finalized,5,8/14/15 22:58,"



Used as treatment.",no_relation,1,,D016685,"<span class=""chemical"">mitomycin</span>",D002289,"<span class=""disease"">NSCLC</span>","Patients with stage IIIb or IV <span class=""disease"">NSCLC</span> were randomized at start of treatment to receive either three or six courses of <span class=""chemical"">mitomycin</span> 8 mg/m(2) (courses 1, 2, 4, and 6), vinblastine 6 mg/m(2), and cisplatin 50 mg/m(2) (MVP) every 21 days.",,11230476,11230476_D016685_D002289,11230476_3,bcv_sentence_task_befree_1401,,770957329,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,1,,D014747,"<span class=""chemical"">vinblastine</span>",D002289,"<span class=""disease"">NSCLC</span>","Patients with stage IIIb or IV <span class=""disease"">NSCLC</span> were randomized at start of treatment to receive either three or six courses of mitomycin 8 mg/m(2) (courses 1, 2, 4, and 6), <span class=""chemical"">vinblastine</span> 6 mg/m(2), and cisplatin 50 mg/m(2) (MVP) every 21 days.",,11230476,11230476_D014747_D002289,11230476_3,bcv_sentence_task_befree_1402,,770957330,FALSE,finalized,5,8/14/15 21:00,"



",no_relation,0.5988,,C108830,"<span class=""chemical"">Y-27632</span>",D009362,"<span class=""disease"">metastasis</span>","Inhibition of intrahepatic <span class=""disease"">metastasis</span> of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor <span class=""chemical"">Y-27632</span>.",,11230737,11230737_C108830_D009362,11230737_0,bcv_sentence_task_befree_1403,,770957331,FALSE,finalized,5,8/14/15 21:44,"



",no_relation,0.601,,C108830,"<span class=""chemical"">Y-27632</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","Inhibition of intrahepatic metastasis of human <span class=""disease"">hepatocellular carcinoma</span> by Rho-associated protein kinase inhibitor <span class=""chemical"">Y-27632</span>.",,11230737,11230737_C108830_D006528,11230737_0,bcv_sentence_task_befree_1404,,770957332,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,C108830,"<span class=""chemical"">Y-27632</span>",D009362,"<span class=""disease"">metastasis</span>","To investigate whether the specific p160ROCK inhibitor, <span class=""chemical"">Y-27632</span>, could also inhibit intrahepatic <span class=""disease"">metastasis</span>, the effect of <span class=""chemical"">Y-27632</span> on the cell motility and intrahepatic <span class=""disease"">metastasis</span> of Li7 was investigated.",,11230737,11230737_C108830_D009362,11230737_4,bcv_sentence_task_befree_1405,,770957333,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,1,,C108830,"<span class=""chemical"">Y-27632</span>",D016511,"<span class=""disease"">SCID</span>","<span class=""chemical"">Y-27632</span> was administered continuously into the peritoneal cavity using a micro-osmotic pump, together with orthotopic implantation of Li7 cells into the liver of <span class=""disease"">SCID</span> mice.",,11230737,11230737_C108830_D016511,11230737_6,bcv_sentence_task_befree_1406,,770957334,FALSE,finalized,5,8/14/15 21:06,"



",no_relation,1,,C108830,"<span class=""chemical"">Y-27632</span>",D009369,"<span class=""disease"">tumor</span>","The primary <span class=""disease"">tumor</span> volume at the site of injection was smaller in the <span class=""chemical"">Y-27632</span>-treated group compared with the control group, but the difference was not statistically significant.",,11230737,11230737_C108830_D009369,11230737_9,bcv_sentence_task_befree_1407,,770957335,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,0.7969,,C108830,"<span class=""chemical"">Y-27632</span>",D009369,"<span class=""disease"">tumor/tumors</span>","Histologically, control <span class=""disease"">tumors</span> showed infiltrative growth into the sinusoidal area at the <span class=""disease"">tumor</span> boundary, whereas <span class=""chemical"">Y-27632</span>-treated <span class=""disease"">tumors</span> showed expansive growth and low invasiveness.",,11230737,11230737_C108830_D009369,11230737_10,bcv_sentence_task_befree_1408,,770957336,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,C108830,"<span class=""chemical"">Y-27632</span>",D009362,"<span class=""disease"">metastasis</span>","These findings confirm the importance of the Rho/p160ROCK signaling pathway in intrahepatic <span class=""disease"">metastasis</span> of human HCC, and indicate that <span class=""chemical"">Y-27632</span> may be useful for the prevention of intrahepatic <span class=""disease"">metastasis</span> of human HCC.",,11230737,11230737_C108830_D009362,11230737_11,bcv_sentence_task_befree_1409,,770957337,FALSE,finalized,5,8/15/15 1:51,"



",no_relation,1,,C108830,"<span class=""chemical"">Y-27632</span>",D006528,"<span class=""disease"">HCC</span>","These findings confirm the importance of the Rho/p160ROCK signaling pathway in intrahepatic metastasis of human <span class=""disease"">HCC</span>, and indicate that <span class=""chemical"">Y-27632</span> may be useful for the prevention of intrahepatic metastasis of human <span class=""disease"">HCC</span>.",,11230737,11230737_C108830_D006528,11230737_11,bcv_sentence_task_befree_1410,,770957338,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D008545,"<span class=""disease"">melanoma</span>","We investigated survival of two kinds of human embryonic cells (CLV102, Lu106) and human <span class=""disease"">melanoma</span> cells (Mel8) exposed to exogenous <span class=""chemical"">iron</span> and copper ions in the absence or in the presence of ascorbic acid, catalase and superoxide dismutase.",,11243246,11243246_D007501_D008545,11243246_1,bcv_sentence_task_befree_1411,,770957339,FALSE,finalized,5,8/14/15 20:58,"



",no_relation,1,,D013481,"<span class=""chemical"">superoxide</span>",D008545,"<span class=""disease"">melanoma</span>","We investigated survival of two kinds of human embryonic cells (CLV102, Lu106) and human <span class=""disease"">melanoma</span> cells (Mel8) exposed to exogenous iron and copper ions in the absence or in the presence of ascorbic acid, catalase and <span class=""chemical"">superoxide</span> dismutase.",,11243246,11243246_D013481_D008545,11243246_1,bcv_sentence_task_befree_1412,,770957340,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,0.813,,D001205,"<span class=""chemical"">ascorbic acid</span>",D008545,"<span class=""disease"">melanoma</span>","We investigated survival of two kinds of human embryonic cells (CLV102, Lu106) and human <span class=""disease"">melanoma</span> cells (Mel8) exposed to exogenous iron and copper ions in the absence or in the presence of <span class=""chemical"">ascorbic acid</span>, catalase and superoxide dismutase.",,11243246,11243246_D001205_D008545,11243246_1,bcv_sentence_task_befree_1413,,770957341,FALSE,finalized,5,8/14/15 20:56,"



",no_relation,1,,D003300,"<span class=""chemical"">copper</span>",D008545,"<span class=""disease"">melanoma</span>","We investigated survival of two kinds of human embryonic cells (CLV102, Lu106) and human <span class=""disease"">melanoma</span> cells (Mel8) exposed to exogenous iron and <span class=""chemical"">copper</span> ions in the absence or in the presence of ascorbic acid, catalase and superoxide dismutase.",,11243246,11243246_D003300_D008545,11243246_1,bcv_sentence_task_befree_1414,,770957342,FALSE,finalized,5,8/15/15 2:05,"



",yes_direct,1,,D007501,"<span class=""chemical"">Iron</span>",D004487,"<span class=""disease"">cytotoxicity</span>","<span class=""chemical"">Iron</span> ions produced <span class=""disease"">cytotoxicity</span> towards both kinds of cells dependent on its concentration.",,11243246,11243246_D007501_D004487,11243246_2,bcv_sentence_task_befree_1415,,770957343,FALSE,finalized,5,8/15/15 0:37,"



",yes_direct,1,,D007501,"<span class=""chemical"">iron</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Catalase suppressed the <span class=""disease"">cytotoxicity</span> induced by <span class=""chemical"">iron</span> ions in Lu106 cells. whereas in CLV102 and Mel8 cells, was ineffective.",,11243246,11243246_D007501_D004487,11243246_3,bcv_sentence_task_befree_1416,,770957344,FALSE,finalized,5,8/14/15 23:31,"



",no_relation,0.7962,,D013481,"<span class=""chemical"">superoxide</span>",D004487,"<span class=""disease"">cytotoxicity</span>","By contrast, <span class=""chemical"">superoxide</span> dismutase abolished the <span class=""disease"">cytotoxicity</span> of iron ions towards CLV102 cells, whereas in Lu106 and Mel8 cells, was ineffective.",,11243246,11243246_D013481_D004487,11243246_4,bcv_sentence_task_befree_1417,,770957345,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,0.6134,,D007501,"<span class=""chemical"">iron</span>",D004487,"<span class=""disease"">cytotoxicity</span>","By contrast, superoxide dismutase abolished the <span class=""disease"">cytotoxicity</span> of <span class=""chemical"">iron</span> ions towards CLV102 cells, whereas in Lu106 and Mel8 cells, was ineffective.",,11243246,11243246_D007501_D004487,11243246_4,bcv_sentence_task_befree_1418,,770957346,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,1,,D005665,"<span class=""chemical"">furosemide</span>",D006973,"<span class=""disease"">hypertensives</span>","Haemoconcentration, shear-stress increase and carotid artery diameter regulation after <span class=""chemical"">furosemide</span> administration in older <span class=""disease"">hypertensives</span>.",,11250127,11250127_D005665_D006973,11250127_0,bcv_sentence_task_befree_1419,,770957347,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,1,,D005665,"<span class=""chemical"">furosemide</span>",D006973,"<span class=""disease"">hypertensives</span>","Arterial wall shear rate (ultrasound technique, profilmeter FRP III), the systo-diastolic diameter (echotracking technique) and the mean blood flow velocity and volume of the common carotid artery, the blood viscosity (rotational viscometer) and the finger arterial blood pressure (Finapress Ohmeda) were measured in 12 young volunteers (aged 25+/-2 years) and in 12 elderly <span class=""disease"">hypertensives</span> (aged 80+/-4 years) treated with short-acting calcium antagonists up to 24h before the study, both at baseline and after intravenous <span class=""chemical"">furosemide</span> infusion (0.5mg/min), when the haematocrit had increased by at least two percentage points.",,11250127,11250127_D005665_D006973,11250127_2,bcv_sentence_task_befree_1420,,770957348,FALSE,finalized,5,8/14/15 22:29,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D006973,"<span class=""disease"">hypertensives</span>","Arterial wall shear rate (ultrasound technique, profilmeter FRP III), the systo-diastolic diameter (echotracking technique) and the mean blood flow velocity and volume of the common carotid artery, the blood viscosity (rotational viscometer) and the finger arterial blood pressure (Finapress Ohmeda) were measured in 12 young volunteers (aged 25+/-2 years) and in 12 elderly <span class=""disease"">hypertensives</span> (aged 80+/-4 years) treated with short-acting <span class=""chemical"">calcium</span> antagonists up to 24h before the study, both at baseline and after intravenous furosemide infusion (0.5mg/min), when the haematocrit had increased by at least two percentage points.",,11250127,11250127_D002118_D006973,11250127_2,bcv_sentence_task_befree_1421,,770957349,FALSE,finalized,5,8/14/15 23:33,"



",yes_direct,0.6041,,D005665,"<span class=""chemical"">furosemide</span>",D007022,"<span class=""disease"">decreased and blood viscosity</span>","After <span class=""chemical"">furosemide</span> administration the mean arterial blood pressure <span class=""disease"">decreased and blood viscosity</span> and carotid systolic shear stress increased in both groups.",,11250127,11250127_D005665_D007022,11250127_3,bcv_sentence_task_befree_1422,,770957350,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,0.5913,,D014700,"<span class=""chemical"">verapamil</span>",D004487,"<span class=""disease"">cytotoxicity</span>","After treatment of the resistant cells with <span class=""chemical"">verapamil</span>, the intracellular levels of doxorubicin were markedly increased and consequent <span class=""disease"">cytotoxicity</span> was improved.",,11261883,11261883_D014700_D004487,11261883_6,bcv_sentence_task_befree_1423,,770957351,FALSE,finalized,5,8/14/15 23:25,"


'Improved' being the key term.
",yes_direct,0.5985,,D004317,"<span class=""chemical"">doxorubicin</span>",D004487,"<span class=""disease"">cytotoxicity</span>","After treatment of the resistant cells with verapamil, the intracellular levels of <span class=""chemical"">doxorubicin</span> were markedly increased and consequent <span class=""disease"">cytotoxicity</span> was improved.",,11261883,11261883_D004317_D004487,11261883_6,bcv_sentence_task_befree_1424,,770957352,FALSE,finalized,5,8/14/15 23:49,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D004938,"<span class=""disease"">esophageal cancer</span>","Pharmacokinetics of intraoperative intrapleural <span class=""chemical"">cisplatin</span> chemotherapy of various osmolarities in cases of <span class=""disease"">esophageal cancer</span>.",,11295088,11295088_D002945_D004938,11295088_0,bcv_sentence_task_befree_1425,,770957353,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin/CDDP</span>",D009369,"<span class=""disease"">cancers</span>","Intraoperative intrapleural (i.pl.) <span class=""chemical"">cisplatin</span> (<span class=""chemical"">CDDP</span>) treatment during thoracotomy was performed for esophageal <span class=""disease"">cancers</span>.",,11295088,11295088_D002945_D009369,11295088_1,bcv_sentence_task_befree_1426,,770957354,FALSE,finalized,5,8/14/15 22:30,"



",no_relation,0.5805,,D002945,"<span class=""chemical"">CDDP</span>",D020335,"<span class=""disease"">Hypotonic</span>","<span class=""disease"">Hypotonic</span> <span class=""chemical"">CDDP</span> treatments with a 154 mOsm/l solution and a 62 mOsm/l solution were administered to 4 and 9 patients, respectively.",,11295088,11295088_D002945_D020335,11295088_3,bcv_sentence_task_befree_1427,,770957355,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D010984,"<span class=""chemical"">platinum</span>",D020335,"<span class=""disease"">hypotonic</span>","The maximum concentrations (Cmax) of both total and filterable <span class=""chemical"">platinum</span> in the plasma after injection of the <span class=""disease"">hypotonic</span> solution were significantly higher than those after injection of the isotonic solution.",,11295088,11295088_D010984_D020335,11295088_4,bcv_sentence_task_befree_1428,,770957356,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,1,,D010984,"<span class=""chemical"">platinum</span>",D020335,"<span class=""disease"">hypotonic</span>","Although higher levels of the Cmax may increase side-effects, the <span class=""disease"">hypotonic</span> condition of the i.pl. fluid and increased AUC in the plasma may escalate the accumulation of <span class=""chemical"">platinum</span> in i.pl. cancer cells.",,11295088,11295088_D010984_D020335,11295088_6,bcv_sentence_task_befree_1429,,770957357,FALSE,finalized,5,8/15/15 1:57,"



",no_relation,1,,D010984,"<span class=""chemical"">platinum</span>",D009369,"<span class=""disease"">cancer</span>","Although higher levels of the Cmax may increase side-effects, the hypotonic condition of the i.pl. fluid and increased AUC in the plasma may escalate the accumulation of <span class=""chemical"">platinum</span> in i.pl. <span class=""disease"">cancer</span> cells.",,11295088,11295088_D010984_D009369,11295088_6,bcv_sentence_task_befree_1430,,770957358,FALSE,finalized,5,8/14/15 23:10,"



",no_relation,1,,D002945,"<span class=""chemical"">CDDP</span>",D002277,"<span class=""disease"">pleural carcinomatosis</span>","<span class=""chemical"">CDDP</span> is tolerable and may be useful for treatment of the incipient phase of <span class=""disease"">pleural carcinomatosis</span> and for prophylaxis of postoperative recurrence.",,11295088,11295088_D002945_D002277,11295088_8,bcv_sentence_task_befree_1431,,770957359,FALSE,finalized,5,8/15/15 2:11,"



",no_relation,0.804,,D008727,"<span class=""chemical"">methotrexate</span>",D001172,"<span class=""disease"">rheumatoid arthritis</span>","Because of radiographic evidence of progressive bone loss and the inability to eliminate synovial proliferation with <span class=""chemical"">methotrexate</span>, it became apparent that therapy for <span class=""disease"">rheumatoid arthritis</span> needed further advancement.",,11304108,11304108_D008727_D001172,11304108_1,bcv_sentence_task_befree_1432,,770957360,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,0.6084,,D008727,"<span class=""chemical"">methotrexate</span>",D016301,"<span class=""disease"">bone loss</span>","Because of radiographic evidence of progressive <span class=""disease"">bone loss</span> and the inability to eliminate synovial proliferation with <span class=""chemical"">methotrexate</span>, it became apparent that therapy for rheumatoid arthritis needed further advancement.",,11304108,11304108_D008727_D016301,11304108_1,bcv_sentence_task_befree_1433,,770957361,FALSE,finalized,5,8/14/15 21:03,"



",yes_direct,1,,D008727,"<span class=""chemical"">Methotrexate</span>",D064420,"<span class=""disease"">toxicity</span>","<span class=""chemical"">Methotrexate</span> is not a remission-inducing drug and may have dose-limiting <span class=""disease"">toxicity</span>.",,11304108,11304108_D008727_D064420,11304108_2,bcv_sentence_task_befree_1434,,770957362,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,C045463,"<span class=""chemical"">leflunomide</span>",D019966,"<span class=""disease"">disease-modifying antirheumatic drugs/DMARDs</span>","In the past 2 years, three new <span class=""disease"">disease-modifying antirheumatic drugs</span> (<span class=""disease"">DMARDs</span>) have been approved: <span class=""chemical"">leflunomide</span>, etanercept, and infliximab.",,11304108,11304108_C045463_D019966,11304108_3,bcv_sentence_task_befree_1435,,770957363,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,1,,D006886,"<span class=""chemical"">hydroxychloroquine</span>",D019966,"<span class=""disease"">DMARDs</span>","Other established <span class=""disease"">DMARDs</span>, such as sulfasalazine and <span class=""chemical"">hydroxychloroquine</span>, have also demonstrated efficacy when used together with methotrexate.",,11304108,11304108_D006886_D019966,11304108_6,bcv_sentence_task_befree_1436,,770957364,FALSE,finalized,5,8/14/15 20:47,"



",no_relation,1,,D012460,"<span class=""chemical"">sulfasalazine</span>",D019966,"<span class=""disease"">DMARDs</span>","Other established <span class=""disease"">DMARDs</span>, such as <span class=""chemical"">sulfasalazine</span> and hydroxychloroquine, have also demonstrated efficacy when used together with methotrexate.",,11304108,11304108_D012460_D019966,11304108_6,bcv_sentence_task_befree_1437,,770957365,FALSE,finalized,5,8/14/15 23:59,"



",no_relation,1,,D008727,"<span class=""chemical"">methotrexate</span>",D019966,"<span class=""disease"">DMARDs</span>","Other established <span class=""disease"">DMARDs</span>, such as sulfasalazine and hydroxychloroquine, have also demonstrated efficacy when used together with <span class=""chemical"">methotrexate</span>.",,11304108,11304108_D008727_D019966,11304108_6,bcv_sentence_task_befree_1438,,770957366,FALSE,finalized,5,8/15/15 0:19,"



",no_relation,1,,D008727,"<span class=""chemical"">methotrexate</span>",D019966,"<span class=""disease"">DMARDs</span>","The results of these combination studies clearly demonstrate that clinical responses can be meaningfully improved when new and existing <span class=""disease"">DMARDs</span> are added to <span class=""chemical"">methotrexate</span>.",,11304108,11304108_D008727_D019966,11304108_7,bcv_sentence_task_befree_1439,,770957367,FALSE,finalized,5,8/14/15 20:56,"



",no_relation,1,,D008727,"<span class=""chemical"">methotrexate</span>",D019966,"<span class=""disease"">DMARDs</span>","It has also become apparent that combinations of new <span class=""disease"">DMARDs</span> and <span class=""chemical"">methotrexate</span> virtually halt radiographic progression over 2 years.",,11304108,11304108_D008727_D019966,11304108_9,bcv_sentence_task_befree_1440,,770957368,FALSE,finalized,5,8/14/15 20:57,"



",no_relation,0.812,,D016049,"<span class=""chemical"">didanosine</span>",D015658,"<span class=""disease"">HIV-1 infection</span>","The role of <span class=""chemical"">didanosine</span> in the management of <span class=""disease"">HIV-1 infection</span>.",,11322269,11322269_D016049_D015658,11322269_0,bcv_sentence_task_befree_1441,,770957369,FALSE,finalized,5,8/14/15 20:56,"



",no_relation,1,,D016049,"<span class=""chemical"">didanosine</span>",D015658,"<span class=""disease"">human immunodeficiency virus (HIV) infection</span>","Large-scale clinical end point studies comparing antiretroviral therapy with zidovudine alone, <span class=""chemical"">didanosine</span> alone, and zidovudine combined with <span class=""chemical"">didanosine</span> indicate that both <span class=""chemical"">didanosine</span> alone and zidovudine/<span class=""chemical"">didanosine</span> provide a better clinical outcome than zidovudine alone in patients with <span class=""disease"">human immunodeficiency virus (HIV) infection</span>.",,11322269,11322269_D016049_D015658,11322269_1,bcv_sentence_task_befree_1442,,770957370,FALSE,finalized,5,8/15/15 2:20,"



",no_relation,1,,D015215,"<span class=""chemical"">zidovudine</span>",D015658,"<span class=""disease"">human immunodeficiency virus (HIV) infection</span>","Large-scale clinical end point studies comparing antiretroviral therapy with <span class=""chemical"">zidovudine</span> alone, didanosine alone, and <span class=""chemical"">zidovudine</span> combined with didanosine indicate that both didanosine alone and <span class=""chemical"">zidovudine</span>/didanosine provide a better clinical outcome than <span class=""chemical"">zidovudine</span> alone in patients with <span class=""disease"">human immunodeficiency virus (HIV) infection</span>.",,11322269,11322269_D015215_D015658,11322269_1,bcv_sentence_task_befree_1443,,770957371,FALSE,finalized,5,8/15/15 2:33,"



",no_relation,0.5993,,D016049,"<span class=""chemical"">didanosine</span>",D001308,"<span class=""disease"">gastrointestinal disturbances</span>","Apart from mostly mild <span class=""disease"">gastrointestinal disturbances</span>, <span class=""chemical"">didanosine</span> alone and in various combination therapies has been generally well tolerated.",,11322269,11322269_D016049_D001308,11322269_4,bcv_sentence_task_befree_1444,,770957372,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,1,,D009705,"<span class=""chemical"">nucleoside</span>",D015658,"<span class=""disease"">HIV infection</span>","Thus, didanosine represents a potent, versatile <span class=""chemical"">nucleoside</span> analogue with potential benefits in both current and future antiretroviral regimens for <span class=""disease"">HIV infection</span>.",,11322269,11322269_D009705_D015658,11322269_5,bcv_sentence_task_befree_1445,,770957373,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,1,,D016049,"<span class=""chemical"">didanosine</span>",D015658,"<span class=""disease"">HIV infection</span>","Thus, <span class=""chemical"">didanosine</span> represents a potent, versatile nucleoside analogue with potential benefits in both current and future antiretroviral regimens for <span class=""disease"">HIV infection</span>.",,11322269,11322269_D016049_D015658,11322269_5,bcv_sentence_task_befree_1446,,770957374,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D009369,"<span class=""disease"">Tumor</span>","<span class=""disease"">Tumor</span> sensitivities as measured by the IC50 (drug concentration producing 50% growth inhibition) varied largely between drugs, ranging larger than 3 x 10(5) ng/mL for <span class=""chemical"">5-FU</span>, larger than 1.5 x 10(2) ng/mL for MMC, 20 ng/mL to 1.4 x 10(3) ng/mL for ADM, and 80 ng/mL to 2.4 x 10(3) ng/mL for CDDP.",,11329936,11329936_D005472_D009369,11329936_5,bcv_sentence_task_befree_1447,,770957375,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,1,,D016685,"<span class=""chemical"">MMC</span>",D009369,"<span class=""disease"">Tumor</span>","<span class=""disease"">Tumor</span> sensitivities as measured by the IC50 (drug concentration producing 50% growth inhibition) varied largely between drugs, ranging larger than 3 x 10(5) ng/mL for 5-FU, larger than 1.5 x 10(2) ng/mL for <span class=""chemical"">MMC</span>, 20 ng/mL to 1.4 x 10(3) ng/mL for ADM, and 80 ng/mL to 2.4 x 10(3) ng/mL for CDDP.",,11329936,11329936_D016685_D009369,11329936_5,bcv_sentence_task_befree_1448,,770957376,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,D002945,"<span class=""chemical"">CDDP</span>",D009369,"<span class=""disease"">Tumor</span>","<span class=""disease"">Tumor</span> sensitivities as measured by the IC50 (drug concentration producing 50% growth inhibition) varied largely between drugs, ranging larger than 3 x 10(5) ng/mL for 5-FU, larger than 1.5 x 10(2) ng/mL for MMC, 20 ng/mL to 1.4 x 10(3) ng/mL for ADM, and 80 ng/mL to 2.4 x 10(3) ng/mL for <span class=""chemical"">CDDP</span>.",,11329936,11329936_D002945_D009369,11329936_5,bcv_sentence_task_befree_1449,,770957377,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D000230,"<span class=""disease"">adenocarcinomas</span>","Nine human pancreatic <span class=""disease"">adenocarcinomas</span> varied widely in their sensitivity to chemotherapies, especially for <span class=""chemical"">5-FU</span>.",,11329936,11329936_D005472_D000230,11329936_10,bcv_sentence_task_befree_1450,,770957378,FALSE,finalized,5,8/14/15 23:45,"



",no_relation,1,,D010889,"<span class=""chemical"">piracetam</span>",D020521,"<span class=""disease"">stroke</span>","Restitution of alpha-topography by <span class=""chemical"">piracetam</span> in post-<span class=""disease"">stroke</span> aphasia.",,11332870,11332870_D010889_D020521,11332870_0,bcv_sentence_task_befree_1451,,770957379,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,D010889,"<span class=""chemical"">piracetam</span>",D001037,"<span class=""disease"">aphasia</span>","Restitution of alpha-topography by <span class=""chemical"">piracetam</span> in post-stroke <span class=""disease"">aphasia</span>.",,11332870,11332870_D010889_D001037,11332870_0,bcv_sentence_task_befree_1452,,770957380,FALSE,finalized,5,8/14/15 22:50,"



",no_relation,1,,D010889,"<span class=""chemical"">piracetam</span>",D020521,"<span class=""disease"">stroke</span>","Electroencephalographic and clinical effects of <span class=""chemical"">piracetam</span> in post-<span class=""disease"">stroke</span> aphasia were evaluated in a prospective, randomized, double-blind, placebo-controlled trial.",,11332870,11332870_D010889_D020521,11332870_1,bcv_sentence_task_befree_1453,,770957381,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,D010889,"<span class=""chemical"">piracetam</span>",D001037,"<span class=""disease"">aphasia</span>","Electroencephalographic and clinical effects of <span class=""chemical"">piracetam</span> in post-stroke <span class=""disease"">aphasia</span> were evaluated in a prospective, randomized, double-blind, placebo-controlled trial.",,11332870,11332870_D010889_D001037,11332870_1,bcv_sentence_task_befree_1454,,770957382,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,1,,C054218,"<span class=""chemical"">manidipine</span>",D003929,"<span class=""disease"">diabetic</span>","Effects on urinary albumin excretion and renal function changes by delapril and <span class=""chemical"">manidipine</span> in normotensive type 2 <span class=""disease"">diabetic</span> patients with microalbuminuria.",,11336083,11336083_C054218_D003929,11336083_0,bcv_sentence_task_befree_1455,,770957383,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D003929,"<span class=""disease"">diabetic</span>","This study was designed to investigate the effect of delapril, an ACE inhibitor, and manidipine, a long action <span class=""chemical"">calcium</span> antagonist, on persistent microalbuminuria in normotensive type 2 <span class=""disease"">diabetic</span> patients.",,11336083,11336083_D002118_D003929,11336083_1,bcv_sentence_task_befree_1456,,770957384,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,1,,C054218,"<span class=""chemical"">manidipine</span>",D003929,"<span class=""disease"">diabetic</span>","This study was designed to investigate the effect of delapril, an ACE inhibitor, and <span class=""chemical"">manidipine</span>, a long action calcium antagonist, on persistent microalbuminuria in normotensive type 2 <span class=""disease"">diabetic</span> patients.",,11336083,11336083_C054218_D003929,11336083_1,bcv_sentence_task_befree_1457,,770957385,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,1,,C047759,"<span class=""chemical"">delapril</span>",D003929,"<span class=""disease"">diabetic</span>","This study was designed to investigate the effect of <span class=""chemical"">delapril</span>, an ACE inhibitor, and manidipine, a long action calcium antagonist, on persistent microalbuminuria in normotensive type 2 <span class=""disease"">diabetic</span> patients.",,11336083,11336083_C047759_D003929,11336083_1,bcv_sentence_task_befree_1458,,770957386,FALSE,finalized,5,8/14/15 22:29,"



",no_relation,1,,C054218,"<span class=""chemical"">manidipine</span>",D003929,"<span class=""disease"">diabetic</span>","Sixty type 2 <span class=""disease"">diabetic</span> patients were randomized to take delapril 30 mg/day or <span class=""chemical"">manidipine</span> 10 mg/day for 48 weeks, in an open label design.",,11336083,11336083_C054218_D003929,11336083_2,bcv_sentence_task_befree_1459,,770957387,FALSE,finalized,5,8/14/15 22:24,"



",no_relation,1,,C047759,"<span class=""chemical"">delapril</span>",D003929,"<span class=""disease"">diabetic</span>","Sixty type 2 <span class=""disease"">diabetic</span> patients were randomized to take <span class=""chemical"">delapril</span> 30 mg/day or manidipine 10 mg/day for 48 weeks, in an open label design.",,11336083,11336083_C047759_D003929,11336083_2,bcv_sentence_task_befree_1460,,770957388,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,0.6043,,C047759,"<span class=""chemical"">delapril</span>",C562889,"<span class=""disease"">nephropathy</span>","After 48 weeks of treatment, two patients in the <span class=""chemical"">delapril</span> group and one patient in the manidipine group converted to normoalbuminuria (urinary albumin:creatinine ratio < 30 mg/g) and one patient in each group progressed to overt <span class=""disease"">nephropathy</span> (urinary albumin:creatinine ratio > 300 mg/g).",,11336083,11336083_C047759_C562889,11336083_6,bcv_sentence_task_befree_1461,,770957389,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,0.7952,,C054218,"<span class=""chemical"">manidipine</span>",C562889,"<span class=""disease"">nephropathy</span>","After 48 weeks of treatment, two patients in the delapril group and one patient in the <span class=""chemical"">manidipine</span> group converted to normoalbuminuria (urinary albumin:creatinine ratio < 30 mg/g) and one patient in each group progressed to overt <span class=""disease"">nephropathy</span> (urinary albumin:creatinine ratio > 300 mg/g).",,11336083,11336083_C054218_C562889,11336083_6,bcv_sentence_task_befree_1462,,770957390,FALSE,finalized,5,8/14/15 20:56,"



",no_relation,0.8026,,D003404,"<span class=""chemical"">creatinine</span>",C562889,"<span class=""disease"">nephropathy</span>","After 48 weeks of treatment, two patients in the delapril group and one patient in the manidipine group converted to normoalbuminuria (urinary albumin:<span class=""chemical"">creatinine</span> ratio < 30 mg/g) and one patient in each group progressed to overt <span class=""disease"">nephropathy</span> (urinary albumin:<span class=""chemical"">creatinine</span> ratio > 300 mg/g).",,11336083,11336083_D003404_C562889,11336083_6,bcv_sentence_task_befree_1463,,770957391,FALSE,finalized,5,8/14/15 23:08,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D044882,"<span class=""disease"">plasma glucose</span>","There were no significant changes in fasting <span class=""disease"">plasma </span><span class=""chemical"">glucose</span>, HbA1c, serum fructosamine, creatinine, potassium and lipid profiles after 48 weeks of treatment in both groups.",,11336083,11336083_D005947_D044882,11336083_7,bcv_sentence_task_befree_1464,,770957392,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,D011188,"<span class=""chemical"">potassium</span>",D044882,"<span class=""disease"">plasma glucose</span>","There were no significant changes in fasting <span class=""disease"">plasma glucose</span>, HbA1c, serum fructosamine, creatinine, <span class=""chemical"">potassium</span> and lipid profiles after 48 weeks of treatment in both groups.",,11336083,11336083_D011188_D044882,11336083_7,bcv_sentence_task_befree_1465,,770957393,FALSE,finalized,5,8/15/15 2:31,"



",no_relation,1,,D019270,"<span class=""chemical"">fructosamine</span>",D044882,"<span class=""disease"">plasma glucose</span>","There were no significant changes in fasting <span class=""disease"">plasma glucose</span>, HbA1c, serum <span class=""chemical"">fructosamine</span>, creatinine, potassium and lipid profiles after 48 weeks of treatment in both groups.",,11336083,11336083_D019270_D044882,11336083_7,bcv_sentence_task_befree_1466,,770957394,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",D044882,"<span class=""disease"">plasma glucose</span>","There were no significant changes in fasting <span class=""disease"">plasma glucose</span>, HbA1c, serum fructosamine, <span class=""chemical"">creatinine</span>, potassium and lipid profiles after 48 weeks of treatment in both groups.",,11336083,11336083_D003404_D044882,11336083_7,bcv_sentence_task_befree_1467,,770957395,FALSE,finalized,5,8/14/15 21:59,"



",no_relation,0.5969,,C047759,"<span class=""chemical"">delapril</span>",D004244,"<span class=""disease"">dizziness</span>","Two cases in the <span class=""chemical"">delapril</span> group were withdrawn during the study because of an intolerable cough and one case in the manidipine group because of intolerable <span class=""disease"">dizziness</span> and headache.",,11336083,11336083_C047759_D004244,11336083_8,bcv_sentence_task_befree_1468,,770957396,FALSE,finalized,5,8/14/15 20:50,"



",yes_direct,0.8193,,C054218,"<span class=""chemical"">manidipine</span>",D004244,"<span class=""disease"">dizziness</span>","Two cases in the delapril group were withdrawn during the study because of an intolerable cough and one case in the <span class=""chemical"">manidipine</span> group because of intolerable <span class=""disease"">dizziness</span> and headache.",,11336083,11336083_C054218_D004244,11336083_8,bcv_sentence_task_befree_1469,,770957397,FALSE,finalized,5,8/15/15 1:57,"



",yes_direct,0.5905,,C047759,"<span class=""chemical"">delapril</span>",D006261,"<span class=""disease"">headache</span>","Two cases in the <span class=""chemical"">delapril</span> group were withdrawn during the study because of an intolerable cough and one case in the manidipine group because of intolerable dizziness and <span class=""disease"">headache</span>.",,11336083,11336083_C047759_D006261,11336083_8,bcv_sentence_task_befree_1470,,770957398,FALSE,finalized,5,8/14/15 22:38,"



",yes_direct,0.7848,,C054218,"<span class=""chemical"">manidipine</span>",D006261,"<span class=""disease"">headache</span>","Two cases in the delapril group were withdrawn during the study because of an intolerable cough and one case in the <span class=""chemical"">manidipine</span> group because of intolerable dizziness and <span class=""disease"">headache</span>.",,11336083,11336083_C054218_D006261,11336083_8,bcv_sentence_task_befree_1471,,770957399,FALSE,finalized,5,8/14/15 23:53,"



",no_relation,1,,C054218,"<span class=""chemical"">manidipine</span>",D003929,"<span class=""disease"">diabetic</span>","In conclusion, both delapril and <span class=""chemical"">manidipine</span> are effective in the reduction of microalbuminuria in normotensive type 2 <span class=""disease"">diabetic</span> patients with persistent microalbuminuria.",,11336083,11336083_C054218_D003929,11336083_9,bcv_sentence_task_befree_1472,,770957400,FALSE,finalized,5,8/15/15 2:47,"



",yes_direct,0.5968,,D000431,"<span class=""chemical"">ethanol</span>",C567108,"<span class=""disease"">testicular atrophy</span>","The presentations were (1) Alcoholic myopathy: Past, present and future, by Timothy J. Peters and Victor R. Preedy; (2) Protein adducts in the type I and II fiber-predominant muscles of the <span class=""chemical"">ethanol</span>-fed rat, by Simon Worrall, Seppo Parkkila, and Onni Niemela; (3) Hydroperoxides and changes in alcoholic myopathy, by Junko Adachi, Migiwa Asamo, and Yasuhino Ueno; and (4) A close association between <span class=""disease"">testicular atrophy</span>, muscle atrophy, and the increase in protein catabolism after chronic <span class=""chemical"">ethanol</span> administration, by Kunihiko Takeda, Masayoshi Yamauchi, Kazuhiko Sakamoto, Masaru Takagi, Hisato Nakajima, and Gotaro Toda.",,11391050,11391050_D000431_C567108,11391050_3,bcv_sentence_task_befree_1473,,770957401,FALSE,finalized,5,8/14/15 22:30,"



",yes_direct,1,,D000431,"<span class=""chemical"">ethanol</span>",D009133,"<span class=""disease"">muscle atrophy</span>","The presentations were (1) Alcoholic myopathy: Past, present and future, by Timothy J. Peters and Victor R. Preedy; (2) Protein adducts in the type I and II fiber-predominant muscles of the <span class=""chemical"">ethanol</span>-fed rat, by Simon Worrall, Seppo Parkkila, and Onni Niemela; (3) Hydroperoxides and changes in alcoholic myopathy, by Junko Adachi, Migiwa Asamo, and Yasuhino Ueno; and (4) A close association between testicular atrophy, <span class=""disease"">muscle atrophy</span>, and the increase in protein catabolism after chronic <span class=""chemical"">ethanol</span> administration, by Kunihiko Takeda, Masayoshi Yamauchi, Kazuhiko Sakamoto, Masaru Takagi, Hisato Nakajima, and Gotaro Toda.",,11391050,11391050_D000431_D009133,11391050_3,bcv_sentence_task_befree_1474,,770957402,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,0.5999,,D000431,"<span class=""chemical"">ethanol</span>",D000437,"<span class=""disease"">Alcoholic myopathy</span>","The presentations were (1) <span class=""disease"">Alcoholic myopathy</span>: Past, present and future, by Timothy J. Peters and Victor R. Preedy; (2) Protein adducts in the type I and II fiber-predominant muscles of the <span class=""chemical"">ethanol</span>-fed rat, by Simon Worrall, Seppo Parkkila, and Onni Niemela; (3) Hydroperoxides and changes in <span class=""disease"">alcoholic myopathy</span>, by Junko Adachi, Migiwa Asamo, and Yasuhino Ueno; and (4) A close association between testicular atrophy, muscle atrophy, and the increase in protein catabolism after chronic <span class=""chemical"">ethanol</span> administration, by Kunihiko Takeda, Masayoshi Yamauchi, Kazuhiko Sakamoto, Masaru Takagi, Hisato Nakajima, and Gotaro Toda.",,11391050,11391050_D000431_D000437,11391050_3,bcv_sentence_task_befree_1475,,770957403,FALSE,finalized,5,8/14/15 20:54,"



",no_relation,1,,D005473,"<span class=""chemical"">Fluoxetine</span>",D019052,"<span class=""disease"">postnatal depression</span>","Appleby et al (1997) reported that <span class=""chemical"">Fluoxetine</span> was significantly more effective than placebo and, after an initial session of counselling, as effective as a full course of cognitive-behavioural counselling in the treatment of <span class=""disease"">postnatal depression</span>.",,11406023,11406023_D005473_D019052,11406023_13,bcv_sentence_task_befree_1476,,770957404,FALSE,finalized,5,8/14/15 20:56,"



",no_relation,1,,D005473,"<span class=""chemical"">fluoxetine</span>",D019052,"<span class=""disease"">postnatal depression</span>","Women with <span class=""disease"">postnatal depression</span> can be effectively treated with <span class=""chemical"">fluoxetine</span>, which is as effective as a course of cognitive-behavioural counselling in the short-term.",,11406023,11406023_D005473_D019052,11406023_15,bcv_sentence_task_befree_1477,,770957405,FALSE,finalized,5,8/14/15 20:52,"



",no_relation,1,,D013759,"<span class=""chemical"">Delta(9)-tetrahydrocannabinol/THC</span>",D013035,"<span class=""disease"">muscle spasms</span>","The active principle in marijuana, <span class=""chemical"">Delta(9)-tetrahydrocannabinol</span> (<span class=""chemical"">THC</span>), has been shown to have wide therapeutic application for a number of important medical conditions, including pain, anxiety, glaucoma, nausea, emesis, <span class=""disease"">muscle spasms</span>, and wasting diseases.",,11448725,11448725_D013759_D013035,11448725_1,bcv_sentence_task_befree_1478,,770957406,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,D013759,"<span class=""chemical"">Delta(9)-tetrahydrocannabinol/THC</span>",D005901,"<span class=""disease"">glaucoma</span>","The active principle in marijuana, <span class=""chemical"">Delta(9)-tetrahydrocannabinol</span> (<span class=""chemical"">THC</span>), has been shown to have wide therapeutic application for a number of important medical conditions, including pain, anxiety, <span class=""disease"">glaucoma</span>, nausea, emesis, muscle spasms, and wasting diseases.",,11448725,11448725_D013759_D005901,11448725_1,bcv_sentence_task_befree_1479,,770957407,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,D013759,"<span class=""chemical"">Delta(9)-tetrahydrocannabinol/THC</span>",D010146,"<span class=""disease"">pain</span>","The active principle in marijuana, <span class=""chemical"">Delta(9)-tetrahydrocannabinol</span> (<span class=""chemical"">THC</span>), has been shown to have wide therapeutic application for a number of important medical conditions, including <span class=""disease"">pain</span>, anxiety, glaucoma, nausea, emesis, muscle spasms, and wasting diseases.",,11448725,11448725_D013759_D010146,11448725_1,bcv_sentence_task_befree_1480,,770957408,FALSE,finalized,5,8/15/15 0:42,"



",no_relation,1,,D013759,"<span class=""chemical"">Delta(9)-tetrahydrocannabinol/THC</span>",D009325,"<span class=""disease"">nausea</span>","The active principle in marijuana, <span class=""chemical"">Delta(9)-tetrahydrocannabinol</span> (<span class=""chemical"">THC</span>), has been shown to have wide therapeutic application for a number of important medical conditions, including pain, anxiety, glaucoma, <span class=""disease"">nausea</span>, emesis, muscle spasms, and wasting diseases.",,11448725,11448725_D013759_D009325,11448725_1,bcv_sentence_task_befree_1481,,770957409,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,D013759,"<span class=""chemical"">Delta(9)-tetrahydrocannabinol/THC</span>",D001008,"<span class=""disease"">anxiety</span>","The active principle in marijuana, <span class=""chemical"">Delta(9)-tetrahydrocannabinol</span> (<span class=""chemical"">THC</span>), has been shown to have wide therapeutic application for a number of important medical conditions, including pain, <span class=""disease"">anxiety</span>, glaucoma, nausea, emesis, muscle spasms, and wasting diseases.",,11448725,11448725_D013759_D001008,11448725_1,bcv_sentence_task_befree_1482,,770957410,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,1,,D013759,"<span class=""chemical"">Delta(9)-tetrahydrocannabinol/THC</span>",D019282,"<span class=""disease"">wasting diseases</span>","The active principle in marijuana, <span class=""chemical"">Delta(9)-tetrahydrocannabinol</span> (<span class=""chemical"">THC</span>), has been shown to have wide therapeutic application for a number of important medical conditions, including pain, anxiety, glaucoma, nausea, emesis, muscle spasms, and <span class=""disease"">wasting diseases</span>.",,11448725,11448725_D013759_D019282,11448725_1,bcv_sentence_task_befree_1483,,770957411,FALSE,finalized,5,8/15/15 1:17,"



",no_relation,1,,D013759,"<span class=""chemical"">Delta(9)-tetrahydrocannabinol/THC</span>",D003699,"<span class=""disease"">Delta(9)-tetrahydrocannabinol/THC</span>","The active principle in marijuana, <span class=""chemical""></span><span class=""disease"">Delta(9)-tetrahydrocannabinol</span> (<span class=""chemical""></span><span class=""disease"">THC</span>), has been shown to have wide therapeutic application for a number of important medical conditions, including pain, anxiety, glaucoma, nausea, emesis, muscle spasms, and wasting diseases.",,11448725,11448725_D013759_D003699,11448725_1,bcv_sentence_task_befree_1484,,770957412,FALSE,finalized,5,8/14/15 23:16,"



",yes_direct,0.8011,,D009599,"<span class=""chemical"">SNP</span>",D013610,"<span class=""disease"">tachycardia</span>","Despite <span class=""disease"">tachycardia</span> and sympathetic activation with both <span class=""chemical"">SNP</span> and phentolamine, LF variability in RR, MSNA, and BP increased during <span class=""chemical"">SNP</span> and decreased during phentolamine (<span class=""chemical"">SNP</span>: RR +20 +/- 6%, MSNA +3 +/- 5%, systolic BP +9 +/- 6%, diastolic BP +7 +/- 5%; phentolamine: RR -2 +/- 7%, MSNA -34 +/- 6%, systolic BP -16 +/- 8%, diastolic BP -13 +/- 4%, P < 0.05 except systolic BP, where P = 0.09).",,11454557,11454557_D009599_D013610,11454557_4,bcv_sentence_task_befree_1485,,770957413,FALSE,finalized,5,8/14/15 20:55,"



",no_relation,0.7769,,D010646,"<span class=""chemical"">phentolamine</span>",D013610,"<span class=""disease"">tachycardia</span>","Despite <span class=""disease"">tachycardia</span> and sympathetic activation with both SNP and <span class=""chemical"">phentolamine</span>, LF variability in RR, MSNA, and BP increased during SNP and decreased during <span class=""chemical"">phentolamine</span> (SNP: RR +20 +/- 6%, MSNA +3 +/- 5%, systolic BP +9 +/- 6%, diastolic BP +7 +/- 5%; <span class=""chemical"">phentolamine</span>: RR -2 +/- 7%, MSNA -34 +/- 6%, systolic BP -16 +/- 8%, diastolic BP -13 +/- 4%, P < 0.05 except systolic BP, where P = 0.09).",,11454557,11454557_D010646_D013610,11454557_4,bcv_sentence_task_befree_1486,,770957414,FALSE,finalized,5,8/15/15 2:33,"



",yes_direct,1,,D009638,"<span class=""chemical"">noradrenaline</span>",D002561,"<span class=""disease"">vascular disorders</span>","Supersensitivity to <span class=""chemical"">noradrenaline</span> contributes to certain <span class=""disease"">vascular disorders</span> (e.g., hypertension) and chronic neuropathic pain conditions (e.g., complex regional pain syndrome).",,11474550,11474550_D009638_D002561,11474550_1,bcv_sentence_task_befree_1487,,770957415,FALSE,finalized,5,8/15/15 1:28,"



",yes_direct,0.6122,,D009638,"<span class=""chemical"">noradrenaline</span>",D006973,"<span class=""disease"">hypertension</span>","Supersensitivity to <span class=""chemical"">noradrenaline</span> contributes to certain vascular disorders (e.g., <span class=""disease"">hypertension</span>) and chronic neuropathic pain conditions (e.g., complex regional pain syndrome).",,11474550,11474550_D009638_D006973,11474550_1,bcv_sentence_task_befree_1488,,770957416,FALSE,finalized,5,8/14/15 22:52,"



",yes_direct,0.5894,,D009638,"<span class=""chemical"">noradrenaline</span>",D010146,"<span class=""disease"">regional pain syndrome/neuropathic pain</span>","Supersensitivity to <span class=""chemical"">noradrenaline</span> contributes to certain vascular disorders (e.g., hypertension) and chronic <span class=""disease"">neuropathic pain</span> conditions (e.g., complex <span class=""disease"">regional pain syndrome</span>).",,11474550,11474550_D009638_D010146,11474550_1,bcv_sentence_task_befree_1489,,770957417,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,1,,D006145,"<span class=""chemical"">guanethidine</span>",D006930,"<span class=""disease"">thermal hyperalgesia</span>","To investigate the effect of <span class=""chemical"">guanethidine</span> pretreatment on <span class=""disease"">thermal hyperalgesia</span>. the experimental sites were sensitized to heat by the topical application of 0.6% capsaicin.",,11474550,11474550_D006145_D006930,11474550_7,bcv_sentence_task_befree_1490,,770957418,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,0.8179,,D002211,"<span class=""chemical"">capsaicin</span>",D006930,"<span class=""disease"">thermal hyperalgesia</span>","To investigate the effect of guanethidine pretreatment on <span class=""disease"">thermal hyperalgesia</span>. the experimental sites were sensitized to heat by the topical application of 0.6% <span class=""chemical"">capsaicin</span>.",,11474550,11474550_D002211_D006930,11474550_7,bcv_sentence_task_befree_1491,,770957419,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D002211,"<span class=""chemical"">capsaicin</span>",D010146,"<span class=""disease"">pain</span>","Both before and after the application of <span class=""chemical"">capsaicin</span>, the heat-<span class=""disease"">pain</span> threshold and heat-<span class=""disease"">pain</span> ratings to suprathreshold stimulation were similar at sites pretreated for 2 weeks with guanethidine or saline.",,11474550,11474550_D002211_D010146,11474550_8,bcv_sentence_task_befree_1492,,770957420,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,0.8005,,D006145,"<span class=""chemical"">guanethidine</span>",D010146,"<span class=""disease"">pain</span>","Both before and after the application of capsaicin, the heat-<span class=""disease"">pain</span> threshold and heat-<span class=""disease"">pain</span> ratings to suprathreshold stimulation were similar at sites pretreated for 2 weeks with <span class=""chemical"">guanethidine</span> or saline.",,11474550,11474550_D006145_D010146,11474550_8,bcv_sentence_task_befree_1493,,770957421,FALSE,finalized,5,8/14/15 22:12,"



",yes_direct,1,,D006145,"<span class=""chemical"">guanethidine</span>",D006930,"<span class=""disease"">thermal hyperalgesia</span>","However, after the iontophoresis of noradrenaline, <span class=""disease"">thermal hyperalgesia</span> was greater at the <span class=""chemical"">guanethidine</span>-pretreated site than the saline pretreated site.",,11474550,11474550_D006145_D006930,11474550_9,bcv_sentence_task_befree_1494,,770957422,FALSE,finalized,5,8/14/15 22:27,"



",yes_direct,0.6181,,D009638,"<span class=""chemical"">noradrenaline</span>",D006930,"<span class=""disease"">thermal hyperalgesia</span>","However, after the iontophoresis of <span class=""chemical"">noradrenaline</span>, <span class=""disease"">thermal hyperalgesia</span> was greater at the guanethidine-pretreated site than the saline pretreated site.",,11474550,11474550_D009638_D006930,11474550_9,bcv_sentence_task_befree_1495,,770957423,FALSE,finalized,5,8/14/15 22:27,"



",yes_indirect,1,,D006145,"<span class=""chemical"">guanethidine</span>",D006930,"<span class=""disease"">thermal hyperalgesia</span>","These observations indicate that prolonged depletion of adrenergic stores by <span class=""chemical"">guanethidine</span> induces adrenergic supersensitivity in cutaneous vessels, and that adrenergic supersensitivity enhances <span class=""disease"">thermal hyperalgesia</span> in the presence of noradrenaline.",,11474550,11474550_D006145_D006930,11474550_10,bcv_sentence_task_befree_1496,,770957424,FALSE,finalized,5,8/15/15 2:33,"



",yes_direct,0.7885,,D009638,"<span class=""chemical"">noradrenaline</span>",D006930,"<span class=""disease"">thermal hyperalgesia</span>","These observations indicate that prolonged depletion of adrenergic stores by guanethidine induces adrenergic supersensitivity in cutaneous vessels, and that adrenergic supersensitivity enhances <span class=""disease"">thermal hyperalgesia</span> in the presence of <span class=""chemical"">noradrenaline</span>.",,11474550,11474550_D009638_D006930,11474550_10,bcv_sentence_task_befree_1497,,770957425,FALSE,finalized,5,8/15/15 0:59,"



",yes_direct,1,,D013012,"<span class=""chemical"">sorbitol</span>",D000140,"<span class=""disease"">lactic acidosis</span>","Another feature of TURP syndrome: hyperglycaemia and <span class=""disease"">lactic acidosis</span> caused by massive absorption of <span class=""chemical"">sorbitol</span>.",,11493513,11493513_D013012_D000140,11493513_0,bcv_sentence_task_befree_1498,,770957426,FALSE,finalized,5,8/14/15 20:51,"



",yes_direct,0.8006,,D013012,"<span class=""chemical"">sorbitol</span>",D013577,"<span class=""disease"">TURP syndrome</span>","Another feature of <span class=""disease"">TURP syndrome</span>: hyperglycaemia and lactic acidosis caused by massive absorption of <span class=""chemical"">sorbitol</span>.",,11493513,11493513_D013012_D013577,11493513_0,bcv_sentence_task_befree_1499,,770957427,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,0.6199,,D013012,"<span class=""chemical"">sorbitol</span>",D000140,"<span class=""disease"">lactic acidosis</span>","We report a case where hyperglycaemia and <span class=""disease"">lactic acidosis</span> complicated the TURP syndrome caused by the massive absorption (approximately 15 litres) of a <span class=""chemical"">sorbitol</span>- mannitol irrigation solution.",,11493513,11493513_D013012_D000140,11493513_3,bcv_sentence_task_befree_1500,,770957428,FALSE,finalized,5,8/15/15 0:00,"



",yes_direct,1,,D013012,"<span class=""chemical"">sorbitol</span>",D013577,"<span class=""disease"">TURP syndrome</span>","We report a case where hyperglycaemia and lactic acidosis complicated the <span class=""disease"">TURP syndrome</span> caused by the massive absorption (approximately 15 litres) of a <span class=""chemical"">sorbitol</span>- mannitol irrigation solution.",,11493513,11493513_D013012_D013577,11493513_3,bcv_sentence_task_befree_1501,,770957429,FALSE,finalized,5,8/14/15 23:59,"



",yes_direct,1,,D008353,"<span class=""chemical"">mannitol</span>",D013577,"<span class=""disease"">TURP syndrome</span>","We report a case where hyperglycaemia and lactic acidosis complicated the <span class=""disease"">TURP syndrome</span> caused by the massive absorption (approximately 15 litres) of a sorbitol- <span class=""chemical"">mannitol</span> irrigation solution.",,11493513,11493513_D008353_D013577,11493513_3,bcv_sentence_task_befree_1502,,770957430,FALSE,finalized,5,8/14/15 23:42,"



It's 'sorbitol- mannitol irrigation solution' and not just 'Mannitol'",no_relation,0.8183,,D008353,"<span class=""chemical"">mannitol</span>",D000140,"<span class=""disease"">lactic acidosis</span>","We report a case where hyperglycaemia and <span class=""disease"">lactic acidosis</span> complicated the TURP syndrome caused by the massive absorption (approximately 15 litres) of a sorbitol- <span class=""chemical"">mannitol</span> irrigation solution.",,11493513,11493513_D008353_D000140,11493513_3,bcv_sentence_task_befree_1503,,770957431,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,0.6131,,D013012,"<span class=""chemical"">sorbitol</span>",D000140,"<span class=""disease"">lactic acidosis</span>","The proposed mechanism is a type B <span class=""disease"">lactic acidosis</span> related to the metabolism of <span class=""chemical"">sorbitol</span>.",,11493513,11493513_D013012_D000140,11493513_4,bcv_sentence_task_befree_1504,,770957432,FALSE,finalized,5,8/15/15 1:00,"



",no_relation,1,,D014364,"<span class=""chemical"">tryptophan</span>",C567529,"<span class=""disease"">bipolar affective disorder</span>","Clinical and neurochemical effect of acute <span class=""chemical"">tryptophan</span> depletion in unaffected relatives of patients with <span class=""disease"">bipolar affective disorder</span>.",,11513817,11513817_D014364_C567529,11513817_0,bcv_sentence_task_befree_1505,,770957433,FALSE,finalized,5,8/14/15 22:59,"



",no_relation,0.6149,,D014364,"<span class=""chemical"">tryptophan</span>",C564108,"<span class=""disease"">manic-depressive illness</span>","The lowering of mood induced by an acute <span class=""chemical"">tryptophan</span> depletion (ATD) has been proposed as a candidate endophenotype for the vulnerability to <span class=""disease"">manic-depressive illness</span>.",,11513817,11513817_D014364_C564108,11513817_1,bcv_sentence_task_befree_1506,,770957434,FALSE,finalized,5,8/14/15 20:57,"



",no_relation,1,,D014364,"<span class=""chemical"">tryptophan</span>",C567529,"<span class=""disease"">BAD</span>","At 5 hours after AA drink ingestion, relative to the placebo, ATD resulted in 74% and 84% decreases in total plasma <span class=""chemical"">tryptophan</span> concentrations in control subjects and relatives of patients with <span class=""disease"">BAD</span>, respectively.",,11513817,11513817_D014364_C567529,11513817_5,bcv_sentence_task_befree_1507,,770957435,FALSE,finalized,5,8/15/15 1:57,"



",no_relation,1,,D014364,"<span class=""chemical"">tryptophan</span>",C567529,"<span class=""disease"">BAD</span>","These results replicate and extend previous findings suggesting that URs of patients with <span class=""disease"">BAD</span> are more susceptible to low <span class=""chemical"">tryptophan</span> availability.",,11513817,11513817_D014364_C567529,11513817_9,bcv_sentence_task_befree_1508,,770957436,FALSE,finalized,5,8/15/15 1:19,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">breast cancer</span>","Assessment of response to <span class=""chemical"">tamoxifen</span> among Iraqi patients with advanced <span class=""disease"">breast cancer</span>.",,11556039,11556039_D013629_D009369,11556039_0,bcv_sentence_task_befree_1509,,770957437,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">breast cancer</span>","Eighty-eight women presenting with locally advanced or metastatic <span class=""disease"">breast cancer</span> were treated with <span class=""chemical"">tamoxifen</span> alone.",,11556039,11556039_D013629_D009369,11556039_1,bcv_sentence_task_befree_1510,,770957438,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,D004967,"<span class=""chemical"">Estrogen</span>",D009369,"<span class=""disease"">tumour</span>","<span class=""chemical"">Estrogen</span> and progesterone receptors (ER and PR) were immunocytochemically analysed in mammary <span class=""disease"">tumour</span> cells obtained by fine needle sampling from 73 patients.",,11556039,11556039_D004967_D009369,11556039_2,bcv_sentence_task_befree_1511,,770957439,FALSE,finalized,5,8/15/15 2:25,"



",no_relation,1,,D011374,"<span class=""chemical"">progesterone</span>",D009369,"<span class=""disease"">tumour</span>","Estrogen and <span class=""chemical"">progesterone</span> receptors (ER and PR) were immunocytochemically analysed in mammary <span class=""disease"">tumour</span> cells obtained by fine needle sampling from 73 patients.",,11556039,11556039_D011374_D009369,11556039_2,bcv_sentence_task_befree_1512,,770957440,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,1,,D013974,"<span class=""chemical"">levothyroxine</span>",D007037,"<span class=""disease"">hypothyroidism</span>","One of my pregnant patients is taking <span class=""chemical"">levothyroxine</span> for <span class=""disease"">hypothyroidism</span>.",,11561329,11561329_D013974_D007037,11561329_1,bcv_sentence_task_befree_1513,,770957441,FALSE,finalized,5,8/14/15 21:08,"



",no_relation,0.8072,,D000431,"<span class=""chemical"">alcohol</span>",D000230,"<span class=""disease"">adenocarcinomas</span>","A multiethnic population-based study of smoking, <span class=""chemical"">alcohol</span> and body size and risk of <span class=""disease"">adenocarcinomas</span> of the stomach and esophagus (United States).",,11562112,11562112_D000431_D000230,11562112_0,bcv_sentence_task_befree_1514,,770957442,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,0.8002,,D000431,"<span class=""chemical"">alcohol</span>",D013272,"<span class=""disease"">gastric cardia, and distal gastric adenocarcinomas</span>","We sought to determine the role of smoking, <span class=""chemical"">alcohol</span> use, and body size characteristics in the etiology of esophageal, <span class=""disease"">gastric cardia, and distal gastric adenocarcinomas</span>.",,11562112,11562112_D000431_D013272,11562112_3,bcv_sentence_task_befree_1515,,770957443,FALSE,finalized,5,8/14/15 23:38,"



",no_relation,1,,D000431,"<span class=""chemical"">Alcohol</span>",D009369,"<span class=""disease"">tumor</span>","<span class=""chemical"">Alcohol</span> use was not associated with an increased risk of these <span class=""disease"">tumor</span> types.",,11562112,11562112_D000431_D009369,11562112_8,bcv_sentence_task_befree_1516,,770957444,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,0.8083,,D000450,"<span class=""chemical"">Aldosterone</span>",D051436,"<span class=""disease"">renal disease</span>","<span class=""chemical"">Aldosterone</span> in progressive <span class=""disease"">renal disease</span>.",,11709805,11709805_D000450_D051436,11709805_0,bcv_sentence_task_befree_1517,,770957445,FALSE,finalized,5,8/14/15 20:53,"



",no_relation,0.8162,,D000450,"<span class=""chemical"">aldosterone</span>",D051436,"<span class=""disease"">renal disease</span>","Blockade of the renin-angiotensin-<span class=""chemical"">aldosterone</span> system has proven effective in retarding progression of <span class=""disease"">renal disease</span> in the remnant kidney model, as well as other experimental diseases, and, most importantly, in a range of progressive human renal diseases.",,11709805,11709805_D000450_D051436,11709805_1,bcv_sentence_task_befree_1518,,770957446,FALSE,finalized,5,8/15/15 0:28,"



",no_relation,0.5949,,D000450,"<span class=""chemical"">aldosterone</span>",D015658,"<span class=""disease"">human renal diseases</span>","Blockade of the renin-angiotensin-<span class=""chemical"">aldosterone</span> system has proven effective in retarding progression of renal disease in the remnant kidney model, as well as other experimental diseases, and, most importantly, in a range of progressive <span class=""disease"">human renal diseases</span>.",,11709805,11709805_D000450_D015658,11709805_1,bcv_sentence_task_befree_1519,,770957447,FALSE,finalized,5,8/14/15 23:33,"



",no_relation,1,,D000450,"<span class=""chemical"">aldosterone</span>",D004194,"<span class=""disease"">diseases</span>","Blockade of the renin-angiotensin-<span class=""chemical"">aldosterone</span> system has proven effective in retarding progression of renal disease in the remnant kidney model, as well as other experimental <span class=""disease"">diseases</span>, and, most importantly, in a range of progressive human renal diseases.",,11709805,11709805_D000450_D004194,11709805_1,bcv_sentence_task_befree_1520,,770957448,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,0.5967,,D000450,"<span class=""chemical"">aldosterone</span>",D006973,"<span class=""disease"">hypertension</span>","Thus, <span class=""chemical"">aldosterone</span>, as well as angiotensin II, appears to be instrumental in sustaining the <span class=""disease"">hypertension</span> and fibroproliferative destruction of the residual kidney.",,11709805,11709805_D000450_D006973,11709805_4,bcv_sentence_task_befree_1521,,770957449,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,0.79,,D000804,"<span class=""chemical"">angiotensin II</span>",D006973,"<span class=""disease"">hypertension</span>","Thus, aldosterone, as well as <span class=""chemical"">angiotensin II</span>, appears to be instrumental in sustaining the <span class=""disease"">hypertension</span> and fibroproliferative destruction of the residual kidney.",,11709805,11709805_D000804_D006973,11709805_4,bcv_sentence_task_befree_1522,,770957450,FALSE,finalized,5,8/14/15 21:57,"



",no_relation,0.6037,,D019256,"<span class=""chemical"">cadmium chloride</span>",D063646,"<span class=""disease"">tumorigenesis</span>","The molecular mechanisms potentially responsible for cadmium-induced cell transformation and <span class=""disease"">tumorigenesis</span> were investigated using Balb/c-3T3 cells transformed with <span class=""chemical"">cadmium chloride</span>.",,11711542,11711542_D019256_D063646,11711542_1,bcv_sentence_task_befree_1523,,770957451,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,0.5716,,D002104,"<span class=""chemical"">cadmium</span>",D063646,"<span class=""disease"">tumorigenesis</span>","The molecular mechanisms potentially responsible for <span class=""chemical"">cadmium</span>-induced cell transformation and <span class=""disease"">tumorigenesis</span> were investigated using Balb/c-3T3 cells transformed with cadmium chloride.",,11711542,11711542_D002104_D063646,11711542_1,bcv_sentence_task_befree_1524,,770957452,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D002104,"<span class=""chemical"">cadmium</span>",D063646,"<span class=""disease"">tumorigenesis</span>","Blocking the translation of TEF-1 delta with antisense TEF-1 delta mRNA resulted in a significant reversal of the oncogenic potential of <span class=""chemical"">cadmium</span>-transformed Balb/c-3T3 cells as evidenced from suppression in anchorage-independent growth and <span class=""disease"">tumorigenesis</span> in nude mice.",,11711542,11711542_D002104_D063646,11711542_8,bcv_sentence_task_befree_1525,,770957453,FALSE,finalized,5,8/14/15 22:19,"



",yes_direct,0.7869,,D002104,"<span class=""chemical"">cadmium</span>",D063646,"<span class=""disease"">tumorigenesis</span>","Our findings demonstrate, for the first time, that the cell transformation and <span class=""disease"">tumorigenesis</span> induced by <span class=""chemical"">cadmium</span> are due, at least in part, to the overexpression of TEF-1 delta, a novel <span class=""chemical"">cadmium</span>-responsive proto-oncogene.",,11711542,11711542_D002104_D063646,11711542_9,bcv_sentence_task_befree_1526,,770957454,FALSE,finalized,5,8/14/15 21:02,"



",no_relation,0.8137,,D004656,"<span class=""chemical"">Enalapril</span>",D006973,"<span class=""disease"">hypertension</span>","<span class=""chemical"">Enalapril</span> acts through release of nitric oxide in patients with essential <span class=""disease"">hypertension</span>.",,11725911,11725911_D004656_D006973,11725911_0,bcv_sentence_task_befree_1527,,770957455,FALSE,finalized,5,8/15/15 1:36,"



",no_relation,1,,D009569,"<span class=""chemical"">nitric oxide</span>",D006973,"<span class=""disease"">hypertension</span>","Enalapril acts through release of <span class=""chemical"">nitric oxide</span> in patients with essential <span class=""disease"">hypertension</span>.",,11725911,11725911_D009569_D006973,11725911_0,bcv_sentence_task_befree_1528,,770957456,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,1,,D004656,"<span class=""chemical"">enalapril</span>",D006973,"<span class=""disease"">hypertension</span>","To study the mechanism of action of <span class=""chemical"">enalapril</span>, an ACEI, serum reactive nitrite intermediates (RNI) and citrulline, by products of nitric oxide metabolism were measured before and after treatment with <span class=""chemical"">enalapril</span> in 25 consecutive patients of essential <span class=""disease"">hypertension</span>.",,11725911,11725911_D004656_D006973,11725911_3,bcv_sentence_task_befree_1529,,770957457,FALSE,finalized,5,8/14/15 23:04,"



",no_relation,1,,D009569,"<span class=""chemical"">nitric oxide</span>",D006973,"<span class=""disease"">hypertension</span>","To study the mechanism of action of enalapril, an ACEI, serum reactive nitrite intermediates (RNI) and citrulline, by products of <span class=""chemical"">nitric oxide</span> metabolism were measured before and after treatment with enalapril in 25 consecutive patients of essential <span class=""disease"">hypertension</span>.",,11725911,11725911_D009569_D006973,11725911_3,bcv_sentence_task_befree_1530,,770957458,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,D009573,"<span class=""chemical"">nitrite</span>",D006973,"<span class=""disease"">hypertension</span>","To study the mechanism of action of enalapril, an ACEI, serum reactive <span class=""chemical"">nitrite</span> intermediates (RNI) and citrulline, by products of nitric oxide metabolism were measured before and after treatment with enalapril in 25 consecutive patients of essential <span class=""disease"">hypertension</span>.",,11725911,11725911_D009573_D006973,11725911_3,bcv_sentence_task_befree_1531,,770957459,FALSE,finalized,5,8/14/15 21:08,"



",no_relation,1,,D013806,"<span class=""chemical"">theophylline</span>",D001249,"<span class=""disease"">asthma</span>","Effect of <span class=""chemical"">theophylline</span> on airway inflammation in <span class=""disease"">asthma</span>.",,11743900,11743900_D013806_D001249,11743900_0,bcv_sentence_task_befree_1532,,770957460,FALSE,finalized,5,8/14/15 20:57,"



",no_relation,1,,D013806,"<span class=""chemical"">theophylline</span>",D001249,"<span class=""disease"">asthma</span>","To investigate whether low dose <span class=""chemical"">theophylline</span> has an anti-inflammatory effect in <span class=""disease"">asthma</span>.",,11743900,11743900_D013806_D001249,11743900_1,bcv_sentence_task_befree_1533,,770957461,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,1,,D013806,"<span class=""chemical"">theophylline</span>",D013224,"<span class=""disease"">asthmatic</span>","Nineteen <span class=""disease"">asthmatic</span> subjects were given 200 mg sustained-release <span class=""chemical"">theophylline</span> preparation twice daily for 4 weeks.",,11743900,11743900_D013806_D013224,11743900_2,bcv_sentence_task_befree_1534,,770957462,FALSE,finalized,5,8/14/15 21:23,"



",no_relation,1,,D013806,"<span class=""chemical"">theophylline</span>",D013224,"<span class=""disease"">asthmatic</span>","Before using <span class=""chemical"">theophylline</span>, sputum eosinophils, EG2+ eosinophils, and ECP in <span class=""disease"">asthmatic</span> group were much higher than those of healthy group.",,11743900,11743900_D013806_D013224,11743900_6,bcv_sentence_task_befree_1535,,770957463,FALSE,finalized,5,8/14/15 20:54,"



",no_relation,1,,D013806,"<span class=""chemical"">theophylline</span>",D001249,"<span class=""disease"">asthma</span>","These results indicated that low dose <span class=""chemical"">theophylline</span> had inhibitory action on airway inflammation in <span class=""disease"">asthma</span> with noticeable improvement of the patients' symptoms and lung function.",,11743900,11743900_D013806_D001249,11743900_11,bcv_sentence_task_befree_1536,,770957464,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D001943,"<span class=""disease"">breast carcinoma</span>","Iodine-labeled <span class=""chemical"">tamoxifen</span> uptake in primary human <span class=""disease"">breast carcinoma</span>.",,11752079,11752079_D013629_D001943,11752079_0,bcv_sentence_task_befree_1537,,770957465,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,D007455,"<span class=""chemical"">Iodine</span>",D001943,"<span class=""disease"">breast carcinoma</span>","<span class=""chemical"">Iodine</span>-labeled tamoxifen uptake in primary human <span class=""disease"">breast carcinoma</span>.",,11752079,11752079_D007455_D001943,11752079_0,bcv_sentence_task_befree_1538,,770957466,FALSE,finalized,5,8/14/15 21:06,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">tumor</span>","Assessing <span class=""disease"">tumor</span> uptake and retention of (123)I-labeled <span class=""chemical"">tamoxifen</span> (TX) could increase our understanding of TX's action and the mechanisms involved in resistance to the drug.",,11752079,11752079_D013629_D009369,11752079_1,bcv_sentence_task_befree_1539,,770957467,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,0.5886,,D004967,"<span class=""chemical"">estrogen</span>",D009369,"<span class=""disease"">Tumor</span>","<span class=""disease"">Tumor</span>-to-normal tissue uptake ratios (T/N) derived from SPECT images were related to <span class=""chemical"">estrogen</span> receptor (ER) and progesterone receptor (PR) status.",,11752079,11752079_D004967_D009369,11752079_3,bcv_sentence_task_befree_1540,,770957468,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,0.8065,,D011374,"<span class=""chemical"">progesterone</span>",D009369,"<span class=""disease"">Tumor</span>","<span class=""disease"">Tumor</span>-to-normal tissue uptake ratios (T/N) derived from SPECT images were related to estrogen receptor (ER) and <span class=""chemical"">progesterone</span> receptor (PR) status.",,11752079,11752079_D011374_D009369,11752079_3,bcv_sentence_task_befree_1541,,770957469,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D006526,"<span class=""disease"">chronic hepatitis C virus</span>","In 55 patients with <span class=""disease"">chronic hepatitis C virus</span> (HCV), 33 treated with interferon (IFN) and 22 treated with IFN + <span class=""chemical"">ribavirin</span>, sera was collected prior to treatment, at 3 + 6 months of therapy and 6 months post-treatment.",,11759109,11759109_D012254_D006526,11759109_2,bcv_sentence_task_befree_1542,,770957470,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,0.8152,,D000409,"<span class=""chemical"">alanine</span>",D005355,"<span class=""disease"">fibrosis</span>","Levels of ICAM-1, VCAM-1 and hyaluronic acid were correlated with <span class=""chemical"">alanine</span> aminotransferase levels, HCV-RNA-polymerase chain reaction status and histological <span class=""disease"">fibrosis</span> scoring.",,11759109,11759109_D000409_D005355,11759109_3,bcv_sentence_task_befree_1543,,770957471,FALSE,finalized,5,8/14/15 20:53,"



",no_relation,0.5927,,D003024,"<span class=""chemical"">clozapine</span>",D000380,"<span class=""disease"">agranulocytosis</span>","A number of studies investigating the use of <span class=""chemical"">clozapine</span> have been published in children; however, owing to the frequent monitoring required for <span class=""disease"">agranulocytosis</span>, the use of <span class=""chemical"">clozapine</span> may be restricted to patients with treatment-refractory disease.",,11772153,11772153_D003024_D000380,11772153_4,bcv_sentence_task_befree_1544,,770957472,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,0.8041,,D003024,"<span class=""chemical"">clozapine</span>",D006402,"<span class=""disease"">blood glucose</span>","With accumulating data on the development of glucose intolerance in adults receiving <span class=""chemical"">clozapine</span>, closer monitoring of bodyweight and fasting <span class=""disease"">blood glucose</span> is imperative.",,11772153,11772153_D003024_D006402,11772153_5,bcv_sentence_task_befree_1545,,770957473,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,0.8372,,D005947,"<span class=""chemical"">glucose</span>",D006402,"<span class=""disease"">blood glucose</span>","With accumulating data on the development of <span class=""chemical"">glucose</span> intolerance in adults receiving clozapine, closer monitoring of bodyweight and fasting <span class=""disease"">blood </span><span class=""chemical"">glucose</span> is imperative.",,11772153,11772153_D005947_D006402,11772153_5,bcv_sentence_task_befree_1546,,770957474,FALSE,finalized,5,8/15/15 0:50,"



",yes_direct,0.6056,,D003024,"<span class=""chemical"">clozapine</span>",D018149,"<span class=""disease"">glucose intolerance</span>","With accumulating data on the development of <span class=""disease"">glucose intolerance</span> in adults receiving <span class=""chemical"">clozapine</span>, closer monitoring of bodyweight and fasting blood glucose is imperative.",,11772153,11772153_D003024_D018149,11772153_5,bcv_sentence_task_befree_1547,,770957475,FALSE,finalized,5,8/15/15 2:04,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D018149,"<span class=""disease"">glucose intolerance</span>","With accumulating data on the development of <span class=""chemical""></span><span class=""disease"">glucose</span> intolerance in adults receiving clozapine, closer monitoring of bodyweight and fasting blood <span class=""chemical"">glucose</span> is imperative.",,11772153,11772153_D005947_D018149,11772153_5,bcv_sentence_task_befree_1548,,770957476,FALSE,finalized,5,8/15/15 1:04,"



",yes_direct,1,,D003024,"<span class=""chemical"">Clozapine</span>",D012640,"<span class=""disease"">seizure</span>","<span class=""chemical"">Clozapine</span> also has an increased <span class=""disease"">seizure</span> risk, therefore a baseline electroencephalogram should be performed, as well as continued vigilance for this adverse effect.",,11772153,11772153_D003024_D012640,11772153_6,bcv_sentence_task_befree_1549,,770957477,FALSE,finalized,5,8/14/15 21:44,"



",no_relation,0.6191,,D003024,"<span class=""chemical"">clozapine</span>",D001480,"<span class=""disease"">extrapyramidal symptoms/EPS</span>","Unlike <span class=""chemical"">clozapine</span>, its receptor interaction profile lends itself toward increased risk of <span class=""disease"">extrapyramidal symptoms</span> (<span class=""disease"">EPS</span>) and hyperprolactinaemia.",,11772153,11772153_D003024_D001480,11772153_8,bcv_sentence_task_befree_1550,,770957478,FALSE,finalized,5,8/15/15 2:03,"



",no_relation,0.5967,,D003024,"<span class=""chemical"">clozapine</span>",D006966,"<span class=""disease"">hyperprolactinaemia</span>","Unlike <span class=""chemical"">clozapine</span>, its receptor interaction profile lends itself toward increased risk of extrapyramidal symptoms (EPS) and <span class=""disease"">hyperprolactinaemia</span>.",,11772153,11772153_D003024_D006966,11772153_8,bcv_sentence_task_befree_1551,,770957479,FALSE,finalized,5,8/15/15 2:02,"



",yes_direct,0.6088,,C076029,"<span class=""chemical"">olanzapine</span>",D015430,"<span class=""disease"">Bodyweight gain</span>","<span class=""disease"">Bodyweight gain</span> is a common adverse effect, although somewhat less than that reported with <span class=""chemical"">olanzapine</span>.",,11772153,11772153_C076029_D015430,11772153_9,bcv_sentence_task_befree_1552,,770957480,FALSE,finalized,5,8/14/15 21:00,"



",yes_direct,1,,D018967,"<span class=""chemical"">Risperidone</span>",D001714,"<span class=""disease"">mania</span>","<span class=""chemical"">Risperidone</span>-induced <span class=""disease"">mania</span> has been reported in adults and, therefore, increased caution should be used when deciding to treat children and adolescents with <span class=""chemical"">risperidone</span>, particularly in those with a predisposition toward <span class=""disease"">mania</span>.",,11772153,11772153_D018967_D001714,11772153_11,bcv_sentence_task_befree_1553,,770957481,FALSE,finalized,5,8/15/15 0:58,"



",yes_direct,1,,C076029,"<span class=""chemical"">Olanzapine</span>",D001714,"<span class=""disease"">mania</span>","<span class=""chemical"">Olanzapine</span>, like risperidone, has also been associated with onset of <span class=""disease"">mania</span> in adults.",,11772153,11772153_C076029_D001714,11772153_12,bcv_sentence_task_befree_1554,,770957482,FALSE,finalized,5,8/15/15 0:26,"



",yes_direct,1,,D018967,"<span class=""chemical"">risperidone</span>",D001714,"<span class=""disease"">mania</span>","Olanzapine, like <span class=""chemical"">risperidone</span>, has also been associated with onset of <span class=""disease"">mania</span> in adults.",,11772153,11772153_D018967_D001714,11772153_12,bcv_sentence_task_befree_1555,,770957483,FALSE,finalized,5,8/15/15 0:55,"



",yes_direct,1,,C076029,"<span class=""chemical"">Olanzapine</span>",D015430,"<span class=""disease"">bodyweight gain</span>","<span class=""chemical"">Olanzapine</span> has a receptor profile that results in significant risk for <span class=""disease"">bodyweight gain</span> and sedation.",,11772153,11772153_C076029_D015430,11772153_13,bcv_sentence_task_befree_1556,,770957484,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,0.8093,,D005947,"<span class=""chemical"">glucose</span>",D006402,"<span class=""disease"">blood glucose</span>","Furthermore, this drug has been linked to the development of <span class=""chemical"">glucose</span> intolerance; thus, it is important to monitor bodyweight and fasting <span class=""disease"">blood </span><span class=""chemical"">glucose</span> on a frequent basis.",,11772153,11772153_D005947_D006402,11772153_14,bcv_sentence_task_befree_1557,,770957485,FALSE,finalized,5,8/15/15 1:08,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D018149,"<span class=""disease"">glucose intolerance</span>","Furthermore, this drug has been linked to the development of <span class=""chemical""></span><span class=""disease"">glucose</span> intolerance; thus, it is important to monitor bodyweight and fasting blood <span class=""chemical"">glucose</span> on a frequent basis.",,11772153,11772153_D005947_D018149,11772153_14,bcv_sentence_task_befree_1558,,770957486,FALSE,finalized,5,8/14/15 21:03,"



",yes_direct,0.607,,C076029,"<span class=""chemical"">olanzapine</span>",D015430,"<span class=""disease"">bodyweight gain</span>","Quetiapine appears to have increased risk for sedation and <span class=""disease"">bodyweight gain</span>, albeit less than that of <span class=""chemical"">olanzapine</span>.",,11772153,11772153_C076029_D015430,11772153_17,bcv_sentence_task_befree_1559,,770957487,FALSE,finalized,5,8/14/15 21:59,"



",yes_direct,1,,C069541,"<span class=""chemical"">Quetiapine</span>",D015430,"<span class=""disease"">bodyweight gain</span>","<span class=""chemical"">Quetiapine</span> appears to have increased risk for sedation and <span class=""disease"">bodyweight gain</span>, albeit less than that of olanzapine.",,11772153,11772153_C069541_D015430,11772153_17,bcv_sentence_task_befree_1560,,770957488,FALSE,finalized,5,8/14/15 23:38,"



",no_relation,1,,C092292,"<span class=""chemical"">ziprasidone</span>",D015430,"<span class=""disease"">bodyweight gain</span>","Lack of evidence for <span class=""disease"">bodyweight gain</span> with <span class=""chemical"">ziprasidone</span> is a considerable advantage.",,11772153,11772153_C092292_D015430,11772153_23,bcv_sentence_task_befree_1561,,770957489,FALSE,finalized,5,8/14/15 20:54,"



",no_relation,1,,D007213,"<span class=""chemical"">Indomethacin</span>",D006831,"<span class=""disease"">polyhydramnios</span>","<span class=""chemical"">Indomethacin</span> therapy in the treatment of <span class=""disease"">polyhydramnios</span> due to placental chorioangioma.",,11776505,11776505_D007213_D006831,11776505_0,bcv_sentence_task_befree_1562,,770957490,FALSE,finalized,5,8/15/15 2:07,"



",no_relation,0.8208,,D007213,"<span class=""chemical"">Indomethacin</span>",D006391,"<span class=""disease"">placental chorioangioma</span>","<span class=""chemical"">Indomethacin</span> therapy in the treatment of polyhydramnios due to <span class=""disease"">placental chorioangioma</span>.",,11776505,11776505_D007213_D006391,11776505_0,bcv_sentence_task_befree_1563,,770957491,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,1,,D007213,"<span class=""chemical"">indomethacin</span>",D012128,"<span class=""disease"">respiratory distress</span>","Preterm labor started with <span class=""disease"">respiratory distress</span> and <span class=""chemical"">indomethacin</span>, 25 mg was given every 6 hours.",,11776505,11776505_D007213_D012128,11776505_4,bcv_sentence_task_befree_1564,,770957492,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,1,,D007213,"<span class=""chemical"">indomethacin</span>",D007752,"<span class=""disease"">Preterm labor</span>","<span class=""disease"">Preterm labor</span> started with respiratory distress and <span class=""chemical"">indomethacin</span>, 25 mg was given every 6 hours.",,11776505,11776505_D007213_D007752,11776505_4,bcv_sentence_task_befree_1565,,770957493,FALSE,finalized,5,8/14/15 23:56,"



",no_relation,0.7943,,D013256,"<span class=""chemical"">steroid</span>",D003093,"<span class=""disease"">ulcerative colitis</span>","Effective maintenance leukocytapheresis for patients with <span class=""chemical"">steroid</span> dependent or resistant <span class=""disease"">ulcerative colitis</span>.",,11800081,11800081_D013256_D003093,11800081_0,bcv_sentence_task_befree_1566,,770957494,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,0.8101,,D000305,"<span class=""chemical"">corticosteroid</span>",D003093,"<span class=""disease"">ulcerative colitis/UC</span>","We prospectively examined the effect of leukocytapheresis (LA) on the maintenance of remission in 7 patients with <span class=""disease"">ulcerative colitis</span> (<span class=""disease"">UC</span>) who were initially refractory to <span class=""chemical"">corticosteroid</span> therapy (steroid resistant or steroid dependent).",,11800081,11800081_D000305_D003093,11800081_1,bcv_sentence_task_befree_1567,,770957495,FALSE,finalized,5,8/14/15 20:56,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",D003093,"<span class=""disease"">ulcerative colitis/UC</span>","We prospectively examined the effect of leukocytapheresis (LA) on the maintenance of remission in 7 patients with <span class=""disease"">ulcerative colitis</span> (<span class=""disease"">UC</span>) who were initially refractory to corticosteroid therapy (<span class=""chemical"">steroid</span> resistant or <span class=""chemical"">steroid</span> dependent).",,11800081,11800081_D013256_D003093,11800081_1,bcv_sentence_task_befree_1568,,770957496,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",D003093,"<span class=""disease"">UC</span>","The patients with refractory <span class=""disease"">UC</span> had been in remission due to LA (induction LA) in combination with the <span class=""chemical"">steroid</span> therapy.",,11800081,11800081_D013256_D003093,11800081_2,bcv_sentence_task_befree_1569,,770957497,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid/steroids</span>",D003093,"<span class=""disease"">UC</span>","It is concluded that the maintenance LA therapy might be effective in some patients with <span class=""chemical"">steroid</span> dependent or resistant <span class=""disease"">UC</span> for the maintenance of remission without <span class=""chemical"">steroids</span>.",,11800081,11800081_D013256_D003093,11800081_10,bcv_sentence_task_befree_1570,,770957498,FALSE,finalized,5,8/14/15 22:42,"



",yes_direct,1,,D006220,"<span class=""chemical"">haloperidol</span>",D009459,"<span class=""disease"">neuroleptic syndrome</span>","A patient suffering from a rare enzyme deficiency developed a malignant <span class=""disease"">neuroleptic syndrome</span> after having been treated with one single dose of <span class=""chemical"">haloperidol</span>.",,11819156,11819156_D006220_D009459,11819156_1,bcv_sentence_task_befree_1571,,770957499,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,1,,D044062,"<span class=""chemical"">prostacyclins</span>",D065627,"<span class=""disease"">PPH</span>","Due to the complicated nature of this therapy, inhaled, sc. and oral <span class=""chemical"">prostacyclins</span> have also been evaluated for treatment of <span class=""disease"">PPH</span>.",,11829729,11829729_D044062_D065627,11829729_5,bcv_sentence_task_befree_1572,,770957500,FALSE,finalized,5,8/15/15 1:38,"



",yes_direct,1,,D002784,"<span class=""chemical"">cholesterol</span>",D003324,"<span class=""disease"">coronary artery disease/CAD</span>","It is commonly agreed that people with a high blood LDL-<span class=""chemical"">cholesterol</span> will have a higher risk of <span class=""disease"">coronary artery disease</span> (<span class=""disease"">CAD</span>) than people with low blood LDL-<span class=""chemical"">cholesterol</span>.",,11835697,11835697_D002784_D003324,11835697_1,bcv_sentence_task_befree_1573,,770957501,FALSE,finalized,5,8/14/15 21:02,"



",no_relation,0.8141,,C008047,"<span class=""chemical"">HMG-CoA</span>",D006937,"<span class=""disease"">hypercholesterolemia</span>","Simvastatin, an <span class=""chemical"">HMG-CoA</span> reductase inhibitor, is listed as an essential drug for the treatment of <span class=""disease"">hypercholesterolemia</span>.",,11835697,11835697_C008047_D006937,11835697_4,bcv_sentence_task_befree_1574,,770957502,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,D019821,"<span class=""chemical"">Simvastatin</span>",D006937,"<span class=""disease"">hypercholesterolemia</span>","<span class=""chemical"">Simvastatin</span>, an HMG-CoA reductase inhibitor, is listed as an essential drug for the treatment of <span class=""disease"">hypercholesterolemia</span>.",,11835697,11835697_D019821_D006937,11835697_4,bcv_sentence_task_befree_1575,,770957503,FALSE,finalized,5,8/14/15 20:55,"



",no_relation,1,,C006632,"<span class=""chemical"">Arsenic trioxide</span>",D007943,"<span class=""disease"">leukemic differentiation</span>","<span class=""chemical"">Arsenic trioxide</span> and methylprednisolone use different signal transduction pathways in <span class=""disease"">leukemic differentiation</span>.",,11839383,11839383_C006632_D007943,11839383_0,bcv_sentence_task_befree_1576,,770957504,FALSE,finalized,5,8/14/15 20:53,"



",no_relation,0.7902,,D008775,"<span class=""chemical"">methylprednisolone</span>",D007943,"<span class=""disease"">leukemic differentiation</span>","Arsenic trioxide and <span class=""chemical"">methylprednisolone</span> use different signal transduction pathways in <span class=""disease"">leukemic differentiation</span>.",,11839383,11839383_D008775_D007943,11839383_0,bcv_sentence_task_befree_1577,,770957505,FALSE,finalized,5,8/14/15 23:00,"



",no_relation,0.4319,,D008775,"<span class=""chemical"">methylprednisolone</span>",D007951,"<span class=""disease"">myeloid leukemia</span>","High dose <span class=""chemical"">methylprednisolone</span> treatment has been shown to induce in vivo and in vitro differentiation of <span class=""disease"">myeloid leukemia</span> cells to mature granulocytes in patients with acute promyelocytic leukemia (APL) and other subtypes of acute myeloid leukemia (AML).",,11839383,11839383_D008775_D007951,11839383_2,bcv_sentence_task_befree_1578,,770957506,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D008775,"<span class=""chemical"">methylprednisolone</span>",D015473,"<span class=""disease"">APL/acute promyelocytic leukemia</span>","High dose <span class=""chemical"">methylprednisolone</span> treatment has been shown to induce in vivo and in vitro differentiation of myeloid leukemia cells to mature granulocytes in patients with <span class=""disease"">acute promyelocytic leukemia</span> (<span class=""disease"">APL</span>) and other subtypes of acute myeloid leukemia (AML).",,11839383,11839383_D008775_D015473,11839383_2,bcv_sentence_task_befree_1579,,770957507,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,0.8125,,D008775,"<span class=""chemical"">methylprednisolone</span>",D015470,"<span class=""disease"">acute myeloid leukemia/AML</span>","High dose <span class=""chemical"">methylprednisolone</span> treatment has been shown to induce in vivo and in vitro differentiation of myeloid leukemia cells to mature granulocytes in patients with acute promyelocytic leukemia (APL) and other subtypes of <span class=""disease"">acute myeloid leukemia</span> (<span class=""disease"">AML</span>).",,11839383,11839383_D008775_D015470,11839383_2,bcv_sentence_task_befree_1580,,770957508,FALSE,finalized,5,8/14/15 20:58,"



",no_relation,0.5989,,C006632,"<span class=""chemical"">Arsenic trioxide</span>",D015473,"<span class=""disease"">APL</span>","<span class=""chemical"">Arsenic trioxide</span> (As(2)O(3)) has been confirmed to have remission induction effects on <span class=""disease"">APL</span>.",,11839383,11839383_C006632_D015473,11839383_3,bcv_sentence_task_befree_1581,,770957509,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D008775,"<span class=""chemical"">methylprednisolone</span>",D007943,"<span class=""disease"">leukemic differentiation</span>","In contrast to <span class=""chemical"">methylprednisolone</span>, there was no effect of phosphatase inhibitors on As(2)O(3)-induced <span class=""disease"">leukemic differentiation</span>.",,11839383,11839383_D008775_D007943,11839383_9,bcv_sentence_task_befree_1582,,770957510,FALSE,finalized,5,8/14/15 22:51,"



",no_relation,1,,D008775,"<span class=""chemical"">methylprednisolone</span>",D007943,"<span class=""disease"">leukemic differentiation</span>","Incomplete <span class=""disease"">leukemic differentiation</span> occurred with lower As(2)O(3) concentration as 10(-6)M. Unlike As(2)O(3), <span class=""chemical"">methylprednisolone</span> induced complete granulocytic and/or monocytic differentiation of HL 60 and K 562 cells via upregulation of PP2A regulatory subunits.",,11839383,11839383_D008775_D007943,11839383_10,bcv_sentence_task_befree_1583,,770957511,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,1,,D008775,"<span class=""chemical"">methylprednisolone</span>",D007943,"<span class=""disease"">leukemic differentiation</span>","Therefore, As(2)O(3) and <span class=""chemical"">methylprednisolone</span> are promising agents that have the potential to be used together in myeloid <span class=""disease"">leukemic differentiation</span> therapy.",,11839383,11839383_D008775_D007943,11839383_11,bcv_sentence_task_befree_1584,,770957512,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D007006,"<span class=""disease"">hypogonadotrophic hypogonadism</span>","These data were consistent with partial <span class=""disease"">hypogonadotrophic hypogonadism</span> of hypothalamic origin, and the patient was treated with <span class=""chemical"">testosterone</span>.",,11874189,11874189_D013739_D007006,11874189_15,bcv_sentence_task_befree_1585,,770957513,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,0.794,,D009569,"<span class=""chemical"">nitric oxide</span>",D009336,"<span class=""disease"">necrosis</span>","Pentoxifylline downregulates <span class=""chemical"">nitric oxide</span> and tumor <span class=""disease"">necrosis</span> factor-alpha induced by mycobacterial lipoarabinomannan in a macrophage cell line.",,11875767,11875767_D009569_D009336,11875767_0,bcv_sentence_task_befree_1586,,770957514,FALSE,finalized,5,8/15/15 1:29,"



",no_relation,1,,D009569,"<span class=""chemical"">nitric oxide</span>",D009369,"<span class=""disease"">tumor</span>","Pentoxifylline downregulates <span class=""chemical"">nitric oxide</span> and <span class=""disease"">tumor</span> necrosis factor-alpha induced by mycobacterial lipoarabinomannan in a macrophage cell line.",,11875767,11875767_D009569_D009369,11875767_0,bcv_sentence_task_befree_1587,,770957515,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,D010431,"<span class=""chemical"">Pentoxifylline</span>",D009369,"<span class=""disease"">tumor</span>","<span class=""chemical"">Pentoxifylline</span> downregulates nitric oxide and <span class=""disease"">tumor</span> necrosis factor-alpha induced by mycobacterial lipoarabinomannan in a macrophage cell line.",,11875767,11875767_D010431_D009369,11875767_0,bcv_sentence_task_befree_1588,,770957516,FALSE,finalized,5,8/14/15 20:51,"



",no_relation,1,,D010431,"<span class=""chemical"">Pentoxifylline</span>",D009336,"<span class=""disease"">necrosis</span>","<span class=""chemical"">Pentoxifylline</span> downregulates nitric oxide and tumor <span class=""disease"">necrosis</span> factor-alpha induced by mycobacterial lipoarabinomannan in a macrophage cell line.",,11875767,11875767_D010431_D009336,11875767_0,bcv_sentence_task_befree_1589,,770957517,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D010431,"<span class=""chemical"">Pentoxifylline/PTX</span>",D009336,"<span class=""disease"">necrosis</span>","<span class=""chemical"">Pentoxifylline</span> (<span class=""chemical"">PTX</span>), a phosphodiesterase inhibitor, is known to downregulate tumor <span class=""disease"">necrosis</span> factor-alpha (TNF-alpha) secretion induced by lipopolysacchride (LPS) and gamma interferon (IFN-gamma).",,11875767,11875767_D010431_D009336,11875767_1,bcv_sentence_task_befree_1590,,770957518,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,1,,D010431,"<span class=""chemical"">Pentoxifylline/PTX</span>",D009369,"<span class=""disease"">tumor</span>","<span class=""chemical"">Pentoxifylline</span> (<span class=""chemical"">PTX</span>), a phosphodiesterase inhibitor, is known to downregulate <span class=""disease"">tumor</span> necrosis factor-alpha (TNF-alpha) secretion induced by lipopolysacchride (LPS) and gamma interferon (IFN-gamma).",,11875767,11875767_D010431_D009369,11875767_1,bcv_sentence_task_befree_1591,,770957519,FALSE,finalized,5,8/14/15 20:56,"



",yes_direct,1,,D014635,"<span class=""chemical"">sodium valproate</span>",D009395,"<span class=""disease"">Tubulo-interstitial nephritis</span>","<span class=""disease"">Tubulo-interstitial nephritis</span> caused by <span class=""chemical"">sodium valproate</span>.",,11891102,11891102_D014635_D009395,11891102_0,bcv_sentence_task_befree_1592,,770957520,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,0.7998,,D014635,"<span class=""chemical"">sodium valproate</span>",D004827,"<span class=""disease"">epilepsy</span>","A severely handicapped 14-year-old Japanese girl had <span class=""disease"">epilepsy</span> and was treated with <span class=""chemical"">sodium valproate</span> (SV) from the age of 7 years.",,11891102,11891102_D014635_D004827,11891102_1,bcv_sentence_task_befree_1593,,770957521,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,1,,D002996,"<span class=""chemical"">clomiphene citrate</span>",D011085,"<span class=""disease"">polycystic ovary syndrome/PCOS</span>","With the availability of laparoscopic ovarian cautery, there has been a resurgence in interest in the surgical treatment of <span class=""chemical"">clomiphene citrate</span>-resistant <span class=""disease"">polycystic ovary syndrome</span> (<span class=""disease"">PCOS</span>).",,11915582,11915582_D002996_D011085,11915582_1,bcv_sentence_task_befree_1594,,770957522,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,D002996,"<span class=""chemical"">clomiphene citrate</span>",D011085,"<span class=""disease"">PCOS</span>","Because of the potential advantages of ovarian cautery, we recommend this surgery as the next line of treatment if <span class=""chemical"">clomiphene citrate</span> fails to induce ovulation in <span class=""disease"">PCOS</span> patients, before gonadotropins are introduced.",,11915582,11915582_D002996_D011085,11915582_4,bcv_sentence_task_befree_1595,,770957523,FALSE,finalized,5,8/15/15 0:41,"



",no_relation,1,,C058218,"<span class=""chemical"">Duloxetine</span>",D003866,"<span class=""disease"">depressive disorder</span>","<span class=""chemical"">Duloxetine</span> in the treatment of major <span class=""disease"">depressive disorder</span>: a double-blind clinical trial.",,11926722,11926722_C058218_D003866,11926722_0,bcv_sentence_task_befree_1596,,770957524,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,C058218,"<span class=""chemical"">Duloxetine hydrochloride</span>",D003865,"<span class=""disease"">major depression</span>","<span class=""chemical"">Duloxetine hydrochloride</span>, a dual reuptake inhibitor of serotonin and norepinephrine, was evaluated for therapeutic efficacy and safety/tolerability in the treatment of <span class=""disease"">major depression</span>.",,11926722,11926722_C058218_D003865,11926722_1,bcv_sentence_task_befree_1597,,770957525,FALSE,finalized,5,8/14/15 20:53,"



",no_relation,1,,D012701,"<span class=""chemical"">serotonin</span>",D003865,"<span class=""disease"">major depression</span>","Duloxetine hydrochloride, a dual reuptake inhibitor of <span class=""chemical"">serotonin</span> and norepinephrine, was evaluated for therapeutic efficacy and safety/tolerability in the treatment of <span class=""disease"">major depression</span>.",,11926722,11926722_D012701_D003865,11926722_1,bcv_sentence_task_befree_1598,,770957526,FALSE,finalized,5,8/15/15 0:49,"



",no_relation,1,,D009638,"<span class=""chemical"">norepinephrine</span>",D003865,"<span class=""disease"">major depression</span>","Duloxetine hydrochloride, a dual reuptake inhibitor of serotonin and <span class=""chemical"">norepinephrine</span>, was evaluated for therapeutic efficacy and safety/tolerability in the treatment of <span class=""disease"">major depression</span>.",,11926722,11926722_D009638_D003865,11926722_1,bcv_sentence_task_befree_1599,,770957527,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,1,,C058218,"<span class=""chemical"">duloxetine</span>",D003866,"<span class=""disease"">depressive disorder</span>","In an 8-week multicenter, double-blind, placebo-controlled study, 173 patients (aged 18-65 years) with DSM-IV major <span class=""disease"">depressive disorder</span> were randomly allocated to receive placebo (N = 70), <span class=""chemical"">duloxetine</span> (N = 70), or fluoxetine, 20 mg q.d.",,11926722,11926722_C058218_D003866,11926722_2,bcv_sentence_task_befree_1600,,770957528,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,0.8002,,D005473,"<span class=""chemical"">fluoxetine</span>",D003866,"<span class=""disease"">depressive disorder</span>","In an 8-week multicenter, double-blind, placebo-controlled study, 173 patients (aged 18-65 years) with DSM-IV major <span class=""disease"">depressive disorder</span> were randomly allocated to receive placebo (N = 70), duloxetine (N = 70), or <span class=""chemical"">fluoxetine</span>, 20 mg q.d.",,11926722,11926722_D005473_D003866,11926722_2,bcv_sentence_task_befree_1601,,770957529,FALSE,finalized,5,8/15/15 0:30,"



",yes_direct,1,,C058218,"<span class=""chemical"">duloxetine</span>",D001247,"<span class=""disease"">asthenia</span>","In general, <span class=""chemical"">duloxetine</span> was well tolerated; 76% of patients achieved the maximum dose, and insomnia and <span class=""disease"">asthenia</span> were the only adverse events reported statistically significantly (p < .05) more frequently by <span class=""chemical"">duloxetine</span>-treated patients compared with placebo-treated patients.",,11926722,11926722_C058218_D001247,11926722_12,bcv_sentence_task_befree_1602,,770957530,FALSE,finalized,5,8/15/15 1:22,"



",yes_direct,0.6118,,C058218,"<span class=""chemical"">duloxetine</span>",D007319,"<span class=""disease"">insomnia</span>","In general, <span class=""chemical"">duloxetine</span> was well tolerated; 76% of patients achieved the maximum dose, and <span class=""disease"">insomnia</span> and asthenia were the only adverse events reported statistically significantly (p < .05) more frequently by <span class=""chemical"">duloxetine</span>-treated patients compared with placebo-treated patients.",,11926722,11926722_C058218_D007319,11926722_12,bcv_sentence_task_befree_1603,,770957531,FALSE,finalized,5,8/14/15 21:05,"



",no_relation,1,,C058218,"<span class=""chemical"">duloxetine</span>",D003866,"<span class=""disease"">depressive disorder</span>","These data indicate that <span class=""chemical"">duloxetine</span> is efficacious for the treatment of major <span class=""disease"">depressive disorder</span> and is well tolerated and safe.",,11926722,11926722_C058218_D003866,11926722_13,bcv_sentence_task_befree_1604,,770957532,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,0.6059,,D003024,"<span class=""chemical"">clozapine</span>",D001008,"<span class=""disease"">anxiety/depression</span>","A new 4-factor model (negative symptoms, reality distortion, disorganization, and <span class=""disease"">anxiety/depression</span>) had better fit in both data sets than two commonly used factor models, and also fit better post-<span class=""chemical"">clozapine</span>.",,11927178,11927178_D003024_D001008,11927178_5,bcv_sentence_task_befree_1605,,770957533,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,0.8038,,D004008,"<span class=""chemical"">Diclofenac</span>",D000699,"<span class=""disease"">analgesia</span>","<span class=""chemical"">Diclofenac</span> or paracetamol for <span class=""disease"">analgesia</span> in paediatric myringotomy outpatients.",,11939442,11939442_D004008_D000699,11939442_0,bcv_sentence_task_befree_1606,,770957534,FALSE,finalized,5,8/15/15 0:34,"



",no_relation,0.792,,D000082,"<span class=""chemical"">paracetamol</span>",D000699,"<span class=""disease"">analgesia</span>","Diclofenac or <span class=""chemical"">paracetamol</span> for <span class=""disease"">analgesia</span> in paediatric myringotomy outpatients.",,11939442,11939442_D000082_D000699,11939442_0,bcv_sentence_task_befree_1607,,770957535,FALSE,finalized,5,8/14/15 23:59,"



",no_relation,1,,D000082,"<span class=""chemical"">paracetamol</span>",D010146,"<span class=""disease"">postoperative pain</span>","This prospective, randomized, double-blind study compared the analgesic efficacy of oral diclofenac resinate 0.5 mg.kg(-1) with <span class=""chemical"">paracetamol</span> 15 mg/kg(-1) for control of <span class=""disease"">postoperative pain</span> in paediatric patients for outpatient bilateral myringotomy and tube insertion.",,11939442,11939442_D000082_D010146,11939442_1,bcv_sentence_task_befree_1608,,770957536,FALSE,finalized,5,8/14/15 21:32,"



",no_relation,0.5741,,D004008,"<span class=""chemical"">diclofenac</span>",D000699,"<span class=""disease"">analgesia</span>","Twenty per cent of the <span class=""chemical"">diclofenac</span> group and 27% of the paracetamol group required rescue <span class=""disease"">analgesia</span> (not statistically significant).",,11939442,11939442_D004008_D000699,11939442_12,bcv_sentence_task_befree_1609,,770957537,FALSE,finalized,5,8/14/15 21:41,"



",no_relation,1,,D000082,"<span class=""chemical"">paracetamol</span>",D000699,"<span class=""disease"">analgesia</span>","Twenty per cent of the diclofenac group and 27% of the <span class=""chemical"">paracetamol</span> group required rescue <span class=""disease"">analgesia</span> (not statistically significant).",,11939442,11939442_D000082_D000699,11939442_12,bcv_sentence_task_befree_1610,,770957538,FALSE,finalized,5,8/14/15 23:56,"



",yes_direct,0.6135,,C476513,"<span class=""chemical"">levobupivacaine</span>",D064420,"<span class=""disease"">toxicity</span>","Cardiac and CNS <span class=""disease"">toxicity</span> of <span class=""chemical"">levobupivacaine</span>: strengths of evidence for advantage over bupivacaine.",,11945112,11945112_C476513_D064420,11945112_0,bcv_sentence_task_befree_1611,,770957539,FALSE,finalized,5,8/14/15 21:31,"



",no_relation,1,,D002045,"<span class=""chemical"">bupivacaine</span>",D064420,"<span class=""disease"">toxicity</span>","Cardiac and CNS <span class=""disease"">toxicity</span> of levobupivacaine: strengths of evidence for advantage over <span class=""chemical"">bupivacaine</span>.",,11945112,11945112_D002045_D064420,11945112_0,bcv_sentence_task_befree_1612,,770957540,FALSE,finalized,5,8/15/15 2:01,"



",no_relation,1,,C476513,"<span class=""chemical"">Levobupivacaine</span>",D064420,"<span class=""disease"">toxicity</span>","<span class=""chemical"">Levobupivacaine</span>, a single enantiomer of bupivacaine, has recently been introduced as a new long-acting local anaesthetic with a potentially reduced <span class=""disease"">toxicity</span> compared with bupivacaine.",,11945112,11945112_C476513_D064420,11945112_3,bcv_sentence_task_befree_1613,,770957541,FALSE,finalized,5,8/15/15 2:20,"



",no_relation,0.5814,,D002045,"<span class=""chemical"">bupivacaine</span>",D064420,"<span class=""disease"">toxicity</span>","Levobupivacaine, a single enantiomer of <span class=""chemical"">bupivacaine</span>, has recently been introduced as a new long-acting local anaesthetic with a potentially reduced <span class=""disease"">toxicity</span> compared with <span class=""chemical"">bupivacaine</span>.",,11945112,11945112_D002045_D064420,11945112_3,bcv_sentence_task_befree_1614,,770957542,FALSE,finalized,5,8/15/15 1:03,"



",yes_direct,0.6035,,C476513,"<span class=""chemical"">levobupivacaine</span>",D003643,"<span class=""disease"">death</span>","In awake sheep, for example, almost 78% more <span class=""chemical"">levobupivacaine</span> was required to cause <span class=""disease"">death</span>.",,11945112,11945112_C476513_D003643,11945112_7,bcv_sentence_task_befree_1615,,770957543,FALSE,finalized,5,8/14/15 22:40,"



",no_relation,0.5913,,C476513,"<span class=""chemical"">levobupivacaine</span>",D017180,"<span class=""disease"">ventricular tachycardia</span>","In contrast, in anaesthetised dogs no differences were seen in the incidence of spontaneous or electrical stimulation- induced <span class=""disease"">ventricular tachycardia</span> and fibrillations among animals exposed to <span class=""chemical"">levobupivacaine</span> or bupivacaine.",,11945112,11945112_C476513_D017180,11945112_8,bcv_sentence_task_befree_1616,,770957544,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,0.795,,C476513,"<span class=""chemical"">levobupivacaine</span>",D014693,"<span class=""disease"">fibrillations</span>","In contrast, in anaesthetised dogs no differences were seen in the incidence of spontaneous or electrical stimulation- induced ventricular tachycardia and <span class=""disease"">fibrillations</span> among animals exposed to <span class=""chemical"">levobupivacaine</span> or bupivacaine.",,11945112,11945112_C476513_D014693,11945112_8,bcv_sentence_task_befree_1617,,770957545,FALSE,finalized,5,8/14/15 21:15,"



",no_relation,0.7936,,D002045,"<span class=""chemical"">bupivacaine</span>",D017180,"<span class=""disease"">ventricular tachycardia</span>","In contrast, in anaesthetised dogs no differences were seen in the incidence of spontaneous or electrical stimulation- induced <span class=""disease"">ventricular tachycardia</span> and fibrillations among animals exposed to levobupivacaine or <span class=""chemical"">bupivacaine</span>.",,11945112,11945112_D002045_D017180,11945112_8,bcv_sentence_task_befree_1618,,770957546,FALSE,finalized,5,8/14/15 23:15,"



",no_relation,0.5884,,D002045,"<span class=""chemical"">bupivacaine</span>",D014693,"<span class=""disease"">fibrillations</span>","In contrast, in anaesthetised dogs no differences were seen in the incidence of spontaneous or electrical stimulation- induced ventricular tachycardia and <span class=""disease"">fibrillations</span> among animals exposed to levobupivacaine or <span class=""chemical"">bupivacaine</span>.",,11945112,11945112_D002045_D014693,11945112_8,bcv_sentence_task_befree_1619,,770957547,FALSE,finalized,5,8/15/15 2:17,"



",yes_direct,1,,C476513,"<span class=""chemical"">levobupivacaine</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","The reversibility of <span class=""chemical"">levobupivacaine</span>-induced <span class=""disease"">cardiotoxicity</span> has also been assessed.",,11945112,11945112_C476513_D066126,11945112_9,bcv_sentence_task_befree_1620,,770957548,FALSE,finalized,5,8/15/15 1:08,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",D004679,"<span class=""disease"">encephalomyelitis</span>","Effectiveness of intravenous immunoglobulin treatment in adult patients with <span class=""chemical"">steroid</span>-resistant monophasic or recurrent acute disseminated <span class=""disease"">encephalomyelitis</span>.",,11954856,11954856_D013256_D004679,11954856_0,bcv_sentence_task_befree_1621,,770957549,FALSE,finalized,5,8/15/15 1:21,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",D004679,"<span class=""disease"">encephalomyelitis</span>","We present here five patients, 3 of them affected by classic disseminated <span class=""disease"">encephalomyelitis</span> and 2 by a post infectious myelitis, which showed a good response to intravenous immunoglobulin (IVIg) after <span class=""chemical"">steroid</span> treatment failure.",,11954856,11954856_D013256_D004679,11954856_4,bcv_sentence_task_befree_1622,,770957550,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",D009187,"<span class=""disease"">infectious myelitis</span>","We present here five patients, 3 of them affected by classic disseminated encephalomyelitis and 2 by a post <span class=""disease"">infectious myelitis</span>, which showed a good response to intravenous immunoglobulin (IVIg) after <span class=""chemical"">steroid</span> treatment failure.",,11954856,11954856_D013256_D009187,11954856_4,bcv_sentence_task_befree_1623,,770957551,FALSE,finalized,5,8/15/15 2:23,"



",no_relation,1,,D011239,"<span class=""chemical"">prednisolone</span>",D054198,"<span class=""disease"">ALL</span>","Adult Ph+ (n = 12) <span class=""disease"">ALL</span> was more resistant to <span class=""chemical"">prednisolone</span> (> 270-fold, P = 0.030), and displayed an overall tendency to resistance when compared to matched cases of Ph- (n = 15) adult precursor B-cell <span class=""disease"">ALL</span>.",,11984797,11984797_D011239_D054198,11984797_6,bcv_sentence_task_befree_1624,,770957552,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D011239,"<span class=""chemical"">prednisolone</span>",D054198,"<span class=""disease"">ALL</span>","Within Ph+ <span class=""disease"">ALL</span>, in vitro <span class=""chemical"">prednisolone</span> resistance increased significantly with age (P = 0.006).",,11984797,11984797_D011239_D054198,11984797_7,bcv_sentence_task_befree_1625,,770957553,FALSE,finalized,5,8/14/15 21:05,"



",no_relation,1,,D011239,"<span class=""chemical"">prednisolone</span>",D054198,"<span class=""disease"">ALL</span>","The correlation of <span class=""chemical"">prednisolone</span> resistance with age within the Ph+ cases might help explain the poorer prognosis of adult Ph+ <span class=""disease"">ALL</span>.",,11984797,11984797_D011239_D054198,11984797_11,bcv_sentence_task_befree_1626,,770957554,FALSE,finalized,5,8/15/15 1:11,"



",no_relation,1,,D008874,"<span class=""chemical"">midazolam</span>",D013226,"<span class=""disease"">status epilepticus</span>","The potential of <span class=""chemical"">midazolam</span> given via a nasal spray in the acute treatment of <span class=""disease"">status epilepticus</span> and other seizure disruptions should be evaluated.",,11994056,11994056_D008874_D013226,11994056_13,bcv_sentence_task_befree_1627,,770957555,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,1,,D008874,"<span class=""chemical"">midazolam</span>",D012640,"<span class=""disease"">seizure</span>","The potential of <span class=""chemical"">midazolam</span> given via a nasal spray in the acute treatment of status epilepticus and other <span class=""disease"">seizure</span> disruptions should be evaluated.",,11994056,11994056_D008874_D012640,11994056_13,bcv_sentence_task_befree_1628,,770957556,FALSE,finalized,5,8/15/15 0:49,"



",no_relation,1,,C001758,"<span class=""chemical"">Bendamustine</span>",D008223,"<span class=""disease"">indolent lymphomas</span>","<span class=""chemical"">Bendamustine</span> (B) and mitoxantrone (M) have been shown to be potent cytotoxic drugs for the treatment of relapsed or refractory <span class=""disease"">indolent lymphomas</span>.",,11999564,11999564_C001758_D008223,11999564_1,bcv_sentence_task_befree_1629,,770957557,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D008942,"<span class=""chemical"">mitoxantrone</span>",D008223,"<span class=""disease"">indolent lymphomas</span>","Bendamustine (B) and <span class=""chemical"">mitoxantrone</span> (M) have been shown to be potent cytotoxic drugs for the treatment of relapsed or refractory <span class=""disease"">indolent lymphomas</span>.",,11999564,11999564_D008942_D008223,11999564_1,bcv_sentence_task_befree_1630,,770957558,FALSE,finalized,5,8/15/15 0:00,"



",no_relation,1,,D014801,"<span class=""chemical"">vitamin A</span>",C538659,"<span class=""disease"">rural South</span>","Increased <span class=""chemical"">vitamin A</span> intake in children aged 2-5 years through targeted home-gardens in a <span class=""disease"">rural South</span> African community.",,12001973,12001973_D014801_C538659,12001973_0,bcv_sentence_task_befree_1631,,770957559,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D014801,"<span class=""chemical"">vitamin A</span>",C538659,"<span class=""disease"">rural South</span>","To determine <span class=""chemical"">vitamin A</span> intake of children aged 2-5 years in a <span class=""disease"">rural South</span> African community one year after the implementation of a home-based food production programme targeting beta-carotene-rich fruits and vegetables.",,12001973,12001973_D014801_C538659,12001973_1,bcv_sentence_task_befree_1632,,770957560,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,D019207,"<span class=""chemical"">beta-carotene</span>",C538659,"<span class=""disease"">rural South</span>","To determine vitamin A intake of children aged 2-5 years in a <span class=""disease"">rural South</span> African community one year after the implementation of a home-based food production programme targeting <span class=""chemical"">beta-carotene</span>-rich fruits and vegetables.",,12001973,12001973_D019207_C538659,12001973_1,bcv_sentence_task_befree_1633,,770957561,FALSE,finalized,5,8/14/15 21:22,"



",yes_direct,0.6262,,D011803,"<span class=""chemical"">Quinine</span>",D064420,"<span class=""disease"">ocular toxicity</span>","<span class=""chemical"">Quinine</span> <span class=""disease"">ocular toxicity</span>: treatment of blindness using therapy for vasospasm.",,12002937,12002937_D011803_D064420,12002937_0,bcv_sentence_task_befree_1634,,770957562,FALSE,finalized,5,8/15/15 2:26,"



",no_relation,0.7906,,D011803,"<span class=""chemical"">Quinine</span>",D001766,"<span class=""disease"">blindness</span>","<span class=""chemical"">Quinine</span> ocular toxicity: treatment of <span class=""disease"">blindness</span> using therapy for vasospasm.",,12002937,12002937_D011803_D001766,12002937_0,bcv_sentence_task_befree_1635,,770957563,FALSE,finalized,5,8/14/15 21:10,"



",no_relation,1,,D011803,"<span class=""chemical"">Quinine</span>",D020301,"<span class=""disease"">vasospasm</span>","<span class=""chemical"">Quinine</span> ocular toxicity: treatment of blindness using therapy for <span class=""disease"">vasospasm</span>.",,12002937,12002937_D011803_D020301,12002937_0,bcv_sentence_task_befree_1636,,770957564,FALSE,finalized,5,8/14/15 23:48,"



",yes_direct,1,,D011803,"<span class=""chemical"">quinine</span>",D064420,"<span class=""disease"">ocular toxicity</span>","A case of <span class=""disease"">ocular toxicity</span> with vasospasm secondary to <span class=""chemical"">quinine</span> poisoning is described.",,12002937,12002937_D011803_D064420,12002937_1,bcv_sentence_task_befree_1637,,770957565,FALSE,finalized,5,8/15/15 2:12,"



",yes_direct,0.8033,,D011803,"<span class=""chemical"">quinine</span>",D020301,"<span class=""disease"">vasospasm</span>","A case of ocular toxicity with <span class=""disease"">vasospasm</span> secondary to <span class=""chemical"">quinine</span> poisoning is described.",,12002937,12002937_D011803_D020301,12002937_1,bcv_sentence_task_befree_1638,,770957566,FALSE,finalized,5,8/15/15 2:06,"



",no_relation,0.6163,,D011803,"<span class=""chemical"">quinine</span>",D011041,"<span class=""disease"">poisoning</span>","A case of ocular toxicity with vasospasm secondary to <span class=""chemical"">quinine</span> <span class=""disease"">poisoning</span> is described.",,12002937,12002937_D011803_D011041,12002937_1,bcv_sentence_task_befree_1639,,770957567,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,0.7937,,D009553,"<span class=""chemical"">nimodipine</span>",D006973,"<span class=""disease"">hypertension</span>","Therapy for vasospasm using <span class=""chemical"">nimodipine</span>, <span class=""disease"">hypertension</span>, haemodilution and hypervolaemia was instituted with subsequent resolution of symptoms.",,12002937,12002937_D009553_D006973,12002937_2,bcv_sentence_task_befree_1640,,770957568,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D009553,"<span class=""chemical"">nimodipine</span>",D020301,"<span class=""disease"">vasospasm</span>","Therapy for <span class=""disease"">vasospasm</span> using <span class=""chemical"">nimodipine</span>, hypertension, haemodilution and hypervolaemia was instituted with subsequent resolution of symptoms.",,12002937,12002937_D009553_D020301,12002937_2,bcv_sentence_task_befree_1641,,770957569,FALSE,finalized,5,8/15/15 0:32,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D006470,"<span class=""disease"">bleeding</span>","Thirty-seven consecutive patients with portal hypertension and endoscopic evidence of isolated GVs, 17 presenting with histories of active <span class=""disease"">bleeding</span>, were randomized to receive endoscopic intervention either with <span class=""chemical"">alcohol</span> (n = 17) or with cyanoacrylate glue (n = 20) injection.",,12003381,12003381_D000431_D006470,12003381_3,bcv_sentence_task_befree_1642,,770957570,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,0.6314,,D000431,"<span class=""chemical"">alcohol</span>",D004932,"<span class=""disease"">GVs</span>","Thirty-seven consecutive patients with portal hypertension and endoscopic evidence of isolated <span class=""disease"">GVs</span>, 17 presenting with histories of active bleeding, were randomized to receive endoscopic intervention either with <span class=""chemical"">alcohol</span> (n = 17) or with cyanoacrylate glue (n = 20) injection.",,12003381,12003381_D000431_D004932,12003381_3,bcv_sentence_task_befree_1643,,770957571,FALSE,finalized,5,8/15/15 1:26,"



",no_relation,0.7981,,D000431,"<span class=""chemical"">alcohol</span>",D006973,"<span class=""disease"">hypertension</span>","Thirty-seven consecutive patients with portal <span class=""disease"">hypertension</span> and endoscopic evidence of isolated GVs, 17 presenting with histories of active bleeding, were randomized to receive endoscopic intervention either with <span class=""chemical"">alcohol</span> (n = 17) or with cyanoacrylate glue (n = 20) injection.",,12003381,12003381_D000431_D006973,12003381_3,bcv_sentence_task_befree_1644,,770957572,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,0.7912,,D000431,"<span class=""chemical"">alcohol</span>",D006470,"<span class=""disease"">arrest of acute GV bleeding</span>","Cyanoacrylate glue injection could achieve <span class=""disease"">arrest of acute GV bleeding</span> more often than <span class=""chemical"">alcohol</span> (89% vs 62%), and the need for rescue surgery was less; the difference was, however, not significant.",,12003381,12003381_D000431_D006470,12003381_7,bcv_sentence_task_befree_1645,,770957573,FALSE,finalized,5,8/14/15 21:47,"



",yes_direct,0.8172,,D003487,"<span class=""chemical"">Cyanoacrylate</span>",D006470,"<span class=""disease"">arrest of acute GV bleeding</span>","<span class=""chemical"">Cyanoacrylate</span> glue injection could achieve <span class=""disease"">arrest of acute GV bleeding</span> more often than alcohol (89% vs 62%), and the need for rescue surgery was less; the difference was, however, not significant.",,12003381,12003381_D003487_D006470,12003381_7,bcv_sentence_task_befree_1646,,770957574,FALSE,finalized,5,8/14/15 22:04,"



",yes_direct,0.5939,,D000431,"<span class=""chemical"">alcohol</span>",D006470,"<span class=""disease"">bleeding</span>","Six patients died from uncontrolled GV <span class=""disease"">bleeding</span>, four being in the <span class=""chemical"">alcohol</span> group.",,12003381,12003381_D000431_D006470,12003381_8,bcv_sentence_task_befree_1647,,770957575,FALSE,finalized,5,8/14/15 23:23,"



",yes_direct,0.581,,D008628,"<span class=""chemical"">Hg</span>",D000419,"<span class=""disease"">Albuminuria</span>","<span class=""disease"">Albuminuria</span> significantly correlated with blood and urine <span class=""chemical"">Hg</span>.",,12018634,12018634_D008628_D000419,12018634_11,bcv_sentence_task_befree_1648,,770957576,FALSE,finalized,5,8/14/15 21:14,"



",yes_direct,0.6347,,D008628,"<span class=""chemical"">Hg</span>",D064420,"<span class=""disease"">toxicity</span>","From the nephrotoxicity point of view, dental amalgam is an unsuitable filling material, as it may give rise to <span class=""chemical"">Hg</span> <span class=""disease"">toxicity</span>.",,12018634,12018634_D008628_D064420,12018634_12,bcv_sentence_task_befree_1649,,770957577,FALSE,finalized,5,8/15/15 1:19,"



",no_relation,0.607,,D008628,"<span class=""chemical"">Hg</span>",D064420,"<span class=""disease"">toxicity</span>","<span class=""chemical"">Hg</span> levels in blood and urine are good markers of such <span class=""disease"">toxicity</span>.",,12018634,12018634_D008628_D064420,12018634_13,bcv_sentence_task_befree_1650,,770957578,FALSE,finalized,5,8/14/15 23:19,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D008181,"<span class=""disease"">lupus nephritis</span>","The patient required steroids and repeated courses of <span class=""chemical"">cyclophosphamide</span> for the management of <span class=""disease"">lupus nephritis</span>, and ursodeoxycholic acid (ursolite) administration resulted in amelioration of cholestatic laboratory abnormalities.",,12028402,12028402_D003520_D008181,12028402_4,bcv_sentence_task_befree_1651,,770957579,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,D014580,"<span class=""chemical"">ursodeoxycholic acid/ursolite</span>",D008181,"<span class=""disease"">lupus nephritis</span>","The patient required steroids and repeated courses of cyclophosphamide for the management of <span class=""disease"">lupus nephritis</span>, and <span class=""chemical"">ursodeoxycholic acid</span> (<span class=""chemical"">ursolite</span>) administration resulted in amelioration of cholestatic laboratory abnormalities.",,12028402,12028402_D014580_D008181,12028402_4,bcv_sentence_task_befree_1652,,770957580,FALSE,finalized,5,8/15/15 0:26,"



",yes_direct,0.612,,D014580,"<span class=""chemical"">ursodeoxycholic acid/ursolite</span>",D007757,"<span class=""disease"">laboratory abnormalities</span>","The patient required steroids and repeated courses of cyclophosphamide for the management of lupus nephritis, and <span class=""chemical"">ursodeoxycholic acid</span> (<span class=""chemical"">ursolite</span>) administration resulted in amelioration of cholestatic <span class=""disease"">laboratory abnormalities</span>.",,12028402,12028402_D014580_D007757,12028402_4,bcv_sentence_task_befree_1653,,770957581,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,D013256,"<span class=""chemical"">steroids</span>",D007757,"<span class=""disease"">laboratory abnormalities</span>","The patient required <span class=""chemical"">steroids</span> and repeated courses of cyclophosphamide for the management of lupus nephritis, and ursodeoxycholic acid (ursolite) administration resulted in amelioration of cholestatic <span class=""disease"">laboratory abnormalities</span>.",,12028402,12028402_D013256_D007757,12028402_4,bcv_sentence_task_befree_1654,,770957582,FALSE,finalized,5,8/15/15 0:39,"



",no_relation,0.5994,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D007757,"<span class=""disease"">laboratory abnormalities</span>","The patient required steroids and repeated courses of <span class=""chemical"">cyclophosphamide</span> for the management of lupus nephritis, and ursodeoxycholic acid (ursolite) administration resulted in amelioration of cholestatic <span class=""disease"">laboratory abnormalities</span>.",,12028402,12028402_D003520_D007757,12028402_4,bcv_sentence_task_befree_1655,,770957583,FALSE,finalized,5,8/14/15 23:45,"



",no_relation,1,,D013256,"<span class=""chemical"">steroids</span>",D008181,"<span class=""disease"">lupus nephritis</span>","The patient required <span class=""chemical"">steroids</span> and repeated courses of cyclophosphamide for the management of <span class=""disease"">lupus nephritis</span>, and ursodeoxycholic acid (ursolite) administration resulted in amelioration of cholestatic laboratory abnormalities.",,12028402,12028402_D013256_D008181,12028402_4,bcv_sentence_task_befree_1656,,770957584,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,D012828,"<span class=""chemical"">silicone</span>",D009369,"<span class=""disease"">breast-cancer</span>","Comparative examination of complaints of patients with <span class=""disease"">breast-cancer</span> with and without <span class=""chemical"">silicone</span> implants.",,12039092,12039092_D012828_D009369,12039092_0,bcv_sentence_task_befree_1657,,770957585,FALSE,finalized,5,8/15/15 2:27,"



",no_relation,1,,D012828,"<span class=""chemical"">silicone</span>",D009369,"<span class=""disease"">breast-cancer</span>","A matched-pair-analysis of 96 women with <span class=""disease"">breast-cancer</span> (32 with <span class=""chemical"">silicone</span> implants (K I); 64 without implants (K II)) was performed with help of a standardized questionnaire in respect to 50 single criteria.",,12039092,12039092_D012828_D009369,12039092_2,bcv_sentence_task_befree_1658,,770957586,FALSE,finalized,5,8/15/15 1:43,"



",yes_direct,0.6208,,D003042,"<span class=""chemical"">cocaine</span>",D005334,"<span class=""disease"">hyperthermia</span>","Mechanism of <span class=""chemical"">cocaine</span>-induced <span class=""disease"">hyperthermia</span> in humans.",,12044126,12044126_D003042_D005334,12044126_0,bcv_sentence_task_befree_1659,,770957587,FALSE,finalized,5,8/15/15 0:52,"



",yes_direct,0.7933,,D003042,"<span class=""chemical"">cocaine</span>",D005334,"<span class=""disease"">hyperthermia</span>","The lethal effects of <span class=""chemical"">cocaine</span> are unique among those of other illicit drugs because <span class=""chemical"">cocaine</span> has the propensity to cause <span class=""disease"">hyperthermia</span>.",,12044126,12044126_D003042_D005334,12044126_1,bcv_sentence_task_befree_1660,,770957588,FALSE,finalized,5,8/15/15 0:01,"



",yes_direct,1,,D003042,"<span class=""chemical"">cocaine</span>",C565498,"<span class=""disease"">hypermetabolic</span>","The traditional view is that <span class=""chemical"">cocaine</span> causes a <span class=""disease"">hypermetabolic</span> state with increased heat production.",,12044126,12044126_D003042_C565498,12044126_2,bcv_sentence_task_befree_1661,,770957589,FALSE,finalized,5,8/14/15 22:20,"



",yes_direct,1,,D003042,"<span class=""chemical"">cocaine</span>",D005334,"<span class=""disease"">hyperthermia</span>","However, because <span class=""chemical"">cocaine</span>-induced <span class=""disease"">hyperthermia</span> occurs primarily in hot weather, it is hypothesized that <span class=""chemical"">cocaine</span> also impairs thermoregulatory adjustments that mediate heat dissipation.",,12044126,12044126_D003042_D005334,12044126_3,bcv_sentence_task_befree_1662,,770957590,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,0.8068,,D008012,"<span class=""chemical"">lidocaine</span>",D018882,"<span class=""disease"">heat stress</span>","Progressive passive <span class=""disease"">heat stress</span>, during which each participant received intranasal cocaine (2 mg/kg of body weight) or placebo (<span class=""chemical"">lidocaine</span>, 2 mg/kg).",,12044126,12044126_D008012_D018882,12044126_8,bcv_sentence_task_befree_1663,,770957591,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,0.5996,,D003042,"<span class=""chemical"">cocaine</span>",D018882,"<span class=""disease"">heat stress</span>","Progressive passive <span class=""disease"">heat stress</span>, during which each participant received intranasal <span class=""chemical"">cocaine</span> (2 mg/kg of body weight) or placebo (lidocaine, 2 mg/kg).",,12044126,12044126_D003042_D018882,12044126_8,bcv_sentence_task_befree_1664,,770957592,FALSE,finalized,5,8/15/15 1:09,"



",no_relation,0.6032,,D003042,"<span class=""chemical"">cocaine</span>",D018882,"<span class=""disease"">heat stress</span>","First, <span class=""chemical"">cocaine</span> substantially augmented the progressive increase in esophageal temperature during <span class=""disease"">heat stress</span> (P < 0.001).",,12044126,12044126_D003042_D018882,12044126_11,bcv_sentence_task_befree_1665,,770957593,FALSE,finalized,5,8/15/15 0:01,"



",no_relation,0.6233,,D003042,"<span class=""chemical"">cocaine</span>",D018882,"<span class=""disease"">heat stress</span>","Third, <span class=""chemical"">cocaine</span> paradoxically impaired the perception of heating by attenuating the progressive increase in thermal discomfort associated with <span class=""disease"">heat stress</span>.",,12044126,12044126_D003042_D018882,12044126_13,bcv_sentence_task_befree_1666,,770957594,FALSE,finalized,5,8/14/15 21:16,"



",no_relation,0.5792,,D003042,"<span class=""chemical"">cocaine</span>",D018883,"<span class=""disease"">impaired heat dissipation</span>","In humans, <span class=""disease"">impaired heat dissipation</span> is a major mechanism by which <span class=""chemical"">cocaine</span> elevates body temperature.",,12044126,12044126_D003042_D018883,12044126_14,bcv_sentence_task_befree_1667,,770957595,FALSE,finalized,5,8/14/15 21:40,"



",no_relation,1,,D003613,"<span class=""chemical"">danazol</span>",D000799,"<span class=""disease"">angioedema</span>","Autoimmune acquired form of <span class=""disease"">angioedema</span> that responded to <span class=""chemical"">danazol</span> therapy.",,12058892,12058892_D003613_D000799,12058892_0,bcv_sentence_task_befree_1668,,770957596,FALSE,finalized,5,8/15/15 1:48,"



",no_relation,1,,D003613,"<span class=""chemical"">danazol</span>",D000799,"<span class=""disease"">angioedema</span>","The <span class=""chemical"">danazol</span> treatment relieved the symptoms of <span class=""disease"">angioedema</span> and increased the C1 INH activity and concentration with the normalization of CH50, C1q and C4 levels.",,12058892,12058892_D003613_D000799,12058892_2,bcv_sentence_task_befree_1669,,770957597,FALSE,finalized,5,8/14/15 23:56,"



",no_relation,1,,D011223,"<span class=""chemical"">praziquantel</span>",D012552,"<span class=""disease"">schistosomiasis</span>","Reduction in the prevalence and intensity of hookworm infections after <span class=""chemical"">praziquantel</span> treatment for <span class=""disease"">schistosomiasis</span> infection.",,12062494,12062494_D011223_D012552,12062494_0,bcv_sentence_task_befree_1670,,770957598,FALSE,finalized,5,8/14/15 21:30,"



",no_relation,0.7987,,D011223,"<span class=""chemical"">praziquantel</span>",D006725,"<span class=""disease"">hookworm infections</span>","Reduction in the prevalence and intensity of <span class=""disease"">hookworm infections</span> after <span class=""chemical"">praziquantel</span> treatment for schistosomiasis infection.",,12062494,12062494_D011223_D006725,12062494_0,bcv_sentence_task_befree_1671,,770957599,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,D011223,"<span class=""chemical"">Praziquantel</span>",D012552,"<span class=""disease"">schistosomiasis</span>","<span class=""chemical"">Praziquantel</span> exhibits activity against all major human schistosome parasites and has become the cornerstone for treatment and morbidity control of <span class=""disease"">schistosomiasis</span>.",,12062494,12062494_D011223_D012552,12062494_1,bcv_sentence_task_befree_1672,,770957600,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,1,,D011223,"<span class=""chemical"">Praziquantel</span>",D014201,"<span class=""disease"">trematodes</span>","<span class=""chemical"">Praziquantel</span> is also active against a wide range of <span class=""disease"">trematodes</span>, human and veterinary cestodes and displays cysticidal effects.",,12062494,12062494_D011223_D014201,12062494_2,bcv_sentence_task_befree_1673,,770957601,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,D011223,"<span class=""chemical"">praziquantel</span>",D012555,"<span class=""disease"">Schistosoma</span>","Here, we report a study among 96 schoolchildren from an area highly endemic for <span class=""disease"">Schistosoma</span> mansoni and hookworm infection, and place particular emphasis on the effect of <span class=""chemical"">praziquantel</span> on the prevalence and intensity of hookworm infections.",,12062494,12062494_D011223_D012555,12062494_4,bcv_sentence_task_befree_1674,,770957602,FALSE,finalized,5,8/14/15 21:27,"



",no_relation,0.607,,D011223,"<span class=""chemical"">praziquantel</span>",D006725,"<span class=""disease"">hookworm infection/hookworm infections</span>","Here, we report a study among 96 schoolchildren from an area highly endemic for Schistosoma mansoni and <span class=""disease"">hookworm infection</span>, and place particular emphasis on the effect of <span class=""chemical"">praziquantel</span> on the prevalence and intensity of <span class=""disease"">hookworm infections</span>.",,12062494,12062494_D011223_D006725,12062494_4,bcv_sentence_task_befree_1675,,770957603,FALSE,finalized,5,8/14/15 22:18,"



",no_relation,1,,D011223,"<span class=""chemical"">praziquantel</span>",D012552,"<span class=""disease"">schistosomiasis</span>","In areas where both schistosome and hookworm coexist, and <span class=""chemical"">praziquantel</span> is being recommended for <span class=""disease"">schistosomiasis</span> control, large-scale application of this drug might also reduce the burden of hookworms.",,12062494,12062494_D011223_D012552,12062494_9,bcv_sentence_task_befree_1676,,770957604,FALSE,finalized,5,8/15/15 1:28,"



",no_relation,1,,D011223,"<span class=""chemical"">praziquantel</span>",D006725,"<span class=""disease"">hookworm coexist</span>","In areas where both schistosome and <span class=""disease"">hookworm coexist</span>, and <span class=""chemical"">praziquantel</span> is being recommended for schistosomiasis control, large-scale application of this drug might also reduce the burden of hookworms.",,12062494,12062494_D011223_D006725,12062494_9,bcv_sentence_task_befree_1677,,770957605,FALSE,finalized,5,8/14/15 21:36,"



",yes_direct,1,,D019819,"<span class=""chemical"">budesonide</span>",D003872,"<span class=""disease"">dermatitis</span>","Allergic contact <span class=""disease"">dermatitis</span> in response to <span class=""chemical"">budesonide</span> reactivated by inhalation of the allergen.",,12063485,12063485_D019819_D003872,12063485_0,bcv_sentence_task_befree_1678,,770957606,FALSE,finalized,5,8/14/15 21:31,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D003872,"<span class=""disease"">dermatitis</span>","Up to 5% of patients with <span class=""disease"">dermatitis</span> who are consecutively patch tested are allergic to one or more <span class=""chemical"">corticosteroids</span>.",,12063485,12063485_D000305_D003872,12063485_1,bcv_sentence_task_befree_1679,,770957607,FALSE,finalized,5,8/14/15 21:27,"



",yes_direct,0.6096,,D019819,"<span class=""chemical"">budesonide</span>",D004342,"<span class=""disease"">hypersensitivity</span>","Fifteen nonasthmatic patients who were initially given a diagnosis of budesonide <span class=""disease"">hypersensitivity</span> on patch testing from less than 1 up to 8 years before the study were provoked with <span class=""chemical"">budesonide</span> or placebo by inhalation 6 weeks after they had been patch tested with <span class=""chemical"">budesonide</span>, its R and S diastereomers, and potentially cross-reacting substances.",,12063485,12063485_D019819_D004342,12063485_5,bcv_sentence_task_befree_1680,,770957608,FALSE,finalized,5,8/14/15 22:19,"



",yes_direct,1,,D019819,"<span class=""chemical"">budesonide</span>",D006967,"<span class=""disease"">allergy</span>","This study shows that allergic skin reactions may occur in patients with contact <span class=""disease"">allergy</span> to <span class=""chemical"">budesonide</span> when inhaled forms of the drug are used.",,12063485,12063485_D019819_D006967,12063485_9,bcv_sentence_task_befree_1681,,770957609,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,0.5773,,D018943,"<span class=""chemical"">anthracycline</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","Functional monitoring of <span class=""chemical"">anthracycline</span> <span class=""disease"">cardiotoxicity</span>: a prospective, blinded, long-term observational study of outcome in 120 patients.",,12075737,12075737_D018943_D066126,12075737_0,bcv_sentence_task_befree_1682,,770957610,FALSE,finalized,5,8/14/15 23:30,"



",yes_direct,1,,D018943,"<span class=""chemical"">anthracycline</span>",D006177,"<span class=""disease"">heart damage</span>","With increasing doses the highly tumoricidal <span class=""chemical"">anthracycline</span> drugs cause <span class=""disease"">heart damage</span>.",,12075737,12075737_D018943_D006177,12075737_1,bcv_sentence_task_befree_1683,,770957611,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,0.5989,,D018943,"<span class=""chemical"">anthracycline</span>",D006333,"<span class=""disease"">CHF</span>","To avoid <span class=""disease"">CHF</span> there is a consensus recommendation that cardiac function should be monitored in close connection with <span class=""chemical"">anthracycline</span> administration.",,12075737,12075737_D018943_D006333,12075737_3,bcv_sentence_task_befree_1684,,770957612,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,0.8089,,D015251,"<span class=""chemical"">epirubicin</span>",D009369,"<span class=""disease"">breast cancer</span>","In a prospective, blinded observational study 120 patients with advanced <span class=""disease"">breast cancer</span> were followed before, during, and a median 3 years after treatment with <span class=""chemical"">epirubicin</span>.",,12075737,12075737_D015251_D009369,12075737_5,bcv_sentence_task_befree_1685,,770957613,FALSE,finalized,5,8/14/15 22:18,"



",yes_direct,0.6092,,D018943,"<span class=""chemical"">Anthracycline</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","<span class=""chemical"">Anthracycline</span> <span class=""disease"">cardiotoxicity</span> was closely correlated with the cumulative dose, with a great variability in individual susceptibility and a dramatic increase with advancing age.",,12075737,12075737_D018943_D066126,12075737_7,bcv_sentence_task_befree_1686,,770957614,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,0.612,,D015251,"<span class=""chemical"">epirubicin</span>",D006333,"<span class=""disease"">CHF</span>","An actuarial estimation of 59% of the patients experienced a 25% relative reduction in LVEF 3 years after 850-1000 mg/m2 of <span class=""chemical"">epirubicin</span> and 20% had deteriorated into a <span class=""disease"">CHF</span>.",,12075737,12075737_D015251_D006333,12075737_9,bcv_sentence_task_befree_1687,,770957615,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,0.6055,,D018943,"<span class=""chemical"">anthracycline</span>",D066126,"<span class=""disease"">cardiotoxic</span>","Due to the displaced <span class=""disease"">cardiotoxic</span> manifestation, functional monitoring in close connection with <span class=""chemical"">anthracycline</span> administration appears to be a poorly effective method while later monitoring is essential.",,12075737,12075737_D018943_D066126,12075737_11,bcv_sentence_task_befree_1688,,770957616,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D004164,"<span class=""chemical"">Bisphosphonates</span>",D009369,"<span class=""disease"">cancer</span>","<span class=""chemical"">Bisphosphonates</span> for <span class=""disease"">cancer</span> patients: why, how, and when?",,12136223,12136223_D004164_D009369,12136223_0,bcv_sentence_task_befree_1689,,770957617,FALSE,finalized,5,8/15/15 0:33,"



",no_relation,0.6285,,D004164,"<span class=""chemical"">BPs/Bisphosphonates</span>",D009369,"<span class=""disease"">tumor/breast cancer/cancer</span>","<span class=""chemical"">Bisphosphonates</span> (<span class=""chemical"">BPs</span>) are potent inhibitors of osteoclast-mediated bone resorption, and it is well accepted that <span class=""disease"">tumor</span> cells in bone, especially <span class=""disease"">breast cancer</span> and myeloma cells, can stimulate osteoclast formation and activity leading to the release of growth factors or cytokines, which will further stimulate <span class=""disease"">cancer</span> cells' growth and their secretion of osteolytic factors.",,12136223,12136223_D004164_D009369,12136223_1,bcv_sentence_task_befree_1690,,770957618,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,0.8062,,D004164,"<span class=""chemical"">BPs/Bisphosphonates</span>",D009101,"<span class=""disease"">myeloma</span>","<span class=""chemical"">Bisphosphonates</span> (<span class=""chemical"">BPs</span>) are potent inhibitors of osteoclast-mediated bone resorption, and it is well accepted that tumor cells in bone, especially breast cancer and <span class=""disease"">myeloma</span> cells, can stimulate osteoclast formation and activity leading to the release of growth factors or cytokines, which will further stimulate cancer cells' growth and their secretion of osteolytic factors.",,12136223,12136223_D004164_D009101,12136223_1,bcv_sentence_task_befree_1691,,770957619,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,D004164,"<span class=""chemical"">BPs</span>",D009369,"<span class=""disease"">cancer hypercalcemia</span>","<span class=""chemical"">BPs</span> are now the standard treatment for <span class=""disease"">cancer hypercalcemia</span>, for which a dose of 90 mg of pamidronate or 1500 mg of clodronate is recommended; the former compound is more potent and has a longer lasting effect.",,12136223,12136223_D004164_D009369,12136223_2,bcv_sentence_task_befree_1692,,770957620,FALSE,finalized,5,8/15/15 2:22,"



",no_relation,1,,C019248,"<span class=""chemical"">pamidronate</span>",D009369,"<span class=""disease"">cancer hypercalcemia</span>","BPs are now the standard treatment for <span class=""disease"">cancer hypercalcemia</span>, for which a dose of 90 mg of <span class=""chemical"">pamidronate</span> or 1500 mg of clodronate is recommended; the former compound is more potent and has a longer lasting effect.",,12136223,12136223_C019248_D009369,12136223_2,bcv_sentence_task_befree_1693,,770957621,FALSE,finalized,5,8/14/15 22:01,"



",no_relation,0.8111,,C019248,"<span class=""chemical"">pamidronate</span>",D010146,"<span class=""disease"">bone pain</span>","Repeated <span class=""chemical"">pamidronate</span> infusions exert clinically relevant analgesic effects in more than half of patients with metastatic <span class=""disease"">bone pain</span>.",,12136223,12136223_C019248_D010146,12136223_3,bcv_sentence_task_befree_1694,,770957622,FALSE,finalized,5,8/14/15 22:44,"



",no_relation,1,,D004002,"<span class=""chemical"">clodronate</span>",D009369,"<span class=""disease"">breast cancer</span>","Lifelong administration of oral <span class=""chemical"">clodronate</span> to patients with <span class=""disease"">breast cancer</span> metastatic to bone reduces the frequency of morbid skeletal events by more than one-fourth.",,12136223,12136223_D004002_D009369,12136223_7,bcv_sentence_task_befree_1695,,770957623,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,0.8123,,D004164,"<span class=""chemical"">BPs</span>",D001847,"<span class=""disease"">bone disease</span>","However, preference can be given to the oral route when <span class=""chemical"">BPs</span> are started early in the process of metastatic <span class=""disease"">bone disease</span> in a patient receiving hormone therapy.",,12136223,12136223_D004164_D001847,12136223_10,bcv_sentence_task_befree_1696,,770957624,FALSE,finalized,5,8/15/15 2:09,"



",no_relation,1,,C019248,"<span class=""chemical"">pamidronate</span>",D009369,"<span class=""disease"">breast cancer</span>","According to the recently published ASCO guidelines, <span class=""chemical"">pamidronate</span> 90 mg i.v. delivered over 2 h every 3-4 weeks can be recommended in patients with metastatic <span class=""disease"">breast cancer</span> who have imaging evidence of lytic destruction of bone and who are concurrently receiving systemic therapy with hormonal therapy or chemotherapy.",,12136223,12136223_C019248_D009369,12136223_11,bcv_sentence_task_befree_1697,,770957625,FALSE,finalized,5,8/15/15 0:00,"



",no_relation,1,,D004164,"<span class=""chemical"">BPs</span>",D001847,"<span class=""disease"">bone disease</span>","Because <span class=""chemical"">BPs</span> are providing supportive care, reducing the rate of skeletal morbidity but evidently not abolishing it, the criteria for stopping their administration have to be different from those used for classic antineoplastic drugs, and they should not be stopped when metastatic <span class=""disease"">bone disease</span> is progressing.",,12136223,12136223_D004164_D001847,12136223_15,bcv_sentence_task_befree_1698,,770957626,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,1,,D004164,"<span class=""chemical"">BPs</span>",D004194,"<span class=""disease"">lytic disease</span>","Even better results have been achieved in patients with multiple myeloma, and the general consensus is that <span class=""chemical"">BPs</span> should be started as soon as the diagnosis of <span class=""disease"">lytic disease</span> is made in myeloma patients.",,12136223,12136223_D004164_D004194,12136223_18,bcv_sentence_task_befree_1699,,770957627,FALSE,finalized,5,8/15/15 0:14,"



",no_relation,1,,D004164,"<span class=""chemical"">BPs</span>",D009101,"<span class=""disease"">myeloma/multiple myeloma</span>","Even better results have been achieved in patients with <span class=""disease"">multiple myeloma</span>, and the general consensus is that <span class=""chemical"">BPs</span> should be started as soon as the diagnosis of lytic disease is made in <span class=""disease"">myeloma</span> patients.",,12136223,12136223_D004164_D009101,12136223_18,bcv_sentence_task_befree_1700,,770957628,FALSE,finalized,5,8/15/15 0:49,"



",no_relation,1,,D004164,"<span class=""chemical"">BPs</span>",D011471,"<span class=""disease"">prostate cancer</span>","On the other hand, data are scanty in <span class=""disease"">prostate cancer</span>, but large-scale trials with potent <span class=""chemical"">BPs</span> are ongoing or planned in such patients.",,12136223,12136223_D004164_D011471,12136223_19,bcv_sentence_task_befree_1701,,770957629,FALSE,finalized,5,8/14/15 21:31,"



",no_relation,1,,C019248,"<span class=""chemical"">pamidronate</span>",D009369,"<span class=""disease"">breast cancer</span>","Similar results to those achieved with <span class=""chemical"">pamidronate</span> have been obtained with monthly 6-mg infusions of the newer BP ibandronate in patients with <span class=""disease"">breast cancer</span> metastatic to bone.",,12136223,12136223_C019248_D009369,12136223_20,bcv_sentence_task_befree_1702,,770957630,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,1,,D004164,"<span class=""chemical"">BPs</span>",D018222,"<span class=""disease"">aggressive osteolytic disease</span>","These newer <span class=""chemical"">BPs</span> will simplify the current therapeutic schemes and improve the cost-effectiveness ratio; they also have the potential to improve the therapeutic efficacy, at least in patients with an <span class=""disease"">aggressive osteolytic disease</span> or when given as adjuvant therapy.",,12136223,12136223_D004164_D018222,12136223_23,bcv_sentence_task_befree_1703,,770957631,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,1,,D011142,"<span class=""chemical"">polyvinyl alcohol</span>",C564648,"<span class=""disease"">intraosseous lesion</span>","The patients were embolized with fiber coils through direct puncture, and the coils were placed directly into the center of the <span class=""disease"">intraosseous lesion</span>, in some cases in conjunction with <span class=""chemical"">polyvinyl alcohol</span> foam and N-butyl-2-cyanoacrylate through vascular access.",,12149733,12149733_D011142_C564648,12149733_3,bcv_sentence_task_befree_1704,,770957632,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,D004659,"<span class=""chemical"">N-butyl-2-cyanoacrylate</span>",C564648,"<span class=""disease"">intraosseous lesion</span>","The patients were embolized with fiber coils through direct puncture, and the coils were placed directly into the center of the <span class=""disease"">intraosseous lesion</span>, in some cases in conjunction with polyvinyl alcohol foam and <span class=""chemical"">N-butyl-2-cyanoacrylate</span> through vascular access.",,12149733,12149733_D004659_C564648,12149733_3,bcv_sentence_task_befree_1705,,770957633,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,0.8266,,D013974,"<span class=""chemical"">levothyroxine</span>",D013964,"<span class=""disease"">thyroid cancer</span>","We performed a series of neuropsychological tests in 13 <span class=""disease"">thyroid cancer</span> patients while they continued to take their usual dose of <span class=""chemical"">levothyroxine</span> (LT4) and again after discontinuing thyroid hormone.",,12186506,12186506_D013974_D013964,12186506_2,bcv_sentence_task_befree_1706,,770957634,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,0.8039,,D015032,"<span class=""chemical"">zinc</span>",D007239,"<span class=""disease"">infection</span>","Supplementation of infant formula with the probiotic lactobacillus reuteri and <span class=""chemical"">zinc</span>: impact on enteric <span class=""disease"">infection</span> and nutrition in infant rhesus monkeys.",,12187291,12187291_D015032_D007239,12187291_0,bcv_sentence_task_befree_1707,,770957635,FALSE,finalized,5,8/14/15 21:43,"



",no_relation,1,,D015032,"<span class=""chemical"">zinc</span>",D005767,"<span class=""disease"">gastrointestinal infection</span>","To study effects of probiotic supplementation of infant formula (with or without supplemental <span class=""chemical"">zinc</span>) on nutritional status, gut colonization and the ability to resist <span class=""disease"">gastrointestinal infection</span> in an infant rhesus monkey model.",,12187291,12187291_D015032_D005767,12187291_3,bcv_sentence_task_befree_1708,,770957636,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D007239,"<span class=""disease"">infection</span>","-supplementation of infant formula is safe, improves <span class=""chemical"">iron</span> status and decreases diarrhea severity in infant rhesus monkeys and thus may help protect formula-fed human infants from <span class=""disease"">infection</span> and nutritional deficiencies.",,12187291,12187291_D007501_D007239,12187291_9,bcv_sentence_task_befree_1709,,770957637,FALSE,finalized,5,8/14/15 22:31,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D003967,"<span class=""disease"">decreases diarrhea severity</span>","-supplementation of infant formula is safe, improves <span class=""chemical"">iron</span> status and <span class=""disease"">decreases diarrhea severity</span> in infant rhesus monkeys and thus may help protect formula-fed human infants from infection and nutritional deficiencies.",,12187291,12187291_D007501_D003967,12187291_9,bcv_sentence_task_befree_1710,,770957638,FALSE,finalized,5,8/15/15 0:49,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D044342,"<span class=""disease"">nutritional deficiencies</span>","-supplementation of infant formula is safe, improves <span class=""chemical"">iron</span> status and decreases diarrhea severity in infant rhesus monkeys and thus may help protect formula-fed human infants from infection and <span class=""disease"">nutritional deficiencies</span>.",,12187291,12187291_D007501_D044342,12187291_9,bcv_sentence_task_befree_1711,,770957639,FALSE,finalized,5,8/14/15 21:05,"



",no_relation,1,,D006493,"<span class=""chemical"">heparin</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","The use of <span class=""chemical"">heparin</span>-coated circuits reduced the mean length of stay in hospital from 7.8 +/- 2.5 to 7.3 +/- 1.8 days (p = 0.040) and postoperative ventilation time from 9.7 +/- 9.2 to 8.2 +/- 8.5 h (p = 0.018), blood loss 8 h post surgery from 676 +/- 385 to 540 +/- 245 ml (p = 0.001), individual perioperative change of haemoglobin loss (p = 0.001), leukocyte count (p = 0.000) and creatinine elevation (p = 0.000), proportion of patients exposed to allogenous blood transfusions 39.2 vs 23.9% (p = 0.001), postoperative coagulation disturbances 4.4 vs 0.4% (p = 0.006), postoperative deviations from the normal postoperative course 47.2 vs 36.7% (p = 0.035), neurological deviations 9.4 vs 3.9% (p = 0.021) and <span class=""disease"">atrial fibrillation</span> 26.4 vs 18.0% (p = 0.041).",,12201973,12201973_D006493_D001281,12201973_9,bcv_sentence_task_befree_1712,,770957640,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","The use of heparin-coated circuits reduced the mean length of stay in hospital from 7.8 +/- 2.5 to 7.3 +/- 1.8 days (p = 0.040) and postoperative ventilation time from 9.7 +/- 9.2 to 8.2 +/- 8.5 h (p = 0.018), blood loss 8 h post surgery from 676 +/- 385 to 540 +/- 245 ml (p = 0.001), individual perioperative change of haemoglobin loss (p = 0.001), leukocyte count (p = 0.000) and <span class=""chemical"">creatinine</span> elevation (p = 0.000), proportion of patients exposed to allogenous blood transfusions 39.2 vs 23.9% (p = 0.001), postoperative coagulation disturbances 4.4 vs 0.4% (p = 0.006), postoperative deviations from the normal postoperative course 47.2 vs 36.7% (p = 0.035), neurological deviations 9.4 vs 3.9% (p = 0.021) and <span class=""disease"">atrial fibrillation</span> 26.4 vs 18.0% (p = 0.041).",,12201973,12201973_D003404_D001281,12201973_9,bcv_sentence_task_befree_1713,,770957641,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,D006493,"<span class=""chemical"">heparin</span>",D019106,"<span class=""disease"">blood loss</span>","The use of <span class=""chemical"">heparin</span>-coated circuits reduced the mean length of stay in hospital from 7.8 +/- 2.5 to 7.3 +/- 1.8 days (p = 0.040) and postoperative ventilation time from 9.7 +/- 9.2 to 8.2 +/- 8.5 h (p = 0.018), <span class=""disease"">blood loss</span> 8 h post surgery from 676 +/- 385 to 540 +/- 245 ml (p = 0.001), individual perioperative change of haemoglobin loss (p = 0.001), leukocyte count (p = 0.000) and creatinine elevation (p = 0.000), proportion of patients exposed to allogenous blood transfusions 39.2 vs 23.9% (p = 0.001), postoperative coagulation disturbances 4.4 vs 0.4% (p = 0.006), postoperative deviations from the normal postoperative course 47.2 vs 36.7% (p = 0.035), neurological deviations 9.4 vs 3.9% (p = 0.021) and atrial fibrillation 26.4 vs 18.0% (p = 0.041).",,12201973,12201973_D006493_D019106,12201973_9,bcv_sentence_task_befree_1714,,770957642,FALSE,finalized,5,8/15/15 0:12,"



",no_relation,0.7997,,D006493,"<span class=""chemical"">heparin</span>",D001308,"<span class=""disease"">postoperative coagulation disturbances</span>","The use of <span class=""chemical"">heparin</span>-coated circuits reduced the mean length of stay in hospital from 7.8 +/- 2.5 to 7.3 +/- 1.8 days (p = 0.040) and postoperative ventilation time from 9.7 +/- 9.2 to 8.2 +/- 8.5 h (p = 0.018), blood loss 8 h post surgery from 676 +/- 385 to 540 +/- 245 ml (p = 0.001), individual perioperative change of haemoglobin loss (p = 0.001), leukocyte count (p = 0.000) and creatinine elevation (p = 0.000), proportion of patients exposed to allogenous blood transfusions 39.2 vs 23.9% (p = 0.001), <span class=""disease"">postoperative coagulation disturbances</span> 4.4 vs 0.4% (p = 0.006), postoperative deviations from the normal postoperative course 47.2 vs 36.7% (p = 0.035), neurological deviations 9.4 vs 3.9% (p = 0.021) and atrial fibrillation 26.4 vs 18.0% (p = 0.041).",,12201973,12201973_D006493_D001308,12201973_9,bcv_sentence_task_befree_1715,,770957643,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",D001308,"<span class=""disease"">postoperative coagulation disturbances</span>","The use of heparin-coated circuits reduced the mean length of stay in hospital from 7.8 +/- 2.5 to 7.3 +/- 1.8 days (p = 0.040) and postoperative ventilation time from 9.7 +/- 9.2 to 8.2 +/- 8.5 h (p = 0.018), blood loss 8 h post surgery from 676 +/- 385 to 540 +/- 245 ml (p = 0.001), individual perioperative change of haemoglobin loss (p = 0.001), leukocyte count (p = 0.000) and <span class=""chemical"">creatinine</span> elevation (p = 0.000), proportion of patients exposed to allogenous blood transfusions 39.2 vs 23.9% (p = 0.001), <span class=""disease"">postoperative coagulation disturbances</span> 4.4 vs 0.4% (p = 0.006), postoperative deviations from the normal postoperative course 47.2 vs 36.7% (p = 0.035), neurological deviations 9.4 vs 3.9% (p = 0.021) and atrial fibrillation 26.4 vs 18.0% (p = 0.041).",,12201973,12201973_D003404_D001308,12201973_9,bcv_sentence_task_befree_1716,,770957644,FALSE,finalized,5,8/15/15 1:13,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",D019106,"<span class=""disease"">blood loss</span>","The use of heparin-coated circuits reduced the mean length of stay in hospital from 7.8 +/- 2.5 to 7.3 +/- 1.8 days (p = 0.040) and postoperative ventilation time from 9.7 +/- 9.2 to 8.2 +/- 8.5 h (p = 0.018), <span class=""disease"">blood loss</span> 8 h post surgery from 676 +/- 385 to 540 +/- 245 ml (p = 0.001), individual perioperative change of haemoglobin loss (p = 0.001), leukocyte count (p = 0.000) and <span class=""chemical"">creatinine</span> elevation (p = 0.000), proportion of patients exposed to allogenous blood transfusions 39.2 vs 23.9% (p = 0.001), postoperative coagulation disturbances 4.4 vs 0.4% (p = 0.006), postoperative deviations from the normal postoperative course 47.2 vs 36.7% (p = 0.035), neurological deviations 9.4 vs 3.9% (p = 0.021) and atrial fibrillation 26.4 vs 18.0% (p = 0.041).",,12201973,12201973_D003404_D019106,12201973_9,bcv_sentence_task_befree_1717,,770957645,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,C422649,"<span class=""chemical"">etoricoxib</span>",D010146,"<span class=""disease"">postoperative pain</span>","Clinical trials have demonstrated the efficacy and safety of celecoxib and rofecoxib for <span class=""disease"">postoperative pain</span> and for preemptive analgesia, and newer agents such as valdecoxib and <span class=""chemical"">etoricoxib</span> also have demonstrated efficacy in these settings.",,12204484,12204484_C422649_D010146,12204484_5,bcv_sentence_task_befree_1718,,770957646,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,1,,C406224,"<span class=""chemical"">valdecoxib</span>",D010146,"<span class=""disease"">postoperative pain</span>","Clinical trials have demonstrated the efficacy and safety of celecoxib and rofecoxib for <span class=""disease"">postoperative pain</span> and for preemptive analgesia, and newer agents such as <span class=""chemical"">valdecoxib</span> and etoricoxib also have demonstrated efficacy in these settings.",,12204484,12204484_C406224_D010146,12204484_5,bcv_sentence_task_befree_1719,,770957647,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,0.7998,,C406224,"<span class=""chemical"">valdecoxib</span>",D000699,"<span class=""disease"">analgesia</span>","Clinical trials have demonstrated the efficacy and safety of celecoxib and rofecoxib for postoperative pain and for preemptive <span class=""disease"">analgesia</span>, and newer agents such as <span class=""chemical"">valdecoxib</span> and etoricoxib also have demonstrated efficacy in these settings.",,12204484,12204484_C406224_D000699,12204484_5,bcv_sentence_task_befree_1720,,770957648,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,1,,C105934,"<span class=""chemical"">celecoxib</span>",D000699,"<span class=""disease"">analgesia</span>","Clinical trials have demonstrated the efficacy and safety of <span class=""chemical"">celecoxib</span> and rofecoxib for postoperative pain and for preemptive <span class=""disease"">analgesia</span>, and newer agents such as valdecoxib and etoricoxib also have demonstrated efficacy in these settings.",,12204484,12204484_C105934_D000699,12204484_5,bcv_sentence_task_befree_1721,,770957649,FALSE,finalized,5,8/15/15 0:17,"



",no_relation,1,,C116926,"<span class=""chemical"">rofecoxib</span>",D010146,"<span class=""disease"">postoperative pain</span>","Clinical trials have demonstrated the efficacy and safety of celecoxib and <span class=""chemical"">rofecoxib</span> for <span class=""disease"">postoperative pain</span> and for preemptive analgesia, and newer agents such as valdecoxib and etoricoxib also have demonstrated efficacy in these settings.",,12204484,12204484_C116926_D010146,12204484_5,bcv_sentence_task_befree_1722,,770957650,FALSE,finalized,5,8/14/15 22:12,"



",no_relation,1,,C105934,"<span class=""chemical"">celecoxib</span>",D010146,"<span class=""disease"">postoperative pain</span>","Clinical trials have demonstrated the efficacy and safety of <span class=""chemical"">celecoxib</span> and rofecoxib for <span class=""disease"">postoperative pain</span> and for preemptive analgesia, and newer agents such as valdecoxib and etoricoxib also have demonstrated efficacy in these settings.",,12204484,12204484_C105934_D010146,12204484_5,bcv_sentence_task_befree_1723,,770957651,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,0.7867,,C116926,"<span class=""chemical"">rofecoxib</span>",D000699,"<span class=""disease"">analgesia</span>","Clinical trials have demonstrated the efficacy and safety of celecoxib and <span class=""chemical"">rofecoxib</span> for postoperative pain and for preemptive <span class=""disease"">analgesia</span>, and newer agents such as valdecoxib and etoricoxib also have demonstrated efficacy in these settings.",,12204484,12204484_C116926_D000699,12204484_5,bcv_sentence_task_befree_1724,,770957652,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,0.8079,,C422649,"<span class=""chemical"">etoricoxib</span>",D000699,"<span class=""disease"">analgesia</span>","Clinical trials have demonstrated the efficacy and safety of celecoxib and rofecoxib for postoperative pain and for preemptive <span class=""disease"">analgesia</span>, and newer agents such as valdecoxib and <span class=""chemical"">etoricoxib</span> also have demonstrated efficacy in these settings.",,12204484,12204484_C422649_D000699,12204484_5,bcv_sentence_task_befree_1725,,770957653,FALSE,finalized,5,8/14/15 21:58,"



",no_relation,1,,D011464,"<span class=""chemical"">epoprostenol</span>",D065627,"<span class=""disease"">primary pulmonary hypertension</span>","Long-term intravenous <span class=""chemical"">epoprostenol</span> infusion in <span class=""disease"">primary pulmonary hypertension</span>: prognostic factors and survival.",,12204511,12204511_D011464_D065627,12204511_0,bcv_sentence_task_befree_1726,,770957654,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,1,,D011464,"<span class=""chemical"">epoprostenol</span>",D065627,"<span class=""disease"">primary pulmonary hypertension/PPH</span>","We sought to determine the factors associated with long-term survival in patients with <span class=""disease"">primary pulmonary hypertension</span> (<span class=""disease"">PPH</span>) treated with continuous <span class=""chemical"">epoprostenol</span> infusion.",,12204511,12204511_D011464_D065627,12204511_1,bcv_sentence_task_befree_1727,,770957655,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,1,,D011464,"<span class=""chemical"">Epoprostenol</span>",D065627,"<span class=""disease"">PPH</span>","<span class=""chemical"">Epoprostenol</span> improves survival in patients with <span class=""disease"">PPH</span> in New York Heart Association (NYHA) functional class III or IV.",,12204511,12204511_D011464_D065627,12204511_2,bcv_sentence_task_befree_1728,,770957656,FALSE,finalized,5,8/14/15 22:18,"



",no_relation,0.809,,D011464,"<span class=""chemical"">epoprostenol</span>",D065627,"<span class=""disease"">PPH</span>","Between December 1992 and January 2001, 178 patients with <span class=""disease"">PPH</span> in NYHA functional class III or IV were treated with <span class=""chemical"">epoprostenol</span>.",,12204511,12204511_D011464_D065627,12204511_5,bcv_sentence_task_befree_1729,,770957657,FALSE,finalized,5,8/14/15 21:27,"



",no_relation,0.5886,,D011464,"<span class=""chemical"">epoprostenol</span>",D006333,"<span class=""disease"">right-sided heart failure</span>","On multivariate analysis, including both baseline variables and those measured after three months on <span class=""chemical"">epoprostenol</span>, a history of <span class=""disease"">right-sided heart failure</span>, persistence of NYHA functional class III or IV at three months, and the absence of a fall in total pulmonary resistance of >30%, relative to baseline, were associated with poor survival.",,12204511,12204511_D011464_D006333,12204511_9,bcv_sentence_task_befree_1730,,770957658,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D011464,"<span class=""chemical"">epoprostenol</span>",D065627,"<span class=""disease"">PPH</span>","Survival of patients with <span class=""disease"">PPH</span> treated with <span class=""chemical"">epoprostenol</span> depends on the severity at baseline, as well as the three-month response to therapy.",,12204511,12204511_D011464_D065627,12204511_10,bcv_sentence_task_befree_1731,,770957659,FALSE,finalized,5,8/15/15 2:23,"



",no_relation,1,,C059262,"<span class=""chemical"">cidofovir/CDV</span>",D000257,"<span class=""disease"">adenovirus (Ad) infections</span>","Although there is currently no FDA approved antiviral treatment for <span class=""disease"">adenovirus (Ad) infections</span>, the broad spectrum antiviral <span class=""chemical"">cidofovir</span> (<span class=""chemical"">CDV</span>) has demonstrated potent inhibitory activity against many Ad serotypes in vitro and in an in vivo ocular replication model.",,12323401,12323401_C059262_D000257,12323401_1,bcv_sentence_task_befree_1732,,770957660,FALSE,finalized,5,8/15/15 1:09,"



",no_relation,1,,C059262,"<span class=""chemical"">CDV</span>",D007239,"<span class=""disease"">infection</span>","<span class=""chemical"">CDV</span> resistance was demonstrated by ability to replicate viral DNA in infected cells at <span class=""chemical"">CDV</span> concentrations that inhibit the parental virus, by ability to form plaques in CDV concentrations of >20 microg/ml and by increased progeny release following <span class=""disease"">infection</span> and growth in media containing <span class=""chemical"">CDV</span>.",,12323401,12323401_C059262_D007239,12323401_4,bcv_sentence_task_befree_1733,,770957661,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,0.6082,,D001647,"<span class=""chemical"">bile acids</span>",D007410,"<span class=""disease"">intestinal atrophy</span>","Dietary <span class=""chemical"">bile acids</span> inhibit potentially elemental diet-induced small <span class=""disease"">intestinal atrophy</span> in rats.",,12373304,12373304_D001647_D007410,12373304_0,bcv_sentence_task_befree_1734,,770957662,FALSE,finalized,5,8/14/15 21:27,"



",no_relation,1,,D001647,"<span class=""chemical"">bile acid</span>",D001284,"<span class=""disease"">atrophy</span>","Oral <span class=""chemical"">bile acid</span> administration may prevent this <span class=""disease"">atrophy</span> and the elevations in mucosal DAO and ALP activities, which may lead to new therapeutic strategies in patients managed with ED.",,12373304,12373304_D001647_D001284,12373304_11,bcv_sentence_task_befree_1735,,770957663,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,1,,D008727,"<span class=""chemical"">methotrexate</span>",D001172,"<span class=""disease"">RA</span>","Eleven <span class=""disease"">RA</span> patients (mean age 46+/-5 years; disease duration 9+/-2 years) with high disease activity despite treatment with stable doses of <span class=""chemical"">methotrexate</span> (<or=25 mg/wk) and prednisone (<or=10 mg/d) were investigated.",,12390945,12390945_D008727_D001172,12390945_5,bcv_sentence_task_befree_1736,,770957664,FALSE,finalized,5,8/14/15 23:49,"



",no_relation,1,,D011241,"<span class=""chemical"">prednisone</span>",D001172,"<span class=""disease"">RA</span>","Eleven <span class=""disease"">RA</span> patients (mean age 46+/-5 years; disease duration 9+/-2 years) with high disease activity despite treatment with stable doses of methotrexate (<or=25 mg/wk) and <span class=""chemical"">prednisone</span> (<or=10 mg/d) were investigated.",,12390945,12390945_D011241_D001172,12390945_5,bcv_sentence_task_befree_1737,,770957665,FALSE,finalized,5,8/14/15 22:23,"



",yes_direct,0.7912,,C030110,"<span class=""chemical"">Oxaliplatin</span>",D015179,"<span class=""disease"">colorectal carcinoma</span>","<span class=""chemical"">Oxaliplatin</span>: results in <span class=""disease"">colorectal carcinoma</span>.",,12398998,12398998_C030110_D015179,12398998_0,bcv_sentence_task_befree_1738,,770957666,FALSE,finalized,5,8/14/15 21:23,"



",no_relation,1,,C030110,"<span class=""chemical"">Oxaliplatin</span>",D015179,"<span class=""disease"">CRC/colorectal cancer</span>","<span class=""chemical"">Oxaliplatin</span>, a platinum compound characterized by a diaminocyclohexane (DACH) platinum carrier ligand, has proven its efficacy in first- and second-line advanced <span class=""disease"">colorectal cancer</span> (<span class=""disease"">CRC</span>) treatment.",,12398998,12398998_C030110_D015179,12398998_1,bcv_sentence_task_befree_1739,,770957667,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,1,,D010984,"<span class=""chemical"">platinum</span>",D015179,"<span class=""disease"">CRC/colorectal cancer</span>","Oxaliplatin, a <span class=""chemical"">platinum</span> compound characterized by a diaminocyclohexane (DACH) <span class=""chemical"">platinum</span> carrier ligand, has proven its efficacy in first- and second-line advanced <span class=""disease"">colorectal cancer</span> (<span class=""disease"">CRC</span>) treatment.",,12398998,12398998_D010984_D015179,12398998_1,bcv_sentence_task_befree_1740,,770957668,FALSE,finalized,5,8/15/15 0:59,"



",yes_direct,0.7983,,C030110,"<span class=""chemical"">oxaliplatin</span>",D010523,"<span class=""disease"">peripheral sensory neuropathy</span>","Acute reversible and cumulative <span class=""disease"">peripheral sensory neuropathy</span> has been observed frequently with <span class=""chemical"">oxaliplatin</span> treatment and limits its use.",,12398998,12398998_C030110_D010523,12398998_2,bcv_sentence_task_befree_1741,,770957669,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D015179,"<span class=""disease"">CRC</span>","In three prospective randomized phase III studies in advanced <span class=""disease"">CRC</span>, oxaliplatin plus <span class=""chemical"">5-FU</span>/LV improved significantly progression-free survival without a significant increase in median survival time and without affecting quality of life, compared to treatment with <span class=""chemical"">5-FU</span>/LV.",,12398998,12398998_D005472_D015179,12398998_6,bcv_sentence_task_befree_1742,,770957670,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,C030110,"<span class=""chemical"">oxaliplatin</span>",D015179,"<span class=""disease"">CRC</span>","In three prospective randomized phase III studies in advanced <span class=""disease"">CRC</span>, <span class=""chemical"">oxaliplatin</span> plus 5-FU/LV improved significantly progression-free survival without a significant increase in median survival time and without affecting quality of life, compared to treatment with 5-FU/LV.",,12398998,12398998_C030110_D015179,12398998_6,bcv_sentence_task_befree_1743,,770957671,FALSE,finalized,5,8/14/15 22:06,"



",yes_direct,1,,D018817,"<span class=""chemical"">Ecstasy</span>",D007239,"<span class=""disease"">infections</span>","Depression, memory problems, anxiety, mood fluctuation, poor concentration, <span class=""disease"">infections</span>, tremors/twitches and weight loss, were all significantly associated with the extent of <span class=""chemical"">Ecstasy</span> use.",,12404677,12404677_D018817_D007239,12404677_6,bcv_sentence_task_befree_1744,,770957672,FALSE,finalized,5,8/14/15 21:52,"



",yes_direct,1,,D018817,"<span class=""chemical"">Ecstasy</span>",D008569,"<span class=""disease"">memory problems</span>","Depression, <span class=""disease"">memory problems</span>, anxiety, mood fluctuation, poor concentration, infections, tremors/twitches and weight loss, were all significantly associated with the extent of <span class=""chemical"">Ecstasy</span> use.",,12404677,12404677_D018817_D008569,12404677_6,bcv_sentence_task_befree_1745,,770957673,FALSE,finalized,5,8/14/15 22:12,"



",yes_direct,1,,D018817,"<span class=""chemical"">Ecstasy</span>",D001008,"<span class=""disease"">anxiety</span>","Depression, memory problems, <span class=""disease"">anxiety</span>, mood fluctuation, poor concentration, infections, tremors/twitches and weight loss, were all significantly associated with the extent of <span class=""chemical"">Ecstasy</span> use.",,12404677,12404677_D018817_D001008,12404677_6,bcv_sentence_task_befree_1746,,770957674,FALSE,finalized,5,8/15/15 0:11,"



",yes_direct,1,,D018817,"<span class=""chemical"">Ecstasy</span>",D014202,"<span class=""disease"">tremors</span>","Depression, memory problems, anxiety, mood fluctuation, poor concentration, infections, <span class=""disease"">tremors</span>/twitches and weight loss, were all significantly associated with the extent of <span class=""chemical"">Ecstasy</span> use.",,12404677,12404677_D018817_D014202,12404677_6,bcv_sentence_task_befree_1747,,770957675,FALSE,finalized,5,8/15/15 1:56,"



",yes_direct,1,,D018817,"<span class=""chemical"">Ecstasy</span>",D015431,"<span class=""disease"">weight loss</span>","Depression, memory problems, anxiety, mood fluctuation, poor concentration, infections, tremors/twitches and <span class=""disease"">weight loss</span>, were all significantly associated with the extent of <span class=""chemical"">Ecstasy</span> use.",,12404677,12404677_D018817_D015431,12404677_6,bcv_sentence_task_befree_1748,,770957676,FALSE,finalized,5,8/15/15 2:17,"



",yes_direct,1,,D018817,"<span class=""chemical"">Ecstasy</span>",D003866,"<span class=""disease"">Depression</span>","<span class=""disease"">Depression</span>, memory problems, anxiety, mood fluctuation, poor concentration, infections, tremors/twitches and weight loss, were all significantly associated with the extent of <span class=""chemical"">Ecstasy</span> use.",,12404677,12404677_D018817_D003866,12404677_6,bcv_sentence_task_befree_1749,,770957677,FALSE,finalized,5,8/14/15 23:00,"



",yes_direct,1,,D018817,"<span class=""chemical"">Ecstasy</span>",D008569,"<span class=""disease"">memory problems</span>","Thus <span class=""disease"">memory problems</span> attributed to <span class=""chemical"">Ecstasy</span> were reported by 19% of novice users, 52% of heavy users and 73% of heavy users (chi-square 42.74, df=2, p<0.001); many of the other variables showed similar trends.",,12404677,12404677_D018817_D008569,12404677_7,bcv_sentence_task_befree_1750,,770957678,FALSE,finalized,5,8/14/15 22:31,"



",no_relation,1,,D005682,"<span class=""chemical"">gadolinium</span>",D009103,"<span class=""disease"">MS</span>","Four double-blind trials in relapsing-remitting <span class=""disease"">MS</span> have demonstrated that IVIG may reduce the relapse rate, progression and the number of <span class=""chemical"">gadolinium</span>-enhancing lesions.",,12453069,12453069_D005682_D009103,12453069_2,bcv_sentence_task_befree_1751,,770957679,FALSE,finalized,5,8/15/15 1:29,"



",no_relation,1,,C089995,"<span class=""chemical"">glatiramer acetate</span>",D009103,"<span class=""disease"">multiple sclerosis/MS</span>","However, these trials were smaller than the pivotal trials of interferon-beta and <span class=""chemical"">glatiramer acetate</span>, and therefore, we performed a meta-analysis of the four trials in order to provide an overall assessment of the benefits of IVIG in relapsing-remitting <span class=""disease"">multiple sclerosis</span> in comparison with other drugs currently available for treatment of disease activity in <span class=""disease"">MS</span>.",,12453069,12453069_C089995_D009103,12453069_3,bcv_sentence_task_befree_1752,,770957680,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,1,,D001058,"<span class=""chemical"">apomorphine</span>",D010302,"<span class=""disease"">Parkinson</span>","Iontophoretic delivery of <span class=""chemical"">apomorphine</span>: from in-vitro modelling to the <span class=""disease"">Parkinson</span> patient.",,12460716,12460716_D001058_D010302,12460716_0,bcv_sentence_task_befree_1753,,770957681,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D004298,"<span class=""chemical"">dopamine</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","Apomorphine is a mixed <span class=""chemical"">dopamine</span> D1/D2 receptor agonist which is potentially useful in the treatment of <span class=""disease"">Parkinson's disease</span>.",,12460716,12460716_D004298_D010300,12460716_1,bcv_sentence_task_befree_1754,,770957682,FALSE,finalized,5,8/14/15 22:40,"



",no_relation,1,,D001058,"<span class=""chemical"">Apomorphine</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","<span class=""chemical"">Apomorphine</span> is a mixed dopamine D1/D2 receptor agonist which is potentially useful in the treatment of <span class=""disease"">Parkinson's disease</span>.",,12460716,12460716_D001058_D010300,12460716_1,bcv_sentence_task_befree_1755,,770957683,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,D001058,"<span class=""chemical"">apomorphine</span>",D010302,"<span class=""disease"">Parkinson</span>","The most interesting route for controlled delivery of <span class=""chemical"">apomorphine</span> is transdermal iontophoresis because this could enable the <span class=""disease"">Parkinson</span> patient to directly control the needed amount of <span class=""chemical"">apomorphine</span> by increasing or decreasing the drug input in order to achieve optimal drug therapy ('on-demand') with a minimum of toxic side effects.",,12460716,12460716_D001058_D010302,12460716_3,bcv_sentence_task_befree_1756,,770957684,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D001058,"<span class=""chemical"">apomorphine</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","Transdermal iontophoretic transport of <span class=""chemical"">apomorphine</span> was studied both in vitro with human stratum corneum using a newly developed iontophoretic continuous flow-through transport cell and in vivo in a first exploratory study in patients with <span class=""disease"">Parkinson's disease</span>.",,12460716,12460716_D001058_D010300,12460716_8,bcv_sentence_task_befree_1757,,770957685,FALSE,finalized,5,8/14/15 21:59,"



",no_relation,1,,D016572,"<span class=""chemical"">CsA/cyclosporine</span>",D001168,"<span class=""disease"">arthritis</span>","Methotrexate (MTX), sulfasalazine (SSZ), and <span class=""chemical"">cyclosporine</span> (<span class=""chemical"">CsA</span>) are the most widely used DMARDs in the treatment of PsA and are safe and effective in patients with active peripheral <span class=""disease"">arthritis</span>, although they do not appear to be effective on axial manifestations.",,12463452,12463452_D016572_D001168,12463452_2,bcv_sentence_task_befree_1758,,770957686,FALSE,finalized,5,8/14/15 21:04,"



",no_relation,1,,D012460,"<span class=""chemical"">sulfasalazine/SSZ</span>",D015535,"<span class=""disease"">PsA</span>","Methotrexate (MTX), <span class=""chemical"">sulfasalazine</span> (<span class=""chemical"">SSZ</span>), and cyclosporine (CsA) are the most widely used DMARDs in the treatment of <span class=""disease"">PsA</span> and are safe and effective in patients with active peripheral arthritis, although they do not appear to be effective on axial manifestations.",,12463452,12463452_D012460_D015535,12463452_2,bcv_sentence_task_befree_1759,,770957687,FALSE,finalized,5,8/14/15 21:41,"



",no_relation,1,,D008727,"<span class=""chemical"">Methotrexate/MTX</span>",D015535,"<span class=""disease"">PsA</span>","<span class=""chemical"">Methotrexate</span> (<span class=""chemical"">MTX</span>), sulfasalazine (SSZ), and cyclosporine (CsA) are the most widely used DMARDs in the treatment of <span class=""disease"">PsA</span> and are safe and effective in patients with active peripheral arthritis, although they do not appear to be effective on axial manifestations.",,12463452,12463452_D008727_D015535,12463452_2,bcv_sentence_task_befree_1760,,770957688,FALSE,finalized,5,8/14/15 21:13,"



",no_relation,1,,D008727,"<span class=""chemical"">Methotrexate/MTX</span>",D001168,"<span class=""disease"">arthritis</span>","<span class=""chemical"">Methotrexate</span> (<span class=""chemical"">MTX</span>), sulfasalazine (SSZ), and cyclosporine (CsA) are the most widely used DMARDs in the treatment of PsA and are safe and effective in patients with active peripheral <span class=""disease"">arthritis</span>, although they do not appear to be effective on axial manifestations.",,12463452,12463452_D008727_D001168,12463452_2,bcv_sentence_task_befree_1761,,770957689,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,1,,D012460,"<span class=""chemical"">sulfasalazine/SSZ</span>",D001168,"<span class=""disease"">arthritis</span>","Methotrexate (MTX), <span class=""chemical"">sulfasalazine</span> (<span class=""chemical"">SSZ</span>), and cyclosporine (CsA) are the most widely used DMARDs in the treatment of PsA and are safe and effective in patients with active peripheral <span class=""disease"">arthritis</span>, although they do not appear to be effective on axial manifestations.",,12463452,12463452_D012460_D001168,12463452_2,bcv_sentence_task_befree_1762,,770957690,FALSE,finalized,5,8/14/15 21:30,"



",no_relation,1,,D016572,"<span class=""chemical"">CsA/cyclosporine</span>",D015535,"<span class=""disease"">PsA</span>","Methotrexate (MTX), sulfasalazine (SSZ), and <span class=""chemical"">cyclosporine</span> (<span class=""chemical"">CsA</span>) are the most widely used DMARDs in the treatment of <span class=""disease"">PsA</span> and are safe and effective in patients with active peripheral arthritis, although they do not appear to be effective on axial manifestations.",,12463452,12463452_D016572_D015535,12463452_2,bcv_sentence_task_befree_1763,,770957691,FALSE,finalized,5,8/15/15 0:04,"



",no_relation,1,,C045463,"<span class=""chemical"">leflunomide</span>",D009369,"<span class=""disease"">tumor</span>","It has recently been demonstrated that <span class=""chemical"">leflunomide</span> and anti-<span class=""disease"">tumor</span> necrosis factor (TNF) agents are effective in PsA and psoriasis.",,12463452,12463452_C045463_D009369,12463452_4,bcv_sentence_task_befree_1764,,770957692,FALSE,finalized,5,8/14/15 23:37,"



",no_relation,1,,C045463,"<span class=""chemical"">leflunomide</span>",D011565,"<span class=""disease"">psoriasis</span>","It has recently been demonstrated that <span class=""chemical"">leflunomide</span> and anti-tumor necrosis factor (TNF) agents are effective in PsA and <span class=""disease"">psoriasis</span>.",,12463452,12463452_C045463_D011565,12463452_4,bcv_sentence_task_befree_1765,,770957693,FALSE,finalized,5,8/14/15 22:32,"


It's 'anti-tumor necrosis factor' and not 'necrosis'
",no_relation,1,,C045463,"<span class=""chemical"">leflunomide</span>",D009336,"<span class=""disease"">necrosis</span>","It has recently been demonstrated that <span class=""chemical"">leflunomide</span> and anti-tumor <span class=""disease"">necrosis</span> factor (TNF) agents are effective in PsA and psoriasis.",,12463452,12463452_C045463_D009336,12463452_4,bcv_sentence_task_befree_1766,,770957694,FALSE,finalized,5,8/15/15 0:32,"



",no_relation,1,,C045463,"<span class=""chemical"">leflunomide</span>",D015535,"<span class=""disease"">PsA</span>","It has recently been demonstrated that <span class=""chemical"">leflunomide</span> and anti-tumor necrosis factor (TNF) agents are effective in <span class=""disease"">PsA</span> and psoriasis.",,12463452,12463452_C045463_D015535,12463452_4,bcv_sentence_task_befree_1767,,770957695,FALSE,finalized,5,8/14/15 23:34,"



",no_relation,0.8112,,D013629,"<span class=""chemical"">tamoxifen</span>",D018335,"<span class=""disease"">rhabdoid tumor</span>","Estrogen receptor expression and estrogen receptor-independent cytotoxic effects of <span class=""chemical"">tamoxifen</span> on malignant <span class=""disease"">rhabdoid tumor</span> cells in vitro.",,12495475,12495475_D013629_D018335,12495475_0,bcv_sentence_task_befree_1768,,770957696,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,D004967,"<span class=""chemical"">Estrogen</span>",D018335,"<span class=""disease"">rhabdoid tumor</span>","<span class=""chemical"">Estrogen</span> receptor expression and <span class=""chemical"">estrogen</span> receptor-independent cytotoxic effects of tamoxifen on malignant <span class=""disease"">rhabdoid tumor</span> cells in vitro.",,12495475,12495475_D004967_D018335,12495475_0,bcv_sentence_task_befree_1769,,770957697,FALSE,finalized,5,8/14/15 21:45,"



",no_relation,1,,D013629,"<span class=""chemical"">TAM/tamoxifen</span>",D009369,"<span class=""disease"">breast cancer/malignant neoplasms</span>","Recent studies have shown that the antiestrogen <span class=""chemical"">tamoxifen</span> (<span class=""chemical"">TAM</span>) can be used in the treatment of <span class=""disease"">malignant neoplasms</span> other than <span class=""disease"">breast cancer</span>.",,12495475,12495475_D013629_D009369,12495475_1,bcv_sentence_task_befree_1770,,770957698,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,0.8072,,D004967,"<span class=""chemical"">estrogen</span>",D018335,"<span class=""disease"">rhabdoid tumor</span>","In the present study, we investigated the expression of <span class=""chemical"">estrogen</span> receptor (ER) in six malignant <span class=""disease"">rhabdoid tumor</span> (MRT) cell lines.",,12495475,12495475_D004967_D018335,12495475_2,bcv_sentence_task_befree_1771,,770957699,FALSE,finalized,5,8/15/15 1:24,"



",no_relation,1,,C097613,"<span class=""chemical"">Imatinib</span>",D000796,"<span class=""disease"">eosinophilic disorders</span>","<span class=""chemical"">Imatinib</span> therapy for hypereosinophilic syndrome and other <span class=""disease"">eosinophilic disorders</span>.",,12506022,12506022_C097613_D000796,12506022_0,bcv_sentence_task_befree_1772,,770957700,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,1,,C097613,"<span class=""chemical"">Imatinib</span>",D017681,"<span class=""disease"">hypereosinophilic syndrome</span>","<span class=""chemical"">Imatinib</span> therapy for <span class=""disease"">hypereosinophilic syndrome</span> and other eosinophilic disorders.",,12506022,12506022_C097613_D017681,12506022_0,bcv_sentence_task_befree_1773,,770957701,FALSE,finalized,5,8/15/15 0:09,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D017681,"<span class=""disease"">hypereosinophilic syndrome/HES</span>","Imatinib mesylate (Gleevec), a small molecule inhibitor of abl, kit, and platelet-derived growth factor receptor (PDGFR) <span class=""chemical"">tyrosine</span> kinases, has been reported to be effective in the treatment of <span class=""disease"">hypereosinophilic syndrome</span> (<span class=""disease"">HES</span>) and a rare eosinophilia-associated chronic myeloid disorder (eos-CMD) characterized by the t(5;12)(q33;p13) cytogenetic abnormality.",,12506022,12506022_D014443_D017681,12506022_1,bcv_sentence_task_befree_1774,,770957702,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,C097613,"<span class=""chemical"">Imatinib</span>",D004802,"<span class=""disease"">eosinophilia</span>","<span class=""chemical"">Imatinib</span> mesylate (Gleevec), a small molecule inhibitor of abl, kit, and platelet-derived growth factor receptor (PDGFR) tyrosine kinases, has been reported to be effective in the treatment of hypereosinophilic syndrome (HES) and a rare <span class=""disease"">eosinophilia</span>-associated chronic myeloid disorder (eos-CMD) characterized by the t(5;12)(q33;p13) cytogenetic abnormality.",,12506022,12506022_C097613_D004802,12506022_1,bcv_sentence_task_befree_1775,,770957703,FALSE,finalized,5,8/14/15 23:04,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D007951,"<span class=""disease"">myeloid disorder</span>","Imatinib mesylate (Gleevec), a small molecule inhibitor of abl, kit, and platelet-derived growth factor receptor (PDGFR) <span class=""chemical"">tyrosine</span> kinases, has been reported to be effective in the treatment of hypereosinophilic syndrome (HES) and a rare eosinophilia-associated chronic <span class=""disease"">myeloid disorder</span> (eos-CMD) characterized by the t(5;12)(q33;p13) cytogenetic abnormality.",,12506022,12506022_D014443_D007951,12506022_1,bcv_sentence_task_befree_1776,,770957704,FALSE,finalized,5,8/15/15 1:40,"



",no_relation,1,,C097613,"<span class=""chemical"">Imatinib</span>",C565145,"<span class=""disease"">CMD</span>","<span class=""chemical"">Imatinib</span> mesylate (Gleevec), a small molecule inhibitor of abl, kit, and platelet-derived growth factor receptor (PDGFR) tyrosine kinases, has been reported to be effective in the treatment of hypereosinophilic syndrome (HES) and a rare eosinophilia-associated chronic myeloid disorder (eos-<span class=""disease"">CMD</span>) characterized by the t(5;12)(q33;p13) cytogenetic abnormality.",,12506022,12506022_C097613_C565145,12506022_1,bcv_sentence_task_befree_1777,,770957705,FALSE,finalized,5,8/14/15 21:16,"



",no_relation,0.8232,,C097613,"<span class=""chemical"">Imatinib</span>",D007951,"<span class=""disease"">myeloid disorder</span>","<span class=""chemical"">Imatinib</span> mesylate (Gleevec), a small molecule inhibitor of abl, kit, and platelet-derived growth factor receptor (PDGFR) tyrosine kinases, has been reported to be effective in the treatment of hypereosinophilic syndrome (HES) and a rare eosinophilia-associated chronic <span class=""disease"">myeloid disorder</span> (eos-CMD) characterized by the t(5;12)(q33;p13) cytogenetic abnormality.",,12506022,12506022_C097613_D007951,12506022_1,bcv_sentence_task_befree_1778,,770957706,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D004802,"<span class=""disease"">eosinophilia</span>","Imatinib mesylate (Gleevec), a small molecule inhibitor of abl, kit, and platelet-derived growth factor receptor (PDGFR) <span class=""chemical"">tyrosine</span> kinases, has been reported to be effective in the treatment of hypereosinophilic syndrome (HES) and a rare <span class=""disease"">eosinophilia</span>-associated chronic myeloid disorder (eos-CMD) characterized by the t(5;12)(q33;p13) cytogenetic abnormality.",,12506022,12506022_D014443_D004802,12506022_1,bcv_sentence_task_befree_1779,,770957707,FALSE,finalized,5,8/15/15 0:40,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",C565145,"<span class=""disease"">CMD</span>","Imatinib mesylate (Gleevec), a small molecule inhibitor of abl, kit, and platelet-derived growth factor receptor (PDGFR) <span class=""chemical"">tyrosine</span> kinases, has been reported to be effective in the treatment of hypereosinophilic syndrome (HES) and a rare eosinophilia-associated chronic myeloid disorder (eos-<span class=""disease"">CMD</span>) characterized by the t(5;12)(q33;p13) cytogenetic abnormality.",,12506022,12506022_D014443_C565145,12506022_1,bcv_sentence_task_befree_1780,,770957708,FALSE,finalized,5,8/15/15 1:09,"



",no_relation,1,,C097613,"<span class=""chemical"">Imatinib</span>",D017681,"<span class=""disease"">hypereosinophilic syndrome/HES</span>","<span class=""chemical"">Imatinib</span> mesylate (Gleevec), a small molecule inhibitor of abl, kit, and platelet-derived growth factor receptor (PDGFR) tyrosine kinases, has been reported to be effective in the treatment of <span class=""disease"">hypereosinophilic syndrome</span> (<span class=""disease"">HES</span>) and a rare eosinophilia-associated chronic myeloid disorder (eos-CMD) characterized by the t(5;12)(q33;p13) cytogenetic abnormality.",,12506022,12506022_C097613_D017681,12506022_1,bcv_sentence_task_befree_1781,,770957709,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,1,,C097613,"<span class=""chemical"">imatinib</span>",D017681,"<span class=""disease"">HES</span>","In the current study, we sought to confirm the preliminary observations in <span class=""disease"">HES</span> as well as evaluate the therapeutic value of <span class=""chemical"">imatinib</span> in eos-CMD that is not associated with t(5;12)(q33;p13).",,12506022,12506022_C097613_D017681,12506022_2,bcv_sentence_task_befree_1782,,770957710,FALSE,finalized,5,8/14/15 23:04,"



",no_relation,1,,C097613,"<span class=""chemical"">imatinib</span>",C565145,"<span class=""disease"">CMD</span>","In the current study, we sought to confirm the preliminary observations in HES as well as evaluate the therapeutic value of <span class=""chemical"">imatinib</span> in eos-<span class=""disease"">CMD</span> that is not associated with t(5;12)(q33;p13).",,12506022,12506022_C097613_C565145,12506022_2,bcv_sentence_task_befree_1783,,770957711,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,C097613,"<span class=""chemical"">imatinib</span>",D017681,"<span class=""disease"">HES</span>","Five patients with <span class=""disease"">HES</span> (all men, median age = 46 years) and 2 with eos-CMD (both men, aged 45 and 58 years) were treated with <span class=""chemical"">imatinib</span> at a starting dose of 100 to 400 mg/day.",,12506022,12506022_C097613_D017681,12506022_3,bcv_sentence_task_befree_1784,,770957712,FALSE,finalized,5,8/14/15 21:01,"



",no_relation,1,,C097613,"<span class=""chemical"">imatinib</span>",C565145,"<span class=""disease"">CMD</span>","Five patients with HES (all men, median age = 46 years) and 2 with eos-<span class=""disease"">CMD</span> (both men, aged 45 and 58 years) were treated with <span class=""chemical"">imatinib</span> at a starting dose of 100 to 400 mg/day.",,12506022,12506022_C097613_C565145,12506022_3,bcv_sentence_task_befree_1785,,770957713,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroid</span>",D000796,"<span class=""disease"">eosinophilic infiltration</span>","Myocardial biopsy revealed <span class=""disease"">eosinophilic infiltration</span> and degranulation, and the cardiogenic shock was reversed with the prompt institution of <span class=""chemical"">corticosteroid</span> therapy.",,12506022,12506022_D000305_D000796,12506022_9,bcv_sentence_task_befree_1786,,770957714,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroid</span>",D012770,"<span class=""disease"">cardiogenic shock</span>","Myocardial biopsy revealed eosinophilic infiltration and degranulation, and the <span class=""disease"">cardiogenic shock</span> was reversed with the prompt institution of <span class=""chemical"">corticosteroid</span> therapy.",,12506022,12506022_D000305_D012770,12506022_9,bcv_sentence_task_befree_1787,,770957715,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D001941,"<span class=""disease"">breast feeding</span>","To investigate whether <span class=""disease"">breast feeding</span> is effective for pain relief during venepuncture in term neonates and compare any effect with that of oral <span class=""chemical"">glucose</span> combined with a pacifier.",,12511452,12511452_D005947_D001941,12511452_1,bcv_sentence_task_befree_1788,,770957716,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D010146,"<span class=""disease"">pain</span>","To investigate whether breast feeding is effective for <span class=""disease"">pain</span> relief during venepuncture in term neonates and compare any effect with that of oral <span class=""chemical"">glucose</span> combined with a pacifier.",,12511452,12511452_D005947_D010146,12511452_1,bcv_sentence_task_befree_1789,,770957717,FALSE,finalized,5,8/14/15 21:43,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D001941,"<span class=""disease"">breast feeding</span>","During venepuncture infants were either breast fed (group 1), held in their mother's arms without <span class=""disease"">breast feeding</span> (group 2), given 1 ml of sterile water as placebo (group 3), or given 1 ml of 30% <span class=""chemical"">glucose</span> followed by pacifier (group 4).",,12511452,12511452_D005947_D001941,12511452_4,bcv_sentence_task_befree_1790,,770957718,FALSE,finalized,5,8/14/15 23:55,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D001941,"<span class=""disease"">breast feeding</span>","Median pain scores (interquartile range) for <span class=""disease"">breast feeding</span>, held in mother's arms, placebo, and 30% <span class=""chemical"">glucose</span> plus pacifier groups were 1 (0-3), 10 (8.5-10), 10 (7.5-10), and 3 (0-5) with the Douleur Aigu Nouveau-n scale and 4.5 (2.25-8), 13 (10.5-15), 12 (9-13), and 4 (1-6) with the premature infant pain profile scale.",,12511452,12511452_D005947_D001941,12511452_7,bcv_sentence_task_befree_1791,,770957719,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D010146,"<span class=""disease"">pain</span>","Median <span class=""disease"">pain</span> scores (interquartile range) for breast feeding, held in mother's arms, placebo, and 30% <span class=""chemical"">glucose</span> plus pacifier groups were 1 (0-3), 10 (8.5-10), 10 (7.5-10), and 3 (0-5) with the Douleur Aigu Nouveau-n scale and 4.5 (2.25-8), 13 (10.5-15), 12 (9-13), and 4 (1-6) with the premature infant <span class=""disease"">pain</span> profile scale.",,12511452,12511452_D005947_D010146,12511452_7,bcv_sentence_task_befree_1792,,770957720,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D001941,"<span class=""disease"">breast feeding</span>","There were significant reductions in both scores for the <span class=""disease"">breast feeding</span> and <span class=""chemical"">glucose</span> plus pacifier groups compared with the other two groups (P<0.0001, two tailed Mann-Whitney U tests between groups).",,12511452,12511452_D005947_D001941,12511452_9,bcv_sentence_task_befree_1793,,770957721,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D001941,"<span class=""disease"">breast feeding</span>","The difference in Douleur Aigu Nouveau-n scores between <span class=""disease"">breast feeding</span> and <span class=""chemical"">glucose</span> plus pacifier groups was not significant (P=0.16).",,12511452,12511452_D005947_D001941,12511452_10,bcv_sentence_task_befree_1794,,770957722,FALSE,finalized,5,8/14/15 21:43,"



",no_relation,1,,C056814,"<span class=""chemical"">cefdinir</span>",D011472,"<span class=""disease"">acute bacterial rhinosinusitis</span>","Management update of <span class=""disease"">acute bacterial rhinosinusitis</span> and the use of <span class=""chemical"">cefdinir</span>.",,12511857,12511857_C056814_D011472,12511857_0,bcv_sentence_task_befree_1795,,770957723,FALSE,finalized,5,8/15/15 2:39,"



",no_relation,1,,C056814,"<span class=""chemical"">cefdinir</span>",D011472,"<span class=""disease"">ABRS</span>","A clinical trial was reviewed in which <span class=""chemical"">cefdinir</span> was effective in treating <span class=""disease"">ABRS</span>.",,12511857,12511857_C056814_D011472,12511857_8,bcv_sentence_task_befree_1796,,770957724,FALSE,finalized,5,8/15/15 1:20,"



",no_relation,1,,D000111,"<span class=""chemical"">N-acetylcysteine</span>",C562889,"<span class=""disease"">radiocontrast nephropathy</span>","A review of contemporary prevention strategies for <span class=""disease"">radiocontrast nephropathy</span>: a focus on fenoldopam and <span class=""chemical"">N-acetylcysteine</span>.",,12556733,12556733_D000111_C562889,12556733_0,bcv_sentence_task_befree_1797,,770957725,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,D018818,"<span class=""chemical"">fenoldopam</span>",C562889,"<span class=""disease"">radiocontrast nephropathy</span>","A review of contemporary prevention strategies for <span class=""disease"">radiocontrast nephropathy</span>: a focus on <span class=""chemical"">fenoldopam</span> and N-acetylcysteine.",,12556733,12556733_D018818_C562889,12556733_0,bcv_sentence_task_befree_1798,,770957726,FALSE,finalized,5,8/15/15 1:43,"



",no_relation,1,,D018818,"<span class=""chemical"">fenoldopam</span>",C562889,"<span class=""disease"">RCN</span>","The antihypertensive agent <span class=""chemical"">fenoldopam</span> has been shown in a canine model, as well as in small, retrospective, prospective, and randomized human evaluations, to be effective for preventing <span class=""disease"">RCN</span>.",,12556733,12556733_D018818_C562889,12556733_3,bcv_sentence_task_befree_1799,,770957727,FALSE,finalized,5,8/14/15 21:05,"



",no_relation,1,,D000111,"<span class=""chemical"">NAC/N-acetylcysteine</span>",C562889,"<span class=""disease"">RCN</span>","In addition, studies have reported the ability of the free radical scavenger <span class=""chemical"">N-acetylcysteine</span> (<span class=""chemical"">NAC</span>) to prevent <span class=""disease"">RCN</span>.",,12556733,12556733_D000111_C562889,12556733_4,bcv_sentence_task_befree_1800,,770957728,FALSE,finalized,5,8/14/15 21:46,"



",no_relation,1,,C088658,"<span class=""chemical"">zoledronic acid</span>",D011471,"<span class=""disease"">prostate cancer</span>","Adjuvant studies of <span class=""chemical"">zoledronic acid</span> in patients with breast and <span class=""disease"">prostate cancer</span> are under development, and the results are eagerly anticipated.",,12562049,12562049_C088658_D011471,12562049_7,bcv_sentence_task_befree_1801,,770957729,FALSE,finalized,5,8/15/15 0:44,"



",no_relation,0.799,,D004967,"<span class=""chemical"">Estrogen</span>",D006973,"<span class=""disease"">hypertensive</span>","<span class=""chemical"">Estrogen</span> effect on heart rate variability in <span class=""disease"">hypertensive</span> postmenopausal women.",,12568734,12568734_D004967_D006973,12568734_0,bcv_sentence_task_befree_1802,,770957730,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D006973,"<span class=""disease"">hypertensive</span>","To examine the heart rate variability (HRV) response to <span class=""chemical"">estrogen</span> replacement therapy (ERT) and its association with changes in metabolic variables in <span class=""disease"">hypertensive</span> postmenopausal women.",,12568734,12568734_D004967_D006973,12568734_2,bcv_sentence_task_befree_1803,,770957731,FALSE,finalized,5,8/14/15 23:45,"



",no_relation,1,,D014700,"<span class=""chemical"">verapamil</span>",D006973,"<span class=""disease"">hypertensive</span>","A double-blind, placebo-controlled clinical trial was conducted in 30 <span class=""disease"">hypertensive</span> postmenopausal women receiving 180 mg/day of <span class=""chemical"">verapamil</span>.",,12568734,12568734_D014700_D006973,12568734_3,bcv_sentence_task_befree_1804,,770957732,FALSE,finalized,5,8/14/15 21:40,"



",no_relation,1,,D004837,"<span class=""chemical"">Epinephrine</span>",D008133,"<span class=""disease"">congenital long-QT syndrome</span>","<span class=""chemical"">Epinephrine</span> unmasks latent mutation carriers with LQT1 form of <span class=""disease"">congenital long-QT syndrome</span>.",,12598076,12598076_D004837_D008133,12598076_0,bcv_sentence_task_befree_1805,,770957733,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,1,,D004837,"<span class=""chemical"">Epinephrine</span>",D003643,"<span class=""disease"">cardiac death</span>","<span class=""chemical"">Epinephrine</span> challenge is a powerful test to establish electrocardiographic diagnosis in silent LQT1 mutation carriers, thus allowing implementation of prophylactic measures aimed at reducing sudden <span class=""disease"">cardiac death</span>.",,12598076,12598076_D004837_D003643,12598076_8,bcv_sentence_task_befree_1806,,770957734,FALSE,finalized,5,8/14/15 21:16,"



",yes_direct,0.5995,,D016202,"<span class=""chemical"">NMDA</span>",D010146,"<span class=""disease"">inflammatory pain</span>","Here we propose the hypothesis that forebrain <span class=""chemical"">NMDA</span> receptors play an important role in persistent <span class=""disease"">inflammatory pain</span> by re-enforcing glutamate sensory transmission in the brain.",,12598926,12598926_D016202_D010146,12598926_4,bcv_sentence_task_befree_1807,,770957735,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,0.8013,,D018698,"<span class=""chemical"">glutamate</span>",D010146,"<span class=""disease"">inflammatory pain</span>","Here we propose the hypothesis that forebrain NMDA receptors play an important role in persistent <span class=""disease"">inflammatory pain</span> by re-enforcing <span class=""chemical"">glutamate</span> sensory transmission in the brain.",,12598926,12598926_D018698_D010146,12598926_4,bcv_sentence_task_befree_1808,,770957736,FALSE,finalized,5,8/15/15 1:19,"



",yes_direct,0.8011,,D016202,"<span class=""chemical"">NMDA</span>",D006930,"<span class=""disease"">allodynia</span>","Mice with enhanced function of forebrain <span class=""chemical"">NMDA</span> receptors demonstrate selective enhancement of persistent pain and <span class=""disease"">allodynia</span>.",,12598926,12598926_D016202_D006930,12598926_5,bcv_sentence_task_befree_1809,,770957737,FALSE,finalized,5,8/14/15 21:49,"



",yes_direct,0.6005,,D016202,"<span class=""chemical"">NMDA</span>",D010146,"<span class=""disease"">pain</span>","Mice with enhanced function of forebrain <span class=""chemical"">NMDA</span> receptors demonstrate selective enhancement of persistent <span class=""disease"">pain</span> and allodynia.",,12598926,12598926_D016202_D010146,12598926_5,bcv_sentence_task_befree_1810,,770957738,FALSE,finalized,5,8/15/15 2:23,"



",no_relation,1,,D016202,"<span class=""chemical"">NMDA</span>",D010146,"<span class=""disease"">pain</span>","Drugs targeting forebrain <span class=""chemical"">NMDA</span> NR2B receptors may serve as a new class of medicine to control persistent <span class=""disease"">pain</span> in humans.",,12598926,12598926_D016202_D010146,12598926_6,bcv_sentence_task_befree_1811,,770957739,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D009569,"<span class=""chemical"">nitric oxide</span>",D020521,"<span class=""disease"">stroke</span>","The potential of <span class=""chemical"">nitric oxide</span> therapeutics in <span class=""disease"">stroke</span>.",,12605567,12605567_D009569_D020521,12605567_0,bcv_sentence_task_befree_1812,,770957740,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,1,,D009569,"<span class=""chemical"">NO</span>",D020521,"<span class=""disease"">stroke</span>","In <span class=""disease"">stroke</span>, a useful strategy is to increase <span class=""chemical"">NO</span> availability and thereby exploit its beneficial antiplatelet, antiatherosclerotic, haemodynamic and neuroprotective properties.",,12605567,12605567_D009569_D020521,12605567_2,bcv_sentence_task_befree_1813,,770957741,FALSE,finalized,5,8/15/15 0:33,"



",no_relation,1,,D009569,"<span class=""chemical"">NO</span>",D020521,"<span class=""disease"">stroke</span>","This article reviews developments in <span class=""chemical"">NO</span>-related therapeutics for treatment of <span class=""disease"">stroke</span>, with a particular emphasis on compounds that are in the clinical research and development pipeline.",,12605567,12605567_D009569_D020521,12605567_5,bcv_sentence_task_befree_1814,,770957742,FALSE,finalized,5,8/14/15 22:12,"



",no_relation,1,,D009569,"<span class=""chemical"">NO</span>",D020521,"<span class=""disease"">stroke</span>","Although the routine use of <span class=""chemical"">NO</span> therapeutics for the prevention or treatment of <span class=""disease"">stroke</span> cannot currently be recommended, we are evidently at an exciting stage in their pharmacological development.",,12605567,12605567_D009569_D020521,12605567_6,bcv_sentence_task_befree_1815,,770957743,FALSE,finalized,5,8/14/15 21:18,"



",yes_direct,0.7897,,D013629,"<span class=""chemical"">tamoxifen</span>",D006965,"<span class=""disease"">hyperplasia</span>","Simple endometrial <span class=""disease"">hyperplasia</span> was diagnosed in 18 of the 20 samples exposed to <span class=""chemical"">tamoxifen</span> compared with only 2 of the 20 controls ( P< 0.0005).",,12627041,12627041_D013629_D006965,12627041_6,bcv_sentence_task_befree_1816,,770957744,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D009375,"<span class=""disease"">glandular hyperplasia</span>","Tamoxifen rapidly up-regulated the cell proliferation markers, an effect that was associated with enhanced growth as confirmed by increased expression of <span class=""chemical"">estrogen</span> receptors and Ki-67, in addition to a high incidence of <span class=""disease"">glandular hyperplasia</span>.",,12627041,12627041_D004967_D009375,12627041_9,bcv_sentence_task_befree_1817,,770957745,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,0.5978,,D013629,"<span class=""chemical"">Tamoxifen</span>",D009375,"<span class=""disease"">glandular hyperplasia</span>","<span class=""chemical"">Tamoxifen</span> rapidly up-regulated the cell proliferation markers, an effect that was associated with enhanced growth as confirmed by increased expression of estrogen receptors and Ki-67, in addition to a high incidence of <span class=""disease"">glandular hyperplasia</span>.",,12627041,12627041_D013629_D009375,12627041_9,bcv_sentence_task_befree_1818,,770957746,FALSE,finalized,5,8/15/15 1:50,"



",no_relation,0.8131,,C043259,"<span class=""chemical"">gossypolone</span>",D064420,"<span class=""disease"">toxicity</span>","They react easily with electrophiles in aprotic solvents to regenerate <span class=""chemical"">gossypolone</span> or to form dehydrogossypoldithianes and dehydrogossypoldithiolanes, which display higher <span class=""disease"">toxicity</span> on KB cells.",,12670651,12670651_C043259_D064420,12670651_3,bcv_sentence_task_befree_1819,,770957747,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,0.7969,,D009569,"<span class=""chemical"">nitric oxide</span>",D064420,"<span class=""disease"">toxicity</span>","In addition, the low <span class=""disease"">toxicity</span> of gossypol thioderivatives was reversed by <span class=""chemical"">nitric oxide</span> donors in physiological media.",,12670651,12670651_D009569_D064420,12670651_4,bcv_sentence_task_befree_1820,,770957748,FALSE,finalized,5,8/15/15 1:41,"



",yes_direct,0.8086,,D006072,"<span class=""chemical"">gossypol</span>",D064420,"<span class=""disease"">toxicity</span>","In addition, the low <span class=""disease"">toxicity</span> of <span class=""chemical"">gossypol</span> thioderivatives was reversed by nitric oxide donors in physiological media.",,12670651,12670651_D006072_D064420,12670651_4,bcv_sentence_task_befree_1821,,770957749,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,1,,D006072,"<span class=""chemical"">gossypol</span>",D009369,"<span class=""disease"">tumor</span>","These experiments suggest that <span class=""chemical"">gossypol</span> and gossypolone dithianes and dithiolanes can be used as prodrugs that target <span class=""disease"">tumor</span> cells surrounded by high concentrations of nitric oxide.",,12670651,12670651_D006072_D009369,12670651_5,bcv_sentence_task_befree_1822,,770957750,FALSE,finalized,5,8/14/15 21:05,"



",no_relation,0.812,,D009569,"<span class=""chemical"">nitric oxide</span>",D009369,"<span class=""disease"">tumor</span>","These experiments suggest that gossypol and gossypolone dithianes and dithiolanes can be used as prodrugs that target <span class=""disease"">tumor</span> cells surrounded by high concentrations of <span class=""chemical"">nitric oxide</span>.",,12670651,12670651_D009569_D009369,12670651_5,bcv_sentence_task_befree_1823,,770957751,FALSE,finalized,5,8/14/15 22:42,"



",no_relation,1,,D001418,"<span class=""chemical"">baclofen</span>",D009128,"<span class=""disease"">spasticity</span>","To describe the oral motor, communication, and nutritional status of children receiving intrathecal <span class=""chemical"">baclofen</span> (ITB) therapy for <span class=""disease"">spasticity</span> of cerebral origin.",,12690587,12690587_D001418_D009128,12690587_1,bcv_sentence_task_befree_1824,,770957752,FALSE,finalized,5,8/14/15 21:20,"



",no_relation,1,,D001128,"<span class=""chemical"">argon</span>",D020256,"<span class=""disease"">Choroidal neovascularization</span>","<span class=""disease"">Choroidal neovascularization</span> was treated by <span class=""chemical"">argon</span> laser photocoagulation.",,12696645,12696645_D001128_D020256,12696645_4,bcv_sentence_task_befree_1825,,770957753,FALSE,finalized,5,8/14/15 23:33,"



",no_relation,1,,D002511,"<span class=""chemical"">cephalosporins</span>",D008586,"<span class=""disease"">pneumococcal meningitis</span>","In Belgium, high doses of third generation <span class=""chemical"">cephalosporins</span> remain effective for the treatment of <span class=""disease"">pneumococcal meningitis</span>.",,12723258,12723258_D002511_D008586,12723258_9,bcv_sentence_task_befree_1826,,770957754,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,1,,D024841,"<span class=""chemical"">fluoroquinolones</span>",D008586,"<span class=""disease"">pneumococcal meningitis</span>","The new <span class=""chemical"">fluoroquinolones</span> seem the most promising agents for the treatment of <span class=""disease"">pneumococcal meningitis</span> in the future.",,12723258,12723258_D024841_D008586,12723258_10,bcv_sentence_task_befree_1827,,770957755,FALSE,finalized,5,8/14/15 22:40,"



",no_relation,1,,D007538,"<span class=""chemical"">isoniazid</span>",D014376,"<span class=""disease"">tuberculosis</span>","Retrospective prospective analysis involved an outbreak of 94 <span class=""chemical"">isoniazid</span>-resistant <span class=""disease"">tuberculosis</span> cases in London, United Kingdom, that began after cases were identified at one hospital in January 2000.",,12734218,12734218_D007538_D014376,12734218_9,bcv_sentence_task_befree_1828,,770957756,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,1,,D002220,"<span class=""chemical"">carbamazepine</span>",D019966,"<span class=""disease"">AEDs/antiepileptic drugs</span>","Ninety percent were on <span class=""disease"">antiepileptic drugs</span> (<span class=""disease"">AEDs</span>), most commonly valproate and <span class=""chemical"">carbamazepine</span>.",,12763471,12763471_D002220_D019966,12763471_7,bcv_sentence_task_befree_1829,,770957757,FALSE,finalized,5,8/14/15 21:15,"



",no_relation,1,,D014635,"<span class=""chemical"">valproate</span>",D019966,"<span class=""disease"">AEDs/antiepileptic drugs</span>","Ninety percent were on <span class=""disease"">antiepileptic drugs</span> (<span class=""disease"">AEDs</span>), most commonly <span class=""chemical"">valproate</span> and carbamazepine.",,12763471,12763471_D014635_D019966,12763471_7,bcv_sentence_task_befree_1830,,770957758,FALSE,finalized,5,8/14/15 23:16,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",D000419,"<span class=""disease"">albuminuria</span>","Characteristics of nephropaths identified by existing screening practice (phase I, <span class=""disease"">albuminuria</span> >20 mg/l in three separate urine samples), were compared with those identified by a nurse-led management program (phase II, in which screening for nephropathy was based on albumin-to-<span class=""chemical"">creatinine</span> ratio in a single random urine specimen).",,12766114,12766114_D003404_D000419,12766114_2,bcv_sentence_task_befree_1831,,770957759,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",D003554,"<span class=""disease"">nephropaths</span>","Characteristics of <span class=""disease"">nephropaths</span> identified by existing screening practice (phase I, albuminuria >20 mg/l in three separate urine samples), were compared with those identified by a nurse-led management program (phase II, in which screening for nephropathy was based on albumin-to-<span class=""chemical"">creatinine</span> ratio in a single random urine specimen).",,12766114,12766114_D003404_D003554,12766114_2,bcv_sentence_task_befree_1832,,770957760,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",C562889,"<span class=""disease"">nephropathy</span>","Characteristics of nephropaths identified by existing screening practice (phase I, albuminuria >20 mg/l in three separate urine samples), were compared with those identified by a nurse-led management program (phase II, in which screening for <span class=""disease"">nephropathy</span> was based on albumin-to-<span class=""chemical"">creatinine</span> ratio in a single random urine specimen).",,12766114,12766114_D003404_C562889,12766114_2,bcv_sentence_task_befree_1833,,770957761,FALSE,finalized,5,8/14/15 23:24,"



",no_relation,1,,D013792,"<span class=""chemical"">Thalidomide</span>",D007918,"<span class=""disease"">leprosy</span>","<span class=""chemical"">Thalidomide</span> has recently shown considerable promise in the treatment of a number of conditions, such as <span class=""disease"">leprosy</span> and cancer.",,12803319,12803319_D013792_D007918,12803319_1,bcv_sentence_task_befree_1834,,770957762,FALSE,finalized,5,8/15/15 0:51,"



",no_relation,1,,D013792,"<span class=""chemical"">Thalidomide</span>",D009369,"<span class=""disease"">cancer</span>","<span class=""chemical"">Thalidomide</span> has recently shown considerable promise in the treatment of a number of conditions, such as leprosy and <span class=""disease"">cancer</span>.",,12803319,12803319_D013792_D009369,12803319_1,bcv_sentence_task_befree_1835,,770957763,FALSE,finalized,5,8/15/15 1:58,"



",no_relation,1,,D013792,"<span class=""chemical"">thalidomide</span>",D004409,"<span class=""disease"">SelCIDs/selective cytokine inhibitory drugs</span>","These include <span class=""disease"">selective cytokine inhibitory drugs</span> (<span class=""disease"">SelCIDs</span>), with greatly improved TNF-alpha inhibitory activity, and immunomodulatory drugs (IMiDs) that are structural analogs of <span class=""chemical"">thalidomide</span>, with improved properties.",,12803319,12803319_D013792_D004409,12803319_4,bcv_sentence_task_befree_1836,,770957764,FALSE,finalized,5,8/14/15 21:43,"



",no_relation,1,,D013792,"<span class=""chemical"">thalidomide</span>",D007249,"<span class=""disease"">inflammatory disease</span>","This review describes the emerging immunological properties of <span class=""chemical"">thalidomide</span>, from a historical context to present-day clinical applications, most notably in multiple myeloma but also in other cancers, <span class=""disease"">inflammatory disease</span>, and HIV.",,12803319,12803319_D013792_D007249,12803319_6,bcv_sentence_task_befree_1837,,770957765,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,1,,D013792,"<span class=""chemical"">thalidomide</span>",D009101,"<span class=""disease"">myeloma</span>","This review describes the emerging immunological properties of <span class=""chemical"">thalidomide</span>, from a historical context to present-day clinical applications, most notably in multiple <span class=""disease"">myeloma</span> but also in other cancers, inflammatory disease, and HIV.",,12803319,12803319_D013792_D009101,12803319_6,bcv_sentence_task_befree_1838,,770957766,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,0.7862,,D013792,"<span class=""chemical"">thalidomide</span>",D009369,"<span class=""disease"">cancers</span>","This review describes the emerging immunological properties of <span class=""chemical"">thalidomide</span>, from a historical context to present-day clinical applications, most notably in multiple myeloma but also in other <span class=""disease"">cancers</span>, inflammatory disease, and HIV.",,12803319,12803319_D013792_D009369,12803319_6,bcv_sentence_task_befree_1839,,770957767,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,0.815,,D013792,"<span class=""chemical"">thalidomide</span>",D015658,"<span class=""disease"">HIV</span>","This review describes the emerging immunological properties of <span class=""chemical"">thalidomide</span>, from a historical context to present-day clinical applications, most notably in multiple myeloma but also in other cancers, inflammatory disease, and <span class=""disease"">HIV</span>.",,12803319,12803319_D013792_D015658,12803319_6,bcv_sentence_task_befree_1840,,770957768,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,1,,D013792,"<span class=""chemical"">thalidomide</span>",D009369,"<span class=""disease"">cancers</span>","Early trial data suggest that these novel immunomodulatory compounds may supercede <span class=""chemical"">thalidomide</span> to become established therapies, particularly in certain <span class=""disease"">cancers</span>.",,12803319,12803319_D013792_D009369,12803319_8,bcv_sentence_task_befree_1841,,770957769,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,1,,D010710,"<span class=""chemical"">phosphate</span>",D007676,"<span class=""disease"">ESRD/end-stage renal disease</span>","More than 60% of patients on chronic haemodialysis (HD) have a serum <span class=""chemical"">phosphate</span> level above 5.5 mg/dl (1.75 mmol/l), which recently has been recommended as an appropriate target in patients with <span class=""disease"">end-stage renal disease</span> (<span class=""disease"">ESRD</span>).",,12817070,12817070_D010710_D007676,12817070_1,bcv_sentence_task_befree_1842,,770957770,FALSE,finalized,5,8/14/15 21:04,"



",no_relation,1,,D008353,"<span class=""chemical"">Mannitol</span>",D020521,"<span class=""disease"">acute stroke</span>","<span class=""chemical"">Mannitol</span> use in <span class=""disease"">acute stroke</span>: case fatality at 30 days and 1 year.",,12817105,12817105_D008353_D020521,12817105_0,bcv_sentence_task_befree_1843,,770957771,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,1,,D008353,"<span class=""chemical"">Mannitol</span>",D020521,"<span class=""disease"">acute stroke</span>","<span class=""chemical"">Mannitol</span> is used worldwide to treat <span class=""disease"">acute stroke</span>, although its efficacy and safety have not been proven by randomized trials.",,12817105,12817105_D008353_D020521,12817105_1,bcv_sentence_task_befree_1844,,770957772,FALSE,finalized,5,8/14/15 23:33,"



",no_relation,1,,D008353,"<span class=""chemical"">mannitol</span>",D020521,"<span class=""disease"">stroke</span>","In a tricenter, prospective study, we analyzed the 30-day and 1-year case fatality with respect to <span class=""chemical"">mannitol</span> treatment status in 805 patients consecutively admitted within 72 hours of <span class=""disease"">stroke</span> onset.",,12817105,12817105_D008353_D020521,12817105_2,bcv_sentence_task_befree_1845,,770957773,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,0.8084,,D008353,"<span class=""chemical"">Mannitol</span>",D005334,"<span class=""disease"">fever</span>","<span class=""chemical"">Mannitol</span> treatment effect was adjusted for age, stroke severity, <span class=""disease"">fever</span> in the first 3 days, and aspirin treatment (for ischemic strokes) in logistic regression models.",,12817105,12817105_D008353_D005334,12817105_6,bcv_sentence_task_befree_1846,,770957774,FALSE,finalized,5,8/15/15 2:39,"



",no_relation,1,,D008353,"<span class=""chemical"">Mannitol</span>",D020521,"<span class=""disease"">stroke</span>","<span class=""chemical"">Mannitol</span> treatment effect was adjusted for age, <span class=""disease"">stroke</span> severity, fever in the first 3 days, and aspirin treatment (for ischemic strokes) in logistic regression models.",,12817105,12817105_D008353_D020521,12817105_6,bcv_sentence_task_befree_1847,,770957775,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D002544,"<span class=""disease"">ischemic strokes</span>","Mannitol treatment effect was adjusted for age, stroke severity, fever in the first 3 days, and <span class=""chemical"">aspirin</span> treatment (for <span class=""disease"">ischemic strokes</span>) in logistic regression models.",,12817105,12817105_D001241_D002544,12817105_6,bcv_sentence_task_befree_1848,,770957776,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D020521,"<span class=""disease"">stroke</span>","Mannitol treatment effect was adjusted for age, <span class=""disease"">stroke</span> severity, fever in the first 3 days, and <span class=""chemical"">aspirin</span> treatment (for ischemic strokes) in logistic regression models.",,12817105,12817105_D001241_D020521,12817105_6,bcv_sentence_task_befree_1849,,770957777,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D005334,"<span class=""disease"">fever</span>","Mannitol treatment effect was adjusted for age, stroke severity, <span class=""disease"">fever</span> in the first 3 days, and <span class=""chemical"">aspirin</span> treatment (for ischemic strokes) in logistic regression models.",,12817105,12817105_D001241_D005334,12817105_6,bcv_sentence_task_befree_1850,,770957778,FALSE,finalized,5,8/15/15 2:19,"



",no_relation,1,,D008353,"<span class=""chemical"">Mannitol</span>",D002544,"<span class=""disease"">ischemic strokes</span>","<span class=""chemical"">Mannitol</span> treatment effect was adjusted for age, stroke severity, fever in the first 3 days, and aspirin treatment (for <span class=""disease"">ischemic strokes</span>) in logistic regression models.",,12817105,12817105_D008353_D002544,12817105_6,bcv_sentence_task_befree_1851,,770957779,FALSE,finalized,5,8/15/15 1:37,"



",no_relation,1,,D008353,"<span class=""chemical"">mannitol</span>",D020521,"<span class=""disease"">acute stroke</span>","Based on the results of this study, no recommendations can be made on the use of <span class=""chemical"">mannitol</span> in <span class=""disease"">acute stroke</span>, and properly randomized, controlled trials should be performed to come to a final conclusion.",,12817105,12817105_D008353_D020521,12817105_10,bcv_sentence_task_befree_1852,,770957780,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,1,,C063008,"<span class=""chemical"">mycophenolate mofetil</span>",C535661,"<span class=""disease"">ST</span>","We investigated in vitro monokine responses in 112 patients with long-term stable kidney graft function (<span class=""disease"">ST</span> patients; n=80, non-<span class=""chemical"">mycophenolate mofetil</span> [MMF]; n=32, MMF) and 25 patients with chronic renal transplant rejection (CR patients; non-MMF).",,12829918,12829918_C063008_C535661,12829918_2,bcv_sentence_task_befree_1853,,770957781,FALSE,finalized,5,8/15/15 1:41,"



",no_relation,1,,C063008,"<span class=""chemical"">mycophenolate mofetil</span>",D051436,"<span class=""disease"">chronic renal transplant rejection</span>","We investigated in vitro monokine responses in 112 patients with long-term stable kidney graft function (ST patients; n=80, non-<span class=""chemical"">mycophenolate mofetil</span> [MMF]; n=32, MMF) and 25 patients with <span class=""disease"">chronic renal transplant rejection</span> (CR patients; non-MMF).",,12829918,12829918_C063008_D051436,12829918_2,bcv_sentence_task_befree_1854,,770957782,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",C535661,"<span class=""disease"">ST</span>","Coinciding with a significantly higher <span class=""chemical"">steroid</span> dosage in CR patients, IL-6 receptor and TNF-R1 expression on monocytes were down-regulated (P< or =0.02) and AC was suppressed in CR compared with <span class=""disease"">ST</span> (non-MMF) patients (P<0.01, SED; P<0.05, SEE).",,12829918,12829918_D013256_C535661,12829918_5,bcv_sentence_task_befree_1855,,770957783,FALSE,finalized,5,8/14/15 21:14,"



",no_relation,1,,D008712,"<span class=""chemical"">methicillin</span>",D060467,"<span class=""disease"">methicillin-resistant</span>","Genetic relationship between <span class=""chemical"">methicillin</span>-sensitive and <span class=""chemical""></span><span class=""disease"">methicillin</span>-resistant Staphylococcus aureus strains from France and from international sources: delineation of genomic groups.",,12843025,12843025_D008712_D060467,12843025_0,bcv_sentence_task_befree_1856,,770957784,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,D008712,"<span class=""chemical"">methicillin</span>",D060467,"<span class=""disease"">methicillin-resistant/MRSA</span>","Cluster analysis of the SmaI patterns, generated by pulsed-field gel electrophoresis, of 44 <span class=""chemical""></span><span class=""disease"">methicillin</span>-resistant (<span class=""disease"">MRSA</span>) and 118 <span class=""chemical"">methicillin</span>-sensitive (MSSA) Staphylococcus aureus strains isolated in various French hospitals and 61 <span class=""disease"">MRSA</span> and 48 MSSA strains from 20 other countries revealed 20 genomic groups distributed into four distantly related phylogenic branches.",,12843025,12843025_D008712_D060467,12843025_1,bcv_sentence_task_befree_1857,,770957785,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,D005472,"<span class=""chemical"">5-fluorouracil</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Oxaliplatin with weekly bolus <span class=""chemical"">5-fluorouracil</span> and leucovorin in pretreated advanced <span class=""disease"">colorectal cancer</span> patients: a phase II study.",,12886055,12886055_D005472_D015179,12886055_0,bcv_sentence_task_befree_1858,,770957786,FALSE,finalized,5,8/14/15 21:05,"



",no_relation,1,,C030110,"<span class=""chemical"">Oxaliplatin</span>",D015179,"<span class=""disease"">colorectal cancer</span>","<span class=""chemical"">Oxaliplatin</span> with weekly bolus 5-fluorouracil and leucovorin in pretreated advanced <span class=""disease"">colorectal cancer</span> patients: a phase II study.",,12886055,12886055_C030110_D015179,12886055_0,bcv_sentence_task_befree_1859,,770957787,FALSE,finalized,5,8/14/15 23:51,"



",no_relation,1,,D002955,"<span class=""chemical"">leucovorin</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Oxaliplatin with weekly bolus 5-fluorouracil and <span class=""chemical"">leucovorin</span> in pretreated advanced <span class=""disease"">colorectal cancer</span> patients: a phase II study.",,12886055,12886055_D002955_D015179,12886055_0,bcv_sentence_task_befree_1860,,770957788,FALSE,finalized,5,8/15/15 0:10,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU/5-fluorouracil</span>",D015179,"<span class=""disease"">colorectal cancer</span>","The purpose of this study was to determine the efficacy and toxicity of oxaliplatin in combination with weekly bolus <span class=""chemical"">5-fluorouracil</span> (<span class=""chemical"">5-FU</span>) and leucovorin (LV) in patients with <span class=""chemical"">5-FU</span>-pretreated advanced <span class=""disease"">colorectal cancer</span>.",,12886055,12886055_D005472_D015179,12886055_1,bcv_sentence_task_befree_1861,,770957789,FALSE,finalized,5,8/14/15 21:15,"



",no_relation,1,,C030110,"<span class=""chemical"">oxaliplatin</span>",D015179,"<span class=""disease"">colorectal cancer</span>","The purpose of this study was to determine the efficacy and toxicity of <span class=""chemical"">oxaliplatin</span> in combination with weekly bolus 5-fluorouracil (5-FU) and leucovorin (LV) in patients with 5-FU-pretreated advanced <span class=""disease"">colorectal cancer</span>.",,12886055,12886055_C030110_D015179,12886055_1,bcv_sentence_task_befree_1862,,770957790,FALSE,finalized,5,8/15/15 2:33,"



",no_relation,0.6036,,C030110,"<span class=""chemical"">oxaliplatin</span>",D064420,"<span class=""disease"">toxicity</span>","The purpose of this study was to determine the efficacy and <span class=""disease"">toxicity</span> of <span class=""chemical"">oxaliplatin</span> in combination with weekly bolus 5-fluorouracil (5-FU) and leucovorin (LV) in patients with 5-FU-pretreated advanced colorectal cancer.",,12886055,12886055_C030110_D064420,12886055_1,bcv_sentence_task_befree_1863,,770957791,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,0.7805,,D005472,"<span class=""chemical"">5-FU/5-fluorouracil</span>",D064420,"<span class=""disease"">toxicity</span>","The purpose of this study was to determine the efficacy and <span class=""disease"">toxicity</span> of oxaliplatin in combination with weekly bolus <span class=""chemical"">5-fluorouracil</span> (<span class=""chemical"">5-FU</span>) and leucovorin (LV) in patients with <span class=""chemical"">5-FU</span>-pretreated advanced colorectal cancer.",,12886055,12886055_D005472_D064420,12886055_1,bcv_sentence_task_befree_1864,,770957792,FALSE,finalized,5,8/14/15 21:23,"



",no_relation,1,,D002955,"<span class=""chemical"">leucovorin</span>",D064420,"<span class=""disease"">toxicity</span>","The purpose of this study was to determine the efficacy and <span class=""disease"">toxicity</span> of oxaliplatin in combination with weekly bolus 5-fluorouracil (5-FU) and <span class=""chemical"">leucovorin</span> (LV) in patients with 5-FU-pretreated advanced colorectal cancer.",,12886055,12886055_D002955_D064420,12886055_1,bcv_sentence_task_befree_1865,,770957793,FALSE,finalized,5,8/14/15 21:01,"



",no_relation,1,,D002955,"<span class=""chemical"">leucovorin</span>",D015179,"<span class=""disease"">colorectal cancer</span>","The purpose of this study was to determine the efficacy and toxicity of oxaliplatin in combination with weekly bolus 5-fluorouracil (5-FU) and <span class=""chemical"">leucovorin</span> (LV) in patients with 5-FU-pretreated advanced <span class=""disease"">colorectal cancer</span>.",,12886055,12886055_D002955_D015179,12886055_1,bcv_sentence_task_befree_1866,,770957794,FALSE,finalized,5,8/14/15 21:59,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D015179,"<span class=""disease"">colorectal cancer</span>","A total of 39 patients with documented <span class=""chemical"">5-FU</span>-resistant advanced <span class=""disease"">colorectal cancer</span> were enrolled.",,12886055,12886055_D005472_D015179,12886055_2,bcv_sentence_task_befree_1867,,770957795,FALSE,finalized,5,8/14/15 23:49,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Oxaliplatin in combination with weekly bolus <span class=""chemical"">5-FU</span>/LV is also active in patients with advanced <span class=""disease"">colorectal cancer</span> where first-line treatment has failed.",,12886055,12886055_D005472_D015179,12886055_11,bcv_sentence_task_befree_1868,,770957796,FALSE,finalized,5,8/15/15 0:45,"



",no_relation,1,,C030110,"<span class=""chemical"">Oxaliplatin</span>",D015179,"<span class=""disease"">colorectal cancer</span>","<span class=""chemical"">Oxaliplatin</span> in combination with weekly bolus 5-FU/LV is also active in patients with advanced <span class=""disease"">colorectal cancer</span> where first-line treatment has failed.",,12886055,12886055_C030110_D015179,12886055_11,bcv_sentence_task_befree_1869,,770957797,FALSE,finalized,5,8/14/15 21:08,"



",no_relation,1,,C065179,"<span class=""chemical"">atorvastatin</span>",D054058,"<span class=""disease"">acute coronary syndromes</span>","Comparison of clinical benefits of clopidogrel therapy in patients with <span class=""disease"">acute coronary syndromes</span> taking <span class=""chemical"">atorvastatin</span> versus other statin therapies.",,12888133,12888133_C065179_D054058,12888133_0,bcv_sentence_task_befree_1870,,770957798,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,1,,C055162,"<span class=""chemical"">clopidogrel</span>",D054058,"<span class=""disease"">acute coronary syndromes</span>","Comparison of clinical benefits of <span class=""chemical"">clopidogrel</span> therapy in patients with <span class=""disease"">acute coronary syndromes</span> taking atorvastatin versus other statin therapies.",,12888133,12888133_C055162_D054058,12888133_0,bcv_sentence_task_befree_1871,,770957799,FALSE,finalized,5,8/14/15 21:45,"



",no_relation,1,,C065179,"<span class=""chemical"">atorvastatin</span>",D054058,"<span class=""disease"">acute coronary syndromes</span>","In clinical practice, we found no significant difference between <span class=""chemical"">atorvastatin</span> therapy or other statin therapies in the clinical outcomes of patients with <span class=""disease"">acute coronary syndromes</span> receiving clopidogrel therapy.",,12888133,12888133_C065179_D054058,12888133_1,bcv_sentence_task_befree_1872,,770957800,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,C055162,"<span class=""chemical"">clopidogrel</span>",D054058,"<span class=""disease"">acute coronary syndromes</span>","In clinical practice, we found no significant difference between atorvastatin therapy or other statin therapies in the clinical outcomes of patients with <span class=""disease"">acute coronary syndromes</span> receiving <span class=""chemical"">clopidogrel</span> therapy.",,12888133,12888133_C055162_D054058,12888133_1,bcv_sentence_task_befree_1873,,770957801,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,C055162,"<span class=""chemical"">clopidogrel</span>",D020521,"<span class=""disease"">stroke</span>","In patients receiving atorvastatin therapy, <span class=""chemical"">clopidogrel</span> therapy was associated with a significant decrease in mortality and <span class=""disease"">stroke</span> during univariate analysis and a moderate trend of reduced mortality and <span class=""disease"">stroke</span> without statistical significance in the multivariate analysis.",,12888133,12888133_C055162_D020521,12888133_2,bcv_sentence_task_befree_1874,,770957802,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,C065179,"<span class=""chemical"">atorvastatin</span>",D020521,"<span class=""disease"">stroke</span>","In patients receiving <span class=""chemical"">atorvastatin</span> therapy, clopidogrel therapy was associated with a significant decrease in mortality and <span class=""disease"">stroke</span> during univariate analysis and a moderate trend of reduced mortality and <span class=""disease"">stroke</span> without statistical significance in the multivariate analysis.",,12888133,12888133_C065179_D020521,12888133_2,bcv_sentence_task_befree_1875,,770957803,FALSE,finalized,5,8/14/15 23:22,"



",no_relation,1,,D018698,"<span class=""chemical"">glutamine</span>",D014947,"<span class=""disease"">burn injury</span>","This research was conducted to evaluate the effect of enterally administered <span class=""chemical"">glutamine</span> (gln) dipeptide on metabolic, gastrointestinal, and outcome parameters after severe <span class=""disease"">burn injury</span>.",,12903886,12903886_D018698_D014947,12903886_1,bcv_sentence_task_befree_1876,,770957804,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,1,,D008353,"<span class=""chemical"">mannitol</span>",D014947,"<span class=""disease"">burn injury</span>","Lactulose/<span class=""chemical"">mannitol</span> ratios were increased above normal on POD +1 (control, 0.221 +/- 0.169; gln, 0.268 +/- 0.202; not significant), reflecting increased intestinal permeability after <span class=""disease"">burn injury</span>.",,12903886,12903886_D008353_D014947,12903886_10,bcv_sentence_task_befree_1877,,770957805,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,1,,D007792,"<span class=""chemical"">Lactulose</span>",D014947,"<span class=""disease"">burn injury</span>","<span class=""chemical"">Lactulose</span>/mannitol ratios were increased above normal on POD +1 (control, 0.221 +/- 0.169; gln, 0.268 +/- 0.202; not significant), reflecting increased intestinal permeability after <span class=""disease"">burn injury</span>.",,12903886,12903886_D007792_D014947,12903886_10,bcv_sentence_task_befree_1878,,770957806,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D000109,"<span class=""chemical"">acetylcholine</span>",D006973,"<span class=""disease"">hypertensive</span>","We compared dose-response curves relating changes in coronary blood flow and epicardial diameter to graded infusions of <span class=""chemical"">acetylcholine</span> in 50 African American and 65 white subjects with <span class=""disease"">hypertensive</span> left ventricular hypertrophy (LVH) and normal coronary arteries.",,12913059,12913059_D000109_D006973,12913059_3,bcv_sentence_task_befree_1879,,770957807,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,D000109,"<span class=""chemical"">acetylcholine</span>",D017379,"<span class=""disease"">left ventricular hypertrophy/LVH</span>","We compared dose-response curves relating changes in coronary blood flow and epicardial diameter to graded infusions of <span class=""chemical"">acetylcholine</span> in 50 African American and 65 white subjects with hypertensive <span class=""disease"">left ventricular hypertrophy</span> (<span class=""disease"">LVH</span>) and normal coronary arteries.",,12913059,12913059_D000109_D017379,12913059_3,bcv_sentence_task_befree_1880,,770957808,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,D000241,"<span class=""chemical"">Adenosine</span>",D017379,"<span class=""disease"">LVH</span>","<span class=""chemical"">Adenosine</span> responses, a measure of endothelium-independent function, were similar after partitioning by <span class=""disease"">LVH</span>.",,12913059,12913059_D000241_D017379,12913059_10,bcv_sentence_task_befree_1881,,770957809,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,1,,D000109,"<span class=""chemical"">acetylcholine</span>",D017379,"<span class=""disease"">LVH</span>","Our study demonstrates that there are racial differences in sensitivity of coronary arteries to <span class=""chemical"">acetylcholine</span>-stimulated relaxation among those with <span class=""disease"">LVH</span>.",,12913059,12913059_D000109_D017379,12913059_11,bcv_sentence_task_befree_1882,,770957810,FALSE,finalized,5,8/14/15 21:01,"



",no_relation,0.5786,,D009532,"<span class=""chemical"">nickel</span>",D003872,"<span class=""disease"">dermatitis</span>","Recently, several studies reported that patients affected by cutaneous diseases (i.e. <span class=""disease"">dermatitis</span>, eczema and urticaria) with positive patch test to <span class=""chemical"">nickel</span> have a positive oral <span class=""chemical"">nickel</span> challenge.",,12915773,12915773_D009532_D003872,12915773_2,bcv_sentence_task_befree_1883,,770957811,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,0.8073,,D009532,"<span class=""chemical"">nickel</span>",D004485,"<span class=""disease"">eczema</span>","Recently, several studies reported that patients affected by cutaneous diseases (i.e. dermatitis, <span class=""disease"">eczema</span> and urticaria) with positive patch test to <span class=""chemical"">nickel</span> have a positive oral <span class=""chemical"">nickel</span> challenge.",,12915773,12915773_D009532_D004485,12915773_2,bcv_sentence_task_befree_1884,,770957812,FALSE,finalized,5,8/15/15 0:37,"



",yes_direct,0.6107,,D009532,"<span class=""chemical"">nickel</span>",D014581,"<span class=""disease"">urticaria</span>","Recently, several studies reported that patients affected by cutaneous diseases (i.e. dermatitis, eczema and <span class=""disease"">urticaria</span>) with positive patch test to <span class=""chemical"">nickel</span> have a positive oral <span class=""chemical"">nickel</span> challenge.",,12915773,12915773_D009532_D014581,12915773_2,bcv_sentence_task_befree_1885,,770957813,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,0.8077,,D009532,"<span class=""chemical"">nickel</span>",D004342,"<span class=""disease"">hypersensitivity</span>","The results of this study demonstrate that, in some patients with a positive patch test to nickel sulphate, the perpetuation of RAS can be related to a <span class=""disease"">hypersensitivity</span> to ingested nickel salts, independently of local contact to <span class=""chemical"">nickel</span>.",,12915773,12915773_D009532_D004342,12915773_14,bcv_sentence_task_befree_1886,,770957814,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,C106791,"<span class=""chemical"">Telithromycin</span>",D003147,"<span class=""disease"">community-acquired pneumonia</span>","<span class=""chemical"">Telithromycin</span> 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for <span class=""disease"">community-acquired pneumonia</span>.",,12925111,12925111_C106791_D003147,12925111_0,bcv_sentence_task_befree_1887,,770957815,FALSE,finalized,5,8/14/15 21:18,"



",no_relation,1,,C106791,"<span class=""chemical"">telithromycin/HMR 3647</span>",D003147,"<span class=""disease"">CAP/community-acquired pneumonia</span>","This open, multinational study examined the efficacy and tolerability of <span class=""chemical"">telithromycin</span> (<span class=""chemical"">HMR 3647</span>), the first ketolide antibacterial agent, at an oral dose of 800 mg once daily for seven to ten days (further validated using pharmacokinetic analysis) as an empiric therapy in adults with mild to moderate <span class=""disease"">community-acquired pneumonia</span> (<span class=""disease"">CAP</span>).",,12925111,12925111_C106791_D003147,12925111_1,bcv_sentence_task_befree_1888,,770957816,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,C106791,"<span class=""chemical"">telithromycin</span>",D003147,"<span class=""disease"">CAP</span>","An oral dose of <span class=""chemical"">telithromycin</span> 800 mg once daily for seven to ten days is an effective and well-tolerated first-line treatment for mild to moderate <span class=""disease"">CAP</span> in adults.",,12925111,12925111_C106791_D003147,12925111_14,bcv_sentence_task_befree_1889,,770957817,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,1,,C073007,"<span class=""chemical"">ibandronate</span>",D048909,"<span class=""disease"">skeletal complications</span>","Intravenous <span class=""chemical"">ibandronate</span> reduces the incidence of <span class=""disease"">skeletal complications</span> in patients with breast cancer and bone metastases.",,12954579,12954579_C073007_D048909,12954579_0,bcv_sentence_task_befree_1890,,770957818,FALSE,finalized,5,8/15/15 1:39,"



",no_relation,1,,C073007,"<span class=""chemical"">ibandronate</span>",D009369,"<span class=""disease"">breast cancer</span>","Intravenous <span class=""chemical"">ibandronate</span> reduces the incidence of skeletal complications in patients with <span class=""disease"">breast cancer</span> and bone metastases.",,12954579,12954579_C073007_D009369,12954579_0,bcv_sentence_task_befree_1891,,770957819,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,1,,D004164,"<span class=""chemical"">bisphosphonate</span>",D009369,"<span class=""disease"">breast cancer</span>","This phase III study compared the efficacy of the new potent <span class=""chemical"">bisphosphonate</span>, ibandronate, with placebo as intravenous (i.v.) therapy in metastatic bone disease due to <span class=""disease"">breast cancer</span>.",,12954579,12954579_D004164_D009369,12954579_1,bcv_sentence_task_befree_1892,,770957820,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,1,,D004164,"<span class=""chemical"">bisphosphonate</span>",D001847,"<span class=""disease"">bone disease</span>","This phase III study compared the efficacy of the new potent <span class=""chemical"">bisphosphonate</span>, ibandronate, with placebo as intravenous (i.v.) therapy in metastatic <span class=""disease"">bone disease</span> due to breast cancer.",,12954579,12954579_D004164_D001847,12954579_1,bcv_sentence_task_befree_1893,,770957821,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,C073007,"<span class=""chemical"">ibandronate</span>",D009369,"<span class=""disease"">breast cancer</span>","This phase III study compared the efficacy of the new potent bisphosphonate, <span class=""chemical"">ibandronate</span>, with placebo as intravenous (i.v.) therapy in metastatic bone disease due to <span class=""disease"">breast cancer</span>.",,12954579,12954579_C073007_D009369,12954579_1,bcv_sentence_task_befree_1894,,770957822,FALSE,finalized,5,8/15/15 1:48,"



",no_relation,1,,C073007,"<span class=""chemical"">ibandronate</span>",D001847,"<span class=""disease"">bone disease</span>","This phase III study compared the efficacy of the new potent bisphosphonate, <span class=""chemical"">ibandronate</span>, with placebo as intravenous (i.v.) therapy in metastatic <span class=""disease"">bone disease</span> due to breast cancer.",,12954579,12954579_C073007_D001847,12954579_1,bcv_sentence_task_befree_1895,,770957823,FALSE,finalized,5,8/15/15 1:02,"



",no_relation,0.7933,,C073007,"<span class=""chemical"">ibandronate</span>",D010146,"<span class=""disease"">bone pain</span>","Patients on <span class=""chemical"">ibandronate</span> 6 mg also experienced decreased <span class=""disease"">bone pain</span> scores and analgesic use.",,12954579,12954579_C073007_D010146,12954579_7,bcv_sentence_task_befree_1896,,770957824,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,C073007,"<span class=""chemical"">ibandronate</span>",D009369,"<span class=""disease"">breast cancer</span>","These results indicate that 6 mg i.v. <span class=""chemical"">ibandronate</span> is effective and safe in the treatment of bone metastases from <span class=""disease"">breast cancer</span>.",,12954579,12954579_C073007_D009369,12954579_9,bcv_sentence_task_befree_1897,,770957825,FALSE,finalized,5,8/15/15 0:57,"



",no_relation,1,,D064704,"<span class=""chemical"">levofloxacin</span>",D009181,"<span class=""disease"">bacterial keratitis</span>","Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to <span class=""chemical"">levofloxacin</span>, ciprofloxacin, and ofloxacin using <span class=""disease"">bacterial keratitis</span> isolates.",,12967804,12967804_D064704_D009181,12967804_0,bcv_sentence_task_befree_1898,,770957826,FALSE,finalized,5,8/14/15 21:25,"



",no_relation,1,,C104727,"<span class=""chemical"">moxifloxacin</span>",D009181,"<span class=""disease"">bacterial keratitis</span>","Gatifloxacin and <span class=""chemical"">moxifloxacin</span>: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using <span class=""disease"">bacterial keratitis</span> isolates.",,12967804,12967804_C104727_D009181,12967804_0,bcv_sentence_task_befree_1899,,770957827,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,D002939,"<span class=""chemical"">ciprofloxacin</span>",D009181,"<span class=""disease"">bacterial keratitis</span>","Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, <span class=""chemical"">ciprofloxacin</span>, and ofloxacin using <span class=""disease"">bacterial keratitis</span> isolates.",,12967804,12967804_D002939_D009181,12967804_0,bcv_sentence_task_befree_1900,,770957828,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,1,,C078049,"<span class=""chemical"">Gatifloxacin</span>",D009181,"<span class=""disease"">bacterial keratitis</span>","<span class=""chemical"">Gatifloxacin</span> and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using <span class=""disease"">bacterial keratitis</span> isolates.",,12967804,12967804_C078049_D009181,12967804_0,bcv_sentence_task_befree_1901,,770957829,FALSE,finalized,5,8/15/15 2:04,"



",no_relation,1,,D015242,"<span class=""chemical"">ofloxacin</span>",D009181,"<span class=""disease"">bacterial keratitis</span>","Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and <span class=""chemical"">ofloxacin</span> using <span class=""disease"">bacterial keratitis</span> isolates.",,12967804,12967804_D015242_D009181,12967804_0,bcv_sentence_task_befree_1902,,770957830,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,D002939,"<span class=""chemical"">ciprofloxacin/CIP</span>",D009181,"<span class=""disease"">bacterial keratitis</span>","We compared the in vitro susceptibility patterns and the minimum inhibitory concentrations (MICs) of gatifloxacin (GAT) and moxifloxacin (MOX) (fourth-generation fluoroquinolones) to <span class=""chemical"">ciprofloxacin</span> (<span class=""chemical"">CIP</span>) and ofloxacin (OFX) (second-generation fluoroquinolones) and levofloxacin (LEV; third-generation fluoroquinolone) using <span class=""disease"">bacterial keratitis</span> isolates.",,12967804,12967804_D002939_D009181,12967804_1,bcv_sentence_task_befree_1903,,770957831,FALSE,finalized,5,8/14/15 21:13,"



",no_relation,1,,D015242,"<span class=""chemical"">OFX/ofloxacin</span>",D009181,"<span class=""disease"">bacterial keratitis</span>","We compared the in vitro susceptibility patterns and the minimum inhibitory concentrations (MICs) of gatifloxacin (GAT) and moxifloxacin (MOX) (fourth-generation fluoroquinolones) to ciprofloxacin (CIP) and <span class=""chemical"">ofloxacin</span> (<span class=""chemical"">OFX</span>) (second-generation fluoroquinolones) and levofloxacin (LEV; third-generation fluoroquinolone) using <span class=""disease"">bacterial keratitis</span> isolates.",,12967804,12967804_D015242_D009181,12967804_1,bcv_sentence_task_befree_1904,,770957832,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,1,,D064704,"<span class=""chemical"">LEV/levofloxacin</span>",D009181,"<span class=""disease"">bacterial keratitis</span>","We compared the in vitro susceptibility patterns and the minimum inhibitory concentrations (MICs) of gatifloxacin (GAT) and moxifloxacin (MOX) (fourth-generation fluoroquinolones) to ciprofloxacin (CIP) and ofloxacin (OFX) (second-generation fluoroquinolones) and <span class=""chemical"">levofloxacin</span> (<span class=""chemical"">LEV</span>; third-generation fluoroquinolone) using <span class=""disease"">bacterial keratitis</span> isolates.",,12967804,12967804_D064704_D009181,12967804_1,bcv_sentence_task_befree_1905,,770957833,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,C104727,"<span class=""chemical"">moxifloxacin/MOX</span>",D009181,"<span class=""disease"">bacterial keratitis</span>","We compared the in vitro susceptibility patterns and the minimum inhibitory concentrations (MICs) of gatifloxacin (GAT) and <span class=""chemical"">moxifloxacin</span> (<span class=""chemical"">MOX</span>) (fourth-generation fluoroquinolones) to ciprofloxacin (CIP) and ofloxacin (OFX) (second-generation fluoroquinolones) and levofloxacin (LEV; third-generation fluoroquinolone) using <span class=""disease"">bacterial keratitis</span> isolates.",,12967804,12967804_C104727_D009181,12967804_1,bcv_sentence_task_befree_1906,,770957834,FALSE,finalized,5,8/14/15 21:16,"



",no_relation,1,,D024841,"<span class=""chemical"">fluoroquinolone/fluoroquinolones</span>",D009181,"<span class=""disease"">bacterial keratitis</span>","We compared the in vitro susceptibility patterns and the minimum inhibitory concentrations (MICs) of gatifloxacin (GAT) and moxifloxacin (MOX) (fourth-generation <span class=""chemical"">fluoroquinolones</span>) to ciprofloxacin (CIP) and ofloxacin (OFX) (second-generation <span class=""chemical"">fluoroquinolones</span>) and levofloxacin (LEV; third-generation <span class=""chemical"">fluoroquinolone</span>) using <span class=""disease"">bacterial keratitis</span> isolates.",,12967804,12967804_D024841_D009181,12967804_1,bcv_sentence_task_befree_1907,,770957835,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,C078049,"<span class=""chemical"">gatifloxacin</span>",D009181,"<span class=""disease"">bacterial keratitis</span>","We compared the in vitro susceptibility patterns and the minimum inhibitory concentrations (MICs) of <span class=""chemical"">gatifloxacin</span> (GAT) and moxifloxacin (MOX) (fourth-generation fluoroquinolones) to ciprofloxacin (CIP) and ofloxacin (OFX) (second-generation fluoroquinolones) and levofloxacin (LEV; third-generation fluoroquinolone) using <span class=""disease"">bacterial keratitis</span> isolates.",,12967804,12967804_C078049_D009181,12967804_1,bcv_sentence_task_befree_1908,,770957836,FALSE,finalized,5,8/14/15 22:07,"



",no_relation,1,,D015242,"<span class=""chemical"">OFX</span>",D009181,"<span class=""disease"">bacterial keratitis</span>","In retrospect, the MICs of 177 <span class=""disease"">bacterial keratitis</span> isolates were determined to CIP, <span class=""chemical"">OFX</span>, LEV, GAT, and MOX using E tests.",,12967804,12967804_D015242_D009181,12967804_5,bcv_sentence_task_befree_1909,,770957837,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,1,,D024841,"<span class=""chemical"">fluoroquinolones</span>",D007634,"<span class=""disease"">keratitis</span>","For most <span class=""disease"">keratitis</span> isolates, there were no susceptibility differences among the five <span class=""chemical"">fluoroquinolones</span>.",,12967804,12967804_D024841_D007634,12967804_9,bcv_sentence_task_befree_1910,,770957838,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,D024841,"<span class=""chemical"">fluoroquinolones</span>",D009181,"<span class=""disease"">bacterial keratitis</span>","Based on in vitro testing, the fourth-generation <span class=""chemical"">fluoroquinolones</span> may offer some advantages over those currently available for the treatment of <span class=""disease"">bacterial keratitis</span>.",,12967804,12967804_D024841_D009181,12967804_14,bcv_sentence_task_befree_1911,,770957839,FALSE,finalized,5,8/15/15 1:12,"



",yes_direct,1,,D017886,"<span class=""chemical"">hydroxyapatite</span>",D013492,"<span class=""disease"">suppurative granuloma</span>","Five patients with <span class=""chemical"">hydroxyapatite</span> implants showed lid swelling, discharge, and <span class=""disease"">suppurative granuloma</span> 14 days to 3 years after surgery.",,12967870,12967870_D017886_D013492,12967870_2,bcv_sentence_task_befree_1912,,770957840,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,0.8094,,D017886,"<span class=""chemical"">hydroxyapatite</span>",D011023,"<span class=""disease"">Staphylococcus epidermidis</span>","The culture of specimens removed with swabs from the conjunctiva of patients and from the <span class=""chemical"">hydroxyapatite</span> implants showed growth of Staphylococcus aureus, <span class=""disease"">Staphylococcus epidermidis</span>, alpha-hemolytic streptococcus and peptostreptococcus in 4 patients, whereas Streptococcus pyogenes were cultured from the conjunctiva in the Medpor implant patient.",,12967870,12967870_D017886_D011023,12967870_5,bcv_sentence_task_befree_1913,,770957841,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",D016553,"<span class=""disease"">ITP</span>","We reviewed the medical records of 288 children and adolescents with chronic <span class=""disease"">ITP</span> between 1980 and 1996: 112 were splenectomized; 59 were <span class=""chemical"">steroid</span> resistant and 42 were <span class=""chemical"">steroid</span> dependent, and 11 were managed with repeated courses of intravenous immunoglobulin (IVIG).",,12975552,12975552_D013256_D016553,12975552_2,bcv_sentence_task_befree_1914,,770957842,FALSE,finalized,5,8/14/15 23:48,"


Probably used as treatment.
",no_relation,1,,D016572,"<span class=""chemical"">cyclosporine</span>",D018459,"<span class=""disease"">lichen planopilaris</span>","Short course of oral <span class=""chemical"">cyclosporine</span> in <span class=""disease"">lichen planopilaris</span>.",,14512914,14512914_D016572_D018459,14512914_0,bcv_sentence_task_befree_1915,,770957843,FALSE,finalized,5,8/14/15 21:02,"



",no_relation,1,,D016572,"<span class=""chemical"">cyclosporine</span>",D018459,"<span class=""disease"">lichen planopilaris</span>","We present 3 patients with <span class=""disease"">lichen planopilaris</span> who were treated with a short course of oral <span class=""chemical"">cyclosporine</span> and report their clinical features and responses, using a standardized method of patient assessment and 3 specific outcome measures.",,14512914,14512914_D016572_D018459,14512914_4,bcv_sentence_task_befree_1916,,770957844,FALSE,finalized,5,8/14/15 22:10,"



",yes_direct,0.5936,,D009609,"<span class=""chemical"">nitrous oxide</span>",D000699,"<span class=""disease"">analgesia</span>","Inhalation sedation with <span class=""chemical"">nitrous oxide</span>/oxygen sedation to reach a plane of relative <span class=""disease"">analgesia</span> may be administered easily and safely to children in general dental practice and is a potential alternative to general anaesthesia.",,14558199,14558199_D009609_D000699,14558199_4,bcv_sentence_task_befree_1917,,770957845,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,0.5869,,D010100,"<span class=""chemical"">oxygen</span>",D000699,"<span class=""disease"">analgesia</span>","Inhalation sedation with nitrous oxide/<span class=""chemical"">oxygen</span> sedation to reach a plane of relative <span class=""disease"">analgesia</span> may be administered easily and safely to children in general dental practice and is a potential alternative to general anaesthesia.",,14558199,14558199_D010100_D000699,14558199_4,bcv_sentence_task_befree_1918,,770957846,FALSE,finalized,5,8/14/15 21:09,"



",no_relation,1,,D009761,"<span class=""chemical"">nystatin</span>",D012514,"<span class=""disease"">MCD</span>","In the cell lines, RA#1 and MC116, sIgM aggregated into patches that were insensitive to the disruption of cholesterol-rich membrane microdomains by <span class=""chemical"">nystatin</span> or beta-<span class=""disease"">MCD</span>.",,14565868,14565868_D009761_D012514,14565868_3,bcv_sentence_task_befree_1919,,770957847,FALSE,finalized,5,8/14/15 21:58,"



",no_relation,1,,D002784,"<span class=""chemical"">cholesterol</span>",D012514,"<span class=""disease"">MCD</span>","In the cell lines, RA#1 and MC116, sIgM aggregated into patches that were insensitive to the disruption of <span class=""chemical"">cholesterol</span>-rich membrane microdomains by nystatin or beta-<span class=""disease"">MCD</span>.",,14565868,14565868_D002784_D012514,14565868_3,bcv_sentence_task_befree_1920,,770957848,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,1,,D009761,"<span class=""chemical"">nystatin</span>",D012514,"<span class=""disease"">MCD</span>","However, in this case, the lipid raft inhibitors <span class=""chemical"">nystatin</span> and beta-<span class=""disease"">MCD</span> disrupted the patching.",,14565868,14565868_D009761_D012514,14565868_5,bcv_sentence_task_befree_1921,,770957849,FALSE,finalized,5,8/14/15 21:05,"



",no_relation,0.8079,,D009761,"<span class=""chemical"">nystatin</span>",D012514,"<span class=""disease"">MCD</span>","In 2G6 cells, BCR-mediated apoptosis was not affected by <span class=""chemical"">nystatin</span> treatment, whereas it increased in beta-<span class=""disease"">MCD</span> pretreated cells.",,14565868,14565868_D009761_D012514,14565868_6,bcv_sentence_task_befree_1922,,770957850,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,C459628,"<span class=""chemical"">9-methoxycanthin-6-one</span>",D008175,"<span class=""disease"">human lung cancer</span>","These compounds were screened for in vitro cytotoxic and antimalarial activities, and <span class=""chemical"">9-methoxycanthin-6-one</span> (4) and canthin-6-one (5) demonstrated significant cytotoxicity against <span class=""disease"">human lung cancer</span> (A-549) and human breast cancer (MCF-7) cell lines.",,14575431,14575431_C459628_D008175,14575431_3,bcv_sentence_task_befree_1923,,770957851,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,C453379,"<span class=""chemical"">canthin-6-one</span>",D009369,"<span class=""disease"">breast cancer</span>","These compounds were screened for in vitro cytotoxic and antimalarial activities, and 9-methoxycanthin-6-one (4) and <span class=""chemical"">canthin-6-one</span> (5) demonstrated significant cytotoxicity against human lung cancer (A-549) and human <span class=""disease"">breast cancer</span> (MCF-7) cell lines.",,14575431,14575431_C453379_D009369,14575431_3,bcv_sentence_task_befree_1924,,770957852,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,C459628,"<span class=""chemical"">9-methoxycanthin-6-one</span>",D009369,"<span class=""disease"">breast cancer</span>","These compounds were screened for in vitro cytotoxic and antimalarial activities, and <span class=""chemical"">9-methoxycanthin-6-one</span> (4) and canthin-6-one (5) demonstrated significant cytotoxicity against human lung cancer (A-549) and human <span class=""disease"">breast cancer</span> (MCF-7) cell lines.",,14575431,14575431_C459628_D009369,14575431_3,bcv_sentence_task_befree_1925,,770957853,FALSE,finalized,5,8/14/15 22:08,"



",no_relation,1,,C453379,"<span class=""chemical"">canthin-6-one</span>",D008175,"<span class=""disease"">human lung cancer</span>","These compounds were screened for in vitro cytotoxic and antimalarial activities, and 9-methoxycanthin-6-one (4) and <span class=""chemical"">canthin-6-one</span> (5) demonstrated significant cytotoxicity against <span class=""disease"">human lung cancer</span> (A-549) and human breast cancer (MCF-7) cell lines.",,14575431,14575431_C453379_D008175,14575431_3,bcv_sentence_task_befree_1926,,770957854,FALSE,finalized,5,8/14/15 21:15,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D010146,"<span class=""disease"">chronic pain</span>","Benefit-risk assessment of transdermal <span class=""chemical"">fentanyl</span> for the treatment of <span class=""disease"">chronic pain</span>.",,14583070,14583070_D005283_D010146,14583070_0,bcv_sentence_task_befree_1927,,770957855,FALSE,finalized,5,8/14/15 22:52,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D010146,"<span class=""disease"">chronic pain</span>","Transdermal <span class=""chemical"">fentanyl</span> is effective and well tolerated for the treatment of <span class=""disease"">chronic pain</span> caused by malignancy and non-malignant conditions when administered according to the manufacturer's recommendations.",,14583070,14583070_D005283_D010146,14583070_1,bcv_sentence_task_befree_1928,,770957856,FALSE,finalized,5,8/15/15 0:21,"



",yes_direct,0.8116,,D005283,"<span class=""chemical"">fentanyl</span>",D014839,"<span class=""disease"">vomiting</span>","Compared with oral opioids, the advantages of transdermal <span class=""chemical"">fentanyl</span> include a lower incidence and impact of adverse effects (constipation, nausea and <span class=""disease"">vomiting</span>, and daytime drowsiness), a higher degree of patient satisfaction, improved quality of life, improved convenience and compliance resulting from administration every 72 hours, and decreased use of rescue medication.",,14583070,14583070_D005283_D014839,14583070_2,bcv_sentence_task_befree_1929,,770957857,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,0.8066,,D005283,"<span class=""chemical"">fentanyl</span>",D003248,"<span class=""disease"">constipation</span>","Compared with oral opioids, the advantages of transdermal <span class=""chemical"">fentanyl</span> include a lower incidence and impact of adverse effects (<span class=""disease"">constipation</span>, nausea and vomiting, and daytime drowsiness), a higher degree of patient satisfaction, improved quality of life, improved convenience and compliance resulting from administration every 72 hours, and decreased use of rescue medication.",,14583070,14583070_D005283_D003248,14583070_2,bcv_sentence_task_befree_1930,,770957858,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D009325,"<span class=""disease"">nausea</span>","Compared with oral opioids, the advantages of transdermal <span class=""chemical"">fentanyl</span> include a lower incidence and impact of adverse effects (constipation, <span class=""disease"">nausea</span> and vomiting, and daytime drowsiness), a higher degree of patient satisfaction, improved quality of life, improved convenience and compliance resulting from administration every 72 hours, and decreased use of rescue medication.",,14583070,14583070_D005283_D009325,14583070_2,bcv_sentence_task_befree_1931,,770957859,FALSE,finalized,5,8/14/15 22:07,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D005767,"<span class=""disease"">gastrointestinal problems</span>","Transdermal <span class=""chemical"">fentanyl</span> is a useful analgesic for cancer patients who are unable to swallow or have <span class=""disease"">gastrointestinal problems</span>.",,14583070,14583070_D005283_D005767,14583070_3,bcv_sentence_task_befree_1932,,770957860,FALSE,finalized,5,8/14/15 21:02,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D009369,"<span class=""disease"">cancer</span>","Transdermal <span class=""chemical"">fentanyl</span> is a useful analgesic for <span class=""disease"">cancer</span> patients who are unable to swallow or have gastrointestinal problems.",,14583070,14583070_D005283_D009369,14583070_3,bcv_sentence_task_befree_1933,,770957861,FALSE,finalized,5,8/15/15 0:03,"


Used as treatment.
",no_relation,0.7981,,D005283,"<span class=""chemical"">fentanyl</span>",D010146,"<span class=""disease"">chronic pain/pain</span>","Patients with <span class=""disease"">chronic pain</span> should be titrated to adequate relief with short-acting oral or parenteral opioids prior to the initiation of transdermal <span class=""chemical"">fentanyl</span> in order to prevent exacerbations of <span class=""disease"">pain</span> or opioid-related adverse effects.",,14583070,14583070_D005283_D010146,14583070_6,bcv_sentence_task_befree_1934,,770957862,FALSE,finalized,5,8/14/15 23:38,"



",no_relation,0.8016,,D005283,"<span class=""chemical"">fentanyl</span>",D000699,"<span class=""disease"">analgesia</span>","Transdermal <span class=""chemical"">fentanyl</span> can then be initiated based on the 24-hour opioid requirement once adequate <span class=""disease"">analgesia</span> has been achieved.",,14583070,14583070_D005283_D000699,14583070_7,bcv_sentence_task_befree_1935,,770957863,FALSE,finalized,5,8/15/15 1:40,"



",yes_direct,0.598,,D005283,"<span class=""chemical"">fentanyl</span>",D007040,"<span class=""disease"">hypoventilation</span>","The prolonged elimination of transdermal <span class=""chemical"">fentanyl</span> can become problematic if patients develop opioid-related adverse effects, especially <span class=""disease"">hypoventilation</span>.",,14583070,14583070_D005283_D007040,14583070_8,bcv_sentence_task_befree_1936,,770957864,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,D009270,"<span class=""chemical"">naloxone</span>",D064420,"<span class=""disease"">toxicity</span>","Patients who experience opioid-related <span class=""disease"">toxicity</span> associated with respiratory depression should be treated immediately with an opioid antagonist such as <span class=""chemical"">naloxone</span> and closely monitored for at least 24 hours.",,14583070,14583070_D009270_D064420,14583070_10,bcv_sentence_task_befree_1937,,770957865,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,1,,D009270,"<span class=""chemical"">naloxone</span>",D012131,"<span class=""disease"">respiratory depression</span>","Patients who experience opioid-related toxicity associated with <span class=""disease"">respiratory depression</span> should be treated immediately with an opioid antagonist such as <span class=""chemical"">naloxone</span> and closely monitored for at least 24 hours.",,14583070,14583070_D009270_D012131,14583070_10,bcv_sentence_task_befree_1938,,770957866,FALSE,finalized,5,8/14/15 22:19,"



",yes_direct,0.602,,D005283,"<span class=""chemical"">fentanyl</span>",D007040,"<span class=""disease"">hypoventilation</span>","Transdermal <span class=""chemical"">fentanyl</span> should be administered cautiously to patients with pre-existing conditions such as emphysema that may predispose them to the development of <span class=""disease"">hypoventilation</span>.",,14583070,14583070_D005283_D007040,14583070_12,bcv_sentence_task_befree_1939,,770957867,FALSE,finalized,5,8/14/15 21:45,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D004646,"<span class=""disease"">emphysema</span>","Transdermal <span class=""chemical"">fentanyl</span> should be administered cautiously to patients with pre-existing conditions such as <span class=""disease"">emphysema</span> that may predispose them to the development of hypoventilation.",,14583070,14583070_D005283_D004646,14583070_12,bcv_sentence_task_befree_1940,,770957868,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D010146,"<span class=""disease"">chronic pain</span>","Transdermal <span class=""chemical"">fentanyl</span> is indicated only for patients who require continuous opioid administration for the treatment of <span class=""disease"">chronic pain</span> that cannot be managed with other medications.",,14583070,14583070_D005283_D010146,14583070_13,bcv_sentence_task_befree_1941,,770957869,FALSE,finalized,5,8/14/15 21:45,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D010146,"<span class=""disease"">pain/postoperative pain</span>","It is contraindicated in the management of acute and <span class=""disease"">postoperative pain</span>, as <span class=""disease"">pain</span> may decrease more rapidly in these circumstances than <span class=""chemical"">fentanyl</span> blood levels can be adjusted, leading to the development of life-threatening hypoventilation.",,14583070,14583070_D005283_D010146,14583070_14,bcv_sentence_task_befree_1942,,770957870,FALSE,finalized,5,8/15/15 0:22,"



",yes_direct,0.8061,,D005283,"<span class=""chemical"">fentanyl</span>",D007040,"<span class=""disease"">hypoventilation</span>","It is contraindicated in the management of acute and postoperative pain, as pain may decrease more rapidly in these circumstances than <span class=""chemical"">fentanyl</span> blood levels can be adjusted, leading to the development of life-threatening <span class=""disease"">hypoventilation</span>.",,14583070,14583070_D005283_D007040,14583070_14,bcv_sentence_task_befree_1943,,770957871,FALSE,finalized,5,8/15/15 1:58,"



",yes_direct,1,,D005283,"<span class=""chemical"">fentanyl</span>",D059445,"<span class=""disease"">physical impairments</span>","Cognitive and <span class=""disease"">physical impairments</span> such as confusion and abnormal co-ordination can occur with transdermal <span class=""chemical"">fentanyl</span>.",,14583070,14583070_D005283_D059445,14583070_15,bcv_sentence_task_befree_1944,,770957872,FALSE,finalized,5,8/14/15 23:41,"



",yes_direct,1,,D005283,"<span class=""chemical"">fentanyl</span>",D003221,"<span class=""disease"">confusion</span>","Cognitive and physical impairments such as <span class=""disease"">confusion</span> and abnormal co-ordination can occur with transdermal <span class=""chemical"">fentanyl</span>.",,14583070,14583070_D005283_D003221,14583070_15,bcv_sentence_task_befree_1945,,770957873,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,1,,C406224,"<span class=""chemical"">valdecoxib</span>",D004415,"<span class=""disease"">dyspepsia</span>","In comparative trials of celecoxib or <span class=""chemical"">valdecoxib</span> with non-specific NSAIDs, COX-2-specific inhibitors were demonstrated to have superior <span class=""disease"">dyspepsia</span> tolerability than non-specific NSAIDs.",,14585916,14585916_C406224_D004415,14585916_5,bcv_sentence_task_befree_1946,,770957874,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,1,,C105934,"<span class=""chemical"">celecoxib</span>",D004415,"<span class=""disease"">dyspepsia</span>","In comparative trials of <span class=""chemical"">celecoxib</span> or valdecoxib with non-specific NSAIDs, COX-2-specific inhibitors were demonstrated to have superior <span class=""disease"">dyspepsia</span> tolerability than non-specific NSAIDs.",,14585916,14585916_C105934_D004415,14585916_5,bcv_sentence_task_befree_1947,,770957875,FALSE,finalized,5,8/14/15 23:26,"

Used as treatment.

",no_relation,0.7996,,D002166,"<span class=""chemical"">camptothecin</span>",D001254,"<span class=""disease"">mixed oligoastrocytoma</span>","To determine the efficacy and toxicity of a novel chemotherapeutic approach with topotecan, a <span class=""chemical"">camptothecin</span> analog, for progressive or recurring anaplastic oligodendroglioma or <span class=""disease"">mixed oligoastrocytoma</span>.Patients from seven centers with recurrent or progressive disease were treated with topotecan, 1.5 mg/m(2) intravenously (i.v.), 30 min dailyx5 days every 3 weeks.",,14586216,14586216_D002166_D001254,14586216_1,bcv_sentence_task_befree_1948,,770957876,FALSE,finalized,5,8/15/15 2:31,"



",no_relation,0.8128,,D002166,"<span class=""chemical"">camptothecin</span>",D064420,"<span class=""disease"">toxicity</span>","To determine the efficacy and <span class=""disease"">toxicity</span> of a novel chemotherapeutic approach with topotecan, a <span class=""chemical"">camptothecin</span> analog, for progressive or recurring anaplastic oligodendroglioma or mixed oligoastrocytoma.Patients from seven centers with recurrent or progressive disease were treated with topotecan, 1.5 mg/m(2) intravenously (i.v.), 30 min dailyx5 days every 3 weeks.",,14586216,14586216_D002166_D064420,14586216_1,bcv_sentence_task_befree_1949,,770957877,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,0.5983,,D011078,"<span class=""chemical"">PCBs</span>",D009369,"<span class=""disease"">cancer</span>","Potential human <span class=""disease"">cancer</span> risks from exposure to <span class=""chemical"">PCBs</span>: a tale of two evaluations.",,14594106,14594106_D011078_D009369,14594106_0,bcv_sentence_task_befree_1950,,770957878,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,1,,D011078,"<span class=""chemical"">PCBs</span>",D009369,"<span class=""disease"">cancer</span>","In reviewing the potential human carcinogenicity of <span class=""chemical"">PCBs</span>, ATSDR (1999) concluded that ""The weight of evidence does not support a causal association for <span class=""chemical"">PCBs</span> and human <span class=""disease"">cancer</span> at this time"".",,14594106,14594106_D011078_D009369,14594106_2,bcv_sentence_task_befree_1951,,770957879,FALSE,finalized,5,8/14/15 23:37,"



",yes_direct,0.8078,,D011078,"<span class=""chemical"">PCBs</span>",D009369,"<span class=""disease"">cancer</span>","The present review addresses the additional scientific data that became available between the ATSDR 1999 and 2000 evaluations that was of a magnitude to offset the weight of evidence from numerous epidemiological studies that exposure to <span class=""chemical"">PCBs</span> was not causally associated with human <span class=""disease"">cancer</span> to a conclusion only 1 year later that there was now ""meaningful evidence"" that <span class=""chemical"">PCBs</span> posed a carcinogenic risk to humans.",,14594106,14594106_D011078_D009369,14594106_5,bcv_sentence_task_befree_1952,,770957880,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D009369,"<span class=""disease"">tumors</span>","The levels of CRASH mRNA were significantly up-regulated in <span class=""disease"">tumors</span> compared with normal breast tissues and correlate with lack of <span class=""chemical"">estrogen</span> receptor expression of the <span class=""disease"">tumors</span>.",,14654938,14654938_D004967_D009369,14654938_8,bcv_sentence_task_befree_1953,,770957881,FALSE,finalized,5,8/14/15 22:13,"



",no_relation,0.8038,,D011241,"<span class=""chemical"">prednisone</span>",D009290,"<span class=""disease"">hypocretin-deficiency narcolepsy</span>","Report of a case of immunosuppression with <span class=""chemical"">prednisone</span> in an 8-year-old boy with an acute onset of <span class=""disease"">hypocretin-deficiency narcolepsy</span>.",,14655912,14655912_D011241_D009290,14655912_0,bcv_sentence_task_befree_1954,,770957882,FALSE,finalized,5,8/15/15 2:04,"



",no_relation,1,,D011241,"<span class=""chemical"">prednisone</span>",D009290,"<span class=""disease"">narcolepsy</span>","To explore whether acute destruction of hypocretin cells in a patient with <span class=""disease"">narcolepsy</span> could be detected and if the course of the disease could be reversed or altered by the use of <span class=""chemical"">prednisone</span> for immunosuppression.",,14655912,14655912_D011241_D009290,14655912_1,bcv_sentence_task_befree_1955,,770957883,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,0.8156,,D004298,"<span class=""chemical"">dopamine</span>",D009369,"<span class=""disease"">breast cancer</span>","Are <span class=""chemical"">dopamine</span> antagonists a risk factor for <span class=""disease"">breast cancer</span>?",,14659314,14659314_D004298_D009369,14659314_0,bcv_sentence_task_befree_1956,,770957884,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,0.621,,D004298,"<span class=""chemical"">dopamine</span>",D009369,"<span class=""disease"">breast cancer/cancer</span>","Women undergoing chemotherapy for <span class=""disease"">breast cancer</span> are often administered <span class=""chemical"">dopamine</span> antagonist adjuvant medications that may increase levels of prolactin potentially increasing the risk of <span class=""disease"">cancer</span>.",,14659314,14659314_D004298_D009369,14659314_2,bcv_sentence_task_befree_1957,,770957885,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,0.8282,,D004298,"<span class=""chemical"">dopamine</span>",D010300,"<span class=""disease"">Parkinson's disease/PD</span>","Using nationwide computerized registers of death data for the years 1991 through 1996 we examined 12,430,473 deaths of persons over 40 years of age and extracted 144,364 cases with <span class=""disease"">Parkinson's disease</span> (<span class=""disease"">PD</span>), a <span class=""chemical"">dopamine</span> deficient population.",,14659314,14659314_D004298_D010300,14659314_3,bcv_sentence_task_befree_1958,,770957886,FALSE,finalized,5,8/15/15 1:28,"



",no_relation,1,,C508672,"<span class=""chemical"">methylenecyclopropane</span>",D020031,"<span class=""disease"">HHV-8/EBV</span>","These results indicate that members of this series of <span class=""chemical"">methylenecyclopropane</span> analogs are highly active against HCMV, HHV-6, and <span class=""disease"">HHV-8</span> but are less active against HSV, VZV, and <span class=""disease"">EBV</span>.",,14714760,14714760_C508672_D020031,14714760_9,bcv_sentence_task_befree_1959,,770957887,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,C508672,"<span class=""chemical"">methylenecyclopropane</span>",D020804,"<span class=""disease"">VZV</span>","These results indicate that members of this series of <span class=""chemical"">methylenecyclopropane</span> analogs are highly active against HCMV, HHV-6, and HHV-8 but are less active against HSV, <span class=""disease"">VZV</span>, and EBV.",,14714760,14714760_C508672_D020804,14714760_9,bcv_sentence_task_befree_1960,,770957888,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,1,,D002996,"<span class=""chemical"">clomiphene citrate</span>",D011085,"<span class=""disease"">polycystic ovary syndrome</span>","168 patients with <span class=""chemical"">clomiphene citrate</span> resistant <span class=""disease"">polycystic ovary syndrome</span>: 83 were allocated electrocautery and 85 were allocated recombinant follicle stimulating hormone.",,14739186,14739186_D002996_D011085,14739186_4,bcv_sentence_task_befree_1961,,770957889,FALSE,finalized,5,8/15/15 2:31,"



",no_relation,1,,D002996,"<span class=""chemical"">clomiphene citrate</span>",D011254,"<span class=""disease"">multiple pregnancy</span>","The ongoing pregnancy rate from ovulation induction with laparoscopic electrocautery followed by <span class=""chemical"">clomiphene citrate</span> and recombinant follicle stimulating hormone if anovulation persisted, or recombinant follicle stimulating hormone, seems equivalent to ovulation induction with recombinant follicle stimulating hormone, but the former procedure carries a lower risk of <span class=""disease"">multiple pregnancy</span>.",,14739186,14739186_D002996_D011254,14739186_13,bcv_sentence_task_befree_1962,,770957890,FALSE,finalized,5,8/14/15 21:27,"



",no_relation,1,,D047310,"<span class=""chemical"">apigenin</span>",D053448,"<span class=""disease"">prostate carcinoma</span>","Molecular mechanisms for <span class=""chemical"">apigenin</span>-induced cell-cycle arrest and apoptosis of hormone refractory human <span class=""disease"">prostate carcinoma</span> DU145 cells.",,14750216,14750216_D047310_D053448,14750216_0,bcv_sentence_task_befree_1963,,770957891,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,0.5978,,D047310,"<span class=""chemical"">apigenin</span>",D053448,"<span class=""disease"">prostate carcinoma</span>","We have reported recently that <span class=""chemical"">apigenin</span> (4',5,7-trihydroxyflavone), found in many common fruits and vegetables, has shown remarkable effects in inhibiting cell growth and inducing apoptosis in many human <span class=""disease"">prostate carcinoma</span> cells.",,14750216,14750216_D047310_D053448,14750216_2,bcv_sentence_task_befree_1964,,770957892,FALSE,finalized,5,8/15/15 0:00,"



",no_relation,1,,D047310,"<span class=""chemical"">apigenin</span>",D053448,"<span class=""disease"">prostate carcinoma</span>","Here we demonstrate the molecular mechanism of inhibitory action of <span class=""chemical"">apigenin</span> on androgen-refractory human <span class=""disease"">prostate carcinoma</span> DU145 cells that have mutations in the tumor suppressor gene p53 and pRb.",,14750216,14750216_D047310_D053448,14750216_3,bcv_sentence_task_befree_1965,,770957893,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,0.6011,,D000728,"<span class=""chemical"">androgen</span>",D053448,"<span class=""disease"">prostate carcinoma</span>","Here we demonstrate the molecular mechanism of inhibitory action of apigenin on <span class=""chemical"">androgen</span>-refractory human <span class=""disease"">prostate carcinoma</span> DU145 cells that have mutations in the tumor suppressor gene p53 and pRb.",,14750216,14750216_D000728_D053448,14750216_3,bcv_sentence_task_befree_1966,,770957894,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,D047310,"<span class=""chemical"">apigenin</span>",D009369,"<span class=""disease"">tumor</span>","Here we demonstrate the molecular mechanism of inhibitory action of <span class=""chemical"">apigenin</span> on androgen-refractory human prostate carcinoma DU145 cells that have mutations in the <span class=""disease"">tumor</span> suppressor gene p53 and pRb.",,14750216,14750216_D047310_D009369,14750216_3,bcv_sentence_task_befree_1967,,770957895,FALSE,finalized,5,8/15/15 1:37,"



",no_relation,1,,D000728,"<span class=""chemical"">androgen</span>",D009369,"<span class=""disease"">tumor</span>","Here we demonstrate the molecular mechanism of inhibitory action of apigenin on <span class=""chemical"">androgen</span>-refractory human prostate carcinoma DU145 cells that have mutations in the <span class=""disease"">tumor</span> suppressor gene p53 and pRb.",,14750216,14750216_D000728_D009369,14750216_3,bcv_sentence_task_befree_1968,,770957896,FALSE,finalized,5,8/15/15 1:57,"



",yes_direct,1,,D009532,"<span class=""chemical"">nickel</span>",D009369,"<span class=""disease"">respiratory cancer</span>","Excess risks of <span class=""disease"">respiratory cancer</span> have been demonstrated in some groups of <span class=""chemical"">nickel</span>-exposed workers.",,14963251,14963251_D009532_D009369,14963251_1,bcv_sentence_task_befree_1969,,770957897,FALSE,finalized,5,8/14/15 23:45,"



",yes_direct,1,,D009532,"<span class=""chemical"">nickel</span>",D009369,"<span class=""disease"">cancer/nasal cancer</span>","Aim To determine whether occupational exposures received in the manufacture of <span class=""chemical"">nickel</span> alloys lead to increased risks of <span class=""disease"">cancer</span>, in particular <span class=""disease"">nasal cancer</span> and lung cancer.",,14963251,14963251_D009532_D009369,14963251_3,bcv_sentence_task_befree_1970,,770957898,FALSE,finalized,5,8/14/15 22:09,"



",yes_direct,0.6,,D009532,"<span class=""chemical"">nickel</span>",D008175,"<span class=""disease"">lung cancer</span>","Aim To determine whether occupational exposures received in the manufacture of <span class=""chemical"">nickel</span> alloys lead to increased risks of cancer, in particular nasal cancer and <span class=""disease"">lung cancer</span>.",,14963251,14963251_D009532_D008175,14963251_3,bcv_sentence_task_befree_1971,,770957899,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,0.5915,,D017313,"<span class=""chemical"">N- (4-hydroxyphenyl)retinamide</span>",D009369,"<span class=""disease"">breast cancer</span>","Cyclooxygenase-2 is essential for HER2/neu to suppress <span class=""chemical"">N- (4-hydroxyphenyl)retinamide</span> apoptotic effects in <span class=""disease"">breast cancer</span> cells.",,14973114,14973114_D017313_D009369,14973114_0,bcv_sentence_task_befree_1972,,770957900,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,0.6042,,D009569,"<span class=""chemical"">nitric oxide</span>",D009369,"<span class=""disease"">breast cancer</span>","We reported that HER2/neu reduces the sensitivity of <span class=""disease"">breast cancer</span> cells to N-(4-hydroxyphenyl)retinamide (4-HPR) by suppressing <span class=""chemical"">nitric oxide</span> production.",,14973114,14973114_D009569_D009369,14973114_1,bcv_sentence_task_befree_1973,,770957901,FALSE,finalized,5,8/14/15 23:33,"



",no_relation,0.6045,,D017313,"<span class=""chemical"">N-(4-hydroxyphenyl)retinamide</span>",D009369,"<span class=""disease"">breast cancer</span>","We reported that HER2/neu reduces the sensitivity of <span class=""disease"">breast cancer</span> cells to <span class=""chemical"">N-(4-hydroxyphenyl)retinamide</span> (4-HPR) by suppressing nitric oxide production.",,14973114,14973114_D017313_D009369,14973114_1,bcv_sentence_task_befree_1974,,770957902,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D015232,"<span class=""chemical"">prostaglandin E(2)</span>",D009369,"<span class=""disease"">breast cancer</span>","Apoptosis induced by the 4-HPR and COX-2 inhibitor combination, although unaffected by an anti-HER2/neu antibody, was reversed by the COX-2 product <span class=""chemical"">prostaglandin E(2)</span>, indicating that COX-2 is a major mechanism by which HER2/neu suppresses 4-HPR apoptosis in <span class=""disease"">breast cancer</span> cells.",,14973114,14973114_D015232_D009369,14973114_3,bcv_sentence_task_befree_1975,,770957903,FALSE,finalized,5,8/15/15 1:41,"



",no_relation,0.8253,,D014443,"<span class=""chemical"">tyrosine</span>",D000012,"<span class=""disease"">ABL</span>","Chromosomal translocations of <span class=""chemical"">tyrosine</span> kinase c-<span class=""disease"">ABL</span> gene from chromosome 9 may generate oncogenic kinases exhibiting constitutive <span class=""chemical"">tyrosine</span> kinase activity.",,14987801,14987801_D014443_D000012,14987801_1,bcv_sentence_task_befree_1976,,770957904,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,0.7887,,D014443,"<span class=""chemical"">tyrosine</span>",D000012,"<span class=""disease"">ABL</span>","Recently, we have shown that <span class=""disease"">ABL</span>-fusion oncogenic <span class=""chemical"">tyrosine</span> kinases, BCR/<span class=""disease"">ABL</span> and TEL/<span class=""disease"">ABL</span>, specific to hematopoietic malignances, induced resistance to DNA-damaging agents.",,14987801,14987801_D014443_D000012,14987801_2,bcv_sentence_task_befree_1977,,770957905,FALSE,finalized,5,8/15/15 1:01,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D019337,"<span class=""disease"">hematopoietic malignances</span>","Recently, we have shown that ABL-fusion oncogenic <span class=""chemical"">tyrosine</span> kinases, BCR/ABL and TEL/ABL, specific to <span class=""disease"">hematopoietic malignances</span>, induced resistance to DNA-damaging agents.",,14987801,14987801_D014443_D019337,14987801_2,bcv_sentence_task_befree_1978,,770957906,FALSE,finalized,5,8/14/15 21:28,"



",no_relation,0.8075,,D015255,"<span class=""chemical"">idarubicin</span>",D000012,"<span class=""disease"">ABL</span>","To elucidate the role of DNA repair in this phenomenon we examined the capacity of murine BaF3 lymphoid cells and their TEL/<span class=""disease"">ABL</span>-transformed counterparts to repair DNA lesions caused by gamma- and UV-radiations and the anti-cancer drug, <span class=""chemical"">idarubicin</span>.",,14987801,14987801_D015255_D000012,14987801_3,bcv_sentence_task_befree_1979,,770957907,FALSE,finalized,5,8/15/15 0:02,"



",no_relation,1,,D015255,"<span class=""chemical"">idarubicin</span>",D009369,"<span class=""disease"">cancer</span>","To elucidate the role of DNA repair in this phenomenon we examined the capacity of murine BaF3 lymphoid cells and their TEL/ABL-transformed counterparts to repair DNA lesions caused by gamma- and UV-radiations and the anti-<span class=""disease"">cancer</span> drug, <span class=""chemical"">idarubicin</span>.",,14987801,14987801_D015255_D009369,14987801_3,bcv_sentence_task_befree_1980,,770957908,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,0.8008,,D015255,"<span class=""chemical"">idarubicin</span>",D000012,"<span class=""disease"">ABL</span>","We also examined the capability of BCR/<span class=""disease"">ABL</span>-fusion to modulate the repair of oxidative lesions, considered as a major side effect of various anti-cancer drugs including <span class=""chemical"">idarubicin</span> and radiation.",,14987801,14987801_D015255_D000012,14987801_7,bcv_sentence_task_befree_1981,,770957909,FALSE,finalized,5,8/14/15 23:54,"



",no_relation,1,,D015255,"<span class=""chemical"">idarubicin</span>",D009369,"<span class=""disease"">cancer</span>","We also examined the capability of BCR/ABL-fusion to modulate the repair of oxidative lesions, considered as a major side effect of various anti-<span class=""disease"">cancer</span> drugs including <span class=""chemical"">idarubicin</span> and radiation.",,14987801,14987801_D015255_D009369,14987801_7,bcv_sentence_task_befree_1982,,770957910,FALSE,finalized,5,8/15/15 2:09,"



",no_relation,1,,C029217,"<span class=""chemical"">alpha-phenyl-N-tert-butyl nitrone/PBN</span>",D000012,"<span class=""disease"">ABL</span>","Employing the free radical scavenger <span class=""chemical"">alpha-phenyl-N-tert-butyl nitrone</span> (<span class=""chemical"">PBN</span>, a spin trap) and DNA repair enzymes: endonuclease III (EndoIII) that nicks DNA at sites of oxidized bases, we found that BCR/<span class=""disease"">ABL</span>-transformed cells repaired oxidative DNA lesions more effectively than control cells.",,14987801,14987801_C029217_D000012,14987801_8,bcv_sentence_task_befree_1983,,770957911,FALSE,finalized,5,8/14/15 22:25,"



",no_relation,0.8025,,D010100,"<span class=""chemical"">oxygen</span>",D006973,"<span class=""disease"">hypertension</span>","Reactive <span class=""chemical"">oxygen</span> species in vascular biology: role in arterial <span class=""disease"">hypertension</span>.",,15030300,15030300_D010100_D006973,15030300_0,bcv_sentence_task_befree_1984,,770957912,FALSE,finalized,5,8/15/15 1:26,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D057772,"<span class=""disease"">vascular injury</span>","This development has evoked considerable interest because of the possibilities that therapies targeted against reactive <span class=""chemical"">oxygen</span> intermediates by decreasing the generation of reactive <span class=""chemical"">oxygen</span> species and/or by increasing availability of antioxidants may be useful in minimizing <span class=""disease"">vascular injury</span>.",,15030300,15030300_D010100_D057772,15030300_5,bcv_sentence_task_befree_1985,,770957913,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D006973,"<span class=""disease"">hypertension</span>","This review focuses on the vascular actions of reactive <span class=""chemical"">oxygen</span> species, the role of oxidative stress in vascular damage in <span class=""disease"">hypertension</span> and the therapeutic potential of modulating <span class=""chemical"">oxygen</span> radical bioavailability in <span class=""disease"">hypertension</span>.",,15030300,15030300_D010100_D006973,15030300_6,bcv_sentence_task_befree_1986,,770957914,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D006177,"<span class=""disease"">vascular damage</span>","This review focuses on the vascular actions of reactive <span class=""chemical"">oxygen</span> species, the role of oxidative stress in <span class=""disease"">vascular damage</span> in hypertension and the therapeutic potential of modulating <span class=""chemical"">oxygen</span> radical bioavailability in hypertension.",,15030300,15030300_D010100_D006177,15030300_6,bcv_sentence_task_befree_1987,,770957915,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,0.7886,,D010100,"<span class=""chemical"">oxygen</span>",D006973,"<span class=""disease"">hypertension</span>","In particular, the following topics will be highlighted: chemistry and sources of reactive <span class=""chemical"">oxygen</span> species, antioxidant defense mechanisms, signaling events mediated by reactive <span class=""chemical"">oxygen</span> species, role of reactive <span class=""chemical"">oxygen</span> species in <span class=""disease"">hypertension</span> and the putative therapeutic role of antioxidants in cardiovascular disease.",,15030300,15030300_D010100_D006973,15030300_7,bcv_sentence_task_befree_1988,,770957916,FALSE,finalized,5,8/14/15 21:46,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D002318,"<span class=""disease"">cardiovascular disease</span>","In particular, the following topics will be highlighted: chemistry and sources of reactive <span class=""chemical"">oxygen</span> species, antioxidant defense mechanisms, signaling events mediated by reactive <span class=""chemical"">oxygen</span> species, role of reactive <span class=""chemical"">oxygen</span> species in hypertension and the putative therapeutic role of antioxidants in <span class=""disease"">cardiovascular disease</span>.",,15030300,15030300_D010100_D002318,15030300_7,bcv_sentence_task_befree_1989,,770957917,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","Comparison of long-term effects between intra-arterially delivered <span class=""chemical"">ethanol</span> and Gelfoam for the treatment of severe arterioportal shunt in patients with <span class=""disease"">hepatocellular carcinoma</span>.",,15040025,15040025_D000431_D006528,15040025_0,bcv_sentence_task_befree_1990,,770957918,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",C562451,"<span class=""disease"">arterioportal shunt</span>","Comparison of long-term effects between intra-arterially delivered <span class=""chemical"">ethanol</span> and Gelfoam for the treatment of severe <span class=""disease"">arterioportal shunt</span> in patients with hepatocellular carcinoma.",,15040025,15040025_D000431_C562451,15040025_0,bcv_sentence_task_befree_1991,,770957919,FALSE,finalized,5,8/15/15 1:11,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",D006528,"<span class=""disease"">HCC/hepatocellular carcinoma</span>","To evaluate long-term effect of <span class=""chemical"">ethanol</span> embolization for the treatment of <span class=""disease"">hepatocellular carcinoma</span> (<span class=""disease"">HCC</span>) with severe hepatic arterioportal shunt (APS), compared with Gelfoam embolization.",,15040025,15040025_D000431_D006528,15040025_1,bcv_sentence_task_befree_1992,,770957920,FALSE,finalized,5,8/15/15 0:28,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",C562451,"<span class=""disease"">APS/arterioportal shunt</span>","To evaluate long-term effect of <span class=""chemical"">ethanol</span> embolization for the treatment of hepatocellular carcinoma (HCC) with severe hepatic <span class=""disease"">arterioportal shunt</span> (<span class=""disease"">APS</span>), compared with Gelfoam embolization.",,15040025,15040025_D000431_C562451,15040025_1,bcv_sentence_task_befree_1993,,770957921,FALSE,finalized,5,8/14/15 21:09,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",D006528,"<span class=""disease"">HCC</span>","Sixty-four patients (<span class=""chemical"">ethanol</span> group) and 33 patients (Gelfoam group) with <span class=""disease"">HCC</span> and APS were respectively treated with <span class=""chemical"">ethanol</span> and Gelfoam for APS before the routine interventional treatment for the tumor.",,15040025,15040025_D000431_D006528,15040025_2,bcv_sentence_task_befree_1994,,770957922,FALSE,finalized,5,8/15/15 0:32,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",D009369,"<span class=""disease"">tumor</span>","Sixty-four patients (<span class=""chemical"">ethanol</span> group) and 33 patients (Gelfoam group) with HCC and APS were respectively treated with <span class=""chemical"">ethanol</span> and Gelfoam for APS before the routine interventional treatment for the <span class=""disease"">tumor</span>.",,15040025,15040025_D000431_D009369,15040025_2,bcv_sentence_task_befree_1995,,770957923,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",C562451,"<span class=""disease"">APS</span>","Sixty-four patients (<span class=""chemical"">ethanol</span> group) and 33 patients (Gelfoam group) with HCC and <span class=""disease"">APS</span> were respectively treated with <span class=""chemical"">ethanol</span> and Gelfoam for <span class=""disease"">APS</span> before the routine interventional treatment for the tumor.",,15040025,15040025_D000431_C562451,15040025_2,bcv_sentence_task_befree_1996,,770957924,FALSE,finalized,5,8/15/15 0:23,"



",no_relation,0.7843,,D000431,"<span class=""chemical"">ethanol</span>",C562451,"<span class=""disease"">APS</span>","The occlusion rate of <span class=""disease"">APS</span> after initial treatment in <span class=""chemical"">ethanol</span> group was 70.3%(45/64), and recanalization rate of 1 month after embolization was 17.8%(8/45), and complete occlusion rate was 82.8%(53/64).",,15040025,15040025_D000431_C562451,15040025_4,bcv_sentence_task_befree_1997,,770957925,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",D006528,"<span class=""disease"">HCC</span>","In the <span class=""chemical"">ethanol</span> group, there was a significant prolongation of survival in patients with monofocal <span class=""disease"">HCC</span> (P<0.05) and Child class A (P<0.05).",,15040025,15040025_D000431_D006528,15040025_9,bcv_sentence_task_befree_1998,,770957926,FALSE,finalized,5,8/15/15 1:32,"



",yes_direct,0.8014,,D000431,"<span class=""chemical"">ethanol</span>",D015746,"<span class=""disease"">abdominal pain</span>","The incidence rate of <span class=""disease"">abdominal pain</span> during procedure in <span class=""chemical"">ethanol</span> group was 82.8%.",,15040025,15040025_D000431_D015746,15040025_11,bcv_sentence_task_befree_1999,,770957927,FALSE,finalized,5,8/15/15 2:03,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",D017093,"<span class=""disease"">hepatic failure</span>","Procedure-related <span class=""disease"">hepatic failure</span> did not occur in <span class=""chemical"">ethanol</span> group.",,15040025,15040025_D000431_D017093,15040025_13,bcv_sentence_task_befree_2000,,770957928,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,D000431,"<span class=""chemical"">Ethanol</span>",D006528,"<span class=""disease"">HCC</span>","<span class=""chemical"">Ethanol</span> embolization for patients with <span class=""disease"">HCC</span> and severe APS is efficacious and safe, and may contribute to prolongation of the life span versus Gelfoam embolization.",,15040025,15040025_D000431_D006528,15040025_14,bcv_sentence_task_befree_2001,,770957929,FALSE,finalized,5,8/14/15 23:51,"



",no_relation,1,,D000431,"<span class=""chemical"">Ethanol</span>",C562451,"<span class=""disease"">APS</span>","<span class=""chemical"">Ethanol</span> embolization for patients with HCC and severe <span class=""disease"">APS</span> is efficacious and safe, and may contribute to prolongation of the life span versus Gelfoam embolization.",,15040025,15040025_D000431_C562451,15040025_14,bcv_sentence_task_befree_2002,,770957930,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,1,,D016572,"<span class=""chemical"">CsA</span>",C564016,"<span class=""disease"">chronic allograft nephropathy</span>","This can partly be attributed to the side effects of <span class=""chemical"">CsA</span> and partly to the fact that the use of <span class=""chemical"">CsA</span> has not led to a reduced incidence of <span class=""disease"">chronic allograft nephropathy</span>.",,15041316,15041316_D016572_C564016,15041316_4,bcv_sentence_task_befree_2003,,770957931,FALSE,finalized,5,8/14/15 21:53,"



",yes_direct,0.7933,,D016572,"<span class=""chemical"">CsA</span>",D064420,"<span class=""disease"">toxicity</span>","Thus, there has been a continuing search for strategies that minimize <span class=""chemical"">CsA</span> <span class=""disease"">toxicity</span> but maintain adequate immunosuppression.",,15041316,15041316_D016572_D064420,15041316_5,bcv_sentence_task_befree_2004,,770957932,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,1,,D013792,"<span class=""chemical"">Thalidomide</span>",D007249,"<span class=""disease"">inflammatory skin diseases</span>","<span class=""chemical"">Thalidomide</span> (N-phtalimidoglutarimide), initially used as a tranquilizer, has recently been used in the management of several <span class=""disease"">inflammatory skin diseases</span>.",,15057007,15057007_D013792_D007249,15057007_3,bcv_sentence_task_befree_2005,,770957933,FALSE,finalized,5,8/15/15 0:39,"



",no_relation,1,,D013792,"<span class=""chemical"">thalidomide</span>",D006646,"<span class=""disease"">LCH</span>","In conclusion, <span class=""chemical"">thalidomide</span> monotherapy represents an effective, safe and well-tolerated treatment option that should be considered as first-line therapy for mucocutaneous <span class=""disease"">LCH</span>.",,15057007,15057007_D013792_D006646,15057007_11,bcv_sentence_task_befree_2006,,770957934,FALSE,finalized,5,8/15/15 1:27,"



",no_relation,1,,D002245,"<span class=""chemical"">CO(2)</span>",D006935,"<span class=""disease"">hypercapnia</span>","From normocapnia to <span class=""disease"">hypercapnia</span>, V(op) did not change significantly (mean +/- SD, 18 +/- 4 cm*sec(-1) to 18 +/- 6 cm*sec(-1)), (end-tidal <span class=""chemical"">CO(2)</span>, et<span class=""chemical"">CO(2)</span>, = 43 +/- 5 mmHg to 53 +/- 4 mmHg, respectively).",,15064270,15064270_D002245_D006935,15064270_8,bcv_sentence_task_befree_2007,,770957935,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,0.7948,,D002245,"<span class=""chemical"">CO(2)</span>",D016857,"<span class=""disease"">hypocapnia</span>","The <span class=""chemical"">CO(2)</span>-reactivity slope of V(op) from normocapnia to <span class=""disease"">hypocapnia</span> was 2.57% per mmHg.",,15064270,15064270_D002245_D016857,15064270_10,bcv_sentence_task_befree_2008,,770957936,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,C424862,"<span class=""chemical"">MTH-68/H</span>",D009369,"<span class=""disease"">aggressive neuroectodermal neoplasm</span>","Here we report on the administration of <span class=""chemical"">MTH-68/H</span> to patients with glioblastoma multiforme, the most common and most <span class=""disease"">aggressive neuroectodermal neoplasm</span> with a poor prognosis, averaging six months to a year.",,15072452,15072452_C424862_D009369,15072452_3,bcv_sentence_task_befree_2009,,770957937,FALSE,finalized,5,8/14/15 21:41,"



",no_relation,1,,C424862,"<span class=""chemical"">MTH-68/H</span>",D005909,"<span class=""disease"">glioblastoma</span>","Here we report on the administration of <span class=""chemical"">MTH-68/H</span> to patients with <span class=""disease"">glioblastoma</span> multiforme, the most common and most aggressive neuroectodermal neoplasm with a poor prognosis, averaging six months to a year.",,15072452,15072452_C424862_D005909,15072452_3,bcv_sentence_task_befree_2010,,770957938,FALSE,finalized,5,8/15/15 1:45,"



",yes_direct,0.5822,,C076029,"<span class=""chemical"">olanzapine</span>",D003920,"<span class=""disease"">diabetes mellitus</span>","Management of <span class=""disease"">diabetes mellitus</span> occurring during treatment with <span class=""chemical"">olanzapine</span>: report of six cases and clinical implications.",,15107197,15107197_C076029_D003920,15107197_0,bcv_sentence_task_befree_2011,,770957939,FALSE,finalized,5,8/15/15 0:12,"



",yes_direct,1,,D003024,"<span class=""chemical"">clozapine</span>",D003920,"<span class=""disease"">glucose dysregulation or new onset diabetes mellitus</span>","In spite of conflicting reports, there is emerging evidence that at least two of the atypical antipsychotics, <span class=""chemical"">clozapine</span> and olanzapine, are associated with an increased risk of developing <span class=""disease"">glucose dysregulation or new onset diabetes mellitus</span>.",,15107197,15107197_D003024_D003920,15107197_1,bcv_sentence_task_befree_2012,,770957940,FALSE,finalized,5,8/14/15 21:28,"



",yes_direct,1,,C076029,"<span class=""chemical"">olanzapine</span>",D003920,"<span class=""disease"">glucose dysregulation or new onset diabetes mellitus</span>","In spite of conflicting reports, there is emerging evidence that at least two of the atypical antipsychotics, clozapine and <span class=""chemical"">olanzapine</span>, are associated with an increased risk of developing <span class=""disease"">glucose dysregulation or new onset diabetes mellitus</span>.",,15107197,15107197_C076029_D003920,15107197_1,bcv_sentence_task_befree_2013,,770957941,FALSE,finalized,5,8/14/15 21:50,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003920,"<span class=""disease"">glucose dysregulation or new onset diabetes mellitus</span>","In spite of conflicting reports, there is emerging evidence that at least two of the atypical antipsychotics, clozapine and olanzapine, are associated with an increased risk of developing <span class=""chemical""></span><span class=""disease"">glucose</span> dysregulation or new onset diabetes mellitus.",,15107197,15107197_D005947_D003920,15107197_1,bcv_sentence_task_befree_2014,,770957942,FALSE,finalized,5,8/15/15 1:38,"



",yes_direct,0.5855,,C076029,"<span class=""chemical"">olanzapine</span>",D003929,"<span class=""disease"">diabetes</span>","We report on the management of six patients who developed diabetes mellitus following treatment with <span class=""chemical"">olanzapine</span>, five of whom had independent risk factors for <span class=""disease"">diabetes</span>.",,15107197,15107197_C076029_D003929,15107197_2,bcv_sentence_task_befree_2015,,770957943,FALSE,finalized,5,8/15/15 0:03,"



",yes_direct,0.7911,,C076029,"<span class=""chemical"">olanzapine</span>",D003920,"<span class=""disease"">diabetes mellitus</span>","We report on the management of six patients who developed <span class=""disease"">diabetes mellitus</span> following treatment with <span class=""chemical"">olanzapine</span>, five of whom had independent risk factors for diabetes.",,15107197,15107197_C076029_D003920,15107197_2,bcv_sentence_task_befree_2016,,770957944,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,0.6075,,C076029,"<span class=""chemical"">olanzapine</span>",D003929,"<span class=""disease"">diabetes</span>","In view of the uncertainty of the size and mechanism of the link between <span class=""chemical"">olanzapine</span> and <span class=""disease"">diabetes</span>, we discuss issues surrounding routine clinical management and monitoring of patients on antipsychotics and the clinical implications.",,15107197,15107197_C076029_D003929,15107197_4,bcv_sentence_task_befree_2017,,770957945,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,1,,D005473,"<span class=""chemical"">fluoxetine</span>",D003865,"<span class=""disease"">major depressive disorder</span>","Somatic symptoms as predictors of time to onset of response to <span class=""chemical"">fluoxetine</span> in <span class=""disease"">major depressive disorder</span>.",,15119918,15119918_D005473_D003865,15119918_0,bcv_sentence_task_befree_2018,,770957946,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,0.8036,,D005473,"<span class=""chemical"">fluoxetine</span>",D003865,"<span class=""disease"">major depressive disorder/MDD</span>","In the present study we assessed the relationship between somatic symptoms and the time to onset of clinical response to <span class=""chemical"">fluoxetine</span> in patients with <span class=""disease"">major depressive disorder</span> (<span class=""disease"">MDD</span>).",,15119918,15119918_D005473_D003865,15119918_1,bcv_sentence_task_befree_2019,,770957947,FALSE,finalized,5,8/14/15 23:45,"



Disease is a pre-existing condition",no_relation,0.8072,,D005473,"<span class=""chemical"">fluoxetine</span>",D003865,"<span class=""disease"">DSM-III-R MDD</span>","87 outpatients (mean age = 41.4 +/- 10.2 years; 59.8% women) with <span class=""disease"">DSM-III-R MDD</span> who had sustained acute response to <span class=""chemical"">fluoxetine</span> completed the Symptom Questionnaire (SQ) at baseline.",,15119918,15119918_D005473_D003865,15119918_2,bcv_sentence_task_befree_2020,,770957948,FALSE,finalized,5,8/15/15 0:42,"



",no_relation,1,,D005473,"<span class=""chemical"">fluoxetine</span>",D003865,"<span class=""disease"">MDD</span>","Somatic symptoms of depression were found to be associated with a delayed onset of antidepressant response to <span class=""chemical"">fluoxetine</span> in <span class=""disease"">MDD</span>.",,15119918,15119918_D005473_D003865,15119918_8,bcv_sentence_task_befree_2021,,770957949,FALSE,finalized,5,8/15/15 1:43,"



",yes_direct,0.5978,,D005473,"<span class=""chemical"">fluoxetine</span>",D003866,"<span class=""disease"">depression</span>","Somatic symptoms of <span class=""disease"">depression</span> were found to be associated with a delayed onset of antidepressant response to <span class=""chemical"">fluoxetine</span> in MDD.",,15119918,15119918_D005473_D003866,15119918_8,bcv_sentence_task_befree_2022,,770957950,FALSE,finalized,5,8/14/15 21:20,"



",no_relation,1,,D002784,"<span class=""chemical"">cholesterol</span>",D050197,"<span class=""disease"">atherosclerosis</span>","Conjugated linoleic acid and <span class=""disease"">atherosclerosis</span>: no effect on molecular markers of <span class=""chemical"">cholesterol</span> homeostasis in THP-1 macrophages.",,15136056,15136056_D002784_D050197,15136056_0,bcv_sentence_task_befree_2023,,770957951,FALSE,finalized,5,8/15/15 2:25,"



",no_relation,1,,D019787,"<span class=""chemical"">linoleic acid</span>",D050197,"<span class=""disease"">atherosclerosis</span>","Conjugated <span class=""chemical"">linoleic acid</span> and <span class=""disease"">atherosclerosis</span>: no effect on molecular markers of cholesterol homeostasis in THP-1 macrophages.",,15136056,15136056_D019787_D050197,15136056_0,bcv_sentence_task_befree_2024,,770957952,FALSE,finalized,5,8/15/15 0:34,"



",no_relation,0.6185,,D002784,"<span class=""chemical"">cholesterol</span>",D050197,"<span class=""disease"">atherosclerosis</span>","Macrophage <span class=""chemical"">cholesterol</span> homeostasis is a key process involved in the initiation and progression of <span class=""disease"">atherosclerosis</span>.",,15136056,15136056_D002784_D050197,15136056_1,bcv_sentence_task_befree_2025,,770957953,FALSE,finalized,5,8/14/15 23:56,"



",yes_direct,0.6219,,D002784,"<span class=""chemical"">cholesterol</span>",D050197,"<span class=""disease"">atherosclerosis</span>","Peroxisome proliferator-activated receptors (PPARs) regulate the transcription of the genes involved in <span class=""chemical"">cholesterol</span> homeostasis and thus represent an important therapeutic target in terms of reducing <span class=""disease"">atherosclerosis</span>.",,15136056,15136056_D002784_D050197,15136056_2,bcv_sentence_task_befree_2026,,770957954,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,1,,D019787,"<span class=""chemical"">linoleic acid</span>",D050197,"<span class=""disease"">atherosclerosis</span>","Conjugated <span class=""chemical"">linoleic acid</span> (CLA) is a potent anti-atherogenic dietary fatty acid in animal models of <span class=""disease"">atherosclerosis</span> and is capable of activating PPARs in vitro and in vivo.",,15136056,15136056_D019787_D050197,15136056_3,bcv_sentence_task_befree_2027,,770957955,FALSE,finalized,5,8/14/15 22:30,"



",no_relation,1,,D019821,"<span class=""chemical"">simvastatin</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","Oral <span class=""chemical"">simvastatin</span> treatment in relapsing-remitting <span class=""disease"">multiple sclerosis</span>.",,15145635,15145635_D019821_D009103,15145635_0,bcv_sentence_task_befree_2028,,770957956,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,1,,D019821,"<span class=""chemical"">simvastatin</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","We aimed to investigate use of of oral <span class=""chemical"">simvastatin</span> (80 mg) in 30 individuals with relapsing-remitting <span class=""disease"">multiple sclerosis</span>.",,15145635,15145635_D019821_D009103,15145635_2,bcv_sentence_task_befree_2029,,770957957,FALSE,finalized,5,8/15/15 1:02,"



",no_relation,0.6115,,D019821,"<span class=""chemical"">simvastatin</span>",D009069,"<span class=""disease"">neurological disability</span>","Oral <span class=""chemical"">simvastatin</span> might inhibit inflammatory components of multiple sclerosis that lead to <span class=""disease"">neurological disability</span>.",,15145635,15145635_D019821_D009069,15145635_6,bcv_sentence_task_befree_2030,,770957958,FALSE,finalized,5,8/14/15 21:16,"



",no_relation,1,,D019821,"<span class=""chemical"">simvastatin</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","Oral <span class=""chemical"">simvastatin</span> might inhibit inflammatory components of <span class=""disease"">multiple sclerosis</span> that lead to neurological disability.",,15145635,15145635_D019821_D009103,15145635_6,bcv_sentence_task_befree_2031,,770957959,FALSE,finalized,5,8/14/15 23:59,"



",no_relation,0.8072,,D005905,"<span class=""chemical"">glibenclamide</span>",D018222,"<span class=""disease"">undergoing aggressive diabetes management</span>","In conclusion, severe hypoglycaemia is a serious and not uncommon problem among elderly patients with T2DM; it is more frequent in patients <span class=""disease"">undergoing aggressive diabetes management</span> and in users of a long-acting sulphonylurea (eg, <span class=""chemical"">glibenclamide</span>).",,15163121,15163121_D005905_D018222,15163121_12,bcv_sentence_task_befree_2032,,770957960,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,0.6157,,D005905,"<span class=""chemical"">glibenclamide</span>",D003920,"<span class=""disease"">T2DM</span>","In conclusion, severe hypoglycaemia is a serious and not uncommon problem among elderly patients with <span class=""disease"">T2DM</span>; it is more frequent in patients undergoing aggressive diabetes management and in users of a long-acting sulphonylurea (eg, <span class=""chemical"">glibenclamide</span>).",,15163121,15163121_D005905_D003920,15163121_12,bcv_sentence_task_befree_2033,,770957961,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,0.7987,,D005947,"<span class=""chemical"">glucose</span>",D003920,"<span class=""disease"">diabetes mellitus</span>","Finally, each patient's risk for hypoglycaemia should be considered and therapy should be individualised accordingly; in our opinion, a great number of episodes of serious hypoglycaemia may be prevented by teaching the principles of blood <span class=""chemical"">glucose</span> monitoring and involving general practitioners in outpatient management of <span class=""disease"">diabetes mellitus</span> in the elderly.",,15163121,15163121_D005947_D003920,15163121_14,bcv_sentence_task_befree_2034,,770957962,FALSE,finalized,5,8/15/15 0:35,"



",yes_direct,0.5997,,D012964,"<span class=""chemical"">Na(+)</span>",D006333,"<span class=""disease"">heart failure</span>","[<span class=""chemical"">Na(+)</span>](i) and NCX expression have been reported to be increased in human <span class=""disease"">heart failure</span>.",,15165985,15165985_D012964_D006333,15165985_3,bcv_sentence_task_befree_2035,,770957963,FALSE,finalized,5,8/15/15 2:04,"



",no_relation,1,,D037621,"<span class=""chemical"">artemisinins</span>",D009369,"<span class=""disease"">tumor</span>","Oxidative stress response of <span class=""disease"">tumor</span> cells: microarray-based comparison between <span class=""chemical"">artemisinins</span> and anthracyclines.",,15183112,15183112_D037621_D009369,15183112_0,bcv_sentence_task_befree_2036,,770957964,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,1,,D018943,"<span class=""chemical"">anthracyclines</span>",D009369,"<span class=""disease"">tumor</span>","Oxidative stress response of <span class=""disease"">tumor</span> cells: microarray-based comparison between artemisinins and <span class=""chemical"">anthracyclines</span>.",,15183112,15183112_D018943_D009369,15183112_0,bcv_sentence_task_befree_2037,,770957965,FALSE,finalized,5,8/14/15 23:33,"



",no_relation,1,,D037621,"<span class=""chemical"">artemisinins</span>",D009369,"<span class=""disease"">tumor</span>","The antimalarial <span class=""chemical"">artemisinins</span> also reveal profound cytotoxic activity against <span class=""disease"">tumor</span> cells.",,15183112,15183112_D037621_D009369,15183112_1,bcv_sentence_task_befree_2038,,770957966,FALSE,finalized,5,8/14/15 23:26,"



",yes_direct,1,,D018943,"<span class=""chemical"">anthracyclines</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","Established cancer drugs such as <span class=""chemical"">anthracyclines</span> also form ROS and free radicals that are responsible for the <span class=""disease"">cardiotoxicity</span> of <span class=""chemical"">anthracyclines</span>.",,15183112,15183112_D018943_D066126,15183112_3,bcv_sentence_task_befree_2039,,770957967,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,1,,D018943,"<span class=""chemical"">anthracyclines</span>",D009369,"<span class=""disease"">cancer</span>","Established <span class=""disease"">cancer</span> drugs such as <span class=""chemical"">anthracyclines</span> also form ROS and free radicals that are responsible for the cardiotoxicity of <span class=""chemical"">anthracyclines</span>.",,15183112,15183112_D018943_D009369,15183112_3,bcv_sentence_task_befree_2040,,770957968,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,D037621,"<span class=""chemical"">artemisinins</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","In contrast, <span class=""chemical"">artemisinins</span> do not reveal <span class=""disease"">cardiotoxicity</span>.",,15183112,15183112_D037621_D066126,15183112_4,bcv_sentence_task_befree_2041,,770957969,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,D014805,"<span class=""chemical"">Vitamin B(12)</span>",D000740,"<span class=""disease"">anemia</span>","Frequent strategies included dietary changes, vitamins, modification of routines, rest, exercise, and prescribed medications for <span class=""disease"">anemia</span>, <span class=""chemical"">Vitamin B(12)</span> deficiency, or testosterone deficiency.",,15186711,15186711_D014805_D000740,15186711_5,bcv_sentence_task_befree_2042,,770957970,FALSE,finalized,5,8/15/15 2:19,"



",no_relation,1,,D014805,"<span class=""chemical"">Vitamin B(12)</span>",D003677,"<span class=""disease"">testosterone deficiency</span>","Frequent strategies included dietary changes, vitamins, modification of routines, rest, exercise, and prescribed medications for anemia, <span class=""chemical"">Vitamin B(12)</span> deficiency, or <span class=""disease"">testosterone deficiency</span>.",,15186711,15186711_D014805_D003677,15186711_5,bcv_sentence_task_befree_2043,,770957971,FALSE,finalized,5,8/14/15 23:07,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D000740,"<span class=""disease"">anemia</span>","Frequent strategies included dietary changes, vitamins, modification of routines, rest, exercise, and prescribed medications for <span class=""disease"">anemia</span>, Vitamin B(12) deficiency, or <span class=""chemical"">testosterone</span> deficiency.",,15186711,15186711_D013739_D000740,15186711_5,bcv_sentence_task_befree_2044,,770957972,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D003677,"<span class=""disease"">testosterone deficiency</span>","Frequent strategies included dietary changes, vitamins, modification of routines, rest, exercise, and prescribed medications for anemia, Vitamin B(12) deficiency, or <span class=""chemical""></span><span class=""disease"">testosterone</span> deficiency.",,15186711,15186711_D013739_D003677,15186711_5,bcv_sentence_task_befree_2045,,770957973,FALSE,finalized,5,8/15/15 1:32,"



",no_relation,1,,C097613,"<span class=""chemical"">Imatinib</span>",D015464,"<span class=""disease"">chronic myelogenous leukemia</span>","<span class=""chemical"">Imatinib</span> therapy in <span class=""disease"">chronic myelogenous leukemia</span>: strategies to avoid and overcome resistance.",,15215876,15215876_C097613_D015464,15215876_0,bcv_sentence_task_befree_2046,,770957974,FALSE,finalized,5,8/14/15 23:48,"



Used as treatment.",no_relation,1,,C097613,"<span class=""chemical"">Imatinib</span>",D015464,"<span class=""disease"">CML/chronic myelogenous leukemia</span>","<span class=""chemical"">Imatinib</span> is a molecularly targeted therapy that inhibits the oncogenic fusion protein BCR-ABL, the tyrosine kinase involved in the pathogenesis of <span class=""disease"">chronic myelogenous leukemia</span> (<span class=""disease"">CML</span>).",,15215876,15215876_C097613_D015464,15215876_1,bcv_sentence_task_befree_2047,,770957975,FALSE,finalized,5,8/14/15 21:18,"



",yes_direct,0.5939,,D014443,"<span class=""chemical"">tyrosine</span>",D015464,"<span class=""disease"">CML/chronic myelogenous leukemia</span>","Imatinib is a molecularly targeted therapy that inhibits the oncogenic fusion protein BCR-ABL, the <span class=""chemical"">tyrosine</span> kinase involved in the pathogenesis of <span class=""disease"">chronic myelogenous leukemia</span> (<span class=""disease"">CML</span>).",,15215876,15215876_D014443_D015464,15215876_1,bcv_sentence_task_befree_2048,,770957976,FALSE,finalized,5,8/15/15 1:50,"



",no_relation,1,,C097613,"<span class=""chemical"">imatinib</span>",D015464,"<span class=""disease"">CML</span>","Selective inhibition of BCR-ABL activity by <span class=""chemical"">imatinib</span> has demonstrated efficacy in the treatment of <span class=""disease"">CML</span>, particularly in chronic phase.",,15215876,15215876_C097613_D015464,15215876_2,bcv_sentence_task_befree_2049,,770957977,FALSE,finalized,5,8/15/15 1:00,"



",no_relation,1,,C097613,"<span class=""chemical"">imatinib</span>",D020178,"<span class=""disease"">advanced disease</span>","Some patients, however, primarily those with <span class=""disease"">advanced disease</span>, are either refractory to <span class=""chemical"">imatinib</span> or eventually relapse.",,15215876,15215876_C097613_D020178,15215876_3,bcv_sentence_task_befree_2050,,770957978,FALSE,finalized,5,8/15/15 0:34,"



",no_relation,1,,C097613,"<span class=""chemical"">imatinib</span>",D015464,"<span class=""disease"">CML</span>","These observations and more recent trials with <span class=""chemical"">imatinib</span>, combined with insights provided by an increased understanding of the molecular mechanisms of resistance, have established the rationale for strategies to avoid and overcome <span class=""chemical"">imatinib</span> resistance in the management of <span class=""disease"">CML</span> patients.",,15215876,15215876_C097613_D015464,15215876_6,bcv_sentence_task_befree_2051,,770957979,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D013759,"<span class=""chemical"">Delta(9)-THC</span>",C564052,"<span class=""disease"">THC</span>","Under the clinical point of view, <span class=""chemical"">Delta(9)-</span><span class=""disease"">THC</span> produces some therapeutic benefits which are beyond reasonable doubt.",,15302527,15302527_D013759_C564052,15302527_3,bcv_sentence_task_befree_2052,,770957980,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,0.6053,,D013759,"<span class=""chemical"">Delta(9)-THC</span>",C564052,"<span class=""disease"">THC</span>","<span class=""chemical"">Delta(9)-</span><span class=""disease"">THC</span> is not devoid of ill effects.",,15302527,15302527_D013759_C564052,15302527_5,bcv_sentence_task_befree_2053,,770957981,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,D013759,"<span class=""chemical"">THC</span>",C564052,"<span class=""disease"">THC</span>","On the psychic area Delta(9)-<span class=""chemical""></span><span class=""disease"">THC</span> may induce unpleasant reactions such as disconnected thoughts, panic reactions, disturbing changes in perception, delusions and hallucinatory experiences.",,15302527,15302527_D013759_C564052,15302527_7,bcv_sentence_task_befree_2054,,770957982,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,D013759,"<span class=""chemical"">Delta(9)-THC</span>",C564052,"<span class=""disease"">THC</span>","However, the long term effects on the psyche and cognition are not known as there are no reports of prolonged use of <span class=""chemical"">Delta(9)-</span><span class=""disease"">THC</span>.",,15302527,15302527_D013759_C564052,15302527_8,bcv_sentence_task_befree_2055,,770957983,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,1,,D013759,"<span class=""chemical"">Delta(9)-THC</span>",C564052,"<span class=""disease"">THC</span>","Actually, it has been proposed by WHO that <span class=""chemical"">Delta(9)-</span><span class=""disease"">THC</span> should be rescheduled to schedule IV of the United Nations Convention on Psychotropic Drugs, as it does not constitute a substantial risk to public health and its abuse is rare if at all.",,15302527,15302527_D013759_C564052,15302527_9,bcv_sentence_task_befree_2056,,770957984,FALSE,finalized,5,8/15/15 1:00,"



",yes_direct,0.8248,,D003024,"<span class=""chemical"">clozapine</span>",D010493,"<span class=""disease"">pericarditis</span>","Chart review for potential features of myocarditis, <span class=""disease"">pericarditis</span>, and cardiomyopathy in children and adolescents treated with <span class=""chemical"">clozapine</span>.",,15319023,15319023_D003024_D010493,15319023_0,bcv_sentence_task_befree_2057,,770957985,FALSE,finalized,5,8/14/15 22:09,"



",yes_direct,0.8047,,D003024,"<span class=""chemical"">clozapine</span>",D009205,"<span class=""disease"">myocarditis</span>","Chart review for potential features of <span class=""disease"">myocarditis</span>, pericarditis, and cardiomyopathy in children and adolescents treated with <span class=""chemical"">clozapine</span>.",,15319023,15319023_D003024_D009205,15319023_0,bcv_sentence_task_befree_2058,,770957986,FALSE,finalized,5,8/14/15 22:19,"



",yes_direct,0.5891,,D003024,"<span class=""chemical"">clozapine</span>",D009202,"<span class=""disease"">cardiomyopathy</span>","Chart review for potential features of myocarditis, pericarditis, and <span class=""disease"">cardiomyopathy</span> in children and adolescents treated with <span class=""chemical"">clozapine</span>.",,15319023,15319023_D003024_D009202,15319023_0,bcv_sentence_task_befree_2059,,770957987,FALSE,finalized,5,8/14/15 21:42,"



",yes_direct,1,,D003024,"<span class=""chemical"">Clozapine</span>",D010493,"<span class=""disease"">pericarditis</span>","<span class=""chemical"">Clozapine</span> is known to cause cardiac side effects, including myocarditis, <span class=""disease"">pericarditis</span>, and cardiomyopathy.",,15319023,15319023_D003024_D010493,15319023_1,bcv_sentence_task_befree_2060,,770957988,FALSE,finalized,5,8/15/15 1:31,"



",yes_direct,1,,D003024,"<span class=""chemical"">Clozapine</span>",D009205,"<span class=""disease"">myocarditis</span>","<span class=""chemical"">Clozapine</span> is known to cause cardiac side effects, including <span class=""disease"">myocarditis</span>, pericarditis, and cardiomyopathy.",,15319023,15319023_D003024_D009205,15319023_1,bcv_sentence_task_befree_2061,,770957989,FALSE,finalized,5,8/15/15 2:09,"



",yes_direct,1,,D003024,"<span class=""chemical"">Clozapine</span>",D009202,"<span class=""disease"">cardiomyopathy</span>","<span class=""chemical"">Clozapine</span> is known to cause cardiac side effects, including myocarditis, pericarditis, and <span class=""disease"">cardiomyopathy</span>.",,15319023,15319023_D003024_D009202,15319023_1,bcv_sentence_task_befree_2062,,770957990,FALSE,finalized,5,8/15/15 2:22,"



",yes_direct,1,,D003024,"<span class=""chemical"">clozapine</span>",D010493,"<span class=""disease"">pericarditis</span>","Prompted by a case of <span class=""chemical"">clozapine</span>-related <span class=""disease"">pericarditis</span> in an adolescent, we undertook a retrospective chart review to discover whether any unrecognized cases of myocarditis, <span class=""disease"">pericarditis</span>, or cardiomyopathy were among the children, adolescents, and young adults we had treated with <span class=""chemical"">clozapine</span>.",,15319023,15319023_D003024_D010493,15319023_2,bcv_sentence_task_befree_2063,,770957991,FALSE,finalized,5,8/14/15 23:31,"



",yes_direct,0.5871,,D003024,"<span class=""chemical"">clozapine</span>",D009205,"<span class=""disease"">myocarditis</span>","Prompted by a case of <span class=""chemical"">clozapine</span>-related pericarditis in an adolescent, we undertook a retrospective chart review to discover whether any unrecognized cases of <span class=""disease"">myocarditis</span>, pericarditis, or cardiomyopathy were among the children, adolescents, and young adults we had treated with <span class=""chemical"">clozapine</span>.",,15319023,15319023_D003024_D009205,15319023_2,bcv_sentence_task_befree_2064,,770957992,FALSE,finalized,5,8/14/15 21:42,"



",yes_direct,0.7879,,D003024,"<span class=""chemical"">clozapine</span>",D009202,"<span class=""disease"">cardiomyopathy</span>","Prompted by a case of <span class=""chemical"">clozapine</span>-related pericarditis in an adolescent, we undertook a retrospective chart review to discover whether any unrecognized cases of myocarditis, pericarditis, or <span class=""disease"">cardiomyopathy</span> were among the children, adolescents, and young adults we had treated with <span class=""chemical"">clozapine</span>.",,15319023,15319023_D003024_D009202,15319023_2,bcv_sentence_task_befree_2065,,770957993,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,0.8026,,D003024,"<span class=""chemical"">clozapine</span>",D009358,"<span class=""disease"">such disorder</span>","With the exception of the case which prompted our study, none of the patients were found to have developed any <span class=""disease"">such disorder</span> in the course of further treatment with <span class=""chemical"">clozapine</span>.",,15319023,15319023_D003024_D009358,15319023_8,bcv_sentence_task_befree_2066,,770957994,FALSE,finalized,5,8/14/15 23:16,"



",no_relation,1,,C065179,"<span class=""chemical"">atorvastatin</span>",D054058,"<span class=""disease"">ACS</span>","Early aggressive lipid-lowering therapy by <span class=""chemical"">atorvastatin</span> for 6 months significantly reduced the plaque volume in patients with <span class=""disease"">ACS</span>.",,15326073,15326073_C065179_D054058,15326073_11,bcv_sentence_task_befree_2067,,770957995,FALSE,finalized,5,8/15/15 1:19,"



",no_relation,1,,C104727,"<span class=""chemical"">moxifloxacin</span>",D016470,"<span class=""disease"">iatrogenic oral bacteremia</span>","In vitro activity of <span class=""chemical"">moxifloxacin</span> compared to other antimicrobials against streptococci isolated from <span class=""disease"">iatrogenic oral bacteremia</span> in Spain.",,15327647,15327647_C104727_D016470,15327647_0,bcv_sentence_task_befree_2068,,770957996,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,C104727,"<span class=""chemical"">moxifloxacin</span>",D005490,"<span class=""disease"">focal infections</span>","All the isolates showed a low MIC of <span class=""chemical"">moxifloxacin</span> in vitro, making it a promising antimicrobial alternative for the prevention of streptococcal <span class=""disease"">focal infections</span> associated with certain dental manipulations, when the administration of beta-lactam agents is not indicated.",,15327647,15327647_C104727_D005490,15327647_15,bcv_sentence_task_befree_2069,,770957997,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,1,,D047090,"<span class=""chemical"">beta-lactam</span>",D005490,"<span class=""disease"">focal infections</span>","All the isolates showed a low MIC of moxifloxacin in vitro, making it a promising antimicrobial alternative for the prevention of streptococcal <span class=""disease"">focal infections</span> associated with certain dental manipulations, when the administration of <span class=""chemical"">beta-lactam</span> agents is not indicated.",,15327647,15327647_D047090_D005490,15327647_15,bcv_sentence_task_befree_2070,,770957998,FALSE,finalized,5,8/14/15 21:35,"



",yes_direct,0.6103,,D016898,"<span class=""chemical"">Interferon-alpha</span>",D003866,"<span class=""disease"">symptoms of depression</span>","<span class=""chemical"">Interferon-alpha</span> (IFN-alpha) treatment is frequently complicated by <span class=""disease"">symptoms of depression</span>.",,15331126,15331126_D016898_D003866,15331126_1,bcv_sentence_task_befree_2071,,770957999,FALSE,finalized,5,8/14/15 21:16,"



",no_relation,0.7928,,D009569,"<span class=""chemical"">NO</span>",D009447,"<span class=""disease"">neuroblastoma</span>","We have studied this regulatory function of <span class=""chemical"">NO</span> in <span class=""disease"">neuroblastoma</span> cell lines (SK-N-BE) and in primary cerebellar granule cell cultures.",,15331636,15331636_D009569_D009447,15331636_3,bcv_sentence_task_befree_2072,,770958000,FALSE,finalized,5,8/14/15 21:15,"



",no_relation,0.8096,,D014212,"<span class=""chemical"">retinoic acid</span>",D009447,"<span class=""disease"">neuroblastoma</span>","In a neuronal NO synthase (nNOS) overexpressing <span class=""disease"">neuroblastoma</span> cell line exposed to the differentiative action of <span class=""chemical"">retinoic acid</span>, NO slowed down proliferation and accelerated differentiation towards a neuronal phenotype.",,15331636,15331636_D014212_D009447,15331636_4,bcv_sentence_task_befree_2073,,770958001,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D009569,"<span class=""chemical"">NO</span>",D009447,"<span class=""disease"">neuroblastoma</span>","In a neuronal <span class=""chemical"">NO</span> synthase (nNOS) overexpressing <span class=""disease"">neuroblastoma</span> cell line exposed to the differentiative action of retinoic acid, <span class=""chemical"">NO</span> slowed down proliferation and accelerated differentiation towards a neuronal phenotype.",,15331636,15331636_D009569_D009447,15331636_4,bcv_sentence_task_befree_2074,,770958002,FALSE,finalized,5,8/15/15 1:04,"



",no_relation,1,,D009569,"<span class=""chemical"">NO</span>",D009447,"<span class=""disease"">neuroblastoma</span>","Because a high N-Myc expression level is essential for <span class=""disease"">neuroblastoma</span> progression as well as for proliferation of neuronal precursors, its negative regulation by <span class=""chemical"">NO</span> highlights a novel physiopathological function of this important messenger molecule.",,15331636,15331636_D009569_D009447,15331636_10,bcv_sentence_task_befree_2075,,770958003,FALSE,finalized,5,8/14/15 21:07,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D009369,"<span class=""disease"">tumor</span>","Effect on <span class=""disease"">tumor</span> cells of blocking survival response to <span class=""chemical"">glucose</span> deprivation.",,15339968,15339968_D005947_D009369,15339968_0,bcv_sentence_task_befree_2076,,770958004,FALSE,finalized,5,8/14/15 23:39,"



",no_relation,1,,D005947,"<span class=""chemical"">Glucose</span>",D012892,"<span class=""disease"">Glucose deprivation</span>","<span class=""chemical""></span><span class=""disease"">Glucose</span> deprivation, a feature of poorly vascularized solid tumors, activates the unfolded protein response (UPR), a stress-signaling pathway, in tumor cells.",,15339968,15339968_D005947_D012892,15339968_1,bcv_sentence_task_befree_2077,,770958005,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,0.8299,,D005947,"<span class=""chemical"">Glucose</span>",D009369,"<span class=""disease"">tumor/tumors</span>","<span class=""chemical"">Glucose</span> deprivation, a feature of poorly vascularized solid <span class=""disease"">tumors</span>, activates the unfolded protein response (UPR), a stress-signaling pathway, in <span class=""disease"">tumor</span> cells.",,15339968,15339968_D005947_D009369,15339968_1,bcv_sentence_task_befree_2078,,770958006,FALSE,finalized,5,8/15/15 1:14,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D009369,"<span class=""disease"">tumor</span>","We examined the effect of VST on the UPR induced by <span class=""chemical"">glucose</span> deprivation or other stressors and on <span class=""disease"">tumor</span> growth in vivo.",,15339968,15339968_D005947_D009369,15339968_3,bcv_sentence_task_befree_2079,,770958007,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,0.8306,,D002118,"<span class=""chemical"">calcium</span>",D007003,"<span class=""disease"">hypoglycemia</span>","Human colon cancer HT-29, fibrosarcoma HT1080, and stomach cancer MKN74 cells were cultured in the absence of glucose or in the presence of glucose and a UPR-inducing chemical stressor (the N-glycosylation inhibitor tunicamycin, the <span class=""chemical"">calcium</span> ionophore A23187, or the <span class=""disease"">hypoglycemia</span>-mimicking agent 2-deoxyglucose [2DG]).",,15339968,15339968_D002118_D007003,15339968_4,bcv_sentence_task_befree_2080,,770958008,FALSE,finalized,5,8/14/15 21:50,"



",no_relation,1,,D014415,"<span class=""chemical"">tunicamycin</span>",D007003,"<span class=""disease"">hypoglycemia</span>","Human colon cancer HT-29, fibrosarcoma HT1080, and stomach cancer MKN74 cells were cultured in the absence of glucose or in the presence of glucose and a UPR-inducing chemical stressor (the N-glycosylation inhibitor <span class=""chemical"">tunicamycin</span>, the calcium ionophore A23187, or the <span class=""disease"">hypoglycemia</span>-mimicking agent 2-deoxyglucose [2DG]).",,15339968,15339968_D014415_D007003,15339968_4,bcv_sentence_task_befree_2081,,770958009,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D007003,"<span class=""disease"">hypoglycemia</span>","Human colon cancer HT-29, fibrosarcoma HT1080, and stomach cancer MKN74 cells were cultured in the absence of <span class=""chemical"">glucose</span> or in the presence of <span class=""chemical"">glucose</span> and a UPR-inducing chemical stressor (the N-glycosylation inhibitor tunicamycin, the calcium ionophore A23187, or the <span class=""disease"">hypoglycemia</span>-mimicking agent 2-deoxyglucose [2DG]).",,15339968,15339968_D005947_D007003,15339968_4,bcv_sentence_task_befree_2082,,770958010,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,0.8169,,D000001,"<span class=""chemical"">A23187</span>",D009369,"<span class=""disease"">stomach cancer/colon cancer</span>","Human <span class=""disease"">colon cancer</span> HT-29, fibrosarcoma HT1080, and <span class=""disease"">stomach cancer</span> MKN74 cells were cultured in the absence of glucose or in the presence of glucose and a UPR-inducing chemical stressor (the N-glycosylation inhibitor tunicamycin, the calcium ionophore <span class=""chemical"">A23187</span>, or the hypoglycemia-mimicking agent 2-deoxyglucose [2DG]).",,15339968,15339968_D000001_D009369,15339968_4,bcv_sentence_task_befree_2083,,770958011,FALSE,finalized,5,8/14/15 22:14,"



",no_relation,1,,D000001,"<span class=""chemical"">A23187</span>",D007003,"<span class=""disease"">hypoglycemia</span>","Human colon cancer HT-29, fibrosarcoma HT1080, and stomach cancer MKN74 cells were cultured in the absence of glucose or in the presence of glucose and a UPR-inducing chemical stressor (the N-glycosylation inhibitor tunicamycin, the calcium ionophore <span class=""chemical"">A23187</span>, or the <span class=""disease"">hypoglycemia</span>-mimicking agent 2-deoxyglucose [2DG]).",,15339968,15339968_D000001_D007003,15339968_4,bcv_sentence_task_befree_2084,,770958012,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,0.8241,,D003847,"<span class=""chemical"">2-deoxyglucose</span>",D005354,"<span class=""disease"">fibrosarcoma</span>","Human colon cancer HT-29, <span class=""disease"">fibrosarcoma</span> HT1080, and stomach cancer MKN74 cells were cultured in the absence of glucose or in the presence of glucose and a UPR-inducing chemical stressor (the N-glycosylation inhibitor tunicamycin, the calcium ionophore A23187, or the hypoglycemia-mimicking agent <span class=""chemical"">2-deoxyglucose</span> [2DG]).",,15339968,15339968_D003847_D005354,15339968_4,bcv_sentence_task_befree_2085,,770958013,FALSE,finalized,5,8/15/15 1:33,"



",no_relation,0.8109,,D005947,"<span class=""chemical"">glucose</span>",D005354,"<span class=""disease"">fibrosarcoma</span>","Human colon cancer HT-29, <span class=""disease"">fibrosarcoma</span> HT1080, and stomach cancer MKN74 cells were cultured in the absence of <span class=""chemical"">glucose</span> or in the presence of <span class=""chemical"">glucose</span> and a UPR-inducing chemical stressor (the N-glycosylation inhibitor tunicamycin, the calcium ionophore A23187, or the hypoglycemia-mimicking agent 2-deoxyglucose [2DG]).",,15339968,15339968_D005947_D005354,15339968_4,bcv_sentence_task_befree_2086,,770958014,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D003847,"<span class=""chemical"">2-deoxyglucose</span>",D009369,"<span class=""disease"">stomach cancer/colon cancer</span>","Human <span class=""disease"">colon cancer</span> HT-29, fibrosarcoma HT1080, and <span class=""disease"">stomach cancer</span> MKN74 cells were cultured in the absence of glucose or in the presence of glucose and a UPR-inducing chemical stressor (the N-glycosylation inhibitor tunicamycin, the calcium ionophore A23187, or the hypoglycemia-mimicking agent <span class=""chemical"">2-deoxyglucose</span> [2DG]).",,15339968,15339968_D003847_D009369,15339968_4,bcv_sentence_task_befree_2087,,770958015,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,0.8047,,D014415,"<span class=""chemical"">tunicamycin</span>",D009369,"<span class=""disease"">stomach cancer/colon cancer</span>","Human <span class=""disease"">colon cancer</span> HT-29, fibrosarcoma HT1080, and <span class=""disease"">stomach cancer</span> MKN74 cells were cultured in the absence of glucose or in the presence of glucose and a UPR-inducing chemical stressor (the N-glycosylation inhibitor <span class=""chemical"">tunicamycin</span>, the calcium ionophore A23187, or the hypoglycemia-mimicking agent 2-deoxyglucose [2DG]).",,15339968,15339968_D014415_D009369,15339968_4,bcv_sentence_task_befree_2088,,770958016,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D009369,"<span class=""disease"">stomach cancer/colon cancer</span>","Human <span class=""disease"">colon cancer</span> HT-29, fibrosarcoma HT1080, and <span class=""disease"">stomach cancer</span> MKN74 cells were cultured in the absence of glucose or in the presence of glucose and a UPR-inducing chemical stressor (the N-glycosylation inhibitor tunicamycin, the <span class=""chemical"">calcium</span> ionophore A23187, or the hypoglycemia-mimicking agent 2-deoxyglucose [2DG]).",,15339968,15339968_D002118_D009369,15339968_4,bcv_sentence_task_befree_2089,,770958017,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D009369,"<span class=""disease"">stomach cancer/colon cancer</span>","Human <span class=""disease"">colon cancer</span> HT-29, fibrosarcoma HT1080, and <span class=""disease"">stomach cancer</span> MKN74 cells were cultured in the absence of <span class=""chemical"">glucose</span> or in the presence of <span class=""chemical"">glucose</span> and a UPR-inducing chemical stressor (the N-glycosylation inhibitor tunicamycin, the calcium ionophore A23187, or the hypoglycemia-mimicking agent 2-deoxyglucose [2DG]).",,15339968,15339968_D005947_D009369,15339968_4,bcv_sentence_task_befree_2090,,770958018,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,0.8122,,D003847,"<span class=""chemical"">2-deoxyglucose</span>",D007003,"<span class=""disease"">hypoglycemia</span>","Human colon cancer HT-29, fibrosarcoma HT1080, and stomach cancer MKN74 cells were cultured in the absence of glucose or in the presence of glucose and a UPR-inducing chemical stressor (the N-glycosylation inhibitor tunicamycin, the calcium ionophore A23187, or the <span class=""disease"">hypoglycemia</span>-mimicking agent <span class=""chemical"">2-deoxyglucose</span> [2DG]).",,15339968,15339968_D003847_D007003,15339968_4,bcv_sentence_task_befree_2091,,770958019,FALSE,finalized,5,8/15/15 1:02,"



",no_relation,0.8159,,D002118,"<span class=""chemical"">calcium</span>",D005354,"<span class=""disease"">fibrosarcoma</span>","Human colon cancer HT-29, <span class=""disease"">fibrosarcoma</span> HT1080, and stomach cancer MKN74 cells were cultured in the absence of glucose or in the presence of glucose and a UPR-inducing chemical stressor (the N-glycosylation inhibitor tunicamycin, the <span class=""chemical"">calcium</span> ionophore A23187, or the hypoglycemia-mimicking agent 2-deoxyglucose [2DG]).",,15339968,15339968_D002118_D005354,15339968_4,bcv_sentence_task_befree_2092,,770958020,FALSE,finalized,5,8/14/15 23:51,"



",no_relation,1,,D000001,"<span class=""chemical"">A23187</span>",D005354,"<span class=""disease"">fibrosarcoma</span>","Human colon cancer HT-29, <span class=""disease"">fibrosarcoma</span> HT1080, and stomach cancer MKN74 cells were cultured in the absence of glucose or in the presence of glucose and a UPR-inducing chemical stressor (the N-glycosylation inhibitor tunicamycin, the calcium ionophore <span class=""chemical"">A23187</span>, or the hypoglycemia-mimicking agent 2-deoxyglucose [2DG]).",,15339968,15339968_D000001_D005354,15339968_4,bcv_sentence_task_befree_2093,,770958021,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,1,,D014415,"<span class=""chemical"">tunicamycin</span>",D005354,"<span class=""disease"">fibrosarcoma</span>","Human colon cancer HT-29, <span class=""disease"">fibrosarcoma</span> HT1080, and stomach cancer MKN74 cells were cultured in the absence of glucose or in the presence of glucose and a UPR-inducing chemical stressor (the N-glycosylation inhibitor <span class=""chemical"">tunicamycin</span>, the calcium ionophore A23187, or the hypoglycemia-mimicking agent 2-deoxyglucose [2DG]).",,15339968,15339968_D014415_D005354,15339968_4,bcv_sentence_task_befree_2094,,770958022,FALSE,finalized,5,8/14/15 22:53,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D009369,"<span class=""disease"">tumor</span>","VST alone and in combination with <span class=""chemical"">cisplatin</span> statistically significantly (P =.004 and P<.001 for comparisons with untreated control, respectively) inhibited <span class=""disease"">tumor</span> growth of MKN74 xenografts.",,15339968,15339968_D002945_D009369,15339968_11,bcv_sentence_task_befree_2095,,770958023,FALSE,finalized,5,8/14/15 21:41,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D009369,"<span class=""disease"">tumors</span>","Disruption of the UPR may provide a novel therapeutic approach to targeting <span class=""chemical"">glucose</span>-deprived solid <span class=""disease"">tumors</span>.",,15339968,15339968_D005947_D009369,15339968_12,bcv_sentence_task_befree_2096,,770958024,FALSE,finalized,5,8/15/15 0:04,"



",no_relation,1,,C060076,"<span class=""chemical"">mangafodipir/manganese-DPDP</span>",D010195,"<span class=""disease"">pancreatic lesions</span>","Magnetic resonance with <span class=""chemical"">manganese-DPDP</span> (<span class=""chemical"">mangafodipir</span>) of focal solid <span class=""disease"">pancreatic lesions</span>.",,15343134,15343134_C060076_D010195,15343134_0,bcv_sentence_task_befree_2097,,770958025,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,C060076,"<span class=""chemical"">Mn-DPDP/Mangafodipir</span>",D010195,"<span class=""disease"">pancreatic lesions</span>","To assess the accuracy of magnetic resonance (MR) with <span class=""chemical"">Mangafodipir</span> (<span class=""chemical"">Mn-DPDP</span>) in the identification of focal solid <span class=""disease"">pancreatic lesions</span>.",,15343134,15343134_C060076_D010195,15343134_1,bcv_sentence_task_befree_2098,,770958026,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,C060076,"<span class=""chemical"">Mn-DPDP</span>",D010195,"<span class=""disease"">pancreatitis/pancreatic lesions</span>","<span class=""chemical"">Mn-DPDP</span> MR identified 17/18 malignancies, 2/3 endocrine neoplasms 5/5 focal <span class=""disease"">pancreatitis</span>; the 4 patients with no <span class=""disease"">pancreatic lesions</span> were correctly identified.",,15343134,15343134_C060076_D010195,15343134_11,bcv_sentence_task_befree_2099,,770958027,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,C060076,"<span class=""chemical"">Mn-DPDP</span>",D009369,"<span class=""disease"">neoplasms</span>","<span class=""chemical"">Mn-DPDP</span> MR identified 17/18 malignancies, 2/3 endocrine <span class=""disease"">neoplasms</span> 5/5 focal pancreatitis; the 4 patients with no pancreatic lesions were correctly identified.",,15343134,15343134_C060076_D009369,15343134_11,bcv_sentence_task_befree_2100,,770958028,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,1,,C060076,"<span class=""chemical"">Mn-DPDP</span>",D010195,"<span class=""disease"">pancreatitis</span>","Due to the small number of inflammatory lesions included in the study, no significant differences were found in signal intensity and <span class=""chemical"">Mn-DPDP</span> uptake between focal <span class=""disease"">pancreatitis</span> and neoplasms.",,15343134,15343134_C060076_D010195,15343134_14,bcv_sentence_task_befree_2101,,770958029,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,C060076,"<span class=""chemical"">Mn-DPDP</span>",D009369,"<span class=""disease"">neoplasms</span>","Due to the small number of inflammatory lesions included in the study, no significant differences were found in signal intensity and <span class=""chemical"">Mn-DPDP</span> uptake between focal pancreatitis and <span class=""disease"">neoplasms</span>.",,15343134,15343134_C060076_D009369,15343134_14,bcv_sentence_task_befree_2102,,770958030,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,1,,C060076,"<span class=""chemical"">DPDP</span>",D010195,"<span class=""disease"">pancreatic lesions</span>","MR with Mn-<span class=""chemical"">DPDP</span> is very accurate in the identification of focal solid <span class=""disease"">pancreatic lesions</span>.",,15343134,15343134_C060076_D010195,15343134_15,bcv_sentence_task_befree_2103,,770958031,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,C060076,"<span class=""chemical"">Mangafodi-pir</span>",D010195,"<span class=""disease"">pancreatic lesions</span>","<span class=""chemical"">Mangafodi-pir</span> is also very useful for excluding the presence of <span class=""disease"">pancreatic lesions</span> suspected at US or CT.",,15343134,15343134_C060076_D010195,15343134_16,bcv_sentence_task_befree_2104,,770958032,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,C060076,"<span class=""chemical"">mangafodipir</span>",D006505,"<span class=""disease"">hepatic lesions</span>","Detection and characterization of focal <span class=""disease"">hepatic lesions</span>: <span class=""chemical"">mangafodipir</span> vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.",,15390224,15390224_C060076_D006505,15390224_0,bcv_sentence_task_befree_2105,,770958033,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,0.8089,,C000499,"<span class=""chemical"">iron oxide</span>",D006505,"<span class=""disease"">hepatic lesions</span>","Detection and characterization of focal <span class=""disease"">hepatic lesions</span>: mangafodipir vs. superparamagnetic <span class=""chemical"">iron oxide</span>-enhanced magnetic resonance imaging.",,15390224,15390224_C000499_D006505,15390224_0,bcv_sentence_task_befree_2106,,770958034,FALSE,finalized,5,8/15/15 1:11,"



",no_relation,1,,C060076,"<span class=""chemical"">mangafodipir</span>",D006505,"<span class=""disease"">hepatic lesions</span>","To compare the <span class=""chemical"">mangafodipir</span>-enhanced magnetic resonance (MR) and superparamagnetic iron oxide (SPIO)-enhanced images for their ability to detect and characterize focal <span class=""disease"">hepatic lesions</span>.",,15390224,15390224_C060076_D006505,15390224_1,bcv_sentence_task_befree_2107,,770958035,FALSE,finalized,5,8/14/15 23:41,"



",no_relation,1,,C000499,"<span class=""chemical"">iron oxide</span>",D006505,"<span class=""disease"">hepatic lesions</span>","To compare the mangafodipir-enhanced magnetic resonance (MR) and superparamagnetic <span class=""chemical"">iron oxide</span> (SPIO)-enhanced images for their ability to detect and characterize focal <span class=""disease"">hepatic lesions</span>.",,15390224,15390224_C000499_D006505,15390224_1,bcv_sentence_task_befree_2108,,770958036,FALSE,finalized,5,8/14/15 22:13,"



",no_relation,1,,C060076,"<span class=""chemical"">mangafodipir</span>",D006528,"<span class=""disease"">HCCs</span>","SPIO- and <span class=""chemical"">mangafodipir</span>-enhanced images were comparable for detection of focal hepatic lesions other than small <span class=""disease"">HCCs</span>, which were better detected on the SPIO-enhanced images.",,15390224,15390224_C060076_D006528,15390224_11,bcv_sentence_task_befree_2109,,770958037,FALSE,finalized,5,8/14/15 23:18,"



",no_relation,1,,C060076,"<span class=""chemical"">mangafodipir</span>",D006505,"<span class=""disease"">hepatic lesions</span>","SPIO- and <span class=""chemical"">mangafodipir</span>-enhanced images were comparable for detection of focal <span class=""disease"">hepatic lesions</span> other than small HCCs, which were better detected on the SPIO-enhanced images.",,15390224,15390224_C060076_D006505,15390224_11,bcv_sentence_task_befree_2110,,770958038,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,0.8065,,C060076,"<span class=""chemical"">Mangafodipir</span>",D008107,"<span class=""disease"">liver lesions</span>","<span class=""chemical"">Mangafodipir</span>-enhanced images are likely better than the SPIO-enhanced images for distinguishing between focal <span class=""disease"">liver lesions</span> with a hepatocellular or nonhepatocellular origin.",,15390224,15390224_C060076_D008107,15390224_12,bcv_sentence_task_befree_2111,,770958039,FALSE,finalized,5,8/15/15 0:12,"



",yes_direct,1,,C065655,"<span class=""chemical"">FEIBA</span>",D013927,"<span class=""disease"">Thrombosis</span>","<span class=""disease"">Thrombosis</span> is a rare but well-recognized potential complication of Factor VIII Inhibitor Bypass Activity (<span class=""chemical"">FEIBA</span>) infusion.",,15456478,15456478_C065655_D013927,15456478_1,bcv_sentence_task_befree_2112,,770958040,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,1,,C065655,"<span class=""chemical"">FEIBA</span>",D057049,"<span class=""disease"">thrombotic</span>","Recombinant factor VIIa (rFVIIa) is increasingly used as an alternative to <span class=""chemical"">FEIBA</span>; however, the <span class=""disease"">thrombotic</span> safety profile of rFVIIa remains incompletely characterized.",,15456478,15456478_C065655_D057049,15456478_2,bcv_sentence_task_befree_2113,,770958041,FALSE,finalized,5,8/14/15 21:01,"



",no_relation,0.5845,,C065655,"<span class=""chemical"">FEIBA</span>",D057049,"<span class=""disease"">thrombotic</span>","Data from the MedWatch pharmacovigilance program of the US Food and Drug Administration, as supplemented by published case reports, were used in conjunction with estimated numbers of infusions available from manufacturers to assess comparative incidence of <span class=""disease"">thrombotic</span> AEs in patients receiving rFVIIa or <span class=""chemical"">FEIBA</span> in the period from April 1999 through June 2002.",,15456478,15456478_C065655_D057049,15456478_4,bcv_sentence_task_befree_2114,,770958042,FALSE,finalized,5,8/14/15 22:12,"



",no_relation,1,,C065655,"<span class=""chemical"">FEIBA</span>",D057049,"<span class=""disease"">thrombotic</span>","Reported <span class=""disease"">thrombotic</span> AEs were rare, with incidence rates of 24.6 per 10(5) infusions (CI, 19.1-31.2 per 10(5) infusions) for rFVIIa and 8.24 per 10(5) infusions (CI, 4.71-13.4 per 10(5) infusions) for <span class=""chemical"">FEIBA</span>.",,15456478,15456478_C065655_D057049,15456478_5,bcv_sentence_task_befree_2115,,770958043,FALSE,finalized,5,8/15/15 2:42,"



",no_relation,1,,C065655,"<span class=""chemical"">FEIBA</span>",D057049,"<span class=""disease"">Thrombotic</span>","<span class=""disease"">Thrombotic</span> AEs were significantly more frequent in rFVIIa than <span class=""chemical"">FEIBA</span> recipients (incidence rate ratio, 2.98; CI, 1.71-5.52).",,15456478,15456478_C065655_D057049,15456478_6,bcv_sentence_task_befree_2116,,770958044,FALSE,finalized,5,8/14/15 21:05,"



",no_relation,0.6123,,C065655,"<span class=""chemical"">FEIBA</span>",D057049,"<span class=""disease"">thrombotic</span>","The most commonly documented single type of <span class=""disease"">thrombotic</span> AE after rFVIIa infusion was cerebrovascular thrombosis, while myocardial infarction was the most frequent type in patients receiving <span class=""chemical"">FEIBA</span>.",,15456478,15456478_C065655_D057049,15456478_7,bcv_sentence_task_befree_2117,,770958045,FALSE,finalized,5,8/14/15 23:41,"



",yes_direct,1,,C065655,"<span class=""chemical"">FEIBA</span>",D009203,"<span class=""disease"">myocardial infarction</span>","The most commonly documented single type of thrombotic AE after rFVIIa infusion was cerebrovascular thrombosis, while <span class=""disease"">myocardial infarction</span> was the most frequent type in patients receiving <span class=""chemical"">FEIBA</span>.",,15456478,15456478_C065655_D009203,15456478_7,bcv_sentence_task_befree_2118,,770958046,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,1,,C065655,"<span class=""chemical"">FEIBA</span>",D013927,"<span class=""disease"">thrombosis</span>","The most commonly documented single type of thrombotic AE after rFVIIa infusion was cerebrovascular <span class=""disease"">thrombosis</span>, while myocardial infarction was the most frequent type in patients receiving <span class=""chemical"">FEIBA</span>.",,15456478,15456478_C065655_D013927,15456478_7,bcv_sentence_task_befree_2119,,770958047,FALSE,finalized,5,8/15/15 2:08,"



",no_relation,0.7964,,C065655,"<span class=""chemical"">FEIBA</span>",D057049,"<span class=""disease"">thrombotic</span>","Contrasting AE reporting patterns between rFVIIa and <span class=""chemical"">FEIBA</span> may have contributed to the observed difference in <span class=""disease"">thrombotic</span> event incidence.",,15456478,15456478_C065655_D057049,15456478_8,bcv_sentence_task_befree_2120,,770958048,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,1,,D002045,"<span class=""chemical"">bupivacaine</span>",D010146,"<span class=""disease"">pain</span>","Efficacy of <span class=""chemical"">bupivacaine</span> for post-tonsillectomy <span class=""disease"">pain</span>: a study with the intra-individual design.",,15488969,15488969_D002045_D010146,15488969_0,bcv_sentence_task_befree_2121,,770958049,FALSE,finalized,5,8/14/15 21:52,"



",yes_direct,0.5861,,D000431,"<span class=""chemical"">Alcohol</span>",D011470,"<span class=""disease"">prostatic hyperplasia</span>","<span class=""chemical"">Alcohol</span> and the risk of prostate cancer and benign <span class=""disease"">prostatic hyperplasia</span>.",,15491708,15491708_D000431_D011470,15491708_0,bcv_sentence_task_befree_2122,,770958050,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,0.798,,D000431,"<span class=""chemical"">Alcohol</span>",D011471,"<span class=""disease"">prostate cancer</span>","<span class=""chemical"">Alcohol</span> and the risk of <span class=""disease"">prostate cancer</span> and benign prostatic hyperplasia.",,15491708,15491708_D000431_D011471,15491708_0,bcv_sentence_task_befree_2123,,770958051,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,0.6063,,D000431,"<span class=""chemical"">alcohol</span>",D011471,"<span class=""disease"">BPH/cancer/benign prostatic hyperplasia</span>","To examine the association between <span class=""chemical"">alcohol</span> and the risk of prostate <span class=""disease"">cancer/benign prostatic hyperplasia</span> (<span class=""disease"">BPH</span>) in a population with a wide range of <span class=""chemical"">alcohol</span> consumption, using a hospital-based, case-control study.",,15491708,15491708_D000431_D011471,15491708_1,bcv_sentence_task_befree_2124,,770958052,FALSE,finalized,5,8/14/15 21:13,"



",yes_direct,0.5936,,D000431,"<span class=""chemical"">alcohol</span>",D011471,"<span class=""disease"">prostate cancer</span>","Data from several epidemiologic studies have allowed us to exclude a strong association between <span class=""chemical"">alcohol</span> drinking and <span class=""disease"">prostate cancer</span> risk.",,15491708,15491708_D000431_D011471,15491708_2,bcv_sentence_task_befree_2125,,770958053,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,D000431,"<span class=""chemical"">Alcohol</span>",D011471,"<span class=""disease"">BPH/prostate cancer</span>","<span class=""chemical"">Alcohol</span> consumption showed no consistent association with <span class=""disease"">prostate cancer</span> risk, but a statistically significant inverse trend in risk for <span class=""disease"">BPH</span>.",,15491708,15491708_D000431_D011471,15491708_9,bcv_sentence_task_befree_2126,,770958054,FALSE,finalized,5,8/14/15 21:44,"



",no_relation,0.5894,,D000431,"<span class=""chemical"">alcohol</span>",D011471,"<span class=""disease"">BPH</span>","The inverse relation between elevated <span class=""chemical"">alcohol</span> consumption and <span class=""disease"">BPH</span> was apparently stronger in subjects with a lower body mass index.",,15491708,15491708_D000431_D011471,15491708_12,bcv_sentence_task_befree_2127,,770958055,FALSE,finalized,5,8/15/15 0:37,"



",no_relation,0.8158,,D000431,"<span class=""chemical"">Alcohol</span>",D011471,"<span class=""disease"">prostate cancer</span>","<span class=""chemical"">Alcohol</span> drinking is unrelated to <span class=""disease"">prostate cancer</span> risk.",,15491708,15491708_D000431_D011471,15491708_13,bcv_sentence_task_befree_2128,,770958056,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,0.795,,D000728,"<span class=""chemical"">androgen</span>",D011471,"<span class=""disease"">BPH</span>","The inverse relationship with <span class=""disease"">BPH</span> may be related to the hormonal correlates (ie, lower <span class=""chemical"">androgen</span> levels) of heavy alcohol drinkers.",,15491708,15491708_D000728_D011471,15491708_14,bcv_sentence_task_befree_2129,,770958057,FALSE,finalized,5,8/15/15 0:34,"



",no_relation,0.5999,,D000431,"<span class=""chemical"">alcohol</span>",D011471,"<span class=""disease"">BPH</span>","The inverse relationship with <span class=""disease"">BPH</span> may be related to the hormonal correlates (ie, lower androgen levels) of heavy <span class=""chemical"">alcohol</span> drinkers.",,15491708,15491708_D000431_D011471,15491708_14,bcv_sentence_task_befree_2130,,770958058,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,1,,C116890,"<span class=""chemical"">SU5416</span>",D009369,"<span class=""disease"">tumor</span>","Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (<span class=""chemical"">SU5416</span>) in human endothelial and <span class=""disease"">tumor</span> cells.",,15519795,15519795_C116890_D009369,15519795_0,bcv_sentence_task_befree_2131,,770958059,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,1,,C116890,"<span class=""chemical"">SU5416</span>",C535318,"<span class=""disease"">Triple combination</span>","<span class=""disease"">Triple combination</span> of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (<span class=""chemical"">SU5416</span>) in human endothelial and tumor cells.",,15519795,15519795_C116890_C535318,15519795_0,bcv_sentence_task_befree_2132,,770958060,FALSE,finalized,5,8/14/15 21:58,"



",no_relation,1,,C116890,"<span class=""chemical"">SU5416</span>",D009369,"<span class=""disease"">tumor</span>","The combination of the folate antimetabolite pemetrexed, <span class=""chemical"">SU5416</span>, a receptor tyrosine kinase inhibitor of VEGFR2, and irradiation was investigated in human endothelial cells and <span class=""disease"">tumor</span> cell lines.",,15519795,15519795_C116890_D009369,15519795_2,bcv_sentence_task_befree_2133,,770958061,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,1,,D005492,"<span class=""chemical"">folate</span>",D009369,"<span class=""disease"">tumor</span>","The combination of the <span class=""chemical"">folate</span> antimetabolite pemetrexed, SU5416, a receptor tyrosine kinase inhibitor of VEGFR2, and irradiation was investigated in human endothelial cells and <span class=""disease"">tumor</span> cell lines.",,15519795,15519795_D005492_D009369,15519795_2,bcv_sentence_task_befree_2134,,770958062,FALSE,finalized,5,8/15/15 1:58,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D009369,"<span class=""disease"">tumor</span>","The combination of the folate antimetabolite pemetrexed, SU5416, a receptor <span class=""chemical"">tyrosine</span> kinase inhibitor of VEGFR2, and irradiation was investigated in human endothelial cells and <span class=""disease"">tumor</span> cell lines.",,15519795,15519795_D014443_D009369,15519795_2,bcv_sentence_task_befree_2135,,770958063,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,C116890,"<span class=""chemical"">SU5416</span>",D011471,"<span class=""disease"">prostate cancer</span>","Primary isolated human umbilical vein endothelial cells (HUVEC), human dermal microvascular endothelial cells (HDMEC), and human glioblastoma (U87) and <span class=""disease"">prostate cancer</span> cells (PC3) were exposed to pemetrexed (2 h) alone and in combination with <span class=""chemical"">SU5416</span> (2 h).",,15519795,15519795_C116890_D011471,15519795_3,bcv_sentence_task_befree_2136,,770958064,FALSE,finalized,5,8/15/15 2:23,"



",no_relation,1,,C116890,"<span class=""chemical"">SU5416</span>",D005909,"<span class=""disease"">glioblastoma</span>","Primary isolated human umbilical vein endothelial cells (HUVEC), human dermal microvascular endothelial cells (HDMEC), and human <span class=""disease"">glioblastoma</span> (U87) and prostate cancer cells (PC3) were exposed to pemetrexed (2 h) alone and in combination with <span class=""chemical"">SU5416</span> (2 h).",,15519795,15519795_C116890_D005909,15519795_3,bcv_sentence_task_befree_2137,,770958065,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,0.8143,,C116890,"<span class=""chemical"">SU5416</span>",D009369,"<span class=""disease"">tumor</span>","Triple combination using only a low-toxicity drug exposure of pemetrexed and <span class=""chemical"">SU5416</span> results in greater response than each treatment alone or than each combination of two modalities in all tested endothelial and <span class=""disease"">tumor</span> cell models.",,15519795,15519795_C116890_D009369,15519795_9,bcv_sentence_task_befree_2138,,770958066,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,1,,C116890,"<span class=""chemical"">SU5416</span>",C535318,"<span class=""disease"">Triple combination</span>","<span class=""disease"">Triple combination</span> using only a low-toxicity drug exposure of pemetrexed and <span class=""chemical"">SU5416</span> results in greater response than each treatment alone or than each combination of two modalities in all tested endothelial and tumor cell models.",,15519795,15519795_C116890_C535318,15519795_9,bcv_sentence_task_befree_2139,,770958067,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,0.8038,,C116890,"<span class=""chemical"">SU5416</span>",D064420,"<span class=""disease"">toxicity</span>","Triple combination using only a low-<span class=""disease"">toxicity</span> drug exposure of pemetrexed and <span class=""chemical"">SU5416</span> results in greater response than each treatment alone or than each combination of two modalities in all tested endothelial and tumor cell models.",,15519795,15519795_C116890_D064420,15519795_9,bcv_sentence_task_befree_2140,,770958068,FALSE,finalized,5,8/15/15 2:01,"



",no_relation,1,,D003894,"<span class=""chemical"">Desmopressin</span>",D053158,"<span class=""disease"">nocturia</span>","<span class=""chemical"">Desmopressin</span> is a synthetic vasopressin analogue mainly used in treatment of diabetes insipidus and <span class=""disease"">nocturia</span>.",,15525445,15525445_D003894_D053158,15525445_1,bcv_sentence_task_befree_2141,,770958069,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,1,,D014667,"<span class=""chemical"">vasopressin</span>",D003919,"<span class=""disease"">diabetes insipidus</span>","Desmopressin is a synthetic <span class=""chemical"">vasopressin</span> analogue mainly used in treatment of <span class=""disease"">diabetes insipidus</span> and nocturia.",,15525445,15525445_D014667_D003919,15525445_1,bcv_sentence_task_befree_2142,,770958070,FALSE,finalized,5,8/15/15 0:02,"



",no_relation,1,,D003894,"<span class=""chemical"">Desmopressin</span>",D003919,"<span class=""disease"">diabetes insipidus</span>","<span class=""chemical"">Desmopressin</span> is a synthetic vasopressin analogue mainly used in treatment of <span class=""disease"">diabetes insipidus</span> and nocturia.",,15525445,15525445_D003894_D003919,15525445_1,bcv_sentence_task_befree_2143,,770958071,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,1,,D014667,"<span class=""chemical"">vasopressin</span>",D053158,"<span class=""disease"">nocturia</span>","Desmopressin is a synthetic <span class=""chemical"">vasopressin</span> analogue mainly used in treatment of diabetes insipidus and <span class=""disease"">nocturia</span>.",,15525445,15525445_D014667_D053158,15525445_1,bcv_sentence_task_befree_2144,,770958072,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,1,,D017336,"<span class=""chemical"">loratadine</span>",D011695,"<span class=""disease"">allergic</span>","Systemic antihistamines, such as <span class=""chemical"">loratadine</span> and cetrizine hydrochloride, have proven efficacious in the control of many <span class=""disease"">allergic</span> conditions; however, patients complain about their drying effects.",,15562885,15562885_D017336_D011695,15562885_1,bcv_sentence_task_befree_2145,,770958073,FALSE,finalized,5,8/14/15 21:31,"



",no_relation,0.8092,,D017336,"<span class=""chemical"">loratadine</span>",C535679,"<span class=""disease"">chamber that regulates humidity</span>","Participants were evaluated in a CAE (a <span class=""disease"">chamber that regulates humidity</span>, temperature, airflow, and visual tasking) at baseline and after taking 10 mg of either <span class=""chemical"">loratadine</span> or cetirizine hydrochloride daily for 4 days.",,15562885,15562885_D017336_C535679,15562885_4,bcv_sentence_task_befree_2146,,770958074,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,0.5721,,D017336,"<span class=""chemical"">loratadine</span>",D005128,"<span class=""disease"">ocular discomfort</span>","After 4 days, use of <span class=""chemical"">loratadine</span> yielded a mean increase of 0.75 points (107%) in keratitis (P < .001), a mean increase of 1.35 points (133%) in conjunctival staining (P < .001), a mean decrease of 1.38 seconds (33.7%) in TFBUT (P < .001), and a mean increase of 0.32 points (24.8%) in <span class=""disease"">ocular discomfort</span> (P = .05) vs baseline.",,15562885,15562885_D017336_D005128,15562885_7,bcv_sentence_task_befree_2147,,770958075,FALSE,finalized,5,8/14/15 22:17,"



",yes_direct,0.8012,,D017336,"<span class=""chemical"">loratadine</span>",D007634,"<span class=""disease"">keratitis</span>","After 4 days, use of <span class=""chemical"">loratadine</span> yielded a mean increase of 0.75 points (107%) in <span class=""disease"">keratitis</span> (P < .001), a mean increase of 1.35 points (133%) in conjunctival staining (P < .001), a mean decrease of 1.38 seconds (33.7%) in TFBUT (P < .001), and a mean increase of 0.32 points (24.8%) in ocular discomfort (P = .05) vs baseline.",,15562885,15562885_D017336_D007634,15562885_7,bcv_sentence_task_befree_2148,,770958076,FALSE,finalized,5,8/15/15 1:17,"



",yes_direct,0.7958,,D017336,"<span class=""chemical"">Loratadine</span>",D005128,"<span class=""disease"">increased ocular discomfort</span>","<span class=""chemical"">Loratadine</span> and cetirizine hydrochloride induced signs and symptoms associated with ocular dryness, including increased corneal and conjunctival staining, decreased TFBUT, and <span class=""disease"">increased ocular discomfort</span> in healthy individuals.",,15562885,15562885_D017336_D005128,15562885_10,bcv_sentence_task_befree_2149,,770958077,FALSE,finalized,5,8/15/15 0:21,"



",yes_direct,1,,D017336,"<span class=""chemical"">Loratadine</span>",D014987,"<span class=""disease"">ocular dryness</span>","<span class=""chemical"">Loratadine</span> and cetirizine hydrochloride induced signs and symptoms associated with <span class=""disease"">ocular dryness</span>, including increased corneal and conjunctival staining, decreased TFBUT, and increased ocular discomfort in healthy individuals.",,15562885,15562885_D017336_D014987,15562885_10,bcv_sentence_task_befree_2150,,770958078,FALSE,finalized,5,8/14/15 22:53,"


In many populations, high intakes of saturated fat are associated with elevated serum cholesterol concentrations and increased coronary heart disease (CHD) mortality. 

While ""cholesterol"" and ""coronary heart disease (CHD) mortality"" should be connected, this sentence does not make connection clear, but refers to ""high intakes of saturated fat""
",yes_direct,0.7844,,D002784,"<span class=""chemical"">cholesterol</span>",D003327,"<span class=""disease"">CHD/coronary heart disease</span>","In many populations, high intakes of saturated fat are associated with elevated serum <span class=""chemical"">cholesterol</span> concentrations and increased <span class=""disease"">coronary heart disease</span> (<span class=""disease"">CHD</span>) mortality.",,15563444,15563444_D002784_D003327,15563444_2,bcv_sentence_task_befree_2151,,770958079,FALSE,finalized,5,8/15/15 0:15,"



",yes_direct,0.5899,,D002241,"<span class=""chemical"">carbohydrates</span>",D003327,"<span class=""disease"">CHD</span>","However, the intakes of animal foods, total protein, dietary cholesterol and less plant derived <span class=""chemical"">carbohydrates</span> were predictors of <span class=""disease"">CHD</span>.",,15563444,15563444_D002241_D003327,15563444_12,bcv_sentence_task_befree_2152,,770958080,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,0.5723,,D002784,"<span class=""chemical"">cholesterol</span>",D003327,"<span class=""disease"">CHD</span>","However, the intakes of animal foods, total protein, dietary <span class=""chemical"">cholesterol</span> and less plant derived carbohydrates were predictors of <span class=""disease"">CHD</span>.",,15563444,15563444_D002784_D003327,15563444_12,bcv_sentence_task_befree_2153,,770958081,FALSE,finalized,5,8/14/15 23:40,"



",no_relation,1,,D006493,"<span class=""chemical"">heparin</span>",D054556,"<span class=""disease"">venous thromboembolism</span>","The prolonged administration of <span class=""chemical"">heparin</span> for prevention and treatment of <span class=""disease"">venous thromboembolism</span> has been associated with a risk of heparin-induced osteoporosis.",,15584059,15584059_D006493_D054556,15584059_1,bcv_sentence_task_befree_2154,,770958082,FALSE,finalized,5,8/14/15 22:24,"



",yes_direct,0.8081,,D006493,"<span class=""chemical"">heparin</span>",D010024,"<span class=""disease"">osteoporosis</span>","The prolonged administration of <span class=""chemical"">heparin</span> for prevention and treatment of venous thromboembolism has been associated with a risk of heparin-induced <span class=""disease"">osteoporosis</span>.",,15584059,15584059_D006493_D010024,15584059_1,bcv_sentence_task_befree_2155,,770958083,FALSE,finalized,5,8/15/15 0:57,"



",yes_direct,1,,D006493,"<span class=""chemical"">heparin</span>",D010024,"<span class=""disease"">osteoporosis</span>","Fondaparinux did not inhibit osteoblast proliferation in vitro and may reduce the risk of heparin-induced <span class=""disease"">osteoporosis</span> associated with long-term <span class=""chemical"">heparin</span> administration.",,15584059,15584059_D006493_D010024,15584059_9,bcv_sentence_task_befree_2156,,770958084,FALSE,finalized,5,8/15/15 0:39,"



",no_relation,0.804,,D001663,"<span class=""chemical"">bilirubin</span>",D006980,"<span class=""disease"">hyperthyroidism</span>","The patient's jaundice promptly resolved with therapy for <span class=""disease"">hyperthyroidism</span> and thyroid storm as <span class=""chemical"">bilirubin</span> levels decreased from 35 mg/dL (normal: 0.5-1.2 mg/dL) to 0.4 mg/dL.",,15599331,15599331_D001663_D006980,15599331_5,bcv_sentence_task_befree_2157,,770958085,FALSE,finalized,5,8/14/15 21:49,"



",no_relation,1,,D001663,"<span class=""chemical"">bilirubin</span>",D013958,"<span class=""disease"">thyroid storm</span>","The patient's jaundice promptly resolved with therapy for hyperthyroidism and <span class=""disease"">thyroid storm</span> as <span class=""chemical"">bilirubin</span> levels decreased from 35 mg/dL (normal: 0.5-1.2 mg/dL) to 0.4 mg/dL.",,15599331,15599331_D001663_D013958,15599331_5,bcv_sentence_task_befree_2158,,770958086,FALSE,finalized,5,8/14/15 22:04,"



",no_relation,0.8058,,D001663,"<span class=""chemical"">bilirubin</span>",D007565,"<span class=""disease"">jaundice</span>","The patient's <span class=""disease"">jaundice</span> promptly resolved with therapy for hyperthyroidism and thyroid storm as <span class=""chemical"">bilirubin</span> levels decreased from 35 mg/dL (normal: 0.5-1.2 mg/dL) to 0.4 mg/dL.",,15599331,15599331_D001663_D007565,15599331_5,bcv_sentence_task_befree_2159,,770958087,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,0.7975,,D000431,"<span class=""chemical"">alcohol</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","Cigarette smoking, <span class=""chemical"">alcohol</span> drinking, hepatitis B, and risk for <span class=""disease"">hepatocellular carcinoma</span> in Korea.",,15601641,15601641_D000431_D006528,15601641_0,bcv_sentence_task_befree_2160,,770958088,FALSE,finalized,5,8/14/15 23:00,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D006509,"<span class=""disease"">hepatitis B</span>","Cigarette smoking, <span class=""chemical"">alcohol</span> drinking, <span class=""disease"">hepatitis B</span>, and risk for hepatocellular carcinoma in Korea.",,15601641,15601641_D000431_D006509,15601641_0,bcv_sentence_task_befree_2161,,770958089,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,1,,D000348,"<span class=""chemical"">aflatoxin</span>",D006506,"<span class=""disease"">infectious hepatitis</span>","Liver cancer is one of the most common cancers worldwide, particularly in Asia and Africa, where <span class=""disease"">infectious hepatitis</span> and <span class=""chemical"">aflatoxin</span> exposures are common.",,15601641,15601641_D000348_D006506,15601641_1,bcv_sentence_task_befree_2162,,770958090,FALSE,finalized,5,8/15/15 2:13,"



",yes_direct,0.7989,,D000348,"<span class=""chemical"">aflatoxin</span>",D009369,"<span class=""disease"">cancers/Liver cancer</span>","<span class=""disease"">Liver cancer</span> is one of the most common <span class=""disease"">cancers</span> worldwide, particularly in Asia and Africa, where infectious hepatitis and <span class=""chemical"">aflatoxin</span> exposures are common.",,15601641,15601641_D000348_D009369,15601641_1,bcv_sentence_task_befree_2163,,770958091,FALSE,finalized,5,8/14/15 21:16,"



",no_relation,0.4056,,D000431,"<span class=""chemical"">alcohol</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","We conducted a prospective cohort study of liver cancer in Korea to assess the independent effects and interactions of smoking, <span class=""chemical"">alcohol</span> consumption, and hepatitis B on risk of mortality from <span class=""disease"">hepatocellular carcinoma</span>.",,15601641,15601641_D000431_D006528,15601641_2,bcv_sentence_task_befree_2164,,770958092,FALSE,finalized,5,8/14/15 21:45,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D006509,"<span class=""disease"">hepatitis B</span>","We conducted a prospective cohort study of liver cancer in Korea to assess the independent effects and interactions of smoking, <span class=""chemical"">alcohol</span> consumption, and <span class=""disease"">hepatitis B</span> on risk of mortality from hepatocellular carcinoma.",,15601641,15601641_D000431_D006509,15601641_2,bcv_sentence_task_befree_2165,,770958093,FALSE,finalized,5,8/14/15 22:29,"



",no_relation,0.7946,,D000431,"<span class=""chemical"">alcohol</span>",D009369,"<span class=""disease"">liver cancer</span>","We conducted a prospective cohort study of <span class=""disease"">liver cancer</span> in Korea to assess the independent effects and interactions of smoking, <span class=""chemical"">alcohol</span> consumption, and hepatitis B on risk of mortality from hepatocellular carcinoma.",,15601641,15601641_D000431_D009369,15601641_2,bcv_sentence_task_befree_2166,,770958094,FALSE,finalized,5,8/14/15 21:12,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D006509,"<span class=""disease"">hepatitis B</span>","All participants reported their smoking and <span class=""chemical"">alcohol</span> consumption, and <span class=""disease"">hepatitis B</span> surface antigen (HBsAg) status was documented for 47.2% of the participants.",,15601641,15601641_D000431_D006509,15601641_4,bcv_sentence_task_befree_2167,,770958095,FALSE,finalized,5,8/14/15 21:13,"



",no_relation,1,,D006514,"<span class=""chemical"">hepatitis B surface antigen</span>",D006509,"<span class=""disease"">hepatitis B</span>","All participants reported their smoking and alcohol consumption, and <span class=""chemical""></span><span class=""disease"">hepatitis B</span> surface antigen (HBsAg) status was documented for 47.2% of the participants.",,15601641,15601641_D006514_D006509,15601641_4,bcv_sentence_task_befree_2168,,770958096,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D003929,"<span class=""disease"">diabetes</span>","Relative risk and 95% confidence intervals (CIs) of mortality from hepatocellular carcinoma were calculated using proportional hazards models adjusted for age, <span class=""chemical"">alcohol</span> drinking, <span class=""disease"">diabetes</span>, and HBsAg status.",,15601641,15601641_D000431_D003929,15601641_5,bcv_sentence_task_befree_2169,,770958097,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,0.5954,,D000431,"<span class=""chemical"">alcohol</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","Relative risk and 95% confidence intervals (CIs) of mortality from <span class=""disease"">hepatocellular carcinoma</span> were calculated using proportional hazards models adjusted for age, <span class=""chemical"">alcohol</span> drinking, diabetes, and HBsAg status.",,15601641,15601641_D000431_D006528,15601641_5,bcv_sentence_task_befree_2170,,770958098,FALSE,finalized,5,8/14/15 22:43,"



",yes_direct,0.8073,,D000431,"<span class=""chemical"">alcohol</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","Heavy <span class=""chemical"">alcohol</span> drinking was associated with <span class=""disease"">hepatocellular carcinoma</span> mortality risk in the subgroup of men who were tested for HBsAg (RR =1.5; 95% CI = 1.2 to 2.0).",,15601641,15601641_D000431_D006528,15601641_8,bcv_sentence_task_befree_2171,,770958099,FALSE,finalized,5,8/14/15 21:53,"



",no_relation,1,,D006514,"<span class=""chemical"">HBsAg</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","Heavy alcohol drinking was associated with <span class=""disease"">hepatocellular carcinoma</span> mortality risk in the subgroup of men who were tested for <span class=""chemical"">HBsAg</span> (RR =1.5; 95% CI = 1.2 to 2.0).",,15601641,15601641_D006514_D006528,15601641_8,bcv_sentence_task_befree_2172,,770958100,FALSE,finalized,5,8/14/15 21:58,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","There was no interaction among smoking, <span class=""chemical"">alcohol</span> drinking, and HBsAg in terms of <span class=""disease"">hepatocellular carcinoma</span> mortality.",,15601641,15601641_D000431_D006528,15601641_9,bcv_sentence_task_befree_2173,,770958101,FALSE,finalized,5,8/15/15 2:20,"



",no_relation,1,,D006514,"<span class=""chemical"">HBsAg</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","There was no interaction among smoking, alcohol drinking, and <span class=""chemical"">HBsAg</span> in terms of <span class=""disease"">hepatocellular carcinoma</span> mortality.",,15601641,15601641_D006514_D006528,15601641_9,bcv_sentence_task_befree_2174,,770958102,FALSE,finalized,5,8/14/15 21:37,"



",yes_direct,0.7964,,D000431,"<span class=""chemical"">alcohol</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","Cigarette smoking, heavy <span class=""chemical"">alcohol</span> consumption, and HBsAg were independently associated with increased risk of mortality from <span class=""disease"">hepatocellular carcinoma</span> but did not interact synergistically.",,15601641,15601641_D000431_D006528,15601641_10,bcv_sentence_task_befree_2175,,770958103,FALSE,finalized,5,8/15/15 1:20,"



",yes_direct,1,,D006514,"<span class=""chemical"">HBsAg</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","Cigarette smoking, heavy alcohol consumption, and <span class=""chemical"">HBsAg</span> were independently associated with increased risk of mortality from <span class=""disease"">hepatocellular carcinoma</span> but did not interact synergistically.",,15601641,15601641_D006514_D006528,15601641_10,bcv_sentence_task_befree_2176,,770958104,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,1,,D002794,"<span class=""chemical"">choline</span>",D002796,"<span class=""disease"">CHT/choline uptake transporter</span>","The capacity of the high-affinity <span class=""chemical""></span><span class=""disease"">choline</span> uptake transporter (<span class=""disease"">CHT</span>) to import <span class=""chemical"">choline</span> from the extracellular space to presynaptic terminals is essential for normal acetylcholine synthesis and therefore cholinergic transmission.",,15611726,15611726_D002794_D002796,15611726_2,bcv_sentence_task_befree_2177,,770958105,FALSE,finalized,5,8/15/15 1:12,"



",no_relation,1,,D000109,"<span class=""chemical"">acetylcholine</span>",D002796,"<span class=""disease"">CHT/choline uptake transporter</span>","The capacity of the high-affinity <span class=""disease"">choline uptake transporter</span> (<span class=""disease"">CHT</span>) to import choline from the extracellular space to presynaptic terminals is essential for normal <span class=""chemical"">acetylcholine</span> synthesis and therefore cholinergic transmission.",,15611726,15611726_D000109_D002796,15611726_2,bcv_sentence_task_befree_2178,,770958106,FALSE,finalized,5,8/14/15 21:59,"



",no_relation,0.8058,,D002045,"<span class=""chemical"">bupivacaine</span>",D010146,"<span class=""disease"">pain</span>","Median (25th, 75th centile) visual analog scale <span class=""disease"">pain</span> scores associated with drain removal in the <span class=""chemical"">bupivacaine</span>, Entonox, and morphine groups were 9.5 mm (3, 18 mm), 37.0 mm (13, 56 mm), and 15.0 mm (7, 27 mm), respectively.",,15616079,15616079_D002045_D010146,15616079_4,bcv_sentence_task_befree_2179,,770958107,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D010146,"<span class=""disease"">pain</span>","Median (25th, 75th centile) visual analog scale <span class=""disease"">pain</span> scores associated with drain removal in the bupivacaine, Entonox, and <span class=""chemical"">morphine</span> groups were 9.5 mm (3, 18 mm), 37.0 mm (13, 56 mm), and 15.0 mm (7, 27 mm), respectively.",,15616079,15616079_D009020_D010146,15616079_4,bcv_sentence_task_befree_2180,,770958108,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,0.8085,,D002045,"<span class=""chemical"">bupivacaine</span>",D010146,"<span class=""disease"">pain</span>","The <span class=""disease"">pain</span> scores were higher in the Entonox group compared with the <span class=""chemical"">bupivacaine</span> group (P=0.005) and the morphine group (P=0.047).",,15616079,15616079_D002045_D010146,15616079_5,bcv_sentence_task_befree_2181,,770958109,FALSE,finalized,5,8/14/15 21:15,"



",no_relation,0.8048,,D009020,"<span class=""chemical"">morphine</span>",D010146,"<span class=""disease"">pain</span>","The <span class=""disease"">pain</span> scores were higher in the Entonox group compared with the bupivacaine group (P=0.005) and the <span class=""chemical"">morphine</span> group (P=0.047).",,15616079,15616079_D009020_D010146,15616079_5,bcv_sentence_task_befree_2182,,770958110,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,0.7944,,D002045,"<span class=""chemical"">Bupivacaine</span>",D010146,"<span class=""disease"">pain</span>","<span class=""chemical"">Bupivacaine</span> and morphine, unlike Entonox, produce lower <span class=""disease"">pain</span> scores associated with drain removal.",,15616079,15616079_D002045_D010146,15616079_8,bcv_sentence_task_befree_2183,,770958111,FALSE,finalized,5,8/14/15 21:17,"



",no_relation,0.8033,,D009020,"<span class=""chemical"">morphine</span>",D010146,"<span class=""disease"">pain</span>","Bupivacaine and <span class=""chemical"">morphine</span>, unlike Entonox, produce lower <span class=""disease"">pain</span> scores associated with drain removal.",,15616079,15616079_D009020_D010146,15616079_8,bcv_sentence_task_befree_2184,,770958112,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,D009638,"<span class=""chemical"">norepinephrine</span>",D020210,"<span class=""disease"">Central hypercapnic chemosensitivity</span>","<span class=""disease"">Central hypercapnic chemosensitivity</span> and plasma <span class=""chemical"">norepinephrine</span> were measured in 99 patients with chronic heart failure.",,15632879,15632879_D009638_D020210,15632879_3,bcv_sentence_task_befree_2185,,770958113,FALSE,finalized,5,8/14/15 23:34,"



",no_relation,1,,D009638,"<span class=""chemical"">norepinephrine</span>",D007676,"<span class=""disease"">chronic heart failure</span>","Central hypercapnic chemosensitivity and plasma <span class=""chemical"">norepinephrine</span> were measured in 99 patients with <span class=""disease"">chronic heart failure</span>.",,15632879,15632879_D009638_D007676,15632879_3,bcv_sentence_task_befree_2186,,770958114,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,1,,D019821,"<span class=""chemical"">statins</span>",D003324,"<span class=""disease"">coronary artery disease</span>","Effects of tirofiban and <span class=""chemical"">statins</span> on high-sensitivity C-reactive protein, interleukin-6, and soluble CD40 ligand following percutaneous coronary interventions in patients with stable <span class=""disease"">coronary artery disease</span>.",,15642557,15642557_D019821_D003324,15642557_0,bcv_sentence_task_befree_2187,,770958115,FALSE,finalized,5,8/14/15 23:18,"



",no_relation,1,,D019821,"<span class=""chemical"">statins</span>",D003324,"<span class=""disease"">coronary artery disease</span>","This study assessed the effects of tirofiban and <span class=""chemical"">statins</span> on high-sensitivity C-reactive protein, interleukin-6, and soluble CD40 ligand after percutaneous coronary intervention in patients who had stable <span class=""disease"">coronary artery disease</span>.",,15642557,15642557_D019821_D003324,15642557_1,bcv_sentence_task_befree_2188,,770958116,FALSE,finalized,5,8/14/15 21:31,"



",no_relation,1,,C081643,"<span class=""chemical"">candesartan</span>",D006973,"<span class=""disease"">hypertension</span>","Controlled-release nifedipine and <span class=""chemical"">candesartan</span> low-dose combination therapy in patients with essential <span class=""disease"">hypertension</span>: the NICE Combi (Nifedipine and <span class=""chemical"">Candesartan</span> Combination) Study.",,15662234,15662234_C081643_D006973,15662234_0,bcv_sentence_task_befree_2189,,770958117,FALSE,finalized,5,8/15/15 2:09,"



",no_relation,1,,D009543,"<span class=""chemical"">nifedipine</span>",D006973,"<span class=""disease"">hypertension</span>","Controlled-release <span class=""chemical"">nifedipine</span> and candesartan low-dose combination therapy in patients with essential <span class=""disease"">hypertension</span>: the NICE Combi (<span class=""chemical"">Nifedipine</span> and Candesartan Combination) Study.",,15662234,15662234_D009543_D006973,15662234_0,bcv_sentence_task_befree_2190,,770958118,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,C081643,"<span class=""chemical"">candesartan</span>",D006973,"<span class=""disease"">hypertension</span>","Patients with essential <span class=""disease"">hypertension</span>, who did not achieve their target blood pressure with baseline treatment of <span class=""chemical"">candesartan</span> 8 mg/day for 8 weeks.",,15662234,15662234_C081643_D006973,15662234_4,bcv_sentence_task_befree_2191,,770958119,FALSE,finalized,5,8/15/15 1:32,"



",no_relation,1,,C081643,"<span class=""chemical"">candesartan</span>",D006973,"<span class=""disease"">hypertension</span>","These findings suggest that the low-dose combination therapy of nifedipine CR and <span class=""chemical"">candesartan</span> is superior to the up-titrated monotherapy of <span class=""chemical"">candesartan</span> in terms of blood pressure control and renal protection in patients with essential <span class=""disease"">hypertension</span>.",,15662234,15662234_C081643_D006973,15662234_9,bcv_sentence_task_befree_2192,,770958120,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,1,,D009543,"<span class=""chemical"">nifedipine</span>",D006973,"<span class=""disease"">hypertension</span>","These findings suggest that the low-dose combination therapy of <span class=""chemical"">nifedipine</span> CR and candesartan is superior to the up-titrated monotherapy of candesartan in terms of blood pressure control and renal protection in patients with essential <span class=""disease"">hypertension</span>.",,15662234,15662234_D009543_D006973,15662234_9,bcv_sentence_task_befree_2193,,770958121,FALSE,finalized,5,8/15/15 1:45,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D005909,"<span class=""disease"">glioblastoma</span>","Phase II study of temozolomide and <span class=""chemical"">cisplatin</span> as primary treatment prior to radiotherapy in newly diagnosed <span class=""disease"">glioblastoma</span> multiforme patients with measurable disease.",,15662978,15662978_D002945_D005909,15662978_0,bcv_sentence_task_befree_2194,,770958122,FALSE,finalized,5,8/14/15 22:14,"



",no_relation,1,,C047246,"<span class=""chemical"">temozolomide</span>",D005909,"<span class=""disease"">glioblastoma</span>","Phase II study of <span class=""chemical"">temozolomide</span> and cisplatin as primary treatment prior to radiotherapy in newly diagnosed <span class=""disease"">glioblastoma</span> multiforme patients with measurable disease.",,15662978,15662978_C047246_D005909,15662978_0,bcv_sentence_task_befree_2195,,770958123,FALSE,finalized,5,8/14/15 23:49,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D005909,"<span class=""disease"">glioblastoma</span>","This phase II study evaluates the activity of temozolomide and <span class=""chemical"">cisplatin</span> administered before radiation therapy in newly diagnosed <span class=""disease"">glioblastoma</span> multiforme patients, in terms of response, time to progression and survival.",,15662978,15662978_D002945_D005909,15662978_2,bcv_sentence_task_befree_2196,,770958124,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,C047246,"<span class=""chemical"">temozolomide</span>",D005909,"<span class=""disease"">glioblastoma</span>","This phase II study evaluates the activity of <span class=""chemical"">temozolomide</span> and cisplatin administered before radiation therapy in newly diagnosed <span class=""disease"">glioblastoma</span> multiforme patients, in terms of response, time to progression and survival.",,15662978,15662978_C047246_D005909,15662978_2,bcv_sentence_task_befree_2197,,770958125,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D065631,"<span class=""disease"">allergic rhinitis</span>","The effectiveness of intranasal <span class=""chemical"">corticosteroids</span> in combined <span class=""disease"">allergic rhinitis</span> and asthma syndrome.",,15663563,15663563_D000305_D065631,15663563_0,bcv_sentence_task_befree_2198,,770958126,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D001249,"<span class=""disease"">asthma syndrome</span>","The effectiveness of intranasal <span class=""chemical"">corticosteroids</span> in combined allergic rhinitis and <span class=""disease"">asthma syndrome</span>.",,15663563,15663563_D000305_D001249,15663563_0,bcv_sentence_task_befree_2199,,770958127,FALSE,finalized,5,8/14/15 22:40,"



",no_relation,1,,D005680,"<span class=""chemical"">GABA</span>",D001523,"<span class=""disease"">psychiatric</span>","The <span class=""chemical"">GABA</span> system is an active target for drugs to treat a variety of disorders and the availability of an indirect measure of central <span class=""chemical"">GABA</span> activity would not only enhance <span class=""disease"">psychiatric</span> research, but also permit assessment of the pharmacodynamic effects of drugs designed to act on this system.",,15672555,15672555_D005680_D001523,15672555_1,bcv_sentence_task_befree_2200,,770958128,FALSE,finalized,5,8/15/15 1:53,"



",no_relation,1,,D005680,"<span class=""chemical"">GABA</span>",D003072,"<span class=""disease"">cognitive impairments</span>","The relationships between plasma baseline pre-drug <span class=""chemical"">GABA</span> concentrations and <span class=""disease"">cognitive impairments</span> induced by an acute oral dose of lorazepam (0.5 and 1.0 mg) were investigated in 22 healthy elderly individuals.",,15672555,15672555_D005680_D003072,15672555_2,bcv_sentence_task_befree_2201,,770958129,FALSE,finalized,5,8/14/15 21:40,"



",yes_direct,1,,D008140,"<span class=""chemical"">lorazepam</span>",D003072,"<span class=""disease"">cognitive impairments</span>","The relationships between plasma baseline pre-drug GABA concentrations and <span class=""disease"">cognitive impairments</span> induced by an acute oral dose of <span class=""chemical"">lorazepam</span> (0.5 and 1.0 mg) were investigated in 22 healthy elderly individuals.",,15672555,15672555_D008140_D003072,15672555_2,bcv_sentence_task_befree_2202,,770958130,FALSE,finalized,5,8/14/15 23:03,"



",yes_direct,0.6175,,D001569,"<span class=""chemical"">benzodiazepine</span>",D064420,"<span class=""disease"">cognitive toxicity</span>","Plasma GABA concentration does not appear to be a useful marker of susceptibility to <span class=""chemical"">benzodiazepine</span>-induced <span class=""disease"">cognitive toxicity</span> in the elderly.",,15672555,15672555_D001569_D064420,15672555_4,bcv_sentence_task_befree_2203,,770958131,FALSE,finalized,5,8/14/15 23:04,"



",no_relation,0.8235,,D005680,"<span class=""chemical"">GABA</span>",D064420,"<span class=""disease"">cognitive toxicity</span>","Plasma <span class=""chemical"">GABA</span> concentration does not appear to be a useful marker of susceptibility to benzodiazepine-induced <span class=""disease"">cognitive toxicity</span> in the elderly.",,15672555,15672555_D005680_D064420,15672555_4,bcv_sentence_task_befree_2204,,770958132,FALSE,finalized,5,8/15/15 0:11,"



",no_relation,0.5813,,D008795,"<span class=""chemical"">metronidazole</span>",D012008,"<span class=""disease"">recurrent disease</span>","Vancomycin and <span class=""chemical"">metronidazole</span> have been used for treating Clostridium difficile-associated disease (CDAD) for the past 25 years, but approximately 20 % of patients develop <span class=""disease"">recurrent disease</span>.",,15673502,15673502_D008795_D012008,15673502_1,bcv_sentence_task_befree_2205,,770958133,FALSE,finalized,5,8/14/15 21:49,"



",yes_direct,1,,D014640,"<span class=""chemical"">Vancomycin</span>",D012008,"<span class=""disease"">recurrent disease</span>","<span class=""chemical"">Vancomycin</span> and metronidazole have been used for treating Clostridium difficile-associated disease (CDAD) for the past 25 years, but approximately 20 % of patients develop <span class=""disease"">recurrent disease</span>.",,15673502,15673502_D014640_D012008,15673502_1,bcv_sentence_task_befree_2206,,770958134,FALSE,finalized,5,8/15/15 1:10,"



",no_relation,1,,C465304,"<span class=""chemical"">argentatin A</span>",D009369,"<span class=""disease"">cancer</span>","Synthesis of <span class=""chemical"">argentatin A</span> derivatives as growth inhibitors of human <span class=""disease"">cancer</span> cell lines in vitro.",,15686901,15686901_C465304_D009369,15686901_0,bcv_sentence_task_befree_2207,,770958135,FALSE,finalized,5,8/14/15 22:17,"



",yes_direct,0.8096,,D046934,"<span class=""chemical"">ginkgolides</span>",D006470,"<span class=""disease"">bleeding complications</span>","Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by <span class=""chemical"">ginkgolides</span>: considerations on possible <span class=""disease"">bleeding complications</span> after oral intake of Ginkgo biloba extracts.",,15693702,15693702_D046934_D006470,15693702_0,bcv_sentence_task_befree_2208,,770958136,FALSE,finalized,5,8/15/15 1:22,"



",yes_indirect,0.4104,,D046934,"<span class=""chemical"">ginkgolides</span>",D006470,"<span class=""disease"">bleeding</span>","Although a clear causality between Ginkgo intake and <span class=""disease"">bleeding</span> could not be established, these observations have generally been explained by the platelet-activating factor (PAF)-antagonistic action of <span class=""chemical"">ginkgolides</span>, which represent characteristic constituents of Ginkgo extracts.",,15693702,15693702_D046934_D006470,15693702_4,bcv_sentence_task_befree_2209,,770958137,FALSE,finalized,5,8/14/15 21:03,"



",yes_direct,0.7996,,D046934,"<span class=""chemical"">ginkgolides</span>",D006470,"<span class=""disease"">hemorrhage</span>","These concentrations are generally more than 100 times higher as the peak plasma values measured after oral intake of EGb 761 at recommended doses between 120 and 240 mg. As PAF is a 'weak' platelet activator, which does not appear to be of importance for primary hemostasis, our results rise serious doubts that the PAF antagonistic effect of <span class=""chemical"">ginkgolides</span> could be responsible for <span class=""disease"">hemorrhage</span> in patients taking EGb 761.",,15693702,15693702_D046934_D006470,15693702_8,bcv_sentence_task_befree_2210,,770958138,FALSE,finalized,5,8/14/15 23:49,"



",no_relation,1,,D019829,"<span class=""chemical"">nevirapine/NVP</span>",D015658,"<span class=""disease"">HIV-infected</span>","Babies of <span class=""disease"">HIV-infected</span> women were randomised at birth to receive a single dose of <span class=""chemical"">nevirapine</span> (<span class=""chemical"">NVP</span>) alone or with zidovudine (ZDV) twice daily for a week.",,15720887,15720887_D019829_D015658,15720887_2,bcv_sentence_task_befree_2211,,770958139,FALSE,finalized,5,8/14/15 21:16,"



",no_relation,1,,D015215,"<span class=""chemical"">zidovudine/ZDV</span>",D015658,"<span class=""disease"">HIV-infected</span>","Babies of <span class=""disease"">HIV-infected</span> women were randomised at birth to receive a single dose of nevirapine (NVP) alone or with <span class=""chemical"">zidovudine</span> (<span class=""chemical"">ZDV</span>) twice daily for a week.",,15720887,15720887_D015215_D015658,15720887_2,bcv_sentence_task_befree_2212,,770958140,FALSE,finalized,5,8/14/15 21:07,"



",no_relation,0.7951,,D019829,"<span class=""chemical"">NVP</span>",D000740,"<span class=""disease"">anaemia</span>","Age-specific mean haemoglobin levels and prevalence of <span class=""disease"">anaemia</span> (haemoglobin < 10 g/dL) were not significantly different in cases where only the babies received a single dose of <span class=""chemical"">NVP</span> and cases where <span class=""chemical"">NVP</span> was given to mother/infant pairs or additional ZDV to the baby.",,15720887,15720887_D019829_D000740,15720887_7,bcv_sentence_task_befree_2213,,770958141,FALSE,finalized,5,8/14/15 23:29,"



",no_relation,1,,D015215,"<span class=""chemical"">ZDV</span>",D000740,"<span class=""disease"">anaemia</span>","Age-specific mean haemoglobin levels and prevalence of <span class=""disease"">anaemia</span> (haemoglobin < 10 g/dL) were not significantly different in cases where only the babies received a single dose of NVP and cases where NVP was given to mother/infant pairs or additional <span class=""chemical"">ZDV</span> to the baby.",,15720887,15720887_D015215_D000740,15720887_7,bcv_sentence_task_befree_2214,,770958142,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,0.803,,D002118,"<span class=""chemical"">Calcium</span>",D015663,"<span class=""disease"">postmenopausal bone loss</span>","<span class=""chemical"">Calcium</span> supplementation slows <span class=""disease"">postmenopausal bone loss</span> by inhibiting PTH secretion.",,15755853,15755853_D002118_D015663,15755853_2,bcv_sentence_task_befree_2215,,770958143,FALSE,finalized,5,8/15/15 0:46,"



",no_relation,1,,D019355,"<span class=""chemical"">calcium citrate</span>",D016301,"<span class=""disease"">bone loss</span>","This study explores whether combined treatment with potassium citrate and <span class=""chemical"">calcium citrate</span> is more effective than either agent alone in inhibiting <span class=""disease"">bone loss</span>.",,15755853,15755853_D019355_D016301,15755853_3,bcv_sentence_task_befree_2216,,770958144,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,1,,D019357,"<span class=""chemical"">potassium citrate</span>",D016301,"<span class=""disease"">bone loss</span>","This study explores whether combined treatment with <span class=""chemical"">potassium citrate</span> and calcium citrate is more effective than either agent alone in inhibiting <span class=""disease"">bone loss</span>.",,15755853,15755853_D019357_D016301,15755853_3,bcv_sentence_task_befree_2217,,770958145,FALSE,finalized,5,8/15/15 0:34,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D020250,"<span class=""disease"">PONV/postoperative nausea and vomiting</span>","The secondary outcomes were amplitude of knee flexion, <span class=""chemical"">morphine</span> consumption, and occurrence of <span class=""disease"">postoperative nausea and vomiting</span> (<span class=""disease"">PONV</span>).",,15765454,15765454_D009020_D020250,15765454_7,bcv_sentence_task_befree_2218,,770958146,FALSE,finalized,5,8/14/15 21:04,"



",no_relation,0.8122,,D009020,"<span class=""chemical"">morphine</span>",D020250,"<span class=""disease"">PONV</span>","The combined femoral and sciatic blocks decreased the <span class=""chemical"">morphine</span> consumption by 81% and significantly decreased the occurrence of <span class=""disease"">PONV</span>.",,15765454,15765454_D009020_D020250,15765454_10,bcv_sentence_task_befree_2219,,770958147,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D000699,"<span class=""disease"">analgesia</span>","During the 36 hours immediately after total knee replacement, the combination of continuous femoral and sciatic nerve blocks improves <span class=""disease"">analgesia</span> while decreasing <span class=""chemical"">morphine</span> consumption and PONV.",,15765454,15765454_D009020_D000699,15765454_11,bcv_sentence_task_befree_2220,,770958148,FALSE,finalized,5,8/15/15 1:39,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D020250,"<span class=""disease"">PONV</span>","During the 36 hours immediately after total knee replacement, the combination of continuous femoral and sciatic nerve blocks improves analgesia while decreasing <span class=""chemical"">morphine</span> consumption and <span class=""disease"">PONV</span>.",,15765454,15765454_D009020_D020250,15765454_11,bcv_sentence_task_befree_2221,,770958149,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,C089995,"<span class=""chemical"">Glatiramer acetate</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","<span class=""chemical"">Glatiramer acetate</span> (GLAT) is a well tolerated and safe immunomodulatory drug for the treatment of relapsing-remitting <span class=""disease"">multiple sclerosis</span>.",,15794402,15794402_C089995_D009103,15794402_1,bcv_sentence_task_befree_2222,,770958150,FALSE,finalized,5,8/14/15 21:36,"



Feel like this is not a complete sentence.",no_relation,1,,D014810,"<span class=""chemical"">vitamin E</span>",D001167,"<span class=""disease"">neuropathy</span>","Isolated <span class=""chemical"">vitamin E</span> deficiency with demyelinating <span class=""disease"">neuropathy</span>.",,15803482,15803482_D014810_D001167,15803482_0,bcv_sentence_task_befree_2223,,770958151,FALSE,finalized,5,8/14/15 21:36,"



",yes_direct,0.5876,,D010634,"<span class=""chemical"">phenobarbital</span>",D020754,"<span class=""disease"">spinocerebellar ataxia</span>","A 22-year-old man, with a past history of generalized tonic-clonic seizures treated with <span class=""chemical"">phenobarbital</span>, presented with <span class=""disease"">spinocerebellar ataxia</span>.",,15803482,15803482_D010634_D020754,15803482_1,bcv_sentence_task_befree_2224,,770958152,FALSE,finalized,5,8/14/15 22:08,"



",no_relation,0.8102,,D010634,"<span class=""chemical"">phenobarbital</span>",D012640,"<span class=""disease"">tonic-clonic seizures</span>","A 22-year-old man, with a past history of generalized <span class=""disease"">tonic-clonic seizures</span> treated with <span class=""chemical"">phenobarbital</span>, presented with spinocerebellar ataxia.",,15803482,15803482_D010634_D012640,15803482_1,bcv_sentence_task_befree_2225,,770958153,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,0.8201,,D014810,"<span class=""chemical"">Vitamin E</span>",D014811,"<span class=""disease"">Vitamin E deficiency</span>","<span class=""chemical""></span><span class=""disease"">Vitamin E</span> deficiency leading to a demyelinating neuropathy, as in the present case, suggests that the full spectrum of the disease entity is not fully defined.",,15803482,15803482_D014810_D014811,15803482_7,bcv_sentence_task_befree_2226,,770958154,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,0.8,,D014810,"<span class=""chemical"">Vitamin E</span>",D001167,"<span class=""disease"">neuropathy</span>","<span class=""chemical"">Vitamin E</span> deficiency leading to a demyelinating <span class=""disease"">neuropathy</span>, as in the present case, suggests that the full spectrum of the disease entity is not fully defined.",,15803482,15803482_D014810_D001167,15803482_7,bcv_sentence_task_befree_2227,,770958155,FALSE,finalized,5,8/14/15 21:30,"



",no_relation,0.8094,,D005947,"<span class=""chemical"">glucose</span>",D003929,"<span class=""disease"">diabetics</span>","A fuzzy logic based closed-loop control system for blood <span class=""chemical"">glucose</span> level regulation in <span class=""disease"">diabetics</span>.",,15804854,15804854_D005947_D003929,15804854_0,bcv_sentence_task_befree_2228,,770958156,FALSE,finalized,5,8/14/15 23:16,"


It's 'plasma glucose level' and not just 'Glucose'
",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003920,"<span class=""disease"">diabetes mellitus type</span>","In this study, a closed-loop system to control the plasma <span class=""chemical"">glucose</span> level in patients with <span class=""disease"">diabetes mellitus type</span> 1 is proposed.",,15804854,15804854_D005947_D003920,15804854_1,bcv_sentence_task_befree_2229,,770958157,FALSE,finalized,5,8/14/15 21:07,"



",no_relation,0.8158,,D005947,"<span class=""chemical"">glucose</span>",D003929,"<span class=""disease"">diabetic</span>","This control scheme is based on fuzzy logic control theory to maintain a normoglycaemic average of 4.5 mmol 1(-1) and the normal conditions for free plasma insulin concentration in severe initial state; in particular, when the <span class=""disease"">diabetic</span> patient is subjected to a <span class=""chemical"">glucose</span> meal disturbance or fluctuations in the measured <span class=""chemical"">glucose</span> level due to error in the measuring instrument.",,15804854,15804854_D005947_D003929,15804854_2,bcv_sentence_task_befree_2230,,770958158,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D000547,"<span class=""chemical"">Amantadine</span>",D006689,"<span class=""disease"">granulomatous disease</span>","<span class=""chemical"">Amantadine</span> in chronic <span class=""disease"">granulomatous disease</span>.",,15805000,15805000_D000547_D006689,15805000_0,bcv_sentence_task_befree_2231,,770958159,FALSE,finalized,5,8/15/15 1:00,"



",no_relation,1,,D000547,"<span class=""chemical"">amantadine</span>",D006105,"<span class=""disease"">CGD</span>","Because a weak base such as <span class=""chemical"">amantadine</span> could potentially reverse these pH abnormalities, the authors used this drug to treat 2 <span class=""disease"">CGD</span> patients.",,15805000,15805000_D000547_D006105,15805000_3,bcv_sentence_task_befree_2232,,770958160,FALSE,finalized,5,8/14/15 22:14,"



",no_relation,1,,D000547,"<span class=""chemical"">amantadine</span>",D006105,"<span class=""disease"">CGD</span>","Since the drug has been employed, the patients have not developed new infections, suggesting a role of <span class=""chemical"">amantadine</span> as a part of <span class=""disease"">CGD</span> prophylactic regimen.",,15805000,15805000_D000547_D006105,15805000_5,bcv_sentence_task_befree_2233,,770958161,FALSE,finalized,5,8/14/15 23:54,"



",no_relation,1,,D000547,"<span class=""chemical"">amantadine</span>",D007239,"<span class=""disease"">infections</span>","Since the drug has been employed, the patients have not developed new <span class=""disease"">infections</span>, suggesting a role of <span class=""chemical"">amantadine</span> as a part of CGD prophylactic regimen.",,15805000,15805000_D000547_D007239,15805000_5,bcv_sentence_task_befree_2234,,770958162,FALSE,finalized,5,8/15/15 1:19,"



",no_relation,1,,D008727,"<span class=""chemical"">methotrexate</span>",D001172,"<span class=""disease"">rheumatoid arthritis</span>","Evidence of radiographic benefit of treatment with infliximab plus <span class=""chemical"">methotrexate</span> in <span class=""disease"">rheumatoid arthritis</span> patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in <span class=""disease"">rheumatoid arthritis</span> with concomitant therapy study.",,15818697,15818697_D008727_D001172,15818697_0,bcv_sentence_task_befree_2235,,770958163,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,D008727,"<span class=""chemical"">methotrexate</span>",D009369,"<span class=""disease"">tumor</span>","Evidence of radiographic benefit of treatment with infliximab plus <span class=""chemical"">methotrexate</span> in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-<span class=""disease"">tumor</span> necrosis factor trial in rheumatoid arthritis with concomitant therapy study.",,15818697,15818697_D008727_D009369,15818697_0,bcv_sentence_task_befree_2236,,770958164,FALSE,finalized,5,8/15/15 0:30,"



",no_relation,1,,D008727,"<span class=""chemical"">methotrexate</span>",D009336,"<span class=""disease"">necrosis</span>","Evidence of radiographic benefit of treatment with infliximab plus <span class=""chemical"">methotrexate</span> in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor <span class=""disease"">necrosis</span> factor trial in rheumatoid arthritis with concomitant therapy study.",,15818697,15818697_D008727_D009336,15818697_0,bcv_sentence_task_befree_2237,,770958165,FALSE,finalized,5,8/14/15 23:09,"



",no_relation,1,,D008727,"<span class=""chemical"">methotrexate/MTX</span>",D001172,"<span class=""disease"">RA</span>","Changes from baseline to week 54 in clinical variables and measures of radiographic progression were compared between patients who received infliximab (3 mg/kg or 10 mg/kg every 4 or 8 weeks) plus <span class=""chemical"">methotrexate</span> (<span class=""chemical"">MTX</span>) and those who received <span class=""chemical"">MTX</span> plus placebo in the Anti-Tumor Necrosis Factor Trial in <span class=""disease"">RA</span> with Concomitant Therapy trial.",,15818697,15818697_D008727_D001172,15818697_2,bcv_sentence_task_befree_2238,,770958166,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,1,,D008727,"<span class=""chemical"">methotrexate/MTX</span>",D009369,"<span class=""disease"">Tumor</span>","Changes from baseline to week 54 in clinical variables and measures of radiographic progression were compared between patients who received infliximab (3 mg/kg or 10 mg/kg every 4 or 8 weeks) plus <span class=""chemical"">methotrexate</span> (<span class=""chemical"">MTX</span>) and those who received <span class=""chemical"">MTX</span> plus placebo in the Anti-<span class=""disease"">Tumor</span> Necrosis Factor Trial in RA with Concomitant Therapy trial.",,15818697,15818697_D008727_D009369,15818697_2,bcv_sentence_task_befree_2239,,770958167,FALSE,finalized,5,8/14/15 22:11,"



",no_relation,1,,C043211,"<span class=""chemical"">Carvedilol</span>",D006333,"<span class=""disease"">heart failure</span>","<span class=""chemical"">Carvedilol</span> reduces the costs of medical care in severe <span class=""disease"">heart failure</span>: an economic analysis of the COPERNICUS study applied to the United Kingdom.",,15820297,15820297_C043211_D006333,15820297_0,bcv_sentence_task_befree_2240,,770958168,FALSE,finalized,5,8/14/15 22:59,"



",no_relation,0.8218,,C043211,"<span class=""chemical"">carvedilol</span>",D007676,"<span class=""disease"">chronic heart failure/CHF</span>","The aim of this study was to determine the effects of <span class=""chemical"">carvedilol</span> on the costs related to the treatment of severe <span class=""disease"">chronic heart failure</span> (<span class=""disease"">CHF</span>).",,15820297,15820297_C043211_D007676,15820297_1,bcv_sentence_task_befree_2241,,770958169,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,C043211,"<span class=""chemical"">Carvedilol</span>",D006333,"<span class=""disease"">heart failure</span>","Costs for the treatment for <span class=""disease"">heart failure</span> within the National Health Service (NHS) in the United Kingdom (UK) were applied to resource utilisation data prospectively collected in all patients randomized into the <span class=""chemical"">Carvedilol</span> Prospective Randomized Cumulative Survival (COPERNICUS) Study.",,15820297,15820297_C043211_D006333,15820297_2,bcv_sentence_task_befree_2242,,770958170,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,C043211,"<span class=""chemical"">carvedilol</span>",D007676,"<span class=""disease"">CHF</span>","These findings suggest that not only can <span class=""chemical"">carvedilol</span> treatment increase survival and reduce hospital admissions in patients with severe <span class=""disease"">CHF</span> but that it can also cut costs in the process.",,15820297,15820297_C043211_D007676,15820297_11,bcv_sentence_task_befree_2243,,770958171,FALSE,finalized,5,8/15/15 1:29,"



",no_relation,1,,D013752,"<span class=""chemical"">tetracycline</span>",D009877,"<span class=""disease"">posttraumatic endophthalmitis</span>","We describe a case of <span class=""disease"">posttraumatic endophthalmitis</span> unresponsive to systemic (amoxicillin+clavulanic acid and piperacillin/tazobactam), intra-ocular (vancomycin) and topical (ofloxacin, <span class=""chemical"">tetracycline</span> and sulfametoxazole) antibiotic therapy.",,15834610,15834610_D013752_D009877,15834610_1,bcv_sentence_task_befree_2244,,770958172,FALSE,finalized,5,8/15/15 0:09,"



",no_relation,1,,D014640,"<span class=""chemical"">vancomycin</span>",D009877,"<span class=""disease"">posttraumatic endophthalmitis</span>","We describe a case of <span class=""disease"">posttraumatic endophthalmitis</span> unresponsive to systemic (amoxicillin+clavulanic acid and piperacillin/tazobactam), intra-ocular (<span class=""chemical"">vancomycin</span>) and topical (ofloxacin, tetracycline and sulfametoxazole) antibiotic therapy.",,15834610,15834610_D014640_D009877,15834610_1,bcv_sentence_task_befree_2245,,770958173,FALSE,finalized,5,8/15/15 1:14,"



",no_relation,1,,D015242,"<span class=""chemical"">ofloxacin</span>",D009877,"<span class=""disease"">posttraumatic endophthalmitis</span>","We describe a case of <span class=""disease"">posttraumatic endophthalmitis</span> unresponsive to systemic (amoxicillin+clavulanic acid and piperacillin/tazobactam), intra-ocular (vancomycin) and topical (<span class=""chemical"">ofloxacin</span>, tetracycline and sulfametoxazole) antibiotic therapy.",,15834610,15834610_D015242_D009877,15834610_1,bcv_sentence_task_befree_2246,,770958174,FALSE,finalized,5,8/15/15 1:31,"



",no_relation,1,,C043265,"<span class=""chemical"">tazobactam</span>",D009877,"<span class=""disease"">posttraumatic endophthalmitis</span>","We describe a case of <span class=""disease"">posttraumatic endophthalmitis</span> unresponsive to systemic (amoxicillin+clavulanic acid and piperacillin/<span class=""chemical"">tazobactam</span>), intra-ocular (vancomycin) and topical (ofloxacin, tetracycline and sulfametoxazole) antibiotic therapy.",,15834610,15834610_C043265_D009877,15834610_1,bcv_sentence_task_befree_2247,,770958175,FALSE,finalized,5,8/14/15 21:53,"



",no_relation,1,,D010878,"<span class=""chemical"">piperacillin</span>",D009877,"<span class=""disease"">posttraumatic endophthalmitis</span>","We describe a case of <span class=""disease"">posttraumatic endophthalmitis</span> unresponsive to systemic (amoxicillin+clavulanic acid and <span class=""chemical"">piperacillin</span>/tazobactam), intra-ocular (vancomycin) and topical (ofloxacin, tetracycline and sulfametoxazole) antibiotic therapy.",,15834610,15834610_D010878_D009877,15834610_1,bcv_sentence_task_befree_2248,,770958176,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,1,,D019980,"<span class=""chemical"">amoxicillin+clavulanic acid</span>",D009877,"<span class=""disease"">posttraumatic endophthalmitis</span>","We describe a case of <span class=""disease"">posttraumatic endophthalmitis</span> unresponsive to systemic (<span class=""chemical"">amoxicillin+clavulanic acid</span> and piperacillin/tazobactam), intra-ocular (vancomycin) and topical (ofloxacin, tetracycline and sulfametoxazole) antibiotic therapy.",,15834610,15834610_D019980_D009877,15834610_1,bcv_sentence_task_befree_2249,,770958177,FALSE,finalized,5,8/15/15 0:49,"



",no_relation,1,,D009569,"<span class=""chemical"">nitric oxide</span>",D006261,"<span class=""disease"">headache</span>","To classify the <span class=""disease"">headache</span> syndromes under treatment with calcineurin inhibitors and to investigate whether the latter influence the <span class=""chemical"">nitric oxide</span> production of human brain microvascular cells (HBMEC).",,15836594,15836594_D009569_D006261,15836594_1,bcv_sentence_task_befree_2250,,770958178,FALSE,finalized,5,8/15/15 0:15,"



",yes_direct,0.7967,,D016572,"<span class=""chemical"">cyclosporine</span>",D006261,"<span class=""disease"">headaches</span>","Single cases of <span class=""chemical"">cyclosporine</span>-induced <span class=""disease"">headaches</span> have been reported.",,15836594,15836594_D016572_D006261,15836594_2,bcv_sentence_task_befree_2251,,770958179,FALSE,finalized,5,8/15/15 0:28,"



",yes_direct,0.788,,D009569,"<span class=""chemical"">NO</span>",D018781,"<span class=""disease"">tension-type headache</span>","Since calcineurin inhibitors are known to influence the renal metabolism of <span class=""chemical"">NO</span>, a key molecule in <span class=""disease"">tension-type headache</span> and migraine, we were interested whether calcineurin inhibitors might change <span class=""chemical"">NO</span> metabolism in HBMEC as well.",,15836594,15836594_D009569_D018781,15836594_3,bcv_sentence_task_befree_2252,,770958180,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,1,,D009569,"<span class=""chemical"">NO</span>",D008881,"<span class=""disease"">migraine</span>","Since calcineurin inhibitors are known to influence the renal metabolism of <span class=""chemical"">NO</span>, a key molecule in tension-type headache and <span class=""disease"">migraine</span>, we were interested whether calcineurin inhibitors might change <span class=""chemical"">NO</span> metabolism in HBMEC as well.",,15836594,15836594_D009569_D008881,15836594_3,bcv_sentence_task_befree_2253,,770958181,FALSE,finalized,5,8/15/15 0:55,"



",yes_direct,0.6079,,D016559,"<span class=""chemical"">tacrolimus</span>",D006261,"<span class=""disease"">Headache</span>","<span class=""disease"">Headache</span> symptoms of 74 patients receiving cyclosporine and/or <span class=""chemical"">tacrolimus</span> for organ transplantation were retrospectively assessed.",,15836594,15836594_D016559_D006261,15836594_4,bcv_sentence_task_befree_2254,,770958182,FALSE,finalized,5,8/14/15 23:43,"



",yes_direct,1,,D016572,"<span class=""chemical"">cyclosporine</span>",D006261,"<span class=""disease"">Headache</span>","<span class=""disease"">Headache</span> symptoms of 74 patients receiving <span class=""chemical"">cyclosporine</span> and/or tacrolimus for organ transplantation were retrospectively assessed.",,15836594,15836594_D016572_D006261,15836594_4,bcv_sentence_task_befree_2255,,770958183,FALSE,finalized,5,8/14/15 21:20,"



",yes_direct,0.6207,,D009569,"<span class=""chemical"">NO</span>",D006261,"<span class=""disease"">headaches</span>","The pathophysiological mechanism of these <span class=""disease"">headaches</span> may be connected with an endothelial dysfunction in terms of increased production of <span class=""chemical"">NO</span>.",,15836594,15836594_D009569_D006261,15836594_9,bcv_sentence_task_befree_2256,,770958184,FALSE,finalized,5,8/15/15 2:16,"



",yes_direct,0.6037,,D009569,"<span class=""chemical"">NO</span>",C565156,"<span class=""disease"">endothelial dysfunction</span>","The pathophysiological mechanism of these headaches may be connected with an <span class=""disease"">endothelial dysfunction</span> in terms of increased production of <span class=""chemical"">NO</span>.",,15836594,15836594_D009569_C565156,15836594_9,bcv_sentence_task_befree_2257,,770958185,FALSE,finalized,5,8/14/15 21:58,"



",yes_direct,0.7903,,D004317,"<span class=""chemical"">doxorubicin</span>",D064420,"<span class=""disease"">toxicity</span>","Determining patient preferences for improved chemotoxicity during treatment for advanced bladder cancer Conventional treatment for advanced bladder cancer is methotrexate, vinblastine, <span class=""chemical"">doxorubicin</span> plus cisplatin (MVAC), with a median survival of 1 year but significant <span class=""disease"">toxicity</span>.",,15842461,15842461_D004317_D064420,15842461_1,bcv_sentence_task_befree_2258,,770958186,FALSE,finalized,5,8/14/15 23:02,"



",yes_direct,0.6145,,D002945,"<span class=""chemical"">cisplatin</span>",D064420,"<span class=""disease"">toxicity</span>","Determining patient preferences for improved chemotoxicity during treatment for advanced bladder cancer Conventional treatment for advanced bladder cancer is methotrexate, vinblastine, doxorubicin plus <span class=""chemical"">cisplatin</span> (MVAC), with a median survival of 1 year but significant <span class=""disease"">toxicity</span>.",,15842461,15842461_D002945_D064420,15842461_1,bcv_sentence_task_befree_2259,,770958187,FALSE,finalized,5,8/14/15 23:21,"


Used as treatment.
",no_relation,1,,D008727,"<span class=""chemical"">methotrexate</span>",D001749,"<span class=""disease"">bladder cancer</span>","Determining patient preferences for improved chemotoxicity during treatment for advanced <span class=""disease"">bladder cancer</span> Conventional treatment for advanced <span class=""disease"">bladder cancer</span> is <span class=""chemical"">methotrexate</span>, vinblastine, doxorubicin plus cisplatin (MVAC), with a median survival of 1 year but significant toxicity.",,15842461,15842461_D008727_D001749,15842461_1,bcv_sentence_task_befree_2260,,770958188,FALSE,finalized,5,8/14/15 21:12,"



",yes_direct,0.6045,,D014747,"<span class=""chemical"">vinblastine</span>",D064420,"<span class=""disease"">toxicity</span>","Determining patient preferences for improved chemotoxicity during treatment for advanced bladder cancer Conventional treatment for advanced bladder cancer is methotrexate, <span class=""chemical"">vinblastine</span>, doxorubicin plus cisplatin (MVAC), with a median survival of 1 year but significant <span class=""disease"">toxicity</span>.",,15842461,15842461_D014747_D064420,15842461_1,bcv_sentence_task_befree_2261,,770958189,FALSE,finalized,5,8/15/15 2:20,"



",no_relation,1,,D004317,"<span class=""chemical"">doxorubicin</span>",D001749,"<span class=""disease"">bladder cancer</span>","Determining patient preferences for improved chemotoxicity during treatment for advanced <span class=""disease"">bladder cancer</span> Conventional treatment for advanced <span class=""disease"">bladder cancer</span> is methotrexate, vinblastine, <span class=""chemical"">doxorubicin</span> plus cisplatin (MVAC), with a median survival of 1 year but significant toxicity.",,15842461,15842461_D004317_D001749,15842461_1,bcv_sentence_task_befree_2262,,770958190,FALSE,finalized,5,8/15/15 0:16,"



",yes_direct,0.8174,,D008727,"<span class=""chemical"">methotrexate</span>",D064420,"<span class=""disease"">toxicity</span>","Determining patient preferences for improved chemotoxicity during treatment for advanced bladder cancer Conventional treatment for advanced bladder cancer is <span class=""chemical"">methotrexate</span>, vinblastine, doxorubicin plus cisplatin (MVAC), with a median survival of 1 year but significant <span class=""disease"">toxicity</span>.",,15842461,15842461_D008727_D064420,15842461_1,bcv_sentence_task_befree_2263,,770958191,FALSE,finalized,5,8/15/15 0:02,"



",no_relation,1,,D014747,"<span class=""chemical"">vinblastine</span>",D001749,"<span class=""disease"">bladder cancer</span>","Determining patient preferences for improved chemotoxicity during treatment for advanced <span class=""disease"">bladder cancer</span> Conventional treatment for advanced <span class=""disease"">bladder cancer</span> is methotrexate, <span class=""chemical"">vinblastine</span>, doxorubicin plus cisplatin (MVAC), with a median survival of 1 year but significant toxicity.",,15842461,15842461_D014747_D001749,15842461_1,bcv_sentence_task_befree_2264,,770958192,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,0.8146,,D002945,"<span class=""chemical"">cisplatin</span>",D001749,"<span class=""disease"">bladder cancer</span>","Determining patient preferences for improved chemotoxicity during treatment for advanced <span class=""disease"">bladder cancer</span> Conventional treatment for advanced <span class=""disease"">bladder cancer</span> is methotrexate, vinblastine, doxorubicin plus <span class=""chemical"">cisplatin</span> (MVAC), with a median survival of 1 year but significant toxicity.",,15842461,15842461_D002945_D001749,15842461_1,bcv_sentence_task_befree_2265,,770958193,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,1,,C056507,"<span class=""chemical"">gemcitabine</span>",D064420,"<span class=""disease"">toxicity</span>","The newer combination of <span class=""chemical"">gemcitabine</span> plus cisplatin (GC) has demonstrated comparable survival and an improved <span class=""disease"">toxicity</span> profile (Von der Maase et al.",,15842461,15842461_C056507_D064420,15842461_2,bcv_sentence_task_befree_2266,,770958194,FALSE,finalized,5,8/14/15 23:24,"



",no_relation,0.5919,,D002945,"<span class=""chemical"">cisplatin</span>",D064420,"<span class=""disease"">toxicity</span>","The newer combination of gemcitabine plus <span class=""chemical"">cisplatin</span> (GC) has demonstrated comparable survival and an improved <span class=""disease"">toxicity</span> profile (Von der Maase et al.",,15842461,15842461_D002945_D064420,15842461_2,bcv_sentence_task_befree_2267,,770958195,FALSE,finalized,5,8/14/15 22:12,"



",no_relation,0.7968,,D009705,"<span class=""chemical"">nucleoside</span>",D054038,"<span class=""disease"">reverse transcriptase</span>","HIV-1 isolates harboring multiple <span class=""chemical"">nucleoside</span> <span class=""disease"">reverse transcriptase</span> inhibitor (NRTI) resistance mutations are more susceptible (""hypersusceptible"") to the nonnucleoside <span class=""disease"">reverse transcriptase</span> inhibitors (NNRTIs) than isolates lacking NRTI resistance mutations, but this has only been reported with a single-cycle replication phenotypic assay.",,15851917,15851917_D009705_D054038,15851917_1,bcv_sentence_task_befree_2268,,770958196,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,D019829,"<span class=""chemical"">Nevirapine</span>",D054038,"<span class=""disease"">RT</span>","<span class=""chemical"">Nevirapine</span> and efavirenz susceptibilities were tested and compared with a control wild-type virus or <span class=""disease"">RT</span>.",,15851917,15851917_D019829_D054038,15851917_6,bcv_sentence_task_befree_2269,,770958197,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,C098320,"<span class=""chemical"">efavirenz</span>",D054038,"<span class=""disease"">RT</span>","Nevirapine and <span class=""chemical"">efavirenz</span> susceptibilities were tested and compared with a control wild-type virus or <span class=""disease"">RT</span>.",,15851917,15851917_C098320_D054038,15851917_6,bcv_sentence_task_befree_2270,,770958198,FALSE,finalized,5,8/15/15 0:39,"



",no_relation,1,,D009271,"<span class=""chemical"">Naltrexone</span>",D000437,"<span class=""disease"">alcohol dependence</span>","<span class=""chemical"">Naltrexone</span> and disulfiram in patients with <span class=""disease"">alcohol dependence</span> and comorbid psychiatric disorders.",,15866552,15866552_D009271_D000437,15866552_0,bcv_sentence_task_befree_2271,,770958199,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D001523,"<span class=""disease"">psychiatric disorders</span>","Naltrexone and disulfiram in patients with <span class=""chemical"">alcohol</span> dependence and comorbid <span class=""disease"">psychiatric disorders</span>.",,15866552,15866552_D000431_D001523,15866552_0,bcv_sentence_task_befree_2272,,770958200,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,0.8055,,D009271,"<span class=""chemical"">Naltrexone</span>",D001523,"<span class=""disease"">psychiatric disorders</span>","<span class=""chemical"">Naltrexone</span> and disulfiram in patients with alcohol dependence and comorbid <span class=""disease"">psychiatric disorders</span>.",,15866552,15866552_D009271_D001523,15866552_0,bcv_sentence_task_befree_2273,,770958201,FALSE,finalized,5,8/15/15 1:19,"



",no_relation,0.8117,,D004221,"<span class=""chemical"">disulfiram</span>",D000437,"<span class=""disease"">alcohol dependence</span>","Naltrexone and <span class=""chemical"">disulfiram</span> in patients with <span class=""disease"">alcohol dependence</span> and comorbid psychiatric disorders.",,15866552,15866552_D004221_D000437,15866552_0,bcv_sentence_task_befree_2274,,770958202,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,0.8115,,D000431,"<span class=""chemical"">alcohol</span>",D000437,"<span class=""disease"">alcohol dependence</span>","Naltrexone and disulfiram in patients with <span class=""chemical""></span><span class=""disease"">alcohol</span> dependence and comorbid psychiatric disorders.",,15866552,15866552_D000431_D000437,15866552_0,bcv_sentence_task_befree_2275,,770958203,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,1,,D004221,"<span class=""chemical"">disulfiram</span>",D001523,"<span class=""disease"">psychiatric disorders</span>","Naltrexone and <span class=""chemical"">disulfiram</span> in patients with alcohol dependence and comorbid <span class=""disease"">psychiatric disorders</span>.",,15866552,15866552_D004221_D001523,15866552_0,bcv_sentence_task_befree_2276,,770958204,FALSE,finalized,5,8/14/15 21:23,"



",no_relation,1,,D009271,"<span class=""chemical"">naltrexone</span>",D000437,"<span class=""disease"">alcoholism</span>","Disulfiram and <span class=""chemical"">naltrexone</span> are approved by the Food and Drug Administration (FDA) for the treatment of <span class=""disease"">alcoholism</span>, but these agents have not been rigorously evaluated in dually diagnosed individuals.",,15866552,15866552_D009271_D000437,15866552_1,bcv_sentence_task_befree_2277,,770958205,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D004221,"<span class=""chemical"">Disulfiram</span>",D000437,"<span class=""disease"">alcoholism</span>","<span class=""chemical"">Disulfiram</span> and naltrexone are approved by the Food and Drug Administration (FDA) for the treatment of <span class=""disease"">alcoholism</span>, but these agents have not been rigorously evaluated in dually diagnosed individuals.",,15866552,15866552_D004221_D000437,15866552_1,bcv_sentence_task_befree_2278,,770958206,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,0.6076,,D000431,"<span class=""chemical"">alcohol</span>",D001523,"<span class=""disease"">psychiatric disorder</span>","Two-hundred and fifty-four patients with an Axis I <span class=""disease"">psychiatric disorder</span> and comorbid <span class=""chemical"">alcohol</span> dependence were treated for 12 weeks in an outpatient medication study conducted at three Veterans Administration outpatient clinics.",,15866552,15866552_D000431_D001523,15866552_2,bcv_sentence_task_befree_2279,,770958207,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,0.7945,,D000431,"<span class=""chemical"">alcohol</span>",D000437,"<span class=""disease"">alcohol dependence</span>","Two-hundred and fifty-four patients with an Axis I psychiatric disorder and comorbid <span class=""chemical""></span><span class=""disease"">alcohol</span> dependence were treated for 12 weeks in an outpatient medication study conducted at three Veterans Administration outpatient clinics.",,15866552,15866552_D000431_D000437,15866552_2,bcv_sentence_task_befree_2280,,770958208,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D001523,"<span class=""disease"">psychiatric symptoms</span>","Secondary outcomes included <span class=""disease"">psychiatric symptoms</span>, <span class=""chemical"">alcohol</span> craving, g-GGT levels and adverse events.",,15866552,15866552_D000431_D001523,15866552_6,bcv_sentence_task_befree_2281,,770958209,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",D012595,"<span class=""disease"">SSc</span>","At baseline, subjects had stable, moderately severe, diffuse <span class=""disease"">SSc</span> of disease duration < or = 5 years, modified Rodnan skin score > or = 20, serum <span class=""chemical"">creatinine</span> < 2.0 mg/dl, percentage forced vital capacity (% FVC) predicted > or = 50%, and % DLCO predicted > or = 40% and were not receiving concomitant disease modifying therapies.",,15868618,15868618_D003404_D012595,15868618_3,bcv_sentence_task_befree_2282,,770958210,FALSE,finalized,5,8/14/15 21:09,"



",no_relation,1,,D014747,"<span class=""chemical"">vinblastine</span>",D001749,"<span class=""disease"">bladder cancer</span>","Phase II study of radiochemotherapy with <span class=""chemical"">vinblastine</span> in invasive <span class=""disease"">bladder cancer</span>.",,15878100,15878100_D014747_D001749,15878100_0,bcv_sentence_task_befree_2283,,770958211,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,1,,D003000,"<span class=""chemical"">clonidine</span>",D065446,"<span class=""disease"">premenstrual dysphoric disorder</span>","Histories of sexual abuse are associated with differential effects of <span class=""chemical"">clonidine</span> on autonomic function in women with <span class=""disease"">premenstrual dysphoric disorder</span>.",,15925031,15925031_D003000_D065446,15925031_0,bcv_sentence_task_befree_2284,,770958212,FALSE,finalized,5,8/15/15 0:09,"


'Histories of sexual abuse' and not just 'sexual abuse'
",yes_direct,0.5957,,D003000,"<span class=""chemical"">clonidine</span>",D019966,"<span class=""disease"">sexual abuse</span>","Histories of <span class=""disease"">sexual abuse</span> are associated with differential effects of <span class=""chemical"">clonidine</span> on autonomic function in women with premenstrual dysphoric disorder.",,15925031,15925031_D003000_D019966,15925031_0,bcv_sentence_task_befree_2285,,770958213,FALSE,finalized,5,8/15/15 1:42,"



",no_relation,1,,D003000,"<span class=""chemical"">clonidine</span>",D065446,"<span class=""disease"">PMDD/premenstrual dysphoric disorder</span>","In women meeting strict criteria for <span class=""disease"">premenstrual dysphoric disorder</span> (<span class=""disease"">PMDD</span>), we examined whether <span class=""chemical"">clonidine</span>, an alpha2-adrenergic receptor (AR) agonist, would have different effects on sexually abused versus non-abused <span class=""disease"">PMDD</span> women for measures of autonomic nervous system function.",,15925031,15925031_D003000_D065446,15925031_1,bcv_sentence_task_befree_2286,,770958214,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,1,,D003000,"<span class=""chemical"">clonidine</span>",D065446,"<span class=""disease"">PMDD</span>","Twelve women meeting prospective, DSM-IV criteria for <span class=""disease"">PMDD</span>, five of whom had a history of sexual abuse, participated in a randomized, placebo-controlled, double-blind, cross-over design study, comparing 2 months of on oral <span class=""chemical"">clonidine</span> (0.3 mg/day) with 2 months on active placebo.",,15925031,15925031_D003000_D065446,15925031_2,bcv_sentence_task_befree_2287,,770958215,FALSE,finalized,5,8/15/15 2:16,"



",no_relation,0.827,,D003000,"<span class=""chemical"">clonidine</span>",D019966,"<span class=""disease"">sexual abuse</span>","Twelve women meeting prospective, DSM-IV criteria for PMDD, five of whom had a history of <span class=""disease"">sexual abuse</span>, participated in a randomized, placebo-controlled, double-blind, cross-over design study, comparing 2 months of on oral <span class=""chemical"">clonidine</span> (0.3 mg/day) with 2 months on active placebo.",,15925031,15925031_D003000_D019966,15925031_2,bcv_sentence_task_befree_2288,,770958216,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,D003000,"<span class=""chemical"">clonidine</span>",D065446,"<span class=""disease"">PMDD</span>","Results revealed that in comparison to placebo, <span class=""chemical"">clonidine</span> significantly reduced plasma norepinephrine concentrations, increased both beta1- and beta2-AR responsivity, and reduced resting and stress heart rate (HR) and blood pressure (BP) (p < 0.05) in all <span class=""disease"">PMDD</span> women.",,15925031,15925031_D003000_D065446,15925031_4,bcv_sentence_task_befree_2289,,770958217,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,D009638,"<span class=""chemical"">norepinephrine</span>",D007022,"<span class=""disease"">stress heart rate (HR) and blood pressure</span>","Results revealed that in comparison to placebo, clonidine significantly reduced plasma <span class=""chemical"">norepinephrine</span> concentrations, increased both beta1- and beta2-AR responsivity, and reduced resting and <span class=""disease"">stress heart rate (HR) and blood pressure</span> (BP) (p < 0.05) in all PMDD women.",,15925031,15925031_D009638_D007022,15925031_4,bcv_sentence_task_befree_2290,,770958218,FALSE,finalized,5,8/15/15 2:26,"



",no_relation,1,,D003000,"<span class=""chemical"">clonidine</span>",D007022,"<span class=""disease"">stress heart rate (HR) and blood pressure</span>","Results revealed that in comparison to placebo, <span class=""chemical"">clonidine</span> significantly reduced plasma norepinephrine concentrations, increased both beta1- and beta2-AR responsivity, and reduced resting and <span class=""disease"">stress heart rate (HR) and blood pressure</span> (BP) (p < 0.05) in all PMDD women.",,15925031,15925031_D003000_D007022,15925031_4,bcv_sentence_task_befree_2291,,770958219,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,1,,D009638,"<span class=""chemical"">norepinephrine</span>",D065446,"<span class=""disease"">PMDD</span>","Results revealed that in comparison to placebo, clonidine significantly reduced plasma <span class=""chemical"">norepinephrine</span> concentrations, increased both beta1- and beta2-AR responsivity, and reduced resting and stress heart rate (HR) and blood pressure (BP) (p < 0.05) in all <span class=""disease"">PMDD</span> women.",,15925031,15925031_D009638_D065446,15925031_4,bcv_sentence_task_befree_2292,,770958220,FALSE,finalized,5,8/14/15 22:24,"



",no_relation,1,,D003000,"<span class=""chemical"">clonidine</span>",D065446,"<span class=""disease"">PMDD</span>","With <span class=""chemical"">clonidine</span>, sexually abused <span class=""disease"">PMDD</span> women exhibited greater decreases in resting and stress-induced HR (p < 0.01) and stress-induced systolic BP (p < 0.05), while non-abused <span class=""disease"">PMDD</span> women exhibited greater reductions in plasma NE concentration (p = 0.07), and greater increases in beta2-AR responsivity (p < 0.05) than abused <span class=""disease"">PMDD</span> women.",,15925031,15925031_D003000_D065446,15925031_5,bcv_sentence_task_befree_2293,,770958221,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,D003000,"<span class=""chemical"">clonidine</span>",D065446,"<span class=""disease"">PMDD</span>","These results suggest <span class=""disease"">PMDD</span> women with and without a history of sexual abuse respond differently to a <span class=""chemical"">clonidine</span> challenge in measures reflecting autonomic nervous system functioning, indicating that abuse may modify presynaptic alpha2-AR function in <span class=""disease"">PMDD</span>.",,15925031,15925031_D003000_D065446,15925031_6,bcv_sentence_task_befree_2294,,770958222,FALSE,finalized,5,8/15/15 2:01,"



",no_relation,1,,D003000,"<span class=""chemical"">clonidine</span>",D019966,"<span class=""disease"">sexual abuse</span>","These results suggest PMDD women with and without a history of <span class=""disease"">sexual abuse</span> respond differently to a <span class=""chemical"">clonidine</span> challenge in measures reflecting autonomic nervous system functioning, indicating that abuse may modify presynaptic alpha2-AR function in PMDD.",,15925031,15925031_D003000_D019966,15925031_6,bcv_sentence_task_befree_2295,,770958223,FALSE,finalized,5,8/15/15 1:57,"



",no_relation,0.8288,,D005947,"<span class=""chemical"">glucose</span>",D003929,"<span class=""disease"">diabetic</span>","Two days of a very low calorie diet reduces endogenous <span class=""chemical"">glucose</span> production in obese type 2 <span class=""disease"">diabetic</span> patients despite the withdrawal of blood <span class=""chemical"">glucose</span>-lowering therapies including insulin.",,15931603,15931603_D005947_D003929,15931603_0,bcv_sentence_task_befree_2296,,770958224,FALSE,finalized,5,8/14/15 21:49,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D009765,"<span class=""disease"">obese</span>","Two days of a very low calorie diet reduces endogenous <span class=""chemical"">glucose</span> production in <span class=""disease"">obese</span> type 2 diabetic patients despite the withdrawal of blood <span class=""chemical"">glucose</span>-lowering therapies including insulin.",,15931603,15931603_D005947_D009765,15931603_0,bcv_sentence_task_befree_2297,,770958225,FALSE,finalized,5,8/15/15 1:19,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003929,"<span class=""disease"">diabetic</span>","The mechanism of the blood <span class=""chemical"">glucose</span>-lowering effect of a 2-day very low calorie diet (VLCD; 1890 kJ/d) in combination with the cessation of all blood <span class=""chemical"">glucose</span>-lowering agents was studied in 12 (7 women, 5 men) obese (body mass index, 36.3 +/- 1.0 kg/m 2 [mean +/- SEM]) type 2 <span class=""disease"">diabetic</span> patients (age, 55 +/- 4 years; HbA 1c , 7.3% +/- 0.4%) undergoing insulin therapy.",,15931603,15931603_D005947_D003929,15931603_1,bcv_sentence_task_befree_2298,,770958226,FALSE,finalized,5,8/14/15 22:01,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D009765,"<span class=""disease"">obese</span>","The mechanism of the blood <span class=""chemical"">glucose</span>-lowering effect of a 2-day very low calorie diet (VLCD; 1890 kJ/d) in combination with the cessation of all blood <span class=""chemical"">glucose</span>-lowering agents was studied in 12 (7 women, 5 men) <span class=""disease"">obese</span> (body mass index, 36.3 +/- 1.0 kg/m 2 [mean +/- SEM]) type 2 diabetic patients (age, 55 +/- 4 years; HbA 1c , 7.3% +/- 0.4%) undergoing insulin therapy.",,15931603,15931603_D005947_D009765,15931603_1,bcv_sentence_task_befree_2299,,770958227,FALSE,finalized,5,8/14/15 21:15,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D006946,"<span class=""disease"">hyperinsulinemia</span>","During <span class=""disease"">hyperinsulinemia</span>, EGP (5.5 +/- 0.8 to 5.2 +/- 0.5 mu mol/kg per minute), whole body <span class=""chemical"">glucose</span> disposal (12.1 +/- 0.7 to 11.3 +/- 1.0 mu mol/kg per minute), the metabolic clearance rate of <span class=""chemical"">glucose</span>, and the rate of lipolysis did not change after the 2-day intervention.",,15931603,15931603_D005947_D006946,15931603_6,bcv_sentence_task_befree_2300,,770958228,FALSE,finalized,5,8/14/15 23:22,"

No relationship found.

",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D006943,"<span class=""disease"">hyperglycemia</span>","Cessation of blood <span class=""chemical"">glucose</span>-lowering therapy in combination with a 2-day VLCD does not lead to <span class=""disease"">hyperglycemia</span> and is associated with a reduction in basal EGP.",,15931603,15931603_D005947_D006943,15931603_7,bcv_sentence_task_befree_2301,,770958229,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D007249,"<span class=""disease"">inflammatory</span>","Anti-<span class=""disease"">inflammatory</span> effect of selective <span class=""chemical"">estrogen</span> receptor modulators (SERMs) in microglial cells.",,15953991,15953991_D004967_D007249,15953991_0,bcv_sentence_task_befree_2302,,770958230,FALSE,finalized,5,8/14/15 22:55,"



",no_relation,1,,D004958,"<span class=""chemical"">17beta-estradiol</span>",D007249,"<span class=""disease"">inflammatory</span>","SERMs but not <span class=""chemical"">17beta-estradiol</span> induced a significant, concentration-dependent anti-<span class=""disease"">inflammatory</span> response both in rat primary microglial cells and in mouse N9 microglial cells.",,15953991,15953991_D004958_D007249,15953991_5,bcv_sentence_task_befree_2303,,770958231,FALSE,finalized,5,8/14/15 23:51,"


'anti' being the key term.
",no_relation,1,,D020849,"<span class=""chemical"">raloxifene</span>",D007249,"<span class=""disease"">inflammatory</span>","Our results show that tamoxifen, <span class=""chemical"">raloxifene</span> and ICI 182.780 induce an anti-<span class=""disease"">inflammatory</span> response in acute models of mouse and rat microglial cells.",,15953991,15953991_D020849_D007249,15953991_12,bcv_sentence_task_befree_2304,,770958232,FALSE,finalized,5,8/14/15 23:24,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D007249,"<span class=""disease"">inflammatory</span>","Our results show that <span class=""chemical"">tamoxifen</span>, raloxifene and ICI 182.780 induce an anti-<span class=""disease"">inflammatory</span> response in acute models of mouse and rat microglial cells.",,15953991,15953991_D013629_D007249,15953991_12,bcv_sentence_task_befree_2305,,770958233,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,0.6214,,C070081,"<span class=""chemical"">ICI 182.780</span>",D007249,"<span class=""disease"">inflammatory</span>","Our results show that tamoxifen, raloxifene and <span class=""chemical"">ICI 182.780</span> induce an anti-<span class=""disease"">inflammatory</span> response in acute models of mouse and rat microglial cells.",,15953991,15953991_C070081_D007249,15953991_12,bcv_sentence_task_befree_2306,,770958234,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D007249,"<span class=""disease"">inflammatory</span>","It seems that this response is not <span class=""chemical"">estrogen</span> receptor-mediated but, probably, is attributable to some SERM-induced modulation of LPS-activated pro-<span class=""disease"">inflammatory</span> signalling cascades.",,15953991,15953991_D004967_D007249,15953991_13,bcv_sentence_task_befree_2307,,770958235,FALSE,finalized,5,8/15/15 0:23,"



",no_relation,1,,D009569,"<span class=""chemical"">Nitric oxide</span>",D000544,"<span class=""disease"">Alzheimer's disease</span>","<span class=""chemical"">Nitric oxide</span> mimetic molecules as therapeutic agents in <span class=""disease"">Alzheimer's disease</span>.",,15974915,15974915_D009569_D000544,15974915_0,bcv_sentence_task_befree_2308,,770958236,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,1,,D009569,"<span class=""chemical"">NO</span>",D003704,"<span class=""disease"">dementia</span>","Small molecules that mimic the biological activity of <span class=""chemical"">NO</span>, <span class=""chemical"">NO</span> mimetics, will bypass cholinergic receptor activation and are anticipated to provide multiple pathways of treating and circumventing <span class=""disease"">dementia</span> in Alzheimer's disease.",,15974915,15974915_D009569_D003704,15974915_2,bcv_sentence_task_befree_2309,,770958237,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,1,,D009569,"<span class=""chemical"">NO</span>",D000544,"<span class=""disease"">Alzheimer's disease</span>","Small molecules that mimic the biological activity of <span class=""chemical"">NO</span>, <span class=""chemical"">NO</span> mimetics, will bypass cholinergic receptor activation and are anticipated to provide multiple pathways of treating and circumventing dementia in <span class=""disease"">Alzheimer's disease</span>.",,15974915,15974915_D009569_D000544,15974915_2,bcv_sentence_task_befree_2310,,770958238,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D009569,"<span class=""chemical"">NO</span>",D003704,"<span class=""disease"">dementia</span>","Substantial evidence suggests that <span class=""chemical"">NO</span> mimetics may display cGMP-dependent and cGMP-independent activity and may operate via multiple biochemical signaling pathways, both to ensure the survival of neurons subjected to stress and also to provide cognition-enabling pathways to circumvent <span class=""disease"">dementia</span>.",,15974915,15974915_D009569_D003704,15974915_4,bcv_sentence_task_befree_2311,,770958239,FALSE,finalized,5,8/15/15 0:30,"



",no_relation,1,,D011092,"<span class=""chemical"">polyethylene glycol</span>",C531816,"<span class=""disease"">ADA deficiency/adenosine deaminase/ADA</span>","<span class=""chemical"">polyethylene glycol</span>-conjugated <span class=""disease"">adenosine deaminase</span> (<span class=""disease"">ADA</span>) therapy provides temporary immune reconstitution to a child with delayed-onset <span class=""disease"">ADA deficiency</span>.",,16002636,16002636_D011092_C531816,16002636_0,bcv_sentence_task_befree_2312,,770958240,FALSE,finalized,5,8/15/15 1:40,"



",no_relation,1,,D000241,"<span class=""chemical"">adenosine</span>",C531816,"<span class=""disease"">ADA deficiency/adenosine deaminase/ADA</span>","polyethylene glycol-conjugated <span class=""chemical""></span><span class=""disease"">adenosine</span> deaminase (<span class=""disease"">ADA</span>) therapy provides temporary immune reconstitution to a child with delayed-onset <span class=""disease"">ADA deficiency</span>.",,16002636,16002636_D000241_C531816,16002636_0,bcv_sentence_task_befree_2313,,770958241,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,D011092,"<span class=""chemical"">polyethylene glycol</span>",C531816,"<span class=""disease"">ADA deficiency/adenosine deaminase/ADA</span>","We describe the effects of <span class=""chemical"">polyethylene glycol</span>-conjugated <span class=""disease"">adenosine deaminase</span> (<span class=""disease"">ADA</span>) replacement therapy on lymphocyte counts, activation, apoptosis, proliferation, and cytokine secretion in a 14-month-old girl with ""delayed-onset"" <span class=""disease"">ADA deficiency</span> and marked immunodysregulation.",,16002636,16002636_D011092_C531816,16002636_1,bcv_sentence_task_befree_2314,,770958242,FALSE,finalized,5,8/15/15 0:08,"



",no_relation,1,,D000241,"<span class=""chemical"">adenosine</span>",C531816,"<span class=""disease"">ADA deficiency/adenosine deaminase/ADA</span>","We describe the effects of polyethylene glycol-conjugated <span class=""chemical""></span><span class=""disease"">adenosine</span> deaminase (<span class=""disease"">ADA</span>) replacement therapy on lymphocyte counts, activation, apoptosis, proliferation, and cytokine secretion in a 14-month-old girl with ""delayed-onset"" <span class=""disease"">ADA deficiency</span> and marked immunodysregulation.",,16002636,16002636_D000241_C531816,16002636_1,bcv_sentence_task_befree_2315,,770958243,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,0.5815,,C056507,"<span class=""chemical"">gemcitabine</span>",D006463,"<span class=""disease"">Hemolytic-uremic syndrome</span>","<span class=""disease"">Hemolytic-uremic syndrome</span> associated with <span class=""chemical"">gemcitabine</span>: a case report and review of literature.",,16006690,16006690_C056507_D006463,16006690_0,bcv_sentence_task_befree_2316,,770958244,FALSE,finalized,5,8/14/15 21:04,"



",yes_direct,0.8173,,D016685,"<span class=""chemical"">mitomycin</span>",D006463,"<span class=""disease"">Hemolytic uremic syndrome</span>","<span class=""disease"">Hemolytic uremic syndrome</span> may be associated with a variety of etiologies, and chemotherapeutic agents have also been reported to be associated with <span class=""disease"">hemolytic uremic syndrome</span>, including <span class=""chemical"">mitomycin</span>, cisplatin, bleomycin, and most recently gemcitabine.",,16006690,16006690_D016685_D006463,16006690_2,bcv_sentence_task_befree_2317,,770958245,FALSE,finalized,5,8/14/15 22:05,"



",yes_direct,0.8248,,D002945,"<span class=""chemical"">cisplatin</span>",D006463,"<span class=""disease"">Hemolytic uremic syndrome</span>","<span class=""disease"">Hemolytic uremic syndrome</span> may be associated with a variety of etiologies, and chemotherapeutic agents have also been reported to be associated with <span class=""disease"">hemolytic uremic syndrome</span>, including mitomycin, <span class=""chemical"">cisplatin</span>, bleomycin, and most recently gemcitabine.",,16006690,16006690_D002945_D006463,16006690_2,bcv_sentence_task_befree_2318,,770958246,FALSE,finalized,5,8/14/15 23:32,"



",yes_direct,1,,D001761,"<span class=""chemical"">bleomycin</span>",D006463,"<span class=""disease"">Hemolytic uremic syndrome</span>","<span class=""disease"">Hemolytic uremic syndrome</span> may be associated with a variety of etiologies, and chemotherapeutic agents have also been reported to be associated with <span class=""disease"">hemolytic uremic syndrome</span>, including mitomycin, cisplatin, <span class=""chemical"">bleomycin</span>, and most recently gemcitabine.",,16006690,16006690_D001761_D006463,16006690_2,bcv_sentence_task_befree_2319,,770958247,FALSE,finalized,5,8/14/15 23:01,"



",yes_direct,0.8075,,C056507,"<span class=""chemical"">gemcitabine</span>",D006463,"<span class=""disease"">Hemolytic uremic syndrome</span>","<span class=""disease"">Hemolytic uremic syndrome</span> may be associated with a variety of etiologies, and chemotherapeutic agents have also been reported to be associated with <span class=""disease"">hemolytic uremic syndrome</span>, including mitomycin, cisplatin, bleomycin, and most recently <span class=""chemical"">gemcitabine</span>.",,16006690,16006690_C056507_D006463,16006690_2,bcv_sentence_task_befree_2320,,770958248,FALSE,finalized,5,8/14/15 23:31,"



",yes_direct,0.7967,,C056507,"<span class=""chemical"">gemcitabine</span>",D006463,"<span class=""disease"">hemolytic uremic syndrome</span>","A 72-year-old Caucasian male treated with four cycles of <span class=""chemical"">gemcitabine</span> at 1,000 mg/m2 developed clinical and laboratory findings compatible with <span class=""disease"">hemolytic uremic syndrome</span>.",,16006690,16006690_C056507_D006463,16006690_3,bcv_sentence_task_befree_2321,,770958249,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,0.5973,,C056507,"<span class=""chemical"">gemcitabine</span>",D006463,"<span class=""disease"">hemolytic uremic syndrome</span>","With multiple reports of <span class=""disease"">hemolytic uremic syndrome</span> complicating <span class=""chemical"">gemcitabine</span> therapy, it is imperative that clinicians heighten their awareness of this potentially lethal complication.",,16006690,16006690_C056507_D006463,16006690_6,bcv_sentence_task_befree_2322,,770958250,FALSE,finalized,5,8/14/15 22:29,"



",yes_direct,0.8125,,D000070,"<span class=""chemical"">Acebutolol</span>",D008178,"<span class=""disease"">cutaneous lupus erythematosus</span>","<span class=""chemical"">Acebutolol</span>-induced subacute <span class=""disease"">cutaneous lupus erythematosus</span>.",,16015021,16015021_D000070_D008178,16015021_0,bcv_sentence_task_befree_2323,,770958251,FALSE,finalized,5,8/15/15 1:59,"



",yes_direct,0.8168,,D000070,"<span class=""chemical"">acebutolol</span>",D008178,"<span class=""disease"">SCLE</span>","We present herein the first case of <span class=""disease"">SCLE</span> induced by <span class=""chemical"">acebutolol</span>.",,16015021,16015021_D000070_D008178,16015021_2,bcv_sentence_task_befree_2324,,770958252,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,D000070,"<span class=""chemical"">acebutolol</span>",D006973,"<span class=""disease"">hypertension</span>","One month ago, the patient had started a treatment with oral <span class=""chemical"">acebutolol</span> to cure a <span class=""disease"">hypertension</span> of 1-year evolution.",,16015021,16015021_D000070_D006973,16015021_4,bcv_sentence_task_befree_2325,,770958253,FALSE,finalized,5,8/15/15 1:35,"



",yes_direct,1,,D000070,"<span class=""chemical"">acebutolol</span>",C536397,"<span class=""disease"">lupus syndrome</span>","Literature data, along with our case, suggest a link between <span class=""chemical"">acebutolol</span> therapy and the onset of a <span class=""disease"">lupus syndrome</span>.",,16015021,16015021_D000070_C536397,16015021_8,bcv_sentence_task_befree_2326,,770958254,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,0.8011,,D000070,"<span class=""chemical"">acebutolol</span>",D008180,"<span class=""disease"">lupus erythematosus</span>","Although this is the first report of <span class=""chemical"">acebutolol</span>-induced SCLE, we should be aware of this occurrence, and avoidance of <span class=""chemical"">acebutolol</span> is recommended in patients with stigmata of <span class=""disease"">lupus erythematosus</span>.",,16015021,16015021_D000070_D008180,16015021_9,bcv_sentence_task_befree_2327,,770958255,FALSE,finalized,5,8/14/15 22:28,"



",yes_direct,1,,D000070,"<span class=""chemical"">acebutolol</span>",D008178,"<span class=""disease"">SCLE</span>","Although this is the first report of <span class=""chemical"">acebutolol</span>-induced <span class=""disease"">SCLE</span>, we should be aware of this occurrence, and avoidance of <span class=""chemical"">acebutolol</span> is recommended in patients with stigmata of lupus erythematosus.",,16015021,16015021_D000070_D008178,16015021_9,bcv_sentence_task_befree_2328,,770958256,FALSE,finalized,5,8/15/15 0:02,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogens</span>",D014947,"<span class=""disease"">traumatic injuries</span>","For the most part, in almost all work on HT, <span class=""chemical"">estrogens</span> have been given the primary focus despite the fact that progesterone has important properties that can enhance the repair of neurodegenerative and <span class=""disease"">traumatic injuries</span> to the central nervous system.",,16024758,16024758_D004967_D014947,16024758_4,bcv_sentence_task_befree_2329,,770958257,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogens</span>",D016609,"<span class=""disease"">HT</span>","For the most part, in almost all work on <span class=""disease"">HT</span>, <span class=""chemical"">estrogens</span> have been given the primary focus despite the fact that progesterone has important properties that can enhance the repair of neurodegenerative and traumatic injuries to the central nervous system.",,16024758,16024758_D004967_D016609,16024758_4,bcv_sentence_task_befree_2330,,770958258,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,1,,D011374,"<span class=""chemical"">progesterone</span>",D014947,"<span class=""disease"">traumatic injuries</span>","For the most part, in almost all work on HT, estrogens have been given the primary focus despite the fact that <span class=""chemical"">progesterone</span> has important properties that can enhance the repair of neurodegenerative and <span class=""disease"">traumatic injuries</span> to the central nervous system.",,16024758,16024758_D011374_D014947,16024758_4,bcv_sentence_task_befree_2331,,770958259,FALSE,finalized,5,8/14/15 22:08,"



",no_relation,1,,D011374,"<span class=""chemical"">progesterone</span>",D016609,"<span class=""disease"">HT</span>","For the most part, in almost all work on <span class=""disease"">HT</span>, estrogens have been given the primary focus despite the fact that <span class=""chemical"">progesterone</span> has important properties that can enhance the repair of neurodegenerative and traumatic injuries to the central nervous system.",,16024758,16024758_D011374_D016609,16024758_4,bcv_sentence_task_befree_2332,,770958260,FALSE,finalized,5,8/14/15 21:57,"



",no_relation,0.7978,,D011374,"<span class=""chemical"">progesterone</span>",D016609,"<span class=""disease"">HT</span>","This article reviews some of those properties and discusses the evidence suggesting that, if <span class=""disease"">HT</span> is to be reconsidered, <span class=""chemical"">progesterone</span> should be given more attention as a potent neurotrophic agent that may play an important role in reducing or preventing motor, cognitive, and sensory impairments that can accompany senescence in both males and females.",,16024758,16024758_D011374_D016609,16024758_5,bcv_sentence_task_befree_2333,,770958261,FALSE,finalized,5,8/14/15 23:58,"



",no_relation,1,,D011374,"<span class=""chemical"">progesterone</span>",D034381,"<span class=""disease"">sensory impairments</span>","This article reviews some of those properties and discusses the evidence suggesting that, if HT is to be reconsidered, <span class=""chemical"">progesterone</span> should be given more attention as a potent neurotrophic agent that may play an important role in reducing or preventing motor, cognitive, and <span class=""disease"">sensory impairments</span> that can accompany senescence in both males and females.",,16024758,16024758_D011374_D034381,16024758_5,bcv_sentence_task_befree_2334,,770958262,FALSE,finalized,5,8/15/15 2:32,"



",no_relation,1,,C008047,"<span class=""chemical"">3-hydroxy-3-methylglutaryl coenzyme A</span>",D009369,"<span class=""disease"">rectal cancer</span>","To assess whether <span class=""chemical"">3-hydroxy-3-methylglutaryl coenzyme A</span> reductase inhibitors, or statins, might enhance the efficacy of neoadjuvant chemoradiation in <span class=""disease"">rectal cancer</span>.",,16029794,16029794_C008047_D009369,16029794_1,bcv_sentence_task_befree_2335,,770958263,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,D002045,"<span class=""chemical"">bupivacaine</span>",D010146,"<span class=""disease"">pain</span>","To evaluate the efficacy of intraoperative infusion of <span class=""chemical"">bupivacaine</span> solution for the relief of <span class=""disease"">pain</span> after operative gynecologic laparoscopy.",,16036193,16036193_D002045_D010146,16036193_1,bcv_sentence_task_befree_2336,,770958264,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,1,,D002045,"<span class=""chemical"">bupivacaine</span>",D015746,"<span class=""disease"">AVP</span>","Intraperitoneal <span class=""chemical"">bupivacaine</span> administration both immediately after placement of trocars and at the end of surgery was found to be effective in reducing the intensity of <span class=""disease"">AVP</span> but not in reducing STP, APP, or postoperative analgesia consumption after nonadvanced gynecologic laparoscopic procedures.",,16036193,16036193_D002045_D015746,16036193_13,bcv_sentence_task_befree_2337,,770958265,FALSE,finalized,5,8/14/15 21:18,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D009369,"<span class=""disease"">delirious cancer</span>","Opioid rotation from <span class=""chemical"">morphine</span> to fentanyl in <span class=""disease"">delirious cancer</span> patients: an open-label trial.",,16043013,16043013_D009020_D009369,16043013_0,bcv_sentence_task_befree_2338,,770958266,FALSE,finalized,5,8/15/15 1:45,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D009369,"<span class=""disease"">delirious cancer</span>","Opioid rotation from morphine to <span class=""chemical"">fentanyl</span> in <span class=""disease"">delirious cancer</span> patients: an open-label trial.",,16043013,16043013_D005283_D009369,16043013_0,bcv_sentence_task_befree_2339,,770958267,FALSE,finalized,5,8/14/15 21:02,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D009759,"<span class=""disease"">opioid rotation</span>","Although recent studies suggest that <span class=""disease"">opioid rotation</span> could be an effective treatment strategy for morphine-induced delirium, there have been no prospective studies to investigate the treatment effects of <span class=""disease"">opioid rotation</span> using <span class=""chemical"">fentanyl</span>.",,16043013,16043013_D005283_D009759,16043013_1,bcv_sentence_task_befree_2340,,770958268,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D003693,"<span class=""disease"">delirium</span>","Although recent studies suggest that opioid rotation could be an effective treatment strategy for morphine-induced <span class=""disease"">delirium</span>, there have been no prospective studies to investigate the treatment effects of opioid rotation using <span class=""chemical"">fentanyl</span>.",,16043013,16043013_D005283_D003693,16043013_1,bcv_sentence_task_befree_2341,,770958269,FALSE,finalized,5,8/14/15 21:29,"



",yes_direct,0.6005,,D009020,"<span class=""chemical"">morphine</span>",D003693,"<span class=""disease"">delirium</span>","Although recent studies suggest that opioid rotation could be an effective treatment strategy for <span class=""chemical"">morphine</span>-induced <span class=""disease"">delirium</span>, there have been no prospective studies to investigate the treatment effects of opioid rotation using fentanyl.",,16043013,16043013_D009020_D003693,16043013_1,bcv_sentence_task_befree_2342,,770958270,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D009759,"<span class=""disease"">opioid rotation</span>","Although recent studies suggest that <span class=""disease"">opioid rotation</span> could be an effective treatment strategy for <span class=""chemical"">morphine</span>-induced delirium, there have been no prospective studies to investigate the treatment effects of <span class=""disease"">opioid rotation</span> using fentanyl.",,16043013,16043013_D009020_D009759,16043013_1,bcv_sentence_task_befree_2343,,770958271,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D009759,"<span class=""disease"">opioid rotation</span>","The primary aim of this study was to clarify the efficacy of <span class=""disease"">opioid rotation</span> from morphine to <span class=""chemical"">fentanyl</span> in symptom palliation of morphine-induced delirium.",,16043013,16043013_D005283_D009759,16043013_2,bcv_sentence_task_befree_2344,,770958272,FALSE,finalized,5,8/14/15 23:21,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D003693,"<span class=""disease"">delirium</span>","The primary aim of this study was to clarify the efficacy of opioid rotation from morphine to <span class=""chemical"">fentanyl</span> in symptom palliation of morphine-induced <span class=""disease"">delirium</span>.",,16043013,16043013_D005283_D003693,16043013_2,bcv_sentence_task_befree_2345,,770958273,FALSE,finalized,5,8/14/15 22:30,"



",yes_direct,1,,D009020,"<span class=""chemical"">morphine</span>",D003693,"<span class=""disease"">delirium</span>","The primary aim of this study was to clarify the efficacy of opioid rotation from <span class=""chemical"">morphine</span> to fentanyl in symptom palliation of <span class=""chemical"">morphine</span>-induced <span class=""disease"">delirium</span>.",,16043013,16043013_D009020_D003693,16043013_2,bcv_sentence_task_befree_2346,,770958274,FALSE,finalized,5,8/14/15 21:01,"



",no_relation,0.795,,D009020,"<span class=""chemical"">morphine</span>",D009759,"<span class=""disease"">opioid rotation</span>","The primary aim of this study was to clarify the efficacy of <span class=""disease"">opioid rotation</span> from <span class=""chemical"">morphine</span> to fentanyl in symptom palliation of <span class=""chemical"">morphine</span>-induced delirium.",,16043013,16043013_D009020_D009759,16043013_2,bcv_sentence_task_befree_2347,,770958275,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D009369,"<span class=""disease"">cancer</span>","Twenty-one consecutive <span class=""disease"">cancer</span> patients with <span class=""chemical"">morphine</span>-induced delirium underwent opioid rotation to fentanyl.",,16043013,16043013_D009020_D009369,16043013_3,bcv_sentence_task_befree_2348,,770958276,FALSE,finalized,5,8/15/15 0:57,"



",no_relation,0.8375,,D005283,"<span class=""chemical"">fentanyl</span>",D003693,"<span class=""disease"">delirium</span>","Twenty-one consecutive cancer patients with morphine-induced <span class=""disease"">delirium</span> underwent opioid rotation to <span class=""chemical"">fentanyl</span>.",,16043013,16043013_D005283_D003693,16043013_3,bcv_sentence_task_befree_2349,,770958277,FALSE,finalized,5,8/14/15 21:25,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D009369,"<span class=""disease"">cancer</span>","Twenty-one consecutive <span class=""disease"">cancer</span> patients with morphine-induced delirium underwent opioid rotation to <span class=""chemical"">fentanyl</span>.",,16043013,16043013_D005283_D009369,16043013_3,bcv_sentence_task_befree_2350,,770958278,FALSE,finalized,5,8/14/15 23:29,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D009759,"<span class=""disease"">opioid rotation</span>","Twenty-one consecutive cancer patients with morphine-induced delirium underwent <span class=""disease"">opioid rotation</span> to <span class=""chemical"">fentanyl</span>.",,16043013,16043013_D005283_D009759,16043013_3,bcv_sentence_task_befree_2351,,770958279,FALSE,finalized,5,8/15/15 0:02,"



",yes_direct,0.8073,,D009020,"<span class=""chemical"">morphine</span>",D003693,"<span class=""disease"">delirium</span>","Twenty-one consecutive cancer patients with <span class=""chemical"">morphine</span>-induced <span class=""disease"">delirium</span> underwent opioid rotation to fentanyl.",,16043013,16043013_D009020_D003693,16043013_3,bcv_sentence_task_befree_2352,,770958280,FALSE,finalized,5,8/15/15 1:51,"



",yes_direct,0.7834,,D009020,"<span class=""chemical"">morphine</span>",D009759,"<span class=""disease"">opioid rotation</span>","Twenty-one consecutive cancer patients with <span class=""chemical"">morphine</span>-induced delirium underwent <span class=""disease"">opioid rotation</span> to fentanyl.",,16043013,16043013_D009020_D009759,16043013_3,bcv_sentence_task_befree_2353,,770958281,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D009369,"<span class=""disease"">cancer</span>","Opioid rotation from <span class=""chemical"">morphine</span> to fentanyl may be effective in alleviating delirium and pain in <span class=""disease"">cancer</span> patients with <span class=""chemical"">morphine</span>-induced delirium.",,16043013,16043013_D009020_D009369,16043013_12,bcv_sentence_task_befree_2354,,770958282,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D003693,"<span class=""disease"">delirium</span>","Opioid rotation from morphine to <span class=""chemical"">fentanyl</span> may be effective in alleviating <span class=""disease"">delirium</span> and pain in cancer patients with morphine-induced <span class=""disease"">delirium</span>.",,16043013,16043013_D005283_D003693,16043013_12,bcv_sentence_task_befree_2355,,770958283,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,0.7968,,D009020,"<span class=""chemical"">morphine</span>",D010146,"<span class=""disease"">pain</span>","Opioid rotation from <span class=""chemical"">morphine</span> to fentanyl may be effective in alleviating delirium and <span class=""disease"">pain</span> in cancer patients with <span class=""chemical"">morphine</span>-induced delirium.",,16043013,16043013_D009020_D010146,16043013_12,bcv_sentence_task_befree_2356,,770958284,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D009369,"<span class=""disease"">cancer</span>","Opioid rotation from morphine to <span class=""chemical"">fentanyl</span> may be effective in alleviating delirium and pain in <span class=""disease"">cancer</span> patients with morphine-induced delirium.",,16043013,16043013_D005283_D009369,16043013_12,bcv_sentence_task_befree_2357,,770958285,FALSE,finalized,5,8/15/15 2:33,"



",no_relation,0.8113,,D005283,"<span class=""chemical"">fentanyl</span>",D010146,"<span class=""disease"">pain</span>","Opioid rotation from morphine to <span class=""chemical"">fentanyl</span> may be effective in alleviating delirium and <span class=""disease"">pain</span> in cancer patients with morphine-induced delirium.",,16043013,16043013_D005283_D010146,16043013_12,bcv_sentence_task_befree_2358,,770958286,FALSE,finalized,5,8/14/15 21:14,"



",yes_direct,0.7928,,D009020,"<span class=""chemical"">morphine</span>",D003693,"<span class=""disease"">delirium</span>","Opioid rotation from <span class=""chemical"">morphine</span> to fentanyl may be effective in alleviating <span class=""disease"">delirium</span> and pain in cancer patients with <span class=""chemical"">morphine</span>-induced <span class=""disease"">delirium</span>.",,16043013,16043013_D009020_D003693,16043013_12,bcv_sentence_task_befree_2359,,770958287,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,0.8024,,D014212,"<span class=""chemical"">Retinoic acid</span>",D009369,"<span class=""disease"">cancer</span>","<span class=""chemical"">Retinoic acid</span>-induced downmodulation of telomerase activity in human <span class=""disease"">cancer</span> cells.",,16054129,16054129_D014212_D009369,16054129_0,bcv_sentence_task_befree_2360,,770958288,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D014284,"<span class=""chemical"">triiodothyronine</span>",D003865,"<span class=""disease"">major depressive disorder</span>","An open study of <span class=""chemical"">triiodothyronine</span> augmentation of selective serotonin reuptake inhibitors in treatment-resistant <span class=""disease"">major depressive disorder</span>.",,16086620,16086620_D014284_D003865,16086620_0,bcv_sentence_task_befree_2361,,770958289,FALSE,finalized,5,8/14/15 21:12,"



",no_relation,1,,D012701,"<span class=""chemical"">serotonin</span>",D003865,"<span class=""disease"">major depressive disorder</span>","An open study of triiodothyronine augmentation of selective <span class=""chemical"">serotonin</span> reuptake inhibitors in treatment-resistant <span class=""disease"">major depressive disorder</span>.",,16086620,16086620_D012701_D003865,16086620_0,bcv_sentence_task_befree_2362,,770958290,FALSE,finalized,5,8/14/15 22:24,"



",no_relation,1,,D014284,"<span class=""chemical"">triiodothyronine</span>",D003865,"<span class=""disease"">major depressive disorder/MDD</span>","In an open trial, we investigated the efficacy of <span class=""chemical"">triiodothyronine</span> (T(3)) adjuvant to selective serotonin reuptake inhibitors (SSRIs) in subjects with <span class=""disease"">major depressive disorder</span> (<span class=""disease"">MDD</span>) resistant to SSRI treatment.",,16086620,16086620_D014284_D003865,16086620_1,bcv_sentence_task_befree_2363,,770958291,FALSE,finalized,5,8/14/15 21:27,"



",no_relation,1,,D017367,"<span class=""chemical"">SSRI</span>",D003865,"<span class=""disease"">major depressive disorder/MDD</span>","In an open trial, we investigated the efficacy of triiodothyronine (T(3)) adjuvant to selective serotonin reuptake inhibitors (SSRIs) in subjects with <span class=""disease"">major depressive disorder</span> (<span class=""disease"">MDD</span>) resistant to <span class=""chemical"">SSRI</span> treatment.",,16086620,16086620_D017367_D003865,16086620_1,bcv_sentence_task_befree_2364,,770958292,FALSE,finalized,5,8/14/15 21:18,"



",no_relation,1,,D012701,"<span class=""chemical"">serotonin</span>",D003865,"<span class=""disease"">major depressive disorder/MDD</span>","In an open trial, we investigated the efficacy of triiodothyronine (T(3)) adjuvant to selective <span class=""chemical"">serotonin</span> reuptake inhibitors (SSRIs) in subjects with <span class=""disease"">major depressive disorder</span> (<span class=""disease"">MDD</span>) resistant to SSRI treatment.",,16086620,16086620_D012701_D003865,16086620_1,bcv_sentence_task_befree_2365,,770958293,FALSE,finalized,5,8/14/15 23:55,"



",no_relation,1,,D014284,"<span class=""chemical"">Triiodothyronine</span>",D003865,"<span class=""disease"">MDD</span>","<span class=""chemical"">Triiodothyronine</span> augmentation of SSRIs may be a promising treatment strategy in SSRI-resistant <span class=""disease"">MDD</span>, particularly in subjects with the atypical <span class=""disease"">MDD</span> subtype.",,16086620,16086620_D014284_D003865,16086620_9,bcv_sentence_task_befree_2366,,770958294,FALSE,finalized,5,8/15/15 2:31,"



",no_relation,1,,C402769,"<span class=""chemical"">Tipifarnib/R115777</span>",D009369,"<span class=""disease"">breast cancer</span>","Biomarkers of anticancer activity of <span class=""chemical"">R115777</span> (<span class=""chemical"">Tipifarnib</span>, Zarnestra) in human <span class=""disease"">breast cancer</span> models in vitro.",,16101130,16101130_C402769_D009369,16101130_0,bcv_sentence_task_befree_2367,,770958295,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,1,,C402769,"<span class=""chemical"">R115777</span>",D009369,"<span class=""disease"">breast cancer</span>","Farnesyltransferase inhibitor <span class=""chemical"">R115777</span> (Tipifamib, Zarnestra) is active in <span class=""disease"">breast cancer</span>, but its efficacy in drug combinations has not been extensively investigated.",,16101130,16101130_C402769_D009369,16101130_1,bcv_sentence_task_befree_2368,,770958296,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,D017239,"<span class=""chemical"">paclitaxel</span>",D009369,"<span class=""disease"">tumor/breast cancer</span>","The activity of R115777 and <span class=""chemical"">paclitaxel</span>, alone and in combination, was studied in the human <span class=""disease"">breast cancer</span> cell lines, BT-474 (overexpressed HER2/neu) and MDA-MB-231 (low HER2/neu), with cell viability and biomarkers for farnesylation (HDJ-2, Rho B), <span class=""disease"">tumor</span> growth (Raf/MEK/ERK), survival (PI3K/Akt) and angiogenesis (VEGF, FGF-2, MMP-1, MMP-2, MMP-9) as the endpoints.",,16101130,16101130_D017239_D009369,16101130_2,bcv_sentence_task_befree_2369,,770958297,FALSE,finalized,5,8/15/15 2:04,"



",no_relation,1,,C402769,"<span class=""chemical"">R115777</span>",D009369,"<span class=""disease"">tumor/breast cancer</span>","The activity of <span class=""chemical"">R115777</span> and paclitaxel, alone and in combination, was studied in the human <span class=""disease"">breast cancer</span> cell lines, BT-474 (overexpressed HER2/neu) and MDA-MB-231 (low HER2/neu), with cell viability and biomarkers for farnesylation (HDJ-2, Rho B), <span class=""disease"">tumor</span> growth (Raf/MEK/ERK), survival (PI3K/Akt) and angiogenesis (VEGF, FGF-2, MMP-1, MMP-2, MMP-9) as the endpoints.",,16101130,16101130_C402769_D009369,16101130_2,bcv_sentence_task_befree_2370,,770958298,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,C045645,"<span class=""chemical"">cilostazol</span>",D007383,"<span class=""disease"">claudication</span>","Symptomatic treatment of <span class=""disease"">claudication</span> includes smoking cessation, exercise, <span class=""chemical"">cilostazol</span>, statins, and revascularization with percutaneous or surgical therapy.",,16105478,16105478_C045645_D007383,16105478_4,bcv_sentence_task_befree_2371,,770958299,FALSE,finalized,5,8/14/15 21:16,"



",no_relation,1,,D019821,"<span class=""chemical"">statins</span>",D007383,"<span class=""disease"">claudication</span>","Symptomatic treatment of <span class=""disease"">claudication</span> includes smoking cessation, exercise, cilostazol, <span class=""chemical"">statins</span>, and revascularization with percutaneous or surgical therapy.",,16105478,16105478_D019821_D007383,16105478_4,bcv_sentence_task_befree_2372,,770958300,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D007383,"<span class=""disease"">claudication</span>","Antithrombotic therapy with <span class=""chemical"">aspirin</span> or clopidogrel is important to reduce cardiovascular events but does not affect symptoms of <span class=""disease"">claudication</span>.",,16105478,16105478_D001241_D007383,16105478_5,bcv_sentence_task_befree_2373,,770958301,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,C055162,"<span class=""chemical"">clopidogrel</span>",D007383,"<span class=""disease"">claudication</span>","Antithrombotic therapy with aspirin or <span class=""chemical"">clopidogrel</span> is important to reduce cardiovascular events but does not affect symptoms of <span class=""disease"">claudication</span>.",,16105478,16105478_C055162_D007383,16105478_5,bcv_sentence_task_befree_2374,,770958302,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,1,,C099154,"<span class=""chemical"">Ruboxistaurin</span>",D020151,"<span class=""disease"">protein kinase C</span>","<span class=""chemical"">Ruboxistaurin</span>, a <span class=""disease"">protein kinase C</span> beta inhibitor, as an emerging treatment for diabetes microvascular complications.",,16160002,16160002_C099154_D020151,16160002_0,bcv_sentence_task_befree_2375,,770958303,FALSE,finalized,5,8/14/15 21:41,"



",no_relation,1,,C099154,"<span class=""chemical"">ruboxistaurin/LY333531</span>",D020151,"<span class=""disease"">PKC/protein kinase C</span>","To review current clinical data regarding the pharmacologic actions of <span class=""chemical"">ruboxistaurin</span> (<span class=""chemical"">LY333531</span>) mesylate, an inhibitor of <span class=""disease"">protein kinase C</span> (<span class=""disease"">PKC</span>) beta, and its role to potentially reduce the development and/or the progression of diabetic microvascular complications.",,16160002,16160002_C099154_D020151,16160002_1,bcv_sentence_task_befree_2376,,770958304,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,0.798,,D008698,"<span class=""chemical"">mesylate</span>",D020151,"<span class=""disease"">PKC/protein kinase C</span>","To review current clinical data regarding the pharmacologic actions of ruboxistaurin (LY333531) <span class=""chemical"">mesylate</span>, an inhibitor of <span class=""disease"">protein kinase C</span> (<span class=""disease"">PKC</span>) beta, and its role to potentially reduce the development and/or the progression of diabetic microvascular complications.",,16160002,16160002_D008698_D020151,16160002_1,bcv_sentence_task_befree_2377,,770958305,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,C099154,"<span class=""chemical"">ruboxistaurin</span>",D020151,"<span class=""disease"">PKC</span>","Literature relevant to <span class=""disease"">PKC</span> physiology, the pharmacokinetics of <span class=""chemical"">ruboxistaurin</span>, and data evaluating the use of <span class=""chemical"">ruboxistaurin</span> in treating diabetic microvascular complications in human and relevant animal models was reviewed.",,16160002,16160002_C099154_D020151,16160002_3,bcv_sentence_task_befree_2378,,770958306,FALSE,finalized,5,8/14/15 21:08,"



",yes_direct,0.7849,,D024841,"<span class=""chemical"">fluoroquinolone</span>",D052256,"<span class=""disease"">tendinopathy</span>","Achilles <span class=""disease"">tendinopathy</span> after treatment with <span class=""chemical"">fluoroquinolone</span>.",,16174181,16174181_D024841_D052256,16174181_0,bcv_sentence_task_befree_2379,,770958307,FALSE,finalized,5,8/15/15 2:13,"



",yes_direct,0.6069,,D024841,"<span class=""chemical"">Fluoroquinolone</span>",D052256,"<span class=""disease"">tendinopathy</span>","<span class=""chemical"">Fluoroquinolone</span> antibiotic therapy is a recognized but poorly understood cause for Achilles <span class=""disease"">tendinopathy</span>.",,16174181,16174181_D024841_D052256,16174181_1,bcv_sentence_task_befree_2380,,770958308,FALSE,finalized,5,8/15/15 0:33,"



",no_relation,0.7959,,D014443,"<span class=""chemical"">tyrosine</span>",D002289,"<span class=""disease"">nonsmall cell lung cancer</span>","Inhibitors of the <span class=""chemical"">tyrosine</span> kinase activity associated with this receptor have been approved for the treatment of chemotherapy-refractory <span class=""disease"">nonsmall cell lung cancer</span>, and are in clinical trials for additional tumor types.",,16177570,16177570_D014443_D002289,16177570_2,bcv_sentence_task_befree_2381,,770958309,FALSE,finalized,5,8/14/15 23:51,"


It's 'tyrosine kinase' and not just 'Tyrosine'
",no_relation,0.8029,,D014443,"<span class=""chemical"">tyrosine</span>",D009369,"<span class=""disease"">tumor</span>","Inhibitors of the <span class=""chemical"">tyrosine</span> kinase activity associated with this receptor have been approved for the treatment of chemotherapy-refractory nonsmall cell lung cancer, and are in clinical trials for additional <span class=""disease"">tumor</span> types.",,16177570,16177570_D014443_D009369,16177570_2,bcv_sentence_task_befree_2382,,770958310,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,1,,C419708,"<span class=""chemical"">gefitinib</span>",D009369,"<span class=""disease"">tumor</span>","While these inhibitors, <span class=""chemical"">gefitinib</span> and erlotinib, display limited response rates when assessed in cohorts that include all patients, there are subgroups, defined by patient and <span class=""disease"">tumor</span> characteristics, that preferentially respond to these agents.",,16177570,16177570_C419708_D009369,16177570_3,bcv_sentence_task_befree_2383,,770958311,FALSE,finalized,5,8/14/15 21:55,"



",no_relation,1,,C400278,"<span class=""chemical"">erlotinib</span>",D009369,"<span class=""disease"">tumor</span>","While these inhibitors, gefitinib and <span class=""chemical"">erlotinib</span>, display limited response rates when assessed in cohorts that include all patients, there are subgroups, defined by patient and <span class=""disease"">tumor</span> characteristics, that preferentially respond to these agents.",,16177570,16177570_C400278_D009369,16177570_3,bcv_sentence_task_befree_2384,,770958312,FALSE,finalized,5,8/14/15 21:02,"



",no_relation,1,,C400278,"<span class=""chemical"">erlotinib</span>",D005909,"<span class=""disease"">glioblastoma</span>","We recently performed an analysis of tumors obtained from a Phase I trial of <span class=""chemical"">erlotinib</span> in patients with <span class=""disease"">glioblastoma</span> multiforme (GBM), the most common malignant brain tumor in adults.",,16177570,16177570_C400278_D005909,16177570_4,bcv_sentence_task_befree_2385,,770958313,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,C400278,"<span class=""chemical"">erlotinib</span>",D001932,"<span class=""disease"">brain tumor</span>","We recently performed an analysis of tumors obtained from a Phase I trial of <span class=""chemical"">erlotinib</span> in patients with glioblastoma multiforme (GBM), the most common malignant <span class=""disease"">brain tumor</span> in adults.",,16177570,16177570_C400278_D001932,16177570_4,bcv_sentence_task_befree_2386,,770958314,FALSE,finalized,5,8/15/15 1:43,"



",no_relation,1,,C400278,"<span class=""chemical"">erlotinib</span>",D009369,"<span class=""disease"">tumors</span>","We recently performed an analysis of <span class=""disease"">tumors</span> obtained from a Phase I trial of <span class=""chemical"">erlotinib</span> in patients with glioblastoma multiforme (GBM), the most common malignant brain tumor in adults.",,16177570,16177570_C400278_D009369,16177570_4,bcv_sentence_task_befree_2387,,770958315,FALSE,finalized,5,8/15/15 1:24,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D006973,"<span class=""disease"">hypertension</span>","Children and adolescents were classified as having the metabolic syndrome if they met three or more of the following criteria: hypertriglyceridemia, low levels of high-density lipoprotein (HDL), high fasting <span class=""chemical"">glucose</span>, obesity, and <span class=""disease"">hypertension</span>.",,16189445,16189445_D005947_D006973,16189445_3,bcv_sentence_task_befree_2388,,770958316,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,0.6049,,D005947,"<span class=""chemical"">glucose</span>",D008659,"<span class=""disease"">metabolic syndrome</span>","Children and adolescents were classified as having the <span class=""disease"">metabolic syndrome</span> if they met three or more of the following criteria: hypertriglyceridemia, low levels of high-density lipoprotein (HDL), high fasting <span class=""chemical"">glucose</span>, obesity, and hypertension.",,16189445,16189445_D005947_D008659,16189445_3,bcv_sentence_task_befree_2389,,770958317,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,0.7989,,D005947,"<span class=""chemical"">glucose</span>",D009765,"<span class=""disease"">glucose, obesity</span>","Children and adolescents were classified as having the metabolic syndrome if they met three or more of the following criteria: hypertriglyceridemia, low levels of high-density lipoprotein (HDL), high fasting <span class=""chemical""></span><span class=""disease"">glucose</span>, obesity, and hypertension.",,16189445,16189445_D005947_D009765,16189445_3,bcv_sentence_task_befree_2390,,770958318,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D015228,"<span class=""disease"">hypertriglyceridemia</span>","Children and adolescents were classified as having the metabolic syndrome if they met three or more of the following criteria: <span class=""disease"">hypertriglyceridemia</span>, low levels of high-density lipoprotein (HDL), high fasting <span class=""chemical"">glucose</span>, obesity, and hypertension.",,16189445,16189445_D005947_D015228,16189445_3,bcv_sentence_task_befree_2391,,770958319,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D008659,"<span class=""disease"">metabolic syndrome</span>","Three criteria for the <span class=""disease"">metabolic syndrome</span> (high triglyceride levels, <span class=""chemical"">glucose</span> intolerance, and obesity) were fulfilled by three subjects (5.76%).",,16189445,16189445_D005947_D008659,16189445_12,bcv_sentence_task_befree_2392,,770958320,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D009765,"<span class=""disease"">obesity</span>","Three criteria for the metabolic syndrome (high triglyceride levels, <span class=""chemical"">glucose</span> intolerance, and <span class=""disease"">obesity</span>) were fulfilled by three subjects (5.76%).",,16189445,16189445_D005947_D009765,16189445_12,bcv_sentence_task_befree_2393,,770958321,FALSE,finalized,5,8/14/15 21:05,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D018149,"<span class=""disease"">glucose intolerance</span>","Three criteria for the metabolic syndrome (high triglyceride levels, <span class=""chemical""></span><span class=""disease"">glucose</span> intolerance, and obesity) were fulfilled by three subjects (5.76%).",,16189445,16189445_D005947_D018149,16189445_12,bcv_sentence_task_befree_2394,,770958322,FALSE,finalized,5,8/14/15 23:03,"



",yes_direct,0.5968,,D047228,"<span class=""chemical"">sartans</span>",D006973,"<span class=""disease"">hypertensive</span>","We report two cases of adverse fetal outcome in <span class=""disease"">hypertensive</span> pregnancies exposed to <span class=""chemical"">sartans</span>.",,16203601,16203601_D047228_D006973,16203601_3,bcv_sentence_task_befree_2395,,770958323,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,1,,D000255,"<span class=""chemical"">ATP</span>",D012480,"<span class=""disease"">Salmonella</span>","We showed that the cell-free culture supernatant of L. acidophilus strain LB (LB-CFCS) induced the following effects in S. enterica SL1344: (i) a decrease in intracellular <span class=""chemical"">ATP</span> that paralleled bacterial death, (ii) the release of lipopolysaccharide, (iii) permeabilization of the bacterial membrane, and (iv) an increase in the sensitivity of <span class=""disease"">Salmonella</span> to the lytic action of sodium dodecyl sulfate.",,16204528,16204528_D000255_D012480,16204528_3,bcv_sentence_task_befree_2396,,770958324,FALSE,finalized,5,8/15/15 0:11,"



",yes_direct,0.6013,,D012967,"<span class=""chemical"">sodium dodecyl sulfate</span>",D012480,"<span class=""disease"">Salmonella</span>","We showed that the cell-free culture supernatant of L. acidophilus strain LB (LB-CFCS) induced the following effects in S. enterica SL1344: (i) a decrease in intracellular ATP that paralleled bacterial death, (ii) the release of lipopolysaccharide, (iii) permeabilization of the bacterial membrane, and (iv) an increase in the sensitivity of <span class=""disease"">Salmonella</span> to the lytic action of <span class=""chemical"">sodium dodecyl sulfate</span>.",,16204528,16204528_D012967_D012480,16204528_3,bcv_sentence_task_befree_2397,,770958325,FALSE,finalized,5,8/14/15 23:20,"

Used in treatment.

",no_relation,1,,D000109,"<span class=""chemical"">acetylcholine</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","Striatal alpha6* nicotinic <span class=""chemical"">acetylcholine</span> receptors: potential targets for <span class=""disease"">Parkinson's disease</span> therapy.",,16210393,16210393_D000109_D010300,16210393_0,bcv_sentence_task_befree_2398,,770958326,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,0.8154,,D009538,"<span class=""chemical"">nicotine</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","This latter observation coupled with the finding that <span class=""chemical"">nicotine</span> protects against nigrostriatal damage suggest that alpha6(*) nAChRs may represent unique targets for neurodegenerative disorders linked to the nigrostriatal system such as <span class=""disease"">Parkinson's disease</span>.",,16210393,16210393_D009538_D010300,16210393_7,bcv_sentence_task_befree_2399,,770958327,FALSE,finalized,5,8/14/15 21:25,"



",no_relation,1,,D009538,"<span class=""chemical"">nicotine</span>",D019636,"<span class=""disease"">neurodegenerative disorders</span>","This latter observation coupled with the finding that <span class=""chemical"">nicotine</span> protects against nigrostriatal damage suggest that alpha6(*) nAChRs may represent unique targets for <span class=""disease"">neurodegenerative disorders</span> linked to the nigrostriatal system such as Parkinson's disease.",,16210393,16210393_D009538_D019636,16210393_7,bcv_sentence_task_befree_2400,,770958328,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D011085,"<span class=""disease"">PCOS</span>","Treatment with insulin sensitizers, <span class=""chemical"">metformin</span>, and thiazolidinediones (TZDs) improve both metabolic and hormonal patterns and also improve ovulation in <span class=""disease"">PCOS</span>.",,16217983,16217983_D008687_D011085,16217983_6,bcv_sentence_task_befree_2401,,770958329,FALSE,finalized,5,8/15/15 0:49,"



",no_relation,1,,D045162,"<span class=""chemical"">thiazolidinediones/TZDs</span>",D011085,"<span class=""disease"">PCOS</span>","Treatment with insulin sensitizers, metformin, and <span class=""chemical"">thiazolidinediones</span> (<span class=""chemical"">TZDs</span>) improve both metabolic and hormonal patterns and also improve ovulation in <span class=""disease"">PCOS</span>.",,16217983,16217983_D045162_D011085,16217983_6,bcv_sentence_task_befree_2402,,770958330,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,1,,D009569,"<span class=""chemical"">nitric oxide/NO</span>",D009336,"<span class=""disease"">necrosis</span>","EP has been shown to decrease the expression of various pro-inflammatory mediators, including <span class=""chemical"">nitric oxide</span> (<span class=""chemical"">NO</span>*), tumor <span class=""disease"">necrosis</span> factor (TNF), cyclooxygenase-2, and interleukin (IL)-6, in a variety of in vitro and in vivo model systems.",,16226725,16226725_D009569_D009336,16226725_2,bcv_sentence_task_befree_2403,,770958331,FALSE,finalized,5,8/14/15 22:39,"



",no_relation,1,,D009569,"<span class=""chemical"">nitric oxide/NO</span>",D009369,"<span class=""disease"">tumor</span>","EP has been shown to decrease the expression of various pro-inflammatory mediators, including <span class=""chemical"">nitric oxide</span> (<span class=""chemical"">NO</span>*), <span class=""disease"">tumor</span> necrosis factor (TNF), cyclooxygenase-2, and interleukin (IL)-6, in a variety of in vitro and in vivo model systems.",,16226725,16226725_D009569_D009369,16226725_2,bcv_sentence_task_befree_2404,,770958332,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,1,,D014280,"<span class=""chemical"">triacylglycerol</span>",D018205,"<span class=""disease"">ADRP</span>","When J774 murine macrophages were incubated with either VLDL or oleic acid, their content of both <span class=""disease"">ADRP</span> and <span class=""chemical"">triacylglycerol</span> (TG) increased 3- to 4-fold.",,16230742,16230742_D014280_D018205,16230742_3,bcv_sentence_task_befree_2405,,770958333,FALSE,finalized,5,8/14/15 22:07,"



",yes_direct,0.7935,,D019301,"<span class=""chemical"">oleic acid</span>",D018205,"<span class=""disease"">ADRP</span>","When J774 murine macrophages were incubated with either VLDL or <span class=""chemical"">oleic acid</span>, their content of both <span class=""disease"">ADRP</span> and triacylglycerol (TG) increased 3- to 4-fold.",,16230742,16230742_D019301_D018205,16230742_3,bcv_sentence_task_befree_2406,,770958334,FALSE,finalized,5,8/14/15 21:13,"



",yes_direct,0.6312,,D019301,"<span class=""chemical"">oleic acid</span>",D018205,"<span class=""disease"">ADRP</span>","Induction of <span class=""disease"">ADRP</span> during TG accumulation was also observed in <span class=""chemical"">oleic acid</span>-treated HuH-7 human liver cells.",,16230742,16230742_D019301_D018205,16230742_4,bcv_sentence_task_befree_2407,,770958335,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,0.7967,,C034613,"<span class=""chemical"">triacsin C</span>",D018205,"<span class=""disease"">ADRP</span>","Addition of <span class=""chemical"">triacsin C</span>, a potent inhibitor of acyl-CoA synthase, for 6 h decreased the amount of TG in VLDL-induced foam cells and oleic acid-treated liver cells; it decreased the amount of <span class=""disease"">ADRP</span> protein in parallel, indicating the amount of <span class=""disease"">ADRP</span> reduced during regression of the lipid-storing cells.",,16230742,16230742_C034613_D018205,16230742_5,bcv_sentence_task_befree_2408,,770958336,FALSE,finalized,5,8/14/15 23:45,"



",no_relation,1,,D000214,"<span class=""chemical"">acyl-CoA</span>",D018205,"<span class=""disease"">ADRP</span>","Addition of triacsin C, a potent inhibitor of <span class=""chemical"">acyl-CoA</span> synthase, for 6 h decreased the amount of TG in VLDL-induced foam cells and oleic acid-treated liver cells; it decreased the amount of <span class=""disease"">ADRP</span> protein in parallel, indicating the amount of <span class=""disease"">ADRP</span> reduced during regression of the lipid-storing cells.",,16230742,16230742_D000214_D018205,16230742_5,bcv_sentence_task_befree_2409,,770958337,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,D019301,"<span class=""chemical"">oleic acid</span>",D018205,"<span class=""disease"">ADRP</span>","Addition of triacsin C, a potent inhibitor of acyl-CoA synthase, for 6 h decreased the amount of TG in VLDL-induced foam cells and <span class=""chemical"">oleic acid</span>-treated liver cells; it decreased the amount of <span class=""disease"">ADRP</span> protein in parallel, indicating the amount of <span class=""disease"">ADRP</span> reduced during regression of the lipid-storing cells.",,16230742,16230742_D019301_D018205,16230742_5,bcv_sentence_task_befree_2410,,770958338,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,0.7962,,C034613,"<span class=""chemical"">triacsin C</span>",D018205,"<span class=""disease"">ADRP</span>","Addition of a proteasome inhibitor during <span class=""chemical"">triacsin C</span> treatment abolished the <span class=""disease"">ADRP</span> decrease and accumulated polyubiquitinated <span class=""disease"">ADRP</span>.",,16230742,16230742_C034613_D018205,16230742_6,bcv_sentence_task_befree_2411,,770958339,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,0.7874,,C034613,"<span class=""chemical"">triacsin C</span>",D018205,"<span class=""disease"">ADRP</span>","In addition, the proteasome inhibitor reversed not only the degradation of <span class=""disease"">ADRP</span> but also TG reduction by <span class=""chemical"">triacsin C</span>. These results suggest that cellular amounts of <span class=""disease"">ADRP</span> and TG regulate each other and that the ubiquitin-proteasome system is involved in degradation of <span class=""disease"">ADRP</span> during regression of lipid-storing cells.",,16230742,16230742_C034613_D018205,16230742_7,bcv_sentence_task_befree_2412,,770958340,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,1,,D043823,"<span class=""chemical"">taxanes</span>",D009369,"<span class=""disease"">breast cancer</span>","Trastuzumab has been repeatedly shown to result in significant clinical benefits and was subsequently accepted as the treatment of choice for HER2-positive advanced <span class=""disease"">breast cancer</span> - particularly as first-line treatment in combination with <span class=""chemical"">taxanes</span> and as monotherapy in the second-line or third-line setting.",,16249641,16249641_D043823_D009369,16249641_1,bcv_sentence_task_befree_2413,,770958341,FALSE,finalized,5,8/14/15 21:32,"



",no_relation,1,,C110904,"<span class=""chemical"">capecitabine</span>",D009369,"<span class=""disease"">breast cancer</span>","We determined the safety of i.v. trastuzumab (8 mg/kg followed by 6 mg/kg) every 3 weeks in combination with chemotherapeutic agents administered in 3-weekly courses (docetaxel, vinorelbine and <span class=""chemical"">capecitabine</span>) in 31 patients with HER2-positive recurrent locoregional and/or metastatic <span class=""disease"">breast cancer</span>.",,16249641,16249641_C110904_D009369,16249641_3,bcv_sentence_task_befree_2414,,770958342,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,1,,C030852,"<span class=""chemical"">vinorelbine</span>",D009369,"<span class=""disease"">breast cancer</span>","We determined the safety of i.v. trastuzumab (8 mg/kg followed by 6 mg/kg) every 3 weeks in combination with chemotherapeutic agents administered in 3-weekly courses (docetaxel, <span class=""chemical"">vinorelbine</span> and capecitabine) in 31 patients with HER2-positive recurrent locoregional and/or metastatic <span class=""disease"">breast cancer</span>.",,16249641,16249641_C030852_D009369,16249641_3,bcv_sentence_task_befree_2415,,770958343,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,C067311,"<span class=""chemical"">docetaxel</span>",D009369,"<span class=""disease"">breast cancer</span>","We determined the safety of i.v. trastuzumab (8 mg/kg followed by 6 mg/kg) every 3 weeks in combination with chemotherapeutic agents administered in 3-weekly courses (<span class=""chemical"">docetaxel</span>, vinorelbine and capecitabine) in 31 patients with HER2-positive recurrent locoregional and/or metastatic <span class=""disease"">breast cancer</span>.",,16249641,16249641_C067311_D009369,16249641_3,bcv_sentence_task_befree_2416,,770958344,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,1,,C056507,"<span class=""chemical"">Gemcitabine</span>",D006689,"<span class=""disease"">refractory Hodgkin's disease</span>","<span class=""chemical"">Gemcitabine</span> in the treatment of relapsed and <span class=""disease"">refractory Hodgkin's disease</span>.",,16249642,16249642_C056507_D006689,16249642_0,bcv_sentence_task_befree_2417,,770958345,FALSE,finalized,5,8/15/15 1:27,"



",no_relation,1,,C056507,"<span class=""chemical"">gemcitabine</span>",D006689,"<span class=""disease"">refractory Hodgkin's disease</span>","We treated 14 patients with relapsed or <span class=""disease"">refractory Hodgkin's disease</span> with <span class=""chemical"">gemcitabine</span>.",,16249642,16249642_C056507_D006689,16249642_3,bcv_sentence_task_befree_2418,,770958346,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,C056507,"<span class=""chemical"">Gemcitabine</span>",D006689,"<span class=""disease"">Hodgkin's disease</span>","<span class=""chemical"">Gemcitabine</span> is an effective treatment for <span class=""disease"">Hodgkin's disease</span>.",,16249642,16249642_C056507_D006689,16249642_18,bcv_sentence_task_befree_2419,,770958347,FALSE,finalized,5,8/14/15 22:12,"



",no_relation,1,,D007665,"<span class=""chemical"">ketotifen</span>",D012167,"<span class=""disease"">artificial tear substitute</span>","Comparison of the effects of <span class=""chemical"">ketotifen</span> fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, <span class=""disease"">artificial tear substitute</span>-controlled trial.",,16291412,16291412_D007665_D012167,16291412_0,bcv_sentence_task_befree_2420,,770958348,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,C074921,"<span class=""chemical"">olopatadine</span>",D003233,"<span class=""disease"">SAC</span>","The aims of this study were to compare the clinical efficacy of topical ketotifen and <span class=""chemical"">olopatadine</span> eye drops and to determine the effects of these 2 drugs on the expression of cell adhesion molecules (CAMs) and inflammatory markers in conjunctival surface cells in patients with <span class=""disease"">SAC</span>.",,16291412,16291412_C074921_D003233,16291412_4,bcv_sentence_task_befree_2421,,770958349,FALSE,finalized,5,8/14/15 23:51,"



",no_relation,1,,D007665,"<span class=""chemical"">ketotifen</span>",D003233,"<span class=""disease"">SAC</span>","The aims of this study were to compare the clinical efficacy of topical <span class=""chemical"">ketotifen</span> and olopatadine eye drops and to determine the effects of these 2 drugs on the expression of cell adhesion molecules (CAMs) and inflammatory markers in conjunctival surface cells in patients with <span class=""disease"">SAC</span>.",,16291412,16291412_D007665_D003233,16291412_4,bcv_sentence_task_befree_2422,,770958350,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,D007665,"<span class=""chemical"">ketotifen fumarate</span>",D012167,"<span class=""disease"">ATS</span>","Patients with SAC were included in the study and randomly assigned to 1 of 3 groups: topical <span class=""chemical"">ketotifen fumarate</span> 0.025% ophthalmic solution, topical olopatadine HCl 0.1% ophthalmic solution, or <span class=""disease"">ATS</span> (control group).",,16291412,16291412_D007665_D012167,16291412_6,bcv_sentence_task_befree_2423,,770958351,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,D007665,"<span class=""chemical"">ketotifen fumarate</span>",D003233,"<span class=""disease"">SAC</span>","Patients with <span class=""disease"">SAC</span> were included in the study and randomly assigned to 1 of 3 groups: topical <span class=""chemical"">ketotifen fumarate</span> 0.025% ophthalmic solution, topical olopatadine HCl 0.1% ophthalmic solution, or ATS (control group).",,16291412,16291412_D007665_D003233,16291412_6,bcv_sentence_task_befree_2424,,770958352,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,C074921,"<span class=""chemical"">olopatadine</span>",D012167,"<span class=""disease"">ATS</span>","Twelve patients received ketotifen; 13, <span class=""chemical"">olopatadine</span>; and 14, <span class=""disease"">ATS</span>.",,16291412,16291412_C074921_D012167,16291412_13,bcv_sentence_task_befree_2425,,770958353,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D007665,"<span class=""chemical"">ketotifen</span>",D012167,"<span class=""disease"">ATS</span>","Twelve patients received <span class=""chemical"">ketotifen</span>; 13, olopatadine; and 14, <span class=""disease"">ATS</span>.",,16291412,16291412_D007665_D012167,16291412_13,bcv_sentence_task_befree_2426,,770958354,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,1,,C074921,"<span class=""chemical"">olopatadine</span>",D012167,"<span class=""disease"">ATS</span>","In both active-treatment groups, the improvements of clinical scores (tearing and itching) were more pronounced compared with those in the <span class=""disease"">ATS</span> group, although the day-30 difference in tearing score between the <span class=""chemical"">olopatadine</span> and <span class=""disease"">ATS</span> groups was not statistically significant.",,16291412,16291412_C074921_D012167,16291412_14,bcv_sentence_task_befree_2427,,770958355,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,1,,C074921,"<span class=""chemical"">olopatadine</span>",D012167,"<span class=""disease"">ATS</span>","The expression rates of CAMs and inflammatory markers in conjunctival surface cells were significantly more reduced with ketotifen and <span class=""chemical"">olopatadine</span> compared with <span class=""disease"">ATS</span>.",,16291412,16291412_C074921_D012167,16291412_16,bcv_sentence_task_befree_2428,,770958356,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,1,,D007665,"<span class=""chemical"">ketotifen</span>",D012167,"<span class=""disease"">ATS</span>","The expression rates of CAMs and inflammatory markers in conjunctival surface cells were significantly more reduced with <span class=""chemical"">ketotifen</span> and olopatadine compared with <span class=""disease"">ATS</span>.",,16291412,16291412_D007665_D012167,16291412_16,bcv_sentence_task_befree_2429,,770958357,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,C074921,"<span class=""chemical"">olopatadine</span>",D003233,"<span class=""disease"">SAC</span>","In this short-term study in a selected, small study population with <span class=""disease"">SAC</span>, ketotifen and <span class=""chemical"">olopatadine</span> diminished the expression of CAMs and inflammatory markers on the conjunctival surface cells effectively.",,16291412,16291412_C074921_D003233,16291412_19,bcv_sentence_task_befree_2430,,770958358,FALSE,finalized,5,8/14/15 21:40,"



",no_relation,1,,D007665,"<span class=""chemical"">ketotifen</span>",D003233,"<span class=""disease"">SAC</span>","In this short-term study in a selected, small study population with <span class=""disease"">SAC</span>, <span class=""chemical"">ketotifen</span> and olopatadine diminished the expression of CAMs and inflammatory markers on the conjunctival surface cells effectively.",,16291412,16291412_D007665_D003233,16291412_19,bcv_sentence_task_befree_2431,,770958359,FALSE,finalized,5,8/14/15 21:34,"



",no_relation,1,,D000111,"<span class=""chemical"">N-acetyl cysteine</span>",D029424,"<span class=""disease"">chronic obstructive pulmonary disease</span>","Oxygen therapy at low flow causes oxidative stress in <span class=""disease"">chronic obstructive pulmonary disease</span>: Prevention by <span class=""chemical"">N-acetyl cysteine</span>.",,16298736,16298736_D000111_D029424,16298736_0,bcv_sentence_task_befree_2432,,770958360,FALSE,finalized,5,8/15/15 0:01,"

Oxygen is not a chemical.

",no_relation,0.5959,,D010100,"<span class=""chemical"">Oxygen</span>",D029424,"<span class=""disease"">chronic obstructive pulmonary disease</span>","<span class=""chemical"">Oxygen</span> therapy at low flow causes oxidative stress in <span class=""disease"">chronic obstructive pulmonary disease</span>: Prevention by N-acetyl cysteine.",,16298736,16298736_D010100_D029424,16298736_0,bcv_sentence_task_befree_2433,,770958361,FALSE,finalized,5,8/14/15 22:14,"



",yes_direct,1,,D010100,"<span class=""chemical"">oxygen</span>",D064420,"<span class=""disease"">toxicity</span>","Exposure to high <span class=""chemical"">oxygen</span> concentration produces <span class=""disease"">toxicity</span> by free radical release.",,16298736,16298736_D010100_D064420,16298736_1,bcv_sentence_task_befree_2434,,770958362,FALSE,finalized,5,8/15/15 1:20,"



",no_relation,0.8285,,D000111,"<span class=""chemical"">N-acetyl-cysteine/NAC</span>",D029424,"<span class=""disease"">chronic obstructive pulmonary disease/COPD</span>","We aimed to study: whether stable <span class=""disease"">chronic obstructive pulmonary disease</span> (<span class=""disease"">COPD</span>) patients present an unbalance in the blood redox status; the effect of oxygen administration on blood redox balance; the efficacy of <span class=""chemical"">N-acetyl-cysteine</span> (<span class=""chemical"">NAC</span>) treatment against the oxidative stress-induced by oxygen administration and whether it is dose-related.",,16298736,16298736_D000111_D029424,16298736_2,bcv_sentence_task_befree_2435,,770958363,FALSE,finalized,5,8/15/15 0:45,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D029424,"<span class=""disease"">chronic obstructive pulmonary disease/COPD</span>","We aimed to study: whether stable <span class=""disease"">chronic obstructive pulmonary disease</span> (<span class=""disease"">COPD</span>) patients present an unbalance in the blood redox status; the effect of <span class=""chemical"">oxygen</span> administration on blood redox balance; the efficacy of N-acetyl-cysteine (NAC) treatment against the oxidative stress-induced by <span class=""chemical"">oxygen</span> administration and whether it is dose-related.",,16298736,16298736_D010100_D029424,16298736_2,bcv_sentence_task_befree_2436,,770958364,FALSE,finalized,5,8/14/15 21:05,"



",no_relation,1,,D019803,"<span class=""chemical"">GSSG</span>",D029424,"<span class=""disease"">COPD</span>","To this, 45 stable state III <span class=""disease"">COPD</span> patients were recruited and reduced glutathione (GSH) and oxidised glutathione (<span class=""chemical"">GSSG</span>) in erythrocytes and thiol proteins (P-SH) and carbonyl proteins (PC) in both erythrocytes and plasma were evaluated.",,16298736,16298736_D019803_D029424,16298736_3,bcv_sentence_task_befree_2437,,770958365,FALSE,finalized,5,8/15/15 0:41,"



",no_relation,1,,D005978,"<span class=""chemical"">GSH/glutathione</span>",D029424,"<span class=""disease"">COPD</span>","To this, 45 stable state III <span class=""disease"">COPD</span> patients were recruited and reduced <span class=""chemical"">glutathione</span> (<span class=""chemical"">GSH</span>) and oxidised glutathione (GSSG) in erythrocytes and thiol proteins (P-SH) and carbonyl proteins (PC) in both erythrocytes and plasma were evaluated.",,16298736,16298736_D005978_D029424,16298736_3,bcv_sentence_task_befree_2438,,770958366,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,1,,D000111,"<span class=""chemical"">NAC</span>",D029424,"<span class=""disease"">COPD</span>","All <span class=""disease"">COPD</span> patients underwent 2 l/m oxygen for 18 h and <span class=""chemical"">NAC</span> at 1200 or 1800 mg/day or placebo for 48 h starting with oxygen administration.",,16298736,16298736_D000111_D029424,16298736_4,bcv_sentence_task_befree_2439,,770958367,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D029424,"<span class=""disease"">COPD</span>","All <span class=""disease"">COPD</span> patients underwent 2 l/m <span class=""chemical"">oxygen</span> for 18 h and NAC at 1200 or 1800 mg/day or placebo for 48 h starting with <span class=""chemical"">oxygen</span> administration.",,16298736,16298736_D010100_D029424,16298736_4,bcv_sentence_task_befree_2440,,770958368,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,D000111,"<span class=""chemical"">NAC</span>",D029424,"<span class=""disease"">COPD</span>","In conclusion, stable state III <span class=""disease"">COPD</span> patients present an unstable redox balance; long term low flow oxygen administration induces systemic oxidative stress, which is prevented by <span class=""chemical"">NAC</span> treatment.",,16298736,16298736_D000111_D029424,16298736_9,bcv_sentence_task_befree_2441,,770958369,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D029424,"<span class=""disease"">COPD</span>","In conclusion, stable state III <span class=""disease"">COPD</span> patients present an unstable redox balance; long term low flow <span class=""chemical"">oxygen</span> administration induces systemic oxidative stress, which is prevented by NAC treatment.",,16298736,16298736_D010100_D029424,16298736_9,bcv_sentence_task_befree_2442,,770958370,FALSE,finalized,5,8/15/15 0:10,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D001523,"<span class=""disease"">psychiatric</span>","In the preceding 12 months, respondents who screened positive on the MDQ had greater use of <span class=""disease"">psychiatric</span> hospitals, emergency departments, and urgent care centers and also had more outpatient visits to primary care physicians, psychiatrists, and <span class=""chemical"">alcohol</span> treatment centers than those who screened negative.",,16339614,16339614_D000431_D001523,16339614_6,bcv_sentence_task_befree_2443,,770958371,FALSE,finalized,5,8/14/15 21:42,"



",yes_direct,1,,D005947,"<span class=""chemical"">glucose</span>",D010995,"<span class=""disease"">pleural thickening</span>","The development of <span class=""disease"">pleural thickening</span> was related to the level of pleural fluid <span class=""chemical"">glucose</span> (p = 0.04).",,16340225,16340225_D005947_D010995,16340225_9,bcv_sentence_task_befree_2444,,770958372,FALSE,finalized,5,8/15/15 0:57,"



",yes_direct,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">breast cancer/uterine cancer</span>","There is a greater than 7-fold increased risk of <span class=""disease"">uterine cancer</span> in women with <span class=""disease"">breast cancer</span> exposed to <span class=""chemical"">tamoxifen</span>.",,16352333,16352333_D013629_D009369,16352333_1,bcv_sentence_task_befree_2445,,770958373,FALSE,finalized,5,8/15/15 0:45,"



",yes_direct,0.611,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">uterine cancer</span>","The objective of this study was to determine the percentage of women who developed <span class=""disease"">uterine cancer</span> more than 12 months after discontinuing <span class=""chemical"">tamoxifen</span> (past users) and to compare their clinical and pathologic features with those of women who developed <span class=""disease"">uterine cancer</span> while on <span class=""chemical"">tamoxifen</span> therapy or within 12 months of stopping therapy (recent users).",,16352333,16352333_D013629_D009369,16352333_2,bcv_sentence_task_befree_2446,,770958375,FALSE,finalized,5,8/14/15 23:23,"



",no_relation,0.6071,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">breast cancer/uterine cancer</span>","All women with a diagnosis of <span class=""disease"">uterine cancer</span> at Memorial Sloan-Kettering Cancer Center between 1980 and June 2004 with a past history of <span class=""disease"">breast cancer</span> treated with <span class=""chemical"">tamoxifen</span> were identified.",,16352333,16352333_D013629_D009369,16352333_3,bcv_sentence_task_befree_2447,,770958376,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,0.7906,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">breast cancer/uterine cancer</span>","There were 106 women identified with a history of <span class=""disease"">breast cancer</span> treated with <span class=""chemical"">tamoxifen</span> preceding their diagnosis of <span class=""disease"">uterine cancer</span>.",,16352333,16352333_D013629_D009369,16352333_5,bcv_sentence_task_befree_2448,,770958377,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,0.8117,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">uterine cancer</span>","Thirty-nine (37%) developed <span class=""disease"">uterine cancer</span> more than 12 months after discontinuing <span class=""chemical"">tamoxifen</span>.",,16352333,16352333_D013629_D009369,16352333_6,bcv_sentence_task_befree_2449,,770958378,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">breast cancer</span>","There were no significant differences in age at <span class=""disease"">breast cancer</span> diagnosis, body mass index, parity, stage of <span class=""disease"">breast cancer</span>, modality of <span class=""disease"">breast cancer</span> treatment, or duration of <span class=""chemical"">tamoxifen</span> therapy between past and recent users of <span class=""chemical"">tamoxifen</span>.",,16352333,16352333_D013629_D009369,16352333_8,bcv_sentence_task_befree_2450,,770958379,FALSE,finalized,5,8/14/15 22:22,"



",yes_direct,0.7929,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">uterine cancer</span>","More than one third of women treated with <span class=""chemical"">tamoxifen</span> develop <span class=""disease"">uterine cancer</span> more than 12 months after discontinuing therapy.",,16352333,16352333_D013629_D009369,16352333_10,bcv_sentence_task_befree_2451,,770958380,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,0.5888,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">uterine cancer</span>","Therefore, women with a past history of <span class=""chemical"">tamoxifen</span> therapy should have continued surveillance after completion of <span class=""chemical"">tamoxifen</span> to ensure early diagnosis of <span class=""disease"">uterine cancer</span>.",,16352333,16352333_D013629_D009369,16352333_12,bcv_sentence_task_befree_2452,,770958381,FALSE,finalized,5,8/14/15 21:33,"



This has no sense.",no_relation,1,,D009173,"<span class=""chemical"">mycophenolic acid/MPA</span>",C531854,"<span class=""disease"">mycophenolic acid/MPA</span>","Therapeutic drug monitoring of <span class=""chemical""></span><span class=""disease"">mycophenolic acid</span> (<span class=""chemical""></span><span class=""disease"">MPA</span>) in combination with cyclosporine 2-h concentration (CsA C2, n = 68) or tacrolimus trough concentration (n = 10) was investigated by repeated measurements of <span class=""chemical""></span><span class=""disease"">MPA</span> and <span class=""disease"">MPA</span>-glucuronide (MPAG) trough concentrations in renal allograft recipients during the first 3 months post-transplant.",,16359376,16359376_D009173_C531854,16359376_1,bcv_sentence_task_befree_2453,,770958382,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,D016572,"<span class=""chemical"">cyclosporine</span>",C531854,"<span class=""disease"">mycophenolic acid/MPA</span>","Therapeutic drug monitoring of <span class=""disease"">mycophenolic acid</span> (<span class=""disease"">MPA</span>) in combination with <span class=""chemical"">cyclosporine</span> 2-h concentration (CsA C2, n = 68) or tacrolimus trough concentration (n = 10) was investigated by repeated measurements of <span class=""disease"">MPA</span> and <span class=""disease"">MPA</span>-glucuronide (MPAG) trough concentrations in renal allograft recipients during the first 3 months post-transplant.",,16359376,16359376_D016572_C531854,16359376_1,bcv_sentence_task_befree_2454,,770958383,FALSE,finalized,5,8/15/15 1:00,"



",no_relation,1,,D016559,"<span class=""chemical"">tacrolimus</span>",C531854,"<span class=""disease"">mycophenolic acid/MPA</span>","Therapeutic drug monitoring of <span class=""disease"">mycophenolic acid</span> (<span class=""disease"">MPA</span>) in combination with cyclosporine 2-h concentration (CsA C2, n = 68) or <span class=""chemical"">tacrolimus</span> trough concentration (n = 10) was investigated by repeated measurements of <span class=""disease"">MPA</span> and <span class=""disease"">MPA</span>-glucuronide (MPAG) trough concentrations in renal allograft recipients during the first 3 months post-transplant.",,16359376,16359376_D016559_C531854,16359376_1,bcv_sentence_task_befree_2455,,770958384,FALSE,finalized,5,8/14/15 23:16,"



",no_relation,1,,C113145,"<span class=""chemical"">MPA-glucuronide/MPAG</span>",C531854,"<span class=""disease"">mycophenolic acid/MPA</span>","Therapeutic drug monitoring of <span class=""disease"">mycophenolic acid</span> (<span class=""disease"">MPA</span>) in combination with cyclosporine 2-h concentration (CsA C2, n = 68) or tacrolimus trough concentration (n = 10) was investigated by repeated measurements of <span class=""disease"">MPA</span> and <span class=""chemical""></span><span class=""disease"">MPA</span>-glucuronide (<span class=""chemical"">MPAG</span>) trough concentrations in renal allograft recipients during the first 3 months post-transplant.",,16359376,16359376_C113145_C531854,16359376_1,bcv_sentence_task_befree_2456,,770958385,FALSE,finalized,5,8/14/15 21:41,"



",no_relation,1,,D009173,"<span class=""chemical"">MPA</span>",C531854,"<span class=""disease"">MPA</span>","Median <span class=""chemical""></span><span class=""disease"">MPA</span> concentration was 0.9 and 1.2 microg/ml in patients within or below C2 range, respectively (P = 0.19).",,16359376,16359376_D009173_C531854,16359376_3,bcv_sentence_task_befree_2457,,770958386,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,1,,D009173,"<span class=""chemical"">MPA</span>",C531854,"<span class=""disease"">MPA</span>","CsA C2 correlated with MPAG-to-<span class=""chemical""></span><span class=""disease"">MPA</span> ratio (P < 0.01, r = 0.91) and gamma-glutamyl-transpeptidase (GGT, P < 0.01, r = 0.86).",,16359376,16359376_D009173_C531854,16359376_4,bcv_sentence_task_befree_2458,,770958387,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,1,,D009173,"<span class=""chemical"">MPA</span>",C564422,"<span class=""disease"">gamma-glutamyl-transpeptidase/GGT</span>","CsA C2 correlated with MPAG-to-<span class=""chemical"">MPA</span> ratio (P < 0.01, r = 0.91) and <span class=""disease"">gamma-glutamyl-transpeptidase</span> (<span class=""disease"">GGT</span>, P < 0.01, r = 0.86).",,16359376,16359376_D009173_C564422,16359376_4,bcv_sentence_task_befree_2459,,770958388,FALSE,finalized,5,8/15/15 0:44,"



",no_relation,1,,D009173,"<span class=""chemical"">MPA</span>",C531854,"<span class=""disease"">MPA</span>","Total <span class=""chemical""></span><span class=""disease"">MPA</span> concentration increased during the 3 months, but not in patients on tacrolimus.",,16359376,16359376_D009173_C531854,16359376_5,bcv_sentence_task_befree_2460,,770958389,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,D016559,"<span class=""chemical"">tacrolimus</span>",C531854,"<span class=""disease"">MPA</span>","Total <span class=""disease"">MPA</span> concentration increased during the 3 months, but not in patients on <span class=""chemical"">tacrolimus</span>.",,16359376,16359376_D016559_C531854,16359376_5,bcv_sentence_task_befree_2461,,770958390,FALSE,finalized,5,8/14/15 21:43,"



",no_relation,1,,D009173,"<span class=""chemical"">MPA</span>",C531854,"<span class=""disease"">MPA</span>","High CsA C2 lowered the acute rejection rate and plasma <span class=""chemical""></span><span class=""disease"">MPA</span>.",,16359376,16359376_D009173_C531854,16359376_6,bcv_sentence_task_befree_2462,,770958391,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,0.7843,,D009173,"<span class=""chemical"">MPA</span>",C531854,"<span class=""disease"">MPA</span>","High CsA C2 is associated with elevated GGT, probably because of cholestatic effects, which explain the increased MPAG-to-<span class=""chemical""></span><span class=""disease"">MPA</span> ratio.",,16359376,16359376_D009173_C531854,16359376_7,bcv_sentence_task_befree_2463,,770958392,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,D009173,"<span class=""chemical"">MPA</span>",C564422,"<span class=""disease"">GGT</span>","High CsA C2 is associated with elevated <span class=""disease"">GGT</span>, probably because of cholestatic effects, which explain the increased MPAG-to-<span class=""chemical"">MPA</span> ratio.",,16359376,16359376_D009173_C564422,16359376_7,bcv_sentence_task_befree_2464,,770958393,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,C113145,"<span class=""chemical"">MPAG</span>",C531854,"<span class=""disease"">MPA</span>","High CsA C2 is associated with elevated GGT, probably because of cholestatic effects, which explain the increased <span class=""chemical"">MPAG</span>-to-<span class=""disease"">MPA</span> ratio.",,16359376,16359376_C113145_C531854,16359376_7,bcv_sentence_task_befree_2465,,770958394,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,0.7992,,C113145,"<span class=""chemical"">MPAG</span>",C564422,"<span class=""disease"">GGT</span>","High CsA C2 is associated with elevated <span class=""disease"">GGT</span>, probably because of cholestatic effects, which explain the increased <span class=""chemical"">MPAG</span>-to-MPA ratio.",,16359376,16359376_C113145_C564422,16359376_7,bcv_sentence_task_befree_2466,,770958395,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,D009173,"<span class=""chemical"">MPA</span>",C531854,"<span class=""disease"">MPA</span>","Increasing <span class=""chemical""></span><span class=""disease"">MPA</span> concentration is ascribed to per-protocol CsA C2 reductions.",,16359376,16359376_D009173_C531854,16359376_8,bcv_sentence_task_befree_2467,,770958396,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,1,,D009173,"<span class=""chemical"">MPA</span>",C531854,"<span class=""disease"">MPA</span>","In conclusion, CsA may confound the relationship between <span class=""chemical""></span><span class=""disease"">MPA</span> and the incidence of rejection, and contribute to the difficulty of obtaining a therapeutic range for <span class=""chemical""></span><span class=""disease"">MPA</span> in clinical practice.",,16359376,16359376_D009173_C531854,16359376_9,bcv_sentence_task_befree_2468,,770958397,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,0.8086,,D016572,"<span class=""chemical"">CsA</span>",C531854,"<span class=""disease"">MPA</span>","In conclusion, <span class=""chemical"">CsA</span> may confound the relationship between <span class=""disease"">MPA</span> and the incidence of rejection, and contribute to the difficulty of obtaining a therapeutic range for <span class=""disease"">MPA</span> in clinical practice.",,16359376,16359376_D016572_C531854,16359376_9,bcv_sentence_task_befree_2469,,770958398,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,1,,D014859,"<span class=""chemical"">Warfarin</span>",D003027,"<span class=""disease"">cluster headache</span>","<span class=""chemical"">Warfarin</span> as a therapeutic option in the control of chronic <span class=""disease"">cluster headache</span>: a report of three cases.",,16362716,16362716_D014859_D003027,16362716_0,bcv_sentence_task_befree_2470,,770958399,FALSE,finalized,5,8/14/15 23:49,"



",no_relation,0.8158,,D014859,"<span class=""chemical"">warfarin</span>",D003027,"<span class=""disease"">cluster headache</span>","Two of them remained <span class=""disease"">cluster headache</span>-free while taking <span class=""chemical"">warfarin</span>.",,16362716,16362716_D014859_D003027,16362716_4,bcv_sentence_task_befree_2471,,770958400,FALSE,finalized,5,8/14/15 21:56,"



",yes_direct,1,,D014859,"<span class=""chemical"">warfarin</span>",D003027,"<span class=""disease"">cluster headache</span>","In the third patient, the use of <span class=""chemical"">warfarin</span> for three weeks initially increased the frequency and intensity of <span class=""disease"">cluster headache</span> attacks but subsequently induced a prolonged remission.",,16362716,16362716_D014859_D003027,16362716_5,bcv_sentence_task_befree_2472,,770958401,FALSE,finalized,5,8/14/15 23:35,"


Used as treatment.
",no_relation,1,,D007372,"<span class=""chemical"">interferon</span>",D006526,"<span class=""disease"">HIV/hepatitis C virus-coinfected</span>","With the introduction of pegylated <span class=""chemical"">interferon</span>/ribavirin combination therapy significantly improved treatment options for <span class=""disease"">HIV/hepatitis C virus-coinfected</span> patients have become available, leading to sustained virological response rates of over 40%.",,16374211,16374211_D007372_D006526,16374211_4,bcv_sentence_task_befree_2473,,770958402,FALSE,finalized,5,8/15/15 0:24,"



",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D006526,"<span class=""disease"">HIV/hepatitis C virus-coinfected</span>","With the introduction of pegylated interferon/<span class=""chemical"">ribavirin</span> combination therapy significantly improved treatment options for <span class=""disease"">HIV/hepatitis C virus-coinfected</span> patients have become available, leading to sustained virological response rates of over 40%.",,16374211,16374211_D012254_D006526,16374211_4,bcv_sentence_task_befree_2474,,770958403,FALSE,finalized,5,8/14/15 21:51,"



",no_relation,1,,C417083,"<span class=""chemical"">pegylated interferon</span>",D006526,"<span class=""disease"">HIV/hepatitis C virus-coinfected</span>","Treatment with <span class=""chemical"">pegylated interferon</span> plus ribavirin is safe and effective in <span class=""disease"">HIV/hepatitis C virus-coinfected</span> patients.",,16374211,16374211_C417083_D006526,16374211_6,bcv_sentence_task_befree_2475,,770958404,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D006526,"<span class=""disease"">HIV/hepatitis C virus-coinfected</span>","Treatment with pegylated interferon plus <span class=""chemical"">ribavirin</span> is safe and effective in <span class=""disease"">HIV/hepatitis C virus-coinfected</span> patients.",,16374211,16374211_D012254_D006526,16374211_6,bcv_sentence_task_befree_2476,,770958405,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,0.7876,,D008942,"<span class=""chemical"">mitoxantrone</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","Suppression of <span class=""chemical"">mitoxantrone</span> <span class=""disease"">cardiotoxicity</span> in multiple sclerosis patients by dexrazoxane.",,16374818,16374818_D008942_D066126,16374818_0,bcv_sentence_task_befree_2477,,770958406,FALSE,finalized,5,8/14/15 23:08,"



",no_relation,1,,D064730,"<span class=""chemical"">dexrazoxane</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","Suppression of mitoxantrone <span class=""disease"">cardiotoxicity</span> in multiple sclerosis patients by <span class=""chemical"">dexrazoxane</span>.",,16374818,16374818_D064730_D066126,16374818_0,bcv_sentence_task_befree_2478,,770958407,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,D064730,"<span class=""chemical"">dexrazoxane</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","Suppression of mitoxantrone cardiotoxicity in <span class=""disease"">multiple sclerosis</span> patients by <span class=""chemical"">dexrazoxane</span>.",,16374818,16374818_D064730_D009103,16374818_0,bcv_sentence_task_befree_2479,,770958408,FALSE,finalized,5,8/15/15 0:42,"



",no_relation,0.8073,,D008942,"<span class=""chemical"">mitoxantrone</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","Suppression of <span class=""chemical"">mitoxantrone</span> cardiotoxicity in <span class=""disease"">multiple sclerosis</span> patients by dexrazoxane.",,16374818,16374818_D008942_D009103,16374818_0,bcv_sentence_task_befree_2480,,770958409,FALSE,finalized,5,8/15/15 2:25,"



",yes_direct,0.6058,,D008942,"<span class=""chemical"">mitoxantrone</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","To explore the potential of dexrazoxane to suppress subclinical <span class=""disease"">cardiotoxicity</span> in MS patients receiving <span class=""chemical"">mitoxantrone</span>.",,16374818,16374818_D008942_D066126,16374818_1,bcv_sentence_task_befree_2481,,770958410,FALSE,finalized,5,8/14/15 23:38,"



",no_relation,1,,D064730,"<span class=""chemical"">dexrazoxane</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","To explore the potential of <span class=""chemical"">dexrazoxane</span> to suppress subclinical <span class=""disease"">cardiotoxicity</span> in MS patients receiving mitoxantrone.",,16374818,16374818_D064730_D066126,16374818_1,bcv_sentence_task_befree_2482,,770958411,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,1,,D064730,"<span class=""chemical"">dexrazoxane</span>",D009103,"<span class=""disease"">MS</span>","To explore the potential of <span class=""chemical"">dexrazoxane</span> to suppress subclinical cardiotoxicity in <span class=""disease"">MS</span> patients receiving mitoxantrone.",,16374818,16374818_D064730_D009103,16374818_1,bcv_sentence_task_befree_2483,,770958412,FALSE,finalized,5,8/15/15 1:00,"



",no_relation,1,,D008942,"<span class=""chemical"">mitoxantrone</span>",D009103,"<span class=""disease"">MS</span>","To explore the potential of dexrazoxane to suppress subclinical cardiotoxicity in <span class=""disease"">MS</span> patients receiving <span class=""chemical"">mitoxantrone</span>.",,16374818,16374818_D008942_D009103,16374818_1,bcv_sentence_task_befree_2484,,770958413,FALSE,finalized,5,8/14/15 21:03,"



",no_relation,0.7872,,D008942,"<span class=""chemical"">mitoxantrone</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","An open-label study was performed to evaluate possible subclinical <span class=""disease"">cardiotoxicity</span> in multiple sclerosis patients treated quarterly with <span class=""chemical"">mitoxantrone</span> (48 mg/m(2) cumulative), with and without concomitant dexrazoxane, using blinded serial radionucleide ventriculography.",,16374818,16374818_D008942_D066126,16374818_2,bcv_sentence_task_befree_2485,,770958414,FALSE,finalized,5,8/15/15 0:07,"



",no_relation,1,,D064730,"<span class=""chemical"">dexrazoxane</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","An open-label study was performed to evaluate possible subclinical <span class=""disease"">cardiotoxicity</span> in multiple sclerosis patients treated quarterly with mitoxantrone (48 mg/m(2) cumulative), with and without concomitant <span class=""chemical"">dexrazoxane</span>, using blinded serial radionucleide ventriculography.",,16374818,16374818_D064730_D066126,16374818_2,bcv_sentence_task_befree_2486,,770958415,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,D064730,"<span class=""chemical"">dexrazoxane</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","An open-label study was performed to evaluate possible subclinical cardiotoxicity in <span class=""disease"">multiple sclerosis</span> patients treated quarterly with mitoxantrone (48 mg/m(2) cumulative), with and without concomitant <span class=""chemical"">dexrazoxane</span>, using blinded serial radionucleide ventriculography.",,16374818,16374818_D064730_D009103,16374818_2,bcv_sentence_task_befree_2487,,770958416,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,0.8119,,D008942,"<span class=""chemical"">mitoxantrone</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","An open-label study was performed to evaluate possible subclinical cardiotoxicity in <span class=""disease"">multiple sclerosis</span> patients treated quarterly with <span class=""chemical"">mitoxantrone</span> (48 mg/m(2) cumulative), with and without concomitant dexrazoxane, using blinded serial radionucleide ventriculography.",,16374818,16374818_D008942_D009103,16374818_2,bcv_sentence_task_befree_2488,,770958417,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,1,,D008942,"<span class=""chemical"">mitoxantrone</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","These results support a cardioprotective effect of dexrazoxane in <span class=""chemical"">mitoxantrone</span> treated <span class=""disease"">multiple sclerosis</span> patients.",,16374818,16374818_D008942_D009103,16374818_5,bcv_sentence_task_befree_2489,,770958418,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,D064730,"<span class=""chemical"">dexrazoxane</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","These results support a cardioprotective effect of <span class=""chemical"">dexrazoxane</span> in mitoxantrone treated <span class=""disease"">multiple sclerosis</span> patients.",,16374818,16374818_D064730_D009103,16374818_5,bcv_sentence_task_befree_2490,,770958419,FALSE,finalized,5,8/15/15 1:32,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",D020338,"<span class=""disease"">vestibular neuritis</span>","He was diagnosed with <span class=""disease"">vestibular neuritis</span>, and <span class=""chemical"">steroid</span> therapy was initiated.",,16376278,16376278_D013256_D020338,16376278_7,bcv_sentence_task_befree_2491,,770958420,FALSE,finalized,5,8/15/15 0:09,"



",no_relation,1,,D019793,"<span class=""chemical"">fluorescein</span>",D004487,"<span class=""disease"">Cytotoxicity</span>","<span class=""disease"">Cytotoxicity</span> remained the same whether cells were treated with anginex at 4 degrees C or at 37 degrees C. At low temperatures, <span class=""chemical"">fluorescein</span>-conjugated anginex accumulated on the endothelial surface, but did not reach into the cytoplasm, indicating that the cell membrane is the primary target for the peptide.",,16403516,16403516_D019793_D004487,16403516_3,bcv_sentence_task_befree_2492,,770958421,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,1,,D000728,"<span class=""chemical"">Androgen</span>",D011471,"<span class=""disease"">prostate cancer</span>","<span class=""chemical"">Androgen</span> ablation remains the cornerstone of management for advanced <span class=""disease"">prostate cancer</span>.",,16406864,16406864_D000728_D011471,16406864_1,bcv_sentence_task_befree_2493,,770958422,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,D007987,"<span class=""chemical"">gonadotropin-releasing hormone</span>",D011471,"<span class=""disease"">prostate cancer</span>","A comprehensive review of the peer reviewed literature was performed on the topic of secondary hormonal therapies, including oral antiandrogens, adrenal androgen inhibitors, corticosteroids, estrogenic compounds, <span class=""chemical"">gonadotropin-releasing hormone</span> antagonists and alternative hormonal therapies for advanced <span class=""disease"">prostate cancer</span>.",,16406864,16406864_D007987_D011471,16406864_5,bcv_sentence_task_befree_2494,,770958423,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D011471,"<span class=""disease"">prostate cancer</span>","A comprehensive review of the peer reviewed literature was performed on the topic of secondary hormonal therapies, including oral antiandrogens, adrenal androgen inhibitors, <span class=""chemical"">corticosteroids</span>, estrogenic compounds, gonadotropin-releasing hormone antagonists and alternative hormonal therapies for advanced <span class=""disease"">prostate cancer</span>.",,16406864,16406864_D000305_D011471,16406864_5,bcv_sentence_task_befree_2495,,770958424,FALSE,finalized,5,8/14/15 23:18,"



",no_relation,1,,D000728,"<span class=""chemical"">androgen</span>",D011471,"<span class=""disease"">prostate cancer</span>","A comprehensive review of the peer reviewed literature was performed on the topic of secondary hormonal therapies, including oral antiandrogens, adrenal <span class=""chemical"">androgen</span> inhibitors, corticosteroids, estrogenic compounds, gonadotropin-releasing hormone antagonists and alternative hormonal therapies for advanced <span class=""disease"">prostate cancer</span>.",,16406864,16406864_D000728_D011471,16406864_5,bcv_sentence_task_befree_2496,,770958425,FALSE,finalized,5,8/14/15 21:15,"



",no_relation,1,,C076731,"<span class=""chemical"">Levosimendan</span>",D017682,"<span class=""disease"">myocardial stunning</span>","<span class=""chemical"">Levosimendan</span>: a promising treatment for <span class=""disease"">myocardial stunning</span>?",,16409345,16409345_C076731_D017682,16409345_0,bcv_sentence_task_befree_2497,,770958426,FALSE,finalized,5,8/14/15 21:14,"



",no_relation,1,,D002395,"<span class=""chemical"">catecholamine</span>",D054549,"<span class=""disease"">intra aortic balloon counterpulsation</span>","Immediate percutaneous transluminal coronary angioplasty, <span class=""disease"">intra aortic balloon counterpulsation</span>, and <span class=""chemical"">catecholamine</span> therapy failed to stabilise haemodynamics.",,16409345,16409345_D002395_D054549,16409345_4,bcv_sentence_task_befree_2498,,770958427,FALSE,finalized,5,8/14/15 22:42,"



",no_relation,1,,D005419,"<span class=""chemical"">flavonoids</span>",D015459,"<span class=""disease"">human cell line/HL</span>","This study was designed to screen antichlamydial activity of natural <span class=""chemical"">flavonoids</span> and other natural and structurally similar synthetic compounds against Chlamydia pneumoniae in <span class=""disease"">human cell line</span> (<span class=""disease"">HL</span>).",,16414027,16414027_D005419_D015459,16414027_4,bcv_sentence_task_befree_2499,,770958428,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,1,,D005419,"<span class=""chemical"">flavonoids</span>",D002690,"<span class=""disease"">Chlamydia pneumoniae</span>","This study was designed to screen antichlamydial activity of natural <span class=""chemical"">flavonoids</span> and other natural and structurally similar synthetic compounds against <span class=""disease"">Chlamydia pneumoniae</span> in human cell line (HL).",,16414027,16414027_D005419_D002690,16414027_4,bcv_sentence_task_befree_2500,,770958429,FALSE,finalized,5,8/14/15 21:23,"



",no_relation,1,,C057823,"<span class=""chemical"">Salmeterol</span>",D001249,"<span class=""disease"">asthma</span>","The <span class=""chemical"">Salmeterol</span> Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for <span class=""disease"">asthma</span> or usual pharmacotherapy plus <span class=""chemical"">salmeterol</span>.",,16424409,16424409_C057823_D001249,16424409_0,bcv_sentence_task_befree_2501,,770958430,FALSE,finalized,5,8/15/15 0:57,"



",no_relation,0.829,,C057823,"<span class=""chemical"">Salmeterol</span>",D058545,"<span class=""disease"">MDI/metered-dose inhaler</span>","<span class=""chemical"">Salmeterol</span>, 42 mug bid via <span class=""disease"">metered-dose inhaler</span> (<span class=""disease"">MDI</span>), and placebo bid via <span class=""disease"">MDI</span>.",,16424409,16424409_C057823_D058545,16424409_7,bcv_sentence_task_befree_2502,,770958431,FALSE,finalized,5,8/14/15 21:04,"



",no_relation,0.6134,,C057823,"<span class=""chemical"">salmeterol</span>",D003643,"<span class=""disease"">deaths</span>","The occurrence of the primary outcome, respiratory-related <span class=""disease"">deaths</span>, or life-threatening experiences was low and not significantly different for <span class=""chemical"">salmeterol</span> vs placebo (50 vs 36; relative risk [RR] = 1.40; 95% confidence interval [CI], 0.91 to 2.14).",,16424409,16424409_C057823_D003643,16424409_9,bcv_sentence_task_befree_2503,,770958432,FALSE,finalized,5,8/15/15 1:18,"



",yes_direct,0.6195,,C057823,"<span class=""chemical"">salmeterol</span>",D003643,"<span class=""disease"">deaths</span>","There was a small, significant increase in respiratory-related <span class=""disease"">deaths</span> (24 vs 11; RR, 2.16; 95% CI, 1.06 to 4.41) and asthma-related <span class=""disease"">deaths</span> (13 vs 3; RR, 4.37; 95% CI, 1.25 to 15.34), and in combined asthma-related <span class=""disease"">deaths</span> or life-threatening experiences (37 vs 22; RR, 1.71; 95% CI, 1.01 to 2.89) in subjects receiving <span class=""chemical"">salmeterol</span> vs placebo.",,16424409,16424409_C057823_D003643,16424409_10,bcv_sentence_task_befree_2504,,770958433,FALSE,finalized,5,8/14/15 22:13,"



",yes_direct,0.6223,,C057823,"<span class=""chemical"">salmeterol</span>",D001249,"<span class=""disease"">asthma</span>","There was a small, significant increase in respiratory-related deaths (24 vs 11; RR, 2.16; 95% CI, 1.06 to 4.41) and <span class=""disease"">asthma</span>-related deaths (13 vs 3; RR, 4.37; 95% CI, 1.25 to 15.34), and in combined <span class=""disease"">asthma</span>-related deaths or life-threatening experiences (37 vs 22; RR, 1.71; 95% CI, 1.01 to 2.89) in subjects receiving <span class=""chemical"">salmeterol</span> vs placebo.",,16424409,16424409_C057823_D001249,16424409_10,bcv_sentence_task_befree_2505,,770958434,FALSE,finalized,5,8/15/15 1:30,"



",no_relation,0.6008,,C057823,"<span class=""chemical"">salmeterol</span>",D003643,"<span class=""disease"">deaths</span>","The imbalance occurred largely in the African-American subpopulation: respiratory-related <span class=""disease"">deaths</span> or life-threatening experiences (20 vs 5; RR, 4.10; 95% CI, 1.54 to 10.90) and combined asthma-related <span class=""disease"">deaths</span> or life-threatening experiences (19 vs 4; RR, 4.92; 95% CI, 1.68 to 14.45) in subjects receiving <span class=""chemical"">salmeterol</span> vs placebo.",,16424409,16424409_C057823_D003643,16424409_11,bcv_sentence_task_befree_2506,,770958435,FALSE,finalized,5,8/14/15 21:10,"



",yes_direct,1,,C057823,"<span class=""chemical"">salmeterol</span>",D001249,"<span class=""disease"">asthma</span>","The imbalance occurred largely in the African-American subpopulation: respiratory-related deaths or life-threatening experiences (20 vs 5; RR, 4.10; 95% CI, 1.54 to 10.90) and combined <span class=""disease"">asthma</span>-related deaths or life-threatening experiences (19 vs 4; RR, 4.92; 95% CI, 1.68 to 14.45) in subjects receiving <span class=""chemical"">salmeterol</span> vs placebo.",,16424409,16424409_C057823_D001249,16424409_11,bcv_sentence_task_befree_2507,,770958436,FALSE,finalized,5,8/15/15 0:43,"



",yes_indirect,0.4222,,C057823,"<span class=""chemical"">salmeterol</span>",D003643,"<span class=""disease"">deaths</span>","There were small, but statistically significant increases in respiratory-related and asthma-related <span class=""disease"">deaths</span> and combined asthma-related <span class=""disease"">deaths</span> or life-threatening experiences in the total population receiving <span class=""chemical"">salmeterol</span>.",,16424409,16424409_C057823_D003643,16424409_13,bcv_sentence_task_befree_2508,,770958437,FALSE,finalized,5,8/14/15 21:38,"



",yes_direct,1,,C057823,"<span class=""chemical"">salmeterol</span>",D001249,"<span class=""disease"">asthma</span>","There were small, but statistically significant increases in respiratory-related and <span class=""disease"">asthma</span>-related deaths and combined <span class=""disease"">asthma</span>-related deaths or life-threatening experiences in the total population receiving <span class=""chemical"">salmeterol</span>.",,16424409,16424409_C057823_D001249,16424409_13,bcv_sentence_task_befree_2509,,770958438,FALSE,finalized,5,8/15/15 0:12,"



",no_relation,1,,D010406,"<span class=""chemical"">penicillin</span>",D006948,"<span class=""disease"">neuropsychiatric symptoms</span>","His <span class=""disease"">neuropsychiatric symptoms</span> recovered gradually after <span class=""chemical"">penicillin</span> treatment two months later.",,16425549,16425549_D010406_D006948,16425549_4,bcv_sentence_task_befree_2510,,770958439,FALSE,finalized,5,8/15/15 1:45,"



",no_relation,1,,C509125,"<span class=""chemical"">marinomycin A</span>",D008545,"<span class=""disease"">melanoma</span>","In room light, <span class=""chemical"">marinomycin A</span> slowly isomerizes to its geometrical isomers marinomycins B and C. Marinomycins A-D show significant antimicrobial activities against drug resistant bacterial pathogens and demonstrate impressive and selective cancer cell cytotoxicities against six of the eight <span class=""disease"">melanoma</span> cell lines in the National Cancer Institute's 60 cell line panel.",,16448135,16448135_C509125_D008545,16448135_3,bcv_sentence_task_befree_2511,,770958440,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,1,,C509125,"<span class=""chemical"">marinomycin A</span>",D009369,"<span class=""disease"">cancer</span>","In room light, <span class=""chemical"">marinomycin A</span> slowly isomerizes to its geometrical isomers marinomycins B and C. Marinomycins A-D show significant antimicrobial activities against drug resistant bacterial pathogens and demonstrate impressive and selective <span class=""disease"">cancer</span> cell cytotoxicities against six of the eight melanoma cell lines in the National Cancer Institute's 60 cell line panel.",,16448135,16448135_C509125_D009369,16448135_3,bcv_sentence_task_befree_2512,,770958441,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,0.8213,,D013498,"<span class=""chemical"">suramin</span>",D014352,"<span class=""disease"">trypanosomiasis</span>","The first reported human case of <span class=""disease"">trypanosomiasis</span> caused by Trypanosoma evansi was treated using <span class=""chemical"">suramin</span>.",,16455122,16455122_D013498_D014352,16455122_1,bcv_sentence_task_befree_2513,,770958442,FALSE,finalized,5,8/14/15 21:02,"



",no_relation,1,,D013498,"<span class=""chemical"">Suramin</span>",D007239,"<span class=""disease"">infection</span>","<span class=""chemical"">Suramin</span> should be considered in the treatment of other cases of human T. evansi <span class=""disease"">infection</span>, if they occur.",,16455122,16455122_D013498_D007239,16455122_4,bcv_sentence_task_befree_2514,,770958443,FALSE,finalized,5,8/14/15 21:11,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D006470,"<span class=""disease"">SAH</span>","Continuous monitoring of arterial blood pressure (ABP), ICP, cerebral perfusion pressure (CPP), brain tissue <span class=""chemical"">oxygen</span> (PbO2), middle cerebral artery flow velocity (FV), and microdialysis was performed in 14 poor grade <span class=""disease"">SAH</span> patients.",,16463835,16463835_D010100_D006470,16463835_5,bcv_sentence_task_befree_2515,,770958444,FALSE,finalized,5,8/15/15 0:04,"



",no_relation,1,,D006820,"<span class=""chemical"">sodium hyaluronate</span>",D008173,"<span class=""disease"">postoperative small bowel obstruction</span>","This study aimed to evaluate the efficacy of <span class=""chemical"">sodium hyaluronate</span> and carboxymethylcellulose membrane (Seprafilm) on early <span class=""disease"">postoperative small bowel obstruction</span> (EPSBO).",,16468536,16468536_D006820_D008173,16468536_1,bcv_sentence_task_befree_2516,,770958445,FALSE,finalized,5,8/15/15 0:32,"



",no_relation,1,,C118198,"<span class=""chemical"">Seprafilm</span>",D009371,"<span class=""disease"">surgical site infection</span>","It also examined whether using <span class=""chemical"">Seprafilm</span> affected <span class=""disease"">surgical site infection</span> rates in gastrointestinal surgery.",,16468536,16468536_C118198_D009371,16468536_2,bcv_sentence_task_befree_2517,,770958446,FALSE,finalized,5,8/14/15 21:49,"



",no_relation,1,,C022616,"<span class=""chemical"">3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Our results show that at nanomolar concentrations S100B protects cells against Abeta-mediated <span class=""disease"">cytotoxicity</span>, as assessed by <span class=""chemical"">3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide</span> (MTT) and terminal deoxynucleotidyl transferase-mediated dUTP-fluorescein isothiocyanate nick end-labeling (TUNEL) experiments, by countering the Abeta-mediated decrease in the expression of the anti-apoptotic factor Bcl-2.",,16477616,16477616_C022616_D004487,16477616_6,bcv_sentence_task_befree_2518,,770958447,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,1,,C003223,"<span class=""chemical"">propionylcarnitine</span>",D007383,"<span class=""disease"">intermittent claudication</span>","Effect of <span class=""chemical"">propionylcarnitine</span> on changes in endothelial function and plasma levels of adhesion molecules induced by acute exercise in patients with <span class=""disease"">intermittent claudication</span>.",,16518521,16518521_C003223_D007383,16518521_0,bcv_sentence_task_befree_2519,,770958448,FALSE,finalized,5,8/14/15 22:35,"



",no_relation,1,,C047638,"<span class=""chemical"">Alfuzosin</span>",D011470,"<span class=""disease"">benign prostatic hyperplasia</span>","<span class=""chemical"">Alfuzosin</span> 10 mg once daily prevents overall clinical progression of <span class=""disease"">benign prostatic hyperplasia</span> but not acute urinary retention: results of a 2-year placebo-controlled study.",,16536764,16536764_C047638_D011470,16536764_0,bcv_sentence_task_befree_2520,,770958449,FALSE,finalized,5,8/14/15 21:16,"



",no_relation,1,,C047638,"<span class=""chemical"">alfuzosin</span>",D011470,"<span class=""disease"">benign prostatic hyperplasia</span>","To evaluate the effect of <span class=""chemical"">alfuzosin</span> 10 mg once daily administered for 2 years on progression events in men with lower urinary tract symptoms/<span class=""disease"">benign prostatic hyperplasia</span> (LUTS/BPH).",,16536764,16536764_C047638_D011470,16536764_1,bcv_sentence_task_befree_2521,,770958450,FALSE,finalized,5,8/14/15 22:39,"



",no_relation,1,,C101426,"<span class=""chemical"">Sildenafil citrate</span>",D018917,"<span class=""disease"">ischemic optic neuropathy</span>","<span class=""chemical"">Sildenafil citrate</span> use and the incidence of nonarteritic anterior <span class=""disease"">ischemic optic neuropathy</span>.",,16620369,16620369_C101426_D018917,16620369_0,bcv_sentence_task_befree_2522,,770958451,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,0.5822,,C101426,"<span class=""chemical"">sildenafil</span>",D018917,"<span class=""disease"">ischemic optic neuropathy</span>","Nonarteritic anterior <span class=""disease"">ischemic optic neuropathy</span> (NAION) has been reported rarely in men after taking <span class=""chemical"">sildenafil</span> or other phosphodiesterase 5 inhibitors for erectile dysfunction (ED).",,16620369,16620369_C101426_D018917,16620369_1,bcv_sentence_task_befree_2523,,770958452,FALSE,finalized,5,8/15/15 1:24,"



",no_relation,0.8165,,C101426,"<span class=""chemical"">sildenafil</span>",D007172,"<span class=""disease"">ED/erectile dysfunction</span>","Nonarteritic anterior ischemic optic neuropathy (NAION) has been reported rarely in men after taking <span class=""chemical"">sildenafil</span> or other phosphodiesterase 5 inhibitors for <span class=""disease"">erectile dysfunction</span> (<span class=""disease"">ED</span>).",,16620369,16620369_C101426_D007172,16620369_1,bcv_sentence_task_befree_2524,,770958453,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,1,,C101426,"<span class=""chemical"">sildenafil</span>",D007172,"<span class=""disease"">ED</span>","The incidence of NAION in men receiving <span class=""chemical"">sildenafil</span> treatment for <span class=""disease"">ED</span> was estimated using pooled safety data from global clinical trials and European observational studies.",,16620369,16620369_C101426_D007172,16620369_2,bcv_sentence_task_befree_2525,,770958454,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,1,,C101426,"<span class=""chemical"">sildenafil</span>",D007172,"<span class=""disease"">ED</span>","The data cited herein do not suggest an increased incidence of NAION in men who took <span class=""chemical"">sildenafil</span> for <span class=""disease"">ED</span>.",,16620369,16620369_C101426_D007172,16620369_5,bcv_sentence_task_befree_2526,,770958455,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,0.8069,,C111217,"<span class=""chemical"">vinflunine</span>",D001749,"<span class=""disease"">bladder cancer</span>","A phase II study of <span class=""chemical"">vinflunine</span> in <span class=""disease"">bladder cancer</span> patients progressing after first-line platinum-containing regimen.",,16622447,16622447_C111217_D001749,16622447_0,bcv_sentence_task_befree_2527,,770958456,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D010984,"<span class=""chemical"">platinum</span>",D001749,"<span class=""disease"">bladder cancer</span>","A phase II study of vinflunine in <span class=""disease"">bladder cancer</span> patients progressing after first-line <span class=""chemical"">platinum</span>-containing regimen.",,16622447,16622447_D010984_D001749,16622447_0,bcv_sentence_task_befree_2528,,770958457,FALSE,finalized,5,8/14/15 21:25,"



",yes_direct,0.5953,,C111217,"<span class=""chemical"">vinflunine</span>",D064420,"<span class=""disease"">toxicity</span>","A multicentre phase II trial to determine the efficacy of <span class=""chemical"">vinflunine</span> as second-line therapy in patients with advanced transitional cell carcinoma (TCC) of the bladder; secondary objectives were to assess duration of response, progression-free survival (PFS) and overall survival (OS), and to evaluate the <span class=""disease"">toxicity</span> associated with this treatment.",,16622447,16622447_C111217_D064420,16622447_1,bcv_sentence_task_befree_2529,,770958458,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,1,,C111217,"<span class=""chemical"">vinflunine</span>",D002295,"<span class=""disease"">transitional cell carcinoma/TCC</span>","A multicentre phase II trial to determine the efficacy of <span class=""chemical"">vinflunine</span> as second-line therapy in patients with advanced <span class=""disease"">transitional cell carcinoma</span> (<span class=""disease"">TCC</span>) of the bladder; secondary objectives were to assess duration of response, progression-free survival (PFS) and overall survival (OS), and to evaluate the toxicity associated with this treatment.",,16622447,16622447_C111217_D002295,16622447_1,bcv_sentence_task_befree_2530,,770958459,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,0.8067,,D010984,"<span class=""chemical"">platinum</span>",D009369,"<span class=""disease"">tumours</span>","Patients had <span class=""disease"">tumours</span> that failed or progressed after first-line <span class=""chemical"">platinum</span>-containing regimens for advanced or metastatic disease, or had progressive disease after <span class=""chemical"">platinum</span>-containing chemotherapy given with adjuvant or neoadjuvant intent.",,16622447,16622447_D010984_D009369,16622447_2,bcv_sentence_task_befree_2531,,770958460,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,D010984,"<span class=""chemical"">platinum</span>",D018223,"<span class=""disease"">metastatic disease</span>","Patients had tumours that failed or progressed after first-line <span class=""chemical"">platinum</span>-containing regimens for advanced or <span class=""disease"">metastatic disease</span>, or had progressive disease after <span class=""chemical"">platinum</span>-containing chemotherapy given with adjuvant or neoadjuvant intent.",,16622447,16622447_D010984_D018223,16622447_2,bcv_sentence_task_befree_2532,,770958461,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,1,,D014748,"<span class=""chemical"">vinca alkaloids</span>",D018223,"<span class=""disease"">metastatic disease</span>","Of note, responses were seen in patients with relatively poor prognostic factors such as a short (<12 months) interval from prior platinum therapy (19%, including an 11% response rate in those progressing <3 months after platinum treatment), prior treatment for <span class=""disease"">metastatic disease</span> (24%), prior treatment with <span class=""chemical"">vinca alkaloids</span> (14%) and visceral involvement (20%).",,16622447,16622447_D014748_D018223,16622447_5,bcv_sentence_task_befree_2533,,770958462,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,1,,D010984,"<span class=""chemical"">platinum</span>",D018223,"<span class=""disease"">metastatic disease</span>","Of note, responses were seen in patients with relatively poor prognostic factors such as a short (<12 months) interval from prior <span class=""chemical"">platinum</span> therapy (19%, including an 11% response rate in those progressing <3 months after <span class=""chemical"">platinum</span> treatment), prior treatment for <span class=""disease"">metastatic disease</span> (24%), prior treatment with vinca alkaloids (14%) and visceral involvement (20%).",,16622447,16622447_D010984_D018223,16622447_5,bcv_sentence_task_befree_2534,,770958463,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,C111217,"<span class=""chemical"">Vinflunine</span>",D002295,"<span class=""disease"">TCC</span>","<span class=""chemical"">Vinflunine</span> is an active agent for the treatment of platinum-pretreated bladder cancer, and these results warrant further investigation in phase III trials, either as monotherapy or in combination with other agents as treatment of advanced/metastatic <span class=""disease"">TCC</span> of the bladder.",,16622447,16622447_C111217_D002295,16622447_14,bcv_sentence_task_befree_2535,,770958464,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,1,,C111217,"<span class=""chemical"">Vinflunine</span>",D001749,"<span class=""disease"">bladder cancer</span>","<span class=""chemical"">Vinflunine</span> is an active agent for the treatment of platinum-pretreated <span class=""disease"">bladder cancer</span>, and these results warrant further investigation in phase III trials, either as monotherapy or in combination with other agents as treatment of advanced/metastatic TCC of the bladder.",,16622447,16622447_C111217_D001749,16622447_14,bcv_sentence_task_befree_2536,,770958465,FALSE,finalized,5,8/14/15 21:49,"



",no_relation,1,,D010984,"<span class=""chemical"">platinum</span>",D001749,"<span class=""disease"">bladder cancer</span>","Vinflunine is an active agent for the treatment of <span class=""chemical"">platinum</span>-pretreated <span class=""disease"">bladder cancer</span>, and these results warrant further investigation in phase III trials, either as monotherapy or in combination with other agents as treatment of advanced/metastatic TCC of the bladder.",,16622447,16622447_D010984_D001749,16622447_14,bcv_sentence_task_befree_2537,,770958466,FALSE,finalized,5,8/14/15 21:57,"



",no_relation,1,,D010984,"<span class=""chemical"">platinum</span>",D002295,"<span class=""disease"">TCC</span>","Vinflunine is an active agent for the treatment of <span class=""chemical"">platinum</span>-pretreated bladder cancer, and these results warrant further investigation in phase III trials, either as monotherapy or in combination with other agents as treatment of advanced/metastatic <span class=""disease"">TCC</span> of the bladder.",,16622447,16622447_D010984_D002295,16622447_14,bcv_sentence_task_befree_2538,,770958467,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,1,,D010672,"<span class=""chemical"">phenytoin</span>",D019966,"<span class=""disease"">antiepileptic drugs</span>","Pharmacoresistance in epileptic patients may be ascribed to at least two, not mutually exclusive, mechanisms: a pharmacokinetic mechanism and a decreased sensitivity or availability of targets to <span class=""disease"">antiepileptic drugs</span> (AEDs; i.e., carbamazepine and <span class=""chemical"">phenytoin</span> (CBZ, PHT)).",,16631625,16631625_D010672_D019966,16631625_1,bcv_sentence_task_befree_2539,,770958468,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,1,,D002220,"<span class=""chemical"">CBZ/carbamazepine</span>",D019966,"<span class=""disease"">antiepileptic drugs</span>","Pharmacoresistance in epileptic patients may be ascribed to at least two, not mutually exclusive, mechanisms: a pharmacokinetic mechanism and a decreased sensitivity or availability of targets to <span class=""disease"">antiepileptic drugs</span> (AEDs; i.e., <span class=""chemical"">carbamazepine</span> and phenytoin (<span class=""chemical"">CBZ</span>, PHT)).",,16631625,16631625_D002220_D019966,16631625_1,bcv_sentence_task_befree_2540,,770958469,FALSE,finalized,5,8/15/15 0:44,"



",no_relation,1,,D010672,"<span class=""chemical"">phenytoin</span>",D004827,"<span class=""disease"">epileptic</span>","Pharmacoresistance in <span class=""disease"">epileptic</span> patients may be ascribed to at least two, not mutually exclusive, mechanisms: a pharmacokinetic mechanism and a decreased sensitivity or availability of targets to antiepileptic drugs (AEDs; i.e., carbamazepine and <span class=""chemical"">phenytoin</span> (CBZ, PHT)).",,16631625,16631625_D010672_D004827,16631625_1,bcv_sentence_task_befree_2541,,770958470,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,D002220,"<span class=""chemical"">CBZ/carbamazepine</span>",D004827,"<span class=""disease"">epileptic</span>","Pharmacoresistance in <span class=""disease"">epileptic</span> patients may be ascribed to at least two, not mutually exclusive, mechanisms: a pharmacokinetic mechanism and a decreased sensitivity or availability of targets to antiepileptic drugs (AEDs; i.e., <span class=""chemical"">carbamazepine</span> and phenytoin (<span class=""chemical"">CBZ</span>, PHT)).",,16631625,16631625_D002220_D004827,16631625_1,bcv_sentence_task_befree_2542,,770958471,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,1,,D010672,"<span class=""chemical"">phenytoin</span>",D006976,"<span class=""disease"">PHT</span>","Pharmacoresistance in epileptic patients may be ascribed to at least two, not mutually exclusive, mechanisms: a pharmacokinetic mechanism and a decreased sensitivity or availability of targets to antiepileptic drugs (AEDs; i.e., carbamazepine and <span class=""chemical"">phenytoin</span> (CBZ, <span class=""disease"">PHT</span>)).",,16631625,16631625_D010672_D006976,16631625_1,bcv_sentence_task_befree_2543,,770958472,FALSE,finalized,5,8/15/15 0:51,"



",no_relation,1,,D002220,"<span class=""chemical"">CBZ/carbamazepine</span>",D006976,"<span class=""disease"">PHT</span>","Pharmacoresistance in epileptic patients may be ascribed to at least two, not mutually exclusive, mechanisms: a pharmacokinetic mechanism and a decreased sensitivity or availability of targets to antiepileptic drugs (AEDs; i.e., <span class=""chemical"">carbamazepine</span> and phenytoin (<span class=""chemical"">CBZ</span>, <span class=""disease"">PHT</span>)).",,16631625,16631625_D002220_D006976,16631625_1,bcv_sentence_task_befree_2544,,770958473,FALSE,finalized,5,8/15/15 1:42,"



",no_relation,1,,D005680,"<span class=""chemical"">GABA</span>",D004827,"<span class=""disease"">epileptic</span>","Slices from drug-resistant <span class=""disease"">epileptic</span> patients made hypersynchronous/hyperexcitable by elevated potassium or inhibition of <span class=""chemical"">GABA</span>-A receptors behaved similarly.",,16631625,16631625_D005680_D004827,16631625_7,bcv_sentence_task_befree_2545,,770958474,FALSE,finalized,5,8/14/15 21:09,"



",no_relation,0.7936,,D011188,"<span class=""chemical"">potassium</span>",D004827,"<span class=""disease"">epileptic</span>","Slices from drug-resistant <span class=""disease"">epileptic</span> patients made hypersynchronous/hyperexcitable by elevated <span class=""chemical"">potassium</span> or inhibition of GABA-A receptors behaved similarly.",,16631625,16631625_D011188_D004827,16631625_7,bcv_sentence_task_befree_2546,,770958475,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,1,,D019821,"<span class=""chemical"">statins</span>",C535382,"<span class=""disease"">renal dysfunction</span>","The aim of the present study was to assess the effect of <span class=""chemical"">statins</span> on renal function in patients at high risk for <span class=""disease"">renal dysfunction</span>, that is, those who underwent suprarenal aortic cross clamping-declamping.",,16635616,16635616_D019821_C535382,16635616_2,bcv_sentence_task_befree_2547,,770958476,FALSE,finalized,5,8/15/15 1:09,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",D019106,"<span class=""disease"">blood loss</span>","An analysis-of-variance model for repeated measurements was applied to compare <span class=""chemical"">creatinine</span> levels between statin users and nonusers, with adjustment for clamping time and <span class=""disease"">blood loss</span>.",,16635616,16635616_D003404_D019106,16635616_5,bcv_sentence_task_befree_2548,,770958477,FALSE,finalized,5,8/14/15 23:34,"

It's 'Alcohol-impaired driving' and not just 'Alcohol-impaired' :)

",no_relation,0.6021,,D000431,"<span class=""chemical"">Alcohol</span>",D000437,"<span class=""disease"">Alcohol-impaired</span>","<span class=""chemical""></span><span class=""disease"">Alcohol</span>-impaired driving and its consequences in the United States: the past 25 years.",,16647085,16647085_D000431_D000437,16647085_0,bcv_sentence_task_befree_2549,,770958478,FALSE,finalized,5,8/14/15 21:25,"



",no_relation,0.6051,,D000431,"<span class=""chemical"">Alcohol</span>",D000437,"<span class=""disease"">Alcohol-impaired</span>","<span class=""chemical""></span><span class=""disease"">Alcohol</span>-impaired driving is still a major problem that needs continuing attention.",,16647085,16647085_D000431_D000437,16647085_11,bcv_sentence_task_befree_2550,,770958479,FALSE,finalized,5,8/15/15 0:32,"



",no_relation,0.6032,,D002118,"<span class=""chemical"">calcium</span>",D012516,"<span class=""disease"">osteosarcoma</span>","Bone-like tissue formation by three-dimensional culture of MG63 <span class=""disease"">osteosarcoma</span> cells in gelatin hydrogels using <span class=""chemical"">calcium</span>-enriched medium.",,16674304,16674304_D002118_D012516,16674304_0,bcv_sentence_task_befree_2551,,770958480,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D012516,"<span class=""disease"">Human osteosarcoma</span>","<span class=""disease"">Human osteosarcoma</span> MG63 cells were cultured on tissue culture dish under various Ca(2+) concentrations to evaluate the effect of Ca(2+) concentration on <span class=""chemical"">calcium</span> deposition.",,16674304,16674304_D002118_D012516,16674304_2,bcv_sentence_task_befree_2552,,770958481,FALSE,finalized,5,8/14/15 21:23,"



",no_relation,1,,C064276,"<span class=""chemical"">Pantoprazole</span>",D006470,"<span class=""disease"">ulcer bleeding</span>","<span class=""chemical"">Pantoprazole</span> infusion as adjuvant therapy to endoscopic treatment in patients with peptic <span class=""disease"">ulcer bleeding</span>: prospective randomized controlled trial.",,16677158,16677158_C064276_D006470,16677158_0,bcv_sentence_task_befree_2553,,770958482,FALSE,finalized,5,8/14/15 23:20,"

'Improve the outcome' being the key term.

",no_relation,1,,C064276,"<span class=""chemical"">pantoprazole</span>",D006470,"<span class=""disease"">ulcer bleeding</span>","We investigated whether or not administration of <span class=""chemical"">pantoprazole</span> infusion would improve the outcome in <span class=""disease"">ulcer bleeding</span> following successful endoscopic therapy.",,16677158,16677158_C064276_D006470,16677158_3,bcv_sentence_task_befree_2554,,770958483,FALSE,finalized,5,8/14/15 21:10,"



",no_relation,1,,D004837,"<span class=""chemical"">epinephrine</span>",D013276,"<span class=""disease"">gastric or duodenal ulcers with active bleeding</span>","In this double-blind, placebo-controlled, prospective trial, patients who had <span class=""disease"">gastric or duodenal ulcers with active bleeding</span> or non-bleeding visible vessel received combined endoscopy therapy with injection of <span class=""chemical"">epinephrine</span> and heater probe application.",,16677158,16677158_D004837_D013276,16677158_4,bcv_sentence_task_befree_2555,,770958484,FALSE,finalized,5,8/14/15 23:32,"



",no_relation,1,,D004837,"<span class=""chemical"">epinephrine</span>",D006470,"<span class=""disease"">bleeding</span>","In this double-blind, placebo-controlled, prospective trial, patients who had gastric or duodenal ulcers with active bleeding or non-<span class=""disease"">bleeding</span> visible vessel received combined endoscopy therapy with injection of <span class=""chemical"">epinephrine</span> and heater probe application.",,16677158,16677158_D004837_D006470,16677158_4,bcv_sentence_task_befree_2556,,770958485,FALSE,finalized,5,8/14/15 21:31,"



",no_relation,0.5942,,C064276,"<span class=""chemical"">pantoprazole</span>",D006470,"<span class=""disease"">bleeding</span>","Three (2.9%) patients in the <span class=""chemical"">pantoprazole</span> group and eight (7.9%) in the placebo group required surgery to control their <span class=""disease"">bleeding</span> (P = 0.12).",,16677158,16677158_C064276_D006470,16677158_9,bcv_sentence_task_befree_2557,,770958486,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,C064276,"<span class=""chemical"">pantoprazole</span>",D010438,"<span class=""disease"">bleeding peptic ulcers</span>","In patients with <span class=""disease"">bleeding peptic ulcers</span>, the use of high dose <span class=""chemical"">pantoprazole</span> infusion following successful endoscopic therapy is effective in reducing rebleeding, transfusion requirements and hospital stay.",,16677158,16677158_C064276_D010438,16677158_11,bcv_sentence_task_befree_2558,,770958487,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,1,,C037663,"<span class=""chemical"">Ropivacaine</span>",D004409,"<span class=""disease"">akinesia</span>","<span class=""chemical"">Ropivacaine</span> used for retrobulbar-peribulbar combined anesthesia in vitreoretinal surgery showed excellent clinical efficacy as regards analgesia and muscle <span class=""disease"">akinesia</span>.",,16703549,16703549_C037663_D004409,16703549_16,bcv_sentence_task_befree_2559,,770958488,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,D000728,"<span class=""chemical"">androgen</span>",D011471,"<span class=""disease"">prostate cancer</span>","Prostate <span class=""chemical"">androgen</span>-regulated gene: a novel potential target for <span class=""chemical"">androgen</span>-independent <span class=""disease"">prostate cancer</span> therapy.",,16763722,16763722_D000728_D011471,16763722_0,bcv_sentence_task_befree_2560,,770958489,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,D000728,"<span class=""chemical"">androgen</span>",D011471,"<span class=""disease"">prostate cancer/PCa</span>","To investigate the involvement of the prostate <span class=""chemical"">androgen</span>-regulated (PAR) gene in the <span class=""chemical"">androgen</span> receptor (AR) signaling pathway and the malignant phenotype of <span class=""chemical"">androgen</span>-independent <span class=""disease"">prostate cancer</span> (<span class=""disease"">PCa</span>) cells.",,16763722,16763722_D000728_D011471,16763722_1,bcv_sentence_task_befree_2561,,770958490,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,0.7879,,D000728,"<span class=""chemical"">androgen</span>",D011471,"<span class=""disease"">PCa</span>","To determine the importance of PAR in the malignant proliferation of <span class=""chemical"">androgen</span>-independent <span class=""disease"">PCa</span> cells, we used small interfering RNA (siRNA) transfection to knock down the expression of the gene in PC3 cells.",,16763722,16763722_D000728_D011471,16763722_4,bcv_sentence_task_befree_2562,,770958491,FALSE,finalized,5,8/15/15 2:04,"



",no_relation,1,,D000728,"<span class=""chemical"">androgen</span>",D011471,"<span class=""disease"">PCa</span>","Because of the possibility that PAR is downstream from the AR, and because of its contribution to malignant proliferation in <span class=""chemical"">androgen</span>-independent <span class=""disease"">PCa</span> cells, the gene could be a potential therapeutic target for <span class=""chemical"">androgen</span>-independent <span class=""disease"">PCa</span> with AR signaling pathway alteration.",,16763722,16763722_D000728_D011471,16763722_11,bcv_sentence_task_befree_2563,,770958492,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,1,,C047781,"<span class=""chemical"">lamotrigine</span>",D001523,"<span class=""disease"">Mental Disorders</span>","We evaluated all patients under age 18 with Diagnostic and Statistical Manual of <span class=""disease"">Mental Disorders</span>, fourth edition, text revision (DSM-IV-TR) bipolar disorder in our outpatient clinic treated with <span class=""chemical"">lamotrigine</span>, using the Clinical Global Impression (CGI) scale.",,16768643,16768643_C047781_D001523,16768643_2,bcv_sentence_task_befree_2564,,770958493,FALSE,finalized,5,8/14/15 21:07,"



",no_relation,1,,C047781,"<span class=""chemical"">lamotrigine</span>",D001714,"<span class=""disease"">bipolar disorder</span>","We evaluated all patients under age 18 with Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision (DSM-IV-TR) <span class=""disease"">bipolar disorder</span> in our outpatient clinic treated with <span class=""chemical"">lamotrigine</span>, using the Clinical Global Impression (CGI) scale.",,16768643,16768643_C047781_D001714,16768643_2,bcv_sentence_task_befree_2565,,770958494,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,C047781,"<span class=""chemical"">lamotrigine</span>",D001714,"<span class=""disease"">bipolar disorder</span>","This open, retrospective chart review suggests that <span class=""chemical"">lamotrigine</span> may be effective and well tolerated as an adjunctive treatment in adolescents with <span class=""disease"">bipolar disorder</span>.",,16768643,16768643_C047781_D001714,16768643_12,bcv_sentence_task_befree_2566,,770958495,FALSE,finalized,5,8/15/15 1:21,"



",yes_direct,1,,D002104,"<span class=""chemical"">Cd</span>",D006470,"<span class=""disease"">hemorrhage</span>","In animal experiments, high-dose exposure to <span class=""chemical"">Cd</span> induced severe testicular interstitial <span class=""disease"">hemorrhage</span> with edema, and increased incidence of fetal death and placental necrosis.",,16788562,16788562_D002104_D006470,16788562_3,bcv_sentence_task_befree_2567,,770958496,FALSE,finalized,5,8/15/15 2:10,"



",yes_direct,0.7946,,D002104,"<span class=""chemical"">Cd</span>",D009336,"<span class=""disease"">necrosis</span>","In animal experiments, high-dose exposure to <span class=""chemical"">Cd</span> induced severe testicular interstitial hemorrhage with edema, and increased incidence of fetal death and placental <span class=""disease"">necrosis</span>.",,16788562,16788562_D002104_D009336,16788562_3,bcv_sentence_task_befree_2568,,770958497,FALSE,finalized,5,8/15/15 1:21,"



",yes_direct,0.6045,,D002104,"<span class=""chemical"">Cd</span>",D005313,"<span class=""disease"">fetal death</span>","In animal experiments, high-dose exposure to <span class=""chemical"">Cd</span> induced severe testicular interstitial hemorrhage with edema, and increased incidence of <span class=""disease"">fetal death</span> and placental necrosis.",,16788562,16788562_D002104_D005313,16788562_3,bcv_sentence_task_befree_2569,,770958498,FALSE,finalized,5,8/15/15 2:12,"



",yes_direct,0.6051,,D002104,"<span class=""chemical"">Cd</span>",D004487,"<span class=""disease"">edema</span>","In animal experiments, high-dose exposure to <span class=""chemical"">Cd</span> induced severe testicular interstitial hemorrhage with <span class=""disease"">edema</span>, and increased incidence of fetal death and placental necrosis.",,16788562,16788562_D002104_D004487,16788562_3,bcv_sentence_task_befree_2570,,770958499,FALSE,finalized,5,8/15/15 2:02,"



",yes_direct,0.7838,,C110904,"<span class=""chemical"">Capecitabine</span>",D064420,"<span class=""disease"">cerebellar toxicity</span>","<span class=""chemical"">Capecitabine</span>-induced <span class=""disease"">cerebellar toxicity</span>.",,16796795,16796795_C110904_D064420,16796795_0,bcv_sentence_task_befree_2571,,770958500,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,C110904,"<span class=""chemical"">Capecitabine</span>",D000230,"<span class=""disease"">adenocarcinoma of the colon</span>","<span class=""chemical"">Capecitabine</span> is an oral prodrug of 5-fluorouracil used in the treatment of <span class=""disease"">adenocarcinoma of the colon</span>.",,16796795,16796795_C110904_D000230,16796795_1,bcv_sentence_task_befree_2572,,770958501,FALSE,finalized,5,8/14/15 21:31,"



",no_relation,1,,D005472,"<span class=""chemical"">5-fluorouracil</span>",D000230,"<span class=""disease"">adenocarcinoma of the colon</span>","Capecitabine is an oral prodrug of <span class=""chemical"">5-fluorouracil</span> used in the treatment of <span class=""disease"">adenocarcinoma of the colon</span>.",,16796795,16796795_D005472_D000230,16796795_1,bcv_sentence_task_befree_2573,,770958502,FALSE,finalized,5,8/14/15 23:13,"



",yes_direct,0.5956,,C110904,"<span class=""chemical"">capecitabine</span>",D020258,"<span class=""disease"">Neurotoxicity</span>","<span class=""disease"">Neurotoxicity</span> is an infrequently reported toxicity of <span class=""chemical"">capecitabine</span>.",,16796795,16796795_C110904_D020258,16796795_2,bcv_sentence_task_befree_2574,,770958503,FALSE,finalized,5,8/15/15 1:24,"



",yes_direct,0.7993,,C110904,"<span class=""chemical"">capecitabine</span>",D064420,"<span class=""disease"">toxicity</span>","Neurotoxicity is an infrequently reported <span class=""disease"">toxicity</span> of <span class=""chemical"">capecitabine</span>.",,16796795,16796795_C110904_D064420,16796795_2,bcv_sentence_task_befree_2575,,770958504,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D014031,"<span class=""chemical"">tobramycin</span>",D003550,"<span class=""disease"">cystic fibrosis</span>","Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily <span class=""chemical"">tobramycin</span> in <span class=""disease"">cystic fibrosis</span> patients.",,16801404,16801404_D014031_D003550,16801404_0,bcv_sentence_task_befree_2576,,770958505,FALSE,finalized,5,8/15/15 0:51,"



",no_relation,1,,D014031,"<span class=""chemical"">tobramycin</span>",D003550,"<span class=""disease"">cystic fibrosis</span>","We undertook assessment of hearing in patients with <span class=""disease"">cystic fibrosis</span> who were taking part in a large randomized controlled trial of once- versus three-times-daily <span class=""chemical"">tobramycin</span> for pulmonary exacerbations of <span class=""disease"">cystic fibrosis</span> (the TOPIC study).",,16801404,16801404_D014031_D003550,16801404_1,bcv_sentence_task_befree_2577,,770958506,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D014031,"<span class=""chemical"">tobramycin</span>",D009461,"<span class=""disease"">auditory deficit</span>","We conclude that for a single 14-day course of <span class=""chemical"">tobramycin</span> treatment in patients with cystic fibrosis with no preexisiting <span class=""disease"">auditory deficit</span>, no measurable effect on hearing was apparent with either once- or three-times-daily treatment.",,16801404,16801404_D014031_D009461,16801404_11,bcv_sentence_task_befree_2578,,770958507,FALSE,finalized,5,8/15/15 2:30,"



",no_relation,1,,D014031,"<span class=""chemical"">tobramycin</span>",D003550,"<span class=""disease"">cystic fibrosis</span>","We conclude that for a single 14-day course of <span class=""chemical"">tobramycin</span> treatment in patients with <span class=""disease"">cystic fibrosis</span> with no preexisiting auditory deficit, no measurable effect on hearing was apparent with either once- or three-times-daily treatment.",,16801404,16801404_D014031_D003550,16801404_11,bcv_sentence_task_befree_2579,,770958508,FALSE,finalized,5,8/15/15 0:27,"



",yes_direct,0.5888,,D000617,"<span class=""chemical"">aminoglycoside</span>",D034381,"<span class=""disease"">hearing loss</span>","Estimation of the cumulative cochleotoxic risk in cystic fibrosis patients due to repeated <span class=""chemical"">aminoglycoside</span> therapy, as evidenced by the patients excluded from this study due to <span class=""disease"">hearing loss</span>, also requires further characterization.",,16801404,16801404_D000617_D034381,16801404_12,bcv_sentence_task_befree_2580,,770958509,FALSE,finalized,5,8/14/15 23:19,"



",yes_direct,0.5734,,D000617,"<span class=""chemical"">aminoglycoside</span>",D003550,"<span class=""disease"">cystic fibrosis</span>","Estimation of the cumulative cochleotoxic risk in <span class=""disease"">cystic fibrosis</span> patients due to repeated <span class=""chemical"">aminoglycoside</span> therapy, as evidenced by the patients excluded from this study due to hearing loss, also requires further characterization.",,16801404,16801404_D000617_D003550,16801404_12,bcv_sentence_task_befree_2581,,770958510,FALSE,finalized,5,8/15/15 1:26,"



",no_relation,1,,D014280,"<span class=""chemical"">triacylglycerol</span>",D064250,"<span class=""disease"">hypertriglyceridemic</span>","Ten healthy elderly men (70-78 y of age, body mass index 21-27 kg/m(2)) and 10 healthy young men (19-45 y of age, body mass index 19-26 kg/m(2)) were studied with a <span class=""disease"">hypertriglyceridemic</span> clamp (primed infusion of a long-chain <span class=""chemical"">triacylglycerol</span> emulsion to reach and stabilize at a <span class=""chemical"">triacylglycerol</span> concentration of 4 mmol/L for 180 min).",,16815487,16815487_D014280_D064250,16815487_2,bcv_sentence_task_befree_2582,,770958511,FALSE,finalized,5,8/15/15 1:38,"



",no_relation,1,,D014280,"<span class=""chemical"">triacylglycerol</span>",D064250,"<span class=""disease"">hypertriglyceridemic</span>","Elderly healthy men have a similar capacity as young healthy men to clear and oxidize a high <span class=""chemical"">triacylglycerol</span> load administered as a <span class=""disease"">hypertriglyceridemic</span> clamp.",,16815487,16815487_D014280_D064250,16815487_11,bcv_sentence_task_befree_2583,,770958512,FALSE,finalized,5,8/15/15 2:07,"



",no_relation,1,,C068329,"<span class=""chemical"">clofarabine</span>",D015451,"<span class=""disease"">chronic lymphocytic leukemia</span>","Clinical and pharmacokinetic study of <span class=""chemical"">clofarabine</span> in <span class=""disease"">chronic lymphocytic leukemia</span>: strategy for treatment.",,16818700,16818700_C068329_D015451,16818700_0,bcv_sentence_task_befree_2584,,770958513,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,1,,C024352,"<span class=""chemical"">fludarabine</span>",D007938,"<span class=""disease"">leukemias</span>","Based on its mechanistic similarity to <span class=""chemical"">fludarabine</span> and cladribine and the success of these analogues for treatment of chronic lymphocytic leukemia (CLL), we hypothesized that clofarabine would be effective for indolent <span class=""disease"">leukemias</span>.",,16818700,16818700_C024352_D007938,16818700_1,bcv_sentence_task_befree_2585,,770958514,FALSE,finalized,5,8/14/15 23:16,"



",no_relation,1,,D017338,"<span class=""chemical"">cladribine</span>",D007938,"<span class=""disease"">leukemias</span>","Based on its mechanistic similarity to fludarabine and <span class=""chemical"">cladribine</span> and the success of these analogues for treatment of chronic lymphocytic leukemia (CLL), we hypothesized that clofarabine would be effective for indolent <span class=""disease"">leukemias</span>.",,16818700,16818700_D017338_D007938,16818700_1,bcv_sentence_task_befree_2586,,770958515,FALSE,finalized,5,8/14/15 23:32,"



",no_relation,1,,C024352,"<span class=""chemical"">fludarabine</span>",D015451,"<span class=""disease"">CLL/chronic lymphocytic leukemia</span>","Based on its mechanistic similarity to <span class=""chemical"">fludarabine</span> and cladribine and the success of these analogues for treatment of <span class=""disease"">chronic lymphocytic leukemia</span> (<span class=""disease"">CLL</span>), we hypothesized that clofarabine would be effective for indolent leukemias.",,16818700,16818700_C024352_D015451,16818700_1,bcv_sentence_task_befree_2587,,770958516,FALSE,finalized,5,8/14/15 23:11,"


Used as treatment.
",no_relation,1,,C068329,"<span class=""chemical"">clofarabine</span>",D015451,"<span class=""disease"">CLL/chronic lymphocytic leukemia</span>","Based on its mechanistic similarity to fludarabine and cladribine and the success of these analogues for treatment of <span class=""disease"">chronic lymphocytic leukemia</span> (<span class=""disease"">CLL</span>), we hypothesized that <span class=""chemical"">clofarabine</span> would be effective for indolent leukemias.",,16818700,16818700_C068329_D015451,16818700_1,bcv_sentence_task_befree_2588,,770958517,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,1,,D017338,"<span class=""chemical"">cladribine</span>",D015451,"<span class=""disease"">CLL/chronic lymphocytic leukemia</span>","Based on its mechanistic similarity to fludarabine and <span class=""chemical"">cladribine</span> and the success of these analogues for treatment of <span class=""disease"">chronic lymphocytic leukemia</span> (<span class=""disease"">CLL</span>), we hypothesized that clofarabine would be effective for indolent leukemias.",,16818700,16818700_D017338_D015451,16818700_1,bcv_sentence_task_befree_2589,,770958518,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,1,,C068329,"<span class=""chemical"">clofarabine</span>",D007938,"<span class=""disease"">leukemias</span>","Based on its mechanistic similarity to fludarabine and cladribine and the success of these analogues for treatment of chronic lymphocytic leukemia (CLL), we hypothesized that <span class=""chemical"">clofarabine</span> would be effective for indolent <span class=""disease"">leukemias</span>.",,16818700,16818700_C068329_D007938,16818700_1,bcv_sentence_task_befree_2590,,770958519,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,C068329,"<span class=""chemical"">clofarabine</span>",D015451,"<span class=""disease"">CLL</span>","The present study was conducted to determine the efficacy and cellular pharmacology during clinical trials of single-agent <span class=""chemical"">clofarabine</span> in <span class=""disease"">CLL</span>.",,16818700,16818700_C068329_D015451,16818700_2,bcv_sentence_task_befree_2591,,770958520,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,C005692,"<span class=""chemical"">triphosphate</span>",D015451,"<span class=""disease"">CLL</span>","In the majority of cases, >50% of the analogue <span class=""chemical"">triphosphate</span> was present 24 hours after infusion, indicating prolonged retention of the <span class=""chemical"">triphosphate</span> in <span class=""disease"">CLL</span> cells.",,16818700,16818700_C005692_D015451,16818700_9,bcv_sentence_task_befree_2592,,770958521,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,0.6051,,C068329,"<span class=""chemical"">clofarabine</span>",D015451,"<span class=""disease"">CLL</span>","In vitro <span class=""chemical"">clofarabine</span> incubation of leukemic lymphocytes from 29 <span class=""disease"">CLL</span> patients showed that clofarabine monophosphate accumulated to a higher concentration compared with the triphosphate.",,16818700,16818700_C068329_D015451,16818700_11,bcv_sentence_task_befree_2593,,770958522,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,C005692,"<span class=""chemical"">triphosphate</span>",D015451,"<span class=""disease"">CLL</span>","In vitro clofarabine incubation of leukemic lymphocytes from 29 <span class=""disease"">CLL</span> patients showed that clofarabine monophosphate accumulated to a higher concentration compared with the <span class=""chemical"">triphosphate</span>.",,16818700,16818700_C005692_D015451,16818700_11,bcv_sentence_task_befree_2594,,770958523,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,C068329,"<span class=""chemical"">clofarabine</span>",D015451,"<span class=""disease"">CLL</span>","Levels of clofarabine triphosphate at higher doses and prolonged maintenance of clofarabine triphosphate in leukemic lymphocytes provide a rationale to treat <span class=""disease"">CLL</span> in a weekly <span class=""chemical"">clofarabine</span> schedule.",,16818700,16818700_C068329_D015451,16818700_13,bcv_sentence_task_befree_2595,,770958524,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,1,,C024307,"<span class=""chemical"">bucindolol</span>",D006333,"<span class=""disease"">HF</span>","Potential pathophysiologic correlates were assessed in a placebo-controlled trial of <span class=""chemical"">bucindolol</span> in 1,040 <span class=""disease"">HF</span> patients.",,16844790,16844790_C024307_D006333,16844790_7,bcv_sentence_task_befree_2596,,770958525,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,D000305,"<span class=""chemical"">Corticosteroid</span>",D003424,"<span class=""disease"">Crohn's disease</span>","<span class=""chemical"">Corticosteroid</span> therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with <span class=""disease"">Crohn's disease</span>.",,16861053,16861053_D000305_D003424,16861053_0,bcv_sentence_task_befree_2597,,770958526,FALSE,finalized,5,8/14/15 21:41,"



",no_relation,1,,D019829,"<span class=""chemical"">nevirapine/NVP</span>",D000163,"<span class=""disease"">AIDS</span>","We analyzed progression to death from any cause and to <span class=""disease"">AIDS</span> or death (<span class=""disease"">AIDS</span>/death), comparing efavirenz (EFV), <span class=""chemical"">nevirapine</span> (<span class=""chemical"">NVP</span>), nelfinavir, idinavir, ritonavir (RTV), RTV-boosted protease inhibitors (PIs), saquinavir, and abacavir.",,16897660,16897660_D019829_D000163,16897660_3,bcv_sentence_task_befree_2598,,770958527,FALSE,finalized,5,8/15/15 1:00,"



",no_relation,1,,C098320,"<span class=""chemical"">EFV/efavirenz</span>",D000163,"<span class=""disease"">AIDS</span>","We analyzed progression to death from any cause and to <span class=""disease"">AIDS</span> or death (<span class=""disease"">AIDS</span>/death), comparing <span class=""chemical"">efavirenz</span> (<span class=""chemical"">EFV</span>), nevirapine (NVP), nelfinavir, idinavir, ritonavir (RTV), RTV-boosted protease inhibitors (PIs), saquinavir, and abacavir.",,16897660,16897660_C098320_D000163,16897660_3,bcv_sentence_task_befree_2599,,770958528,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,C106538,"<span class=""chemical"">abacavir</span>",D000163,"<span class=""disease"">AIDS</span>","We analyzed progression to death from any cause and to <span class=""disease"">AIDS</span> or death (<span class=""disease"">AIDS</span>/death), comparing efavirenz (EFV), nevirapine (NVP), nelfinavir, idinavir, ritonavir (RTV), RTV-boosted protease inhibitors (PIs), saquinavir, and <span class=""chemical"">abacavir</span>.",,16897660,16897660_C106538_D000163,16897660_3,bcv_sentence_task_befree_2600,,770958529,FALSE,finalized,5,8/14/15 23:43,"

Used as treatment.

",no_relation,1,,D019829,"<span class=""chemical"">nevirapine/NVP</span>",D003643,"<span class=""disease"">death</span>","We analyzed progression to <span class=""disease"">death</span> from any cause and to AIDS or <span class=""disease"">death</span> (AIDS/<span class=""disease"">death</span>), comparing efavirenz (EFV), <span class=""chemical"">nevirapine</span> (<span class=""chemical"">NVP</span>), nelfinavir, idinavir, ritonavir (RTV), RTV-boosted protease inhibitors (PIs), saquinavir, and abacavir.",,16897660,16897660_D019829_D003643,16897660_3,bcv_sentence_task_befree_2601,,770958530,FALSE,finalized,5,8/15/15 1:30,"



",no_relation,1,,C098320,"<span class=""chemical"">EFV/efavirenz</span>",D003643,"<span class=""disease"">death</span>","We analyzed progression to <span class=""disease"">death</span> from any cause and to AIDS or <span class=""disease"">death</span> (AIDS/<span class=""disease"">death</span>), comparing <span class=""chemical"">efavirenz</span> (<span class=""chemical"">EFV</span>), nevirapine (NVP), nelfinavir, idinavir, ritonavir (RTV), RTV-boosted protease inhibitors (PIs), saquinavir, and abacavir.",,16897660,16897660_C098320_D003643,16897660_3,bcv_sentence_task_befree_2602,,770958531,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,D019258,"<span class=""chemical"">saquinavir</span>",D000163,"<span class=""disease"">AIDS</span>","We analyzed progression to death from any cause and to <span class=""disease"">AIDS</span> or death (<span class=""disease"">AIDS</span>/death), comparing efavirenz (EFV), nevirapine (NVP), nelfinavir, idinavir, ritonavir (RTV), RTV-boosted protease inhibitors (PIs), <span class=""chemical"">saquinavir</span>, and abacavir.",,16897660,16897660_D019258_D000163,16897660_3,bcv_sentence_task_befree_2603,,770958532,FALSE,finalized,5,8/15/15 1:39,"



",no_relation,1,,C106538,"<span class=""chemical"">abacavir</span>",D003643,"<span class=""disease"">death</span>","We analyzed progression to <span class=""disease"">death</span> from any cause and to AIDS or <span class=""disease"">death</span> (AIDS/<span class=""disease"">death</span>), comparing efavirenz (EFV), nevirapine (NVP), nelfinavir, idinavir, ritonavir (RTV), RTV-boosted protease inhibitors (PIs), saquinavir, and <span class=""chemical"">abacavir</span>.",,16897660,16897660_C106538_D003643,16897660_3,bcv_sentence_task_befree_2604,,770958533,FALSE,finalized,5,8/14/15 21:49,"



",no_relation,1,,D019888,"<span class=""chemical"">nelfinavir</span>",D000163,"<span class=""disease"">AIDS</span>","We analyzed progression to death from any cause and to <span class=""disease"">AIDS</span> or death (<span class=""disease"">AIDS</span>/death), comparing efavirenz (EFV), nevirapine (NVP), <span class=""chemical"">nelfinavir</span>, idinavir, ritonavir (RTV), RTV-boosted protease inhibitors (PIs), saquinavir, and abacavir.",,16897660,16897660_D019888_D000163,16897660_3,bcv_sentence_task_befree_2605,,770958534,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,1,,D019258,"<span class=""chemical"">saquinavir</span>",D003643,"<span class=""disease"">death</span>","We analyzed progression to <span class=""disease"">death</span> from any cause and to AIDS or <span class=""disease"">death</span> (AIDS/<span class=""disease"">death</span>), comparing efavirenz (EFV), nevirapine (NVP), nelfinavir, idinavir, ritonavir (RTV), RTV-boosted protease inhibitors (PIs), <span class=""chemical"">saquinavir</span>, and abacavir.",,16897660,16897660_D019258_D003643,16897660_3,bcv_sentence_task_befree_2606,,770958535,FALSE,finalized,5,8/14/15 22:03,"



",no_relation,1,,D019888,"<span class=""chemical"">nelfinavir</span>",D003643,"<span class=""disease"">death</span>","We analyzed progression to <span class=""disease"">death</span> from any cause and to AIDS or <span class=""disease"">death</span> (AIDS/<span class=""disease"">death</span>), comparing efavirenz (EFV), nevirapine (NVP), <span class=""chemical"">nelfinavir</span>, idinavir, ritonavir (RTV), RTV-boosted protease inhibitors (PIs), saquinavir, and abacavir.",,16897660,16897660_D019888_D003643,16897660_3,bcv_sentence_task_befree_2607,,770958536,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D019438,"<span class=""chemical"">ritonavir/RTV</span>",D000163,"<span class=""disease"">AIDS</span>","We analyzed progression to death from any cause and to <span class=""disease"">AIDS</span> or death (<span class=""disease"">AIDS</span>/death), comparing efavirenz (EFV), nevirapine (NVP), nelfinavir, idinavir, <span class=""chemical"">ritonavir</span> (<span class=""chemical"">RTV</span>), RTV-boosted protease inhibitors (PIs), saquinavir, and abacavir.",,16897660,16897660_D019438_D000163,16897660_3,bcv_sentence_task_befree_2608,,770958537,FALSE,finalized,5,8/14/15 21:15,"



",no_relation,0.8046,,D019438,"<span class=""chemical"">ritonavir/RTV</span>",D003643,"<span class=""disease"">death</span>","We analyzed progression to <span class=""disease"">death</span> from any cause and to AIDS or <span class=""disease"">death</span> (AIDS/<span class=""disease"">death</span>), comparing efavirenz (EFV), nevirapine (NVP), nelfinavir, idinavir, <span class=""chemical"">ritonavir</span> (<span class=""chemical"">RTV</span>), RTV-boosted protease inhibitors (PIs), saquinavir, and abacavir.",,16897660,16897660_D019438_D003643,16897660_3,bcv_sentence_task_befree_2609,,770958538,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,1,,D019829,"<span class=""chemical"">NVP</span>",D000163,"<span class=""disease"">AIDS</span>","Compared with EFV, the adjusted hazard ratio (HR) for <span class=""disease"">AIDS</span>/death was 1.28 (95% confidence interval [CI], 1.03-1.60) for <span class=""chemical"">NVP</span>, 1.31 (95% CI, 1.01-1.71) for RTV, and 1.45 (95% CI, 1.15-1.81) for RTV-boosted PIs.",,16897660,16897660_D019829_D000163,16897660_6,bcv_sentence_task_befree_2610,,770958539,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,1,,D019438,"<span class=""chemical"">RTV</span>",D000163,"<span class=""disease"">AIDS</span>","Compared with EFV, the adjusted hazard ratio (HR) for <span class=""disease"">AIDS</span>/death was 1.28 (95% confidence interval [CI], 1.03-1.60) for NVP, 1.31 (95% CI, 1.01-1.71) for RTV, and 1.45 (95% CI, 1.15-1.81) for <span class=""chemical"">RTV</span>-boosted PIs.",,16897660,16897660_D019438_D000163,16897660_6,bcv_sentence_task_befree_2611,,770958540,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,0.7923,,D019829,"<span class=""chemical"">NVP</span>",D003643,"<span class=""disease"">death</span>","Compared with EFV, the adjusted hazard ratio (HR) for AIDS/<span class=""disease"">death</span> was 1.28 (95% confidence interval [CI], 1.03-1.60) for <span class=""chemical"">NVP</span>, 1.31 (95% CI, 1.01-1.71) for RTV, and 1.45 (95% CI, 1.15-1.81) for RTV-boosted PIs.",,16897660,16897660_D019829_D003643,16897660_6,bcv_sentence_task_befree_2612,,770958541,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,D019438,"<span class=""chemical"">RTV</span>",D003643,"<span class=""disease"">death</span>","Compared with EFV, the adjusted hazard ratio (HR) for AIDS/<span class=""disease"">death</span> was 1.28 (95% confidence interval [CI], 1.03-1.60) for NVP, 1.31 (95% CI, 1.01-1.71) for RTV, and 1.45 (95% CI, 1.15-1.81) for <span class=""chemical"">RTV</span>-boosted PIs.",,16897660,16897660_D019438_D003643,16897660_6,bcv_sentence_task_befree_2613,,770958542,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,D019829,"<span class=""chemical"">NVP</span>",D003643,"<span class=""disease"">death</span>","For <span class=""disease"">death</span>, the adjusted HR for <span class=""chemical"">NVP</span> was 1.65 (95% CI, 1.16-2.36).",,16897660,16897660_D019829_D003643,16897660_7,bcv_sentence_task_befree_2614,,770958543,FALSE,finalized,5,8/15/15 1:55,"



",no_relation,1,,D019259,"<span class=""chemical"">3TC</span>",D003643,"<span class=""disease"">death</span>","The adjusted HR for <span class=""disease"">death</span> for D4T/3TC was 1.35 (95% CI, 1.14-1.59), compared with AZT/<span class=""chemical"">3TC</span>.",,16897660,16897660_D019259_D003643,16897660_8,bcv_sentence_task_befree_2615,,770958544,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,0.7999,,D015215,"<span class=""chemical"">AZT</span>",D003643,"<span class=""disease"">death</span>","The adjusted HR for <span class=""disease"">death</span> for D4T/3TC was 1.35 (95% CI, 1.14-1.59), compared with <span class=""chemical"">AZT</span>/3TC.",,16897660,16897660_D015215_D003643,16897660_8,bcv_sentence_task_befree_2616,,770958545,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,0.5989,,C099041,"<span class=""chemical"">Tolterodine</span>",D053201,"<span class=""disease"">overactive bladder/overactive bladder symptoms</span>","<span class=""chemical"">Tolterodine</span> extended release improves <span class=""disease"">overactive bladder symptoms</span> in men with <span class=""disease"">overactive bladder</span> and nocturia.",,16904446,16904446_C099041_D053201,16904446_0,bcv_sentence_task_befree_2617,,770958546,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,1,,C099041,"<span class=""chemical"">Tolterodine</span>",D053158,"<span class=""disease"">nocturia</span>","<span class=""chemical"">Tolterodine</span> extended release improves overactive bladder symptoms in men with overactive bladder and <span class=""disease"">nocturia</span>.",,16904446,16904446_C099041_D053158,16904446_0,bcv_sentence_task_befree_2618,,770958547,FALSE,finalized,5,8/14/15 21:16,"



",no_relation,1,,C099041,"<span class=""chemical"">tolterodine</span>",D053201,"<span class=""disease"">overactive bladder/OAB</span>","To evaluate the efficacy and safety of nighttime dosing with <span class=""chemical"">tolterodine</span> extended release (TER) in men with <span class=""disease"">overactive bladder</span> (<span class=""disease"">OAB</span>) and nocturia.",,16904446,16904446_C099041_D053201,16904446_1,bcv_sentence_task_befree_2619,,770958548,FALSE,finalized,5,8/15/15 1:40,"



",no_relation,0.8111,,C099041,"<span class=""chemical"">tolterodine</span>",D053158,"<span class=""disease"">nocturia</span>","To evaluate the efficacy and safety of nighttime dosing with <span class=""chemical"">tolterodine</span> extended release (TER) in men with overactive bladder (OAB) and <span class=""disease"">nocturia</span>.",,16904446,16904446_C099041_D053158,16904446_1,bcv_sentence_task_befree_2620,,770958549,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,D004280,"<span class=""chemical"">Dobutamine</span>",D009203,"<span class=""disease"">myocardial infarct</span>","<span class=""chemical"">Dobutamine</span> response and <span class=""disease"">myocardial infarct</span> transmurality: functional improvement after coronary artery bypass grafting--initial experience.",,16926330,16926330_D004280_D009203,16926330_0,bcv_sentence_task_befree_2621,,770958550,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,1,,D004280,"<span class=""chemical"">dobutamine</span>",D007238,"<span class=""disease"">infarction</span>","The purpose of the study was to prospectively test the hypothesis that addition of low-dose <span class=""chemical"">dobutamine</span> and quantification of inotropic reserve in segments with 1%-50% infarct transmurality (IT) would improve the predictive value for functional recovery after revascularization in chronic <span class=""disease"">infarction</span>.",,16926330,16926330_D004280_D007238,16926330_3,bcv_sentence_task_befree_2622,,770958551,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,1,,C080245,"<span class=""chemical"">Pregabalin</span>",D010146,"<span class=""disease"">neuropathic pain</span>","<span class=""chemical"">Pregabalin</span> for peripheral <span class=""disease"">neuropathic pain</span>: results of a multicenter, non-comparative, open-label study in Indian patients.",,16939547,16939547_C080245_D010146,16939547_0,bcv_sentence_task_befree_2623,,770958552,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,C080245,"<span class=""chemical"">pregabalin</span>",D010146,"<span class=""disease"">neuropathic pain</span>","The aim of this study was to evaluate the tolerability, safety and efficacy of <span class=""chemical"">pregabalin</span> in Indian patients with peripheral <span class=""disease"">neuropathic pain</span>.",,16939547,16939547_C080245_D010146,16939547_1,bcv_sentence_task_befree_2624,,770958553,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,1,,C080245,"<span class=""chemical"">pregabalin</span>",D010146,"<span class=""disease"">neuropathic pain</span>","In this prospective, multicenter, non-comparative, open-label study, patients with peripheral <span class=""disease"">neuropathic pain</span> (n = 111) received <span class=""chemical"">pregabalin</span> in doses ranging from 75 to 300 mg twice daily for 3 weeks.",,16939547,16939547_C080245_D010146,16939547_2,bcv_sentence_task_befree_2625,,770958554,FALSE,finalized,5,8/15/15 0:10,"



",yes_direct,0.8029,,C080245,"<span class=""chemical"">Pregabalin</span>",D004244,"<span class=""disease"">dizziness</span>","<span class=""chemical"">Pregabalin</span> was well tolerated, and the most common adverse events were <span class=""disease"">dizziness</span> and somnolence.",,16939547,16939547_C080245_D004244,16939547_6,bcv_sentence_task_befree_2626,,770958555,FALSE,finalized,5,8/15/15 2:33,"



",yes_direct,1,,C080245,"<span class=""chemical"">Pregabalin</span>",D006970,"<span class=""disease"">somnolence</span>","<span class=""chemical"">Pregabalin</span> was well tolerated, and the most common adverse events were dizziness and <span class=""disease"">somnolence</span>.",,16939547,16939547_C080245_D006970,16939547_6,bcv_sentence_task_befree_2627,,770958556,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,1,,C080245,"<span class=""chemical"">pregabalin</span>",D010146,"<span class=""disease"">neuropathic pain</span>","This study has demonstrated the safety, tolerability and efficacy of <span class=""chemical"">pregabalin</span> for peripheral <span class=""disease"">neuropathic pain</span> in Indian patients.",,16939547,16939547_C080245_D010146,16939547_8,bcv_sentence_task_befree_2628,,770958557,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,0.832,,D001151,"<span class=""chemical"">arsenic</span>",D007938,"<span class=""disease"">leukemia</span>","Relationship of expression of aquaglyceroporin 9 with <span class=""chemical"">arsenic</span> uptake and sensitivity in <span class=""disease"">leukemia</span> cells.",,16968895,16968895_D001151_D007938,16968895_0,bcv_sentence_task_befree_2629,,770958558,FALSE,finalized,5,8/14/15 21:18,"



",no_relation,1,,C006632,"<span class=""chemical"">Arsenic trioxide</span>",D015473,"<span class=""disease"">APL/acute promyelocytic leukemia</span>","<span class=""chemical"">Arsenic trioxide</span> (As2O3) is highly efficacious in <span class=""disease"">acute promyelocytic leukemia</span> (<span class=""disease"">APL</span>).",,16968895,16968895_C006632_D015473,16968895_1,bcv_sentence_task_befree_2630,,770958559,FALSE,finalized,5,8/15/15 1:53,"



",yes_direct,0.6074,,D001151,"<span class=""chemical"">arsenic</span>",D004487,"<span class=""disease"">cytotoxicity</span>","The K562(EGFP-AQP9) transfectant accumulated significantly higher levels of intracellular <span class=""chemical"">arsenic</span> than control K562(EGFP) when incubated with As2O3, resulting in significantly increased As2O3-induced <span class=""disease"">cytotoxicity</span>.",,16968895,16968895_D001151_D004487,16968895_6,bcv_sentence_task_befree_2631,,770958560,FALSE,finalized,5,8/14/15 21:14,"



",no_relation,0.8057,,D014212,"<span class=""chemical"">ATRA/all-trans retinoic acid</span>",D007951,"<span class=""disease"">myeloid leukemia</span>","Pretreatment of the <span class=""disease"">myeloid leukemia</span> line HL-60 with <span class=""chemical"">all-trans retinoic acid</span> (<span class=""chemical"">ATRA</span>) up-regulated AQP9, leading to a significantly increased arsenic uptake and As2O3-induced cytotoxicity on incubation with As2O3, which might explain the synergism between <span class=""chemical"">ATRA</span> and As2O3.",,16968895,16968895_D014212_D007951,16968895_7,bcv_sentence_task_befree_2632,,770958561,FALSE,finalized,5,8/15/15 2:39,"



",no_relation,0.7897,,D014212,"<span class=""chemical"">ATRA/all-trans retinoic acid</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Pretreatment of the myeloid leukemia line HL-60 with <span class=""chemical"">all-trans retinoic acid</span> (<span class=""chemical"">ATRA</span>) up-regulated AQP9, leading to a significantly increased arsenic uptake and As2O3-induced <span class=""disease"">cytotoxicity</span> on incubation with As2O3, which might explain the synergism between <span class=""chemical"">ATRA</span> and As2O3.",,16968895,16968895_D014212_D004487,16968895_7,bcv_sentence_task_befree_2633,,770958562,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,D001151,"<span class=""chemical"">arsenic</span>",D007951,"<span class=""disease"">myeloid leukemia</span>","Pretreatment of the <span class=""disease"">myeloid leukemia</span> line HL-60 with all-trans retinoic acid (ATRA) up-regulated AQP9, leading to a significantly increased <span class=""chemical"">arsenic</span> uptake and As2O3-induced cytotoxicity on incubation with As2O3, which might explain the synergism between ATRA and As2O3.",,16968895,16968895_D001151_D007951,16968895_7,bcv_sentence_task_befree_2634,,770958563,FALSE,finalized,5,8/14/15 23:18,"



",no_relation,0.8011,,D001151,"<span class=""chemical"">arsenic</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Pretreatment of the myeloid leukemia line HL-60 with all-trans retinoic acid (ATRA) up-regulated AQP9, leading to a significantly increased <span class=""chemical"">arsenic</span> uptake and As2O3-induced <span class=""disease"">cytotoxicity</span> on incubation with As2O3, which might explain the synergism between ATRA and As2O3.",,16968895,16968895_D001151_D004487,16968895_7,bcv_sentence_task_befree_2635,,770958564,FALSE,finalized,5,8/14/15 23:16,"



",no_relation,1,,D001663,"<span class=""chemical"">bilirubin</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","Higher <span class=""chemical"">bilirubin</span> level, refractory ascites, and the presence of <span class=""disease"">hepatocellular carcinoma</span> were the predictive parameters for mortality in 77 patients as determined by multivariate analysis.",,16984593,16984593_D001663_D006528,16984593_11,bcv_sentence_task_befree_2636,,770958565,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D009369,"<span class=""disease"">breast cancer</span>","To describe the baseline healthy lifestyle behaviors (dietary, calcium, vitamin D, caffeine and <span class=""chemical"">alcohol</span> intake, smoking history, and physical activity) of postmenopausal <span class=""disease"">breast cancer</span> survivors (BCS); and to identify any relationship of healthy lifestyle behaviors with bone mineral density (BMD) at the forearm, total hip and spine, L1-L4.",,16999712,16999712_D000431_D009369,16999712_1,bcv_sentence_task_befree_2637,,770958566,FALSE,finalized,5,8/14/15 21:11,"



",no_relation,1,,D014807,"<span class=""chemical"">vitamin D</span>",D009369,"<span class=""disease"">breast cancer</span>","To describe the baseline healthy lifestyle behaviors (dietary, calcium, <span class=""chemical"">vitamin D</span>, caffeine and alcohol intake, smoking history, and physical activity) of postmenopausal <span class=""disease"">breast cancer</span> survivors (BCS); and to identify any relationship of healthy lifestyle behaviors with bone mineral density (BMD) at the forearm, total hip and spine, L1-L4.",,16999712,16999712_D014807_D009369,16999712_1,bcv_sentence_task_befree_2638,,770958567,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,D002110,"<span class=""chemical"">caffeine</span>",D009369,"<span class=""disease"">breast cancer</span>","To describe the baseline healthy lifestyle behaviors (dietary, calcium, vitamin D, <span class=""chemical"">caffeine</span> and alcohol intake, smoking history, and physical activity) of postmenopausal <span class=""disease"">breast cancer</span> survivors (BCS); and to identify any relationship of healthy lifestyle behaviors with bone mineral density (BMD) at the forearm, total hip and spine, L1-L4.",,16999712,16999712_D002110_D009369,16999712_1,bcv_sentence_task_befree_2639,,770958568,FALSE,finalized,5,8/14/15 23:44,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D009369,"<span class=""disease"">breast cancer</span>","To describe the baseline healthy lifestyle behaviors (dietary, <span class=""chemical"">calcium</span>, vitamin D, caffeine and alcohol intake, smoking history, and physical activity) of postmenopausal <span class=""disease"">breast cancer</span> survivors (BCS); and to identify any relationship of healthy lifestyle behaviors with bone mineral density (BMD) at the forearm, total hip and spine, L1-L4.",,16999712,16999712_D002118_D009369,16999712_1,bcv_sentence_task_befree_2640,,770958569,FALSE,finalized,5,8/15/15 0:19,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",C536430,"<span class=""disease"">coaching</span>","The healthcare provider must incorporate appropriate teaching strategies, intensive counseling, and <span class=""disease"">coaching</span>, along with a support mechanism, to enable BCS to understand the importance of a healthy diet, <span class=""chemical"">calcium</span>, and vitamin D supplement, and a regular strength/weight program that will be integrated into their daily lifestyle.",,16999712,16999712_D002118_C536430,16999712_15,bcv_sentence_task_befree_2641,,770958570,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,D014807,"<span class=""chemical"">vitamin D</span>",C536430,"<span class=""disease"">coaching</span>","The healthcare provider must incorporate appropriate teaching strategies, intensive counseling, and <span class=""disease"">coaching</span>, along with a support mechanism, to enable BCS to understand the importance of a healthy diet, calcium, and <span class=""chemical"">vitamin D</span> supplement, and a regular strength/weight program that will be integrated into their daily lifestyle.",,16999712,16999712_D014807_C536430,16999712_15,bcv_sentence_task_befree_2642,,770958571,FALSE,finalized,5,8/15/15 0:17,"



",no_relation,1,,D013974,"<span class=""chemical"">levothyroxine</span>",D007037,"<span class=""disease"">hypothyroidism</span>","Effect of <span class=""chemical"">levothyroxine</span> on total lipid profiles as assessed by analytical capillary isotachophoresis in a patient with <span class=""disease"">hypothyroidism</span>.",,17001111,17001111_D013974_D007037,17001111_0,bcv_sentence_task_befree_2643,,770958572,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,1,,C065179,"<span class=""chemical"">atorvastatin</span>",D006949,"<span class=""disease"">hyperlipidemia</span>","Since <span class=""disease"">hyperlipidemia</span> was not improved by pravastatin, <span class=""chemical"">atorvastatin</span> or niceritrol, and since the levels of thyroid-stimulating hormone (TSH) and free T4 were 730 IU/ml and 0.3 ng/dl, respectively, the patient was diagnosed as secondary <span class=""disease"">hyperlipidemia</span> with hypothyroidism.",,17001111,17001111_C065179_D006949,17001111_3,bcv_sentence_task_befree_2644,,770958573,FALSE,finalized,5,8/15/15 2:07,"



",no_relation,0.8245,,D017035,"<span class=""chemical"">pravastatin</span>",D006949,"<span class=""disease"">hyperlipidemia</span>","Since <span class=""disease"">hyperlipidemia</span> was not improved by <span class=""chemical"">pravastatin</span>, atorvastatin or niceritrol, and since the levels of thyroid-stimulating hormone (TSH) and free T4 were 730 IU/ml and 0.3 ng/dl, respectively, the patient was diagnosed as secondary <span class=""disease"">hyperlipidemia</span> with hypothyroidism.",,17001111,17001111_D017035_D006949,17001111_3,bcv_sentence_task_befree_2645,,770958574,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,D017035,"<span class=""chemical"">pravastatin</span>",D007037,"<span class=""disease"">hypothyroidism</span>","Since hyperlipidemia was not improved by <span class=""chemical"">pravastatin</span>, atorvastatin or niceritrol, and since the levels of thyroid-stimulating hormone (TSH) and free T4 were 730 IU/ml and 0.3 ng/dl, respectively, the patient was diagnosed as secondary hyperlipidemia with <span class=""disease"">hypothyroidism</span>.",,17001111,17001111_D017035_D007037,17001111_3,bcv_sentence_task_befree_2646,,770958575,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,1,,D009531,"<span class=""chemical"">niceritrol</span>",D006949,"<span class=""disease"">hyperlipidemia</span>","Since <span class=""disease"">hyperlipidemia</span> was not improved by pravastatin, atorvastatin or <span class=""chemical"">niceritrol</span>, and since the levels of thyroid-stimulating hormone (TSH) and free T4 were 730 IU/ml and 0.3 ng/dl, respectively, the patient was diagnosed as secondary <span class=""disease"">hyperlipidemia</span> with hypothyroidism.",,17001111,17001111_D009531_D006949,17001111_3,bcv_sentence_task_befree_2647,,770958576,FALSE,finalized,5,8/14/15 23:34,"



",no_relation,1,,D009531,"<span class=""chemical"">niceritrol</span>",D007037,"<span class=""disease"">hypothyroidism</span>","Since hyperlipidemia was not improved by pravastatin, atorvastatin or <span class=""chemical"">niceritrol</span>, and since the levels of thyroid-stimulating hormone (TSH) and free T4 were 730 IU/ml and 0.3 ng/dl, respectively, the patient was diagnosed as secondary hyperlipidemia with <span class=""disease"">hypothyroidism</span>.",,17001111,17001111_D009531_D007037,17001111_3,bcv_sentence_task_befree_2648,,770958577,FALSE,finalized,5,8/14/15 21:27,"



",no_relation,1,,C065179,"<span class=""chemical"">atorvastatin</span>",D007037,"<span class=""disease"">hypothyroidism</span>","Since hyperlipidemia was not improved by pravastatin, <span class=""chemical"">atorvastatin</span> or niceritrol, and since the levels of thyroid-stimulating hormone (TSH) and free T4 were 730 IU/ml and 0.3 ng/dl, respectively, the patient was diagnosed as secondary hyperlipidemia with <span class=""disease"">hypothyroidism</span>.",,17001111,17001111_C065179_D007037,17001111_3,bcv_sentence_task_befree_2649,,770958578,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,0.5976,,D002784,"<span class=""chemical"">cholesterol</span>",D003327,"<span class=""disease"">coronary heart disease</span>","A method for the charge isolation of lipoproteins using capillary isotachophoresis (cITP) is proposed as a clinical application because it allows us to quantitatively measure electronegative low-density lipoprotein <span class=""chemical"">cholesterol</span> (LDL-C), a potent marker of <span class=""disease"">coronary heart disease</span>.",,17001111,17001111_D002784_D003327,17001111_4,bcv_sentence_task_befree_2650,,770958579,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,D013974,"<span class=""chemical"">levothyroxine</span>",D007037,"<span class=""disease"">hypothyroidism</span>","The cITP analysis was able to obtain more information about coronary risk factors and may be clinically useful for evaluating the effect of treatment with <span class=""chemical"">levothyroxine</span> in patients with <span class=""disease"">hypothyroidism</span> and secondary hyperlipidemia.",,17001111,17001111_D013974_D007037,17001111_7,bcv_sentence_task_befree_2651,,770958580,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,D013974,"<span class=""chemical"">levothyroxine</span>",D006949,"<span class=""disease"">hyperlipidemia</span>","The cITP analysis was able to obtain more information about coronary risk factors and may be clinically useful for evaluating the effect of treatment with <span class=""chemical"">levothyroxine</span> in patients with hypothyroidism and secondary <span class=""disease"">hyperlipidemia</span>.",,17001111,17001111_D013974_D006949,17001111_7,bcv_sentence_task_befree_2652,,770958581,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D014859,"<span class=""chemical"">warfarin</span>",D020521,"<span class=""disease"">stroke</span>","Pooled data from trials comparing antithrombotic treatment with placebo have shown that <span class=""chemical"">warfarin</span> reduces the risk of <span class=""disease"">stroke</span> by 62%, and that aspirin alone reduces the risk by 22%.",,17020434,17020434_D014859_D020521,17020434_2,bcv_sentence_task_befree_2653,,770958582,FALSE,finalized,5,8/14/15 21:59,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D020521,"<span class=""disease"">stroke</span>","Pooled data from trials comparing antithrombotic treatment with placebo have shown that warfarin reduces the risk of <span class=""disease"">stroke</span> by 62%, and that <span class=""chemical"">aspirin</span> alone reduces the risk by 22%.",,17020434,17020434_D001241_D020521,17020434_2,bcv_sentence_task_befree_2654,,770958583,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,1,,D014859,"<span class=""chemical"">warfarin</span>",D020521,"<span class=""disease"">strokes</span>","Overall, in high-risk patients, <span class=""chemical"">warfarin</span> is superior to aspirin in preventing <span class=""disease"">strokes</span>, with a relative risk reduction of 36%.",,17020434,17020434_D014859_D020521,17020434_3,bcv_sentence_task_befree_2655,,770958584,FALSE,finalized,5,8/14/15 23:35,"


'Preventing' being the key term
",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D020521,"<span class=""disease"">strokes</span>","Overall, in high-risk patients, warfarin is superior to <span class=""chemical"">aspirin</span> in preventing <span class=""disease"">strokes</span>, with a relative risk reduction of 36%.",,17020434,17020434_D001241_D020521,17020434_3,bcv_sentence_task_befree_2656,,770958585,FALSE,finalized,5,8/15/15 0:21,"



",yes_direct,1,,C426686,"<span class=""chemical"">Ximelagatran</span>",D011681,"<span class=""disease"">abnormal liver function</span>","<span class=""chemical"">Ximelagatran</span>, an oral direct thrombin inhibitor, was found to be as efficient as vitamin K antagonist drugs in the prevention of embolic events, but has been recently withdrawn because of <span class=""disease"">abnormal liver function</span> tests.",,17020434,17020434_C426686_D011681,17020434_4,bcv_sentence_task_befree_2657,,770958586,FALSE,finalized,5,8/14/15 21:46,"



",no_relation,0.819,,D014812,"<span class=""chemical"">vitamin K</span>",D011681,"<span class=""disease"">abnormal liver function</span>","Ximelagatran, an oral direct thrombin inhibitor, was found to be as efficient as <span class=""chemical"">vitamin K</span> antagonist drugs in the prevention of embolic events, but has been recently withdrawn because of <span class=""disease"">abnormal liver function</span> tests.",,17020434,17020434_D014812_D011681,17020434_4,bcv_sentence_task_befree_2658,,770958587,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,1,,D014812,"<span class=""chemical"">vitamin K</span>",D004617,"<span class=""disease"">embolic events</span>","Ximelagatran, an oral direct thrombin inhibitor, was found to be as efficient as <span class=""chemical"">vitamin K</span> antagonist drugs in the prevention of <span class=""disease"">embolic events</span>, but has been recently withdrawn because of abnormal liver function tests.",,17020434,17020434_D014812_D004617,17020434_4,bcv_sentence_task_befree_2659,,770958588,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,C426686,"<span class=""chemical"">Ximelagatran</span>",D004617,"<span class=""disease"">embolic events</span>","<span class=""chemical"">Ximelagatran</span>, an oral direct thrombin inhibitor, was found to be as efficient as vitamin K antagonist drugs in the prevention of <span class=""disease"">embolic events</span>, but has been recently withdrawn because of abnormal liver function tests.",,17020434,17020434_C426686_D004617,17020434_4,bcv_sentence_task_befree_2660,,770958589,FALSE,finalized,5,8/14/15 21:05,"



",no_relation,1,,C055162,"<span class=""chemical"">Clopidogrel</span>",D001281,"<span class=""disease"">Atrial Fibrillation</span>","The ACTIVE-W (<span class=""disease"">Atrial Fibrillation</span> <span class=""chemical"">Clopidogrel</span> Trial with Irbesartan for Prevention of Vascular Events) study has demonstrated that warfarin is superior to platelet therapy (<span class=""chemical"">clopidogrel</span> plus aspirin) in the prevention af embolic events.",,17020434,17020434_C055162_D001281,17020434_5,bcv_sentence_task_befree_2661,,770958590,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,C081309,"<span class=""chemical"">Irbesartan</span>",D004617,"<span class=""disease"">embolic events</span>","The ACTIVE-W (Atrial Fibrillation Clopidogrel Trial with <span class=""chemical"">Irbesartan</span> for Prevention of Vascular Events) study has demonstrated that warfarin is superior to platelet therapy (clopidogrel plus aspirin) in the prevention af <span class=""disease"">embolic events</span>.",,17020434,17020434_C081309_D004617,17020434_5,bcv_sentence_task_befree_2662,,770958591,FALSE,finalized,5,8/15/15 2:09,"



",no_relation,1,,D014859,"<span class=""chemical"">warfarin</span>",D004617,"<span class=""disease"">embolic events</span>","The ACTIVE-W (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) study has demonstrated that <span class=""chemical"">warfarin</span> is superior to platelet therapy (clopidogrel plus aspirin) in the prevention af <span class=""disease"">embolic events</span>.",,17020434,17020434_D014859_D004617,17020434_5,bcv_sentence_task_befree_2663,,770958592,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,C055162,"<span class=""chemical"">Clopidogrel</span>",D004617,"<span class=""disease"">embolic events</span>","The ACTIVE-W (Atrial Fibrillation <span class=""chemical"">Clopidogrel</span> Trial with Irbesartan for Prevention of Vascular Events) study has demonstrated that warfarin is superior to platelet therapy (<span class=""chemical"">clopidogrel</span> plus aspirin) in the prevention af <span class=""disease"">embolic events</span>.",,17020434,17020434_C055162_D004617,17020434_5,bcv_sentence_task_befree_2664,,770958593,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,0.814,,D001241,"<span class=""chemical"">aspirin</span>",D001281,"<span class=""disease"">Atrial Fibrillation</span>","The ACTIVE-W (<span class=""disease"">Atrial Fibrillation</span> Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) study has demonstrated that warfarin is superior to platelet therapy (clopidogrel plus <span class=""chemical"">aspirin</span>) in the prevention af embolic events.",,17020434,17020434_D001241_D001281,17020434_5,bcv_sentence_task_befree_2665,,770958594,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,D014859,"<span class=""chemical"">warfarin</span>",D001281,"<span class=""disease"">Atrial Fibrillation</span>","The ACTIVE-W (<span class=""disease"">Atrial Fibrillation</span> Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) study has demonstrated that <span class=""chemical"">warfarin</span> is superior to platelet therapy (clopidogrel plus aspirin) in the prevention af embolic events.",,17020434,17020434_D014859_D001281,17020434_5,bcv_sentence_task_befree_2666,,770958595,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D004617,"<span class=""disease"">embolic events</span>","The ACTIVE-W (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) study has demonstrated that warfarin is superior to platelet therapy (clopidogrel plus <span class=""chemical"">aspirin</span>) in the prevention af <span class=""disease"">embolic events</span>.",,17020434,17020434_D001241_D004617,17020434_5,bcv_sentence_task_befree_2667,,770958596,FALSE,finalized,5,8/14/15 21:11,"



",no_relation,1,,C081309,"<span class=""chemical"">Irbesartan</span>",D001281,"<span class=""disease"">Atrial Fibrillation</span>","The ACTIVE-W (<span class=""disease"">Atrial Fibrillation</span> Clopidogrel Trial with <span class=""chemical"">Irbesartan</span> for Prevention of Vascular Events) study has demonstrated that warfarin is superior to platelet therapy (clopidogrel plus aspirin) in the prevention af embolic events.",,17020434,17020434_C081309_D001281,17020434_5,bcv_sentence_task_befree_2668,,770958597,FALSE,finalized,5,8/15/15 2:16,"



",no_relation,0.8134,,D000809,"<span class=""chemical"">Angiotensin</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","<span class=""chemical"">Angiotensin</span>-converting enzyme inhibitors and angiotensin II receptor-blocking drugs hold promise in <span class=""disease"">atrial fibrillation</span> through cardiac remodelling.",,17020434,17020434_D000809_D001281,17020434_7,bcv_sentence_task_befree_2669,,770958598,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,1,,D000809,"<span class=""chemical"">Angiotensin</span>",D020257,"<span class=""disease"">cardiac remodelling</span>","<span class=""chemical"">Angiotensin</span>-converting enzyme inhibitors and angiotensin II receptor-blocking drugs hold promise in atrial fibrillation through <span class=""disease"">cardiac remodelling</span>.",,17020434,17020434_D000809_D020257,17020434_7,bcv_sentence_task_befree_2670,,770958599,FALSE,finalized,5,8/15/15 1:28,"



",no_relation,1,,D001647,"<span class=""chemical"">bile acid</span>",D001471,"<span class=""disease"">Barrett's esophagus</span>","Expression of the <span class=""chemical"">bile acid</span> receptor FXR in <span class=""disease"">Barrett's esophagus</span> and enhancement of apoptosis by guggulsterone in vitro.",,17054793,17054793_D001647_D001471,17054793_0,bcv_sentence_task_befree_2671,,770958600,FALSE,finalized,5,8/15/15 1:19,"



",no_relation,1,,D001647,"<span class=""chemical"">bile acid</span>",D001471,"<span class=""disease"">Barrett's esophagus</span>","The aim of this study was to assess the expression of <span class=""chemical"">bile acid</span> receptors in the esophagus (normal, esophagitis, <span class=""disease"">Barrett's esophagus</span> and adenocarcinoma) and to investigate their possible function.",,17054793,17054793_D001647_D001471,17054793_2,bcv_sentence_task_befree_2672,,770958601,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,1,,D001647,"<span class=""chemical"">bile acid</span>",D000230,"<span class=""disease"">adenocarcinoma</span>","The aim of this study was to assess the expression of <span class=""chemical"">bile acid</span> receptors in the esophagus (normal, esophagitis, Barrett's esophagus and <span class=""disease"">adenocarcinoma</span>) and to investigate their possible function.",,17054793,17054793_D001647_D000230,17054793_2,bcv_sentence_task_befree_2673,,770958602,FALSE,finalized,5,8/14/15 23:45,"



",no_relation,1,,D001647,"<span class=""chemical"">bile acid</span>",D004941,"<span class=""disease"">esophagitis</span>","The aim of this study was to assess the expression of <span class=""chemical"">bile acid</span> receptors in the esophagus (normal, <span class=""disease"">esophagitis</span>, Barrett's esophagus and adenocarcinoma) and to investigate their possible function.",,17054793,17054793_D001647_D004941,17054793_2,bcv_sentence_task_befree_2674,,770958603,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,1,,D001647,"<span class=""chemical"">bile acid</span>",D001471,"<span class=""disease"">Barrett's esophagus</span>","The expression of the <span class=""chemical"">bile acid</span> receptors FXR and VDR in esophageal biopsies from patients with a normal mucosa, esophagitis, <span class=""disease"">Barrett's esophagus</span> or adenocarcinoma (n = 6 per group) and in cell lines derived from <span class=""disease"">Barrett's esophagus</span> and esophageal adenocarcinoma, was assessed by real time Q-PCR and immunohistochemistry.",,17054793,17054793_D001647_D001471,17054793_3,bcv_sentence_task_befree_2675,,770958604,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,D001647,"<span class=""chemical"">bile acid</span>",D000230,"<span class=""disease"">esophageal adenocarcinoma/adenocarcinoma</span>","The expression of the <span class=""chemical"">bile acid</span> receptors FXR and VDR in esophageal biopsies from patients with a normal mucosa, esophagitis, Barrett's esophagus or <span class=""disease"">adenocarcinoma</span> (n = 6 per group) and in cell lines derived from Barrett's esophagus and <span class=""disease"">esophageal adenocarcinoma</span>, was assessed by real time Q-PCR and immunohistochemistry.",,17054793,17054793_D001647_D000230,17054793_3,bcv_sentence_task_befree_2676,,770958605,FALSE,finalized,5,8/14/15 22:12,"



",no_relation,1,,D001647,"<span class=""chemical"">bile acid</span>",D004941,"<span class=""disease"">esophagitis</span>","The expression of the <span class=""chemical"">bile acid</span> receptors FXR and VDR in esophageal biopsies from patients with a normal mucosa, <span class=""disease"">esophagitis</span>, Barrett's esophagus or adenocarcinoma (n = 6 per group) and in cell lines derived from Barrett's esophagus and esophageal adenocarcinoma, was assessed by real time Q-PCR and immunohistochemistry.",,17054793,17054793_D001647_D004941,17054793_3,bcv_sentence_task_befree_2677,,770958606,FALSE,finalized,5,8/15/15 0:19,"



",no_relation,1,,D001647,"<span class=""chemical"">bile acid</span>",D001471,"<span class=""disease"">Barrett's esophagus</span>","The effect of guggulsterone, an antagonist of <span class=""chemical"">bile acid</span> receptors, on apoptosis of <span class=""disease"">Barrett's esophagus</span>-derived cells was assessed morphologically, by flow cytometry and by measuring caspase 3 activity.",,17054793,17054793_D001647_D001471,17054793_4,bcv_sentence_task_befree_2678,,770958607,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,0.8095,,C023617,"<span class=""chemical"">guggulsterone</span>",D001471,"<span class=""disease"">Barrett's esophagus</span>","The effect of <span class=""chemical"">guggulsterone</span>, an antagonist of bile acid receptors, on apoptosis of <span class=""disease"">Barrett's esophagus</span>-derived cells was assessed morphologically, by flow cytometry and by measuring caspase 3 activity.",,17054793,17054793_C023617_D001471,17054793_4,bcv_sentence_task_befree_2679,,770958608,FALSE,finalized,5,8/15/15 2:04,"



",no_relation,1,,D001647,"<span class=""chemical"">bile acid</span>",D001471,"<span class=""disease"">Barrett's esophagus</span>","The <span class=""chemical"">bile acid</span> receptor FXR is significantly overexpressed in <span class=""disease"">Barrett's esophagus</span> compared to normal mucosa, esophagitis and esophageal adenocarcinoma.",,17054793,17054793_D001647_D001471,17054793_10,bcv_sentence_task_befree_2680,,770958609,FALSE,finalized,5,8/15/15 0:44,"



",no_relation,1,,D001647,"<span class=""chemical"">bile acid</span>",D000230,"<span class=""disease"">esophageal adenocarcinoma</span>","The <span class=""chemical"">bile acid</span> receptor FXR is significantly overexpressed in Barrett's esophagus compared to normal mucosa, esophagitis and <span class=""disease"">esophageal adenocarcinoma</span>.",,17054793,17054793_D001647_D000230,17054793_10,bcv_sentence_task_befree_2681,,770958610,FALSE,finalized,5,8/14/15 22:31,"



",no_relation,1,,D001647,"<span class=""chemical"">bile acid</span>",D004941,"<span class=""disease"">esophagitis</span>","The <span class=""chemical"">bile acid</span> receptor FXR is significantly overexpressed in Barrett's esophagus compared to normal mucosa, <span class=""disease"">esophagitis</span> and esophageal adenocarcinoma.",,17054793,17054793_D001647_D004941,17054793_10,bcv_sentence_task_befree_2682,,770958611,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,1,,D003487,"<span class=""chemical"">cyanoacrylate</span>",D005402,"<span class=""disease"">bronchopleural fistula</span>","Transthoracic closure of a postpneumonectomy <span class=""disease"">bronchopleural fistula</span> with coils and <span class=""chemical"">cyanoacrylate</span>.",,17062286,17062286_D003487_D005402,17062286_0,bcv_sentence_task_befree_2683,,770958612,FALSE,finalized,5,8/15/15 1:48,"



",no_relation,1,,C036854|D017338,"<span class=""chemical"">2-chloro-2'-deoxyadenosine</span>",D015448,"<span class=""disease"">B-cell leukemia</span>","Inhibition of the ERK pathway promotes apoptosis induced by <span class=""chemical"">2-chloro-2'-deoxyadenosine</span> in the <span class=""disease"">B-cell leukemia</span> cell line EHEB.",,17065055,17065055_C036854|D017338_D015448,17065055_0,bcv_sentence_task_befree_2684,,770958613,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,0.7973,,D009705,"<span class=""chemical"">nucleoside</span>",D015451,"<span class=""disease"">chronic lymphocytic leukemia</span>","2-Chloro-2'-deoxyadenosine (CdA) is a <span class=""chemical"">nucleoside</span> analogue active in B-cell <span class=""disease"">chronic lymphocytic leukemia</span> (B-CLL).",,17065055,17065055_D009705_D015451,17065055_1,bcv_sentence_task_befree_2685,,770958614,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,1,,C036854|D017338,"<span class=""chemical"">CdA/2-Chloro-2'-deoxyadenosine</span>",D015451,"<span class=""disease"">chronic lymphocytic leukemia</span>","<span class=""chemical"">2-Chloro-2'-deoxyadenosine</span> (<span class=""chemical"">CdA</span>) is a nucleoside analogue active in B-cell <span class=""disease"">chronic lymphocytic leukemia</span> (B-CLL).",,17065055,17065055_C036854|D017338_D015451,17065055_1,bcv_sentence_task_befree_2686,,770958615,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,D002976,"<span class=""chemical"">clenbuterol</span>",D009202,"<span class=""disease"">myocardial atrophy</span>","Once regression of left ventricular enlargement had been achieved, the beta2-adrenergic-receptor agonist <span class=""chemical"">clenbuterol</span> was administered to prevent <span class=""disease"">myocardial atrophy</span>.",,17079761,17079761_D002976_D009202,17079761_6,bcv_sentence_task_befree_2687,,770958616,FALSE,finalized,5,8/14/15 21:28,"



",no_relation,1,,D002976,"<span class=""chemical"">clenbuterol</span>",D006332,"<span class=""disease"">ventricular enlargement</span>","Once regression of left <span class=""disease"">ventricular enlargement</span> had been achieved, the beta2-adrenergic-receptor agonist <span class=""chemical"">clenbuterol</span> was administered to prevent myocardial atrophy.",,17079761,17079761_D002976_D006332,17079761_6,bcv_sentence_task_befree_2688,,770958617,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,0.7904,,D000420,"<span class=""chemical"">salbutamol</span>",D054318,"<span class=""disease"">Flow-mediated dilation</span>","<span class=""disease"">Flow-mediated dilation</span> (p < 0.001) and PWA with <span class=""chemical"">salbutamol</span> (p = 0.03) responses fell after typhoid vaccination, and PCA (p = 0.7) was unchanged.",,17084260,17084260_D000420_D054318,17084260_9,bcv_sentence_task_befree_2689,,770958618,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D000420,"<span class=""chemical"">salbutamol</span>",D014652,"<span class=""disease"">Vascular dysfunction</span>","<span class=""disease"">Vascular dysfunction</span> during acute inflammation can be measured by FMD and by PWA with <span class=""chemical"">salbutamol</span>.",,17084260,17084260_D000420_D014652,17084260_10,bcv_sentence_task_befree_2690,,770958619,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D000420,"<span class=""chemical"">salbutamol</span>",D054318,"<span class=""disease"">FMD</span>","Vascular dysfunction during acute inflammation can be measured by <span class=""disease"">FMD</span> and by PWA with <span class=""chemical"">salbutamol</span>.",,17084260,17084260_D000420_D054318,17084260_10,bcv_sentence_task_befree_2691,,770958620,FALSE,finalized,5,8/14/15 23:18,"

Measuring drug.

",no_relation,1,,D000420,"<span class=""chemical"">salbutamol</span>",D007249,"<span class=""disease"">inflammation</span>","Vascular dysfunction during acute <span class=""disease"">inflammation</span> can be measured by FMD and by PWA with <span class=""chemical"">salbutamol</span>.",,17084260,17084260_D000420_D007249,17084260_10,bcv_sentence_task_befree_2692,,770958621,FALSE,finalized,5,8/15/15 2:09,"



",no_relation,1,,D011729,"<span class=""chemical"">pyridostigmine</span>",D001327,"<span class=""disease"">Autoimmune gastrointestinal dysmotility</span>","<span class=""disease"">Autoimmune gastrointestinal dysmotility</span> treated successfully with <span class=""chemical"">pyridostigmine</span>.",,17101331,17101331_D011729_D001327,17101331_0,bcv_sentence_task_befree_2693,,770958622,FALSE,finalized,5,8/14/15 22:14,"



",no_relation,1,,D000109,"<span class=""chemical"">acetylcholine</span>",D001327,"<span class=""disease"">AGID</span>","Of numerous autoantibodies currently recognized as biomarkers of <span class=""disease"">AGID</span>, the ganglionic <span class=""chemical"">acetylcholine</span> receptor autoantibody is the only proven pathophysiologic effector.",,17101331,17101331_D000109_D001327,17101331_15,bcv_sentence_task_befree_2694,,770958623,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,1,,D006513,"<span class=""chemical"">HBeAg</span>",D006509,"<span class=""disease"">hepatitis B</span>","Predicting response to peginterferon alpha-2a, lamivudine and the two combined for <span class=""chemical"">HBeAg</span>-negative chronic <span class=""disease"">hepatitis B</span>.",,17127704,17127704_D006513_D006509,17127704_0,bcv_sentence_task_befree_2695,,770958624,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,1,,D019259,"<span class=""chemical"">lamivudine</span>",D006509,"<span class=""disease"">hepatitis B</span>","Predicting response to peginterferon alpha-2a, <span class=""chemical"">lamivudine</span> and the two combined for HBeAg-negative chronic <span class=""disease"">hepatitis B</span>.",,17127704,17127704_D019259_D006509,17127704_0,bcv_sentence_task_befree_2696,,770958625,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,0.7946,,D006513,"<span class=""chemical"">HBeAg/hepatitis B e antigen</span>",D006509,"<span class=""disease"">hepatitis B</span>","In a trial of patients with <span class=""chemical""></span><span class=""disease"">hepatitis B</span> e antigen (<span class=""chemical"">HBeAg</span>)-negative chronic <span class=""disease"">hepatitis B</span>, 24 week post-treatment biochemical and virological response rates with peginterferon alpha-2a with or without lamivudine were significantly higher than with lamivudine alone.",,17127704,17127704_D006513_D006509,17127704_1,bcv_sentence_task_befree_2697,,770958626,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,D019259,"<span class=""chemical"">lamivudine</span>",D006509,"<span class=""disease"">hepatitis B</span>","In a trial of patients with <span class=""disease"">hepatitis B</span> e antigen (HBeAg)-negative chronic <span class=""disease"">hepatitis B</span>, 24 week post-treatment biochemical and virological response rates with peginterferon alpha-2a with or without <span class=""chemical"">lamivudine</span> were significantly higher than with <span class=""chemical"">lamivudine</span> alone.",,17127704,17127704_D019259_D006509,17127704_1,bcv_sentence_task_befree_2698,,770958627,FALSE,finalized,5,8/15/15 0:41,"



",no_relation,1,,D000409,"<span class=""chemical"">alanine</span>",D006509,"<span class=""disease"">hepatitis B</span>","A post-treatment response was defined as <span class=""chemical"">alanine</span> aminotransferase (ALT) normalisation and <span class=""disease"">hepatitis B</span> virus (HBV) DNA level of <20,000 copies/ml.",,17127704,17127704_D000409_D006509,17127704_4,bcv_sentence_task_befree_2699,,770958628,FALSE,finalized,5,8/15/15 1:29,"



",no_relation,1,,D020913,"<span class=""chemical"">perindopril</span>",D002318,"<span class=""disease"">cardiovascular events</span>","Cost effectiveness of <span class=""chemical"">perindopril</span> in reducing <span class=""disease"">cardiovascular events</span> in patients with stable coronary artery disease using data from the EUROPA study.",,17135223,17135223_D020913_D002318,17135223_0,bcv_sentence_task_befree_2700,,770958629,FALSE,finalized,5,8/14/15 21:12,"



",no_relation,1,,D020913,"<span class=""chemical"">perindopril</span>",D003324,"<span class=""disease"">coronary artery disease</span>","Cost effectiveness of <span class=""chemical"">perindopril</span> in reducing cardiovascular events in patients with stable <span class=""disease"">coronary artery disease</span> using data from the EUROPA study.",,17135223,17135223_D020913_D003324,17135223_0,bcv_sentence_task_befree_2701,,770958630,FALSE,finalized,5,8/14/15 21:08,"



",no_relation,1,,D020913,"<span class=""chemical"">Perindopril</span>",D064420,"<span class=""disease"">cardiac events</span>","The EUropean trial on Reduction Of <span class=""disease"">cardiac events</span> with <span class=""chemical"">Perindopril</span> in stable coronary Artery disease (EUROPA) trial has recently reported.",,17135223,17135223_D020913_D064420,17135223_1,bcv_sentence_task_befree_2702,,770958631,FALSE,finalized,5,8/14/15 21:08,"



",no_relation,1,,D020913,"<span class=""chemical"">Perindopril</span>",D003324,"<span class=""disease"">coronary Artery disease</span>","The EUropean trial on Reduction Of cardiac events with <span class=""chemical"">Perindopril</span> in stable <span class=""disease"">coronary Artery disease</span> (EUROPA) trial has recently reported.",,17135223,17135223_D020913_D003324,17135223_1,bcv_sentence_task_befree_2703,,770958632,FALSE,finalized,5,8/15/15 0:37,"



",no_relation,1,,D020913,"<span class=""chemical"">perindopril</span>",D003327,"<span class=""disease"">coronary heart disease</span>","To assess the cost effectiveness of <span class=""chemical"">perindopril</span> in stable <span class=""disease"">coronary heart disease</span> in the UK.",,17135223,17135223_D020913_D003327,17135223_2,bcv_sentence_task_befree_2704,,770958633,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D007052,"<span class=""chemical"">ibuprofen</span>",D000699,"<span class=""disease"">analgesia</span>","To compare the effects of iv acetaminophen with those of oral <span class=""chemical"">ibuprofen</span> with respect to postoperative pain control and morphine requirements in patients receiving morphine patient-controlled iv <span class=""disease"">analgesia</span> (PCIA) after Cesarean delivery.",,17142654,17142654_D007052_D000699,17142654_1,bcv_sentence_task_befree_2705,,770958634,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,1,,D000082,"<span class=""chemical"">acetaminophen</span>",D010146,"<span class=""disease"">postoperative pain</span>","To compare the effects of iv <span class=""chemical"">acetaminophen</span> with those of oral ibuprofen with respect to <span class=""disease"">postoperative pain</span> control and morphine requirements in patients receiving morphine patient-controlled iv analgesia (PCIA) after Cesarean delivery.",,17142654,17142654_D000082_D010146,17142654_1,bcv_sentence_task_befree_2706,,770958635,FALSE,finalized,5,8/14/15 22:32,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D010146,"<span class=""disease"">postoperative pain</span>","To compare the effects of iv acetaminophen with those of oral ibuprofen with respect to <span class=""disease"">postoperative pain</span> control and <span class=""chemical"">morphine</span> requirements in patients receiving <span class=""chemical"">morphine</span> patient-controlled iv analgesia (PCIA) after Cesarean delivery.",,17142654,17142654_D009020_D010146,17142654_1,bcv_sentence_task_befree_2707,,770958636,FALSE,finalized,5,8/15/15 1:41,"



",no_relation,1,,D007052,"<span class=""chemical"">ibuprofen</span>",D010146,"<span class=""disease"">postoperative pain</span>","To compare the effects of iv acetaminophen with those of oral <span class=""chemical"">ibuprofen</span> with respect to <span class=""disease"">postoperative pain</span> control and morphine requirements in patients receiving morphine patient-controlled iv analgesia (PCIA) after Cesarean delivery.",,17142654,17142654_D007052_D010146,17142654_1,bcv_sentence_task_befree_2708,,770958637,FALSE,finalized,5,8/14/15 23:20,"

It's 'patient-controlled iv analgesia' and not just 'Analgesia'

",no_relation,1,,D000082,"<span class=""chemical"">acetaminophen</span>",D000699,"<span class=""disease"">analgesia</span>","To compare the effects of iv <span class=""chemical"">acetaminophen</span> with those of oral ibuprofen with respect to postoperative pain control and morphine requirements in patients receiving morphine patient-controlled iv <span class=""disease"">analgesia</span> (PCIA) after Cesarean delivery.",,17142654,17142654_D000082_D000699,17142654_1,bcv_sentence_task_befree_2709,,770958638,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,0.8246,,D009020,"<span class=""chemical"">morphine</span>",D000699,"<span class=""disease"">analgesia</span>","To compare the effects of iv acetaminophen with those of oral ibuprofen with respect to postoperative pain control and <span class=""chemical"">morphine</span> requirements in patients receiving <span class=""chemical"">morphine</span> patient-controlled iv <span class=""disease"">analgesia</span> (PCIA) after Cesarean delivery.",,17142654,17142654_D009020_D000699,17142654_1,bcv_sentence_task_befree_2710,,770958639,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,0.5949,,D007052,"<span class=""chemical"">ibuprofen</span>",D000699,"<span class=""disease"">analgesia</span>","Intravenous acetaminophen is a reasonable alternative to oral <span class=""chemical"">ibuprofen</span> as an adjunct to morphine patient-controlled <span class=""disease"">analgesia</span> after Cesarean delivery.",,17142654,17142654_D007052_D000699,17142654_9,bcv_sentence_task_befree_2711,,770958640,FALSE,finalized,5,8/15/15 0:00,"



",no_relation,0.8074,,D000082,"<span class=""chemical"">acetaminophen</span>",D000699,"<span class=""disease"">analgesia</span>","Intravenous <span class=""chemical"">acetaminophen</span> is a reasonable alternative to oral ibuprofen as an adjunct to morphine patient-controlled <span class=""disease"">analgesia</span> after Cesarean delivery.",,17142654,17142654_D000082_D000699,17142654_9,bcv_sentence_task_befree_2712,,770958641,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,D019829,"<span class=""chemical"">nevirapine/NVP</span>",D000744,"<span class=""disease"">immunodeficiency</span>","Impact of <span class=""chemical"">nevirapine</span> (<span class=""chemical"">NVP</span>) plasma concentration on selection of resistant virus in mothers who received single-dose <span class=""chemical"">NVP</span> to prevent perinatal human <span class=""disease"">immunodeficiency</span> virus type 1 transmission and persistence of resistant virus in their infected children.",,17178792,17178792_D019829_D000744,17178792_0,bcv_sentence_task_befree_2713,,770958642,FALSE,finalized,5,8/15/15 2:11,"



",no_relation,1,,D019829,"<span class=""chemical"">NVP</span>",D000744,"<span class=""disease"">immunodeficiency</span>","Genotypic resistance analysis was performed on mothers' plasma samples at week 4 postpartum (PP) and on human <span class=""disease"">immunodeficiency</span> virus (HIV) DNA in peripheral blood mononuclear cells (PBMC) when an <span class=""chemical"">NVP</span> resistance mutation was detected.",,17178792,17178792_D019829_D000744,17178792_4,bcv_sentence_task_befree_2714,,770958643,FALSE,finalized,5,8/14/15 23:30,"



",yes_direct,1,,D001556,"<span class=""chemical"">lindane</span>",D005203,"<span class=""disease"">farmer's lung</span>","The insecticides DDT, <span class=""chemical"">lindane</span>, and aldicarb were positively associated with <span class=""disease"">farmer's lung</span> among farmers.",,17182642,17182642_D001556_D005203,17182642_8,bcv_sentence_task_befree_2715,,770958644,FALSE,finalized,5,8/14/15 22:42,"



",yes_direct,1,,D003634,"<span class=""chemical"">DDT</span>",D005203,"<span class=""disease"">farmer's lung</span>","The insecticides <span class=""chemical"">DDT</span>, lindane, and aldicarb were positively associated with <span class=""disease"">farmer's lung</span> among farmers.",,17182642,17182642_D003634_D005203,17182642_8,bcv_sentence_task_befree_2716,,770958645,FALSE,finalized,5,8/15/15 1:47,"



",yes_direct,1,,D000448,"<span class=""chemical"">aldicarb</span>",D005203,"<span class=""disease"">farmer's lung</span>","The insecticides DDT, lindane, and <span class=""chemical"">aldicarb</span> were positively associated with <span class=""disease"">farmer's lung</span> among farmers.",,17182642,17182642_D000448_D005203,17182642_8,bcv_sentence_task_befree_2717,,770958646,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,D007987,"<span class=""chemical"">Gonadotropin-releasing hormone</span>",D009214,"<span class=""disease"">myoma</span>","<span class=""chemical"">Gonadotropin-releasing hormone</span> agonist (GnRH agonist) therapy has been useful as an adjunct before myomectomy or hysterectomy for uterine <span class=""disease"">myoma</span>.",,17197363,17197363_D007987_D009214,17197363_1,bcv_sentence_task_befree_2718,,770958647,FALSE,finalized,5,8/14/15 22:32,"


'Spontaneous expulsion of submucosal myomas' and not just 'submucosal myomas'
",yes_direct,0.6131,,D007987,"<span class=""chemical"">GnRH</span>",D009214,"<span class=""disease"">submucosal myomas</span>","Spontaneous expulsion of <span class=""disease"">submucosal myomas</span> might occur after the administration of <span class=""chemical"">GnRH</span> agonist; hence, it may be an acceptable alternative for symptomatic females without sexual exposure.",,17197363,17197363_D007987_D009214,17197363_10,bcv_sentence_task_befree_2719,,770958648,FALSE,finalized,5,8/15/15 0:17,"



",no_relation,0.5975,,D016685,"<span class=""chemical"">mitomycin</span>",D064420,"<span class=""disease"">toxicity</span>","The feasibility, <span class=""disease"">toxicity</span> and local response rates of intra-arterial chemotherapy with 5-fluorouracil, epirubicin and <span class=""chemical"">mitomycin</span> in patients over 75 years with locally advanced breast cancer was evaluated.",,17203763,17203763_D016685_D064420,17203763_1,bcv_sentence_task_befree_2720,,770958649,FALSE,finalized,5,8/14/15 23:32,"



",no_relation,1,,D016685,"<span class=""chemical"">mitomycin</span>",D009369,"<span class=""disease"">locally advanced breast cancer</span>","The feasibility, toxicity and local response rates of intra-arterial chemotherapy with 5-fluorouracil, epirubicin and <span class=""chemical"">mitomycin</span> in patients over 75 years with <span class=""disease"">locally advanced breast cancer</span> was evaluated.",,17203763,17203763_D016685_D009369,17203763_1,bcv_sentence_task_befree_2721,,770958650,FALSE,finalized,5,8/14/15 22:04,"



",no_relation,0.7948,,D005472,"<span class=""chemical"">5-fluorouracil</span>",D064420,"<span class=""disease"">toxicity</span>","The feasibility, <span class=""disease"">toxicity</span> and local response rates of intra-arterial chemotherapy with <span class=""chemical"">5-fluorouracil</span>, epirubicin and mitomycin in patients over 75 years with locally advanced breast cancer was evaluated.",,17203763,17203763_D005472_D064420,17203763_1,bcv_sentence_task_befree_2722,,770958651,FALSE,finalized,5,8/14/15 22:22,"



",yes_direct,0.5987,,D015251,"<span class=""chemical"">epirubicin</span>",D064420,"<span class=""disease"">toxicity</span>","The feasibility, <span class=""disease"">toxicity</span> and local response rates of intra-arterial chemotherapy with 5-fluorouracil, <span class=""chemical"">epirubicin</span> and mitomycin in patients over 75 years with locally advanced breast cancer was evaluated.",,17203763,17203763_D015251_D064420,17203763_1,bcv_sentence_task_befree_2723,,770958652,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,1,,D005472,"<span class=""chemical"">5-fluorouracil</span>",D009369,"<span class=""disease"">locally advanced breast cancer</span>","The feasibility, toxicity and local response rates of intra-arterial chemotherapy with <span class=""chemical"">5-fluorouracil</span>, epirubicin and mitomycin in patients over 75 years with <span class=""disease"">locally advanced breast cancer</span> was evaluated.",,17203763,17203763_D005472_D009369,17203763_1,bcv_sentence_task_befree_2724,,770958653,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,0.8142,,D015251,"<span class=""chemical"">epirubicin</span>",D009369,"<span class=""disease"">locally advanced breast cancer</span>","The feasibility, toxicity and local response rates of intra-arterial chemotherapy with 5-fluorouracil, <span class=""chemical"">epirubicin</span> and mitomycin in patients over 75 years with <span class=""disease"">locally advanced breast cancer</span> was evaluated.",,17203763,17203763_D015251_D009369,17203763_1,bcv_sentence_task_befree_2725,,770958654,FALSE,finalized,5,8/14/15 23:37,"



",yes_direct,1,,D004298,"<span class=""chemical"">dopamine</span>",D001480,"<span class=""disease"">extrapyramidal symptoms</span>","The presence of PDE10A in both striatal output pathways may reduce the incidence and severity of <span class=""chemical"">dopamine</span> D2 receptor antagonist-like side effects, including <span class=""disease"">extrapyramidal symptoms</span>.",,17263185,17263185_D004298_D001480,17263185_6,bcv_sentence_task_befree_2726,,770958655,FALSE,finalized,5,8/15/15 0:44,"



",no_relation,1,,D002131,"<span class=""chemical"">calcium pyrophosphate dihydrate</span>",D001177,"<span class=""disease"">arthropathy</span>","To the best of our knowledge, no case of <span class=""chemical"">calcium pyrophosphate dihydrate</span> <span class=""disease"">arthropathy</span> after total knee arthroplasty has been reported previously.",,17275646,17275646_D002131_D001177,17275646_6,bcv_sentence_task_befree_2727,,770958656,FALSE,finalized,5,8/15/15 0:45,"



",no_relation,0.7978,,D004967,"<span class=""chemical"">Estrogen</span>",D009369,"<span class=""disease"">breast cancer</span>","<span class=""chemical"">Estrogen</span> receptor alpha regulates expression of the <span class=""disease"">breast cancer</span> 1 associated ring domain 1 (BARD1) gene through intronic DNA sequence.",,17275994,17275994_D004967_D009369,17275994_0,bcv_sentence_task_befree_2728,,770958657,FALSE,finalized,5,8/14/15 22:32,"



",no_relation,0.808,,D004967,"<span class=""chemical"">estrogen</span>",D009369,"<span class=""disease"">breast cancer</span>","We have used a chromatin immunoprecipitation (ChIP)-based cloning strategy to isolate and identify genes associated with <span class=""chemical"">estrogen</span> receptor alpha (ERalpha) in MCF-7 human <span class=""disease"">breast cancer</span> cells.",,17275994,17275994_D004967_D009369,17275994_1,bcv_sentence_task_befree_2729,,770958658,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,C065179,"<span class=""chemical"">Atorvastatin</span>",D003929,"<span class=""disease"">diabetes</span>","<span class=""chemical"">Atorvastatin</span> exerts beneficial vascular effects in <span class=""disease"">diabetes</span>, but the underlying mechanisms are yet to be elucidated.",,17279352,17279352_C065179_D003929,17279352_1,bcv_sentence_task_befree_2730,,770958659,FALSE,finalized,5,8/14/15 22:09,"



",yes_direct,0.5774,,C065179,"<span class=""chemical"">atorvastatin</span>",D014652,"<span class=""disease"">vascular dysfunction</span>","The aim of the present study was to determine whether Rac-1 is involved in the effect of <span class=""chemical"">atorvastatin</span> on oxidative stress and <span class=""disease"">vascular dysfunction</span>.",,17279352,17279352_C065179_D014652,17279352_2,bcv_sentence_task_befree_2731,,770958660,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,0.5924,,C065179,"<span class=""chemical"">Atorvastatin</span>",D014652,"<span class=""disease"">vascular abnormalities</span>","<span class=""chemical"">Atorvastatin</span> failed to afford protection against <span class=""disease"">vascular abnormalities</span> in the presence of a constitutively active mutant of Rac-1.",,17279352,17279352_C065179_D014652,17279352_10,bcv_sentence_task_befree_2732,,770958661,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,1,,C065179,"<span class=""chemical"">atorvastatin</span>",D003929,"<span class=""disease"">diabetes</span>","The results of this study demonstrate that the vascular antioxidant effect of <span class=""chemical"">atorvastatin</span> in <span class=""disease"">diabetes</span> is mediated through inhibition of Rac-1 via a reduction in GGPP.",,17279352,17279352_C065179_D003929,17279352_11,bcv_sentence_task_befree_2733,,770958662,FALSE,finalized,5,8/15/15 0:35,"



",no_relation,0.5773,,D005283,"<span class=""chemical"">fentanyl</span>",D007022,"<span class=""disease"">hypotension</span>","Episodes of <span class=""disease"">hypotension</span> and transient reduction in splanchnic perfusion were more common in patients treated with remifentanil when compared to those receiving the <span class=""chemical"">fentanyl</span> opioid regimen.",,17285425,17285425_D005283_D007022,17285425_10,bcv_sentence_task_befree_2734,,770958663,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,0.8002,,D005283,"<span class=""chemical"">fentanyl</span>",D015431,"<span class=""disease"">reduction in splanchnic perfusion</span>","Episodes of hypotension and transient <span class=""disease"">reduction in splanchnic perfusion</span> were more common in patients treated with remifentanil when compared to those receiving the <span class=""chemical"">fentanyl</span> opioid regimen.",,17285425,17285425_D005283_D015431,17285425_10,bcv_sentence_task_befree_2735,,770958664,FALSE,finalized,5,8/15/15 0:19,"



",yes_direct,1,,C071741,"<span class=""chemical"">remifentanil</span>",D007022,"<span class=""disease"">hypotension</span>","Episodes of <span class=""disease"">hypotension</span> and transient reduction in splanchnic perfusion were more common in patients treated with <span class=""chemical"">remifentanil</span> when compared to those receiving the fentanyl opioid regimen.",,17285425,17285425_C071741_D007022,17285425_10,bcv_sentence_task_befree_2736,,770958665,FALSE,finalized,5,8/14/15 22:27,"



",yes_direct,1,,C071741,"<span class=""chemical"">remifentanil</span>",D015431,"<span class=""disease"">reduction in splanchnic perfusion</span>","Episodes of hypotension and transient <span class=""disease"">reduction in splanchnic perfusion</span> were more common in patients treated with <span class=""chemical"">remifentanil</span> when compared to those receiving the fentanyl opioid regimen.",,17285425,17285425_C071741_D015431,17285425_10,bcv_sentence_task_befree_2737,,770958666,FALSE,finalized,5,8/15/15 1:58,"



",no_relation,1,,D008094,"<span class=""chemical"">lithium</span>",D003866,"<span class=""disease"">depression</span>","Available options for the treatment of bipolar disorder (including those for mania, hypomania, <span class=""disease"">depression</span>, or maintenance) in the elderly include <span class=""chemical"">lithium</span>, antiepileptics, antipsychotics, benzodiazepines, antidepressants, electroconvulsive therapy (ECT), and psychotherapy.",,17296540,17296540_D008094_D003866,17296540_21,bcv_sentence_task_befree_2738,,770958667,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,D000928,"<span class=""chemical"">antidepressants</span>",D001714,"<span class=""disease"">mania/bipolar disorder</span>","Available options for the treatment of <span class=""disease"">bipolar disorder</span> (including those for <span class=""disease"">mania</span>, hypomania, depression, or maintenance) in the elderly include lithium, antiepileptics, antipsychotics, benzodiazepines, <span class=""chemical"">antidepressants</span>, electroconvulsive therapy (ECT), and psychotherapy.",,17296540,17296540_D000928_D001714,17296540_21,bcv_sentence_task_befree_2739,,770958668,FALSE,finalized,5,8/15/15 1:57,"



",no_relation,0.8278,,D000928,"<span class=""chemical"">antidepressants</span>",D003866,"<span class=""disease"">depression</span>","Available options for the treatment of bipolar disorder (including those for mania, hypomania, <span class=""disease"">depression</span>, or maintenance) in the elderly include lithium, antiepileptics, antipsychotics, benzodiazepines, <span class=""chemical"">antidepressants</span>, electroconvulsive therapy (ECT), and psychotherapy.",,17296540,17296540_D000928_D003866,17296540_21,bcv_sentence_task_befree_2740,,770958669,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,D001569,"<span class=""chemical"">benzodiazepines</span>",D003866,"<span class=""disease"">depression</span>","Available options for the treatment of bipolar disorder (including those for mania, hypomania, <span class=""disease"">depression</span>, or maintenance) in the elderly include lithium, antiepileptics, antipsychotics, <span class=""chemical"">benzodiazepines</span>, antidepressants, electroconvulsive therapy (ECT), and psychotherapy.",,17296540,17296540_D001569_D003866,17296540_21,bcv_sentence_task_befree_2741,,770958670,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,D008094,"<span class=""chemical"">lithium</span>",D001714,"<span class=""disease"">mania/bipolar disorder</span>","Available options for the treatment of <span class=""disease"">bipolar disorder</span> (including those for <span class=""disease"">mania</span>, hypomania, depression, or maintenance) in the elderly include <span class=""chemical"">lithium</span>, antiepileptics, antipsychotics, benzodiazepines, antidepressants, electroconvulsive therapy (ECT), and psychotherapy.",,17296540,17296540_D008094_D001714,17296540_21,bcv_sentence_task_befree_2742,,770958671,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,1,,D001569,"<span class=""chemical"">benzodiazepines</span>",D001714,"<span class=""disease"">mania/bipolar disorder</span>","Available options for the treatment of <span class=""disease"">bipolar disorder</span> (including those for <span class=""disease"">mania</span>, hypomania, depression, or maintenance) in the elderly include lithium, antiepileptics, antipsychotics, <span class=""chemical"">benzodiazepines</span>, antidepressants, electroconvulsive therapy (ECT), and psychotherapy.",,17296540,17296540_D001569_D001714,17296540_21,bcv_sentence_task_befree_2743,,770958672,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,1,,D002220,"<span class=""chemical"">carbamazepine</span>",D001714,"<span class=""disease"">bipolar disorder</span>","Lithium, divalproex sodium, <span class=""chemical"">carbamazepine</span>, lamotrigine, atypical antipsychotics, and antidepressants have all been found to be beneficial in the treatment of elderly patients with <span class=""disease"">bipolar disorder</span>.",,17296540,17296540_D002220_D001714,17296540_23,bcv_sentence_task_befree_2744,,770958673,FALSE,finalized,5,8/14/15 21:46,"



",no_relation,1,,D014635,"<span class=""chemical"">divalproex sodium</span>",D001714,"<span class=""disease"">bipolar disorder</span>","Lithium, <span class=""chemical"">divalproex sodium</span>, carbamazepine, lamotrigine, atypical antipsychotics, and antidepressants have all been found to be beneficial in the treatment of elderly patients with <span class=""disease"">bipolar disorder</span>.",,17296540,17296540_D014635_D001714,17296540_23,bcv_sentence_task_befree_2745,,770958674,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,1,,C047781,"<span class=""chemical"">lamotrigine</span>",D001714,"<span class=""disease"">bipolar disorder</span>","Lithium, divalproex sodium, carbamazepine, <span class=""chemical"">lamotrigine</span>, atypical antipsychotics, and antidepressants have all been found to be beneficial in the treatment of elderly patients with <span class=""disease"">bipolar disorder</span>.",,17296540,17296540_C047781_D001714,17296540_23,bcv_sentence_task_befree_2746,,770958675,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,1,,D008094,"<span class=""chemical"">Lithium</span>",D001714,"<span class=""disease"">bipolar disorder</span>","<span class=""chemical"">Lithium</span>, divalproex sodium, carbamazepine, lamotrigine, atypical antipsychotics, and antidepressants have all been found to be beneficial in the treatment of elderly patients with <span class=""disease"">bipolar disorder</span>.",,17296540,17296540_D008094_D001714,17296540_23,bcv_sentence_task_befree_2747,,770958676,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,D006415,"<span class=""chemical"">hematoporphyrin</span>",D009369,"<span class=""disease"">NMSC</span>","The objective was to present six patients with multiple, nodular, and/or pigmented <span class=""disease"">NMSC</span> treated successfully with purified <span class=""chemical"">hematoporphyrin</span> derivative (PHD) and PDT using prior debulking.",,17300605,17300605_D006415_D009369,17300605_3,bcv_sentence_task_befree_2748,,770958677,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,0.8083,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D009369,"<span class=""disease"">breast cancer</span>","Sequenced compared with simultaneous anthracycline and <span class=""chemical"">cyclophosphamide</span> in high-risk stage I and II <span class=""disease"">breast cancer</span>: final analysis from INT-0137 (S9313).",,17308269,17308269_D003520_D009369,17308269_0,bcv_sentence_task_befree_2749,,770958678,FALSE,finalized,5,8/15/15 2:23,"



",no_relation,0.8069,,D018943,"<span class=""chemical"">anthracycline</span>",D009369,"<span class=""disease"">breast cancer</span>","Sequenced compared with simultaneous <span class=""chemical"">anthracycline</span> and cyclophosphamide in high-risk stage I and II <span class=""disease"">breast cancer</span>: final analysis from INT-0137 (S9313).",,17308269,17308269_D018943_D009369,17308269_0,bcv_sentence_task_befree_2750,,770958679,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D003520,"<span class=""chemical"">C/cyclophosphamide</span>",D011475,"<span class=""disease"">OS/overall survival</span>","We conducted a phase III randomized study of two adjuvant treatment schedules of doxorubicin (A) and <span class=""chemical"">cyclophosphamide</span> (<span class=""chemical"">C</span>) in early-stage breast cancer to determine if administration of sequential single agents (A --> C) results in superior disease-free survival (DFS) and <span class=""disease"">overall survival</span> (<span class=""disease"">OS</span>) versus the same total dose given in combination (AC).",,17308269,17308269_D003520_D011475,17308269_1,bcv_sentence_task_befree_2751,,770958680,FALSE,finalized,5,8/15/15 0:08,"



",no_relation,1,,D003520,"<span class=""chemical"">C/cyclophosphamide</span>",D009369,"<span class=""disease"">breast cancer</span>","We conducted a phase III randomized study of two adjuvant treatment schedules of doxorubicin (A) and <span class=""chemical"">cyclophosphamide</span> (<span class=""chemical"">C</span>) in early-stage <span class=""disease"">breast cancer</span> to determine if administration of sequential single agents (A --> C) results in superior disease-free survival (DFS) and overall survival (OS) versus the same total dose given in combination (AC).",,17308269,17308269_D003520_D009369,17308269_1,bcv_sentence_task_befree_2752,,770958681,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,0.7993,,D004317,"<span class=""chemical"">doxorubicin</span>",D009369,"<span class=""disease"">breast cancer</span>","We conducted a phase III randomized study of two adjuvant treatment schedules of <span class=""chemical"">doxorubicin</span> (A) and cyclophosphamide (C) in early-stage <span class=""disease"">breast cancer</span> to determine if administration of sequential single agents (A --> C) results in superior disease-free survival (DFS) and overall survival (OS) versus the same total dose given in combination (AC).",,17308269,17308269_D004317_D009369,17308269_1,bcv_sentence_task_befree_2753,,770958682,FALSE,finalized,5,8/15/15 0:45,"



",no_relation,0.601,,D004317,"<span class=""chemical"">doxorubicin</span>",D011475,"<span class=""disease"">OS/overall survival</span>","We conducted a phase III randomized study of two adjuvant treatment schedules of <span class=""chemical"">doxorubicin</span> (A) and cyclophosphamide (C) in early-stage breast cancer to determine if administration of sequential single agents (A --> C) results in superior disease-free survival (DFS) and <span class=""disease"">overall survival</span> (<span class=""disease"">OS</span>) versus the same total dose given in combination (AC).",,17308269,17308269_D004317_D011475,17308269_1,bcv_sentence_task_befree_2754,,770958683,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D009369,"<span class=""disease"">breast cancer</span>","High-risk node-negative or low-risk node-positive <span class=""disease"">breast cancer</span> patients received AC given: (arm I) concurrently (AC) doxorubicin 54 mg/m2 and <span class=""chemical"">cyclophosphamide</span> 1.2 g/m2 intravenously (IV) every 3 weeks for six cycles; or (arm II) in sequence (A C) doxorubicin 40.5 mg/m2 IV days 1 and 2 every 3 weeks for four cycles followed by <span class=""chemical"">cyclophosphamide</span> 2.4 gm/m2 IV every 2 weeks for three cycles.",,17308269,17308269_D003520_D009369,17308269_2,bcv_sentence_task_befree_2755,,770958684,FALSE,finalized,5,8/14/15 22:14,"



",no_relation,1,,D004317,"<span class=""chemical"">doxorubicin</span>",D009369,"<span class=""disease"">breast cancer</span>","High-risk node-negative or low-risk node-positive <span class=""disease"">breast cancer</span> patients received AC given: (arm I) concurrently (AC) <span class=""chemical"">doxorubicin</span> 54 mg/m2 and cyclophosphamide 1.2 g/m2 intravenously (IV) every 3 weeks for six cycles; or (arm II) in sequence (A C) <span class=""chemical"">doxorubicin</span> 40.5 mg/m2 IV days 1 and 2 every 3 weeks for four cycles followed by cyclophosphamide 2.4 gm/m2 IV every 2 weeks for three cycles.",,17308269,17308269_D004317_D009369,17308269_2,bcv_sentence_task_befree_2756,,770958685,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">tumors</span>","All but premenopausal women with receptor negative <span class=""disease"">tumors</span> received <span class=""chemical"">tamoxifen</span> after chemotherapy.",,17308269,17308269_D013629_D009369,17308269_4,bcv_sentence_task_befree_2757,,770958686,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,D003520,"<span class=""chemical"">C</span>",D011475,"<span class=""disease"">OS</span>","No significant differences in <span class=""disease"">OS</span> or DFS were observed; 5-year estimates of <span class=""disease"">OS</span> (95% CI) were 88% (87% to 90%) on AC and 89% (87% to 91%) on A --> C. Grade 4 hematologic toxicity was greater on A --> <span class=""chemical"">C</span>, but nonhematological grade 4 was similar.",,17308269,17308269_D003520_D011475,17308269_7,bcv_sentence_task_befree_2758,,770958687,FALSE,finalized,5,8/14/15 21:08,"



",no_relation,0.79,,D003520,"<span class=""chemical"">C</span>",D064420,"<span class=""disease"">toxicity</span>","No significant differences in OS or DFS were observed; 5-year estimates of OS (95% CI) were 88% (87% to 90%) on AC and 89% (87% to 91%) on A --> C. Grade 4 hematologic <span class=""disease"">toxicity</span> was greater on A --> <span class=""chemical"">C</span>, but nonhematological grade 4 was similar.",,17308269,17308269_D003520_D064420,17308269_7,bcv_sentence_task_befree_2759,,770958688,FALSE,finalized,5,8/15/15 2:39,"



",no_relation,1,,C071315,"<span class=""chemical"">ramosetron</span>",D043183,"<span class=""disease"">IBS</span>","Pharmacological profile of <span class=""chemical"">ramosetron</span>, a novel therapeutic agent for <span class=""disease"">IBS</span>.",,17323187,17323187_C071315_D043183,17323187_0,bcv_sentence_task_befree_2760,,770958689,FALSE,finalized,5,8/14/15 23:16,"



",no_relation,0.6153,,D012701,"<span class=""chemical"">serotonin/5-HT</span>",D015746,"<span class=""disease"">abdominal pain</span>","Ramosetron is a potent and selective <span class=""chemical"">serotonin</span> (<span class=""chemical"">5-HT</span>)(3) receptor antagonist that has been shown to affect abnormal colonic function and <span class=""disease"">abdominal pain</span> in animals.",,17323187,17323187_D012701_D015746,17323187_1,bcv_sentence_task_befree_2761,,770958690,FALSE,finalized,5,8/14/15 23:38,"



",yes_direct,0.8043,,C071315,"<span class=""chemical"">Ramosetron</span>",D015746,"<span class=""disease"">abdominal pain</span>","<span class=""chemical"">Ramosetron</span> is a potent and selective serotonin (5-HT)(3) receptor antagonist that has been shown to affect abnormal colonic function and <span class=""disease"">abdominal pain</span> in animals.",,17323187,17323187_C071315_D015746,17323187_1,bcv_sentence_task_befree_2762,,770958691,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,0.788,,C084473,"<span class=""chemical"">cilansetron</span>",D049913,"<span class=""disease"">corticotropin releasing factor/CRF</span>","Ramosetron (0.3 to 100 microg/kg, p.o.) has been found to significantly suppress abnormal defecation induced by conditioned-fear stress (CFS), restraint stress, <span class=""disease"">corticotropin releasing factor</span> (<span class=""disease"">CRF</span>) and 5-HT in rats and mice, and these effects were more potent than those of alosetron, <span class=""chemical"">cilansetron</span> or loperamide.",,17323187,17323187_C084473_D049913,17323187_2,bcv_sentence_task_befree_2763,,770958692,FALSE,finalized,5,8/15/15 2:33,"



",no_relation,1,,C090840,"<span class=""chemical"">alosetron</span>",D002869,"<span class=""disease"">abnormal defecation</span>","Ramosetron (0.3 to 100 microg/kg, p.o.) has been found to significantly suppress <span class=""disease"">abnormal defecation</span> induced by conditioned-fear stress (CFS), restraint stress, corticotropin releasing factor (CRF) and 5-HT in rats and mice, and these effects were more potent than those of <span class=""chemical"">alosetron</span>, cilansetron or loperamide.",,17323187,17323187_C090840_D002869,17323187_2,bcv_sentence_task_befree_2764,,770958693,FALSE,finalized,5,8/15/15 1:33,"



",no_relation,0.7948,,C090840,"<span class=""chemical"">alosetron</span>",D049913,"<span class=""disease"">corticotropin releasing factor/CRF</span>","Ramosetron (0.3 to 100 microg/kg, p.o.) has been found to significantly suppress abnormal defecation induced by conditioned-fear stress (CFS), restraint stress, <span class=""disease"">corticotropin releasing factor</span> (<span class=""disease"">CRF</span>) and 5-HT in rats and mice, and these effects were more potent than those of <span class=""chemical"">alosetron</span>, cilansetron or loperamide.",,17323187,17323187_C090840_D049913,17323187_2,bcv_sentence_task_befree_2765,,770958694,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,C084473,"<span class=""chemical"">cilansetron</span>",D002869,"<span class=""disease"">abnormal defecation</span>","Ramosetron (0.3 to 100 microg/kg, p.o.) has been found to significantly suppress <span class=""disease"">abnormal defecation</span> induced by conditioned-fear stress (CFS), restraint stress, corticotropin releasing factor (CRF) and 5-HT in rats and mice, and these effects were more potent than those of alosetron, <span class=""chemical"">cilansetron</span> or loperamide.",,17323187,17323187_C084473_D002869,17323187_2,bcv_sentence_task_befree_2766,,770958695,FALSE,finalized,5,8/15/15 1:22,"



",no_relation,1,,D012701,"<span class=""chemical"">5-HT</span>",D049913,"<span class=""disease"">corticotropin releasing factor/CRF</span>","Ramosetron (0.3 to 100 microg/kg, p.o.) has been found to significantly suppress abnormal defecation induced by conditioned-fear stress (CFS), restraint stress, <span class=""disease"">corticotropin releasing factor</span> (<span class=""disease"">CRF</span>) and <span class=""chemical"">5-HT</span> in rats and mice, and these effects were more potent than those of alosetron, cilansetron or loperamide.",,17323187,17323187_D012701_D049913,17323187_2,bcv_sentence_task_befree_2767,,770958696,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,0.7981,,D008139,"<span class=""chemical"">loperamide</span>",D049913,"<span class=""disease"">corticotropin releasing factor/CRF</span>","Ramosetron (0.3 to 100 microg/kg, p.o.) has been found to significantly suppress abnormal defecation induced by conditioned-fear stress (CFS), restraint stress, <span class=""disease"">corticotropin releasing factor</span> (<span class=""disease"">CRF</span>) and 5-HT in rats and mice, and these effects were more potent than those of alosetron, cilansetron or <span class=""chemical"">loperamide</span>.",,17323187,17323187_D008139_D049913,17323187_2,bcv_sentence_task_befree_2768,,770958697,FALSE,finalized,5,8/14/15 21:59,"



",no_relation,0.6029,,C071315,"<span class=""chemical"">Ramosetron</span>",D049913,"<span class=""disease"">corticotropin releasing factor/CRF</span>","<span class=""chemical"">Ramosetron</span> (0.3 to 100 microg/kg, p.o.) has been found to significantly suppress abnormal defecation induced by conditioned-fear stress (CFS), restraint stress, <span class=""disease"">corticotropin releasing factor</span> (<span class=""disease"">CRF</span>) and 5-HT in rats and mice, and these effects were more potent than those of alosetron, cilansetron or loperamide.",,17323187,17323187_C071315_D049913,17323187_2,bcv_sentence_task_befree_2769,,770958698,FALSE,finalized,5,8/15/15 0:42,"



",no_relation,1,,C071315,"<span class=""chemical"">Ramosetron</span>",D002869,"<span class=""disease"">abnormal defecation</span>","<span class=""chemical"">Ramosetron</span> (0.3 to 100 microg/kg, p.o.) has been found to significantly suppress <span class=""disease"">abnormal defecation</span> induced by conditioned-fear stress (CFS), restraint stress, corticotropin releasing factor (CRF) and 5-HT in rats and mice, and these effects were more potent than those of alosetron, cilansetron or loperamide.",,17323187,17323187_C071315_D002869,17323187_2,bcv_sentence_task_befree_2770,,770958699,FALSE,finalized,5,8/14/15 22:01,"



",no_relation,1,,D008139,"<span class=""chemical"">loperamide</span>",D002869,"<span class=""disease"">abnormal defecation</span>","Ramosetron (0.3 to 100 microg/kg, p.o.) has been found to significantly suppress <span class=""disease"">abnormal defecation</span> induced by conditioned-fear stress (CFS), restraint stress, corticotropin releasing factor (CRF) and 5-HT in rats and mice, and these effects were more potent than those of alosetron, cilansetron or <span class=""chemical"">loperamide</span>.",,17323187,17323187_D008139_D002869,17323187_2,bcv_sentence_task_befree_2771,,770958700,FALSE,finalized,5,8/14/15 21:15,"



",no_relation,0.599,,D012701,"<span class=""chemical"">5-HT</span>",D002869,"<span class=""disease"">abnormal defecation</span>","Ramosetron (0.3 to 100 microg/kg, p.o.) has been found to significantly suppress <span class=""disease"">abnormal defecation</span> induced by conditioned-fear stress (CFS), restraint stress, corticotropin releasing factor (CRF) and <span class=""chemical"">5-HT</span> in rats and mice, and these effects were more potent than those of alosetron, cilansetron or loperamide.",,17323187,17323187_D012701_D002869,17323187_2,bcv_sentence_task_befree_2772,,770958701,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,C071315,"<span class=""chemical"">Ramosetron</span>",D049913,"<span class=""disease"">CRF</span>","<span class=""chemical"">Ramosetron</span> (3 to 100 microg/kg, p. o.) also significantly prevented CFS-induced acceleration of colonic transit and <span class=""disease"">CRF</span>-induced abnormal water transport in rats, respectively.",,17323187,17323187_C071315_D049913,17323187_4,bcv_sentence_task_befree_2773,,770958702,FALSE,finalized,5,8/14/15 22:14,"



",no_relation,1,,C071315,"<span class=""chemical"">ramosetron</span>",D010146,"<span class=""disease"">colonic pain</span>","Moreover, <span class=""chemical"">ramosetron</span> (0.3 to 3 microg/kg, p. o.) significantly suppressed restraint stress-induced decrease in <span class=""disease"">colonic pain</span> threshold, an effect not observed with loperamide.",,17323187,17323187_C071315_D010146,17323187_5,bcv_sentence_task_befree_2774,,770958703,FALSE,finalized,5,8/14/15 23:44,"



",no_relation,1,,D008139,"<span class=""chemical"">loperamide</span>",D010146,"<span class=""disease"">colonic pain</span>","Moreover, ramosetron (0.3 to 3 microg/kg, p. o.) significantly suppressed restraint stress-induced decrease in <span class=""disease"">colonic pain</span> threshold, an effect not observed with <span class=""chemical"">loperamide</span>.",,17323187,17323187_D008139_D010146,17323187_5,bcv_sentence_task_befree_2775,,770958704,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,C071315,"<span class=""chemical"">ramosetron</span>",D043183,"<span class=""disease"">IBS</span>","These results indicate that <span class=""chemical"">ramosetron</span> produce beneficial clinical effects on <span class=""disease"">IBS</span> symptoms.",,17323187,17323187_C071315_D043183,17323187_6,bcv_sentence_task_befree_2776,,770958705,FALSE,finalized,5,8/15/15 2:16,"



",no_relation,1,,D017239,"<span class=""chemical"">paclitaxel</span>",D005354,"<span class=""disease"">fibrosarcoma</span>","Experiments using human <span class=""disease"">fibrosarcoma</span> HT1080 respiratory-deficient cells (rho(0)) and uncoupler of the mitochondrial respiratory chain (MRC) showed that betaTAC and N-betaTAC impaired the MRC. rho(0) cells displayed an increased sensitivity toward N-betaTAC as compared with rho(+) cells but, in contrast, were resistant to betaTAC or classic chemotherapeutics, such as <span class=""chemical"">paclitaxel</span>.",,17332362,17332362_D017239_D005354,17332362_4,bcv_sentence_task_befree_2777,,770958706,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D009369,"<span class=""disease"">breast cancer</span>","Inhibition of cyclooxygenase-2 and induction of apoptosis in <span class=""chemical"">estrogen</span>-nonresponsive <span class=""disease"">breast cancer</span> cells by Antrodia camphorata.",,17391824,17391824_D004967_D009369,17391824_0,bcv_sentence_task_befree_2778,,770958707,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D009369,"<span class=""disease"">breast cancer</span>","The objective of this study was to investigate the fermented culture broth of Antrodia camphorata (A. camphorata) to induce apoptosis and inhibit cyclooxygenase-2 (COX-2) in <span class=""chemical"">estrogen</span>-nonresponsive (MDA-MB-231) human <span class=""disease"">breast cancer</span> cells.",,17391824,17391824_D004967_D009369,17391824_1,bcv_sentence_task_befree_2779,,770958708,FALSE,finalized,5,8/15/15 1:14,"



",no_relation,0.7925,,D004967,"<span class=""chemical"">estrogen</span>",D009369,"<span class=""disease"">breast cancer</span>","Analysis of the study data suggests that A. camphorata exerts growth inhibition on (highly invasive) <span class=""chemical"">estrogen</span>-nonresponsive human <span class=""disease"">breast cancer</span> cells through apoptosis induction associated with COX-2 inhibition, and that it may possess anticancer properties potentially valuable for application in drug products.",,17391824,17391824_D004967_D009369,17391824_6,bcv_sentence_task_befree_2780,,770958709,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,C047426,"<span class=""chemical"">venlafaxine</span>",D003866,"<span class=""disease"">depressive disorder</span>","Effects of high dose <span class=""chemical"">venlafaxine</span> (mean 346.15 mg;) on the cardiovascular system in 37 patients with major <span class=""disease"">depressive disorder</span> were evaluated: BP, ECG (PR, QT, QRSD and QTc intervals) and heart rate.",,17397100,17397100_C047426_D003866,17397100_2,bcv_sentence_task_befree_2781,,770958710,FALSE,finalized,5,8/15/15 2:14,"



",yes_direct,1,,C047426,"<span class=""chemical"">venlafaxine</span>",D006973,"<span class=""disease"">hypertension</span>","12.5% of patients developed <span class=""disease"">hypertension</span> after starting treatment with <span class=""chemical"">venlafaxine</span>.",,17397100,17397100_C047426_D006973,17397100_3,bcv_sentence_task_befree_2782,,770958711,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,0.794,,D012701,"<span class=""chemical"">serotonin</span>",D020230,"<span class=""disease"">serotonin reuptake inhibitors/SRIs</span>","There are a growing number of concerns about the utilization of <span class=""chemical""></span><span class=""disease"">serotonin</span> reuptake inhibitors (<span class=""disease"">SRIs</span>) in late pregnancy and the onset of perinatal complications.",,17407365,17407365_D012701_D020230,17407365_1,bcv_sentence_task_befree_2783,,770958712,FALSE,finalized,5,8/15/15 1:52,"



",yes_direct,0.7841,,D000431,"<span class=""chemical"">Alcohol</span>",D014947,"<span class=""disease"">injury in older adults</span>","<span class=""chemical"">Alcohol</span>-drinking history and fatal <span class=""disease"">injury in older adults</span>.",,17418699,17418699_D000431_D014947,17418699_0,bcv_sentence_task_befree_2784,,770958713,FALSE,finalized,5,8/15/15 0:33,"



",no_relation,1,,D009538,"<span class=""chemical"">nicotine</span>",D020961,"<span class=""disease"">Lewy body diseases</span>","Anti-fibrillogenic and fibril-destabilizing activity of <span class=""chemical"">nicotine</span> in vitro: implications for the prevention and therapeutics of <span class=""disease"">Lewy body diseases</span>.",,17425956,17425956_D009538_D020961,17425956_0,bcv_sentence_task_befree_2785,,770958714,FALSE,finalized,5,8/15/15 0:23,"



",no_relation,1,,D010073,"<span class=""chemical"">oxamniquine</span>",D000208,"<span class=""disease"">acute schistosomiasis</span>","Treatment of human <span class=""disease"">acute schistosomiasis</span> with <span class=""chemical"">oxamniquine</span> induces an increase in interferon-gamma response to Schistosoma mansoni antigens.",,17426890,17426890_D010073_D000208,17426890_0,bcv_sentence_task_befree_2786,,770958715,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,1,,D010073,"<span class=""chemical"">oxamniquine</span>",D000208,"<span class=""disease"">acute schistosomiasis</span>","Patients with <span class=""disease"">acute schistosomiasis</span> were studied before and after <span class=""chemical"">oxamniquine</span> treatment.",,17426890,17426890_D010073_D000208,17426890_1,bcv_sentence_task_befree_2787,,770958716,FALSE,finalized,5,8/14/15 21:49,"



",no_relation,1,,D010073,"<span class=""chemical"">oxamniquine</span>",D000208,"<span class=""disease"">acute schistosomiasis</span>","The <span class=""chemical"">oxamniquine</span> treatment of <span class=""disease"">acute schistosomiasis</span> patients is followed by an improvement of a Th1 response in vitro.",,17426890,17426890_D010073_D000208,17426890_5,bcv_sentence_task_befree_2788,,770958717,FALSE,finalized,5,8/14/15 23:56,"



",no_relation,1,,D001623,"<span class=""chemical"">betamethasone</span>",D005076,"<span class=""disease"">rash</span>","However, both dexchlorpheniramine and <span class=""chemical"">betamethasone</span> alone seem to be better at clearing <span class=""disease"">rash</span> than the combination of dexchlorpheniramine and <span class=""chemical"">betamethasone</span>.",,17443568,17443568_D001623_D005076,17443568_14,bcv_sentence_task_befree_2789,,770958718,FALSE,finalized,5,8/14/15 21:12,"



",no_relation,1,,C018904,"<span class=""chemical"">dexchlorpheniramine</span>",D005076,"<span class=""disease"">rash</span>","However, both <span class=""chemical"">dexchlorpheniramine</span> and betamethasone alone seem to be better at clearing <span class=""disease"">rash</span> than the combination of <span class=""chemical"">dexchlorpheniramine</span> and betamethasone.",,17443568,17443568_C018904_D005076,17443568_14,bcv_sentence_task_befree_2790,,770958719,FALSE,finalized,5,8/14/15 21:15,"



",no_relation,1,,D004917,"<span class=""chemical"">erythromycin</span>",D005076,"<span class=""disease"">rash</span>","The small good quality trial (40 people) that compared oral <span class=""chemical"">erythromycin</span> and placebo found that <span class=""chemical"">erythromycin</span> was more effective than placebo in terms of <span class=""disease"">rash</span> improvement, as rated by the trialists, after two weeks (RR 13.00; 95% CI 1.91 to 88.64).",,17443568,17443568_D004917_D005076,17443568_16,bcv_sentence_task_befree_2791,,770958720,FALSE,finalized,5,8/15/15 0:32,"



",yes_direct,0.8068,,D004917,"<span class=""chemical"">erythromycin</span>",D005767,"<span class=""disease"">gastrointestinal upset</span>","Two out of 17 people on oral <span class=""chemical"">erythromycin</span> and 1 out of 17 on placebo reported minor <span class=""disease"">gastrointestinal upset</span>.",,17443568,17443568_D004917_D005767,17443568_19,bcv_sentence_task_befree_2792,,770958721,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,1,,D004917,"<span class=""chemical"">erythromycin</span>",D005076,"<span class=""disease"">rash</span>","Oral <span class=""chemical"">erythromycin</span> may be effective in treating the <span class=""disease"">rash</span> and decreasing the itch.",,17443568,17443568_D004917_D005076,17443568_21,bcv_sentence_task_befree_2793,,770958722,FALSE,finalized,5,8/15/15 0:44,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D006402,"<span class=""disease"">blood glucose</span>","In most of the studies examined, the efficacy of BIAsp 30 was evaluated in terms of glycaemic control (glycosylated haemoglobin [HbA(1c)] reduction, proportion of patients achieving HbA(1c) target of <6.5% or <7%, fasting <span class=""disease"">blood </span><span class=""chemical"">glucose</span>, <span class=""disease"">blood </span><span class=""chemical"">glucose</span> profile and/or prandial and postprandial <span class=""chemical"">glucose</span> increments).",,17451279,17451279_D005947_D006402,17451279_9,bcv_sentence_task_befree_2794,,770958723,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D019270,"<span class=""chemical"">fructosamine</span>",D007003,"<span class=""disease"">postprandial hyperlipidaemia</span>","In some studies, efficacy was further evaluated using plasma insulin and glucose infusion rates, plasma C-peptide levels, mean serum <span class=""chemical"">fructosamine</span> levels, <span class=""disease"">postprandial hyperlipidaemia</span>, overall well-being, treatment satisfaction and quality of life.",,17451279,17451279_D019270_D007003,17451279_10,bcv_sentence_task_befree_2795,,770958724,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D007003,"<span class=""disease"">postprandial hyperlipidaemia</span>","In some studies, efficacy was further evaluated using plasma insulin and <span class=""chemical"">glucose</span> infusion rates, plasma C-peptide levels, mean serum fructosamine levels, <span class=""disease"">postprandial hyperlipidaemia</span>, overall well-being, treatment satisfaction and quality of life.",,17451279,17451279_D005947_D007003,17451279_10,bcv_sentence_task_befree_2796,,770958725,FALSE,finalized,5,8/15/15 1:17,"



",no_relation,1,,C400278,"<span class=""chemical"">erlotinib</span>",D009369,"<span class=""disease"">pancreatic cancer</span>","ErbB3 expression and dimerization with EGFR influence <span class=""disease"">pancreatic cancer</span> cell sensitivity to <span class=""chemical"">erlotinib</span>.",,17457047,17457047_C400278_D009369,17457047_0,bcv_sentence_task_befree_2797,,770958726,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,C400278,"<span class=""chemical"">Erlotinib</span>",D009369,"<span class=""disease"">pancreatic cancer</span>","<span class=""chemical"">Erlotinib</span>, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), has been recently approved for <span class=""disease"">pancreatic cancer</span> treatment, but there are no reliable predictors of patient response.",,17457047,17457047_C400278_D009369,17457047_2,bcv_sentence_task_befree_2798,,770958727,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D009369,"<span class=""disease"">pancreatic cancer</span>","Erlotinib, an epidermal growth factor receptor <span class=""chemical"">tyrosine</span> kinase inhibitor (EGFR-TKI), has been recently approved for <span class=""disease"">pancreatic cancer</span> treatment, but there are no reliable predictors of patient response.",,17457047,17457047_D014443_D009369,17457047_2,bcv_sentence_task_befree_2799,,770958728,FALSE,finalized,5,8/14/15 23:55,"



",no_relation,1,,C400278,"<span class=""chemical"">erlotinib</span>",D009369,"<span class=""disease"">pancreatic cancer</span>","We analyzed the influence of ErbB3 expression on <span class=""disease"">pancreatic cancer</span> cell response to <span class=""chemical"">erlotinib</span> treatment.",,17457047,17457047_C400278_D009369,17457047_4,bcv_sentence_task_befree_2800,,770958729,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,C400278,"<span class=""chemical"">erlotinib</span>",D009369,"<span class=""disease"">pancreatic cancer</span>","Proliferation assays of five human <span class=""disease"">pancreatic cancer</span> cell lines were performed following treatment with <span class=""chemical"">erlotinib</span>.",,17457047,17457047_C400278_D009369,17457047_5,bcv_sentence_task_befree_2801,,770958730,FALSE,finalized,5,8/15/15 2:03,"



",no_relation,1,,C400278,"<span class=""chemical"">erlotinib</span>",D009369,"<span class=""disease"">pancreatic cancer</span>","The effects of RNA inhibition of ErbB3 on sensitivity to <span class=""chemical"">erlotinib</span> treatment were evaluated in AsPC-1 <span class=""disease"">pancreatic cancer</span> cells.",,17457047,17457047_C400278_D009369,17457047_8,bcv_sentence_task_befree_2802,,770958731,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,C400278,"<span class=""chemical"">erlotinib</span>",D009369,"<span class=""disease"">Pancreatic cancer</span>","<span class=""disease"">Pancreatic cancer</span> cells which lack ErbB3 do not display activation of the ErbB3-PI3K-Akt cascade induced by EGFR/ErbB3 heterodimers and become less critically dependent on EGFR signaling and therefore resistant to <span class=""chemical"">erlotinib</span>.",,17457047,17457047_C400278_D009369,17457047_12,bcv_sentence_task_befree_2803,,770958732,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,1,,D005231,"<span class=""chemical"">polyunsaturated fatty acids</span>",D003929,"<span class=""disease"">diabetic</span>","Although a supplement of low-dose n-3 long-chain <span class=""chemical"">polyunsaturated fatty acids</span> had no effect on the plasma high-sensitivity CRP of the supplemented group, a reduction in CRP levels was found when patients were stratified for tertiles of CRP (for the upper tertile) and <span class=""disease"">diabetic</span> status (for nondiabetic patients).",,17462553,17462553_D005231_D003929,17462553_13,bcv_sentence_task_befree_2804,,770958733,FALSE,finalized,5,8/15/15 1:32,"



",no_relation,1,,D008694,"<span class=""chemical"">methamphetamine</span>",D015658,"<span class=""disease"">HIV-1 neurodegeneration</span>","Progress in understanding basal ganglia dysfunction as a common target for <span class=""chemical"">methamphetamine</span> abuse and <span class=""disease"">HIV-1 neurodegeneration</span>.",,17504172,17504172_D008694_D015658,17504172_0,bcv_sentence_task_befree_2805,,770958734,FALSE,finalized,5,8/14/15 21:24,"



",yes_direct,1,,D008694,"<span class=""chemical"">methamphetamine</span>",D003704,"<span class=""disease"">dementia</span>","HIV-1 infection with concurrent <span class=""chemical"">methamphetamine</span> (MA) abuse results in exacerbated neurodegenerative changes and rapid progression of a form of sub-cortical <span class=""disease"">dementia</span> termed HIV-1 associated <span class=""disease"">dementia</span> (HAD).",,17504172,17504172_D008694_D003704,17504172_1,bcv_sentence_task_befree_2806,,770958735,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D008694,"<span class=""chemical"">methamphetamine</span>",D015658,"<span class=""disease"">HIV-1 infection</span>","<span class=""disease"">HIV-1 infection</span> with concurrent <span class=""chemical"">methamphetamine</span> (MA) abuse results in exacerbated neurodegenerative changes and rapid progression of a form of sub-cortical dementia termed HIV-1 associated dementia (HAD).",,17504172,17504172_D008694_D015658,17504172_1,bcv_sentence_task_befree_2807,,770958736,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D009705,"<span class=""chemical"">Nucleoside</span>",D000744,"<span class=""disease"">immunodeficiency</span>","<span class=""chemical"">Nucleoside</span> reverse transcriptase inhibitors and human <span class=""disease"">immunodeficiency</span> virus proteins cause axonal injury in human dorsal root ganglia cultures.",,17505984,17505984_D009705_D000744,17505984_0,bcv_sentence_task_befree_2808,,770958737,FALSE,finalized,5,8/14/15 22:26,"



",yes_direct,0.7951,,D009705,"<span class=""chemical"">Nucleoside</span>",D014947,"<span class=""disease"">axonal injury</span>","<span class=""chemical"">Nucleoside</span> reverse transcriptase inhibitors and human immunodeficiency virus proteins cause <span class=""disease"">axonal injury</span> in human dorsal root ganglia cultures.",,17505984,17505984_D009705_D014947,17505984_0,bcv_sentence_task_befree_2809,,770958738,FALSE,finalized,5,8/15/15 2:33,"



",yes_direct,0.8359,,D009705,"<span class=""chemical"">nucleoside</span>",D028361,"<span class=""disease"">mitochondrial injury</span>","In conclusion, both HIV proteins and <span class=""chemical"">nucleoside</span> reverse transcriptase inhibitors (NRTIs) cause axonal damage by inducing <span class=""disease"">mitochondrial injury</span> and rearrangement of microtubules.",,17505984,17505984_D009705_D028361,17505984_9,bcv_sentence_task_befree_2810,,770958739,FALSE,finalized,5,8/15/15 1:06,"



",yes_direct,0.802,,D009705,"<span class=""chemical"">nucleoside</span>",D006177,"<span class=""disease"">axonal damage</span>","In conclusion, both HIV proteins and <span class=""chemical"">nucleoside</span> reverse transcriptase inhibitors (NRTIs) cause <span class=""disease"">axonal damage</span> by inducing mitochondrial injury and rearrangement of microtubules.",,17505984,17505984_D009705_D006177,17505984_9,bcv_sentence_task_befree_2811,,770958740,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,1,,C483604,"<span class=""chemical"">Cloretazine</span>",D009369,"<span class=""disease"">CNS tumor</span>","Activity of VNP40101M (<span class=""chemical"">Cloretazine</span>) in the treatment of <span class=""disease"">CNS tumor</span> xenografts in athymic mice.",,17522334,17522334_C483604_D009369,17522334_0,bcv_sentence_task_befree_2812,,770958741,FALSE,finalized,5,8/14/15 21:20,"



",no_relation,0.8048,,D006513,"<span class=""chemical"">HBeAg</span>",D008107,"<span class=""disease"">liver disease</span>","Our aims were to investigate the relationship between serum leptin concentrations and the severity of <span class=""disease"">liver disease</span> in a cohort of subjects with <span class=""chemical"">HBeAg</span> negative chronic hepatitis B (CHB) and C (CHC) and to analyze the effect of body composition, the leptin system and insulin resistance together with viral factors on virologic response to antiviral treatment.",,17540037,17540037_D006513_D008107,17540037_2,bcv_sentence_task_befree_2813,,770958742,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,1,,D006513,"<span class=""chemical"">HBeAg</span>",D019694,"<span class=""disease"">HBeAg negative chronic hepatitis B/CHB</span>","Our aims were to investigate the relationship between serum leptin concentrations and the severity of liver disease in a cohort of subjects with <span class=""chemical""></span><span class=""disease"">HBeAg</span> negative chronic hepatitis B (<span class=""disease"">CHB</span>) and C (CHC) and to analyze the effect of body composition, the leptin system and insulin resistance together with viral factors on virologic response to antiviral treatment.",,17540037,17540037_D006513_D019694,17540037_2,bcv_sentence_task_befree_2814,,770958743,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,0.8343,,D019259,"<span class=""chemical"">lamivudine</span>",D019694,"<span class=""disease"">CHB</span>","An inverse correlation between lower leptin levels and response to <span class=""chemical"">lamivudine</span> monotherapy was noted in patients with <span class=""disease"">CHB</span>; those with a virologic response presented lower serum leptin levels (5334 vs 13111.5 pg/ml; p-value = 0.003) than non-responders.",,17540037,17540037_D019259_D019694,17540037_7,bcv_sentence_task_befree_2815,,770958744,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,D019259,"<span class=""chemical"">lamivudine</span>",D019694,"<span class=""disease"">CHB</span>","Increased serum leptin levels represent a negative prognostic factor for response to <span class=""chemical"">lamivudine</span> monotherapy in patients with <span class=""disease"">CHB</span>.",,17540037,17540037_D019259_D019694,17540037_10,bcv_sentence_task_befree_2816,,770958745,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,1,,C012629,"<span class=""chemical"">formoterol</span>",D029424,"<span class=""disease"">COPD</span>","Lung deposition and efficacy of inhaled <span class=""chemical"">formoterol</span> in patients with moderate to severe <span class=""disease"">COPD</span>.",,17544264,17544264_C012629_D029424,17544264_0,bcv_sentence_task_befree_2817,,770958746,FALSE,finalized,5,8/15/15 0:01,"



",no_relation,1,,C012629,"<span class=""chemical"">formoterol</span>",D029424,"<span class=""disease"">COPD</span>","Nineteen patients with varying degrees of <span class=""disease"">COPD</span> were randomized to inhale single doses of <span class=""chemical"">formoterol</span> (Oxis) Turbuhaler 4.5, 9, 18, and 36 microg in a double blind, placebo-controlled, crossover design.",,17544264,17544264_C012629_D029424,17544264_2,bcv_sentence_task_befree_2818,,770958747,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,C012629,"<span class=""chemical"">formoterol</span>",D029424,"<span class=""disease"">COPD</span>","This study could not show any difference in lung deposition of <span class=""chemical"">formoterol</span> inhaled via Turbuhaler between patients with moderate and severe <span class=""disease"">COPD</span>.",,17544264,17544264_C012629_D029424,17544264_11,bcv_sentence_task_befree_2819,,770958748,FALSE,finalized,5,8/15/15 0:37,"



",yes_direct,0.5895,,D005227,"<span class=""chemical"">fatty acids</span>",D015212,"<span class=""disease"">inflammatory bowel disease</span>","Numerous clinical trials utilizing various types of lipids, including fish oil and short chain <span class=""chemical"">fatty acids</span>, suggest that fats play an important role in the inflammatory response that characterizes <span class=""disease"">inflammatory bowel disease</span>.",,17545776,17545776_D005227_D015212,17545776_5,bcv_sentence_task_befree_2820,,770958749,FALSE,finalized,5,8/15/15 0:34,"



",no_relation,0.804,,D009599,"<span class=""chemical"">nitroprusside</span>",D006461,"<span class=""disease"">hemolysis</span>","Cardiopulmonary bypass, <span class=""disease"">hemolysis</span>, and <span class=""chemical"">nitroprusside</span>-induced cyanide production.",,17578949,17578949_D009599_D006461,17578949_0,bcv_sentence_task_befree_2821,,770958750,FALSE,finalized,5,8/15/15 0:18,"



",yes_direct,1,,D009599,"<span class=""chemical"">sodium nitroprusside</span>",D064420,"<span class=""disease"">toxicity</span>","Cyanide <span class=""disease"">toxicity</span> is a complication of <span class=""chemical"">sodium nitroprusside</span> administration.",,17578949,17578949_D009599_D064420,17578949_1,bcv_sentence_task_befree_2822,,770958751,FALSE,finalized,5,8/14/15 23:57,"



",no_relation,0.6143,,D009599,"<span class=""chemical"">sodium nitroprusside</span>",D064420,"<span class=""disease"">toxicity</span>","Cardiac surgery may increase the risk of cyanide <span class=""disease"">toxicity</span>, because hemolysis during cardiopulmonary bypass (CPB) may catalyze the release of free cyanide from <span class=""chemical"">sodium nitroprusside</span>.",,17578949,17578949_D009599_D064420,17578949_2,bcv_sentence_task_befree_2823,,770958752,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D009599,"<span class=""chemical"">sodium nitroprusside</span>",D006461,"<span class=""disease"">hemolysis</span>","Cardiac surgery may increase the risk of cyanide toxicity, because <span class=""disease"">hemolysis</span> during cardiopulmonary bypass (CPB) may catalyze the release of free cyanide from <span class=""chemical"">sodium nitroprusside</span>.",,17578949,17578949_D009599_D006461,17578949_2,bcv_sentence_task_befree_2824,,770958753,FALSE,finalized,5,8/15/15 1:29,"



",no_relation,1,,D009599,"<span class=""chemical"">sodium nitroprusside</span>",D006461,"<span class=""disease"">hemolysis</span>","CPB-associated <span class=""disease"">hemolysis</span> and free hemoglobin release accelerated the immediate release of free cyanide from <span class=""chemical"">sodium nitroprusside</span>.",,17578949,17578949_D009599_D006461,17578949_7,bcv_sentence_task_befree_2825,,770958754,FALSE,finalized,5,8/15/15 2:13,"



",yes_direct,0.8057,,D009599,"<span class=""chemical"">sodium nitroprusside</span>",D064420,"<span class=""disease"">toxicity</span>","These in vitro findings suggest that cardiac surgical patients may be at increased risk of cyanide <span class=""disease"">toxicity</span> in response to the perioperative administration of <span class=""chemical"">sodium nitroprusside</span>.",,17578949,17578949_D009599_D064420,17578949_8,bcv_sentence_task_befree_2826,,770958755,FALSE,finalized,5,8/14/15 21:30,"



",no_relation,1,,D014221,"<span class=""chemical"">triamcinolone</span>",D004487,"<span class=""disease"">macular oedema</span>","Intravitreal <span class=""chemical"">triamcinolone</span> as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant <span class=""disease"">macular oedema</span>.",,17608830,17608830_D014221_D004487,17608830_0,bcv_sentence_task_befree_2827,,770958756,FALSE,finalized,5,8/14/15 22:12,"



",no_relation,1,,D014222,"<span class=""chemical"">triamcinolone acetonide</span>",D004487,"<span class=""disease"">macular oedema</span>","To evaluate the effect of intravitreal injections of <span class=""chemical"">triamcinolone acetonide</span> (IVTA) combined with panretinal photocoagulation (PRP) on visual acuity (VA) and foveal thickness in patients with concomitant high-risk proliferative diabetic retinopathy (PDR) and clinically significant <span class=""disease"">macular oedema</span> (CSMO).",,17608830,17608830_D014222_D004487,17608830_1,bcv_sentence_task_befree_2828,,770958757,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,0.8032,,D014807,"<span class=""chemical"">vitamin D</span>",D010024,"<span class=""disease"">osteoporosis</span>","Experimental <span class=""disease"">osteoporosis</span> induced by ovariectomy and <span class=""chemical"">vitamin D</span> deficiency does not markedly affect fracture healing in rats.",,17611855,17611855_D014807_D010024,17611855_0,bcv_sentence_task_befree_2829,,770958758,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D014807,"<span class=""chemical"">vitamin D</span>",D014082,"<span class=""disease"">fracture</span>","Experimental osteoporosis induced by ovariectomy and <span class=""chemical"">vitamin D</span> deficiency does not markedly affect <span class=""disease"">fracture</span> healing in rats.",,17611855,17611855_D014807_D014082,17611855_0,bcv_sentence_task_befree_2830,,770958759,FALSE,finalized,5,8/14/15 21:10,"



",yes_direct,0.5818,,D014807,"<span class=""chemical"">vitamin D</span>",D005265,"<span class=""disease"">weakening of the femoral neck</span>","We therefore studied this issue in <span class=""chemical"">vitamin D</span>-depleted ovariectomized (OVX) rats, an OP model previously shown to induce <span class=""disease"">weakening of the femoral neck</span>, and thus thought to be closer to the human condition than the classic OVX rat model.",,17611855,17611855_D014807_D005265,17611855_2,bcv_sentence_task_befree_2831,,770958760,FALSE,finalized,5,8/14/15 21:31,"



",no_relation,1,,D014807,"<span class=""chemical"">vitamin D</span>",D010024,"<span class=""disease"">OP</span>","We therefore studied this issue in <span class=""chemical"">vitamin D</span>-depleted ovariectomized (OVX) rats, an <span class=""disease"">OP</span> model previously shown to induce weakening of the femoral neck, and thus thought to be closer to the human condition than the classic OVX rat model.",,17611855,17611855_D014807_D010024,17611855_2,bcv_sentence_task_befree_2832,,770958761,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,0.8011,,D004958,"<span class=""chemical"">estradiol</span>",D016301,"<span class=""disease"">Bone loss</span>","<span class=""disease"">Bone loss</span> and callus formation were monitored with DXA; serum levels of <span class=""chemical"">estradiol</span> and vitamin D3 were measured and histomorphometric analyses were performed.",,17611855,17611855_D004958_D016301,17611855_5,bcv_sentence_task_befree_2833,,770958762,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,D002762,"<span class=""chemical"">vitamin D3</span>",D016301,"<span class=""disease"">Bone loss</span>","<span class=""disease"">Bone loss</span> and callus formation were monitored with DXA; serum levels of estradiol and <span class=""chemical"">vitamin D3</span> were measured and histomorphometric analyses were performed.",,17611855,17611855_D002762_D016301,17611855_5,bcv_sentence_task_befree_2834,,770958763,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D014082,"<span class=""disease"">fracture</span>","Our results suggest that the systemic effects of <span class=""chemical"">estrogen</span> and vitamin D deficiency are not crucial for <span class=""disease"">fracture</span> healing or mechanical properties of the callus.",,17611855,17611855_D004967_D014082,17611855_10,bcv_sentence_task_befree_2835,,770958764,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,D014807,"<span class=""chemical"">vitamin D</span>",D014082,"<span class=""disease"">fracture</span>","Our results suggest that the systemic effects of estrogen and <span class=""chemical"">vitamin D</span> deficiency are not crucial for <span class=""disease"">fracture</span> healing or mechanical properties of the callus.",,17611855,17611855_D014807_D014082,17611855_10,bcv_sentence_task_befree_2836,,770958765,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,0.6154,,D002945,"<span class=""chemical"">cisplatin</span>",D003643,"<span class=""disease"">death</span>","A meta-analysis of early trials of adjuvant chemotherapy by the Non-Small Cell Lung Cancer Collaborative Group showed that while chemotherapy with alkylating agents was also detrimental, chemotherapy with <span class=""chemical"">cisplatin</span>-based adjuvant chemotherapy was associated with an improved hazard ratio for <span class=""disease"">death</span> (HR = 0.87), equating to a 5 percent survival benefit at 5 years.",,17612931,17612931_D002945_D003643,17612931_3,bcv_sentence_task_befree_2837,,770958766,FALSE,finalized,5,8/15/15 0:57,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D002289,"<span class=""disease"">NSCLC</span>","Three trials (IALT, JBR 10, and ANITA) that utilized <span class=""chemical"">cisplatin</span>-based doublets showed a significantly positive survival benefit of adjuvant chemotherapy in patients with Stage II-IIIA <span class=""disease"">NSCLC</span>.",,17612931,17612931_D002945_D002289,17612931_6,bcv_sentence_task_befree_2838,,770958767,FALSE,finalized,5,8/14/15 21:10,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D002289,"<span class=""disease"">NSCLC</span>","These data indicate that medically fit patients with resected Stage II-IIIA <span class=""disease"">NSCLC</span> should be offered adjuvant chemotherapy with a modern <span class=""chemical"">cisplatin</span>-based doublet.",,17612931,17612931_D002945_D002289,17612931_8,bcv_sentence_task_befree_2839,,770958768,FALSE,finalized,5,8/14/15 21:20,"



",no_relation,1,,D002945,"<span class=""chemical"">Cisplatin</span>",D009369,"<span class=""disease"">primary tumor</span>","<span class=""chemical"">Cisplatin</span>-DNA adduct formation in patients treated with <span class=""chemical"">cisplatin</span>-based chemoradiation: lack of correlation between normal tissues and <span class=""disease"">primary tumor</span>.",,17639394,17639394_D002945_D009369,17639394_0,bcv_sentence_task_befree_2840,,770958769,FALSE,finalized,5,8/14/15 23:20,"



",no_relation,0.7895,,D002945,"<span class=""chemical"">cisplatin</span>",D009369,"<span class=""disease"">primary tumor</span>","In this study, the formation of <span class=""chemical"">cisplatin</span>-DNA adducts after concurrent <span class=""chemical"">cisplatin</span>-radiation and the relationship between adduct-formation in <span class=""disease"">primary tumor</span> tissue and normal tissue were investigated.",,17639394,17639394_D002945_D009369,17639394_1,bcv_sentence_task_befree_2841,,770958770,FALSE,finalized,5,8/14/15 23:48,"



",no_relation,0.7963,,D006151,"<span class=""chemical"">guanosine</span>",D009369,"<span class=""disease"">tumor</span>","Linear relationships and high correlations were observed between the levels of two <span class=""chemical"">guanosine</span>- and adenosine-<span class=""chemical"">guanosine</span>-adducts in normal and <span class=""disease"">tumor</span> tissue.",,17639394,17639394_D006151_D009369,17639394_5,bcv_sentence_task_befree_2842,,770958771,FALSE,finalized,5,8/15/15 1:13,"



",no_relation,0.5764,,D000241,"<span class=""chemical"">adenosine</span>",D009369,"<span class=""disease"">tumor</span>","Linear relationships and high correlations were observed between the levels of two guanosine- and <span class=""chemical"">adenosine</span>-guanosine-adducts in normal and <span class=""disease"">tumor</span> tissue.",,17639394,17639394_D000241_D009369,17639394_5,bcv_sentence_task_befree_2843,,770958772,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,0.6022,,D002945,"<span class=""chemical"">cisplatin</span>",D009369,"<span class=""disease"">tumors</span>","In concurrent chemoradiotherapy schedules, <span class=""chemical"">cisplatin</span> adduct levels in <span class=""disease"">tumors</span> were significantly higher than in normal tissues (WBC).",,17639394,17639394_D002945_D009369,17639394_8,bcv_sentence_task_befree_2844,,770958773,FALSE,finalized,5,8/14/15 22:06,"



",no_relation,1,,D000666,"<span class=""chemical"">amphotericin B</span>",D004696,"<span class=""disease"">valve endocarditis</span>","We describe a diabetic patient with Lecythophora mutabilis prosthetic <span class=""disease"">valve endocarditis</span> who was treated surgically, as well as with <span class=""chemical"">amphotericin B</span> lipid complex and voriconazole, which were subsequently followed by prolonged voriconazole suppressive therapy.",,17654274,17654274_D000666_D004696,17654274_3,bcv_sentence_task_befree_2845,,770958774,FALSE,finalized,5,8/14/15 21:46,"



",no_relation,1,,C102790,"<span class=""chemical"">voriconazole</span>",D004696,"<span class=""disease"">valve endocarditis</span>","We describe a diabetic patient with Lecythophora mutabilis prosthetic <span class=""disease"">valve endocarditis</span> who was treated surgically, as well as with amphotericin B lipid complex and <span class=""chemical"">voriconazole</span>, which were subsequently followed by prolonged <span class=""chemical"">voriconazole</span> suppressive therapy.",,17654274,17654274_C102790_D004696,17654274_3,bcv_sentence_task_befree_2846,,770958775,FALSE,finalized,5,8/15/15 2:22,"



",no_relation,1,,C102790,"<span class=""chemical"">voriconazole</span>",D003929,"<span class=""disease"">diabetic</span>","We describe a <span class=""disease"">diabetic</span> patient with Lecythophora mutabilis prosthetic valve endocarditis who was treated surgically, as well as with amphotericin B lipid complex and <span class=""chemical"">voriconazole</span>, which were subsequently followed by prolonged <span class=""chemical"">voriconazole</span> suppressive therapy.",,17654274,17654274_C102790_D003929,17654274_3,bcv_sentence_task_befree_2847,,770958776,FALSE,finalized,5,8/15/15 2:27,"



",no_relation,1,,D000666,"<span class=""chemical"">amphotericin B</span>",D003929,"<span class=""disease"">diabetic</span>","We describe a <span class=""disease"">diabetic</span> patient with Lecythophora mutabilis prosthetic valve endocarditis who was treated surgically, as well as with <span class=""chemical"">amphotericin B</span> lipid complex and voriconazole, which were subsequently followed by prolonged voriconazole suppressive therapy.",,17654274,17654274_D000666_D003929,17654274_3,bcv_sentence_task_befree_2848,,770958777,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,D003024,"<span class=""chemical"">Clozapine</span>",D012559,"<span class=""disease"">schizophrenia</span>","<span class=""chemical"">Clozapine</span> is uniquely effective in refractory <span class=""disease"">schizophrenia</span>, but treatment attrition is high.",,17685738,17685738_D003024_D012559,17685738_1,bcv_sentence_task_befree_2849,,770958778,FALSE,finalized,5,8/14/15 21:25,"



",yes_direct,0.6081,,D003024,"<span class=""chemical"">Clozapine</span>",D019217,"<span class=""disease"">attrition</span>","<span class=""chemical"">Clozapine</span> is uniquely effective in refractory schizophrenia, but treatment <span class=""disease"">attrition</span> is high.",,17685738,17685738_D003024_D019217,17685738_1,bcv_sentence_task_befree_2850,,770958779,FALSE,finalized,5,8/15/15 0:00,"



",no_relation,0.6094,,D003024,"<span class=""chemical"">clozapine</span>",D003643,"<span class=""disease"">Death</span>","<span class=""disease"">Death</span> is a common cause of <span class=""chemical"">clozapine</span> cessation.",,17685738,17685738_D003024_D003643,17685738_12,bcv_sentence_task_befree_2851,,770958780,FALSE,finalized,5,8/14/15 22:06,"



",no_relation,0.8042,,D002981,"<span class=""chemical"">clindamycin</span>",D011014,"<span class=""disease"">pneumonia</span>","An HIV-infected man became increasingly breathless and cyanosed while receiving <span class=""chemical"">clindamycin</span> and primaquine treatment for Pneumocystis jirovecii <span class=""disease"">pneumonia</span>.",,17686226,17686226_D002981_D011014,17686226_1,bcv_sentence_task_befree_2852,,770958781,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,D011319,"<span class=""chemical"">primaquine</span>",D016720,"<span class=""disease"">Pneumocystis</span>","An HIV-infected man became increasingly breathless and cyanosed while receiving clindamycin and <span class=""chemical"">primaquine</span> treatment for <span class=""disease"">Pneumocystis</span> jirovecii pneumonia.",,17686226,17686226_D011319_D016720,17686226_1,bcv_sentence_task_befree_2853,,770958782,FALSE,finalized,5,8/14/15 21:10,"



",no_relation,0.7849,,D002981,"<span class=""chemical"">clindamycin</span>",D016720,"<span class=""disease"">Pneumocystis</span>","An HIV-infected man became increasingly breathless and cyanosed while receiving <span class=""chemical"">clindamycin</span> and primaquine treatment for <span class=""disease"">Pneumocystis</span> jirovecii pneumonia.",,17686226,17686226_D002981_D016720,17686226_1,bcv_sentence_task_befree_2854,,770958783,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D011319,"<span class=""chemical"">primaquine</span>",D011014,"<span class=""disease"">pneumonia</span>","An HIV-infected man became increasingly breathless and cyanosed while receiving clindamycin and <span class=""chemical"">primaquine</span> treatment for Pneumocystis jirovecii <span class=""disease"">pneumonia</span>.",,17686226,17686226_D011319_D011014,17686226_1,bcv_sentence_task_befree_2855,,770958784,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,0.8018,,D011319,"<span class=""chemical"">primaquine</span>",D015658,"<span class=""disease"">HIV-infected</span>","An <span class=""disease"">HIV-infected</span> man became increasingly breathless and cyanosed while receiving clindamycin and <span class=""chemical"">primaquine</span> treatment for Pneumocystis jirovecii pneumonia.",,17686226,17686226_D011319_D015658,17686226_1,bcv_sentence_task_befree_2856,,770958785,FALSE,finalized,5,8/15/15 2:20,"



",no_relation,1,,D002981,"<span class=""chemical"">clindamycin</span>",D015658,"<span class=""disease"">HIV-infected</span>","An <span class=""disease"">HIV-infected</span> man became increasingly breathless and cyanosed while receiving <span class=""chemical"">clindamycin</span> and primaquine treatment for Pneumocystis jirovecii pneumonia.",,17686226,17686226_D002981_D015658,17686226_1,bcv_sentence_task_befree_2857,,770958786,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,1,,D010710,"<span class=""chemical"">phosphate</span>",D006177,"<span class=""disease"">ileal villous damage</span>","In the hemorrhagic-shock model, rats pretreated with Bifidobacteria showed decreases in total aerobes in cecum, magnitude of total aerobes to BT, levels of plasma endotoxin, and percentage of <span class=""disease"">ileal villous damage</span> when compared with rats treated with <span class=""chemical"">phosphate</span> buffered saline.",,17706400,17706400_D010710_D006177,17706400_5,bcv_sentence_task_befree_2858,,770958787,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,0.5987,,D010710,"<span class=""chemical"">phosphate</span>",D006470,"<span class=""disease"">hemorrhagic-shock</span>","In the <span class=""disease"">hemorrhagic-shock</span> model, rats pretreated with Bifidobacteria showed decreases in total aerobes in cecum, magnitude of total aerobes to BT, levels of plasma endotoxin, and percentage of ileal villous damage when compared with rats treated with <span class=""chemical"">phosphate</span> buffered saline.",,17706400,17706400_D010710_D006470,17706400_5,bcv_sentence_task_befree_2859,,770958788,FALSE,finalized,5,8/14/15 21:59,"



",no_relation,1,,D014975,"<span class=""chemical"">lutein</span>",D008545,"<span class=""disease"">melanoma</span>","Regulation of the extracellular matrix remodeling by <span class=""chemical"">lutein</span> in dermal fibroblasts, <span class=""disease"">melanoma</span> cells, and ultraviolet radiation exposed fibroblasts.",,17710425,17710425_D014975_D008545,17710425_0,bcv_sentence_task_befree_2860,,770958789,FALSE,finalized,5,8/14/15 21:27,"



",no_relation,1,,D014975,"<span class=""chemical"">lutein</span>",D008545,"<span class=""disease"">melanoma</span>","To this purpose, the effects of <span class=""chemical"">lutein</span> on the expression of MMPs and their inhibitors (TIMPs, tissue inhibitors of metalloproteinases) in dermal fibroblasts (intrinsic aging) and <span class=""disease"">melanoma</span> cells were examined.",,17710425,17710425_D014975_D008545,17710425_5,bcv_sentence_task_befree_2861,,770958790,FALSE,finalized,5,8/14/15 21:10,"



",no_relation,1,,D014975,"<span class=""chemical"">Lutein</span>",D008545,"<span class=""disease"">melanoma</span>","<span class=""chemical"">Lutein</span> did not alter fibroblast or <span class=""disease"">melanoma</span> cell viability or membrane integrity.",,17710425,17710425_D014975_D008545,17710425_9,bcv_sentence_task_befree_2862,,770958791,FALSE,finalized,5,8/14/15 23:58,"



",no_relation,1,,D014975,"<span class=""chemical"">lutein</span>",D008545,"<span class=""disease"">melanoma</span>","In summary, the mechanism to <span class=""chemical"">lutein</span>'s anti-aging and anti-carcinogenic effects include the inhibition of MMP to TIMP ratio in dermal fibroblasts and <span class=""disease"">melanoma</span> cells, and the inhibition of cell loss, membrane damage and elastin expression in ultraviolet radiation exposed fibroblasts.",,17710425,17710425_D014975_D008545,17710425_11,bcv_sentence_task_befree_2863,,770958792,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,1,,D007792,"<span class=""chemical"">lactulose</span>",D003248,"<span class=""disease"">constipation</span>","The presence of methane on <span class=""chemical"">lactulose</span> breath testing is associated with <span class=""disease"">constipation</span>-predominant IBS.",,17713456,17713456_D007792_D003248,17713456_6,bcv_sentence_task_befree_2864,,770958793,FALSE,finalized,5,8/14/15 23:11,"



",yes_direct,1,,D008697,"<span class=""chemical"">methane</span>",D003248,"<span class=""disease"">constipation</span>","The presence of <span class=""chemical"">methane</span> on lactulose breath testing is associated with <span class=""disease"">constipation</span>-predominant IBS.",,17713456,17713456_D008697_D003248,17713456_6,bcv_sentence_task_befree_2865,,770958794,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,0.8121,,D007792,"<span class=""chemical"">lactulose</span>",D043183,"<span class=""disease"">IBS</span>","The presence of methane on <span class=""chemical"">lactulose</span> breath testing is associated with constipation-predominant <span class=""disease"">IBS</span>.",,17713456,17713456_D007792_D043183,17713456_6,bcv_sentence_task_befree_2866,,770958795,FALSE,finalized,5,8/14/15 23:03,"



",yes_direct,0.8121,,D008697,"<span class=""chemical"">methane</span>",D043183,"<span class=""disease"">IBS</span>","The presence of <span class=""chemical"">methane</span> on lactulose breath testing is associated with constipation-predominant <span class=""disease"">IBS</span>.",,17713456,17713456_D008697_D043183,17713456_6,bcv_sentence_task_befree_2867,,770958796,FALSE,finalized,5,8/14/15 23:44,"



",no_relation,1,,D007792,"<span class=""chemical"">lactulose</span>",D001765,"<span class=""disease"">bacterial overgrowth</span>","Once a good clinical response and normalization of the <span class=""chemical"">lactulose</span> breath test are achieved, a prokinetic agent may be used to stimulate phase III of interdigestive motility to delay relapse of <span class=""disease"">bacterial overgrowth</span>.",,17713456,17713456_D007792_D001765,17713456_9,bcv_sentence_task_befree_2868,,770958797,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,C009687,"<span class=""chemical"">wortmannin</span>",D009369,"<span class=""disease"">tumor</span>","In addition, platelets taken from mice treated with <span class=""chemical"">wortmannin</span> were blocked from PAR-induced ex vivo activation concomitantly with a decrease in phosphorylation of AKT from excised <span class=""disease"">tumor</span> xenografts.",,17766838,17766838_C009687_D009369,17766838_6,bcv_sentence_task_befree_2869,,770958798,FALSE,finalized,5,8/14/15 23:49,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D009369,"<span class=""disease"">pediatric cancer</span>","BK virus-associated hemorrhagic cystitis in <span class=""disease"">pediatric cancer</span> patients receiving high-dose <span class=""chemical"">cyclophosphamide</span>.",,17805036,17805036_D003520_D009369,17805036_0,bcv_sentence_task_befree_2870,,770958799,FALSE,finalized,5,8/15/15 2:02,"



",yes_direct,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D003556,"<span class=""disease"">hemorrhagic cystitis</span>","BK virus-associated <span class=""disease"">hemorrhagic cystitis</span> in pediatric cancer patients receiving high-dose <span class=""chemical"">cyclophosphamide</span>.",,17805036,17805036_D003520_D003556,17805036_0,bcv_sentence_task_befree_2871,,770958800,FALSE,finalized,5,8/14/15 22:22,"



",yes_direct,0.589,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D006417,"<span class=""disease"">hematuria</span>","BK virus (BKV) has been commonly found to be associated with <span class=""disease"">hematuria</span> in stem cell transplant patients; however, it has rarely been reported after <span class=""chemical"">cyclophosphamide</span> chemotherapy alone.",,17805036,17805036_D003520_D006417,17805036_2,bcv_sentence_task_befree_2872,,770958801,FALSE,finalized,5,8/14/15 21:18,"



",no_relation,1,,C059262,"<span class=""chemical"">cidofovir</span>",D006417,"<span class=""disease"">hematuria</span>","One patient was treated with intravenous <span class=""chemical"">cidofovir</span> with resolution of BK viruria and <span class=""disease"">hematuria</span>.",,17805036,17805036_C059262_D006417,17805036_6,bcv_sentence_task_befree_2873,,770958802,FALSE,finalized,5,8/14/15 21:48,"



",yes_direct,0.6006,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D003556,"<span class=""disease"">HC</span>","Patients with <span class=""disease"">HC</span> after <span class=""chemical"">cyclophosphamide</span> or ifosfamide with negative bacterial cultures should be studied for BKV.",,17805036,17805036_D003520_D003556,17805036_9,bcv_sentence_task_befree_2874,,770958803,FALSE,finalized,5,8/15/15 0:12,"



",no_relation,0.5956,,D007069,"<span class=""chemical"">ifosfamide</span>",D003556,"<span class=""disease"">HC</span>","Patients with <span class=""disease"">HC</span> after cyclophosphamide or <span class=""chemical"">ifosfamide</span> with negative bacterial cultures should be studied for BKV.",,17805036,17805036_D007069_D003556,17805036_9,bcv_sentence_task_befree_2875,,770958804,FALSE,finalized,5,8/15/15 0:57,"



",no_relation,1,,C059262,"<span class=""chemical"">Cidofovir</span>",D003556,"<span class=""disease"">HC</span>","<span class=""chemical"">Cidofovir</span> may be beneficial in certain patients with BK viruria and <span class=""disease"">HC</span>; however, definitive data will require a clinical trial.",,17805036,17805036_C059262_D003556,17805036_10,bcv_sentence_task_befree_2876,,770958805,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D002955,"<span class=""chemical"">leukovorin</span>",D002833,"<span class=""disease"">choroidal melanoma</span>","A 59-year-old patient with a coexisting primary <span class=""disease"">choroidal melanoma</span> and colorectal cancer was treated with external beam radiation (EBR) of his <span class=""disease"">choroidal melanoma</span> and systemic chemotherapy with <span class=""chemical"">leukovorin</span>/5 fluorouracil (FU) for treatment of his metastatic colorectal cancer.",,17823640,17823640_D002955_D002833,17823640_1,bcv_sentence_task_befree_2877,,770958806,FALSE,finalized,5,8/14/15 21:34,"



",no_relation,1,,D005472,"<span class=""chemical"">fluorouracil</span>",D015179,"<span class=""disease"">colorectal cancer</span>","A 59-year-old patient with a coexisting primary choroidal melanoma and <span class=""disease"">colorectal cancer</span> was treated with external beam radiation (EBR) of his choroidal melanoma and systemic chemotherapy with leukovorin/5 <span class=""chemical"">fluorouracil</span> (FU) for treatment of his metastatic <span class=""disease"">colorectal cancer</span>.",,17823640,17823640_D005472_D015179,17823640_1,bcv_sentence_task_befree_2878,,770958807,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,D002955,"<span class=""chemical"">leukovorin</span>",D015179,"<span class=""disease"">colorectal cancer</span>","A 59-year-old patient with a coexisting primary choroidal melanoma and <span class=""disease"">colorectal cancer</span> was treated with external beam radiation (EBR) of his choroidal melanoma and systemic chemotherapy with <span class=""chemical"">leukovorin</span>/5 fluorouracil (FU) for treatment of his metastatic <span class=""disease"">colorectal cancer</span>.",,17823640,17823640_D002955_D015179,17823640_1,bcv_sentence_task_befree_2879,,770958808,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,1,,D005472,"<span class=""chemical"">fluorouracil</span>",D002833,"<span class=""disease"">choroidal melanoma</span>","A 59-year-old patient with a coexisting primary <span class=""disease"">choroidal melanoma</span> and colorectal cancer was treated with external beam radiation (EBR) of his <span class=""disease"">choroidal melanoma</span> and systemic chemotherapy with leukovorin/5 <span class=""chemical"">fluorouracil</span> (FU) for treatment of his metastatic colorectal cancer.",,17823640,17823640_D005472_D002833,17823640_1,bcv_sentence_task_befree_2880,,770958809,FALSE,finalized,5,8/15/15 0:04,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D009369,"<span class=""disease"">ovarian cancer</span>","Resveratrol inhibits <span class=""chemical"">glucose</span> metabolism in human <span class=""disease"">ovarian cancer</span> cells.",,17825886,17825886_D005947_D009369,17825886_0,bcv_sentence_task_befree_2881,,770958810,FALSE,finalized,5,8/14/15 23:45,"



",no_relation,1,,C059514,"<span class=""chemical"">Resveratrol</span>",D009369,"<span class=""disease"">ovarian cancer</span>","<span class=""chemical"">Resveratrol</span> inhibits glucose metabolism in human <span class=""disease"">ovarian cancer</span> cells.",,17825886,17825886_C059514_D009369,17825886_0,bcv_sentence_task_befree_2882,,770958811,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,0.7806,,C059514,"<span class=""chemical"">Resveratrol</span>",D009369,"<span class=""disease"">tumor</span>","<span class=""chemical"">Resveratrol</span> is a phytoalexin found in grapes that inhibits the in vitro growth of multiple <span class=""disease"">tumor</span> cell types.",,17825886,17825886_C059514_D009369,17825886_1,bcv_sentence_task_befree_2883,,770958812,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,0.8084,,C059514,"<span class=""chemical"">resveratrol</span>",D003643,"<span class=""disease"">death</span>","We showed previously that <span class=""chemical"">resveratrol</span> induces autophagic cell <span class=""disease"">death</span> in ovarian cancer cells.",,17825886,17825886_C059514_D003643,17825886_2,bcv_sentence_task_befree_2884,,770958813,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,0.8112,,C059514,"<span class=""chemical"">resveratrol</span>",D009369,"<span class=""disease"">ovarian cancer</span>","We showed previously that <span class=""chemical"">resveratrol</span> induces autophagic cell death in <span class=""disease"">ovarian cancer</span> cells.",,17825886,17825886_C059514_D009369,17825886_2,bcv_sentence_task_befree_2885,,770958814,FALSE,finalized,5,8/15/15 1:24,"



",no_relation,0.8142,,C059514,"<span class=""chemical"">resveratrol</span>",D009369,"<span class=""disease"">ovarian cancer</span>","Because autophagy is typically an adaptive response to nutrient starvation, we hypothesized that autophagy would also be triggered when <span class=""disease"">ovarian cancer</span> cells are nutrient deprived and that <span class=""chemical"">resveratrol</span> could in fact be acting by inducing a starvation-like signaling response.",,17825886,17825886_C059514_D009369,17825886_3,bcv_sentence_task_befree_2886,,770958815,FALSE,finalized,5,8/14/15 21:09,"



",no_relation,1,,D000596,"<span class=""chemical"">amino acids</span>",D009369,"<span class=""disease"">Ovarian cancer</span>","<span class=""disease"">Ovarian cancer</span> cells were incubated with normal media, media containing resveratrol, glucose free media, or media lacking <span class=""chemical"">amino acids</span>.",,17825886,17825886_D000596_D009369,17825886_4,bcv_sentence_task_befree_2887,,770958816,FALSE,finalized,5,8/14/15 22:03,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D009369,"<span class=""disease"">Ovarian cancer</span>","<span class=""disease"">Ovarian cancer</span> cells were incubated with normal media, media containing resveratrol, <span class=""chemical"">glucose</span> free media, or media lacking amino acids.",,17825886,17825886_D005947_D009369,17825886_4,bcv_sentence_task_befree_2888,,770958817,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,0.7995,,C059514,"<span class=""chemical"">resveratrol</span>",D009369,"<span class=""disease"">Ovarian cancer</span>","<span class=""disease"">Ovarian cancer</span> cells were incubated with normal media, media containing <span class=""chemical"">resveratrol</span>, glucose free media, or media lacking amino acids.",,17825886,17825886_C059514_D009369,17825886_4,bcv_sentence_task_befree_2889,,770958818,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003643,"<span class=""disease"">death</span>","We show here that epithelial ovarian cancer cells are highly sensitive to <span class=""chemical"">glucose</span>-deprivation-induced cell <span class=""disease"">death</span> and like resveratrol, <span class=""chemical"">glucose</span> deprivation induces caspase-independent cell <span class=""disease"">death</span> with hallmarks of autophagy.",,17825886,17825886_D005947_D003643,17825886_8,bcv_sentence_task_befree_2890,,770958819,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,0.7981,,D005947,"<span class=""chemical"">glucose</span>",D009369,"<span class=""disease"">ovarian cancer</span>","We show here that epithelial <span class=""disease"">ovarian cancer</span> cells are highly sensitive to <span class=""chemical"">glucose</span>-deprivation-induced cell death and like resveratrol, <span class=""chemical"">glucose</span> deprivation induces caspase-independent cell death with hallmarks of autophagy.",,17825886,17825886_D005947_D009369,17825886_8,bcv_sentence_task_befree_2891,,770958820,FALSE,finalized,5,8/15/15 1:09,"



",no_relation,1,,C059514,"<span class=""chemical"">resveratrol</span>",D003643,"<span class=""disease"">death</span>","We show here that epithelial ovarian cancer cells are highly sensitive to glucose-deprivation-induced cell <span class=""disease"">death</span> and like <span class=""chemical"">resveratrol</span>, glucose deprivation induces caspase-independent cell <span class=""disease"">death</span> with hallmarks of autophagy.",,17825886,17825886_C059514_D003643,17825886_8,bcv_sentence_task_befree_2892,,770958821,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,0.7921,,C059514,"<span class=""chemical"">resveratrol</span>",D009369,"<span class=""disease"">ovarian cancer</span>","We show here that epithelial <span class=""disease"">ovarian cancer</span> cells are highly sensitive to glucose-deprivation-induced cell death and like <span class=""chemical"">resveratrol</span>, glucose deprivation induces caspase-independent cell death with hallmarks of autophagy.",,17825886,17825886_C059514_D009369,17825886_8,bcv_sentence_task_befree_2893,,770958822,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,0.8053,,D005947,"<span class=""chemical"">glucose</span>",D009369,"<span class=""disease"">ovarian cancer</span>","Our findings are consistent with the hypothesis that resveratrol-induced changes in <span class=""chemical"">glucose</span> utilization comprise the mechanism that underlies resveratrol-induced autophagocytosis in <span class=""disease"">ovarian cancer</span>.",,17825886,17825886_D005947_D009369,17825886_11,bcv_sentence_task_befree_2894,,770958823,FALSE,finalized,5,8/15/15 0:46,"



",no_relation,0.7914,,C059514,"<span class=""chemical"">resveratrol</span>",D009369,"<span class=""disease"">ovarian cancer</span>","Our findings are consistent with the hypothesis that <span class=""chemical"">resveratrol</span>-induced changes in glucose utilization comprise the mechanism that underlies <span class=""chemical"">resveratrol</span>-induced autophagocytosis in <span class=""disease"">ovarian cancer</span>.",,17825886,17825886_C059514_D009369,17825886_11,bcv_sentence_task_befree_2895,,770958824,FALSE,finalized,5,8/15/15 2:49,"



",no_relation,1,,C059514,"<span class=""chemical"">resveratrol</span>",D009369,"<span class=""disease"">ovarian cancer</span>","Inhibition of glycolysis in <span class=""disease"">ovarian cancer</span> with <span class=""chemical"">resveratrol</span> or other compounds may be effective therapy for <span class=""disease"">ovarian cancer</span>.",,17825886,17825886_C059514_D009369,17825886_12,bcv_sentence_task_befree_2896,,770958825,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D065631,"<span class=""disease"">allergic rhinitis</span>","Efficacy of nasal <span class=""chemical"">corticosteroids</span> alone or combined with antihistamines or montelukast in treatment of <span class=""disease"">allergic rhinitis</span>.",,17826020,17826020_D000305_D065631,17826020_0,bcv_sentence_task_befree_2897,,770958826,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",D065631,"<span class=""disease"">AR</span>","We investigated clinical efficacy of monotherapy with topical <span class=""chemical"">steroid</span> and combined therapy in <span class=""disease"">AR</span> patients.",,17826020,17826020_D013256_D065631,17826020_2,bcv_sentence_task_befree_2898,,770958827,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D065631,"<span class=""disease"">allergic rhinitis</span>","Although <span class=""chemical"">corticosteroids</span> are the mainstay of treatment in <span class=""disease"">allergic rhinitis</span>, montelukast may be considered as an additional agent especially in treatment of patients with impaired quality of life and it may be used to reduce nasal symptom scores.",,17826020,17826020_D000305_D065631,17826020_11,bcv_sentence_task_befree_2899,,770958828,FALSE,finalized,5,8/14/15 21:50,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",D019966,"<span class=""disease"">drug abuse</span>","Therefore attenuation of the activity of the EC system would have therapeutic benefit in treating disorders that might have a component of excess appetite drive or over-activity of the endocannabinoid system, such as obesity, <span class=""chemical"">ethanol</span> and other <span class=""disease"">drug abuse</span>, and a variety of central nervous system and other disorders.",,17879500,17879500_D000431_D019966,17879500_2,bcv_sentence_task_befree_2900,,770958829,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",D009765,"<span class=""disease"">obesity</span>","Therefore attenuation of the activity of the EC system would have therapeutic benefit in treating disorders that might have a component of excess appetite drive or over-activity of the endocannabinoid system, such as <span class=""disease"">obesity</span>, <span class=""chemical"">ethanol</span> and other drug abuse, and a variety of central nervous system and other disorders.",,17879500,17879500_D000431_D009765,17879500_2,bcv_sentence_task_befree_2901,,770958830,FALSE,finalized,5,8/14/15 21:41,"



",no_relation,1,,C089032,"<span class=""chemical"">Rimonabant</span>",D009765,"<span class=""disease"">obesity</span>","<span class=""chemical"">Rimonabant</span> is the only compound in this group which along this pathway is now approved as a selective CB (1) (cannabinoid receptor subtype 1) antagonist, or inverse agonist, in the European Union and India and under regulatory review in the United States for the treatment of <span class=""disease"">obesity</span> and associated cardiometabolic risk.",,17879500,17879500_C089032_D009765,17879500_4,bcv_sentence_task_befree_2902,,770958831,FALSE,finalized,5,8/14/15 21:57,"



",no_relation,1,,C007734,"<span class=""chemical"">flunisolide</span>",D001249,"<span class=""disease"">asthma</span>","A reappraisal of the clinical efficacy of nebulized <span class=""chemical"">flunisolide</span> in pediatric <span class=""disease"">asthma</span>: the Italian experience.",,17883883,17883883_C007734_D001249,17883883_0,bcv_sentence_task_befree_2903,,770958832,FALSE,finalized,5,8/15/15 0:40,"



",no_relation,1,,C007734,"<span class=""chemical"">FLU</span>",D001249,"<span class=""disease"">asthma</span>","Clinical data indicate that nebulized <span class=""chemical"">FLU</span> is effective in <span class=""disease"">asthma</span> treatment in infants and children.",,17883883,17883883_C007734_D001249,17883883_14,bcv_sentence_task_befree_2904,,770958833,FALSE,finalized,5,8/14/15 21:51,"



",no_relation,0.8108,,D011092,"<span class=""chemical"">polyethylene glycol</span>",D016638,"<span class=""disease"">critically ill</span>","Laxation of <span class=""disease"">critically ill</span> patients with lactulose or <span class=""chemical"">polyethylene glycol</span>: a two-center randomized, double-blind, placebo-controlled trial.",,17893628,17893628_D011092_D016638,17893628_0,bcv_sentence_task_befree_2905,,770958834,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,0.8057,,D007792,"<span class=""chemical"">lactulose</span>",D016638,"<span class=""disease"">critically ill</span>","Laxation of <span class=""disease"">critically ill</span> patients with <span class=""chemical"">lactulose</span> or polyethylene glycol: a two-center randomized, double-blind, placebo-controlled trial.",,17893628,17893628_D007792_D016638,17893628_0,bcv_sentence_task_befree_2906,,770958835,FALSE,finalized,5,8/14/15 23:25,"


Disease is a pre-existing condition.
",no_relation,1,,D011092,"<span class=""chemical"">polyethylene glycol</span>",D016638,"<span class=""disease"">critically ill</span>","To study whether lactulose or <span class=""chemical"">polyethylene glycol</span> is effective to promote defecation in <span class=""disease"">critically ill</span> patients, whether either of the two is superior, and whether the use of enteral laxatives is related to clinical outcome.",,17893628,17893628_D011092_D016638,17893628_1,bcv_sentence_task_befree_2907,,770958836,FALSE,finalized,5,8/15/15 0:28,"



",no_relation,1,,D007792,"<span class=""chemical"">lactulose</span>",D016638,"<span class=""disease"">critically ill</span>","To study whether <span class=""chemical"">lactulose</span> or polyethylene glycol is effective to promote defecation in <span class=""disease"">critically ill</span> patients, whether either of the two is superior, and whether the use of enteral laxatives is related to clinical outcome.",,17893628,17893628_D007792_D016638,17893628_1,bcv_sentence_task_befree_2908,,770958837,FALSE,finalized,5,8/15/15 1:41,"



",yes_direct,0.576,,D007792,"<span class=""chemical"">lactulose</span>",D007418,"<span class=""disease"">Intestinal pseudoobstruction</span>","<span class=""disease"">Intestinal pseudoobstruction</span> or Ogilvie's syndrome occurred in 4.1% of patients in the placebo group, 5.5% of patients in the <span class=""chemical"">lactulose</span> group, and 1.0% of patients in the polyethylene glycol group.",,17893628,17893628_D007792_D007418,17893628_9,bcv_sentence_task_befree_2909,,770958838,FALSE,finalized,5,8/15/15 1:57,"



",yes_direct,0.7976,,D007792,"<span class=""chemical"">lactulose</span>",D003112,"<span class=""disease"">Ogilvie's syndrome</span>","Intestinal pseudoobstruction or <span class=""disease"">Ogilvie's syndrome</span> occurred in 4.1% of patients in the placebo group, 5.5% of patients in the <span class=""chemical"">lactulose</span> group, and 1.0% of patients in the polyethylene glycol group.",,17893628,17893628_D007792_D003112,17893628_9,bcv_sentence_task_befree_2910,,770958839,FALSE,finalized,5,8/15/15 0:33,"



",no_relation,0.5924,,D011092,"<span class=""chemical"">polyethylene glycol</span>",D007418,"<span class=""disease"">Intestinal pseudoobstruction</span>","<span class=""disease"">Intestinal pseudoobstruction</span> or Ogilvie's syndrome occurred in 4.1% of patients in the placebo group, 5.5% of patients in the lactulose group, and 1.0% of patients in the <span class=""chemical"">polyethylene glycol</span> group.",,17893628,17893628_D011092_D007418,17893628_9,bcv_sentence_task_befree_2911,,770958840,FALSE,finalized,5,8/14/15 21:12,"



",yes_direct,0.5981,,D011092,"<span class=""chemical"">polyethylene glycol</span>",D003112,"<span class=""disease"">Ogilvie's syndrome</span>","Intestinal pseudoobstruction or <span class=""disease"">Ogilvie's syndrome</span> occurred in 4.1% of patients in the placebo group, 5.5% of patients in the lactulose group, and 1.0% of patients in the <span class=""chemical"">polyethylene glycol</span> group.",,17893628,17893628_D011092_D003112,17893628_9,bcv_sentence_task_befree_2912,,770958841,FALSE,finalized,5,8/14/15 21:41,"



",no_relation,1,,D007792,"<span class=""chemical"">lactulose</span>",D007418,"<span class=""disease"">intestinal pseudoobstruction</span>","Patients receiving polyethylene glycol had a slightly lower incidence of acute <span class=""disease"">intestinal pseudoobstruction</span>, whereas length of stay was shorter in <span class=""chemical"">lactulose</span>-treated patients.",,17893628,17893628_D007792_D007418,17893628_14,bcv_sentence_task_befree_2913,,770958842,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,0.8003,,D011092,"<span class=""chemical"">polyethylene glycol</span>",D007418,"<span class=""disease"">intestinal pseudoobstruction</span>","Patients receiving <span class=""chemical"">polyethylene glycol</span> had a slightly lower incidence of acute <span class=""disease"">intestinal pseudoobstruction</span>, whereas length of stay was shorter in lactulose-treated patients.",,17893628,17893628_D011092_D007418,17893628_14,bcv_sentence_task_befree_2914,,770958843,FALSE,finalized,5,8/14/15 23:08,"



",no_relation,0.6017,,C110904,"<span class=""chemical"">capecitabine</span>",D009369,"<span class=""disease"">tumour/breast cancer</span>","Effects of <span class=""chemical"">capecitabine</span> and vinorelbine on cell proliferation, metabolism and COX2 and p16 expression in <span class=""disease"">breast cancer</span> cell lines and solid <span class=""disease"">tumour</span> tissues.",,17904787,17904787_C110904_D009369,17904787_0,bcv_sentence_task_befree_2915,,770958844,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,0.7942,,C030852,"<span class=""chemical"">vinorelbine</span>",D009369,"<span class=""disease"">tumour/breast cancer</span>","Effects of capecitabine and <span class=""chemical"">vinorelbine</span> on cell proliferation, metabolism and COX2 and p16 expression in <span class=""disease"">breast cancer</span> cell lines and solid <span class=""disease"">tumour</span> tissues.",,17904787,17904787_C030852_D009369,17904787_0,bcv_sentence_task_befree_2916,,770958845,FALSE,finalized,5,8/14/15 22:43,"


'Theraputic' being the key word.
",no_relation,1,,C110904,"<span class=""chemical"">capecitabine</span>",D009369,"<span class=""disease"">tumour/breast cancer</span>","The present study investigates the therapeutic value of single use <span class=""chemical"">capecitabine</span> on solid <span class=""disease"">tumour</span> tissues in vitro using <span class=""disease"">breast cancer</span> cell lines and as reference.",,17904787,17904787_C110904_D009369,17904787_4,bcv_sentence_task_befree_2917,,770958846,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,1,,C030852,"<span class=""chemical"">vinorelbine</span>",D009369,"<span class=""disease"">breast cancer</span>","The data is to be compared with the use of <span class=""chemical"">vinorelbine</span> which is a conventionally applied drug for advanced <span class=""disease"">breast cancer</span> patients.",,17904787,17904787_C030852_D009369,17904787_5,bcv_sentence_task_befree_2918,,770958847,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,1,,C110904,"<span class=""chemical"">Capecitabine</span>",D009369,"<span class=""disease"">tumor/tumour/breast cancer</span>","<span class=""chemical"">Capecitabine</span> demonstrated similar inhibitory effects as vinorelbine in <span class=""disease"">breast cancer</span> cell lines and solid <span class=""disease"">tumour</span> tissues at decreasing cell proliferation and metabolism as well as decreasing the expression of metabolic proteins and <span class=""disease"">tumor</span> suppressor genes.",,17904787,17904787_C110904_D009369,17904787_16,bcv_sentence_task_befree_2919,,770958848,FALSE,finalized,5,8/15/15 1:45,"



",no_relation,1,,C030852,"<span class=""chemical"">vinorelbine</span>",D009369,"<span class=""disease"">tumor/tumour/breast cancer</span>","Capecitabine demonstrated similar inhibitory effects as <span class=""chemical"">vinorelbine</span> in <span class=""disease"">breast cancer</span> cell lines and solid <span class=""disease"">tumour</span> tissues at decreasing cell proliferation and metabolism as well as decreasing the expression of metabolic proteins and <span class=""disease"">tumor</span> suppressor genes.",,17904787,17904787_C030852_D009369,17904787_16,bcv_sentence_task_befree_2920,,770958849,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,0.6022,,D014280,"<span class=""chemical"">triglycerides</span>",D051436,"<span class=""disease"">CKD/Chronic kidney disease</span>","<span class=""disease"">Chronic kidney disease</span> (<span class=""disease"">CKD</span>) is associated with a highly atherogenic lipid profile, characterized by elevated <span class=""chemical"">triglycerides</span>, low high-density lipoprotein (HDL) cholesterol and accumulation of small dense low-density lipoprotein (LDL) particles.",,17912226,17912226_D014280_D051436,17912226_1,bcv_sentence_task_befree_2921,,770958850,FALSE,finalized,5,8/15/15 0:43,"



",yes_direct,0.5995,,D002784,"<span class=""chemical"">cholesterol</span>",D051436,"<span class=""disease"">CKD/Chronic kidney disease</span>","<span class=""disease"">Chronic kidney disease</span> (<span class=""disease"">CKD</span>) is associated with a highly atherogenic lipid profile, characterized by elevated triglycerides, low high-density lipoprotein (HDL) <span class=""chemical"">cholesterol</span> and accumulation of small dense low-density lipoprotein (LDL) particles.",,17912226,17912226_D002784_D051436,17912226_1,bcv_sentence_task_befree_2922,,770958851,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,0.5951,,D019821,"<span class=""chemical"">statins</span>",D018805,"<span class=""disease"">sepsis</span>","Observational studies found a reduction in the risk of contrast media induced nephropathy and a reduction in the risk of hospitalization for <span class=""disease"">sepsis</span> in patients who had CKD and were treated with <span class=""chemical"">statins</span>.",,17912226,17912226_D019821_D018805,17912226_4,bcv_sentence_task_befree_2923,,770958852,FALSE,finalized,5,8/15/15 1:19,"



",no_relation,0.809,,D019821,"<span class=""chemical"">statins</span>",D051436,"<span class=""disease"">CKD</span>","Observational studies found a reduction in the risk of contrast media induced nephropathy and a reduction in the risk of hospitalization for sepsis in patients who had <span class=""disease"">CKD</span> and were treated with <span class=""chemical"">statins</span>.",,17912226,17912226_D019821_D051436,17912226_4,bcv_sentence_task_befree_2924,,770958853,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,0.822,,D019821,"<span class=""chemical"">statins</span>",C562889,"<span class=""disease"">nephropathy</span>","Observational studies found a reduction in the risk of contrast media induced <span class=""disease"">nephropathy</span> and a reduction in the risk of hospitalization for sepsis in patients who had CKD and were treated with <span class=""chemical"">statins</span>.",,17912226,17912226_D019821_C562889,17912226_4,bcv_sentence_task_befree_2925,,770958854,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,1,,C056493,"<span class=""chemical"">imiquimod</span>",D002280,"<span class=""disease"">basal cell carcinomas</span>","Induction of the members of Notch pathway in superficial <span class=""disease"">basal cell carcinomas</span> treated with <span class=""chemical"">imiquimod</span>.",,17922128,17922128_C056493_D002280,17922128_0,bcv_sentence_task_befree_2926,,770958855,FALSE,finalized,5,8/15/15 2:23,"



",no_relation,1,,C056493,"<span class=""chemical"">imiquimod</span>",D009369,"<span class=""disease"">tumor</span>","In this way, <span class=""chemical"">imiquimod</span> may act as a stimulator of the Notch pathway in sBCC <span class=""disease"">tumor</span> cells by up-regulating protein expression of the Notch ligand, Jagged1.",,17922128,17922128_C056493_D009369,17922128_8,bcv_sentence_task_befree_2927,,770958856,FALSE,finalized,5,8/14/15 23:31,"



",no_relation,1,,C079150,"<span class=""chemical"">Paliperidone</span>",D012559,"<span class=""disease"">schizophrenia</span>","<span class=""chemical"">Paliperidone</span> extended release (ER) is the most recent atypical antipsychotic to become available for the treatment of <span class=""disease"">schizophrenia</span>.",,17927485,17927485_C079150_D012559,17927485_1,bcv_sentence_task_befree_2928,,770958857,FALSE,finalized,5,8/14/15 21:12,"



",no_relation,1,,C079150,"<span class=""chemical"">paliperidone</span>",D012559,"<span class=""disease"">schizophrenia</span>","Several randomized, double-blinded, placebo-controlled trials have shown <span class=""chemical"">paliperidone</span> ER to be efficacious in the management of acute <span class=""disease"">schizophrenia</span> as well as for the prevention of symptom recurrence when compared with placebo.",,17927485,17927485_C079150_D012559,17927485_3,bcv_sentence_task_befree_2929,,770958858,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,1,,C079150,"<span class=""chemical"">Paliperidone</span>",D012559,"<span class=""disease"">schizophrenia</span>","<span class=""chemical"">Paliperidone</span> ER has the potential to offer advantages over its parent compound and other second generation agents, and may aid in ensuring compliance among persons with <span class=""disease"">schizophrenia</span>.",,17927485,17927485_C079150_D012559,17927485_8,bcv_sentence_task_befree_2930,,770958859,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,0.6021,,D017879,"<span class=""chemical"">isothiocyanates</span>",D007249,"<span class=""disease"">chronic inflammation</span>","Aberrant patterns of DNA methylation develop as a result of pathological processes such as <span class=""disease"">chronic inflammation</span>, and in response to various dietary factors, including imbalances in the supply of methyl donors, particularly folates, and exposure to DNA methyltransferase inhibitors, which include polyphenols and possibly <span class=""chemical"">isothiocyanates</span> from plant foods.",,17976883,17976883_D017879_D007249,17976883_4,bcv_sentence_task_befree_2931,,770958860,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,0.5803,,D059808,"<span class=""chemical"">polyphenols</span>",D007249,"<span class=""disease"">chronic inflammation</span>","Aberrant patterns of DNA methylation develop as a result of pathological processes such as <span class=""disease"">chronic inflammation</span>, and in response to various dietary factors, including imbalances in the supply of methyl donors, particularly folates, and exposure to DNA methyltransferase inhibitors, which include <span class=""chemical"">polyphenols</span> and possibly isothiocyanates from plant foods.",,17976883,17976883_D059808_D007249,17976883_4,bcv_sentence_task_befree_2932,,770958861,FALSE,finalized,5,8/14/15 23:42,"



",yes_direct,1,,D007213,"<span class=""chemical"">indomethacin</span>",D007969,"<span class=""disease"">periventricular leukomalacia</span>","Antenatal <span class=""chemical"">indomethacin</span> was associated with an increased risk of <span class=""disease"">periventricular leukomalacia</span> (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.3-3.1).",,17980183,17980183_D007213_D007969,17980183_10,bcv_sentence_task_befree_2933,,770958862,FALSE,finalized,5,8/15/15 0:55,"



",yes_direct,1,,D007213,"<span class=""chemical"">indomethacin</span>",D009336,"<span class=""disease"">necrotizing enterocolitis</span>","Recent exposure to antenatal <span class=""chemical"">indomethacin</span> was associated with <span class=""disease"">necrotizing enterocolitis</span> (OR, 2.2; 95% CI; 1.1-4.2).",,17980183,17980183_D007213_D009336,17980183_11,bcv_sentence_task_befree_2934,,770958863,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,1,,D007213,"<span class=""chemical"">indomethacin</span>",D004374,"<span class=""disease"">patent ductus arteriosus</span>","Antenatal <span class=""chemical"">indomethacin</span> was not associated with intraventricular hemorrhage, <span class=""disease"">patent ductus arteriosus</span>, respiratory distress syndrome, bronchopulmonary dysplasia, and mortality.",,17980183,17980183_D007213_D004374,17980183_12,bcv_sentence_task_befree_2935,,770958864,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D007213,"<span class=""chemical"">indomethacin</span>",D012128,"<span class=""disease"">respiratory distress syndrome</span>","Antenatal <span class=""chemical"">indomethacin</span> was not associated with intraventricular hemorrhage, patent ductus arteriosus, <span class=""disease"">respiratory distress syndrome</span>, bronchopulmonary dysplasia, and mortality.",,17980183,17980183_D007213_D012128,17980183_12,bcv_sentence_task_befree_2936,,770958865,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D007213,"<span class=""chemical"">indomethacin</span>",D006470,"<span class=""disease"">intraventricular hemorrhage</span>","Antenatal <span class=""chemical"">indomethacin</span> was not associated with <span class=""disease"">intraventricular hemorrhage</span>, patent ductus arteriosus, respiratory distress syndrome, bronchopulmonary dysplasia, and mortality.",,17980183,17980183_D007213_D006470,17980183_12,bcv_sentence_task_befree_2937,,770958866,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,D007213,"<span class=""chemical"">indomethacin</span>",D001997,"<span class=""disease"">bronchopulmonary dysplasia</span>","Antenatal <span class=""chemical"">indomethacin</span> was not associated with intraventricular hemorrhage, patent ductus arteriosus, respiratory distress syndrome, <span class=""disease"">bronchopulmonary dysplasia</span>, and mortality.",,17980183,17980183_D007213_D001997,17980183_12,bcv_sentence_task_befree_2938,,770958867,FALSE,finalized,5,8/14/15 21:54,"



",yes_direct,1,,D007213,"<span class=""chemical"">indomethacin</span>",D007969,"<span class=""disease"">periventricular leukomalacia</span>","Antenatal <span class=""chemical"">indomethacin</span> may be associated with an increased risk of <span class=""disease"">periventricular leukomalacia</span> and necrotizing enterocolitis in premature infants and therefore should be used judiciously for tocolysis.",,17980183,17980183_D007213_D007969,17980183_13,bcv_sentence_task_befree_2939,,770958868,FALSE,finalized,5,8/14/15 23:31,"

As long as it's antenatal.

",yes_direct,1,,D007213,"<span class=""chemical"">indomethacin</span>",D009336,"<span class=""disease"">necrotizing enterocolitis</span>","Antenatal <span class=""chemical"">indomethacin</span> may be associated with an increased risk of periventricular leukomalacia and <span class=""disease"">necrotizing enterocolitis</span> in premature infants and therefore should be used judiciously for tocolysis.",,17980183,17980183_D007213_D009336,17980183_13,bcv_sentence_task_befree_2940,,770958869,FALSE,finalized,5,8/14/15 23:18,"



",no_relation,1,,D008774,"<span class=""chemical"">methylphenidate</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","Low dose <span class=""chemical"">methylphenidate</span> improves freezing in advanced <span class=""disease"">Parkinson's disease</span> during off-state.",,17982887,17982887_D008774_D010300,17982887_0,bcv_sentence_task_befree_2941,,770958870,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,1,,D008774,"<span class=""chemical"">methylphenidate/MPD</span>",D010300,"<span class=""disease"">PD/idiopathic Parkinson's disease</span>","Five men with advanced <span class=""disease"">idiopathic Parkinson's disease</span> (<span class=""disease"">PD</span>) were examined to assess the effect of low dose <span class=""chemical"">methylphenidate</span> (<span class=""chemical"">MPD</span>) on gait.",,17982887,17982887_D008774_D010300,17982887_1,bcv_sentence_task_befree_2942,,770958871,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,0.796,,D008774,"<span class=""chemical"">MPD</span>",D010300,"<span class=""disease"">PD</span>","The study demonstrates that low dose of <span class=""chemical"">MPD</span> may improve gait, and especially freezing, in patients with severe <span class=""disease"">PD</span>, without the need for exogenous L-dopa.",,17982887,17982887_D008774_D010300,17982887_7,bcv_sentence_task_befree_2943,,770958872,FALSE,finalized,5,8/14/15 22:53,"



",no_relation,1,,D007980,"<span class=""chemical"">L-dopa</span>",D010300,"<span class=""disease"">PD</span>","The study demonstrates that low dose of MPD may improve gait, and especially freezing, in patients with severe <span class=""disease"">PD</span>, without the need for exogenous <span class=""chemical"">L-dopa</span>.",,17982887,17982887_D007980_D010300,17982887_7,bcv_sentence_task_befree_2944,,770958873,FALSE,finalized,5,8/15/15 2:08,"



",no_relation,1,,D008774,"<span class=""chemical"">MPD</span>",D010300,"<span class=""disease"">PD</span>","The mechanism of <span class=""chemical"">MPD</span> action in patients with advanced <span class=""disease"">PD</span> is further discussed.",,17982887,17982887_D008774_D010300,17982887_8,bcv_sentence_task_befree_2945,,770958874,FALSE,finalized,5,8/15/15 0:35,"



",no_relation,1,,D008790,"<span class=""chemical"">metoprolol</span>",D016891,"<span class=""disease"">autosomal dominant polycystic kidney disease</span>","Renal and cardiac effects of antihypertensive treatment with ramipril vs <span class=""chemical"">metoprolol</span> in <span class=""disease"">autosomal dominant polycystic kidney disease</span>.",,17984104,17984104_D008790_D016891,17984104_0,bcv_sentence_task_befree_2946,,770958875,FALSE,finalized,5,8/14/15 23:32,"



",no_relation,1,,D017257,"<span class=""chemical"">ramipril</span>",D016891,"<span class=""disease"">autosomal dominant polycystic kidney disease</span>","Renal and cardiac effects of antihypertensive treatment with <span class=""chemical"">ramipril</span> vs metoprolol in <span class=""disease"">autosomal dominant polycystic kidney disease</span>.",,17984104,17984104_D017257_D016891,17984104_0,bcv_sentence_task_befree_2947,,770958876,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,1,,D017257,"<span class=""chemical"">ramipril</span>",D006973,"<span class=""disease"">hypertension</span>","This prospective randomized double-blind study was performed to compare the renal and cardiac effects of the ACE inhibitor <span class=""chemical"">ramipril</span> and the beta-blocker metoprolol as first line therapy in ADPKD patients with <span class=""disease"">hypertension</span>.",,17984104,17984104_D017257_D006973,17984104_2,bcv_sentence_task_befree_2948,,770958877,FALSE,finalized,5,8/14/15 22:32,"



",no_relation,1,,D008790,"<span class=""chemical"">metoprolol</span>",D016891,"<span class=""disease"">ADPKD</span>","This prospective randomized double-blind study was performed to compare the renal and cardiac effects of the ACE inhibitor ramipril and the beta-blocker <span class=""chemical"">metoprolol</span> as first line therapy in <span class=""disease"">ADPKD</span> patients with hypertension.",,17984104,17984104_D008790_D016891,17984104_2,bcv_sentence_task_befree_2949,,770958878,FALSE,finalized,5,8/15/15 1:50,"



",no_relation,1,,D017257,"<span class=""chemical"">ramipril</span>",D016891,"<span class=""disease"">ADPKD</span>","This prospective randomized double-blind study was performed to compare the renal and cardiac effects of the ACE inhibitor <span class=""chemical"">ramipril</span> and the beta-blocker metoprolol as first line therapy in <span class=""disease"">ADPKD</span> patients with hypertension.",,17984104,17984104_D017257_D016891,17984104_2,bcv_sentence_task_befree_2950,,770958879,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,D008790,"<span class=""chemical"">metoprolol</span>",D006973,"<span class=""disease"">hypertension</span>","This prospective randomized double-blind study was performed to compare the renal and cardiac effects of the ACE inhibitor ramipril and the beta-blocker <span class=""chemical"">metoprolol</span> as first line therapy in ADPKD patients with <span class=""disease"">hypertension</span>.",,17984104,17984104_D008790_D006973,17984104_2,bcv_sentence_task_befree_2951,,770958880,FALSE,finalized,5,8/14/15 21:09,"



",no_relation,1,,D008790,"<span class=""chemical"">metoprolol</span>",D016891,"<span class=""disease"">ADPKD</span>","Forty-six hypertensive <span class=""disease"">ADPKD</span> patients were randomized to either ramipril (n = 23) or <span class=""chemical"">metoprolol</span> (n = 23).",,17984104,17984104_D008790_D016891,17984104_3,bcv_sentence_task_befree_2952,,770958881,FALSE,finalized,5,8/15/15 0:02,"



",no_relation,1,,D017257,"<span class=""chemical"">ramipril</span>",D016891,"<span class=""disease"">ADPKD</span>","Forty-six hypertensive <span class=""disease"">ADPKD</span> patients were randomized to either <span class=""chemical"">ramipril</span> (n = 23) or metoprolol (n = 23).",,17984104,17984104_D017257_D016891,17984104_3,bcv_sentence_task_befree_2953,,770958882,FALSE,finalized,5,8/14/15 22:04,"



",no_relation,1,,D008790,"<span class=""chemical"">metoprolol</span>",D016891,"<span class=""disease"">ADPKD</span>","In our study population of hypertensive <span class=""disease"">ADPKD</span> patients, no differences in renal function, urinary albumin excretion and LVMI were detected between those treated with ramipril or <span class=""chemical"">metoprolol</span>, respectively, during a 3 years follow-up.",,17984104,17984104_D008790_D016891,17984104_12,bcv_sentence_task_befree_2954,,770958883,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,1,,D017257,"<span class=""chemical"">ramipril</span>",D016891,"<span class=""disease"">ADPKD</span>","In our study population of hypertensive <span class=""disease"">ADPKD</span> patients, no differences in renal function, urinary albumin excretion and LVMI were detected between those treated with <span class=""chemical"">ramipril</span> or metoprolol, respectively, during a 3 years follow-up.",,17984104,17984104_D017257_D016891,17984104_12,bcv_sentence_task_befree_2955,,770958884,FALSE,finalized,5,8/15/15 1:11,"



",no_relation,0.8117,,D009566,"<span class=""chemical"">nitrate</span>",D002318,"<span class=""disease"">cardiovascular disease</span>","Data on individuals with purchase of antihypertensive or serum lipid-reducing agents, but without a diagnosis of <span class=""disease"">cardiovascular disease</span>, were also linked to purchase of <span class=""chemical"">nitrate</span> vasodilators (C01D).",,17987590,17987590_D009566_D002318,17987590_6,bcv_sentence_task_befree_2956,,770958885,FALSE,finalized,5,8/15/15 1:59,"



",yes_direct,0.8056,,D009538,"<span class=""chemical"">Nicotine</span>",D009759,"<span class=""disease"">NIN/nicotine-induced nystagmus</span>","<span class=""chemical"">Nicotine</span> has wellknown, unpleasant side effects, e.g., transient dizziness, nausea, and <span class=""chemical""></span><span class=""disease"">nicotine</span>-induced nystagmus (<span class=""disease"">NIN</span>).",,17990061,17990061_D009538_D009759,17990061_1,bcv_sentence_task_befree_2957,,770958886,FALSE,finalized,5,8/14/15 22:23,"



",yes_direct,1,,D009538,"<span class=""chemical"">Nicotine</span>",D009325,"<span class=""disease"">nausea</span>","<span class=""chemical"">Nicotine</span> has wellknown, unpleasant side effects, e.g., transient dizziness, <span class=""disease"">nausea</span>, and <span class=""chemical"">nicotine</span>-induced nystagmus (NIN).",,17990061,17990061_D009538_D009325,17990061_1,bcv_sentence_task_befree_2958,,770958887,FALSE,finalized,5,8/15/15 1:48,"



",yes_direct,1,,D009538,"<span class=""chemical"">Nicotine</span>",D004244,"<span class=""disease"">dizziness</span>","<span class=""chemical"">Nicotine</span> has wellknown, unpleasant side effects, e.g., transient <span class=""disease"">dizziness</span>, nausea, and <span class=""chemical"">nicotine</span>-induced nystagmus (NIN).",,17990061,17990061_D009538_D004244,17990061_1,bcv_sentence_task_befree_2959,,770958888,FALSE,finalized,5,8/14/15 21:41,"



it is a question whether there is a link. It is not answered here, so ""it doesn't say""",no_relation,1,,D009538,"<span class=""chemical"">nicotine</span>",D009759,"<span class=""disease"">NIN</span>","To investigate factors influencing these effects, we addressed three questions: (1) Is the intensity of dizziness, nausea, <span class=""disease"">NIN</span>, and unsteadiness dependent on <span class=""chemical"">nicotine</span> dosage?",,17990061,17990061_D009538_D009759,17990061_2,bcv_sentence_task_befree_2960,,770958889,FALSE,finalized,5,8/15/15 2:13,"



",yes_direct,0.5957,,D009538,"<span class=""chemical"">nicotine</span>",D020233,"<span class=""disease"">unsteadiness</span>","To investigate factors influencing these effects, we addressed three questions: (1) Is the intensity of dizziness, nausea, NIN, and <span class=""disease"">unsteadiness</span> dependent on <span class=""chemical"">nicotine</span> dosage?",,17990061,17990061_D009538_D020233,17990061_2,bcv_sentence_task_befree_2961,,770958890,FALSE,finalized,5,8/14/15 23:00,"



",yes_direct,0.793,,D009538,"<span class=""chemical"">nicotine</span>",D009325,"<span class=""disease"">nausea</span>","To investigate factors influencing these effects, we addressed three questions: (1) Is the intensity of dizziness, <span class=""disease"">nausea</span>, NIN, and unsteadiness dependent on <span class=""chemical"">nicotine</span> dosage?",,17990061,17990061_D009538_D009325,17990061_2,bcv_sentence_task_befree_2962,,770958891,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,0.6094,,D009538,"<span class=""chemical"">nicotine</span>",D004244,"<span class=""disease"">dizziness</span>","To investigate factors influencing these effects, we addressed three questions: (1) Is the intensity of <span class=""disease"">dizziness</span>, nausea, NIN, and unsteadiness dependent on <span class=""chemical"">nicotine</span> dosage?",,17990061,17990061_D009538_D004244,17990061_2,bcv_sentence_task_befree_2963,,770958892,FALSE,finalized,5,8/14/15 23:30,"



",yes_direct,0.8056,,D009538,"<span class=""chemical"">nicotine</span>",D009759,"<span class=""disease"">NIN/nystagmus</span>","Dizziness, nausea, <span class=""disease"">NIN</span>, and unsteadiness also depended on the <span class=""chemical"">nicotine</span> dosage (p < 0.01).<span class=""chemical"">Nicotine</span> blood concentration was a better predictor for the temporal dependence of <span class=""disease"">nystagmus</span> than <span class=""chemical"">nicotine</span> dosage.",,17990061,17990061_D009538_D009759,17990061_7,bcv_sentence_task_befree_2964,,770958893,FALSE,finalized,5,8/14/15 22:03,"



",yes_direct,1,,D009538,"<span class=""chemical"">nicotine</span>",D020233,"<span class=""disease"">unsteadiness</span>","Dizziness, nausea, NIN, and <span class=""disease"">unsteadiness</span> also depended on the <span class=""chemical"">nicotine</span> dosage (p < 0.01).<span class=""chemical"">Nicotine</span> blood concentration was a better predictor for the temporal dependence of nystagmus than <span class=""chemical"">nicotine</span> dosage.",,17990061,17990061_D009538_D020233,17990061_7,bcv_sentence_task_befree_2965,,770958894,FALSE,finalized,5,8/14/15 21:07,"



",yes_direct,0.7769,,D009538,"<span class=""chemical"">nicotine</span>",D009325,"<span class=""disease"">nausea</span>","Dizziness, <span class=""disease"">nausea</span>, NIN, and unsteadiness also depended on the <span class=""chemical"">nicotine</span> dosage (p < 0.01).<span class=""chemical"">Nicotine</span> blood concentration was a better predictor for the temporal dependence of nystagmus than <span class=""chemical"">nicotine</span> dosage.",,17990061,17990061_D009538_D009325,17990061_7,bcv_sentence_task_befree_2966,,770958895,FALSE,finalized,5,8/14/15 21:54,"



",yes_direct,0.5912,,D009538,"<span class=""chemical"">nicotine</span>",D004244,"<span class=""disease"">Dizziness</span>","<span class=""disease"">Dizziness</span>, nausea, NIN, and unsteadiness also depended on the <span class=""chemical"">nicotine</span> dosage (p < 0.01).<span class=""chemical"">Nicotine</span> blood concentration was a better predictor for the temporal dependence of nystagmus than <span class=""chemical"">nicotine</span> dosage.",,17990061,17990061_D009538_D004244,17990061_7,bcv_sentence_task_befree_2967,,770958896,FALSE,finalized,5,8/14/15 21:48,"



",yes_direct,1,,D009538,"<span class=""chemical"">nicotine</span>",D009325,"<span class=""disease"">nausea</span>","The degree of <span class=""chemical"">nicotine</span>-induced <span class=""disease"">nausea</span> significantly correlated with postural imbalance.",,17990061,17990061_D009538_D009325,17990061_9,bcv_sentence_task_befree_2968,,770958897,FALSE,finalized,5,8/15/15 2:03,"



",no_relation,1,,D009538,"<span class=""chemical"">nicotine</span>",D009759,"<span class=""disease"">NIN</span>","Motion stimulation increased <span class=""chemical"">nicotine</span>-induced dizziness and nausea, but did not significantly influence <span class=""disease"">NIN</span> or postural imbalance.",,17990061,17990061_D009538_D009759,17990061_11,bcv_sentence_task_befree_2969,,770958898,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,0.4134,,D009538,"<span class=""chemical"">nicotine</span>",D009325,"<span class=""disease"">nausea</span>","Motion stimulation increased <span class=""chemical"">nicotine</span>-induced dizziness and <span class=""disease"">nausea</span>, but did not significantly influence NIN or postural imbalance.",,17990061,17990061_D009538_D009325,17990061_11,bcv_sentence_task_befree_2970,,770958899,FALSE,finalized,5,8/14/15 23:13,"



",yes_direct,0.408,,D009538,"<span class=""chemical"">nicotine</span>",D004244,"<span class=""disease"">dizziness</span>","Motion stimulation increased <span class=""chemical"">nicotine</span>-induced <span class=""disease"">dizziness</span> and nausea, but did not significantly influence NIN or postural imbalance.",,17990061,17990061_D009538_D004244,17990061_11,bcv_sentence_task_befree_2971,,770958900,FALSE,finalized,5,8/14/15 21:41,"



",yes_direct,0.6028,,D009538,"<span class=""chemical"">nicotine</span>",D015837,"<span class=""disease"">vestibular dysfunction</span>","Our data support the view that all measured adverse effects reflect dose-dependent <span class=""chemical"">nicotine</span>-induced <span class=""disease"">vestibular dysfunction</span>.",,17990061,17990061_D009538_D015837,17990061_12,bcv_sentence_task_befree_2972,,770958901,FALSE,finalized,5,8/15/15 0:32,"



",yes_direct,0.8026,,D009538,"<span class=""chemical"">nicotine</span>",D004244,"<span class=""disease"">dizziness</span>","Additional motion stimulation aggravates <span class=""disease"">dizziness</span> and nausea, i.e., <span class=""chemical"">nicotine</span> increases sensitivity to motion sickness.",,17990061,17990061_D009538_D004244,17990061_13,bcv_sentence_task_befree_2973,,770958902,FALSE,finalized,5,8/14/15 21:35,"



",yes_direct,0.5952,,D009538,"<span class=""chemical"">nicotine</span>",D009325,"<span class=""disease"">nausea</span>","Additional motion stimulation aggravates dizziness and <span class=""disease"">nausea</span>, i.e., <span class=""chemical"">nicotine</span> increases sensitivity to motion sickness.",,17990061,17990061_D009538_D009325,17990061_13,bcv_sentence_task_befree_2974,,770958903,FALSE,finalized,5,8/14/15 22:04,"



",yes_direct,1,,D009538,"<span class=""chemical"">nicotine</span>",D009041,"<span class=""disease"">motion sickness</span>","Additional motion stimulation aggravates dizziness and nausea, i.e., <span class=""chemical"">nicotine</span> increases sensitivity to <span class=""disease"">motion sickness</span>.",,17990061,17990061_D009538_D009041,17990061_13,bcv_sentence_task_befree_2975,,770958904,FALSE,finalized,5,8/15/15 2:16,"



",no_relation,1,,D000255,"<span class=""chemical"">ATP</span>",D016403,"<span class=""disease"">DLBCL</span>","Herein, we assess the role of SYK-dependent tonic BCR survival signals in <span class=""disease"">DLBCL</span> cell lines and primary tumors and evaluate the efficacy of an <span class=""chemical"">ATP</span>-competitive inhibitor of SYK, R406, in vitro.",,18006696,18006696_D000255_D016403,18006696_4,bcv_sentence_task_befree_2976,,770958905,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,1,,D000255,"<span class=""chemical"">ATP</span>",D009369,"<span class=""disease"">primary tumors</span>","Herein, we assess the role of SYK-dependent tonic BCR survival signals in DLBCL cell lines and <span class=""disease"">primary tumors</span> and evaluate the efficacy of an <span class=""chemical"">ATP</span>-competitive inhibitor of SYK, R406, in vitro.",,18006696,18006696_D000255_D009369,18006696_4,bcv_sentence_task_befree_2977,,770958906,FALSE,finalized,5,8/14/15 21:28,"



",yes_direct,0.5815,,D013256,"<span class=""chemical"">steroids</span>",D007027,"<span class=""disease"">hypothalamic networks</span>","These <span class=""chemical"">steroids</span> are reported to activate the <span class=""disease"">hypothalamic networks</span> in a sex-differentiated way.",,18056697,18056697_D013256_D007027,18056697_3,bcv_sentence_task_befree_2978,,770958907,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,0.5902,,D004967,"<span class=""chemical"">Estrogens/estrogen</span>",D009369,"<span class=""disease"">tumors/breast cancer</span>","<span class=""chemical"">Estrogens</span> are required for the proliferation of hormone dependent <span class=""disease"">breast cancer</span> cells, making <span class=""chemical"">estrogen</span> receptor (ER) positive <span class=""disease"">tumors</span> amenable to endocrine therapies such as antiestrogens.",,18060053,18060053_D004967_D009369,18060053_1,bcv_sentence_task_befree_2979,,770958908,FALSE,finalized,5,8/15/15 0:44,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D012175,"<span class=""disease"">retinoblastoma</span>","We previously demonstrated that inactivation of the <span class=""disease"">retinoblastoma</span> protein (pRb) family tumor suppressors causes antiestrogen resistance in MCF-7 cells, a widely studied model of <span class=""chemical"">estrogen</span> responsive human breast cancers.",,18060053,18060053_D004967_D012175,18060053_3,bcv_sentence_task_befree_2980,,770958909,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,0.6239,,D004967,"<span class=""chemical"">estrogen</span>",D009369,"<span class=""disease"">tumor/breast cancers</span>","We previously demonstrated that inactivation of the retinoblastoma protein (pRb) family <span class=""disease"">tumor</span> suppressors causes antiestrogen resistance in MCF-7 cells, a widely studied model of <span class=""chemical"">estrogen</span> responsive human <span class=""disease"">breast cancers</span>.",,18060053,18060053_D004967_D009369,18060053_3,bcv_sentence_task_befree_2981,,770958910,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D019821,"<span class=""chemical"">Simvastatin</span>",D002544,"<span class=""disease"">ischemic stroke</span>","<span class=""chemical"">Simvastatin</span> in the acute phase of <span class=""disease"">ischemic stroke</span>: a safety and efficacy pilot trial.",,18070096,18070096_D019821_D002544,18070096_0,bcv_sentence_task_befree_2982,,770958911,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,D019821,"<span class=""chemical"">statins</span>",D002544,"<span class=""disease"">ischemic stroke</span>","Although <span class=""chemical"">statins</span> are being used for secondary prevention of <span class=""disease"">ischemic stroke</span>, recent experimental data have shown new pleiotropic effects of these drugs responsible for their role in neuroprotection.",,18070096,18070096_D019821_D002544,18070096_1,bcv_sentence_task_befree_2983,,770958912,FALSE,finalized,5,8/15/15 1:41,"



",no_relation,1,,D019821,"<span class=""chemical"">simvastatin</span>",D002544,"<span class=""disease"">ischemic stroke</span>","We conducted a pilot, double-blind, randomized, multicenter clinical trial to study for the first time safety and efficacy of <span class=""chemical"">simvastatin</span> in the acute phase of <span class=""disease"">ischemic stroke</span>.",,18070096,18070096_D019821_D002544,18070096_2,bcv_sentence_task_befree_2984,,770958913,FALSE,finalized,5,8/15/15 1:42,"



",no_relation,0.8179,,D019821,"<span class=""chemical"">Simvastatin</span>",D020521,"<span class=""disease"">cortical strokes</span>","<span class=""chemical"">Simvastatin</span>/placebo was given at 3-12 h from symptom onset to 60 patients with <span class=""disease"">cortical strokes</span>.",,18070096,18070096_D019821_D020521,18070096_3,bcv_sentence_task_befree_2985,,770958914,FALSE,finalized,5,8/15/15 1:02,"



",yes_direct,0.8084,,D019821,"<span class=""chemical"">simvastatin</span>",D007239,"<span class=""disease"">infections</span>","Although <span class=""chemical"">simvastatin</span> patients improved significantly by the third day (46.4% vs. 17.9%, P = 0.022), a non-significant increase in mortality and greater proportion of <span class=""disease"">infections</span> (odds ratio 2.4, confidence interval 1.06-5.4) in the <span class=""chemical"">simvastatin</span> group were the main safety concerns.",,18070096,18070096_D019821_D007239,18070096_6,bcv_sentence_task_befree_2986,,770958915,FALSE,finalized,5,8/14/15 23:18,"



",no_relation,1,,C523467,"<span class=""chemical"">CJ-042794</span>",D009369,"<span class=""disease"">tumor</span>","PGE(2) inhibited the lipopolysaccharide (LPS)-induced production of <span class=""disease"">tumor</span> necrosis factor alpha (TNFalpha) in human whole blood (HWB); <span class=""chemical"">CJ-042794</span> reversed the inhibitory effects of PGE(2) on LPS-induced TNFalpha production in a concentration-dependent manner.",,18155068,18155068_C523467_D009369,18155068_6,bcv_sentence_task_befree_2987,,770958916,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,1,,D015232,"<span class=""chemical"">PGE(2)</span>",D009369,"<span class=""disease"">tumor</span>","<span class=""chemical"">PGE(2)</span> inhibited the lipopolysaccharide (LPS)-induced production of <span class=""disease"">tumor</span> necrosis factor alpha (TNFalpha) in human whole blood (HWB); CJ-042794 reversed the inhibitory effects of <span class=""chemical"">PGE(2)</span> on LPS-induced TNFalpha production in a concentration-dependent manner.",,18155068,18155068_D015232_D009369,18155068_6,bcv_sentence_task_befree_2988,,770958917,FALSE,finalized,5,8/15/15 1:43,"



",no_relation,1,,C523467,"<span class=""chemical"">CJ-042794</span>",D009336,"<span class=""disease"">necrosis</span>","PGE(2) inhibited the lipopolysaccharide (LPS)-induced production of tumor <span class=""disease"">necrosis</span> factor alpha (TNFalpha) in human whole blood (HWB); <span class=""chemical"">CJ-042794</span> reversed the inhibitory effects of PGE(2) on LPS-induced TNFalpha production in a concentration-dependent manner.",,18155068,18155068_C523467_D009336,18155068_6,bcv_sentence_task_befree_2989,,770958918,FALSE,finalized,5,8/14/15 22:04,"



",no_relation,0.7961,,D015232,"<span class=""chemical"">PGE(2)</span>",D009336,"<span class=""disease"">necrosis</span>","<span class=""chemical"">PGE(2)</span> inhibited the lipopolysaccharide (LPS)-induced production of tumor <span class=""disease"">necrosis</span> factor alpha (TNFalpha) in human whole blood (HWB); CJ-042794 reversed the inhibitory effects of <span class=""chemical"">PGE(2)</span> on LPS-induced TNFalpha production in a concentration-dependent manner.",,18155068,18155068_D015232_D009336,18155068_6,bcv_sentence_task_befree_2990,,770958919,FALSE,finalized,5,8/14/15 21:23,"



",yes_direct,1,,C006632,"<span class=""chemical"">arsenic trioxide</span>",D003643,"<span class=""disease"">death</span>","Dynamic effects of autophagy on <span class=""chemical"">arsenic trioxide</span>-induced <span class=""disease"">death</span> of human leukemia cell line HL60 cells.",,18158874,18158874_C006632_D003643,18158874_0,bcv_sentence_task_befree_2991,,770958920,FALSE,finalized,5,8/14/15 23:08,"



",no_relation,0.7947,,C006632,"<span class=""chemical"">arsenic trioxide</span>",D007938,"<span class=""disease"">leukemia</span>","Dynamic effects of autophagy on <span class=""chemical"">arsenic trioxide</span>-induced death of human <span class=""disease"">leukemia</span> cell line HL60 cells.",,18158874,18158874_C006632_D007938,18158874_0,bcv_sentence_task_befree_2992,,770958921,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,0.8203,,C025946,"<span class=""chemical"">3-methyladenine/3-MA</span>",D003643,"<span class=""disease"">death</span>","The blockade of autophagy maturation with the autophagy-specific inhibitor <span class=""chemical"">3-methyladenine</span> (<span class=""chemical"">3-MA</span>) or the lysosome-neutralizing agent NH4Cl 1 h before As2O3 potentiated the As2O3-induced <span class=""disease"">death</span> of HL60 cells.",,18158874,18158874_C025946_D003643,18158874_7,bcv_sentence_task_befree_2993,,770958922,FALSE,finalized,5,8/14/15 21:04,"



",no_relation,0.612,,D000643,"<span class=""chemical"">NH4Cl</span>",D003643,"<span class=""disease"">death</span>","The blockade of autophagy maturation with the autophagy-specific inhibitor 3-methyladenine (3-MA) or the lysosome-neutralizing agent <span class=""chemical"">NH4Cl</span> 1 h before As2O3 potentiated the As2O3-induced <span class=""disease"">death</span> of HL60 cells.",,18158874,18158874_D000643_D003643,18158874_7,bcv_sentence_task_befree_2994,,770958923,FALSE,finalized,5,8/14/15 23:34,"



",yes_direct,0.5958,,C025946,"<span class=""chemical"">3-MA</span>",D003643,"<span class=""disease"">death</span>","In contrast, <span class=""chemical"">3-MA</span> attenuated As2O3-induced <span class=""disease"">death</span> when administered 30 min after As2O3.",,18158874,18158874_C025946_D003643,18158874_8,bcv_sentence_task_befree_2995,,770958924,FALSE,finalized,5,8/15/15 0:43,"



",yes_direct,0.801,,D014212,"<span class=""chemical"">ATRA/all-trans retinoic acid</span>",C538324,"<span class=""disease"">HL</span>","In the present study, we demonstrated that bufalin enhanced <span class=""chemical"">all-trans retinoic acid</span> (<span class=""chemical"">ATRA</span>) induced differentiation of <span class=""disease"">HL</span>-60 cells, accompanied by up-regulation of the Cbl family of ubiquitin ligases.",,18164258,18164258_D014212_C538324,18164258_4,bcv_sentence_task_befree_2996,,770958925,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,D014212,"<span class=""chemical"">ATRA</span>",C538324,"<span class=""disease"">HL</span>","These results suggested that up-regulation of c-Cbl and Cbl-b was involved in the regulation of <span class=""chemical"">ATRA</span> and bufalin-induced <span class=""disease"">HL</span>-60 cell adhesion rather than cell differentiation, which might be mediated by lipid raft localization, ubiquitin ligase activity and C-terminal structure of Cbl proteins.",,18164258,18164258_D014212_C538324,18164258_9,bcv_sentence_task_befree_2997,,770958926,FALSE,finalized,5,8/14/15 21:58,"



",no_relation,0.6007,,D004318,"<span class=""chemical"">doxycycline</span>",D017823,"<span class=""disease"">furcation defects</span>","Regeneration of degree ii <span class=""disease"">furcation defects</span> with a 4% <span class=""chemical"">doxycycline</span> hyclate bioabsorbable barrier.",,18166095,18166095_D004318_D017823,18166095_0,bcv_sentence_task_befree_2998,,770958927,FALSE,finalized,5,8/14/15 21:51,"



",no_relation,1,,C473478,"<span class=""chemical"">sunitinib</span>",D002276,"<span class=""disease"">Thymic carcinoid</span>","<span class=""disease"">Thymic carcinoid</span> responds to neoadjuvant therapy with <span class=""chemical"">sunitinib</span> and octreotide: a case report.",,18166847,18166847_C473478_D002276,18166847_0,bcv_sentence_task_befree_2999,,770958928,FALSE,finalized,5,8/15/15 0:10,"



",no_relation,1,,D015282,"<span class=""chemical"">octreotide</span>",D002276,"<span class=""disease"">Thymic carcinoid</span>","<span class=""disease"">Thymic carcinoid</span> responds to neoadjuvant therapy with sunitinib and <span class=""chemical"">octreotide</span>: a case report.",,18166847,18166847_D015282_D002276,18166847_0,bcv_sentence_task_befree_3000,,770958929,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,0.8032,,C473478,"<span class=""chemical"">sunitinib</span>",D002276,"<span class=""disease"">thymic carcinoid</span>","We report a case of atypical <span class=""disease"">thymic carcinoid</span> that responded to neoadjuvant therapy with octreotide and <span class=""chemical"">sunitinib</span>, an oral multikinase inhibitor.",,18166847,18166847_C473478_D002276,18166847_2,bcv_sentence_task_befree_3001,,770958930,FALSE,finalized,5,8/14/15 21:27,"



",no_relation,0.5999,,D015282,"<span class=""chemical"">octreotide</span>",D002276,"<span class=""disease"">thymic carcinoid</span>","We report a case of atypical <span class=""disease"">thymic carcinoid</span> that responded to neoadjuvant therapy with <span class=""chemical"">octreotide</span> and sunitinib, an oral multikinase inhibitor.",,18166847,18166847_D015282_D002276,18166847_2,bcv_sentence_task_befree_3002,,770958931,FALSE,finalized,5,8/14/15 22:02,"



",no_relation,1,,D015282,"<span class=""chemical"">octreotide</span>",D018358,"<span class=""disease"">management of neuroendocrine tumors</span>","We believe that further study of sunitinib and <span class=""chemical"">octreotide</span> with the neoadjuvant intent of preparing tumors for resection is warranted as a strategy to improve curative <span class=""disease"">management of neuroendocrine tumors</span>.",,18166847,18166847_D015282_D018358,18166847_4,bcv_sentence_task_befree_3003,,770958932,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,D015282,"<span class=""chemical"">octreotide</span>",D009369,"<span class=""disease"">tumors</span>","We believe that further study of sunitinib and <span class=""chemical"">octreotide</span> with the neoadjuvant intent of preparing <span class=""disease"">tumors</span> for resection is warranted as a strategy to improve curative management of neuroendocrine tumors.",,18166847,18166847_D015282_D009369,18166847_4,bcv_sentence_task_befree_3004,,770958933,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,C473478,"<span class=""chemical"">sunitinib</span>",D009369,"<span class=""disease"">tumors</span>","We believe that further study of <span class=""chemical"">sunitinib</span> and octreotide with the neoadjuvant intent of preparing <span class=""disease"">tumors</span> for resection is warranted as a strategy to improve curative management of neuroendocrine tumors.",,18166847,18166847_C473478_D009369,18166847_4,bcv_sentence_task_befree_3005,,770958934,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,C473478,"<span class=""chemical"">sunitinib</span>",D018358,"<span class=""disease"">management of neuroendocrine tumors</span>","We believe that further study of <span class=""chemical"">sunitinib</span> and octreotide with the neoadjuvant intent of preparing tumors for resection is warranted as a strategy to improve curative <span class=""disease"">management of neuroendocrine tumors</span>.",,18166847,18166847_C473478_D018358,18166847_4,bcv_sentence_task_befree_3006,,770958935,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,0.5956,,D007455,"<span class=""chemical"">iodine</span>",D003244,"<span class=""disease"">consciousness</span>","Iodoform intoxication; a case report of prolonged <span class=""disease"">consciousness</span> disturbance in a patient with a high plasma <span class=""chemical"">iodine</span> level.",,18186295,18186295_D007455_D003244,18186295_0,bcv_sentence_task_befree_3007,,770958936,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,1,,D007455,"<span class=""chemical"">iodine</span>",D014946,"<span class=""disease"">infected wounds</span>","This report describes a case in which a consciousness disturbance was associated with a high plasma <span class=""chemical"">iodine</span> level and which improved after the removal of iodoform gauze that had been applied to <span class=""disease"">infected wounds</span>.",,18186295,18186295_D007455_D014946,18186295_1,bcv_sentence_task_befree_3008,,770958937,FALSE,finalized,5,8/14/15 21:25,"



",yes_direct,0.7923,,D007455,"<span class=""chemical"">iodine</span>",D003244,"<span class=""disease"">consciousness</span>","This report describes a case in which a <span class=""disease"">consciousness</span> disturbance was associated with a high plasma <span class=""chemical"">iodine</span> level and which improved after the removal of iodoform gauze that had been applied to infected wounds.",,18186295,18186295_D007455_D003244,18186295_1,bcv_sentence_task_befree_3009,,770958938,FALSE,finalized,5,8/15/15 1:13,"



",no_relation,0.6114,,D007455,"<span class=""chemical"">iodine</span>",D003244,"<span class=""disease"">consciousness</span>","His <span class=""disease"">consciousness</span> recovered gradually with a concomitant decrease in the plasma <span class=""chemical"">iodine</span> level.",,18186295,18186295_D007455_D003244,18186295_6,bcv_sentence_task_befree_3010,,770958939,FALSE,finalized,5,8/15/15 2:47,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",C531854,"<span class=""disease"">oleic acid/OA</span>","The influence of propylen glycol (PG), <span class=""chemical"">ethanol</span>, and <span class=""disease"">oleic acid</span> (<span class=""disease"">OA</span>) on nortriptyline hydrochloride (NTH) penetration through human epidermis was studied in vitro at two different pH values (5.5 and 7.4).",,18191555,18191555_D000431_C531854,18191555_1,bcv_sentence_task_befree_3011,,770958940,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,D009661,"<span class=""chemical"">nortriptyline hydrochloride</span>",C531854,"<span class=""disease"">oleic acid/OA</span>","The influence of propylen glycol (PG), ethanol, and <span class=""disease"">oleic acid</span> (<span class=""disease"">OA</span>) on <span class=""chemical"">nortriptyline hydrochloride</span> (NTH) penetration through human epidermis was studied in vitro at two different pH values (5.5 and 7.4).",,18191555,18191555_D009661_C531854,18191555_1,bcv_sentence_task_befree_3012,,770958941,FALSE,finalized,5,8/15/15 0:46,"



",no_relation,1,,D019301,"<span class=""chemical"">oleic acid</span>",C531854,"<span class=""disease"">oleic acid/OA</span>","The influence of propylen glycol (PG), ethanol, and <span class=""chemical""></span><span class=""disease"">oleic acid</span> (<span class=""disease"">OA</span>) on nortriptyline hydrochloride (NTH) penetration through human epidermis was studied in vitro at two different pH values (5.5 and 7.4).",,18191555,18191555_D019301_C531854,18191555_1,bcv_sentence_task_befree_3013,,770958942,FALSE,finalized,5,8/15/15 0:45,"



",no_relation,1,,D011136,"<span class=""chemical"">polysorbate 80</span>",C531854,"<span class=""disease"">OA</span>","The vehicles showed an increasing enhancement effect in the order: <span class=""chemical"">polysorbate 80</span>>ethanol/PG/<span class=""disease"">OA</span>>PG>ethanol>ethanol/lactic acid>lactic acid at pH 5.5 while they reduced the permeation of NTH at pH 7.4.",,18191555,18191555_D011136_C531854,18191555_5,bcv_sentence_task_befree_3014,,770958943,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",C531854,"<span class=""disease"">OA</span>","The vehicles showed an increasing enhancement effect in the order: polysorbate 80><span class=""chemical"">ethanol</span>/PG/<span class=""disease"">OA</span>>PG><span class=""chemical"">ethanol</span>><span class=""chemical"">ethanol</span>/lactic acid>lactic acid at pH 5.5 while they reduced the permeation of NTH at pH 7.4.",,18191555,18191555_D000431_C531854,18191555_5,bcv_sentence_task_befree_3015,,770958944,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,D011136,"<span class=""chemical"">polysorbate 80</span>",C531854,"<span class=""disease"">OA</span>","Considering the results obtained at pH 5.5, the maximum enhancement ratios were found for <span class=""chemical"">polysorbate 80</span> and the combination ethanol/PG/<span class=""disease"">OA</span> (10.72 and 3.90).",,18191555,18191555_D011136_C531854,18191555_6,bcv_sentence_task_befree_3016,,770958945,FALSE,finalized,5,8/14/15 21:08,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",C531854,"<span class=""disease"">OA</span>","Considering the results obtained at pH 5.5, the maximum enhancement ratios were found for polysorbate 80 and the combination <span class=""chemical"">ethanol</span>/PG/<span class=""disease"">OA</span> (10.72 and 3.90).",,18191555,18191555_D000431_C531854,18191555_6,bcv_sentence_task_befree_3017,,770958946,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",C531854,"<span class=""disease"">OA</span>","The NTH-TDS based on the combination of <span class=""chemical"">ethanol</span>/PG/<span class=""disease"">OA</span> showed an enhancement ratio with respect to control of 2.09 and the addition of polysorbate 80 to the matrix, of 5.82.",,18191555,18191555_D000431_C531854,18191555_8,bcv_sentence_task_befree_3018,,770958947,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,1,,D025762,"<span class=""chemical"">pristinamycin</span>",D011023,"<span class=""disease"">Staphylococcus epidermidis</span>","Analysis of <span class=""chemical"">pristinamycin</span>-resistant <span class=""disease"">Staphylococcus epidermidis</span> isolates in the Tunisian Bone Marrow Transplant Center.",,18194160,18194160_D025762_D011023,18194160_0,bcv_sentence_task_befree_3019,,770958948,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,0.8055,,D025762,"<span class=""chemical"">pristinamycin</span>",D011023,"<span class=""disease"">Staphylococcus epidermidis</span>","We report the analysis of genetic determinants conferring resistance to <span class=""chemical"">pristinamycin</span> in <span class=""disease"">Staphylococcus epidermidis</span> strains and epidemiology typing of these strains by pulsed-field gel electrophoresis.",,18194160,18194160_D025762_D011023,18194160_1,bcv_sentence_task_befree_3020,,770958949,FALSE,finalized,5,8/15/15 1:37,"



",no_relation,1,,D025762,"<span class=""chemical"">pristinamycin</span>",D011023,"<span class=""disease"">Staphylococcus epidermidis</span>","<span class=""disease"">Staphylococcus epidermidis</span> (346 isolates) were searched for strains with <span class=""chemical"">pristinamycin</span> resistance.",,18194160,18194160_D025762_D011023,18194160_2,bcv_sentence_task_befree_3021,,770958950,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,1,,D025762,"<span class=""chemical"">Pristinamycin</span>",D009369,"<span class=""disease"">cancer</span>","<span class=""chemical"">Pristinamycin</span>-resistant strains (seven isolates) were isolated in five patients with haematological <span class=""disease"">cancer</span> in the Bone Marrow Transplant Centre of Tunisia in 2002.",,18194160,18194160_D025762_D009369,18194160_3,bcv_sentence_task_befree_3022,,770958951,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,D002395,"<span class=""chemical"">catecholamines</span>",D014947,"<span class=""disease"">trauma</span>","Effect of exogenous <span class=""chemical"">catecholamines</span> on tumor necrosis factor alpha, interleukin-6, interleukin-10 and beta-endorphin levels following severe <span class=""disease"">trauma</span>.",,18234565,18234565_D002395_D014947,18234565_0,bcv_sentence_task_befree_3023,,770958952,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,0.7924,,D002395,"<span class=""chemical"">catecholamines</span>",D009336,"<span class=""disease"">tumor necrosis factor alpha</span>","Effect of exogenous <span class=""chemical"">catecholamines</span> on <span class=""disease"">tumor necrosis factor alpha</span>, interleukin-6, interleukin-10 and beta-endorphin levels following severe trauma.",,18234565,18234565_D002395_D009336,18234565_0,bcv_sentence_task_befree_3024,,770958953,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,1,,D002395,"<span class=""chemical"">catecholamines</span>",D014947,"<span class=""disease"">trauma</span>","The aim of this study was to determine the effect of exogenous <span class=""chemical"">catecholamines</span> on tumor necrosis factor alpha (TNFa), interleukin-6 (IL-6), interleukin-10 (IL-10) and beta(beta)-endorphin levels in patients with severe <span class=""disease"">trauma</span>, during the first 24 h after injury.",,18234565,18234565_D002395_D014947,18234565_2,bcv_sentence_task_befree_3025,,770958954,FALSE,finalized,5,8/15/15 0:10,"



",no_relation,1,,D002395,"<span class=""chemical"">catecholamines</span>",D009336,"<span class=""disease"">tumor necrosis factor alpha/TNFa</span>","The aim of this study was to determine the effect of exogenous <span class=""chemical"">catecholamines</span> on <span class=""disease"">tumor necrosis factor alpha</span> (<span class=""disease"">TNFa</span>), interleukin-6 (IL-6), interleukin-10 (IL-10) and beta(beta)-endorphin levels in patients with severe trauma, during the first 24 h after injury.",,18234565,18234565_D002395_D009336,18234565_2,bcv_sentence_task_befree_3026,,770958955,FALSE,finalized,5,8/15/15 2:17,"



",yes_direct,0.5924,,D002395,"<span class=""chemical"">catecholamines</span>",D009336,"<span class=""disease"">TNFa</span>","Baseline values were different between the two groups, but an altered pattern of release was observed for <span class=""disease"">TNFa</span>, IL-6, IL-10 and beta-endorphin levels in patients treated with <span class=""chemical"">catecholamines</span>.",,18234565,18234565_D002395_D009336,18234565_6,bcv_sentence_task_befree_3027,,770958956,FALSE,finalized,5,8/15/15 1:29,"



",no_relation,1,,D002395,"<span class=""chemical"">catecholamine</span>",D014947,"<span class=""disease"">trauma</span>","Findings support an altered pattern of cytokine release during the early phase after <span class=""disease"">trauma</span>, probably due to <span class=""chemical"">catecholamine</span> presence.",,18234565,18234565_D002395_D014947,18234565_8,bcv_sentence_task_befree_3028,,770958957,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D004005,"<span class=""chemical"">dichlorphenamide/DCP</span>",D010243,"<span class=""disease"">paralysis</span>","In one study <span class=""chemical"">dichlorphenamide</span> (<span class=""chemical"">DCP</span>) vs placebo was tested in two groups of participants: 42 with hypokalemic periodic paralysis (HypoPP) and 31 with hyperkalemic periodic <span class=""disease"">paralysis</span> (HyperPP), based on clinical criteria.",,18254068,18254068_D004005_D010243,18254068_8,bcv_sentence_task_befree_3029,,770958958,FALSE,finalized,5,8/15/15 2:08,"



",no_relation,1,,D004005,"<span class=""chemical"">dichlorphenamide/DCP</span>",D020514,"<span class=""disease"">HypoPP/hypokalemic periodic paralysis</span>","In one study <span class=""chemical"">dichlorphenamide</span> (<span class=""chemical"">DCP</span>) vs placebo was tested in two groups of participants: 42 with <span class=""disease"">hypokalemic periodic paralysis</span> (<span class=""disease"">HypoPP</span>) and 31 with hyperkalemic periodic paralysis (HyperPP), based on clinical criteria.",,18254068,18254068_D004005_D020514,18254068_8,bcv_sentence_task_befree_3030,,770958959,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,1,,D004005,"<span class=""chemical"">dichlorphenamide/DCP</span>",D020513,"<span class=""disease"">hyperkalemic</span>","In one study <span class=""chemical"">dichlorphenamide</span> (<span class=""chemical"">DCP</span>) vs placebo was tested in two groups of participants: 42 with hypokalemic periodic paralysis (HypoPP) and 31 with <span class=""disease"">hyperkalemic</span> periodic paralysis (HyperPP), based on clinical criteria.",,18254068,18254068_D004005_D020513,18254068_8,bcv_sentence_task_befree_3031,,770958960,FALSE,finalized,5,8/15/15 2:34,"



",no_relation,1,,D004005,"<span class=""chemical"">DCP</span>",D010243,"<span class=""disease"">paralysis</span>","Twenty-four of 31 participants with hyperkalemic periodic <span class=""disease"">paralysis</span> completed both treatment phases: for the 16 participants who had attack rate data for both treatment phases, the mean improvement in attack rate (P = 0.006) and in severity-weighted attack rate (P = 0.02) on <span class=""chemical"">DCP</span> relative to placebo were significant.",,18254068,18254068_D004005_D010243,18254068_12,bcv_sentence_task_befree_3032,,770958961,FALSE,finalized,5,8/14/15 23:21,"



",no_relation,1,,D004005,"<span class=""chemical"">DCP</span>",D020513,"<span class=""disease"">hyperkalemic</span>","Twenty-four of 31 participants with <span class=""disease"">hyperkalemic</span> periodic paralysis completed both treatment phases: for the 16 participants who had attack rate data for both treatment phases, the mean improvement in attack rate (P = 0.006) and in severity-weighted attack rate (P = 0.02) on <span class=""chemical"">DCP</span> relative to placebo were significant.",,18254068,18254068_D004005_D020513,18254068_12,bcv_sentence_task_befree_3033,,770958962,FALSE,finalized,5,8/14/15 21:18,"



",no_relation,1,,D020110,"<span class=""chemical"">pinacidil</span>",D020514,"<span class=""disease"">HypoPP</span>","Acetazolamide proved to improve muscle strength in eight participants with <span class=""disease"">HypoPP</span> in one other study and <span class=""chemical"">pinacidil</span>, a potassium channel opener, also improved muscle strength in 2/4 participants with <span class=""disease"">HypoPP</span> in a third study.",,18254068,18254068_D020110_D020514,18254068_14,bcv_sentence_task_befree_3034,,770958963,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,D011188,"<span class=""chemical"">potassium</span>",D020514,"<span class=""disease"">HypoPP</span>","Acetazolamide proved to improve muscle strength in eight participants with <span class=""disease"">HypoPP</span> in one other study and pinacidil, a <span class=""chemical"">potassium</span> channel opener, also improved muscle strength in 2/4 participants with <span class=""disease"">HypoPP</span> in a third study.",,18254068,18254068_D011188_D020514,18254068_14,bcv_sentence_task_befree_3035,,770958964,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,D000086,"<span class=""chemical"">Acetazolamide</span>",D020514,"<span class=""disease"">HypoPP</span>","<span class=""chemical"">Acetazolamide</span> proved to improve muscle strength in eight participants with <span class=""disease"">HypoPP</span> in one other study and pinacidil, a potassium channel opener, also improved muscle strength in 2/4 participants with <span class=""disease"">HypoPP</span> in a third study.",,18254068,18254068_D000086_D020514,18254068_14,bcv_sentence_task_befree_3036,,770958965,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,1,,D004005,"<span class=""chemical"">DCP</span>",D010243,"<span class=""disease"">paralyses</span>","The largest included study that met our inclusion criteria suggested that <span class=""chemical"">DCP</span> was effective in the prevention of episodic weakness in both hypokalemic and hyperkalemic periodic <span class=""disease"">paralyses</span>.",,18254068,18254068_D004005_D010243,18254068_15,bcv_sentence_task_befree_3037,,770958966,FALSE,finalized,5,8/14/15 21:12,"



",no_relation,1,,D004005,"<span class=""chemical"">DCP</span>",D018908,"<span class=""disease"">weakness in both hypokalemic</span>","The largest included study that met our inclusion criteria suggested that <span class=""chemical"">DCP</span> was effective in the prevention of episodic <span class=""disease"">weakness in both hypokalemic</span> and hyperkalemic periodic paralyses.",,18254068,18254068_D004005_D018908,18254068_15,bcv_sentence_task_befree_3038,,770958967,FALSE,finalized,5,8/14/15 23:00,"



",no_relation,1,,D004005,"<span class=""chemical"">DCP</span>",D020513,"<span class=""disease"">hyperkalemic</span>","The largest included study that met our inclusion criteria suggested that <span class=""chemical"">DCP</span> was effective in the prevention of episodic weakness in both hypokalemic and <span class=""disease"">hyperkalemic</span> periodic paralyses.",,18254068,18254068_D004005_D020513,18254068_15,bcv_sentence_task_befree_3039,,770958968,FALSE,finalized,5,8/14/15 23:22,"



",no_relation,1,,C012629,"<span class=""chemical"">arformoterol</span>",D029424,"<span class=""disease"">COPD</span>","Effect of nebulized <span class=""chemical"">arformoterol</span> on airway function in <span class=""disease"">COPD</span>: results from two randomized trials.",,18259972,18259972_C012629_D029424,18259972_0,bcv_sentence_task_befree_3040,,770958969,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,1,,C012629,"<span class=""chemical"">Arformoterol</span>",D029424,"<span class=""disease"">COPD</span>","<span class=""chemical"">Arformoterol</span>, a single isomer long-acting beta(2)-agonist, was developed as an inhalation solution for the maintenance treatment of bronchoconstriction in <span class=""disease"">COPD</span>.",,18259972,18259972_C012629_D029424,18259972_1,bcv_sentence_task_befree_3041,,770958970,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,C012629,"<span class=""chemical"">arformoterol</span>",D029424,"<span class=""disease"">COPD</span>","In these trials, <span class=""disease"">COPD</span> subjects administered nebulized <span class=""chemical"">arformoterol</span> demonstrated significant and sustained improvement in lung function over 12 weeks.",,18259972,18259972_C012629_D029424,18259972_9,bcv_sentence_task_befree_3042,,770958971,FALSE,finalized,5,8/14/15 23:22,"


Used as treatment.
",no_relation,1,,D010431,"<span class=""chemical"">pentoxifylline</span>",D004715,"<span class=""disease"">endometriosis</span>","To compare outcomes after conservative surgery for <span class=""disease"">endometriosis</span> with and without <span class=""chemical"">pentoxifylline</span> and to assess the efficacy of <span class=""chemical"">pentoxifylline</span> in preventing recurrence of <span class=""disease"">endometriosis</span> after conservative surgery.",,18262146,18262146_D010431_D004715,18262146_1,bcv_sentence_task_befree_3043,,770958972,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,1,,D010431,"<span class=""chemical"">pentoxifylline</span>",D004715,"<span class=""disease"">endometriosis</span>","The use of <span class=""chemical"">pentoxifylline</span> after conservative surgery for <span class=""disease"">endometriosis</span> resulted in improved VAS scores at 2 and 3 months after the procedure when compared with patients having conservative surgery only.",,18262146,18262146_D010431_D004715,18262146_24,bcv_sentence_task_befree_3044,,770958973,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,1,,D010431,"<span class=""chemical"">pentoxifylline</span>",D004715,"<span class=""disease"">endometriosis</span>","The longer-term use of <span class=""chemical"">pentoxifylline</span> after conservative surgery may improve long-term outcomes after surgical treatment for <span class=""disease"">endometriosis</span>.",,18262146,18262146_D010431_D004715,18262146_25,bcv_sentence_task_befree_3045,,770958974,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,1,,D015122,"<span class=""chemical"">6-mercaptopurine</span>",D015212,"<span class=""disease"">inflammatory bowel disease</span>","Increased dosing requirements for <span class=""chemical"">6-mercaptopurine</span> and azathioprine in <span class=""disease"">inflammatory bowel disease</span> patients six years and younger.",,18266236,18266236_D015122_D015212,18266236_0,bcv_sentence_task_befree_3046,,770958975,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,0.8178,,D001379,"<span class=""chemical"">azathioprine</span>",D015212,"<span class=""disease"">inflammatory bowel disease</span>","Increased dosing requirements for 6-mercaptopurine and <span class=""chemical"">azathioprine</span> in <span class=""disease"">inflammatory bowel disease</span> patients six years and younger.",,18266236,18266236_D001379_D015212,18266236_0,bcv_sentence_task_befree_3047,,770958976,FALSE,finalized,5,8/15/15 0:19,"



",no_relation,1,,D015122,"<span class=""chemical"">6-MP/6-Mercaptopurine</span>",D015212,"<span class=""disease"">IBD/inflammatory bowel disease</span>","<span class=""chemical"">6-Mercaptopurine</span> (<span class=""chemical"">6-MP</span>) and its prodrug azathioprine (AZA) are effective for the induction and maintenance of remission and reduction of corticosteroid exposure for pediatric <span class=""disease"">inflammatory bowel disease</span> (<span class=""disease"">IBD</span>).",,18266236,18266236_D015122_D015212,18266236_1,bcv_sentence_task_befree_3048,,770958977,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D001379,"<span class=""chemical"">AZA/azathioprine</span>",D015212,"<span class=""disease"">IBD/inflammatory bowel disease</span>","6-Mercaptopurine (6-MP) and its prodrug <span class=""chemical"">azathioprine</span> (<span class=""chemical"">AZA</span>) are effective for the induction and maintenance of remission and reduction of corticosteroid exposure for pediatric <span class=""disease"">inflammatory bowel disease</span> (<span class=""disease"">IBD</span>).",,18266236,18266236_D001379_D015212,18266236_1,bcv_sentence_task_befree_3049,,770958978,FALSE,finalized,5,8/14/15 23:39,"



",no_relation,1,,D015122,"<span class=""chemical"">6-MP</span>",D015212,"<span class=""disease"">IBD</span>","The aim of this study was to determine whether <span class=""disease"">IBD</span> patients 6 years of age and younger require higher than standard doses of <span class=""chemical"">6-MP</span>/AZA to achieve clinical remission.",,18266236,18266236_D015122_D015212,18266236_3,bcv_sentence_task_befree_3050,,770958979,FALSE,finalized,5,8/15/15 2:25,"



",no_relation,1,,D001379,"<span class=""chemical"">AZA</span>",D015212,"<span class=""disease"">IBD</span>","The aim of this study was to determine whether <span class=""disease"">IBD</span> patients 6 years of age and younger require higher than standard doses of 6-MP/<span class=""chemical"">AZA</span> to achieve clinical remission.",,18266236,18266236_D001379_D015212,18266236_3,bcv_sentence_task_befree_3051,,770958980,FALSE,finalized,5,8/14/15 21:14,"



",no_relation,0.806,,D015122,"<span class=""chemical"">6-MP</span>",D015212,"<span class=""disease"">IBD</span>","Clinical data was collected retrospectively for all <span class=""disease"">IBD</span> patients 6 years of age or younger treated with <span class=""chemical"">6-MP</span>/AZA at The Children's Hospital of Philadelphia.",,18266236,18266236_D015122_D015212,18266236_4,bcv_sentence_task_befree_3052,,770958981,FALSE,finalized,5,8/14/15 22:04,"



",no_relation,1,,D001379,"<span class=""chemical"">AZA</span>",D015212,"<span class=""disease"">IBD</span>","Clinical data was collected retrospectively for all <span class=""disease"">IBD</span> patients 6 years of age or younger treated with 6-MP/<span class=""chemical"">AZA</span> at The Children's Hospital of Philadelphia.",,18266236,18266236_D001379_D015212,18266236_4,bcv_sentence_task_befree_3053,,770958982,FALSE,finalized,5,8/14/15 22:56,"



",no_relation,1,,D015122,"<span class=""chemical"">6-MP</span>",D015212,"<span class=""disease"">IBD</span>","<span class=""disease"">IBD</span> was diagnosed at a median age of 3.3 years (25-75th %ile 2.3-4.6 years) and <span class=""chemical"">6-MP</span>/AZA was initiated at a median age of 3.9 years (range 0.8-6.8 years).",,18266236,18266236_D015122_D015212,18266236_6,bcv_sentence_task_befree_3054,,770958983,FALSE,finalized,5,8/14/15 22:18,"



",no_relation,1,,D001379,"<span class=""chemical"">AZA</span>",D015212,"<span class=""disease"">IBD</span>","<span class=""disease"">IBD</span> was diagnosed at a median age of 3.3 years (25-75th %ile 2.3-4.6 years) and 6-MP/<span class=""chemical"">AZA</span> was initiated at a median age of 3.9 years (range 0.8-6.8 years).",,18266236,18266236_D001379_D015212,18266236_6,bcv_sentence_task_befree_3055,,770958984,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,0.805,,D001379,"<span class=""chemical"">AZA</span>",D007757,"<span class=""disease"">laboratory abnormalities</span>","No patients had to discontinue 6-MP/<span class=""chemical"">AZA</span>, and all <span class=""disease"">laboratory abnormalities</span> improved spontaneously or with dose reduction.",,18266236,18266236_D001379_D007757,18266236_11,bcv_sentence_task_befree_3056,,770958985,FALSE,finalized,5,8/14/15 21:13,"



",no_relation,0.5932,,D015122,"<span class=""chemical"">6-MP</span>",D007757,"<span class=""disease"">laboratory abnormalities</span>","No patients had to discontinue <span class=""chemical"">6-MP</span>/AZA, and all <span class=""disease"">laboratory abnormalities</span> improved spontaneously or with dose reduction.",,18266236,18266236_D015122_D007757,18266236_11,bcv_sentence_task_befree_3057,,770958986,FALSE,finalized,5,8/15/15 1:43,"



",no_relation,1,,D015122,"<span class=""chemical"">6-MP</span>",D015212,"<span class=""disease"">IBD</span>","The standard dose of <span class=""chemical"">6-MP</span>/AZA may not be adequate for <span class=""disease"">IBD</span> patients 6 years of age and younger.",,18266236,18266236_D015122_D015212,18266236_12,bcv_sentence_task_befree_3058,,770958987,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,D001379,"<span class=""chemical"">AZA</span>",D015212,"<span class=""disease"">IBD</span>","The standard dose of 6-MP/<span class=""chemical"">AZA</span> may not be adequate for <span class=""disease"">IBD</span> patients 6 years of age and younger.",,18266236,18266236_D001379_D015212,18266236_12,bcv_sentence_task_befree_3059,,770958988,FALSE,finalized,5,8/14/15 21:09,"



",no_relation,0.4244,,D008353,"<span class=""chemical"">mannitol</span>",D065627,"<span class=""disease"">arterial hypertension</span>","Other first-tier options include induced hypocapnea (hyperventilation; paCO2 < 35 mmHg), hyperosmolar therapy (<span class=""chemical"">mannitol</span>, hypertonic saline) and induced <span class=""disease"">arterial hypertension</span> (CPP concept).",,18286835,18286835_D008353_D065627,18286835_14,bcv_sentence_task_befree_3060,,770958989,FALSE,finalized,5,8/14/15 21:13,"



",no_relation,1,,D008353,"<span class=""chemical"">mannitol</span>",D006944,"<span class=""disease"">hyperosmolar</span>","Other first-tier options include induced hypocapnea (hyperventilation; paCO2 < 35 mmHg), <span class=""disease"">hyperosmolar</span> therapy (<span class=""chemical"">mannitol</span>, hypertonic saline) and induced arterial hypertension (CPP concept).",,18286835,18286835_D008353_D006944,18286835_14,bcv_sentence_task_befree_3061,,770958990,FALSE,finalized,5,8/14/15 21:15,"



",no_relation,1,,D007213,"<span class=""chemical"">indomethacin</span>",D018476,"<span class=""disease"">coma</span>","These include 'forced hyperventilation' (paCO2 < 25 mmHg), barbiturate <span class=""disease"">coma</span> or experimental protocols such as tris buffer, <span class=""chemical"">indomethacin</span> or induced hypothermia.",,18286835,18286835_D007213_D018476,18286835_17,bcv_sentence_task_befree_3062,,770958991,FALSE,finalized,5,8/14/15 21:45,"



",no_relation,0.8216,,D007213,"<span class=""chemical"">indomethacin</span>",D007035,"<span class=""disease"">hypothermia</span>","These include 'forced hyperventilation' (paCO2 < 25 mmHg), barbiturate coma or experimental protocols such as tris buffer, <span class=""chemical"">indomethacin</span> or induced <span class=""disease"">hypothermia</span>.",,18286835,18286835_D007213_D007035,18286835_17,bcv_sentence_task_befree_3063,,770958992,FALSE,finalized,5,8/14/15 21:09,"



",yes_direct,0.6201,,C032232,"<span class=""chemical"">barbiturate</span>",D018476,"<span class=""disease"">coma</span>","These include 'forced hyperventilation' (paCO2 < 25 mmHg), <span class=""chemical"">barbiturate</span> <span class=""disease"">coma</span> or experimental protocols such as tris buffer, indomethacin or induced hypothermia.",,18286835,18286835_C032232_D018476,18286835_17,bcv_sentence_task_befree_3064,,770958993,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,C032232,"<span class=""chemical"">barbiturate</span>",D007035,"<span class=""disease"">hypothermia</span>","These include 'forced hyperventilation' (paCO2 < 25 mmHg), <span class=""chemical"">barbiturate</span> coma or experimental protocols such as tris buffer, indomethacin or induced <span class=""disease"">hypothermia</span>.",,18286835,18286835_C032232_D007035,18286835_17,bcv_sentence_task_befree_3065,,770958994,FALSE,finalized,5,8/14/15 21:23,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D007006,"<span class=""disease"">hypogonadism</span>","Clinically, reports of patients with erectile dysfunction (ED) combined with <span class=""disease"">hypogonadism</span> who receive <span class=""chemical"">testosterone</span> therapy have inconsistent results.",,18305486,18305486_D013739_D007006,18305486_6,bcv_sentence_task_befree_3066,,770958995,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,0.7879,,D013739,"<span class=""chemical"">testosterone</span>",D007172,"<span class=""disease"">ED/erectile dysfunction</span>","Clinically, reports of patients with <span class=""disease"">erectile dysfunction</span> (<span class=""disease"">ED</span>) combined with hypogonadism who receive <span class=""chemical"">testosterone</span> therapy have inconsistent results.",,18305486,18305486_D013739_D007172,18305486_6,bcv_sentence_task_befree_3067,,770958996,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,0.6242,,D013739,"<span class=""chemical"">testosterone</span>",D011471,"<span class=""disease"">prostate cancer</span>","Because of potential risks in clinical use, <span class=""chemical"">testosterone</span> therapy should be individualized, carefully considered and closely monitored, especially, in patients with possible occult <span class=""disease"">prostate cancer</span>, and large benign prostatic hyperplasia.",,18305486,18305486_D013739_D011471,18305486_8,bcv_sentence_task_befree_3068,,770958997,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D011470,"<span class=""disease"">prostatic hyperplasia</span>","Because of potential risks in clinical use, <span class=""chemical"">testosterone</span> therapy should be individualized, carefully considered and closely monitored, especially, in patients with possible occult prostate cancer, and large benign <span class=""disease"">prostatic hyperplasia</span>.",,18305486,18305486_D013739_D011470,18305486_8,bcv_sentence_task_befree_3069,,770958998,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,D008140,"<span class=""chemical"">lorazepam</span>",D002389,"<span class=""disease"">catatonia</span>","Although <span class=""chemical"">lorazepam</span> is helpful in treating <span class=""disease"">catatonia</span>, it may not suffice, as in the cases presented.",,18327024,18327024_D008140_D002389,18327024_9,bcv_sentence_task_befree_3070,,770958999,FALSE,finalized,5,8/15/15 2:08,"



",no_relation,1,,D008140,"<span class=""chemical"">lorazepam</span>",D004660,"<span class=""disease"">encephalitis</span>","ECT deserves serious consideration early in the course of malignant catatonia and for catatonia nested in encephalopathy secondary to <span class=""disease"">encephalitis</span>, unresolved with <span class=""chemical"">lorazepam</span>.",,18327024,18327024_D008140_D004660,18327024_10,bcv_sentence_task_befree_3071,,770959000,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,1,,D008140,"<span class=""chemical"">lorazepam</span>",D001925,"<span class=""disease"">encephalopathy</span>","ECT deserves serious consideration early in the course of malignant catatonia and for catatonia nested in <span class=""disease"">encephalopathy</span> secondary to encephalitis, unresolved with <span class=""chemical"">lorazepam</span>.",,18327024,18327024_D008140_D001925,18327024_10,bcv_sentence_task_befree_3072,,770959001,FALSE,finalized,5,8/15/15 0:22,"



",no_relation,1,,D008140,"<span class=""chemical"">lorazepam</span>",D002389,"<span class=""disease"">catatonia</span>","ECT deserves serious consideration early in the course of malignant <span class=""disease"">catatonia</span> and for <span class=""disease"">catatonia</span> nested in encephalopathy secondary to encephalitis, unresolved with <span class=""chemical"">lorazepam</span>.",,18327024,18327024_D008140_D002389,18327024_10,bcv_sentence_task_befree_3073,,770959002,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,D015283,"<span class=""chemical"">escitalopram</span>",D003866,"<span class=""disease"">depressive disorder</span>","A Markov cost-utility analysis of <span class=""chemical"">escitalopram</span> and duloxetine for the treatment of major <span class=""disease"">depressive disorder</span>.",,18331669,18331669_D015283_D003866,18331669_0,bcv_sentence_task_befree_3074,,770959003,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,1,,C058218,"<span class=""chemical"">duloxetine</span>",D003866,"<span class=""disease"">depressive disorder</span>","A Markov cost-utility analysis of escitalopram and <span class=""chemical"">duloxetine</span> for the treatment of major <span class=""disease"">depressive disorder</span>.",,18331669,18331669_C058218_D003866,18331669_0,bcv_sentence_task_befree_3075,,770959004,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,1,,D015283,"<span class=""chemical"">escitalopram</span>",D003866,"<span class=""disease"">depression</span>","This analysis suggests that <span class=""chemical"">escitalopram</span> was more effective in terms of QALWs and less costly than duloxetine for treatment of <span class=""disease"">depression</span>.",,18331669,18331669_D015283_D003866,18331669_14,bcv_sentence_task_befree_3076,,770959005,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,1,,C058218,"<span class=""chemical"">duloxetine</span>",D003866,"<span class=""disease"">depression</span>","This analysis suggests that escitalopram was more effective in terms of QALWs and less costly than <span class=""chemical"">duloxetine</span> for treatment of <span class=""disease"">depression</span>.",,18331669,18331669_C058218_D003866,18331669_14,bcv_sentence_task_befree_3077,,770959006,FALSE,finalized,5,8/15/15 2:20,"



",no_relation,1,,C117268,"<span class=""chemical"">Pimecrolimus</span>",D003876,"<span class=""disease"">atopic dermatitis</span>","<span class=""chemical"">Pimecrolimus</span> cream 1% in the long-term management of adult <span class=""disease"">atopic dermatitis</span>: prevention of flare progression.",,18341665,18341665_C117268_D003876,18341665_0,bcv_sentence_task_befree_3078,,770959007,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,C117268,"<span class=""chemical"">pimecrolimus</span>",D003876,"<span class=""disease"">atopic dermatitis/AD</span>","Previous studies suggested that early intervention with <span class=""chemical"">pimecrolimus</span> cream 1% at the first signs and/or symptoms of a relapse of <span class=""disease"">atopic dermatitis</span> (<span class=""disease"">AD</span>) following remission may prevent the occurrence of more severe flares and therefore reduce corticosteroid exposure in the long term.",,18341665,18341665_C117268_D003876,18341665_2,bcv_sentence_task_befree_3079,,770959008,FALSE,finalized,5,8/15/15 1:23,"



",no_relation,1,,C117268,"<span class=""chemical"">pimecrolimus</span>",D003876,"<span class=""disease"">AD</span>","To evaluate the effectiveness of <span class=""chemical"">pimecrolimus</span> cream 1% for the prevention of flare progression in adults with <span class=""disease"">AD</span>.",,18341665,18341665_C117268_D003876,18341665_4,bcv_sentence_task_befree_3080,,770959009,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,0.7894,,C117268,"<span class=""chemical"">pimecrolimus</span>",D003876,"<span class=""disease"">AD</span>","A 26-week randomized controlled study was conducted in 543 patients aged>or=18 years, with a history of mild or moderate <span class=""disease"">AD</span>, who were clear/almost clear of disease before randomization to <span class=""chemical"">pimecrolimus</span> cream 1% (n=277) or matching vehicle cream (n=266).",,18341665,18341665_C117268_D003876,18341665_5,bcv_sentence_task_befree_3081,,770959010,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,C117268,"<span class=""chemical"">pimecrolimus</span>",D003876,"<span class=""disease"">AD</span>","In adults with a history of mild or moderate <span class=""disease"">AD</span> but free of active skin lesions, intervention with <span class=""chemical"">pimecrolimus</span> cream 1% at the first signs and/or symptoms of a subsequent recurrence reduces the number of flares requiring TCS use and decreases the number of disease-related office visits.",,18341665,18341665_C117268_D003876,18341665_12,bcv_sentence_task_befree_3082,,770959011,FALSE,finalized,5,8/15/15 0:03,"


Used as treatment.
",no_relation,1,,C117268,"<span class=""chemical"">pimecrolimus</span>",C537466,"<span class=""disease"">skin lesions</span>","In adults with a history of mild or moderate AD but free of active <span class=""disease"">skin lesions</span>, intervention with <span class=""chemical"">pimecrolimus</span> cream 1% at the first signs and/or symptoms of a subsequent recurrence reduces the number of flares requiring TCS use and decreases the number of disease-related office visits.",,18341665,18341665_C117268_C537466,18341665_12,bcv_sentence_task_befree_3083,,770959012,FALSE,finalized,5,8/14/15 21:18,"



",no_relation,1,,C056507,"<span class=""chemical"">gemcitabine</span>",D007938,"<span class=""disease"">leukemia</span>","Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, <span class=""chemical"">gemcitabine</span>, irinotecan and topotecan in human <span class=""disease"">leukemia</span> and lymphoma cells.",,18398748,18398748_C056507_D007938,18398748_0,bcv_sentence_task_befree_3084,,770959013,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,1,,D015255,"<span class=""chemical"">idarubicin</span>",D008223,"<span class=""disease"">lymphoma</span>","Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), <span class=""chemical"">idarubicin</span>, gemcitabine, irinotecan and topotecan in human leukemia and <span class=""disease"">lymphoma</span> cells.",,18398748,18398748_D015255_D008223,18398748_0,bcv_sentence_task_befree_3085,,770959014,FALSE,finalized,5,8/15/15 0:37,"



",no_relation,1,,C483604,"<span class=""chemical"">cloretazine</span>",D007938,"<span class=""disease"">leukemia</span>","Anti proliferative activity of ELACY (CP-4055) in combination with <span class=""chemical"">cloretazine</span> (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human <span class=""disease"">leukemia</span> and lymphoma cells.",,18398748,18398748_C483604_D007938,18398748_0,bcv_sentence_task_befree_3086,,770959015,FALSE,finalized,5,8/14/15 21:58,"



",no_relation,1,,D015255,"<span class=""chemical"">idarubicin</span>",D007938,"<span class=""disease"">leukemia</span>","Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), <span class=""chemical"">idarubicin</span>, gemcitabine, irinotecan and topotecan in human <span class=""disease"">leukemia</span> and lymphoma cells.",,18398748,18398748_D015255_D007938,18398748_0,bcv_sentence_task_befree_3087,,770959016,FALSE,finalized,5,8/15/15 0:24,"



",no_relation,1,,C483604,"<span class=""chemical"">cloretazine</span>",D008223,"<span class=""disease"">lymphoma</span>","Anti proliferative activity of ELACY (CP-4055) in combination with <span class=""chemical"">cloretazine</span> (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and <span class=""disease"">lymphoma</span> cells.",,18398748,18398748_C483604_D008223,18398748_0,bcv_sentence_task_befree_3088,,770959017,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,1,,D019772,"<span class=""chemical"">topotecan</span>",D008223,"<span class=""disease"">lymphoma</span>","Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and <span class=""chemical"">topotecan</span> in human leukemia and <span class=""disease"">lymphoma</span> cells.",,18398748,18398748_D019772_D008223,18398748_0,bcv_sentence_task_befree_3089,,770959018,FALSE,finalized,5,8/14/15 22:06,"



",no_relation,1,,C051890,"<span class=""chemical"">irinotecan</span>",D008223,"<span class=""disease"">lymphoma</span>","Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, <span class=""chemical"">irinotecan</span> and topotecan in human leukemia and <span class=""disease"">lymphoma</span> cells.",,18398748,18398748_C051890_D008223,18398748_0,bcv_sentence_task_befree_3090,,770959019,FALSE,finalized,5,8/15/15 2:25,"



",no_relation,1,,D019772,"<span class=""chemical"">topotecan</span>",D007938,"<span class=""disease"">leukemia</span>","Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and <span class=""chemical"">topotecan</span> in human <span class=""disease"">leukemia</span> and lymphoma cells.",,18398748,18398748_D019772_D007938,18398748_0,bcv_sentence_task_befree_3091,,770959020,FALSE,finalized,5,8/15/15 0:24,"



",no_relation,1,,C047645,"<span class=""chemical"">CP-4055</span>",D008223,"<span class=""disease"">lymphoma</span>","Anti proliferative activity of ELACY (<span class=""chemical"">CP-4055</span>) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and <span class=""disease"">lymphoma</span> cells.",,18398748,18398748_C047645_D008223,18398748_0,bcv_sentence_task_befree_3092,,770959021,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,1,,C051890,"<span class=""chemical"">irinotecan</span>",D007938,"<span class=""disease"">leukemia</span>","Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, <span class=""chemical"">irinotecan</span> and topotecan in human <span class=""disease"">leukemia</span> and lymphoma cells.",,18398748,18398748_C051890_D007938,18398748_0,bcv_sentence_task_befree_3093,,770959022,FALSE,finalized,5,8/15/15 0:52,"



",no_relation,1,,C056507,"<span class=""chemical"">gemcitabine</span>",D008223,"<span class=""disease"">lymphoma</span>","Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, <span class=""chemical"">gemcitabine</span>, irinotecan and topotecan in human leukemia and <span class=""disease"">lymphoma</span> cells.",,18398748,18398748_C056507_D008223,18398748_0,bcv_sentence_task_befree_3094,,770959023,FALSE,finalized,5,8/15/15 0:23,"



",no_relation,1,,C047645,"<span class=""chemical"">CP-4055</span>",D007938,"<span class=""disease"">leukemia</span>","Anti proliferative activity of ELACY (<span class=""chemical"">CP-4055</span>) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human <span class=""disease"">leukemia</span> and lymphoma cells.",,18398748,18398748_C047645_D007938,18398748_0,bcv_sentence_task_befree_3095,,770959024,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,1,,C047645,"<span class=""chemical"">CP-4055</span>",D008223,"<span class=""disease"">lymphoma</span>","In summary, <span class=""chemical"">CP-4055</span> produced additive to synergistic anti proliferative activity when combined simultaneously with drugs from four mechanistic classes in cell culture models of human leukemia and <span class=""disease"">lymphoma</span>.",,18398748,18398748_C047645_D008223,18398748_7,bcv_sentence_task_befree_3096,,770959025,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,C047645,"<span class=""chemical"">CP-4055</span>",D007938,"<span class=""disease"">leukemia</span>","In summary, <span class=""chemical"">CP-4055</span> produced additive to synergistic anti proliferative activity when combined simultaneously with drugs from four mechanistic classes in cell culture models of human <span class=""disease"">leukemia</span> and lymphoma.",,18398748,18398748_C047645_D007938,18398748_7,bcv_sentence_task_befree_3097,,770959026,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,0.7955,,D004801,"<span class=""chemical"">eosin</span>",D009369,"<span class=""disease"">cancer</span>","Uni- and multivariable variable analyses showed that the lowest recurrence rates were reported in studies performed in <span class=""disease"">cancer</span> centres, in studies that described the use of (99m)Tc-sulphur colloid, and also when investigators used the superficial injection technique or evaluated the harvested sentinel nodes with haematoxylin-<span class=""chemical"">eosin</span> and immunohistochemistry staining (p<0.01).",,18406100,18406100_D004801_D009369,18406100_8,bcv_sentence_task_befree_3098,,770959027,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,1,,D014280,"<span class=""chemical"">triglycerides</span>",D015228,"<span class=""disease"">hypertriglyceridemia</span>","Moderate <span class=""disease"">hypertriglyceridemia</span> is fairly common, and elevated <span class=""chemical"">triglycerides</span> are a risk factor for coronary heart disease.",,18422480,18422480_D014280_D015228,18422480_1,bcv_sentence_task_befree_3099,,770959028,FALSE,finalized,5,8/15/15 2:47,"



",yes_direct,0.798,,D014280,"<span class=""chemical"">triglycerides</span>",D003327,"<span class=""disease"">coronary heart disease</span>","Moderate hypertriglyceridemia is fairly common, and elevated <span class=""chemical"">triglycerides</span> are a risk factor for <span class=""disease"">coronary heart disease</span>.",,18422480,18422480_D014280_D003327,18422480_1,bcv_sentence_task_befree_3100,,770959029,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,1,,D014280,"<span class=""chemical"">triglycerides</span>",D015228,"<span class=""disease"">hypertriglyceridemia</span>","This review provides an overview of the use of omega-3 concentrates (both P-OM3 and over-the-counter fish oil) to lower <span class=""chemical"">triglycerides</span> in people who have moderate <span class=""disease"">hypertriglyceridemia</span> (<span class=""chemical"">triglycerides</span> in the range of 150 - 500 mg/dl).",,18422480,18422480_D014280_D015228,18422480_5,bcv_sentence_task_befree_3101,,770959030,FALSE,finalized,5,8/15/15 1:41,"



",no_relation,1,,D014280,"<span class=""chemical"">triglycerides</span>",D050171,"<span class=""disease"">dyslipidemia</span>","P-OM3 are effective in reducing <span class=""chemical"">triglycerides</span> by approximately 30% in this population and are likely to be combined with other drugs (e.g., statins) to treat combined <span class=""disease"">dyslipidemia</span>.",,18422480,18422480_D014280_D050171,18422480_9,bcv_sentence_task_befree_3102,,770959031,FALSE,finalized,5,8/15/15 1:29,"



",yes_direct,0.6081,,C022202,"<span class=""chemical"">9-anilinoacridine</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Caspase-dependent cell death mediates potent <span class=""disease"">cytotoxicity</span> of sulfide derivatives of <span class=""chemical"">9-anilinoacridine</span>.",,18454048,18454048_C022202_D004487,18454048_0,bcv_sentence_task_befree_3103,,770959032,FALSE,finalized,5,8/14/15 21:20,"



",no_relation,1,,C530271,"<span class=""chemical"">2-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(2-hydroxyethyl)amino)ethan-1-ol/CK0402</span>",D009369,"<span class=""disease"">multiple cancer</span>","Two recently developed sulfide derivatives of 9-anilinoacridines, <span class=""chemical"">2-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(2-hydroxyethyl)amino)ethan-1-ol</span> (<span class=""chemical"">CK0402</span>) and 3-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(3-hydroxypropyl)amino)propan-1-ol (CK0403), displayed potent cytotoxic activity in <span class=""disease"">multiple cancer</span> cell lines.",,18454048,18454048_C530271_D009369,18454048_2,bcv_sentence_task_befree_3104,,770959033,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,0.6165,,C530272,"<span class=""chemical"">3-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(3-hydroxypropyl)amino)propan-1-ol/CK0403</span>",D009369,"<span class=""disease"">multiple cancer</span>","Two recently developed sulfide derivatives of 9-anilinoacridines, 2-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(2-hydroxyethyl)amino)ethan-1-ol (CK0402) and <span class=""chemical"">3-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(3-hydroxypropyl)amino)propan-1-ol</span> (<span class=""chemical"">CK0403</span>), displayed potent cytotoxic activity in <span class=""disease"">multiple cancer</span> cell lines.",,18454048,18454048_C530272_D009369,18454048_2,bcv_sentence_task_befree_3105,,770959034,FALSE,finalized,5,8/14/15 22:12,"



",no_relation,1,,C098350,"<span class=""chemical"">verteporfin</span>",D020256,"<span class=""disease"">choroidal neovascularization</span>","Intravitreal injection of bevacizumab combined with <span class=""chemical"">verteporfin</span> photodynamic therapy for <span class=""disease"">choroidal neovascularization</span> in age-related macular degeneration.",,18463509,18463509_C098350_D020256,18463509_0,bcv_sentence_task_befree_3106,,770959035,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,C098350,"<span class=""chemical"">verteporfin</span>",D008268,"<span class=""disease"">age-related macular degeneration</span>","Intravitreal injection of bevacizumab combined with <span class=""chemical"">verteporfin</span> photodynamic therapy for choroidal neovascularization in <span class=""disease"">age-related macular degeneration</span>.",,18463509,18463509_C098350_D008268,18463509_0,bcv_sentence_task_befree_3107,,770959036,FALSE,finalized,5,8/14/15 21:43,"



",no_relation,1,,C098350,"<span class=""chemical"">verteporfin</span>",D020256,"<span class=""disease"">choroidal neovascularization/CNV</span>","To report the outcome for eyes treated with intravitreal injection of bevacizumab combined with <span class=""chemical"">verteporfin</span> photodynamic therapy (PDT) for <span class=""disease"">choroidal neovascularization</span> (<span class=""disease"">CNV</span>) in age-related macular degeneration (AMD).",,18463509,18463509_C098350_D020256,18463509_1,bcv_sentence_task_befree_3108,,770959037,FALSE,finalized,5,8/14/15 21:27,"



",no_relation,1,,C098350,"<span class=""chemical"">verteporfin</span>",D008268,"<span class=""disease"">AMD/age-related macular degeneration</span>","To report the outcome for eyes treated with intravitreal injection of bevacizumab combined with <span class=""chemical"">verteporfin</span> photodynamic therapy (PDT) for choroidal neovascularization (CNV) in <span class=""disease"">age-related macular degeneration</span> (<span class=""disease"">AMD</span>).",,18463509,18463509_C098350_D008268,18463509_1,bcv_sentence_task_befree_3109,,770959038,FALSE,finalized,5,8/14/15 22:09,"



",yes_direct,1,,D019797,"<span class=""chemical"">MIBG</span>",D006976,"<span class=""disease"">pulmonary hypertension</span>","(123)I-<span class=""chemical"">MIBG</span> is also used as a potential marker of pulmonary endothelial cell function and may be related to <span class=""disease"">pulmonary hypertension</span>.",,18471462,18471462_D019797_D006976,18471462_2,bcv_sentence_task_befree_3110,,770959039,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,1,,D019797,"<span class=""chemical"">MIBG</span>",D002311,"<span class=""disease"">idiopathic dilated cardiomyopathy</span>","In conclusion, the combined assessment of lung and heart 123I-<span class=""chemical"">MIBG</span> uptake may help to predict future clinical outcome for patients with <span class=""disease"">idiopathic dilated cardiomyopathy</span> more accurately than myocardial evaluation alone.",,18471462,18471462_D019797_D002311,18471462_12,bcv_sentence_task_befree_3111,,770959040,FALSE,finalized,5,8/14/15 21:10,"



",no_relation,1,,C015542,"<span class=""chemical"">gaboxadol</span>",D012893,"<span class=""disease"">Slow wave sleep/daytime sleepiness/sleep restriction</span>","<span class=""disease"">Slow wave sleep</span> enhancement with <span class=""chemical"">gaboxadol</span> reduces <span class=""disease"">daytime sleepiness</span> during <span class=""disease"">sleep restriction</span>.",,18517036,18517036_C015542_D012893,18517036_0,bcv_sentence_task_befree_3112,,770959041,FALSE,finalized,5,8/14/15 23:20,"



",no_relation,1,,C015542,"<span class=""chemical"">gaboxadol</span>",D012893,"<span class=""disease"">SWS/sleep restriction</span>","A double-blind, parallel group, placebo-controlled design was used to compare <span class=""chemical"">gaboxadol</span> (GBX) 15 mg, a <span class=""disease"">SWS</span>-enhancing drug, to placebo during 4 nights of <span class=""disease"">sleep restriction</span> (5 h/night).",,18517036,18517036_C015542_D012893,18517036_2,bcv_sentence_task_befree_3113,,770959042,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,C015542,"<span class=""chemical"">GBX</span>",D012893,"<span class=""disease"">sleep restriction</span>","Each group received either <span class=""chemical"">GBX</span> 15 mg or placebo on all <span class=""disease"">sleep restriction</span> nights, and both groups received placebo on baseline and recovery nights.",,18517036,18517036_C015542_D012893,18517036_7,bcv_sentence_task_befree_3114,,770959043,FALSE,finalized,5,8/14/15 22:11,"



",no_relation,1,,D012503,"<span class=""chemical"">Saponins</span>",D009369,"<span class=""disease"">tumor</span>","<span class=""chemical"">Saponins</span> in <span class=""disease"">tumor</span> therapy.",,18537712,18537712_D012503_D009369,18537712_0,bcv_sentence_task_befree_3115,,770959044,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,1,,D012503,"<span class=""chemical"">Saponins</span>",D002471,"<span class=""disease"">tumorigenic</span>","<span class=""chemical"">Saponins</span> are plant glycosides with favorable anti-<span class=""disease"">tumorigenic</span> properties.",,18537712,18537712_D012503_D002471,18537712_1,bcv_sentence_task_befree_3116,,770959045,FALSE,finalized,5,8/15/15 0:10,"



",no_relation,0.8008,,D012503,"<span class=""chemical"">saponins</span>",D009369,"<span class=""disease"">tumor</span>","Several <span class=""chemical"">saponins</span> inhibit <span class=""disease"">tumor</span> cell growth by cell cycle arrest and apoptosis with IC50 values of up to 0.2 microM.",,18537712,18537712_D012503_D009369,18537712_2,bcv_sentence_task_befree_3117,,770959046,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,0.8179,,C025759,"<span class=""chemical"">saikosaponins</span>",D009369,"<span class=""disease"">tumor</span>","We discuss diverse groups of saponins (dioscins, <span class=""chemical"">saikosaponins</span>, julibrosides, soy saponins, ginseng saponins and avicins) investigated in relation to <span class=""disease"">tumor</span> therapy and focus on cellular and systemic mechanisms of <span class=""disease"">tumor</span> cell growth inhibition both in vitro and in vivo.",,18537712,18537712_C025759_D009369,18537712_3,bcv_sentence_task_befree_3118,,770959047,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,1,,D012503,"<span class=""chemical"">saponins</span>",D009369,"<span class=""disease"">tumor</span>","We discuss diverse groups of <span class=""chemical"">saponins</span> (dioscins, saikosaponins, julibrosides, soy <span class=""chemical"">saponins</span>, ginseng <span class=""chemical"">saponins</span> and avicins) investigated in relation to <span class=""disease"">tumor</span> therapy and focus on cellular and systemic mechanisms of <span class=""disease"">tumor</span> cell growth inhibition both in vitro and in vivo.",,18537712,18537712_D012503_D009369,18537712_3,bcv_sentence_task_befree_3119,,770959048,FALSE,finalized,5,8/14/15 21:14,"



",no_relation,1,,D012503,"<span class=""chemical"">saponins</span>",D009369,"<span class=""disease"">tumor</span>","The review also describes <span class=""chemical"">saponins</span> in combination with conventional <span class=""disease"">tumor</span> treatment strategies, which result in improved therapeutic success.",,18537712,18537712_D012503_D009369,18537712_4,bcv_sentence_task_befree_3120,,770959049,FALSE,finalized,5,8/14/15 22:49,"



",no_relation,1,,D012503,"<span class=""chemical"">saponins</span>",D002471,"<span class=""disease"">tumorigenic</span>","Some combinations of <span class=""chemical"">saponins</span> and anti-<span class=""disease"">tumorigenic</span> drugs induce synergistic effects with potentiated growth inhibition.",,18537712,18537712_D012503_D002471,18537712_5,bcv_sentence_task_befree_3121,,770959050,FALSE,finalized,5,8/14/15 23:23,"



",no_relation,1,,D012643,"<span class=""chemical"">selenium</span>",D015658,"<span class=""disease"">HIV-infected</span>","Randomized, double-blind, placebo-controlled trial of <span class=""chemical"">selenium</span> supplements among <span class=""disease"">HIV-infected</span> pregnant women in Tanzania: effects on maternal and child outcomes.",,18541571,18541571_D012643_D015658,18541571_0,bcv_sentence_task_befree_3122,,770959051,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,D012643,"<span class=""chemical"">selenium</span>",D015658,"<span class=""disease"">HIV disease progression</span>","In observational studies, adequate <span class=""chemical"">selenium</span> status has been associated with better pregnancy outcomes and slowed <span class=""disease"">HIV disease progression</span>.",,18541571,18541571_D012643_D015658,18541571_1,bcv_sentence_task_befree_3123,,770959052,FALSE,finalized,5,8/15/15 1:11,"



",no_relation,1,,D012643,"<span class=""chemical"">selenium</span>",D015658,"<span class=""disease"">HIV-infected</span>","We investigated the effects of daily <span class=""chemical"">selenium</span> supplements on CD4 cell counts, viral load, pregnancy outcomes, and maternal and infant mortality among 913 <span class=""disease"">HIV-infected</span> pregnant women.",,18541571,18541571_D012643_D015658,18541571_2,bcv_sentence_task_befree_3124,,770959053,FALSE,finalized,5,8/15/15 1:06,"



",yes_direct,1,,D012643,"<span class=""chemical"">Selenium</span>",D005313,"<span class=""disease"">fetal death</span>","<span class=""chemical"">Selenium</span> was marginally associated with a reduced risk of low birth weight [relative risk (RR) = 0.71; 95% CI: 0.49, 1.05; P = 0.09] and increased risk of <span class=""disease"">fetal death</span> (RR = 1.58; 95% CI = 0.95, 2.63; P = 0.08), but had no effect on risk of prematurity or small-for-gestational age birth.",,18541571,18541571_D012643_D005313,18541571_6,bcv_sentence_task_befree_3125,,770959054,FALSE,finalized,5,8/14/15 23:23,"


Used as a lame treatment.
",no_relation,1,,D012643,"<span class=""chemical"">selenium</span>",D015658,"<span class=""disease"">HIV disease progression/HIV-infected</span>","Among <span class=""disease"">HIV-infected</span> women from Dar es Salaam, Tanzania, <span class=""chemical"">selenium</span> supplements given during and after pregnancy did not improve <span class=""disease"">HIV disease progression</span> or pregnancy outcomes, but may improve child survival.",,18541571,18541571_D012643_D015658,18541571_9,bcv_sentence_task_befree_3126,,770959055,FALSE,finalized,5,8/14/15 22:06,"



",no_relation,1,,D011794,"<span class=""chemical"">Quercetin</span>",D009369,"<span class=""disease"">tumor</span>","<span class=""chemical"">Quercetin</span> dose-dependently inhibited in vitro lipopolysaccharide-induced <span class=""disease"">tumor</span> necrosis factor-alpha production in the blood of healthy volunteers.",,18549926,18549926_D011794_D009369,18549926_4,bcv_sentence_task_befree_3127,,770959056,FALSE,finalized,5,8/14/15 21:09,"



",no_relation,0.8192,,D011794,"<span class=""chemical"">Quercetin</span>",D009336,"<span class=""disease"">necrosis</span>","<span class=""chemical"">Quercetin</span> dose-dependently inhibited in vitro lipopolysaccharide-induced tumor <span class=""disease"">necrosis</span> factor-alpha production in the blood of healthy volunteers.",,18549926,18549926_D011794_D009336,18549926_4,bcv_sentence_task_befree_3128,,770959057,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D010146,"<span class=""disease"">neuropathic pain</span>","Broad modulation of <span class=""disease"">neuropathic pain</span> states by a selective <span class=""chemical"">estrogen</span> receptor beta agonist.",,18559275,18559275_D004967_D010146,18559275_0,bcv_sentence_task_befree_3129,,770959058,FALSE,finalized,5,8/14/15 21:15,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogens</span>",D010146,"<span class=""disease"">pain</span>","The effects of <span class=""chemical"">estrogens</span> on <span class=""disease"">pain</span> perception remain controversial.",,18559275,18559275_D004967_D010146,18559275_1,bcv_sentence_task_befree_3130,,770959059,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D010146,"<span class=""disease"">pain animal models involving nerve injury or sensitization</span>","ERb-131 a non-steroidal <span class=""chemical"">estrogen</span> receptor beta ligand was evaluated in several <span class=""disease"">pain animal models involving nerve injury or sensitization</span>.",,18559275,18559275_D004967_D010146,18559275_3,bcv_sentence_task_befree_3131,,770959060,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,D002211,"<span class=""chemical"">capsaicin</span>",D020436,"<span class=""disease"">spinal nerve ligation</span>","ERb-131 alleviated tactile hyperalgesia induced by <span class=""chemical"">capsaicin</span>, and reversed tactile allodynia caused by <span class=""disease"">spinal nerve ligation</span> and various chemical insults.",,18559275,18559275_D002211_D020436,18559275_6,bcv_sentence_task_befree_3132,,770959061,FALSE,finalized,5,8/14/15 21:35,"



",yes_direct,0.7959,,D002211,"<span class=""chemical"">capsaicin</span>",D006930,"<span class=""disease"">tactile hyperalgesia/allodynia</span>","ERb-131 alleviated <span class=""disease"">tactile hyperalgesia</span> induced by <span class=""chemical"">capsaicin</span>, and reversed tactile <span class=""disease"">allodynia</span> caused by spinal nerve ligation and various chemical insults.",,18559275,18559275_D002211_D006930,18559275_6,bcv_sentence_task_befree_3133,,770959062,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,D014700,"<span class=""chemical"">verapamil</span>",D001281,"<span class=""disease"">AF</span>","Intravenous beta blockers, <span class=""chemical"">verapamil</span>, or diltiazem may be given to immediately slow a very rapid ventricular rate in <span class=""disease"">AF</span>.",,18562808,18562808_D014700_D001281,18562808_4,bcv_sentence_task_befree_3134,,770959063,FALSE,finalized,5,8/15/15 2:39,"



",no_relation,1,,D004110,"<span class=""chemical"">diltiazem</span>",D001281,"<span class=""disease"">AF</span>","Intravenous beta blockers, verapamil, or <span class=""chemical"">diltiazem</span> may be given to immediately slow a very rapid ventricular rate in <span class=""disease"">AF</span>.",,18562808,18562808_D004110_D001281,18562808_4,bcv_sentence_task_befree_3135,,770959064,FALSE,finalized,5,8/14/15 21:17,"



",no_relation,1,,D014700,"<span class=""chemical"">verapamil</span>",D001281,"<span class=""disease"">AF</span>","An oral beta blocker, <span class=""chemical"">verapamil</span>, or diltiazem should be used in persons with <span class=""disease"">AF</span> if a fast ventricular rate occurs at rest or during exercise despite digoxin.",,18562808,18562808_D014700_D001281,18562808_5,bcv_sentence_task_befree_3136,,770959065,FALSE,finalized,5,8/14/15 23:25,"


Used as treatment.
",no_relation,1,,D004110,"<span class=""chemical"">diltiazem</span>",D001281,"<span class=""disease"">AF</span>","An oral beta blocker, verapamil, or <span class=""chemical"">diltiazem</span> should be used in persons with <span class=""disease"">AF</span> if a fast ventricular rate occurs at rest or during exercise despite digoxin.",,18562808,18562808_D004110_D001281,18562808_5,bcv_sentence_task_befree_3137,,770959066,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,1,,D004077,"<span class=""chemical"">digoxin</span>",D001281,"<span class=""disease"">AF</span>","An oral beta blocker, verapamil, or diltiazem should be used in persons with <span class=""disease"">AF</span> if a fast ventricular rate occurs at rest or during exercise despite <span class=""chemical"">digoxin</span>.",,18562808,18562808_D004077_D001281,18562808_5,bcv_sentence_task_befree_3138,,770959067,FALSE,finalized,5,8/14/15 22:40,"



",no_relation,1,,D000638,"<span class=""chemical"">Amiodarone</span>",D001281,"<span class=""disease"">AF</span>","<span class=""chemical"">Amiodarone</span> may be used in selected patients with symptomatic life-threatening <span class=""disease"">AF</span> refractory to other drugs.",,18562808,18562808_D000638_D001281,18562808_6,bcv_sentence_task_befree_3139,,770959068,FALSE,finalized,5,8/14/15 21:25,"



",no_relation,1,,D004077,"<span class=""chemical"">Digoxin</span>",D001281,"<span class=""disease"">AF</span>","<span class=""chemical"">Digoxin</span> should not be used to treat patients with paroxysmal <span class=""disease"">AF</span>.",,18562808,18562808_D004077_D001281,18562808_7,bcv_sentence_task_befree_3140,,770959069,FALSE,finalized,5,8/15/15 1:52,"



",yes_direct,0.6086,,D034261,"<span class=""chemical"">epothilones</span>",D010523,"<span class=""disease"">peripheral neuropathy</span>","Microtubule inhibitor (MTI)-based chemotherapies used in the treatment of breast cancer--including vinca alkaloids, taxanes, and <span class=""chemical"">epothilones</span>--are known to be associated with <span class=""disease"">peripheral neuropathy</span>.",,18567992,18567992_D034261_D010523,18567992_1,bcv_sentence_task_befree_3141,,770959070,FALSE,finalized,5,8/14/15 21:24,"



",yes_direct,0.8026,,D043823,"<span class=""chemical"">taxanes</span>",D010523,"<span class=""disease"">peripheral neuropathy</span>","Microtubule inhibitor (MTI)-based chemotherapies used in the treatment of breast cancer--including vinca alkaloids, <span class=""chemical"">taxanes</span>, and epothilones--are known to be associated with <span class=""disease"">peripheral neuropathy</span>.",,18567992,18567992_D043823_D010523,18567992_1,bcv_sentence_task_befree_3142,,770959071,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,D014748,"<span class=""chemical"">vinca alkaloids</span>",D009369,"<span class=""disease"">breast cancer</span>","Microtubule inhibitor (MTI)-based chemotherapies used in the treatment of <span class=""disease"">breast cancer</span>--including <span class=""chemical"">vinca alkaloids</span>, taxanes, and epothilones--are known to be associated with peripheral neuropathy.",,18567992,18567992_D014748_D009369,18567992_1,bcv_sentence_task_befree_3143,,770959072,FALSE,finalized,5,8/15/15 1:20,"



",no_relation,1,,D043823,"<span class=""chemical"">taxanes</span>",D009369,"<span class=""disease"">breast cancer</span>","Microtubule inhibitor (MTI)-based chemotherapies used in the treatment of <span class=""disease"">breast cancer</span>--including vinca alkaloids, <span class=""chemical"">taxanes</span>, and epothilones--are known to be associated with peripheral neuropathy.",,18567992,18567992_D043823_D009369,18567992_1,bcv_sentence_task_befree_3144,,770959073,FALSE,finalized,5,8/14/15 23:10,"



",no_relation,1,,D034261,"<span class=""chemical"">epothilones</span>",D009369,"<span class=""disease"">breast cancer</span>","Microtubule inhibitor (MTI)-based chemotherapies used in the treatment of <span class=""disease"">breast cancer</span>--including vinca alkaloids, taxanes, and <span class=""chemical"">epothilones</span>--are known to be associated with peripheral neuropathy.",,18567992,18567992_D034261_D009369,18567992_1,bcv_sentence_task_befree_3145,,770959074,FALSE,finalized,5,8/14/15 23:31,"



",yes_direct,1,,D014748,"<span class=""chemical"">vinca alkaloids</span>",D010523,"<span class=""disease"">peripheral neuropathy</span>","Microtubule inhibitor (MTI)-based chemotherapies used in the treatment of breast cancer--including <span class=""chemical"">vinca alkaloids</span>, taxanes, and epothilones--are known to be associated with <span class=""disease"">peripheral neuropathy</span>.",,18567992,18567992_D014748_D010523,18567992_1,bcv_sentence_task_befree_3146,,770959075,FALSE,finalized,5,8/14/15 23:34,"



",yes_direct,1,,D014750,"<span class=""chemical"">vincristine</span>",D015417,"<span class=""disease"">sensory/motor neuropathy</span>","Although some first-generation vinca alkaloids, such as <span class=""chemical"">vincristine</span>, were associated with severe mixed <span class=""disease"">sensory/motor neuropathy</span>, the deficits associated with newer agents in this class (eg, vinflunine) are generally milder and limited to distal sensory signs and symptoms.",,18567992,18567992_D014750_D015417,18567992_3,bcv_sentence_task_befree_3147,,770959076,FALSE,finalized,5,8/15/15 1:51,"



",no_relation,0.5916,,C111217,"<span class=""chemical"">vinflunine</span>",D015417,"<span class=""disease"">sensory/motor neuropathy</span>","Although some first-generation vinca alkaloids, such as vincristine, were associated with severe mixed <span class=""disease"">sensory/motor neuropathy</span>, the deficits associated with newer agents in this class (eg, <span class=""chemical"">vinflunine</span>) are generally milder and limited to distal sensory signs and symptoms.",,18567992,18567992_C111217_D015417,18567992_3,bcv_sentence_task_befree_3148,,770959077,FALSE,finalized,5,8/14/15 21:54,"



",yes_direct,1,,D034261,"<span class=""chemical"">Epothilones</span>",D010523,"<span class=""disease"">peripheral neuropathy</span>","<span class=""chemical"">Epothilones</span>, a new class of MTI, may be associated with grade 3/4 <span class=""disease"">peripheral neuropathy</span>; however, the neuropathy associated with ixabepilone, a novel epothilone B analog, is generally mild to moderate and reversible to baseline or grade 1 levels.",,18567992,18567992_D034261_D010523,18567992_5,bcv_sentence_task_befree_3149,,770959078,FALSE,finalized,5,8/14/15 21:16,"



",yes_direct,0.5983,,C093788,"<span class=""chemical"">epothilone B</span>",D001167,"<span class=""disease"">neuropathy</span>","Epothilones, a new class of MTI, may be associated with grade 3/4 peripheral neuropathy; however, the <span class=""disease"">neuropathy</span> associated with ixabepilone, a novel <span class=""chemical"">epothilone B</span> analog, is generally mild to moderate and reversible to baseline or grade 1 levels.",,18567992,18567992_C093788_D001167,18567992_5,bcv_sentence_task_befree_3150,,770959079,FALSE,finalized,5,8/15/15 0:41,"



",yes_direct,0.8199,,C430592,"<span class=""chemical"">ixabepilone</span>",D010523,"<span class=""disease"">peripheral neuropathy</span>","Epothilones, a new class of MTI, may be associated with grade 3/4 <span class=""disease"">peripheral neuropathy</span>; however, the neuropathy associated with <span class=""chemical"">ixabepilone</span>, a novel epothilone B analog, is generally mild to moderate and reversible to baseline or grade 1 levels.",,18567992,18567992_C430592_D010523,18567992_5,bcv_sentence_task_befree_3151,,770959080,FALSE,finalized,5,8/15/15 1:52,"



",yes_direct,0.7976,,D034261,"<span class=""chemical"">Epothilones</span>",D001167,"<span class=""disease"">neuropathy</span>","<span class=""chemical"">Epothilones</span>, a new class of MTI, may be associated with grade 3/4 peripheral neuropathy; however, the <span class=""disease"">neuropathy</span> associated with ixabepilone, a novel epothilone B analog, is generally mild to moderate and reversible to baseline or grade 1 levels.",,18567992,18567992_D034261_D001167,18567992_5,bcv_sentence_task_befree_3152,,770959081,FALSE,finalized,5,8/14/15 23:48,"



",yes_direct,1,,C430592,"<span class=""chemical"">ixabepilone</span>",D001167,"<span class=""disease"">neuropathy</span>","Epothilones, a new class of MTI, may be associated with grade 3/4 peripheral neuropathy; however, the <span class=""disease"">neuropathy</span> associated with <span class=""chemical"">ixabepilone</span>, a novel epothilone B analog, is generally mild to moderate and reversible to baseline or grade 1 levels.",,18567992,18567992_C430592_D001167,18567992_5,bcv_sentence_task_befree_3153,,770959082,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,0.5861,,C093788,"<span class=""chemical"">epothilone B</span>",D010523,"<span class=""disease"">peripheral neuropathy</span>","Epothilones, a new class of MTI, may be associated with grade 3/4 <span class=""disease"">peripheral neuropathy</span>; however, the neuropathy associated with ixabepilone, a novel <span class=""chemical"">epothilone B</span> analog, is generally mild to moderate and reversible to baseline or grade 1 levels.",,18567992,18567992_C093788_D010523,18567992_5,bcv_sentence_task_befree_3154,,770959083,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,0.7912,,D043823,"<span class=""chemical"">taxanes</span>",D020258,"<span class=""disease"">neurotoxicities</span>","This article provides an overview of the incidence, characteristics, and management of MTI-associated <span class=""disease"">neurotoxicities</span> for known vinca alkaloids and <span class=""chemical"">taxanes</span>, as well as newer agents, such as vinflunine and ixabepilone.",,18567992,18567992_D043823_D020258,18567992_7,bcv_sentence_task_befree_3155,,770959084,FALSE,finalized,5,8/14/15 22:03,"



",yes_direct,0.6274,,C111217,"<span class=""chemical"">vinflunine</span>",D020258,"<span class=""disease"">neurotoxicities</span>","This article provides an overview of the incidence, characteristics, and management of MTI-associated <span class=""disease"">neurotoxicities</span> for known vinca alkaloids and taxanes, as well as newer agents, such as <span class=""chemical"">vinflunine</span> and ixabepilone.",,18567992,18567992_C111217_D020258,18567992_7,bcv_sentence_task_befree_3156,,770959085,FALSE,finalized,5,8/15/15 2:25,"



",no_relation,1,,D014748,"<span class=""chemical"">vinca alkaloids</span>",D020258,"<span class=""disease"">neurotoxicities</span>","This article provides an overview of the incidence, characteristics, and management of MTI-associated <span class=""disease"">neurotoxicities</span> for known <span class=""chemical"">vinca alkaloids</span> and taxanes, as well as newer agents, such as vinflunine and ixabepilone.",,18567992,18567992_D014748_D020258,18567992_7,bcv_sentence_task_befree_3157,,770959086,FALSE,finalized,5,8/15/15 0:00,"



",yes_direct,0.6012,,C430592,"<span class=""chemical"">ixabepilone</span>",D020258,"<span class=""disease"">neurotoxicities</span>","This article provides an overview of the incidence, characteristics, and management of MTI-associated <span class=""disease"">neurotoxicities</span> for known vinca alkaloids and taxanes, as well as newer agents, such as vinflunine and <span class=""chemical"">ixabepilone</span>.",,18567992,18567992_C430592_D020258,18567992_7,bcv_sentence_task_befree_3158,,770959087,FALSE,finalized,5,8/14/15 23:54,"



",yes_direct,0.7974,,C535053,"<span class=""chemical"">AEG40730</span>",D015431,"<span class=""disease"">dramatic reduction</span>","We demonstrate that <span class=""chemical"">AEG40730</span>, a compound modeled on BIR-binding tetrapeptides, binds to cIAP1 and cIAP2, facilitates their autoubiquitination and proteosomal degradation, and causes a <span class=""disease"">dramatic reduction</span> in RIP1 ubiquitination.",,18570872,18570872_C535053_D015431,18570872_3,bcv_sentence_task_befree_3159,,770959088,FALSE,finalized,5,8/14/15 21:18,"



",no_relation,1,,C055162,"<span class=""chemical"">clopidogrel</span>",D009203,"<span class=""disease"">STEMI</span>","Long-term cost-effectiveness of <span class=""chemical"">clopidogrel</span> in <span class=""disease"">STEMI</span> patients.",,18586338,18586338_C055162_D009203,18586338_0,bcv_sentence_task_befree_3160,,770959089,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,1,,C055162,"<span class=""chemical"">clopidogrel</span>",D020521,"<span class=""disease"">stroke</span>","The COMMIT trial demonstrated that <span class=""chemical"">clopidogrel</span> produced a 9% relative reduction in death, reinfarction or <span class=""disease"">stroke</span> (9.2% vs. 10.1%, 95% CI: 0.86-0.97) in ST-elevated myocardial infarction (STEMI) patients.",,18586338,18586338_C055162_D020521,18586338_1,bcv_sentence_task_befree_3161,,770959090,FALSE,finalized,5,8/15/15 1:51,"



",no_relation,1,,C055162,"<span class=""chemical"">clopidogrel</span>",D009203,"<span class=""disease"">ST-elevated myocardial infarction/STEMI</span>","The COMMIT trial demonstrated that <span class=""chemical"">clopidogrel</span> produced a 9% relative reduction in death, reinfarction or stroke (9.2% vs. 10.1%, 95% CI: 0.86-0.97) in <span class=""disease"">ST-elevated myocardial infarction</span> (<span class=""disease"">STEMI</span>) patients.",,18586338,18586338_C055162_D009203,18586338_1,bcv_sentence_task_befree_3162,,770959091,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,0.8001,,C055162,"<span class=""chemical"">clopidogrel</span>",D003643,"<span class=""disease"">death</span>","The COMMIT trial demonstrated that <span class=""chemical"">clopidogrel</span> produced a 9% relative reduction in <span class=""disease"">death</span>, reinfarction or stroke (9.2% vs. 10.1%, 95% CI: 0.86-0.97) in ST-elevated myocardial infarction (STEMI) patients.",,18586338,18586338_C055162_D003643,18586338_1,bcv_sentence_task_befree_3163,,770959092,FALSE,finalized,5,8/14/15 22:29,"



",no_relation,1,,C055162,"<span class=""chemical"">clopidogrel</span>",D009203,"<span class=""disease"">STEMI</span>","Between 08/1999 and 05/2005, 45,852 <span class=""disease"">STEMI</span> patients were randomized to <span class=""chemical"">clopidogrel</span> (n=22,961) or matching placebo (n=22,891) in addition to aspirin.",,18586338,18586338_C055162_D009203,18586338_2,bcv_sentence_task_befree_3164,,770959093,FALSE,finalized,5,8/15/15 0:57,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D009203,"<span class=""disease"">STEMI</span>","Between 08/1999 and 05/2005, 45,852 <span class=""disease"">STEMI</span> patients were randomized to clopidogrel (n=22,961) or matching placebo (n=22,891) in addition to <span class=""chemical"">aspirin</span>.",,18586338,18586338_D001241_D009203,18586338_2,bcv_sentence_task_befree_3165,,770959094,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,C055162,"<span class=""chemical"">clopidogrel</span>",D009203,"<span class=""disease"">STEMI</span>","Addition of <span class=""chemical"">clopidogrel</span> to aspirin, given up to 1 year, in the setting of <span class=""disease"">STEMI</span> is a highly cost-effective strategy.",,18586338,18586338_C055162_D009203,18586338_12,bcv_sentence_task_befree_3166,,770959095,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D009203,"<span class=""disease"">STEMI</span>","Addition of clopidogrel to <span class=""chemical"">aspirin</span>, given up to 1 year, in the setting of <span class=""disease"">STEMI</span> is a highly cost-effective strategy.",,18586338,18586338_D001241_D009203,18586338_12,bcv_sentence_task_befree_3167,,770959096,FALSE,finalized,5,8/14/15 21:36,"



",yes_direct,0.7902,,D008774,"<span class=""chemical"">methylphenidate</span>",D006816,"<span class=""disease"">Juvenile Huntington disease</span>","<span class=""disease"">Juvenile Huntington disease</span> exacerbated by <span class=""chemical"">methylphenidate</span>: case report.",,18658080,18658080_D008774_D006816,18658080_0,bcv_sentence_task_befree_3168,,770959097,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,1,,D008774,"<span class=""chemical"">methylphenidate</span>",D001289,"<span class=""disease"">attention-deficit hyperactivity disorder/ADHD</span>","The authors describe the case of an 8-year-old boy, otherwise healthy, who presented with symptoms consistent with <span class=""disease"">attention-deficit hyperactivity disorder</span> (<span class=""disease"">ADHD</span>) and was started on a trial of <span class=""chemical"">methylphenidate</span>.",,18658080,18658080_D008774_D001289,18658080_1,bcv_sentence_task_befree_3169,,770959098,FALSE,finalized,5,8/15/15 1:53,"



",yes_direct,0.6181,,D004967,"<span class=""chemical"">estrogen</span>",D009369,"<span class=""disease"">breast cancer</span>","After EPHT recruited in 1999-2001 the Women's Health Initiative (WHI) in the USA decided to stop the <span class=""chemical"">estrogen</span>-progestin trial after a mean of 5.2 years in July 2002 because of increased risk of <span class=""disease"">breast cancer</span> and later in 2004 the <span class=""chemical"">estrogen</span>-only trial because HT increased the risk of stroke, decreased the risk of hip fracture, and did not affect coronary heart disease incidence.",,18673555,18673555_D004967_D009369,18673555_5,bcv_sentence_task_befree_3170,,770959099,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D003327,"<span class=""disease"">coronary heart disease</span>","After EPHT recruited in 1999-2001 the Women's Health Initiative (WHI) in the USA decided to stop the <span class=""chemical"">estrogen</span>-progestin trial after a mean of 5.2 years in July 2002 because of increased risk of breast cancer and later in 2004 the <span class=""chemical"">estrogen</span>-only trial because HT increased the risk of stroke, decreased the risk of hip fracture, and did not affect <span class=""disease"">coronary heart disease</span> incidence.",,18673555,18673555_D004967_D003327,18673555_5,bcv_sentence_task_befree_3171,,770959100,FALSE,finalized,5,8/14/15 21:32,"



",yes_direct,1,,D004967,"<span class=""chemical"">estrogen</span>",D020521,"<span class=""disease"">stroke</span>","After EPHT recruited in 1999-2001 the Women's Health Initiative (WHI) in the USA decided to stop the <span class=""chemical"">estrogen</span>-progestin trial after a mean of 5.2 years in July 2002 because of increased risk of breast cancer and later in 2004 the <span class=""chemical"">estrogen</span>-only trial because HT increased the risk of <span class=""disease"">stroke</span>, decreased the risk of hip fracture, and did not affect coronary heart disease incidence.",,18673555,18673555_D004967_D020521,18673555_5,bcv_sentence_task_befree_3172,,770959101,FALSE,finalized,5,8/15/15 1:26,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D006620,"<span class=""disease"">hip fracture</span>","After EPHT recruited in 1999-2001 the Women's Health Initiative (WHI) in the USA decided to stop the <span class=""chemical"">estrogen</span>-progestin trial after a mean of 5.2 years in July 2002 because of increased risk of breast cancer and later in 2004 the <span class=""chemical"">estrogen</span>-only trial because HT increased the risk of stroke, decreased the risk of <span class=""disease"">hip fracture</span>, and did not affect coronary heart disease incidence.",,18673555,18673555_D004967_D006620,18673555_5,bcv_sentence_task_befree_3173,,770959102,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,D013256,"<span class=""chemical"">steroids</span>",D029424,"<span class=""disease"">COPD</span>","In addition, high doses of <span class=""chemical"">steroids</span> have a minimal effect on the inexorable decline in lung function in <span class=""disease"">COPD</span> patients and only a small effect on reducing exacerbations.",,18682458,18682458_D013256_D029424,18682458_3,bcv_sentence_task_befree_3174,,770959103,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,D002725,"<span class=""chemical"">chloroform</span>",D008223,"<span class=""disease"">glycoprotein of mouse lymphoma</span>","In the present work, extracts of 12 selected herbs were prepared with methanol, <span class=""chemical"">chloroform</span>, ethyl acetate and water, and the effects of these on the multidrug resistance (MDR) and P-<span class=""disease"">glycoprotein of mouse lymphoma</span> cells transfected with the human mdr1 gene and on a human lung alveolar epithelial cell line were investigated.",,18690658,18690658_D002725_D008223,18690658_2,bcv_sentence_task_befree_3175,,770959104,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,1,,D000432,"<span class=""chemical"">methanol</span>",D008223,"<span class=""disease"">glycoprotein of mouse lymphoma</span>","In the present work, extracts of 12 selected herbs were prepared with <span class=""chemical"">methanol</span>, chloroform, ethyl acetate and water, and the effects of these on the multidrug resistance (MDR) and P-<span class=""disease"">glycoprotein of mouse lymphoma</span> cells transfected with the human mdr1 gene and on a human lung alveolar epithelial cell line were investigated.",,18690658,18690658_D000432_D008223,18690658_2,bcv_sentence_task_befree_3176,,770959105,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,C007650,"<span class=""chemical"">ethyl acetate</span>",D008223,"<span class=""disease"">glycoprotein of mouse lymphoma</span>","In the present work, extracts of 12 selected herbs were prepared with methanol, chloroform, <span class=""chemical"">ethyl acetate</span> and water, and the effects of these on the multidrug resistance (MDR) and P-<span class=""disease"">glycoprotein of mouse lymphoma</span> cells transfected with the human mdr1 gene and on a human lung alveolar epithelial cell line were investigated.",,18690658,18690658_C007650_D008223,18690658_2,bcv_sentence_task_befree_3177,,770959106,FALSE,finalized,5,8/14/15 23:44,"



",no_relation,0.7889,,D002725,"<span class=""chemical"">chloroform</span>",D008175,"<span class=""disease"">lung cancer</span>","The possible chemopreventive effect of the <span class=""chemical"">chloroform</span> extracts was studied on the expression of cytomegalovirus (CMV) immediate-early (IE) antigen in human <span class=""disease"">lung cancer</span> cells (A549).",,18690658,18690658_D002725_D008175,18690658_4,bcv_sentence_task_befree_3178,,770959107,FALSE,finalized,5,8/15/15 0:28,"



",no_relation,1,,D002725,"<span class=""chemical"">chloroform</span>",D008223,"<span class=""disease"">MDR mouse lymphoma</span>","Two of the <span class=""chemical"">chloroform</span> extracts enhanced the antiproliferative effect of doxorubicin on <span class=""disease"">MDR mouse lymphoma</span> cells.",,18690658,18690658_D002725_D008223,18690658_7,bcv_sentence_task_befree_3179,,770959108,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,D004317,"<span class=""chemical"">doxorubicin</span>",D008223,"<span class=""disease"">MDR mouse lymphoma</span>","Two of the chloroform extracts enhanced the antiproliferative effect of <span class=""chemical"">doxorubicin</span> on <span class=""disease"">MDR mouse lymphoma</span> cells.",,18690658,18690658_D004317_D008223,18690658_7,bcv_sentence_task_befree_3180,,770959109,FALSE,finalized,5,8/14/15 23:16,"


It's the mutation that causes the hyperthermia
",no_relation,0.6206,,D012433,"<span class=""chemical"">ryanodine</span>",D008305,"<span class=""disease"">malignant hyperthermia</span>","Novel <span class=""chemical"">ryanodine</span> receptor mutation that may cause <span class=""disease"">malignant hyperthermia</span>.",,18719443,18719443_D012433_D008305,18719443_0,bcv_sentence_task_befree_3181,,770959110,FALSE,finalized,5,8/14/15 21:42,"



",yes_direct,0.7979,,D002118,"<span class=""chemical"">Ca</span>",D008305,"<span class=""disease"">Malignant hyperthermia/MH</span>","<span class=""disease"">Malignant hyperthermia</span> (<span class=""disease"">MH</span>) is a hypermetabolic condition caused by a genetic disposition leading to increased <span class=""chemical"">Ca</span> release from the sarcoplasmic reticulum after exposure to triggering agents.",,18719443,18719443_D002118_D008305,18719443_1,bcv_sentence_task_befree_3182,,770959111,FALSE,finalized,5,8/15/15 1:24,"



",no_relation,1,,D012433,"<span class=""chemical"">ryanodine</span>",D008305,"<span class=""disease"">MH</span>","In the authors' ongoing evaluation of patients undergoing <span class=""disease"">MH</span> testing in Austria, they detected a family with a new variant of the <span class=""chemical"">ryanodine</span> receptor 1.",,18719443,18719443_D012433_D008305,18719443_2,bcv_sentence_task_befree_3183,,770959112,FALSE,finalized,5,8/15/15 2:08,"



",no_relation,0.7965,,D011239,"<span class=""chemical"">prednisolone</span>",D011125,"<span class=""disease"">polyposis</span>","Thirty-two patients with nasal <span class=""disease"">polyposis</span> were randomized to unilateral endoscopic sinus surgery after pretreatment with oral <span class=""chemical"">prednisolone</span> for 10 days and nasal budesonide bilaterally for 1 month.",,18720067,18720067_D011239_D011125,18720067_3,bcv_sentence_task_befree_3184,,770959113,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,D019819,"<span class=""chemical"">budesonide</span>",D011125,"<span class=""disease"">polyposis</span>","Thirty-two patients with nasal <span class=""disease"">polyposis</span> were randomized to unilateral endoscopic sinus surgery after pretreatment with oral prednisolone for 10 days and nasal <span class=""chemical"">budesonide</span> bilaterally for 1 month.",,18720067,18720067_D019819_D011125,18720067_3,bcv_sentence_task_befree_3185,,770959114,FALSE,finalized,5,8/15/15 0:10,"



",no_relation,1,,D019344,"<span class=""chemical"">lactic acid/lactate</span>",D009336,"<span class=""disease"">necrosis</span>","Concentrations of tumor <span class=""disease"">necrosis</span> factor alpha, interleukin-6, vascular endothelial growth factor, <span class=""chemical"">lactic acid</span>, <span class=""chemical"">lactate</span> dehydrogenase, and HMGB-1 were measured in synovial fluid (SF) samples from patients with inflammatory arthropathy (rheumatoid arthritis and pseudogout) and patients with noninflammatory arthropathy (osteoarthritis).",,18759291,18759291_D019344_D009336,18759291_3,bcv_sentence_task_befree_3186,,770959115,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,1,,D019344,"<span class=""chemical"">lactic acid/lactate</span>",D007249,"<span class=""disease"">inflammatory arthropathy</span>","Concentrations of tumor necrosis factor alpha, interleukin-6, vascular endothelial growth factor, <span class=""chemical"">lactic acid</span>, <span class=""chemical"">lactate</span> dehydrogenase, and HMGB-1 were measured in synovial fluid (SF) samples from patients with <span class=""disease"">inflammatory arthropathy</span> (rheumatoid arthritis and pseudogout) and patients with noninflammatory arthropathy (osteoarthritis).",,18759291,18759291_D019344_D007249,18759291_3,bcv_sentence_task_befree_3187,,770959116,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D019344,"<span class=""chemical"">lactic acid/lactate</span>",D010003,"<span class=""disease"">osteoarthritis</span>","Concentrations of tumor necrosis factor alpha, interleukin-6, vascular endothelial growth factor, <span class=""chemical"">lactic acid</span>, <span class=""chemical"">lactate</span> dehydrogenase, and HMGB-1 were measured in synovial fluid (SF) samples from patients with inflammatory arthropathy (rheumatoid arthritis and pseudogout) and patients with noninflammatory arthropathy (<span class=""disease"">osteoarthritis</span>).",,18759291,18759291_D019344_D010003,18759291_3,bcv_sentence_task_befree_3188,,770959117,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,1,,D019344,"<span class=""chemical"">lactic acid/lactate</span>",D001172,"<span class=""disease"">rheumatoid arthritis</span>","Concentrations of tumor necrosis factor alpha, interleukin-6, vascular endothelial growth factor, <span class=""chemical"">lactic acid</span>, <span class=""chemical"">lactate</span> dehydrogenase, and HMGB-1 were measured in synovial fluid (SF) samples from patients with inflammatory arthropathy (<span class=""disease"">rheumatoid arthritis</span> and pseudogout) and patients with noninflammatory arthropathy (osteoarthritis).",,18759291,18759291_D019344_D001172,18759291_3,bcv_sentence_task_befree_3189,,770959118,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,D019344,"<span class=""chemical"">lactic acid/lactate</span>",D001177,"<span class=""disease"">arthropathy</span>","Concentrations of tumor necrosis factor alpha, interleukin-6, vascular endothelial growth factor, <span class=""chemical"">lactic acid</span>, <span class=""chemical"">lactate</span> dehydrogenase, and HMGB-1 were measured in synovial fluid (SF) samples from patients with inflammatory arthropathy (rheumatoid arthritis and pseudogout) and patients with noninflammatory <span class=""disease"">arthropathy</span> (osteoarthritis).",,18759291,18759291_D019344_D001177,18759291_3,bcv_sentence_task_befree_3190,,770959119,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,D019344,"<span class=""chemical"">lactic acid/lactate</span>",D002805,"<span class=""disease"">pseudogout</span>","Concentrations of tumor necrosis factor alpha, interleukin-6, vascular endothelial growth factor, <span class=""chemical"">lactic acid</span>, <span class=""chemical"">lactate</span> dehydrogenase, and HMGB-1 were measured in synovial fluid (SF) samples from patients with inflammatory arthropathy (rheumatoid arthritis and <span class=""disease"">pseudogout</span>) and patients with noninflammatory arthropathy (osteoarthritis).",,18759291,18759291_D019344_D002805,18759291_3,bcv_sentence_task_befree_3191,,770959120,FALSE,finalized,5,8/14/15 23:13,"



",no_relation,0.4196,,D019344,"<span class=""chemical"">lactic acid</span>",D007249,"<span class=""disease"">inflammatory arthropathy</span>","In SF samples from patients with HMGB-1-associated <span class=""disease"">inflammatory arthropathy</span> (i.e., samples with HMGB-1 levels >2 SD above the mean level in samples from patients with noninflammatory arthropathy), concentrations of HMGB-1 were significantly correlated with those of <span class=""chemical"">lactic acid</span>, a marker of tissue hypoxia.",,18759291,18759291_D019344_D007249,18759291_6,bcv_sentence_task_befree_3192,,770959121,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,0.5947,,D019344,"<span class=""chemical"">lactic acid</span>",D001177,"<span class=""disease"">arthropathy</span>","In SF samples from patients with HMGB-1-associated inflammatory arthropathy (i.e., samples with HMGB-1 levels >2 SD above the mean level in samples from patients with noninflammatory <span class=""disease"">arthropathy</span>), concentrations of HMGB-1 were significantly correlated with those of <span class=""chemical"">lactic acid</span>, a marker of tissue hypoxia.",,18759291,18759291_D019344_D001177,18759291_6,bcv_sentence_task_befree_3193,,770959122,FALSE,finalized,5,8/15/15 0:40,"



",no_relation,0.6084,,D019344,"<span class=""chemical"">lactic acid</span>",D000860,"<span class=""disease"">hypoxia</span>","In SF samples from patients with HMGB-1-associated inflammatory arthropathy (i.e., samples with HMGB-1 levels >2 SD above the mean level in samples from patients with noninflammatory arthropathy), concentrations of HMGB-1 were significantly correlated with those of <span class=""chemical"">lactic acid</span>, a marker of tissue <span class=""disease"">hypoxia</span>.",,18759291,18759291_D019344_D000860,18759291_6,bcv_sentence_task_befree_3194,,770959123,FALSE,finalized,5,8/14/15 21:23,"



",no_relation,1,,D012965,"<span class=""chemical"">sodium chloride</span>",C562889,"<span class=""disease"">nephropathy</span>","Sodium bicarbonate vs <span class=""chemical"">sodium chloride</span> for the prevention of contrast medium-induced <span class=""disease"">nephropathy</span> in patients undergoing coronary angiography: a randomized trial.",,18768415,18768415_D012965_C562889,18768415_0,bcv_sentence_task_befree_3195,,770959124,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,0.8186,,D017693,"<span class=""chemical"">Sodium bicarbonate</span>",C562889,"<span class=""disease"">nephropathy</span>","<span class=""chemical"">Sodium bicarbonate</span> vs sodium chloride for the prevention of contrast medium-induced <span class=""disease"">nephropathy</span> in patients undergoing coronary angiography: a randomized trial.",,18768415,18768415_D017693_C562889,18768415_0,bcv_sentence_task_befree_3196,,770959125,FALSE,finalized,5,8/14/15 21:12,"



",no_relation,1,,D017693,"<span class=""chemical"">Sodium bicarbonate</span>",D051437,"<span class=""disease"">renal failure</span>","<span class=""chemical"">Sodium bicarbonate</span> has been suggested as a possible strategy for prevention of contrast medium-induced nephropathy, a common cause of <span class=""disease"">renal failure</span> associated with prolonged hospitalization, increased health care costs, and substantial morbidity and mortality.",,18768415,18768415_D017693_D051437,18768415_1,bcv_sentence_task_befree_3197,,770959126,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,1,,D017693,"<span class=""chemical"">Sodium bicarbonate</span>",C562889,"<span class=""disease"">nephropathy</span>","<span class=""chemical"">Sodium bicarbonate</span> has been suggested as a possible strategy for prevention of contrast medium-induced <span class=""disease"">nephropathy</span>, a common cause of renal failure associated with prolonged hospitalization, increased health care costs, and substantial morbidity and mortality.",,18768415,18768415_D017693_C562889,18768415_1,bcv_sentence_task_befree_3198,,770959127,FALSE,finalized,5,8/15/15 2:31,"



",no_relation,1,,D012965,"<span class=""chemical"">sodium chloride</span>",C562889,"<span class=""disease"">nephropathy</span>","To determine if sodium bicarbonate is superior to <span class=""chemical"">sodium chloride</span> for preventing contrast medium-induced <span class=""disease"">nephropathy</span> in patients with moderate to severe chronic kidney dysfunction who are undergoing coronary angiography.",,18768415,18768415_D012965_C562889,18768415_2,bcv_sentence_task_befree_3199,,770959128,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,1,,D017693,"<span class=""chemical"">sodium bicarbonate</span>",C562889,"<span class=""disease"">nephropathy</span>","To determine if <span class=""chemical"">sodium bicarbonate</span> is superior to sodium chloride for preventing contrast medium-induced <span class=""disease"">nephropathy</span> in patients with moderate to severe chronic kidney dysfunction who are undergoing coronary angiography.",,18768415,18768415_D017693_C562889,18768415_2,bcv_sentence_task_befree_3200,,770959129,FALSE,finalized,5,8/15/15 0:01,"



",no_relation,1,,D017693,"<span class=""chemical"">sodium bicarbonate</span>",D007674,"<span class=""disease"">kidney dysfunction</span>","To determine if <span class=""chemical"">sodium bicarbonate</span> is superior to sodium chloride for preventing contrast medium-induced nephropathy in patients with moderate to severe chronic <span class=""disease"">kidney dysfunction</span> who are undergoing coronary angiography.",,18768415,18768415_D017693_D007674,18768415_2,bcv_sentence_task_befree_3201,,770959130,FALSE,finalized,5,8/15/15 1:13,"



",no_relation,1,,D012965,"<span class=""chemical"">sodium chloride</span>",D007674,"<span class=""disease"">kidney dysfunction</span>","To determine if sodium bicarbonate is superior to <span class=""chemical"">sodium chloride</span> for preventing contrast medium-induced nephropathy in patients with moderate to severe chronic <span class=""disease"">kidney dysfunction</span> who are undergoing coronary angiography.",,18768415,18768415_D012965_D007674,18768415_2,bcv_sentence_task_befree_3202,,770959131,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,0.8042,,D012965,"<span class=""chemical"">sodium chloride</span>",D003643,"<span class=""disease"">death</span>","In patients randomized to receive sodium bicarbonate vs <span class=""chemical"">sodium chloride</span>, the rates of <span class=""disease"">death</span>, dialysis, myocardial infarction, and cerebrovascular events did not differ significantly at 30 days (1.7% vs 1.7%, 0.6% vs 1.1%, 0.6% vs 0%, and 0% vs 2.2%, respectively) or at 30 days to 6 months (0.6% vs 2.3%, 0.6% vs 1.1%, 0.6% vs 2.3%, and 0.6% vs 1.7%, respectively) (P > .10 for all).",,18768415,18768415_D012965_D003643,18768415_10,bcv_sentence_task_befree_3203,,770959132,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,0.7908,,D017693,"<span class=""chemical"">sodium bicarbonate</span>",D009203,"<span class=""disease"">myocardial infarction</span>","In patients randomized to receive <span class=""chemical"">sodium bicarbonate</span> vs sodium chloride, the rates of death, dialysis, <span class=""disease"">myocardial infarction</span>, and cerebrovascular events did not differ significantly at 30 days (1.7% vs 1.7%, 0.6% vs 1.1%, 0.6% vs 0%, and 0% vs 2.2%, respectively) or at 30 days to 6 months (0.6% vs 2.3%, 0.6% vs 1.1%, 0.6% vs 2.3%, and 0.6% vs 1.7%, respectively) (P > .10 for all).",,18768415,18768415_D017693_D009203,18768415_10,bcv_sentence_task_befree_3204,,770959133,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,1,,D012965,"<span class=""chemical"">sodium chloride</span>",D009203,"<span class=""disease"">myocardial infarction</span>","In patients randomized to receive sodium bicarbonate vs <span class=""chemical"">sodium chloride</span>, the rates of death, dialysis, <span class=""disease"">myocardial infarction</span>, and cerebrovascular events did not differ significantly at 30 days (1.7% vs 1.7%, 0.6% vs 1.1%, 0.6% vs 0%, and 0% vs 2.2%, respectively) or at 30 days to 6 months (0.6% vs 2.3%, 0.6% vs 1.1%, 0.6% vs 2.3%, and 0.6% vs 1.7%, respectively) (P > .10 for all).",,18768415,18768415_D012965_D009203,18768415_10,bcv_sentence_task_befree_3205,,770959134,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,1,,D017693,"<span class=""chemical"">sodium bicarbonate</span>",D003643,"<span class=""disease"">death</span>","In patients randomized to receive <span class=""chemical"">sodium bicarbonate</span> vs sodium chloride, the rates of <span class=""disease"">death</span>, dialysis, myocardial infarction, and cerebrovascular events did not differ significantly at 30 days (1.7% vs 1.7%, 0.6% vs 1.1%, 0.6% vs 0%, and 0% vs 2.2%, respectively) or at 30 days to 6 months (0.6% vs 2.3%, 0.6% vs 1.1%, 0.6% vs 2.3%, and 0.6% vs 1.7%, respectively) (P > .10 for all).",,18768415,18768415_D017693_D003643,18768415_10,bcv_sentence_task_befree_3206,,770959135,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D017693,"<span class=""chemical"">sodium bicarbonate</span>",D051436,"<span class=""disease"">chronic kidney disease</span>","The results of this study do not suggest that hydration with <span class=""chemical"">sodium bicarbonate</span> is superior to hydration with sodium chloride for the prevention of contrast medium-induced nephropathy in patients with moderate to severe <span class=""disease"">chronic kidney disease</span> who are undergoing coronary angiography.",,18768415,18768415_D017693_D051436,18768415_11,bcv_sentence_task_befree_3207,,770959136,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D012965,"<span class=""chemical"">sodium chloride</span>",C562889,"<span class=""disease"">nephropathy</span>","The results of this study do not suggest that hydration with sodium bicarbonate is superior to hydration with <span class=""chemical"">sodium chloride</span> for the prevention of contrast medium-induced <span class=""disease"">nephropathy</span> in patients with moderate to severe chronic kidney disease who are undergoing coronary angiography.",,18768415,18768415_D012965_C562889,18768415_11,bcv_sentence_task_befree_3208,,770959137,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,0.798,,D017693,"<span class=""chemical"">sodium bicarbonate</span>",C562889,"<span class=""disease"">nephropathy</span>","The results of this study do not suggest that hydration with <span class=""chemical"">sodium bicarbonate</span> is superior to hydration with sodium chloride for the prevention of contrast medium-induced <span class=""disease"">nephropathy</span> in patients with moderate to severe chronic kidney disease who are undergoing coronary angiography.",,18768415,18768415_D017693_C562889,18768415_11,bcv_sentence_task_befree_3209,,770959138,FALSE,finalized,5,8/14/15 21:45,"



",no_relation,1,,D012965,"<span class=""chemical"">sodium chloride</span>",D051436,"<span class=""disease"">chronic kidney disease</span>","The results of this study do not suggest that hydration with sodium bicarbonate is superior to hydration with <span class=""chemical"">sodium chloride</span> for the prevention of contrast medium-induced nephropathy in patients with moderate to severe <span class=""disease"">chronic kidney disease</span> who are undergoing coronary angiography.",,18768415,18768415_D012965_D051436,18768415_11,bcv_sentence_task_befree_3210,,770959139,FALSE,finalized,5,8/14/15 21:36,"



",yes_direct,1,,D001241,"<span class=""chemical"">aspirin</span>",D052016,"<span class=""disease"">mucosal defects</span>","Investigation of gastric and duodenal <span class=""disease"">mucosal defects</span> caused by low-dose <span class=""chemical"">aspirin</span> in patients with ischemic heart disease.",,18779739,18779739_D001241_D052016,18779739_0,bcv_sentence_task_befree_3211,,770959140,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D007511,"<span class=""disease"">ischemic heart disease</span>","Investigation of gastric and duodenal mucosal defects caused by low-dose <span class=""chemical"">aspirin</span> in patients with <span class=""disease"">ischemic heart disease</span>.",,18779739,18779739_D001241_D007511,18779739_0,bcv_sentence_task_befree_3212,,770959141,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D007511,"<span class=""disease"">ischemic cerebrovascular disease/ischemic heart disease</span>","Low-dose <span class=""chemical"">aspirin</span> is used for secondary prevention of <span class=""disease"">ischemic heart disease</span> and <span class=""disease"">ischemic cerebrovascular disease</span>.",,18779739,18779739_D001241_D007511,18779739_1,bcv_sentence_task_befree_3213,,770959142,FALSE,finalized,5,8/15/15 0:14,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D005767,"<span class=""disease"">gastrointestinal disorder</span>","Currently, the frequency of <span class=""disease"">gastrointestinal disorder</span> among users of low-dose <span class=""chemical"">aspirin</span> is unknown.",,18779739,18779739_D001241_D005767,18779739_2,bcv_sentence_task_befree_3214,,770959143,FALSE,finalized,5,8/15/15 2:18,"



",yes_direct,0.8178,,D001241,"<span class=""chemical"">aspirin</span>",D010437,"<span class=""disease"">gastroduodenal disorder</span>","To investigate through endoscopic examination the frequency of <span class=""disease"">gastroduodenal disorder</span> associated with buffered and enteric-coated <span class=""chemical"">aspirin</span> (ECA).",,18779739,18779739_D001241_D010437,18779739_3,bcv_sentence_task_befree_3215,,770959144,FALSE,finalized,5,8/15/15 1:22,"



",no_relation,0.5869,,D001241,"<span class=""chemical"">aspirin</span>",D052016,"<span class=""disease"">mucosal defects</span>","There were significantly more <span class=""disease"">mucosal defects</span> among users of low-dose <span class=""chemical"">aspirin</span> than among those using no <span class=""chemical"">aspirin</span> (P<0.0001).",,18779739,18779739_D001241_D052016,18779739_7,bcv_sentence_task_befree_3216,,770959145,FALSE,finalized,5,8/14/15 23:50,"



",yes_direct,0.5936,,D001241,"<span class=""chemical"">aspirin</span>",D052016,"<span class=""disease"">mucosal defects</span>","Mucosal defects were found in 54 of 98 (60.7%) users of buffered <span class=""chemical"">aspirin</span> (BA), whereas 38 of 101 (37.6%) users of ECA had <span class=""disease"">mucosal defects</span>.",,18779739,18779739_D001241_D052016,18779739_8,bcv_sentence_task_befree_3217,,770959146,FALSE,finalized,5,8/15/15 0:40,"



",yes_direct,0.8001,,D001241,"<span class=""chemical"">aspirin</span>",D010437,"<span class=""disease"">gastroduodenal disorder</span>","As endoscopy frequently reveals <span class=""disease"">gastroduodenal disorder</span> among low-dose <span class=""chemical"">aspirin</span> users, both administration of BA and of enteric-coated <span class=""chemical"">aspirin</span> warrant concern for gastroduodenal ulcer.",,18779739,18779739_D001241_D010437,18779739_11,bcv_sentence_task_befree_3218,,770959147,FALSE,finalized,5,8/14/15 21:08,"



",yes_direct,1,,D001241,"<span class=""chemical"">aspirin</span>",D014456,"<span class=""disease"">ulcer</span>","As endoscopy frequently reveals gastroduodenal disorder among low-dose <span class=""chemical"">aspirin</span> users, both administration of BA and of enteric-coated <span class=""chemical"">aspirin</span> warrant concern for gastroduodenal <span class=""disease"">ulcer</span>.",,18779739,18779739_D001241_D014456,18779739_11,bcv_sentence_task_befree_3219,,770959148,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,1,,D000305,"<span class=""chemical"">Corticosteroids</span>",D003715,"<span class=""disease"">dengue illness</span>","<span class=""chemical"">Corticosteroids</span> in the treatment of <span class=""disease"">dengue illness</span>.",,18789467,18789467_D000305_D003715,18789467_0,bcv_sentence_task_befree_3220,,770959149,FALSE,finalized,5,8/14/15 21:10,"



",no_relation,0.7975,,D000305,"<span class=""chemical"">corticosteroids</span>",D013921,"<span class=""disease"">thrombocytopenia</span>","Studies so far have only been in patients with shock syndrome, and the possible effects of <span class=""chemical"">corticosteroids</span> on <span class=""disease"">thrombocytopenia</span> and bleeding as well as other complications of dengue are unknown.",,18789467,18789467_D000305_D013921,18789467_5,bcv_sentence_task_befree_3221,,770959150,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D012769,"<span class=""disease"">shock syndrome</span>","Studies so far have only been in patients with <span class=""disease"">shock syndrome</span>, and the possible effects of <span class=""chemical"">corticosteroids</span> on thrombocytopenia and bleeding as well as other complications of dengue are unknown.",,18789467,18789467_D000305_D012769,18789467_5,bcv_sentence_task_befree_3222,,770959151,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,0.5903,,D000305,"<span class=""chemical"">corticosteroids</span>",D006470,"<span class=""disease"">bleeding</span>","Studies so far have only been in patients with shock syndrome, and the possible effects of <span class=""chemical"">corticosteroids</span> on thrombocytopenia and <span class=""disease"">bleeding</span> as well as other complications of dengue are unknown.",,18789467,18789467_D000305_D006470,18789467_5,bcv_sentence_task_befree_3223,,770959152,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroid</span>",D003715,"<span class=""disease"">dengue infection</span>","All previous studies have been in children; the effect of <span class=""chemical"">corticosteroid</span> treatment in adults with <span class=""disease"">dengue infection</span> has not been evaluated.",,18789467,18789467_D000305_D003715,18789467_6,bcv_sentence_task_befree_3224,,770959153,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D003715,"<span class=""disease"">dengue infection</span>","The possible beneficial effects of <span class=""chemical"">corticosteroids</span> on the various manifestations of <span class=""disease"">dengue infection</span> need evaluation by adequately powered, well designed, randomised controlled trials.",,18789467,18789467_D000305_D003715,18789467_7,bcv_sentence_task_befree_3225,,770959154,FALSE,finalized,5,8/14/15 22:24,"



",no_relation,0.804,,C037663,"<span class=""chemical"">ropivacaine</span>",D000699,"<span class=""disease"">analgesia</span>","Comparison of three different concentrations of <span class=""chemical"">ropivacaine</span> for postoperative patient-controlled thoracic epidural <span class=""disease"">analgesia</span> after upper abdominal surgery.",,18809519,18809519_C037663_D000699,18809519_0,bcv_sentence_task_befree_3226,,770959155,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,1,,C037663,"<span class=""chemical"">ropivacaine</span>",D000699,"<span class=""disease"">analgesia</span>","Previous studies have reported the comparable efficacy of <span class=""chemical"">ropivacaine</span>/fentanyl for patient-controlled epidural <span class=""disease"">analgesia</span> (PCEA).",,18809519,18809519_C037663_D000699,18809519_1,bcv_sentence_task_befree_3227,,770959156,FALSE,finalized,5,8/14/15 21:30,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D000699,"<span class=""disease"">analgesia</span>","Previous studies have reported the comparable efficacy of ropivacaine/<span class=""chemical"">fentanyl</span> for patient-controlled epidural <span class=""disease"">analgesia</span> (PCEA).",,18809519,18809519_D005283_D000699,18809519_1,bcv_sentence_task_befree_3228,,770959157,FALSE,finalized,5,8/15/15 0:14,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D010146,"<span class=""disease"">pain</span>","In addition to comparing the analgesic effects and the incidence of motor block and opioid-related side effects of these three different ropivacaine/<span class=""chemical"">fentanyl</span> solutions, we also evaluated the workload of our <span class=""disease"">pain</span> staff.",,18809519,18809519_D005283_D010146,18809519_4,bcv_sentence_task_befree_3229,,770959158,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,C037663,"<span class=""chemical"">ropivacaine</span>",D010146,"<span class=""disease"">pain</span>","In addition to comparing the analgesic effects and the incidence of motor block and opioid-related side effects of these three different <span class=""chemical"">ropivacaine</span>/fentanyl solutions, we also evaluated the workload of our <span class=""disease"">pain</span> staff.",,18809519,18809519_C037663_D010146,18809519_4,bcv_sentence_task_befree_3230,,770959159,FALSE,finalized,5,8/15/15 1:21,"



",no_relation,1,,C037663,"<span class=""chemical"">ropivacaine</span>",D010146,"<span class=""disease"">pain</span>","The main purpose of our study was to determine which of these three regimens of <span class=""chemical"">ropivacaine</span> was most satisfactory with the least workload for the <span class=""disease"">pain</span> service staff.",,18809519,18809519_C037663_D010146,18809519_5,bcv_sentence_task_befree_3231,,770959160,FALSE,finalized,5,8/15/15 2:09,"



",no_relation,1,,D005283,"<span class=""chemical"">fentanyl</span>",D010146,"<span class=""disease"">postoperative pain</span>","Both thoracic epidural 0.15% and 0.2% ropivacaine provide effective <span class=""disease"">postoperative pain</span> control in combination with <span class=""chemical"">fentanyl</span> without motor block.",,18809519,18809519_D005283_D010146,18809519_16,bcv_sentence_task_befree_3232,,770959161,FALSE,finalized,5,8/15/15 0:22,"



",no_relation,0.7961,,C037663,"<span class=""chemical"">ropivacaine</span>",D010146,"<span class=""disease"">postoperative pain</span>","Both thoracic epidural 0.15% and 0.2% <span class=""chemical"">ropivacaine</span> provide effective <span class=""disease"">postoperative pain</span> control in combination with fentanyl without motor block.",,18809519,18809519_C037663_D010146,18809519_16,bcv_sentence_task_befree_3233,,770959162,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,0.8299,,D002945,"<span class=""chemical"">Cisplatin</span>",D002289,"<span class=""disease"">non-small-cell lung cancer</span>","<span class=""chemical"">Cisplatin</span> and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III <span class=""disease"">non-small-cell lung cancer</span>.",,18818921,18818921_D002945_D002289,18818921_0,bcv_sentence_task_befree_3234,,770959163,FALSE,finalized,5,8/14/15 21:11,"



",no_relation,1,,C067311,"<span class=""chemical"">docetaxel</span>",D002289,"<span class=""disease"">non-small-cell lung cancer</span>","Cisplatin and weekly <span class=""chemical"">docetaxel</span> with concurrent thoracic radiotherapy for locally advanced stage III <span class=""disease"">non-small-cell lung cancer</span>.",,18818921,18818921_C067311_D002289,18818921_0,bcv_sentence_task_befree_3235,,770959164,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D002289,"<span class=""disease"">non-small-cell lung cancer/NSCLC</span>","Our objective was to assess the efficacy and toxicity of concurrent chemoradiotherapy with <span class=""chemical"">cisplatin</span> + weekly divided-dose docetaxel in patients with stage III <span class=""disease"">non-small-cell lung cancer</span> (<span class=""disease"">NSCLC</span>).",,18818921,18818921_D002945_D002289,18818921_1,bcv_sentence_task_befree_3236,,770959165,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,0.7818,,C067311,"<span class=""chemical"">docetaxel</span>",D064420,"<span class=""disease"">toxicity</span>","Our objective was to assess the efficacy and <span class=""disease"">toxicity</span> of concurrent chemoradiotherapy with cisplatin + weekly divided-dose <span class=""chemical"">docetaxel</span> in patients with stage III non-small-cell lung cancer (NSCLC).",,18818921,18818921_C067311_D064420,18818921_1,bcv_sentence_task_befree_3237,,770959166,FALSE,finalized,5,8/15/15 2:19,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D064420,"<span class=""disease"">toxicity</span>","Our objective was to assess the efficacy and <span class=""disease"">toxicity</span> of concurrent chemoradiotherapy with <span class=""chemical"">cisplatin</span> + weekly divided-dose docetaxel in patients with stage III non-small-cell lung cancer (NSCLC).",,18818921,18818921_D002945_D064420,18818921_1,bcv_sentence_task_befree_3238,,770959167,FALSE,finalized,5,8/14/15 23:32,"



",no_relation,1,,C067311,"<span class=""chemical"">docetaxel</span>",D002289,"<span class=""disease"">non-small-cell lung cancer/NSCLC</span>","Our objective was to assess the efficacy and toxicity of concurrent chemoradiotherapy with cisplatin + weekly divided-dose <span class=""chemical"">docetaxel</span> in patients with stage III <span class=""disease"">non-small-cell lung cancer</span> (<span class=""disease"">NSCLC</span>).",,18818921,18818921_C067311_D002289,18818921_1,bcv_sentence_task_befree_3239,,770959168,FALSE,finalized,5,8/15/15 0:14,"



",no_relation,1,,D002945,"<span class=""chemical"">Cisplatin</span>",D002289,"<span class=""disease"">NSCLC</span>","<span class=""chemical"">Cisplatin</span> + weekly docetaxel with concurrent radiotherapy is a feasible and effective regimen for locally advanced <span class=""disease"">NSCLC</span>.",,18818921,18818921_D002945_D002289,18818921_8,bcv_sentence_task_befree_3240,,770959169,FALSE,finalized,5,8/15/15 0:19,"



",no_relation,1,,C067311,"<span class=""chemical"">docetaxel</span>",D002289,"<span class=""disease"">NSCLC</span>","Cisplatin + weekly <span class=""chemical"">docetaxel</span> with concurrent radiotherapy is a feasible and effective regimen for locally advanced <span class=""disease"">NSCLC</span>.",,18818921,18818921_C067311_D002289,18818921_8,bcv_sentence_task_befree_3241,,770959170,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,0.4148,,D006861,"<span class=""chemical"">H2O2</span>",D064420,"<span class=""disease"">toxicity</span>","<span class=""chemical"">H2O2</span>-dependent hyperoxidation of peroxiredoxin 6 (Prdx6) plays a role in cellular <span class=""disease"">toxicity</span> via up-regulation of iPLA2 activity.",,18826942,18826942_D006861_D064420,18826942_0,bcv_sentence_task_befree_3242,,770959171,FALSE,finalized,5,8/15/15 2:57,"



",yes_direct,1,,D006861,"<span class=""chemical"">H2O2</span>",D064420,"<span class=""disease"">toxicity</span>","Here, we report that <span class=""chemical"">H2O2</span>-induced cellular <span class=""disease"">toxicity</span> acts through Prdx6 hyperoxidation.",,18826942,18826942_D006861_D064420,18826942_2,bcv_sentence_task_befree_3243,,770959172,FALSE,finalized,5,8/14/15 21:14,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003922,"<span class=""disease"">type 1 diabetes</span>","JDRF randomized clinical trial to assess the efficacy of real-time continuous <span class=""chemical"">glucose</span> monitoring in the management of <span class=""disease"">type 1 diabetes</span>: research design and methods.",,18828243,18828243_D005947_D003922,18828243_0,bcv_sentence_task_befree_3244,,770959173,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D000377,"<span class=""disease"">real-time</span>","JDRF randomized clinical trial to assess the efficacy of <span class=""disease"">real-time</span> continuous <span class=""chemical"">glucose</span> monitoring in the management of type 1 diabetes: research design and methods.",,18828243,18828243_D005947_D000377,18828243_0,bcv_sentence_task_befree_3245,,770959174,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003922,"<span class=""disease"">T1D/type 1 diabetes</span>","While real-time (RT) continuous <span class=""chemical"">glucose</span> monitoring (CGM) systems may revolutionize treatment of <span class=""disease"">type 1 diabetes</span> (<span class=""disease"">T1D</span>), there is insufficient evidence currently available to support widespread utilization of these devices.",,18828243,18828243_D005947_D003922,18828243_1,bcv_sentence_task_befree_3246,,770959175,FALSE,finalized,5,8/15/15 0:44,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D000377,"<span class=""disease"">RT/real-time</span>","While <span class=""disease"">real-time</span> (<span class=""disease"">RT</span>) continuous <span class=""chemical"">glucose</span> monitoring (CGM) systems may revolutionize treatment of type 1 diabetes (T1D), there is insufficient evidence currently available to support widespread utilization of these devices.",,18828243,18828243_D005947_D000377,18828243_1,bcv_sentence_task_befree_3247,,770959176,FALSE,finalized,5,8/14/15 21:09,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D000377,"<span class=""disease"">RT</span>","Subjects with T1DM who meet eligibility criteria are randomized to either standard self-monitoring of blood <span class=""chemical"">glucose</span> (SMBG) alone or use of any of the three current <span class=""disease"">RT</span>-CGM systems as a supplement to SMBG.",,18828243,18828243_D005947_D000377,18828243_5,bcv_sentence_task_befree_3248,,770959177,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003922,"<span class=""disease"">T1D</span>","Other outcomes include the percentage of sensor <span class=""chemical"">glucose</span> values within the 70-180 mg/dL range, scores on questionnaires that assess the impact of RT-CGM on living with <span class=""disease"">T1D</span>, and the cost-effectiveness of RT-CGM.",,18828243,18828243_D005947_D003922,18828243_9,bcv_sentence_task_befree_3249,,770959178,FALSE,finalized,5,8/14/15 23:49,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D000377,"<span class=""disease"">RT</span>","Other outcomes include the percentage of sensor <span class=""chemical"">glucose</span> values within the 70-180 mg/dL range, scores on questionnaires that assess the impact of <span class=""disease"">RT</span>-CGM on living with T1D, and the cost-effectiveness of <span class=""disease"">RT</span>-CGM.",,18828243,18828243_D005947_D000377,18828243_9,bcv_sentence_task_befree_3250,,770959179,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D009765,"<span class=""disease"">Obesity</span>","<span class=""disease"">Obesity</span>, low <span class=""chemical"">testosterone</span> levels and erectile dysfunction.",,18843273,18843273_D013739_D009765,18843273_0,bcv_sentence_task_befree_3251,,770959180,FALSE,finalized,5,8/14/15 21:09,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D007172,"<span class=""disease"">erectile dysfunction</span>","Obesity, low <span class=""chemical"">testosterone</span> levels and <span class=""disease"">erectile dysfunction</span>.",,18843273,18843273_D013739_D007172,18843273_0,bcv_sentence_task_befree_3252,,770959181,FALSE,finalized,5,8/14/15 21:28,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D009765,"<span class=""disease"">obesity</span>","The relationships among <span class=""disease"">obesity</span>, metabolic syndrome, ED, sex hormone-binding globulin (SHBG) and serum total and free <span class=""chemical"">testosterone</span> levels are complex and often confusing to the physician.",,18843273,18843273_D013739_D009765,18843273_4,bcv_sentence_task_befree_3253,,770959182,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D007172,"<span class=""disease"">ED</span>","The relationships among obesity, metabolic syndrome, <span class=""disease"">ED</span>, sex hormone-binding globulin (SHBG) and serum total and free <span class=""chemical"">testosterone</span> levels are complex and often confusing to the physician.",,18843273,18843273_D013739_D007172,18843273_4,bcv_sentence_task_befree_3254,,770959183,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,0.8324,,D013739,"<span class=""chemical"">testosterone</span>",D008659,"<span class=""disease"">metabolic syndrome</span>","The relationships among obesity, <span class=""disease"">metabolic syndrome</span>, ED, sex hormone-binding globulin (SHBG) and serum total and free <span class=""chemical"">testosterone</span> levels are complex and often confusing to the physician.",,18843273,18843273_D013739_D008659,18843273_4,bcv_sentence_task_befree_3255,,770959184,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D009765,"<span class=""disease"">obesity</span>","It is known that BMI is inversely proportional to serum total <span class=""chemical"">testosterone</span> concentrations; low serum SHBG levels in <span class=""disease"">obesity</span> contribute to the low serum total <span class=""chemical"">testosterone</span>.",,18843273,18843273_D013739_D009765,18843273_5,bcv_sentence_task_befree_3256,,770959185,FALSE,finalized,5,8/15/15 2:07,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D009765,"<span class=""disease"">obese</span>","The characteristic low serum <span class=""chemical"">testosterone</span> concentrations observed in <span class=""disease"">obese</span> men are also present in men with the metabolic syndrome and type 2 diabetes mellitus.",,18843273,18843273_D013739_D009765,18843273_7,bcv_sentence_task_befree_3257,,770959186,FALSE,finalized,5,8/14/15 23:19,"



",no_relation,0.8068,,D013739,"<span class=""chemical"">testosterone</span>",D003920,"<span class=""disease"">type 2 diabetes mellitus</span>","The characteristic low serum <span class=""chemical"">testosterone</span> concentrations observed in obese men are also present in men with the metabolic syndrome and <span class=""disease"">type 2 diabetes mellitus</span>.",,18843273,18843273_D013739_D003920,18843273_7,bcv_sentence_task_befree_3258,,770959187,FALSE,finalized,5,8/15/15 1:02,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D008659,"<span class=""disease"">metabolic syndrome</span>","The characteristic low serum <span class=""chemical"">testosterone</span> concentrations observed in obese men are also present in men with the <span class=""disease"">metabolic syndrome</span> and type 2 diabetes mellitus.",,18843273,18843273_D013739_D008659,18843273_7,bcv_sentence_task_befree_3259,,770959188,FALSE,finalized,5,8/14/15 21:13,"



",no_relation,0.8241,,D013739,"<span class=""chemical"">testosterone</span>",C537389,"<span class=""disease"">type</span>","ED is a common symptom in patients with <span class=""disease"">type</span> 2 diabetes who also have low <span class=""chemical"">testosterone</span> levels.",,18843273,18843273_D013739_C537389,18843273_9,bcv_sentence_task_befree_3260,,770959189,FALSE,finalized,5,8/15/15 1:41,"



",yes_direct,0.6078,,D013739,"<span class=""chemical"">testosterone</span>",D007172,"<span class=""disease"">ED</span>","<span class=""disease"">ED</span> is a common symptom in patients with type 2 diabetes who also have low <span class=""chemical"">testosterone</span> levels.",,18843273,18843273_D013739_D007172,18843273_9,bcv_sentence_task_befree_3261,,770959190,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,0.8119,,D013739,"<span class=""chemical"">testosterone</span>",D003929,"<span class=""disease"">diabetes</span>","ED is a common symptom in patients with type 2 <span class=""disease"">diabetes</span> who also have low <span class=""chemical"">testosterone</span> levels.",,18843273,18843273_D013739_D003929,18843273_9,bcv_sentence_task_befree_3262,,770959191,FALSE,finalized,5,8/14/15 23:39,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D003920,"<span class=""disease"">type 2 diabetes mellitus</span>","This review describes the relationships between low serum <span class=""chemical"">testosterone</span> concentrations and ED in obese patients and those with metabolic syndrome and <span class=""disease"">type 2 diabetes mellitus</span>.",,18843273,18843273_D013739_D003920,18843273_10,bcv_sentence_task_befree_3263,,770959192,FALSE,finalized,5,8/14/15 21:10,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D009765,"<span class=""disease"">obese</span>","This review describes the relationships between low serum <span class=""chemical"">testosterone</span> concentrations and ED in <span class=""disease"">obese</span> patients and those with metabolic syndrome and type 2 diabetes mellitus.",,18843273,18843273_D013739_D009765,18843273_10,bcv_sentence_task_befree_3264,,770959193,FALSE,finalized,5,8/15/15 1:13,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D007172,"<span class=""disease"">ED</span>","This review describes the relationships between low serum <span class=""chemical"">testosterone</span> concentrations and <span class=""disease"">ED</span> in obese patients and those with metabolic syndrome and type 2 diabetes mellitus.",,18843273,18843273_D013739_D007172,18843273_10,bcv_sentence_task_befree_3265,,770959194,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,0.8148,,D013739,"<span class=""chemical"">testosterone</span>",D008659,"<span class=""disease"">metabolic syndrome</span>","This review describes the relationships between low serum <span class=""chemical"">testosterone</span> concentrations and ED in obese patients and those with <span class=""disease"">metabolic syndrome</span> and type 2 diabetes mellitus.",,18843273,18843273_D013739_D008659,18843273_10,bcv_sentence_task_befree_3266,,770959195,FALSE,finalized,5,8/14/15 21:07,"



",no_relation,1,,C043265,"<span class=""chemical"">tazobactam</span>",D008554,"<span class=""disease"">melioidosis</span>","The role of piperacillin/ <span class=""chemical"">tazobactam</span> for <span class=""disease"">melioidosis</span> remains undefined.",,18854938,18854938_C043265_D008554,18854938_10,bcv_sentence_task_befree_3267,,770959196,FALSE,finalized,5,8/14/15 23:47,"



",no_relation,1,,D010878,"<span class=""chemical"">piperacillin</span>",D008554,"<span class=""disease"">melioidosis</span>","The role of <span class=""chemical"">piperacillin</span>/ tazobactam for <span class=""disease"">melioidosis</span> remains undefined.",,18854938,18854938_D010878_D008554,18854938_10,bcv_sentence_task_befree_3268,,770959197,FALSE,finalized,5,8/14/15 23:54,"



",no_relation,0.6029,,C097613,"<span class=""chemical"">imatinib</span>",D009369,"<span class=""disease"">GIST/gastrointestinal stromal tumours</span>","Although the tyrosine kinase inhibitor <span class=""chemical"">imatinib</span> has been shown to be an active agent in patients with <span class=""disease"">gastrointestinal stromal tumours</span> (<span class=""disease"">GIST</span>), complete remissions are almost never seen and most patients finally experience disease progression during their course of treatment.",,18941456,18941456_C097613_D009369,18941456_1,bcv_sentence_task_befree_3269,,770959198,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D009369,"<span class=""disease"">GIST/gastrointestinal stromal tumours</span>","Although the <span class=""chemical"">tyrosine</span> kinase inhibitor imatinib has been shown to be an active agent in patients with <span class=""disease"">gastrointestinal stromal tumours</span> (<span class=""disease"">GIST</span>), complete remissions are almost never seen and most patients finally experience disease progression during their course of treatment.",,18941456,18941456_D014443_D009369,18941456_1,bcv_sentence_task_befree_3270,,770959199,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,0.8096,,D004958,"<span class=""chemical"">17beta-estradiol</span>",D009369,"<span class=""disease"">breast cancer</span>","STEAP1 is over-expressed in <span class=""disease"">breast cancer</span> and down-regulated by <span class=""chemical"">17beta-estradiol</span> in MCF-7 cells and in the rat mammary gland.",,18958632,18958632_D004958_D009369,18958632_0,bcv_sentence_task_befree_3271,,770959200,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D009369,"<span class=""disease"">tumor/breast cancer</span>","It is also demonstrated that STEAP1 transcription correlates negatively with <span class=""chemical"">estrogen</span> receptor (ER) immunoreactivity, and positively with <span class=""disease"">tumor</span> grading in <span class=""disease"">breast cancer</span> cases.",,18958632,18958632_D004967_D009369,18958632_4,bcv_sentence_task_befree_3272,,770959201,FALSE,finalized,5,8/15/15 1:30,"



",yes_direct,0.804,,D004967,"<span class=""chemical"">estrogens</span>",D009369,"<span class=""disease"">breast cancer</span>","As <span class=""chemical"">estrogens</span> are involved in <span class=""disease"">breast cancer</span> onset and progression, the response of STEAP1 to 17beta-estradiol (E2) was investigated in the mammary gland of rats, and in the human <span class=""disease"">breast cancer</span> cell line, MCF-7.",,18958632,18958632_D004967_D009369,18958632_5,bcv_sentence_task_befree_3273,,770959202,FALSE,finalized,5,8/14/15 23:13,"



",no_relation,0.796,,D004958,"<span class=""chemical"">17beta-estradiol</span>",D009369,"<span class=""disease"">breast cancer</span>","As estrogens are involved in <span class=""disease"">breast cancer</span> onset and progression, the response of STEAP1 to <span class=""chemical"">17beta-estradiol</span> (E2) was investigated in the mammary gland of rats, and in the human <span class=""disease"">breast cancer</span> cell line, MCF-7.",,18958632,18958632_D004958_D009369,18958632_5,bcv_sentence_task_befree_3274,,770959203,FALSE,finalized,5,8/14/15 21:10,"



",no_relation,1,,D000803,"<span class=""chemical"">angiotensin I</span>",D051436,"<span class=""disease"">chronic kidney disease</span>","The combination of <span class=""chemical"">angiotensin I</span>-converting enzyme inhibitors and angiotensin receptor blockers has been shown to be more effective than the individual drugs alone in the treatment of <span class=""disease"">chronic kidney disease</span> and chronic heart failure.",,18971536,18971536_D000803_D051436,18971536_1,bcv_sentence_task_befree_3275,,770959204,FALSE,finalized,5,8/14/15 22:29,"



",no_relation,1,,D000803,"<span class=""chemical"">angiotensin I</span>",D007676,"<span class=""disease"">chronic heart failure</span>","The combination of <span class=""chemical"">angiotensin I</span>-converting enzyme inhibitors and angiotensin receptor blockers has been shown to be more effective than the individual drugs alone in the treatment of chronic kidney disease and <span class=""disease"">chronic heart failure</span>.",,18971536,18971536_D000803_D007676,18971536_1,bcv_sentence_task_befree_3276,,770959205,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,1,,D017311,"<span class=""chemical"">amlodipine</span>",D006973,"<span class=""disease"">hypertension</span>","In the present study, we evaluated the effect of treatment with the calcium channel blocker <span class=""chemical"">amlodipine</span> or the angiotensin I-converting enzyme inhibitor perindopril on vascular endothelial function and arteriosclerosis in patients with essential <span class=""disease"">hypertension</span> who had already been receiving angiotensin receptor blocker monotherapy.",,18971536,18971536_D017311_D006973,18971536_2,bcv_sentence_task_befree_3277,,770959206,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D006973,"<span class=""disease"">hypertension</span>","In the present study, we evaluated the effect of treatment with the <span class=""chemical"">calcium</span> channel blocker amlodipine or the angiotensin I-converting enzyme inhibitor perindopril on vascular endothelial function and arteriosclerosis in patients with essential <span class=""disease"">hypertension</span> who had already been receiving angiotensin receptor blocker monotherapy.",,18971536,18971536_D002118_D006973,18971536_2,bcv_sentence_task_befree_3278,,770959207,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,D017311,"<span class=""chemical"">amlodipine</span>",D001161,"<span class=""disease"">arteriosclerosis</span>","In the present study, we evaluated the effect of treatment with the calcium channel blocker <span class=""chemical"">amlodipine</span> or the angiotensin I-converting enzyme inhibitor perindopril on vascular endothelial function and <span class=""disease"">arteriosclerosis</span> in patients with essential hypertension who had already been receiving angiotensin receptor blocker monotherapy.",,18971536,18971536_D017311_D001161,18971536_2,bcv_sentence_task_befree_3279,,770959208,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,1,,D020913,"<span class=""chemical"">perindopril</span>",D006973,"<span class=""disease"">hypertension</span>","In the present study, we evaluated the effect of treatment with the calcium channel blocker amlodipine or the angiotensin I-converting enzyme inhibitor <span class=""chemical"">perindopril</span> on vascular endothelial function and arteriosclerosis in patients with essential <span class=""disease"">hypertension</span> who had already been receiving angiotensin receptor blocker monotherapy.",,18971536,18971536_D020913_D006973,18971536_2,bcv_sentence_task_befree_3280,,770959209,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D020913,"<span class=""chemical"">perindopril</span>",D001161,"<span class=""disease"">arteriosclerosis</span>","In the present study, we evaluated the effect of treatment with the calcium channel blocker amlodipine or the angiotensin I-converting enzyme inhibitor <span class=""chemical"">perindopril</span> on vascular endothelial function and <span class=""disease"">arteriosclerosis</span> in patients with essential hypertension who had already been receiving angiotensin receptor blocker monotherapy.",,18971536,18971536_D020913_D001161,18971536_2,bcv_sentence_task_befree_3281,,770959210,FALSE,finalized,5,8/14/15 22:52,"



",no_relation,1,,D000809,"<span class=""chemical"">angiotensin</span>",D006973,"<span class=""disease"">hypertension</span>","In the present study, we evaluated the effect of treatment with the calcium channel blocker amlodipine or the angiotensin I-converting enzyme inhibitor perindopril on vascular endothelial function and arteriosclerosis in patients with essential <span class=""disease"">hypertension</span> who had already been receiving <span class=""chemical"">angiotensin</span> receptor blocker monotherapy.",,18971536,18971536_D000809_D006973,18971536_2,bcv_sentence_task_befree_3282,,770959211,FALSE,finalized,5,8/15/15 0:28,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D001161,"<span class=""disease"">arteriosclerosis</span>","In the present study, we evaluated the effect of treatment with the <span class=""chemical"">calcium</span> channel blocker amlodipine or the angiotensin I-converting enzyme inhibitor perindopril on vascular endothelial function and <span class=""disease"">arteriosclerosis</span> in patients with essential hypertension who had already been receiving angiotensin receptor blocker monotherapy.",,18971536,18971536_D002118_D001161,18971536_2,bcv_sentence_task_befree_3283,,770959212,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,0.8127,,D000809,"<span class=""chemical"">angiotensin</span>",D001161,"<span class=""disease"">arteriosclerosis</span>","In the present study, we evaluated the effect of treatment with the calcium channel blocker amlodipine or the angiotensin I-converting enzyme inhibitor perindopril on vascular endothelial function and <span class=""disease"">arteriosclerosis</span> in patients with essential hypertension who had already been receiving <span class=""chemical"">angiotensin</span> receptor blocker monotherapy.",,18971536,18971536_D000809_D001161,18971536_2,bcv_sentence_task_befree_3284,,770959213,FALSE,finalized,5,8/14/15 21:09,"



",no_relation,0.8212,,D017311,"<span class=""chemical"">amlodipine</span>",D006973,"<span class=""disease"">hypertension</span>","Thirty-two patients with essential <span class=""disease"">hypertension</span> treated with angiotensin receptor blocker monotherapy were randomized to receive 5 mg of <span class=""chemical"">amlodipine</span> (n=16) or 4 mg of perindopril (n=16) once daily in the morning for 24 weeks.",,18971536,18971536_D017311_D006973,18971536_3,bcv_sentence_task_befree_3285,,770959214,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,D020913,"<span class=""chemical"">perindopril</span>",D006973,"<span class=""disease"">hypertension</span>","Thirty-two patients with essential <span class=""disease"">hypertension</span> treated with angiotensin receptor blocker monotherapy were randomized to receive 5 mg of amlodipine (n=16) or 4 mg of <span class=""chemical"">perindopril</span> (n=16) once daily in the morning for 24 weeks.",,18971536,18971536_D020913_D006973,18971536_3,bcv_sentence_task_befree_3286,,770959215,FALSE,finalized,5,8/15/15 0:00,"



",no_relation,1,,D000809,"<span class=""chemical"">angiotensin</span>",D006973,"<span class=""disease"">hypertension</span>","Thirty-two patients with essential <span class=""disease"">hypertension</span> treated with <span class=""chemical"">angiotensin</span> receptor blocker monotherapy were randomized to receive 5 mg of amlodipine (n=16) or 4 mg of perindopril (n=16) once daily in the morning for 24 weeks.",,18971536,18971536_D000809_D006973,18971536_3,bcv_sentence_task_befree_3287,,770959216,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D017311,"<span class=""chemical"">amlodipine</span>",D006973,"<span class=""disease"">hypertension</span>","In conclusion, these results suggest that the angiotensin I-converting enzyme inhibitor perindopril is superior to the calcium channel blocker <span class=""chemical"">amlodipine</span> for reducing vascular endothelial dysfunction when co-administered with angiotensin receptor blockers in patients with essential <span class=""disease"">hypertension</span>.",,18971536,18971536_D017311_D006973,18971536_8,bcv_sentence_task_befree_3288,,770959217,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,D020913,"<span class=""chemical"">perindopril</span>",D014652,"<span class=""disease"">vascular endothelial dysfunction</span>","In conclusion, these results suggest that the angiotensin I-converting enzyme inhibitor <span class=""chemical"">perindopril</span> is superior to the calcium channel blocker amlodipine for reducing <span class=""disease"">vascular endothelial dysfunction</span> when co-administered with angiotensin receptor blockers in patients with essential hypertension.",,18971536,18971536_D020913_D014652,18971536_8,bcv_sentence_task_befree_3289,,770959218,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D006973,"<span class=""disease"">hypertension</span>","In conclusion, these results suggest that the angiotensin I-converting enzyme inhibitor perindopril is superior to the <span class=""chemical"">calcium</span> channel blocker amlodipine for reducing vascular endothelial dysfunction when co-administered with angiotensin receptor blockers in patients with essential <span class=""disease"">hypertension</span>.",,18971536,18971536_D002118_D006973,18971536_8,bcv_sentence_task_befree_3290,,770959219,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D014652,"<span class=""disease"">vascular endothelial dysfunction</span>","In conclusion, these results suggest that the angiotensin I-converting enzyme inhibitor perindopril is superior to the <span class=""chemical"">calcium</span> channel blocker amlodipine for reducing <span class=""disease"">vascular endothelial dysfunction</span> when co-administered with angiotensin receptor blockers in patients with essential hypertension.",,18971536,18971536_D002118_D014652,18971536_8,bcv_sentence_task_befree_3291,,770959220,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D020913,"<span class=""chemical"">perindopril</span>",D006973,"<span class=""disease"">hypertension</span>","In conclusion, these results suggest that the angiotensin I-converting enzyme inhibitor <span class=""chemical"">perindopril</span> is superior to the calcium channel blocker amlodipine for reducing vascular endothelial dysfunction when co-administered with angiotensin receptor blockers in patients with essential <span class=""disease"">hypertension</span>.",,18971536,18971536_D020913_D006973,18971536_8,bcv_sentence_task_befree_3292,,770959221,FALSE,finalized,5,8/15/15 1:09,"



",no_relation,1,,D017311,"<span class=""chemical"">amlodipine</span>",D014652,"<span class=""disease"">vascular endothelial dysfunction</span>","In conclusion, these results suggest that the angiotensin I-converting enzyme inhibitor perindopril is superior to the calcium channel blocker <span class=""chemical"">amlodipine</span> for reducing <span class=""disease"">vascular endothelial dysfunction</span> when co-administered with angiotensin receptor blockers in patients with essential hypertension.",,18971536,18971536_D017311_D014652,18971536_8,bcv_sentence_task_befree_3293,,770959222,FALSE,finalized,5,8/14/15 21:18,"



",no_relation,0.8078,,C438273,"<span class=""chemical"">aviptadil</span>",D065627,"<span class=""disease"">PAH/idiopathic pulmonary arterial hypertension</span>","In <span class=""disease"">idiopathic pulmonary arterial hypertension</span> (<span class=""disease"">PAH</span>) the vasodilating vasoactive intestinal peptide (<span class=""chemical"">aviptadil</span>) is deficient.",,18978135,18978135_C438273_D065627,18978135_2,bcv_sentence_task_befree_3294,,770959223,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,0.8049,,C438273,"<span class=""chemical"">aviptadil</span>",D013923,"<span class=""disease"">thromboembolic</span>","A total of 20 patients with PH (PAH in nine, PH in lung disease in eight and chronic <span class=""disease"">thromboembolic</span> PH in three) inhaled a single 100-microg dose of <span class=""chemical"">aviptadil</span> during right-heart catheterisation.",,18978135,18978135_C438273_D013923,18978135_4,bcv_sentence_task_befree_3295,,770959224,FALSE,finalized,5,8/15/15 1:11,"



",no_relation,0.8101,,C438273,"<span class=""chemical"">aviptadil</span>",D008171,"<span class=""disease"">lung disease</span>","A total of 20 patients with PH (PAH in nine, PH in <span class=""disease"">lung disease</span> in eight and chronic thromboembolic PH in three) inhaled a single 100-microg dose of <span class=""chemical"">aviptadil</span> during right-heart catheterisation.",,18978135,18978135_C438273_D008171,18978135_4,bcv_sentence_task_befree_3296,,770959225,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,C438273,"<span class=""chemical"">aviptadil</span>",D065627,"<span class=""disease"">PAH</span>","A total of 20 patients with PH (<span class=""disease"">PAH</span> in nine, PH in lung disease in eight and chronic thromboembolic PH in three) inhaled a single 100-microg dose of <span class=""chemical"">aviptadil</span> during right-heart catheterisation.",,18978135,18978135_C438273_D065627,18978135_4,bcv_sentence_task_befree_3297,,770959226,FALSE,finalized,5,8/14/15 21:12,"



",yes_direct,0.5903,,C438273,"<span class=""chemical"">Aviptadil</span>",D020521,"<span class=""disease"">stroke</span>","<span class=""chemical"">Aviptadil</span> aerosol caused a small and temporary but significant selective pulmonary vasodilation, an improved <span class=""disease"">stroke</span> volume and mixed venous oxygen saturation.",,18978135,18978135_C438273_D020521,18978135_6,bcv_sentence_task_befree_3298,,770959227,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D020521,"<span class=""disease"">stroke</span>","Aviptadil aerosol caused a small and temporary but significant selective pulmonary vasodilation, an improved <span class=""disease"">stroke</span> volume and mixed venous <span class=""chemical"">oxygen</span> saturation.",,18978135,18978135_D010100_D020521,18978135_6,bcv_sentence_task_befree_3299,,770959228,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,C438273,"<span class=""chemical"">aviptadil</span>",D008171,"<span class=""disease"">lung disease</span>","In patients with significant <span class=""disease"">lung disease</span>, <span class=""chemical"">aviptadil</span> tended to improve oxygenation.",,18978135,18978135_C438273_D008171,18978135_8,bcv_sentence_task_befree_3300,,770959229,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,1,,C438273,"<span class=""chemical"">Aviptadil</span>",D008171,"<span class=""disease"">lung disease</span>","<span class=""chemical"">Aviptadil</span> inhalation tended to improve oxygenation in patients with significant <span class=""disease"">lung disease</span>.",,18978135,18978135_C438273_D008171,18978135_10,bcv_sentence_task_befree_3301,,770959230,FALSE,finalized,5,8/14/15 22:11,"



",no_relation,1,,D000409,"<span class=""chemical"">alanine</span>",D064420,"<span class=""disease"">adverse drug reactions</span>","Among 2,930 eligible patients, <span class=""disease"">adverse drug reactions</span> were observed in 3.6%, with the most common being abdominal distension, flatulence, diarrhea, and increased <span class=""chemical"">alanine</span> aminotransferase levels.",,18987459,18987459_D000409_D064420,18987459_5,bcv_sentence_task_befree_3302,,770959231,FALSE,finalized,5,8/14/15 21:59,"



",no_relation,1,,D000409,"<span class=""chemical"">alanine</span>",D005414,"<span class=""disease"">flatulence</span>","Among 2,930 eligible patients, adverse drug reactions were observed in 3.6%, with the most common being abdominal distension, <span class=""disease"">flatulence</span>, diarrhea, and increased <span class=""chemical"">alanine</span> aminotransferase levels.",,18987459,18987459_D000409_D005414,18987459_5,bcv_sentence_task_befree_3303,,770959232,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,0.8082,,D000409,"<span class=""chemical"">alanine</span>",D003967,"<span class=""disease"">diarrhea</span>","Among 2,930 eligible patients, adverse drug reactions were observed in 3.6%, with the most common being abdominal distension, flatulence, <span class=""disease"">diarrhea</span>, and increased <span class=""chemical"">alanine</span> aminotransferase levels.",,18987459,18987459_D000409_D003967,18987459_5,bcv_sentence_task_befree_3304,,770959233,FALSE,finalized,5,8/14/15 23:31,"



",no_relation,0.8066,,C088155,"<span class=""chemical"">R(+)-methanandamide</span>",D002277,"<span class=""disease"">carcinoma</span>","<span class=""chemical"">R(+)-methanandamide</span>-induced apoptosis of human cervical <span class=""disease"">carcinoma</span> cells involves a cyclooxygenase-2-dependent pathway.",,19015962,19015962_C088155_D002277,19015962_0,bcv_sentence_task_befree_3305,,770959234,FALSE,finalized,5,8/15/15 0:10,"



",no_relation,0.7937,,C088155,"<span class=""chemical"">R(+)-methanandamide</span>",D002277,"<span class=""disease"">carcinoma</span>","Using human cervical <span class=""disease"">carcinoma</span> cells (HeLa), this study investigates the role of cyclooxygenase-2 (COX-2) in apoptosis elicited by the endocannabinoid analog <span class=""chemical"">R(+)-methanandamide</span> (MA).",,19015962,19015962_C088155_D002277,19015962_2,bcv_sentence_task_befree_3306,,770959235,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,C005581,"<span class=""chemical"">3,4-dihydroxybenzaldehyde</span>",D009369,"<span class=""disease"">cancer</span>","Concentration of 300 microM <span class=""chemical"">3,4-dihydroxybenzaldehyde</span> caused 50% growth inhibition of human <span class=""disease"">cancer</span> cell U937.",,19023807,19023807_C005581_D009369,19023807_6,bcv_sentence_task_befree_3307,,770959236,FALSE,finalized,5,8/15/15 2:25,"



",no_relation,0.8267,,C005581,"<span class=""chemical"">3,4-dihydroxybenzaldehyde</span>",D063646,"<span class=""disease"">oncogenesis</span>","Since CKII is involved in cell proliferation and <span class=""disease"">oncogenesis</span>, these results suggest that <span class=""chemical"">3,4-dihydroxybenzaldehyde</span> may function by inhibiting oncogenic disease, at least in part, through the inhibition of CKII activity.",,19023807,19023807_C005581_D063646,19023807_10,bcv_sentence_task_befree_3308,,770959237,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,C022616,"<span class=""chemical"">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</span>",D004487,"<span class=""disease"">cytotoxicity</span>","For <span class=""disease"">cytotoxicity</span> testing, the <span class=""chemical"">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</span> (MTT) test was performed.",,19027573,19027573_C022616_D004487,19027573_3,bcv_sentence_task_befree_3309,,770959238,FALSE,finalized,5,8/14/15 21:07,"



",yes_direct,0.5986,,D002444,"<span class=""chemical"">cefuroxime</span>",D064420,"<span class=""disease"">toxicity</span>","These data suggest a dose-dependent <span class=""disease"">toxicity</span> of <span class=""chemical"">cefuroxime</span> and vancomycin on HCECs in vitro with a narrow range of safety.",,19027573,19027573_D002444_D064420,19027573_12,bcv_sentence_task_befree_3310,,770959239,FALSE,finalized,5,8/15/15 0:13,"



",yes_direct,0.6045,,D014640,"<span class=""chemical"">vancomycin</span>",D064420,"<span class=""disease"">toxicity</span>","These data suggest a dose-dependent <span class=""disease"">toxicity</span> of cefuroxime and <span class=""chemical"">vancomycin</span> on HCECs in vitro with a narrow range of safety.",,19027573,19027573_D014640_D064420,19027573_12,bcv_sentence_task_befree_3311,,770959240,FALSE,finalized,5,8/14/15 23:40,"



",no_relation,1,,C037663,"<span class=""chemical"">ropivacaine</span>",D009461,"<span class=""disease"">TNS</span>","Six lidocaine patients reported <span class=""disease"">TNS</span> (40%) as compared with no patient receiving <span class=""chemical"">ropivacaine</span> (0%) (P=0.005).",,19032560,19032560_C037663_D009461,19032560_7,bcv_sentence_task_befree_3312,,770959241,FALSE,finalized,5,8/14/15 22:14,"



",yes_direct,0.7891,,D008012,"<span class=""chemical"">lidocaine</span>",D009461,"<span class=""disease"">TNS</span>","Recovery of unassisted ambulation and spontaneous voiding occurred earlier with <span class=""chemical"">lidocaine</span>, but this was associated with a markedly higher incidence of <span class=""disease"">TNS</span>.",,19032560,19032560_D008012_D009461,19032560_9,bcv_sentence_task_befree_3313,,770959242,FALSE,finalized,5,8/14/15 21:16,"



",yes_direct,0.6269,,D002248,"<span class=""chemical"">Carbon monoxide</span>",D064420,"<span class=""disease"">toxicity</span>","<span class=""chemical"">Carbon monoxide</span> <span class=""disease"">toxicity</span>.",,19060737,19060737_D002248_D064420,19060737_0,bcv_sentence_task_befree_3314,,770959243,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,1,,C097933,"<span class=""chemical"">olmesartan medoxomil</span>",D006973,"<span class=""disease"">hypertension</span>","Efficacy and tolerability of <span class=""chemical"">olmesartan medoxomil</span> combined with amlodipine in patients with moderate to severe <span class=""disease"">hypertension</span> after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.",,19067471,19067471_C097933_D006973,19067471_0,bcv_sentence_task_befree_3315,,770959244,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,0.5772,,D017311,"<span class=""chemical"">amlodipine</span>",D006973,"<span class=""disease"">hypertension</span>","Efficacy and tolerability of olmesartan medoxomil combined with <span class=""chemical"">amlodipine</span> in patients with moderate to severe <span class=""disease"">hypertension</span> after <span class=""chemical"">amlodipine</span> monotherapy: a randomized, double-blind, parallel-group, multicentre study.",,19067471,19067471_D017311_D006973,19067471_0,bcv_sentence_task_befree_3316,,770959245,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,1,,C097933,"<span class=""chemical"">olmesartan medoxomil</span>",D006973,"<span class=""disease"">hypertension</span>","The objective of this randomized, double-blind, parallel-group, multicentre study was to determine the efficacy and safety of <span class=""chemical"">olmesartan medoxomil</span>/amlodipine combination therapy in patients with moderate to severe <span class=""disease"">hypertension</span> who had failed to respond to treatment with 8 weeks of open-label amlodipine.",,19067471,19067471_C097933_D006973,19067471_2,bcv_sentence_task_befree_3317,,770959246,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D017311,"<span class=""chemical"">amlodipine</span>",D006973,"<span class=""disease"">hypertension</span>","The objective of this randomized, double-blind, parallel-group, multicentre study was to determine the efficacy and safety of olmesartan medoxomil/<span class=""chemical"">amlodipine</span> combination therapy in patients with moderate to severe <span class=""disease"">hypertension</span> who had failed to respond to treatment with 8 weeks of open-label <span class=""chemical"">amlodipine</span>.",,19067471,19067471_D017311_D006973,19067471_2,bcv_sentence_task_befree_3318,,770959247,FALSE,finalized,5,8/15/15 1:57,"



",no_relation,1,,C097933,"<span class=""chemical"">olmesartan medoxomil</span>",D006973,"<span class=""disease"">hypertension</span>","These results suggest that <span class=""chemical"">olmesartan medoxomil</span> combined with amlodipine is effective and well tolerated in reducing BP in patients with moderate to severe <span class=""disease"">hypertension</span>.",,19067471,19067471_C097933_D006973,19067471_14,bcv_sentence_task_befree_3319,,770959248,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,D017311,"<span class=""chemical"">amlodipine</span>",D006973,"<span class=""disease"">hypertension</span>","These results suggest that olmesartan medoxomil combined with <span class=""chemical"">amlodipine</span> is effective and well tolerated in reducing BP in patients with moderate to severe <span class=""disease"">hypertension</span>.",,19067471,19067471_D017311_D006973,19067471_14,bcv_sentence_task_befree_3320,,770959249,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,0.8282,,D005947,"<span class=""chemical"">glucose</span>",C537389,"<span class=""disease"">Type</span>","<span class=""disease"">Type</span> 2 diabetes occurs when the endocrine pancreas can no longer secrete enough insulin to maintain <span class=""chemical"">glucose</span> and lipid homeostasis.",,19106615,19106615_D005947_C537389,19106615_1,bcv_sentence_task_befree_3321,,770959250,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003929,"<span class=""disease"">diabetes</span>","Type 2 <span class=""disease"">diabetes</span> occurs when the endocrine pancreas can no longer secrete enough insulin to maintain <span class=""chemical"">glucose</span> and lipid homeostasis.",,19106615,19106615_D005947_D003929,19106615_1,bcv_sentence_task_befree_3322,,770959251,FALSE,finalized,5,8/15/15 2:03,"



",yes_direct,0.6216,,D005227,"<span class=""chemical"">fatty acids</span>",D003643,"<span class=""disease"">death</span>","It is clear from these studies and others, that there are multiple pathways by which <span class=""chemical"">fatty acids</span> such as palmitate can lead to beta-cell dysfunction and <span class=""disease"">death</span>.",,19106615,19106615_D005227_D003643,19106615_4,bcv_sentence_task_befree_3323,,770959252,FALSE,finalized,5,8/15/15 0:10,"



",no_relation,1,,D013936,"<span class=""chemical"">thymidine</span>",D006258,"<span class=""disease"">head and neck cancer</span>","The predictive and therapeutic value of <span class=""chemical"">thymidine</span> phosphorylase and dihydropyrimidine dehydrogenase in capecitabine (Xeloda)-based chemotherapy for <span class=""disease"">head and neck cancer</span>.",,19117293,19117293_D013936_D006258,19117293_0,bcv_sentence_task_befree_3324,,770959253,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,C110904,"<span class=""chemical"">capecitabine</span>",D006258,"<span class=""disease"">head and neck cancer</span>","The predictive and therapeutic value of thymidine phosphorylase and dihydropyrimidine dehydrogenase in <span class=""chemical"">capecitabine</span> (Xeloda)-based chemotherapy for <span class=""disease"">head and neck cancer</span>.",,19117293,19117293_C110904_D006258,19117293_0,bcv_sentence_task_befree_3325,,770959254,FALSE,finalized,5,8/15/15 0:40,"



",no_relation,1,,C025034,"<span class=""chemical"">5'-DFUR</span>",C535575,"<span class=""disease"">head and neck squamous cell carcinoma/HNSCC</span>","To evaluate whether two molecular biomarkers, thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD), could be clinically useful in predicting and improving the chemotherapeutic outcome of the oral fluoropyrimidine capecitabine (<span class=""chemical"">5'-DFUR</span> or Xeloda), in the treatment of human <span class=""disease"">head and neck squamous cell carcinoma</span> (<span class=""disease"">HNSCC</span>).",,19117293,19117293_C025034_C535575,19117293_1,bcv_sentence_task_befree_3326,,770959255,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,C110904,"<span class=""chemical"">capecitabine</span>",C535575,"<span class=""disease"">head and neck squamous cell carcinoma/HNSCC</span>","To evaluate whether two molecular biomarkers, thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD), could be clinically useful in predicting and improving the chemotherapeutic outcome of the oral fluoropyrimidine <span class=""chemical"">capecitabine</span> (5'-DFUR or Xeloda), in the treatment of human <span class=""disease"">head and neck squamous cell carcinoma</span> (<span class=""disease"">HNSCC</span>).",,19117293,19117293_C110904_C535575,19117293_1,bcv_sentence_task_befree_3327,,770959256,FALSE,finalized,5,8/15/15 1:18,"



",no_relation,1,,D013936,"<span class=""chemical"">thymidine</span>",C535575,"<span class=""disease"">head and neck squamous cell carcinoma/HNSCC</span>","To evaluate whether two molecular biomarkers, <span class=""chemical"">thymidine</span> phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD), could be clinically useful in predicting and improving the chemotherapeutic outcome of the oral fluoropyrimidine capecitabine (5'-DFUR or Xeloda), in the treatment of human <span class=""disease"">head and neck squamous cell carcinoma</span> (<span class=""disease"">HNSCC</span>).",,19117293,19117293_D013936_C535575,19117293_1,bcv_sentence_task_befree_3328,,770959257,FALSE,finalized,5,8/14/15 22:03,"



",no_relation,1,,C110904,"<span class=""chemical"">capecitabine</span>",C535575,"<span class=""disease"">HNSCC</span>","The effect of TP transgene expression to alter the TP to DPD ratio and hence optimize the therapeutic outcome of <span class=""chemical"">capecitabine</span> treatment was further evaluated in a murine model of human <span class=""disease"">HNSCC</span> using immunohistochemistry to detect TP and DPD expression in vivo.",,19117293,19117293_C110904_C535575,19117293_4,bcv_sentence_task_befree_3329,,770959258,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,C025034,"<span class=""chemical"">5'-DFUR</span>",C535575,"<span class=""disease"">HNSCC</span>","No correlation was detected between sensitivity to <span class=""chemical"">5'-DFUR</span> and the relative expression levels of TP or DPD in the multiple <span class=""disease"">HNSCC</span> cell lines tested.",,19117293,19117293_C025034_C535575,19117293_5,bcv_sentence_task_befree_3330,,770959259,FALSE,finalized,5,8/15/15 1:45,"



",no_relation,0.802,,C110904,"<span class=""chemical"">capecitabine</span>",C535575,"<span class=""disease"">HNSCC tumors</span>","In addition, we demonstrate that transgene expression of TP significantly enhanced the tumoricidal effect of <span class=""chemical"">capecitabine</span> in <span class=""disease"">HNSCC tumors</span> with otherwise low endogenous TP to DPD ratios.",,19117293,19117293_C110904_C535575,19117293_7,bcv_sentence_task_befree_3331,,770959260,FALSE,finalized,5,8/14/15 21:10,"



",no_relation,1,,C110904,"<span class=""chemical"">capecitabine</span>",D009369,"<span class=""disease"">tumors</span>","The results of this study suggest that HNSCC patients who would most benefit from <span class=""chemical"">capecitabine</span>-based chemotherapy could be identified by examining the TP to DPD ratio of their <span class=""disease"">tumors</span>.",,19117293,19117293_C110904_D009369,19117293_9,bcv_sentence_task_befree_3332,,770959261,FALSE,finalized,5,8/15/15 2:22,"



",no_relation,1,,C110904,"<span class=""chemical"">capecitabine</span>",C535575,"<span class=""disease"">HNSCC</span>","The results of this study suggest that <span class=""disease"">HNSCC</span> patients who would most benefit from <span class=""chemical"">capecitabine</span>-based chemotherapy could be identified by examining the TP to DPD ratio of their tumors.",,19117293,19117293_C110904_C535575,19117293_9,bcv_sentence_task_befree_3333,,770959262,FALSE,finalized,5,8/15/15 1:30,"



",no_relation,1,,C014347,"<span class=""chemical"">5-aza-2'-deoxycytidine</span>",D009369,"<span class=""disease"">tumor</span>","We find that clinically achievable levels of <span class=""chemical"">5-aza-2'-deoxycytidine</span> (5-AZA-dC), a potent inhibitor of DNA methylation, can modify chromatin and restore the ability of <span class=""disease"">tumor</span> necrosis factor alpha (TNFalpha) to induce monocytic differentiation of the acute myeloid leukemia cells NB4 and U937.",,19117987,19117987_C014347_D009369,19117987_2,bcv_sentence_task_befree_3334,,770959263,FALSE,finalized,5,8/14/15 22:24,"



",yes_direct,0.6021,,C014347,"<span class=""chemical"">5-aza-2'-deoxycytidine</span>",D009336,"<span class=""disease"">necrosis</span>","We find that clinically achievable levels of <span class=""chemical"">5-aza-2'-deoxycytidine</span> (5-AZA-dC), a potent inhibitor of DNA methylation, can modify chromatin and restore the ability of tumor <span class=""disease"">necrosis</span> factor alpha (TNFalpha) to induce monocytic differentiation of the acute myeloid leukemia cells NB4 and U937.",,19117987,19117987_C014347_D009336,19117987_2,bcv_sentence_task_befree_3335,,770959264,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,0.8283,,C014347,"<span class=""chemical"">5-aza-2'-deoxycytidine</span>",D015470,"<span class=""disease"">acute myeloid leukemia</span>","We find that clinically achievable levels of <span class=""chemical"">5-aza-2'-deoxycytidine</span> (5-AZA-dC), a potent inhibitor of DNA methylation, can modify chromatin and restore the ability of tumor necrosis factor alpha (TNFalpha) to induce monocytic differentiation of the <span class=""disease"">acute myeloid leukemia</span> cells NB4 and U937.",,19117987,19117987_C014347_D015470,19117987_2,bcv_sentence_task_befree_3336,,770959265,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,1,,D008712,"<span class=""chemical"">methicillin</span>",D011023,"<span class=""disease"">Staphylococcus aureus carriage</span>","Clustering and risk factors of <span class=""chemical"">methicillin</span>-resistant <span class=""disease"">Staphylococcus aureus carriage</span> in two Italian long-term care facilities.",,19148574,19148574_D008712_D011023,19148574_0,bcv_sentence_task_befree_3337,,770959266,FALSE,finalized,5,8/15/15 0:46,"



",no_relation,1,,D008712,"<span class=""chemical"">Methicillin</span>",D011023,"<span class=""disease"">MRSA/Methicillin-resistant Staphylococcus aureus</span>","<span class=""chemical""></span><span class=""disease"">Methicillin</span>-resistant Staphylococcus aureus (<span class=""disease"">MRSA</span>) is a well-recognized agent of health care-associated infections in long-term care facilities, but few data about the circulation of <span class=""disease"">MRSA</span> in this setting in Italy are available.",,19148574,19148574_D008712_D011023,19148574_1,bcv_sentence_task_befree_3338,,770959267,FALSE,finalized,5,8/15/15 0:14,"



",no_relation,0.789,,D008712,"<span class=""chemical"">Methicillin</span>",D007239,"<span class=""disease"">infections</span>","<span class=""chemical"">Methicillin</span>-resistant Staphylococcus aureus (MRSA) is a well-recognized agent of health care-associated <span class=""disease"">infections</span> in long-term care facilities, but few data about the circulation of MRSA in this setting in Italy are available.",,19148574,19148574_D008712_D007239,19148574_1,bcv_sentence_task_befree_3339,,770959268,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,1,,D009532,"<span class=""chemical"">nickel</span>",D006949,"<span class=""disease"">hyperlipidemia</span>","According to multivariate analysis, the most significant predictor for CR-ISR was reference vessel diameter (P=.0010) followed by <span class=""chemical"">nickel</span>-positive (P=.0033) and <span class=""disease"">hyperlipidemia</span> (P=.0305).",,19159850,19159850_D009532_D006949,19159850_7,bcv_sentence_task_befree_3340,,770959269,FALSE,finalized,5,8/15/15 2:19,"



",no_relation,0.5768,,D016572,"<span class=""chemical"">cyclosporine</span>",D001171,"<span class=""disease"">Still's disease</span>","Glucocorticoid and <span class=""chemical"">cyclosporine</span> refractory adult onset <span class=""disease"">Still's disease</span> successfully treated with tocilizumab.",,19184270,19184270_D016572_D001171,19184270_0,bcv_sentence_task_befree_3341,,770959270,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,0.7982,,D013256,"<span class=""chemical"">steroid</span>",D006013,"<span class=""disease"">Her disease</span>","<span class=""disease"">Her disease</span> was refractory to high-dose glucocorticoids, two courses of <span class=""chemical"">steroid</span> pulse therapy, and addition of cyclosporine (3.5 mg/kg/day).",,19184270,19184270_D013256_D006013,19184270_2,bcv_sentence_task_befree_3342,,770959271,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,0.6062,,D016572,"<span class=""chemical"">cyclosporine</span>",D006013,"<span class=""disease"">Her disease</span>","<span class=""disease"">Her disease</span> was refractory to high-dose glucocorticoids, two courses of steroid pulse therapy, and addition of <span class=""chemical"">cyclosporine</span> (3.5 mg/kg/day).",,19184270,19184270_D016572_D006013,19184270_2,bcv_sentence_task_befree_3343,,770959272,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,1,,D016572,"<span class=""chemical"">Cyclosporine</span>",D017093,"<span class=""disease"">hepatic failure</span>","<span class=""chemical"">Cyclosporine</span> is one of the first-line immunosuppressants for AOSD, especially when associated with DIC, <span class=""disease"">hepatic failure</span>, or hemophagocytic syndrome.",,19184270,19184270_D016572_D017093,19184270_7,bcv_sentence_task_befree_3344,,770959273,FALSE,finalized,5,8/14/15 21:04,"



",no_relation,0.8089,,D016572,"<span class=""chemical"">Cyclosporine</span>",D051359,"<span class=""disease"">hemophagocytic syndrome</span>","<span class=""chemical"">Cyclosporine</span> is one of the first-line immunosuppressants for AOSD, especially when associated with DIC, hepatic failure, or <span class=""disease"">hemophagocytic syndrome</span>.",,19184270,19184270_D016572_D051359,19184270_7,bcv_sentence_task_befree_3345,,770959274,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,1,,D005472,"<span class=""chemical"">5-fluorouracil</span>",D009369,"<span class=""disease"">rectal cancer</span>","Patients with histological proven <span class=""disease"">rectal cancer</span> staged T2N+ or T3 are randomized to receive either SCRT (25 Gy in five fractions of 5 Gy) plus TME-surgery within 5 days or RCT (50.4 Gy in 28 fractions of 1.8 Gy, continuous infusion <span class=""chemical"">5-fluorouracil</span>) plus TME-surgery 4-6 weeks later.",,19200365,19200365_D005472_D009369,19200365_6,bcv_sentence_task_befree_3346,,770959275,FALSE,finalized,5,8/14/15 21:43,"



",no_relation,1,,D005472,"<span class=""chemical"">5-fluorouracil</span>",C535338,"<span class=""disease"">TME</span>","Patients with histological proven rectal cancer staged T2N+ or T3 are randomized to receive either SCRT (25 Gy in five fractions of 5 Gy) plus <span class=""disease"">TME</span>-surgery within 5 days or RCT (50.4 Gy in 28 fractions of 1.8 Gy, continuous infusion <span class=""chemical"">5-fluorouracil</span>) plus <span class=""disease"">TME</span>-surgery 4-6 weeks later.",,19200365,19200365_D005472_C535338,19200365_6,bcv_sentence_task_befree_3347,,770959276,FALSE,finalized,5,8/14/15 21:10,"



",no_relation,0.8009,,C089995,"<span class=""chemical"">glatiramer acetate</span>",D003866,"<span class=""disease"">depressive symptoms</span>","There is some evidence that interferon-beta treatment may exacerbate <span class=""disease"">depressive symptoms</span> and a switch to <span class=""chemical"">glatiramer acetate</span> can be envisaged in patients treated with an interferon-beta in whom <span class=""disease"">depressive symptoms</span> become an issue.",,19200865,19200865_C089995_D003866,19200865_5,bcv_sentence_task_befree_3348,,770959277,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,0.6074,,C089995,"<span class=""chemical"">glatiramer acetate</span>",D005221,"<span class=""disease"">fatigue</span>","There is growing evidence that immunomodulatory treatments, in particular <span class=""chemical"">glatiramer acetate</span>, improve <span class=""disease"">fatigue</span> symptoms in patients with multiple sclerosis.",,19200865,19200865_C089995_D005221,19200865_8,bcv_sentence_task_befree_3349,,770959278,FALSE,finalized,5,8/14/15 23:29,"



",no_relation,1,,C089995,"<span class=""chemical"">glatiramer acetate</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","There is growing evidence that immunomodulatory treatments, in particular <span class=""chemical"">glatiramer acetate</span>, improve fatigue symptoms in patients with <span class=""disease"">multiple sclerosis</span>.",,19200865,19200865_C089995_D009103,19200865_8,bcv_sentence_task_befree_3350,,770959279,FALSE,finalized,5,8/15/15 2:08,"



",no_relation,1,,D015032,"<span class=""chemical"">zinc</span>",D006527,"<span class=""disease"">Wilson disease</span>","Systematic review: clinical efficacy of chelator agents and <span class=""chemical"">zinc</span> in the initial treatment of <span class=""disease"">Wilson disease</span>.",,19210288,19210288_D015032_D006527,19210288_0,bcv_sentence_task_befree_3351,,770959280,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,1,,D010396,"<span class=""chemical"">D-penicillamine</span>",D006527,"<span class=""disease"">Wilson disease</span>","Original studies on clinical efficacy of <span class=""chemical"">D-penicillamine</span>, trientine, tetrathiomolybdate or zinc monotherapy as initial treatment in <span class=""disease"">Wilson disease</span> were included.",,19210288,19210288_D010396_D006527,19210288_4,bcv_sentence_task_befree_3352,,770959281,FALSE,finalized,5,8/14/15 21:20,"



",no_relation,1,,D015032,"<span class=""chemical"">zinc</span>",D006527,"<span class=""disease"">Wilson disease</span>","Original studies on clinical efficacy of D-penicillamine, trientine, tetrathiomolybdate or <span class=""chemical"">zinc</span> monotherapy as initial treatment in <span class=""disease"">Wilson disease</span> were included.",,19210288,19210288_D015032_D006527,19210288_4,bcv_sentence_task_befree_3353,,770959282,FALSE,finalized,5,8/14/15 21:49,"



",no_relation,1,,D014266,"<span class=""chemical"">trientine</span>",D006527,"<span class=""disease"">Wilson disease</span>","Original studies on clinical efficacy of D-penicillamine, <span class=""chemical"">trientine</span>, tetrathiomolybdate or zinc monotherapy as initial treatment in <span class=""disease"">Wilson disease</span> were included.",,19210288,19210288_D014266_D006527,19210288_4,bcv_sentence_task_befree_3354,,770959283,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,1,,C020809,"<span class=""chemical"">tetrathiomolybdate</span>",D006527,"<span class=""disease"">Wilson disease</span>","Original studies on clinical efficacy of D-penicillamine, trientine, <span class=""chemical"">tetrathiomolybdate</span> or zinc monotherapy as initial treatment in <span class=""disease"">Wilson disease</span> were included.",,19210288,19210288_C020809_D006527,19210288_4,bcv_sentence_task_befree_3355,,770959284,FALSE,finalized,5,8/14/15 23:23,"



",no_relation,1,,D010396,"<span class=""chemical"">D-penicillamine</span>",D006527,"<span class=""disease"">Wilson disease</span>","Nevertheless, according to currently available data, patients with hepatic presentation of <span class=""disease"">Wilson disease</span> are probably most effectively treated by <span class=""chemical"">D-penicillamine</span>.",,19210288,19210288_D010396_D006527,19210288_8,bcv_sentence_task_befree_3356,,770959285,FALSE,finalized,5,8/15/15 1:43,"



",no_relation,1,,D012428,"<span class=""chemical"">ruthenium</span>",D009369,"<span class=""disease"">tumors</span>","Among these drugs, <span class=""chemical"">ruthenium</span> compounds have been showing promising results to treat <span class=""disease"">tumors</span> and represent an important development of new antitumor therapy.",,19214395,19214395_D012428_D009369,19214395_2,bcv_sentence_task_befree_3357,,770959286,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,1,,C543901,"<span class=""chemical"">cis-[RuCl(2)(NH(3))(4)]Cl</span>",C536987,"<span class=""disease"">MI</span>","<span class=""disease"">MI</span> in human peripheral blood lymphocyte cultures treated with 1, 10, 100, and 1,000 microg mL(-1) <span class=""chemical"">cis-[RuCl(2)(NH(3))(4)]Cl</span> were 5.9%, 4.6%, 3.9%, and 0%, respectively.",,19214395,19214395_C543901_C536987,19214395_5,bcv_sentence_task_befree_3358,,770959287,FALSE,finalized,5,8/15/15 1:19,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroid</span>",D015472,"<span class=""disease"">acute eosinophilic pneumonia</span>","With the exception of <span class=""disease"">acute eosinophilic pneumonia</span>, which responds well to <span class=""chemical"">corticosteroid</span> therapy, the role of <span class=""chemical"">corticosteroid</span> and other immune-suppressive treatments in the management of smoking-related interstitial lung diseases is not entirely clear and is probably of limited utility, particularly in the absence of smoking cessation.",,19221962,19221962_D000305_D015472,19221962_6,bcv_sentence_task_befree_3359,,770959288,FALSE,finalized,5,8/15/15 0:23,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroid</span>",D017563,"<span class=""disease"">interstitial lung diseases</span>","With the exception of acute eosinophilic pneumonia, which responds well to <span class=""chemical"">corticosteroid</span> therapy, the role of <span class=""chemical"">corticosteroid</span> and other immune-suppressive treatments in the management of smoking-related <span class=""disease"">interstitial lung diseases</span> is not entirely clear and is probably of limited utility, particularly in the absence of smoking cessation.",,19221962,19221962_D000305_D017563,19221962_6,bcv_sentence_task_befree_3360,,770959289,FALSE,finalized,5,8/14/15 21:15,"



",no_relation,0.8048,,D002784,"<span class=""chemical"">cholesterol</span>",D052439,"<span class=""disease"">lipid disorders</span>","In this cross-sectional study in dyslipidaemic patients receiving lipid-lowering therapy, <span class=""disease"">lipid disorders</span> were defined as triglyceride greater than 1.5 g/L, HDL-C lesser than 0.4 g/L and low-density lipoprotein <span class=""chemical"">cholesterol</span> (LDL-C) above the recommended concentration according to French guidelines.",,19233108,19233108_D002784_D052439,19233108_2,bcv_sentence_task_befree_3361,,770959290,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,D015761,"<span class=""chemical"">4-aminopyridine</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","Clinical studies suggested that fampridine (<span class=""chemical"">4-aminopyridine</span>) improves motor function in people with <span class=""disease"">multiple sclerosis</span>.",,19249634,19249634_D015761_D009103,19249634_1,bcv_sentence_task_befree_3362,,770959291,FALSE,finalized,5,8/14/15 21:43,"



",no_relation,1,,D008012,"<span class=""chemical"">lidocaine</span>",D005356,"<span class=""disease"">fibromyalgia</span>","Intravenous <span class=""chemical"">lidocaine</span> for <span class=""disease"">fibromyalgia</span> syndrome: an open trial.",,19263182,19263182_D008012_D005356,19263182_0,bcv_sentence_task_befree_3363,,770959292,FALSE,finalized,5,8/14/15 21:59,"



",no_relation,1,,D008012,"<span class=""chemical"">lidocaine</span>",D005356,"<span class=""disease"">fibromyalgia</span>","In this study, we investigated the effect of intravenous infusions of <span class=""chemical"">lidocaine</span> in pain and quality of life of patients with <span class=""disease"">fibromyalgia</span>.",,19263182,19263182_D008012_D005356,19263182_2,bcv_sentence_task_befree_3364,,770959293,FALSE,finalized,5,8/15/15 0:30,"



",no_relation,0.7951,,D008012,"<span class=""chemical"">lidocaine</span>",D010146,"<span class=""disease"">pain</span>","In this study, we investigated the effect of intravenous infusions of <span class=""chemical"">lidocaine</span> in <span class=""disease"">pain</span> and quality of life of patients with fibromyalgia.",,19263182,19263182_D008012_D010146,19263182_2,bcv_sentence_task_befree_3365,,770959294,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,1,,D008012,"<span class=""chemical"">lidocaine</span>",D005356,"<span class=""disease"">Fibromyalgia</span>","<span class=""disease"">Fibromyalgia</span> Impact Questionnaire (FIQ), Health Assessment Questionnaire, and a visual analog scale (VAS) for pain were applied before the first <span class=""chemical"">lidocaine</span> infusion, immediately after the fifth infusion and 30 days after the fifth infusion.",,19263182,19263182_D008012_D005356,19263182_4,bcv_sentence_task_befree_3366,,770959295,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,0.6101,,D008012,"<span class=""chemical"">lidocaine</span>",D010146,"<span class=""disease"">pain</span>","Fibromyalgia Impact Questionnaire (FIQ), Health Assessment Questionnaire, and a visual analog scale (VAS) for <span class=""disease"">pain</span> were applied before the first <span class=""chemical"">lidocaine</span> infusion, immediately after the fifth infusion and 30 days after the fifth infusion.",,19263182,19263182_D008012_D010146,19263182_4,bcv_sentence_task_befree_3367,,770959296,FALSE,finalized,5,8/14/15 21:07,"



",no_relation,1,,D008012,"<span class=""chemical"">lidocaine</span>",D005356,"<span class=""disease"">fibromyalgia</span>","Intravenous <span class=""chemical"">lidocaine</span> infusions are safe and effective in the management of <span class=""disease"">fibromyalgia</span>.",,19263182,19263182_D008012_D005356,19263182_7,bcv_sentence_task_befree_3368,,770959297,FALSE,finalized,5,8/15/15 2:34,"



",no_relation,1,,C060836,"<span class=""chemical"">Pioglitazone</span>",D044882,"<span class=""disease"">impaired glucose tolerance</span>","<span class=""chemical"">Pioglitazone</span> does not enhance the effectiveness of lifestyle modification in preventing conversion of <span class=""disease"">impaired glucose tolerance</span> to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2).",,19277602,19277602_C060836_D044882,19277602_0,bcv_sentence_task_befree_3369,,770959298,FALSE,finalized,5,8/15/15 2:07,"



",no_relation,1,,C060836,"<span class=""chemical"">Pioglitazone</span>",D003929,"<span class=""disease"">diabetes</span>","<span class=""chemical"">Pioglitazone</span> does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to <span class=""disease"">diabetes</span> in Asian Indians: results of the Indian <span class=""disease"">Diabetes</span> Prevention Programme-2 (IDPP-2).",,19277602,19277602_C060836_D003929,19277602_0,bcv_sentence_task_befree_3370,,770959299,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D044882,"<span class=""disease"">impaired glucose tolerance</span>","Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of <span class=""disease"">impaired </span><span class=""chemical"">glucose</span> tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2).",,19277602,19277602_D005947_D044882,19277602_0,bcv_sentence_task_befree_3371,,770959300,FALSE,finalized,5,8/14/15 21:18,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003929,"<span class=""disease"">diabetes</span>","Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired <span class=""chemical"">glucose</span> tolerance to <span class=""disease"">diabetes</span> in Asian Indians: results of the Indian <span class=""disease"">Diabetes</span> Prevention Programme-2 (IDPP-2).",,19277602,19277602_D005947_D003929,19277602_0,bcv_sentence_task_befree_3372,,770959301,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,0.801,,D005947,"<span class=""chemical"">glucose</span>",D003929,"<span class=""disease"">diabetes</span>","The objective of this prevention programme was to study whether combining pioglitazone with lifestyle modification would enhance the efficacy of lifestyle modification in preventing type 2 <span class=""disease"">diabetes</span> in Asian Indians with impaired <span class=""chemical"">glucose</span> tolerance.",,19277602,19277602_D005947_D003929,19277602_1,bcv_sentence_task_befree_3373,,770959302,FALSE,finalized,5,8/14/15 21:40,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D044882,"<span class=""disease"">impaired glucose tolerance</span>","The objective of this prevention programme was to study whether combining pioglitazone with lifestyle modification would enhance the efficacy of lifestyle modification in preventing type 2 diabetes in Asian Indians with <span class=""disease"">impaired </span><span class=""chemical"">glucose</span> tolerance.",,19277602,19277602_D005947_D044882,19277602_1,bcv_sentence_task_befree_3374,,770959303,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",C537389,"<span class=""disease"">type</span>","The objective of this prevention programme was to study whether combining pioglitazone with lifestyle modification would enhance the efficacy of lifestyle modification in preventing <span class=""disease"">type</span> 2 diabetes in Asian Indians with impaired <span class=""chemical"">glucose</span> tolerance.",,19277602,19277602_D005947_C537389,19277602_1,bcv_sentence_task_befree_3375,,770959304,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,C060836,"<span class=""chemical"">pioglitazone</span>",D044882,"<span class=""disease"">impaired glucose tolerance</span>","The objective of this prevention programme was to study whether combining <span class=""chemical"">pioglitazone</span> with lifestyle modification would enhance the efficacy of lifestyle modification in preventing type 2 diabetes in Asian Indians with <span class=""disease"">impaired glucose tolerance</span>.",,19277602,19277602_C060836_D044882,19277602_1,bcv_sentence_task_befree_3376,,770959305,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,C060836,"<span class=""chemical"">pioglitazone</span>",D003929,"<span class=""disease"">diabetes</span>","The objective of this prevention programme was to study whether combining <span class=""chemical"">pioglitazone</span> with lifestyle modification would enhance the efficacy of lifestyle modification in preventing type 2 <span class=""disease"">diabetes</span> in Asian Indians with impaired glucose tolerance.",,19277602,19277602_C060836_D003929,19277602_1,bcv_sentence_task_befree_3377,,770959306,FALSE,finalized,5,8/15/15 2:22,"



",no_relation,1,,C060836,"<span class=""chemical"">pioglitazone</span>",C537389,"<span class=""disease"">type</span>","The objective of this prevention programme was to study whether combining <span class=""chemical"">pioglitazone</span> with lifestyle modification would enhance the efficacy of lifestyle modification in preventing <span class=""disease"">type</span> 2 diabetes in Asian Indians with impaired glucose tolerance.",,19277602,19277602_C060836_C537389,19277602_1,bcv_sentence_task_befree_3378,,770959307,FALSE,finalized,5,8/15/15 1:38,"



",no_relation,1,,C060836,"<span class=""chemical"">pioglitazone</span>",D044882,"<span class=""disease"">impaired glucose tolerance</span>","In a community-based, placebo-controlled 3 year prospective study, 407 participants with <span class=""disease"">impaired glucose tolerance</span> (mean age 45.3 +/- 6.2 years, mean BMI 25.9 +/- 3.3 kg/m(2)) were sequentially grouped to receive either: lifestyle modification plus <span class=""chemical"">pioglitazone</span>, 30 mg (n = 204) or lifestyle modification plus placebo (n = 203).",,19277602,19277602_C060836_D044882,19277602_2,bcv_sentence_task_befree_3379,,770959308,FALSE,finalized,5,8/14/15 22:50,"



'impaired glucose tolerance' is the whole term and should not be evaluated as the juxtaposition of its parts. :)",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D044882,"<span class=""disease"">impaired glucose tolerance</span>","In a community-based, placebo-controlled 3 year prospective study, 407 participants with <span class=""disease"">impaired </span><span class=""chemical"">glucose</span> tolerance (mean age 45.3 +/- 6.2 years, mean BMI 25.9 +/- 3.3 kg/m(2)) were sequentially grouped to receive either: lifestyle modification plus pioglitazone, 30 mg (n = 204) or lifestyle modification plus placebo (n = 203).",,19277602,19277602_D005947_D044882,19277602_2,bcv_sentence_task_befree_3380,,770959309,FALSE,finalized,5,8/14/15 21:42,"



",yes_direct,0.8045,,C060836,"<span class=""chemical"">pioglitazone</span>",D003929,"<span class=""disease"">diabetes</span>","The cumulative incidence of <span class=""disease"">diabetes</span> was 29.8% with <span class=""chemical"">pioglitazone</span> and 31.6% with placebo (unadjusted HR 1.084 [95% CI 0.753-1.560], p = 0.665).",,19277602,19277602_C060836_D003929,19277602_7,bcv_sentence_task_befree_3381,,770959310,FALSE,finalized,5,8/14/15 21:04,"



",no_relation,0.6036,,C060836,"<span class=""chemical"">pioglitazone</span>",D006331,"<span class=""disease"">cardiac disease</span>","In <span class=""chemical"">pioglitazone</span> group, two deaths and two non-fatal hospitalisations occurred due to cardiac problems; in the placebo group there were two occurrences of <span class=""disease"">cardiac disease</span>.",,19277602,19277602_C060836_D006331,19277602_9,bcv_sentence_task_befree_3382,,770959311,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,0.7818,,C060836,"<span class=""chemical"">pioglitazone</span>",D003643,"<span class=""disease"">deaths</span>","In <span class=""chemical"">pioglitazone</span> group, two <span class=""disease"">deaths</span> and two non-fatal hospitalisations occurred due to cardiac problems; in the placebo group there were two occurrences of cardiac disease.",,19277602,19277602_C060836_D003643,19277602_9,bcv_sentence_task_befree_3383,,770959312,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,C060836,"<span class=""chemical"">pioglitazone</span>",D003929,"<span class=""disease"">diabetes</span>","The results are at variance with studies that showed significant relative risk reduction in conversion to <span class=""disease"">diabetes</span> with <span class=""chemical"">pioglitazone</span> in Americans with IGT.",,19277602,19277602_C060836_D003929,19277602_12,bcv_sentence_task_befree_3384,,770959313,FALSE,finalized,5,8/14/15 21:12,"



",no_relation,1,,C060836,"<span class=""chemical"">pioglitazone</span>",D003929,"<span class=""disease"">diabetic</span>","An ethnicity-related difference in the action of <span class=""chemical"">pioglitazone</span> in non-<span class=""disease"">diabetic</span> participants may be one explanation.",,19277602,19277602_C060836_D003929,19277602_13,bcv_sentence_task_befree_3385,,770959314,FALSE,finalized,5,8/15/15 0:17,"



",no_relation,1,,D016190,"<span class=""chemical"">carboplatin</span>",D009369,"<span class=""disease"">tumor</span>","Rational and successful use of <span class=""chemical"">carboplatin</span> and albumin-bound paclitaxel in a patient with recurrent metaplastic carcinoma who presented with multi-organ <span class=""disease"">tumor</span> emboli.",,19299243,19299243_D016190_D009369,19299243_0,bcv_sentence_task_befree_3386,,770959315,FALSE,finalized,5,8/14/15 21:53,"



",no_relation,1,,D016190,"<span class=""chemical"">carboplatin</span>",D002277,"<span class=""disease"">metaplastic carcinoma</span>","Rational and successful use of <span class=""chemical"">carboplatin</span> and albumin-bound paclitaxel in a patient with recurrent <span class=""disease"">metaplastic carcinoma</span> who presented with multi-organ tumor emboli.",,19299243,19299243_D016190_D002277,19299243_0,bcv_sentence_task_befree_3387,,770959316,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,D017239,"<span class=""chemical"">paclitaxel</span>",D009369,"<span class=""disease"">tumor</span>","Rational and successful use of carboplatin and albumin-bound <span class=""chemical"">paclitaxel</span> in a patient with recurrent metaplastic carcinoma who presented with multi-organ <span class=""disease"">tumor</span> emboli.",,19299243,19299243_D017239_D009369,19299243_0,bcv_sentence_task_befree_3388,,770959317,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D017239,"<span class=""chemical"">paclitaxel</span>",D002277,"<span class=""disease"">metaplastic carcinoma</span>","Rational and successful use of carboplatin and albumin-bound <span class=""chemical"">paclitaxel</span> in a patient with recurrent <span class=""disease"">metaplastic carcinoma</span> who presented with multi-organ tumor emboli.",,19299243,19299243_D017239_D002277,19299243_0,bcv_sentence_task_befree_3389,,770959318,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,0.824,,D002945,"<span class=""chemical"">cisplatin</span>",D000860,"<span class=""disease"">hypoxia</span>","NSC606985 induces apoptosis, exerts synergistic effects with <span class=""chemical"">cisplatin</span>, and inhibits <span class=""disease"">hypoxia</span>-stabilized HIF-1alpha protein in human ovarian cancer cells.",,19339107,19339107_D002945_D000860,19339107_0,bcv_sentence_task_befree_3390,,770959319,FALSE,finalized,5,8/14/15 21:34,"



",no_relation,1,,C514334,"<span class=""chemical"">NSC606985</span>",D000860,"<span class=""disease"">hypoxia</span>","<span class=""chemical"">NSC606985</span> induces apoptosis, exerts synergistic effects with cisplatin, and inhibits <span class=""disease"">hypoxia</span>-stabilized HIF-1alpha protein in human ovarian cancer cells.",,19339107,19339107_C514334_D000860,19339107_0,bcv_sentence_task_befree_3391,,770959320,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D009369,"<span class=""disease"">ovarian cancer</span>","NSC606985 induces apoptosis, exerts synergistic effects with <span class=""chemical"">cisplatin</span>, and inhibits hypoxia-stabilized HIF-1alpha protein in human <span class=""disease"">ovarian cancer</span> cells.",,19339107,19339107_D002945_D009369,19339107_0,bcv_sentence_task_befree_3392,,770959321,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,0.8126,,C514334,"<span class=""chemical"">NSC606985</span>",D009369,"<span class=""disease"">ovarian cancer</span>","<span class=""chemical"">NSC606985</span> induces apoptosis, exerts synergistic effects with cisplatin, and inhibits hypoxia-stabilized HIF-1alpha protein in human <span class=""disease"">ovarian cancer</span> cells.",,19339107,19339107_C514334_D009369,19339107_0,bcv_sentence_task_befree_3393,,770959322,FALSE,finalized,5,8/15/15 0:03,"


Possible treatment.
",no_relation,0.6058,,C514334,"<span class=""chemical"">NSC606985</span>",D009369,"<span class=""disease"">ovarian cancer</span>","In the present study, we investigated the potential anti-human <span class=""disease"">ovarian cancer</span> effects of <span class=""chemical"">NSC606985</span>, a novel and rarely studied camptothecin analog, and its combination with cisplatin (CDDP).",,19339107,19339107_C514334_D009369,19339107_2,bcv_sentence_task_befree_3394,,770959323,FALSE,finalized,5,8/14/15 22:55,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin/CDDP</span>",D009369,"<span class=""disease"">ovarian cancer</span>","In the present study, we investigated the potential anti-human <span class=""disease"">ovarian cancer</span> effects of NSC606985, a novel and rarely studied camptothecin analog, and its combination with <span class=""chemical"">cisplatin</span> (<span class=""chemical"">CDDP</span>).",,19339107,19339107_D002945_D009369,19339107_2,bcv_sentence_task_befree_3395,,770959324,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,D002166,"<span class=""chemical"">camptothecin</span>",D009369,"<span class=""disease"">ovarian cancer</span>","In the present study, we investigated the potential anti-human <span class=""disease"">ovarian cancer</span> effects of NSC606985, a novel and rarely studied <span class=""chemical"">camptothecin</span> analog, and its combination with cisplatin (CDDP).",,19339107,19339107_D002166_D009369,19339107_2,bcv_sentence_task_befree_3396,,770959325,FALSE,finalized,5,8/14/15 21:49,"



",no_relation,1,,D002945,"<span class=""chemical"">CDDP</span>",D009369,"<span class=""disease"">ovarian cancer</span>","Human <span class=""disease"">ovarian cancer</span> cell line COC1 cells were treated with different nanomolar of NSC606985 with or without <span class=""chemical"">CDDP</span>, and cell growth and apoptosis were evaluated, respectively, by MTT assay and annexin-V assay on flow cytometry.",,19339107,19339107_D002945_D009369,19339107_3,bcv_sentence_task_befree_3397,,770959326,FALSE,finalized,5,8/14/15 22:08,"



",no_relation,1,,C514334,"<span class=""chemical"">NSC606985</span>",D009369,"<span class=""disease"">ovarian cancer</span>","Human <span class=""disease"">ovarian cancer</span> cell line COC1 cells were treated with different nanomolar of <span class=""chemical"">NSC606985</span> with or without CDDP, and cell growth and apoptosis were evaluated, respectively, by MTT assay and annexin-V assay on flow cytometry.",,19339107,19339107_C514334_D009369,19339107_3,bcv_sentence_task_befree_3398,,770959327,FALSE,finalized,5,8/15/15 1:41,"



",no_relation,0.7878,,C514334,"<span class=""chemical"">NSC606985</span>",D000860,"<span class=""disease"">hypoxia</span>","In addition, <span class=""chemical"">NSC606985</span> significantly antagonized the accumulation of HIF-1alpha stabilized by <span class=""disease"">hypoxia</span> or <span class=""disease"">hypoxia</span>-mimetic agent.",,19339107,19339107_C514334_D000860,19339107_8,bcv_sentence_task_befree_3399,,770959328,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,1,,D002945,"<span class=""chemical"">CDDP</span>",D009369,"<span class=""disease"">ovarian cancer</span>","These results suggest that NSC606985 and its combination with <span class=""chemical"">CDDP</span> present the therapeutic potential on <span class=""disease"">ovarian cancer</span>, and deserve further preclinical and clinical studies.",,19339107,19339107_D002945_D009369,19339107_9,bcv_sentence_task_befree_3400,,770959329,FALSE,finalized,5,8/15/15 0:51,"



",no_relation,1,,C514334,"<span class=""chemical"">NSC606985</span>",D009369,"<span class=""disease"">ovarian cancer</span>","These results suggest that <span class=""chemical"">NSC606985</span> and its combination with CDDP present the therapeutic potential on <span class=""disease"">ovarian cancer</span>, and deserve further preclinical and clinical studies.",,19339107,19339107_C514334_D009369,19339107_9,bcv_sentence_task_befree_3401,,770959330,FALSE,finalized,5,8/14/15 21:49,"



",no_relation,0.7906,,D008985,"<span class=""chemical"">monensin</span>",D000230,"<span class=""disease"">adenocarcinoma</span>","The monolayers of Human ileocecal <span class=""disease"">adenocarcinoma</span> cells (HCT-8) were infected by sporozoites excysted directly on the cells and were incubated with <span class=""chemical"">monensin</span>, halofuginone bromide and hexadecylphosphocholine until 45h post infection (p.i.).",,19342176,19342176_D008985_D000230,19342176_3,bcv_sentence_task_befree_3402,,770959331,FALSE,finalized,5,8/14/15 21:11,"



",no_relation,0.8018,,D008985,"<span class=""chemical"">monensin</span>",D007239,"<span class=""disease"">infection</span>","The monolayers of Human ileocecal adenocarcinoma cells (HCT-8) were infected by sporozoites excysted directly on the cells and were incubated with <span class=""chemical"">monensin</span>, halofuginone bromide and hexadecylphosphocholine until 45h post <span class=""disease"">infection</span> (p.i.).",,19342176,19342176_D008985_D007239,19342176_3,bcv_sentence_task_befree_3403,,770959332,FALSE,finalized,5,8/15/15 1:28,"



",no_relation,1,,C039128,"<span class=""chemical"">hexadecylphosphocholine</span>",D000230,"<span class=""disease"">adenocarcinoma</span>","The monolayers of Human ileocecal <span class=""disease"">adenocarcinoma</span> cells (HCT-8) were infected by sporozoites excysted directly on the cells and were incubated with monensin, halofuginone bromide and <span class=""chemical"">hexadecylphosphocholine</span> until 45h post infection (p.i.).",,19342176,19342176_C039128_D000230,19342176_3,bcv_sentence_task_befree_3404,,770959333,FALSE,finalized,5,8/14/15 22:31,"



",no_relation,1,,C039128,"<span class=""chemical"">hexadecylphosphocholine</span>",D007239,"<span class=""disease"">infection</span>","The monolayers of Human ileocecal adenocarcinoma cells (HCT-8) were infected by sporozoites excysted directly on the cells and were incubated with monensin, halofuginone bromide and <span class=""chemical"">hexadecylphosphocholine</span> until 45h post <span class=""disease"">infection</span> (p.i.).",,19342176,19342176_C039128_D007239,19342176_3,bcv_sentence_task_befree_3405,,770959334,FALSE,finalized,5,8/15/15 0:10,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D002289,"<span class=""disease"">non-small cell lung cancer</span>","Epidermal growth factor receptor <span class=""chemical"">tyrosine</span> kinase inhibitors in elderly or poor performance status patients with advanced <span class=""disease"">non-small cell lung cancer</span>.",,19343300,19343300_D014443_D002289,19343300_0,bcv_sentence_task_befree_3406,,770959335,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,1,,D014443,"<span class=""chemical"">Tyrosine</span>",D002289,"<span class=""disease"">NSCLC</span>","<span class=""chemical"">Tyrosine</span> kinase inhibitors (TKIs) of the epidermal growth factor receptor (EGFR), erlotinib and gefitinib, are active agents in the treatment of advanced <span class=""disease"">NSCLC</span>.",,19343300,19343300_D014443_D002289,19343300_3,bcv_sentence_task_befree_3407,,770959336,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,1,,C400278,"<span class=""chemical"">erlotinib</span>",D002289,"<span class=""disease"">NSCLC</span>","Tyrosine kinase inhibitors (TKIs) of the epidermal growth factor receptor (EGFR), <span class=""chemical"">erlotinib</span> and gefitinib, are active agents in the treatment of advanced <span class=""disease"">NSCLC</span>.",,19343300,19343300_C400278_D002289,19343300_3,bcv_sentence_task_befree_3408,,770959337,FALSE,finalized,5,8/14/15 21:10,"



",no_relation,1,,C419708,"<span class=""chemical"">gefitinib</span>",D002289,"<span class=""disease"">NSCLC</span>","Tyrosine kinase inhibitors (TKIs) of the epidermal growth factor receptor (EGFR), erlotinib and <span class=""chemical"">gefitinib</span>, are active agents in the treatment of advanced <span class=""disease"">NSCLC</span>.",,19343300,19343300_C419708_D002289,19343300_3,bcv_sentence_task_befree_3409,,770959338,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,1,,C400278,"<span class=""chemical"">erlotinib</span>",D002289,"<span class=""disease"">NSCLC</span>","This review will summarize the results of <span class=""chemical"">erlotinib</span> or gefitinib in these subsets of patients with advanced <span class=""disease"">NSCLC</span>.",,19343300,19343300_C400278_D002289,19343300_5,bcv_sentence_task_befree_3410,,770959339,FALSE,finalized,5,8/15/15 1:29,"



",no_relation,0.8032,,C419708,"<span class=""chemical"">gefitinib</span>",D002289,"<span class=""disease"">NSCLC</span>","This review will summarize the results of erlotinib or <span class=""chemical"">gefitinib</span> in these subsets of patients with advanced <span class=""disease"">NSCLC</span>.",,19343300,19343300_C419708_D002289,19343300_5,bcv_sentence_task_befree_3411,,770959340,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,D009241,"<span class=""chemical"">ipratropium bromide</span>",D002559,"<span class=""disease"">rhinorrhea</span>","This review assesses two widely used intranasal treatments for nasal congestion and <span class=""disease"">rhinorrhea</span> in the common cold: xylometazoline hydrochloride and <span class=""chemical"">ipratropium bromide</span>.",,19351236,19351236_D009241_D002559,19351236_2,bcv_sentence_task_befree_3412,,770959341,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,1,,C009695,"<span class=""chemical"">xylometazoline hydrochloride</span>",D002559,"<span class=""disease"">rhinorrhea</span>","This review assesses two widely used intranasal treatments for nasal congestion and <span class=""disease"">rhinorrhea</span> in the common cold: <span class=""chemical"">xylometazoline hydrochloride</span> and ipratropium bromide.",,19351236,19351236_C009695_D002559,19351236_2,bcv_sentence_task_befree_3413,,770959342,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,1,,D009241,"<span class=""chemical"">ipratropium</span>",D002559,"<span class=""disease"">rhinorrhea</span>","Xylometazoline quickly and effectively relieves nasal congestion, while <span class=""chemical"">ipratropium</span> is effective at reducing <span class=""disease"">rhinorrhea</span>.",,19351236,19351236_D009241_D002559,19351236_3,bcv_sentence_task_befree_3414,,770959343,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,1,,C009695,"<span class=""chemical"">Xylometazoline</span>",D002559,"<span class=""disease"">rhinorrhea</span>","<span class=""chemical"">Xylometazoline</span> quickly and effectively relieves nasal congestion, while ipratropium is effective at reducing <span class=""disease"">rhinorrhea</span>.",,19351236,19351236_C009695_D002559,19351236_3,bcv_sentence_task_befree_3415,,770959344,FALSE,finalized,5,8/14/15 22:24,"



",no_relation,1,,C471405,"<span class=""chemical"">sorafenib</span>",C536915,"<span class=""disease"">papillary thyroid carcinoma</span>","The successful use of <span class=""chemical"">sorafenib</span> to treat pediatric <span class=""disease"">papillary thyroid carcinoma</span>.",,19355831,19355831_C471405_C536915,19355831_0,bcv_sentence_task_befree_3416,,770959345,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,C471405,"<span class=""chemical"">Sorafenib</span>",D013964,"<span class=""disease"">thyroid cancer</span>","<span class=""chemical"">Sorafenib</span> is an orally administered multi-kinase inhibitor that has shown promise in the treatment of adults with advanced <span class=""disease"">thyroid cancer</span>, but it has not yet been studied in children with this disease.",,19355831,19355831_C471405_D013964,19355831_3,bcv_sentence_task_befree_3417,,770959346,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,1,,C471405,"<span class=""chemical"">sorafenib</span>",C536915,"<span class=""disease"">PTC</span>","Our objective is to present an adolescent with a progressive RAI-resistant <span class=""disease"">PTC</span> who was successfully treated with <span class=""chemical"">sorafenib</span>.",,19355831,19355831_C471405_C536915,19355831_4,bcv_sentence_task_befree_3418,,770959347,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,C471405,"<span class=""chemical"">Sorafenib</span>",C536915,"<span class=""disease"">PTC</span>","A 14-year-old girl had progressive lung metastases from <span class=""disease"">PTC</span> despite previous therapies with almost 400 mCi (131)I. <span class=""chemical"">Sorafenib</span> was initiated at a starting dose of 200 mg twice daily and decreased to a maintenance dose of 200 mg daily due to side effects that developed within 3 weeks of treatment.",,19355831,19355831_C471405_C536915,19355831_5,bcv_sentence_task_befree_3419,,770959348,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,C471405,"<span class=""chemical"">sorafenib</span>",C536915,"<span class=""disease"">PTC</span>","In the very rare case of the pediatric patient with progressive RAI-refractory <span class=""disease"">PTC</span>, for which no good systemic therapy exists, <span class=""chemical"">sorafenib</span> may play an important role in the management of this disease.",,19355831,19355831_C471405_C536915,19355831_10,bcv_sentence_task_befree_3420,,770959349,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,0.8144,,D008727,"<span class=""chemical"">methotrexate</span>",D006660,"<span class=""disease"">histoplasmosis</span>","We present a rare case of isolated granulomatous hepatitis due to <span class=""disease"">histoplasmosis</span> in a 35-year-old female with dermatomyositis receiving low-dose prednisone and <span class=""chemical"">methotrexate</span>.",,19434026,19434026_D008727_D006660,19434026_4,bcv_sentence_task_befree_3421,,770959350,FALSE,finalized,5,8/14/15 22:22,"



",yes_direct,0.5882,,D011241,"<span class=""chemical"">prednisone</span>",D006660,"<span class=""disease"">histoplasmosis</span>","We present a rare case of isolated granulomatous hepatitis due to <span class=""disease"">histoplasmosis</span> in a 35-year-old female with dermatomyositis receiving low-dose <span class=""chemical"">prednisone</span> and methotrexate.",,19434026,19434026_D011241_D006660,19434026_4,bcv_sentence_task_befree_3422,,770959351,FALSE,finalized,5,8/14/15 21:20,"



",no_relation,0.4211,,D008727,"<span class=""chemical"">methotrexate</span>",D006689,"<span class=""disease"">granulomatous hepatitis</span>","We present a rare case of isolated <span class=""disease"">granulomatous hepatitis</span> due to histoplasmosis in a 35-year-old female with dermatomyositis receiving low-dose prednisone and <span class=""chemical"">methotrexate</span>.",,19434026,19434026_D008727_D006689,19434026_4,bcv_sentence_task_befree_3423,,770959352,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,0.8011,,D011241,"<span class=""chemical"">prednisone</span>",D003882,"<span class=""disease"">dermatomyositis</span>","We present a rare case of isolated granulomatous hepatitis due to histoplasmosis in a 35-year-old female with <span class=""disease"">dermatomyositis</span> receiving low-dose <span class=""chemical"">prednisone</span> and methotrexate.",,19434026,19434026_D011241_D003882,19434026_4,bcv_sentence_task_befree_3424,,770959353,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,1,,D011241,"<span class=""chemical"">prednisone</span>",D006689,"<span class=""disease"">granulomatous hepatitis</span>","We present a rare case of isolated <span class=""disease"">granulomatous hepatitis</span> due to histoplasmosis in a 35-year-old female with dermatomyositis receiving low-dose <span class=""chemical"">prednisone</span> and methotrexate.",,19434026,19434026_D011241_D006689,19434026_4,bcv_sentence_task_befree_3425,,770959354,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,D008727,"<span class=""chemical"">methotrexate</span>",D003882,"<span class=""disease"">dermatomyositis</span>","We present a rare case of isolated granulomatous hepatitis due to histoplasmosis in a 35-year-old female with <span class=""disease"">dermatomyositis</span> receiving low-dose prednisone and <span class=""chemical"">methotrexate</span>.",,19434026,19434026_D008727_D003882,19434026_4,bcv_sentence_task_befree_3426,,770959355,FALSE,finalized,5,8/15/15 1:42,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D009369,"<span class=""disease"">breast cancer</span>","Targeting the vascular endothelial growth factor (VEGF) and <span class=""chemical"">estrogen</span> receptor (ER) signaling pathways concomitantly may provide enhanced therapeutic benefit in ER-positive <span class=""disease"">breast cancer</span>.",,19435899,19435899_D004967_D009369,19435899_2,bcv_sentence_task_befree_3427,,770959356,FALSE,finalized,5,8/15/15 2:49,"



",no_relation,1,,C404768,"<span class=""chemical"">ZK222584</span>",D009369,"<span class=""disease"">breast cancer</span>","Therefore, the effects of the VEGF receptor (VEGFR) tyrosine kinase inhibitor PTK787/<span class=""chemical"">ZK222584</span> (PTK/ZK) were investigated using human <span class=""disease"">breast cancer</span> cell lines engineered to express aromatase.",,19435899,19435899_C404768_D009369,19435899_3,bcv_sentence_task_befree_3428,,770959357,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,D000212,"<span class=""chemical"">aciclovir</span>",D018792,"<span class=""disease"">viral encephalitis</span>","The management of infants and children treated with <span class=""chemical"">aciclovir</span> for suspected <span class=""disease"">viral encephalitis</span>.",,19457882,19457882_D000212_D018792,19457882_0,bcv_sentence_task_befree_3429,,770959358,FALSE,finalized,5,8/14/15 22:51,"



",no_relation,0.8074,,D000212,"<span class=""chemical"">aciclovir</span>",D004660,"<span class=""disease"">encephalitis</span>","Case notes of all infants and children who received intravenous <span class=""chemical"">aciclovir</span> for suspected <span class=""disease"">encephalitis</span> over a 6-month period were reviewed.",,19457882,19457882_D000212_D004660,19457882_2,bcv_sentence_task_befree_3430,,770959359,FALSE,finalized,5,8/15/15 1:13,"



",no_relation,1,,D012701,"<span class=""chemical"">serotonin</span>",D003866,"<span class=""disease"">depression</span>","We aimed to determine the potential correlations of 5-HTT/NET gene polymorphisms with the susceptibility to <span class=""disease"">depression</span> and the antidepressant response to selective <span class=""chemical"">serotonin</span> reuptake inhibitors (SSRIs) or dual selective <span class=""chemical"">serotonin</span>/norepinephrine reuptake inhibitors (SNRIs).",,19468717,19468717_D012701_D003866,19468717_2,bcv_sentence_task_befree_3431,,770959360,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,0.6023,,D009638,"<span class=""chemical"">norepinephrine</span>",D003866,"<span class=""disease"">depression</span>","We aimed to determine the potential correlations of 5-HTT/NET gene polymorphisms with the susceptibility to <span class=""disease"">depression</span> and the antidepressant response to selective serotonin reuptake inhibitors (SSRIs) or dual selective serotonin/<span class=""chemical"">norepinephrine</span> reuptake inhibitors (SNRIs).",,19468717,19468717_D009638_D003866,19468717_2,bcv_sentence_task_befree_3432,,770959361,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,1,,D000666,"<span class=""chemical"">AMB/amphotericin B</span>",D009091,"<span class=""disease"">mucormycosis</span>","Standard therapy for invasive <span class=""disease"">mucormycosis</span> includes parenteral <span class=""chemical"">amphotericin B</span> (<span class=""chemical"">AMB</span>) in combination with radical debridement of infected tissues.",,19485785,19485785_D000666_D009091,19485785_3,bcv_sentence_task_befree_3433,,770959362,FALSE,finalized,5,8/14/15 22:30,"



",no_relation,1,,C101425,"<span class=""chemical"">Posaconazole</span>",D009091,"<span class=""disease"">mucormycosis</span>","<span class=""chemical"">Posaconazole</span> is a novel, extended-spectrum triazole oral antifungal agent with documented success in the treatment of patients with invasive <span class=""disease"">mucormycosis</span>.",,19485785,19485785_C101425_D009091,19485785_6,bcv_sentence_task_befree_3434,,770959363,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,1,,D000666,"<span class=""chemical"">AMB</span>",D007239,"<span class=""disease"">infection</span>","The <span class=""disease"">infection</span> did not respond to <span class=""chemical"">AMB</span> but was treated successfully with a combination of posaconazole and liposomal <span class=""chemical"">AMB</span> (LAMB) without surgical debridement.",,19485785,19485785_D000666_D007239,19485785_9,bcv_sentence_task_befree_3435,,770959364,FALSE,finalized,5,8/14/15 21:51,"



",no_relation,1,,C101425,"<span class=""chemical"">posaconazole</span>",D007239,"<span class=""disease"">infection</span>","The <span class=""disease"">infection</span> did not respond to AMB but was treated successfully with a combination of <span class=""chemical"">posaconazole</span> and liposomal AMB (LAMB) without surgical debridement.",,19485785,19485785_C101425_D007239,19485785_9,bcv_sentence_task_befree_3436,,770959365,FALSE,finalized,5,8/15/15 2:16,"



",yes_direct,0.609,,C101425,"<span class=""chemical"">posaconazole</span>",D013272,"<span class=""disease"">gastric and intrahepatic mucormycosis</span>","To our knowledge, this is the first reported case of extensive <span class=""disease"">gastric and intrahepatic mucormycosis</span> that responded to combination <span class=""chemical"">posaconazole</span> and LAMB without surgical debridement.",,19485785,19485785_C101425_D013272,19485785_10,bcv_sentence_task_befree_3437,,770959366,FALSE,finalized,5,8/14/15 21:31,"



",no_relation,1,,D004837,"<span class=""chemical"">epinephrine</span>",D008309,"<span class=""disease"">Mallory-Weiss syndrome</span>","Endoscopic band ligation could decrease recurrent bleeding in <span class=""disease"">Mallory-Weiss syndrome</span> as compared to haemostasis by hemoclips plus <span class=""chemical"">epinephrine</span>.",,19485979,19485979_D004837_D008309,19485979_0,bcv_sentence_task_befree_3438,,770959367,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,D004837,"<span class=""chemical"">epinephrine</span>",D006470,"<span class=""disease"">bleeding</span>","Endoscopic band ligation could decrease recurrent <span class=""disease"">bleeding</span> in Mallory-Weiss syndrome as compared to haemostasis by hemoclips plus <span class=""chemical"">epinephrine</span>.",,19485979,19485979_D004837_D006470,19485979_0,bcv_sentence_task_befree_3439,,770959368,FALSE,finalized,5,8/14/15 21:16,"



",no_relation,1,,D004837,"<span class=""chemical"">adrenaline/epinephrine</span>",D008309,"<span class=""disease"">MWS</span>","To compare the efficacy of endoscopic band ligation vs. hemoclip plus <span class=""chemical"">epinephrine</span> (<span class=""chemical"">adrenaline</span>) in bleeding <span class=""disease"">MWS</span>.",,19485979,19485979_D004837_D008309,19485979_2,bcv_sentence_task_befree_3440,,770959369,FALSE,finalized,5,8/15/15 0:30,"



",no_relation,1,,D004837,"<span class=""chemical"">adrenaline/epinephrine</span>",D006470,"<span class=""disease"">bleeding</span>","To compare the efficacy of endoscopic band ligation vs. hemoclip plus <span class=""chemical"">epinephrine</span> (<span class=""chemical"">adrenaline</span>) in <span class=""disease"">bleeding</span> MWS.",,19485979,19485979_D004837_D006470,19485979_2,bcv_sentence_task_befree_3441,,770959370,FALSE,finalized,5,8/14/15 22:31,"



",yes_direct,0.5969,,D004837,"<span class=""chemical"">epinephrine</span>",D006470,"<span class=""disease"">bleeding</span>","The use of hemoclips plus <span class=""chemical"">epinephrine</span> (OR = 3; 95% CI = 1.15-15.8) and active <span class=""disease"">bleeding</span> at endoscopy (OR = 1.9; 95% CI = 1.04-5.2) were independent predictive factors of early recurrent <span class=""disease"">bleeding</span>.",,19485979,19485979_D004837_D006470,19485979_9,bcv_sentence_task_befree_3442,,770959371,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,D017239,"<span class=""chemical"">paclitaxel</span>",D009369,"<span class=""disease"">breast cancer</span>","The telomerase template antagonist GRN163L alters MDA-MB-231 <span class=""disease"">breast cancer</span> cell morphology, inhibits growth, and augments the effects of <span class=""chemical"">paclitaxel</span>.",,19509275,19509275_D017239_D009369,19509275_0,bcv_sentence_task_befree_3443,,770959372,FALSE,finalized,5,8/14/15 21:11,"



",no_relation,1,,D017239,"<span class=""chemical"">paclitaxel</span>",D009369,"<span class=""disease"">breast cancer</span>","Importantly, the cellular response to GRN163L significantly augmented the effects of the microtubule stabilizer <span class=""chemical"">paclitaxel</span> in MDA-MB-231 <span class=""disease"">breast cancer</span> cell growth in vitro and in vivo compared with <span class=""chemical"">paclitaxel</span> alone or a mismatch control oligonucleotide plus <span class=""chemical"">paclitaxel</span>.",,19509275,19509275_D017239_D009369,19509275_7,bcv_sentence_task_befree_3444,,770959373,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,1,,D017239,"<span class=""chemical"">paclitaxel</span>",D009369,"<span class=""disease"">breast cancer</span>","These data support a rationale for potentially combining GRN163L with <span class=""chemical"">paclitaxel</span> for the treatment of <span class=""disease"">breast cancer</span> in the clinical setting.",,19509275,19509275_D017239_D009369,19509275_9,bcv_sentence_task_befree_3445,,770959374,FALSE,finalized,5,8/15/15 1:39,"



",no_relation,0.8211,,C055162,"<span class=""chemical"">clopidogrel</span>",D009203,"<span class=""disease"">ST-elevation myocardial infarction/STEMI</span>","The present single-center, longitudinal, cohort study will include 1,750 consecutive patients with <span class=""disease"">ST-elevation myocardial infarction</span> (<span class=""disease"">STEMI</span>), undergoing pPCI after pretreatment with 300 mg aspirin and 600 mg <span class=""chemical"">clopidogrel</span>.",,19515084,19515084_C055162_D009203,19515084_3,bcv_sentence_task_befree_3446,,770959375,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,0.6126,,D001241,"<span class=""chemical"">aspirin</span>",D009203,"<span class=""disease"">ST-elevation myocardial infarction/STEMI</span>","The present single-center, longitudinal, cohort study will include 1,750 consecutive patients with <span class=""disease"">ST-elevation myocardial infarction</span> (<span class=""disease"">STEMI</span>), undergoing pPCI after pretreatment with 300 mg <span class=""chemical"">aspirin</span> and 600 mg clopidogrel.",,19515084,19515084_D001241_D009203,19515084_3,bcv_sentence_task_befree_3447,,770959376,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",C537389,"<span class=""disease"">type</span>","Rosiglitazone significantly increased <span class=""chemical"">glucose</span> uptake in wild-<span class=""disease"">type</span> podocytes and this was associated with translocation of GLUT1 to the plasma membrane.",,19533082,19533082_D005947_C537389,19533082_8,bcv_sentence_task_befree_3448,,770959377,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,C089730,"<span class=""chemical"">Rosiglitazone</span>",C537389,"<span class=""disease"">type</span>","<span class=""chemical"">Rosiglitazone</span> significantly increased glucose uptake in wild-<span class=""disease"">type</span> podocytes and this was associated with translocation of GLUT1 to the plasma membrane.",,19533082,19533082_C089730_C537389,19533082_8,bcv_sentence_task_befree_3449,,770959378,FALSE,finalized,5,8/15/15 0:33,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",C537389,"<span class=""disease"">type</span>","In conclusion, rosiglitazone has a direct and protective effect on <span class=""chemical"">glucose</span> uptake in wild-<span class=""disease"">type</span> human podocytes.",,19533082,19533082_D005947_C537389,19533082_12,bcv_sentence_task_befree_3450,,770959379,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,1,,C089730,"<span class=""chemical"">rosiglitazone</span>",C537389,"<span class=""disease"">type</span>","In conclusion, <span class=""chemical"">rosiglitazone</span> has a direct and protective effect on glucose uptake in wild-<span class=""disease"">type</span> human podocytes.",,19533082,19533082_C089730_C537389,19533082_12,bcv_sentence_task_befree_3451,,770959380,FALSE,finalized,5,8/14/15 23:38,"



",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D006505,"<span class=""disease"">hepatitis</span>","The pattern of pegylated interferon-alpha2b and <span class=""chemical"">ribavirin</span> treatment failure in cirrhotic patients depends on <span class=""disease"">hepatitis</span> C virus genotype.",,19578243,19578243_D012254_D006505,19578243_0,bcv_sentence_task_befree_3452,,770959381,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,C417083,"<span class=""chemical"">pegylated interferon-alpha2b</span>",D006505,"<span class=""disease"">hepatitis</span>","The pattern of <span class=""chemical"">pegylated interferon-alpha2b</span> and ribavirin treatment failure in cirrhotic patients depends on <span class=""disease"">hepatitis</span> C virus genotype.",,19578243,19578243_C417083_D006505,19578243_0,bcv_sentence_task_befree_3453,,770959382,FALSE,finalized,5,8/14/15 21:18,"



",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D005355,"<span class=""disease"">cirrhosis</span>","Treatment failure to pegylated interferon (PEG-IFN)-alpha2b and <span class=""chemical"">ribavirin</span> (RBV) largely depends upon virus genotype, but the interaction between genotype, <span class=""disease"">cirrhosis</span> and pattern of treatment failure is unclear.",,19578243,19578243_D012254_D005355,19578243_2,bcv_sentence_task_befree_3454,,770959383,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,1,,C417083,"<span class=""chemical"">pegylated interferon (PEG-IFN)-alpha2b</span>",D005355,"<span class=""disease"">cirrhosis</span>","Treatment failure to <span class=""chemical"">pegylated interferon (PEG-IFN)-alpha2b</span> and ribavirin (RBV) largely depends upon virus genotype, but the interaction between genotype, <span class=""disease"">cirrhosis</span> and pattern of treatment failure is unclear.",,19578243,19578243_C417083_D005355,19578243_2,bcv_sentence_task_befree_3455,,770959384,FALSE,finalized,5,8/14/15 21:52,"



",yes_direct,0.6132,,D003622,"<span class=""chemical"">dapsone</span>",D054537,"<span class=""disease"">atrioventricular block</span>","Complete <span class=""disease"">atrioventricular block</span> associated with <span class=""chemical"">dapsone</span> therapy: a rare complication of <span class=""chemical"">dapsone</span>-induced hypersensitivity syndrome.",,19583683,19583683_D003622_D054537,19583683_0,bcv_sentence_task_befree_3456,,770959385,FALSE,finalized,5,8/14/15 22:21,"



",yes_direct,0.6247,,D003622,"<span class=""chemical"">dapsone</span>",D063926,"<span class=""disease"">dapsone-induced hypersensitivity syndrome</span>","Complete atrioventricular block associated with <span class=""chemical"">dapsone</span> therapy: a rare complication of <span class=""chemical""></span><span class=""disease"">dapsone</span>-induced hypersensitivity syndrome.",,19583683,19583683_D003622_D063926,19583683_0,bcv_sentence_task_befree_3457,,770959386,FALSE,finalized,5,8/14/15 23:01,"



",no_relation,1,,D003622,"<span class=""chemical"">Dapsone</span>",D007249,"<span class=""disease"">infectious and inflammatory diseases</span>","<span class=""chemical"">Dapsone</span> is still widely used for a range of <span class=""disease"">infectious and inflammatory diseases</span>.",,19583683,19583683_D003622_D007249,19583683_1,bcv_sentence_task_befree_3458,,770959387,FALSE,finalized,5,8/15/15 0:12,"



",yes_direct,0.4077,,D003622,"<span class=""chemical"">dapsone</span>",D063926,"<span class=""disease"">DHS/dapsone-induced hypersensitivity syndrome</span>","A potential severe side-effect, known as <span class=""chemical""></span><span class=""disease"">dapsone</span>-induced hypersensitivity syndrome (<span class=""disease"">DHS</span>), may occur.",,19583683,19583683_D003622_D063926,19583683_2,bcv_sentence_task_befree_3459,,770959388,FALSE,finalized,5,8/15/15 1:46,"



",yes_direct,0.7922,,D003622,"<span class=""chemical"">dapsone</span>",D063926,"<span class=""disease"">DHS</span>","We describe here a 45-year-old Chinese woman who developed <span class=""disease"">DHS</span> after 5 weeks of <span class=""chemical"">dapsone</span> therapy for pustular palmoplantar psoriasis.",,19583683,19583683_D003622_D063926,19583683_5,bcv_sentence_task_befree_3460,,770959389,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,0.8219,,D003622,"<span class=""chemical"">dapsone</span>",D011565,"<span class=""disease"">psoriasis</span>","We describe here a 45-year-old Chinese woman who developed DHS after 5 weeks of <span class=""chemical"">dapsone</span> therapy for pustular palmoplantar <span class=""disease"">psoriasis</span>.",,19583683,19583683_D003622_D011565,19583683_5,bcv_sentence_task_befree_3461,,770959390,FALSE,finalized,5,8/14/15 21:43,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",C563738,"<span class=""disease"">RT</span>","Two studies used supplemental <span class=""chemical"">iron</span> in the <span class=""disease"">RT</span> plus EPO group and not in the <span class=""disease"">RT</span> alone group.",,19588382,19588382_D007501_C563738,19588382_15,bcv_sentence_task_befree_3462,,770959391,FALSE,finalized,5,8/15/15 2:39,"



",no_relation,1,,C011049,"<span class=""chemical"">Oil Red O</span>",D012175,"<span class=""disease"">Rb/retinoblastoma</span>","The effects of lactoferrin on adipogenesis were studied through the expression of different lipogenic markers, AMP-activated protein kinase (AMPK) activation, <span class=""disease"">retinoblastoma</span> (<span class=""disease"">Rb</span>) activity and <span class=""chemical"">Oil Red O</span> staining in 3T3-L1 cells.",,19652659,19652659_C011049_D012175,19652659_5,bcv_sentence_task_befree_3463,,770959392,FALSE,finalized,5,8/14/15 23:01,"



",no_relation,0.8037,,D000667,"<span class=""chemical"">AMP</span>",D012175,"<span class=""disease"">Rb/retinoblastoma</span>","The effects of lactoferrin on adipogenesis were studied through the expression of different lipogenic markers, <span class=""chemical"">AMP</span>-activated protein kinase (AMPK) activation, <span class=""disease"">retinoblastoma</span> (<span class=""disease"">Rb</span>) activity and Oil Red O staining in 3T3-L1 cells.",,19652659,19652659_D000667_D012175,19652659_5,bcv_sentence_task_befree_3464,,770959393,FALSE,finalized,5,8/15/15 1:18,"



",yes_direct,0.5839,,D005227,"<span class=""chemical"">saturated fatty acids/SFAs</span>",D007249,"<span class=""disease"">inflammation</span>","It has been proposed that dietary <span class=""chemical"">saturated fatty acids</span> (<span class=""chemical"">SFAs</span>) may also serve as endogenous ligands of TLR2 or TLR4, thereby promoting diseases associated with <span class=""disease"">inflammation</span> and dyslipidemia, including atherosclerosis and insulin resistance.",,19661481,19661481_D005227_D007249,19661481_2,bcv_sentence_task_befree_3465,,770959394,FALSE,finalized,5,8/14/15 22:17,"



",yes_direct,1,,D005227,"<span class=""chemical"">saturated fatty acids/SFAs</span>",D050171,"<span class=""disease"">dyslipidemia</span>","It has been proposed that dietary <span class=""chemical"">saturated fatty acids</span> (<span class=""chemical"">SFAs</span>) may also serve as endogenous ligands of TLR2 or TLR4, thereby promoting diseases associated with inflammation and <span class=""disease"">dyslipidemia</span>, including atherosclerosis and insulin resistance.",,19661481,19661481_D005227_D050171,19661481_2,bcv_sentence_task_befree_3466,,770959395,FALSE,finalized,5,8/14/15 23:19,"



",yes_direct,0.7936,,D005227,"<span class=""chemical"">saturated fatty acids/SFAs</span>",D050197,"<span class=""disease"">atherosclerosis</span>","It has been proposed that dietary <span class=""chemical"">saturated fatty acids</span> (<span class=""chemical"">SFAs</span>) may also serve as endogenous ligands of TLR2 or TLR4, thereby promoting diseases associated with inflammation and dyslipidemia, including <span class=""disease"">atherosclerosis</span> and insulin resistance.",,19661481,19661481_D005227_D050197,19661481_2,bcv_sentence_task_befree_3467,,770959396,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,0.5775,,D005227,"<span class=""chemical"">SFAs</span>",C536528,"<span class=""disease"">LPS</span>","Further analysis showed that the effect seen with the complexed <span class=""chemical"">SFAs</span> was attributable to <span class=""disease"">LPS</span> and lipopeptide contamination of fatty-acid-free BSA.",,19661481,19661481_D005227_C536528,19661481_6,bcv_sentence_task_befree_3468,,770959397,FALSE,finalized,5,8/14/15 23:23,"



",no_relation,0.7874,,D005227,"<span class=""chemical"">SFAs</span>",C536528,"<span class=""disease"">LPS</span>","<span class=""disease"">LPS</span> and lipopeptide contamination of the widely used reagent fatty-acid-free BSA explains the previously reported stimulation of TLR2 and TLR4 by <span class=""chemical"">SFAs</span>.",,19661481,19661481_D005227_C536528,19661481_9,bcv_sentence_task_befree_3469,,770959398,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,D009569,"<span class=""chemical"">nitric oxide</span>",D003550,"<span class=""disease"">cystic fibrosis</span>","Extended <span class=""chemical"">nitric oxide</span> measurements in exhaled air of <span class=""disease"">cystic fibrosis</span> and healthy adults.",,19669109,19669109_D009569_D003550,19669109_0,bcv_sentence_task_befree_3470,,770959399,FALSE,finalized,5,8/15/15 0:57,"



",no_relation,1,,D009569,"<span class=""chemical"">nitric oxide</span>",D003550,"<span class=""disease"">cystic fibrosis/CF</span>","In <span class=""disease"">cystic fibrosis</span> (<span class=""disease"">CF</span>) lung disease, exhaled <span class=""chemical"">nitric oxide</span> (FeNO) is not raised, but rather is normal or even decreased when measured at a single expiratory flow.",,19669109,19669109_D009569_D003550,19669109_1,bcv_sentence_task_befree_3471,,770959400,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,0.8077,,D009569,"<span class=""chemical"">nitric oxide</span>",D008171,"<span class=""disease"">lung disease</span>","In cystic fibrosis (CF) <span class=""disease"">lung disease</span>, exhaled <span class=""chemical"">nitric oxide</span> (FeNO) is not raised, but rather is normal or even decreased when measured at a single expiratory flow.",,19669109,19669109_D009569_D008171,19669109_1,bcv_sentence_task_befree_3472,,770959401,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,D009569,"<span class=""chemical"">NO</span>",D003550,"<span class=""disease"">CF</span>","The median J(<span class=""chemical"">NO</span>,Br) was significantly lower in <span class=""disease"">CF</span> adults than in healthy controls [0.31 nl/s (range = 0.11-0.63) vs. 0.70 nl/s (0.27-3.52); P < 0.001], while the median C(Alv) was similar in both groups [1.7 ppb (0.3-3.9) vs. 1.2 (0.1-5.2)].",,19669109,19669109_D009569_D003550,19669109_8,bcv_sentence_task_befree_3473,,770959402,FALSE,finalized,5,8/15/15 1:39,"



",no_relation,1,,D009569,"<span class=""chemical"">NO</span>",D003550,"<span class=""disease"">CF</span>","Pulmonary <span class=""chemical"">NO</span> exchange did not differ significantly between subgroups of <span class=""disease"">CF</span> patients with and without chronic Pseudomonas aeruginosa infection.",,19669109,19669109_D009569_D003550,19669109_9,bcv_sentence_task_befree_3474,,770959403,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,1,,D009569,"<span class=""chemical"">NO</span>",D011552,"<span class=""disease"">Pseudomonas aeruginosa infection</span>","Pulmonary <span class=""chemical"">NO</span> exchange did not differ significantly between subgroups of CF patients with and without chronic <span class=""disease"">Pseudomonas aeruginosa infection</span>.",,19669109,19669109_D009569_D011552,19669109_9,bcv_sentence_task_befree_3475,,770959404,FALSE,finalized,5,8/14/15 22:13,"



",no_relation,0.8043,,D009569,"<span class=""chemical"">NO</span>",D003550,"<span class=""disease"">CF</span>","Extended FeNO measurements can separate alveolar and bronchial <span class=""chemical"">NO</span> outputs in <span class=""disease"">CF</span> adults.",,19669109,19669109_D009569_D003550,19669109_11,bcv_sentence_task_befree_3476,,770959405,FALSE,finalized,5,8/14/15 21:24,"



",no_relation,1,,D019808,"<span class=""chemical"">losartan</span>",D007674,"<span class=""disease"">kidney diseases</span>","CYP2C9 genotype and pharmacodynamic responses to <span class=""chemical"">losartan</span> in patients with primary and secondary <span class=""disease"">kidney diseases</span>.",,19669737,19669737_D019808_D007674,19669737_0,bcv_sentence_task_befree_3477,,770959406,FALSE,finalized,5,8/14/15 22:13,"



",no_relation,1,,D019808,"<span class=""chemical"">Losartan</span>",D051436,"<span class=""disease"">CKD/chronic kidney disease</span>","<span class=""chemical"">Losartan</span> is used for anti-proteinuric as well as blood pressure effects in <span class=""disease"">chronic kidney disease</span> (<span class=""disease"">CKD</span>).",,19669737,19669737_D019808_D051436,19669737_1,bcv_sentence_task_befree_3478,,770959407,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,0.7928,,D019808,"<span class=""chemical"">losartan</span>",D051436,"<span class=""disease"">CKD</span>","These preliminary results suggest a possible influence of CYP2C9 genotype on proteinuria and blood pressure in Caucasian <span class=""disease"">CKD</span> patients treated with <span class=""chemical"">losartan</span>.",,19669737,19669737_D019808_D051436,19669737_8,bcv_sentence_task_befree_3479,,770959408,FALSE,finalized,5,8/15/15 1:50,"



",no_relation,0.5917,,D019808,"<span class=""chemical"">losartan</span>",D011507,"<span class=""disease"">proteinuria</span>","These preliminary results suggest a possible influence of CYP2C9 genotype on <span class=""disease"">proteinuria</span> and blood pressure in Caucasian CKD patients treated with <span class=""chemical"">losartan</span>.",,19669737,19669737_D019808_D011507,19669737_8,bcv_sentence_task_befree_3480,,770959409,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D003920,"<span class=""disease"">type 2 diabetes mellitus</span>","A question often asked by health-care providers is whether <span class=""chemical"">metformin</span> has added benefits if continued after patients with <span class=""disease"">type 2 diabetes mellitus</span> switch to insulin.",,19690559,19690559_D008687_D003920,19690559_1,bcv_sentence_task_befree_3481,,770959410,FALSE,finalized,5,8/14/15 21:08,"



",no_relation,1,,C422923,"<span class=""chemical"">Rosuvastatin</span>",D007003,"<span class=""disease"">impaired fasting glucose</span>","<span class=""chemical"">Rosuvastatin</span> treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with <span class=""disease"">impaired fasting glucose</span>.",,19691613,19691613_C422923_D007003,19691613_0,bcv_sentence_task_befree_3482,,770959411,FALSE,finalized,5,8/15/15 1:21,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D007003,"<span class=""disease"">impaired fasting glucose</span>","Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with <span class=""disease"">impaired fasting </span><span class=""chemical"">glucose</span>.",,19691613,19691613_D005947_D007003,19691613_0,bcv_sentence_task_befree_3483,,770959412,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003929,"<span class=""disease"">diabetes</span>","The increase in physician-reported <span class=""disease"">diabetes</span> following rosuvastatin treatment in the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin study has raised concerns whether this statin exerts a detrimental effect on <span class=""chemical"">glucose</span> metabolism.",,19691613,19691613_D005947_D003929,19691613_1,bcv_sentence_task_befree_3484,,770959413,FALSE,finalized,5,8/15/15 2:02,"



",yes_direct,0.6285,,C422923,"<span class=""chemical"">rosuvastatin</span>",D003929,"<span class=""disease"">diabetes</span>","The increase in physician-reported <span class=""disease"">diabetes</span> following <span class=""chemical"">rosuvastatin</span> treatment in the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating <span class=""chemical"">Rosuvastatin</span> study has raised concerns whether this statin exerts a detrimental effect on glucose metabolism.",,19691613,19691613_C422923_D003929,19691613_1,bcv_sentence_task_befree_3485,,770959414,FALSE,finalized,5,8/15/15 2:31,"



",no_relation,1,,C422923,"<span class=""chemical"">rosuvastatin</span>",D007003,"<span class=""disease"">IFG/impaired fasting glucose</span>","We assessed the effect of <span class=""chemical"">rosuvastatin</span> treatment across dose range on glucose homeostasis in hyperlipidaemic patients with <span class=""disease"">impaired fasting glucose</span> (<span class=""disease"">IFG</span>), who are at high risk to develop diabetes mellitus.",,19691613,19691613_C422923_D007003,19691613_2,bcv_sentence_task_befree_3486,,770959415,FALSE,finalized,5,8/14/15 22:08,"



",no_relation,0.5969,,C422923,"<span class=""chemical"">rosuvastatin</span>",D003920,"<span class=""disease"">diabetes mellitus</span>","We assessed the effect of <span class=""chemical"">rosuvastatin</span> treatment across dose range on glucose homeostasis in hyperlipidaemic patients with impaired fasting glucose (IFG), who are at high risk to develop <span class=""disease"">diabetes mellitus</span>.",,19691613,19691613_C422923_D003920,19691613_2,bcv_sentence_task_befree_3487,,770959416,FALSE,finalized,5,8/14/15 21:11,"



",no_relation,0.7998,,D005947,"<span class=""chemical"">glucose</span>",D007003,"<span class=""disease"">IFG/impaired fasting glucose</span>","We assessed the effect of rosuvastatin treatment across dose range on <span class=""chemical"">glucose</span> homeostasis in hyperlipidaemic patients with <span class=""disease"">impaired fasting </span><span class=""chemical"">glucose</span> (<span class=""disease"">IFG</span>), who are at high risk to develop diabetes mellitus.",,19691613,19691613_D005947_D007003,19691613_2,bcv_sentence_task_befree_3488,,770959417,FALSE,finalized,5,8/14/15 23:57,"



",no_relation,0.807,,D005947,"<span class=""chemical"">glucose</span>",D003920,"<span class=""disease"">diabetes mellitus</span>","We assessed the effect of rosuvastatin treatment across dose range on <span class=""chemical"">glucose</span> homeostasis in hyperlipidaemic patients with impaired fasting <span class=""chemical"">glucose</span> (IFG), who are at high risk to develop <span class=""disease"">diabetes mellitus</span>.",,19691613,19691613_D005947_D003920,19691613_2,bcv_sentence_task_befree_3489,,770959418,FALSE,finalized,5,8/14/15 23:16,"



",no_relation,0.7986,,C422923,"<span class=""chemical"">rosuvastatin</span>",D007003,"<span class=""disease"">IFG</span>","The medical records of 72 hypelipidaemic patients with <span class=""disease"">IFG</span> on <span class=""chemical"">rosuvastatin</span> 10 (RSV10 group), 20 (RSV20 group) and 40 mg/day (RSV40 group) were reviewed.",,19691613,19691613_C422923_D007003,19691613_3,bcv_sentence_task_befree_3490,,770959419,FALSE,finalized,5,8/15/15 1:27,"



",no_relation,0.8032,,C422923,"<span class=""chemical"">rosuvastatin</span>",D007003,"<span class=""disease"">IFG</span>","In patients with <span class=""disease"">IFG</span> and hyperlipidaemia, <span class=""chemical"">rosuvastatin</span> treatment was associated with a dose-dependent increase in insulin resistance.",,19691613,19691613_C422923_D007003,19691613_8,bcv_sentence_task_befree_3491,,770959420,FALSE,finalized,5,8/14/15 23:37,"



",no_relation,1,,D016572,"<span class=""chemical"">cyclosporin</span>",D064420,"<span class=""disease"">toxicity</span>","The relationship between drug transporter function and endogenous melanogenic <span class=""disease"">toxicity</span> was assessed by treating cells with the <span class=""chemical"">cyclosporin</span> analog PSC-833 and by assessing vacuole formation and cell growth inhibition.",,19704071,19704071_D016572_D064420,19704071_6,bcv_sentence_task_befree_3492,,770959421,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,0.8055,,C070272,"<span class=""chemical"">PSC-833</span>",D064420,"<span class=""disease"">toxicity</span>","The relationship between drug transporter function and endogenous melanogenic <span class=""disease"">toxicity</span> was assessed by treating cells with the cyclosporin analog <span class=""chemical"">PSC-833</span> and by assessing vacuole formation and cell growth inhibition.",,19704071,19704071_C070272_D064420,19704071_6,bcv_sentence_task_befree_3493,,770959422,FALSE,finalized,5,8/14/15 21:19,"



",no_relation,1,,C042382,"<span class=""chemical"">fludarabine phosphate</span>",D013577,"<span class=""disease"">HPS</span>","We aimed to identify the contribution of <span class=""disease"">HPS</span> to engraftment failure after CBT, following preparative regimens containing <span class=""chemical"">fludarabine phosphate</span>, in 119 patients (median age, 55 years; range; 17-69 years) with haematological diseases.",,19709082,19709082_C042382_D013577,19709082_2,bcv_sentence_task_befree_3494,,770959423,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,0.8042,,C042382,"<span class=""chemical"">fludarabine phosphate</span>",D004194,"<span class=""disease"">haematological diseases</span>","We aimed to identify the contribution of HPS to engraftment failure after CBT, following preparative regimens containing <span class=""chemical"">fludarabine phosphate</span>, in 119 patients (median age, 55 years; range; 17-69 years) with <span class=""disease"">haematological diseases</span>.",,19709082,19709082_C042382_D004194,19709082_2,bcv_sentence_task_befree_3495,,770959424,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,1,,C063008,"<span class=""chemical"">mycophenolate mofetil</span>",D006086,"<span class=""disease"">Graft-versus-host disease</span>","<span class=""disease"">Graft-versus-host disease</span> prophylaxis comprised continuous infusion of a calcineurin inhibitor with or without <span class=""chemical"">mycophenolate mofetil</span>.",,19709082,19709082_C063008_D006086,19709082_3,bcv_sentence_task_befree_3496,,770959425,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,1,,D014212,"<span class=""chemical"">retinoic acid</span>",D009447,"<span class=""disease"">neuroblastoma</span>","We studied miR-128, a brain-enriched microRNA, in <span class=""chemical"">retinoic acid</span>-differentiated <span class=""disease"">neuroblastoma</span> cells, and we found that this microRNA is up-regulated in treated cells, where it down-modulates the expression of two proteins involved in the migratory potential of neural cells: Reelin and DCX.",,19713529,19713529_D014212_D009447,19713529_3,bcv_sentence_task_befree_3497,,770959426,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,0.811,,D006632,"<span class=""chemical"">histamine</span>",D003072,"<span class=""disease"">sleep or cognitive disorders</span>","Antagonism of the <span class=""chemical"">histamine</span>-H(3) receptor is one tactic being explored to increase wakefulness for the treatment of disorders such as excessive daytime sleepiness (EDS) as well as other <span class=""disease"">sleep or cognitive disorders</span>.",,19722526,19722526_D006632_D003072,19722526_1,bcv_sentence_task_befree_3498,,770959427,FALSE,finalized,5,8/14/15 21:41,"



",no_relation,0.8129,,D006859,"<span class=""chemical"">H</span>",D012893,"<span class=""disease"">daytime sleepiness</span>","Antagonism of the histamine-<span class=""chemical"">H</span>(3) receptor is one tactic being explored to increase wakefulness for the treatment of disorders such as excessive <span class=""disease"">daytime sleepiness</span> (EDS) as well as other sleep or cognitive disorders.",,19722526,19722526_D006859_D012893,19722526_1,bcv_sentence_task_befree_3499,,770959428,FALSE,finalized,5,8/15/15 1:23,"



",no_relation,0.8111,,D006632,"<span class=""chemical"">histamine</span>",D012893,"<span class=""disease"">daytime sleepiness</span>","Antagonism of the <span class=""chemical"">histamine</span>-H(3) receptor is one tactic being explored to increase wakefulness for the treatment of disorders such as excessive <span class=""disease"">daytime sleepiness</span> (EDS) as well as other sleep or cognitive disorders.",,19722526,19722526_D006632_D012893,19722526_1,bcv_sentence_task_befree_3500,,770959429,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,0.8086,,D006859,"<span class=""chemical"">H</span>",D003072,"<span class=""disease"">sleep or cognitive disorders</span>","Antagonism of the histamine-<span class=""chemical"">H</span>(3) receptor is one tactic being explored to increase wakefulness for the treatment of disorders such as excessive daytime sleepiness (EDS) as well as other <span class=""disease"">sleep or cognitive disorders</span>.",,19722526,19722526_D006859_D003072,19722526_1,bcv_sentence_task_befree_3501,,770959430,FALSE,finalized,5,8/14/15 21:12,"



",no_relation,1,,C426063,"<span class=""chemical"">Vardenafil</span>",D007172,"<span class=""disease"">ED/erectile dysfunction</span>","<span class=""chemical"">Vardenafil</span> is reported to improve success rates in the maintenance of an erection sufficient for completion of intercourse (SEP-3) compared with placebo in <span class=""disease"">erectile dysfunction</span> (<span class=""disease"">ED</span>) patients who attempted intercourse from as early as 15 minutes after dosing.",,19732311,19732311_C426063_D007172,19732311_1,bcv_sentence_task_befree_3502,,770959431,FALSE,finalized,5,8/14/15 23:29,"



",no_relation,1,,C426063,"<span class=""chemical"">vardenafil</span>",D003920,"<span class=""disease"">DM</span>","To determine whether early onset of activity with <span class=""chemical"">vardenafil</span> is also achievable in ED patients with <span class=""disease"">DM</span>.",,19732311,19732311_C426063_D003920,19732311_4,bcv_sentence_task_befree_3503,,770959432,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,1,,C426063,"<span class=""chemical"">vardenafil</span>",D007172,"<span class=""disease"">ED</span>","To determine whether early onset of activity with <span class=""chemical"">vardenafil</span> is also achievable in <span class=""disease"">ED</span> patients with DM.",,19732311,19732311_C426063_D007172,19732311_4,bcv_sentence_task_befree_3504,,770959433,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,1,,C426063,"<span class=""chemical"">Vardenafil</span>",D003920,"<span class=""disease"">DM</span>","<span class=""chemical"">Vardenafil</span> improved successful intercourse rates compared with placebo in Japanese <span class=""disease"">DM</span> patients who inserted from as early as 15 minutes to >120 minutes after dosing.",,19732311,19732311_C426063_D003920,19732311_13,bcv_sentence_task_befree_3505,,770959434,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,1,,D016190,"<span class=""chemical"">carboplatin</span>",D009369,"<span class=""disease"">ovarian cancer</span>","Between January 1998 and April 2004, we reviewed the records of 95 patients with high-risk, early stage epithelial <span class=""disease"">ovarian cancer</span> who had elevated CA125 levels at the time of diagnosis and were complete responders after 6 cycles of adjuvant paclitaxel/<span class=""chemical"">carboplatin</span> chemotherapy.",,19818996,19818996_D016190_D009369,19818996_2,bcv_sentence_task_befree_3506,,770959435,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D017239,"<span class=""chemical"">paclitaxel</span>",D009369,"<span class=""disease"">ovarian cancer</span>","Between January 1998 and April 2004, we reviewed the records of 95 patients with high-risk, early stage epithelial <span class=""disease"">ovarian cancer</span> who had elevated CA125 levels at the time of diagnosis and were complete responders after 6 cycles of adjuvant <span class=""chemical"">paclitaxel</span>/carboplatin chemotherapy.",,19818996,19818996_D017239_D009369,19818996_2,bcv_sentence_task_befree_3507,,770959436,FALSE,finalized,5,8/14/15 23:48,"



",yes_direct,0.5984,,D001548,"<span class=""chemical"">benzalkonium chloride</span>",D007249,"<span class=""disease"">inflammation</span>","Evaluation of biomarkers of <span class=""disease"">inflammation</span> in response to <span class=""chemical"">benzalkonium chloride</span> on corneal and conjunctival epithelial cells.",,19857103,19857103_D001548_D007249,19857103_0,bcv_sentence_task_befree_3508,,770959437,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,0.7997,,D006861,"<span class=""chemical"">H(2)O(2)</span>",D007249,"<span class=""disease"">inflammation</span>","To evaluate the <span class=""disease"">inflammation</span> BAK causes to the ocular surface, enzyme linked immunosorbant assays (ELISAs) were utilized to quantify the levels of inflammatory biomarkers in response to BAK and/or <span class=""chemical"">H(2)O(2)</span>.",,19857103,19857103_D006861_D007249,19857103_5,bcv_sentence_task_befree_3509,,770959438,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,1,,D006861,"<span class=""chemical"">H(2)O(2)</span>",D009336,"<span class=""disease"">necrosis</span>","Additional experimentation was performed in which testing solutions were replaced with media after 1 h and the resulting supernatants quantified after 24 h. BAK induced significant amounts of interleukin (IL-) 1 and tumor <span class=""disease"">necrosis</span> factor (TNF), but only moderate amounts of C-reactive protein (CRP), IL- 10 and 12, and <span class=""chemical"">H(2)O(2)</span>.",,19857103,19857103_D006861_D009336,19857103_7,bcv_sentence_task_befree_3510,,770959439,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,1,,D012293,"<span class=""chemical"">rifampicin</span>",D014376,"<span class=""disease"">tuberculosis</span>","Molecular characterisation of <span class=""chemical"">rifampicin</span>-resistant Mycobacterium <span class=""disease"">tuberculosis</span> strains from Morocco.",,19861020,19861020_D012293_D014376,19861020_0,bcv_sentence_task_befree_3511,,770959440,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,1,,D012293,"<span class=""chemical"">rifampicin/RMP</span>",D014376,"<span class=""disease"">tuberculosis</span>","Mutations in the rpoB gene associated with <span class=""chemical"">rifampicin</span> (<span class=""chemical"">RMP</span>) resistance were studied in 47 RMP-resistant and 147 RMP-susceptible clinical strains of Mycobacterium <span class=""disease"">tuberculosis</span> from Morocco using probe-based assay and DNA sequencing.",,19861020,19861020_D012293_D014376,19861020_1,bcv_sentence_task_befree_3512,,770959441,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,C045463,"<span class=""chemical"">leflunomide</span>",D001172,"<span class=""disease"">rheumatoid arthritis</span>","Recurrent pneumothorax associated with pulmonary nodules after <span class=""chemical"">leflunomide</span> therapy in <span class=""disease"">rheumatoid arthritis</span>: a case report and review of the literature.",,19862529,19862529_C045463_D001172,19862529_0,bcv_sentence_task_befree_3513,,770959442,FALSE,finalized,5,8/14/15 23:00,"



",yes_direct,1,,D008727,"<span class=""chemical"">methotrexate</span>",D012218,"<span class=""disease"">rheumatoid nodule</span>","Antirheumatic drugs, <span class=""chemical"">methotrexate</span>, leflunomide (LEF), infliximab and etanercept, were known as risk factors for developing <span class=""disease"">rheumatoid nodule</span>.",,19862529,19862529_D008727_D012218,19862529_4,bcv_sentence_task_befree_3514,,770959443,FALSE,finalized,5,8/15/15 1:19,"



",yes_direct,1,,C045463,"<span class=""chemical"">leflunomide</span>",D012218,"<span class=""disease"">rheumatoid nodule</span>","Antirheumatic drugs, methotrexate, <span class=""chemical"">leflunomide</span> (LEF), infliximab and etanercept, were known as risk factors for developing <span class=""disease"">rheumatoid nodule</span>.",,19862529,19862529_C045463_D012218,19862529_4,bcv_sentence_task_befree_3515,,770959444,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,1,,D005996,"<span class=""chemical"">nitroglycerin</span>",D054058,"<span class=""disease"">acute coronary syndromes</span>","Current guidelines call for <span class=""chemical"">nitroglycerin</span> to be prescribed in patients with coronary heart disease, including those with stable angina and those recovering from <span class=""disease"">acute coronary syndromes</span> and myocardial infarction.",,19887953,19887953_D005996_D054058,19887953_1,bcv_sentence_task_befree_3516,,770959445,FALSE,finalized,5,8/15/15 1:48,"



",no_relation,1,,D005996,"<span class=""chemical"">nitroglycerin</span>",D009203,"<span class=""disease"">myocardial infarction</span>","Current guidelines call for <span class=""chemical"">nitroglycerin</span> to be prescribed in patients with coronary heart disease, including those with stable angina and those recovering from acute coronary syndromes and <span class=""disease"">myocardial infarction</span>.",,19887953,19887953_D005996_D009203,19887953_1,bcv_sentence_task_befree_3517,,770959446,FALSE,finalized,5,8/15/15 0:37,"



",no_relation,1,,D005996,"<span class=""chemical"">nitroglycerin</span>",D060050,"<span class=""disease"">stable angina</span>","Current guidelines call for <span class=""chemical"">nitroglycerin</span> to be prescribed in patients with coronary heart disease, including those with <span class=""disease"">stable angina</span> and those recovering from acute coronary syndromes and myocardial infarction.",,19887953,19887953_D005996_D060050,19887953_1,bcv_sentence_task_befree_3518,,770959447,FALSE,finalized,5,8/15/15 1:09,"



",no_relation,1,,D005996,"<span class=""chemical"">nitroglycerin</span>",D003327,"<span class=""disease"">coronary heart disease</span>","Current guidelines call for <span class=""chemical"">nitroglycerin</span> to be prescribed in patients with <span class=""disease"">coronary heart disease</span>, including those with stable angina and those recovering from acute coronary syndromes and myocardial infarction.",,19887953,19887953_D005996_D003327,19887953_1,bcv_sentence_task_befree_3519,,770959448,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,1,,D005996,"<span class=""chemical"">nitroglycerin</span>",D017202,"<span class=""disease"">myocardial ischemia</span>","These patients are at risk for coronary events, and <span class=""chemical"">nitroglycerin</span> may be required to treat acute symptoms of <span class=""disease"">myocardial ischemia</span>.",,19887953,19887953_D005996_D017202,19887953_2,bcv_sentence_task_befree_3520,,770959449,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,D005996,"<span class=""chemical"">nitroglycerin</span>",D003327,"<span class=""disease"">coronary heart disease</span>","The prescription of <span class=""chemical"">nitroglycerin</span> is frequently omitted in patients with <span class=""disease"">coronary heart disease</span>.",,19887953,19887953_D005996_D003327,19887953_11,bcv_sentence_task_befree_3521,,770959450,FALSE,finalized,5,8/14/15 21:12,"



",no_relation,0.799,,D005947,"<span class=""chemical"">glucose</span>",D009062,"<span class=""disease"">oral glucose tolerance</span>","Fasting <span class=""chemical"">glucose</span>, insulin, lipid, and lipoprotein profiles; <span class=""disease"">oral </span><span class=""chemical"">glucose</span> tolerance; insulin secretion and insulin-mediated <span class=""chemical"">glucose</span> disposal by hyperglycemic clamp; and body composition by dual energy X-ray absorptiometry were determined before and after lopinavir/ritonavir administration.",,19890203,19890203_D005947_D009062,19890203_5,bcv_sentence_task_befree_3522,,770959451,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,C558899,"<span class=""chemical"">lopinavir/ritonavir</span>",D007003,"<span class=""disease"">Fasting glucose</span>","<span class=""disease"">Fasting glucose</span>, insulin, lipid, and lipoprotein profiles; oral glucose tolerance; insulin secretion and insulin-mediated glucose disposal by hyperglycemic clamp; and body composition by dual energy X-ray absorptiometry were determined before and after <span class=""chemical"">lopinavir/ritonavir</span> administration.",,19890203,19890203_C558899_D007003,19890203_5,bcv_sentence_task_befree_3523,,770959452,FALSE,finalized,5,8/14/15 23:32,"



",no_relation,0.794,,D005947,"<span class=""chemical"">glucose</span>",D007003,"<span class=""disease"">Fasting glucose</span>","<span class=""disease"">Fasting </span><span class=""chemical"">glucose</span>, insulin, lipid, and lipoprotein profiles; oral <span class=""chemical"">glucose</span> tolerance; insulin secretion and insulin-mediated <span class=""chemical"">glucose</span> disposal by hyperglycemic clamp; and body composition by dual energy X-ray absorptiometry were determined before and after lopinavir/ritonavir administration.",,19890203,19890203_D005947_D007003,19890203_5,bcv_sentence_task_befree_3524,,770959453,FALSE,finalized,5,8/15/15 2:33,"



",no_relation,0.7892,,C558899,"<span class=""chemical"">lopinavir/ritonavir</span>",D009062,"<span class=""disease"">oral glucose tolerance</span>","Fasting glucose, insulin, lipid, and lipoprotein profiles; <span class=""disease"">oral glucose tolerance</span>; insulin secretion and insulin-mediated glucose disposal by hyperglycemic clamp; and body composition by dual energy X-ray absorptiometry were determined before and after <span class=""chemical"">lopinavir/ritonavir</span> administration.",,19890203,19890203_C558899_D009062,19890203_5,bcv_sentence_task_befree_3525,,770959454,FALSE,finalized,5,8/14/15 22:35,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D009062,"<span class=""disease"">oral glucose tolerance</span>","There was no change in first-phase insulin secretion (2.82 +/- 0.30 versus 2.71 +/- 0.31 nmol/l; P = 0.60), as well as fasting insulin and <span class=""chemical"">glucose</span> levels, <span class=""disease"">oral </span><span class=""chemical"">glucose</span> tolerance, or insulin-mediated <span class=""chemical"">glucose</span> disposal after 4 weeks administration of lopinavir/ritonavir.",,19890203,19890203_D005947_D009062,19890203_6,bcv_sentence_task_befree_3526,,770959455,FALSE,finalized,5,8/14/15 21:08,"



",no_relation,0.7928,,D019438,"<span class=""chemical"">ritonavir</span>",D009062,"<span class=""disease"">oral glucose tolerance</span>","There was no change in first-phase insulin secretion (2.82 +/- 0.30 versus 2.71 +/- 0.31 nmol/l; P = 0.60), as well as fasting insulin and glucose levels, <span class=""disease"">oral glucose tolerance</span>, or insulin-mediated glucose disposal after 4 weeks administration of lopinavir/<span class=""chemical"">ritonavir</span>.",,19890203,19890203_D019438_D009062,19890203_6,bcv_sentence_task_befree_3527,,770959456,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D061466,"<span class=""chemical"">lopinavir</span>",D009062,"<span class=""disease"">oral glucose tolerance</span>","There was no change in first-phase insulin secretion (2.82 +/- 0.30 versus 2.71 +/- 0.31 nmol/l; P = 0.60), as well as fasting insulin and glucose levels, <span class=""disease"">oral glucose tolerance</span>, or insulin-mediated glucose disposal after 4 weeks administration of <span class=""chemical"">lopinavir</span>/ritonavir.",,19890203,19890203_D061466_D009062,19890203_6,bcv_sentence_task_befree_3528,,770959457,FALSE,finalized,5,8/14/15 21:18,"



",no_relation,0.808,,D008712,"<span class=""chemical"">methicillin</span>",D018461,"<span class=""disease"">tissue infections</span>","The role of antimicrobial therapy for treatment of uncomplicated skin and soft <span class=""disease"">tissue infections</span> from community-acquired <span class=""chemical"">methicillin</span>-resistant Staphylococcus aureus in children.",,19949756,19949756_D008712_D018461,19949756_0,bcv_sentence_task_befree_3529,,770959458,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,0.6208,,D008712,"<span class=""chemical"">methicillin</span>",D007239,"<span class=""disease"">infections</span>","Community-acquired <span class=""chemical"">methicillin</span>-resistant Staphylococcus aureus (CA-MRSA) <span class=""disease"">infections</span> in skin and soft tissues are increasing in children in Taiwan.",,19949756,19949756_D008712_D007239,19949756_1,bcv_sentence_task_befree_3530,,770959459,FALSE,finalized,5,8/15/15 2:30,"



",no_relation,1,,C078284,"<span class=""chemical"">Panton-Valentine leukocidin</span>",D018461,"<span class=""disease"">tissue infections</span>","This study investigated the outcomes of therapy with or without appropriate antibiotics among children with CA-MRSA skin and soft <span class=""disease"">tissue infections</span> (SSTIs), and analyzed the outcomes of management among children with <span class=""chemical"">Panton-Valentine leukocidin</span> (PVL)-positive strains and PVL-negative strains.",,19949756,19949756_C078284_D018461,19949756_2,bcv_sentence_task_befree_3531,,770959460,FALSE,finalized,5,8/15/15 1:20,"



",no_relation,1,,D016210,"<span class=""chemical"">methacholine</span>",D001249,"<span class=""disease"">asthma</span>","Prolonged bronchoprotection against inhaled <span class=""chemical"">methacholine</span> by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild <span class=""disease"">asthma</span>.",,20004781,20004781_D016210_D001249,20004781_0,bcv_sentence_task_befree_3532,,770959461,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,D016210,"<span class=""chemical"">methacholine</span>",D001249,"<span class=""disease"">asthma</span>","To examine the bronchoprotective effects of single doses of BI 1744 against <span class=""chemical"">methacholine</span> provocation in subjects with mild <span class=""disease"">asthma</span>.",,20004781,20004781_D016210_D001249,20004781_3,bcv_sentence_task_befree_3533,,770959462,FALSE,finalized,5,8/14/15 22:11,"



",no_relation,0.7976,,D005472,"<span class=""chemical"">5-FU</span>",D013274,"<span class=""disease"">gastric cancer</span>","HIF-1alpha is an unfavorable determinant of relapse in <span class=""disease"">gastric cancer</span> patients who underwent curative surgery followed by adjuvant <span class=""chemical"">5-FU</span> chemotherapy.",,20020496,20020496_D005472_D013274,20020496_0,bcv_sentence_task_befree_3534,,770959463,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU/5-fluorouracil</span>",D013274,"<span class=""disease"">gastric cancer</span>","Among several chemotherapeutic agents, <span class=""chemical"">5-fluorouracil</span> (<span class=""chemical"">5-FU</span>) has been widely used as a key drug in adjuvant chemotherapy for <span class=""disease"">gastric cancer</span>.",,20020496,20020496_D005472_D013274,20020496_1,bcv_sentence_task_befree_3535,,770959464,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D013274,"<span class=""disease"">gastric cancer</span>","We established 2 HIF-1alpha knockdown <span class=""disease"">gastric cancer</span> cell lines in order to clarify the role of HIF-1alpha in chemo-resistance against <span class=""chemical"">5-FU</span>.",,20020496,20020496_D005472_D013274,20020496_5,bcv_sentence_task_befree_3536,,770959465,FALSE,finalized,5,8/14/15 21:53,"



",no_relation,0.7887,,D005472,"<span class=""chemical"">5-FU</span>",D013274,"<span class=""disease"">gastric cancer</span>","In conclusion, the current study confirmed, for the first time that HIF-1alpha expression is an independent risk factor for relapse in high-risk <span class=""disease"">gastric cancer</span> patients who underwent curative surgery followed by adjuvant <span class=""chemical"">5-FU</span> chemotherapy.",,20020496,20020496_D005472_D013274,20020496_10,bcv_sentence_task_befree_3537,,770959466,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D002945,"<span class=""chemical"">Cisplatin</span>",D009369,"<span class=""disease"">tumours</span>","<span class=""chemical"">Cisplatin</span> remains a principal chemotherapy agent in the treatment of many solid <span class=""disease"">tumours</span>.",,20084783,20084783_D002945_D009369,20084783_1,bcv_sentence_task_befree_3538,,770959467,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,0.8045,,C110904,"<span class=""chemical"">capecitabine</span>",D009369,"<span class=""disease"">rectal cancer</span>","Neoadjuvant <span class=""chemical"">capecitabine</span> and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk <span class=""disease"">rectal cancer</span>: a phase 2 trial.",,20106720,20106720_C110904_D009369,20106720_0,bcv_sentence_task_befree_3539,,770959468,FALSE,finalized,5,8/15/15 0:04,"



",no_relation,1,,C030110,"<span class=""chemical"">oxaliplatin</span>",D009369,"<span class=""disease"">rectal cancer</span>","Neoadjuvant capecitabine and <span class=""chemical"">oxaliplatin</span> before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk <span class=""disease"">rectal cancer</span>: a phase 2 trial.",,20106720,20106720_C030110_D009369,20106720_0,bcv_sentence_task_befree_3540,,770959469,FALSE,finalized,5,8/14/15 21:43,"



",no_relation,1,,D003676,"<span class=""chemical"">Deferoxamine</span>",D012497,"<span class=""disease"">beta-thalassemic</span>","<span class=""chemical"">Deferoxamine</span> versus combined therapy for chelating liver, spleen and bone marrow iron in <span class=""disease"">beta-thalassemic</span> patients: a quantitative magnetic resonance imaging study.",,20113293,20113293_D003676_D012497,20113293_0,bcv_sentence_task_befree_3541,,770959470,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,1,,D003676,"<span class=""chemical"">DFO/deferoxamine</span>",D012497,"<span class=""disease"">beta-thalassemic</span>","We examined 21 <span class=""disease"">beta-thalassemic</span> patients undergoing <span class=""chemical"">deferoxamine</span> (<span class=""chemical"">DFO</span>) (9/21) or combined therapy [<span class=""chemical"">DFO</span> and deferiprone (L1), 12/21] with two abdominal MRI studies using T1-w/Pd-w/T2*-wGRE and T1-wTSE sequences.",,20113293,20113293_D003676_D012497,20113293_2,bcv_sentence_task_befree_3542,,770959471,FALSE,finalized,5,8/14/15 21:09,"



",no_relation,0.801,,C044919,"<span class=""chemical"">deferiprone</span>",D012497,"<span class=""disease"">beta-thalassemic</span>","We examined 21 <span class=""disease"">beta-thalassemic</span> patients undergoing deferoxamine (DFO) (9/21) or combined therapy [DFO and <span class=""chemical"">deferiprone</span> (L1), 12/21] with two abdominal MRI studies using T1-w/Pd-w/T2*-wGRE and T1-wTSE sequences.",,20113293,20113293_C044919_D012497,20113293_2,bcv_sentence_task_befree_3543,,770959472,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D003676,"<span class=""chemical"">DFO</span>",D012497,"<span class=""disease"">beta-thalassemic</span>","Combined therapy is more effective than <span class=""chemical"">DFO</span> for removing and preventing liver, spleen and bone marrow iron accumulation in <span class=""disease"">beta-thalassemic</span> patients.",,20113293,20113293_D003676_D012497,20113293_7,bcv_sentence_task_befree_3544,,770959473,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,0.8135,,D007501,"<span class=""chemical"">iron</span>",D012497,"<span class=""disease"">beta-thalassemic</span>","Combined therapy is more effective than DFO for removing and preventing liver, spleen and bone marrow <span class=""chemical"">iron</span> accumulation in <span class=""disease"">beta-thalassemic</span> patients.",,20113293,20113293_D007501_D012497,20113293_7,bcv_sentence_task_befree_3545,,770959474,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,1,,D003374,"<span class=""chemical"">coumarins</span>",D006470,"<span class=""disease"">alveolar hemorrhage</span>","We hypothesized that in patients treated with <span class=""chemical"">coumarins</span>, <span class=""disease"">alveolar hemorrhage</span> is associated with vitamin K epoxide reductase (VKORC1) and cytochrome P450 (CYP) 2C9 (CYP2C9) variant alleles.",,20121287,20121287_D003374_D006470,20121287_2,bcv_sentence_task_befree_3546,,770959475,FALSE,finalized,5,8/14/15 23:49,"



",yes_direct,0.8047,,C016186,"<span class=""chemical"">vitamin K epoxide</span>",D006470,"<span class=""disease"">alveolar hemorrhage</span>","We hypothesized that in patients treated with coumarins, <span class=""disease"">alveolar hemorrhage</span> is associated with <span class=""chemical"">vitamin K epoxide</span> reductase (VKORC1) and cytochrome P450 (CYP) 2C9 (CYP2C9) variant alleles.",,20121287,20121287_C016186_D006470,20121287_2,bcv_sentence_task_befree_3547,,770959476,FALSE,finalized,5,8/15/15 1:20,"



",no_relation,1,,D004298,"<span class=""chemical"">Dopamine</span>",D012893,"<span class=""disease"">sleep disturbances</span>","<span class=""chemical"">Dopamine</span> receptor agonists and <span class=""disease"">sleep disturbances</span> in Parkinson's disease.",,20123546,20123546_D004298_D012893,20123546_0,bcv_sentence_task_befree_3548,,770959477,FALSE,finalized,5,8/14/15 22:29,"



",no_relation,1,,D004298,"<span class=""chemical"">Dopamine</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","<span class=""chemical"">Dopamine</span> receptor agonists and sleep disturbances in <span class=""disease"">Parkinson's disease</span>.",,20123546,20123546_D004298_D010300,20123546_0,bcv_sentence_task_befree_3549,,770959478,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,1,,C046649,"<span class=""chemical"">ropinirole</span>",D010300,"<span class=""disease"">Parkinson's disease/PD</span>","Non-ergot dopamine receptor agonists, such as <span class=""chemical"">ropinirole</span>, pramipexole, rotigotine and apomorphine, may alleviate some non-motor symptoms in <span class=""disease"">Parkinson's disease</span> (<span class=""disease"">PD</span>) while others may be precipitated.",,20123546,20123546_C046649_D010300,20123546_1,bcv_sentence_task_befree_3550,,770959479,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,0.8088,,C061333,"<span class=""chemical"">pramipexole</span>",D010300,"<span class=""disease"">Parkinson's disease/PD</span>","Non-ergot dopamine receptor agonists, such as ropinirole, <span class=""chemical"">pramipexole</span>, rotigotine and apomorphine, may alleviate some non-motor symptoms in <span class=""disease"">Parkinson's disease</span> (<span class=""disease"">PD</span>) while others may be precipitated.",,20123546,20123546_C061333_D010300,20123546_1,bcv_sentence_task_befree_3551,,770959480,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,C047508,"<span class=""chemical"">rotigotine</span>",D010300,"<span class=""disease"">Parkinson's disease/PD</span>","Non-ergot dopamine receptor agonists, such as ropinirole, pramipexole, <span class=""chemical"">rotigotine</span> and apomorphine, may alleviate some non-motor symptoms in <span class=""disease"">Parkinson's disease</span> (<span class=""disease"">PD</span>) while others may be precipitated.",,20123546,20123546_C047508_D010300,20123546_1,bcv_sentence_task_befree_3552,,770959481,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,D004298,"<span class=""chemical"">dopamine</span>",D010300,"<span class=""disease"">Parkinson's disease/PD</span>","Non-ergot <span class=""chemical"">dopamine</span> receptor agonists, such as ropinirole, pramipexole, rotigotine and apomorphine, may alleviate some non-motor symptoms in <span class=""disease"">Parkinson's disease</span> (<span class=""disease"">PD</span>) while others may be precipitated.",,20123546,20123546_D004298_D010300,20123546_1,bcv_sentence_task_befree_3553,,770959482,FALSE,finalized,5,8/15/15 0:34,"



",no_relation,0.8095,,D001058,"<span class=""chemical"">apomorphine</span>",D010300,"<span class=""disease"">Parkinson's disease/PD</span>","Non-ergot dopamine receptor agonists, such as ropinirole, pramipexole, rotigotine and <span class=""chemical"">apomorphine</span>, may alleviate some non-motor symptoms in <span class=""disease"">Parkinson's disease</span> (<span class=""disease"">PD</span>) while others may be precipitated.",,20123546,20123546_D001058_D010300,20123546_1,bcv_sentence_task_befree_3554,,770959483,FALSE,finalized,5,8/14/15 21:10,"



",no_relation,0.5912,,D004298,"<span class=""chemical"">dopamine</span>",D010300,"<span class=""disease"">PD</span>","In this review, we discuss how <span class=""chemical"">dopamine</span> receptor agonists can both ameliorate and aggravate the sleep problems in <span class=""disease"">PD</span>, a key non-motor symptom of this disease.",,20123546,20123546_D004298_D010300,20123546_2,bcv_sentence_task_befree_3555,,770959484,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,1,,D004999,"<span class=""chemical"">amifostine</span>",D013964,"<span class=""disease"">thyroid cancer</span>","Does <span class=""chemical"">amifostine</span> have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated <span class=""disease"">thyroid cancer</span>.",,20130857,20130857_D004999_D013964,20130857_0,bcv_sentence_task_befree_3556,,770959485,FALSE,finalized,5,8/15/15 1:58,"



",no_relation,1,,D007455,"<span class=""chemical"">iodine</span>",D013964,"<span class=""disease"">thyroid cancer</span>","Does amifostine have radioprotective effects on salivary glands in high-dose radioactive <span class=""chemical"">iodine</span>-treated differentiated <span class=""disease"">thyroid cancer</span>.",,20130857,20130857_D007455_D013964,20130857_0,bcv_sentence_task_befree_3557,,770959486,FALSE,finalized,5,8/14/15 21:32,"



",no_relation,0.8072,,D004999,"<span class=""chemical"">amifostine</span>",D013964,"<span class=""disease"">thyroid cancer</span>","To assess the effects of <span class=""chemical"">amifostine</span> on salivary glands in radioactive iodine-treated differentiated <span class=""disease"">thyroid cancer</span>.",,20130857,20130857_D004999_D013964,20130857_1,bcv_sentence_task_befree_3558,,770959487,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,1,,D007455,"<span class=""chemical"">iodine</span>",D013964,"<span class=""disease"">thyroid cancer</span>","To assess the effects of amifostine on salivary glands in radioactive <span class=""chemical"">iodine</span>-treated differentiated <span class=""disease"">thyroid cancer</span>.",,20130857,20130857_D007455_D013964,20130857_1,bcv_sentence_task_befree_3559,,770959488,FALSE,finalized,5,8/15/15 2:33,"



",no_relation,1,,D004999,"<span class=""chemical"">amifostine</span>",D014987,"<span class=""disease"">xerostomia</span>","There were no statistically significant differences between the effects of <span class=""chemical"">amifostine</span> and acid-stimulating agents on the incidence of <span class=""disease"">xerostomia</span> (RR 0.24, 95% CI 0.01 to 9.52), the decrease of scintigraphically measured uptake of (99m)Tc by the parotid (RR 0.30, 95% CI -2.28 to 2.88) or submandibular glands (RR 1.90, 95% CI -1.46 to 5.26) at 12 months, or the reduction in blood pressure (RR 5.00, 95% CI 0.25 to 99.16).",,20130857,20130857_D004999_D014987,20130857_5,bcv_sentence_task_befree_3560,,770959489,FALSE,finalized,5,8/15/15 1:33,"



",no_relation,1,,D004999,"<span class=""chemical"">amifostine</span>",D013964,"<span class=""disease"">thyroid cancer</span>","The results of two randomized controlled clinical trials suggest that <span class=""chemical"">amifostine</span> has no significant radioprotective effects on salivary glands in radioactive iodine treatment of differentiated <span class=""disease"">thyroid cancer</span>.",,20130857,20130857_D004999_D013964,20130857_7,bcv_sentence_task_befree_3561,,770959490,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,1,,D007455,"<span class=""chemical"">iodine</span>",D013964,"<span class=""disease"">thyroid cancer</span>","The results of two randomized controlled clinical trials suggest that amifostine has no significant radioprotective effects on salivary glands in radioactive <span class=""chemical"">iodine</span> treatment of differentiated <span class=""disease"">thyroid cancer</span>.",,20130857,20130857_D007455_D013964,20130857_7,bcv_sentence_task_befree_3562,,770959491,FALSE,finalized,5,8/14/15 22:04,"



",no_relation,1,,C495058,"<span class=""chemical"">pegaptanib</span>",D008269,"<span class=""disease"">diabetic macular edema</span>","For <span class=""disease"">diabetic macular edema</span>, phase II trials of intravitreal <span class=""chemical"">pegaptanib</span> and intravitreal ranibizumab have shown short-term benefit in visual acuity.",,20174816,20174816_C495058_D008269,20174816_4,bcv_sentence_task_befree_3563,,770959492,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D007249,"<span class=""disease"">inflammation</span>","The aim was to investigate the effects of daily coffee consumption on biomarkers of coffee intake, subclinical <span class=""disease"">inflammation</span>, oxidative stress, <span class=""chemical"">glucose</span>, and lipid metabolism.",,20181814,20181814_D005947_D007249,20181814_3,bcv_sentence_task_befree_3564,,770959493,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,1,,D002784,"<span class=""chemical"">cholesterol</span>",D007249,"<span class=""disease"">inflammation</span>","Coffee consumption appears to have beneficial effects on subclinical <span class=""disease"">inflammation</span> and HDL <span class=""chemical"">cholesterol</span>, whereas no changes in glucose metabolism were found in our study.",,20181814,20181814_D002784_D007249,20181814_10,bcv_sentence_task_befree_3565,,770959494,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D007249,"<span class=""disease"">inflammation</span>","Coffee consumption appears to have beneficial effects on subclinical <span class=""disease"">inflammation</span> and HDL cholesterol, whereas no changes in <span class=""chemical"">glucose</span> metabolism were found in our study.",,20181814,20181814_D005947_D007249,20181814_10,bcv_sentence_task_befree_3566,,770959495,FALSE,finalized,5,8/14/15 21:12,"



",no_relation,1,,D010984,"<span class=""chemical"">platinum</span>",D006258,"<span class=""disease"">head and neck cancer</span>","Survival gains were achieved in <span class=""disease"">head and neck cancer</span> patients treated with a multidisciplinary approach, including <span class=""chemical"">platinum</span>-based concurrent chemoradiation, with a substantial increase in toxicity.",,20186057,20186057_D010984_D006258,20186057_1,bcv_sentence_task_befree_3567,,770959496,FALSE,finalized,5,8/15/15 1:30,"



",no_relation,0.5857,,D010984,"<span class=""chemical"">platinum</span>",D064420,"<span class=""disease"">toxicity</span>","Survival gains were achieved in head and neck cancer patients treated with a multidisciplinary approach, including <span class=""chemical"">platinum</span>-based concurrent chemoradiation, with a substantial increase in <span class=""disease"">toxicity</span>.",,20186057,20186057_D010984_D064420,20186057_1,bcv_sentence_task_befree_3568,,770959497,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D004999,"<span class=""chemical"">Amifostine</span>",D014987,"<span class=""disease"">xerostomia</span>","<span class=""chemical"">Amifostine</span>, as an acute and late <span class=""disease"">xerostomia</span>-preventive agent, may be considered in patients undergoing fractionated radiation therapy alone.",,20186057,20186057_D004999_D014987,20186057_4,bcv_sentence_task_befree_3569,,770959498,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,1,,D013110,"<span class=""chemical"">sphingosine</span>",D006323,"<span class=""disease"">growth arrest</span>","These inhibitors display K(I) values in the submicromolar range for both <span class=""chemical"">sphingosine</span> kinases and, in cultured vascular smooth muscle cells, decrease S1P levels and initiate <span class=""disease"">growth arrest</span>.",,20205392,20205392_D013110_D006323,20205392_4,bcv_sentence_task_befree_3570,,770959499,FALSE,finalized,5,8/15/15 0:17,"



",no_relation,1,,D002857,"<span class=""chemical"">chromium</span>",D007938,"<span class=""disease"">leukemia</span>","Clonogenic assays measure <span class=""disease"">leukemia</span> stem cell killing not detectable by <span class=""chemical"">chromium</span> release and flow cytometric cytotoxicity assays.",,20230219,20230219_D002857_D007938,20230219_0,bcv_sentence_task_befree_3571,,770959500,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D002857,"<span class=""chemical"">chromium</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Clonogenic assays measure leukemia stem cell killing not detectable by <span class=""chemical"">chromium</span> release and flow cytometric <span class=""disease"">cytotoxicity</span> assays.",,20230219,20230219_D002857_D004487,20230219_0,bcv_sentence_task_befree_3572,,770959501,FALSE,finalized,5,8/15/15 1:39,"



",no_relation,1,,D002857,"<span class=""chemical"">chromium</span>",D004487,"<span class=""disease"">cytotoxicity</span>","While the <span class=""chemical"">chromium</span>-release assay is the most common method for assessing <span class=""disease"">cytotoxicity</span> of immune effectors, and flow cytometry is increasingly used, the relationship of either assay to clonogenic readouts remains unknown.",,20230219,20230219_D002857_D004487,20230219_3,bcv_sentence_task_befree_3573,,770959502,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,0.5894,,D003561,"<span class=""chemical"">cytarabine</span>",D004487,"<span class=""disease"">Cytotoxicity</span>","<span class=""disease"">Cytotoxicity</span> of NK-92, daunorubicin and <span class=""chemical"">cytarabine</span> against KG1 was measured using the chromium-release assay, flow cytometry and clonogenic assays.",,20230219,20230219_D003561_D004487,20230219_6,bcv_sentence_task_befree_3574,,770959503,FALSE,finalized,5,8/14/15 21:57,"



",yes_direct,0.6205,,D003630,"<span class=""chemical"">daunorubicin</span>",D004487,"<span class=""disease"">Cytotoxicity</span>","<span class=""disease"">Cytotoxicity</span> of NK-92, <span class=""chemical"">daunorubicin</span> and cytarabine against KG1 was measured using the chromium-release assay, flow cytometry and clonogenic assays.",,20230219,20230219_D003630_D004487,20230219_6,bcv_sentence_task_befree_3575,,770959504,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,D002857,"<span class=""chemical"">chromium</span>",D004487,"<span class=""disease"">Cytotoxicity</span>","<span class=""disease"">Cytotoxicity</span> of NK-92, daunorubicin and cytarabine against KG1 was measured using the <span class=""chemical"">chromium</span>-release assay, flow cytometry and clonogenic assays.",,20230219,20230219_D002857_D004487,20230219_6,bcv_sentence_task_befree_3576,,770959505,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,1,,D002857,"<span class=""chemical"">chromium</span>",D004487,"<span class=""disease"">cytotoxicity</span>","The cumulative flow <span class=""disease"">cytotoxicity</span> assay was more sensitive than the <span class=""chemical"">chromium</span>-release assay in detecting target cell killing.",,20230219,20230219_D002857_D004487,20230219_9,bcv_sentence_task_befree_3577,,770959506,FALSE,finalized,5,8/14/15 23:33,"



",no_relation,1,,D018943,"<span class=""chemical"">anthracycline</span>",D015473,"<span class=""disease"">acute promyelocytic leukaemia</span>","Favourable outcome of patients with childhood <span class=""disease"">acute promyelocytic leukaemia</span> after treatment with reduced cumulative <span class=""chemical"">anthracycline</span> doses.",,20230404,20230404_D018943_D015473,20230404_0,bcv_sentence_task_befree_3578,,770959507,FALSE,finalized,5,8/14/15 21:19,"



",yes_direct,1,,D018943,"<span class=""chemical"">anthracyclines</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","Acute promyelocytic leukaemia (APL) treatment often includes high cumulative doses of <span class=""chemical"">anthracyclines</span>, which can cause long-term <span class=""disease"">cardiotoxicity</span>.",,20230404,20230404_D018943_D066126,20230404_1,bcv_sentence_task_befree_3579,,770959508,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,1,,D018943,"<span class=""chemical"">anthracyclines</span>",D015473,"<span class=""disease"">Acute promyelocytic leukaemia/APL</span>","<span class=""disease"">Acute promyelocytic leukaemia</span> (<span class=""disease"">APL</span>) treatment often includes high cumulative doses of <span class=""chemical"">anthracyclines</span>, which can cause long-term cardiotoxicity.",,20230404,20230404_D018943_D015473,20230404_1,bcv_sentence_task_befree_3580,,770959509,FALSE,finalized,5,8/14/15 21:13,"



",no_relation,1,,D018943,"<span class=""chemical"">anthracycline</span>",D015473,"<span class=""disease"">APL</span>","Here, we report the favourable outcome in 81 paediatric <span class=""disease"">APL</span> patients treated according to the consecutive acute myeloid leukaemia-Berlin/Frankfurt/Muenster (AML-BFM) trials -93/-98/-2004 with an <span class=""chemical"">anthracycline</span>-cytarabine regimen in combination with all-trans-retinoid acid (ATRA).",,20230404,20230404_D018943_D015473,20230404_2,bcv_sentence_task_befree_3581,,770959510,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,D003561,"<span class=""chemical"">cytarabine</span>",D015473,"<span class=""disease"">APL</span>","Here, we report the favourable outcome in 81 paediatric <span class=""disease"">APL</span> patients treated according to the consecutive acute myeloid leukaemia-Berlin/Frankfurt/Muenster (AML-BFM) trials -93/-98/-2004 with an anthracycline-<span class=""chemical"">cytarabine</span> regimen in combination with all-trans-retinoid acid (ATRA).",,20230404,20230404_D003561_D015473,20230404_2,bcv_sentence_task_befree_3582,,770959511,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,1,,D003561,"<span class=""chemical"">cytarabine</span>",C580075,"<span class=""disease"">acute myeloid leukaemia</span>","Here, we report the favourable outcome in 81 paediatric APL patients treated according to the consecutive <span class=""disease"">acute myeloid leukaemia</span>-Berlin/Frankfurt/Muenster (AML-BFM) trials -93/-98/-2004 with an anthracycline-<span class=""chemical"">cytarabine</span> regimen in combination with all-trans-retinoid acid (ATRA).",,20230404,20230404_D003561_C580075,20230404_2,bcv_sentence_task_befree_3583,,770959512,FALSE,finalized,5,8/14/15 23:18,"



",no_relation,1,,D018943,"<span class=""chemical"">anthracycline</span>",C580075,"<span class=""disease"">acute myeloid leukaemia</span>","Here, we report the favourable outcome in 81 paediatric APL patients treated according to the consecutive <span class=""disease"">acute myeloid leukaemia</span>-Berlin/Frankfurt/Muenster (AML-BFM) trials -93/-98/-2004 with an <span class=""chemical"">anthracycline</span>-cytarabine regimen in combination with all-trans-retinoid acid (ATRA).",,20230404,20230404_D018943_C580075,20230404_2,bcv_sentence_task_befree_3584,,770959513,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,C006632,"<span class=""chemical"">arsenic trioxide</span>",D015473,"<span class=""disease"">APL</span>","Salvage treatment was effective in 7/9 patients (78%) with relapsed <span class=""disease"">APL</span>, who now are long-term survivors after second line combination treatment with <span class=""chemical"">arsenic trioxide</span> (4/7 patients) and stem cell transplantation (5/7 patients).",,20230404,20230404_C006632_D015473,20230404_10,bcv_sentence_task_befree_3585,,770959514,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,1,,D018943,"<span class=""chemical"">anthracycline</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","Our results demonstrate that - combined with ATRA - a lower cumulative <span class=""chemical"">anthracycline</span> dose can be used safely to maintain high cure rates and promote the reduction of long-term sequelae, such as <span class=""disease"">cardiotoxicity</span> in APL patients.",,20230404,20230404_D018943_D066126,20230404_11,bcv_sentence_task_befree_3586,,770959515,FALSE,finalized,5,8/14/15 21:51,"



",no_relation,1,,D018943,"<span class=""chemical"">anthracycline</span>",D015473,"<span class=""disease"">APL</span>","Our results demonstrate that - combined with ATRA - a lower cumulative <span class=""chemical"">anthracycline</span> dose can be used safely to maintain high cure rates and promote the reduction of long-term sequelae, such as cardiotoxicity in <span class=""disease"">APL</span> patients.",,20230404,20230404_D018943_D015473,20230404_11,bcv_sentence_task_befree_3587,,770959516,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,1,,C048159,"<span class=""chemical"">monostearin</span>",C531854,"<span class=""disease"">oleic acid/OA</span>","Anionic lipid nanoparticles consisting of <span class=""chemical"">monostearin</span> (MS) and different content of <span class=""disease"">oleic acid</span> (<span class=""disease"">OA</span>) were prepared.",,20230883,20230883_C048159_C531854,20230883_2,bcv_sentence_task_befree_3588,,770959517,FALSE,finalized,5,8/14/15 21:22,"



",no_relation,1,,D019301,"<span class=""chemical"">oleic acid</span>",C531854,"<span class=""disease"">oleic acid/OA</span>","Anionic lipid nanoparticles consisting of monostearin (MS) and different content of <span class=""chemical""></span><span class=""disease"">oleic acid</span> (<span class=""disease"">OA</span>) were prepared.",,20230883,20230883_D019301_C531854,20230883_2,bcv_sentence_task_befree_3589,,770959518,FALSE,finalized,5,8/14/15 22:44,"



",no_relation,1,,D000638,"<span class=""chemical"">amiodarone</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus <span class=""chemical"">amiodarone</span> in patients with persistent <span class=""disease"">atrial fibrillation</span>: the DIONYSOS study.",,20384650,20384650_D000638_D001281,20384650_0,bcv_sentence_task_befree_3590,,770959519,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,1,,C118667,"<span class=""chemical"">dronedarone</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of <span class=""chemical"">dronedarone</span> versus amiodarone in patients with persistent <span class=""disease"">atrial fibrillation</span>: the DIONYSOS study.",,20384650,20384650_C118667_D001281,20384650_0,bcv_sentence_task_befree_3591,,770959520,FALSE,finalized,5,8/14/15 21:10,"



",no_relation,1,,D000638,"<span class=""chemical"">amiodarone</span>",D001281,"<span class=""disease"">atrial fibrillation/AF</span>","We compared the efficacy and safety of <span class=""chemical"">amiodarone</span> and dronedarone in patients with persistent <span class=""disease"">atrial fibrillation</span> (<span class=""disease"">AF</span>).",,20384650,20384650_D000638_D001281,20384650_1,bcv_sentence_task_befree_3592,,770959521,FALSE,finalized,5,8/14/15 22:11,"



",no_relation,1,,C118667,"<span class=""chemical"">dronedarone</span>",D001281,"<span class=""disease"">atrial fibrillation/AF</span>","We compared the efficacy and safety of amiodarone and <span class=""chemical"">dronedarone</span> in patients with persistent <span class=""disease"">atrial fibrillation</span> (<span class=""disease"">AF</span>).",,20384650,20384650_C118667_D001281,20384650_1,bcv_sentence_task_befree_3593,,770959522,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,1,,D000638,"<span class=""chemical"">amiodarone</span>",D001281,"<span class=""disease"">AF</span>","The primary composite endpoint was 75.1 and 58.8% with dronedarone and <span class=""chemical"">amiodarone</span>, respectively, at 12 months (hazard ratio [HR] 1.59; 95% confidence interval [CI] 1.28-1.98; P < 0.0001), mainly driven by <span class=""disease"">AF</span> recurrence with dronedarone compared with <span class=""chemical"">amiodarone</span> (63.5 vs 42.0%).",,20384650,20384650_D000638_D001281,20384650_6,bcv_sentence_task_befree_3594,,770959523,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,0.6238,,C118667,"<span class=""chemical"">dronedarone</span>",D001281,"<span class=""disease"">AF</span>","The primary composite endpoint was 75.1 and 58.8% with <span class=""chemical"">dronedarone</span> and amiodarone, respectively, at 12 months (hazard ratio [HR] 1.59; 95% confidence interval [CI] 1.28-1.98; P < 0.0001), mainly driven by <span class=""disease"">AF</span> recurrence with <span class=""chemical"">dronedarone</span> compared with amiodarone (63.5 vs 42.0%).",,20384650,20384650_C118667_D001281,20384650_6,bcv_sentence_task_befree_3595,,770959524,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,D000638,"<span class=""chemical"">amiodarone</span>",D001281,"<span class=""disease"">AF</span>","<span class=""disease"">AF</span> recurrence after successful cardioversion was 36.5 and 24.3% with dronedarone and <span class=""chemical"">amiodarone</span>, respectively.",,20384650,20384650_D000638_D001281,20384650_7,bcv_sentence_task_befree_3596,,770959525,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,C118667,"<span class=""chemical"">dronedarone</span>",D001281,"<span class=""disease"">AF</span>","<span class=""disease"">AF</span> recurrence after successful cardioversion was 36.5 and 24.3% with <span class=""chemical"">dronedarone</span> and amiodarone, respectively.",,20384650,20384650_C118667_D001281,20384650_7,bcv_sentence_task_befree_3597,,770959526,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,1,,D000638,"<span class=""chemical"">amiodarone</span>",D001281,"<span class=""disease"">AF</span>","In this short-term study, dronedarone was less effective than <span class=""chemical"">amiodarone</span> in decreasing <span class=""disease"">AF</span> recurrence, but had a better safety profile, specifically with regard to thyroid and neurologic events and a lack of interaction with oral anticoagulants.",,20384650,20384650_D000638_D001281,20384650_10,bcv_sentence_task_befree_3598,,770959527,FALSE,finalized,5,8/14/15 23:34,"



",no_relation,1,,C118667,"<span class=""chemical"">dronedarone</span>",D001281,"<span class=""disease"">AF</span>","In this short-term study, <span class=""chemical"">dronedarone</span> was less effective than amiodarone in decreasing <span class=""disease"">AF</span> recurrence, but had a better safety profile, specifically with regard to thyroid and neurologic events and a lack of interaction with oral anticoagulants.",,20384650,20384650_C118667_D001281,20384650_10,bcv_sentence_task_befree_3599,,770959528,FALSE,finalized,5,8/15/15 2:34,"



",no_relation,0.8156,,D006493,"<span class=""chemical"">heparin</span>",D013923,"<span class=""disease"">thromboembolic</span>","We retrospectively evaluated the effects of <span class=""chemical"">heparin</span> use on <span class=""disease"">thromboembolic</span> and bleeding complications after implantation of the HeartMate II left ventricular assist device (LVAD).",,20400335,20400335_D006493_D013923,20400335_2,bcv_sentence_task_befree_3600,,770959529,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,0.8164,,D006493,"<span class=""chemical"">heparin</span>",D006470,"<span class=""disease"">bleeding</span>","We retrospectively evaluated the effects of <span class=""chemical"">heparin</span> use on thromboembolic and <span class=""disease"">bleeding</span> complications after implantation of the HeartMate II left ventricular assist device (LVAD).",,20400335,20400335_D006493_D006470,20400335_2,bcv_sentence_task_befree_3601,,770959530,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D057049,"<span class=""disease"">thrombotic</span>","In patients receiving the HeartMate II LVAD who were directly transitioned to warfarin and <span class=""chemical"">aspirin</span> therapy without intravenous heparin there was no short-term increase in risk of <span class=""disease"">thrombotic</span> or thromboembolic events, and bleeding requiring transfusion was significantly reduced.",,20400335,20400335_D001241_D057049,20400335_9,bcv_sentence_task_befree_3602,,770959531,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,0.8121,,D014859,"<span class=""chemical"">warfarin</span>",D006470,"<span class=""disease"">bleeding</span>","In patients receiving the HeartMate II LVAD who were directly transitioned to <span class=""chemical"">warfarin</span> and aspirin therapy without intravenous heparin there was no short-term increase in risk of thrombotic or thromboembolic events, and <span class=""disease"">bleeding</span> requiring transfusion was significantly reduced.",,20400335,20400335_D014859_D006470,20400335_9,bcv_sentence_task_befree_3603,,770959532,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,0.7971,,D001241,"<span class=""chemical"">aspirin</span>",D006470,"<span class=""disease"">bleeding</span>","In patients receiving the HeartMate II LVAD who were directly transitioned to warfarin and <span class=""chemical"">aspirin</span> therapy without intravenous heparin there was no short-term increase in risk of thrombotic or thromboembolic events, and <span class=""disease"">bleeding</span> requiring transfusion was significantly reduced.",,20400335,20400335_D001241_D006470,20400335_9,bcv_sentence_task_befree_3604,,770959533,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D013923,"<span class=""disease"">thromboembolic</span>","In patients receiving the HeartMate II LVAD who were directly transitioned to warfarin and <span class=""chemical"">aspirin</span> therapy without intravenous heparin there was no short-term increase in risk of thrombotic or <span class=""disease"">thromboembolic</span> events, and bleeding requiring transfusion was significantly reduced.",,20400335,20400335_D001241_D013923,20400335_9,bcv_sentence_task_befree_3605,,770959534,FALSE,finalized,5,8/15/15 0:12,"



",no_relation,1,,D014859,"<span class=""chemical"">warfarin</span>",D057049,"<span class=""disease"">thrombotic</span>","In patients receiving the HeartMate II LVAD who were directly transitioned to <span class=""chemical"">warfarin</span> and aspirin therapy without intravenous heparin there was no short-term increase in risk of <span class=""disease"">thrombotic</span> or thromboembolic events, and bleeding requiring transfusion was significantly reduced.",,20400335,20400335_D014859_D057049,20400335_9,bcv_sentence_task_befree_3606,,770959535,FALSE,finalized,5,8/14/15 21:40,"



",no_relation,0.7956,,D014859,"<span class=""chemical"">warfarin</span>",D013923,"<span class=""disease"">thromboembolic</span>","In patients receiving the HeartMate II LVAD who were directly transitioned to <span class=""chemical"">warfarin</span> and aspirin therapy without intravenous heparin there was no short-term increase in risk of thrombotic or <span class=""disease"">thromboembolic</span> events, and bleeding requiring transfusion was significantly reduced.",,20400335,20400335_D014859_D013923,20400335_9,bcv_sentence_task_befree_3607,,770959536,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D014474,"<span class=""disease"">loss of consciousness</span>","On tracking the course of cerebral <span class=""chemical"">oxygen</span> saturation and pilot performance during gravity-induced <span class=""disease"">loss of consciousness</span>.",,20415154,20415154_D010100_D014474,20415154_0,bcv_sentence_task_befree_3608,,770959537,FALSE,finalized,5,8/14/15 23:12,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D014474,"<span class=""disease"">loss of consciousness</span>","The aim of this study was to track the course of cerebral tissue <span class=""chemical"">oxygen</span> saturation (rSO2) and pilot performance during an episode of gravity-induced <span class=""disease"">loss of consciousness</span> (GLOC).",,20415154,20415154_D010100_D014474,20415154_1,bcv_sentence_task_befree_3609,,770959538,FALSE,finalized,5,8/15/15 1:18,"



",no_relation,1,,D003276,"<span class=""chemical"">oral contraceptives</span>",D010146,"<span class=""disease"">endogenous pain</span>","Influence of <span class=""chemical"">oral contraceptives</span> on <span class=""disease"">endogenous pain</span> control in healthy women.",,20419369,20419369_D003276_D010146,20419369_0,bcv_sentence_task_befree_3610,,770959539,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D003929,"<span class=""disease"">diabetes</span>","Hyperbaric <span class=""chemical"">oxygen</span> therapy facilitates healing of chronic foot ulcers in patients with <span class=""disease"">diabetes</span>.",,20427683,20427683_D010100_D003929,20427683_0,bcv_sentence_task_befree_3611,,770959540,FALSE,finalized,5,8/14/15 22:12,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D017719,"<span class=""disease"">diabetic foot ulcers</span>","The aim of this study was to evaluate the effect of hyperbaric <span class=""chemical"">oxygen</span> therapy (HBOT) in the management of chronic <span class=""disease"">diabetic foot ulcers</span>.",,20427683,20427683_D010100_D017719,20427683_2,bcv_sentence_task_befree_3612,,770959541,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,0.8341,,D004298,"<span class=""chemical"">dopamine</span>",D013981,"<span class=""disease"">tic disorders</span>","While alpha-2 agonists and <span class=""chemical"">dopamine</span> antagonists constitute the mainstay of pharmacological agents for <span class=""disease"">tic disorders</span>, advances in neurobiology and psychopharmacology have discovered newer avenues for treatment of <span class=""disease"">tic disorders</span>.",,20459362,20459362_D004298_D013981,20459362_4,bcv_sentence_task_befree_3613,,770959542,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D018698,"<span class=""chemical"">glutamate</span>",D013981,"<span class=""disease"">tic disorders</span>","Apart from reviewing evidence based literature and recent updates on alpha-2 agonists and dopamine antagonists in treating <span class=""disease"">tic disorders</span>, the review also includes novel treatment approaches such as <span class=""chemical"">glutamate</span> modulators, nicotinic agents, antiandrogens and botulinum injection.",,20459362,20459362_D018698_D013981,20459362_5,bcv_sentence_task_befree_3614,,770959543,FALSE,finalized,5,8/15/15 1:38,"



",no_relation,1,,D004298,"<span class=""chemical"">dopamine</span>",D013981,"<span class=""disease"">tic disorders</span>","Apart from reviewing evidence based literature and recent updates on alpha-2 agonists and <span class=""chemical"">dopamine</span> antagonists in treating <span class=""disease"">tic disorders</span>, the review also includes novel treatment approaches such as glutamate modulators, nicotinic agents, antiandrogens and botulinum injection.",,20459362,20459362_D004298_D013981,20459362_5,bcv_sentence_task_befree_3615,,770959544,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,D004298,"<span class=""chemical"">dopamine</span>",D013981,"<span class=""disease"">tic disorders</span>","In addition to psychosocial interventions, alpha-2 agonists and <span class=""chemical"">dopamine</span> antagonists constitute the mainstay of treatment approaches for treating <span class=""disease"">tic disorders</span>.",,20459362,20459362_D004298_D013981,20459362_8,bcv_sentence_task_befree_3616,,770959545,FALSE,finalized,5,8/15/15 0:09,"



",no_relation,1,,D015363,"<span class=""chemical"">quinolones</span>",D004927,"<span class=""disease"">Escherichia</span>","<span class=""disease"">Escherichia</span> coli resistance to <span class=""chemical"">quinolones</span> at a comprehensive cancer center.",,20471765,20471765_D015363_D004927,20471765_0,bcv_sentence_task_befree_3617,,770959546,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,1,,D015363,"<span class=""chemical"">quinolones</span>",D009369,"<span class=""disease"">cancer</span>","Escherichia coli resistance to <span class=""chemical"">quinolones</span> at a comprehensive <span class=""disease"">cancer</span> center.",,20471765,20471765_D015363_D009369,20471765_0,bcv_sentence_task_befree_3618,,770959547,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,1,,C059500,"<span class=""chemical"">Meropenem</span>",D004927,"<span class=""disease"">Escherichia</span>","As part of <span class=""chemical"">Meropenem</span> Yearly Susceptibility Test Information Collection/USA Surveillance Programme, we monitored the occurrence of quinolone resistance in <span class=""disease"">Escherichia</span> coli over a 10-year period.",,20471765,20471765_C059500_D004927,20471765_1,bcv_sentence_task_befree_3619,,770959548,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,0.815,,C400082,"<span class=""chemical"">Bortezomib</span>",C562729,"<span class=""disease"">esophageal squamous cell carcinoma</span>","<span class=""chemical"">Bortezomib</span> sensitizes human <span class=""disease"">esophageal squamous cell carcinoma</span> cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.",,20515944,20515944_C400082_C562729,20515944_0,bcv_sentence_task_befree_3620,,770959549,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,0.8367,,C400082,"<span class=""chemical"">bortezomib/Velcade</span>",C562729,"<span class=""disease"">ESCC</span>","We investigated the therapeutic potential of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) in combination with the proteasome inhibitor <span class=""chemical"">bortezomib</span> (<span class=""chemical"">Velcade</span>) on human <span class=""disease"">ESCC</span> cell lines.",,20515944,20515944_C400082_C562729,20515944_2,bcv_sentence_task_befree_3621,,770959550,FALSE,finalized,5,8/15/15 0:00,"



",no_relation,1,,C400082,"<span class=""chemical"">bortezomib/Velcade</span>",D009369,"<span class=""disease"">tumor</span>","We investigated the therapeutic potential of the <span class=""disease"">tumor</span> necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) in combination with the proteasome inhibitor <span class=""chemical"">bortezomib</span> (<span class=""chemical"">Velcade</span>) on human ESCC cell lines.",,20515944,20515944_C400082_D009369,20515944_2,bcv_sentence_task_befree_3622,,770959551,FALSE,finalized,5,8/14/15 23:24,"



",no_relation,1,,C400082,"<span class=""chemical"">bortezomib/Velcade</span>",D009336,"<span class=""disease"">necrosis</span>","We investigated the therapeutic potential of the tumor <span class=""disease"">necrosis</span> factor-related apoptosis-inducing ligand (TRAIL/Apo2L) in combination with the proteasome inhibitor <span class=""chemical"">bortezomib</span> (<span class=""chemical"">Velcade</span>) on human ESCC cell lines.",,20515944,20515944_C400082_D009336,20515944_2,bcv_sentence_task_befree_3623,,770959552,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,C400082,"<span class=""chemical"">Bortezomib</span>",C562729,"<span class=""disease"">ESCC</span>","<span class=""chemical"">Bortezomib</span> enhanced the susceptibility to TRAIL in 12 of the 15 <span class=""disease"">ESCC</span> cell lines tested, although most showed low sensitivity to TRAIL as a single agent.",,20515944,20515944_C400082_C562729,20515944_3,bcv_sentence_task_befree_3624,,770959553,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,0.8098,,C400082,"<span class=""chemical"">bortezomib</span>",D003643,"<span class=""disease"">death</span>","However, the increased cell surface expression of <span class=""disease"">death</span> receptors observed on <span class=""chemical"">bortezomib</span> treatment did not seem to be crucial for this effect.",,20515944,20515944_C400082_D003643,20515944_6,bcv_sentence_task_befree_3625,,770959554,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,1,,C400082,"<span class=""chemical"">bortezomib</span>",C562729,"<span class=""disease"">ESCC</span>","For some <span class=""disease"">ESCC</span>, <span class=""chemical"">bortezomib</span> treatment resulted in a more efficient recruitment of caspase-8 and the Fas-associated death domain to the death-inducing signaling complex.",,20515944,20515944_C400082_C562729,20515944_7,bcv_sentence_task_befree_3626,,770959555,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,C400082,"<span class=""chemical"">bortezomib</span>",D003643,"<span class=""disease"">death</span>","For some ESCC, <span class=""chemical"">bortezomib</span> treatment resulted in a more efficient recruitment of caspase-8 and the Fas-associated <span class=""disease"">death</span> domain to the <span class=""disease"">death</span>-inducing signaling complex.",,20515944,20515944_C400082_D003643,20515944_7,bcv_sentence_task_befree_3627,,770959556,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,C400082,"<span class=""chemical"">bortezomib</span>",C562729,"<span class=""disease"">ESCC</span>","For other <span class=""disease"">ESCC</span>, the crucial effect of <span class=""chemical"">bortezomib</span> treatment seemed to be increased signaling via the intrinsic apoptotic pathway on subsequent exposure to TRAIL.",,20515944,20515944_C400082_C562729,20515944_9,bcv_sentence_task_befree_3628,,770959557,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,0.8213,,C400082,"<span class=""chemical"">bortezomib</span>",C562729,"<span class=""disease"">ESCC</span>","Thus, <span class=""chemical"">bortezomib</span> could sensitize <span class=""disease"">ESCC</span> to TRAIL apoptosis by multiple molecular mechanisms of action.",,20515944,20515944_C400082_C562729,20515944_10,bcv_sentence_task_befree_3629,,770959558,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,1,,C400082,"<span class=""chemical"">bortezomib</span>",C562729,"<span class=""disease"">ESCC</span>","Therefore, the combination of <span class=""chemical"">bortezomib</span> and TRAIL might be a novel therapeutic strategy for <span class=""disease"">ESCC</span> patients who fail to respond to standard chemoradiotherapy that predominantly targets the mitochondrial apoptotic pathway.",,20515944,20515944_C400082_C562729,20515944_11,bcv_sentence_task_befree_3630,,770959559,FALSE,finalized,5,8/15/15 2:26,"



",no_relation,0.5998,,D012964,"<span class=""chemical"">sodium</span>",D001145,"<span class=""disease"">cardiac arrhythmias</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac <span class=""chemical"">sodium</span> and calcium channels causing nausea, vomiting, abdominal pain, <span class=""disease"">cardiac arrhythmias</span>, respiratory distress, coma, seizures, and death in yew poisoning.",,20528617,20528617_D012964_D001145,20528617_2,bcv_sentence_task_befree_3631,,770959560,FALSE,finalized,5,8/14/15 21:51,"



",no_relation,0.5977,,D012964,"<span class=""chemical"">sodium</span>",D014839,"<span class=""disease"">vomiting</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac <span class=""chemical"">sodium</span> and calcium channels causing nausea, <span class=""disease"">vomiting</span>, abdominal pain, cardiac arrhythmias, respiratory distress, coma, seizures, and death in yew poisoning.",,20528617,20528617_D012964_D014839,20528617_2,bcv_sentence_task_befree_3632,,770959561,FALSE,finalized,5,8/14/15 21:49,"



",no_relation,0.8097,,D002118,"<span class=""chemical"">calcium</span>",D012128,"<span class=""disease"">respiratory distress</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac sodium and <span class=""chemical"">calcium</span> channels causing nausea, vomiting, abdominal pain, cardiac arrhythmias, <span class=""disease"">respiratory distress</span>, coma, seizures, and death in yew poisoning.",,20528617,20528617_D002118_D012128,20528617_2,bcv_sentence_task_befree_3633,,770959562,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,0.8194,,D002118,"<span class=""chemical"">calcium</span>",D011041,"<span class=""disease"">poisoning</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac sodium and <span class=""chemical"">calcium</span> channels causing nausea, vomiting, abdominal pain, cardiac arrhythmias, respiratory distress, coma, seizures, and death in yew <span class=""disease"">poisoning</span>.",,20528617,20528617_D002118_D011041,20528617_2,bcv_sentence_task_befree_3634,,770959563,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,0.6094,,D012964,"<span class=""chemical"">sodium</span>",D018476,"<span class=""disease"">coma</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac <span class=""chemical"">sodium</span> and calcium channels causing nausea, vomiting, abdominal pain, cardiac arrhythmias, respiratory distress, <span class=""disease"">coma</span>, seizures, and death in yew poisoning.",,20528617,20528617_D012964_D018476,20528617_2,bcv_sentence_task_befree_3635,,770959564,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,0.6281,,D012964,"<span class=""chemical"">sodium</span>",D011041,"<span class=""disease"">poisoning</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac <span class=""chemical"">sodium</span> and calcium channels causing nausea, vomiting, abdominal pain, cardiac arrhythmias, respiratory distress, coma, seizures, and death in yew <span class=""disease"">poisoning</span>.",,20528617,20528617_D012964_D011041,20528617_2,bcv_sentence_task_befree_3636,,770959565,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,0.6036,,D002118,"<span class=""chemical"">calcium</span>",D015746,"<span class=""disease"">abdominal pain</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac sodium and <span class=""chemical"">calcium</span> channels causing nausea, vomiting, <span class=""disease"">abdominal pain</span>, cardiac arrhythmias, respiratory distress, coma, seizures, and death in yew poisoning.",,20528617,20528617_D002118_D015746,20528617_2,bcv_sentence_task_befree_3637,,770959566,FALSE,finalized,5,8/15/15 2:30,"



",yes_direct,1,,D012964,"<span class=""chemical"">sodium</span>",D015746,"<span class=""disease"">abdominal pain</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac <span class=""chemical"">sodium</span> and calcium channels causing nausea, vomiting, <span class=""disease"">abdominal pain</span>, cardiac arrhythmias, respiratory distress, coma, seizures, and death in yew poisoning.",,20528617,20528617_D012964_D015746,20528617_2,bcv_sentence_task_befree_3638,,770959567,FALSE,finalized,5,8/15/15 0:30,"



",no_relation,0.8067,,D002118,"<span class=""chemical"">calcium</span>",D001145,"<span class=""disease"">cardiac arrhythmias</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac sodium and <span class=""chemical"">calcium</span> channels causing nausea, vomiting, abdominal pain, <span class=""disease"">cardiac arrhythmias</span>, respiratory distress, coma, seizures, and death in yew poisoning.",,20528617,20528617_D002118_D001145,20528617_2,bcv_sentence_task_befree_3639,,770959568,FALSE,finalized,5,8/15/15 2:11,"



",no_relation,0.809,,D012964,"<span class=""chemical"">sodium</span>",D012640,"<span class=""disease"">seizures</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac <span class=""chemical"">sodium</span> and calcium channels causing nausea, vomiting, abdominal pain, cardiac arrhythmias, respiratory distress, coma, <span class=""disease"">seizures</span>, and death in yew poisoning.",,20528617,20528617_D012964_D012640,20528617_2,bcv_sentence_task_befree_3640,,770959569,FALSE,finalized,5,8/14/15 22:44,"



",no_relation,0.7964,,D002118,"<span class=""chemical"">calcium</span>",D003643,"<span class=""disease"">death</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac sodium and <span class=""chemical"">calcium</span> channels causing nausea, vomiting, abdominal pain, cardiac arrhythmias, respiratory distress, coma, seizures, and <span class=""disease"">death</span> in yew poisoning.",,20528617,20528617_D002118_D003643,20528617_2,bcv_sentence_task_befree_3641,,770959570,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D014839,"<span class=""disease"">vomiting</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac sodium and <span class=""chemical"">calcium</span> channels causing nausea, <span class=""disease"">vomiting</span>, abdominal pain, cardiac arrhythmias, respiratory distress, coma, seizures, and death in yew poisoning.",,20528617,20528617_D002118_D014839,20528617_2,bcv_sentence_task_befree_3642,,770959571,FALSE,finalized,5,8/14/15 21:41,"



",no_relation,0.599,,D002118,"<span class=""chemical"">calcium</span>",D018476,"<span class=""disease"">coma</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac sodium and <span class=""chemical"">calcium</span> channels causing nausea, vomiting, abdominal pain, cardiac arrhythmias, respiratory distress, <span class=""disease"">coma</span>, seizures, and death in yew poisoning.",,20528617,20528617_D002118_D018476,20528617_2,bcv_sentence_task_befree_3643,,770959572,FALSE,finalized,5,8/15/15 2:11,"



",no_relation,0.8121,,D012964,"<span class=""chemical"">sodium</span>",D009325,"<span class=""disease"">nausea</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac <span class=""chemical"">sodium</span> and calcium channels causing <span class=""disease"">nausea</span>, vomiting, abdominal pain, cardiac arrhythmias, respiratory distress, coma, seizures, and death in yew poisoning.",,20528617,20528617_D012964_D009325,20528617_2,bcv_sentence_task_befree_3644,,770959573,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,D012964,"<span class=""chemical"">sodium</span>",D012128,"<span class=""disease"">respiratory distress</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac <span class=""chemical"">sodium</span> and calcium channels causing nausea, vomiting, abdominal pain, cardiac arrhythmias, <span class=""disease"">respiratory distress</span>, coma, seizures, and death in yew poisoning.",,20528617,20528617_D012964_D012128,20528617_2,bcv_sentence_task_befree_3645,,770959574,FALSE,finalized,5,8/14/15 22:24,"



",no_relation,0.6111,,D002118,"<span class=""chemical"">calcium</span>",D012640,"<span class=""disease"">seizures</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac sodium and <span class=""chemical"">calcium</span> channels causing nausea, vomiting, abdominal pain, cardiac arrhythmias, respiratory distress, coma, <span class=""disease"">seizures</span>, and death in yew poisoning.",,20528617,20528617_D002118_D012640,20528617_2,bcv_sentence_task_befree_3646,,770959575,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,1,,D012964,"<span class=""chemical"">sodium</span>",D003643,"<span class=""disease"">death</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac <span class=""chemical"">sodium</span> and calcium channels causing nausea, vomiting, abdominal pain, cardiac arrhythmias, respiratory distress, coma, seizures, and <span class=""disease"">death</span> in yew poisoning.",,20528617,20528617_D012964_D003643,20528617_2,bcv_sentence_task_befree_3647,,770959576,FALSE,finalized,5,8/14/15 21:43,"



",no_relation,0.4051,,D002118,"<span class=""chemical"">calcium</span>",D009325,"<span class=""disease"">nausea</span>","Taxine A and taxine B, the toxic alkaloids of Taxus, block cardiac sodium and <span class=""chemical"">calcium</span> channels causing <span class=""disease"">nausea</span>, vomiting, abdominal pain, cardiac arrhythmias, respiratory distress, coma, seizures, and death in yew poisoning.",,20528617,20528617_D002118_D009325,20528617_2,bcv_sentence_task_befree_3648,,770959577,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,D017311,"<span class=""chemical"">amlodipine</span>",D020521,"<span class=""disease"">stroke</span>","Reduced blood pressure variability in ASCOT-BPLA trial favours use of <span class=""chemical"">amlodipine</span>/perindopril combination to reduce <span class=""disease"">stroke</span> risk.",,20532438,20532438_D017311_D020521,20532438_0,bcv_sentence_task_befree_3649,,770959578,FALSE,finalized,5,8/15/15 0:08,"



",no_relation,1,,D020913,"<span class=""chemical"">perindopril</span>",D020521,"<span class=""disease"">stroke</span>","Reduced blood pressure variability in ASCOT-BPLA trial favours use of amlodipine/<span class=""chemical"">perindopril</span> combination to reduce <span class=""disease"">stroke</span> risk.",,20532438,20532438_D020913_D020521,20532438_0,bcv_sentence_task_befree_3650,,770959579,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,0.5989,,D017311,"<span class=""chemical"">amlodipine</span>",D020521,"<span class=""disease"">effective stroke reduction</span>","Lower within-individual visit-to-visit variability in blood pressure readings in the <span class=""chemical"">amlodipine</span>/perindopril combination treatment arm of the ASCOT study has been shown to account for the more <span class=""disease"">effective stroke reduction</span> rate with this combination compared to atenolol and diuretic-based therapies, despite overall similar blood pressure lowering.",,20532438,20532438_D017311_D020521,20532438_1,bcv_sentence_task_befree_3651,,770959580,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,0.7809,,D001262,"<span class=""chemical"">atenolol</span>",D020521,"<span class=""disease"">effective stroke reduction</span>","Lower within-individual visit-to-visit variability in blood pressure readings in the amlodipine/perindopril combination treatment arm of the ASCOT study has been shown to account for the more <span class=""disease"">effective stroke reduction</span> rate with this combination compared to <span class=""chemical"">atenolol</span> and diuretic-based therapies, despite overall similar blood pressure lowering.",,20532438,20532438_D001262_D020521,20532438_1,bcv_sentence_task_befree_3652,,770959581,FALSE,finalized,5,8/14/15 22:27,"



",yes_direct,0.8232,,D020913,"<span class=""chemical"">perindopril</span>",D020521,"<span class=""disease"">effective stroke reduction</span>","Lower within-individual visit-to-visit variability in blood pressure readings in the amlodipine/<span class=""chemical"">perindopril</span> combination treatment arm of the ASCOT study has been shown to account for the more <span class=""disease"">effective stroke reduction</span> rate with this combination compared to atenolol and diuretic-based therapies, despite overall similar blood pressure lowering.",,20532438,20532438_D020913_D020521,20532438_1,bcv_sentence_task_befree_3653,,770959582,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,C026455,"<span class=""chemical"">Thymalfasin</span>",D006509,"<span class=""disease"">hepatitis B</span>","<span class=""chemical"">Thymalfasin</span> in the treatment of <span class=""disease"">hepatitis B</span> and C. <span class=""chemical"">Thymalfasin</span> exhibited an immunomodulatory and a direct antiviral mechanism of action.",,20536462,20536462_C026455_D006509,20536462_0,bcv_sentence_task_befree_3654,,770959583,FALSE,finalized,5,8/15/15 1:33,"



",no_relation,1,,C026455,"<span class=""chemical"">thymalfasin</span>",D019694,"<span class=""disease"">chronic hepatitis B</span>","It has been suggested that <span class=""chemical"">thymalfasin</span> may have efficacy in the treatment of <span class=""disease"">chronic hepatitis B</span> and C. Pilots studies in patients with <span class=""disease"">chronic hepatitis B</span> treated with <span class=""chemical"">thymalfasin</span> in combination with interferon or nucleoside analogue, showed a 70% complete sustained response rate.",,20536462,20536462_C026455_D019694,20536462_2,bcv_sentence_task_befree_3655,,770959584,FALSE,finalized,5,8/14/15 22:25,"



",no_relation,1,,D009705,"<span class=""chemical"">nucleoside</span>",D019694,"<span class=""disease"">chronic hepatitis B</span>","It has been suggested that thymalfasin may have efficacy in the treatment of <span class=""disease"">chronic hepatitis B</span> and C. Pilots studies in patients with <span class=""disease"">chronic hepatitis B</span> treated with thymalfasin in combination with interferon or <span class=""chemical"">nucleoside</span> analogue, showed a 70% complete sustained response rate.",,20536462,20536462_D009705_D019694,20536462_2,bcv_sentence_task_befree_3656,,770959585,FALSE,finalized,5,8/14/15 21:50,"



",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D019698,"<span class=""disease"">chronic hepatitis C</span>","Studies in <span class=""disease"">chronic hepatitis C</span> patients, would indicate that thymalfasin in combination with standard or pegylated interferon with <span class=""chemical"">ribavirin</span> may improve response rate in hepatitis C virus (HCV) nave and nonresponder patients.",,20536462,20536462_D012254_D019698,20536462_3,bcv_sentence_task_befree_3657,,770959586,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,1,,C026455,"<span class=""chemical"">thymalfasin</span>",D019698,"<span class=""disease"">chronic hepatitis C</span>","Studies in <span class=""disease"">chronic hepatitis C</span> patients, would indicate that <span class=""chemical"">thymalfasin</span> in combination with standard or pegylated interferon with ribavirin may improve response rate in hepatitis C virus (HCV) nave and nonresponder patients.",,20536462,20536462_C026455_D019698,20536462_3,bcv_sentence_task_befree_3658,,770959587,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,0.7912,,D012254,"<span class=""chemical"">ribavirin</span>",D006526,"<span class=""disease"">hepatitis C virus/HCV</span>","Studies in chronic hepatitis C patients, would indicate that thymalfasin in combination with standard or pegylated interferon with <span class=""chemical"">ribavirin</span> may improve response rate in <span class=""disease"">hepatitis C virus</span> (<span class=""disease"">HCV</span>) nave and nonresponder patients.",,20536462,20536462_D012254_D006526,20536462_3,bcv_sentence_task_befree_3659,,770959588,FALSE,finalized,5,8/14/15 22:50,"



",no_relation,1,,C026455,"<span class=""chemical"">thymalfasin</span>",D006526,"<span class=""disease"">hepatitis C virus/HCV</span>","Studies in chronic hepatitis C patients, would indicate that <span class=""chemical"">thymalfasin</span> in combination with standard or pegylated interferon with ribavirin may improve response rate in <span class=""disease"">hepatitis C virus</span> (<span class=""disease"">HCV</span>) nave and nonresponder patients.",,20536462,20536462_C026455_D006526,20536462_3,bcv_sentence_task_befree_3660,,770959589,FALSE,finalized,5,8/14/15 23:52,"



",no_relation,1,,C026455,"<span class=""chemical"">thymalfasin</span>",D006526,"<span class=""disease"">HCV</span>","However, a large phase-III randomized study conducted in Europe in <span class=""disease"">HCV</span> patients nonresponder to Peg-interferon with ribavirin, demonstrated that <span class=""chemical"">thymalfasin</span> did not improve the rate of sustained virologic responses, but, in patients who completed therapy, <span class=""chemical"">thymalfasin</span> significantly diminished the relapse rate.",,20536462,20536462_C026455_D006526,20536462_4,bcv_sentence_task_befree_3661,,770959590,FALSE,finalized,5,8/15/15 0:32,"


HCV stands for Hepatitis C virus, therefore it's not a disease, but a virus
",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D006526,"<span class=""disease"">HCV</span>","However, a large phase-III randomized study conducted in Europe in <span class=""disease"">HCV</span> patients nonresponder to Peg-interferon with <span class=""chemical"">ribavirin</span>, demonstrated that thymalfasin did not improve the rate of sustained virologic responses, but, in patients who completed therapy, thymalfasin significantly diminished the relapse rate.",,20536462,20536462_D012254_D006526,20536462_4,bcv_sentence_task_befree_3662,,770959591,FALSE,finalized,5,8/14/15 23:28,"



",no_relation,1,,C026455,"<span class=""chemical"">thymalfasin</span>",D019694,"<span class=""disease"">chronic hepatitis B</span>","In conclusion, <span class=""chemical"">thymalfasin</span>, in combination with the standard of care, may be helpful as an adjuvant in the treatment of patients with <span class=""disease"">chronic hepatitis B</span> and C.",,20536462,20536462_C026455_D019694,20536462_5,bcv_sentence_task_befree_3663,,770959592,FALSE,finalized,5,8/14/15 21:34,"



",yes_direct,1,,D002945,"<span class=""chemical"">Cisplatin</span>",D020258,"<span class=""disease"">neurotoxicity</span>","<span class=""chemical"">Cisplatin</span> is one of the commonly-used chemotherapeutic drugs to efficiently treat malignant tumors in clinic, however, the adverse effects of <span class=""chemical"">cisplatin</span> such as nephrotoxicity, <span class=""disease"">neurotoxicity</span>, and hemolytic uremic syndrome are often observed at its clinical doses (approximately 60 mg/m(2)), which limit its broader application.",,20540689,20540689_D002945_D020258,20540689_1,bcv_sentence_task_befree_3664,,770959593,FALSE,finalized,5,8/14/15 21:49,"



",yes_direct,1,,D002945,"<span class=""chemical"">Cisplatin</span>",D006463,"<span class=""disease"">hemolytic uremic syndrome</span>","<span class=""chemical"">Cisplatin</span> is one of the commonly-used chemotherapeutic drugs to efficiently treat malignant tumors in clinic, however, the adverse effects of <span class=""chemical"">cisplatin</span> such as nephrotoxicity, neurotoxicity, and <span class=""disease"">hemolytic uremic syndrome</span> are often observed at its clinical doses (approximately 60 mg/m(2)), which limit its broader application.",,20540689,20540689_D002945_D006463,20540689_1,bcv_sentence_task_befree_3665,,770959594,FALSE,finalized,5,8/14/15 21:44,"



",no_relation,1,,D002945,"<span class=""chemical"">Cisplatin</span>",D009369,"<span class=""disease"">malignant tumors</span>","<span class=""chemical"">Cisplatin</span> is one of the commonly-used chemotherapeutic drugs to efficiently treat <span class=""disease"">malignant tumors</span> in clinic, however, the adverse effects of <span class=""chemical"">cisplatin</span> such as nephrotoxicity, neurotoxicity, and hemolytic uremic syndrome are often observed at its clinical doses (approximately 60 mg/m(2)), which limit its broader application.",,20540689,20540689_D002945_D009369,20540689_1,bcv_sentence_task_befree_3666,,770959595,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,0.6116,,D002945,"<span class=""chemical"">cisplatin</span>",D006528,"<span class=""disease"">hepatoma</span>","This paper reviews current understanding of <span class=""chemical"">cisplatin</span>-induced erythrocyte injury, and presents our latest finding that a low dose of <span class=""chemical"">cisplatin</span> (3.6 mg/m(2)/day, 14 days) could induce specific hemosiderin deposition in spleen of both normal and <span class=""disease"">hepatoma</span>-22 (H22) inoculated Balb/C mice.",,20540689,20540689_D002945_D006528,20540689_3,bcv_sentence_task_befree_3667,,770959596,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,0.6024,,D002945,"<span class=""chemical"">cisplatin</span>",D001201,"<span class=""disease"">ascites</span>","This dose of <span class=""chemical"">cisplatin</span> significantly inhibited H22-induced acute <span class=""disease"">ascites</span> development.",,20540689,20540689_D002945_D001201,20540689_4,bcv_sentence_task_befree_3668,,770959597,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D009369,"<span class=""disease"">tumor</span>","No significant toxicity was induced by this dose of <span class=""chemical"">cisplatin</span> to tissues except for hemosiderin accumulation in the spleen of both normal and H22 <span class=""disease"">tumor</span>-bearing mice.",,20540689,20540689_D002945_D009369,20540689_5,bcv_sentence_task_befree_3669,,770959598,FALSE,finalized,5,8/15/15 0:01,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D064420,"<span class=""disease"">toxicity</span>","No significant <span class=""disease"">toxicity</span> was induced by this dose of <span class=""chemical"">cisplatin</span> to tissues except for hemosiderin accumulation in the spleen of both normal and H22 tumor-bearing mice.",,20540689,20540689_D002945_D064420,20540689_5,bcv_sentence_task_befree_3670,,770959599,FALSE,finalized,5,8/14/15 22:10,"



",yes_direct,0.5929,,D002945,"<span class=""chemical"">cisplatin</span>",D013158,"<span class=""disease"">splenic</span>","Increased <span class=""disease"">splenic</span> iron content and erythrocyte injury were observed after treatment with the low dose of <span class=""chemical"">cisplatin</span>.",,20540689,20540689_D002945_D013158,20540689_6,bcv_sentence_task_befree_3671,,770959600,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,0.7999,,D007501,"<span class=""chemical"">iron</span>",D013158,"<span class=""disease"">splenic</span>","Increased <span class=""disease"">splenic</span> <span class=""chemical"">iron</span> content and erythrocyte injury were observed after treatment with the low dose of cisplatin.",,20540689,20540689_D007501_D013158,20540689_6,bcv_sentence_task_befree_3672,,770959601,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,0.5988,,C428463,"<span class=""chemical"">Hepcidin</span>",D013158,"<span class=""disease"">splenic</span>","<span class=""chemical"">Hepcidin</span> inhibits the function of FPN1 as iron-exporter leading to iron overloaded inside ferritins of <span class=""disease"">splenic</span> cells, which are stained with abnormal hemosiderin accumulation.",,20540689,20540689_C428463_D013158,20540689_11,bcv_sentence_task_befree_3673,,770959602,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,0.8283,,D007501,"<span class=""chemical"">iron</span>",D013158,"<span class=""disease"">splenic</span>","Hepcidin inhibits the function of FPN1 as <span class=""chemical"">iron</span>-exporter leading to iron overloaded inside ferritins of <span class=""disease"">splenic</span> cells, which are stained with abnormal hemosiderin accumulation.",,20540689,20540689_D007501_D013158,20540689_11,bcv_sentence_task_befree_3674,,770959603,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D064420,"<span class=""disease"">toxicity</span>","These results demonstrate that cisplatin-caused hemosiderin deposition in spleen provides a valuable clue for understanding the molecular basis of <span class=""disease"">toxicity</span> of cisplatin and hemosiderin accumulation and <span class=""chemical"">iron</span> metabolism in vivo.",,20540689,20540689_D007501_D064420,20540689_12,bcv_sentence_task_befree_3675,,770959604,FALSE,finalized,5,8/15/15 0:24,"



",yes_direct,0.6214,,D002945,"<span class=""chemical"">cisplatin</span>",D064420,"<span class=""disease"">toxicity</span>","These results demonstrate that <span class=""chemical"">cisplatin</span>-caused hemosiderin deposition in spleen provides a valuable clue for understanding the molecular basis of <span class=""disease"">toxicity</span> of <span class=""chemical"">cisplatin</span> and hemosiderin accumulation and iron metabolism in vivo.",,20540689,20540689_D002945_D064420,20540689_12,bcv_sentence_task_befree_3676,,770959605,FALSE,finalized,5,8/14/15 22:26,"



",yes_direct,0.801,,D003300,"<span class=""chemical"">copper</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Real-time monitoring of <span class=""chemical"">copper</span> ions-induced <span class=""disease"">cytotoxicity</span> by EIS cell chips.",,20547054,20547054_D003300_D004487,20547054_0,bcv_sentence_task_befree_3677,,770959606,FALSE,finalized,5,8/14/15 23:22,"



",no_relation,1,,D019289,"<span class=""chemical"">pyruvate</span>",D008105,"<span class=""disease"">primary biliary cirrhosis/PBC</span>","Our understanding of <span class=""disease"">primary biliary cirrhosis</span> (<span class=""disease"">PBC</span>) has been significantly enhanced by the rigorous dissection of the multilineage T and B cell response against the immunodominant mitochondrial autoantigen, the E2 component of the <span class=""chemical"">pyruvate</span> dehydrogenase complex (PDC-E2).",,20568301,20568301_D019289_D008105,20568301_1,bcv_sentence_task_befree_3678,,770959607,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,1,,D014580,"<span class=""chemical"">ursodiol</span>",D008105,"<span class=""disease"">PBC</span>","These results provide a mechanism for the biliary specificity of <span class=""disease"">PBC</span>, the recurrence of disease after liver transplantation, and the success of <span class=""chemical"">ursodiol</span> in treatment.",,20568301,20568301_D014580_D008105,20568301_9,bcv_sentence_task_befree_3679,,770959608,FALSE,finalized,5,8/14/15 22:24,"



",no_relation,1,,D002244,"<span class=""chemical"">carbon</span>",D010003,"<span class=""disease"">OA</span>","Analysis of f(SC)K(SA)delta(OCT)/F(OM)K(<span class=""disease"">OA</span>) ratios revealed a significant role of adsorption and absorption in unusually high elemental <span class=""chemical"">carbon</span> fractions (ie low OC/EC ratio) in fine particles collected at waste incinerators and the abnormally high organic <span class=""chemical"">carbon</span> fractions (ie high OC/EC ratio) observed in those fine particles of an urban residential zone, respectively.",,20578474,20578474_D002244_D010003,20578474_4,bcv_sentence_task_befree_3680,,770959609,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,1,,C043211,"<span class=""chemical"">Carvedilol</span>",D000544,"<span class=""disease"">Alzheimer's disease</span>","<span class=""chemical"">Carvedilol</span> as a potential novel agent for the treatment of <span class=""disease"">Alzheimer's disease</span>.",,20579773,20579773_C043211_D000544,20579773_0,bcv_sentence_task_befree_3681,,770959610,FALSE,finalized,5,8/15/15 1:18,"



",no_relation,1,,C043211,"<span class=""chemical"">carvedilol</span>",D000544,"<span class=""disease"">AD mouse</span>","Here we present evidence that chronic oral administration of <span class=""chemical"">carvedilol</span>, a nonselective _-adrenergic receptor blocker, significantly attenuates brain oligomeric _-amyloid content and cognitive deterioration in 2 independent <span class=""disease"">AD mouse</span> models.",,20579773,20579773_C043211_D000544,20579773_2,bcv_sentence_task_befree_3682,,770959611,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,0.8073,,C043211,"<span class=""chemical"">carvedilol</span>",D003072,"<span class=""disease"">cognitive deterioration</span>","Here we present evidence that chronic oral administration of <span class=""chemical"">carvedilol</span>, a nonselective _-adrenergic receptor blocker, significantly attenuates brain oligomeric _-amyloid content and <span class=""disease"">cognitive deterioration</span> in 2 independent AD mouse models.",,20579773,20579773_C043211_D003072,20579773_2,bcv_sentence_task_befree_3683,,770959612,FALSE,finalized,5,8/15/15 0:23,"



",no_relation,1,,C043211,"<span class=""chemical"">carvedilol</span>",D000544,"<span class=""disease"">AD</span>","We found that <span class=""chemical"">carvedilol</span> treatment significantly improved neuronal transmission, and that this improvement was associated with the maintenance of number of the less stable ""learning"" thin spines in the brains of <span class=""disease"">AD</span> mice.",,20579773,20579773_C043211_D000544,20579773_3,bcv_sentence_task_befree_3684,,770959613,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,C043211,"<span class=""chemical"">carvedilol</span>",D000544,"<span class=""disease"">AD</span>","Our novel observation that <span class=""chemical"">carvedilol</span> interferes with the neuropathologic, biochemical, and electrophysiological mechanisms underlying cognitive deterioration in <span class=""disease"">AD</span> supports the potential development of <span class=""chemical"">carvedilol</span> as a treatment for <span class=""disease"">AD</span>.",,20579773,20579773_C043211_D000544,20579773_4,bcv_sentence_task_befree_3685,,770959614,FALSE,finalized,5,8/14/15 23:56,"



Used as treatment",no_relation,0.7854,,C043211,"<span class=""chemical"">carvedilol</span>",D003072,"<span class=""disease"">cognitive deterioration</span>","Our novel observation that <span class=""chemical"">carvedilol</span> interferes with the neuropathologic, biochemical, and electrophysiological mechanisms underlying <span class=""disease"">cognitive deterioration</span> in AD supports the potential development of <span class=""chemical"">carvedilol</span> as a treatment for AD.",,20579773,20579773_C043211_D003072,20579773_4,bcv_sentence_task_befree_3686,,770959615,FALSE,finalized,5,8/14/15 22:13,"



",no_relation,0.8212,,D024841,"<span class=""chemical"">fluoroquinolone</span>",D009175,"<span class=""disease"">Mycoplasma</span>","Emergence of clinical strains of <span class=""disease"">Mycoplasma</span> genitalium harbouring alterations in ParC associated with <span class=""chemical"">fluoroquinolone</span> resistance.",,20580532,20580532_D024841_D009175,20580532_0,bcv_sentence_task_befree_3687,,770959616,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,D024841,"<span class=""chemical"">fluoroquinolone</span>",D009175,"<span class=""disease"">Mycoplasma</span>","The alterations of Ser-83-->Asn, Asp-87-->Tyr and Asp-87-->Val in ParC found in 3 (10.7%) of 28 specimens were analogous to those commonly observed in <span class=""chemical"">fluoroquinolone</span>-resistant mutants of other <span class=""disease"">Mycoplasma</span> and Ureaplasma spp.",,20580532,20580532_D024841_D009175,20580532_7,bcv_sentence_task_befree_3688,,770959617,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",D011778,"<span class=""disease"">acute Q fever granulomatous hepatitis</span>","Circulating cytokines and procalcitonin in <span class=""disease"">acute Q fever granulomatous hepatitis</span> with poor response to antibiotic and short-course <span class=""chemical"">steroid</span> therapy: a case report.",,20594295,20594295_D013256_D011778,20594295_0,bcv_sentence_task_befree_3689,,770959618,FALSE,finalized,5,8/15/15 1:33,"



",no_relation,0.7795,,D011239,"<span class=""chemical"">prednisolone</span>",D011778,"<span class=""disease"">acute Q fever granulomatous hepatitis</span>","We report a rare case of <span class=""disease"">acute Q fever granulomatous hepatitis</span> remained pyrexia despite several antibiotic therapy and 6-day course of oral <span class=""chemical"">prednisolone</span>.",,20594295,20594295_D011239_D011778,20594295_3,bcv_sentence_task_befree_3690,,770959619,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D011239,"<span class=""chemical"">prednisolone</span>",D005334,"<span class=""disease"">pyrexia</span>","We report a rare case of acute Q fever granulomatous hepatitis remained <span class=""disease"">pyrexia</span> despite several antibiotic therapy and 6-day course of oral <span class=""chemical"">prednisolone</span>.",,20594295,20594295_D011239_D005334,20594295_3,bcv_sentence_task_befree_3691,,770959620,FALSE,finalized,5,8/15/15 2:09,"



",no_relation,1,,D009609,"<span class=""chemical"">nitrous oxide</span>",D010146,"<span class=""disease"">pain</span>","The aims of this project were to longitudinally follow plasma levels of beta-endorphin during pregnancy in women with a healthy pregnancy and to investigate whether plasma levels of beta-endorphin in late pregnancy are associated with need for additional <span class=""disease"">pain</span> medication beyond <span class=""chemical"">nitrous oxide</span> during labor.",,20595705,20595705_D009609_D010146,20595705_2,bcv_sentence_task_befree_3692,,770959621,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,1,,D009609,"<span class=""chemical"">nitrous oxide</span>",D010146,"<span class=""disease"">pain</span>","Low levels of beta-endorphin at the end of pregnancy were associated with need for additional <span class=""disease"">pain</span> medication beyond <span class=""chemical"">nitrous oxide</span> during labor, although the causal relationship is unclear.",,20595705,20595705_D009609_D010146,20595705_6,bcv_sentence_task_befree_3693,,770959622,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D001249,"<span class=""disease"">asthma</span>","Association of SLC6A12 variants with <span class=""chemical"">aspirin</span>-intolerant <span class=""disease"">asthma</span> in a Korean population.",,20597903,20597903_D001241_D001249,20597903_0,bcv_sentence_task_befree_3694,,770959623,FALSE,finalized,5,8/14/15 21:43,"



",yes_direct,0.6072,,D001241,"<span class=""chemical"">Aspirin</span>",D001249,"<span class=""disease"">asthma</span>","<span class=""chemical"">Aspirin</span>-intolerant <span class=""disease"">asthma</span> (AIA) occurs from <span class=""disease"">asthma</span> exacerbation after exposure to <span class=""chemical"">aspirin</span>.",,20597903,20597903_D001241_D001249,20597903_1,bcv_sentence_task_befree_3695,,770959624,FALSE,finalized,5,8/15/15 1:45,"



",no_relation,0.7982,,D005680,"<span class=""chemical"">GABA</span>",D001249,"<span class=""disease"">asthma</span>","The critical role of the solute carrier family 6 (neurotransmitter transporter, betaine/<span class=""chemical"">GABA</span>) member 12 (SLC6A12) gene in GABAergic transmission, which is associated with mucus production in <span class=""disease"">asthma</span>, makes it a candidate gene for AIA association study.",,20597903,20597903_D005680_D001249,20597903_3,bcv_sentence_task_befree_3696,,770959625,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D001249,"<span class=""disease"">asthma</span>","Eight single nucleotide polymorphisms (SNPs) in SLC6A12 were genotyped in 163 <span class=""chemical"">aspirin</span>-intolerant <span class=""disease"">asthma</span> (AIA) and 429 <span class=""chemical"">aspirin</span>-tolerant asthma (ATA) patients of Korean ethnicity.",,20597903,20597903_D001241_D001249,20597903_4,bcv_sentence_task_befree_3697,,770959626,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D055963,"<span class=""disease"">aspirin-tolerant asthma/ATA</span>","Eight single nucleotide polymorphisms (SNPs) in SLC6A12 were genotyped in 163 <span class=""chemical"">aspirin</span>-intolerant asthma (AIA) and 429 <span class=""chemical""></span><span class=""disease"">aspirin</span>-tolerant asthma (<span class=""disease"">ATA</span>) patients of Korean ethnicity.",,20597903,20597903_D001241_D055963,20597903_4,bcv_sentence_task_befree_3698,,770959627,FALSE,finalized,5,8/15/15 1:58,"



",no_relation,1,,D017963,"<span class=""chemical"">azithromycin</span>",D008173,"<span class=""disease"">obstructive pulmonary diseases</span>","In addition to its antibiotic properties, <span class=""chemical"">azithromycin</span> has immune-modulating effects and is used for this reason in the management of cystic fibrosis and chronic <span class=""disease"">obstructive pulmonary diseases</span>.",,20604763,20604763_D017963_D008173,20604763_3,bcv_sentence_task_befree_3699,,770959628,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,D017963,"<span class=""chemical"">azithromycin</span>",D005355,"<span class=""disease"">fibrosis</span>","In addition to its antibiotic properties, <span class=""chemical"">azithromycin</span> has immune-modulating effects and is used for this reason in the management of cystic <span class=""disease"">fibrosis</span> and chronic obstructive pulmonary diseases.",,20604763,20604763_D017963_D005355,20604763_3,bcv_sentence_task_befree_3700,,770959629,FALSE,finalized,5,8/15/15 1:45,"



",no_relation,0.8098,,D002118,"<span class=""chemical"">calcium</span>",D055113,"<span class=""disease"">chronic periodontitis</span>","Azithromycin, together with monthly subgingival debridement, was the treatment in Case 3 (severe <span class=""disease"">chronic periodontitis</span> in a poorly controlled diabetic complicated by gingival overgrowth related to medication with a <span class=""chemical"">calcium</span> channel blocker).",,20604763,20604763_D002118_D055113,20604763_7,bcv_sentence_task_befree_3701,,770959630,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,0.8245,,D017963,"<span class=""chemical"">Azithromycin</span>",D019214,"<span class=""disease"">gingival overgrowth</span>","<span class=""chemical"">Azithromycin</span>, together with monthly subgingival debridement, was the treatment in Case 3 (severe chronic periodontitis in a poorly controlled diabetic complicated by <span class=""disease"">gingival overgrowth</span> related to medication with a calcium channel blocker).",,20604763,20604763_D017963_D019214,20604763_7,bcv_sentence_task_befree_3702,,770959631,FALSE,finalized,5,8/14/15 21:34,"



",no_relation,1,,D017963,"<span class=""chemical"">Azithromycin</span>",D003929,"<span class=""disease"">diabetic</span>","<span class=""chemical"">Azithromycin</span>, together with monthly subgingival debridement, was the treatment in Case 3 (severe chronic periodontitis in a poorly controlled <span class=""disease"">diabetic</span> complicated by gingival overgrowth related to medication with a calcium channel blocker).",,20604763,20604763_D017963_D003929,20604763_7,bcv_sentence_task_befree_3703,,770959632,FALSE,finalized,5,8/14/15 22:08,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D003929,"<span class=""disease"">diabetic</span>","Azithromycin, together with monthly subgingival debridement, was the treatment in Case 3 (severe chronic periodontitis in a poorly controlled <span class=""disease"">diabetic</span> complicated by gingival overgrowth related to medication with a <span class=""chemical"">calcium</span> channel blocker).",,20604763,20604763_D002118_D003929,20604763_7,bcv_sentence_task_befree_3704,,770959633,FALSE,finalized,5,8/14/15 22:07,"



",no_relation,0.6098,,D002118,"<span class=""chemical"">calcium</span>",D019214,"<span class=""disease"">gingival overgrowth</span>","Azithromycin, together with monthly subgingival debridement, was the treatment in Case 3 (severe chronic periodontitis in a poorly controlled diabetic complicated by <span class=""disease"">gingival overgrowth</span> related to medication with a <span class=""chemical"">calcium</span> channel blocker).",,20604763,20604763_D002118_D019214,20604763_7,bcv_sentence_task_befree_3705,,770959634,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,1,,D017963,"<span class=""chemical"">Azithromycin</span>",D055113,"<span class=""disease"">chronic periodontitis</span>","<span class=""chemical"">Azithromycin</span>, together with monthly subgingival debridement, was the treatment in Case 3 (severe <span class=""disease"">chronic periodontitis</span> in a poorly controlled diabetic complicated by gingival overgrowth related to medication with a calcium channel blocker).",,20604763,20604763_D017963_D055113,20604763_7,bcv_sentence_task_befree_3706,,770959635,FALSE,finalized,5,8/14/15 22:04,"



",no_relation,0.8045,,D002392,"<span class=""chemical"">(-)-epicatechin</span>",D008175,"<span class=""disease"">lung cancer</span>","New role of <span class=""chemical"">(-)-epicatechin</span> in enhancing the induction of growth inhibition and apoptosis in human <span class=""disease"">lung cancer</span> cells by curcumin.",,20606042,20606042_D002392_D008175,20606042_0,bcv_sentence_task_befree_3707,,770959636,FALSE,finalized,5,8/15/15 0:14,"



",no_relation,0.6145,,D003474,"<span class=""chemical"">curcumin</span>",D008175,"<span class=""disease"">lung cancer</span>","New role of (-)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human <span class=""disease"">lung cancer</span> cells by <span class=""chemical"">curcumin</span>.",,20606042,20606042_D003474_D008175,20606042_0,bcv_sentence_task_befree_3708,,770959637,FALSE,finalized,5,8/14/15 21:44,"



",yes_direct,1,,D003474,"<span class=""chemical"">Curcumin</span>",D009369,"<span class=""disease"">cancer-preventive activity</span>","<span class=""chemical"">Curcumin</span>, a phenolic compound isolated from the plant Curcuma longa (Linn), is ingested every day in the Indian subcontinent and is well reported to possess <span class=""disease"">cancer-preventive activity</span>.",,20606042,20606042_D003474_D009369,20606042_1,bcv_sentence_task_befree_3709,,770959638,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,D003474,"<span class=""chemical"">curcumin</span>",D009369,"<span class=""disease"">cancer</span>","To achieve effective <span class=""disease"">cancer</span> prevention with <span class=""chemical"">curcumin</span>, we need to find a new method to enhance the effects of <span class=""chemical"">curcumin</span> in the diet.",,20606042,20606042_D003474_D009369,20606042_2,bcv_sentence_task_befree_3710,,770959639,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,0.581,,D002392,"<span class=""chemical"">catechin/(-)-epicatechin</span>",D009369,"<span class=""disease"">cancer-preventive activity</span>","Based on our evidence that <span class=""chemical"">(-)-epicatechin</span> (EC), an inert <span class=""chemical"">catechin</span>, enhances the <span class=""disease"">cancer-preventive activity</span> of green tea catechins, we studied the enhancing effects of EC on inductions of growth inhibition and apoptosis in human lung cancer cell lines PC-9 and A549 with curcumin.",,20606042,20606042_D002392_D009369,20606042_3,bcv_sentence_task_befree_3711,,770959640,FALSE,finalized,5,8/14/15 21:39,"



",no_relation,1,,D002392,"<span class=""chemical"">catechin/(-)-epicatechin</span>",D008175,"<span class=""disease"">lung cancer</span>","Based on our evidence that <span class=""chemical"">(-)-epicatechin</span> (EC), an inert <span class=""chemical"">catechin</span>, enhances the cancer-preventive activity of green tea catechins, we studied the enhancing effects of EC on inductions of growth inhibition and apoptosis in human <span class=""disease"">lung cancer</span> cell lines PC-9 and A549 with curcumin.",,20606042,20606042_D002392_D008175,20606042_3,bcv_sentence_task_befree_3712,,770959641,FALSE,finalized,5,8/14/15 21:58,"



""cancer-preventive activity""  is not a disease",no_relation,1,,D003474,"<span class=""chemical"">curcumin</span>",D009369,"<span class=""disease"">cancer-preventive activity</span>","Based on our evidence that (-)-epicatechin (EC), an inert catechin, enhances the <span class=""disease"">cancer-preventive activity</span> of green tea catechins, we studied the enhancing effects of EC on inductions of growth inhibition and apoptosis in human lung cancer cell lines PC-9 and A549 with <span class=""chemical"">curcumin</span>.",,20606042,20606042_D003474_D009369,20606042_3,bcv_sentence_task_befree_3713,,770959642,FALSE,finalized,5,8/14/15 23:39,"



",no_relation,0.8091,,D003474,"<span class=""chemical"">curcumin</span>",D008175,"<span class=""disease"">lung cancer</span>","Based on our evidence that (-)-epicatechin (EC), an inert catechin, enhances the cancer-preventive activity of green tea catechins, we studied the enhancing effects of EC on inductions of growth inhibition and apoptosis in human <span class=""disease"">lung cancer</span> cell lines PC-9 and A549 with <span class=""chemical"">curcumin</span>.",,20606042,20606042_D003474_D008175,20606042_3,bcv_sentence_task_befree_3714,,770959643,FALSE,finalized,5,8/15/15 0:35,"



",yes_direct,0.5913,,D003474,"<span class=""chemical"">curcumin</span>",D009369,"<span class=""disease"">cancer-preventive activity</span>","This report is the first report on the enhancing effects of EC on <span class=""chemical"">curcumin</span>, and the data suggest that EC plays a significant role in the enhancement of the <span class=""disease"">cancer-preventive activity</span> of <span class=""chemical"">curcumin</span> in the diet.",,20606042,20606042_D003474_D009369,20606042_9,bcv_sentence_task_befree_3715,,770959644,FALSE,finalized,5,8/15/15 0:16,"



",yes_direct,1,,D014640,"<span class=""chemical"">vancomycin</span>",D016470,"<span class=""disease"">Corynebacterium falsenii bacteremia</span>","<span class=""disease"">Corynebacterium falsenii bacteremia</span> occurring in an infant on <span class=""chemical"">vancomycin</span> therapy.",,20610679,20610679_D014640_D016470,20610679_0,bcv_sentence_task_befree_3716,,770959645,FALSE,finalized,5,8/14/15 21:33,"



",yes_direct,1,,D014640,"<span class=""chemical"">vancomycin</span>",D016470,"<span class=""disease"">Corynebacterium falsenii bacteremia</span>","We give the first detailed description of a clinically significant <span class=""disease"">Corynebacterium falsenii bacteremia</span> occurring in an infant while on <span class=""chemical"">vancomycin</span> therapy.",,20610679,20610679_D014640_D016470,20610679_2,bcv_sentence_task_befree_3717,,770959646,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,0.8101,,D017311,"<span class=""chemical"">amlodipine</span>",D006973,"<span class=""disease"">hypertension</span>","Efficacy of fixed-dose combination therapy in the treatment of patients with <span class=""disease"">hypertension</span>: focus on <span class=""chemical"">amlodipine</span>/valsartan.",,20626210,20626210_D017311_D006973,20626210_0,bcv_sentence_task_befree_3718,,770959647,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,1,,C081489,"<span class=""chemical"">valsartan</span>",D006973,"<span class=""disease"">hypertension</span>","Efficacy of fixed-dose combination therapy in the treatment of patients with <span class=""disease"">hypertension</span>: focus on amlodipine/<span class=""chemical"">valsartan</span>.",,20626210,20626210_C081489_D006973,20626210_0,bcv_sentence_task_befree_3719,,770959648,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,1,,D000450,"<span class=""chemical"">aldosterone</span>",D002318,"<span class=""disease"">renal and cardiovascular morbidity</span>","Combination therapy with a calcium channel antagonist (calcium channel blocker [CCB]) and an inhibitor of the renin-angiotensin-<span class=""chemical"">aldosterone</span> system (RAAS) is a rational approach to achieve BP goals and provide protection against <span class=""disease"">renal and cardiovascular morbidity</span> and mortality.",,20626210,20626210_D000450_D002318,20626210_3,bcv_sentence_task_befree_3720,,770959649,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D002318,"<span class=""disease"">renal and cardiovascular morbidity</span>","Combination therapy with a <span class=""chemical"">calcium</span> channel antagonist (<span class=""chemical"">calcium</span> channel blocker [CCB]) and an inhibitor of the renin-angiotensin-aldosterone system (RAAS) is a rational approach to achieve BP goals and provide protection against <span class=""disease"">renal and cardiovascular morbidity</span> and mortality.",,20626210,20626210_D002118_D002318,20626210_3,bcv_sentence_task_befree_3721,,770959650,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,D017311,"<span class=""chemical"">amlodipine</span>",D006973,"<span class=""disease"">hypertensive</span>","The efficacy of the CCB <span class=""chemical"">amlodipine</span> and the ARB valsartan in lowering BP and protecting against cardiovascular events and stroke across a range of <span class=""disease"">hypertensive</span> patient populations has been established over many years.",,20626210,20626210_D017311_D006973,20626210_7,bcv_sentence_task_befree_3722,,770959651,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,D017311,"<span class=""chemical"">amlodipine</span>",D020521,"<span class=""disease"">stroke</span>","The efficacy of the CCB <span class=""chemical"">amlodipine</span> and the ARB valsartan in lowering BP and protecting against cardiovascular events and <span class=""disease"">stroke</span> across a range of hypertensive patient populations has been established over many years.",,20626210,20626210_D017311_D020521,20626210_7,bcv_sentence_task_befree_3723,,770959652,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,C081489,"<span class=""chemical"">valsartan</span>",D002318,"<span class=""disease"">cardiovascular events</span>","The efficacy of the CCB amlodipine and the ARB <span class=""chemical"">valsartan</span> in lowering BP and protecting against <span class=""disease"">cardiovascular events</span> and stroke across a range of hypertensive patient populations has been established over many years.",,20626210,20626210_C081489_D002318,20626210_7,bcv_sentence_task_befree_3724,,770959653,FALSE,finalized,5,8/15/15 2:22,"



",no_relation,1,,C081489,"<span class=""chemical"">valsartan</span>",D020521,"<span class=""disease"">stroke</span>","The efficacy of the CCB amlodipine and the ARB <span class=""chemical"">valsartan</span> in lowering BP and protecting against cardiovascular events and <span class=""disease"">stroke</span> across a range of hypertensive patient populations has been established over many years.",,20626210,20626210_C081489_D020521,20626210_7,bcv_sentence_task_befree_3725,,770959654,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,1,,D017311,"<span class=""chemical"">amlodipine</span>",D002318,"<span class=""disease"">cardiovascular events</span>","The efficacy of the CCB <span class=""chemical"">amlodipine</span> and the ARB valsartan in lowering BP and protecting against <span class=""disease"">cardiovascular events</span> and stroke across a range of hypertensive patient populations has been established over many years.",,20626210,20626210_D017311_D002318,20626210_7,bcv_sentence_task_befree_3726,,770959655,FALSE,finalized,5,8/15/15 0:24,"



",no_relation,1,,C081489,"<span class=""chemical"">valsartan</span>",D006973,"<span class=""disease"">hypertensive</span>","The efficacy of the CCB amlodipine and the ARB <span class=""chemical"">valsartan</span> in lowering BP and protecting against cardiovascular events and stroke across a range of <span class=""disease"">hypertensive</span> patient populations has been established over many years.",,20626210,20626210_C081489_D006973,20626210_7,bcv_sentence_task_befree_3727,,770959656,FALSE,finalized,5,8/14/15 22:44,"



",no_relation,1,,D017311,"<span class=""chemical"">amlodipine</span>",D006973,"<span class=""disease"">hypertension</span>","Once-daily <span class=""chemical"">amlodipine</span>/valsartan is a rational and convenient treatment option for the effective management of patients with <span class=""disease"">hypertension</span>, improving adherence to antihypertensive medication and protecting against cardiovascular and renal morbidity and mortality.",,20626210,20626210_D017311_D006973,20626210_9,bcv_sentence_task_befree_3728,,770959657,FALSE,finalized,5,8/15/15 0:09,"


Used as treatment
",no_relation,1,,C081489,"<span class=""chemical"">valsartan</span>",D006973,"<span class=""disease"">hypertension</span>","Once-daily amlodipine/<span class=""chemical"">valsartan</span> is a rational and convenient treatment option for the effective management of patients with <span class=""disease"">hypertension</span>, improving adherence to antihypertensive medication and protecting against cardiovascular and renal morbidity and mortality.",,20626210,20626210_C081489_D006973,20626210_9,bcv_sentence_task_befree_3729,,770959658,FALSE,finalized,5,8/14/15 22:00,"



",yes_direct,0.593,,D004958,"<span class=""chemical"">estradiol</span>",D007249,"<span class=""disease"">inflammation</span>","C-reactive protein (CRP), a marker of generalized <span class=""disease"">inflammation</span>, is raised by oral <span class=""chemical"">estradiol</span> therapy (ET).",,20632462,20632462_D004958_D007249,20632462_2,bcv_sentence_task_befree_3730,,770959659,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,1,,D004967,"<span class=""chemical"">Estrogen</span>",D050197,"<span class=""disease"">Atherosclerosis</span>","This observational study includes postmenopausal women participating in the <span class=""chemical"">Estrogen</span> in the Prevention of <span class=""disease"">Atherosclerosis</span> Trial.",,20632462,20632462_D004967_D050197,20632462_4,bcv_sentence_task_befree_3731,,770959660,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,1,,D011166,"<span class=""chemical"">porphyrins</span>",D016609,"<span class=""disease"">PDT/photodynamic therapy</span>","Light-based treatments and <span class=""disease"">photodynamic therapy</span> (<span class=""disease"">PDT</span>) using topical precursors of <span class=""chemical"">porphyrins</span> are off-label alternative treatments for acne vulgaris, with their own advantages and disadvantages.",,20633796,20633796_D011166_D016609,20633796_3,bcv_sentence_task_befree_3732,,770959661,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,D011166,"<span class=""chemical"">porphyrins</span>",D000152,"<span class=""disease"">acne vulgaris</span>","Light-based treatments and photodynamic therapy (PDT) using topical precursors of <span class=""chemical"">porphyrins</span> are off-label alternative treatments for <span class=""disease"">acne vulgaris</span>, with their own advantages and disadvantages.",,20633796,20633796_D011166_D000152,20633796_3,bcv_sentence_task_befree_3733,,770959662,FALSE,finalized,5,8/14/15 23:57,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D018798,"<span class=""disease"">iron deficiency anemia</span>","We investigated the efficacy of co-administration of DFAIII with water-insoluble <span class=""chemical"">iron</span> in the treatment of <span class=""chemical""></span><span class=""disease"">iron</span> deficiency anemia in Vietnamese women.",,20651460,20651460_D007501_D018798,20651460_2,bcv_sentence_task_befree_3734,,770959663,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,1,,D026023,"<span class=""chemical"">permethrin</span>",D013984,"<span class=""disease"">Dermanyssus gallinae infestation</span>","<span class=""disease"">Dermanyssus gallinae infestation</span>: an unusual cause of scalp pruritus treated with <span class=""chemical"">permethrin</span> shampoo.",,20687864,20687864_D026023_D013984,20687864_0,bcv_sentence_task_befree_3735,,770959664,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,D002230,"<span class=""chemical"">carbidopa</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","A combination of levodopa (L-DOPA) and <span class=""chemical"">carbidopa</span> is the most commonly-used treatment for symptom management in <span class=""disease"">Parkinson's disease</span>.",,20700524,20700524_D002230_D010300,20700524_1,bcv_sentence_task_befree_3736,,770959665,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,1,,D007980,"<span class=""chemical"">levodopa/L-DOPA</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","A combination of <span class=""chemical"">levodopa</span> (<span class=""chemical"">L-DOPA</span>) and carbidopa is the most commonly-used treatment for symptom management in <span class=""disease"">Parkinson's disease</span>.",,20700524,20700524_D007980_D010300,20700524_1,bcv_sentence_task_befree_3737,,770959666,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,D002230,"<span class=""chemical"">carbidopa</span>",D010300,"<span class=""disease"">Parkinson's</span>","These observations suggest that oral administration of EGCG may have significant beneficial effects in <span class=""disease"">Parkinson's</span> patients treated with L-DOPA and <span class=""chemical"">carbidopa</span> by exerting a modest inhibition of L-DOPA methylation plus a strong neuroprotection against oxidative damage and degeneration.",,20700524,20700524_D002230_D010300,20700524_9,bcv_sentence_task_befree_3738,,770959667,FALSE,finalized,5,8/15/15 1:26,"



",no_relation,1,,C045651,"<span class=""chemical"">EGCG</span>",D010300,"<span class=""disease"">Parkinson's</span>","These observations suggest that oral administration of <span class=""chemical"">EGCG</span> may have significant beneficial effects in <span class=""disease"">Parkinson's</span> patients treated with L-DOPA and carbidopa by exerting a modest inhibition of L-DOPA methylation plus a strong neuroprotection against oxidative damage and degeneration.",,20700524,20700524_C045651_D010300,20700524_9,bcv_sentence_task_befree_3739,,770959668,FALSE,finalized,5,8/14/15 21:28,"



",no_relation,1,,D007980,"<span class=""chemical"">L-DOPA</span>",D010300,"<span class=""disease"">Parkinson's</span>","These observations suggest that oral administration of EGCG may have significant beneficial effects in <span class=""disease"">Parkinson's</span> patients treated with <span class=""chemical"">L-DOPA</span> and carbidopa by exerting a modest inhibition of <span class=""chemical"">L-DOPA</span> methylation plus a strong neuroprotection against oxidative damage and degeneration.",,20700524,20700524_D007980_D010300,20700524_9,bcv_sentence_task_befree_3740,,770959669,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D009705,"<span class=""chemical"">nucleoside</span>",D015658,"<span class=""disease"">HIV-infected</span>","HAART-related long-term toxicities, many of them ascribed to mitochondrial (mt) toxicity of the <span class=""chemical"">nucleoside</span> analogues, are being increasingly reported in <span class=""disease"">HIV-infected</span> children.",,20707732,20707732_D009705_D015658,20707732_1,bcv_sentence_task_befree_3741,,770959670,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,0.5844,,D009705,"<span class=""chemical"">nucleoside</span>",D064420,"<span class=""disease"">toxicity/toxicities</span>","HAART-related long-term <span class=""disease"">toxicities</span>, many of them ascribed to mitochondrial (mt) <span class=""disease"">toxicity</span> of the <span class=""chemical"">nucleoside</span> analogues, are being increasingly reported in HIV-infected children.",,20707732,20707732_D009705_D064420,20707732_1,bcv_sentence_task_befree_3742,,770959671,FALSE,finalized,5,8/15/15 1:41,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D003929,"<span class=""disease"">diabetic</span>","In a 24-week, open-label, parallel-group trial, type 2 <span class=""disease"">diabetic</span> patients who were not maintaining glycemic control on basal insulin (glargine or neutral protamine Hagedorn) + oral antidiabetic drugs were randomly assigned to twice-daily BIAsp 30 + <span class=""chemical"">metformin</span> or once-daily glargine + <span class=""chemical"">metformin</span> + secretagogues (secretagogues were discontinued in the BIAsp 30 arm).",,20713345,20713345_D008687_D003929,20713345_2,bcv_sentence_task_befree_3743,,770959672,FALSE,finalized,5,8/15/15 0:15,"



",yes_direct,0.79,,C005846,"<span class=""chemical"">tremolite</span>",D008654,"<span class=""disease"">mesothelioma</span>","A case of occupational peritoneal <span class=""disease"">mesothelioma</span> from exposure to <span class=""chemical"">tremolite</span>-free chrysotile in Quebec, Canada: A black swan case.",,20721899,20721899_C005846_D008654,20721899_0,bcv_sentence_task_befree_3744,,770959673,FALSE,finalized,5,8/15/15 1:06,"



",yes_direct,1,,C005846,"<span class=""chemical"">Tremolite</span>",D008654,"<span class=""disease"">mesothelioma</span>","<span class=""chemical"">Tremolite</span> contamination has been proposed as the cause of <span class=""disease"">mesothelioma</span> in workers exposed to commercial chrysotile.",,20721899,20721899_C005846_D008654,20721899_1,bcv_sentence_task_befree_3745,,770959674,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,0.6306,,C005846,"<span class=""chemical"">tremolite</span>",D008654,"<span class=""disease"">mesothelioma</span>","Chrysotile without <span class=""chemical"">tremolite</span> can cause peritoneal <span class=""disease"">mesothelioma</span>.",,20721899,20721899_C005846_D008654,20721899_5,bcv_sentence_task_befree_3746,,770959675,FALSE,finalized,5,8/14/15 22:42,"



",yes_direct,0.8095,,D000244,"<span class=""chemical"">ADP</span>",C566800,"<span class=""disease"">platelet aggregation</span>","In a cross-sectional protocol, <span class=""disease"">platelet aggregation</span> in response to <span class=""chemical"">ADP</span> and epinephrine, von Willebrand antigen (vWF:AG), and collagen-binding capacity (vWF:CB) were obtained.",,20739614,20739614_D000244_C566800,20739614_5,bcv_sentence_task_befree_3747,,770959676,FALSE,finalized,5,8/15/15 2:01,"



",no_relation,0.7867,,D004837,"<span class=""chemical"">epinephrine</span>",C566800,"<span class=""disease"">platelet aggregation</span>","In a cross-sectional protocol, <span class=""disease"">platelet aggregation</span> in response to ADP and <span class=""chemical"">epinephrine</span>, von Willebrand antigen (vWF:AG), and collagen-binding capacity (vWF:CB) were obtained.",,20739614,20739614_D004837_C566800,20739614_5,bcv_sentence_task_befree_3748,,770959677,FALSE,finalized,5,8/15/15 2:30,"



",no_relation,0.8094,,D013654,"<span class=""chemical"">taurine</span>",D008545,"<span class=""disease"">melanoma</span>","Effect of combination of <span class=""chemical"">taurine</span> and azelaic acid on antimelanogenesis in murine <span class=""disease"">melanoma</span> cells.",,20804622,20804622_D013654_D008545,20804622_0,bcv_sentence_task_befree_3749,,770959678,FALSE,finalized,5,8/14/15 21:30,"



",no_relation,1,,C010038,"<span class=""chemical"">azelaic acid</span>",D008545,"<span class=""disease"">melanoma</span>","Effect of combination of taurine and <span class=""chemical"">azelaic acid</span> on antimelanogenesis in murine <span class=""disease"">melanoma</span> cells.",,20804622,20804622_C010038_D008545,20804622_0,bcv_sentence_task_befree_3750,,770959679,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,1,,D013654,"<span class=""chemical"">taurine/Tau</span>",D008545,"<span class=""disease"">melanoma</span>","In this study, we investigated the antimelanogenic activity of combination of AZ and <span class=""chemical"">taurine</span> (<span class=""chemical"">Tau</span>) in B16F10 mouse <span class=""disease"">melanoma</span> cells.",,20804622,20804622_D013654_D008545,20804622_6,bcv_sentence_task_befree_3751,,770959680,FALSE,finalized,5,8/15/15 1:45,"



",no_relation,1,,D013654,"<span class=""chemical"">Tau</span>",D008545,"<span class=""disease"">melanoma</span>","AZ combined with <span class=""chemical"">Tau</span> inhibited the melanin production and tyrosinase activity of B16F10 <span class=""disease"">melanoma</span> cells without significant cytotoxicity.",,20804622,20804622_D013654_D008545,20804622_11,bcv_sentence_task_befree_3752,,770959681,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,1,,D013654,"<span class=""chemical"">Tau</span>",D004487,"<span class=""disease"">cytotoxicity</span>","AZ combined with <span class=""chemical"">Tau</span> inhibited the melanin production and tyrosinase activity of B16F10 melanoma cells without significant <span class=""disease"">cytotoxicity</span>.",,20804622,20804622_D013654_D004487,20804622_11,bcv_sentence_task_befree_3753,,770959682,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,D005419,"<span class=""chemical"">flavonoids</span>",D003920,"<span class=""disease"">diabetes mellitus</span>","Artificial neural network-based drug design for <span class=""disease"">diabetes mellitus</span> using <span class=""chemical"">flavonoids</span>.",,20806262,20806262_D005419_D003920,20806262_0,bcv_sentence_task_befree_3754,,770959683,FALSE,finalized,5,8/15/15 1:57,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003920,"<span class=""disease"">Diabetes mellitus</span>","<span class=""disease"">Diabetes mellitus</span> is a chronic metabolic disease involving the failure to regulate <span class=""chemical"">glucose</span> blood levels in the body and has been linked with numerous detrimental complications.",,20806262,20806262_D005947_D003920,20806262_1,bcv_sentence_task_befree_3755,,770959684,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D009369,"<span class=""disease"">BCa</span>","Mono-layer cell culture models of p53-wild type <span class=""chemical"">estrogen</span> receptor (ER)-dependent MCF-7 <span class=""disease"">BCa</span> cells and p53-mutant ER-/progesterone receptor (PR)- and Her2-regular (triple-negative) MDA-MB-231 <span class=""disease"">BCa</span> were exposed to PGG for a comprehensive investigation of cellular consequences and molecular targets/mediators.",,20809980,20809980_D004967_D009369,20809980_5,bcv_sentence_task_befree_3756,,770959685,FALSE,finalized,5,8/14/15 22:21,"



",no_relation,1,,D011374,"<span class=""chemical"">progesterone</span>",D009369,"<span class=""disease"">BCa</span>","Mono-layer cell culture models of p53-wild type estrogen receptor (ER)-dependent MCF-7 <span class=""disease"">BCa</span> cells and p53-mutant ER-/<span class=""chemical"">progesterone</span> receptor (PR)- and Her2-regular (triple-negative) MDA-MB-231 <span class=""disease"">BCa</span> were exposed to PGG for a comprehensive investigation of cellular consequences and molecular targets/mediators.",,20809980,20809980_D011374_D009369,20809980_5,bcv_sentence_task_befree_3757,,770959686,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D000699,"<span class=""disease"">analgesia</span>","Adequate intra-operative <span class=""chemical"">morphine</span> use can minimize post-operative pain and subsequent need for rescue <span class=""disease"">analgesia</span>.",,20827460,20827460_D009020_D000699,20827460_10,bcv_sentence_task_befree_3758,,770959687,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D010146,"<span class=""disease"">pain</span>","Adequate intra-operative <span class=""chemical"">morphine</span> use can minimize post-operative <span class=""disease"">pain</span> and subsequent need for rescue analgesia.",,20827460,20827460_D009020_D010146,20827460_10,bcv_sentence_task_befree_3759,,770959688,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,C437965,"<span class=""chemical"">olmesartan</span>",D007022,"<span class=""disease"">MBPS</span>","In amlodipine-<span class=""chemical"">olmesartan</span> combination therapy, the bedtime administration reduced better <span class=""disease"">MBPS</span> with correcting nocturnal BP fall and improved urinary albumin excretion.",,20828223,20828223_C437965_D007022,20828223_11,bcv_sentence_task_befree_3760,,770959689,FALSE,finalized,5,8/15/15 1:32,"



",no_relation,1,,C437965,"<span class=""chemical"">olmesartan</span>",D048968,"<span class=""disease"">MBPS</span>","In amlodipine-<span class=""chemical"">olmesartan</span> combination therapy, the bedtime administration reduced better <span class=""disease"">MBPS</span> with correcting nocturnal BP fall and improved urinary albumin excretion.",,20828223,20828223_C437965_D048968,20828223_11,bcv_sentence_task_befree_3761,,770959690,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,D017311,"<span class=""chemical"">amlodipine</span>",D048968,"<span class=""disease"">MBPS</span>","In <span class=""chemical"">amlodipine</span>-olmesartan combination therapy, the bedtime administration reduced better <span class=""disease"">MBPS</span> with correcting nocturnal BP fall and improved urinary albumin excretion.",,20828223,20828223_D017311_D048968,20828223_11,bcv_sentence_task_befree_3762,,770959691,FALSE,finalized,5,8/15/15 2:20,"



",no_relation,1,,D017311,"<span class=""chemical"">amlodipine</span>",D007022,"<span class=""disease"">MBPS</span>","In <span class=""chemical"">amlodipine</span>-olmesartan combination therapy, the bedtime administration reduced better <span class=""disease"">MBPS</span> with correcting nocturnal BP fall and improved urinary albumin excretion.",,20828223,20828223_D017311_D007022,20828223_11,bcv_sentence_task_befree_3763,,770959692,FALSE,finalized,5,8/14/15 23:45,"



",no_relation,0.7904,,D000450,"<span class=""chemical"">Aldosterone</span>",D006929,"<span class=""disease"">primary aldosteronism</span>","<span class=""chemical"">Aldosterone</span> synthase inhibition with LCI699: a proof-of-concept study in patients with <span class=""disease"">primary aldosteronism</span>.",,20837883,20837883_D000450_D006929,20837883_0,bcv_sentence_task_befree_3764,,770959693,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,0.7964,,D000450,"<span class=""chemical"">aldosterone</span>",D006929,"<span class=""disease"">primary aldosteronism</span>","We report the first administration of an orally active <span class=""chemical"">aldosterone</span> synthase inhibitor, LCI699, to 14 patients with <span class=""disease"">primary aldosteronism</span>.",,20837883,20837883_D000450_D006929,20837883_1,bcv_sentence_task_befree_3765,,770959694,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,0.8041,,D000450,"<span class=""chemical"">aldosterone</span>",D006929,"<span class=""disease"">primary aldosteronism</span>","In conclusion, the administration of LCI699, up to 1.0 mg BID, effectively and safely inhibits <span class=""chemical"">aldosterone</span> synthase in patients with <span class=""disease"">primary aldosteronism</span>.",,20837883,20837883_D000450_D006929,20837883_11,bcv_sentence_task_befree_3766,,770959695,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,1,,D012701,"<span class=""chemical"">Serotonin</span>",D017180,"<span class=""disease"">ventricular tachycardia</span>","<span class=""chemical"">Serotonin</span> and catecholaminergic polymorphic <span class=""disease"">ventricular tachycardia</span>: a possible therapeutic role for SSRIs?",,20838725,20838725_D012701_D017180,20838725_0,bcv_sentence_task_befree_3767,,770959696,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,1,,D012701,"<span class=""chemical"">serotonin</span>",D017180,"<span class=""disease"">ventricular tachycardia</span>","However, after a selective <span class=""chemical"">serotonin</span> re-uptake inhibitor (SSRI) was added to the therapeutic regimen, no further episodes of <span class=""disease"">ventricular tachycardia</span> occurred during the following two years.",,20838725,20838725_D012701_D017180,20838725_4,bcv_sentence_task_befree_3768,,770959697,FALSE,finalized,5,8/14/15 21:56,"



",yes_direct,1,,D020106,"<span class=""chemical"">acrylamide</span>",D064420,"<span class=""disease"">Toxicity</span>","<span class=""disease"">Toxicity</span> of <span class=""chemical"">acrylamide</span> and evaluation of its exposure in baby foods.",,20843409,20843409_D020106_D064420,20843409_0,bcv_sentence_task_befree_3769,,770959698,FALSE,finalized,5,8/15/15 0:19,"



",yes_direct,1,,D020106,"<span class=""chemical"">acrylamide</span>",D064420,"<span class=""disease"">toxicity</span>","The present review focuses on the several adverse health effects of <span class=""chemical"">acrylamide</span> including mutagenicity, genotoxicity, carcinogenicity, neurotoxicity and reproductive <span class=""disease"">toxicity</span>, and the possible outcomes of childhood exposure from baby foods and infant formulas.",,20843409,20843409_D020106_D064420,20843409_5,bcv_sentence_task_befree_3770,,770959699,FALSE,finalized,5,8/15/15 2:22,"



",yes_direct,1,,D020106,"<span class=""chemical"">acrylamide</span>",D020258,"<span class=""disease"">neurotoxicity</span>","The present review focuses on the several adverse health effects of <span class=""chemical"">acrylamide</span> including mutagenicity, genotoxicity, carcinogenicity, <span class=""disease"">neurotoxicity</span> and reproductive toxicity, and the possible outcomes of childhood exposure from baby foods and infant formulas.",,20843409,20843409_D020106_D020258,20843409_5,bcv_sentence_task_befree_3771,,770959700,FALSE,finalized,5,8/14/15 21:40,"



",no_relation,0.812,,D005459,"<span class=""chemical"">fluoride</span>",D010520,"<span class=""disease"">generalized aggressive periodontitis/G-AgP</span>","To compare the clinical and microbiological effects of ultrasonic mechanical instrumentation (UMI) associated to home-care use of amine fluoride/stannous <span class=""chemical"">fluoride</span> (AmF/SnF(2) )-containing mouthrinse and toothpaste in smoker and non-smoker patients affected by <span class=""disease"">generalized aggressive periodontitis</span> (<span class=""disease"">G-AgP</span>) during a recall session of supportive periodontal therapy (SPT).",,20849433,20849433_D005459_D010520,20849433_1,bcv_sentence_task_befree_3772,,770959701,FALSE,finalized,5,8/14/15 22:18,"



",no_relation,0.809,,D002738,"<span class=""chemical"">chloroquine</span>",D003550,"<span class=""disease"">cystic fibrosis</span>","Treatment of <span class=""disease"">cystic fibrosis</span> associated cutaneous vasculitis with <span class=""chemical"">chloroquine</span>.",,20863769,20863769_D002738_D003550,20863769_0,bcv_sentence_task_befree_3773,,770959702,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,0.805,,D002738,"<span class=""chemical"">chloroquine</span>",D014657,"<span class=""disease"">cutaneous vasculitis</span>","Treatment of cystic fibrosis associated <span class=""disease"">cutaneous vasculitis</span> with <span class=""chemical"">chloroquine</span>.",,20863769,20863769_D002738_D014657,20863769_0,bcv_sentence_task_befree_3774,,770959703,FALSE,finalized,5,8/14/15 21:59,"



",no_relation,1,,D002738,"<span class=""chemical"">chloroquine</span>",D014657,"<span class=""disease"">cutaneous vasculitis</span>","We describe a case of steroid resistant <span class=""disease"">cutaneous vasculitis</span> which was successfully treated with <span class=""chemical"">chloroquine</span> in addition to corticosteroids and a subsequent relapse with <span class=""chemical"">chloroquine</span> alone.",,20863769,20863769_D002738_D014657,20863769_3,bcv_sentence_task_befree_3775,,770959704,FALSE,finalized,5,8/14/15 22:14,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D014657,"<span class=""disease"">cutaneous vasculitis</span>","We describe a case of steroid resistant <span class=""disease"">cutaneous vasculitis</span> which was successfully treated with chloroquine in addition to <span class=""chemical"">corticosteroids</span> and a subsequent relapse with chloroquine alone.",,20863769,20863769_D000305_D014657,20863769_3,bcv_sentence_task_befree_3776,,770959705,FALSE,finalized,5,8/15/15 1:53,"



",no_relation,0.8098,,D013256,"<span class=""chemical"">steroid</span>",D014657,"<span class=""disease"">cutaneous vasculitis</span>","We describe a case of <span class=""chemical"">steroid</span> resistant <span class=""disease"">cutaneous vasculitis</span> which was successfully treated with chloroquine in addition to corticosteroids and a subsequent relapse with chloroquine alone.",,20863769,20863769_D013256_D014657,20863769_3,bcv_sentence_task_befree_3777,,770959706,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,1,,D003907,"<span class=""chemical"">dexamethasone</span>",D009336,"<span class=""disease"">necrosis</span>","Stimulation of primary human corneal epithelial cells, keratocytes, and retinal endothelial cells with 1 to 10 ng/mL interleukin 1_ (IL-1_) resulted in a significant increase in numerous inflammatory cytokines, including IL-6, IL-8, and tumor <span class=""disease"">necrosis</span> factor  (TNF-); and <span class=""chemical"">dexamethasone</span> was able to significantly inhibit these effects.",,20884859,20884859_D003907_D009336,20884859_3,bcv_sentence_task_befree_3778,,770959707,FALSE,finalized,5,8/15/15 0:19,"



",no_relation,1,,D003907,"<span class=""chemical"">dexamethasone</span>",D009369,"<span class=""disease"">tumor</span>","Stimulation of primary human corneal epithelial cells, keratocytes, and retinal endothelial cells with 1 to 10 ng/mL interleukin 1_ (IL-1_) resulted in a significant increase in numerous inflammatory cytokines, including IL-6, IL-8, and <span class=""disease"">tumor</span> necrosis factor  (TNF-); and <span class=""chemical"">dexamethasone</span> was able to significantly inhibit these effects.",,20884859,20884859_D003907_D009369,20884859_3,bcv_sentence_task_befree_3779,,770959708,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,C119467,"<span class=""chemical"">Lanthanum carbonate</span>",D051436,"<span class=""disease"">CKD/chronic kidney disease</span>","<span class=""chemical"">Lanthanum carbonate</span> and sevelamer carbonate are non-calcium-based phosphate binders used to manage hyperphosphataemia in patients with <span class=""disease"">chronic kidney disease</span> (<span class=""disease"">CKD</span>).",,20921291,20921291_C119467_D051436,20921291_1,bcv_sentence_task_befree_3780,,770959709,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D051436,"<span class=""disease"">CKD/chronic kidney disease</span>","Lanthanum carbonate and sevelamer carbonate are non-<span class=""chemical"">calcium</span>-based phosphate binders used to manage hyperphosphataemia in patients with <span class=""disease"">chronic kidney disease</span> (<span class=""disease"">CKD</span>).",,20921291,20921291_D002118_D051436,20921291_1,bcv_sentence_task_befree_3781,,770959710,FALSE,finalized,5,8/14/15 23:11,"


It's 'phosphate binders' and not just 'Phosphate'
",no_relation,1,,D010710,"<span class=""chemical"">phosphate</span>",D051436,"<span class=""disease"">CKD/chronic kidney disease</span>","Lanthanum carbonate and sevelamer carbonate are non-calcium-based <span class=""chemical"">phosphate</span> binders used to manage hyperphosphataemia in patients with <span class=""disease"">chronic kidney disease</span> (<span class=""disease"">CKD</span>).",,20921291,20921291_D010710_D051436,20921291_1,bcv_sentence_task_befree_3782,,770959711,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,1,,D002117,"<span class=""chemical"">calcitriol</span>",D051436,"<span class=""disease"">CKD</span>","Patients with <span class=""disease"">CKD</span> may require intravenous or oral active vitamin D. We investigated the effects of lanthanum carbonate and sevelamer carbonate on the bioavailability of oral <span class=""chemical"">calcitriol</span>.",,20921291,20921291_D002117_D051436,20921291_2,bcv_sentence_task_befree_3783,,770959712,FALSE,finalized,5,8/14/15 21:43,"



",no_relation,1,,C405346,"<span class=""chemical"">sevelamer carbonate</span>",D051436,"<span class=""disease"">CKD</span>","Patients with <span class=""disease"">CKD</span> may require intravenous or oral active vitamin D. We investigated the effects of lanthanum carbonate and <span class=""chemical"">sevelamer carbonate</span> on the bioavailability of oral calcitriol.",,20921291,20921291_C405346_D051436,20921291_2,bcv_sentence_task_befree_3784,,770959713,FALSE,finalized,5,8/14/15 21:34,"



",no_relation,1,,D014807,"<span class=""chemical"">vitamin D</span>",D051436,"<span class=""disease"">CKD</span>","Patients with <span class=""disease"">CKD</span> may require intravenous or oral active <span class=""chemical"">vitamin D</span>. We investigated the effects of lanthanum carbonate and sevelamer carbonate on the bioavailability of oral calcitriol.",,20921291,20921291_D014807_D051436,20921291_2,bcv_sentence_task_befree_3785,,770959714,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,1,,C119467,"<span class=""chemical"">lanthanum carbonate</span>",D051436,"<span class=""disease"">CKD</span>","Patients with <span class=""disease"">CKD</span> may require intravenous or oral active vitamin D. We investigated the effects of <span class=""chemical"">lanthanum carbonate</span> and sevelamer carbonate on the bioavailability of oral calcitriol.",,20921291,20921291_C119467_D051436,20921291_2,bcv_sentence_task_befree_3786,,770959715,FALSE,finalized,5,8/15/15 0:22,"



",no_relation,1,,D010710,"<span class=""chemical"">phosphate</span>",D051436,"<span class=""disease"">CKD</span>","This should be considered when treating <span class=""disease"">CKD</span> patients who require <span class=""chemical"">phosphate</span> binders and oral vitamin D.",,20921291,20921291_D010710_D051436,20921291_11,bcv_sentence_task_befree_3787,,770959716,FALSE,finalized,5,8/15/15 0:57,"



",no_relation,1,,D014807,"<span class=""chemical"">vitamin D</span>",D051436,"<span class=""disease"">CKD</span>","This should be considered when treating <span class=""disease"">CKD</span> patients who require phosphate binders and oral <span class=""chemical"">vitamin D</span>.",,20921291,20921291_D014807_D051436,20921291_11,bcv_sentence_task_befree_3788,,770959717,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,0.8116,,C517975,"<span class=""chemical"">AZD6244/selumetinib</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Identification of predictive markers of response to the MEK1/2 inhibitor <span class=""chemical"">selumetinib</span> (<span class=""chemical"">AZD6244</span>) in K-ras-mutated <span class=""disease"">colorectal cancer</span>.",,20923857,20923857_C517975_D015179,20923857_0,bcv_sentence_task_befree_3789,,770959718,FALSE,finalized,5,8/14/15 22:17,"



",no_relation,1,,C517975,"<span class=""chemical"">AZD6244</span>",D015179,"<span class=""disease"">CRC</span>","The aim of this study was to develop and characterize predictive biomarkers of response to the MEK1/2 inhibitor <span class=""chemical"">AZD6244</span> in <span class=""disease"">CRC</span> in order to maximize the clinical utility of this agent.",,20923857,20923857_C517975_D015179,20923857_3,bcv_sentence_task_befree_3790,,770959719,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,1,,C517975,"<span class=""chemical"">AZD6244</span>",D015179,"<span class=""disease"">CRC</span>","Twenty-seven human <span class=""disease"">CRC</span> cell lines were exposed to <span class=""chemical"">AZD6244</span> and classified according to the IC(50) value as sensitive (_ 0.1 _mol/L) or resistant (>1 _mol/L).",,20923857,20923857_C517975_D015179,20923857_4,bcv_sentence_task_befree_3791,,770959720,FALSE,finalized,5,8/14/15 21:53,"



",no_relation,1,,C517975,"<span class=""chemical"">AZD6244</span>",D015179,"<span class=""disease"">CRC</span>","Further testing was done in cell line xenografts and K-ras mutant <span class=""disease"">CRC</span> human explants models to develop a predictive genomic classifier for <span class=""chemical"">AZD6244</span>.",,20923857,20923857_C517975_D015179,20923857_6,bcv_sentence_task_befree_3792,,770959721,FALSE,finalized,5,8/15/15 2:01,"



",no_relation,1,,C517975,"<span class=""chemical"">AZD6244</span>",D015179,"<span class=""disease"">CRC</span>","Baseline gene array data from <span class=""disease"">CRC</span> cell lines and xenografts were used to develop a k-top scoring pair (k-TSP) classifier, which predicted with 71% accuracy which of a test set of patient-derived K-ras mutant <span class=""disease"">CRC</span> explants would respond to <span class=""chemical"">AZD6244</span>, providing the basis for a patient-selective clinical trial.",,20923857,20923857_C517975_D015179,20923857_9,bcv_sentence_task_befree_3793,,770959722,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,0.7914,,C517975,"<span class=""chemical"">AZD6244</span>",D015179,"<span class=""disease"">CRC</span>","These results also indicate that resistance to <span class=""chemical"">AZD6244</span> may be mediated, in part, by the upregulation of the Wnt pathway, suggesting potential rational combination partners for <span class=""chemical"">AZD6244</span> in <span class=""disease"">CRC</span>.",,20923857,20923857_C517975_D015179,20923857_10,bcv_sentence_task_befree_3794,,770959723,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D001379,"<span class=""chemical"">AZA/Azathioprine</span>",D009358,"<span class=""disease"">rheumatologic disorders</span>","<span class=""chemical"">Azathioprine</span> (<span class=""chemical"">AZA</span>) is a commonly used drug for the management of various <span class=""disease"">rheumatologic disorders</span>.",,20953224,20953224_D001379_D009358,20953224_1,bcv_sentence_task_befree_3795,,770959724,FALSE,finalized,5,8/15/15 0:59,"



",yes_direct,0.7807,,D001379,"<span class=""chemical"">AZA</span>",D064420,"<span class=""disease"">toxicity</span>","To determine the current local practice of <span class=""chemical"">AZA</span> dosing, identify <span class=""chemical"">AZA</span>-related <span class=""disease"">toxicity</span> and to compare the local practice with the British Society of Rheumatology (BSR) recommendations.",,20953224,20953224_D001379_D064420,20953224_4,bcv_sentence_task_befree_3796,,770959725,FALSE,finalized,5,8/14/15 23:38,"



",no_relation,0.801,,D001379,"<span class=""chemical"">AZA</span>",D064420,"<span class=""disease"">toxicities</span>","Data were collected on patient's demographics, treatment history including <span class=""chemical"">AZA</span> dosing regimen, TPMT testing, drug-related <span class=""disease"">toxicities</span> and their management.",,20953224,20953224_D001379_D064420,20953224_6,bcv_sentence_task_befree_3797,,770959726,FALSE,finalized,5,8/14/15 23:29,"



",yes_direct,1,,D001379,"<span class=""chemical"">AZA</span>",D064420,"<span class=""disease"">toxicity</span>","Average initial dose of <span class=""chemical"">AZA</span> prescribed was 10037 mg. 45% developed <span class=""chemical"">AZA</span> related <span class=""disease"">toxicity</span>.",,20953224,20953224_D001379_D064420,20953224_10,bcv_sentence_task_befree_3798,,770959727,FALSE,finalized,5,8/14/15 22:17,"



",yes_direct,0.7972,,D001379,"<span class=""chemical"">AZA</span>",D064420,"<span class=""disease"">toxicity</span>","A significant proportion of the studied cohort of rheumatologic patients on <span class=""chemical"">AZA</span> had drug-related <span class=""disease"">toxicity</span> resulting in discontinuation of <span class=""chemical"">AZA</span>.",,20953224,20953224_D001379_D064420,20953224_14,bcv_sentence_task_befree_3799,,770959728,FALSE,finalized,5,8/14/15 21:28,"



",no_relation,0.8092,,D014750,"<span class=""chemical"">vincristine</span>",D008228,"<span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma</span>","Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, <span class=""chemical"">vincristine</span>, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated <span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma</span>.",,20960528,20960528_D014750_D008228,20960528_0,bcv_sentence_task_befree_3800,,770959729,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,D011241,"<span class=""chemical"">prednisone</span>",D008228,"<span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma</span>","Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and <span class=""chemical"">prednisone</span> chemotherapy with rituximab in very elderly patients with poor-prognostic untreated <span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma</span>.",,20960528,20960528_D011241_D008228,20960528_0,bcv_sentence_task_befree_3801,,770959730,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,1,,D004317,"<span class=""chemical"">doxorubicin</span>",D008228,"<span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma</span>","Activity and safety of dose-adjusted infusional cyclophosphamide, <span class=""chemical"">doxorubicin</span>, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated <span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma</span>.",,20960528,20960528_D004317_D008228,20960528_0,bcv_sentence_task_befree_3802,,770959731,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D008228,"<span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma</span>","Activity and safety of dose-adjusted infusional <span class=""chemical"">cyclophosphamide</span>, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated <span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma</span>.",,20960528,20960528_D003520_D008228,20960528_0,bcv_sentence_task_befree_3803,,770959732,FALSE,finalized,5,8/14/15 22:07,"



",no_relation,1,,D014750,"<span class=""chemical"">vincristine</span>",D008228,"<span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma/DLBCL</span>","This study was designed to assess the activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, <span class=""chemical"">vincristine</span>, and prednisone chemotherapy with rituximab (DA-POCH-R) in elderly patients with poor-prognostic untreated <span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma</span> (<span class=""disease"">DLBCL</span>).",,20960528,20960528_D014750_D008228,20960528_1,bcv_sentence_task_befree_3804,,770959733,FALSE,finalized,5,8/14/15 21:42,"



",no_relation,1,,D011241,"<span class=""chemical"">prednisone</span>",D008228,"<span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma/DLBCL</span>","This study was designed to assess the activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and <span class=""chemical"">prednisone</span> chemotherapy with rituximab (DA-POCH-R) in elderly patients with poor-prognostic untreated <span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma</span> (<span class=""disease"">DLBCL</span>).",,20960528,20960528_D011241_D008228,20960528_1,bcv_sentence_task_befree_3805,,770959734,FALSE,finalized,5,8/14/15 22:18,"



",no_relation,1,,D004317,"<span class=""chemical"">doxorubicin</span>",D008228,"<span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma/DLBCL</span>","This study was designed to assess the activity and safety of dose-adjusted infusional cyclophosphamide, <span class=""chemical"">doxorubicin</span>, vincristine, and prednisone chemotherapy with rituximab (DA-POCH-R) in elderly patients with poor-prognostic untreated <span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma</span> (<span class=""disease"">DLBCL</span>).",,20960528,20960528_D004317_D008228,20960528_1,bcv_sentence_task_befree_3806,,770959735,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D008228,"<span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma/DLBCL</span>","This study was designed to assess the activity and safety of dose-adjusted infusional <span class=""chemical"">cyclophosphamide</span>, doxorubicin, vincristine, and prednisone chemotherapy with rituximab (DA-POCH-R) in elderly patients with poor-prognostic untreated <span class=""disease"">diffuse large B-cell non-Hodgkin lymphoma</span> (<span class=""disease"">DLBCL</span>).",,20960528,20960528_D003520_D008228,20960528_1,bcv_sentence_task_befree_3807,,770959736,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,1,,C010119,"<span class=""chemical"">latrepirdine</span>",D006967,"<span class=""disease"">allergy</span>","Dimebon (<span class=""chemical"">latrepirdine</span>) was developed and used in Russia as an over-the-counter oral antihistamine for <span class=""disease"">allergy</span> treatment.",,21031168,21031168_C010119_D006967,21031168_1,bcv_sentence_task_befree_3808,,770959737,FALSE,finalized,5,8/15/15 1:45,"



",no_relation,1,,C006632,"<span class=""chemical"">arsenic trioxide</span>",D018197,"<span class=""disease"">hepatoblastoma</span>","In this study the effect of chemotherapeutics (cisplatin, doxorubicin, cytosin arabinoside); differentiating agent (13 cis-retinoic acid) and apoptotic agents (5-aza-2'-deoxycytidine, <span class=""chemical"">arsenic trioxide</span>) on notch expression in <span class=""disease"">hepatoblastoma</span> were evaluated.",,21033247,21033247_C006632_D018197,21033247_2,bcv_sentence_task_befree_3809,,770959738,FALSE,finalized,5,8/15/15 1:42,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D018197,"<span class=""disease"">hepatoblastoma</span>","In this study the effect of chemotherapeutics (<span class=""chemical"">cisplatin</span>, doxorubicin, cytosin arabinoside); differentiating agent (13 cis-retinoic acid) and apoptotic agents (5-aza-2'-deoxycytidine, arsenic trioxide) on notch expression in <span class=""disease"">hepatoblastoma</span> were evaluated.",,21033247,21033247_D002945_D018197,21033247_2,bcv_sentence_task_befree_3810,,770959739,FALSE,finalized,5,8/14/15 21:43,"



",no_relation,1,,D004317,"<span class=""chemical"">doxorubicin</span>",D018197,"<span class=""disease"">hepatoblastoma</span>","In this study the effect of chemotherapeutics (cisplatin, <span class=""chemical"">doxorubicin</span>, cytosin arabinoside); differentiating agent (13 cis-retinoic acid) and apoptotic agents (5-aza-2'-deoxycytidine, arsenic trioxide) on notch expression in <span class=""disease"">hepatoblastoma</span> were evaluated.",,21033247,21033247_D004317_D018197,21033247_2,bcv_sentence_task_befree_3811,,770959740,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,1,,D015474,"<span class=""chemical"">13 cis-retinoic acid</span>",D018197,"<span class=""disease"">hepatoblastoma</span>","In this study the effect of chemotherapeutics (cisplatin, doxorubicin, cytosin arabinoside); differentiating agent (<span class=""chemical"">13 cis-retinoic acid</span>) and apoptotic agents (5-aza-2'-deoxycytidine, arsenic trioxide) on notch expression in <span class=""disease"">hepatoblastoma</span> were evaluated.",,21033247,21033247_D015474_D018197,21033247_2,bcv_sentence_task_befree_3812,,770959741,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,C014347,"<span class=""chemical"">5-aza-2'-deoxycytidine</span>",D018197,"<span class=""disease"">hepatoblastoma</span>","In this study the effect of chemotherapeutics (cisplatin, doxorubicin, cytosin arabinoside); differentiating agent (13 cis-retinoic acid) and apoptotic agents (<span class=""chemical"">5-aza-2'-deoxycytidine</span>, arsenic trioxide) on notch expression in <span class=""disease"">hepatoblastoma</span> were evaluated.",,21033247,21033247_C014347_D018197,21033247_2,bcv_sentence_task_befree_3813,,770959742,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,0.8111,,D014212,"<span class=""chemical"">retinoic acid</span>",D018197,"<span class=""disease"">hepatoblastoma</span>","The use of <span class=""chemical"">retinoic acid</span> in the control of minimal residual disease of <span class=""disease"">hepatoblastoma</span> should be discussed.",,21033247,21033247_D014212_D018197,21033247_11,bcv_sentence_task_befree_3814,,770959743,FALSE,finalized,5,8/14/15 21:28,"



",no_relation,0.8117,,D002945,"<span class=""chemical"">Cisplatin</span>",D018197,"<span class=""disease"">hepatoblastoma</span>","<span class=""chemical"">Cisplatin</span> as main chemotherapeutic agent treatment is shown to change gene expression levels in notch signalling pathway in <span class=""disease"">hepatoblastoma</span>.",,21033247,21033247_D002945_D018197,21033247_13,bcv_sentence_task_befree_3815,,770959744,FALSE,finalized,5,8/15/15 1:00,"



",no_relation,0.8011,,D006854,"<span class=""chemical"">cortisol</span>",D000309,"<span class=""disease"">adrenal insufficiency</span>","Comparison of the <span class=""chemical"">cortisol</span> responses to testing with two doses of ACTH in patients with suspected <span class=""disease"">adrenal insufficiency</span>.",,21036888,21036888_D006854_D000309,21036888_0,bcv_sentence_task_befree_3816,,770959745,FALSE,finalized,5,8/14/15 23:54,"



",no_relation,1,,D006854,"<span class=""chemical"">cortisol</span>",D000309,"<span class=""disease"">adrenal insufficiency</span>","To compare the <span class=""chemical"">cortisol</span> response of the 1__g and the 250__g ACTH test in a large study of patients with suspected <span class=""disease"">adrenal insufficiency</span>.",,21036888,21036888_D006854_D000309,21036888_1,bcv_sentence_task_befree_3817,,770959746,FALSE,finalized,5,8/14/15 21:40,"



",no_relation,0.8011,,D006854,"<span class=""chemical"">cortisol</span>",D000309,"<span class=""disease"">adrenal insufficiency</span>","This study shows that the 1__g and the 250__g ACTH tests have comparable <span class=""chemical"">cortisol</span> responses in patients with suspected <span class=""disease"">adrenal insufficiency</span>.",,21036888,21036888_D006854_D000309,21036888_8,bcv_sentence_task_befree_3818,,770959747,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,1,,D016190,"<span class=""chemical"">carboplatin</span>",D009447,"<span class=""disease"">neuroblastoma</span>","High-dose <span class=""chemical"">carboplatin</span>-irinotecan-temozolomide: treatment option for <span class=""disease"">neuroblastoma</span> resistant to topotecan.",,21049517,21049517_D016190_D009447,21049517_0,bcv_sentence_task_befree_3819,,770959748,FALSE,finalized,5,8/15/15 2:42,"



",no_relation,1,,C051890,"<span class=""chemical"">irinotecan</span>",D009447,"<span class=""disease"">neuroblastoma</span>","High-dose carboplatin-<span class=""chemical"">irinotecan</span>-temozolomide: treatment option for <span class=""disease"">neuroblastoma</span> resistant to topotecan.",,21049517,21049517_C051890_D009447,21049517_0,bcv_sentence_task_befree_3820,,770959749,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,1,,C047246,"<span class=""chemical"">temozolomide</span>",D009447,"<span class=""disease"">neuroblastoma</span>","High-dose carboplatin-irinotecan-<span class=""chemical"">temozolomide</span>: treatment option for <span class=""disease"">neuroblastoma</span> resistant to topotecan.",,21049517,21049517_C047246_D009447,21049517_0,bcv_sentence_task_befree_3821,,770959750,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,0.824,,D000305,"<span class=""chemical"">corticosteroids</span>",D065631,"<span class=""disease"">allergic rhinitis</span>","The effect of intranasal <span class=""chemical"">corticosteroids</span> on asthma control and quality of life in <span class=""disease"">allergic rhinitis</span> with mild asthma.",,21050027,21050027_D000305_D065631,21050027_0,bcv_sentence_task_befree_3822,,770959751,FALSE,finalized,5,8/15/15 0:09,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D001249,"<span class=""disease"">mild asthma/asthma</span>","The effect of intranasal <span class=""chemical"">corticosteroids</span> on <span class=""disease"">asthma</span> control and quality of life in allergic rhinitis with <span class=""disease"">mild asthma</span>.",,21050027,21050027_D000305_D001249,21050027_0,bcv_sentence_task_befree_3823,,770959752,FALSE,finalized,5,8/14/15 23:38,"



",no_relation,0.8178,,D019819,"<span class=""chemical"">budesonide</span>",D001249,"<span class=""disease"">mild asthma</span>","Allergic rhinitics with <span class=""disease"">mild asthma</span> were randomized to a 14-day treatment period with either nasal <span class=""chemical"">budesonide</span> 100 _g, 1 puff per nostril twice a day, or placebo.",,21050027,21050027_D019819_D001249,21050027_3,bcv_sentence_task_befree_3824,,770959753,FALSE,finalized,5,8/14/15 21:49,"



",no_relation,1,,D004110,"<span class=""chemical"">diltiazem</span>",D002318,"<span class=""disease"">cardiovascular disease</span>","As diuretics and _-blockers inhibit renal sodium reabsorption and renin release, respectively, we hypothesized that the _-blocker or diuretic-induced blood pressure reduction and prevention of <span class=""disease"">cardiovascular disease</span> would be greater in patients with the highest ENaC expression (rs4149601 G-allele), whereas there would be no such genetically mediated differences in treatment efficacy among patients treated with the vasodilator <span class=""chemical"">diltiazem</span>.",,21052022,21052022_D004110_D002318,21052022_2,bcv_sentence_task_befree_3825,,770959754,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,1,,D012964,"<span class=""chemical"">sodium</span>",D002318,"<span class=""disease"">cardiovascular disease</span>","As diuretics and _-blockers inhibit renal <span class=""chemical"">sodium</span> reabsorption and renin release, respectively, we hypothesized that the _-blocker or diuretic-induced blood pressure reduction and prevention of <span class=""disease"">cardiovascular disease</span> would be greater in patients with the highest ENaC expression (rs4149601 G-allele), whereas there would be no such genetically mediated differences in treatment efficacy among patients treated with the vasodilator diltiazem.",,21052022,21052022_D012964_D002318,21052022_2,bcv_sentence_task_befree_3826,,770959755,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,1,,D004110,"<span class=""chemical"">diltiazem</span>",D006973,"<span class=""disease"">hypertensive</span>","We related rs4149601 status to 6-month blood pressure reduction and risk of cardiovascular events in 5152 <span class=""disease"">hypertensive</span> patients (DBP  100 mmHg) from the Nordic Diltiazem Study (NORDIL) randomized to either _-blocker and/or diuretic-based treatment or <span class=""chemical"">diltiazem</span>-based treatment.",,21052022,21052022_D004110_D006973,21052022_3,bcv_sentence_task_befree_3827,,770959756,FALSE,finalized,5,8/15/15 0:19,"



",no_relation,1,,D004110,"<span class=""chemical"">diltiazem</span>",D002318,"<span class=""disease"">cardiovascular disease</span>","The functional NEDD4L rs4149601 polymorphism influences the efficacy of _-blocker and/or diuretic-based antihypertensive treatment both in terms of blood pressure reduction and <span class=""disease"">cardiovascular disease</span> protection, whereas <span class=""chemical"">diltiazem</span>-based antihypertensive treatment efficacy is not influenced by this NEDD4L polymorphism.",,21052022,21052022_D004110_D002318,21052022_7,bcv_sentence_task_befree_3828,,770959757,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,C440975,"<span class=""chemical"">silibinin</span>",D015470,"<span class=""disease"">AML</span>","Inhibition of Cot1/Tlp2 oncogene in <span class=""disease"">AML</span> cells reduces ERK5 activation and up-regulates p27Kip1 concomitant with enhancement of differentiation and cell cycle arrest induced by <span class=""chemical"">silibinin</span> and 1,25-dihydroxyvitamin D(3).",,21084834,21084834_C440975_D015470,21084834_0,bcv_sentence_task_befree_3829,,770959758,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,1,,D002117,"<span class=""chemical"">1,25-dihydroxyvitamin D(3)</span>",D015470,"<span class=""disease"">AML</span>","Inhibition of Cot1/Tlp2 oncogene in <span class=""disease"">AML</span> cells reduces ERK5 activation and up-regulates p27Kip1 concomitant with enhancement of differentiation and cell cycle arrest induced by silibinin and <span class=""chemical"">1,25-dihydroxyvitamin D(3)</span>.",,21084834,21084834_D002117_D015470,21084834_0,bcv_sentence_task_befree_3830,,770959759,FALSE,finalized,5,8/14/15 22:13,"



",no_relation,0.8182,,D002117,"<span class=""chemical"">1,25-dihydroxyvitamin D3</span>",D007938,"<span class=""disease"">leukemia</span>","We have investigated in preclinical studies the potential anti-<span class=""disease"">leukemia</span> use of the plant-derived polyphenol Silibinin (SIL) in combination with <span class=""chemical"">1,25-dihydroxyvitamin D3</span> (1,25D).",,21084834,21084834_D002117_D007938,21084834_3,bcv_sentence_task_befree_3831,,770959760,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",D001416,"<span class=""disease"">chronic function-limiting mid back or upper back pain</span>","To determine the clinical effectiveness of therapeutic local anesthetic medial branch blocks with or without <span class=""chemical"">steroid</span> in managing <span class=""disease"">chronic function-limiting mid back or upper back pain</span> of facet joint origin.",,21102966,21102966_D013256_D001416,21102966_5,bcv_sentence_task_befree_3832,,770959761,FALSE,finalized,5,8/15/15 2:08,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",D001416,"<span class=""disease"">chronic function-limiting mid back or upper back pain</span>","Therapeutic thoracic medial branch blocks, with or without <span class=""chemical"">steroid</span>, may provide a management option for <span class=""disease"">chronic function-limiting mid back or upper back pain</span> of facet joint origin.",,21102966,21102966_D013256_D001416,21102966_15,bcv_sentence_task_befree_3833,,770959762,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,1,,C092292,"<span class=""chemical"">ziprasidone</span>",C564058,"<span class=""disease"">multiple neurocognitive domains</span>","The more robust findings, that is those significant across <span class=""disease"">multiple neurocognitive domains</span> and having adjacent SNPs showing evidence for association, were rs286913 at the EHF gene (p-value 6.99  10(-8), q-value 0.034, mediating the effects of <span class=""chemical"">ziprasidone</span> on vigilance), rs11240594 at SLC26A9 (p-value 1.4  10(-7), q-value 0.068, mediating the effects of olanzapine on processing speed), and rs11677416 at IL1A (p-value 6.67  10(-7), q-value 0.081, mediating the effects of olanzapine on working memory).",,21107309,21107309_C092292_C564058,21107309_7,bcv_sentence_task_befree_3834,,770959763,FALSE,finalized,5,8/15/15 1:12,"



",no_relation,0.7902,,C076029,"<span class=""chemical"">olanzapine</span>",C564058,"<span class=""disease"">multiple neurocognitive domains</span>","The more robust findings, that is those significant across <span class=""disease"">multiple neurocognitive domains</span> and having adjacent SNPs showing evidence for association, were rs286913 at the EHF gene (p-value 6.99  10(-8), q-value 0.034, mediating the effects of ziprasidone on vigilance), rs11240594 at SLC26A9 (p-value 1.4  10(-7), q-value 0.068, mediating the effects of <span class=""chemical"">olanzapine</span> on processing speed), and rs11677416 at IL1A (p-value 6.67  10(-7), q-value 0.081, mediating the effects of <span class=""chemical"">olanzapine</span> on working memory).",,21107309,21107309_C076029_C564058,21107309_7,bcv_sentence_task_befree_3835,,770959764,FALSE,finalized,5,8/15/15 1:24,"



",no_relation,1,,C084178,"<span class=""chemical"">telmisartan</span>",D006973,"<span class=""disease"">hypertension</span>","Recent meta-analysis demonstrated the possibility that <span class=""chemical"">telmisartan</span> was the strongest ARB for the reduction of BP in patients with essential <span class=""disease"">hypertension</span>.",,21130741,21130741_C084178_D006973,21130741_3,bcv_sentence_task_befree_3836,,770959765,FALSE,finalized,5,8/14/15 21:55,"



",no_relation,1,,C084178,"<span class=""chemical"">telmisartan</span>",D002318,"<span class=""disease"">cardiovascular disease</span>","Our present study suggests that due to its ""delta lock"" structure, <span class=""chemical"">telmisartan</span> may be superior to other ARBs in halting <span class=""disease"">cardiovascular disease</span> in patients with hypertension.",,21130741,21130741_C084178_D002318,21130741_9,bcv_sentence_task_befree_3837,,770959766,FALSE,finalized,5,8/14/15 23:32,"



",no_relation,0.8173,,C084178,"<span class=""chemical"">telmisartan</span>",D006973,"<span class=""disease"">hypertension</span>","Our present study suggests that due to its ""delta lock"" structure, <span class=""chemical"">telmisartan</span> may be superior to other ARBs in halting cardiovascular disease in patients with <span class=""disease"">hypertension</span>.",,21130741,21130741_C084178_D006973,21130741_9,bcv_sentence_task_befree_3838,,770959767,FALSE,finalized,5,8/15/15 1:56,"



",yes_direct,0.8074,,D001241,"<span class=""chemical"">aspirin</span>",D014947,"<span class=""disease"">small bowel injury</span>","Combination of low-dose <span class=""chemical"">aspirin</span> and thienopyridine exacerbates <span class=""disease"">small bowel injury</span>.",,21133822,21133822_D001241_D014947,21133822_0,bcv_sentence_task_befree_3839,,770959768,FALSE,finalized,5,8/14/15 23:38,"



",yes_direct,1,,C446540,"<span class=""chemical"">thienopyridine</span>",D014947,"<span class=""disease"">small bowel injury</span>","Combination of low-dose aspirin and <span class=""chemical"">thienopyridine</span> exacerbates <span class=""disease"">small bowel injury</span>.",,21133822,21133822_C446540_D014947,21133822_0,bcv_sentence_task_befree_3840,,770959769,FALSE,finalized,5,8/14/15 21:34,"



",yes_direct,1,,D001241,"<span class=""chemical"">aspirin</span>",D014947,"<span class=""disease"">small bowel injury</span>","In more recent studies, <span class=""disease"">small bowel injury</span> and enteropathy associated with low-dose <span class=""chemical"">aspirin</span> are increasingly being recognized.",,21133822,21133822_D001241_D014947,21133822_2,bcv_sentence_task_befree_3841,,770959770,FALSE,finalized,5,8/14/15 21:39,"



",yes_direct,0.8071,,D001241,"<span class=""chemical"">aspirin</span>",C538273,"<span class=""disease"">enteropathy</span>","In more recent studies, small bowel injury and <span class=""disease"">enteropathy</span> associated with low-dose <span class=""chemical"">aspirin</span> are increasingly being recognized.",,21133822,21133822_D001241_C538273,21133822_2,bcv_sentence_task_befree_3842,,770959771,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,0.5892,,D001241,"<span class=""chemical"">aspirin</span>",D014947,"<span class=""disease"">small bowel injury</span>","Aim of this study was to evaluate <span class=""disease"">small bowel injury</span> using video capsule endoscopy (VCE) in obscure gastrointestinal bleeding (OGIB) patients taking low-dose <span class=""chemical"">aspirin</span> including other antithrombotics.",,21133822,21133822_D001241_D014947,21133822_3,bcv_sentence_task_befree_3843,,770959772,FALSE,finalized,5,8/15/15 1:13,"



",no_relation,0.4121,,D001241,"<span class=""chemical"">aspirin</span>",D006470,"<span class=""disease"">OGIB/obscure gastrointestinal bleeding</span>","Aim of this study was to evaluate small bowel injury using video capsule endoscopy (VCE) in <span class=""disease"">obscure gastrointestinal bleeding</span> (<span class=""disease"">OGIB</span>) patients taking low-dose <span class=""chemical"">aspirin</span> including other antithrombotics.",,21133822,21133822_D001241_D006470,21133822_3,bcv_sentence_task_befree_3844,,770959773,FALSE,finalized,5,8/14/15 22:35,"



",no_relation,1,,D014859,"<span class=""chemical"">warfarin</span>",D001768,"<span class=""disease"">redness lesions</span>","The median number of <span class=""disease"">redness lesions</span> in the combined group was the highest among the four groups and was significantly higher than that in the <span class=""chemical"">warfarin</span> group.",,21133822,21133822_D014859_D001768,21133822_9,bcv_sentence_task_befree_3845,,770959774,FALSE,finalized,5,8/14/15 21:53,"



",yes_direct,0.6056,,D001241,"<span class=""chemical"">aspirin</span>",D014077,"<span class=""disease"">redness or small erosions</span>","The lesions of <span class=""disease"">redness or small erosions</span> in the <span class=""chemical"">aspirin</span> and the combined groups tended to exist in the proximal part of small bowel.",,21133822,21133822_D001241_D014077,21133822_10,bcv_sentence_task_befree_3846,,770959775,FALSE,finalized,5,8/15/15 1:21,"



",yes_direct,0.8113,,D001241,"<span class=""chemical"">aspirin</span>",D014947,"<span class=""disease"">small bowel injury</span>","Combination of low-dose <span class=""chemical"">aspirin</span> therapy and thienopyridine may exacerbate <span class=""disease"">small bowel injury</span>, and the preventive strategies should be established.",,21133822,21133822_D001241_D014947,21133822_11,bcv_sentence_task_befree_3847,,770959776,FALSE,finalized,5,8/14/15 21:33,"



",yes_direct,1,,C446540,"<span class=""chemical"">thienopyridine</span>",D014947,"<span class=""disease"">small bowel injury</span>","Combination of low-dose aspirin therapy and <span class=""chemical"">thienopyridine</span> may exacerbate <span class=""disease"">small bowel injury</span>, and the preventive strategies should be established.",,21133822,21133822_C446540_D014947,21133822_11,bcv_sentence_task_befree_3848,,770959777,FALSE,finalized,5,8/14/15 22:26,"



",yes_direct,0.5966,,D012436,"<span class=""chemical"">S-adenosylmethionine</span>",D005354,"<span class=""disease"">fibrosarcoma</span>","Chaotic neovascularization induced by aggressive <span class=""disease"">fibrosarcoma</span> cells overexpressing <span class=""chemical"">S-adenosylmethionine</span> decarboxylase.",,21134486,21134486_D012436_D005354,21134486_0,bcv_sentence_task_befree_3849,,770959778,FALSE,finalized,5,8/14/15 23:44,"



",no_relation,1,,C103100,"<span class=""chemical"">silver acetate</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Novel benzyl-substituted N-heterocyclic carbene-<span class=""chemical"">silver acetate</span> complexes: synthesis, <span class=""disease"">cytotoxicity</span> and antibacterial studies.",,21135954,21135954_C103100_D004487,21135954_0,bcv_sentence_task_befree_3850,,770959779,FALSE,finalized,5,8/14/15 23:58,"



",no_relation,1,,D012834,"<span class=""chemical"">silver</span>",D004927,"<span class=""disease"">Escherichia</span>","Preliminary in vitro antibacterial activity of the NHC-precursors and NHC-<span class=""chemical"">silver</span> complexes was investigated against Gram-positive bacteria Staphylococcus aureus, and Gram-negative bacteria <span class=""disease"">Escherichia</span> coli using the qualitative Kirby-Bauer disk-diffusion method.",,21135954,21135954_D012834_D004927,21135954_4,bcv_sentence_task_befree_3851,,770959780,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,0.7914,,D012834,"<span class=""chemical"">silver</span>",D009369,"<span class=""disease"">renal-cancer</span>","All six NHC-<span class=""chemical"">silver</span> complexes were tested for their cytotoxicity through MTT based in vitro tests on the human <span class=""disease"">renal-cancer</span> cell line Caki-1 in order to determine their IC values.",,21135954,21135954_D012834_D009369,21135954_6,bcv_sentence_task_befree_3852,,770959781,FALSE,finalized,5,8/14/15 21:28,"



",no_relation,1,,D012834,"<span class=""chemical"">silver</span>",D004487,"<span class=""disease"">cytotoxicity</span>","All six NHC-<span class=""chemical"">silver</span> complexes were tested for their <span class=""disease"">cytotoxicity</span> through MTT based in vitro tests on the human renal-cancer cell line Caki-1 in order to determine their IC values.",,21135954,21135954_D012834_D004487,21135954_6,bcv_sentence_task_befree_3853,,770959782,FALSE,finalized,5,8/15/15 1:22,"



",no_relation,0.593,,D002945,"<span class=""chemical"">cisplatin</span>",D004487,"<span class=""disease"">cytotoxicity</span>","These values represent improved <span class=""disease"">cytotoxicity</span> against Caki-1, most notably for 4c, which is a three times more cytotoxic than <span class=""chemical"">cisplatin</span> (IC value = 3.3 _M) itself.",,21135954,21135954_D002945_D004487,21135954_8,bcv_sentence_task_befree_3854,,770959783,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,1,,D014801,"<span class=""chemical"">vitamin A</span>",D014802,"<span class=""disease"">A deficiencies</span>","Iron and <span class=""chemical"">vitamin </span><span class=""disease"">A</span> deficiencies impact anemia and the immune system.",,21147712,21147712_D014801_D014802,21147712_1,bcv_sentence_task_befree_3855,,770959784,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,0.5869,,D007501,"<span class=""chemical"">Iron</span>",D000740,"<span class=""disease"">anemia</span>","<span class=""chemical"">Iron</span> and vitamin A deficiencies impact <span class=""disease"">anemia</span> and the immune system.",,21147712,21147712_D007501_D000740,21147712_1,bcv_sentence_task_befree_3856,,770959785,FALSE,finalized,5,8/15/15 1:48,"



",no_relation,0.5982,,D014801,"<span class=""chemical"">vitamin A</span>",D000740,"<span class=""disease"">anemia</span>","Iron and <span class=""chemical"">vitamin A</span> deficiencies impact <span class=""disease"">anemia</span> and the immune system.",,21147712,21147712_D014801_D000740,21147712_1,bcv_sentence_task_befree_3857,,770959786,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,1,,D007501,"<span class=""chemical"">Iron</span>",D014802,"<span class=""disease"">A deficiencies</span>","<span class=""chemical"">Iron</span> and vitamin <span class=""disease"">A deficiencies</span> impact anemia and the immune system.",,21147712,21147712_D007501_D014802,21147712_1,bcv_sentence_task_befree_3858,,770959787,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,0.7977,,C012589,"<span class=""chemical"">Trichostatin A/TSA</span>",D007249,"<span class=""disease"">inflammation</span>","To examine the effects of a histone deacetylase inhibitor, <span class=""chemical"">Trichostatin A</span> (<span class=""chemical"">TSA</span>), on the behavior of macrophages and subconjunctival fibroblasts in vitro and on ocular surface <span class=""disease"">inflammation</span> and scarring in vivo using an alkali burn wound healing model.",,21203344,21203344_C012589_D007249,21203344_1,bcv_sentence_task_befree_3859,,770959788,FALSE,finalized,5,8/14/15 21:52,"



",no_relation,0.8024,,C012589,"<span class=""chemical"">TSA</span>",D007249,"<span class=""disease"">inflammation</span>","Effects of <span class=""chemical"">TSA</span> on expression of <span class=""disease"">inflammation</span>-related growth factors or collagen I were examined by real-time RT-PCR or immunoassay in mouse macrophages or human subconjunctival fibroblasts.",,21203344,21203344_C012589_D007249,21203344_2,bcv_sentence_task_befree_3860,,770959789,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,C012589,"<span class=""chemical"">TSA</span>",D065306,"<span class=""disease"">cornea</span>","Histology and real-time RT-PCR investigations evaluated the effects of <span class=""chemical"">TSA</span> on the healing process of the <span class=""disease"">cornea</span>.",,21203344,21203344_C012589_D065306,21203344_6,bcv_sentence_task_befree_3861,,770959790,FALSE,finalized,5,8/14/15 21:46,"



",no_relation,1,,C012589,"<span class=""chemical"">TSA</span>",D065306,"<span class=""disease"">cornea</span>","Real-time PCR and immunocytochemistry studies showed that systemic administration of <span class=""chemical"">TSA</span> suppressed the inflammation and fibrotic response in the stroma and accelerated epithelial healing in the alkali-burned mouse <span class=""disease"">cornea</span>.",,21203344,21203344_C012589_D065306,21203344_9,bcv_sentence_task_befree_3862,,770959791,FALSE,finalized,5,8/14/15 21:39,"



",no_relation,1,,C012589,"<span class=""chemical"">TSA</span>",D007249,"<span class=""disease"">inflammation</span>","Real-time PCR and immunocytochemistry studies showed that systemic administration of <span class=""chemical"">TSA</span> suppressed the <span class=""disease"">inflammation</span> and fibrotic response in the stroma and accelerated epithelial healing in the alkali-burned mouse cornea.",,21203344,21203344_C012589_D007249,21203344_9,bcv_sentence_task_befree_3863,,770959792,FALSE,finalized,5,8/14/15 21:58,"



",no_relation,0.6312,,D014443,"<span class=""chemical"">tyrosine</span>",D009369,"<span class=""disease"">cancer</span>","Studying S->A nonphosphorylatable point mutants suggests that these sites coordinately upregulate FAK Y397 <span class=""chemical"">tyrosine</span> phosphorylation, which conventionally initiates FAK activation, and mediate pressure-induced <span class=""disease"">cancer</span> cell adhesion.",,21209368,21209368_D014443_D009369,21209368_6,bcv_sentence_task_befree_3864,,770959793,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,0.8044,,D000638,"<span class=""chemical"">amiodarone</span>",D001281,"<span class=""disease"">atrial fibrillation</span>","Vernakalant has been demonstrated more effective than both placebo and <span class=""chemical"">amiodarone</span> for the rapid conversion of <span class=""disease"">atrial fibrillation</span>, without significant adverse events.",,21235460,21235460_D000638_D001281,21235460_5,bcv_sentence_task_befree_3865,,770959794,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,1,,D015125,"<span class=""chemical"">8-quinolinol</span>",D004487,"<span class=""disease"">cytotoxicity</span>","The lanthanide complexes 1-3 exhibited significantly enhanced <span class=""disease"">cytotoxicity</span> vs. free substituted <span class=""chemical"">8-quinolinol</span>.",,21258737,21258737_D015125_D004487,21258737_6,bcv_sentence_task_befree_3866,,770959795,FALSE,finalized,5,8/15/15 1:08,"



",no_relation,1,,C098010,"<span class=""chemical"">linezolid</span>",D003550,"<span class=""disease"">cystic fibrosis</span>","Emergence of <span class=""chemical"">linezolid</span>-resistant Staphylococcus aureus after prolonged treatment of <span class=""disease"">cystic fibrosis</span> patients in Cleveland, Ohio.",,21263048,21263048_C098010_D003550,21263048_0,bcv_sentence_task_befree_3867,,770959796,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,1,,C098010,"<span class=""chemical"">LZD</span>",D003550,"<span class=""disease"">CF</span>","Analysis of clinical data showed that the 8 <span class=""disease"">CF</span> patients with LRSA received more LZD courses (18.8 versus 5.9; P = 0.001) for a longer duration (546.5 versus 211.9 days; P < 0.001) and had extended periods of exposure to <span class=""chemical"">LZD</span> (83.1 versus 30.1 days/year; P < 0.001) than the 69 with LZD-susceptible isolates.",,21263048,21263048_C098010_D003550,21263048_4,bcv_sentence_task_befree_3868,,770959797,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,0.5878,,C098010,"<span class=""chemical"">LZD</span>",D003550,"<span class=""disease"">CF</span>","Emergence of LRSA is a serious concern for <span class=""disease"">CF</span> patients who undergo prolonged courses of <span class=""chemical"">LZD</span> therapy.",,21263048,21263048_C098010_D003550,21263048_12,bcv_sentence_task_befree_3869,,770959798,FALSE,finalized,5,8/15/15 0:17,"



",yes_direct,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D017449,"<span class=""disease"">Allergic contact dermatitis</span>","<span class=""disease"">Allergic contact dermatitis</span> following ocular use of <span class=""chemical"">corticosteroids</span>.",,21265627,21265627_D000305_D017449,21265627_0,bcv_sentence_task_befree_3870,,770959799,FALSE,finalized,5,8/15/15 0:41,"



",no_relation,0.622,,D014443,"<span class=""chemical"">tyrosine</span>",D034721,"<span class=""disease"">systemic mastocytosis</span>","Activating mutations in codon D816 of the <span class=""chemical"">tyrosine</span> kinase receptor, KIT, are found in the majority of patients with <span class=""disease"">systemic mastocytosis</span>.",,21273305,21273305_D014443_D034721,21273305_1,bcv_sentence_task_befree_3871,,770959800,FALSE,finalized,5,8/15/15 0:04,"



",no_relation,1,,C523074,"<span class=""chemical"">allylpyrocatechol</span>",D001172,"<span class=""disease"">Rheumatoid Arthritis</span>","Attenuation of oxidative stress by <span class=""chemical"">allylpyrocatechol</span> in synovial cellular infiltrate of patients with <span class=""disease"">Rheumatoid Arthritis</span>.",,21284489,21284489_C523074_D001172,21284489_0,bcv_sentence_task_befree_3872,,770959801,FALSE,finalized,5,8/15/15 0:56,"



",no_relation,1,,C523074,"<span class=""chemical"">Allylpyrocatechol</span>",D001172,"<span class=""disease"">Rheumatoid arthritis</span>","<span class=""chemical"">Allylpyrocatechol</span>, a phytoconstituent of Piper betle leaves, has potent anti-inflammatory activity and this study evaluated its anti-oxidant effect on the synovial infiltrate of patients with <span class=""disease"">Rheumatoid arthritis</span>.",,21284489,21284489_C523074_D001172,21284489_2,bcv_sentence_task_befree_3873,,770959802,FALSE,finalized,5,8/14/15 21:38,"



",no_relation,1,,C523074,"<span class=""chemical"">allylpyrocatechol</span>",D001172,"<span class=""disease"">Rheumatoid Arthritis</span>","Taken together, this ex vivo study has established that <span class=""chemical"">allylpyrocatechol</span> has potent scavenging activity and could be considered as an add-on therapy in the treatment of inflammation-associated disorders like <span class=""disease"">Rheumatoid Arthritis</span>.",,21284489,21284489_C523074_D001172,21284489_7,bcv_sentence_task_befree_3874,,770959803,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,0.7987,,C523074,"<span class=""chemical"">allylpyrocatechol</span>",D007249,"<span class=""disease"">inflammation-associated disorders</span>","Taken together, this ex vivo study has established that <span class=""chemical"">allylpyrocatechol</span> has potent scavenging activity and could be considered as an add-on therapy in the treatment of <span class=""disease"">inflammation-associated disorders</span> like Rheumatoid Arthritis.",,21284489,21284489_C523074_D007249,21284489_7,bcv_sentence_task_befree_3875,,770959804,FALSE,finalized,5,8/15/15 1:37,"



",no_relation,1,,C074679,"<span class=""chemical"">reboxetine</span>",D001289,"<span class=""disease"">attention-deficit/hyperactivity disorder</span>","Efficacy of <span class=""chemical"">reboxetine</span> in adults with <span class=""disease"">attention-deficit/hyperactivity disorder</span>: a randomized, placebo-controlled clinical trial.",,21312292,21312292_C074679_D001289,21312292_0,bcv_sentence_task_befree_3876,,770959805,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,C074679,"<span class=""chemical"">reboxetine</span>",D001289,"<span class=""disease"">attention-deficit/hyperactivity disorder/ADHD</span>","The main aim of this study is to evaluate the efficacy of <span class=""chemical"">reboxetine</span>, a specific noradrenergic reuptake inhibitor, in adults with <span class=""disease"">attention-deficit/hyperactivity disorder</span> (<span class=""disease"">ADHD</span>).",,21312292,21312292_C074679_D001289,21312292_1,bcv_sentence_task_befree_3877,,770959806,FALSE,finalized,5,8/15/15 2:20,"



",no_relation,1,,C074679,"<span class=""chemical"">reboxetine</span>",D001289,"<span class=""disease"">ADHD</span>","In a double blind placebo-controlled clinical trial, the efficacy of 8mg/day of <span class=""chemical"">reboxetine</span> (twice daily) was compared with placebo in 40 adults diagnosed with <span class=""disease"">ADHD</span> during 6 weeks.",,21312292,21312292_C074679_D001289,21312292_2,bcv_sentence_task_befree_3878,,770959807,FALSE,finalized,5,8/15/15 1:34,"



",yes_direct,1,,C074679,"<span class=""chemical"">reboxetine</span>",D001008,"<span class=""disease"">anxiety</span>","Irritability, <span class=""disease"">anxiety</span>, sleep disturbance, and dry mouth were the common side effects of <span class=""chemical"">reboxetine</span>.",,21312292,21312292_C074679_D001008,21312292_7,bcv_sentence_task_befree_3879,,770959808,FALSE,finalized,5,8/14/15 21:58,"



",yes_direct,1,,C074679,"<span class=""chemical"">reboxetine</span>",D012893,"<span class=""disease"">sleep disturbance</span>","Irritability, anxiety, <span class=""disease"">sleep disturbance</span>, and dry mouth were the common side effects of <span class=""chemical"">reboxetine</span>.",,21312292,21312292_C074679_D012893,21312292_7,bcv_sentence_task_befree_3880,,770959809,FALSE,finalized,5,8/14/15 21:46,"



",yes_direct,1,,C074679,"<span class=""chemical"">reboxetine</span>",D014987,"<span class=""disease"">dry mouth</span>","Irritability, anxiety, sleep disturbance, and <span class=""disease"">dry mouth</span> were the common side effects of <span class=""chemical"">reboxetine</span>.",,21312292,21312292_C074679_D014987,21312292_7,bcv_sentence_task_befree_3881,,770959810,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,1,,C074679,"<span class=""chemical"">Reboxetine</span>",D001289,"<span class=""disease"">ADHD</span>","<span class=""chemical"">Reboxetine</span> could be used and tolerated as an effective treatment for adults with <span class=""disease"">ADHD</span>.",,21312292,21312292_C074679_D001289,21312292_8,bcv_sentence_task_befree_3882,,770959811,FALSE,finalized,5,8/14/15 21:28,"



",no_relation,1,,C024352,"<span class=""chemical"">fludarabine</span>",D015451,"<span class=""disease"">CLL/chronic lymphocytic leukemia</span>","Over the past few years, more effective therapies have emerged in the treatment of <span class=""disease"">chronic lymphocytic leukemia</span> (<span class=""disease"">CLL</span>); these are mainly combinations of immunotherapy with <span class=""chemical"">fludarabine</span>-based regimens.",,21322776,21322776_C024352_D015451,21322776_1,bcv_sentence_task_befree_3883,,770959812,FALSE,finalized,5,8/15/15 1:20,"



",no_relation,1,,C522667,"<span class=""chemical"">Asenapine</span>",D001714,"<span class=""disease"">bipolar I disorder/mania</span>","<span class=""chemical"">Asenapine</span>: a review of its use in the management of <span class=""disease"">mania</span> in adults with <span class=""disease"">bipolar I disorder</span>.",,21323396,21323396_C522667_D001714,21323396_0,bcv_sentence_task_befree_3884,,770959813,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,C522667,"<span class=""chemical"">Asenapine</span>",D001714,"<span class=""disease"">manic/bipolar I disorder</span>","<span class=""chemical"">Asenapine</span> is an atypical antipsychotic agent available in sublingual formulations (5 or 10 mg) and indicated in the US (Saphris) for the acute treatment, as monotherapy or adjunctive therapy, of <span class=""disease"">manic</span> and mixed episodes and in the EU (Sycrest) for the treatment of moderate to severe <span class=""disease"">manic</span> episodes, in adult patients with <span class=""disease"">bipolar I disorder</span>.",,21323396,21323396_C522667_D001714,21323396_1,bcv_sentence_task_befree_3885,,770959814,FALSE,finalized,5,8/14/15 23:18,"



",no_relation,1,,C522667,"<span class=""chemical"">asenapine</span>",D001714,"<span class=""disease"">bipolar I disorder/mania</span>","In two large (both n = 480), well designed, 3-week trials in adult patients with <span class=""disease"">bipolar I disorder</span>, <span class=""chemical"">asenapine</span> monotherapy was significantly more effective than placebo at improving <span class=""disease"">mania</span> symptoms, as assessed using the Young Mania Rating Scale total score (YMRS; primary endpoint), with significant differences between the <span class=""chemical"">asenapine</span> and placebo groups occurring after 2 days of treatment.",,21323396,21323396_C522667_D001714,21323396_2,bcv_sentence_task_befree_3886,,770959815,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,1,,C076029,"<span class=""chemical"">olanzapine</span>",D001714,"<span class=""disease"">mania</span>","In a 9-week extension study that recruited completers from the monotherapy trials, there were no significant differences between asenapine and <span class=""chemical"">olanzapine</span> groups in terms in Montgomery-sberg Depression Rating Scale (MADRS) scores, CGI-BP <span class=""disease"">mania</span> severity scores, YMRS response rates or YMRS remission rates during the extension phase.",,21323396,21323396_C076029_D001714,21323396_5,bcv_sentence_task_befree_3887,,770959816,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,1,,C522667,"<span class=""chemical"">asenapine</span>",D001714,"<span class=""disease"">mania</span>","In a 9-week extension study that recruited completers from the monotherapy trials, there were no significant differences between <span class=""chemical"">asenapine</span> and olanzapine groups in terms in Montgomery-sberg Depression Rating Scale (MADRS) scores, CGI-BP <span class=""disease"">mania</span> severity scores, YMRS response rates or YMRS remission rates during the extension phase.",,21323396,21323396_C522667_D001714,21323396_5,bcv_sentence_task_befree_3888,,770959817,FALSE,finalized,5,8/15/15 1:28,"



",no_relation,1,,D014635,"<span class=""chemical"">valproate</span>",D001714,"<span class=""disease"">manic symptoms</span>","In a 12-week trial of asenapine as adjunctive therapy to lithium or <span class=""chemical"">valproate</span>, asenapine was more effective than placebo in improving <span class=""disease"">manic symptoms</span>, based on the difference between groups in the YMRS total score at week 3 (primary endpoint).",,21323396,21323396_D014635_D001714,21323396_7,bcv_sentence_task_befree_3889,,770959818,FALSE,finalized,5,8/14/15 21:31,"



",no_relation,1,,C522667,"<span class=""chemical"">asenapine</span>",D001714,"<span class=""disease"">manic symptoms</span>","In a 12-week trial of <span class=""chemical"">asenapine</span> as adjunctive therapy to lithium or valproate, <span class=""chemical"">asenapine</span> was more effective than placebo in improving <span class=""disease"">manic symptoms</span>, based on the difference between groups in the YMRS total score at week 3 (primary endpoint).",,21323396,21323396_C522667_D001714,21323396_7,bcv_sentence_task_befree_3890,,770959819,FALSE,finalized,5,8/14/15 22:31,"



",no_relation,1,,D008094,"<span class=""chemical"">lithium</span>",D001714,"<span class=""disease"">manic symptoms</span>","In a 12-week trial of asenapine as adjunctive therapy to <span class=""chemical"">lithium</span> or valproate, asenapine was more effective than placebo in improving <span class=""disease"">manic symptoms</span>, based on the difference between groups in the YMRS total score at week 3 (primary endpoint).",,21323396,21323396_D008094_D001714,21323396_7,bcv_sentence_task_befree_3891,,770959820,FALSE,finalized,5,8/15/15 1:41,"



",yes_direct,0.797,,C522667,"<span class=""chemical"">asenapine</span>",D004244,"<span class=""disease"">dizziness</span>","In a pooled analysis of the monotherapy trials, the most common adverse events (occurring in  5% of patients and at twice the incidence of placebo) reported during acute phase <span class=""chemical"">asenapine</span> monotherapy for bipolar mania were somnolence, <span class=""disease"">dizziness</span>, extrapyramidal symptoms (EPS, other than akathisia) and increased bodyweight, which were similar in nature to those occurring during longer-term monotherapy with <span class=""chemical"">asenapine</span>.",,21323396,21323396_C522667_D004244,21323396_9,bcv_sentence_task_befree_3892,,770959821,FALSE,finalized,5,8/15/15 1:15,"



",yes_direct,1,,C522667,"<span class=""chemical"">asenapine</span>",D001480,"<span class=""disease"">extrapyramidal symptoms/EPS</span>","In a pooled analysis of the monotherapy trials, the most common adverse events (occurring in  5% of patients and at twice the incidence of placebo) reported during acute phase <span class=""chemical"">asenapine</span> monotherapy for bipolar mania were somnolence, dizziness, <span class=""disease"">extrapyramidal symptoms</span> (<span class=""disease"">EPS</span>, other than akathisia) and increased bodyweight, which were similar in nature to those occurring during longer-term monotherapy with <span class=""chemical"">asenapine</span>.",,21323396,21323396_C522667_D001480,21323396_9,bcv_sentence_task_befree_3893,,770959822,FALSE,finalized,5,8/15/15 0:26,"



",yes_direct,0.8132,,C522667,"<span class=""chemical"">asenapine</span>",D006970,"<span class=""disease"">somnolence</span>","In a pooled analysis of the monotherapy trials, the most common adverse events (occurring in  5% of patients and at twice the incidence of placebo) reported during acute phase <span class=""chemical"">asenapine</span> monotherapy for bipolar mania were <span class=""disease"">somnolence</span>, dizziness, extrapyramidal symptoms (EPS, other than akathisia) and increased bodyweight, which were similar in nature to those occurring during longer-term monotherapy with <span class=""chemical"">asenapine</span>.",,21323396,21323396_C522667_D006970,21323396_9,bcv_sentence_task_befree_3894,,770959823,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,0.7972,,C522667,"<span class=""chemical"">asenapine</span>",D011595,"<span class=""disease"">akathisia</span>","In a pooled analysis of the monotherapy trials, the most common adverse events (occurring in  5% of patients and at twice the incidence of placebo) reported during acute phase <span class=""chemical"">asenapine</span> monotherapy for bipolar mania were somnolence, dizziness, extrapyramidal symptoms (EPS, other than <span class=""disease"">akathisia</span>) and increased bodyweight, which were similar in nature to those occurring during longer-term monotherapy with <span class=""chemical"">asenapine</span>.",,21323396,21323396_C522667_D011595,21323396_9,bcv_sentence_task_befree_3895,,770959824,FALSE,finalized,5,8/14/15 21:40,"



",no_relation,0.6192,,C522667,"<span class=""chemical"">asenapine</span>",D001714,"<span class=""disease"">bipolar mania</span>","In a pooled analysis of the monotherapy trials, the most common adverse events (occurring in  5% of patients and at twice the incidence of placebo) reported during acute phase <span class=""chemical"">asenapine</span> monotherapy for <span class=""disease"">bipolar mania</span> were somnolence, dizziness, extrapyramidal symptoms (EPS, other than akathisia) and increased bodyweight, which were similar in nature to those occurring during longer-term monotherapy with <span class=""chemical"">asenapine</span>.",,21323396,21323396_C522667_D001714,21323396_9,bcv_sentence_task_befree_3896,,770959825,FALSE,finalized,5,8/14/15 21:28,"



",no_relation,1,,C522667,"<span class=""chemical"">asenapine</span>",D001480,"<span class=""disease"">EPS</span>","<span class=""disease"">EPS</span> did not worsen in severity during longer-term <span class=""chemical"">asenapine</span> monotherapy.",,21323396,21323396_C522667_D001480,21323396_10,bcv_sentence_task_befree_3897,,770959826,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,C522667,"<span class=""chemical"">asenapine</span>",D001714,"<span class=""disease"">manic/bipolar I disorder</span>","In the meantime, <span class=""chemical"">asenapine</span> is a further option for the management of <span class=""disease"">manic</span> and/or mixed symptoms in patients with <span class=""disease"">bipolar I disorder</span> and may be of particular value for patients who are at high risk for metabolic abnormalities.",,21323396,21323396_C522667_D001714,21323396_13,bcv_sentence_task_befree_3898,,770959827,FALSE,finalized,5,8/14/15 23:33,"



",no_relation,1,,C522667,"<span class=""chemical"">asenapine</span>",C566454,"<span class=""disease"">metabolic abnormalities</span>","In the meantime, <span class=""chemical"">asenapine</span> is a further option for the management of manic and/or mixed symptoms in patients with bipolar I disorder and may be of particular value for patients who are at high risk for <span class=""disease"">metabolic abnormalities</span>.",,21323396,21323396_C522667_C566454,21323396_13,bcv_sentence_task_befree_3899,,770959828,FALSE,finalized,5,8/14/15 22:04,"



",no_relation,0.6048,,D013256,"<span class=""chemical"">steroids</span>",D000230,"<span class=""disease"">PDAC</span>","Of the 518 patients resected for <span class=""disease"">PDAC</span>, 13.3% were being treated preoperatively with insulin, 14.8% were on a statin, 1.7% were on <span class=""chemical"">steroids</span>, and 7.6% were on thyroxin.",,21327533,21327533_D013256_D000230,21327533_5,bcv_sentence_task_befree_3900,,770959829,FALSE,finalized,5,8/14/15 22:13,"



",yes_direct,0.6057,,D019888,"<span class=""chemical"">nelfinavir</span>",D008228,"<span class=""disease"">endoplasmic reticulum stress</span>","Analysis of <span class=""chemical"">nelfinavir</span>-induced <span class=""disease"">endoplasmic reticulum stress</span>.",,21329798,21329798_D019888_D008228,21329798_0,bcv_sentence_task_befree_3901,,770959830,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,1,,D019888,"<span class=""chemical"">Nelfinavir</span>",D009369,"<span class=""disease"">cancer</span>","<span class=""chemical"">Nelfinavir</span> (Viracept) is an HIV protease inhibitor that has been shown to induce the endoplasmic reticulum (ER) stress reaction in human <span class=""disease"">cancer</span> cells.",,21329798,21329798_D019888_D009369,21329798_1,bcv_sentence_task_befree_3902,,770959831,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,D019888,"<span class=""chemical"">nelfinavir</span>",D009369,"<span class=""disease"">cancer</span>","Although the presumed drug doses needed for an efficient ER stress reaction and ensuing apoptosis in <span class=""disease"">cancer</span> cells is somewhat higher than those prescribed for HIV-infected persons, <span class=""chemical"">nelfinavir</span> represents one of the few clinically applicable ER stress-inducing agents, and is currently being tested in clinical studies on <span class=""disease"">cancer</span> patients.",,21329798,21329798_D019888_D009369,21329798_2,bcv_sentence_task_befree_3903,,770959832,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D019888,"<span class=""chemical"">nelfinavir</span>",D015658,"<span class=""disease"">HIV-infected</span>","Although the presumed drug doses needed for an efficient ER stress reaction and ensuing apoptosis in cancer cells is somewhat higher than those prescribed for <span class=""disease"">HIV-infected</span> persons, <span class=""chemical"">nelfinavir</span> represents one of the few clinically applicable ER stress-inducing agents, and is currently being tested in clinical studies on cancer patients.",,21329798,21329798_D019888_D015658,21329798_2,bcv_sentence_task_befree_3904,,770959833,FALSE,finalized,5,8/14/15 22:27,"



",no_relation,0.602,,D019888,"<span class=""chemical"">nelfinavir</span>",D009369,"<span class=""disease"">cancer</span>","In addition, methods are described that might facilitate the analysis and monitoring of the <span class=""chemical"">nelfinavir</span>-induced ER stress response either in <span class=""disease"">cancer</span> cells in cell culture or in <span class=""disease"">cancer</span> tissue biopsies.",,21329798,21329798_D019888_D009369,21329798_4,bcv_sentence_task_befree_3905,,770959834,FALSE,finalized,5,8/15/15 2:14,"



",no_relation,1,,D016559,"<span class=""chemical"">Tacrolimus</span>",D003093,"<span class=""disease"">ulcerative colitis</span>","<span class=""chemical"">Tacrolimus</span> therapy as an alternative to thiopurines for maintaining remission in patients with refractory <span class=""disease"">ulcerative colitis</span>.",,21336140,21336140_D016559_D003093,21336140_0,bcv_sentence_task_befree_3906,,770959835,FALSE,finalized,5,8/14/15 21:34,"



",no_relation,0.818,,D016559,"<span class=""chemical"">tacrolimus</span>",D003093,"<span class=""disease"">ulcerative colitis/UC</span>","Although the efficacy of <span class=""chemical"">tacrolimus</span> for inducing remission of refractory <span class=""disease"">ulcerative colitis</span> (<span class=""disease"">UC</span>) is established, its efficacy for maintaining remission of <span class=""disease"">UC</span> has not been evaluated.",,21336140,21336140_D016559_D003093,21336140_1,bcv_sentence_task_befree_3907,,770959836,FALSE,finalized,5,8/14/15 21:46,"



",no_relation,1,,D016559,"<span class=""chemical"">tacrolimus</span>",D003093,"<span class=""disease"">UC</span>","The aim of this study was to evaluate the efficacy of <span class=""chemical"">tacrolimus</span> compared with thiopurines for maintaining remission in patients with refractory <span class=""disease"">UC</span>.",,21336140,21336140_D016559_D003093,21336140_2,bcv_sentence_task_befree_3908,,770959837,FALSE,finalized,5,8/14/15 21:47,"



",no_relation,1,,D016559,"<span class=""chemical"">tacrolimus</span>",D003093,"<span class=""disease"">UC</span>","Twenty-four <span class=""disease"">UC</span> patients treated with <span class=""chemical"">tacrolimus</span> and 34 treated with thiopurines to maintain remission were enrolled as the <span class=""chemical"">tacrolimus</span> group and the thiopurine group, respectively.",,21336140,21336140_D016559_D003093,21336140_3,bcv_sentence_task_befree_3909,,770959838,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D016559,"<span class=""chemical"">tacrolimus</span>",D003093,"<span class=""disease"">UC</span>","Maintenance therapy with <span class=""chemical"">tacrolimus</span> for patients with <span class=""disease"">UC</span> could be considered an alternative to thiopurine therapy.",,21336140,21336140_D016559_D003093,21336140_10,bcv_sentence_task_befree_3910,,770959839,FALSE,finalized,5,8/14/15 21:40,"



",no_relation,0.8051,,D019829,"<span class=""chemical"">nevirapine</span>",D015658,"<span class=""disease"">HIV-infected</span>","We examined antiretroviral resistance among a cohort of 323 South African <span class=""disease"">HIV-infected</span> children <2 years old exposed to <span class=""chemical"">nevirapine</span> for prevention of mother-to-child transmission.",,21345162,21345162_D019829_D015658,21345162_2,bcv_sentence_task_befree_3911,,770959840,FALSE,finalized,5,8/14/15 23:37,"



",no_relation,1,,D004997,"<span class=""chemical"">ethinyl estradiol</span>",D007246,"<span class=""disease"">infertility</span>","The multiple uses of <span class=""chemical"">ethinyl estradiol</span> for treating <span class=""disease"">infertility</span>.",,21355449,21355449_D004997_D007246,21355449_0,bcv_sentence_task_befree_3912,,770959841,FALSE,finalized,5,8/15/15 1:13,"



",no_relation,0.8094,,D004997,"<span class=""chemical"">ethinyl estradiol</span>",D000568,"<span class=""disease"">hypergonadotropic amenorrhea</span>","Twenty to 40 micrograms of <span class=""chemical"">ethinyl estradiol</span> can be started on day 2 or 3 of the cycle and combined with exogenous gonadotropin can be useful in improving hostile cervical mucus or inducing ovulation in women with <span class=""disease"">hypergonadotropic amenorrhea</span>.",,21355449,21355449_D004997_D000568,21355449_2,bcv_sentence_task_befree_3913,,770959842,FALSE,finalized,5,8/15/15 1:57,"



",no_relation,1,,D002738,"<span class=""chemical"">chloroquine</span>",D008180,"<span class=""disease"">systemic lupus erythematosus</span>","In the therapy of <span class=""disease"">systemic lupus erythematosus</span>, antimalarial drugs <span class=""chemical"">chloroquine</span>, hydroxychloroquine, and quinacrine have been used for a long time.",,21398612,21398612_D002738_D008180,21398612_2,bcv_sentence_task_befree_3914,,770959843,FALSE,finalized,5,8/14/15 22:26,"



",no_relation,1,,D011796,"<span class=""chemical"">quinacrine</span>",D008180,"<span class=""disease"">systemic lupus erythematosus</span>","In the therapy of <span class=""disease"">systemic lupus erythematosus</span>, antimalarial drugs chloroquine, hydroxychloroquine, and <span class=""chemical"">quinacrine</span> have been used for a long time.",,21398612,21398612_D011796_D008180,21398612_2,bcv_sentence_task_befree_3915,,770959844,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,D006886,"<span class=""chemical"">hydroxychloroquine</span>",D008180,"<span class=""disease"">systemic lupus erythematosus</span>","In the therapy of <span class=""disease"">systemic lupus erythematosus</span>, antimalarial drugs chloroquine, <span class=""chemical"">hydroxychloroquine</span>, and quinacrine have been used for a long time.",,21398612,21398612_D006886_D008180,21398612_2,bcv_sentence_task_befree_3916,,770959845,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,D003078,"<span class=""chemical"">colchicine</span>",D009336,"<span class=""disease"">necrosis</span>","Successful treatment with anti-tumor <span class=""disease"">necrosis</span> factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to <span class=""chemical"">colchicine</span>: anti-TNF drugs and FMF.",,21431291,21431291_D003078_D009336,21431291_0,bcv_sentence_task_befree_3917,,770959846,FALSE,finalized,5,8/14/15 23:00,"



",no_relation,1,,D003078,"<span class=""chemical"">colchicine</span>",D009369,"<span class=""disease"">tumor</span>","Successful treatment with anti-<span class=""disease"">tumor</span> necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to <span class=""chemical"">colchicine</span>: anti-TNF drugs and FMF.",,21431291,21431291_D003078_D009369,21431291_0,bcv_sentence_task_befree_3918,,770959847,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,1,,D003078,"<span class=""chemical"">colchicine</span>",C536657,"<span class=""disease"">TNF</span>","Successful treatment with anti-tumor necrosis factor (anti-<span class=""disease"">TNF</span>)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to <span class=""chemical"">colchicine</span>: anti-<span class=""disease"">TNF</span> drugs and FMF.",,21431291,21431291_D003078_C536657,21431291_0,bcv_sentence_task_befree_3919,,770959848,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,1,,D003078,"<span class=""chemical"">colchicine</span>",D011507,"<span class=""disease"">proteinuria</span>","Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of <span class=""disease"">proteinuria</span> in a patient with familial mediterranean fever (FMF) resistant to <span class=""chemical"">colchicine</span>: anti-TNF drugs and FMF.",,21431291,21431291_D003078_D011507,21431291_0,bcv_sentence_task_befree_3920,,770959849,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,D003078,"<span class=""chemical"">colchicine</span>",D010505,"<span class=""disease"">FMF/familial mediterranean fever</span>","Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with <span class=""disease"">familial mediterranean fever</span> (<span class=""disease"">FMF</span>) resistant to <span class=""chemical"">colchicine</span>: anti-TNF drugs and <span class=""disease"">FMF</span>.",,21431291,21431291_D003078_D010505,21431291_0,bcv_sentence_task_befree_3921,,770959850,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,D003078,"<span class=""chemical"">colchicine</span>",D000686,"<span class=""disease"">amyloidosis</span>","The major renal involvement in FMF is the occurrence of <span class=""disease"">amyloidosis</span> that can be prevented by a daily regimen of <span class=""chemical"">colchicine</span>.",,21431291,21431291_D003078_D000686,21431291_2,bcv_sentence_task_befree_3922,,770959851,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D003078,"<span class=""chemical"">colchicine</span>",D010505,"<span class=""disease"">FMF</span>","The major renal involvement in <span class=""disease"">FMF</span> is the occurrence of amyloidosis that can be prevented by a daily regimen of <span class=""chemical"">colchicine</span>.",,21431291,21431291_D003078_D010505,21431291_2,bcv_sentence_task_befree_3923,,770959852,FALSE,finalized,5,8/14/15 21:54,"



",no_relation,1,,D003078,"<span class=""chemical"">colchicine</span>",D010505,"<span class=""disease"">familial mediterranean fever</span>","About 5-10% of cases with <span class=""disease"">familial mediterranean fever</span> may be resistant to <span class=""chemical"">colchicine</span>.",,21431291,21431291_D003078_D010505,21431291_3,bcv_sentence_task_befree_3924,,770959853,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D003078,"<span class=""chemical"">colchicine</span>",D010505,"<span class=""disease"">FMF</span>","In literature, there is a controversy about the treatment of <span class=""disease"">FMF</span> patients resistant to <span class=""chemical"">colchicine</span>.",,21431291,21431291_D003078_D010505,21431291_4,bcv_sentence_task_befree_3925,,770959854,FALSE,finalized,5,8/14/15 21:43,"



",no_relation,0.7949,,C467566,"<span class=""chemical"">pomalidomide</span>",D000740,"<span class=""disease"">anemia</span>","Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict <span class=""disease"">anemia</span> response to <span class=""chemical"">pomalidomide</span> therapy in myelofibrosis.",,21442636,21442636_C467566_D000740,21442636_0,bcv_sentence_task_befree_3926,,770959855,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,1,,C467566,"<span class=""chemical"">pomalidomide</span>",D055728,"<span class=""disease"">myelofibrosis</span>","Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to <span class=""chemical"">pomalidomide</span> therapy in <span class=""disease"">myelofibrosis</span>.",,21442636,21442636_C467566_D055728,21442636_0,bcv_sentence_task_befree_3927,,770959856,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,1,,C467566,"<span class=""chemical"">Pomalidomide</span>",D000740,"<span class=""disease"">anemia</span>","<span class=""chemical"">Pomalidomide</span> therapy is effective for alleviating <span class=""disease"">anemia</span> in myelofibrosis; we examined the relationship between plasma cytokine/chemokine levels and response to treatment with <span class=""chemical"">pomalidomide</span>.",,21442636,21442636_C467566_D000740,21442636_2,bcv_sentence_task_befree_3928,,770959857,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,1,,C467566,"<span class=""chemical"">Pomalidomide</span>",D055728,"<span class=""disease"">myelofibrosis</span>","<span class=""chemical"">Pomalidomide</span> therapy is effective for alleviating anemia in <span class=""disease"">myelofibrosis</span>; we examined the relationship between plasma cytokine/chemokine levels and response to treatment with <span class=""chemical"">pomalidomide</span>.",,21442636,21442636_C467566_D055728,21442636_2,bcv_sentence_task_befree_3929,,770959858,FALSE,finalized,5,8/14/15 23:53,"



",no_relation,1,,C467566,"<span class=""chemical"">pomalidomide</span>",D055728,"<span class=""disease"">myelofibrosis</span>","The study population included 32 Mayo Clinic patients (median age 66 years) who participated in two consecutive clinical trials of <span class=""chemical"">pomalidomide</span> therapy for <span class=""disease"">myelofibrosis</span>-associated anemia.",,21442636,21442636_C467566_D055728,21442636_3,bcv_sentence_task_befree_3930,,770959859,FALSE,finalized,5,8/14/15 23:09,"



",no_relation,0.8011,,C467566,"<span class=""chemical"">pomalidomide</span>",D000740,"<span class=""disease"">anemia</span>","The study population included 32 Mayo Clinic patients (median age 66 years) who participated in two consecutive clinical trials of <span class=""chemical"">pomalidomide</span> therapy for myelofibrosis-associated <span class=""disease"">anemia</span>.",,21442636,21442636_C467566_D000740,21442636_3,bcv_sentence_task_befree_3931,,770959860,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,1,,C467566,"<span class=""chemical"">pomalidomide</span>",D013163,"<span class=""disease"">splenomegaly</span>","Current data suggest that, in the context of <span class=""chemical"">pomalidomide</span> treatment, response is more likely in the presence of JAK2V617F and further predicted by the absence of marked <span class=""disease"">splenomegaly</span> or increased levels of proinflammatory cytokines.",,21442636,21442636_C467566_D013163,21442636_8,bcv_sentence_task_befree_3932,,770959861,FALSE,finalized,5,8/14/15 21:36,"



",yes_direct,1,,D013792,"<span class=""chemical"">thalidomide</span>",D054556,"<span class=""disease"">VTE</span>","Since the introduction of the immunomodulatory derivatives (IMiDs) <span class=""chemical"">thalidomide</span> and lenalidomide in the therapeutic armamentarium of MM, <span class=""disease"">VTE</span> has emerged as one of the leading complications, in particular in patients with newly diagnosed MM.",,21455855,21455855_D013792_D054556,21455855_5,bcv_sentence_task_befree_3933,,770959862,FALSE,finalized,5,8/15/15 0:02,"



",yes_direct,0.794,,C467567,"<span class=""chemical"">lenalidomide</span>",D054556,"<span class=""disease"">VTE</span>","Since the introduction of the immunomodulatory derivatives (IMiDs) thalidomide and <span class=""chemical"">lenalidomide</span> in the therapeutic armamentarium of MM, <span class=""disease"">VTE</span> has emerged as one of the leading complications, in particular in patients with newly diagnosed MM.",,21455855,21455855_C467567_D054556,21455855_5,bcv_sentence_task_befree_3934,,770959863,FALSE,finalized,5,8/15/15 2:33,"



",no_relation,0.8087,,C467567,"<span class=""chemical"">lenalidomide</span>",D009101,"<span class=""disease"">MM</span>","Since the introduction of the immunomodulatory derivatives (IMiDs) thalidomide and <span class=""chemical"">lenalidomide</span> in the therapeutic armamentarium of <span class=""disease"">MM</span>, VTE has emerged as one of the leading complications, in particular in patients with newly diagnosed <span class=""disease"">MM</span>.",,21455855,21455855_C467567_D009101,21455855_5,bcv_sentence_task_befree_3935,,770959864,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D013792,"<span class=""chemical"">thalidomide</span>",D009101,"<span class=""disease"">MM</span>","Since the introduction of the immunomodulatory derivatives (IMiDs) <span class=""chemical"">thalidomide</span> and lenalidomide in the therapeutic armamentarium of <span class=""disease"">MM</span>, VTE has emerged as one of the leading complications, in particular in patients with newly diagnosed <span class=""disease"">MM</span>.",,21455855,21455855_D013792_D009101,21455855_5,bcv_sentence_task_befree_3936,,770959865,FALSE,finalized,5,8/14/15 21:42,"



",yes_direct,0.6057,,D003907,"<span class=""chemical"">dexamethasone</span>",D054556,"<span class=""disease"">VTE</span>","In this setting, IMiDs-based treatments are associated with rates of <span class=""disease"">VTE</span> reaching values up to 14 to 26%, particularly when <span class=""chemical"">dexamethasone</span> or chemotherapy are added.",,21455855,21455855_D003907_D054556,21455855_6,bcv_sentence_task_befree_3937,,770959866,FALSE,finalized,5,8/14/15 23:15,"



",no_relation,0.7911,,D005947,"<span class=""chemical"">glucose</span>",D015430,"<span class=""disease"">weight gain</span>","The AHRQ systematic review indicated that premixed insulin analogues are more effective than long-acting insulin analogues in lowering postprandial <span class=""chemical"">glucose</span> and hemoglobin A1c; however, in this comparison the premixed analogues were associated with higher rates of hypoglycemia and more <span class=""disease"">weight gain</span>.",,21476781,21476781_D005947_D015430,21476781_8,bcv_sentence_task_befree_3938,,770959867,FALSE,finalized,5,8/15/15 0:19,"



",no_relation,0.8172,,D005947,"<span class=""chemical"">glucose</span>",D007003,"<span class=""disease"">hypoglycemia</span>","The AHRQ systematic review indicated that premixed insulin analogues are more effective than long-acting insulin analogues in lowering postprandial <span class=""chemical"">glucose</span> and hemoglobin A1c; however, in this comparison the premixed analogues were associated with higher rates of <span class=""disease"">hypoglycemia</span> and more weight gain.",,21476781,21476781_D005947_D007003,21476781_8,bcv_sentence_task_befree_3939,,770959868,FALSE,finalized,5,8/15/15 0:44,"



",no_relation,1,,C515425,"<span class=""chemical"">Ki23057</span>",D013274,"<span class=""disease"">gastric cancer</span>","A FGFR2 inhibitor, <span class=""chemical"">Ki23057</span>, enhances the chemosensitivity of drug-resistant <span class=""disease"">gastric cancer</span> cells.",,21482024,21482024_C515425_D013274,21482024_0,bcv_sentence_task_befree_3940,,770959869,FALSE,finalized,5,8/14/15 21:39,"



",no_relation,1,,D005047,"<span class=""chemical"">etoposide/VP16</span>",D013274,"<span class=""disease"">gastric cancer</span>","Five cancer cell lines resistant to irinotecan (SN38), paclitaxel (PTX), <span class=""chemical"">etoposide</span> (<span class=""chemical"">VP16</span>), oxaliplatin (OXA), and gemcitabine (GEM) were respectively established from a parent <span class=""disease"">gastric cancer</span> cell line, OCUM-2M, and were named OCUM-2M/SN38, OCUM-2M/PTX, OCUM-2M/VP16, OCUM-2M/OXA, and OCUM-2M/GEM.",,21482024,21482024_D005047_D013274,21482024_2,bcv_sentence_task_befree_3941,,770959870,FALSE,finalized,5,8/15/15 0:00,"



",no_relation,1,,D005047,"<span class=""chemical"">etoposide/VP16</span>",D009369,"<span class=""disease"">cancer</span>","Five <span class=""disease"">cancer</span> cell lines resistant to irinotecan (SN38), paclitaxel (PTX), <span class=""chemical"">etoposide</span> (<span class=""chemical"">VP16</span>), oxaliplatin (OXA), and gemcitabine (GEM) were respectively established from a parent gastric cancer cell line, OCUM-2M, and were named OCUM-2M/SN38, OCUM-2M/PTX, OCUM-2M/VP16, OCUM-2M/OXA, and OCUM-2M/GEM.",,21482024,21482024_D005047_D009369,21482024_2,bcv_sentence_task_befree_3942,,770959871,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D017239,"<span class=""chemical"">paclitaxel/PTX</span>",D009369,"<span class=""disease"">cancer</span>","Five <span class=""disease"">cancer</span> cell lines resistant to irinotecan (SN38), <span class=""chemical"">paclitaxel</span> (<span class=""chemical"">PTX</span>), etoposide (VP16), oxaliplatin (OXA), and gemcitabine (GEM) were respectively established from a parent gastric cancer cell line, OCUM-2M, and were named OCUM-2M/SN38, OCUM-2M/<span class=""chemical"">PTX</span>, OCUM-2M/VP16, OCUM-2M/OXA, and OCUM-2M/GEM.",,21482024,21482024_D017239_D009369,21482024_2,bcv_sentence_task_befree_3943,,770959872,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,1,,D017239,"<span class=""chemical"">paclitaxel/PTX</span>",D013274,"<span class=""disease"">gastric cancer</span>","Five cancer cell lines resistant to irinotecan (SN38), <span class=""chemical"">paclitaxel</span> (<span class=""chemical"">PTX</span>), etoposide (VP16), oxaliplatin (OXA), and gemcitabine (GEM) were respectively established from a parent <span class=""disease"">gastric cancer</span> cell line, OCUM-2M, and were named OCUM-2M/SN38, OCUM-2M/<span class=""chemical"">PTX</span>, OCUM-2M/VP16, OCUM-2M/OXA, and OCUM-2M/GEM.",,21482024,21482024_D017239_D013274,21482024_2,bcv_sentence_task_befree_3944,,770959873,FALSE,finalized,5,8/15/15 0:46,"



",no_relation,1,,C051890,"<span class=""chemical"">irinotecan/SN38</span>",D009369,"<span class=""disease"">cancer</span>","Five <span class=""disease"">cancer</span> cell lines resistant to <span class=""chemical"">irinotecan</span> (<span class=""chemical"">SN38</span>), paclitaxel (PTX), etoposide (VP16), oxaliplatin (OXA), and gemcitabine (GEM) were respectively established from a parent gastric cancer cell line, OCUM-2M, and were named OCUM-2M/SN38, OCUM-2M/PTX, OCUM-2M/VP16, OCUM-2M/OXA, and OCUM-2M/GEM.",,21482024,21482024_C051890_D009369,21482024_2,bcv_sentence_task_befree_3945,,770959874,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,0.8176,,C030110,"<span class=""chemical"">OXA/oxaliplatin</span>",D013274,"<span class=""disease"">gastric cancer</span>","Five cancer cell lines resistant to irinotecan (SN38), paclitaxel (PTX), etoposide (VP16), <span class=""chemical"">oxaliplatin</span> (<span class=""chemical"">OXA</span>), and gemcitabine (GEM) were respectively established from a parent <span class=""disease"">gastric cancer</span> cell line, OCUM-2M, and were named OCUM-2M/SN38, OCUM-2M/PTX, OCUM-2M/VP16, OCUM-2M/OXA, and OCUM-2M/GEM.",,21482024,21482024_C030110_D013274,21482024_2,bcv_sentence_task_befree_3946,,770959876,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,C051890,"<span class=""chemical"">irinotecan/SN38</span>",D013274,"<span class=""disease"">gastric cancer</span>","Five cancer cell lines resistant to <span class=""chemical"">irinotecan</span> (<span class=""chemical"">SN38</span>), paclitaxel (PTX), etoposide (VP16), oxaliplatin (OXA), and gemcitabine (GEM) were respectively established from a parent <span class=""disease"">gastric cancer</span> cell line, OCUM-2M, and were named OCUM-2M/SN38, OCUM-2M/PTX, OCUM-2M/VP16, OCUM-2M/OXA, and OCUM-2M/GEM.",,21482024,21482024_C051890_D013274,21482024_2,bcv_sentence_task_befree_3947,,770959877,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,C030110,"<span class=""chemical"">OXA/oxaliplatin</span>",D009369,"<span class=""disease"">cancer</span>","Five <span class=""disease"">cancer</span> cell lines resistant to irinotecan (SN38), paclitaxel (PTX), etoposide (VP16), <span class=""chemical"">oxaliplatin</span> (<span class=""chemical"">OXA</span>), and gemcitabine (GEM) were respectively established from a parent gastric cancer cell line, OCUM-2M, and were named OCUM-2M/SN38, OCUM-2M/PTX, OCUM-2M/VP16, OCUM-2M/OXA, and OCUM-2M/GEM.",,21482024,21482024_C030110_D009369,21482024_2,bcv_sentence_task_befree_3948,,770959878,FALSE,finalized,5,8/14/15 22:16,"



",no_relation,1,,C056507,"<span class=""chemical"">GEM/gemcitabine</span>",D009369,"<span class=""disease"">cancer</span>","Five <span class=""disease"">cancer</span> cell lines resistant to irinotecan (SN38), paclitaxel (PTX), etoposide (VP16), oxaliplatin (OXA), and <span class=""chemical"">gemcitabine</span> (<span class=""chemical"">GEM</span>) were respectively established from a parent gastric cancer cell line, OCUM-2M, and were named OCUM-2M/SN38, OCUM-2M/PTX, OCUM-2M/VP16, OCUM-2M/OXA, and OCUM-2M/GEM.",,21482024,21482024_C056507_D009369,21482024_2,bcv_sentence_task_befree_3949,,770959879,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,1,,C056507,"<span class=""chemical"">GEM/gemcitabine</span>",D013274,"<span class=""disease"">gastric cancer</span>","Five cancer cell lines resistant to irinotecan (SN38), paclitaxel (PTX), etoposide (VP16), oxaliplatin (OXA), and <span class=""chemical"">gemcitabine</span> (<span class=""chemical"">GEM</span>) were respectively established from a parent <span class=""disease"">gastric cancer</span> cell line, OCUM-2M, and were named OCUM-2M/SN38, OCUM-2M/PTX, OCUM-2M/VP16, OCUM-2M/OXA, and OCUM-2M/GEM.",,21482024,21482024_C056507_D013274,21482024_2,bcv_sentence_task_befree_3950,,770959880,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,0.7956,,D005047,"<span class=""chemical"">VP16</span>",D013274,"<span class=""disease"">gastric cancer</span>","The FGFR2 inhibitor Ki23057 might be therapeutically promising for treating drug-resistant <span class=""disease"">gastric cancer</span> cells, especially when used in combination with SN38, PTX, or <span class=""chemical"">VP16</span>.",,21482024,21482024_D005047_D013274,21482024_8,bcv_sentence_task_befree_3951,,770959881,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,C515425,"<span class=""chemical"">Ki23057</span>",D013274,"<span class=""disease"">gastric cancer</span>","The FGFR2 inhibitor <span class=""chemical"">Ki23057</span> might be therapeutically promising for treating drug-resistant <span class=""disease"">gastric cancer</span> cells, especially when used in combination with SN38, PTX, or VP16.",,21482024,21482024_C515425_D013274,21482024_8,bcv_sentence_task_befree_3952,,770959882,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,D017239,"<span class=""chemical"">PTX</span>",D013274,"<span class=""disease"">gastric cancer</span>","The FGFR2 inhibitor Ki23057 might be therapeutically promising for treating drug-resistant <span class=""disease"">gastric cancer</span> cells, especially when used in combination with SN38, <span class=""chemical"">PTX</span>, or VP16.",,21482024,21482024_D017239_D013274,21482024_8,bcv_sentence_task_befree_3953,,770959883,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,1,,D016190,"<span class=""chemical"">Carboplatin</span>",D009369,"<span class=""disease"">breast cancer</span>","<span class=""chemical"">Carboplatin</span> and gemcitabine combination in metastatic triple-negative anthracycline- and taxane-pretreated <span class=""disease"">breast cancer</span> patients: a phase II study.",,21482494,21482494_D016190_D009369,21482494_0,bcv_sentence_task_befree_3954,,770959884,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,1,,C056507,"<span class=""chemical"">gemcitabine</span>",D009369,"<span class=""disease"">breast cancer</span>","Carboplatin and <span class=""chemical"">gemcitabine</span> combination in metastatic triple-negative anthracycline- and taxane-pretreated <span class=""disease"">breast cancer</span> patients: a phase II study.",,21482494,21482494_C056507_D009369,21482494_0,bcv_sentence_task_befree_3955,,770959885,FALSE,finalized,5,8/14/15 22:50,"



Used as treatment.",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D009369,"<span class=""disease"">tumors</span>","Preclinical data indicate <span class=""chemical"">cisplatin</span> sensitivity, suggesting that these <span class=""disease"">tumors</span> may have defects in the BRCA1 pathway.",,21482494,21482494_D002945_D009369,21482494_2,bcv_sentence_task_befree_3956,,770959886,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,C080625,"<span class=""chemical"">taxane</span>",D064726,"<span class=""disease"">TNBC</span>","The carboplatin and gemcitabine (CG) combination is active in unselected anthracycline/<span class=""chemical"">taxane</span> pretreated metastatic breast cancer patients, so we carried out a phase II study to evaluate the activity of the CG combination in pretreated metastatic <span class=""disease"">TNBC</span> patients.",,21482494,21482494_C080625_D064726,21482494_3,bcv_sentence_task_befree_3957,,770959887,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,1,,D016190,"<span class=""chemical"">carboplatin</span>",D064726,"<span class=""disease"">TNBC</span>","The <span class=""chemical"">carboplatin</span> and gemcitabine (CG) combination is active in unselected anthracycline/taxane pretreated metastatic breast cancer patients, so we carried out a phase II study to evaluate the activity of the CG combination in pretreated metastatic <span class=""disease"">TNBC</span> patients.",,21482494,21482494_D016190_D064726,21482494_3,bcv_sentence_task_befree_3958,,770959888,FALSE,finalized,5,8/14/15 22:10,"



",no_relation,0.8044,,D018943,"<span class=""chemical"">anthracycline</span>",D064726,"<span class=""disease"">TNBC</span>","The carboplatin and gemcitabine (CG) combination is active in unselected <span class=""chemical"">anthracycline</span>/taxane pretreated metastatic breast cancer patients, so we carried out a phase II study to evaluate the activity of the CG combination in pretreated metastatic <span class=""disease"">TNBC</span> patients.",,21482494,21482494_D018943_D064726,21482494_3,bcv_sentence_task_befree_3959,,770959889,FALSE,finalized,5,8/14/15 21:28,"



",no_relation,1,,C080625,"<span class=""chemical"">taxane</span>",D009369,"<span class=""disease"">breast cancer</span>","The carboplatin and gemcitabine (CG) combination is active in unselected anthracycline/<span class=""chemical"">taxane</span> pretreated metastatic <span class=""disease"">breast cancer</span> patients, so we carried out a phase II study to evaluate the activity of the CG combination in pretreated metastatic TNBC patients.",,21482494,21482494_C080625_D009369,21482494_3,bcv_sentence_task_befree_3960,,770959890,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D018943,"<span class=""chemical"">anthracycline</span>",D009369,"<span class=""disease"">breast cancer</span>","The carboplatin and gemcitabine (CG) combination is active in unselected <span class=""chemical"">anthracycline</span>/taxane pretreated metastatic <span class=""disease"">breast cancer</span> patients, so we carried out a phase II study to evaluate the activity of the CG combination in pretreated metastatic TNBC patients.",,21482494,21482494_D018943_D009369,21482494_3,bcv_sentence_task_befree_3961,,770959891,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,C056507,"<span class=""chemical"">gemcitabine</span>",D064726,"<span class=""disease"">TNBC</span>","The carboplatin and <span class=""chemical"">gemcitabine</span> (CG) combination is active in unselected anthracycline/taxane pretreated metastatic breast cancer patients, so we carried out a phase II study to evaluate the activity of the CG combination in pretreated metastatic <span class=""disease"">TNBC</span> patients.",,21482494,21482494_C056507_D064726,21482494_3,bcv_sentence_task_befree_3962,,770959892,FALSE,finalized,5,8/14/15 22:20,"



",no_relation,0.7948,,D016190,"<span class=""chemical"">carboplatin</span>",D009369,"<span class=""disease"">breast cancer</span>","The <span class=""chemical"">carboplatin</span> and gemcitabine (CG) combination is active in unselected anthracycline/taxane pretreated metastatic <span class=""disease"">breast cancer</span> patients, so we carried out a phase II study to evaluate the activity of the CG combination in pretreated metastatic TNBC patients.",,21482494,21482494_D016190_D009369,21482494_3,bcv_sentence_task_befree_3963,,770959893,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,0.8036,,C056507,"<span class=""chemical"">gemcitabine</span>",D009369,"<span class=""disease"">breast cancer</span>","The carboplatin and <span class=""chemical"">gemcitabine</span> (CG) combination is active in unselected anthracycline/taxane pretreated metastatic <span class=""disease"">breast cancer</span> patients, so we carried out a phase II study to evaluate the activity of the CG combination in pretreated metastatic TNBC patients.",,21482494,21482494_C056507_D009369,21482494_3,bcv_sentence_task_befree_3964,,770959894,FALSE,finalized,5,8/14/15 22:23,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D019966,"<span class=""disease"">drug dependency</span>","Current injecting drug use (odds ratio [OR], 0.26; 95% CI, 0.08-0.77), past and current treatment for <span class=""disease"">drug dependency</span> (OR, 0.34; 95% CI, 0.18-0.67, and OR, 0.42; 95% CI, 0.22-0.81, respectively) and <span class=""chemical"">alcohol</span> use above 20 g/day (OR, 0.20; 95% CI, 0.08-0.46) were independent predictors of deferral of treatment.",,21495939,21495939_D000431_D019966,21495939_7,bcv_sentence_task_befree_3965,,770959895,FALSE,finalized,5,8/14/15 21:36,"



",no_relation,0.8044,,D000431,"<span class=""chemical"">alcohol</span>",D006526,"<span class=""disease"">HCV</span>","Factors related to drug and <span class=""chemical"">alcohol</span> use, rather than clinical factors, influenced uptake of treatment for <span class=""disease"">HCV</span>.",,21495939,21495939_D000431_D006526,21495939_10,bcv_sentence_task_befree_3966,,770959896,FALSE,finalized,5,8/14/15 23:20,"



",no_relation,0.8233,,D000431,"<span class=""chemical"">alcohol</span>",D000437,"<span class=""disease"">alcohol dependency</span>","Further support for patients with drug and <span class=""chemical""></span><span class=""disease"">alcohol</span> dependency is required to optimise treatment uptake.",,21495939,21495939_D000431_D000437,21495939_11,bcv_sentence_task_befree_3967,,770959897,FALSE,finalized,5,8/14/15 21:46,"



",no_relation,1,,C400082,"<span class=""chemical"">Bortezomib</span>",D012008,"<span class=""disease"">relapsed disease</span>","<span class=""chemical"">Bortezomib</span>, thalidomide and lenalidomide have improved the therapeutic armentarium for patients with refractory or <span class=""disease"">relapsed disease</span> and are often used in combination with dexamethasone or chemotherapeutic agents.",,21509688,21509688_C400082_D012008,21509688_3,bcv_sentence_task_befree_3968,,770959898,FALSE,finalized,5,8/14/15 23:16,"



",no_relation,1,,C467567,"<span class=""chemical"">lenalidomide</span>",D012008,"<span class=""disease"">relapsed disease</span>","Bortezomib, thalidomide and <span class=""chemical"">lenalidomide</span> have improved the therapeutic armentarium for patients with refractory or <span class=""disease"">relapsed disease</span> and are often used in combination with dexamethasone or chemotherapeutic agents.",,21509688,21509688_C467567_D012008,21509688_3,bcv_sentence_task_befree_3969,,770959899,FALSE,finalized,5,8/15/15 0:41,"



",no_relation,0.8306,,D013792,"<span class=""chemical"">thalidomide</span>",D012008,"<span class=""disease"">relapsed disease</span>","Bortezomib, <span class=""chemical"">thalidomide</span> and lenalidomide have improved the therapeutic armentarium for patients with refractory or <span class=""disease"">relapsed disease</span> and are often used in combination with dexamethasone or chemotherapeutic agents.",,21509688,21509688_D013792_D012008,21509688_3,bcv_sentence_task_befree_3970,,770959900,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,1,,D003907,"<span class=""chemical"">dexamethasone</span>",D012008,"<span class=""disease"">relapsed disease</span>","Bortezomib, thalidomide and lenalidomide have improved the therapeutic armentarium for patients with refractory or <span class=""disease"">relapsed disease</span> and are often used in combination with <span class=""chemical"">dexamethasone</span> or chemotherapeutic agents.",,21509688,21509688_D003907_D012008,21509688_3,bcv_sentence_task_befree_3971,,770959901,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,0.5866,,D002045,"<span class=""chemical"">bupivacaine</span>",D000699,"<span class=""disease"">analgesia</span>","Doppler velocimetry indices, systolic/diastolic ratios, pulsatility index, and resistance index, of the fetal umbilical artery and uterine artery were recorded in 15 women receiving continuous epidural <span class=""disease"">analgesia</span> with 0.075% <span class=""chemical"">bupivacaine</span> and 0.0002% fentanyl during labor; the same indices were recorded of the fetal umbilical and middle cerebral arteries in 10 women receiving the same <span class=""disease"">analgesia</span>.",,21519310,21519310_D002045_D000699,21519310_3,bcv_sentence_task_befree_3972,,770959902,FALSE,finalized,5,8/15/15 0:22,"



",no_relation,0.5875,,D005283,"<span class=""chemical"">fentanyl</span>",D000699,"<span class=""disease"">analgesia</span>","Doppler velocimetry indices, systolic/diastolic ratios, pulsatility index, and resistance index, of the fetal umbilical artery and uterine artery were recorded in 15 women receiving continuous epidural <span class=""disease"">analgesia</span> with 0.075% bupivacaine and 0.0002% <span class=""chemical"">fentanyl</span> during labor; the same indices were recorded of the fetal umbilical and middle cerebral arteries in 10 women receiving the same <span class=""disease"">analgesia</span>.",,21519310,21519310_D005283_D000699,21519310_3,bcv_sentence_task_befree_3973,,770959903,FALSE,finalized,5,8/14/15 23:46,"



",yes_direct,0.6157,,D003024,"<span class=""chemical"">clozapine</span>",D012798,"<span class=""disease"">sialorrhea</span>","Current treatment strategies for <span class=""chemical"">clozapine</span>-induced <span class=""disease"">sialorrhea</span>.",,21540404,21540404_D003024_D012798,21540404_0,bcv_sentence_task_befree_3974,,770959904,FALSE,finalized,5,8/14/15 23:43,"



",yes_direct,0.8101,,D003024,"<span class=""chemical"">clozapine</span>",D012798,"<span class=""disease"">sialorrhea</span>","To provide an understanding of the underlying pathophysiology and current treatment options for <span class=""chemical"">clozapine</span>-induced <span class=""disease"">sialorrhea</span>.",,21540404,21540404_D003024_D012798,21540404_1,bcv_sentence_task_befree_3975,,770959905,FALSE,finalized,5,8/14/15 21:28,"



",no_relation,1,,D003024,"<span class=""chemical"">clozapine</span>",D012798,"<span class=""disease"">hypersalivation/sialorrhea</span>","Literature was retrieved through MEDLINE (1977-February 2011) using the key search terms <span class=""chemical"">clozapine</span>, <span class=""disease"">sialorrhea</span>, <span class=""disease"">hypersalivation</span>, drooling, and treatment.",,21540404,21540404_D003024_D012798,21540404_2,bcv_sentence_task_befree_3976,,770959906,FALSE,finalized,5,8/15/15 0:27,"



",yes_direct,0.8067,,D003024,"<span class=""chemical"">clozapine</span>",D012798,"<span class=""disease"">Sialorrhea</span>","<span class=""disease"">Sialorrhea</span> is a common and disabling adverse effect of <span class=""chemical"">clozapine</span> use.",,21540404,21540404_D003024_D012798,21540404_5,bcv_sentence_task_befree_3977,,770959907,FALSE,finalized,5,8/14/15 22:03,"



",no_relation,0.5688,,D006024,"<span class=""chemical"">Glycopyrrolate</span>",D012798,"<span class=""disease"">reduction of hypersalivation</span>","<span class=""chemical"">Glycopyrrolate</span>, however, demonstrated significant <span class=""disease"">reduction of hypersalivation</span> in a randomized controlled trial.",,21540404,21540404_D006024_D012798,21540404_10,bcv_sentence_task_befree_3978,,770959908,FALSE,finalized,5,8/14/15 21:37,"



",no_relation,0.6001,,D003024,"<span class=""chemical"">clozapine</span>",D012798,"<span class=""disease"">hypersalivation/sialorrhea</span>","Botulinum toxin also significantly improved <span class=""disease"">sialorrhea</span> in both a case report and double-blind study, although the trial included <span class=""disease"">hypersalivation</span> from other etiologies in addition to <span class=""chemical"">clozapine</span>.",,21540404,21540404_D003024_D012798,21540404_12,bcv_sentence_task_befree_3979,,770959909,FALSE,finalized,5,8/15/15 2:07,"



",yes_direct,0.6075,,D003024,"<span class=""chemical"">clozapine</span>",D012798,"<span class=""disease"">sialorrhea</span>","Current pharmacologic treatment options for <span class=""chemical"">clozapine</span>-induced <span class=""disease"">sialorrhea</span> are limited in number and efficacy.",,21540404,21540404_D003024_D012798,21540404_15,bcv_sentence_task_befree_3980,,770959910,FALSE,finalized,5,8/14/15 23:32,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",D016889,"<span class=""disease"">endometrial cancer</span>","We investigated whether variants in sex <span class=""chemical"">steroid</span> hormone metabolism genes modify the effect of hormone therapy (HT) on <span class=""disease"">endometrial cancer</span> risk in postmenopausal non-Hispanic white women.",,21544810,21544810_D013256_D016889,21544810_1,bcv_sentence_task_befree_3981,,770959911,FALSE,finalized,5,8/14/15 23:38,"



",no_relation,0.8009,,D009828,"<span class=""chemical"">oleanolic acid</span>",C531854,"<span class=""disease"">oleanolic acid/OA</span>","In this study, the main active compound, <span class=""chemical""></span><span class=""disease"">oleanolic acid</span> (<span class=""disease"">OA</span>) was isolated from an ethanol extract and its chemical structure was identified according to the results of high performance liquid chromatography (HPLC), high performance thin layer chromatography (HPTLC) and liquid chromatography-mass spectrography (LC-MS).",,21545203,21545203_D009828_C531854,21545203_2,bcv_sentence_task_befree_3982,,770959912,FALSE,finalized,5,8/15/15 2:11,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",C531854,"<span class=""disease"">oleanolic acid/OA</span>","In this study, the main active compound, <span class=""disease"">oleanolic acid</span> (<span class=""disease"">OA</span>) was isolated from an <span class=""chemical"">ethanol</span> extract and its chemical structure was identified according to the results of high performance liquid chromatography (HPLC), high performance thin layer chromatography (HPTLC) and liquid chromatography-mass spectrography (LC-MS).",,21545203,21545203_D000431_C531854,21545203_2,bcv_sentence_task_befree_3983,,770959913,FALSE,finalized,5,8/14/15 21:46,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",C531854,"<span class=""disease"">OA</span>","Results for cell viability indictated no notable differences between <span class=""disease"">OA</span> and <span class=""chemical"">ethanol</span> extract of PV in lung adenocarcinoma SPC-A-1 cells measured by MTT assay.",,21545203,21545203_D000431_C531854,21545203_3,bcv_sentence_task_befree_3984,,770959914,FALSE,finalized,5,8/14/15 21:57,"



",no_relation,1,,D000431,"<span class=""chemical"">ethanol</span>",C538231,"<span class=""disease"">PV in lung adenocarcinoma</span>","Results for cell viability indictated no notable differences between OA and <span class=""chemical"">ethanol</span> extract of <span class=""disease"">PV in lung adenocarcinoma</span> SPC-A-1 cells measured by MTT assay.",,21545203,21545203_D000431_C538231,21545203_3,bcv_sentence_task_befree_3985,,770959915,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,1,,D004121,"<span class=""chemical"">DMSO</span>",C531854,"<span class=""disease"">OA</span>","<span class=""disease"">OA</span> at 16 and 8 microM group increased significantly the apoptosis rate compared with normal and 1% <span class=""chemical"">DMSO</span> groups (p<0.05).",,21545203,21545203_D004121_C531854,21545203_6,bcv_sentence_task_befree_3986,,770959916,FALSE,finalized,5,8/15/15 0:02,"



",no_relation,1,,C110904,"<span class=""chemical"">capecitabine</span>",D009369,"<span class=""disease"">tumors</span>","Tesetaxel, a new oral taxane, in combination with <span class=""chemical"">capecitabine</span>: a phase I, dose-escalation study in patients with advanced solid <span class=""disease"">tumors</span>.",,21547572,21547572_C110904_D009369,21547572_0,bcv_sentence_task_befree_3987,,770959917,FALSE,finalized,5,8/14/15 21:28,"



",no_relation,1,,C479543,"<span class=""chemical"">Tesetaxel</span>",D009369,"<span class=""disease"">tumors</span>","<span class=""chemical"">Tesetaxel</span>, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid <span class=""disease"">tumors</span>.",,21547572,21547572_C479543_D009369,21547572_0,bcv_sentence_task_befree_3988,,770959918,FALSE,finalized,5,8/14/15 23:45,"



",no_relation,1,,C080625,"<span class=""chemical"">taxane</span>",D009369,"<span class=""disease"">tumors</span>","Tesetaxel, a new oral <span class=""chemical"">taxane</span>, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid <span class=""disease"">tumors</span>.",,21547572,21547572_C080625_D009369,21547572_0,bcv_sentence_task_befree_3989,,770959919,FALSE,finalized,5,8/14/15 22:05,"



",no_relation,1,,C110904,"<span class=""chemical"">capecitabine</span>",D009369,"<span class=""disease"">tumors</span>","This phase I study was conducted primarily to determine the maximum tolerated dose (MTD) of tesetaxel, a novel, orally active, semisynthetic microtubule inhibitor of the taxane class, administered with oral <span class=""chemical"">capecitabine</span> to patients with advanced solid <span class=""disease"">tumors</span>.",,21547572,21547572_C110904_D009369,21547572_1,bcv_sentence_task_befree_3990,,770959920,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,1,,C479543,"<span class=""chemical"">tesetaxel</span>",D009369,"<span class=""disease"">tumors</span>","This phase I study was conducted primarily to determine the maximum tolerated dose (MTD) of <span class=""chemical"">tesetaxel</span>, a novel, orally active, semisynthetic microtubule inhibitor of the taxane class, administered with oral capecitabine to patients with advanced solid <span class=""disease"">tumors</span>.",,21547572,21547572_C479543_D009369,21547572_1,bcv_sentence_task_befree_3991,,770959921,FALSE,finalized,5,8/14/15 23:21,"



",no_relation,1,,C080625,"<span class=""chemical"">taxane</span>",D009369,"<span class=""disease"">tumors</span>","This phase I study was conducted primarily to determine the maximum tolerated dose (MTD) of tesetaxel, a novel, orally active, semisynthetic microtubule inhibitor of the <span class=""chemical"">taxane</span> class, administered with oral capecitabine to patients with advanced solid <span class=""disease"">tumors</span>.",,21547572,21547572_C080625_D009369,21547572_1,bcv_sentence_task_befree_3992,,770959922,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,1,,C479543,"<span class=""chemical"">tesetaxel</span>",D009369,"<span class=""disease"">cancer</span>","These data further support the continued clinical development of <span class=""chemical"">tesetaxel</span> both as a single agent and in combination with other active <span class=""disease"">cancer</span> therapeutics.",,21547572,21547572_C479543_D009369,21547572_14,bcv_sentence_task_befree_3993,,770959923,FALSE,finalized,5,8/14/15 23:53,"



",no_relation,1,,C552042,"<span class=""chemical"">BAL30072</span>",D013180,"<span class=""disease"">pseudomallei strains</span>","In this study, the anti-B. pseudomallei efficacy of a new monosulfactam, <span class=""chemical"">BAL30072</span>, was tested against laboratory strains 1026b and 1710b and several isogenic mutant derivatives as well as a collection of clinical and environmental B. <span class=""disease"">pseudomallei strains</span> from Thailand.",,21596528,21596528_C552042_D013180,21596528_4,bcv_sentence_task_befree_3994,,770959924,FALSE,finalized,5,8/14/15 22:27,"



'blood manganese' is not a disease. :-)",no_relation,1,,D008345,"<span class=""chemical"">manganese</span>",D006402,"<span class=""disease"">blood manganese</span>","Relationship between <span class=""disease"">blood </span><span class=""chemical"">manganese</span> and blood pressure in the Korean general population according to KNHANES 2008.",,21601843,21601843_D008345_D006402,21601843_0,bcv_sentence_task_befree_3995,,770959925,FALSE,finalized,5,8/14/15 23:10,"



",yes_direct,0.5999,,D008345,"<span class=""chemical"">Mn/manganese</span>",D006973,"<span class=""disease"">hypertension</span>","We present data on the association of <span class=""chemical"">manganese</span> (<span class=""chemical"">Mn</span>) level with <span class=""disease"">hypertension</span> in a representative sample of the adult Korean population who participated in the Korean National Health and Nutrition Examination Survey (KNHANES) 2008.",,21601843,21601843_D008345_D006973,21601843_1,bcv_sentence_task_befree_3996,,770959926,FALSE,finalized,5,8/15/15 0:46,"



",yes_direct,1,,D008345,"<span class=""chemical"">Mn</span>",D006973,"<span class=""disease"">hypertension</span>","In addition, doubling the blood <span class=""chemical"">Mn</span> increased the risk of <span class=""disease"">hypertension</span> 1.828, 1.573, and 1.567 fold in women, men, and all participants, respectively, after adjustment for covariates.",,21601843,21601843_D008345_D006973,21601843_5,bcv_sentence_task_befree_3997,,770959927,FALSE,finalized,5,8/14/15 21:57,"



",no_relation,0.7997,,D008345,"<span class=""chemical"">Mn</span>",D006973,"<span class=""disease"">hypertension</span>","The addition of blood lead, mercury, and cadmium as covariates did not affect the association between blood <span class=""chemical"">Mn</span> and the prevalence of <span class=""disease"">hypertension</span>.",,21601843,21601843_D008345_D006973,21601843_6,bcv_sentence_task_befree_3998,,770959928,FALSE,finalized,5,8/14/15 22:59,"



",no_relation,1,,D008628,"<span class=""chemical"">mercury</span>",D006973,"<span class=""disease"">hypertension</span>","The addition of blood lead, <span class=""chemical"">mercury</span>, and cadmium as covariates did not affect the association between blood Mn and the prevalence of <span class=""disease"">hypertension</span>.",,21601843,21601843_D008628_D006973,21601843_6,bcv_sentence_task_befree_3999,,770959929,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,D002104,"<span class=""chemical"">cadmium</span>",D006973,"<span class=""disease"">hypertension</span>","The addition of blood lead, mercury, and <span class=""chemical"">cadmium</span> as covariates did not affect the association between blood Mn and the prevalence of <span class=""disease"">hypertension</span>.",,21601843,21601843_D002104_D006973,21601843_6,bcv_sentence_task_befree_4000,,770959930,FALSE,finalized,5,8/15/15 0:42,"



",yes_direct,1,,D008345,"<span class=""chemical"">Mn</span>",D006973,"<span class=""disease"">hypertension</span>","Blood <span class=""chemical"">Mn</span> level was associated with an increased risk of <span class=""disease"">hypertension</span> in a representative sample of the Korean adult population.",,21601843,21601843_D008345_D006973,21601843_7,bcv_sentence_task_befree_4001,,770959931,FALSE,finalized,5,8/14/15 23:38,"



",no_relation,0.804,,D004298,"<span class=""chemical"">dopamine</span>",D007174,"<span class=""disease"">impulse control disorders</span>","The risky business of <span class=""chemical"">dopamine</span> agonists in Parkinson disease and <span class=""disease"">impulse control disorders</span>.",,21604834,21604834_D004298_D007174,21604834_0,bcv_sentence_task_befree_4002,,770959932,FALSE,finalized,5,8/14/15 22:15,"



",no_relation,0.8069,,D004298,"<span class=""chemical"">dopamine</span>",D010300,"<span class=""disease"">Parkinson disease</span>","The risky business of <span class=""chemical"">dopamine</span> agonists in <span class=""disease"">Parkinson disease</span> and impulse control disorders.",,21604834,21604834_D004298_D010300,21604834_0,bcv_sentence_task_befree_4003,,770959933,FALSE,finalized,5,8/15/15 2:13,"



",yes_direct,0.8078,,D004298,"<span class=""chemical"">dopamine</span>",D007174,"<span class=""disease"">impulse control disorder/ICD</span>","In patients with Parkinson's disease (PD), <span class=""disease"">impulse control disorder</span> (<span class=""disease"">ICD</span>) can result from dopaminergic medication use, particularly <span class=""chemical"">dopamine</span> agonists (DAA).",,21604834,21604834_D004298_D007174,21604834_3,bcv_sentence_task_befree_4004,,770959934,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,1,,D004298,"<span class=""chemical"">dopamine</span>",D010300,"<span class=""disease"">Parkinson's disease/PD</span>","In patients with <span class=""disease"">Parkinson's disease</span> (<span class=""disease"">PD</span>), impulse control disorder (ICD) can result from dopaminergic medication use, particularly <span class=""chemical"">dopamine</span> agonists (DAA).",,21604834,21604834_D004298_D010300,21604834_3,bcv_sentence_task_befree_4005,,770959935,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,D010713,"<span class=""chemical"">phosphatidylcholine</span>",D009362,"<span class=""disease"">metastasis</span>","Therapeutic effects of hybrid liposomes composed of <span class=""chemical"">phosphatidylcholine</span> and docosahexaenoic acid on the hepatic <span class=""disease"">metastasis</span> of colon carcinoma along with apoptosis in vivo.",,21628892,21628892_D010713_D009362,21628892_0,bcv_sentence_task_befree_4006,,770959936,FALSE,finalized,5,8/15/15 1:23,"



",no_relation,0.7924,,D010713,"<span class=""chemical"">phosphatidylcholine</span>",D003108,"<span class=""disease"">colon carcinoma</span>","Therapeutic effects of hybrid liposomes composed of <span class=""chemical"">phosphatidylcholine</span> and docosahexaenoic acid on the hepatic metastasis of <span class=""disease"">colon carcinoma</span> along with apoptosis in vivo.",,21628892,21628892_D010713_D003108,21628892_0,bcv_sentence_task_befree_4007,,770959937,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",C562729,"<span class=""disease"">ESCC</span>","In <span class=""disease"">ESCC</span> cells treated with <span class=""chemical"">cisplatin</span>, a common chemotherapeutic drug, Smac and cytochrome c were released from mitochondria, and caspase-3 and caspase-9 were activated.",,21676925,21676925_D002945_C562729,21676925_9,bcv_sentence_task_befree_4008,,770959938,FALSE,finalized,5,8/14/15 21:29,"



",yes_direct,0.5986,,D002945,"<span class=""chemical"">cisplatin</span>",C565304,"<span class=""disease"">mitochondrial dysfunction</span>","Knockdown of Smac abrogated <span class=""chemical"">cisplatin</span>-induced apoptosis, <span class=""disease"">mitochondrial dysfunction</span>, cytochrome c release, and caspase activation.",,21676925,21676925_D002945_C565304,21676925_10,bcv_sentence_task_befree_4009,,770959939,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D009369,"<span class=""disease"">tumors</span>","Smac deficiency also reduced the effect of <span class=""chemical"">cisplatin</span> on long-term cell viability, and led to <span class=""chemical"">cisplatin</span> resistance in xenograft <span class=""disease"">tumors</span> in vivo.",,21676925,21676925_D002945_D009369,21676925_11,bcv_sentence_task_befree_4010,,770959940,FALSE,finalized,5,8/14/15 22:22,"



",no_relation,0.7894,,C476513,"<span class=""chemical"">Levobupivacaine</span>",D002318,"<span class=""disease"">cardiovascular and central nervous system toxicity</span>","<span class=""chemical"">Levobupivacaine</span> is a new long-acting local anesthetic, which is the isolated S-enantiomer of racemic bupivacaine with less <span class=""disease"">cardiovascular and central nervous system toxicity</span> than bupivacaine.",,21696081,21696081_C476513_D002318,21696081_1,bcv_sentence_task_befree_4011,,770959941,FALSE,finalized,5,8/15/15 1:32,"



",no_relation,0.7942,,D002045,"<span class=""chemical"">bupivacaine</span>",D002318,"<span class=""disease"">cardiovascular and central nervous system toxicity</span>","Levobupivacaine is a new long-acting local anesthetic, which is the isolated S-enantiomer of racemic <span class=""chemical"">bupivacaine</span> with less <span class=""disease"">cardiovascular and central nervous system toxicity</span> than <span class=""chemical"">bupivacaine</span>.",,21696081,21696081_D002045_D002318,21696081_1,bcv_sentence_task_befree_4012,,770959942,FALSE,finalized,5,8/15/15 1:11,"



",no_relation,1,,D014807,"<span class=""chemical"">vitamin D</span>",D014808,"<span class=""disease"">vitamin D deficiency</span>","Diet, environmental factors, and lifestyle underlie the high prevalence of <span class=""chemical""></span><span class=""disease"">vitamin D</span> deficiency in healthy adults in Scotland, and supplementation reduces the proportion that are severely deficient.",,21697298,21697298_D014807_D014808,21697298_0,bcv_sentence_task_befree_4013,,770959943,FALSE,finalized,5,8/14/15 23:17,"



",no_relation,0.5976,,D014807,"<span class=""chemical"">Vitamin D</span>",D004194,"<span class=""disease"">numerous diseases</span>","<span class=""chemical"">Vitamin D</span> deficiency has recently been implicated as a possible risk factor in the etiology of <span class=""disease"">numerous diseases</span>, including nonskeletal conditions.",,21697298,21697298_D014807_D004194,21697298_1,bcv_sentence_task_befree_4014,,770959944,FALSE,finalized,5,8/15/15 1:00,"



",no_relation,1,,D014807,"<span class=""chemical"">Vitamin D</span>",D014808,"<span class=""disease"">Vitamin D deficiency</span>","<span class=""chemical""></span><span class=""disease"">Vitamin D</span> deficiency has recently been implicated as a possible risk factor in the etiology of numerous diseases, including nonskeletal conditions.",,21697298,21697298_D014807_D014808,21697298_1,bcv_sentence_task_befree_4015,,770959945,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,1,,D014807,"<span class=""chemical"">vitamin D</span>",D014808,"<span class=""disease"">vitamin D deficiency</span>","In humans, skin synthesis following exposure to UVB is a potent source of <span class=""chemical"">vitamin D</span>, but in regions with low UVB, individuals are at risk of <span class=""chemical""></span><span class=""disease"">vitamin D</span> deficiency.",,21697298,21697298_D014807_D014808,21697298_2,bcv_sentence_task_befree_4016,,770959946,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,C104450,"<span class=""chemical"">25-hydroxyvitamin D</span>",D014808,"<span class=""disease"">vitamin D deficiency</span>","Our objectives were to describe the prevalence of <span class=""disease"">vitamin D deficiency</span> and to investigate determinants of plasma <span class=""chemical"">25-hydroxyvitamin D</span> (25-OHD) concentrations in a high northern latitude country.",,21697298,21697298_C104450_D014808,21697298_3,bcv_sentence_task_befree_4017,,770959947,FALSE,finalized,5,8/15/15 0:07,"



",no_relation,1,,D014807,"<span class=""chemical"">vitamin D</span>",D014808,"<span class=""disease"">vitamin D deficiency</span>","Our objectives were to describe the prevalence of <span class=""chemical""></span><span class=""disease"">vitamin D</span> deficiency and to investigate determinants of plasma 25-hydroxyvitamin D (25-OHD) concentrations in a high northern latitude country.",,21697298,21697298_D014807_D014808,21697298_3,bcv_sentence_task_befree_4018,,770959948,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D014807,"<span class=""chemical"">vitamin D</span>",D014808,"<span class=""disease"">vitamin D deficiency</span>","Only 36.6% of participants were at low risk of <span class=""chemical""></span><span class=""disease"">vitamin D</span> deficiency or had adequate levels (>40 nmol/L).",,21697298,21697298_D014807_D014808,21697298_7,bcv_sentence_task_befree_4019,,770959949,FALSE,finalized,5,8/14/15 22:15,"



",no_relation,1,,D014807,"<span class=""chemical"">Vitamin D</span>",D014808,"<span class=""disease"">Vitamin D deficiency</span>","<span class=""chemical""></span><span class=""disease"">Vitamin D</span> deficiency in Scotland is highly prevalent due to a combination of insufficient exposure to UVB and insufficient dietary intake.",,21697298,21697298_D014807_D014808,21697298_10,bcv_sentence_task_befree_4020,,770959950,FALSE,finalized,5,8/15/15 1:10,"



",no_relation,1,,C037199,"<span class=""chemical"">poly-N-acetyllactosamine</span>",D007938,"<span class=""disease"">leukemia</span>","The expressions of _1,3-N-acetylglucosamonyltransferase-2 and -8 (_3GnT-2, _3GnT-8),-the two main glycosyltransferases responsible for the synthesis of <span class=""chemical"">poly-N-acetyllactosamine</span> (polyLacNAc) in glycans, and _3GnT-5 participating in the syntheses of sphingoglycolipids were studied in <span class=""disease"">leukemia</span> cell lines during differentiation using RT-PCR method.",,21720768,21720768_C037199_D007938,21720768_1,bcv_sentence_task_befree_4021,,770959951,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,1,,D014212,"<span class=""chemical"">ATRA/all-trans retinoic acid</span>",D015470,"<span class=""disease"">acute myeloid leukemia</span>","<span class=""chemical"">ATRA</span> (<span class=""chemical"">all-trans retinoic acid</span>) and dimethylsulfoxide (DMSO), which induce the differentiation of HL-60 and NB4 (two human <span class=""disease"">acute myeloid leukemia</span> cell lines) to myelocytic lineage, up-regulated these two enzymes with various degrees at 2 and 72 h of treatment.",,21720768,21720768_D014212_D015470,21720768_3,bcv_sentence_task_befree_4022,,770959952,FALSE,finalized,5,8/14/15 22:03,"



",no_relation,0.8046,,D004121,"<span class=""chemical"">DMSO/dimethylsulfoxide</span>",D015470,"<span class=""disease"">acute myeloid leukemia</span>","ATRA (all-trans retinoic acid) and <span class=""chemical"">dimethylsulfoxide</span> (<span class=""chemical"">DMSO</span>), which induce the differentiation of HL-60 and NB4 (two human <span class=""disease"">acute myeloid leukemia</span> cell lines) to myelocytic lineage, up-regulated these two enzymes with various degrees at 2 and 72 h of treatment.",,21720768,21720768_D004121_D015470,21720768_3,bcv_sentence_task_befree_4023,,770959953,FALSE,finalized,5,8/14/15 21:37,"



",yes_direct,0.7858,,D002118,"<span class=""chemical"">calcium</span>",D003643,"<span class=""disease"">death</span>","Cardiomyocyte <span class=""chemical"">calcium</span> (Ca(2+)) loading is recognized to be a major factor in acute ischaemia-reperfusion pathology, promoting cell <span class=""disease"">death</span>, contractile dysfunction and arrhythmogenic activity.",,21722161,21722161_D002118_D003643,21722161_6,bcv_sentence_task_befree_4024,,770959954,FALSE,finalized,5,8/14/15 21:29,"



",no_relation,1,,D002118,"<span class=""chemical"">Ca</span>",D005517,"<span class=""disease"">CRF/Ca-rich-food</span>","The study aimed to (i) segment parents of early adolescents into subgroups according to their <span class=""chemical""></span><span class=""disease"">Ca</span>-rich-food (<span class=""disease"">CRF</span>) practices and perceptions regarding early adolescent <span class=""disease"">CRF</span> intake and (ii) determine whether <span class=""chemical"">Ca</span> intake of parents and early adolescents differed by subgroup.",,21729479,21729479_D002118_D005517,21729479_1,bcv_sentence_task_befree_4025,,770959955,FALSE,finalized,5,8/15/15 2:23,"



",no_relation,1,,D002118,"<span class=""chemical"">Ca</span>",D005517,"<span class=""disease"">CRF</span>","Parent education programmes should address <span class=""disease"">CRF</span> practices/perceptions tailored to parent group to improve <span class=""chemical"">Ca</span> intake of early adolescent children.",,21729479,21729479_D002118_D005517,21729479_10,bcv_sentence_task_befree_4026,,770959956,FALSE,finalized,5,8/15/15 0:45,"



",no_relation,0.6099,,D011736,"<span class=""chemical"">pyridoxine</span>",D012640,"<span class=""disease"">seizures</span>","Long-term follow-up in two siblings with <span class=""chemical"">pyridoxine</span>-dependent <span class=""disease"">seizures</span> associated with a novel ALDH7A1 mutation.",,21733724,21733724_D011736_D012640,21733724_0,bcv_sentence_task_befree_4027,,770959957,FALSE,finalized,5,8/15/15 1:08,"



",no_relation,0.7914,,D011736,"<span class=""chemical"">Pyridoxine</span>",C536254,"<span class=""disease"">Pyridoxine-dependent seizures/PDS</span>","<span class=""chemical""></span><span class=""disease"">Pyridoxine</span>-dependent seizures (<span class=""disease"">PDS</span>) is a rare disorder characterized by seizures resistant to anticonvulsants but controlled by daily pharmacologic doses of <span class=""chemical"">pyridoxine</span>.",,21733724,21733724_D011736_C536254,21733724_1,bcv_sentence_task_befree_4028,,770959958,FALSE,finalized,5,8/14/15 21:49,"



",no_relation,0.6009,,D011736,"<span class=""chemical"">Pyridoxine</span>",D012640,"<span class=""disease"">seizures</span>","<span class=""chemical"">Pyridoxine</span>-dependent seizures (PDS) is a rare disorder characterized by <span class=""disease"">seizures</span> resistant to anticonvulsants but controlled by daily pharmacologic doses of <span class=""chemical"">pyridoxine</span>.",,21733724,21733724_D011736_D012640,21733724_1,bcv_sentence_task_befree_4029,,770959959,FALSE,finalized,5,8/14/15 21:56,"



",no_relation,1,,C110904,"<span class=""chemical"">capecitabine</span>",D009369,"<span class=""disease"">breast cancer</span>","Continuation of trastuzumab plus <span class=""chemical"">capecitabine</span> (XH) showed a significantly improved overall response rate and time to progression compared with <span class=""chemical"">capecitabine</span> (X) alone in women with HER2-positive <span class=""disease"">breast cancer</span> progressing during trastuzumab treatment.",,21741829,21741829_C110904_D009369,21741829_1,bcv_sentence_task_befree_4030,,770959960,FALSE,finalized,5,8/14/15 23:51,"



",no_relation,1,,D003907,"<span class=""chemical"">DEX/dexamethasone</span>",C565529,"<span class=""disease"">HGF/hepatocyte growth factor</span>","We compared the effect of <span class=""disease"">hepatocyte growth factor</span> (<span class=""disease"">HGF</span>), oncostatin M (OSM), <span class=""chemical"">dexamethasone</span> (<span class=""chemical"">DEX</span>), or a combination on the expression of a liver-specific marker, albumin (ALB).",,21751216,21751216_D003907_C565529,21751216_3,bcv_sentence_task_befree_4031,,770959961,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,D014508,"<span class=""chemical"">urea</span>",C565529,"<span class=""disease"">HGF</span>","Moreover, cells exposed to the combination of OSM, DEX, and <span class=""disease"">HGF</span> gradually featured highly differentiated hepatic functions, including ALB secretion, glycogen storage, <span class=""chemical"">urea</span> production, and cytochrome P450 (CYP) activity.",,21751216,21751216_D014508_C565529,21751216_6,bcv_sentence_task_befree_4032,,770959962,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,1,,C058728,"<span class=""chemical"">combretastatin-A4-phosphate</span>",C535575,"<span class=""disease"">squamous cell carcinoma of the head and neck</span>","Phase Ib trial of radiotherapy in combination with <span class=""chemical"">combretastatin-A4-phosphate</span> in patients with non-small-cell lung cancer, prostate adenocarcinoma, and <span class=""disease"">squamous cell carcinoma of the head and neck</span>.",,21765046,21765046_C058728_C535575,21765046_0,bcv_sentence_task_befree_4033,,770959963,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,1,,C058728,"<span class=""chemical"">combretastatin-A4-phosphate</span>",D011471,"<span class=""disease"">prostate adenocarcinoma</span>","Phase Ib trial of radiotherapy in combination with <span class=""chemical"">combretastatin-A4-phosphate</span> in patients with non-small-cell lung cancer, <span class=""disease"">prostate adenocarcinoma</span>, and squamous cell carcinoma of the head and neck.",,21765046,21765046_C058728_D011471,21765046_0,bcv_sentence_task_befree_4034,,770959964,FALSE,finalized,5,8/15/15 0:45,"



",no_relation,1,,C058728,"<span class=""chemical"">combretastatin-A4-phosphate</span>",D002289,"<span class=""disease"">non-small-cell lung cancer</span>","Phase Ib trial of radiotherapy in combination with <span class=""chemical"">combretastatin-A4-phosphate</span> in patients with <span class=""disease"">non-small-cell lung cancer</span>, prostate adenocarcinoma, and squamous cell carcinoma of the head and neck.",,21765046,21765046_C058728_D002289,21765046_0,bcv_sentence_task_befree_4035,,770959965,FALSE,finalized,5,8/14/15 23:00,"



",yes_direct,1,,C058728,"<span class=""chemical"">CA4P</span>",D015840,"<span class=""disease"">oculomotor nerve palsy</span>","Dose-limiting toxic effects (DLTs) of reversible ataxia and <span class=""disease"">oculomotor nerve palsy</span> occurred in two patients with prostate cancer receiving weekly <span class=""chemical"">CA4P</span> at 63 mg/m2.",,21765046,21765046_C058728_D015840,21765046_7,bcv_sentence_task_befree_4036,,770959966,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,1,,C058728,"<span class=""chemical"">CA4P</span>",D011471,"<span class=""disease"">prostate cancer</span>","Dose-limiting toxic effects (DLTs) of reversible ataxia and oculomotor nerve palsy occurred in two patients with <span class=""disease"">prostate cancer</span> receiving weekly <span class=""chemical"">CA4P</span> at 63 mg/m2.",,21765046,21765046_C058728_D011471,21765046_7,bcv_sentence_task_befree_4037,,770959967,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,1,,C058728,"<span class=""chemical"">CA4P</span>",D001259,"<span class=""disease"">ataxia</span>","Dose-limiting toxic effects (DLTs) of reversible <span class=""disease"">ataxia</span> and oculomotor nerve palsy occurred in two patients with prostate cancer receiving weekly <span class=""chemical"">CA4P</span> at 63 mg/m2.",,21765046,21765046_C058728_D001259,21765046_7,bcv_sentence_task_befree_4038,,770959968,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,1,,D011718,"<span class=""chemical"">Pyrazinamide</span>",D014376,"<span class=""disease"">tuberculosis</span>","<span class=""chemical"">Pyrazinamide</span> susceptibility testing in Mycobacterium <span class=""disease"">tuberculosis</span>: a systematic review with meta-analyses.",,21768515,21768515_D011718_D014376,21768515_0,bcv_sentence_task_befree_4039,,770959969,FALSE,finalized,5,8/14/15 21:40,"



",no_relation,0.7875,,D011718,"<span class=""chemical"">pyrazinamide</span>",D014376,"<span class=""disease"">tuberculosis</span>","Standard culture-based testing of the susceptibility of Mycobacterium <span class=""disease"">tuberculosis</span> to <span class=""chemical"">pyrazinamide</span> is difficult to perform.",,21768515,21768515_D011718_D014376,21768515_1,bcv_sentence_task_befree_4040,,770959970,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,1,,D011718,"<span class=""chemical"">pyrazinamide</span>",D014376,"<span class=""disease"">tuberculosis</span>","The median prevalence (range) of <span class=""chemical"">pyrazinamide</span> resistance was 51% (31% to 89%) in multidrug-resistant M. <span class=""disease"">tuberculosis</span> isolates and 5% (0% to 9%) in non-multidrug-resistant isolates.",,21768515,21768515_D011718_D014376,21768515_7,bcv_sentence_task_befree_4041,,770959971,FALSE,finalized,5,8/14/15 22:59,"



",no_relation,1,,D011718,"<span class=""chemical"">pyrazinamide</span>",D014376,"<span class=""disease"">tuberculosis</span>","Considering the prevalence of <span class=""chemical"">pyrazinamide</span> resistance in different clinical settings, PCR-DNA sequencing, and possibly other molecular assays targeting pncA, can detect <span class=""chemical"">pyrazinamide</span> resistance in multidrug-resistant M. <span class=""disease"">tuberculosis</span> isolates, with predictive values largely exceeding 90%, and rule out <span class=""chemical"">pyrazinamide</span> resistance in non-multidrug-resistant isolates, with predictive values exceeding 99%.",,21768515,21768515_D011718_D014376,21768515_10,bcv_sentence_task_befree_4042,,770959972,FALSE,finalized,5,8/15/15 2:14,"



",no_relation,0.802,,C516667,"<span class=""chemical"">pazopanib</span>",D018250,"<span class=""disease"">aggressive pediatric solid tumor</span>","Metronomic oral topotecan with <span class=""chemical"">pazopanib</span> is an active antiangiogenic regimen in mouse models of <span class=""disease"">aggressive pediatric solid tumor</span>.",,21788355,21788355_C516667_D018250,21788355_0,bcv_sentence_task_befree_4043,,770959973,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,C516667,"<span class=""chemical"">pazopanib</span>",D009369,"<span class=""disease"">tumor</span>","We have tested the efficacies of daily oral LDM topotecan alone and in combination with <span class=""chemical"">pazopanib</span>, a VEGF receptor inhibitor, in three pediatric extracranial solid <span class=""disease"">tumor</span> mouse models.",,21788355,21788355_C516667_D009369,21788355_2,bcv_sentence_task_befree_4044,,770959974,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,0.8026,,C516667,"<span class=""chemical"">pazopanib</span>",D009447,"<span class=""disease"">neuroblastoma</span>","In vitro dose-response study of topotecan and <span class=""chemical"">pazopanib</span> was conducted on several <span class=""disease"">neuroblastoma</span>, osteosarcoma, and rhabdomyosarcoma cell lines.",,21788355,21788355_C516667_D009447,21788355_3,bcv_sentence_task_befree_4045,,770959975,FALSE,finalized,5,8/14/15 21:48,"



",no_relation,0.8226,,C516667,"<span class=""chemical"">pazopanib</span>",D012208,"<span class=""disease"">rhabdomyosarcoma</span>","In vitro dose-response study of topotecan and <span class=""chemical"">pazopanib</span> was conducted on several neuroblastoma, osteosarcoma, and <span class=""disease"">rhabdomyosarcoma</span> cell lines.",,21788355,21788355_C516667_D012208,21788355_3,bcv_sentence_task_befree_4046,,770959976,FALSE,finalized,5,8/15/15 1:57,"



",no_relation,0.8114,,C516667,"<span class=""chemical"">pazopanib</span>",D012516,"<span class=""disease"">osteosarcoma</span>","In vitro dose-response study of topotecan and <span class=""chemical"">pazopanib</span> was conducted on several neuroblastoma, <span class=""disease"">osteosarcoma</span>, and rhabdomyosarcoma cell lines.",,21788355,21788355_C516667_D012516,21788355_3,bcv_sentence_task_befree_4047,,770959977,FALSE,finalized,5,8/15/15 0:09,"


Used as treatment.
",no_relation,1,,C516667,"<span class=""chemical"">pazopanib</span>",D009447,"<span class=""disease"">neuroblastoma</span>","In vivo antitumor efficacies of the LDM topotecan and <span class=""chemical"">pazopanib</span> as single agents and in combination were tested on 4 subcutaneous xenograft models and on 2 <span class=""disease"">neuroblastoma</span> metastatic models.",,21788355,21788355_C516667_D009447,21788355_4,bcv_sentence_task_befree_4048,,770959978,FALSE,finalized,5,8/14/15 21:58,"



",no_relation,0.8242,,D016559,"<span class=""chemical"">TAC</span>",D006086,"<span class=""disease"">graft-versus-host disease/GVHD</span>","An 18-year-old Japanese man weighing 53 kg with an anaplastic large cell lymphoma received continuous IV administration of <span class=""chemical"">TAC</span> as post-transplantation prophylaxis against <span class=""disease"">graft-versus-host disease</span> (<span class=""disease"">GVHD</span>) after an allogeneic bone marrow transplantation (BMT).",,21802143,21802143_D016559_D006086,21802143_4,bcv_sentence_task_befree_4049,,770959979,FALSE,finalized,5,8/14/15 22:02,"



",no_relation,1,,D016559,"<span class=""chemical"">TAC</span>",D017728,"<span class=""disease"">anaplastic large cell lymphoma</span>","An 18-year-old Japanese man weighing 53 kg with an <span class=""disease"">anaplastic large cell lymphoma</span> received continuous IV administration of <span class=""chemical"">TAC</span> as post-transplantation prophylaxis against graft-versus-host disease (GVHD) after an allogeneic bone marrow transplantation (BMT).",,21802143,21802143_D016559_D017728,21802143_4,bcv_sentence_task_befree_4050,,770959980,FALSE,finalized,5,8/15/15 2:12,"



",yes_direct,0.5962,,C058687,"<span class=""chemical"">LAN</span>",D006086,"<span class=""disease"">GVHD</span>","The <span class=""chemical"">LAN</span> dose was reduced to 15 mg/d PO on day 26, and the blood TAC concentration subsequently decreased to 6.6 ng/mL, with <span class=""disease"">GVHD</span>-related symptoms emerging on day 28.",,21802143,21802143_C058687_D006086,21802143_8,bcv_sentence_task_befree_4051,,770959981,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,0.6004,,D015777,"<span class=""chemical"">eicosanoids</span>",D007249,"<span class=""disease"">inflammation</span>","The aim of the study was to determine the quantity of produced mediators of <span class=""disease"">inflammation</span> (cytokines and <span class=""chemical"">eicosanoids</span>), during carotid endarterectomy (CEA), which are factors of ischemic damage of the brain.",,21804481,21804481_D015777_D007249,21804481_1,bcv_sentence_task_befree_4052,,770959982,FALSE,finalized,5,8/15/15 2:10,"



",yes_direct,0.4237,,D015777,"<span class=""chemical"">eicosanoids</span>",D007511,"<span class=""disease"">ischemic damage</span>","The aim of the study was to determine the quantity of produced mediators of inflammation (cytokines and <span class=""chemical"">eicosanoids</span>), during carotid endarterectomy (CEA), which are factors of <span class=""disease"">ischemic damage</span> of the brain.",,21804481,21804481_D015777_D007511,21804481_1,bcv_sentence_task_befree_4053,,770959983,FALSE,finalized,5,8/15/15 2:01,"



",no_relation,1,,D013929,"<span class=""chemical"">Thromboxane B2/TXB2</span>",D009336,"<span class=""disease"">tumor necrosis factor-a/TNFa</span>","Plasma concentrations of Interleukin-1b (IL-1b), <span class=""chemical"">Thromboxane B2</span> (<span class=""chemical"">TXB2</span>), Prostaglandin E2 (PGE2) and <span class=""disease"">tumor necrosis factor-a</span> (<span class=""disease"">TNFa</span>) were measured by enzyme-linked immunosorbent assay (ELISA) technique.",,21804481,21804481_D013929_D009336,21804481_4,bcv_sentence_task_befree_4054,,770959984,FALSE,finalized,5,8/14/15 21:28,"



",no_relation,1,,D015232,"<span class=""chemical"">PGE2/Prostaglandin E2</span>",D009336,"<span class=""disease"">tumor necrosis factor-a/TNFa</span>","Plasma concentrations of Interleukin-1b (IL-1b), Thromboxane B2 (TXB2), <span class=""chemical"">Prostaglandin E2</span> (<span class=""chemical"">PGE2</span>) and <span class=""disease"">tumor necrosis factor-a</span> (<span class=""disease"">TNFa</span>) were measured by enzyme-linked immunosorbent assay (ELISA) technique.",,21804481,21804481_D015232_D009336,21804481_4,bcv_sentence_task_befree_4055,,770959985,FALSE,finalized,5,8/15/15 2:07,"



",no_relation,0.8248,,D013929,"<span class=""chemical"">TXB2</span>",D009336,"<span class=""disease"">TNFa</span>","The concentration of IL-1b and <span class=""disease"">TNFa</span> remained almost stable in group B, whereas the concentration of <span class=""chemical"">TXB2</span> reduced but not significantly (P>0.05).",,21804481,21804481_D013929_D009336,21804481_7,bcv_sentence_task_befree_4056,,770959986,FALSE,finalized,5,8/14/15 21:40,"



",no_relation,1,,D012701,"<span class=""chemical"">serotonin</span>",D006470,"<span class=""disease"">oral bleeding complications</span>","Selective <span class=""chemical"">serotonin</span> reuptake inhibitors and <span class=""disease"">oral bleeding complications</span> after invasive dental treatment.",,21821439,21821439_D012701_D006470,21821439_0,bcv_sentence_task_befree_4057,,770959987,FALSE,finalized,5,8/14/15 21:46,"



",no_relation,0.62,,D012701,"<span class=""chemical"">serotonin</span>",D006470,"<span class=""disease"">oral bleeding complications</span>","The purpose of this study was to examine the frequency of <span class=""disease"">oral bleeding complications</span> after invasive dental procedures in patients taking selective <span class=""chemical"">serotonin</span> reuptake inhibitor (SSRI) medications.",,21821439,21821439_D012701_D006470,21821439_1,bcv_sentence_task_befree_4058,,770959988,FALSE,finalized,5,8/15/15 1:28,"



",no_relation,0.8086,,D000583,"<span class=""chemical"">Amikacin</span>",D014947,"<span class=""disease"">increased in burn injury</span>","<span class=""chemical"">Amikacin</span> clearance can be <span class=""disease"">increased in burn injury</span>, which is often complicated by renal insufficiency.",,21825289,21825289_D000583_D014947,21825289_1,bcv_sentence_task_befree_4059,,770959989,FALSE,finalized,5,8/14/15 21:58,"



",no_relation,0.6149,,D000583,"<span class=""chemical"">Amikacin</span>",D051437,"<span class=""disease"">renal insufficiency</span>","<span class=""chemical"">Amikacin</span> clearance can be increased in burn injury, which is often complicated by <span class=""disease"">renal insufficiency</span>.",,21825289,21825289_D000583_D051437,21825289_1,bcv_sentence_task_befree_4060,,770959990,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,0.7986,,D020123,"<span class=""chemical"">rapamycin</span>",D002292,"<span class=""disease"">RCC</span>","Inhibitors of the mammalian target of <span class=""chemical"">rapamycin</span> (mTOR) have entered the landscape of treatment for advanced <span class=""disease"">RCC</span>.",,21827395,21827395_D020123_D002292,21827395_1,bcv_sentence_task_befree_4061,,770959991,FALSE,finalized,5,8/14/15 22:13,"



",no_relation,1,,C401859,"<span class=""chemical"">Temsirolimus</span>",D009369,"<span class=""disease"">tumor</span>","Although <span class=""chemical"">Temsirolimus</span> is capable of improving overall survival it does so only in a minority of selected mRCC patients and its effects on <span class=""disease"">tumor</span> burden reduction and PFS are minimal.",,21827395,21827395_C401859_D009369,21827395_4,bcv_sentence_task_befree_4062,,770959992,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,1,,C107135,"<span class=""chemical"">Everolimus</span>",D009369,"<span class=""disease"">cancer</span>","First, because it is unknown if mTOR becomes the major driver or <span class=""disease"">cancer</span> growth after developing progressive disease on a VEGF inhibitor and secondly because existing sequential VEGF data in same setting appears to be the same if not a bit more robust to that reported with <span class=""chemical"">Everolimus</span>.",,21827395,21827395_C107135_D009369,21827395_6,bcv_sentence_task_befree_4063,,770959993,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,1,,D003078,"<span class=""chemical"">colchicine</span>",D010490,"<span class=""disease"">pericardial effusion</span>","Recurrent <span class=""disease"">pericardial effusion</span> after cardiac surgery: the use of <span class=""chemical"">colchicine</span> after recalcitrant conventional therapy.",,21831274,21831274_D003078_D010490,21831274_0,bcv_sentence_task_befree_4064,,770959994,FALSE,finalized,5,8/14/15 23:38,"



",no_relation,1,,D003078,"<span class=""chemical"">colchicine</span>",D010490,"<span class=""disease"">pericardial effusion</span>","Recent literature shows that <span class=""chemical"">colchicine</span> therapy should be useful in the treatment of recurrent post surgical <span class=""disease"">pericardial effusion</span>.",,21831274,21831274_D003078_D010490,21831274_3,bcv_sentence_task_befree_4065,,770959995,FALSE,finalized,5,8/14/15 22:00,"



",no_relation,0.6032,,D001241,"<span class=""chemical"">Aspirin</span>",D003643,"<span class=""disease"">death</span>","<span class=""chemical"">Aspirin</span> treatment failure and the risk of recurrent stroke and <span class=""disease"">death</span> among patients with ischemic stroke.",,21835634,21835634_D001241_D003643,21835634_0,bcv_sentence_task_befree_4066,,770959996,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,D001241,"<span class=""chemical"">Aspirin</span>",D002544,"<span class=""disease"">ischemic stroke</span>","<span class=""chemical"">Aspirin</span> treatment failure and the risk of recurrent stroke and death among patients with <span class=""disease"">ischemic stroke</span>.",,21835634,21835634_D001241_D002544,21835634_0,bcv_sentence_task_befree_4067,,770959997,FALSE,finalized,5,8/14/15 22:55,"



",no_relation,0.6124,,D001241,"<span class=""chemical"">Aspirin</span>",D020521,"<span class=""disease"">stroke</span>","<span class=""chemical"">Aspirin</span> treatment failure and the risk of recurrent <span class=""disease"">stroke</span> and death among patients with ischemic stroke.",,21835634,21835634_D001241_D020521,21835634_0,bcv_sentence_task_befree_4068,,770959998,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D002544,"<span class=""disease"">ischemic stroke</span>","The prognostic value of occurrence of <span class=""disease"">ischemic stroke</span> in a patient despite <span class=""chemical"">aspirin</span> treatment (<span class=""chemical"">aspirin</span> treatment failure) is not known.",,21835634,21835634_D001241_D002544,21835634_1,bcv_sentence_task_befree_4069,,770959999,FALSE,finalized,5,8/15/15 0:22,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D003643,"<span class=""disease"">death</span>","Our objective was to determine if <span class=""chemical"">aspirin</span> treatment failure predicts recurrent ischemic stroke and/or <span class=""disease"">death</span>.",,21835634,21835634_D001241_D003643,21835634_2,bcv_sentence_task_befree_4070,,770960000,FALSE,finalized,5,8/15/15 2:33,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D002544,"<span class=""disease"">ischemic stroke</span>","Our objective was to determine if <span class=""chemical"">aspirin</span> treatment failure predicts recurrent <span class=""disease"">ischemic stroke</span> and/or death.",,21835634,21835634_D001241_D002544,21835634_2,bcv_sentence_task_befree_4071,,770960001,FALSE,finalized,5,8/14/15 23:08,"



",yes_direct,0.5902,,D001241,"<span class=""chemical"">aspirin</span>",D003643,"<span class=""disease"">death</span>","Multivariate analysis was used to calculate the odds ratio (OR) of recurrent stroke and recurrent stroke or <span class=""disease"">death</span> for <span class=""chemical"">aspirin</span> treatment failure patients for the duration of available follow-up (3 months for TOAST patients; 12 months for NINDS rt-PA trial patients).",,21835634,21835634_D001241_D003643,21835634_4,bcv_sentence_task_befree_4072,,770960002,FALSE,finalized,5,8/14/15 21:38,"



",yes_direct,0.7989,,D001241,"<span class=""chemical"">aspirin</span>",D020521,"<span class=""disease"">stroke</span>","Multivariate analysis was used to calculate the odds ratio (OR) of recurrent <span class=""disease"">stroke</span> and recurrent <span class=""disease"">stroke</span> or death for <span class=""chemical"">aspirin</span> treatment failure patients for the duration of available follow-up (3 months for TOAST patients; 12 months for NINDS rt-PA trial patients).",,21835634,21835634_D001241_D020521,21835634_4,bcv_sentence_task_befree_4073,,770960003,FALSE,finalized,5,8/14/15 22:03,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D003643,"<span class=""disease"">death</span>","The risk of stroke and <span class=""disease"">death</span> at 3 months and 1 year was not higher among patients classified as <span class=""chemical"">aspirin</span> treatment failures among the TOAST (OR 1.1; 95% confidence interval [CI] 0.8-1.6; P = .7) or NINDS rt-PA trial patients (OR 0.8; 95% CI 0.6-1.3; P = .4), respectively.",,21835634,21835634_D001241_D003643,21835634_6,bcv_sentence_task_befree_4074,,770960004,FALSE,finalized,5,8/15/15 2:26,"



",no_relation,0.8105,,D001241,"<span class=""chemical"">aspirin</span>",D020521,"<span class=""disease"">stroke</span>","The risk of <span class=""disease"">stroke</span> and death at 3 months and 1 year was not higher among patients classified as <span class=""chemical"">aspirin</span> treatment failures among the TOAST (OR 1.1; 95% confidence interval [CI] 0.8-1.6; P = .7) or NINDS rt-PA trial patients (OR 0.8; 95% CI 0.6-1.3; P = .4), respectively.",,21835634,21835634_D001241_D020521,21835634_6,bcv_sentence_task_befree_4075,,770960005,FALSE,finalized,5,8/14/15 23:16,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D003643,"<span class=""disease"">death</span>","In subgroup analysis, <span class=""chemical"">aspirin</span> treatment failure was not found to be associated with recurrent stroke or with the combined endpoint of stroke and <span class=""disease"">death</span> among categories defined by etiologic subtype, including those with large artery atherosclerosis.",,21835634,21835634_D001241_D003643,21835634_7,bcv_sentence_task_befree_4076,,770960006,FALSE,finalized,5,8/14/15 22:59,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D020521,"<span class=""disease"">stroke</span>","In subgroup analysis, <span class=""chemical"">aspirin</span> treatment failure was not found to be associated with recurrent <span class=""disease"">stroke</span> or with the combined endpoint of <span class=""disease"">stroke</span> and death among categories defined by etiologic subtype, including those with large artery atherosclerosis.",,21835634,21835634_D001241_D020521,21835634_7,bcv_sentence_task_befree_4077,,770960007,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D050197,"<span class=""disease"">atherosclerosis</span>","In subgroup analysis, <span class=""chemical"">aspirin</span> treatment failure was not found to be associated with recurrent stroke or with the combined endpoint of stroke and death among categories defined by etiologic subtype, including those with large artery <span class=""disease"">atherosclerosis</span>.",,21835634,21835634_D001241_D050197,21835634_7,bcv_sentence_task_befree_4078,,770960008,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D003643,"<span class=""disease"">death</span>","In a post-hoc analysis of 2 randomized ischemic stroke trials, <span class=""chemical"">aspirin</span> treatment failure was not found to be associated with an increased risk of recurrent stroke or <span class=""disease"">death</span>.",,21835634,21835634_D001241_D003643,21835634_8,bcv_sentence_task_befree_4079,,770960009,FALSE,finalized,5,8/14/15 22:28,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D002544,"<span class=""disease"">ischemic stroke</span>","In a post-hoc analysis of 2 randomized <span class=""disease"">ischemic stroke</span> trials, <span class=""chemical"">aspirin</span> treatment failure was not found to be associated with an increased risk of recurrent stroke or death.",,21835634,21835634_D001241_D002544,21835634_8,bcv_sentence_task_befree_4080,,770960010,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D020521,"<span class=""disease"">stroke</span>","In a post-hoc analysis of 2 randomized ischemic stroke trials, <span class=""chemical"">aspirin</span> treatment failure was not found to be associated with an increased risk of recurrent <span class=""disease"">stroke</span> or death.",,21835634,21835634_D001241_D020521,21835634_8,bcv_sentence_task_befree_4081,,770960011,FALSE,finalized,5,8/14/15 22:19,"



",no_relation,1,,D008691,"<span class=""chemical"">methadone</span>",D006526,"<span class=""disease"">hepatitis C</span>","Low risk for <span class=""disease"">hepatitis C</span> seroconversion in <span class=""chemical"">methadone</span> maintenance treatment.",,21844836,21844836_D008691_D006526,21844836_0,bcv_sentence_task_befree_4082,,770960012,FALSE,finalized,5,8/14/15 22:29,"



",no_relation,1,,D008691,"<span class=""chemical"">methadone</span>",D006526,"<span class=""disease"">hepatitis C virus (HCV) infection</span>","To study the risk factors for seroconversion to <span class=""disease"">hepatitis C virus (HCV) infection</span> since admission to <span class=""chemical"">methadone</span> maintenance treatment (MMT) and to characterize the seronegative admitted group.",,21844836,21844836_D008691_D006526,21844836_1,bcv_sentence_task_befree_4083,,770960013,FALSE,finalized,5,8/14/15 22:09,"



",no_relation,1,,D006632,"<span class=""chemical"">histamine</span>",D006967,"<span class=""disease"">allergic reaction</span>","This chemical intoxication, due to high <span class=""chemical"">histamine</span> concentration in fish, is often mistaken for an <span class=""disease"">allergic reaction</span>.",,21875451,21875451_D006632_D006967,21875451_2,bcv_sentence_task_befree_4084,,770960014,FALSE,finalized,5,8/14/15 21:39,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D003920,"<span class=""disease"">diabetes mellitus</span>","Chronic pretreatment of <span class=""chemical"">metformin</span> is associated with the reduction of the no-reflow phenomenon in patients with <span class=""disease"">diabetes mellitus</span> after primary angioplasty for acute myocardial infarction.",,21884027,21884027_D008687_D003920,21884027_0,bcv_sentence_task_befree_4085,,770960015,FALSE,finalized,5,8/15/15 0:57,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D009203,"<span class=""disease"">acute myocardial infarction</span>","Chronic pretreatment of <span class=""chemical"">metformin</span> is associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for <span class=""disease"">acute myocardial infarction</span>.",,21884027,21884027_D008687_D009203,21884027_0,bcv_sentence_task_befree_4086,,770960016,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D008687,"<span class=""chemical"">Metformin</span>",C537389,"<span class=""disease"">type</span>","<span class=""chemical"">Metformin</span> is one of the most commonly prescribed antihyperglycemic agents for the treatment of <span class=""disease"">type</span> 2 diabetes.",,21884027,21884027_D008687_C537389,21884027_1,bcv_sentence_task_befree_4087,,770960017,FALSE,finalized,5,8/14/15 21:34,"



",no_relation,1,,D008687,"<span class=""chemical"">Metformin</span>",D003929,"<span class=""disease"">diabetes</span>","<span class=""chemical"">Metformin</span> is one of the most commonly prescribed antihyperglycemic agents for the treatment of type 2 <span class=""disease"">diabetes</span>.",,21884027,21884027_D008687_D003929,21884027_1,bcv_sentence_task_befree_4088,,770960018,FALSE,finalized,5,8/15/15 2:19,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D003929,"<span class=""disease"">diabetic</span>","However, little is known about the effect of <span class=""chemical"">metformin</span> on no-reflow in <span class=""disease"">diabetic</span> patients.",,21884027,21884027_D008687_D003929,21884027_2,bcv_sentence_task_befree_4089,,770960019,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D003929,"<span class=""disease"">diabetic</span>","In this study, we investigated retrospectively whether chronic pretreatment with <span class=""chemical"">metformin</span> was associated with no-reflow in <span class=""disease"">diabetic</span> patients who underwent primary coronary intervention for acute myocardial infarction (AMI).",,21884027,21884027_D008687_D003929,21884027_3,bcv_sentence_task_befree_4090,,770960020,FALSE,finalized,5,8/14/15 21:43,"



",no_relation,0.8205,,D008687,"<span class=""chemical"">metformin</span>",D009203,"<span class=""disease"">AMI/acute myocardial infarction</span>","In this study, we investigated retrospectively whether chronic pretreatment with <span class=""chemical"">metformin</span> was associated with no-reflow in diabetic patients who underwent primary coronary intervention for <span class=""disease"">acute myocardial infarction</span> (<span class=""disease"">AMI</span>).",,21884027,21884027_D008687_D009203,21884027_3,bcv_sentence_task_befree_4091,,770960021,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,0.8068,,D008687,"<span class=""chemical"">metformin</span>",D009203,"<span class=""disease"">AMI</span>","Multivariable logistic regression analysis revealed that absence of <span class=""chemical"">metformin</span> pretreatment was a significant predictor of the no-reflow along with high-burden thrombus, ejection fraction on admission and anterior <span class=""disease"">AMI</span>.",,21884027,21884027_D008687_D009203,21884027_9,bcv_sentence_task_befree_4092,,770960022,FALSE,finalized,5,8/14/15 21:49,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D003920,"<span class=""disease"">diabetes mellitus</span>","These results suggested that chronic pretreatment with <span class=""chemical"">metformin</span> may be associated with the reduction of the no-reflow phenomenon in patients with <span class=""disease"">diabetes mellitus</span> after primary angioplasty for AMI.",,21884027,21884027_D008687_D003920,21884027_10,bcv_sentence_task_befree_4093,,770960023,FALSE,finalized,5,8/15/15 0:54,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D009203,"<span class=""disease"">AMI</span>","These results suggested that chronic pretreatment with <span class=""chemical"">metformin</span> may be associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for <span class=""disease"">AMI</span>.",,21884027,21884027_D008687_D009203,21884027_10,bcv_sentence_task_befree_4094,,770960024,FALSE,finalized,5,8/14/15 21:33,"



",no_relation,1,,D020123,"<span class=""chemical"">rapamycin</span>",D010195,"<span class=""disease"">pancreatic NET</span>","In this review, we consider the data supporting exploitation of different targets in <span class=""disease"">pancreatic NET</span>, including peptide receptors, receptor tyrosine kinases (involved in tumor angiogenesis and more directly supporting tumor growth), and intracellular targets, such as the mammalian target of <span class=""chemical"">rapamycin</span> (mTOR), which has a central role in regulating cell growth, metabolism, and apoptosis.",,21893937,21893937_D020123_D010195,21893937_4,bcv_sentence_task_befree_4095,,770960025,FALSE,finalized,5,8/14/15 21:35,"



",no_relation,0.8066,,D020123,"<span class=""chemical"">rapamycin</span>",D009369,"<span class=""disease"">tumor</span>","In this review, we consider the data supporting exploitation of different targets in pancreatic NET, including peptide receptors, receptor tyrosine kinases (involved in <span class=""disease"">tumor</span> angiogenesis and more directly supporting <span class=""disease"">tumor</span> growth), and intracellular targets, such as the mammalian target of <span class=""chemical"">rapamycin</span> (mTOR), which has a central role in regulating cell growth, metabolism, and apoptosis.",,21893937,21893937_D020123_D009369,21893937_4,bcv_sentence_task_befree_4096,,770960026,FALSE,finalized,5,8/15/15 2:07,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D010195,"<span class=""disease"">pancreatic NET</span>","In this review, we consider the data supporting exploitation of different targets in <span class=""disease"">pancreatic NET</span>, including peptide receptors, receptor <span class=""chemical"">tyrosine</span> kinases (involved in tumor angiogenesis and more directly supporting tumor growth), and intracellular targets, such as the mammalian target of rapamycin (mTOR), which has a central role in regulating cell growth, metabolism, and apoptosis.",,21893937,21893937_D014443_D010195,21893937_4,bcv_sentence_task_befree_4097,,770960027,FALSE,finalized,5,8/15/15 1:50,"



",no_relation,0.6057,,D014443,"<span class=""chemical"">tyrosine</span>",D009369,"<span class=""disease"">tumor</span>","In this review, we consider the data supporting exploitation of different targets in pancreatic NET, including peptide receptors, receptor <span class=""chemical"">tyrosine</span> kinases (involved in <span class=""disease"">tumor</span> angiogenesis and more directly supporting <span class=""disease"">tumor</span> growth), and intracellular targets, such as the mammalian target of rapamycin (mTOR), which has a central role in regulating cell growth, metabolism, and apoptosis.",,21893937,21893937_D014443_D009369,21893937_4,bcv_sentence_task_befree_4098,,770960028,FALSE,finalized,5,8/14/15 22:18,"



",no_relation,1,,D009638,"<span class=""chemical"">norepinephrine</span>",D001289,"<span class=""disease"">attention deficit-hyperactive disorder/ADHD</span>","Methylphenidate (MPH)-Ritalin(R) , a compound that blocks reuptake of synaptically released <span class=""chemical"">norepinephrine</span> (NE) and dopamine (DA) in the brain, has been used for more than 30 years in low dose, long-term regimens to treat <span class=""disease"">attention deficit-hyperactive disorder</span> (<span class=""disease"">ADHD</span>) in juveniles, adolescents, and adults.",,21901844,21901844_D009638_D001289,21901844_2,bcv_sentence_task_befree_4099,,770960029,FALSE,finalized,5,8/15/15 1:09,"



",no_relation,1,,D008774,"<span class=""chemical"">Methylphenidate/MPH</span>",D001289,"<span class=""disease"">attention deficit-hyperactive disorder/ADHD</span>","<span class=""chemical"">Methylphenidate</span> (<span class=""chemical"">MPH</span>)-Ritalin(R) , a compound that blocks reuptake of synaptically released norepinephrine (NE) and dopamine (DA) in the brain, has been used for more than 30 years in low dose, long-term regimens to treat <span class=""disease"">attention deficit-hyperactive disorder</span> (<span class=""disease"">ADHD</span>) in juveniles, adolescents, and adults.",,21901844,21901844_D008774_D001289,21901844_2,bcv_sentence_task_befree_4100,,770960030,FALSE,finalized,5,8/14/15 22:57,"



",no_relation,1,,D004298,"<span class=""chemical"">dopamine</span>",D001289,"<span class=""disease"">attention deficit-hyperactive disorder/ADHD</span>","Methylphenidate (MPH)-Ritalin(R) , a compound that blocks reuptake of synaptically released norepinephrine (NE) and <span class=""chemical"">dopamine</span> (DA) in the brain, has been used for more than 30 years in low dose, long-term regimens to treat <span class=""disease"">attention deficit-hyperactive disorder</span> (<span class=""disease"">ADHD</span>) in juveniles, adolescents, and adults.",,21901844,21901844_D004298_D001289,21901844_2,bcv_sentence_task_befree_4101,,770960031,FALSE,finalized,5,8/14/15 22:37,"



",no_relation,1,,D008774,"<span class=""chemical"">MPH</span>",D001289,"<span class=""disease"">ADHD</span>","Although there is agreement regarding the primary biochemical action of <span class=""chemical"">MPH</span>, the physiological basis for its efficacy in normal individuals and <span class=""disease"">ADHD</span> patients is lacking.",,21901844,21901844_D008774_D001289,21901844_4,bcv_sentence_task_befree_4102,,770960032,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,1,,D008774,"<span class=""chemical"">MPH</span>",D001289,"<span class=""disease"">ADHD</span>","Study of the behavioral and physiological actions of clinically and behaviorally relevant doses of <span class=""chemical"">MPH</span> in normal animals provides an opportunity to explore the role of catecholamine transmitters in prefrontal cortical function and attentional processes as they relate to normal operation of brain circuits and <span class=""disease"">ADHD</span> pathology.",,21901844,21901844_D008774_D001289,21901844_5,bcv_sentence_task_befree_4103,,770960033,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,0.6026,,D002395,"<span class=""chemical"">catecholamine</span>",D001289,"<span class=""disease"">ADHD</span>","Study of the behavioral and physiological actions of clinically and behaviorally relevant doses of MPH in normal animals provides an opportunity to explore the role of <span class=""chemical"">catecholamine</span> transmitters in prefrontal cortical function and attentional processes as they relate to normal operation of brain circuits and <span class=""disease"">ADHD</span> pathology.",,21901844,21901844_D002395_D001289,21901844_5,bcv_sentence_task_befree_4104,,770960034,FALSE,finalized,5,8/15/15 0:41,"



",no_relation,1,,D020123,"<span class=""chemical"">sirolimus</span>",D006526,"<span class=""disease"">hepatitis C</span>","Limiting <span class=""disease"">hepatitis C</span> virus progression in liver transplant recipients using <span class=""chemical"">sirolimus</span>-based immunosuppression.",,21967703,21967703_D020123_D006526,21967703_0,bcv_sentence_task_befree_4105,,770960035,FALSE,finalized,5,8/14/15 23:13,"


'Hepatitis C virus' is not so much a disease as it is a virus, but also sirolimus is used as treatment, so regardless l choose the third answer
",no_relation,1,,D020123,"<span class=""chemical"">sirolimus</span>",D006526,"<span class=""disease"">HCV</span>","We reviewed 1274 liver recipients from 2002 to 2010 and identified a cohort of <span class=""disease"">HCV</span> recipients exposed to <span class=""chemical"">sirolimus</span> as primary immunosuppression (SRL Cohort) and an <span class=""disease"">HCV</span> Control Group of recipients who had never received <span class=""chemical"">sirolimus</span>.",,21967703,21967703_D020123_D006526,21967703_3,bcv_sentence_task_befree_4106,,770960036,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,1,,D020123,"<span class=""chemical"">SRL</span>",D005355,"<span class=""disease"">fibrosis</span>","In an intent-to-treat analysis, the <span class=""chemical"">SRL</span> Cohort had significantly less advanced <span class=""disease"">fibrosis</span> (stage 2) compared to the HCV Control Group at year one (15.3% vs. 36.2%, p < 0.0001) and year two (30.1% vs. 50.5%, p = 0.001).",,21967703,21967703_D020123_D005355,21967703_5,bcv_sentence_task_befree_4107,,770960037,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,0.8339,,D020123,"<span class=""chemical"">SRL</span>",D006526,"<span class=""disease"">HCV</span>","In an intent-to-treat analysis, the <span class=""chemical"">SRL</span> Cohort had significantly less advanced fibrosis (stage 2) compared to the <span class=""disease"">HCV</span> Control Group at year one (15.3% vs. 36.2%, p < 0.0001) and year two (30.1% vs. 50.5%, p = 0.001).",,21967703,21967703_D020123_D006526,21967703_5,bcv_sentence_task_befree_4108,,770960038,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,0.7971,,D020123,"<span class=""chemical"">sirolimus/SRL</span>",D005355,"<span class=""disease"">fibrosis</span>","Because <span class=""chemical"">sirolimus</span> is sometimes discontinued for side effects, the <span class=""chemical"">SRL</span> Cohort was subgroup stratified for <span class=""chemical"">sirolimus</span> duration, showing progressively less <span class=""disease"">fibrosis</span> with longer <span class=""chemical"">sirolimus</span> duration.",,21967703,21967703_D020123_D005355,21967703_6,bcv_sentence_task_befree_4109,,770960039,FALSE,finalized,5,8/15/15 0:29,"



",no_relation,0.8059,,D020123,"<span class=""chemical"">sirolimus</span>",D005355,"<span class=""disease"">fibrosis</span>","Multivariate analysis demonstrated <span class=""chemical"">sirolimus</span> as an independent predictor of minimal <span class=""disease"">fibrosis</span> at year one, and year two.",,21967703,21967703_D020123_D005355,21967703_7,bcv_sentence_task_befree_4110,,770960040,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D020123,"<span class=""chemical"">sirolimus</span>",D005355,"<span class=""disease"">fibrosis</span>","This is the first study among liver transplant recipients with recurrent HCV to describe the positive impact of <span class=""chemical"">sirolimus</span> in respect of reduced <span class=""disease"">fibrosis</span> extent and rate of progression.",,21967703,21967703_D020123_D005355,21967703_8,bcv_sentence_task_befree_4111,,770960041,FALSE,finalized,5,8/14/15 23:05,"



",no_relation,1,,D020123,"<span class=""chemical"">sirolimus</span>",D006526,"<span class=""disease"">HCV</span>","This is the first study among liver transplant recipients with recurrent <span class=""disease"">HCV</span> to describe the positive impact of <span class=""chemical"">sirolimus</span> in respect of reduced fibrosis extent and rate of progression.",,21967703,21967703_D020123_D006526,21967703_8,bcv_sentence_task_befree_4112,,770960042,FALSE,finalized,5,8/14/15 22:31,"



Probably used as tratment.",no_relation,1,,C031967,"<span class=""chemical"">Rasagiline</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","<span class=""chemical"">Rasagiline</span> in <span class=""disease"">Parkinson's disease</span>.",,21971007,21971007_C031967_D010300,21971007_0,bcv_sentence_task_befree_4113,,770960043,FALSE,finalized,5,8/15/15 2:11,"



",no_relation,1,,C031967,"<span class=""chemical"">Rasagiline</span>",D010300,"<span class=""disease"">PD</span>","<span class=""chemical"">Rasagiline</span> has been shown to be effective as monotherapy for early <span class=""disease"">PD</span> and as an adjunct to dopaminergic therapy.",,21971007,21971007_C031967_D010300,21971007_3,bcv_sentence_task_befree_4114,,770960044,FALSE,finalized,5,8/14/15 23:51,"



",no_relation,1,,C031967,"<span class=""chemical"">rasagiline</span>",D010300,"<span class=""disease"">PD</span>","Clinical trials have also shown putative disease-modifying effects, though <span class=""chemical"">rasagiline</span>'s potential to alter the long-term course of <span class=""disease"">PD</span> remains controversial.",,21971007,21971007_C031967_D010300,21971007_4,bcv_sentence_task_befree_4115,,770960045,FALSE,finalized,5,8/14/15 22:30,"



",no_relation,1,,C031967,"<span class=""chemical"">rasagiline</span>",D010300,"<span class=""disease"">PD</span>","Given the demonstrated benefits of <span class=""chemical"">rasagiline</span>, along with its safety and tolerability profile, it has an important role to play in <span class=""disease"">PD</span> therapy.",,21971007,21971007_C031967_D010300,21971007_5,bcv_sentence_task_befree_4116,,770960046,FALSE,finalized,5,8/14/15 23:37,"



",no_relation,1,,D003276,"<span class=""chemical"">oral contraceptives</span>",D013966,"<span class=""disease"">thyroid dysfunction</span>","Its precise etio-pathogenesis is evasive, genetic influences, exposure to sunlight, pregnancy, <span class=""chemical"">oral contraceptives</span>, estrogen-progesterone therapies, <span class=""disease"">thyroid dysfunction</span>, cosmetics, and drugs have been proposed.",,21981383,21981383_D003276_D013966,21981383_2,bcv_sentence_task_befree_4117,,770960047,FALSE,finalized,5,8/14/15 22:55,"



",no_relation,1,,C031927,"<span class=""chemical"">hydroquinone</span>",D008548,"<span class=""disease"">melasma</span>","The use of broad-spectrum sunscreen is important, lightening agents like retinoic acid (tretinoin), azelaic acid, and combination therapies containing <span class=""chemical"">hydroquinone</span>, tretinoin, and corticosteroids, have been used in the treatment of <span class=""disease"">melasma</span>, and are thought to have increased efficacy as compared with monotherapy.",,21981383,21981383_C031927_D008548,21981383_8,bcv_sentence_task_befree_4118,,770960048,FALSE,finalized,5,8/15/15 0:45,"



",no_relation,1,,D014212,"<span class=""chemical"">retinoic acid/tretinoin</span>",D008548,"<span class=""disease"">melasma</span>","The use of broad-spectrum sunscreen is important, lightening agents like <span class=""chemical"">retinoic acid</span> (<span class=""chemical"">tretinoin</span>), azelaic acid, and combination therapies containing hydroquinone, <span class=""chemical"">tretinoin</span>, and corticosteroids, have been used in the treatment of <span class=""disease"">melasma</span>, and are thought to have increased efficacy as compared with monotherapy.",,21981383,21981383_D014212_D008548,21981383_8,bcv_sentence_task_befree_4119,,770960049,FALSE,finalized,5,8/15/15 1:43,"



",no_relation,1,,C010038,"<span class=""chemical"">azelaic acid</span>",D008548,"<span class=""disease"">melasma</span>","The use of broad-spectrum sunscreen is important, lightening agents like retinoic acid (tretinoin), <span class=""chemical"">azelaic acid</span>, and combination therapies containing hydroquinone, tretinoin, and corticosteroids, have been used in the treatment of <span class=""disease"">melasma</span>, and are thought to have increased efficacy as compared with monotherapy.",,21981383,21981383_C010038_D008548,21981383_8,bcv_sentence_task_befree_4120,,770960050,FALSE,finalized,5,8/14/15 22:32,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D008548,"<span class=""disease"">melasma</span>","The use of broad-spectrum sunscreen is important, lightening agents like retinoic acid (tretinoin), azelaic acid, and combination therapies containing hydroquinone, tretinoin, and <span class=""chemical"">corticosteroids</span>, have been used in the treatment of <span class=""disease"">melasma</span>, and are thought to have increased efficacy as compared with monotherapy.",,21981383,21981383_D000305_D008548,21981383_8,bcv_sentence_task_befree_4121,,770960051,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D010126,"<span class=""chemical"">ozone</span>",D003920,"<span class=""disease"">T2DM/type 2 diabetes mellitus</span>","We examined whether short-term exposures to air pollution (fine particles, <span class=""chemical"">ozone</span>) and heat resulted in perturbation of arterial blood pressure (BP) in persons with <span class=""disease"">type 2 diabetes mellitus</span> (<span class=""disease"">T2DM</span>).",,22020729,22020729_D010126_D003920,22020729_2,bcv_sentence_task_befree_4122,,770960052,FALSE,finalized,5,8/14/15 22:41,"



",no_relation,1,,D010126,"<span class=""chemical"">ozone</span>",D003920,"<span class=""disease"">T2DM</span>","In subjects with <span class=""disease"">T2DM</span>, PM was associated with increased BP, and <span class=""chemical"">ozone</span> was associated with decreased BP.",,22020729,22020729_D010126_D003920,22020729_9,bcv_sentence_task_befree_4123,,770960053,FALSE,finalized,5,8/15/15 0:23,"



",yes_direct,0.6094,,D001920,"<span class=""chemical"">Bradykinin</span>",D014412,"<span class=""disease"">Sindbis virus infection</span>","<span class=""chemical"">Bradykinin</span> enhances <span class=""disease"">Sindbis virus infection</span> in human brain microvascular endothelial cells.",,22047990,22047990_D001920_D014412,22047990_0,bcv_sentence_task_befree_4124,,770960054,FALSE,finalized,5,8/14/15 22:42,"



",yes_direct,0.819,,D001920,"<span class=""chemical"">bradykinin</span>",D004487,"<span class=""disease"">inflammatory edema</span>","We investigated whether endothelial cells infected by SINV are differentially responsive to <span class=""chemical"">bradykinin</span> (BK), a potent inducer of <span class=""disease"">inflammatory edema</span> in a broad range of infectious diseases.",,22047990,22047990_D001920_D004487,22047990_3,bcv_sentence_task_befree_4125,,770960055,FALSE,finalized,5,8/15/15 0:15,"



",yes_direct,0.5811,,D001920,"<span class=""chemical"">bradykinin</span>",D003141,"<span class=""disease"">infectious diseases</span>","We investigated whether endothelial cells infected by SINV are differentially responsive to <span class=""chemical"">bradykinin</span> (BK), a potent inducer of inflammatory edema in a broad range of <span class=""disease"">infectious diseases</span>.",,22047990,22047990_D001920_D003141,22047990_3,bcv_sentence_task_befree_4126,,770960056,FALSE,finalized,5,8/15/15 1:58,"



",no_relation,1,,D004087,"<span class=""chemical"">dihydroergotamine</span>",D006261,"<span class=""disease"">headaches</span>","Intravenous <span class=""chemical"">dihydroergotamine</span> for inpatient management of refractory primary <span class=""disease"">headaches</span>.",,22049203,22049203_D004087_D006261,22049203_0,bcv_sentence_task_befree_4127,,770960057,FALSE,finalized,5,8/14/15 22:44,"



",yes_direct,0.6039,,D004087,"<span class=""chemical"">dihydroergotamine</span>",D051270,"<span class=""disease"">primary headache disorders</span>","To determine dosing and side effects of <span class=""chemical"">dihydroergotamine</span> as they affect outcomes in <span class=""disease"">primary headache disorders</span>.",,22049203,22049203_D004087_D051270,22049203_1,bcv_sentence_task_befree_4128,,770960058,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,D004087,"<span class=""chemical"">dihydroergotamine</span>",D006261,"<span class=""disease"">headache</span>","We audited our use of <span class=""chemical"">dihydroergotamine</span> for inpatient management of disabling primary <span class=""disease"">headache</span>, focusing on the commonly treated problems.",,22049203,22049203_D004087_D006261,22049203_2,bcv_sentence_task_befree_4129,,770960059,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,0.7941,,D004087,"<span class=""chemical"">dihydroergotamine</span>",D006261,"<span class=""disease"">headache</span>","The data suggest that IV <span class=""chemical"">dihydroergotamine</span> given over 5 days produces improvement in <span class=""disease"">headache</span> and disability in patients with migraine more than shorter courses.",,22049203,22049203_D004087_D006261,22049203_5,bcv_sentence_task_befree_4130,,770960060,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D004087,"<span class=""chemical"">dihydroergotamine</span>",D008881,"<span class=""disease"">migraine</span>","The data suggest that IV <span class=""chemical"">dihydroergotamine</span> given over 5 days produces improvement in headache and disability in patients with <span class=""disease"">migraine</span> more than shorter courses.",,22049203,22049203_D004087_D008881,22049203_5,bcv_sentence_task_befree_4131,,770960061,FALSE,finalized,5,8/15/15 0:35,"



",no_relation,1,,D004087,"<span class=""chemical"">dihydroergotamine</span>",D010146,"<span class=""disease"">pain</span>","Giving more <span class=""chemical"">dihydroergotamine</span> predicts a greater <span class=""disease"">pain</span>-free rate.",,22049203,22049203_D004087_D010146,22049203_7,bcv_sentence_task_befree_4132,,770960062,FALSE,finalized,5,8/14/15 22:51,"



",no_relation,0.6097,,D004087,"<span class=""chemical"">dihydroergotamine</span>",D003027,"<span class=""disease"">cluster headache</span>","Patients with <span class=""disease"">cluster headache</span> benefit from IV <span class=""chemical"">dihydroergotamine</span>.",,22049203,22049203_D004087_D003027,22049203_8,bcv_sentence_task_befree_4133,,770960063,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,1,,D019319,"<span class=""chemical"">okadaic acid</span>",D009369,"<span class=""disease"">breast cancer</span>","Here we treated human <span class=""disease"">breast cancer</span> cells with the structurally distinct toxins calyculin A, <span class=""chemical"">okadaic acid</span>, and cantharidin, which are known to inhibit Ser/Thr phosphatases of the PPP family.",,22069692,22069692_D019319_D009369,22069692_4,bcv_sentence_task_befree_4134,,770960064,FALSE,finalized,5,8/14/15 23:01,"



",no_relation,1,,D002193,"<span class=""chemical"">cantharidin</span>",D009369,"<span class=""disease"">breast cancer</span>","Here we treated human <span class=""disease"">breast cancer</span> cells with the structurally distinct toxins calyculin A, okadaic acid, and <span class=""chemical"">cantharidin</span>, which are known to inhibit Ser/Thr phosphatases of the PPP family.",,22069692,22069692_D002193_D009369,22069692_4,bcv_sentence_task_befree_4135,,770960065,FALSE,finalized,5,8/15/15 1:17,"



",no_relation,0.7875,,C059041,"<span class=""chemical"">Calyculin A</span>",D009369,"<span class=""disease"">breast cancer</span>","A reverse phase phosphoprotein array analysis revealed increased phosphorylation of only 6 out of 33 Ser/Thr phosphosites, indicating selective inhibition of phosphatases by calyculin A. <span class=""chemical"">Calyculin A</span> treatment induced cell cycle arrest in MDA-MB-468 and MCF-7 <span class=""disease"">breast cancer</span> cells.",,22069692,22069692_C059041_D009369,22069692_8,bcv_sentence_task_befree_4136,,770960066,FALSE,finalized,5,8/15/15 1:58,"



",no_relation,0.8067,,D005472,"<span class=""chemical"">5-fluorouracil</span>",D009369,"<span class=""disease"">cancer</span>","We evaluated whether an experimental systems biology strategy which analyses the susceptibility of <span class=""disease"">cancer</span> cells to undergo caspase activation can be exploited to predict patient responses to <span class=""chemical"">5-fluorouracil</span>-based chemotherapy and to case-specifically identify potential alternative targeted treatments to reactivate apoptosis.",,22082587,22082587_D005472_D009369,22082587_2,bcv_sentence_task_befree_4137,,770960067,FALSE,finalized,5,8/14/15 22:37,"



Used as treatment.",no_relation,0.7973,,D005472,"<span class=""chemical"">5-fluorouracil</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Systems-level analysis correctly predicted positive or negative outcome in 85% (p=0.004) of <span class=""disease"">colorectal cancer</span> patients receiving <span class=""chemical"">5-fluorouracil</span> based chemotherapy and significantly outperformed common uni- and multi-variate statistical approaches.",,22082587,22082587_D005472_D015179,22082587_6,bcv_sentence_task_befree_4138,,770960068,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D007511,"<span class=""disease"">ischemic</span>","Protection by remote <span class=""disease"">ischemic</span> preconditioning during coronary artery bypass graft surgery with isoflurane but not <span class=""chemical"">propofol</span> - a clinical trial.",,22103808,22103808_D015742_D007511,22103808_0,bcv_sentence_task_befree_4139,,770960069,FALSE,finalized,5,8/14/15 22:31,"



",no_relation,1,,D007530,"<span class=""chemical"">isoflurane</span>",D007511,"<span class=""disease"">ischemic</span>","Protection by remote <span class=""disease"">ischemic</span> preconditioning during coronary artery bypass graft surgery with <span class=""chemical"">isoflurane</span> but not propofol - a clinical trial.",,22103808,22103808_D007530_D007511,22103808_0,bcv_sentence_task_befree_4140,,770960070,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D007511,"<span class=""disease"">RIPC</span>","Specifically, we hypothesized that <span class=""disease"">RIPC</span> during isoflurane anesthesia attenuates myocardial injury in patients undergoing coronary artery bypass graft (CABG) surgery, and that effects may be different during <span class=""chemical"">propofol</span> anesthesia.",,22103808,22103808_D015742_D007511,22103808_3,bcv_sentence_task_befree_4141,,770960071,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,0.5867,,D007530,"<span class=""chemical"">isoflurane</span>",D009202,"<span class=""disease"">myocardial injury</span>","Specifically, we hypothesized that RIPC during <span class=""chemical"">isoflurane</span> anesthesia attenuates <span class=""disease"">myocardial injury</span> in patients undergoing coronary artery bypass graft (CABG) surgery, and that effects may be different during propofol anesthesia.",,22103808,22103808_D007530_D009202,22103808_3,bcv_sentence_task_befree_4142,,770960072,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D009202,"<span class=""disease"">myocardial injury</span>","Specifically, we hypothesized that RIPC during isoflurane anesthesia attenuates <span class=""disease"">myocardial injury</span> in patients undergoing coronary artery bypass graft (CABG) surgery, and that effects may be different during <span class=""chemical"">propofol</span> anesthesia.",,22103808,22103808_D015742_D009202,22103808_3,bcv_sentence_task_befree_4143,,770960073,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D007530,"<span class=""chemical"">isoflurane</span>",D007511,"<span class=""disease"">RIPC</span>","Specifically, we hypothesized that <span class=""disease"">RIPC</span> during <span class=""chemical"">isoflurane</span> anesthesia attenuates myocardial injury in patients undergoing coronary artery bypass graft (CABG) surgery, and that effects may be different during propofol anesthesia.",,22103808,22103808_D007530_D007511,22103808_3,bcv_sentence_task_befree_4144,,770960074,FALSE,finalized,5,8/15/15 2:32,"



",no_relation,1,,D007530,"<span class=""chemical"">isoflurane</span>",D003929,"<span class=""disease"">diabetic</span>","In a randomized, single-blinded, placebo-controlled prospective study, serum troponin I concentration (cTnI) (baseline, and 1, 6, 12, 24, 48, and 72 h postoperatively) were measured during <span class=""chemical"">isoflurane</span>/sufentanil or propofol/sufentanil anesthesia with or without RIPC (three 5-min periods of intermittent left upper arm ischemia with 5 min reperfusion each) in non-<span class=""disease"">diabetic</span> patients (n = 72) with three-vessel coronary artery disease (ClinicalTrials.gov NCT01406678).",,22103808,22103808_D007530_D003929,22103808_4,bcv_sentence_task_befree_4145,,770960075,FALSE,finalized,5,8/15/15 0:12,"



",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D007511,"<span class=""disease"">RIPC/ischemia</span>","In a randomized, single-blinded, placebo-controlled prospective study, serum troponin I concentration (cTnI) (baseline, and 1, 6, 12, 24, 48, and 72 h postoperatively) were measured during isoflurane/sufentanil or <span class=""chemical"">propofol</span>/sufentanil anesthesia with or without <span class=""disease"">RIPC</span> (three 5-min periods of intermittent left upper arm <span class=""disease"">ischemia</span> with 5 min reperfusion each) in non-diabetic patients (n = 72) with three-vessel coronary artery disease (ClinicalTrials.gov NCT01406678).",,22103808,22103808_D015742_D007511,22103808_4,bcv_sentence_task_befree_4146,,770960076,FALSE,finalized,5,8/15/15 2:30,"



",no_relation,1,,D017409,"<span class=""chemical"">sufentanil</span>",D003324,"<span class=""disease"">coronary artery disease</span>","In a randomized, single-blinded, placebo-controlled prospective study, serum troponin I concentration (cTnI) (baseline, and 1, 6, 12, 24, 48, and 72 h postoperatively) were measured during isoflurane/<span class=""chemical"">sufentanil</span> or propofol/<span class=""chemical"">sufentanil</span> anesthesia with or without RIPC (three 5-min periods of intermittent left upper arm ischemia with 5 min reperfusion each) in non-diabetic patients (n = 72) with three-vessel <span class=""disease"">coronary artery disease</span> (ClinicalTrials.gov NCT01406678).",,22103808,22103808_D017409_D003324,22103808_4,bcv_sentence_task_befree_4147,,770960077,FALSE,finalized,5,8/15/15 1:18,"



",no_relation,1,,D017409,"<span class=""chemical"">sufentanil</span>",D003929,"<span class=""disease"">diabetic</span>","In a randomized, single-blinded, placebo-controlled prospective study, serum troponin I concentration (cTnI) (baseline, and 1, 6, 12, 24, 48, and 72 h postoperatively) were measured during isoflurane/<span class=""chemical"">sufentanil</span> or propofol/<span class=""chemical"">sufentanil</span> anesthesia with or without RIPC (three 5-min periods of intermittent left upper arm ischemia with 5 min reperfusion each) in non-<span class=""disease"">diabetic</span> patients (n = 72) with three-vessel coronary artery disease (ClinicalTrials.gov NCT01406678).",,22103808,22103808_D017409_D003929,22103808_4,bcv_sentence_task_befree_4148,,770960078,FALSE,finalized,5,8/14/15 22:58,"

The disease is a pre-existing condition.

",no_relation,1,,D007530,"<span class=""chemical"">isoflurane</span>",D003324,"<span class=""disease"">coronary artery disease</span>","In a randomized, single-blinded, placebo-controlled prospective study, serum troponin I concentration (cTnI) (baseline, and 1, 6, 12, 24, 48, and 72 h postoperatively) were measured during <span class=""chemical"">isoflurane</span>/sufentanil or propofol/sufentanil anesthesia with or without RIPC (three 5-min periods of intermittent left upper arm ischemia with 5 min reperfusion each) in non-diabetic patients (n = 72) with three-vessel <span class=""disease"">coronary artery disease</span> (ClinicalTrials.gov NCT01406678).",,22103808,22103808_D007530_D003324,22103808_4,bcv_sentence_task_befree_4149,,770960079,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,D007530,"<span class=""chemical"">isoflurane</span>",D007511,"<span class=""disease"">RIPC/ischemia</span>","In a randomized, single-blinded, placebo-controlled prospective study, serum troponin I concentration (cTnI) (baseline, and 1, 6, 12, 24, 48, and 72 h postoperatively) were measured during <span class=""chemical"">isoflurane</span>/sufentanil or propofol/sufentanil anesthesia with or without <span class=""disease"">RIPC</span> (three 5-min periods of intermittent left upper arm <span class=""disease"">ischemia</span> with 5 min reperfusion each) in non-diabetic patients (n = 72) with three-vessel coronary artery disease (ClinicalTrials.gov NCT01406678).",,22103808,22103808_D007530_D007511,22103808_4,bcv_sentence_task_befree_4150,,770960080,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D003324,"<span class=""disease"">coronary artery disease</span>","In a randomized, single-blinded, placebo-controlled prospective study, serum troponin I concentration (cTnI) (baseline, and 1, 6, 12, 24, 48, and 72 h postoperatively) were measured during isoflurane/sufentanil or <span class=""chemical"">propofol</span>/sufentanil anesthesia with or without RIPC (three 5-min periods of intermittent left upper arm ischemia with 5 min reperfusion each) in non-diabetic patients (n = 72) with three-vessel <span class=""disease"">coronary artery disease</span> (ClinicalTrials.gov NCT01406678).",,22103808,22103808_D015742_D003324,22103808_4,bcv_sentence_task_befree_4151,,770960081,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,1,,D017409,"<span class=""chemical"">sufentanil</span>",D007511,"<span class=""disease"">RIPC/ischemia</span>","In a randomized, single-blinded, placebo-controlled prospective study, serum troponin I concentration (cTnI) (baseline, and 1, 6, 12, 24, 48, and 72 h postoperatively) were measured during isoflurane/<span class=""chemical"">sufentanil</span> or propofol/<span class=""chemical"">sufentanil</span> anesthesia with or without <span class=""disease"">RIPC</span> (three 5-min periods of intermittent left upper arm <span class=""disease"">ischemia</span> with 5 min reperfusion each) in non-diabetic patients (n = 72) with three-vessel coronary artery disease (ClinicalTrials.gov NCT01406678).",,22103808,22103808_D017409_D007511,22103808_4,bcv_sentence_task_befree_4152,,770960082,FALSE,finalized,5,8/15/15 1:24,"



",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D003929,"<span class=""disease"">diabetic</span>","In a randomized, single-blinded, placebo-controlled prospective study, serum troponin I concentration (cTnI) (baseline, and 1, 6, 12, 24, 48, and 72 h postoperatively) were measured during isoflurane/sufentanil or <span class=""chemical"">propofol</span>/sufentanil anesthesia with or without RIPC (three 5-min periods of intermittent left upper arm ischemia with 5 min reperfusion each) in non-<span class=""disease"">diabetic</span> patients (n = 72) with three-vessel coronary artery disease (ClinicalTrials.gov NCT01406678).",,22103808,22103808_D015742_D003929,22103808_4,bcv_sentence_task_befree_4153,,770960083,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,0.7865,,D007530,"<span class=""chemical"">isoflurane</span>",D007511,"<span class=""disease"">RIPC</span>","<span class=""disease"">RIPC</span> during <span class=""chemical"">isoflurane</span> anesthesia (n = 20) decreased the area under the cTnI time curve (cTnI AUC) (-50%, 190  105 ng/ml  72 h vs. 383  262 ng/ml  72 h, P = 0.004), and the peak (7.3  3.6 ng/ml vs. 11.8  5.5, P = 0.004) and serial (P < 0.041) postoperative cTnI when compared to <span class=""chemical"">isoflurane</span> alone (n = 19).",,22103808,22103808_D007530_D007511,22103808_5,bcv_sentence_task_befree_4154,,770960084,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,0.802,,D015742,"<span class=""chemical"">propofol</span>",D007511,"<span class=""disease"">RIPC</span>","In contrast, <span class=""disease"">RIPC</span> during <span class=""chemical"">propofol</span> anesthesia (n = 14) did not alter the cTnI AUC [263  157 ng/ml  72 h vs. 372  376 ng/ml  72 h (n = 19), P = 0.318] or peak postoperative cTnI (10.1  4.5 ng/ml vs. 12  8.2, P = 0.444).",,22103808,22103808_D015742_D007511,22103808_6,bcv_sentence_task_befree_4155,,770960085,FALSE,finalized,5,8/14/15 23:16,"



I am a fifth year medical student in Hungary, I really enjoyed working on these tasks and if you happen to have some work for me online, I'd be more than willing. My email: daloloparizs@gmail.com
Thanks in advance!",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D007511,"<span class=""disease"">RIPC</span>","Thus, <span class=""disease"">RIPC</span> during isoflurane but not during <span class=""chemical"">propofol</span> anesthesia decreased myocardial damage in patients undergoing CABG surgery.",,22103808,22103808_D015742_D007511,22103808_8,bcv_sentence_task_befree_4156,,770960086,FALSE,finalized,5,8/15/15 2:39,"



",no_relation,1,,D007530,"<span class=""chemical"">isoflurane</span>",D009202,"<span class=""disease"">myocardial damage</span>","Thus, RIPC during <span class=""chemical"">isoflurane</span> but not during propofol anesthesia decreased <span class=""disease"">myocardial damage</span> in patients undergoing CABG surgery.",,22103808,22103808_D007530_D009202,22103808_8,bcv_sentence_task_befree_4157,,770960087,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D009202,"<span class=""disease"">myocardial damage</span>","Thus, RIPC during isoflurane but not during <span class=""chemical"">propofol</span> anesthesia decreased <span class=""disease"">myocardial damage</span> in patients undergoing CABG surgery.",,22103808,22103808_D015742_D009202,22103808_8,bcv_sentence_task_befree_4158,,770960088,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,0.805,,D007530,"<span class=""chemical"">isoflurane</span>",D007511,"<span class=""disease"">RIPC</span>","Thus, <span class=""disease"">RIPC</span> during <span class=""chemical"">isoflurane</span> but not during propofol anesthesia decreased myocardial damage in patients undergoing CABG surgery.",,22103808,22103808_D007530_D007511,22103808_8,bcv_sentence_task_befree_4159,,770960089,FALSE,finalized,5,8/14/15 22:41,"



",no_relation,1,,D007530,"<span class=""chemical"">isoflurane</span>",D007511,"<span class=""disease"">RIPC/ischemia</span>","Accordingly, effects of <span class=""disease"">RIPC</span> evoked by upper limb <span class=""disease"">ischemia</span>/reperfusion depend on background anesthesia, with combined <span class=""disease"">RIPC</span>/<span class=""chemical"">isoflurane</span> exerting greater beneficial effects under conditions studied.",,22103808,22103808_D007530_D007511,22103808_9,bcv_sentence_task_befree_4160,,770960090,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,1,,D004492,"<span class=""chemical"">EDTA</span>",D051436,"<span class=""disease"">Renal Disease</span>","The aim was to evaluate the accuracy of Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in <span class=""disease"">Renal Disease</span> (MDRD) formulae as a substitute for the gold standard measure of glomerular filtration rate (GFR) using chromium 51 <span class=""chemical"">EDTA</span>.",,22104575,22104575_D004492_D051436,22104575_1,bcv_sentence_task_befree_4161,,770960091,FALSE,finalized,5,8/14/15 23:06,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D007018,"<span class=""disease"">hypopituitarism</span>","Effects of oral and transdermal estrogen on IGF1, IGFBP3, IGFBP1, serum lipids, and <span class=""chemical"">glucose</span> in patients with <span class=""disease"">hypopituitarism</span> during GH treatment: a randomized study.",,22108915,22108915_D005947_D007018,22108915_0,bcv_sentence_task_befree_4162,,770960092,FALSE,finalized,5,8/14/15 23:37,"



",no_relation,0.8026,,D004967,"<span class=""chemical"">estrogen</span>",D007018,"<span class=""disease"">hypopituitarism</span>","Effects of oral and transdermal <span class=""chemical"">estrogen</span> on IGF1, IGFBP3, IGFBP1, serum lipids, and glucose in patients with <span class=""disease"">hypopituitarism</span> during GH treatment: a randomized study.",,22108915,22108915_D004967_D007018,22108915_0,bcv_sentence_task_befree_4163,,770960093,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,D004958,"<span class=""chemical"">estradiol</span>",D007018,"<span class=""disease"">hypopituitarism</span>","To evaluate the effects of oral <span class=""chemical"">estradiol</span> and transdermal 17_-<span class=""chemical"">estradiol</span> on serum concentrations of IGF1 and its binding proteins in women with <span class=""disease"">hypopituitarism</span>.",,22108915,22108915_D004958_D007018,22108915_1,bcv_sentence_task_befree_4164,,770960094,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,D004958,"<span class=""chemical"">estradiol</span>",D007018,"<span class=""disease"">hypopituitarism</span>","Eleven patients with <span class=""disease"">hypopituitarism</span> were randomly allocated to receive 2_mg oral <span class=""chemical"">estradiol</span> (n=6) or 50__g/day of transdermal 17_-<span class=""chemical"">estradiol</span> (n=5) for 3 months.",,22108915,22108915_D004958_D007018,22108915_3,bcv_sentence_task_befree_4165,,770960095,FALSE,finalized,5,8/14/15 23:41,"



",no_relation,0.7987,,D004967,"<span class=""chemical"">estrogen</span>",D007018,"<span class=""disease"">hypopituitarism</span>","These findings in patients with <span class=""disease"">hypopituitarism</span> have an impact on their response to treatment with GH, since patients receiving oral <span class=""chemical"">estrogen</span> require increased GH dosage.",,22108915,22108915_D004967_D007018,22108915_10,bcv_sentence_task_befree_4166,,770960096,FALSE,finalized,5,8/14/15 23:55,"



",no_relation,1,,C104450,"<span class=""chemical"">25-hydroxyvitamin D</span>",D014808,"<span class=""disease"">vitamin D deficiency</span>","Several studies in pregnant women and early childhood suggest that <span class=""disease"">vitamin D deficiency</span> (serum <span class=""chemical"">25-hydroxyvitamin D</span> levels <50 nmol/l) is common in both population groups.",,22123632,22123632_C104450_D014808,22123632_1,bcv_sentence_task_befree_4167,,770960097,FALSE,finalized,5,8/14/15 23:32,"



",no_relation,0.7988,,D014807,"<span class=""chemical"">vitamin D</span>",D014808,"<span class=""disease"">vitamin D deficiency</span>","Several studies in pregnant women and early childhood suggest that <span class=""chemical""></span><span class=""disease"">vitamin D</span> deficiency (serum 25-hydroxyvitamin D levels <50 nmol/l) is common in both population groups.",,22123632,22123632_D014807_D014808,22123632_1,bcv_sentence_task_befree_4168,,770960098,FALSE,finalized,5,8/14/15 23:42,"


This one is ambiguous. Logically, lack of Vitamin D directly contributes to or causes vitamin D deficiency - in one sense, therefore,  it is true that ""Vitamin D directly contributes to or causes vitamin D deficiency."" However that is not what most people think, is it?
",no_relation,0.7974,,D014807,"<span class=""chemical"">Vitamin D</span>",D014808,"<span class=""disease"">vitamin D deficiency</span>","In 2011, the US Endocrine Task Force on <span class=""chemical"">Vitamin D</span> commented that 600 IU per day may not be sufficient to correct <span class=""chemical""></span><span class=""disease"">vitamin D</span> deficiency in pregnant and lactating women.",,22123632,22123632_D014807_D014808,22123632_4,bcv_sentence_task_befree_4169,,770960099,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,0.7975,,D014807,"<span class=""chemical"">vitamin D</span>",D014808,"<span class=""disease"">vitamin D deficiency</span>","Their recommendation was 1,500-2,000 IU <span class=""chemical"">vitamin D</span> per day in pregnant and lactating women with <span class=""chemical""></span><span class=""disease"">vitamin D</span> deficiency.",,22123632,22123632_D014807_D014808,22123632_5,bcv_sentence_task_befree_4170,,770960100,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,1,,C473478,"<span class=""chemical"">sunitinib</span>",D002292,"<span class=""disease"">renal cell carcinoma</span>","Cost-effectiveness evaluation of <span class=""chemical"">sunitinib</span> as first-line targeted therapy for metastatic <span class=""disease"">renal cell carcinoma</span> in Spain.",,22126730,22126730_C473478_D002292,22126730_0,bcv_sentence_task_befree_4171,,770960101,FALSE,finalized,5,8/14/15 22:42,"



",no_relation,1,,C473478,"<span class=""chemical"">Sunitinib</span>",C536851,"<span class=""disease"">renal carcinoma</span>","INTRODUCTION <span class=""chemical"">Sunitinib</span>, an oral, multitargeted receptor tyrosine kinase inhibitor, delays disease progression, with a median overall survival (OS) of more than 2 years, improves quality of life and is becoming the first-line standard of care for metastatic <span class=""disease"">renal carcinoma</span> (mRCC).",,22126730,22126730_C473478_C536851,22126730_1,bcv_sentence_task_befree_4172,,770960102,FALSE,finalized,5,8/15/15 1:41,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",C536851,"<span class=""disease"">renal carcinoma</span>","INTRODUCTION Sunitinib, an oral, multitargeted receptor <span class=""chemical"">tyrosine</span> kinase inhibitor, delays disease progression, with a median overall survival (OS) of more than 2 years, improves quality of life and is becoming the first-line standard of care for metastatic <span class=""disease"">renal carcinoma</span> (mRCC).",,22126730,22126730_D014443_C536851,22126730_1,bcv_sentence_task_befree_4173,,770960103,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,1,,D014221,"<span class=""chemical"">triamcinolone</span>",D003251,"<span class=""disease"">stricture</span>","The efficacy of endoscopic <span class=""chemical"">triamcinolone</span> injection for the prevention of esophageal <span class=""disease"">stricture</span> after endoscopic submucosal dissection.",,22136782,22136782_D014221_D003251,22136782_0,bcv_sentence_task_befree_4174,,770960104,FALSE,finalized,5,8/14/15 22:54,"



",no_relation,1,,D014221,"<span class=""chemical"">triamcinolone</span>",D003251,"<span class=""disease"">stricture</span>","The goal of this study was to determine the efficacy of endoscopic <span class=""chemical"">triamcinolone</span> injection (ETI) for the prevention of <span class=""disease"">stricture</span> formation after ESD.",,22136782,22136782_D014221_D003251,22136782_2,bcv_sentence_task_befree_4175,,770960105,FALSE,finalized,5,8/14/15 22:44,"



",no_relation,1,,D005227,"<span class=""chemical"">fatty acids</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Vitamins, minerals, essential <span class=""chemical"">fatty acids</span> and <span class=""disease"">colorectal cancer</span> risk in the United Kingdom Dietary Cohort Consortium.",,22139959,22139959_D005227_D015179,22139959_0,bcv_sentence_task_befree_4176,,770960106,FALSE,finalized,5,8/14/15 22:34,"



",yes_direct,0.8045,,D005227,"<span class=""chemical"">fatty acids</span>",D015179,"<span class=""disease"">colorectal cancer</span>","The risk for <span class=""disease"">colorectal cancer</span> may be influenced by the dietary intake of various vitamins, minerals and essential <span class=""chemical"">fatty acids</span>.",,22139959,22139959_D005227_D015179,22139959_1,bcv_sentence_task_befree_4177,,770960107,FALSE,finalized,5,8/14/15 23:46,"

Used as prevention.

",no_relation,0.5824,,D015525,"<span class=""chemical"">n - 3 fatty acids</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Dietary intakes of retinol, vitamin A, thiamin, riboflavin, vitamin B6, folate, vitamin B12, vitamin D, calcium, iron, magnesium, potassium, n - 6 fatty acids, <span class=""chemical"">n - 3 fatty acids</span> and the ratio of n - 6 to <span class=""chemical"">n - 3 fatty acids</span> were estimated and their associations with <span class=""disease"">colorectal cancer</span> examined using conditional logistic regression models, adjusting for exact age, height, weight, energy intake, alcohol intake, fiber intake, smoking, education, social class and physical activity.",,22139959,22139959_D015525_D015179,22139959_4,bcv_sentence_task_befree_4178,,770960108,FALSE,finalized,5,8/14/15 23:08,"



",no_relation,0.8117,,D025101,"<span class=""chemical"">vitamin B6</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Dietary intakes of retinol, vitamin A, thiamin, riboflavin, <span class=""chemical"">vitamin B6</span>, folate, vitamin B12, vitamin D, calcium, iron, magnesium, potassium, n - 6 fatty acids, n - 3 fatty acids and the ratio of n - 6 to n - 3 fatty acids were estimated and their associations with <span class=""disease"">colorectal cancer</span> examined using conditional logistic regression models, adjusting for exact age, height, weight, energy intake, alcohol intake, fiber intake, smoking, education, social class and physical activity.",,22139959,22139959_D025101_D015179,22139959_4,bcv_sentence_task_befree_4179,,770960109,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,0.8125,,D002118,"<span class=""chemical"">calcium</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Dietary intakes of retinol, vitamin A, thiamin, riboflavin, vitamin B6, folate, vitamin B12, vitamin D, <span class=""chemical"">calcium</span>, iron, magnesium, potassium, n - 6 fatty acids, n - 3 fatty acids and the ratio of n - 6 to n - 3 fatty acids were estimated and their associations with <span class=""disease"">colorectal cancer</span> examined using conditional logistic regression models, adjusting for exact age, height, weight, energy intake, alcohol intake, fiber intake, smoking, education, social class and physical activity.",,22139959,22139959_D002118_D015179,22139959_4,bcv_sentence_task_befree_4180,,770960110,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,0.7939,,D014807,"<span class=""chemical"">vitamin D</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Dietary intakes of retinol, vitamin A, thiamin, riboflavin, vitamin B6, folate, vitamin B12, <span class=""chemical"">vitamin D</span>, calcium, iron, magnesium, potassium, n - 6 fatty acids, n - 3 fatty acids and the ratio of n - 6 to n - 3 fatty acids were estimated and their associations with <span class=""disease"">colorectal cancer</span> examined using conditional logistic regression models, adjusting for exact age, height, weight, energy intake, alcohol intake, fiber intake, smoking, education, social class and physical activity.",,22139959,22139959_D014807_D015179,22139959_4,bcv_sentence_task_befree_4181,,770960111,FALSE,finalized,5,8/15/15 2:27,"



",no_relation,0.8024,,D000431,"<span class=""chemical"">alcohol</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Dietary intakes of retinol, vitamin A, thiamin, riboflavin, vitamin B6, folate, vitamin B12, vitamin D, calcium, iron, magnesium, potassium, n - 6 fatty acids, n - 3 fatty acids and the ratio of n - 6 to n - 3 fatty acids were estimated and their associations with <span class=""disease"">colorectal cancer</span> examined using conditional logistic regression models, adjusting for exact age, height, weight, energy intake, <span class=""chemical"">alcohol</span> intake, fiber intake, smoking, education, social class and physical activity.",,22139959,22139959_D000431_D015179,22139959_4,bcv_sentence_task_befree_4182,,770960112,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,0.808,,D011188,"<span class=""chemical"">potassium</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Dietary intakes of retinol, vitamin A, thiamin, riboflavin, vitamin B6, folate, vitamin B12, vitamin D, calcium, iron, magnesium, <span class=""chemical"">potassium</span>, n - 6 fatty acids, n - 3 fatty acids and the ratio of n - 6 to n - 3 fatty acids were estimated and their associations with <span class=""disease"">colorectal cancer</span> examined using conditional logistic regression models, adjusting for exact age, height, weight, energy intake, alcohol intake, fiber intake, smoking, education, social class and physical activity.",,22139959,22139959_D011188_D015179,22139959_4,bcv_sentence_task_befree_4183,,770960113,FALSE,finalized,5,8/14/15 23:25,"



",no_relation,0.7921,,D007501,"<span class=""chemical"">iron</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Dietary intakes of retinol, vitamin A, thiamin, riboflavin, vitamin B6, folate, vitamin B12, vitamin D, calcium, <span class=""chemical"">iron</span>, magnesium, potassium, n - 6 fatty acids, n - 3 fatty acids and the ratio of n - 6 to n - 3 fatty acids were estimated and their associations with <span class=""disease"">colorectal cancer</span> examined using conditional logistic regression models, adjusting for exact age, height, weight, energy intake, alcohol intake, fiber intake, smoking, education, social class and physical activity.",,22139959,22139959_D007501_D015179,22139959_4,bcv_sentence_task_befree_4184,,770960114,FALSE,finalized,5,8/14/15 22:51,"



",no_relation,0.6044,,D005492,"<span class=""chemical"">folate</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Dietary intakes of retinol, vitamin A, thiamin, riboflavin, vitamin B6, <span class=""chemical"">folate</span>, vitamin B12, vitamin D, calcium, iron, magnesium, potassium, n - 6 fatty acids, n - 3 fatty acids and the ratio of n - 6 to n - 3 fatty acids were estimated and their associations with <span class=""disease"">colorectal cancer</span> examined using conditional logistic regression models, adjusting for exact age, height, weight, energy intake, alcohol intake, fiber intake, smoking, education, social class and physical activity.",,22139959,22139959_D005492_D015179,22139959_4,bcv_sentence_task_befree_4185,,770960115,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,D014801,"<span class=""chemical"">retinol/vitamin A</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Dietary intakes of <span class=""chemical"">retinol</span>, <span class=""chemical"">vitamin A</span>, thiamin, riboflavin, vitamin B6, folate, vitamin B12, vitamin D, calcium, iron, magnesium, potassium, n - 6 fatty acids, n - 3 fatty acids and the ratio of n - 6 to n - 3 fatty acids were estimated and their associations with <span class=""disease"">colorectal cancer</span> examined using conditional logistic regression models, adjusting for exact age, height, weight, energy intake, alcohol intake, fiber intake, smoking, education, social class and physical activity.",,22139959,22139959_D014801_D015179,22139959_4,bcv_sentence_task_befree_4186,,770960116,FALSE,finalized,5,8/14/15 22:52,"



",no_relation,0.8126,,D014805,"<span class=""chemical"">vitamin B12</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Dietary intakes of retinol, vitamin A, thiamin, riboflavin, vitamin B6, folate, <span class=""chemical"">vitamin B12</span>, vitamin D, calcium, iron, magnesium, potassium, n - 6 fatty acids, n - 3 fatty acids and the ratio of n - 6 to n - 3 fatty acids were estimated and their associations with <span class=""disease"">colorectal cancer</span> examined using conditional logistic regression models, adjusting for exact age, height, weight, energy intake, alcohol intake, fiber intake, smoking, education, social class and physical activity.",,22139959,22139959_D014805_D015179,22139959_4,bcv_sentence_task_befree_4187,,770960117,FALSE,finalized,5,8/14/15 22:37,"



",no_relation,1,,D012256,"<span class=""chemical"">riboflavin</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Dietary intakes of retinol, vitamin A, thiamin, <span class=""chemical"">riboflavin</span>, vitamin B6, folate, vitamin B12, vitamin D, calcium, iron, magnesium, potassium, n - 6 fatty acids, n - 3 fatty acids and the ratio of n - 6 to n - 3 fatty acids were estimated and their associations with <span class=""disease"">colorectal cancer</span> examined using conditional logistic regression models, adjusting for exact age, height, weight, energy intake, alcohol intake, fiber intake, smoking, education, social class and physical activity.",,22139959,22139959_D012256_D015179,22139959_4,bcv_sentence_task_befree_4188,,770960118,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,D043371,"<span class=""chemical"">n - 6 fatty acids</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Dietary intakes of retinol, vitamin A, thiamin, riboflavin, vitamin B6, folate, vitamin B12, vitamin D, calcium, iron, magnesium, potassium, <span class=""chemical"">n - 6 fatty acids</span>, n - 3 fatty acids and the ratio of n - 6 to n - 3 fatty acids were estimated and their associations with <span class=""disease"">colorectal cancer</span> examined using conditional logistic regression models, adjusting for exact age, height, weight, energy intake, alcohol intake, fiber intake, smoking, education, social class and physical activity.",,22139959,22139959_D043371_D015179,22139959_4,bcv_sentence_task_befree_4189,,770960119,FALSE,finalized,5,8/14/15 22:55,"



",no_relation,1,,D008274,"<span class=""chemical"">magnesium</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Dietary intakes of retinol, vitamin A, thiamin, riboflavin, vitamin B6, folate, vitamin B12, vitamin D, calcium, iron, <span class=""chemical"">magnesium</span>, potassium, n - 6 fatty acids, n - 3 fatty acids and the ratio of n - 6 to n - 3 fatty acids were estimated and their associations with <span class=""disease"">colorectal cancer</span> examined using conditional logistic regression models, adjusting for exact age, height, weight, energy intake, alcohol intake, fiber intake, smoking, education, social class and physical activity.",,22139959,22139959_D008274_D015179,22139959_4,bcv_sentence_task_befree_4190,,770960120,FALSE,finalized,5,8/14/15 23:05,"



",no_relation,1,,D005227,"<span class=""chemical"">fatty acids</span>",D015179,"<span class=""disease"">colorectal cancer</span>","There were no statistically significant associations between <span class=""disease"">colorectal cancer</span> risk and dietary intake of any of the vitamins, minerals or essential <span class=""chemical"">fatty acids</span> examined.",,22139959,22139959_D005227_D015179,22139959_5,bcv_sentence_task_befree_4191,,770960121,FALSE,finalized,5,8/14/15 23:10,"



",no_relation,1,,D002701,"<span class=""chemical"">chloramphenicol</span>",D002386,"<span class=""disease"">cataract</span>","Endophthalmitis following <span class=""disease"">cataract</span> surgery: the role of prophylactic postoperative <span class=""chemical"">chloramphenicol</span> eye drops.",,22151787,22151787_D002701_D002386,22151787_0,bcv_sentence_task_befree_4192,,770960122,FALSE,finalized,5,8/15/15 0:42,"



",no_relation,1,,D002701,"<span class=""chemical"">chloramphenicol</span>",D009877,"<span class=""disease"">Endophthalmitis</span>","<span class=""disease"">Endophthalmitis</span> following cataract surgery: the role of prophylactic postoperative <span class=""chemical"">chloramphenicol</span> eye drops.",,22151787,22151787_D002701_D009877,22151787_0,bcv_sentence_task_befree_4193,,770960123,FALSE,finalized,5,8/14/15 22:29,"



",no_relation,0.7923,,D002701,"<span class=""chemical"">chloramphenicol</span>",D002386,"<span class=""disease"">cataract</span>","The main aim of the study was to assess whether omitting prophylactic postoperative topical antibiotics (<span class=""chemical"">chloramphenicol</span>) influenced the risk of developing endophthalmitis after <span class=""disease"">cataract</span> surgery.",,22151787,22151787_D002701_D002386,22151787_1,bcv_sentence_task_befree_4194,,770960124,FALSE,finalized,5,8/15/15 1:41,"



",no_relation,0.8089,,D002701,"<span class=""chemical"">chloramphenicol</span>",D009877,"<span class=""disease"">endophthalmitis</span>","The main aim of the study was to assess whether omitting prophylactic postoperative topical antibiotics (<span class=""chemical"">chloramphenicol</span>) influenced the risk of developing <span class=""disease"">endophthalmitis</span> after cataract surgery.",,22151787,22151787_D002701_D009877,22151787_1,bcv_sentence_task_befree_4195,,770960125,FALSE,finalized,5,8/15/15 1:28,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D009877,"<span class=""disease"">PE</span>","We found no difference in the frequency of <span class=""disease"">PE</span> following cataract surgery when changing the postoperative topical medication from a mixture of <span class=""chemical"">corticosteroids</span> and antibiotics to only corticosteroids.",,22151787,22151787_D000305_D009877,22151787_10,bcv_sentence_task_befree_4196,,770960126,FALSE,finalized,5,8/14/15 22:35,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D002386,"<span class=""disease"">cataract</span>","We found no difference in the frequency of PE following <span class=""disease"">cataract</span> surgery when changing the postoperative topical medication from a mixture of <span class=""chemical"">corticosteroids</span> and antibiotics to only corticosteroids.",,22151787,22151787_D000305_D002386,22151787_10,bcv_sentence_task_befree_4197,,770960127,FALSE,finalized,5,8/14/15 22:32,"



",no_relation,1,,D007501,"<span class=""chemical"">Iron</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","<span class=""chemical"">Iron</span> facilitator LS081 reduces hypoxia-inducible factor-1 protein and functions as anticancer agent in <span class=""disease"">hepatocellular carcinoma</span>.",,22181812,22181812_D007501_D006528,22181812_0,bcv_sentence_task_befree_4198,,770960128,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D007501,"<span class=""chemical"">Iron</span>",D000860,"<span class=""disease"">hypoxia</span>","<span class=""chemical"">Iron</span> facilitator LS081 reduces <span class=""disease"">hypoxia</span>-inducible factor-1 protein and functions as anticancer agent in hepatocellular carcinoma.",,22181812,22181812_D007501_D000860,22181812_0,bcv_sentence_task_befree_4199,,770960129,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D009369,"<span class=""disease"">tumor/cancer</span>","Hypoxia inducible factor-1 (HIF-1) has a central role in cellular <span class=""chemical"">oxygen</span>-sensing, and its overexpression in many types of <span class=""disease"">cancer</span> is considered important in <span class=""disease"">tumor</span> progression.",,22181812,22181812_D010100_D009369,22181812_1,bcv_sentence_task_befree_4200,,770960130,FALSE,finalized,5,8/14/15 23:44,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D000860,"<span class=""disease"">Hypoxia</span>","<span class=""disease"">Hypoxia</span> inducible factor-1 (HIF-1) has a central role in cellular <span class=""chemical"">oxygen</span>-sensing, and its overexpression in many types of cancer is considered important in tumor progression.",,22181812,22181812_D010100_D000860,22181812_1,bcv_sentence_task_befree_4201,,770960131,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,0.8118,,D007501,"<span class=""chemical"">iron</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","In the present study, we aimed to inhibit the expression of HIF-1 protein and growth of <span class=""disease"">hepatocellular carcinoma</span> by using the <span class=""chemical"">iron</span>-facilitating activity of LS081.",,22181812,22181812_D007501_D006528,22181812_7,bcv_sentence_task_befree_4202,,770960132,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,1,,C481046,"<span class=""chemical"">ammonium citrate</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","In the human <span class=""disease"">hepatocellular carcinoma</span> cell lines Hep3B and HepG2, a combination of LS081 and ferric <span class=""chemical"">ammonium citrate</span> (LS081/FeAC) inhibited HIF-1 protein expression but did not inhibit HIF-1 mRNA expression.",,22181812,22181812_C481046_D006528,22181812_8,bcv_sentence_task_befree_4203,,770960133,FALSE,finalized,5,8/14/15 23:54,"



",no_relation,1,,C559818,"<span class=""chemical"">LS081</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","In the human <span class=""disease"">hepatocellular carcinoma</span> cell lines Hep3B and HepG2, a combination of LS081 and ferric ammonium citrate (<span class=""chemical"">LS081</span>/FeAC) inhibited HIF-1 protein expression but did not inhibit HIF-1 mRNA expression.",,22181812,22181812_C559818_D006528,22181812_8,bcv_sentence_task_befree_4204,,770960134,FALSE,finalized,5,8/14/15 22:36,"



",no_relation,1,,D007501,"<span class=""chemical"">iron</span>",D006528,"<span class=""disease"">hepatocellular carcinoma</span>","These results indicate that the <span class=""chemical"">iron</span>-facilitating activity of LS081 inhibits HIF-1 expression through prolyl-hydroxylation of HIF-1 and might have a therapeutic effect in the treatment of <span class=""disease"">hepatocellular carcinoma</span>.",,22181812,22181812_D007501_D006528,22181812_11,bcv_sentence_task_befree_4205,,770960135,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D003920,"<span class=""disease"">diabetes mellitus</span>","The influence of <span class=""chemical"">glucose</span>, adjusted for body mass index, age, gender and <span class=""disease"">diabetes mellitus</span> on VTE was assessed by logistic regression analyses.",,22187097,22187097_D005947_D003920,22187097_8,bcv_sentence_task_befree_4206,,770960136,FALSE,finalized,5,8/14/15 22:53,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D054556,"<span class=""disease"">VTE</span>","The influence of <span class=""chemical"">glucose</span>, adjusted for body mass index, age, gender and diabetes mellitus on <span class=""disease"">VTE</span> was assessed by logistic regression analyses.",,22187097,22187097_D005947_D054556,22187097_8,bcv_sentence_task_befree_4207,,770960137,FALSE,finalized,5,8/14/15 22:59,"



",no_relation,0.7876,,D005947,"<span class=""chemical"">glucose</span>",D054556,"<span class=""disease"">VTE</span>","Increased <span class=""chemical"">glucose</span> levels after total hip replacement were associated with total <span class=""disease"">VTE</span>; adjusted odds ratio (OR) highest versus lowest quartile 1.9 (95% confidence interval [CI] 1.3 to 3.0).",,22187097,22187097_D005947_D054556,22187097_10,bcv_sentence_task_befree_4208,,770960138,FALSE,finalized,5,8/15/15 1:58,"



",yes_direct,0.5982,,D005947,"<span class=""chemical"">glucose</span>",D054556,"<span class=""disease"">VTE</span>","Furthermore, increase in <span class=""chemical"">glucose</span> levels during total hip replacement was associated with total <span class=""disease"">VTE</span> (OR highest versus lowest quartile 1.8 (95%CI 1.2 to 2.8).",,22187097,22187097_D005947_D054556,22187097_11,bcv_sentence_task_befree_4209,,770960139,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,0.7992,,D008550,"<span class=""chemical"">Melatonin</span>",D006528,"<span class=""disease"">hepatoma</span>","<span class=""chemical"">Melatonin</span> sensitizes human <span class=""disease"">hepatoma</span> cells to endoplasmic reticulum stress-induced apoptosis.",,22225575,22225575_D008550_D006528,22225575_0,bcv_sentence_task_befree_4210,,770960140,FALSE,finalized,5,8/14/15 23:03,"



",yes_direct,0.8036,,D008550,"<span class=""chemical"">Melatonin</span>",D006528,"<span class=""disease"">HCC/apoptosis in hepatocellular carcinoma</span>","<span class=""chemical"">Melatonin</span> induces <span class=""disease"">apoptosis in hepatocellular carcinoma</span> (<span class=""disease"">HCC</span>) in experimental studies, but the effects of <span class=""chemical"">melatonin</span> on endoplasmic reticulum (ER) stress-induced apoptosis in <span class=""disease"">HCC</span> have not been tested.",,22225575,22225575_D008550_D006528,22225575_2,bcv_sentence_task_befree_4211,,770960141,FALSE,finalized,5,8/14/15 23:26,"



",yes_direct,0.587,,D014415,"<span class=""chemical"">tunicamycin</span>",D006528,"<span class=""disease"">hepatoma</span>","Differences in ER stress-induced apoptosis in human <span class=""disease"">hepatoma</span> cells and normal human hepatocyte were investigated by exposure to <span class=""chemical"">tunicamycin</span> (ER stress inducer).",,22225575,22225575_D014415_D006528,22225575_3,bcv_sentence_task_befree_4212,,770960142,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,C105934,"<span class=""chemical"">celecoxib</span>",D006528,"<span class=""disease"">hepatoma</span>","Furthermore, down-regulation of COX-2 expression using the COX-2 inhibitor, <span class=""chemical"">celecoxib</span>, increased tunicamycin-induced apoptosis concomitant with the up-regulation of pro-apoptotic transcription factor CHOP (GADD153) and down-regulation of B-cell lymphoma 2/Bcl-2-associated X protein (Bcl-2/Bax) ratio, suggesting that inhibition of COX-2 sensitized human <span class=""disease"">hepatoma</span> cells to ER stress-induced apoptosis.",,22225575,22225575_C105934_D006528,22225575_6,bcv_sentence_task_befree_4213,,770960143,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,1,,C105934,"<span class=""chemical"">celecoxib</span>",D016393,"<span class=""disease"">B-cell lymphoma</span>","Furthermore, down-regulation of COX-2 expression using the COX-2 inhibitor, <span class=""chemical"">celecoxib</span>, increased tunicamycin-induced apoptosis concomitant with the up-regulation of pro-apoptotic transcription factor CHOP (GADD153) and down-regulation of <span class=""disease"">B-cell lymphoma</span> 2/Bcl-2-associated X protein (Bcl-2/Bax) ratio, suggesting that inhibition of COX-2 sensitized human hepatoma cells to ER stress-induced apoptosis.",,22225575,22225575_C105934_D016393,22225575_6,bcv_sentence_task_befree_4214,,770960144,FALSE,finalized,5,8/14/15 23:51,"



",no_relation,1,,D014415,"<span class=""chemical"">tunicamycin</span>",D016393,"<span class=""disease"">B-cell lymphoma</span>","Furthermore, down-regulation of COX-2 expression using the COX-2 inhibitor, celecoxib, increased <span class=""chemical"">tunicamycin</span>-induced apoptosis concomitant with the up-regulation of pro-apoptotic transcription factor CHOP (GADD153) and down-regulation of <span class=""disease"">B-cell lymphoma</span> 2/Bcl-2-associated X protein (Bcl-2/Bax) ratio, suggesting that inhibition of COX-2 sensitized human hepatoma cells to ER stress-induced apoptosis.",,22225575,22225575_D014415_D016393,22225575_6,bcv_sentence_task_befree_4215,,770960145,FALSE,finalized,5,8/14/15 23:02,"


Used as treatment.
",no_relation,0.8115,,D014415,"<span class=""chemical"">tunicamycin</span>",D006528,"<span class=""disease"">hepatoma</span>","Furthermore, down-regulation of COX-2 expression using the COX-2 inhibitor, celecoxib, increased <span class=""chemical"">tunicamycin</span>-induced apoptosis concomitant with the up-regulation of pro-apoptotic transcription factor CHOP (GADD153) and down-regulation of B-cell lymphoma 2/Bcl-2-associated X protein (Bcl-2/Bax) ratio, suggesting that inhibition of COX-2 sensitized human <span class=""disease"">hepatoma</span> cells to ER stress-induced apoptosis.",,22225575,22225575_D014415_D006528,22225575_6,bcv_sentence_task_befree_4216,,770960146,FALSE,finalized,5,8/15/15 0:10,"



",no_relation,1,,D008550,"<span class=""chemical"">melatonin</span>",D006528,"<span class=""disease"">hepatoma</span>","These results demonstrate that <span class=""chemical"">melatonin</span> sensitizes human <span class=""disease"">hepatoma</span> cells to ER stress-induced apoptosis by down-regulating COX-2 expression, increasing the levels of CHOP and decreasing the Bcl-2/Bax ratio.",,22225575,22225575_D008550_D006528,22225575_8,bcv_sentence_task_befree_4217,,770960147,FALSE,finalized,5,8/14/15 22:42,"



",no_relation,1,,D000728,"<span class=""chemical"">androgen</span>",D011471,"<span class=""disease"">prostate cancer</span>","""True"" antiandrogens-selective non-ligand-binding pocket disruptors of <span class=""chemical"">androgen</span> receptor-coactivator interactions: novel tools for <span class=""disease"">prostate cancer</span>.",,22280402,22280402_D000728_D011471,22280402_0,bcv_sentence_task_befree_4218,,770960148,FALSE,finalized,5,8/15/15 1:40,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D011471,"<span class=""disease"">Prostate cancer/PCa</span>","<span class=""disease"">Prostate cancer</span> (<span class=""disease"">PCa</span>) therapy typically involves administration of ""classical"" antiandrogens, competitive inhibitors of androgen receptor (AR) ligands, dihydrotestosterone (DHT) and <span class=""chemical"">testosterone</span> (tes), for the ligand-binding pocket (LBP) in the ligand-binding domain (LBD) of AR.",,22280402,22280402_D013739_D011471,22280402_1,bcv_sentence_task_befree_4219,,770960149,FALSE,finalized,5,8/15/15 1:18,"



",no_relation,1,,D000728,"<span class=""chemical"">androgen</span>",D011471,"<span class=""disease"">Prostate cancer/PCa</span>","<span class=""disease"">Prostate cancer</span> (<span class=""disease"">PCa</span>) therapy typically involves administration of ""classical"" antiandrogens, competitive inhibitors of <span class=""chemical"">androgen</span> receptor (AR) ligands, dihydrotestosterone (DHT) and testosterone (tes), for the ligand-binding pocket (LBP) in the ligand-binding domain (LBD) of AR.",,22280402,22280402_D000728_D011471,22280402_1,bcv_sentence_task_befree_4220,,770960150,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,1,,D013196,"<span class=""chemical"">dihydrotestosterone/DHT</span>",D006938,"<span class=""disease"">ligand-binding domain/LBD</span>","Prostate cancer (PCa) therapy typically involves administration of ""classical"" antiandrogens, competitive inhibitors of androgen receptor (AR) ligands, <span class=""chemical"">dihydrotestosterone</span> (<span class=""chemical"">DHT</span>) and testosterone (tes), for the ligand-binding pocket (LBP) in the <span class=""disease"">ligand-binding domain</span> (<span class=""disease"">LBD</span>) of AR.",,22280402,22280402_D013196_D006938,22280402_1,bcv_sentence_task_befree_4221,,770960151,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,0.8034,,D013196,"<span class=""chemical"">dihydrotestosterone/DHT</span>",D011471,"<span class=""disease"">Prostate cancer/PCa</span>","<span class=""disease"">Prostate cancer</span> (<span class=""disease"">PCa</span>) therapy typically involves administration of ""classical"" antiandrogens, competitive inhibitors of androgen receptor (AR) ligands, <span class=""chemical"">dihydrotestosterone</span> (<span class=""chemical"">DHT</span>) and testosterone (tes), for the ligand-binding pocket (LBP) in the ligand-binding domain (LBD) of AR.",,22280402,22280402_D013196_D011471,22280402_1,bcv_sentence_task_befree_4222,,770960152,FALSE,finalized,5,8/14/15 23:05,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D006938,"<span class=""disease"">ligand-binding domain/LBD</span>","Prostate cancer (PCa) therapy typically involves administration of ""classical"" antiandrogens, competitive inhibitors of androgen receptor (AR) ligands, dihydrotestosterone (DHT) and <span class=""chemical"">testosterone</span> (tes), for the ligand-binding pocket (LBP) in the <span class=""disease"">ligand-binding domain</span> (<span class=""disease"">LBD</span>) of AR.",,22280402,22280402_D013739_D006938,22280402_1,bcv_sentence_task_befree_4223,,770960153,FALSE,finalized,5,8/15/15 1:18,"



",no_relation,1,,D000728,"<span class=""chemical"">androgen</span>",D006938,"<span class=""disease"">ligand-binding domain/LBD</span>","Prostate cancer (PCa) therapy typically involves administration of ""classical"" antiandrogens, competitive inhibitors of <span class=""chemical"">androgen</span> receptor (AR) ligands, dihydrotestosterone (DHT) and testosterone (tes), for the ligand-binding pocket (LBP) in the <span class=""disease"">ligand-binding domain</span> (<span class=""disease"">LBD</span>) of AR.",,22280402,22280402_D000728_D006938,22280402_1,bcv_sentence_task_befree_4224,,770960154,FALSE,finalized,5,8/15/15 0:51,"



",no_relation,1,,D012828,"<span class=""chemical"">silicone</span>",D015658,"<span class=""disease"">HIV-1 infection</span>","Progressive granulomatous pneumonitis in response to cosmetic subcutaneous <span class=""chemical"">silicone</span> injections in a patient with <span class=""disease"">HIV-1 infection</span>: case report and review of the literature.",,22288970,22288970_D012828_D015658,22288970_0,bcv_sentence_task_befree_4225,,770960155,FALSE,finalized,5,8/15/15 1:06,"



",yes_direct,0.8097,,D012828,"<span class=""chemical"">silicone</span>",D011014,"<span class=""disease"">granulomatous pneumonitis</span>","Progressive <span class=""disease"">granulomatous pneumonitis</span> in response to cosmetic subcutaneous <span class=""chemical"">silicone</span> injections in a patient with HIV-1 infection: case report and review of the literature.",,22288970,22288970_D012828_D011014,22288970_0,bcv_sentence_task_befree_4226,,770960156,FALSE,finalized,5,8/15/15 1:39,"



",yes_direct,1,,D012828,"<span class=""chemical"">Silicone</span>",D011014,"<span class=""disease"">pneumonitis</span>","<span class=""chemical"">Silicone</span>, commonly used in cosmetic procedures owing to its presumed inertness, can yield serious sequelae including acute embolization and <span class=""disease"">pneumonitis</span>.",,22288970,22288970_D012828_D011014,22288970_1,bcv_sentence_task_befree_4227,,770960157,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,1,,D012828,"<span class=""chemical"">silicone</span>",D015658,"<span class=""disease"">human immunodeficiency virus</span>","We report a case of chronic progressive granulomatous pneumonitis in response to subcutaneous <span class=""chemical"">silicone</span> injections in a transgender male-to-female patient infected with <span class=""disease"">human immunodeficiency virus</span> 1 (HIV-1).",,22288970,22288970_D012828_D015658,22288970_3,bcv_sentence_task_befree_4228,,770960158,FALSE,finalized,5,8/14/15 22:35,"



",yes_direct,1,,D012828,"<span class=""chemical"">silicone</span>",D011014,"<span class=""disease"">granulomatous pneumonitis</span>","We report a case of chronic progressive <span class=""disease"">granulomatous pneumonitis</span> in response to subcutaneous <span class=""chemical"">silicone</span> injections in a transgender male-to-female patient infected with human immunodeficiency virus 1 (HIV-1).",,22288970,22288970_D012828_D011014,22288970_3,bcv_sentence_task_befree_4229,,770960159,FALSE,finalized,5,8/14/15 22:55,"



",yes_direct,1,,D012828,"<span class=""chemical"">silicone</span>",D004417,"<span class=""disease"">dyspnea</span>","After receiving <span class=""chemical"">silicone</span> injections to the buttock, the patient developed rapid onset <span class=""disease"">dyspnea</span>, pleuritic chest pain, fever, and chills.",,22288970,22288970_D012828_D004417,22288970_4,bcv_sentence_task_befree_4230,,770960160,FALSE,finalized,5,8/14/15 22:49,"



",yes_direct,1,,D012828,"<span class=""chemical"">silicone</span>",D002637,"<span class=""disease"">chest pain</span>","After receiving <span class=""chemical"">silicone</span> injections to the buttock, the patient developed rapid onset dyspnea, pleuritic <span class=""disease"">chest pain</span>, fever, and chills.",,22288970,22288970_D012828_D002637,22288970_4,bcv_sentence_task_befree_4231,,770960161,FALSE,finalized,5,8/14/15 23:24,"



",yes_direct,1,,D012828,"<span class=""chemical"">silicone</span>",D005334,"<span class=""disease"">fever</span>","After receiving <span class=""chemical"">silicone</span> injections to the buttock, the patient developed rapid onset dyspnea, pleuritic chest pain, <span class=""disease"">fever</span>, and chills.",,22288970,22288970_D012828_D005334,22288970_4,bcv_sentence_task_befree_4232,,770960162,FALSE,finalized,5,8/15/15 0:33,"



",no_relation,0.7964,,D012828,"<span class=""chemical"">silicone</span>",D007249,"<span class=""disease"">granulomatous inflammation</span>","Lung biopsies demonstrated numerous spheroid <span class=""chemical"">silicone</span> particles within the lung interstitium and small pulmonary vessels, surrounded by foreign body giant cells and nonnecrotizing <span class=""disease"">granulomatous inflammation</span>.",,22288970,22288970_D012828_D007249,22288970_9,bcv_sentence_task_befree_4233,,770960163,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,0.8343,,D012828,"<span class=""chemical"">silicone</span>",D015658,"<span class=""disease"">HIV-1-infected</span>","We speculate that <span class=""disease"">HIV-1-infected</span> patients may be at risk for chronic, progressive granulomatous pneumonitis due to <span class=""chemical"">silicone</span> injection years after their procedure owing to shifting levels of cell-mediated immunity.",,22288970,22288970_D012828_D015658,22288970_10,bcv_sentence_task_befree_4234,,770960164,FALSE,finalized,5,8/14/15 22:53,"



",yes_direct,1,,D012828,"<span class=""chemical"">silicone</span>",D011014,"<span class=""disease"">granulomatous pneumonitis</span>","We speculate that HIV-1-infected patients may be at risk for chronic, progressive <span class=""disease"">granulomatous pneumonitis</span> due to <span class=""chemical"">silicone</span> injection years after their procedure owing to shifting levels of cell-mediated immunity.",,22288970,22288970_D012828_D011014,22288970_10,bcv_sentence_task_befree_4235,,770960165,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,0.8095,,D015525,"<span class=""chemical"">Omega-3 fatty acids</span>",D006331,"<span class=""disease"">cardiac disease</span>","<span class=""chemical"">Omega-3 fatty acids</span> have been shown to reduce platelet and endothelial activation in patients with or at risk of <span class=""disease"">cardiac disease</span>.",,22296885,22296885_D015525_D006331,22296885_1,bcv_sentence_task_befree_4236,,770960166,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D015525,"<span class=""chemical"">Omega-3 fatty acids</span>",D007249,"<span class=""disease"">inflammation</span>","Supplementation with <span class=""chemical"">Omega-3 fatty acids</span> had no affect on platelet and endothelial activation or markers of <span class=""disease"">inflammation</span> in patients with peripheral arterial disease.",,22296885,22296885_D015525_D007249,22296885_11,bcv_sentence_task_befree_4237,,770960167,FALSE,finalized,5,8/15/15 1:10,"



",no_relation,1,,D015525,"<span class=""chemical"">Omega-3 fatty acids</span>",D002539,"<span class=""disease"">arterial disease</span>","Supplementation with <span class=""chemical"">Omega-3 fatty acids</span> had no affect on platelet and endothelial activation or markers of inflammation in patients with peripheral <span class=""disease"">arterial disease</span>.",,22296885,22296885_D015525_D002539,22296885_11,bcv_sentence_task_befree_4238,,770960168,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,1,,D019829,"<span class=""chemical"">nevirapine</span>",D015658,"<span class=""disease"">HIV</span>","Effectiveness of fixed-dose combination stavudine, lamivudine and <span class=""chemical"">nevirapine</span> (GPO-VIR) for treatment of nave <span class=""disease"">HIV</span> patients in Thailand: a 3-year follow-up.",,22299411,22299411_D019829_D015658,22299411_0,bcv_sentence_task_befree_4239,,770960169,FALSE,finalized,5,8/15/15 0:06,"



",no_relation,1,,D018119,"<span class=""chemical"">stavudine</span>",D015658,"<span class=""disease"">HIV</span>","Effectiveness of fixed-dose combination <span class=""chemical"">stavudine</span>, lamivudine and nevirapine (GPO-VIR) for treatment of nave <span class=""disease"">HIV</span> patients in Thailand: a 3-year follow-up.",,22299411,22299411_D018119_D015658,22299411_0,bcv_sentence_task_befree_4240,,770960170,FALSE,finalized,5,8/15/15 2:20,"



",no_relation,1,,D019259,"<span class=""chemical"">lamivudine</span>",D015658,"<span class=""disease"">HIV</span>","Effectiveness of fixed-dose combination stavudine, <span class=""chemical"">lamivudine</span> and nevirapine (GPO-VIR) for treatment of nave <span class=""disease"">HIV</span> patients in Thailand: a 3-year follow-up.",,22299411,22299411_D019259_D015658,22299411_0,bcv_sentence_task_befree_4241,,770960171,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,D019829,"<span class=""chemical"">nevirapine/NVP</span>",D015658,"<span class=""disease"">HIV</span>","Generic fixed dose combination stavudine (d4T), lamivudine (3TC) and <span class=""chemical"">nevirapine</span> (<span class=""chemical"">NVP</span>), named GPO-VIR is recommended in the <span class=""disease"">HIV</span> treatment guidelines for Thailand.",,22299411,22299411_D019829_D015658,22299411_1,bcv_sentence_task_befree_4242,,770960172,FALSE,finalized,5,8/15/15 1:13,"



",no_relation,1,,D018119,"<span class=""chemical"">stavudine/d4T</span>",D015658,"<span class=""disease"">HIV</span>","Generic fixed dose combination <span class=""chemical"">stavudine</span> (<span class=""chemical"">d4T</span>), lamivudine (3TC) and nevirapine (NVP), named GPO-VIR is recommended in the <span class=""disease"">HIV</span> treatment guidelines for Thailand.",,22299411,22299411_D018119_D015658,22299411_1,bcv_sentence_task_befree_4243,,770960173,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,1,,D019259,"<span class=""chemical"">lamivudine/3TC</span>",D015658,"<span class=""disease"">HIV</span>","Generic fixed dose combination stavudine (d4T), <span class=""chemical"">lamivudine</span> (<span class=""chemical"">3TC</span>) and nevirapine (NVP), named GPO-VIR is recommended in the <span class=""disease"">HIV</span> treatment guidelines for Thailand.",,22299411,22299411_D019259_D015658,22299411_1,bcv_sentence_task_befree_4244,,770960174,FALSE,finalized,5,8/14/15 22:49,"



",no_relation,1,,C052342,"<span class=""chemical"">topiramate</span>",D019964,"<span class=""disease"">mood disorders</span>","For binge eating disorder, the best evidence in <span class=""disease"">mood disorders</span> was for cognitive-behavioral therapy as well as <span class=""chemical"">topiramate</span>, zonisamide, and in select cases selective serotonin reuptake inhibitors.",,22303523,22303523_C052342_D019964,22303523_7,bcv_sentence_task_befree_4245,,770960175,FALSE,finalized,5,8/14/15 22:49,"



",no_relation,1,,D012701,"<span class=""chemical"">serotonin</span>",D019964,"<span class=""disease"">mood disorders</span>","For binge eating disorder, the best evidence in <span class=""disease"">mood disorders</span> was for cognitive-behavioral therapy as well as topiramate, zonisamide, and in select cases selective <span class=""chemical"">serotonin</span> reuptake inhibitors.",,22303523,22303523_D012701_D019964,22303523_7,bcv_sentence_task_befree_4246,,770960177,FALSE,finalized,5,8/14/15 22:56,"



",no_relation,0.8023,,D012701,"<span class=""chemical"">serotonin</span>",D056912,"<span class=""disease"">binge eating disorder</span>","For <span class=""disease"">binge eating disorder</span>, the best evidence in mood disorders was for cognitive-behavioral therapy as well as topiramate, zonisamide, and in select cases selective <span class=""chemical"">serotonin</span> reuptake inhibitors.",,22303523,22303523_D012701_D056912,22303523_7,bcv_sentence_task_befree_4247,,770960178,FALSE,finalized,5,8/15/15 2:01,"



",no_relation,0.6065,,C022189,"<span class=""chemical"">zonisamide</span>",D056912,"<span class=""disease"">binge eating disorder</span>","For <span class=""disease"">binge eating disorder</span>, the best evidence in mood disorders was for cognitive-behavioral therapy as well as topiramate, <span class=""chemical"">zonisamide</span>, and in select cases selective serotonin reuptake inhibitors.",,22303523,22303523_C022189_D056912,22303523_7,bcv_sentence_task_befree_4248,,770960179,FALSE,finalized,5,8/15/15 0:40,"



",no_relation,1,,C022189,"<span class=""chemical"">zonisamide</span>",D019964,"<span class=""disease"">mood disorders</span>","For binge eating disorder, the best evidence in <span class=""disease"">mood disorders</span> was for cognitive-behavioral therapy as well as topiramate, <span class=""chemical"">zonisamide</span>, and in select cases selective serotonin reuptake inhibitors.",,22303523,22303523_C022189_D019964,22303523_7,bcv_sentence_task_befree_4249,,770960180,FALSE,finalized,5,8/15/15 0:00,"



",no_relation,0.7991,,C052342,"<span class=""chemical"">topiramate</span>",D056912,"<span class=""disease"">binge eating disorder</span>","For <span class=""disease"">binge eating disorder</span>, the best evidence in mood disorders was for cognitive-behavioral therapy as well as <span class=""chemical"">topiramate</span>, zonisamide, and in select cases selective serotonin reuptake inhibitors.",,22303523,22303523_C052342_D056912,22303523_7,bcv_sentence_task_befree_4250,,770960181,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,C554292|D013755,"<span class=""chemical"">12-O-tetradecanoylphorbol-13-acetate/TPA</span>",D009369,"<span class=""disease"">tumor</span>","Compounds 1-17 were examined for their inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced with <span class=""chemical"">12-O-tetradecanoylphorbol-13-acetate</span> (<span class=""chemical"">TPA</span>) in Raji cells, a known primary screening test for inhibitors of <span class=""disease"">tumor</span> promotion.",,22344919,22344919_C554292|D013755_D009369,22344919_3,bcv_sentence_task_befree_4251,,770960182,FALSE,finalized,5,8/14/15 22:50,"



",no_relation,0.8119,,C554292|D013755,"<span class=""chemical"">TPA</span>",D063646,"<span class=""disease"">skin carcinogenesis</span>","In addition, compounds 1 and 11 exhibited inhibitory effects on skin-tumor promotion in an in vivo two-stage mouse <span class=""disease"">skin carcinogenesis</span> test based on 7,12-dimethylbenz[a]anthracene (DMBA) as initiator, and with <span class=""chemical"">TPA</span> as a promoter.",,22344919,22344919_C554292|D013755_D063646,22344919_5,bcv_sentence_task_befree_4252,,770960183,FALSE,finalized,5,8/14/15 22:59,"



",yes_direct,0.6069,,C554292|D013755,"<span class=""chemical"">TPA</span>",D009369,"<span class=""disease"">skin-tumor promotion</span>","In addition, compounds 1 and 11 exhibited inhibitory effects on <span class=""disease"">skin-tumor promotion</span> in an in vivo two-stage mouse skin carcinogenesis test based on 7,12-dimethylbenz[a]anthracene (DMBA) as initiator, and with <span class=""chemical"">TPA</span> as a promoter.",,22344919,22344919_C554292|D013755_D009369,22344919_5,bcv_sentence_task_befree_4253,,770960184,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,1,,D011803,"<span class=""chemical"">quinine</span>",D016778,"<span class=""disease"">falciparum malaria</span>","Efficacy and safety of <span class=""chemical"">quinine</span> loading dose in patients with severe <span class=""disease"">falciparum malaria</span> at a tertiary care hospital in Pakistan.",,22368898,22368898_D011803_D016778,22368898_0,bcv_sentence_task_befree_4254,,770960185,FALSE,finalized,5,8/15/15 2:01,"



",no_relation,1,,D011803,"<span class=""chemical"">quinine</span>",D016778,"<span class=""disease"">falciparum malaria</span>","To compare the clinical outcomes of a loading dose regimen of <span class=""chemical"">quinine</span> with a uniform dose regimen in patients with severe <span class=""disease"">falciparum malaria</span>.",,22368898,22368898_D011803_D016778,22368898_1,bcv_sentence_task_befree_4255,,770960186,FALSE,finalized,5,8/14/15 23:06,"



",no_relation,1,,D011803,"<span class=""chemical"">quinine</span>",D016778,"<span class=""disease"">falciparum malaria</span>","A retrospective chart review of 315 patients admitted with severe <span class=""disease"">falciparum malaria</span> and treated with <span class=""chemical"">quinine</span> at a tertiary care teaching hospital of Karachi, Pakistan during 1999-2006 was conducted.",,22368898,22368898_D011803_D016778,22368898_2,bcv_sentence_task_befree_4256,,770960187,FALSE,finalized,5,8/14/15 22:38,"



",yes_direct,1,,D011803,"<span class=""chemical"">quinine</span>",D064420,"<span class=""disease"">toxicity</span>","Although <span class=""chemical"">quinine</span> loading dose may be more effective than uniform dose in rapid fever clearance; it also appears to be associated with higher <span class=""disease"">toxicity</span>.",,22368898,22368898_D011803_D064420,22368898_11,bcv_sentence_task_befree_4257,,770960188,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,D011803,"<span class=""chemical"">quinine</span>",D016778,"<span class=""disease"">falciparum malaria</span>","Uniform dose of <span class=""chemical"">quinine</span> may be prescribed in severe <span class=""disease"">falciparum malaria</span> in view of its better safety profile.",,22368898,22368898_D011803_D016778,22368898_12,bcv_sentence_task_befree_4258,,770960189,FALSE,finalized,5,8/15/15 0:12,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D015464,"<span class=""disease"">chronic myeloid leukemia</span>","Mechanisms and novel approaches in overriding <span class=""chemical"">tyrosine</span> kinase inhibitor resistance in <span class=""disease"">chronic myeloid leukemia</span>.",,22369329,22369329_D014443_D015464,22369329_0,bcv_sentence_task_befree_4259,,770960190,FALSE,finalized,5,8/15/15 2:25,"



",no_relation,1,,D014443,"<span class=""chemical"">Tyrosine</span>",D015464,"<span class=""disease"">chronic myeloid leukemia</span>","<span class=""chemical"">Tyrosine</span> kinase inhibitors (TKIs) were introduced in the late 1990s and have revolutionized the management of <span class=""disease"">chronic myeloid leukemia</span> in chronic phase.",,22369329,22369329_D014443_D015464,22369329_2,bcv_sentence_task_befree_4260,,770960191,FALSE,finalized,5,8/14/15 22:29,"



",no_relation,1,,D008687,"<span class=""chemical"">Metformin</span>",C537389,"<span class=""disease"">type</span>","<span class=""chemical"">Metformin</span> use among individuals at risk for <span class=""disease"">type</span> 2 diabetes.",,22399368,22399368_D008687_C537389,22399368_0,bcv_sentence_task_befree_4261,,770960192,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,1,,D008687,"<span class=""chemical"">Metformin</span>",D003929,"<span class=""disease"">diabetes</span>","<span class=""chemical"">Metformin</span> use among individuals at risk for type 2 <span class=""disease"">diabetes</span>.",,22399368,22399368_D008687_D003929,22399368_0,bcv_sentence_task_befree_4262,,770960193,FALSE,finalized,5,8/15/15 2:04,"



",no_relation,0.7882,,D005947,"<span class=""chemical"">glucose</span>",D003929,"<span class=""disease"">diabetes</span>","Clinical trials to lower blood <span class=""chemical"">glucose</span> have been disappointing probably because the participants were too late in the natural history of <span class=""disease"">diabetes</span> and already had extensive vascular disease.",,22399368,22399368_D005947_D003929,22399368_2,bcv_sentence_task_befree_4263,,770960194,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D006402,"<span class=""disease"">blood glucose</span>","Clinical trials to lower <span class=""disease"">blood </span><span class=""chemical"">glucose</span> have been disappointing probably because the participants were too late in the natural history of diabetes and already had extensive vascular disease.",,22399368,22399368_D005947_D006402,22399368_2,bcv_sentence_task_befree_4264,,770960195,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D014652,"<span class=""disease"">vascular disease</span>","Clinical trials to lower blood <span class=""chemical"">glucose</span> have been disappointing probably because the participants were too late in the natural history of diabetes and already had extensive <span class=""disease"">vascular disease</span>.",,22399368,22399368_D005947_D014652,22399368_2,bcv_sentence_task_befree_4265,,770960196,FALSE,finalized,5,8/14/15 23:17,"



",no_relation,0.823,,D005947,"<span class=""chemical"">glucose</span>",D003929,"<span class=""disease"">diabetes</span>","Metformin will prevent development of <span class=""disease"">diabetes</span> among patients with impaired fasting <span class=""chemical"">glucose</span> but only for the short term.",,22399368,22399368_D005947_D003929,22399368_4,bcv_sentence_task_befree_4266,,770960197,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,1,,D008687,"<span class=""chemical"">Metformin</span>",D007003,"<span class=""disease"">impaired fasting glucose</span>","<span class=""chemical"">Metformin</span> will prevent development of diabetes among patients with <span class=""disease"">impaired fasting glucose</span> but only for the short term.",,22399368,22399368_D008687_D007003,22399368_4,bcv_sentence_task_befree_4267,,770960198,FALSE,finalized,5,8/14/15 23:08,"



",no_relation,1,,D008687,"<span class=""chemical"">Metformin</span>",D003929,"<span class=""disease"">diabetes</span>","<span class=""chemical"">Metformin</span> will prevent development of <span class=""disease"">diabetes</span> among patients with impaired fasting glucose but only for the short term.",,22399368,22399368_D008687_D003929,22399368_4,bcv_sentence_task_befree_4268,,770960199,FALSE,finalized,5,8/14/15 23:08,"



",no_relation,0.5946,,D005947,"<span class=""chemical"">glucose</span>",D007003,"<span class=""disease"">impaired fasting glucose</span>","Metformin will prevent development of diabetes among patients with <span class=""disease"">impaired fasting </span><span class=""chemical"">glucose</span> but only for the short term.",,22399368,22399368_D005947_D007003,22399368_4,bcv_sentence_task_befree_4269,,770960200,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,D008687,"<span class=""chemical"">Metformin</span>",D003327,"<span class=""disease"">coronary heart disease</span>","<span class=""chemical"">Metformin</span> reduces risk of <span class=""disease"">coronary heart disease</span>.",,22399368,22399368_D008687_D003327,22399368_5,bcv_sentence_task_befree_4270,,770960201,FALSE,finalized,5,8/15/15 1:44,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D050197,"<span class=""disease"">atherosclerosis</span>","The combination of diet and exercise followed by <span class=""chemical"">metformin</span> in the early phase of ""insulin resistance"" may reduce or delay both <span class=""disease"">atherosclerosis</span> and arteriosclerosis complications associated with diabetes.",,22399368,22399368_D008687_D050197,22399368_7,bcv_sentence_task_befree_4271,,770960202,FALSE,finalized,5,8/14/15 22:44,"



",no_relation,0.7926,,D008687,"<span class=""chemical"">metformin</span>",D003929,"<span class=""disease"">diabetes</span>","The combination of diet and exercise followed by <span class=""chemical"">metformin</span> in the early phase of ""insulin resistance"" may reduce or delay both atherosclerosis and arteriosclerosis complications associated with <span class=""disease"">diabetes</span>.",,22399368,22399368_D008687_D003929,22399368_7,bcv_sentence_task_befree_4272,,770960203,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D001161,"<span class=""disease"">arteriosclerosis</span>","The combination of diet and exercise followed by <span class=""chemical"">metformin</span> in the early phase of ""insulin resistance"" may reduce or delay both atherosclerosis and <span class=""disease"">arteriosclerosis</span> complications associated with diabetes.",,22399368,22399368_D008687_D001161,22399368_7,bcv_sentence_task_befree_4273,,770960204,FALSE,finalized,5,8/14/15 22:37,"



",no_relation,0.8093,,D000667,"<span class=""chemical"">AMP</span>",D015179,"<span class=""disease"">colorectal cancer</span>","Aspirin inhibits mTOR signaling, activates <span class=""chemical"">AMP</span>-activated protein kinase, and induces autophagy in <span class=""disease"">colorectal cancer</span> cells.",,22406476,22406476_D000667_D015179,22406476_0,bcv_sentence_task_befree_4274,,770960205,FALSE,finalized,5,8/14/15 23:39,"



",no_relation,0.6029,,D001241,"<span class=""chemical"">Aspirin</span>",D015179,"<span class=""disease"">colorectal cancer</span>","<span class=""chemical"">Aspirin</span> inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in <span class=""disease"">colorectal cancer</span> cells.",,22406476,22406476_D001241_D015179,22406476_0,bcv_sentence_task_befree_4275,,770960206,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,1,,D001241,"<span class=""chemical"">Aspirin</span>",D015179,"<span class=""disease"">CRC/colorectal cancer</span>","<span class=""chemical"">Aspirin</span> reduces the incidence of and mortality from <span class=""disease"">colorectal cancer</span> (<span class=""disease"">CRC</span>) by unknown mechanisms.",,22406476,22406476_D001241_D015179,22406476_1,bcv_sentence_task_befree_4276,,770960207,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,D020123,"<span class=""chemical"">rapamycin</span>",D009369,"<span class=""disease"">Cancer</span>","<span class=""disease"">Cancer</span> cells have defects in signaling via the mechanistic target of <span class=""chemical"">rapamycin</span> (mTOR), which regulates proliferation.",,22406476,22406476_D020123_D009369,22406476_2,bcv_sentence_task_befree_4277,,770960208,FALSE,finalized,5,8/15/15 0:22,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D015179,"<span class=""disease"">CRC</span>","We investigated whether <span class=""chemical"">aspirin</span> affects adenosine monophosphate-activated protein kinase (AMPK) and mTOR signaling in <span class=""disease"">CRC</span> cells.",,22406476,22406476_D001241_D015179,22406476_3,bcv_sentence_task_befree_4278,,770960209,FALSE,finalized,5,8/15/15 1:20,"



",no_relation,1,,D000249,"<span class=""chemical"">adenosine monophosphate</span>",D015179,"<span class=""disease"">CRC</span>","We investigated whether aspirin affects <span class=""chemical"">adenosine monophosphate</span>-activated protein kinase (AMPK) and mTOR signaling in <span class=""disease"">CRC</span> cells.",,22406476,22406476_D000249_D015179,22406476_3,bcv_sentence_task_befree_4279,,770960210,FALSE,finalized,5,8/14/15 23:00,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D015179,"<span class=""disease"">CRC</span>","The effects of <span class=""chemical"">aspirin</span> on mTOR signaling, the ribosomal protein S6, S6 kinase 1 (S6K1), and eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1) were examined in <span class=""disease"">CRC</span> cells by immunoblotting.",,22406476,22406476_D001241_D015179,22406476_4,bcv_sentence_task_befree_4280,,770960211,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D015179,"<span class=""disease"">CRC</span>","Phosphorylation of AMPK was measured; the effects of loss of AMPK on the <span class=""chemical"">aspirin</span>-induced effects of mTOR were determined using small interfering RNA (siRNA) in <span class=""disease"">CRC</span> cells and in AMPK(1/2-/-) mouse embryonic fibroblasts.",,22406476,22406476_D001241_D015179,22406476_5,bcv_sentence_task_befree_4281,,770960212,FALSE,finalized,5,8/15/15 0:12,"



",no_relation,1,,D001241,"<span class=""chemical"">Aspirin</span>",D015179,"<span class=""disease"">CRC</span>","<span class=""chemical"">Aspirin</span> reduced mTOR signaling in <span class=""disease"">CRC</span> cells by inhibiting the mTOR effectors S6K1 and 4E-BP1.",,22406476,22406476_D001241_D015179,22406476_8,bcv_sentence_task_befree_4282,,770960213,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,0.7948,,D001241,"<span class=""chemical"">Aspirin</span>",D015179,"<span class=""disease"">CRC</span>","<span class=""chemical"">Aspirin</span> changed nucleotide ratios and activated AMPK in <span class=""disease"">CRC</span> cells. mTOR was still inhibited by <span class=""chemical"">aspirin</span> in <span class=""disease"">CRC</span> cells after siRNA knockdown of AMPK, indicating AMPK-dependent and AMPK-independent mechanisms of <span class=""chemical"">aspirin</span>-induced inhibition of mTOR.",,22406476,22406476_D001241_D015179,22406476_9,bcv_sentence_task_befree_4283,,770960214,FALSE,finalized,5,8/15/15 1:18,"



",no_relation,1,,D009711,"<span class=""chemical"">nucleotide</span>",D015179,"<span class=""disease"">CRC</span>","Aspirin changed <span class=""chemical"">nucleotide</span> ratios and activated AMPK in <span class=""disease"">CRC</span> cells. mTOR was still inhibited by aspirin in <span class=""disease"">CRC</span> cells after siRNA knockdown of AMPK, indicating AMPK-dependent and AMPK-independent mechanisms of aspirin-induced inhibition of mTOR.",,22406476,22406476_D009711_D015179,22406476_9,bcv_sentence_task_befree_4284,,770960215,FALSE,finalized,5,8/15/15 0:17,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D015179,"<span class=""disease"">CRC</span>","Aspirin and <span class=""chemical"">metformin</span> (an activator of AMPK) increased inhibition of mTOR and Akt, as well as autophagy in <span class=""disease"">CRC</span> cells.",,22406476,22406476_D008687_D015179,22406476_11,bcv_sentence_task_befree_4285,,770960216,FALSE,finalized,5,8/15/15 0:41,"



",no_relation,0.7907,,D001241,"<span class=""chemical"">Aspirin</span>",D015179,"<span class=""disease"">CRC</span>","<span class=""chemical"">Aspirin</span> and metformin (an activator of AMPK) increased inhibition of mTOR and Akt, as well as autophagy in <span class=""disease"">CRC</span> cells.",,22406476,22406476_D001241_D015179,22406476_11,bcv_sentence_task_befree_4286,,770960217,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,0.794,,D000082,"<span class=""chemical"">paracetamol</span>",D016638,"<span class=""disease"">critically ill</span>","Mechanism of <span class=""chemical"">paracetamol</span>-induced hypotension in <span class=""disease"">critically ill</span> patients: a prospective observational cross-over study.",,22424816,22424816_D000082_D016638,22424816_0,bcv_sentence_task_befree_4287,,770960218,FALSE,finalized,5,8/14/15 23:06,"



",yes_direct,1,,D000082,"<span class=""chemical"">paracetamol</span>",D007022,"<span class=""disease"">hypotension</span>","Mechanism of <span class=""chemical"">paracetamol</span>-induced <span class=""disease"">hypotension</span> in critically ill patients: a prospective observational cross-over study.",,22424816,22424816_D000082_D007022,22424816_0,bcv_sentence_task_befree_4288,,770960219,FALSE,finalized,5,8/15/15 2:30,"



",no_relation,0.5955,,D000082,"<span class=""chemical"">paracetamol/acetaminophen</span>",D007022,"<span class=""disease"">hypotension</span>","To elucidate the mechanism of <span class=""disease"">hypotension</span> following intravenous administration of <span class=""chemical"">paracetamol</span> (<span class=""chemical"">acetaminophen</span>) to patients on the Intensive Care Unit.",,22424816,22424816_D000082_D007022,22424816_1,bcv_sentence_task_befree_4289,,770960220,FALSE,finalized,5,8/15/15 2:20,"



",no_relation,1,,D000082,"<span class=""chemical"">paracetamol</span>",D016638,"<span class=""disease"">critically ill</span>","Ventilated <span class=""disease"">critically ill</span> patients monitored by PiCCO and administered intravenous <span class=""chemical"">paracetamol</span> at the same time were eligible for the study.",,22424816,22424816_D000082_D016638,22424816_4,bcv_sentence_task_befree_4290,,770960221,FALSE,finalized,5,8/14/15 22:43,"



",yes_direct,1,,D000082,"<span class=""chemical"">paracetamol</span>",D007022,"<span class=""disease"">hypotension</span>","Analysis of these cycles suggests that <span class=""disease"">hypotension</span> with <span class=""chemical"">paracetamol</span> can be caused by reduction of both cardiac index and systemic vascular resistance.",,22424816,22424816_D000082_D007022,22424816_11,bcv_sentence_task_befree_4291,,770960222,FALSE,finalized,5,8/14/15 23:23,"


The disease was a pre-existing condition.
",no_relation,1,,D000082,"<span class=""chemical"">paracetamol</span>",D016638,"<span class=""disease"">critically ill</span>","Hypotension with intravenous <span class=""chemical"">paracetamol</span> in <span class=""disease"">critically ill</span> patients is caused by a reduction of both cardiac output and systemic vascular resistance.",,22424816,22424816_D000082_D016638,22424816_14,bcv_sentence_task_befree_4292,,770960223,FALSE,finalized,5,8/14/15 22:59,"



",yes_direct,0.5985,,D000082,"<span class=""chemical"">paracetamol</span>",D007022,"<span class=""disease"">Hypotension</span>","<span class=""disease"">Hypotension</span> with intravenous <span class=""chemical"">paracetamol</span> in critically ill patients is caused by a reduction of both cardiac output and systemic vascular resistance.",,22424816,22424816_D000082_D007022,22424816_14,bcv_sentence_task_befree_4293,,770960224,FALSE,finalized,5,8/14/15 22:54,"



",yes_direct,1,,C066196,"<span class=""chemical"">CS5931</span>",D004487,"<span class=""disease"">cytotoxicity</span>","<span class=""chemical"">CS5931</span> exhibited significant <span class=""disease"">cytotoxicity</span> for several cancer cell types and induced apoptotic death in HCT-8 cells in a dose- and time-dependent manner.",,22440403,22440403_C066196_D004487,22440403_7,bcv_sentence_task_befree_4294,,770960225,FALSE,finalized,5,8/14/15 23:13,"



",no_relation,1,,C066196,"<span class=""chemical"">CS5931</span>",D009369,"<span class=""disease"">cancer</span>","<span class=""chemical"">CS5931</span> exhibited significant cytotoxicity for several <span class=""disease"">cancer</span> cell types and induced apoptotic death in HCT-8 cells in a dose- and time-dependent manner.",,22440403,22440403_C066196_D009369,22440403_7,bcv_sentence_task_befree_4295,,770960226,FALSE,finalized,5,8/15/15 1:11,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",D003920,"<span class=""disease"">type 2 diabetes mellitus</span>","We aimed to investigate the impact of the coadministration of TZD and ACEI/ARB on hematocrit and hemoglobin values in uncomplicated patients with <span class=""disease"">type 2 diabetes mellitus</span> and normal serum <span class=""chemical"">creatinine</span>.Data from patients with type 2 diabetes currently followed, were reviewed and patients treated with ACEI/ARB and/or TZD were identified.",,22441720,22441720_D003404_D003920,22441720_2,bcv_sentence_task_befree_4296,,770960227,FALSE,finalized,5,8/14/15 23:37,"



",no_relation,1,,D045162,"<span class=""chemical"">TZD</span>",D003920,"<span class=""disease"">type 2 diabetes mellitus</span>","We aimed to investigate the impact of the coadministration of <span class=""chemical"">TZD</span> and ACEI/ARB on hematocrit and hemoglobin values in uncomplicated patients with <span class=""disease"">type 2 diabetes mellitus</span> and normal serum creatinine.Data from patients with type 2 diabetes currently followed, were reviewed and patients treated with ACEI/ARB and/or <span class=""chemical"">TZD</span> were identified.",,22441720,22441720_D045162_D003920,22441720_2,bcv_sentence_task_befree_4297,,770960228,FALSE,finalized,5,8/14/15 23:31,"

It's 'type 2 diabetes' and not just 'Type'

",no_relation,1,,D045162,"<span class=""chemical"">TZD</span>",C537389,"<span class=""disease"">type</span>","We aimed to investigate the impact of the coadministration of <span class=""chemical"">TZD</span> and ACEI/ARB on hematocrit and hemoglobin values in uncomplicated patients with type 2 diabetes mellitus and normal serum creatinine.Data from patients with <span class=""disease"">type</span> 2 diabetes currently followed, were reviewed and patients treated with ACEI/ARB and/or <span class=""chemical"">TZD</span> were identified.",,22441720,22441720_D045162_C537389,22441720_2,bcv_sentence_task_befree_4298,,770960229,FALSE,finalized,5,8/14/15 22:50,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",C537389,"<span class=""disease"">type</span>","We aimed to investigate the impact of the coadministration of TZD and ACEI/ARB on hematocrit and hemoglobin values in uncomplicated patients with type 2 diabetes mellitus and normal serum <span class=""chemical"">creatinine</span>.Data from patients with <span class=""disease"">type</span> 2 diabetes currently followed, were reviewed and patients treated with ACEI/ARB and/or TZD were identified.",,22441720,22441720_D003404_C537389,22441720_2,bcv_sentence_task_befree_4299,,770960230,FALSE,finalized,5,8/14/15 22:36,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",D003929,"<span class=""disease"">diabetes</span>","We aimed to investigate the impact of the coadministration of TZD and ACEI/ARB on hematocrit and hemoglobin values in uncomplicated patients with type 2 diabetes mellitus and normal serum <span class=""chemical"">creatinine</span>.Data from patients with type 2 <span class=""disease"">diabetes</span> currently followed, were reviewed and patients treated with ACEI/ARB and/or TZD were identified.",,22441720,22441720_D003404_D003929,22441720_2,bcv_sentence_task_befree_4300,,770960231,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,1,,D045162,"<span class=""chemical"">TZD</span>",D003929,"<span class=""disease"">diabetes</span>","We aimed to investigate the impact of the coadministration of <span class=""chemical"">TZD</span> and ACEI/ARB on hematocrit and hemoglobin values in uncomplicated patients with type 2 diabetes mellitus and normal serum creatinine.Data from patients with type 2 <span class=""disease"">diabetes</span> currently followed, were reviewed and patients treated with ACEI/ARB and/or <span class=""chemical"">TZD</span> were identified.",,22441720,22441720_D045162_D003929,22441720_2,bcv_sentence_task_befree_4301,,770960232,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",D000740,"<span class=""disease"">anemia</span>","Furthermore, incident <span class=""disease"">anemia</span> at the end reached 7% in group TZD and 23% in group ACEI/ARB/TZD.Coadministration of RAS inhibitors and PPAR-_ agonists should be considered in the differential diagnosis of hematocrit lowering and <span class=""disease"">anemia</span> in uncomplicated type 2 diabetic patients with normal serum <span class=""chemical"">creatinine</span>.",,22441720,22441720_D003404_D000740,22441720_7,bcv_sentence_task_befree_4302,,770960233,FALSE,finalized,5,8/14/15 23:00,"



",no_relation,0.7798,,D057911,"<span class=""chemical"">ARB</span>",D000740,"<span class=""disease"">anemia</span>","Furthermore, incident <span class=""disease"">anemia</span> at the end reached 7% in group TZD and 23% in group ACEI/<span class=""chemical"">ARB</span>/TZD.Coadministration of RAS inhibitors and PPAR-_ agonists should be considered in the differential diagnosis of hematocrit lowering and <span class=""disease"">anemia</span> in uncomplicated type 2 diabetic patients with normal serum creatinine.",,22441720,22441720_D057911_D000740,22441720_7,bcv_sentence_task_befree_4303,,770960234,FALSE,finalized,5,8/15/15 0:34,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",D003929,"<span class=""disease"">diabetic</span>","Furthermore, incident anemia at the end reached 7% in group TZD and 23% in group ACEI/ARB/TZD.Coadministration of RAS inhibitors and PPAR-_ agonists should be considered in the differential diagnosis of hematocrit lowering and anemia in uncomplicated type 2 <span class=""disease"">diabetic</span> patients with normal serum <span class=""chemical"">creatinine</span>.",,22441720,22441720_D003404_D003929,22441720_7,bcv_sentence_task_befree_4304,,770960235,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,1,,D045162,"<span class=""chemical"">TZD</span>",D003929,"<span class=""disease"">diabetic</span>","Furthermore, incident anemia at the end reached 7% in group TZD and 23% in group ACEI/ARB/<span class=""chemical"">TZD</span>.Coadministration of RAS inhibitors and PPAR-_ agonists should be considered in the differential diagnosis of hematocrit lowering and anemia in uncomplicated type 2 <span class=""disease"">diabetic</span> patients with normal serum creatinine.",,22441720,22441720_D045162_D003929,22441720_7,bcv_sentence_task_befree_4305,,770960236,FALSE,finalized,5,8/15/15 2:16,"



",no_relation,1,,D057911,"<span class=""chemical"">ARB</span>",D003929,"<span class=""disease"">diabetic</span>","Furthermore, incident anemia at the end reached 7% in group TZD and 23% in group ACEI/<span class=""chemical"">ARB</span>/TZD.Coadministration of RAS inhibitors and PPAR-_ agonists should be considered in the differential diagnosis of hematocrit lowering and anemia in uncomplicated type 2 <span class=""disease"">diabetic</span> patients with normal serum creatinine.",,22441720,22441720_D057911_D003929,22441720_7,bcv_sentence_task_befree_4306,,770960237,FALSE,finalized,5,8/15/15 1:33,"



",no_relation,1,,D057911,"<span class=""chemical"">ARB</span>",C537389,"<span class=""disease"">type</span>","Furthermore, incident anemia at the end reached 7% in group TZD and 23% in group ACEI/<span class=""chemical"">ARB</span>/TZD.Coadministration of RAS inhibitors and PPAR-_ agonists should be considered in the differential diagnosis of hematocrit lowering and anemia in uncomplicated <span class=""disease"">type</span> 2 diabetic patients with normal serum creatinine.",,22441720,22441720_D057911_C537389,22441720_7,bcv_sentence_task_befree_4307,,770960238,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,0.5922,,D045162,"<span class=""chemical"">TZD</span>",D000740,"<span class=""disease"">anemia</span>","Furthermore, incident <span class=""disease"">anemia</span> at the end reached 7% in group TZD and 23% in group ACEI/ARB/<span class=""chemical"">TZD</span>.Coadministration of RAS inhibitors and PPAR-_ agonists should be considered in the differential diagnosis of hematocrit lowering and <span class=""disease"">anemia</span> in uncomplicated type 2 diabetic patients with normal serum creatinine.",,22441720,22441720_D045162_D000740,22441720_7,bcv_sentence_task_befree_4308,,770960239,FALSE,finalized,5,8/14/15 22:30,"



",no_relation,1,,D045162,"<span class=""chemical"">TZD</span>",C537389,"<span class=""disease"">type</span>","Furthermore, incident anemia at the end reached 7% in group TZD and 23% in group ACEI/ARB/<span class=""chemical"">TZD</span>.Coadministration of RAS inhibitors and PPAR-_ agonists should be considered in the differential diagnosis of hematocrit lowering and anemia in uncomplicated <span class=""disease"">type</span> 2 diabetic patients with normal serum creatinine.",,22441720,22441720_D045162_C537389,22441720_7,bcv_sentence_task_befree_4309,,770960240,FALSE,finalized,5,8/14/15 22:29,"



",no_relation,1,,D003404,"<span class=""chemical"">creatinine</span>",C537389,"<span class=""disease"">type</span>","Furthermore, incident anemia at the end reached 7% in group TZD and 23% in group ACEI/ARB/TZD.Coadministration of RAS inhibitors and PPAR-_ agonists should be considered in the differential diagnosis of hematocrit lowering and anemia in uncomplicated <span class=""disease"">type</span> 2 diabetic patients with normal serum <span class=""chemical"">creatinine</span>.",,22441720,22441720_D003404_C537389,22441720_7,bcv_sentence_task_befree_4310,,770960241,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,1,,C055162,"<span class=""chemical"">clopidogrel</span>",D002318,"<span class=""disease"">cardiovascular diseases</span>","Clinical trials have established the value of <span class=""chemical"">clopidogrel</span> therapy in a wide spectrum of patients with <span class=""disease"">cardiovascular diseases</span>.",,22450429,22450429_C055162_D002318,22450429_1,bcv_sentence_task_befree_4311,,770960242,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,0.6067,,C055162,"<span class=""chemical"">clopidogrel</span>",D006470,"<span class=""disease"">bleeding</span>","The rates of ischaemic and <span class=""disease"">bleeding</span> events were compared between carriers and non-carriers of loss-of-function and gain-of-function alleles in patients randomized to <span class=""chemical"">clopidogrel</span> vs. placebo.",,22450429,22450429_C055162_D006470,22450429_6,bcv_sentence_task_befree_4312,,770960243,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,C055162,"<span class=""chemical"">clopidogrel</span>",D006470,"<span class=""disease"">bleeding</span>","However, <span class=""chemical"">clopidogrel</span>-treated patients did have a significantly lower rate of any <span class=""disease"">bleeding</span> in carriers: 36.1% (240/665) vs. 42.5% (681/1601) in non-carriers, HR: 0.80, 95% CI: 0.69-0.93, P = 0.003 (genotype/treatment interaction, P-value = 0.023).",,22450429,22450429_C055162_D006470,22450429_9,bcv_sentence_task_befree_4313,,770960244,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,0.7898,,C055162,"<span class=""chemical"">clopidogrel</span>",D006470,"<span class=""disease"">less bleeding</span>","There was, however, significantly <span class=""disease"">less bleeding</span> with <span class=""chemical"">clopidogrel</span> in carriers of the loss-of-function allele, suggesting less anti-platelet response.",,22450429,22450429_C055162_D006470,22450429_12,bcv_sentence_task_befree_4314,,770960245,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,0.6191,,C055162,"<span class=""chemical"">clopidogrel</span>",D006470,"<span class=""disease"">bleeding</span>","Although several prior studies, including mainly stented patients, have emphasized the relationship between CYP2C19 loss-of-function alleles and efficacy of <span class=""chemical"">clopidogrel</span>, this study of stable patients establishes a potential link with reduced <span class=""disease"">bleeding</span> complications.",,22450429,22450429_C055162_D006470,22450429_13,bcv_sentence_task_befree_4315,,770960246,FALSE,finalized,5,8/14/15 22:43,"



",yes_direct,0.6018,,D012701,"<span class=""chemical"">serotonin/5-HT/5-hydroxytryptamine</span>",D019966,"<span class=""disease"">drug dependence</span>","The present review provides an overview on <span class=""chemical"">serotonin</span> (<span class=""chemical"">5-hydroxytryptamine</span>; <span class=""chemical"">5-HT</span>)(2C) receptors and their relationship to <span class=""disease"">drug dependence</span>.",,22494568,22494568_D012701_D019966,22494568_1,bcv_sentence_task_befree_4316,,770960247,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,1,,D012701,"<span class=""chemical"">5-HT</span>",D019966,"<span class=""disease"">drug dependence</span>","Accordingly, available nonclinical data and some clinical observations targeting <span class=""chemical"">5-HT</span>(2C) receptors may offer innovative translational strategies for combating <span class=""disease"">drug dependence</span>.This article is part of a Special Issue entitled: Brain Integration.",,22494568,22494568_D012701_D019966,22494568_5,bcv_sentence_task_befree_4317,,770960248,FALSE,finalized,5,8/15/15 2:23,"



",no_relation,1,,D004999,"<span class=""chemical"">amifostine</span>",D014987,"<span class=""disease"">xerostomia</span>","Nine patients (20.9%) developed grade 2 acute <span class=""disease"">xerostomia</span>; 2 had grade 0-1 <span class=""disease"">xerostomia</span> (4.7%) but started on <span class=""chemical"">amifostine</span>/pilocarpine.",,22541957,22541957_D004999_D014987,22541957_9,bcv_sentence_task_befree_4318,,770960249,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D010862,"<span class=""chemical"">pilocarpine</span>",D014987,"<span class=""disease"">xerostomia</span>","Nine patients (20.9%) developed grade 2 acute <span class=""disease"">xerostomia</span>; 2 had grade 0-1 <span class=""disease"">xerostomia</span> (4.7%) but started on amifostine/<span class=""chemical"">pilocarpine</span>.",,22541957,22541957_D010862_D014987,22541957_9,bcv_sentence_task_befree_4319,,770960250,FALSE,finalized,5,8/14/15 23:16,"



",yes_direct,0.3952,,D001241,"<span class=""chemical"">aspirin</span>",D005767,"<span class=""disease"">Gastrointestinal lesions</span>","<span class=""disease"">Gastrointestinal lesions</span> and complications of low-dose <span class=""chemical"">aspirin</span> in the gastrointestinal tract.",,22542152,22542152_D001241_D005767,22542152_0,bcv_sentence_task_befree_4320,,770960251,FALSE,finalized,5,8/14/15 23:37,"



",yes_direct,1,,D001241,"<span class=""chemical"">aspirin</span>",D006470,"<span class=""disease"">GI bleeding</span>","Low dose <span class=""chemical"">aspirin</span> (ASA) use has been associated with a wide range of adverse side effects in the upper gastrointestinal (GI) tract, which range from troublesome symptoms without mucosal lesions to more serious toxicity, including ulcers, <span class=""disease"">GI bleeding</span>, perforation and even death.",,22542152,22542152_D001241_D006470,22542152_1,bcv_sentence_task_befree_4321,,770960252,FALSE,finalized,5,8/15/15 0:48,"



",yes_direct,1,,D001241,"<span class=""chemical"">aspirin</span>",D064420,"<span class=""disease"">toxicity</span>","Low dose <span class=""chemical"">aspirin</span> (ASA) use has been associated with a wide range of adverse side effects in the upper gastrointestinal (GI) tract, which range from troublesome symptoms without mucosal lesions to more serious <span class=""disease"">toxicity</span>, including ulcers, GI bleeding, perforation and even death.",,22542152,22542152_D001241_D064420,22542152_1,bcv_sentence_task_befree_4322,,770960253,FALSE,finalized,5,8/14/15 23:16,"


'Without' being the key term.
",no_relation,0.5768,,D001241,"<span class=""chemical"">aspirin</span>",D052016,"<span class=""disease"">mucosal lesions</span>","Low dose <span class=""chemical"">aspirin</span> (ASA) use has been associated with a wide range of adverse side effects in the upper gastrointestinal (GI) tract, which range from troublesome symptoms without <span class=""disease"">mucosal lesions</span> to more serious toxicity, including ulcers, GI bleeding, perforation and even death.",,22542152,22542152_D001241_D052016,22542152_1,bcv_sentence_task_befree_4323,,770960254,FALSE,finalized,5,8/14/15 23:49,"



",yes_direct,0.8013,,D001241,"<span class=""chemical"">aspirin</span>",D014456,"<span class=""disease"">ulcers</span>","Low dose <span class=""chemical"">aspirin</span> (ASA) use has been associated with a wide range of adverse side effects in the upper gastrointestinal (GI) tract, which range from troublesome symptoms without mucosal lesions to more serious toxicity, including <span class=""disease"">ulcers</span>, GI bleeding, perforation and even death.",,22542152,22542152_D001241_D014456,22542152_1,bcv_sentence_task_befree_4324,,770960255,FALSE,finalized,5,8/15/15 1:28,"



",yes_direct,0.7907,,D001241,"<span class=""chemical"">aspirin</span>",D003643,"<span class=""disease"">death</span>","Low dose <span class=""chemical"">aspirin</span> (ASA) use has been associated with a wide range of adverse side effects in the upper gastrointestinal (GI) tract, which range from troublesome symptoms without mucosal lesions to more serious toxicity, including ulcers, GI bleeding, perforation and even <span class=""disease"">death</span>.",,22542152,22542152_D001241_D003643,22542152_1,bcv_sentence_task_befree_4325,,770960256,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,0.7911,,D001241,"<span class=""chemical"">ASA</span>",D014947,"<span class=""disease"">mucosal injury</span>","Upper GI symptoms in low dose <span class=""chemical"">ASA</span> users are common but often careless or misinterpreted and they are not always related to the presence of <span class=""disease"">mucosal injury</span>.",,22542152,22542152_D001241_D014947,22542152_2,bcv_sentence_task_befree_4326,,770960257,FALSE,finalized,5,8/15/15 0:16,"



",yes_direct,1,,D001241,"<span class=""chemical"">ASA</span>",D014456,"<span class=""disease"">ulcers</span>","Usually, low dose <span class=""chemical"">ASA</span> related <span class=""disease"">ulcers</span> are reasonably small and asymptomatic, and probably heal over a period of weeks to a few months.",,22542152,22542152_D001241_D014456,22542152_3,bcv_sentence_task_befree_4327,,770960258,FALSE,finalized,5,8/15/15 2:33,"



",yes_indirect,0.4025,,D001241,"<span class=""chemical"">ASA</span>",D003643,"<span class=""disease"">Death</span>","<span class=""disease"">Death</span> is the worst outcome of GI complications in low dose <span class=""chemical"">ASA</span> users, but data about this aspect are scarce.",,22542152,22542152_D001241_D003643,22542152_6,bcv_sentence_task_befree_4328,,770960259,FALSE,finalized,5,8/14/15 22:35,"



",yes_direct,0.608,,D001241,"<span class=""chemical"">ASA</span>",D005767,"<span class=""disease"">GI complications</span>","Death is the worst outcome of <span class=""disease"">GI complications</span> in low dose <span class=""chemical"">ASA</span> users, but data about this aspect are scarce.",,22542152,22542152_D001241_D005767,22542152_6,bcv_sentence_task_befree_4329,,770960260,FALSE,finalized,5,8/15/15 1:20,"



",no_relation,1,,D007213,"<span class=""chemical"">indomethacin</span>",D004374,"<span class=""disease"">PDA</span>","Cyclo-oxygenase inhibitors such as <span class=""chemical"">indomethacin</span> and ibuprofen remain the mainstay of medical therapy for <span class=""disease"">PDA</span>, and can be used both for prophylaxis as well as for rescue therapy to achieve <span class=""disease"">PDA</span> closure.",,22564132,22564132_D007213_D004374,22564132_4,bcv_sentence_task_befree_4330,,770960261,FALSE,finalized,5,8/15/15 0:19,"



",no_relation,1,,D007052,"<span class=""chemical"">ibuprofen</span>",D004374,"<span class=""disease"">PDA</span>","Cyclo-oxygenase inhibitors such as indomethacin and <span class=""chemical"">ibuprofen</span> remain the mainstay of medical therapy for <span class=""disease"">PDA</span>, and can be used both for prophylaxis as well as for rescue therapy to achieve <span class=""disease"">PDA</span> closure.",,22564132,22564132_D007052_D004374,22564132_4,bcv_sentence_task_befree_4331,,770960262,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,C110904,"<span class=""chemical"">capecitabine</span>",D009369,"<span class=""disease"">rectal cancer</span>","Phase II and gene expression analysis trial of neoadjuvant <span class=""chemical"">capecitabine</span> plus irinotecan followed by <span class=""chemical"">capecitabine</span>-based chemoradiotherapy for locally advanced <span class=""disease"">rectal cancer</span>: Hoosier Oncology Group GI03-53.",,22610353,22610353_C110904_D009369,22610353_0,bcv_sentence_task_befree_4332,,770960263,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,1,,C051890,"<span class=""chemical"">irinotecan</span>",D009369,"<span class=""disease"">rectal cancer</span>","Phase II and gene expression analysis trial of neoadjuvant capecitabine plus <span class=""chemical"">irinotecan</span> followed by capecitabine-based chemoradiotherapy for locally advanced <span class=""disease"">rectal cancer</span>: Hoosier Oncology Group GI03-53.",,22610353,22610353_C051890_D009369,22610353_0,bcv_sentence_task_befree_4333,,770960264,FALSE,finalized,5,8/15/15 0:24,"



",no_relation,1,,C110904,"<span class=""chemical"">capecitabine</span>",D009369,"<span class=""disease"">rectal cancer</span>","We designed this study in locally advanced <span class=""disease"">rectal cancer</span> to determine the pathological response, toxicity, and disease-free survival (DFS) with induction <span class=""chemical"">capecitabine</span> plus irinotecan followed by <span class=""chemical"">capecitabine</span>-based chemoradiotherapy (CRT) and analyze the gene expression of enzymes involved in the metabolism of <span class=""chemical"">capecitabine</span> and irinotecan for associations with response and toxicity.",,22610353,22610353_C110904_D009369,22610353_1,bcv_sentence_task_befree_4334,,770960265,FALSE,finalized,5,8/14/15 23:23,"



",no_relation,1,,C051890,"<span class=""chemical"">irinotecan</span>",D009369,"<span class=""disease"">rectal cancer</span>","We designed this study in locally advanced <span class=""disease"">rectal cancer</span> to determine the pathological response, toxicity, and disease-free survival (DFS) with induction capecitabine plus <span class=""chemical"">irinotecan</span> followed by capecitabine-based chemoradiotherapy (CRT) and analyze the gene expression of enzymes involved in the metabolism of capecitabine and <span class=""chemical"">irinotecan</span> for associations with response and toxicity.",,22610353,22610353_C051890_D009369,22610353_1,bcv_sentence_task_befree_4335,,770960266,FALSE,finalized,5,8/14/15 22:54,"



",no_relation,0.6054,,C051890,"<span class=""chemical"">irinotecan</span>",D064420,"<span class=""disease"">toxicity</span>","We designed this study in locally advanced rectal cancer to determine the pathological response, <span class=""disease"">toxicity</span>, and disease-free survival (DFS) with induction capecitabine plus <span class=""chemical"">irinotecan</span> followed by capecitabine-based chemoradiotherapy (CRT) and analyze the gene expression of enzymes involved in the metabolism of capecitabine and <span class=""chemical"">irinotecan</span> for associations with response and <span class=""disease"">toxicity</span>.",,22610353,22610353_C051890_D064420,22610353_1,bcv_sentence_task_befree_4336,,770960267,FALSE,finalized,5,8/14/15 22:57,"



",no_relation,1,,C110904,"<span class=""chemical"">capecitabine</span>",D064420,"<span class=""disease"">toxicity</span>","We designed this study in locally advanced rectal cancer to determine the pathological response, <span class=""disease"">toxicity</span>, and disease-free survival (DFS) with induction <span class=""chemical"">capecitabine</span> plus irinotecan followed by <span class=""chemical"">capecitabine</span>-based chemoradiotherapy (CRT) and analyze the gene expression of enzymes involved in the metabolism of <span class=""chemical"">capecitabine</span> and irinotecan for associations with response and <span class=""disease"">toxicity</span>.",,22610353,22610353_C110904_D064420,22610353_1,bcv_sentence_task_befree_4337,,770960268,FALSE,finalized,5,8/15/15 1:31,"



",no_relation,1,,C110904,"<span class=""chemical"">capecitabine</span>",D009369,"<span class=""disease"">rectal cancer</span>","Patients with T3/T4 or node positive <span class=""disease"">rectal cancer</span> were treated with <span class=""chemical"">capecitabine</span> 1,000 mg/m(2) twice daily (BID) days 1-14, and irinotecan 200 mg/m(2) on day 1 every 21 days for 2 cycles, followed by <span class=""chemical"">capecitabine</span> 825 mg/m(2) BID days 1-5 per week with concurrent radiotherapy 50.4 Gy in 28 fractions.",,22610353,22610353_C110904_D009369,22610353_2,bcv_sentence_task_befree_4338,,770960269,FALSE,finalized,5,8/15/15 1:39,"



",no_relation,1,,C051890,"<span class=""chemical"">irinotecan</span>",D009369,"<span class=""disease"">rectal cancer</span>","Patients with T3/T4 or node positive <span class=""disease"">rectal cancer</span> were treated with capecitabine 1,000 mg/m(2) twice daily (BID) days 1-14, and <span class=""chemical"">irinotecan</span> 200 mg/m(2) on day 1 every 21 days for 2 cycles, followed by capecitabine 825 mg/m(2) BID days 1-5 per week with concurrent radiotherapy 50.4 Gy in 28 fractions.",,22610353,22610353_C051890_D009369,22610353_2,bcv_sentence_task_befree_4339,,770960270,FALSE,finalized,5,8/14/15 23:21,"



",no_relation,1,,D014530,"<span class=""chemical"">uridine-diphosphate/UDP</span>",D009369,"<span class=""disease"">tumor</span>","Gene expression levels or sequencing were used to analyze carboxylesterase-converting enzymes (CES1, CES2), thymidylate synthase (TS), thymidine phosphorylase (TP), dehydropyrimidine dehydrogenase (DPD), topoisomerase I (TOPO I), and <span class=""chemical"">uridine-diphosphate</span> (<span class=""chemical"">UDP</span>) glucuronosyl transferase 1A1 in pre- and post-treatment <span class=""disease"">tumor</span> and normal tissue samples.",,22610353,22610353_D014530_D009369,22610353_4,bcv_sentence_task_befree_4340,,770960271,FALSE,finalized,5,8/14/15 23:10,"



",no_relation,1,,D013936,"<span class=""chemical"">thymidine</span>",D009369,"<span class=""disease"">tumor</span>","Gene expression levels or sequencing were used to analyze carboxylesterase-converting enzymes (CES1, CES2), thymidylate synthase (TS), <span class=""chemical"">thymidine</span> phosphorylase (TP), dehydropyrimidine dehydrogenase (DPD), topoisomerase I (TOPO I), and uridine-diphosphate (UDP) glucuronosyl transferase 1A1 in pre- and post-treatment <span class=""disease"">tumor</span> and normal tissue samples.",,22610353,22610353_D013936_D009369,22610353_4,bcv_sentence_task_befree_4341,,770960272,FALSE,finalized,5,8/14/15 23:15,"



",no_relation,0.6087,,C471405,"<span class=""chemical"">sorafenib</span>",D010146,"<span class=""disease"">pain</span>","The management strategy was based on preventive measures for reducing the development of cutaneous AEs, including <span class=""disease"">pain</span>, risk of infection and patient discomfort, while avoiding the discontinuation or the reduction of the <span class=""chemical"">sorafenib</span> dosage.",,22646774,22646774_C471405_D010146,22646774_2,bcv_sentence_task_befree_4342,,770960273,FALSE,finalized,5,8/14/15 23:01,"



",no_relation,0.7924,,C471405,"<span class=""chemical"">sorafenib</span>",D007239,"<span class=""disease"">infection</span>","The management strategy was based on preventive measures for reducing the development of cutaneous AEs, including pain, risk of <span class=""disease"">infection</span> and patient discomfort, while avoiding the discontinuation or the reduction of the <span class=""chemical"">sorafenib</span> dosage.",,22646774,22646774_C471405_D007239,22646774_2,bcv_sentence_task_befree_4343,,770960274,FALSE,finalized,5,8/14/15 23:23,"



",no_relation,0.5943,,C058120,"<span class=""chemical"">Cordycepin</span>",D009447,"<span class=""disease"">neuroblastoma</span>","<span class=""chemical"">Cordycepin</span> induces apoptosis in human <span class=""disease"">neuroblastoma</span> SK-N-BE(2)-C and melanoma SK-MEL-2 cells.",,22650004,22650004_C058120_D009447,22650004_0,bcv_sentence_task_befree_4344,,770960275,FALSE,finalized,5,8/15/15 0:09,"



",yes_direct,0.5994,,C058120,"<span class=""chemical"">Cordycepin</span>",D008545,"<span class=""disease"">melanoma</span>","<span class=""chemical"">Cordycepin</span> induces apoptosis in human neuroblastoma SK-N-BE(2)-C and <span class=""disease"">melanoma</span> SK-MEL-2 cells.",,22650004,22650004_C058120_D008545,22650004_0,bcv_sentence_task_befree_4345,,770960276,FALSE,finalized,5,8/15/15 1:04,"



",no_relation,1,,D003839,"<span class=""chemical"">deoxyadenosine</span>",D009447,"<span class=""disease"">neuroblastoma</span>","In this study, the effect of cordycepin (3'-<span class=""chemical"">deoxyadenosine</span>), a major component of Cordyceps militaris, an ingredient of traditional Chinese medicine was investigated for the first time on apoptotsis in human <span class=""disease"">neuroblastoma</span> SK-N-BE(2)-C and melanoma SK-MEL-2 cells.",,22650004,22650004_D003839_D009447,22650004_1,bcv_sentence_task_befree_4346,,770960277,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,D003839,"<span class=""chemical"">deoxyadenosine</span>",D008545,"<span class=""disease"">melanoma</span>","In this study, the effect of cordycepin (3'-<span class=""chemical"">deoxyadenosine</span>), a major component of Cordyceps militaris, an ingredient of traditional Chinese medicine was investigated for the first time on apoptotsis in human neuroblastoma SK-N-BE(2)-C and <span class=""disease"">melanoma</span> SK-MEL-2 cells.",,22650004,22650004_D003839_D008545,22650004_1,bcv_sentence_task_befree_4347,,770960278,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,0.8136,,C058120,"<span class=""chemical"">Cordycepin</span>",D009447,"<span class=""disease"">neuroblastoma</span>","<span class=""chemical"">Cordycepin</span> significantly inhibited the proliferation of human <span class=""disease"">neuroblastoma</span> SK-N-BE(2)-C and human melanoma SK-MEL-2 cells with IC50 values of 120 microM and 80 microM, respectively.",,22650004,22650004_C058120_D009447,22650004_2,bcv_sentence_task_befree_4348,,770960279,FALSE,finalized,5,8/14/15 23:59,"



",no_relation,1,,C058120,"<span class=""chemical"">Cordycepin</span>",D008545,"<span class=""disease"">melanoma</span>","<span class=""chemical"">Cordycepin</span> significantly inhibited the proliferation of human neuroblastoma SK-N-BE(2)-C and human <span class=""disease"">melanoma</span> SK-MEL-2 cells with IC50 values of 120 microM and 80 microM, respectively.",,22650004,22650004_C058120_D008545,22650004_2,bcv_sentence_task_befree_4349,,770960280,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,D006497,"<span class=""chemical"">heparan sulphate</span>",C536656,"<span class=""disease"">HARP</span>","In this work, <span class=""disease"">HARP</span> was tested for its capacity to modulate the anticoagulant activity of heparin and <span class=""chemical"">heparan sulphate</span> mimetics (OTR4120).",,22672269,22672269_D006497_C536656,22672269_2,bcv_sentence_task_befree_4350,,770960281,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,C533322,"<span class=""chemical"">OTR4120</span>",C536656,"<span class=""disease"">HARP</span>","In this work, <span class=""disease"">HARP</span> was tested for its capacity to modulate the anticoagulant activity of heparin and heparan sulphate mimetics (<span class=""chemical"">OTR4120</span>).",,22672269,22672269_C533322_C536656,22672269_2,bcv_sentence_task_befree_4351,,770960282,FALSE,finalized,5,8/15/15 1:32,"



",no_relation,1,,D006497,"<span class=""chemical"">heparan sulphate</span>",C536656,"<span class=""disease"">HARP</span>","<span class=""disease"">HARP</span> was found to be differently effective for neutralization of the anticoagulant activity of the mimetic <span class=""chemical"">heparan sulphate</span> (OTR4120) and heparin in purified system and human plasma.",,22672269,22672269_D006497_C536656,22672269_4,bcv_sentence_task_befree_4352,,770960283,FALSE,finalized,5,8/14/15 23:09,"



",no_relation,1,,C533322,"<span class=""chemical"">OTR4120</span>",C536656,"<span class=""disease"">HARP</span>","<span class=""disease"">HARP</span> was found to be differently effective for neutralization of the anticoagulant activity of the mimetic heparan sulphate (<span class=""chemical"">OTR4120</span>) and heparin in purified system and human plasma.",,22672269,22672269_C533322_C536656,22672269_4,bcv_sentence_task_befree_4353,,770960284,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,D006493,"<span class=""chemical"">heparin</span>",C536656,"<span class=""disease"">HARP</span>","<span class=""disease"">HARP</span> was found to be differently effective for neutralization of the anticoagulant activity of the mimetic heparan sulphate (OTR4120) and <span class=""chemical"">heparin</span> in purified system and human plasma.",,22672269,22672269_D006493_C536656,22672269_4,bcv_sentence_task_befree_4354,,770960285,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,C533322,"<span class=""chemical"">OTR4120</span>",C536656,"<span class=""disease"">HARP</span>","<span class=""disease"">HARP</span> was shown to compete with both antithrombin and thrombin for binding to heparin and to <span class=""chemical"">OTR4120</span>, respectively.",,22672269,22672269_C533322_C536656,22672269_5,bcv_sentence_task_befree_4355,,770960286,FALSE,finalized,5,8/15/15 0:30,"



",no_relation,1,,C533322,"<span class=""chemical"">OTR4120</span>",C536656,"<span class=""disease"">HARP</span>","In the presence of <span class=""chemical"">OTR4120</span>, the V(max) was constant and the calculated maximum velocity was 1.56U/min; the thrombin Km value (0.011nM) was affected by <span class=""disease"">HARP</span> concentrations.",,22672269,22672269_C533322_C536656,22672269_6,bcv_sentence_task_befree_4356,,770960287,FALSE,finalized,5,8/15/15 1:24,"



",no_relation,1,,C533322,"<span class=""chemical"">OTR4120</span>",C536656,"<span class=""disease"">HARP</span>","The Km (<span class=""disease"">HARP</span>) value was 0.085nM, which is consistent with high affinity of <span class=""disease"">HARP</span> to <span class=""chemical"">OTR4120</span>.",,22672269,22672269_C533322_C536656,22672269_7,bcv_sentence_task_befree_4357,,770960288,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,1,,C533322,"<span class=""chemical"">OTR4120</span>",C536656,"<span class=""disease"">HARP</span>","Interestingly, intraperitoneally administered <span class=""disease"">HARP</span> decreased the anticoagulant activity of heparin and of <span class=""chemical"">OTR4120</span> in mice.",,22672269,22672269_C533322_C536656,22672269_11,bcv_sentence_task_befree_4358,,770960289,FALSE,finalized,5,8/14/15 22:54,"



",no_relation,1,,D000804,"<span class=""chemical"">angiotensin II</span>",D005355,"<span class=""disease"">cardiac fibrosis</span>","In cardiac fibroblasts and rats treated with <span class=""chemical"">angiotensin II</span>, berberine was found to suppress fibroblast activation, collagen synthesis, and extent of <span class=""disease"">cardiac fibrosis</span> through up-regulating relaxin.",,22673230,22673230_D000804_D005355,22673230_10,bcv_sentence_task_befree_4359,,770960290,FALSE,finalized,5,8/14/15 23:21,"


'Supress' being the key term.
",no_relation,0.7922,,D001599,"<span class=""chemical"">berberine</span>",D005355,"<span class=""disease"">cardiac fibrosis</span>","In cardiac fibroblasts and rats treated with angiotensin II, <span class=""chemical"">berberine</span> was found to suppress fibroblast activation, collagen synthesis, and extent of <span class=""disease"">cardiac fibrosis</span> through up-regulating relaxin.",,22673230,22673230_D001599_D005355,22673230_10,bcv_sentence_task_befree_4360,,770960291,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,1,,C008911,"<span class=""chemical"">pimaric acid/PiMA</span>",D009369,"<span class=""disease"">tumor</span>","In this study, we revealed that <span class=""chemical"">pimaric acid</span> (<span class=""chemical"">PiMA</span>) purified from Aralia cordata had an inhibitory effect on MMP-9 production and migration of human aortic smooth muscle cells (HASMCs) induced by <span class=""disease"">tumor</span> necrosis factor (TNF)-. Down-regulated MMP-9 mRNA transcription was detected in PiMA-treated cells using RT-PCR and the luciferase-tagged MMP-9 promoter assay.",,22705379,22705379_C008911_D009369,22705379_2,bcv_sentence_task_befree_4361,,770960292,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,C008911,"<span class=""chemical"">pimaric acid/PiMA</span>",D009336,"<span class=""disease"">necrosis</span>","In this study, we revealed that <span class=""chemical"">pimaric acid</span> (<span class=""chemical"">PiMA</span>) purified from Aralia cordata had an inhibitory effect on MMP-9 production and migration of human aortic smooth muscle cells (HASMCs) induced by tumor <span class=""disease"">necrosis</span> factor (TNF)-. Down-regulated MMP-9 mRNA transcription was detected in PiMA-treated cells using RT-PCR and the luciferase-tagged MMP-9 promoter assay.",,22705379,22705379_C008911_D009336,22705379_2,bcv_sentence_task_befree_4362,,770960293,FALSE,finalized,5,8/15/15 1:22,"



",no_relation,1,,C008911,"<span class=""chemical"">PiMA</span>",D050197,"<span class=""disease"">atherosclerotic</span>","These results suggest that <span class=""chemical"">PiMA</span> has potent anti-<span class=""disease"">atherosclerotic</span> activity with inhibitory action on MMP-9 production and cell migration in TNF--induced HASMCs.",,22705379,22705379_C008911_D050197,22705379_8,bcv_sentence_task_befree_4363,,770960294,FALSE,finalized,5,8/15/15 0:42,"



",no_relation,1,,D012545,"<span class=""chemical"">Schiff base</span>",D009369,"<span class=""disease"">cancer</span>","Anti-<span class=""disease"">cancer</span> activity and mutagenic potential of novel copper(II) quinolinone <span class=""chemical"">Schiff base</span> complexes in hepatocarcinoma cells.",,22705894,22705894_D012545_D009369,22705894_0,bcv_sentence_task_befree_4364,,770960295,FALSE,finalized,5,8/14/15 22:35,"



",no_relation,1,,D012545,"<span class=""chemical"">Schiff base</span>",D006505,"<span class=""disease"">hepatic carcinoma</span>","This study determined the cytotoxic, cyto-selective and mutagenic potential of novel quinolinone <span class=""chemical"">Schiff base</span> ligands and their corresponding copper(II) complexes in human-derived <span class=""disease"">hepatic carcinoma</span> cells (Hep-G2) and non-malignant human-derived hepatic cells (Chang).",,22705894,22705894_D012545_D006505,22705894_1,bcv_sentence_task_befree_4365,,770960296,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,0.6059,,D012545,"<span class=""chemical"">Schiff bases</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Results indicated that complexation of quinolinone <span class=""chemical"">Schiff bases</span> with copper served to significantly enhance <span class=""disease"">cytotoxicity</span>.",,22705894,22705894_D012545_D004487,22705894_2,bcv_sentence_task_befree_4366,,770960297,FALSE,finalized,5,8/14/15 22:49,"



",yes_direct,0.6073,,D003300,"<span class=""chemical"">copper</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Results indicated that complexation of quinolinone Schiff bases with <span class=""chemical"">copper</span> served to significantly enhance <span class=""disease"">cytotoxicity</span>.",,22705894,22705894_D003300_D004487,22705894_2,bcv_sentence_task_befree_4367,,770960298,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,0.8032,,D002738,"<span class=""chemical"">Chloroquine</span>",D009369,"<span class=""disease"">colon cancer</span>","<span class=""chemical"">Chloroquine</span> enhances the chemotherapeutic activity of 5-fluorouracil in a <span class=""disease"">colon cancer</span> cell line via cell cycle alteration.",,22716215,22716215_D002738_D009369,22716215_0,bcv_sentence_task_befree_4368,,770960299,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,0.8091,,D005472,"<span class=""chemical"">5-fluorouracil</span>",D009369,"<span class=""disease"">colon cancer</span>","Chloroquine enhances the chemotherapeutic activity of <span class=""chemical"">5-fluorouracil</span> in a <span class=""disease"">colon cancer</span> cell line via cell cycle alteration.",,22716215,22716215_D005472_D009369,22716215_0,bcv_sentence_task_befree_4369,,770960300,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,D002738,"<span class=""chemical"">chloroquine</span>",D009369,"<span class=""disease"">cancer</span>","A number of <span class=""disease"">cancer</span> cell lines have been exposed to <span class=""chemical"">chloroquine</span>, an anti-malarial drug, with the aim of inhibiting cell growth and inducing cell death.",,22716215,22716215_D002738_D009369,22716215_3,bcv_sentence_task_befree_4370,,770960301,FALSE,finalized,5,8/15/15 0:49,"



",no_relation,1,,D002738,"<span class=""chemical"">chloroquine</span>",D009369,"<span class=""disease"">cancer/colon cancer</span>","This study was conducted to investigate the anti-<span class=""disease"">cancer</span> effect of autophagy inhibition, using <span class=""chemical"">chloroquine</span> together with 5-fluorouracil (5-FU) in a <span class=""disease"">colon cancer</span> cell line.",,22716215,22716215_D002738_D009369,22716215_5,bcv_sentence_task_befree_4371,,770960302,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU/5-fluorouracil</span>",D009369,"<span class=""disease"">cancer/colon cancer</span>","This study was conducted to investigate the anti-<span class=""disease"">cancer</span> effect of autophagy inhibition, using chloroquine together with <span class=""chemical"">5-fluorouracil</span> (<span class=""chemical"">5-FU</span>) in a <span class=""disease"">colon cancer</span> cell line.",,22716215,22716215_D005472_D009369,22716215_5,bcv_sentence_task_befree_4372,,770960303,FALSE,finalized,5,8/15/15 0:19,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D009369,"<span class=""disease"">colon cancer</span>","Human <span class=""disease"">colon cancer</span> DLD-1 cells were treated with <span class=""chemical"">5-FU</span> (10 _) or chloroquine (100 _), or a combination of both.",,22716215,22716215_D005472_D009369,22716215_6,bcv_sentence_task_befree_4373,,770960304,FALSE,finalized,5,8/15/15 2:09,"



",no_relation,1,,D002738,"<span class=""chemical"">chloroquine</span>",D009369,"<span class=""disease"">colon cancer</span>","Human <span class=""disease"">colon cancer</span> DLD-1 cells were treated with 5-FU (10 _) or <span class=""chemical"">chloroquine</span> (100 _), or a combination of both.",,22716215,22716215_D002738_D009369,22716215_6,bcv_sentence_task_befree_4374,,770960305,FALSE,finalized,5,8/14/15 22:45,"



",no_relation,0.5831,,D005472,"<span class=""chemical"">5-FU</span>",D004487,"<span class=""disease"">cytotoxicity</span>","LC3-II protein increased after treatment with <span class=""chemical"">5-FU</span>, and chloroquine potentiated the <span class=""disease"">cytotoxicity</span> of <span class=""chemical"">5-FU</span>.",,22716215,22716215_D005472_D004487,22716215_9,bcv_sentence_task_befree_4375,,770960306,FALSE,finalized,5,8/14/15 23:18,"



",yes_direct,0.8174,,D002738,"<span class=""chemical"">chloroquine</span>",D004487,"<span class=""disease"">cytotoxicity</span>","LC3-II protein increased after treatment with 5-FU, and <span class=""chemical"">chloroquine</span> potentiated the <span class=""disease"">cytotoxicity</span> of 5-FU.",,22716215,22716215_D002738_D004487,22716215_9,bcv_sentence_task_befree_4376,,770960307,FALSE,finalized,5,8/15/15 1:43,"



",no_relation,1,,D002738,"<span class=""chemical"">chloroquine</span>",D009369,"<span class=""disease"">cancer</span>","These results suggest that <span class=""chemical"">chloroquine</span> may potentiate the anti-<span class=""disease"">cancer</span> effect of 5-FU via cell cycle inhibition.",,22716215,22716215_D002738_D009369,22716215_12,bcv_sentence_task_befree_4377,,770960308,FALSE,finalized,5,8/15/15 1:24,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D009369,"<span class=""disease"">cancer</span>","These results suggest that chloroquine may potentiate the anti-<span class=""disease"">cancer</span> effect of <span class=""chemical"">5-FU</span> via cell cycle inhibition.",,22716215,22716215_D005472_D009369,22716215_12,bcv_sentence_task_befree_4378,,770960309,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,D002738,"<span class=""chemical"">Chloroquine</span>",D009369,"<span class=""disease"">cancer/colon cancer</span>","<span class=""chemical"">Chloroquine</span> potentiates the anti-<span class=""disease"">cancer</span> effect of 5-FU in <span class=""disease"">colon cancer</span> cells.",,22716215,22716215_D002738_D009369,22716215_13,bcv_sentence_task_befree_4379,,770960310,FALSE,finalized,5,8/15/15 0:00,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D009369,"<span class=""disease"">cancer/colon cancer</span>","Chloroquine potentiates the anti-<span class=""disease"">cancer</span> effect of <span class=""chemical"">5-FU</span> in <span class=""disease"">colon cancer</span> cells.",,22716215,22716215_D005472_D009369,22716215_13,bcv_sentence_task_befree_4380,,770960311,FALSE,finalized,5,8/15/15 0:14,"



",no_relation,1,,D002738,"<span class=""chemical"">chloroquine</span>",D009369,"<span class=""disease"">cancer</span>","Supplementation of conventional chemotherapy with <span class=""chemical"">chloroquine</span> may provide a new <span class=""disease"">cancer</span> therapy modality.",,22716215,22716215_D002738_D009369,22716215_14,bcv_sentence_task_befree_4381,,770960312,FALSE,finalized,5,8/14/15 23:23,"



",no_relation,0.81,,C012566,"<span class=""chemical"">taurolidine</span>",D018805,"<span class=""disease"">sepsis</span>","We further evaluated the immunomodulatory role of the amino-acid derivative <span class=""chemical"">taurolidine</span> in our in vitro <span class=""disease"">sepsis</span> model.",,22727544,22727544_C012566_D018805,22727544_5,bcv_sentence_task_befree_4382,,770960313,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,1,,D000596,"<span class=""chemical"">amino-acid</span>",D018805,"<span class=""disease"">sepsis</span>","We further evaluated the immunomodulatory role of the <span class=""chemical"">amino-acid</span> derivative taurolidine in our in vitro <span class=""disease"">sepsis</span> model.",,22727544,22727544_D000596_D018805,22727544_5,bcv_sentence_task_befree_4383,,770960314,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,C012566,"<span class=""chemical"">Taurolidine</span>",D009336,"<span class=""disease"">necrosis</span>","<span class=""chemical"">Taurolidine</span> inhibited immunoglobulin (IL)-6, IL-8 and tumor <span class=""disease"">necrosis</span> factor-alpha expression in a dose dependent-fashion in both, pediatric oncology patients and healthy controls.",,22727544,22727544_C012566_D009336,22727544_8,bcv_sentence_task_befree_4384,,770960315,FALSE,finalized,5,8/14/15 22:53,"



",no_relation,1,,D011433,"<span class=""chemical"">propranolol</span>",D006391,"<span class=""disease"">hemangiomas</span>","Outpatient treatment of infantile <span class=""disease"">hemangiomas</span> with <span class=""chemical"">propranolol</span>: a prospective study.",,22727954,22727954_D011433_D006391,22727954_0,bcv_sentence_task_befree_4385,,770960316,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,1,,D011433,"<span class=""chemical"">propranolol</span>",D006391,"<span class=""disease"">hemangiomas</span>","To assess thesafety and effectiveness of oral <span class=""chemical"">propranolol</span>(OP) in the treatment of infantile <span class=""disease"">hemangiomas</span>.",,22727954,22727954_D011433_D006391,22727954_1,bcv_sentence_task_befree_4386,,770960317,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,1,,D011433,"<span class=""chemical"">propranolol</span>",D006391,"<span class=""disease"">hemangiomas</span>","We conducted a prospective study of infantile <span class=""disease"">hemangiomas</span>(IHs) treated with oral <span class=""chemical"">propranolol</span> between October 2008 and March 2011.",,22727954,22727954_D011433_D006391,22727954_2,bcv_sentence_task_befree_4387,,770960318,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,1,,D011433,"<span class=""chemical"">propranolol</span>",D006391,"<span class=""disease"">hemangiomas</span>","Oral <span class=""chemical"">propranolol</span> was clinically effective in reducing the volume and color of infantile <span class=""disease"">hemangiomas</span>, although the reduction was not complete and telangiectasia and scarring persisted after treatment.",,22727954,22727954_D011433_D006391,22727954_16,bcv_sentence_task_befree_4388,,770960319,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,D011433,"<span class=""chemical"">propranolol</span>",D013684,"<span class=""disease"">telangiectasia</span>","Oral <span class=""chemical"">propranolol</span> was clinically effective in reducing the volume and color of infantile hemangiomas, although the reduction was not complete and <span class=""disease"">telangiectasia</span> and scarring persisted after treatment.",,22727954,22727954_D011433_D013684,22727954_16,bcv_sentence_task_befree_4389,,770960320,FALSE,finalized,5,8/14/15 23:21,"



",no_relation,0.7984,,D014212,"<span class=""chemical"">ATRA</span>",D015473,"<span class=""disease"">APL</span>","Patients with <span class=""disease"">APL</span> and t(15;17) alone are significantly more sensitive to treatment with <span class=""chemical"">ATRA</span> than are patients with t(15;17) and additional cytogenetic abnormalities.",,22729365,22729365_D014212_D015473,22729365_6,bcv_sentence_task_befree_4390,,770960321,FALSE,finalized,5,8/14/15 22:39,"



",no_relation,0.792,,D017294,"<span class=""chemical"">ondansetron</span>",D020250,"<span class=""disease"">prophylaxis of postoperative vomiting</span>","Dexamethasone versus <span class=""chemical"">ondansetron</span> in combination with dexamethasone for the <span class=""disease"">prophylaxis of postoperative vomiting</span> in pediatric outpatients: a double-blind, randomized, placebo-controlled clinical trial.",,22731240,22731240_D017294_D020250,22731240_0,bcv_sentence_task_befree_4391,,770960322,FALSE,finalized,5,8/14/15 23:20,"



",no_relation,1,,D003907,"<span class=""chemical"">Dexamethasone</span>",D020250,"<span class=""disease"">prophylaxis of postoperative vomiting</span>","<span class=""chemical"">Dexamethasone</span> versus ondansetron in combination with <span class=""chemical"">dexamethasone</span> for the <span class=""disease"">prophylaxis of postoperative vomiting</span> in pediatric outpatients: a double-blind, randomized, placebo-controlled clinical trial.",,22731240,22731240_D003907_D020250,22731240_0,bcv_sentence_task_befree_4392,,770960323,FALSE,finalized,5,8/14/15 23:32,"

Used as a not-so-useful prevention.

",no_relation,0.6112,,D017294,"<span class=""chemical"">ondansetron</span>",D020250,"<span class=""disease"">Postoperative vomiting</span>","<span class=""disease"">Postoperative vomiting</span> occurred in 12.4% of the children, with no statistically significant difference between the groups: 6.8% in the group receiving <span class=""chemical"">ondansetron</span> combined with dexamethasone, 14.3% in the placebo group, and 14% in the group that received dexamethasone alone (P = 0.47).",,22731240,22731240_D017294_D020250,22731240_8,bcv_sentence_task_befree_4393,,770960324,FALSE,finalized,5,8/15/15 1:54,"



",yes_direct,0.5731,,D003907,"<span class=""chemical"">dexamethasone</span>",D020250,"<span class=""disease"">Postoperative vomiting</span>","<span class=""disease"">Postoperative vomiting</span> occurred in 12.4% of the children, with no statistically significant difference between the groups: 6.8% in the group receiving ondansetron combined with <span class=""chemical"">dexamethasone</span>, 14.3% in the placebo group, and 14% in the group that received <span class=""chemical"">dexamethasone</span> alone (P = 0.47).",,22731240,22731240_D003907_D020250,22731240_8,bcv_sentence_task_befree_4394,,770960325,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,0.7954,,D013256,"<span class=""chemical"">steroid</span>",D029461,"<span class=""disease"">SD</span>","Before <span class=""chemical"">steroid</span> treatment, 60 recurrences occurred, corresponding to a mean of 4.03  4.22 (<span class=""disease"">SD</span>) relapses per year.",,22731702,22731702_D013256_D029461,22731702_7,bcv_sentence_task_befree_4395,,770960326,FALSE,finalized,5,8/14/15 22:49,"



",yes_direct,0.5907,,D011241,"<span class=""chemical"">prednisone</span>",D029461,"<span class=""disease"">SD</span>","After the first treatment with <span class=""chemical"">prednisone</span>, patients experienced 47 relapses, representing a mean of 1.11  1.27 (<span class=""disease"">SD</span>) relapses per year (p = 0.0371).",,22731702,22731702_D011241_D029461,22731702_8,bcv_sentence_task_befree_4396,,770960327,FALSE,finalized,5,8/14/15 22:42,"



",no_relation,0.6139,,D000255,"<span class=""chemical"">ATP</span>",D019636,"<span class=""disease"">neurodegenerative diseases</span>","In addition to <span class=""chemical"">ATP</span> synthesis mitochondria are key regulators of calcium homeostasis, free radical production, steroid synthesis and apoptosis, each of these factors could also be associated with essential mechanisms involved in <span class=""disease"">neurodegenerative diseases</span>.",,22743330,22743330_D000255_D019636,22743330_2,bcv_sentence_task_befree_4397,,770960328,FALSE,finalized,5,8/14/15 23:09,"



",no_relation,0.4084,,D002118,"<span class=""chemical"">calcium</span>",D019636,"<span class=""disease"">neurodegenerative diseases</span>","In addition to ATP synthesis mitochondria are key regulators of <span class=""chemical"">calcium</span> homeostasis, free radical production, steroid synthesis and apoptosis, each of these factors could also be associated with essential mechanisms involved in <span class=""disease"">neurodegenerative diseases</span>.",,22743330,22743330_D002118_D019636,22743330_2,bcv_sentence_task_befree_4398,,770960329,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,0.7908,,D013256,"<span class=""chemical"">steroid</span>",D019636,"<span class=""disease"">neurodegenerative diseases</span>","In addition to ATP synthesis mitochondria are key regulators of calcium homeostasis, free radical production, <span class=""chemical"">steroid</span> synthesis and apoptosis, each of these factors could also be associated with essential mechanisms involved in <span class=""disease"">neurodegenerative diseases</span>.",,22743330,22743330_D013256_D019636,22743330_2,bcv_sentence_task_befree_4399,,770960330,FALSE,finalized,5,8/14/15 23:45,"



'improved dramatically' being the key term.",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D009069,"<span class=""disease"">ipsilateral ear vesicles</span>","We report a case of Ramsay Hunt syndrome in an immune compromised patient, with classic facial nerve palsy and <span class=""disease"">ipsilateral ear vesicles</span>, which rapidly evolved to involve multiple cranial neuropathies, and improved dramatically with antiviral therapy and <span class=""chemical"">corticosteroids</span>.",,22772935,22772935_D000305_D009069,22772935_2,bcv_sentence_task_befree_4400,,770960331,FALSE,finalized,5,8/15/15 1:22,"



",no_relation,0.8075,,D000305,"<span class=""chemical"">corticosteroids</span>",D016697,"<span class=""disease"">Ramsay Hunt syndrome</span>","We report a case of <span class=""disease"">Ramsay Hunt syndrome</span> in an immune compromised patient, with classic facial nerve palsy and ipsilateral ear vesicles, which rapidly evolved to involve multiple cranial neuropathies, and improved dramatically with antiviral therapy and <span class=""chemical"">corticosteroids</span>.",,22772935,22772935_D000305_D016697,22772935_2,bcv_sentence_task_befree_4401,,770960332,FALSE,finalized,5,8/14/15 22:35,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D003389,"<span class=""disease"">multiple cranial neuropathies</span>","We report a case of Ramsay Hunt syndrome in an immune compromised patient, with classic facial nerve palsy and ipsilateral ear vesicles, which rapidly evolved to involve <span class=""disease"">multiple cranial neuropathies</span>, and improved dramatically with antiviral therapy and <span class=""chemical"">corticosteroids</span>.",,22772935,22772935_D000305_D003389,22772935_2,bcv_sentence_task_befree_4402,,770960333,FALSE,finalized,5,8/14/15 22:52,"



",no_relation,0.8005,,D000305,"<span class=""chemical"">corticosteroids</span>",D005155,"<span class=""disease"">facial nerve palsy</span>","We report a case of Ramsay Hunt syndrome in an immune compromised patient, with classic <span class=""disease"">facial nerve palsy</span> and ipsilateral ear vesicles, which rapidly evolved to involve multiple cranial neuropathies, and improved dramatically with antiviral therapy and <span class=""chemical"">corticosteroids</span>.",,22772935,22772935_D000305_D005155,22772935_2,bcv_sentence_task_befree_4403,,770960334,FALSE,finalized,5,8/15/15 1:53,"



",no_relation,1,,D000212,"<span class=""chemical"">acyclovir</span>",D003389,"<span class=""disease"">multiple cranial neuropathies</span>","Varicella zoster virus should be considered as a cause of <span class=""disease"">multiple cranial neuropathies</span> in an immune compromised patient, and abrupt treatment with <span class=""chemical"">acyclovir</span> should be initiated once this diagnosis is suspected.",,22772935,22772935_D000212_D003389,22772935_3,bcv_sentence_task_befree_4404,,770960335,FALSE,finalized,5,8/14/15 22:37,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D000230,"<span class=""disease"">adenocarcinomas</span>","We aimed to determine whether a receptor <span class=""chemical"">tyrosine</span> kinase (RTK) array could be used to select the most effective therapeutic strategies in molecularly heterogeneous oesophago-gastric <span class=""disease"">adenocarcinomas</span>.",,22773546,22773546_D014443_D000230,22773546_2,bcv_sentence_task_befree_4405,,770960336,FALSE,finalized,5,8/15/15 1:25,"



",yes_direct,1,,D015575,"<span class=""chemical"">Roxithromycin</span>",D064420,"<span class=""disease"">toxic epidermal necrolysis</span>","<span class=""chemical"">Roxithromycin</span>-induced <span class=""disease"">toxic epidermal necrolysis</span>.",,22777150,22777150_D015575_D064420,22777150_0,bcv_sentence_task_befree_4406,,770960337,FALSE,finalized,5,8/15/15 1:57,"



",yes_direct,0.7946,,D015575,"<span class=""chemical"">roxithromycin</span>",D064420,"<span class=""disease"">adverse drug reaction/TEN/toxic epidermal necrolysis</span>","This case report highlights a very rare <span class=""disease"">adverse drug reaction</span> of oral <span class=""chemical"">roxithromycin</span> causing <span class=""disease"">toxic epidermal necrolysis</span> (<span class=""disease"">TEN</span>).",,22777150,22777150_D015575_D064420,22777150_1,bcv_sentence_task_befree_4407,,770960338,FALSE,finalized,5,8/14/15 22:41,"



",no_relation,1,,D015575,"<span class=""chemical"">roxithromycin</span>",D012141,"<span class=""disease"">upper respiratory tract infection</span>","A 54-year-old male patient diagnosed with <span class=""disease"">upper respiratory tract infection</span> was prescribed oral <span class=""chemical"">roxithromycin</span> 150 mg twice daily for 7 days.",,22777150,22777150_D015575_D012141,22777150_2,bcv_sentence_task_befree_4408,,770960339,FALSE,finalized,5,8/15/15 0:49,"



",yes_direct,1,,D015575,"<span class=""chemical"">roxithromycin</span>",D064420,"<span class=""disease"">TEN</span>","This episode of <span class=""disease"">TEN</span> was probably drug (<span class=""chemical"">roxithromycin</span>) induced.",,22777150,22777150_D015575_D064420,22777150_8,bcv_sentence_task_befree_4409,,770960340,FALSE,finalized,5,8/14/15 23:26,"



",yes_direct,1,,D015575,"<span class=""chemical"">roxithromycin</span>",D064420,"<span class=""disease"">adverse drug reaction/TEN</span>","Naranjo <span class=""disease"">adverse drug reaction</span> probability scale suggested the likelihood that oral administration of <span class=""chemical"">roxithromycin</span> was responsible for the <span class=""disease"">TEN</span> was 'probable.",,22777150,22777150_D015575_D064420,22777150_10,bcv_sentence_task_befree_4410,,770960341,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,0.8185,,D009173,"<span class=""chemical"">mycophenolic acid/MPA</span>",D005767,"<span class=""disease"">gastrointestinal (GI) complications</span>","To evaluate the incidence of <span class=""disease"">gastrointestinal (GI) complications</span> in solid organ transplant (SOT) recipients, impact of the complications on transplant outcomes, and the potential interactions between <span class=""chemical"">mycophenolic acid</span> (<span class=""chemical"">MPA</span>) derivatives and proton pump inhibitors (PPIs).",,22811345,22811345_D009173_D005767,22811345_1,bcv_sentence_task_befree_4411,,770960342,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,0.7945,,D009173,"<span class=""chemical"">mycophenolic acid</span>",D005767,"<span class=""disease"">GI complications</span>","An unrestricted literature search (1980-January 2012) was performed with MEDLINE and EMBASE using the following key words: drug-drug interaction, enteric-coated <span class=""chemical"">mycophenolic acid</span>, <span class=""disease"">GI complications</span>, mycophenolate mofetil, solid organ transplant, and proton pump inhibitor, including individual agents within the class.",,22811345,22811345_D009173_D005767,22811345_2,bcv_sentence_task_befree_4412,,770960343,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,1,,C063008,"<span class=""chemical"">mycophenolate mofetil</span>",D005767,"<span class=""disease"">GI complications</span>","An unrestricted literature search (1980-January 2012) was performed with MEDLINE and EMBASE using the following key words: drug-drug interaction, enteric-coated mycophenolic acid, <span class=""disease"">GI complications</span>, <span class=""chemical"">mycophenolate mofetil</span>, solid organ transplant, and proton pump inhibitor, including individual agents within the class.",,22811345,22811345_C063008_D005767,22811345_2,bcv_sentence_task_befree_4413,,770960344,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,1,,D016559,"<span class=""chemical"">tacrolimus</span>",D006086,"<span class=""disease"">ocular graft versus host disease</span>","Therapeutic effect of 0.03% <span class=""chemical"">tacrolimus</span> ointment for <span class=""disease"">ocular graft versus host disease</span> and vernal keratoconjunctivitis.",,22870021,22870021_D016559_D006086,22870021_0,bcv_sentence_task_befree_4414,,770960345,FALSE,finalized,5,8/14/15 23:40,"



",no_relation,1,,D016559,"<span class=""chemical"">tacrolimus</span>",D003233,"<span class=""disease"">vernal keratoconjunctivitis</span>","Therapeutic effect of 0.03% <span class=""chemical"">tacrolimus</span> ointment for ocular graft versus host disease and <span class=""disease"">vernal keratoconjunctivitis</span>.",,22870021,22870021_D016559_D003233,22870021_0,bcv_sentence_task_befree_4415,,770960346,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,1,,D016559,"<span class=""chemical"">tacrolimus</span>",D006086,"<span class=""disease"">ocular graft versus host disease/GVHD</span>","To determine whether topical <span class=""chemical"">tacrolimus</span> might prove effective in the treatment of refractory anterior segment inflammatory diseases, and to evaluate its efficacy in eyes with <span class=""disease"">ocular graft versus host disease</span> (<span class=""disease"">GVHD</span>), and vernal keratoconjunctivitis (VKC).",,22870021,22870021_D016559_D006086,22870021_1,bcv_sentence_task_befree_4416,,770960347,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,1,,D016559,"<span class=""chemical"">tacrolimus</span>",D007249,"<span class=""disease"">inflammatory diseases</span>","To determine whether topical <span class=""chemical"">tacrolimus</span> might prove effective in the treatment of refractory anterior segment <span class=""disease"">inflammatory diseases</span>, and to evaluate its efficacy in eyes with ocular graft versus host disease (GVHD), and vernal keratoconjunctivitis (VKC).",,22870021,22870021_D016559_D007249,22870021_1,bcv_sentence_task_befree_4417,,770960348,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,1,,D016559,"<span class=""chemical"">tacrolimus</span>",D003233,"<span class=""disease"">vernal keratoconjunctivitis/VKC</span>","To determine whether topical <span class=""chemical"">tacrolimus</span> might prove effective in the treatment of refractory anterior segment inflammatory diseases, and to evaluate its efficacy in eyes with ocular graft versus host disease (GVHD), and <span class=""disease"">vernal keratoconjunctivitis</span> (<span class=""disease"">VKC</span>).",,22870021,22870021_D016559_D003233,22870021_1,bcv_sentence_task_befree_4418,,770960349,FALSE,finalized,5,8/14/15 23:20,"



",no_relation,1,,D016559,"<span class=""chemical"">tacrolimus</span>",D007249,"<span class=""disease"">inflammation</span>","Twenty-eight eyes of 14 patients with anterior segment <span class=""disease"">inflammation</span> refractory to steroid treatment were treated with 0.03% <span class=""chemical"">tacrolimus</span> ointment at the Samsung Medical Center, Seoul, Korea from March 2008 through August 2009.",,22870021,22870021_D016559_D007249,22870021_2,bcv_sentence_task_befree_4419,,770960350,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,D013256,"<span class=""chemical"">steroid</span>",D007249,"<span class=""disease"">inflammation</span>","Twenty-eight eyes of 14 patients with anterior segment <span class=""disease"">inflammation</span> refractory to <span class=""chemical"">steroid</span> treatment were treated with 0.03% tacrolimus ointment at the Samsung Medical Center, Seoul, Korea from March 2008 through August 2009.",,22870021,22870021_D013256_D007249,22870021_2,bcv_sentence_task_befree_4420,,770960351,FALSE,finalized,5,8/14/15 23:25,"


Used as treatment.
",no_relation,1,,D016559,"<span class=""chemical"">tacrolimus</span>",D007249,"<span class=""disease"">inflammatory disease</span>","0.03% <span class=""chemical"">tacrolimus</span> ointment was safe and effective for use in anterior segment <span class=""disease"">inflammatory disease</span> refractory to steroid.",,22870021,22870021_D016559_D007249,22870021_13,bcv_sentence_task_befree_4421,,770960352,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,0.8164,,D013256,"<span class=""chemical"">steroid</span>",D007249,"<span class=""disease"">inflammatory disease</span>","0.03% tacrolimus ointment was safe and effective for use in anterior segment <span class=""disease"">inflammatory disease</span> refractory to <span class=""chemical"">steroid</span>.",,22870021,22870021_D013256_D007249,22870021_13,bcv_sentence_task_befree_4422,,770960353,FALSE,finalized,5,8/14/15 22:51,"



",yes_direct,0.7787,,D007980,"<span class=""chemical"">levodopa</span>",D014082,"<span class=""disease"">fractures</span>","Recurrent bilateral metatarsal ""stress-and-insufficiency"" <span class=""disease"">fractures</span> in a <span class=""chemical"">levodopa</span>-treated young woman with Parkinson's disease.",,22875460,22875460_D007980_D014082,22875460_0,bcv_sentence_task_befree_4423,,770960354,FALSE,finalized,5,8/14/15 23:24,"



",no_relation,1,,D007980,"<span class=""chemical"">levodopa</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","Recurrent bilateral metatarsal ""stress-and-insufficiency"" fractures in a <span class=""chemical"">levodopa</span>-treated young woman with <span class=""disease"">Parkinson's disease</span>.",,22875460,22875460_D007980_D010300,22875460_0,bcv_sentence_task_befree_4424,,770960355,FALSE,finalized,5,8/14/15 22:42,"



",no_relation,0.5946,,D007980,"<span class=""chemical"">Levodopa</span>",C536141,"<span class=""disease"">disease course</span>","<span class=""chemical"">Levodopa</span> treatment of Parkinson's disease is very effective, but many types of adverse events can complicate the <span class=""disease"">disease course</span>, especially dyskinesias.",,22875460,22875460_D007980_C536141,22875460_1,bcv_sentence_task_befree_4425,,770960356,FALSE,finalized,5,8/14/15 23:06,"



",yes_direct,0.7977,,D007980,"<span class=""chemical"">Levodopa</span>",D004409,"<span class=""disease"">dyskinesias</span>","<span class=""chemical"">Levodopa</span> treatment of Parkinson's disease is very effective, but many types of adverse events can complicate the disease course, especially <span class=""disease"">dyskinesias</span>.",,22875460,22875460_D007980_D004409,22875460_1,bcv_sentence_task_befree_4426,,770960357,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,1,,D007980,"<span class=""chemical"">Levodopa</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","<span class=""chemical"">Levodopa</span> treatment of <span class=""disease"">Parkinson's disease</span> is very effective, but many types of adverse events can complicate the disease course, especially dyskinesias.",,22875460,22875460_D007980_D010300,22875460_1,bcv_sentence_task_befree_4427,,770960358,FALSE,finalized,5,8/15/15 1:15,"



",yes_indirect,1,,D007980,"<span class=""chemical"">levodopa</span>",D058866,"<span class=""disease"">osteoporotic fractures</span>","(Calcif Tissue Int 86:132-41, 2010), <span class=""chemical"">levodopa</span> intake is associated with increased homocysteinemia that is known to be linked to poorer bone quality and, consequently, <span class=""disease"">osteoporotic fractures</span>.",,22875460,22875460_D007980_D058866,22875460_3,bcv_sentence_task_befree_4428,,770960359,FALSE,finalized,5,8/14/15 23:11,"



",yes_direct,1,,D007980,"<span class=""chemical"">levodopa</span>",C566403,"<span class=""disease"">homocysteinemia</span>","(Calcif Tissue Int 86:132-41, 2010), <span class=""chemical"">levodopa</span> intake is associated with increased <span class=""disease"">homocysteinemia</span> that is known to be linked to poorer bone quality and, consequently, osteoporotic fractures.",,22875460,22875460_D007980_C566403,22875460_3,bcv_sentence_task_befree_4429,,770960360,FALSE,finalized,5,8/14/15 23:55,"



",yes_direct,0.816,,D007980,"<span class=""chemical"">levodopa</span>",D014082,"<span class=""disease"">fractures</span>","Herein, we report the case of a young woman who suffered recurrent metatarsal <span class=""disease"">fractures</span> in the context of <span class=""chemical"">levodopa</span>-treated early-onset Parkinson's disease.",,22875460,22875460_D007980_D014082,22875460_4,bcv_sentence_task_befree_4430,,770960361,FALSE,finalized,5,8/14/15 22:32,"



",no_relation,1,,D007980,"<span class=""chemical"">levodopa</span>",D010300,"<span class=""disease"">Parkinson's disease</span>","Herein, we report the case of a young woman who suffered recurrent metatarsal fractures in the context of <span class=""chemical"">levodopa</span>-treated early-onset <span class=""disease"">Parkinson's disease</span>.",,22875460,22875460_D007980_D010300,22875460_4,bcv_sentence_task_befree_4431,,770960362,FALSE,finalized,5,8/15/15 1:23,"



",yes_direct,0.6093,,D006220,"<span class=""chemical"">haloperidol</span>",D002375,"<span class=""disease"">catalepsy</span>","Further, THPP-1 displays significantly fewer preclinical adverse events in assays measuring prolactin secretion, <span class=""disease"">catalepsy</span>, and weight gain, in contrast to the typical and atypical antipsychotics <span class=""chemical"">haloperidol</span> and olanzapine.",,22892116,22892116_D006220_D002375,22892116_5,bcv_sentence_task_befree_4432,,770960363,FALSE,finalized,5,8/15/15 2:34,"



",yes_direct,0.589,,C076029,"<span class=""chemical"">olanzapine</span>",D015430,"<span class=""disease"">weight gain</span>","Further, THPP-1 displays significantly fewer preclinical adverse events in assays measuring prolactin secretion, catalepsy, and <span class=""disease"">weight gain</span>, in contrast to the typical and atypical antipsychotics haloperidol and <span class=""chemical"">olanzapine</span>.",,22892116,22892116_C076029_D015430,22892116_5,bcv_sentence_task_befree_4433,,770960364,FALSE,finalized,5,8/14/15 22:47,"



",no_relation,0.7982,,D006220,"<span class=""chemical"">haloperidol</span>",D015430,"<span class=""disease"">weight gain</span>","Further, THPP-1 displays significantly fewer preclinical adverse events in assays measuring prolactin secretion, catalepsy, and <span class=""disease"">weight gain</span>, in contrast to the typical and atypical antipsychotics <span class=""chemical"">haloperidol</span> and olanzapine.",,22892116,22892116_D006220_D015430,22892116_5,bcv_sentence_task_befree_4434,,770960365,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,0.8039,,C076029,"<span class=""chemical"">olanzapine</span>",D002375,"<span class=""disease"">catalepsy</span>","Further, THPP-1 displays significantly fewer preclinical adverse events in assays measuring prolactin secretion, <span class=""disease"">catalepsy</span>, and weight gain, in contrast to the typical and atypical antipsychotics haloperidol and <span class=""chemical"">olanzapine</span>.",,22892116,22892116_C076029_D002375,22892116_5,bcv_sentence_task_befree_4435,,770960366,FALSE,finalized,5,8/15/15 1:12,"



",no_relation,0.7908,,D002945,"<span class=""chemical"">cisplatin</span>",D009447,"<span class=""disease"">neuroblastoma</span>","MicroRNA-204 increases sensitivity of <span class=""disease"">neuroblastoma</span> cells to <span class=""chemical"">cisplatin</span> and is associated with a favourable clinical outcome.",,22892391,22892391_D002945_D009447,22892391_0,bcv_sentence_task_befree_4436,,770960367,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D009447,"<span class=""disease"">neuroblastoma</span>","MiR-204 is a novel predictor of outcome in <span class=""disease"">neuroblastoma</span>, functioning, at least in part, through increasing sensitivity to <span class=""chemical"">cisplatin</span> by direct targeting and downregulation of anti-apoptotic BCL2. miR-204 also targets full-length NTRK2, a potent oncogene involved with chemotherapy drug resistance in <span class=""disease"">neuroblastoma</span>.",,22892391,22892391_D002945_D009447,22892391_8,bcv_sentence_task_befree_4437,,770960368,FALSE,finalized,5,8/15/15 1:21,"



",yes_direct,0.7942,,C098720,"<span class=""chemical"">fingolimod</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","Severe <span class=""disease"">multiple sclerosis</span> reactivation under <span class=""chemical"">fingolimod</span> 3 months after natalizumab withdrawal.",,22907938,22907938_C098720_D009103,22907938_0,bcv_sentence_task_befree_4438,,770960369,FALSE,finalized,5,8/14/15 22:43,"



",yes_direct,0.5771,,C098720,"<span class=""chemical"">fingolimod</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","We report the case of a woman with <span class=""disease"">multiple sclerosis</span> who developed a severe neurological condition following natalizumab (NZB) withdrawal and soon after <span class=""chemical"">fingolimod</span> (FTY) initiation.",,22907938,22907938_C098720_D009103,22907938_1,bcv_sentence_task_befree_4439,,770960370,FALSE,finalized,5,8/15/15 1:50,"



",yes_direct,1,,C098720,"<span class=""chemical"">fingolimod</span>",D019636,"<span class=""disease"">neurological condition</span>","We report the case of a woman with multiple sclerosis who developed a severe <span class=""disease"">neurological condition</span> following natalizumab (NZB) withdrawal and soon after <span class=""chemical"">fingolimod</span> (FTY) initiation.",,22907938,22907938_C098720_D019636,22907938_1,bcv_sentence_task_befree_4440,,770960371,FALSE,finalized,5,8/14/15 22:41,"



",no_relation,1,,D001564,"<span class=""chemical"">benzo[a]pyrene</span>",C535575,"<span class=""disease"">HNSCC</span>","Treatment of these cell lines with the AhR antagonists 6, 2', 4'-trimethoxyflavone, or the more potent GNF351, decreased migration and invasion of <span class=""disease"">HNSCC</span> cells and prevented <span class=""chemical"">benzo[a]pyrene</span>-mediated induction of the chemotherapy efflux protein ABCG2.",,22912337,22912337_D001564_C535575,22912337_9,bcv_sentence_task_befree_4441,,770960372,FALSE,finalized,5,8/15/15 2:49,"



",no_relation,1,,D053243,"<span class=""chemical"">zanamivir</span>",D007251,"<span class=""disease"">influenza-like illness</span>","An uncontrolled open-label, multicenter study to monitor the antiviral activity and safety of inhaled <span class=""chemical"">zanamivir</span> (as Rotadisk via Diskhaler device) among Chinese adolescents and adults with <span class=""disease"">influenza-like illness</span>.",,22932170,22932170_D053243_D007251,22932170_0,bcv_sentence_task_befree_4442,,770960373,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,1,,D053243,"<span class=""chemical"">zanamivir</span>",D007251,"<span class=""disease"">influenza-like illness/ILI</span>","It is the first multicenter clinical study in China to investigate <span class=""chemical"">zanamivir</span> use among Chinese adolescents and adults with <span class=""disease"">influenza-like illness</span> (<span class=""disease"">ILI</span>) since 2009, when inhaled <span class=""chemical"">zanamivir</span> (RELENZA()) was marketed in China.",,22932170,22932170_D053243_D007251,22932170_1,bcv_sentence_task_befree_4443,,770960374,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D053243,"<span class=""chemical"">zanamivir</span>",D007251,"<span class=""disease"">ILI</span>","An uncontrolled open-label, multicentre study to evaluate the antiviral activity, and safety of inhaled <span class=""chemical"">zanamivir</span> (as Rotadisk via Diskhaler device); 10 mg administered twice daily for 5 days in subjects  12 years old with <span class=""disease"">ILI</span>.",,22932170,22932170_D053243_D007251,22932170_2,bcv_sentence_task_befree_4444,,770960375,FALSE,finalized,5,8/14/15 23:34,"



",yes_direct,0.8028,,D053243,"<span class=""chemical"">zanamivir</span>",D001986,"<span class=""disease"">Bronchospasm</span>","<span class=""disease"">Bronchospasm</span> was found in a 38 years old woman whose symptoms disappeared after stopping <span class=""chemical"">zanamivir</span> and without additional treatment.",,22932170,22932170_D053243_D001986,22932170_13,bcv_sentence_task_befree_4445,,770960376,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,0.5773,,D014443,"<span class=""chemical"">tyrosine</span>",D007037,"<span class=""disease"">Hypothyroidism</span>","<span class=""disease"">Hypothyroidism</span> during treatment with <span class=""chemical"">tyrosine</span> kinase inhibitors.",,22933166,22933166_D014443_D007037,22933166_0,bcv_sentence_task_befree_4446,,770960378,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,D014443,"<span class=""chemical"">Tyrosine</span>",D009369,"<span class=""disease"">pancreatic neuroendocrine tumours/gastrointestinal stromal tumours</span>","<span class=""chemical"">Tyrosine</span> kinase inhibitors are relatively new targeted therapy drugs used for the treatment of metastatic clear cell kidney carcinoma, <span class=""disease"">gastrointestinal stromal tumours</span>, thyroid carcinoma and <span class=""disease"">pancreatic neuroendocrine tumours</span> during the progression of the disease.",,22933166,22933166_D014443_D009369,22933166_1,bcv_sentence_task_befree_4447,,770960379,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,D014443,"<span class=""chemical"">Tyrosine</span>",D007674,"<span class=""disease"">clear cell kidney carcinoma</span>","<span class=""chemical"">Tyrosine</span> kinase inhibitors are relatively new targeted therapy drugs used for the treatment of metastatic <span class=""disease"">clear cell kidney carcinoma</span>, gastrointestinal stromal tumours, thyroid carcinoma and pancreatic neuroendocrine tumours during the progression of the disease.",,22933166,22933166_D014443_D007674,22933166_1,bcv_sentence_task_befree_4448,,770960380,FALSE,finalized,5,8/14/15 23:15,"



",no_relation,1,,D014443,"<span class=""chemical"">Tyrosine</span>",D013964,"<span class=""disease"">thyroid carcinoma</span>","<span class=""chemical"">Tyrosine</span> kinase inhibitors are relatively new targeted therapy drugs used for the treatment of metastatic clear cell kidney carcinoma, gastrointestinal stromal tumours, <span class=""disease"">thyroid carcinoma</span> and pancreatic neuroendocrine tumours during the progression of the disease.",,22933166,22933166_D014443_D013964,22933166_1,bcv_sentence_task_befree_4449,,770960381,FALSE,finalized,5,8/14/15 23:53,"



",no_relation,0.6104,,D014443,"<span class=""chemical"">tyrosine</span>",D007037,"<span class=""disease"">hypothyroidism</span>","This is the most described <span class=""chemical"">tyrosine</span> kinase inhibitor which causes <span class=""disease"">hypothyroidism</span>.",,22933166,22933166_D014443_D007037,22933166_6,bcv_sentence_task_befree_4450,,770960382,FALSE,finalized,5,8/14/15 23:01,"



",no_relation,0.805,,C471405,"<span class=""chemical"">sorafenib</span>",D002292,"<span class=""disease"">renal cell carcinoma</span>","Symptoms of hypothyroidism occur in 18% of patients treated with <span class=""chemical"">sorafenib</span> due to metastatic <span class=""disease"">renal cell carcinoma</span>.",,22933166,22933166_C471405_D002292,22933166_9,bcv_sentence_task_befree_4451,,770960383,FALSE,finalized,5,8/15/15 0:12,"



",yes_direct,1,,C471405,"<span class=""chemical"">sorafenib</span>",D007037,"<span class=""disease"">hypothyroidism</span>","Symptoms of <span class=""disease"">hypothyroidism</span> occur in 18% of patients treated with <span class=""chemical"">sorafenib</span> due to metastatic renal cell carcinoma.",,22933166,22933166_C471405_D007037,22933166_9,bcv_sentence_task_befree_4452,,770960384,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,1,,D004967,"<span class=""chemical"">oestrogen</span>",D006470,"<span class=""disease"">bleeding</span>","Progestogens with or without <span class=""chemical"">oestrogen</span> for irregular uterine <span class=""disease"">bleeding</span> associated with anovulation.",,22972055,22972055_D004967_D006470,22972055_0,bcv_sentence_task_befree_4453,,770960385,FALSE,finalized,5,8/14/15 23:10,"



",no_relation,0.8068,,D004967,"<span class=""chemical"">oestrogen</span>",D000858,"<span class=""disease"">anovulation</span>","Progestogens with or without <span class=""chemical"">oestrogen</span> for irregular uterine bleeding associated with <span class=""disease"">anovulation</span>.",,22972055,22972055_D004967_D000858,22972055_0,bcv_sentence_task_befree_4454,,770960386,FALSE,finalized,5,8/15/15 1:03,"



",yes_direct,1,,D013256,"<span class=""chemical"">steroids</span>",D006470,"<span class=""disease"">menstrual bleeding</span>","Irregular <span class=""disease"">menstrual bleeding</span> may arise due to exogenous sex <span class=""chemical"">steroids</span>, lesions of the genital tract or be associated with anovulation.",,22972055,22972055_D013256_D006470,22972055_1,bcv_sentence_task_befree_4455,,770960387,FALSE,finalized,5,8/14/15 22:56,"



",no_relation,0.8075,,D013256,"<span class=""chemical"">steroids</span>",D000858,"<span class=""disease"">anovulation</span>","Irregular menstrual bleeding may arise due to exogenous sex <span class=""chemical"">steroids</span>, lesions of the genital tract or be associated with <span class=""disease"">anovulation</span>.",,22972055,22972055_D013256_D000858,22972055_1,bcv_sentence_task_befree_4456,,770960388,FALSE,finalized,5,8/15/15 1:11,"



",yes_indirect,0.4167,,D004967,"<span class=""chemical"">oestrogen</span>",D006470,"<span class=""disease"">bleeding</span>","In anovulatory cycles there may be prolonged <span class=""chemical"">oestrogen</span> stimulation of the endometrium without progesterone withdrawal and so cycles are irregular and <span class=""disease"">bleeding</span> may be heavy.",,22972055,22972055_D004967_D006470,22972055_3,bcv_sentence_task_befree_4457,,770960389,FALSE,finalized,5,8/14/15 22:29,"



",no_relation,0.5934,,D011374,"<span class=""chemical"">progesterone</span>",D006470,"<span class=""disease"">bleeding</span>","In anovulatory cycles there may be prolonged oestrogen stimulation of the endometrium without <span class=""chemical"">progesterone</span> withdrawal and so cycles are irregular and <span class=""disease"">bleeding</span> may be heavy.",,22972055,22972055_D011374_D006470,22972055_3,bcv_sentence_task_befree_4458,,770960390,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,0.7908,,D004967,"<span class=""chemical"">oestrogen</span>",D056806,"<span class=""disease"">anovulatory cycles</span>","In <span class=""disease"">anovulatory cycles</span> there may be prolonged <span class=""chemical"">oestrogen</span> stimulation of the endometrium without progesterone withdrawal and so cycles are irregular and bleeding may be heavy.",,22972055,22972055_D004967_D056806,22972055_3,bcv_sentence_task_befree_4459,,770960391,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,0.8155,,D011374,"<span class=""chemical"">progesterone</span>",D056806,"<span class=""disease"">anovulatory cycles</span>","In <span class=""disease"">anovulatory cycles</span> there may be prolonged oestrogen stimulation of the endometrium without <span class=""chemical"">progesterone</span> withdrawal and so cycles are irregular and bleeding may be heavy.",,22972055,22972055_D011374_D056806,22972055_3,bcv_sentence_task_befree_4460,,770960392,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,1,,D004967,"<span class=""chemical"">oestrogen</span>",D014591,"<span class=""disease"">endometrial atrophy</span>","Continuous progestogen is intended to induce <span class=""disease"">endometrial atrophy</span> and hence to prevent <span class=""chemical"">oestrogen</span>-stimulated endometrial proliferation.",,22972055,22972055_D004967_D014591,22972055_5,bcv_sentence_task_befree_4461,,770960393,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,D004967,"<span class=""chemical"">oestrogens</span>",D006470,"<span class=""disease"">menstrual bleeding</span>","Progestogens, and <span class=""chemical"">oestrogens</span> and progestogens in combination, are widely used in the management of irregular <span class=""disease"">menstrual bleeding</span>, but the regime, dose and type of progestogen used vary widely, with little consensus about the optimum treatment approach.",,22972055,22972055_D004967_D006470,22972055_6,bcv_sentence_task_befree_4462,,770960394,FALSE,finalized,5,8/14/15 23:00,"



",no_relation,1,,D011374,"<span class=""chemical"">progestogens</span>",D006470,"<span class=""disease"">menstrual bleeding</span>","To determine the effectiveness and acceptability of <span class=""chemical"">progestogens</span> alone or in combination with oestrogens in the regulation of irregular <span class=""disease"">menstrual bleeding</span> associated with oligo/anovulation.",,22972055,22972055_D011374_D006470,22972055_7,bcv_sentence_task_befree_4463,,770960395,FALSE,finalized,5,8/14/15 23:06,"



",no_relation,1,,D011374,"<span class=""chemical"">progestogens</span>",D000858,"<span class=""disease"">anovulation</span>","To determine the effectiveness and acceptability of <span class=""chemical"">progestogens</span> alone or in combination with oestrogens in the regulation of irregular menstrual bleeding associated with oligo/<span class=""disease"">anovulation</span>.",,22972055,22972055_D011374_D000858,22972055_7,bcv_sentence_task_befree_4464,,770960396,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,D004967,"<span class=""chemical"">oestrogens</span>",D006470,"<span class=""disease"">menstrual bleeding</span>","To determine the effectiveness and acceptability of progestogens alone or in combination with <span class=""chemical"">oestrogens</span> in the regulation of irregular <span class=""disease"">menstrual bleeding</span> associated with oligo/anovulation.",,22972055,22972055_D004967_D006470,22972055_7,bcv_sentence_task_befree_4465,,770960397,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,D004967,"<span class=""chemical"">oestrogens</span>",D000858,"<span class=""disease"">anovulation</span>","To determine the effectiveness and acceptability of progestogens alone or in combination with <span class=""chemical"">oestrogens</span> in the regulation of irregular menstrual bleeding associated with oligo/<span class=""disease"">anovulation</span>.",,22972055,22972055_D004967_D000858,22972055_7,bcv_sentence_task_befree_4466,,770960398,FALSE,finalized,5,8/15/15 2:17,"



",no_relation,1,,D004967,"<span class=""chemical"">oestrogens</span>",D006470,"<span class=""disease"">menstrual bleeding</span>","All randomised controlled trials of progestogens (via any route) alone or in combination with <span class=""chemical"">oestrogens</span> in the treatment of irregular <span class=""disease"">menstrual bleeding</span> associated with oligo/anovulation.",,22972055,22972055_D004967_D006470,22972055_9,bcv_sentence_task_befree_4467,,770960399,FALSE,finalized,5,8/14/15 22:39,"



",no_relation,1,,D004967,"<span class=""chemical"">oestrogens</span>",D000858,"<span class=""disease"">anovulation</span>","All randomised controlled trials of progestogens (via any route) alone or in combination with <span class=""chemical"">oestrogens</span> in the treatment of irregular menstrual bleeding associated with oligo/<span class=""disease"">anovulation</span>.",,22972055,22972055_D004967_D000858,22972055_9,bcv_sentence_task_befree_4468,,770960400,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,1,,D004967,"<span class=""chemical"">oestrogens</span>",D006470,"<span class=""disease"">bleeding</span>","No randomised trials were identified that compared progestogens with <span class=""chemical"">oestrogens</span> and progestogens or with placebo in the management of irregular <span class=""disease"">bleeding</span> associated with oligo/anovulation.",,22972055,22972055_D004967_D006470,22972055_12,bcv_sentence_task_befree_4469,,770960401,FALSE,finalized,5,8/14/15 23:06,"



",no_relation,1,,D004967,"<span class=""chemical"">oestrogens</span>",D000858,"<span class=""disease"">anovulation</span>","No randomised trials were identified that compared progestogens with <span class=""chemical"">oestrogens</span> and progestogens or with placebo in the management of irregular bleeding associated with oligo/<span class=""disease"">anovulation</span>.",,22972055,22972055_D004967_D000858,22972055_12,bcv_sentence_task_befree_4470,,770960402,FALSE,finalized,5,8/14/15 22:49,"



",no_relation,1,,D004967,"<span class=""chemical"">oestrogens</span>",D006470,"<span class=""disease"">menstrual bleeding</span>","There is a paucity of randomised studies relating to the use of progestogens and of <span class=""chemical"">oestrogens</span> and progestogens in combination in the treatment of irregular <span class=""disease"">menstrual bleeding</span> associated with anovulation.",,22972055,22972055_D004967_D006470,22972055_13,bcv_sentence_task_befree_4471,,770960403,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,0.8115,,D004967,"<span class=""chemical"">oestrogens</span>",D000858,"<span class=""disease"">anovulation</span>","There is a paucity of randomised studies relating to the use of progestogens and of <span class=""chemical"">oestrogens</span> and progestogens in combination in the treatment of irregular menstrual bleeding associated with <span class=""disease"">anovulation</span>.",,22972055,22972055_D004967_D000858,22972055_13,bcv_sentence_task_befree_4472,,770960404,FALSE,finalized,5,8/15/15 1:42,"



",no_relation,1,,C408153,"<span class=""chemical"">prasugrel</span>",D009203,"<span class=""disease"">Myocardial Infarction</span>","The data from 422 patients undergoing isolated coronary artery bypass grafting from the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with <span class=""chemical"">prasugrel</span> Thrombolysis In <span class=""disease"">Myocardial Infarction</span> 38 were analyzed retrospectively.",,22995726,22995726_C408153_D009203,22995726_3,bcv_sentence_task_befree_4473,,770960405,FALSE,finalized,5,8/14/15 23:05,"



",no_relation,0.8026,,C060836,"<span class=""chemical"">pioglitazone</span>",D009765,"<span class=""disease"">obese</span>","Free carnitine and acylcarnitines in<span class=""disease"">obese</span> patients with polycystic ovary syndrome and effects of<span class=""chemical"">pioglitazone</span> treatment.",,22999793,22999793_C060836_D009765,22999793_0,bcv_sentence_task_befree_4474,,770960406,FALSE,finalized,5,8/14/15 22:51,"



",no_relation,1,,D002331,"<span class=""chemical"">carnitine</span>",D009765,"<span class=""disease"">obese</span>","Free <span class=""chemical"">carnitine</span> and acylcarnitines in<span class=""disease"">obese</span> patients with polycystic ovary syndrome and effects ofpioglitazone treatment.",,22999793,22999793_D002331_D009765,22999793_0,bcv_sentence_task_befree_4475,,770960407,FALSE,finalized,5,8/14/15 23:17,"



",no_relation,1,,C060836,"<span class=""chemical"">pioglitazone</span>",D011085,"<span class=""disease"">polycystic ovary syndrome</span>","Free carnitine and acylcarnitines inobese patients with <span class=""disease"">polycystic ovary syndrome</span> and effects of<span class=""chemical"">pioglitazone</span> treatment.",,22999793,22999793_C060836_D011085,22999793_0,bcv_sentence_task_befree_4476,,770960408,FALSE,finalized,5,8/14/15 22:55,"



",no_relation,1,,D002331,"<span class=""chemical"">carnitine</span>",D011085,"<span class=""disease"">polycystic ovary syndrome</span>","Free <span class=""chemical"">carnitine</span> and acylcarnitines inobese patients with <span class=""disease"">polycystic ovary syndrome</span> and effects ofpioglitazone treatment.",,22999793,22999793_D002331_D011085,22999793_0,bcv_sentence_task_befree_4477,,770960409,FALSE,finalized,5,8/15/15 2:09,"



",no_relation,1,,D002331,"<span class=""chemical"">carnitine</span>",D011085,"<span class=""disease"">polycystic ovary syndrome/PCOS</span>","To determine fasting and insulin-stimulated levels of <span class=""chemical"">carnitine</span> precursors, total and free <span class=""chemical"">carnitine</span>, and acylcarnitines, and evaluate the impact of pioglitazone treatment in obese patients with <span class=""disease"">polycystic ovary syndrome</span> (<span class=""disease"">PCOS</span>).",,22999793,22999793_D002331_D011085,22999793_1,bcv_sentence_task_befree_4478,,770960410,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,C060836,"<span class=""chemical"">pioglitazone</span>",D009765,"<span class=""disease"">obese</span>","To determine fasting and insulin-stimulated levels of carnitine precursors, total and free carnitine, and acylcarnitines, and evaluate the impact of <span class=""chemical"">pioglitazone</span> treatment in <span class=""disease"">obese</span> patients with polycystic ovary syndrome (PCOS).",,22999793,22999793_C060836_D009765,22999793_1,bcv_sentence_task_befree_4479,,770960411,FALSE,finalized,5,8/14/15 22:57,"



",no_relation,1,,C060836,"<span class=""chemical"">pioglitazone</span>",D015673,"<span class=""disease"">total and free carnitine</span>","To determine fasting and insulin-stimulated levels of carnitine precursors, <span class=""disease"">total and free carnitine</span>, and acylcarnitines, and evaluate the impact of <span class=""chemical"">pioglitazone</span> treatment in obese patients with polycystic ovary syndrome (PCOS).",,22999793,22999793_C060836_D015673,22999793_1,bcv_sentence_task_befree_4480,,770960412,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,0.7954,,D002331,"<span class=""chemical"">carnitine</span>",D015673,"<span class=""disease"">total and free carnitine</span>","To determine fasting and insulin-stimulated levels of <span class=""chemical"">carnitine</span> precursors, <span class=""disease"">total and free </span><span class=""chemical"">carnitine</span>, and acylcarnitines, and evaluate the impact of pioglitazone treatment in obese patients with polycystic ovary syndrome (PCOS).",,22999793,22999793_D002331_D015673,22999793_1,bcv_sentence_task_befree_4481,,770960413,FALSE,finalized,5,8/14/15 22:58,"



",no_relation,0.8005,,D002331,"<span class=""chemical"">carnitine</span>",D009765,"<span class=""disease"">obese</span>","To determine fasting and insulin-stimulated levels of <span class=""chemical"">carnitine</span> precursors, total and free <span class=""chemical"">carnitine</span>, and acylcarnitines, and evaluate the impact of pioglitazone treatment in <span class=""disease"">obese</span> patients with polycystic ovary syndrome (PCOS).",,22999793,22999793_D002331_D009765,22999793_1,bcv_sentence_task_befree_4482,,770960414,FALSE,finalized,5,8/14/15 22:53,"



",no_relation,1,,C060836,"<span class=""chemical"">pioglitazone</span>",D011085,"<span class=""disease"">polycystic ovary syndrome/PCOS</span>","To determine fasting and insulin-stimulated levels of carnitine precursors, total and free carnitine, and acylcarnitines, and evaluate the impact of <span class=""chemical"">pioglitazone</span> treatment in obese patients with <span class=""disease"">polycystic ovary syndrome</span> (<span class=""disease"">PCOS</span>).",,22999793,22999793_C060836_D011085,22999793_1,bcv_sentence_task_befree_4483,,770960415,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,D002331,"<span class=""chemical"">carnitine</span>",D015673,"<span class=""disease"">total and free carnitine</span>","Contrary to controls, patients with PCOS were characterized with slightly lower levels of fasting <span class=""disease"">total and free </span><span class=""chemical"">carnitine</span>, its precursors, and derivatives.",,22999793,22999793_D002331_D015673,22999793_7,bcv_sentence_task_befree_4484,,770960416,FALSE,finalized,5,8/14/15 22:53,"



",no_relation,1,,D002331,"<span class=""chemical"">carnitine</span>",D011085,"<span class=""disease"">PCOS</span>","Contrary to controls, patients with <span class=""disease"">PCOS</span> were characterized with slightly lower levels of fasting total and free <span class=""chemical"">carnitine</span>, its precursors, and derivatives.",,22999793,22999793_D002331_D011085,22999793_7,bcv_sentence_task_befree_4485,,770960417,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,D002331,"<span class=""chemical"">carnitine</span>",D011085,"<span class=""disease"">PCOS</span>","Total and free <span class=""chemical"">carnitine</span> correlated inversely to sex hormone-binding globulin (SHBG) in patients with <span class=""disease"">PCOS</span>, whereas no associations were found between acylcarnitines and androgenes.",,22999793,22999793_D002331_D011085,22999793_8,bcv_sentence_task_befree_4486,,770960418,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D002331,"<span class=""chemical"">carnitine</span>",D015673,"<span class=""disease"">total and free carnitine</span>","Insulin stimulation-induced changes in the levels of <span class=""disease"">total and free </span><span class=""chemical"">carnitine</span>, <span class=""chemical"">carnitine</span> precursors, and acylcarnitines in the PCOS group followed the same trends as in the control group.",,22999793,22999793_D002331_D015673,22999793_9,bcv_sentence_task_befree_4487,,770960419,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,1,,D002331,"<span class=""chemical"">carnitine</span>",D011085,"<span class=""disease"">PCOS</span>","Insulin stimulation-induced changes in the levels of total and free <span class=""chemical"">carnitine</span>, <span class=""chemical"">carnitine</span> precursors, and acylcarnitines in the <span class=""disease"">PCOS</span> group followed the same trends as in the control group.",,22999793,22999793_D002331_D011085,22999793_9,bcv_sentence_task_befree_4488,,770960420,FALSE,finalized,5,8/15/15 2:33,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D011085,"<span class=""disease"">polycystic ovary syndrome</span>","On the potential of <span class=""chemical"">metformin</span> to prevent preterm delivery in women with <span class=""disease"">polycystic ovary syndrome</span> - an epi-analysis.",,23006146,23006146_D008687_D011085,23006146_0,bcv_sentence_task_befree_4489,,770960421,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D047928,"<span class=""disease"">preterm delivery</span>","On the potential of <span class=""chemical"">metformin</span> to prevent <span class=""disease"">preterm delivery</span> in women with polycystic ovary syndrome - an epi-analysis.",,23006146,23006146_D008687_D047928,23006146_0,bcv_sentence_task_befree_4490,,770960422,FALSE,finalized,5,8/15/15 0:11,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D011085,"<span class=""disease"">polycystic ovary syndrome/PCOS</span>","Our aim was to re-evaluate whether <span class=""chemical"">metformin</span> may reduce late miscarriage/preterm delivery, pre-eclampsia and gestational diabetes in women with <span class=""disease"">polycystic ovary syndrome</span> (<span class=""disease"">PCOS</span>).",,23006146,23006146_D008687_D011085,23006146_1,bcv_sentence_task_befree_4491,,770960423,FALSE,finalized,5,8/14/15 22:57,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D047928,"<span class=""disease"">preterm delivery</span>","Our aim was to re-evaluate whether <span class=""chemical"">metformin</span> may reduce late miscarriage/<span class=""disease"">preterm delivery</span>, pre-eclampsia and gestational diabetes in women with polycystic ovary syndrome (PCOS).",,23006146,23006146_D008687_D047928,23006146_1,bcv_sentence_task_befree_4492,,770960424,FALSE,finalized,5,8/15/15 1:57,"



",no_relation,0.8028,,D008687,"<span class=""chemical"">metformin</span>",D016640,"<span class=""disease"">gestational diabetes</span>","Our aim was to re-evaluate whether <span class=""chemical"">metformin</span> may reduce late miscarriage/preterm delivery, pre-eclampsia and <span class=""disease"">gestational diabetes</span> in women with polycystic ovary syndrome (PCOS).",,23006146,23006146_D008687_D016640,23006146_1,bcv_sentence_task_befree_4493,,770960425,FALSE,finalized,5,8/15/15 0:40,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D011225,"<span class=""disease"">pre-eclampsia</span>","Our aim was to re-evaluate whether <span class=""chemical"">metformin</span> may reduce late miscarriage/preterm delivery, <span class=""disease"">pre-eclampsia</span> and gestational diabetes in women with polycystic ovary syndrome (PCOS).",,23006146,23006146_D008687_D011225,23006146_1,bcv_sentence_task_befree_4494,,770960426,FALSE,finalized,5,8/15/15 1:37,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D047928,"<span class=""disease"">preterm delivery</span>","The <span class=""chemical"">metformin</span>-treated patients had less late miscarriage/<span class=""disease"">preterm delivery</span>; five (3%) vs. 18 (11%) in the placebo group (p < 0.01).",,23006146,23006146_D008687_D047928,23006146_6,bcv_sentence_task_befree_4495,,770960427,FALSE,finalized,5,8/14/15 23:26,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D016640,"<span class=""disease"">gestational diabetes</span>","There was no difference in the prevalence of <span class=""disease"">gestational diabetes</span> and pre-eclampsia between the <span class=""chemical"">metformin</span> and the placebo group.",,23006146,23006146_D008687_D016640,23006146_7,bcv_sentence_task_befree_4496,,770960428,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D011225,"<span class=""disease"">pre-eclampsia</span>","There was no difference in the prevalence of gestational diabetes and <span class=""disease"">pre-eclampsia</span> between the <span class=""chemical"">metformin</span> and the placebo group.",,23006146,23006146_D008687_D011225,23006146_7,bcv_sentence_task_befree_4497,,770960429,FALSE,finalized,5,8/15/15 0:33,"



",no_relation,1,,D008687,"<span class=""chemical"">metformin</span>",D011085,"<span class=""disease"">PCOS</span>","In this epi-analysis, <span class=""chemical"">metformin</span> treatment during pregnancy seems to reduce early delivery in women with <span class=""disease"">PCOS</span>.",,23006146,23006146_D008687_D011085,23006146_8,bcv_sentence_task_befree_4498,,770960430,FALSE,finalized,5,8/15/15 0:58,"



",yes_direct,1,,D000638,"<span class=""chemical"">amiodarone</span>",D011014,"<span class=""disease"">pneumonia</span>","In vivo probe-based confocal laser endomicroscopy in <span class=""chemical"">amiodarone</span>-related <span class=""disease"">pneumonia</span>.",,23018901,23018901_D000638_D011014,23018901_0,bcv_sentence_task_befree_4499,,770960431,FALSE,finalized,5,8/15/15 2:15,"



",yes_direct,0.8029,,D000638,"<span class=""chemical"">amiodarone</span>",D011014,"<span class=""disease"">pneumonia</span>","The objective of the study was to assess the diagnostic accuracy of pCLE for <span class=""chemical"">amiodarone</span>-related <span class=""disease"">pneumonia</span> (AMR-IP).",,23018901,23018901_D000638_D011014,23018901_2,bcv_sentence_task_befree_4500,,770960432,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,0.8026,,D000638,"<span class=""chemical"">amiodarone</span>",D017563,"<span class=""disease"">interstitial lung disease/ILD</span>","Alveolar pCLE was performed in 36 nonsmoking patients, including 33 consecutive patients with acute or subacute <span class=""disease"">interstitial lung disease</span> (<span class=""disease"">ILD</span>), of which 17 were undergoing treatment with <span class=""chemical"">amiodarone</span>, and three were <span class=""chemical"">amiodarone</span>-treated patients without <span class=""disease"">ILD</span>.",,23018901,23018901_D000638_D017563,23018901_3,bcv_sentence_task_befree_4501,,770960433,FALSE,finalized,5,8/15/15 1:18,"



",no_relation,1,,D000638,"<span class=""chemical"">amiodarone</span>",D007184,"<span class=""disease"">HP-AMR-IP</span>","In contrast, these cells were observed in only two out of 39 areas from LP-AMR-IP patients, in one out of 59 areas from ILD patients not receiving <span class=""chemical"">amiodarone</span> and in none of the 10 areas from <span class=""chemical"">amiodarone</span>-treated patients without ILD (p<0.001; <span class=""disease"">HP-AMR-IP</span> versus other groups).",,23018901,23018901_D000638_D007184,23018901_7,bcv_sentence_task_befree_4502,,770960434,FALSE,finalized,5,8/14/15 23:08,"



",no_relation,1,,D000638,"<span class=""chemical"">amiodarone</span>",D017563,"<span class=""disease"">ILD</span>","In contrast, these cells were observed in only two out of 39 areas from LP-AMR-IP patients, in one out of 59 areas from <span class=""disease"">ILD</span> patients not receiving <span class=""chemical"">amiodarone</span> and in none of the 10 areas from <span class=""chemical"">amiodarone</span>-treated patients without <span class=""disease"">ILD</span> (p<0.001; HP-AMR-IP versus other groups).",,23018901,23018901_D000638_D017563,23018901_7,bcv_sentence_task_befree_4503,,770960435,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,1,,D010406,"<span class=""chemical"">penicillin</span>",D013587,"<span class=""disease"">syphilis</span>","It was not until 1943, amid world war, that <span class=""chemical"">penicillin</span> was found to be an effective treatment for <span class=""disease"">syphilis</span>.",,23054260,23054260_D010406_D013587,23054260_1,bcv_sentence_task_befree_4504,,770960436,FALSE,finalized,5,8/14/15 23:49,"



",no_relation,0.7883,,D010406,"<span class=""chemical"">penicillin</span>",D013587,"<span class=""disease"">syphilis</span>","This study investigated the hypothesis that a decrease in the cost of <span class=""disease"">syphilis</span> due to <span class=""chemical"">penicillin</span> spurred an increase in risky non-traditional sex.",,23054260,23054260_D010406_D013587,23054260_2,bcv_sentence_task_befree_4505,,770960437,FALSE,finalized,5,8/15/15 0:39,"



",no_relation,1,,D010406,"<span class=""chemical"">penicillin</span>",D013587,"<span class=""disease"">syphilis</span>","Together, the findings supported the notion that the discovery of <span class=""chemical"">penicillin</span> decreased the cost of <span class=""disease"">syphilis</span> and thereby played an important role in shaping modern sexuality.",,23054260,23054260_D010406_D013587,23054260_8,bcv_sentence_task_befree_4506,,770960438,FALSE,finalized,5,8/14/15 23:13,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D054549,"<span class=""disease"">OS</span>","Our aim was to study the response of lymphomonocyte <span class=""disease"">OS</span> status and reactive <span class=""chemical"">oxygen</span> species by-products after an oral unsaturated fat load test (OFLT) in those with FH and to compare this response with that obtained in normolipidemic, normoglycemic subjects.",,23072926,23072926_D010100_D054549,23072926_4,bcv_sentence_task_befree_4507,,770960439,FALSE,finalized,5,8/15/15 1:58,"



",no_relation,1,,C022616,"<span class=""chemical"">3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide</span>",D015179,"<span class=""disease"">CRC</span>","ST13-overexpressed and ST13-knockdown <span class=""disease"">CRC</span> cells were constructed respectively by lentiviral transduction, followed by <span class=""chemical"">3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide</span> (MTT) assay, plate colony formation, cell-cycle analysis, and migration assays to evaluate the influence of ST13 on proliferation and migration in vitro.",,23125081,23125081_C022616_D015179,23125081_5,bcv_sentence_task_befree_4508,,770960440,FALSE,finalized,5,8/14/15 22:37,"



",no_relation,0.802,,D005947,"<span class=""chemical"">glucose</span>",D003929,"<span class=""disease"">diabetes</span>","Notably, high-<span class=""chemical"">glucose</span> treatment or <span class=""disease"">diabetes</span> reduced miR-126 levels of CD34(+) PBMCs, associated with impaired proangiogenic properties that could be rescued by miR-mimic-126 treatment.",,23144172,23144172_D005947_D003929,23144172_9,bcv_sentence_task_befree_4509,,770960441,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,1,,D015780,"<span class=""chemical"">Carbapenems</span>",D007239,"<span class=""disease"">infections</span>","<span class=""chemical"">Carbapenems</span> are important antimicrobial agents for treating <span class=""disease"">infections</span> due to multidrug resistant Acinetobacter spp.",,23154047,23154047_D015780_D007239,23154047_2,bcv_sentence_task_befree_4510,,770960442,FALSE,finalized,5,8/14/15 22:41,"



",no_relation,1,,D001599,"<span class=""chemical"">berberine</span>",D009369,"<span class=""disease"">cancer</span>","Most strikingly, nonetheless, of the six compounds prepared, sample 8, a farnesyl 9-O-substituted <span class=""chemical"">berberine</span>, showed either comparable or better cytotoxic activity against human <span class=""disease"">cancer</span> HepG2 cell line than that of <span class=""chemical"">berberine</span>.",,23182088,23182088_D001599_D009369,23182088_3,bcv_sentence_task_befree_4511,,770960443,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,1,,D001599,"<span class=""chemical"">berberine</span>",D006528,"<span class=""disease"">hepatoma</span>","Compound 8 had also shown a 104-fold antiproliferation activity in compare with <span class=""chemical"">berberine</span> against human <span class=""disease"">hepatoma</span> HepG2 cell lines after 48 incubation hours.",,23182088,23182088_D001599_D006528,23182088_4,bcv_sentence_task_befree_4512,,770960444,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,0.5986,,D009388,"<span class=""chemical"">Neostigmine</span>",D000699,"<span class=""disease"">analgesia</span>","<span class=""chemical"">Neostigmine</span>, an anticholinesterase, presents a novel approach to providing <span class=""disease"">analgesia</span>.",,23185923,23185923_D009388_D000699,23185923_3,bcv_sentence_task_befree_4513,,770960445,FALSE,finalized,5,8/15/15 0:33,"



",yes_direct,0.8045,,D009388,"<span class=""chemical"">Neostigmine</span>",D000699,"<span class=""disease"">analgesia</span>","<span class=""chemical"">Neostigmine</span>, when given intrathecally, inhibits breakdown of an endogenous spinal neurotransmitter, acetylcholine, thereby inducing <span class=""disease"">analgesia</span>.",,23185923,23185923_D009388_D000699,23185923_4,bcv_sentence_task_befree_4514,,770960446,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,0.8122,,D000109,"<span class=""chemical"">acetylcholine</span>",D000699,"<span class=""disease"">analgesia</span>","Neostigmine, when given intrathecally, inhibits breakdown of an endogenous spinal neurotransmitter, <span class=""chemical"">acetylcholine</span>, thereby inducing <span class=""disease"">analgesia</span>.",,23185923,23185923_D000109_D000699,23185923_4,bcv_sentence_task_befree_4515,,770960447,FALSE,finalized,5,8/14/15 22:31,"



Though technically, analgesia is not a disease.",no_relation,0.5841,,D009388,"<span class=""chemical"">neostigmine</span>",D000699,"<span class=""disease"">analgesia</span>","The mean duration of effective <span class=""disease"">analgesia</span> was 485.6 +/- 37.6 minutes in <span class=""chemical"">neostigmine</span> group compared with saline group, 316.0 +/- 49.15 minutes, p < 0.001.",,23185923,23185923_D009388_D000699,23185923_8,bcv_sentence_task_befree_4516,,770960448,FALSE,finalized,5,8/14/15 23:32,"



",yes_direct,0.8041,,D009388,"<span class=""chemical"">neostigmine</span>",D000699,"<span class=""disease"">analgesia</span>","This study showed that spinal <span class=""chemical"">neostigmine</span> 25 microg added to hyperbaric bupivacaine and fentanyl provided a significantly longer surgical <span class=""disease"">analgesia</span> and insignificant adverse effects in male adults who had lower abdominal surgery under spinal anaesthesia.",,23185923,23185923_D009388_D000699,23185923_11,bcv_sentence_task_befree_4517,,770960449,FALSE,finalized,5,8/14/15 23:25,"



",yes_direct,0.8095,,D002045,"<span class=""chemical"">bupivacaine</span>",D000699,"<span class=""disease"">analgesia</span>","This study showed that spinal neostigmine 25 microg added to hyperbaric <span class=""chemical"">bupivacaine</span> and fentanyl provided a significantly longer surgical <span class=""disease"">analgesia</span> and insignificant adverse effects in male adults who had lower abdominal surgery under spinal anaesthesia.",,23185923,23185923_D002045_D000699,23185923_11,bcv_sentence_task_befree_4518,,770960450,FALSE,finalized,5,8/14/15 22:59,"



",yes_direct,0.6175,,D005283,"<span class=""chemical"">fentanyl</span>",D000699,"<span class=""disease"">analgesia</span>","This study showed that spinal neostigmine 25 microg added to hyperbaric bupivacaine and <span class=""chemical"">fentanyl</span> provided a significantly longer surgical <span class=""disease"">analgesia</span> and insignificant adverse effects in male adults who had lower abdominal surgery under spinal anaesthesia.",,23185923,23185923_D005283_D000699,23185923_11,bcv_sentence_task_befree_4519,,770960451,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,C503983,"<span class=""chemical"">Axitinib</span>",D002292,"<span class=""disease"">renal cell carcinoma</span>","<span class=""chemical"">Axitinib</span>: in advanced, treatment-experienced <span class=""disease"">renal cell carcinoma</span>.",,23190347,23190347_C503983_D002292,23190347_0,bcv_sentence_task_befree_4520,,770960452,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,C471405,"<span class=""chemical"">sorafenib</span>",D002292,"<span class=""disease"">renal cell carcinoma</span>","In a pivotal phase III trial in patients with advanced <span class=""disease"">renal cell carcinoma</span> that had progressed despite first-line therapy, axitinib 5mg twice daily significantly prolonged median progression-free survival (primary endpoint) compared with <span class=""chemical"">sorafenib</span> 400mg twice daily.",,23190347,23190347_C471405_D002292,23190347_2,bcv_sentence_task_befree_4521,,770960453,FALSE,finalized,5,8/14/15 23:01,"



",no_relation,1,,C503983,"<span class=""chemical"">axitinib</span>",D002292,"<span class=""disease"">renal cell carcinoma</span>","In a pivotal phase III trial in patients with advanced <span class=""disease"">renal cell carcinoma</span> that had progressed despite first-line therapy, <span class=""chemical"">axitinib</span> 5mg twice daily significantly prolonged median progression-free survival (primary endpoint) compared with sorafenib 400mg twice daily.",,23190347,23190347_C503983_D002292,23190347_2,bcv_sentence_task_befree_4522,,770960454,FALSE,finalized,5,8/15/15 1:21,"



",no_relation,1,,C503983,"<span class=""chemical"">axitinib</span>",D003643,"<span class=""disease"">death</span>","Significantly more <span class=""chemical"">axitinib</span> than sorafenib recipients achieved an objective response, and <span class=""chemical"">axitinib</span> therapy significantly prolonged time to deterioration (a composite endpoint of <span class=""disease"">death</span>, disease progression and symptom worsening) relative to sorafenib therapy.",,23190347,23190347_C503983_D003643,23190347_5,bcv_sentence_task_befree_4523,,770960455,FALSE,finalized,5,8/14/15 22:53,"



",no_relation,0.5774,,C471405,"<span class=""chemical"">sorafenib</span>",D003643,"<span class=""disease"">death</span>","Significantly more axitinib than <span class=""chemical"">sorafenib</span> recipients achieved an objective response, and axitinib therapy significantly prolonged time to deterioration (a composite endpoint of <span class=""disease"">death</span>, disease progression and symptom worsening) relative to <span class=""chemical"">sorafenib</span> therapy.",,23190347,23190347_C471405_D003643,23190347_5,bcv_sentence_task_befree_4524,,770960456,FALSE,finalized,5,8/15/15 0:28,"



",yes_direct,0.6007,,C503983,"<span class=""chemical"">axitinib</span>",D017499,"<span class=""disease"">palmar-plantar erythrodysaesthesia</span>","While its tolerability profile was generally consistent with that of other VEGF receptor inhibitors, <span class=""chemical"">axitinib</span> was associated with a numerically lower incidence of <span class=""disease"">palmar-plantar erythrodysaesthesia</span>, cutaneous toxicity and anaemia than sorafenib in the phase III trial.",,23190347,23190347_C503983_D017499,23190347_6,bcv_sentence_task_befree_4525,,770960457,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,0.7951,,C471405,"<span class=""chemical"">sorafenib</span>",D017499,"<span class=""disease"">palmar-plantar erythrodysaesthesia</span>","While its tolerability profile was generally consistent with that of other VEGF receptor inhibitors, axitinib was associated with a numerically lower incidence of <span class=""disease"">palmar-plantar erythrodysaesthesia</span>, cutaneous toxicity and anaemia than <span class=""chemical"">sorafenib</span> in the phase III trial.",,23190347,23190347_C471405_D017499,23190347_6,bcv_sentence_task_befree_4526,,770960458,FALSE,finalized,5,8/14/15 22:31,"



It's 'cutaneous toxicity' and not just toxicity",yes_direct,0.8022,,C503983,"<span class=""chemical"">axitinib</span>",D064420,"<span class=""disease"">toxicity</span>","While its tolerability profile was generally consistent with that of other VEGF receptor inhibitors, <span class=""chemical"">axitinib</span> was associated with a numerically lower incidence of palmar-plantar erythrodysaesthesia, cutaneous <span class=""disease"">toxicity</span> and anaemia than sorafenib in the phase III trial.",,23190347,23190347_C503983_D064420,23190347_6,bcv_sentence_task_befree_4527,,770960459,FALSE,finalized,5,8/14/15 23:35,"



",yes_direct,0.6113,,C503983,"<span class=""chemical"">axitinib</span>",D000740,"<span class=""disease"">anaemia</span>","While its tolerability profile was generally consistent with that of other VEGF receptor inhibitors, <span class=""chemical"">axitinib</span> was associated with a numerically lower incidence of palmar-plantar erythrodysaesthesia, cutaneous toxicity and <span class=""disease"">anaemia</span> than sorafenib in the phase III trial.",,23190347,23190347_C503983_D000740,23190347_6,bcv_sentence_task_befree_4528,,770960460,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,C471405,"<span class=""chemical"">sorafenib</span>",D000740,"<span class=""disease"">anaemia</span>","While its tolerability profile was generally consistent with that of other VEGF receptor inhibitors, axitinib was associated with a numerically lower incidence of palmar-plantar erythrodysaesthesia, cutaneous toxicity and <span class=""disease"">anaemia</span> than <span class=""chemical"">sorafenib</span> in the phase III trial.",,23190347,23190347_C471405_D000740,23190347_6,bcv_sentence_task_befree_4529,,770960461,FALSE,finalized,5,8/14/15 22:35,"



",no_relation,1,,C471405,"<span class=""chemical"">sorafenib</span>",D064420,"<span class=""disease"">toxicity</span>","While its tolerability profile was generally consistent with that of other VEGF receptor inhibitors, axitinib was associated with a numerically lower incidence of palmar-plantar erythrodysaesthesia, cutaneous <span class=""disease"">toxicity</span> and anaemia than <span class=""chemical"">sorafenib</span> in the phase III trial.",,23190347,23190347_C471405_D064420,23190347_6,bcv_sentence_task_befree_4530,,770960462,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,1,,C016063,"<span class=""chemical"">pinocembrin</span>",D050197,"<span class=""disease"">atherosclerosis</span>","Inhibitory effect of the combination therapy of simvastatin and <span class=""chemical"">pinocembrin</span> on <span class=""disease"">atherosclerosis</span> in ApoE-deficient mice.",,23216643,23216643_C016063_D050197,23216643_0,bcv_sentence_task_befree_4531,,770960463,FALSE,finalized,5,8/14/15 23:13,"



",no_relation,1,,D019821,"<span class=""chemical"">simvastatin</span>",D050197,"<span class=""disease"">atherosclerosis</span>","Inhibitory effect of the combination therapy of <span class=""chemical"">simvastatin</span> and pinocembrin on <span class=""disease"">atherosclerosis</span> in ApoE-deficient mice.",,23216643,23216643_D019821_D050197,23216643_0,bcv_sentence_task_befree_4532,,770960464,FALSE,finalized,5,8/14/15 23:01,"



",no_relation,1,,D019821,"<span class=""chemical"">simvastatin</span>",D006949,"<span class=""disease"">hyperlipidemia</span>","The combination of <span class=""chemical"">simvastatin</span> and pinocembrin synergistically inhibited atherosclerotic lesion development in ApoE-/- mice with <span class=""disease"">hyperlipidemia</span>, which is partially dependent on the protective of vascular endothelium.",,23216643,23216643_D019821_D006949,23216643_10,bcv_sentence_task_befree_4533,,770960465,FALSE,finalized,5,8/14/15 23:42,"



Used as treatment.",no_relation,1,,C016063,"<span class=""chemical"">pinocembrin</span>",D006949,"<span class=""disease"">hyperlipidemia</span>","The combination of simvastatin and <span class=""chemical"">pinocembrin</span> synergistically inhibited atherosclerotic lesion development in ApoE-/- mice with <span class=""disease"">hyperlipidemia</span>, which is partially dependent on the protective of vascular endothelium.",,23216643,23216643_C016063_D006949,23216643_10,bcv_sentence_task_befree_4534,,770960466,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,0.8356,,C448659,"<span class=""chemical"">alvespimycin</span>",D006528,"<span class=""disease"">HCC</span>","Using SVM, several known <span class=""disease"">HCC</span> inhibitors, such as geldanamycin, <span class=""chemical"">alvespimycin</span> (HSP90 inhibitors), and doxorubicin (chemotherapy drug), were predicted.",,23220021,23220021_C448659_D006528,23220021_9,bcv_sentence_task_befree_4535,,770960467,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,1,,C001277,"<span class=""chemical"">geldanamycin</span>",D006528,"<span class=""disease"">HCC</span>","Using SVM, several known <span class=""disease"">HCC</span> inhibitors, such as <span class=""chemical"">geldanamycin</span>, alvespimycin (HSP90 inhibitors), and doxorubicin (chemotherapy drug), were predicted.",,23220021,23220021_C001277_D006528,23220021_9,bcv_sentence_task_befree_4536,,770960468,FALSE,finalized,5,8/14/15 23:51,"



",no_relation,1,,D004317,"<span class=""chemical"">doxorubicin</span>",D006528,"<span class=""disease"">HCC</span>","Using SVM, several known <span class=""disease"">HCC</span> inhibitors, such as geldanamycin, alvespimycin (HSP90 inhibitors), and <span class=""chemical"">doxorubicin</span> (chemotherapy drug), were predicted.",,23220021,23220021_D004317_D006528,23220021_9,bcv_sentence_task_befree_4537,,770960469,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D008727,"<span class=""chemical"">methotrexate/MTX</span>",D054198,"<span class=""disease"">acute lymphoblastic leukemia</span>","Polymorphisms in the <span class=""chemical"">methotrexate</span> transport pathway: a new tool for <span class=""chemical"">MTX</span> plasma level prediction in pediatric <span class=""disease"">acute lymphoblastic leukemia</span>.",,23222202,23222202_D008727_D054198,23222202_0,bcv_sentence_task_befree_4538,,770960470,FALSE,finalized,5,8/14/15 23:25,"



",no_relation,1,,D008727,"<span class=""chemical"">Methotrexate/MTX</span>",D054198,"<span class=""disease"">acute lymphoblastic leukemia/ALL</span>","<span class=""chemical"">Methotrexate</span> (<span class=""chemical"">MTX</span>) is an important component of therapy for pediatric <span class=""disease"">acute lymphoblastic leukemia</span> (<span class=""disease"">ALL</span>).",,23222202,23222202_D008727_D054198,23222202_1,bcv_sentence_task_befree_4539,,770960471,FALSE,finalized,5,8/15/15 0:28,"



",yes_direct,1,,D008727,"<span class=""chemical"">MTX</span>",D064420,"<span class=""disease"">toxicity</span>","Treatment with <span class=""chemical"">MTX</span> often causes <span class=""disease"">toxicity</span>, which can necessitate dose reduction or treatment cessation.",,23222202,23222202_D008727_D064420,23222202_2,bcv_sentence_task_befree_4540,,770960472,FALSE,finalized,5,8/14/15 23:37,"

polymorphisms in genes from this pathway causes toxicity

",yes_direct,0.8039,,D008727,"<span class=""chemical"">MTX</span>",D064420,"<span class=""disease"">toxicity</span>","As SLCO1B1 is a transporter involved in <span class=""chemical"">MTX</span> elimination, other polymorphisms in genes from this pathway could also have a role in <span class=""chemical"">MTX</span> <span class=""disease"">toxicity</span>.",,23222202,23222202_D008727_D064420,23222202_5,bcv_sentence_task_befree_4541,,770960473,FALSE,finalized,5,8/14/15 23:08,"



",no_relation,1,,D008727,"<span class=""chemical"">MTX</span>",D054198,"<span class=""disease"">ALL</span>","The aim of the present study was to analyze in depth the role of polymorphisms in the genes of the <span class=""chemical"">MTX</span> transport pathway as putative toxicity predictors in pediatric <span class=""disease"">ALL</span>.",,23222202,23222202_D008727_D054198,23222202_6,bcv_sentence_task_befree_4542,,770960474,FALSE,finalized,5,8/15/15 1:06,"



",no_relation,0.806,,D008727,"<span class=""chemical"">MTX</span>",D064420,"<span class=""disease"">toxicity</span>","The aim of the present study was to analyze in depth the role of polymorphisms in the genes of the <span class=""chemical"">MTX</span> transport pathway as putative <span class=""disease"">toxicity</span> predictors in pediatric ALL.",,23222202,23222202_D008727_D064420,23222202_6,bcv_sentence_task_befree_4543,,770960475,FALSE,finalized,5,8/14/15 22:36,"



",no_relation,0.788,,D008727,"<span class=""chemical"">MTX</span>",D054198,"<span class=""disease"">ALL</span>","Our results suggest that polymorphisms in ABCC4 and ABCC2 could be novel markers for <span class=""chemical"">MTX</span> toxicity in pediatric <span class=""disease"">ALL</span>.",,23222202,23222202_D008727_D054198,23222202_10,bcv_sentence_task_befree_4544,,770960476,FALSE,finalized,5,8/14/15 22:37,"



The polymorphisms in ABCC4 and ABCC2 causes the toxicity.",yes_direct,0.6027,,D008727,"<span class=""chemical"">MTX</span>",D064420,"<span class=""disease"">toxicity</span>","Our results suggest that polymorphisms in ABCC4 and ABCC2 could be novel markers for <span class=""chemical"">MTX</span> <span class=""disease"">toxicity</span> in pediatric ALL.",,23222202,23222202_D008727_D064420,23222202_10,bcv_sentence_task_befree_4545,,770960477,FALSE,finalized,5,8/14/15 23:19,"



",no_relation,0.8155,,C005466,"<span class=""chemical"">Ursolic acid</span>",D011471,"<span class=""disease"">prostate cancer</span>","<span class=""chemical"">Ursolic acid</span> sensitizes <span class=""disease"">prostate cancer</span> cells to TRAIL-mediated apoptosis.",,23247106,23247106_C005466_D011471,23247106_0,bcv_sentence_task_befree_4546,,770960478,FALSE,finalized,5,8/15/15 1:45,"



",no_relation,0.8097,,C005466,"<span class=""chemical"">ursolic acid</span>",D011471,"<span class=""disease"">prostate cancer</span>","Here, we investigated the sensitizing effects of <span class=""chemical"">ursolic acid</span> (UA), a pentacyclic triterpenoid found in many plants, on TRAIL-induced <span class=""disease"">prostate cancer</span> cell apoptosis.",,23247106,23247106_C005466_D011471,23247106_4,bcv_sentence_task_befree_4547,,770960479,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,0.5911,,D009705,"<span class=""chemical"">nucleoside</span>",D018088,"<span class=""disease"">TDRM</span>","The prevalence of HIV <span class=""disease"">TDRM</span> was 5.6% for <span class=""chemical"">nucleoside</span> reverse transcriptase inhibitors, 2.0% for nonnucleoside reverse transcriptase inhibitors, and 3.0% for protease inhibitors.",,23259924,23259924_D009705_D018088,23259924_8,bcv_sentence_task_befree_4548,,770960480,FALSE,finalized,5,8/15/15 0:01,"



",no_relation,1,,C467567,"<span class=""chemical"">lenalidomide</span>",D009101,"<span class=""disease"">MM</span>","Immunomodulatory agents (IMiDs), such as thalidomide and <span class=""chemical"">lenalidomide</span>, have changed the landscape in the treatment of patients with <span class=""disease"">MM</span> while newer IMiDs such as pomalidomide are showing promise in early clinical trials.",,23265189,23265189_C467567_D009101,23265189_2,bcv_sentence_task_befree_4549,,770960481,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,C467566,"<span class=""chemical"">pomalidomide</span>",D009101,"<span class=""disease"">MM</span>","Immunomodulatory agents (IMiDs), such as thalidomide and lenalidomide, have changed the landscape in the treatment of patients with <span class=""disease"">MM</span> while newer IMiDs such as <span class=""chemical"">pomalidomide</span> are showing promise in early clinical trials.",,23265189,23265189_C467566_D009101,23265189_2,bcv_sentence_task_befree_4550,,770960482,FALSE,finalized,5,8/15/15 2:01,"



",no_relation,1,,D013792,"<span class=""chemical"">thalidomide</span>",D009101,"<span class=""disease"">MM</span>","Immunomodulatory agents (IMiDs), such as <span class=""chemical"">thalidomide</span> and lenalidomide, have changed the landscape in the treatment of patients with <span class=""disease"">MM</span> while newer IMiDs such as pomalidomide are showing promise in early clinical trials.",,23265189,23265189_D013792_D009101,23265189_2,bcv_sentence_task_befree_4551,,770960483,FALSE,finalized,5,8/15/15 1:33,"



",no_relation,0.5933,,C467567,"<span class=""chemical"">Lenalidomide</span>",D064420,"<span class=""disease"">better toxicity</span>","<span class=""chemical"">Lenalidomide</span> has a <span class=""disease"">better toxicity</span> profile than thalidomide.",,23265189,23265189_C467567_D064420,23265189_8,bcv_sentence_task_befree_4552,,770960484,FALSE,finalized,5,8/14/15 22:35,"



",no_relation,1,,D013792,"<span class=""chemical"">thalidomide</span>",D064420,"<span class=""disease"">better toxicity</span>","Lenalidomide has a <span class=""disease"">better toxicity</span> profile than <span class=""chemical"">thalidomide</span>.",,23265189,23265189_D013792_D064420,23265189_8,bcv_sentence_task_befree_4553,,770960485,FALSE,finalized,5,8/15/15 0:37,"



",yes_direct,1,,D010269,"<span class=""chemical"">Paraquat</span>",D011041,"<span class=""disease"">poisoning</span>","<span class=""chemical"">Paraquat</span> (1,1'-dimethyl-4,4'-bipyridinium chloride, PQ) is a non-selective herbicide, and PQ <span class=""disease"">poisoning</span> by accidental or intentional ingestion is a cause of numerous fatalities around the world every year.",,23291665,23291665_D010269_D011041,23291665_1,bcv_sentence_task_befree_4554,,770960486,FALSE,finalized,5,8/14/15 22:39,"



",no_relation,1,,D000596,"<span class=""chemical"">amino acids</span>",D002872,"<span class=""disease"">deletion</span>","Furthermore, <span class=""disease"">deletion</span> or substitution of the N-terminal 12 <span class=""chemical"">amino acids</span> in DJ-1 resulted in re-localization of E18A, M26I and L166P DJ-1 from mitochondria into the cytoplasm.",,23326576,23326576_D000596_D002872,23326576_9,bcv_sentence_task_befree_4555,,770960487,FALSE,finalized,5,8/14/15 22:59,"



",yes_direct,0.603,,D019284,"<span class=""chemical"">thapsigargin</span>",D008228,"<span class=""disease"">endoplasmic reticulum</span>","XBP1 mRNA splicing and expression of <span class=""disease"">endoplasmic reticulum</span> stress response genes were determined in cells exposed to <span class=""chemical"">thapsigargin</span> in the presence or absence of quinotrierixin.",,23335849,23335849_D019284_D008228,23335849_4,bcv_sentence_task_befree_4556,,770960488,FALSE,finalized,5,8/15/15 0:10,"



",no_relation,1,,C532275,"<span class=""chemical"">quinotrierixin</span>",D008228,"<span class=""disease"">endoplasmic reticulum</span>","XBP1 mRNA splicing and expression of <span class=""disease"">endoplasmic reticulum</span> stress response genes were determined in cells exposed to thapsigargin in the presence or absence of <span class=""chemical"">quinotrierixin</span>.",,23335849,23335849_C532275_D008228,23335849_4,bcv_sentence_task_befree_4557,,770960489,FALSE,finalized,5,8/15/15 2:39,"



",no_relation,1,,D019284,"<span class=""chemical"">thapsigargin</span>",D008228,"<span class=""disease"">endoplasmic reticulum</span>","In cells exposed to <span class=""chemical"">thapsigargin</span>, quinotrierixin inhibited XBP1 mRNA splicing and PKR-like <span class=""disease"">endoplasmic reticulum</span> kinase activation, and reduced cellular and nuclear levels of spliced XBP1 and C/EBP homologous protein.",,23335849,23335849_D019284_D008228,23335849_7,bcv_sentence_task_befree_4558,,770960490,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,C532275,"<span class=""chemical"">quinotrierixin</span>",D008228,"<span class=""disease"">endoplasmic reticulum</span>","In cells exposed to thapsigargin, <span class=""chemical"">quinotrierixin</span> inhibited XBP1 mRNA splicing and PKR-like <span class=""disease"">endoplasmic reticulum</span> kinase activation, and reduced cellular and nuclear levels of spliced XBP1 and C/EBP homologous protein.",,23335849,23335849_C532275_D008228,23335849_7,bcv_sentence_task_befree_4559,,770960491,FALSE,finalized,5,8/15/15 1:00,"



",yes_direct,0.6057,,C532275,"<span class=""chemical"">quinotrierixin</span>",D008228,"<span class=""disease"">endoplasmic reticulum</span>","Paradoxically, <span class=""chemical"">quinotrierixin</span> exacerbated <span class=""disease"">endoplasmic reticulum</span> stress-induced phosphorylation of eIF2, which in turn led to decreased protein translation.",,23335849,23335849_C532275_D008228,23335849_8,bcv_sentence_task_befree_4560,,770960492,FALSE,finalized,5,8/14/15 23:29,"



",no_relation,1,,C532275,"<span class=""chemical"">quinotrierixin</span>",D019320,"<span class=""disease"">Paradoxically</span>","<span class=""disease"">Paradoxically</span>, <span class=""chemical"">quinotrierixin</span> exacerbated endoplasmic reticulum stress-induced phosphorylation of eIF2, which in turn led to decreased protein translation.",,23335849,23335849_C532275_D019320,23335849_8,bcv_sentence_task_befree_4561,,770960493,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,1,,C532275,"<span class=""chemical"">quinotrierixin</span>",D018630,"<span class=""disease"">proliferative vitreoretinopathy</span>","Future studies are needed to investigate the in vivo effect of <span class=""chemical"">quinotrierixin</span> on RPE proliferation in animal models of <span class=""disease"">proliferative vitreoretinopathy</span>.",,23335849,23335849_C532275_D018630,23335849_12,bcv_sentence_task_befree_4562,,770960494,FALSE,finalized,5,8/14/15 22:41,"



",no_relation,1,,D013004,"<span class=""chemical"">somatostatin</span>",D018358,"<span class=""disease"">neuroendocrine tumors</span>","For treatment of patients with inoperable or metastasized <span class=""disease"">neuroendocrine tumors</span>, <span class=""chemical"">somatostatin</span> analogues labeled with the radioisotopes (111)In, (90)Y and (177)Lu have been used so far.",,23339764,23339764_D013004_D018358,23339764_6,bcv_sentence_task_befree_4563,,770960495,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,D013004,"<span class=""chemical"">somatostatin</span>",D009369,"<span class=""disease"">tumor</span>","Labeling with (111)In, mainly an Auger electron emitter, resulted in no reduction of <span class=""disease"">tumor</span> size while <span class=""chemical"">somatostatin</span> analogues labeled with (90)Y and (177)Lu gave overall positive response and improved the patients' quality of life.",,23339764,23339764_D013004_D009369,23339764_7,bcv_sentence_task_befree_4564,,770960496,FALSE,finalized,5,8/14/15 22:39,"



",no_relation,0.7872,,D005419,"<span class=""chemical"">Flavonoids</span>",D009369,"<span class=""disease"">breast cancer</span>","<span class=""chemical"">Flavonoids</span>, flavonoid subclasses and <span class=""disease"">breast cancer</span> risk: a meta-analysis of epidemiologic studies.",,23349849,23349849_D005419_D009369,23349849_0,bcv_sentence_task_befree_4565,,770960497,FALSE,finalized,5,8/14/15 23:51,"


'chemopreventive'  being the key term.
",no_relation,1,,D005419,"<span class=""chemical"">flavonoids</span>",D063646,"<span class=""disease"">carcinogenesis</span>","Studies have suggested the chemopreventive effects of <span class=""chemical"">flavonoids</span> on <span class=""disease"">carcinogenesis</span>.",,23349849,23349849_D005419_D063646,23349849_1,bcv_sentence_task_befree_4566,,770960498,FALSE,finalized,5,8/14/15 23:26,"

Used as possible prevention.

",no_relation,1,,D005419,"<span class=""chemical"">flavonoids</span>",D009369,"<span class=""disease"">breast cancer</span>","Yet numbers of epidemiologic studies assessing dietary <span class=""chemical"">flavonoids</span> and <span class=""disease"">breast cancer</span> risk have yielded inconsistent results.",,23349849,23349849_D005419_D009369,23349849_2,bcv_sentence_task_befree_4567,,770960499,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,1,,D005419,"<span class=""chemical"">flavonoids</span>",D009369,"<span class=""disease"">breast cancer</span>","The association between <span class=""chemical"">flavonoids</span>, flavonoid subclasses (flavonols, flavan-3-ols, etc.) and the risk of <span class=""disease"">breast cancer</span> lacks systematic analysis.",,23349849,23349849_D005419_D009369,23349849_3,bcv_sentence_task_befree_4568,,770960500,FALSE,finalized,5,8/14/15 23:01,"



",no_relation,0.8154,,D005419,"<span class=""chemical"">flavonoids</span>",D009369,"<span class=""disease"">breast cancer</span>","We aimed to examine the association between <span class=""chemical"">flavonoids</span>, each flavonoid subclass (except isoflavones) and the risk of <span class=""disease"">breast cancer</span> by conducting a meta-analysis.",,23349849,23349849_D005419_D009369,23349849_4,bcv_sentence_task_befree_4569,,770960501,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,1,,D007529,"<span class=""chemical"">isoflavones</span>",D009369,"<span class=""disease"">breast cancer</span>","We aimed to examine the association between flavonoids, each flavonoid subclass (except <span class=""chemical"">isoflavones</span>) and the risk of <span class=""disease"">breast cancer</span> by conducting a meta-analysis.",,23349849,23349849_D007529_D009369,23349849_4,bcv_sentence_task_befree_4570,,770960502,FALSE,finalized,5,8/14/15 22:59,"



",no_relation,1,,D047309,"<span class=""chemical"">flavones</span>",D009369,"<span class=""disease"">breast cancer</span>","The risk of <span class=""disease"">breast cancer</span> significantly decreased in women with high intake of flavonols (RR=0.88, 95% CI 0.80-0.98) and <span class=""chemical"">flavones</span> (RR=0.83, 95% CI: 0.76-0.91) compared with that in those with low intake of flavonols and <span class=""chemical"">flavones</span>.",,23349849,23349849_D047309_D009369,23349849_10,bcv_sentence_task_befree_4571,,770960503,FALSE,finalized,5,8/14/15 23:17,"



",no_relation,0.8223,,D005419,"<span class=""chemical"">flavonoids</span>",D009369,"<span class=""disease"">breast cancer</span>","However, no significant association of flavan-3-ols (RR=0.93, 95% CI: 0.84-1.02), flavanones (summary RR=0.95, 95% CI: 0.88-1.03), anthocyanins (summary RR=0.97, 95% CI: 0.87-1.08) or total <span class=""chemical"">flavonoids</span> (summary RR=0.98, 95% CI: 0.86-1.12) intake with <span class=""disease"">breast cancer</span> risk was observed.",,23349849,23349849_D005419_D009369,23349849_11,bcv_sentence_task_befree_4572,,770960504,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,D044950,"<span class=""chemical"">flavanones</span>",D009369,"<span class=""disease"">breast cancer</span>","However, no significant association of flavan-3-ols (RR=0.93, 95% CI: 0.84-1.02), <span class=""chemical"">flavanones</span> (summary RR=0.95, 95% CI: 0.88-1.03), anthocyanins (summary RR=0.97, 95% CI: 0.87-1.08) or total flavonoids (summary RR=0.98, 95% CI: 0.86-1.12) intake with <span class=""disease"">breast cancer</span> risk was observed.",,23349849,23349849_D044950_D009369,23349849_11,bcv_sentence_task_befree_4573,,770960505,FALSE,finalized,5,8/15/15 1:58,"



",no_relation,1,,D000872,"<span class=""chemical"">anthocyanins</span>",D009369,"<span class=""disease"">breast cancer</span>","However, no significant association of flavan-3-ols (RR=0.93, 95% CI: 0.84-1.02), flavanones (summary RR=0.95, 95% CI: 0.88-1.03), <span class=""chemical"">anthocyanins</span> (summary RR=0.97, 95% CI: 0.87-1.08) or total flavonoids (summary RR=0.98, 95% CI: 0.86-1.12) intake with <span class=""disease"">breast cancer</span> risk was observed.",,23349849,23349849_D000872_D009369,23349849_11,bcv_sentence_task_befree_4574,,770960506,FALSE,finalized,5,8/15/15 2:09,"



",no_relation,1,,D047309,"<span class=""chemical"">flavones</span>",D009369,"<span class=""disease"">breast cancer</span>","Furthermore, summary RRs of 3 case-control studies stratified by menopausal status suggested flavonols, <span class=""chemical"">flavones</span> or flavan-3-ols intake is associated with a significant reduced risk of <span class=""disease"">breast cancer</span> in post-menopausal while not in pre-menopausal women.",,23349849,23349849_D047309_D009369,23349849_12,bcv_sentence_task_befree_4575,,770960507,FALSE,finalized,5,8/14/15 22:36,"



",no_relation,0.8104,,D005419,"<span class=""chemical"">flavonoids</span>",D009369,"<span class=""disease"">breast cancer</span>","The present study suggests the intake of flavonols and flavones, but not other flavonoid subclasses or total <span class=""chemical"">flavonoids</span>, is associated with a decreased risk of <span class=""disease"">breast cancer</span>, especially among post-menopausal women.",,23349849,23349849_D005419_D009369,23349849_13,bcv_sentence_task_befree_4576,,770960508,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,0.7968,,D047309,"<span class=""chemical"">flavones</span>",D009369,"<span class=""disease"">breast cancer</span>","The present study suggests the intake of flavonols and <span class=""chemical"">flavones</span>, but not other flavonoid subclasses or total flavonoids, is associated with a decreased risk of <span class=""disease"">breast cancer</span>, especially among post-menopausal women.",,23349849,23349849_D047309_D009369,23349849_13,bcv_sentence_task_befree_4577,,770960509,FALSE,finalized,5,8/14/15 22:31,"



",no_relation,1,,D008715,"<span class=""chemical"">methionine</span>",D009369,"<span class=""disease"">colon cancer</span>","Fluorinated N,N-dialkylaminostilbenes repress <span class=""disease"">colon cancer</span> by targeting <span class=""chemical"">methionine</span> S-adenosyltransferase 2A.",,23363077,23363077_D008715_D009369,23363077_0,bcv_sentence_task_befree_4578,,770960510,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,1,,D019787,"<span class=""chemical"">linoleic acid</span>",D009369,"<span class=""disease"">breast cancer</span>","The anti-proliferative and pro-apoptotic effects of the trans9, trans11 conjugated <span class=""chemical"">linoleic acid</span> isomer on MCF-7 <span class=""disease"">breast cancer</span> cells are associated with LXR activation.",,23375583,23375583_D019787_D009369,23375583_0,bcv_sentence_task_befree_4579,,770960511,FALSE,finalized,5,8/14/15 22:54,"



",no_relation,1,,D008041,"<span class=""chemical"">linoleic acids</span>",D009369,"<span class=""disease"">breast cancer</span>","Conjugated <span class=""chemical"">linoleic acids</span> (CLA), naturally found in dairy products and ruminant meat, are positional and geometric isomers (trans: t or cis: c) of linoleic acid, and have been widely reported to possess anti-tumoral activity against <span class=""disease"">breast cancer</span> both in vitro and in vivo.",,23375583,23375583_D008041_D009369,23375583_1,bcv_sentence_task_befree_4580,,770960512,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,1,,D019787,"<span class=""chemical"">linoleic acid</span>",D009369,"<span class=""disease"">breast cancer</span>","Conjugated linoleic acids (CLA), naturally found in dairy products and ruminant meat, are positional and geometric isomers (trans: t or cis: c) of <span class=""chemical"">linoleic acid</span>, and have been widely reported to possess anti-tumoral activity against <span class=""disease"">breast cancer</span> both in vitro and in vivo.",,23375583,23375583_D019787_D009369,23375583_1,bcv_sentence_task_befree_4581,,770960513,FALSE,finalized,5,8/14/15 22:30,"



",yes_direct,0.7914,,D005472,"<span class=""chemical"">5-FU</span>",D064420,"<span class=""disease"">toxicities</span>","Drug resistance and severe <span class=""disease"">toxicities</span> are limitations when handling <span class=""chemical"">5-FU</span>.",,23386105,23386105_D005472_D064420,23386105_1,bcv_sentence_task_befree_4582,,770960514,FALSE,finalized,5,8/15/15 0:01,"



",no_relation,1,,D002955,"<span class=""chemical"">folinic acid</span>",D064420,"<span class=""disease"">toxicity</span>","We have developed a triple liposomal formulation of 5-FU combined to 2'-deoxyinosine and <span class=""chemical"">folinic acid</span> to improve its efficacy-<span class=""disease"">toxicity</span> balance.",,23386105,23386105_D002955_D064420,23386105_2,bcv_sentence_task_befree_4583,,770960515,FALSE,finalized,5,8/15/15 2:00,"



",no_relation,1,,C012271,"<span class=""chemical"">2'-deoxyinosine</span>",D064420,"<span class=""disease"">toxicity</span>","We have developed a triple liposomal formulation of 5-FU combined to <span class=""chemical"">2'-deoxyinosine</span> and folinic acid to improve its efficacy-<span class=""disease"">toxicity</span> balance.",,23386105,23386105_C012271_D064420,23386105_2,bcv_sentence_task_befree_4584,,770960516,FALSE,finalized,5,8/14/15 22:40,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D064420,"<span class=""disease"">toxicity</span>","We have developed a triple liposomal formulation of <span class=""chemical"">5-FU</span> combined to 2'-deoxyinosine and folinic acid to improve its efficacy-<span class=""disease"">toxicity</span> balance.",,23386105,23386105_D005472_D064420,23386105_2,bcv_sentence_task_befree_4585,,770960517,FALSE,finalized,5,8/15/15 2:11,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D054067,"<span class=""disease"">DPD-deficiency</span>","Beside, milder neutropenia was observed when giving LipoFufol to animals with transient partial <span class=""disease"">DPD-deficiency</span>, as compared with standard <span class=""chemical"">5-FU</span>.",,23386105,23386105_D005472_D054067,23386105_11,bcv_sentence_task_befree_4586,,770960518,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,1,,D005472,"<span class=""chemical"">5-FU</span>",D009503,"<span class=""disease"">neutropenia</span>","Beside, milder <span class=""disease"">neutropenia</span> was observed when giving LipoFufol to animals with transient partial DPD-deficiency, as compared with standard <span class=""chemical"">5-FU</span>.",,23386105,23386105_D005472_D009503,23386105_11,bcv_sentence_task_befree_4587,,770960519,FALSE,finalized,5,8/14/15 23:15,"



",no_relation,0.794,,D005472,"<span class=""chemical"">5-FU</span>",D064420,"<span class=""disease"">toxicity</span>","The issues of drug-resistance and drug-related <span class=""disease"">toxicity</span> can be both addressed using a stealth liposomal formulation of modulated <span class=""chemical"">5-FU</span>.",,23386105,23386105_D005472_D064420,23386105_13,bcv_sentence_task_befree_4588,,770960520,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,1,,C047246,"<span class=""chemical"">temozolomide</span>",D009369,"<span class=""disease"">tumor</span>","We propose a mathematical model that takes into account a classical maximum tolerated dose (MTD) chemotherapy regimen (whose primary targets are the <span class=""disease"">tumor</span> cells) as well as a metronomic chemotherapy regimen (whose primary targets are the <span class=""disease"">tumor</span> endothelial cells) for the administration of <span class=""chemical"">temozolomide</span> (Temodal()) in order to compare the effectiveness of these two types of protocols.",,23389760,23389760_C047246_D009369,23389760_1,bcv_sentence_task_befree_4589,,770960521,FALSE,finalized,5,8/14/15 23:05,"



",no_relation,1,,C047246,"<span class=""chemical"">temozolomide</span>",D009369,"<span class=""disease"">tumor/cancer</span>","The model is built from 4 natural hypotheses: (H1) without treatment the <span class=""disease"">tumor</span> growth follows a Gompertz model, (H2) endothelial cells are more sensitive to <span class=""chemical"">temozolomide</span> than <span class=""disease"">cancer</span> cells, (H3) the anti-angiogenic effect blocks tumor growth, and (H4) endothelial cells are more genetically stable than <span class=""disease"">cancer</span> cells and thus less likely to develop resistance to <span class=""chemical"">temozolomide</span>.",,23389760,23389760_C047246_D009369,23389760_2,bcv_sentence_task_befree_4590,,770960522,FALSE,finalized,5,8/15/15 1:12,"



",no_relation,0.5769,,C047246,"<span class=""chemical"">temozolomide</span>",D006327,"<span class=""disease"">blocks tumor</span>","The model is built from 4 natural hypotheses: (H1) without treatment the tumor growth follows a Gompertz model, (H2) endothelial cells are more sensitive to <span class=""chemical"">temozolomide</span> than cancer cells, (H3) the anti-angiogenic effect <span class=""disease"">blocks tumor</span> growth, and (H4) endothelial cells are more genetically stable than cancer cells and thus less likely to develop resistance to <span class=""chemical"">temozolomide</span>.",,23389760,23389760_C047246_D006327,23389760_2,bcv_sentence_task_befree_4591,,770960523,FALSE,finalized,5,8/15/15 0:06,"



",no_relation,1,,C047246,"<span class=""chemical"">temozolomide</span>",D009369,"<span class=""disease"">tumor/cancer</span>","Our mathematical model shows that the metronomic regimen induces <span class=""disease"">tumor</span> regression through anti-angiogenic effects while the MTD regimen fails to do so, due to the emergence of <span class=""chemical"">temozolomide</span> resistance in <span class=""disease"">cancer</span> cells.",,23389760,23389760_C047246_D009369,23389760_4,bcv_sentence_task_befree_4592,,770960524,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,C101426,"<span class=""chemical"">Sildenafil</span>",D009203,"<span class=""disease"">myocardial infarction</span>","<span class=""chemical"">Sildenafil</span> and diastolic dysfunction after acute <span class=""disease"">myocardial infarction</span> in patients with preserved ejection fraction: the <span class=""chemical"">Sildenafil</span> and Diastolic Dysfunction After Acute <span class=""disease"">Myocardial Infarction</span> (SIDAMI) trial.",,23406672,23406672_C101426_D009203,23406672_0,bcv_sentence_task_befree_4593,,770960525,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,C101426,"<span class=""chemical"">Sildenafil</span>",D054144,"<span class=""disease"">diastolic dysfunction</span>","<span class=""chemical"">Sildenafil</span> and <span class=""disease"">diastolic dysfunction</span> after acute myocardial infarction in patients with preserved ejection fraction: the <span class=""chemical"">Sildenafil</span> and <span class=""disease"">Diastolic Dysfunction</span> After Acute Myocardial Infarction (SIDAMI) trial.",,23406672,23406672_C101426_D054144,23406672_0,bcv_sentence_task_befree_4594,,770960526,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,1,,C101426,"<span class=""chemical"">sildenafil</span>",D009203,"<span class=""disease"">myocardial infarction</span>","We hypothesized that <span class=""chemical"">sildenafil</span> would reduce filling pressure during exercise in patients with diastolic dysfunction after <span class=""disease"">myocardial infarction</span>.",,23406672,23406672_C101426_D009203,23406672_2,bcv_sentence_task_befree_4595,,770960527,FALSE,finalized,5,8/15/15 1:11,"



",no_relation,1,,C101426,"<span class=""chemical"">sildenafil</span>",D054144,"<span class=""disease"">diastolic dysfunction</span>","We hypothesized that <span class=""chemical"">sildenafil</span> would reduce filling pressure during exercise in patients with <span class=""disease"">diastolic dysfunction</span> after myocardial infarction.",,23406672,23406672_C101426_D054144,23406672_2,bcv_sentence_task_befree_4596,,770960528,FALSE,finalized,5,8/14/15 23:08,"



",no_relation,1,,C101426,"<span class=""chemical"">sildenafil</span>",D054144,"<span class=""disease"">diastolic dysfunction</span>","Seventy patients with <span class=""disease"">diastolic dysfunction</span> and near normal left ventricular ejection fraction on echocardiography were randomly assigned <span class=""chemical"">sildenafil</span> 40 mg thrice daily or matching placebo for 9 weeks.",,23406672,23406672_C101426_D054144,23406672_3,bcv_sentence_task_befree_4597,,770960529,FALSE,finalized,5,8/14/15 23:01,"



",no_relation,0.8154,,C101426,"<span class=""chemical"">Sildenafil</span>",D009203,"<span class=""disease"">myocardial infarction</span>","<span class=""chemical"">Sildenafil</span> did not decrease filling pressure at rest or during exercise in post-<span class=""disease"">myocardial infarction</span> patients with diastolic dysfunction.",,23406672,23406672_C101426_D009203,23406672_9,bcv_sentence_task_befree_4598,,770960530,FALSE,finalized,5,8/14/15 22:37,"



",no_relation,1,,C101426,"<span class=""chemical"">Sildenafil</span>",D054144,"<span class=""disease"">diastolic dysfunction</span>","<span class=""chemical"">Sildenafil</span> did not decrease filling pressure at rest or during exercise in post-myocardial infarction patients with <span class=""disease"">diastolic dysfunction</span>.",,23406672,23406672_C101426_D054144,23406672_9,bcv_sentence_task_befree_4599,,770960531,FALSE,finalized,5,8/15/15 0:27,"



",no_relation,1,,D013974,"<span class=""chemical"">l-thyroxine</span>",D007037,"<span class=""disease"">hypothyroidism</span>","At re-evaluation, 34.5% of patients showed permanent <span class=""disease"">hypothyroidism</span> and needed <span class=""chemical"">l-thyroxine</span> reintroduction, 27.4% had persistent hyperthyrotropinemia (TSH 5-10 mU/L), and 38.1% had transient <span class=""disease"">hypothyroidism</span>.",,23426615,23426615_D013974_D007037,23426615_6,bcv_sentence_task_befree_4600,,770960532,FALSE,finalized,5,8/14/15 22:51,"



",no_relation,1,,D013974,"<span class=""chemical"">l-thyroxine</span>",C562568,"<span class=""disease"">hypoplasia</span>","Major risk factors for permanent CH were prematurity, first-degree familial history of goiter/nodules, thyroid <span class=""disease"">hypoplasia</span> at diagnosis, and high <span class=""chemical"">l-thyroxine</span> requirements at follow-up.",,23426615,23426615_D013974_C562568,23426615_7,bcv_sentence_task_befree_4601,,770960533,FALSE,finalized,5,8/14/15 23:25,"



",no_relation,0.5918,,D013974,"<span class=""chemical"">l-thyroxine</span>",D003409,"<span class=""disease"">CH</span>","Major risk factors for permanent <span class=""disease"">CH</span> were prematurity, first-degree familial history of goiter/nodules, thyroid hypoplasia at diagnosis, and high <span class=""chemical"">l-thyroxine</span> requirements at follow-up.",,23426615,23426615_D013974_D003409,23426615_7,bcv_sentence_task_befree_4602,,770960534,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,D013974,"<span class=""chemical"">l-thyroxine</span>",D003409,"<span class=""disease"">CH</span>","Only one-third of patients with <span class=""disease"">CH</span> and eutopic thyroid gland needed to continue <span class=""chemical"">l-thyroxine</span> therapy after re-evaluation.",,23426615,23426615_D013974_D003409,23426615_10,bcv_sentence_task_befree_4603,,770960535,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D009336,"<span class=""disease"">necrosis</span>","We report an unusual case of invasive papillary carcinoma of the breast with high nuclear grade, brisk mitosis, <span class=""disease"">necrosis</span>, extensive apocrine differentiation, and intense lymphoplasmacytic infiltrate; additionally triple-negativity for <span class=""chemical"">estrogen</span> and progesterone receptors and Her2 neu.",,23455801,23455801_D004967_D009336,23455801_2,bcv_sentence_task_befree_4604,,770960536,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,1,,D011374,"<span class=""chemical"">progesterone</span>",D009336,"<span class=""disease"">necrosis</span>","We report an unusual case of invasive papillary carcinoma of the breast with high nuclear grade, brisk mitosis, <span class=""disease"">necrosis</span>, extensive apocrine differentiation, and intense lymphoplasmacytic infiltrate; additionally triple-negativity for estrogen and <span class=""chemical"">progesterone</span> receptors and Her2 neu.",,23455801,23455801_D011374_D009336,23455801_2,bcv_sentence_task_befree_4605,,770960537,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,1,,D011374,"<span class=""chemical"">progesterone</span>",D002291,"<span class=""disease"">papillary carcinoma of the breast</span>","We report an unusual case of invasive <span class=""disease"">papillary carcinoma of the breast</span> with high nuclear grade, brisk mitosis, necrosis, extensive apocrine differentiation, and intense lymphoplasmacytic infiltrate; additionally triple-negativity for estrogen and <span class=""chemical"">progesterone</span> receptors and Her2 neu.",,23455801,23455801_D011374_D002291,23455801_2,bcv_sentence_task_befree_4606,,770960538,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D002291,"<span class=""disease"">papillary carcinoma of the breast</span>","We report an unusual case of invasive <span class=""disease"">papillary carcinoma of the breast</span> with high nuclear grade, brisk mitosis, necrosis, extensive apocrine differentiation, and intense lymphoplasmacytic infiltrate; additionally triple-negativity for <span class=""chemical"">estrogen</span> and progesterone receptors and Her2 neu.",,23455801,23455801_D004967_D002291,23455801_2,bcv_sentence_task_befree_4607,,770960539,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,1,,C072042,"<span class=""chemical"">latanoprost</span>",D002386,"<span class=""disease"">cataract</span>","This study evaluated the effects of acetazolamide, <span class=""chemical"">latanoprost</span>, travoprost, bimatoprost, brimonidine, brinzolamide, and timolol on pain during phacoemulsification <span class=""disease"">cataract</span> surgery.",,23461283,23461283_C072042_D002386,23461283_1,bcv_sentence_task_befree_4608,,770960540,FALSE,finalized,5,8/15/15 1:23,"



",no_relation,0.7979,,D000086,"<span class=""chemical"">acetazolamide</span>",D010146,"<span class=""disease"">pain</span>","This study evaluated the effects of <span class=""chemical"">acetazolamide</span>, latanoprost, travoprost, bimatoprost, brimonidine, brinzolamide, and timolol on <span class=""disease"">pain</span> during phacoemulsification cataract surgery.",,23461283,23461283_D000086_D010146,23461283_1,bcv_sentence_task_befree_4609,,770960541,FALSE,finalized,5,8/15/15 0:02,"



",no_relation,1,,C111827,"<span class=""chemical"">brinzolamide</span>",D010146,"<span class=""disease"">pain</span>","This study evaluated the effects of acetazolamide, latanoprost, travoprost, bimatoprost, brimonidine, <span class=""chemical"">brinzolamide</span>, and timolol on <span class=""disease"">pain</span> during phacoemulsification cataract surgery.",,23461283,23461283_C111827_D010146,23461283_1,bcv_sentence_task_befree_4610,,770960542,FALSE,finalized,5,8/14/15 23:23,"



",no_relation,1,,C072042,"<span class=""chemical"">latanoprost</span>",D010146,"<span class=""disease"">pain</span>","This study evaluated the effects of acetazolamide, <span class=""chemical"">latanoprost</span>, travoprost, bimatoprost, brimonidine, brinzolamide, and timolol on <span class=""disease"">pain</span> during phacoemulsification cataract surgery.",,23461283,23461283_C072042_D010146,23461283_1,bcv_sentence_task_befree_4611,,770960543,FALSE,finalized,5,8/14/15 22:49,"



",no_relation,1,,D000086,"<span class=""chemical"">acetazolamide</span>",D002386,"<span class=""disease"">cataract</span>","This study evaluated the effects of <span class=""chemical"">acetazolamide</span>, latanoprost, travoprost, bimatoprost, brimonidine, brinzolamide, and timolol on pain during phacoemulsification <span class=""disease"">cataract</span> surgery.",,23461283,23461283_D000086_D002386,23461283_1,bcv_sentence_task_befree_4612,,770960544,FALSE,finalized,5,8/14/15 22:50,"



",no_relation,1,,C111827,"<span class=""chemical"">brinzolamide</span>",D002386,"<span class=""disease"">cataract</span>","This study evaluated the effects of acetazolamide, latanoprost, travoprost, bimatoprost, brimonidine, <span class=""chemical"">brinzolamide</span>, and timolol on pain during phacoemulsification <span class=""disease"">cataract</span> surgery.",,23461283,23461283_C111827_D002386,23461283_1,bcv_sentence_task_befree_4613,,770960545,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,1,,C015620,"<span class=""chemical"">brimonidine</span>",D010146,"<span class=""disease"">pain</span>","This study evaluated the effects of acetazolamide, latanoprost, travoprost, bimatoprost, <span class=""chemical"">brimonidine</span>, brinzolamide, and timolol on <span class=""disease"">pain</span> during phacoemulsification cataract surgery.",,23461283,23461283_C015620_D010146,23461283_1,bcv_sentence_task_befree_4614,,770960546,FALSE,finalized,5,8/14/15 22:37,"



",no_relation,1,,D013999,"<span class=""chemical"">timolol</span>",D002386,"<span class=""disease"">cataract</span>","This study evaluated the effects of acetazolamide, latanoprost, travoprost, bimatoprost, brimonidine, brinzolamide, and <span class=""chemical"">timolol</span> on pain during phacoemulsification <span class=""disease"">cataract</span> surgery.",,23461283,23461283_D013999_D002386,23461283_1,bcv_sentence_task_befree_4615,,770960547,FALSE,finalized,5,8/14/15 22:58,"

Suspenseful abstract is suspenseful

",no_relation,1,,C015620,"<span class=""chemical"">brimonidine</span>",D002386,"<span class=""disease"">cataract</span>","This study evaluated the effects of acetazolamide, latanoprost, travoprost, bimatoprost, <span class=""chemical"">brimonidine</span>, brinzolamide, and timolol on pain during phacoemulsification <span class=""disease"">cataract</span> surgery.",,23461283,23461283_C015620_D002386,23461283_1,bcv_sentence_task_befree_4616,,770960548,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,D013999,"<span class=""chemical"">timolol</span>",D010146,"<span class=""disease"">pain</span>","This study evaluated the effects of acetazolamide, latanoprost, travoprost, bimatoprost, brimonidine, brinzolamide, and <span class=""chemical"">timolol</span> on <span class=""disease"">pain</span> during phacoemulsification cataract surgery.",,23461283,23461283_D013999_D010146,23461283_1,bcv_sentence_task_befree_4617,,770960549,FALSE,finalized,5,8/14/15 23:10,"



",no_relation,0.8106,,D011453,"<span class=""chemical"">prostanoids</span>",D010146,"<span class=""disease"">pain</span>","The brimonidine group exhibited the lowest visual analog <span class=""disease"">pain</span>-scale scores, and the <span class=""chemical"">prostanoids</span>, especially the bimatoprost group, demonstrated the highest visual analog <span class=""disease"">pain</span>-scale scores (medianstandard deviation were 0.01.50 and 2.01.91, respectively).",,23461283,23461283_D011453_D010146,23461283_7,bcv_sentence_task_befree_4618,,770960550,FALSE,finalized,5,8/14/15 23:18,"



",no_relation,1,,C015620,"<span class=""chemical"">brimonidine</span>",D010146,"<span class=""disease"">pain</span>","The <span class=""chemical"">brimonidine</span> group exhibited the lowest visual analog <span class=""disease"">pain</span>-scale scores, and the prostanoids, especially the bimatoprost group, demonstrated the highest visual analog <span class=""disease"">pain</span>-scale scores (medianstandard deviation were 0.01.50 and 2.01.91, respectively).",,23461283,23461283_C015620_D010146,23461283_7,bcv_sentence_task_befree_4619,,770960551,FALSE,finalized,5,8/15/15 1:41,"



",no_relation,0.8073,,C111827,"<span class=""chemical"">brinzolamide</span>",D010146,"<span class=""disease"">pain</span>","The median visual analog <span class=""disease"">pain</span>-scale scores of the acetazolamide, latanoprost, travoprost, <span class=""chemical"">brinzolamide</span>, and timolol groups were 0.01.62, 2.01.67, 2.01.73, 0.01.66, and 1.01.54, respectively.",,23461283,23461283_C111827_D010146,23461283_8,bcv_sentence_task_befree_4620,,770960552,FALSE,finalized,5,8/14/15 23:11,"



",yes_direct,0.6045,,D000086,"<span class=""chemical"">acetazolamide</span>",D010146,"<span class=""disease"">pain</span>","The median visual analog <span class=""disease"">pain</span>-scale scores of the <span class=""chemical"">acetazolamide</span>, latanoprost, travoprost, brinzolamide, and timolol groups were 0.01.62, 2.01.67, 2.01.73, 0.01.66, and 1.01.54, respectively.",,23461283,23461283_D000086_D010146,23461283_8,bcv_sentence_task_befree_4621,,770960553,FALSE,finalized,5,8/14/15 22:53,"



",yes_direct,0.6214,,C072042,"<span class=""chemical"">latanoprost</span>",D010146,"<span class=""disease"">pain</span>","The median visual analog <span class=""disease"">pain</span>-scale scores of the acetazolamide, <span class=""chemical"">latanoprost</span>, travoprost, brinzolamide, and timolol groups were 0.01.62, 2.01.67, 2.01.73, 0.01.66, and 1.01.54, respectively.",,23461283,23461283_C072042_D010146,23461283_8,bcv_sentence_task_befree_4622,,770960554,FALSE,finalized,5,8/15/15 1:43,"



",no_relation,1,,D013999,"<span class=""chemical"">timolol</span>",D010146,"<span class=""disease"">pain</span>","The median visual analog <span class=""disease"">pain</span>-scale scores of the acetazolamide, latanoprost, travoprost, brinzolamide, and <span class=""chemical"">timolol</span> groups were 0.01.62, 2.01.67, 2.01.73, 0.01.66, and 1.01.54, respectively.",,23461283,23461283_D013999_D010146,23461283_8,bcv_sentence_task_befree_4623,,770960555,FALSE,finalized,5,8/15/15 0:23,"



",no_relation,1,,D013792,"<span class=""chemical"">thalidomide</span>",D009101,"<span class=""disease"">multiple myeloma</span>","Clinical profile of <span class=""disease"">multiple myeloma</span> and effect of <span class=""chemical"">thalidomide</span> based treatment on its outcome.",,23469567,23469567_D013792_D009101,23469567_0,bcv_sentence_task_befree_4624,,770960556,FALSE,finalized,5,8/14/15 22:52,"



",no_relation,0.8265,,D013792,"<span class=""chemical"">thalidomide</span>",D009101,"<span class=""disease"">multiple myeloma</span>","Recently, <span class=""chemical"">thalidomide</span> has demonstrated significant activity in the treatment of <span class=""disease"">multiple myeloma</span> in various western studies.",,23469567,23469567_D013792_D009101,23469567_2,bcv_sentence_task_befree_4625,,770960557,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D013792,"<span class=""chemical"">thalidomide</span>",D009101,"<span class=""disease"">multiple myeloma</span>","To study the clinical profile of <span class=""disease"">multiple myeloma</span> and the effect of <span class=""chemical"">thalidomide</span> based treatment on its outcome in the Indian scenario are the aims and objective of the study.",,23469567,23469567_D013792_D009101,23469567_4,bcv_sentence_task_befree_4626,,770960558,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,0.8002,,D013792,"<span class=""chemical"">thalidomide</span>",D009101,"<span class=""disease"">multiple myeloma</span>","Although <span class=""disease"">multiple myeloma</span> has remained an incurable disease to date, presently available <span class=""chemical"">thalidomide</span> based combination chemotherapy represents an active inductive regimen to improve the outcome and achieve eventual cure.",,23469567,23469567_D013792_D009101,23469567_14,bcv_sentence_task_befree_4627,,770960559,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,0.5894,,C011421,"<span class=""chemical"">Methylchloroisothiazolinone</span>",D017449,"<span class=""disease"">allergic contact dermatitis</span>","<span class=""chemical"">Methylchloroisothiazolinone</span> and methylisothiazolinone <span class=""disease"">allergic contact dermatitis</span> and the effect of patch test concentration.",,23474447,23474447_C011421_D017449,23474447_0,bcv_sentence_task_befree_4628,,770960560,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,0.5933,,C011506,"<span class=""chemical"">methylisothiazolinone</span>",D017449,"<span class=""disease"">allergic contact dermatitis</span>","Methylchloroisothiazolinone and <span class=""chemical"">methylisothiazolinone</span> <span class=""disease"">allergic contact dermatitis</span> and the effect of patch test concentration.",,23474447,23474447_C011506_D017449,23474447_0,bcv_sentence_task_befree_4629,,770960561,FALSE,finalized,5,8/14/15 22:37,"



",yes_direct,0.5969,,D003042,"<span class=""chemical"">cocaine</span>",D019970,"<span class=""disease"">cocaine dependence</span>","Impact of DCS-facilitated cue exposure therapy on brain activation to <span class=""chemical"">cocaine</span> cues in <span class=""chemical""></span><span class=""disease"">cocaine</span> dependence.",,23497788,23497788_D003042_D019970,23497788_0,bcv_sentence_task_befree_4630,,770960562,FALSE,finalized,5,8/14/15 22:41,"



",no_relation,0.58,,D003042,"<span class=""chemical"">cocaine</span>",D019970,"<span class=""disease"">cocaine dependence</span>","To better understand the impact of DCS-facilitated extinction on neural reactivity to drug cues, the present study reports fMRI findings from a randomized, double-blind, placebo-controlled trial of DCS-facilitated cue exposure for <span class=""chemical""></span><span class=""disease"">cocaine</span> dependence.",,23497788,23497788_D003042_D019970,23497788_3,bcv_sentence_task_befree_4631,,770960563,FALSE,finalized,5,8/15/15 0:06,"



",no_relation,0.7894,,D003042,"<span class=""chemical"">cocaine</span>",D019970,"<span class=""disease"">cocaine dependence</span>","Three trials of DCS-facilitated cue exposure therapy for <span class=""chemical""></span><span class=""disease"">cocaine</span> dependence have found that DCS either increases or does not significantly impact response to <span class=""chemical"">cocaine</span> cues.",,23497788,23497788_D003042_D019970,23497788_9,bcv_sentence_task_befree_4632,,770960564,FALSE,finalized,5,8/14/15 23:05,"



",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D000208,"<span class=""disease"">acute hepatitis C infection</span>","Spontaneous clearance and treatment of <span class=""disease"">acute hepatitis C infection</span> in HIV-positive men with 48 weeks of interferon-alpha and <span class=""chemical"">ribavirin</span>.",,23514835,23514835_D012254_D000208,23514835_0,bcv_sentence_task_befree_4633,,770960565,FALSE,finalized,5,8/14/15 23:17,"



",no_relation,1,,D016898,"<span class=""chemical"">interferon-alpha</span>",D000208,"<span class=""disease"">acute hepatitis C infection</span>","Spontaneous clearance and treatment of <span class=""disease"">acute hepatitis C infection</span> in HIV-positive men with 48 weeks of <span class=""chemical"">interferon-alpha</span> and ribavirin.",,23514835,23514835_D016898_D000208,23514835_0,bcv_sentence_task_befree_4634,,770960566,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,D000596,"<span class=""chemical"">amino-acid</span>",D006526,"<span class=""disease"">HCV infection</span>","Lipid pathway impairment, decrease in the antioxidant pool and downregulation in <span class=""chemical"">amino-acid</span> metabolism are just some of the metabolic variations attributed to chronic <span class=""disease"">HCV infection</span>.",,23529134,23529134_D000596_D006526,23529134_1,bcv_sentence_task_befree_4635,,770960567,FALSE,finalized,5,8/15/15 0:10,"



",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D003920,"<span class=""disease"">diabetes mellitus</span>","We performed proteomic analysis on liver specimens of a 28-year-old woman affected by hepatitis C genotype 1a, alcoholism and <span class=""disease"">diabetes mellitus</span> type 1, before and after antiviral treatment with pegylated interferon alpha 2b and <span class=""chemical"">ribavirin</span>.",,23529134,23529134_D012254_D003920,23529134_4,bcv_sentence_task_befree_4636,,770960568,FALSE,finalized,5,8/14/15 22:37,"



",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D006526,"<span class=""disease"">hepatitis C</span>","We performed proteomic analysis on liver specimens of a 28-year-old woman affected by <span class=""disease"">hepatitis C</span> genotype 1a, alcoholism and diabetes mellitus type 1, before and after antiviral treatment with pegylated interferon alpha 2b and <span class=""chemical"">ribavirin</span>.",,23529134,23529134_D012254_D006526,23529134_4,bcv_sentence_task_befree_4637,,770960569,FALSE,finalized,5,8/14/15 23:47,"



",no_relation,1,,C417083,"<span class=""chemical"">pegylated interferon alpha 2b</span>",D006526,"<span class=""disease"">hepatitis C</span>","We performed proteomic analysis on liver specimens of a 28-year-old woman affected by <span class=""disease"">hepatitis C</span> genotype 1a, alcoholism and diabetes mellitus type 1, before and after antiviral treatment with <span class=""chemical"">pegylated interferon alpha 2b</span> and ribavirin.",,23529134,23529134_C417083_D006526,23529134_4,bcv_sentence_task_befree_4638,,770960570,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D000437,"<span class=""disease"">alcoholism</span>","We performed proteomic analysis on liver specimens of a 28-year-old woman affected by hepatitis C genotype 1a, <span class=""disease"">alcoholism</span> and diabetes mellitus type 1, before and after antiviral treatment with pegylated interferon alpha 2b and <span class=""chemical"">ribavirin</span>.",,23529134,23529134_D012254_D000437,23529134_4,bcv_sentence_task_befree_4639,,770960571,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,1,,C417083,"<span class=""chemical"">pegylated interferon alpha 2b</span>",D000437,"<span class=""disease"">alcoholism</span>","We performed proteomic analysis on liver specimens of a 28-year-old woman affected by hepatitis C genotype 1a, <span class=""disease"">alcoholism</span> and diabetes mellitus type 1, before and after antiviral treatment with <span class=""chemical"">pegylated interferon alpha 2b</span> and ribavirin.",,23529134,23529134_C417083_D000437,23529134_4,bcv_sentence_task_befree_4640,,770960572,FALSE,finalized,5,8/14/15 22:37,"



",no_relation,1,,C417083,"<span class=""chemical"">pegylated interferon alpha 2b</span>",D003920,"<span class=""disease"">diabetes mellitus</span>","We performed proteomic analysis on liver specimens of a 28-year-old woman affected by hepatitis C genotype 1a, alcoholism and <span class=""disease"">diabetes mellitus</span> type 1, before and after antiviral treatment with <span class=""chemical"">pegylated interferon alpha 2b</span> and ribavirin.",,23529134,23529134_C417083_D003920,23529134_4,bcv_sentence_task_befree_4641,,770960573,FALSE,finalized,5,8/15/15 0:30,"



",no_relation,1,,D000596,"<span class=""chemical"">amino acid</span>",D000437,"<span class=""disease"">alcohol abuse</span>","The proteomic analysis showed that after therapy, a downregulation of enzymes involved in <span class=""chemical"">amino acid</span> metabolism, glycolysis/gluconeogenesis and alcohol catabolism takes place, the latter probably due to cessation of <span class=""disease"">alcohol abuse</span>.",,23529134,23529134_D000596_D000437,23529134_8,bcv_sentence_task_befree_4642,,770960574,FALSE,finalized,5,8/14/15 23:30,"



This one is very obvious but probably not what you meant.",no_relation,0.7881,,D000431,"<span class=""chemical"">alcohol</span>",D000437,"<span class=""disease"">alcohol abuse</span>","The proteomic analysis showed that after therapy, a downregulation of enzymes involved in amino acid metabolism, glycolysis/gluconeogenesis and <span class=""chemical"">alcohol</span> catabolism takes place, the latter probably due to cessation of <span class=""chemical""></span><span class=""disease"">alcohol</span> abuse.",,23529134,23529134_D000431_D000437,23529134_8,bcv_sentence_task_befree_4643,,770960575,FALSE,finalized,5,8/14/15 22:51,"



",no_relation,0.7917,,D005227,"<span class=""chemical"">fatty acids</span>",D006526,"<span class=""disease"">HCV infection</span>","These ""real time"" data confirm in vivo, in humans, that during <span class=""disease"">HCV infection</span>, the pathways related to <span class=""chemical"">fatty acids</span>, glucose metabolism and free radical scavenging are inhibited.",,23529134,23529134_D005227_D006526,23529134_11,bcv_sentence_task_befree_4644,,770960576,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D006526,"<span class=""disease"">HCV infection</span>","These ""real time"" data confirm in vivo, in humans, that during <span class=""disease"">HCV infection</span>, the pathways related to fatty acids, <span class=""chemical"">glucose</span> metabolism and free radical scavenging are inhibited.",,23529134,23529134_D005947_D006526,23529134_11,bcv_sentence_task_befree_4645,,770960577,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,D003474,"<span class=""chemical"">curcumin</span>",D008659,"<span class=""disease"">metabolic syndrome</span>","200 mg/kg <span class=""chemical"">curcumin</span> was gavaged to adult male Sprague-Dawley rats with high-fat-diet-induced <span class=""disease"">metabolic syndrome</span> for 2 months.",,23533564,23533564_D003474_D008659,23533564_5,bcv_sentence_task_befree_4646,,770960578,FALSE,finalized,5,8/14/15 23:06,"



",no_relation,1,,D003474,"<span class=""chemical"">Curcumin</span>",D009765,"<span class=""disease"">obese</span>","<span class=""chemical"">Curcumin</span> reduced serum glucose, cholesterol, triglyceride, low density lipoprotein levels in high-fat-diet-induced <span class=""disease"">obese</span> rats.",,23533564,23533564_D003474_D009765,23533564_8,bcv_sentence_task_befree_4647,,770960579,FALSE,finalized,5,8/14/15 23:05,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D009765,"<span class=""disease"">obese</span>","Curcumin reduced serum <span class=""chemical"">glucose</span>, cholesterol, triglyceride, low density lipoprotein levels in high-fat-diet-induced <span class=""disease"">obese</span> rats.",,23533564,23533564_D005947_D009765,23533564_8,bcv_sentence_task_befree_4648,,770960580,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,D002784,"<span class=""chemical"">cholesterol</span>",D009765,"<span class=""disease"">obese</span>","Curcumin reduced serum glucose, <span class=""chemical"">cholesterol</span>, triglyceride, low density lipoprotein levels in high-fat-diet-induced <span class=""disease"">obese</span> rats.",,23533564,23533564_D002784_D009765,23533564_8,bcv_sentence_task_befree_4649,,770960581,FALSE,finalized,5,8/14/15 22:47,"



",no_relation,1,,D003474,"<span class=""chemical"">curcumin</span>",D008659,"<span class=""disease"">metabolic syndrome</span>","In conclusion, <span class=""chemical"">curcumin</span> is effective for the treatment of <span class=""disease"">metabolic syndrome</span> and four novel <span class=""chemical"">curcumin</span> derivatives had high potencies for inhibition of human 11_-HSD1 with selectivity against 11_-HSD2.",,23533564,23533564_D003474_D008659,23533564_12,bcv_sentence_task_befree_4650,,770960582,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,0.5783,,D059808,"<span class=""chemical"">polyphenols</span>",D002318,"<span class=""disease"">cardiovascular health</span>","Oxidative stress and <span class=""disease"">cardiovascular health</span>: therapeutic potential of <span class=""chemical"">polyphenols</span>.",,23537433,23537433_D059808_D002318,23537433_0,bcv_sentence_task_befree_4651,,770960583,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,1,,D059808,"<span class=""chemical"">polyphenols</span>",D002318,"<span class=""disease"">cardiovascular health</span>","In addition, this review summarizes the health benefits of <span class=""chemical"">polyphenols</span>, and the recent progress on understanding the cellular and physiological actions by which <span class=""chemical"">polyphenols</span> may impart their beneficial properties on <span class=""disease"">cardiovascular health</span>.",,23537433,23537433_D059808_D002318,23537433_4,bcv_sentence_task_befree_4652,,770960584,FALSE,finalized,5,8/15/15 2:33,"



",no_relation,1,,D008712,"<span class=""chemical"">methicillin</span>",D011023,"<span class=""disease"">vancomycin-intermediate S. aureus/VISA</span>","We used 2 in vitro experimental systems to compare phenotypic and genotypic changes that accompany selection of mutants of <span class=""chemical"">methicillin</span>-resistant Staphylococcus aureus (MRSA) strain JH1 with low-level vancomycin resistance similar to the type found in <span class=""disease"">vancomycin-intermediate S. aureus</span> (<span class=""disease"">VISA</span>).",,23539745,23539745_D008712_D011023,23539745_1,bcv_sentence_task_befree_4653,,770960585,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,D014640,"<span class=""chemical"">vancomycin</span>",D011023,"<span class=""disease"">vancomycin-intermediate S. aureus/VISA</span>","We used 2 in vitro experimental systems to compare phenotypic and genotypic changes that accompany selection of mutants of methicillin-resistant Staphylococcus aureus (MRSA) strain JH1 with low-level <span class=""chemical"">vancomycin</span> resistance similar to the type found in <span class=""chemical""></span><span class=""disease"">vancomycin</span>-intermediate S. aureus (<span class=""disease"">VISA</span>).",,23539745,23539745_D014640_D011023,23539745_1,bcv_sentence_task_befree_4654,,770960586,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,1,,D014640,"<span class=""chemical"">vancomycin</span>",D018458,"<span class=""disease"">SEVs/simulated endocardial vegetations</span>","Mutants of JH1 were selected in vitro by means of a pharmacokinetic/pharmacodynamic (PK/PD) model of <span class=""disease"">simulated endocardial vegetations</span> (<span class=""disease"">SEVs</span>) and by exposure to <span class=""chemical"">vancomycin</span> in laboratory growth medium.",,23539745,23539745_D014640_D018458,23539745_3,bcv_sentence_task_befree_4655,,770960587,FALSE,finalized,5,8/15/15 1:31,"



",no_relation,1,,D017576,"<span class=""chemical"">daptomycin</span>",D011023,"<span class=""disease"">VISA</span>","Both mutants displayed reduced vancomycin and <span class=""chemical"">daptomycin</span> susceptibility and phenotypic alterations (eg, thicker cell walls and abnormal autolysis) that are typical of in vivo <span class=""disease"">VISA</span> mutants.",,23539745,23539745_D017576_D011023,23539745_6,bcv_sentence_task_befree_4656,,770960588,FALSE,finalized,5,8/15/15 0:41,"



",no_relation,1,,D014640,"<span class=""chemical"">vancomycin</span>",D011023,"<span class=""disease"">VISA</span>","Both mutants displayed reduced <span class=""chemical"">vancomycin</span> and daptomycin susceptibility and phenotypic alterations (eg, thicker cell walls and abnormal autolysis) that are typical of in vivo <span class=""disease"">VISA</span> mutants.",,23539745,23539745_D014640_D011023,23539745_6,bcv_sentence_task_befree_4657,,770960589,FALSE,finalized,5,8/14/15 22:57,"



",yes_direct,1,,C022172,"<span class=""chemical"">Zotepine</span>",D012640,"<span class=""disease"">seizures</span>","<span class=""chemical"">Zotepine</span>-induced convulsive <span class=""disease"">seizures</span> in a chronic case of treatment resistant paranoid schizophrenia.",,23543675,23543675_C022172_D012640,23543675_0,bcv_sentence_task_befree_4658,,770960590,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,0.8195,,C022172,"<span class=""chemical"">Zotepine</span>",D012559,"<span class=""disease"">schizophrenia</span>","<span class=""chemical"">Zotepine</span>-induced convulsive seizures in a chronic case of treatment resistant paranoid <span class=""disease"">schizophrenia</span>.",,23543675,23543675_C022172_D012559,23543675_0,bcv_sentence_task_befree_4659,,770960591,FALSE,finalized,5,8/15/15 1:13,"



",yes_direct,1,,C022172,"<span class=""chemical"">zotepine</span>",D012640,"<span class=""disease"">seizure</span>","The adverse event of <span class=""chemical"">zotepine</span> induced <span class=""disease"">seizure</span> is published in few case reports.",,23543675,23543675_C022172_D012640,23543675_4,bcv_sentence_task_befree_4660,,770960592,FALSE,finalized,5,8/15/15 0:36,"



",yes_direct,0.618,,C022172,"<span class=""chemical"">zotepine</span>",D012640,"<span class=""disease"">tonic-clonic seizures</span>","We report the occurrence of myoclonic seizure progressing to generalized <span class=""disease"">tonic-clonic seizures</span> with <span class=""chemical"">zotepine</span> along with clear temporal association of dose dependent modulation evident in this case.",,23543675,23543675_C022172_D012640,23543675_5,bcv_sentence_task_befree_4661,,770960593,FALSE,finalized,5,8/15/15 1:29,"



",yes_direct,0.807,,C022172,"<span class=""chemical"">zotepine</span>",D004831,"<span class=""disease"">myoclonic seizure</span>","We report the occurrence of <span class=""disease"">myoclonic seizure</span> progressing to generalized tonic-clonic seizures with <span class=""chemical"">zotepine</span> along with clear temporal association of dose dependent modulation evident in this case.",,23543675,23543675_C022172_D004831,23543675_5,bcv_sentence_task_befree_4662,,770960594,FALSE,finalized,5,8/14/15 22:37,"



",no_relation,1,,C551177,"<span class=""chemical"">vemurafenib</span>",D008545,"<span class=""disease"">melanoma</span>","To discuss the clinical efficacy and safety of ipilimumab, <span class=""chemical"">vemurafenib</span>, and investigational agents for the treatment of unresectable stage III and stage IV <span class=""disease"">melanoma</span> and define current strategies of first-line treatment selection.",,23548648,23548648_C551177_D008545,23548648_1,bcv_sentence_task_befree_4663,,770960595,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,1,,C560077,"<span class=""chemical"">trametinib</span>",D008545,"<span class=""disease"">melanoma</span>","Literature was accessed through MEDLINE and International Pharmaceutical Abstracts (1970-November 2012) using the terms <span class=""disease"">melanoma</span>, metastatic <span class=""disease"">melanoma</span>, ipilimumab, vemurafenib, dabrafenib, and <span class=""chemical"">trametinib</span>.",,23548648,23548648_C560077_D008545,23548648_2,bcv_sentence_task_befree_4664,,770960596,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,1,,C551177,"<span class=""chemical"">vemurafenib</span>",D008545,"<span class=""disease"">melanoma</span>","Literature was accessed through MEDLINE and International Pharmaceutical Abstracts (1970-November 2012) using the terms <span class=""disease"">melanoma</span>, metastatic <span class=""disease"">melanoma</span>, ipilimumab, <span class=""chemical"">vemurafenib</span>, dabrafenib, and trametinib.",,23548648,23548648_C551177_D008545,23548648_2,bcv_sentence_task_befree_4665,,770960597,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,1,,C561627,"<span class=""chemical"">dabrafenib</span>",D008545,"<span class=""disease"">melanoma</span>","Literature was accessed through MEDLINE and International Pharmaceutical Abstracts (1970-November 2012) using the terms <span class=""disease"">melanoma</span>, metastatic <span class=""disease"">melanoma</span>, ipilimumab, vemurafenib, <span class=""chemical"">dabrafenib</span>, and trametinib.",,23548648,23548648_C561627_D008545,23548648_2,bcv_sentence_task_befree_4666,,770960598,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,D003606,"<span class=""chemical"">dacarbazine</span>",D008545,"<span class=""disease"">melanoma</span>","Two randomized Phase 3 clinical trials have demonstrated a significant survival benefit with the use of ipilimumab compared to a <span class=""disease"">melanoma</span> vaccine (10.1 vs 6.4 months; p = 0.003) and compared to <span class=""chemical"">dacarbazine</span> (11.2 months, 95% CI 9.4-13.6 vs 9.1 months, 95% CI 7.8-10.5).",,23548648,23548648_D003606_D008545,23548648_7,bcv_sentence_task_befree_4667,,770960599,FALSE,finalized,5,8/15/15 1:51,"



",yes_direct,0.59,,C551177,"<span class=""chemical"">vemurafenib</span>",D064420,"<span class=""disease"">toxicity</span>","Both new agents possess unique <span class=""disease"">toxicity</span> profiles including immune-related adverse events with ipilimumab and secondary cutaneous cancers reported with <span class=""chemical"">vemurafenib</span> use.",,23548648,23548648_C551177_D064420,23548648_10,bcv_sentence_task_befree_4668,,770960600,FALSE,finalized,5,8/15/15 1:45,"



",yes_direct,1,,C551177,"<span class=""chemical"">vemurafenib</span>",D009369,"<span class=""disease"">cancers</span>","Both new agents possess unique toxicity profiles including immune-related adverse events with ipilimumab and secondary cutaneous <span class=""disease"">cancers</span> reported with <span class=""chemical"">vemurafenib</span> use.",,23548648,23548648_C551177_D009369,23548648_10,bcv_sentence_task_befree_4669,,770960601,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,1,,C551177,"<span class=""chemical"">vemurafenib</span>",D008545,"<span class=""disease"">melanoma</span>","Treatment strategies have changed for patients with advanced <span class=""disease"">melanoma</span> with the use of ipilimumab and <span class=""chemical"">vemurafenib</span> as first-line agents.",,23548648,23548648_C551177_D008545,23548648_11,bcv_sentence_task_befree_4670,,770960602,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,0.7913,,D005839,"<span class=""chemical"">gentamicin</span>",D016470,"<span class=""disease"">bacteremia</span>","In chronic <span class=""disease"">bacteremia</span>, <span class=""chemical"">gentamicin</span> and doxycycline significantly increased the resolution rate.",,23602630,23602630_D005839_D016470,23602630_8,bcv_sentence_task_befree_4671,,770960603,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,1,,D004318,"<span class=""chemical"">doxycycline</span>",D016470,"<span class=""disease"">bacteremia</span>","In chronic <span class=""disease"">bacteremia</span>, gentamicin and <span class=""chemical"">doxycycline</span> significantly increased the resolution rate.",,23602630,23602630_D004318_D016470,23602630_8,bcv_sentence_task_befree_4672,,770960604,FALSE,finalized,5,8/14/15 23:09,"



",yes_direct,0.6122,,D005665,"<span class=""chemical"">furosemide</span>",D013921,"<span class=""disease"">thrombocytopenia</span>","A 7-year case of <span class=""chemical"">furosemide</span>-induced immune <span class=""disease"">thrombocytopenia</span>.",,23625769,23625769_D005665_D013921,23625769_0,bcv_sentence_task_befree_4673,,770960605,FALSE,finalized,5,8/15/15 2:32,"



",yes_direct,0.8106,,D005665,"<span class=""chemical"">furosemide</span>",D013921,"<span class=""disease"">thrombocytopenia</span>","In this report, we describe a case in which <span class=""chemical"">furosemide</span> was identified as the probable cause of drug-induced <span class=""disease"">thrombocytopenia</span> in an 84-year-old man with chronic symptomatic idiopathic <span class=""disease"">thrombocytopenia</span> for seven years before discovery.",,23625769,23625769_D005665_D013921,23625769_4,bcv_sentence_task_befree_4674,,770960606,FALSE,finalized,5,8/14/15 22:33,"



",yes_direct,1,,D005665,"<span class=""chemical"">furosemide</span>",D013921,"<span class=""disease"">thrombocytopenia</span>","Based on the observations of this case report, clinicians should more readily consider <span class=""chemical"">furosemide</span> as a potential cause of <span class=""disease"">thrombocytopenia</span>.",,23625769,23625769_D005665_D013921,23625769_9,bcv_sentence_task_befree_4675,,770960607,FALSE,finalized,5,8/15/15 1:53,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">breast cancer</span>","Prophylactic use of levonorgestrel-releasing intrauterine system in women with <span class=""disease"">breast cancer</span> treated with <span class=""chemical"">tamoxifen</span>: a randomized controlled trial.",,23635729,23635729_D013629_D009369,23635729_0,bcv_sentence_task_befree_4676,,770960608,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,1,,D016912,"<span class=""chemical"">levonorgestrel</span>",D009369,"<span class=""disease"">breast cancer</span>","Prophylactic use of <span class=""chemical"">levonorgestrel</span>-releasing intrauterine system in women with <span class=""disease"">breast cancer</span> treated with tamoxifen: a randomized controlled trial.",,23635729,23635729_D016912_D009369,23635729_0,bcv_sentence_task_befree_4677,,770960609,FALSE,finalized,5,8/14/15 23:23,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">breast cancer</span>","To estimate the rate of endometrial pathology with the prophylactic use of levonorgestrel-releasing intrauterine system in women with <span class=""disease"">breast cancer</span> treated with <span class=""chemical"">tamoxifen</span>.",,23635729,23635729_D013629_D009369,23635729_1,bcv_sentence_task_befree_4678,,770960610,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D016912,"<span class=""chemical"">levonorgestrel</span>",D009369,"<span class=""disease"">breast cancer</span>","To estimate the rate of endometrial pathology with the prophylactic use of <span class=""chemical"">levonorgestrel</span>-releasing intrauterine system in women with <span class=""disease"">breast cancer</span> treated with tamoxifen.",,23635729,23635729_D016912_D009369,23635729_1,bcv_sentence_task_befree_4679,,770960611,FALSE,finalized,5,8/14/15 22:51,"



",no_relation,1,,D013629,"<span class=""chemical"">tamoxifen</span>",D009369,"<span class=""disease"">breast cancer</span>","This was a randomized contro-lled trial of 129 Chinese women who attended a university hospital in Hong Kong and required adjuvant <span class=""chemical"">tamoxifen</span> for <span class=""disease"">breast cancer</span> after the completion of postoperative radiotherapy and chemotherapy.",,23635729,23635729_D013629_D009369,23635729_2,bcv_sentence_task_befree_4680,,770960612,FALSE,finalized,5,8/14/15 22:57,"



",no_relation,1,,D016912,"<span class=""chemical"">Levonorgestrel</span>",D014591,"<span class=""disease"">endometrial polyps</span>","<span class=""chemical"">Levonorgestrel</span>-releasing intrauterine system significantly reduced de novo <span class=""disease"">endometrial polyps</span> (hazard ratio 0.19, 95% confidence interval 0.07-0.48) over the course of 5 years on an intention-to-treat basis.",,23635729,23635729_D016912_D014591,23635729_8,bcv_sentence_task_befree_4681,,770960613,FALSE,finalized,5,8/14/15 23:57,"

'levonorgestrel-releasing intrauterine system' and not just 'levonorgestrel' ... Also it prevents it.

",no_relation,1,,D016912,"<span class=""chemical"">levonorgestrel</span>",D014591,"<span class=""disease"">endometrial polyps</span>","Prophylactic <span class=""chemical"">levonorgestrel</span>-releasing intrauterine system prevents de novo <span class=""disease"">endometrial polyps</span> in women using tamoxifen.",,23635729,23635729_D016912_D014591,23635729_10,bcv_sentence_task_befree_4682,,770960614,FALSE,finalized,5,8/15/15 0:51,"



",no_relation,0.8009,,D013629,"<span class=""chemical"">tamoxifen</span>",D014591,"<span class=""disease"">endometrial polyps</span>","Prophylactic levonorgestrel-releasing intrauterine system prevents de novo <span class=""disease"">endometrial polyps</span> in women using <span class=""chemical"">tamoxifen</span>.",,23635729,23635729_D013629_D014591,23635729_10,bcv_sentence_task_befree_4683,,770960615,FALSE,finalized,5,8/14/15 23:16,"



",no_relation,0.8015,,D006513,"<span class=""chemical"">HBeAg/hepatitis B e antigen</span>",D006509,"<span class=""disease"">HBV infection/hepatitis B</span>","HBV markers, including <span class=""disease"">hepatitis B</span> surface antigen (HBsAg) and antibody (anti-HBs), anti-HBc, <span class=""chemical""></span><span class=""disease"">hepatitis B</span> e antigen (<span class=""chemical"">HBeAg</span>) and antibody (anti-HBe) were determined in both donors and recipients before LT and in recipients after LT. HBV DNA titer was measured if the recipients were strongly suspected of de novo <span class=""disease"">HBV infection</span>.",,23638710,23638710_D006513_D006509,23638710_3,bcv_sentence_task_befree_4684,,770960616,FALSE,finalized,5,8/14/15 22:51,"


No proper highlighting for the chemical(s).
",no_relation,0.7965,,D006514,"<span class=""chemical"">hepatitis B surface antigen</span>",D006509,"<span class=""disease"">HBV infection/hepatitis B</span>","HBV markers, including <span class=""chemical""></span><span class=""disease"">hepatitis B</span> surface antigen (HBsAg) and antibody (anti-HBs), anti-HBc, <span class=""disease"">hepatitis B</span> e antigen (HBeAg) and antibody (anti-HBe) were determined in both donors and recipients before LT and in recipients after LT. HBV DNA titer was measured if the recipients were strongly suspected of de novo <span class=""disease"">HBV infection</span>.",,23638710,23638710_D006514_D006509,23638710_3,bcv_sentence_task_befree_4685,,770960617,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,1,,D019259,"<span class=""chemical"">lamivudine</span>",D006509,"<span class=""disease"">HBV-infected</span>","Two de novo <span class=""disease"">HBV-infected</span> patients who had YMDD mutation were given adefovir combined with <span class=""chemical"">lamivudine</span>, and their liver function gradually improved during the follow-up period.",,23638710,23638710_D019259_D006509,23638710_7,bcv_sentence_task_befree_4686,,770960618,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,1,,C053001,"<span class=""chemical"">adefovir</span>",D006509,"<span class=""disease"">HBV-infected</span>","Two de novo <span class=""disease"">HBV-infected</span> patients who had YMDD mutation were given <span class=""chemical"">adefovir</span> combined with lamivudine, and their liver function gradually improved during the follow-up period.",,23638710,23638710_C053001_D006509,23638710_7,bcv_sentence_task_befree_4687,,770960619,FALSE,finalized,5,8/14/15 23:13,"



",no_relation,1,,D019259,"<span class=""chemical"">lamivudine</span>",D006509,"<span class=""disease"">HBV infection</span>","Administration with adefovir in patients who are resistant to <span class=""chemical"">lamivudine</span> seems to be an effective and safe way for de novo <span class=""disease"">HBV infection</span>.",,23638710,23638710_D019259_D006509,23638710_9,bcv_sentence_task_befree_4688,,770960620,FALSE,finalized,5,8/14/15 22:36,"



",no_relation,0.8061,,C053001,"<span class=""chemical"">adefovir</span>",D006509,"<span class=""disease"">HBV infection</span>","Administration with <span class=""chemical"">adefovir</span> in patients who are resistant to lamivudine seems to be an effective and safe way for de novo <span class=""disease"">HBV infection</span>.",,23638710,23638710_C053001_D006509,23638710_9,bcv_sentence_task_befree_4689,,770960621,FALSE,finalized,5,8/14/15 23:15,"



",yes_direct,0.8064,,D008094,"<span class=""chemical"">lithium</span>",D064420,"<span class=""disease"">toxicity</span>","In this research, we used standardized leaching tests, life-cycle impact assessment (LCIA), and hazard assessment models to evaluate hazardous waste classification, resource depletion potential, and <span class=""disease"">toxicity</span> potentials of <span class=""chemical"">lithium</span> batteries used in cellphones.",,23638841,23638841_D008094_D064420,23638841_3,bcv_sentence_task_befree_4690,,770960622,FALSE,finalized,5,8/15/15 2:29,"



",no_relation,1,,D009532,"<span class=""chemical"">nickel</span>",D004670,"<span class=""disease"">California regulations</span>","However, according to <span class=""disease"">California regulations</span>, all lithium batteries tested are classified hazardous due to excessive levels of cobalt (average 163,544 mg/kg;  = 62,897; limit 8000), copper (average 98,694 mg/kg;  = 28,734; limit 2500), and <span class=""chemical"">nickel</span> (average 9525 mg/kg;  = 11,438; limit 2000).",,23638841,23638841_D009532_D004670,23638841_5,bcv_sentence_task_befree_4691,,770960623,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,D003300,"<span class=""chemical"">copper</span>",D004670,"<span class=""disease"">California regulations</span>","However, according to <span class=""disease"">California regulations</span>, all lithium batteries tested are classified hazardous due to excessive levels of cobalt (average 163,544 mg/kg;  = 62,897; limit 8000), <span class=""chemical"">copper</span> (average 98,694 mg/kg;  = 28,734; limit 2500), and nickel (average 9525 mg/kg;  = 11,438; limit 2000).",,23638841,23638841_D003300_D004670,23638841_5,bcv_sentence_task_befree_4692,,770960624,FALSE,finalized,5,8/15/15 1:01,"



",no_relation,0.8301,,D003035,"<span class=""chemical"">cobalt</span>",D004670,"<span class=""disease"">California regulations</span>","However, according to <span class=""disease"">California regulations</span>, all lithium batteries tested are classified hazardous due to excessive levels of <span class=""chemical"">cobalt</span> (average 163,544 mg/kg;  = 62,897; limit 8000), copper (average 98,694 mg/kg;  = 28,734; limit 2500), and nickel (average 9525 mg/kg;  = 11,438; limit 2000).",,23638841,23638841_D003035_D004670,23638841_5,bcv_sentence_task_befree_4693,,770960625,FALSE,finalized,5,8/15/15 0:22,"



",no_relation,1,,D008094,"<span class=""chemical"">lithium</span>",D004670,"<span class=""disease"">California regulations</span>","However, according to <span class=""disease"">California regulations</span>, all <span class=""chemical"">lithium</span> batteries tested are classified hazardous due to excessive levels of cobalt (average 163,544 mg/kg;  = 62,897; limit 8000), copper (average 98,694 mg/kg;  = 28,734; limit 2500), and nickel (average 9525 mg/kg;  = 11,438; limit 2000).",,23638841,23638841_D008094_D004670,23638841_5,bcv_sentence_task_befree_4694,,770960626,FALSE,finalized,5,8/14/15 23:06,"



",yes_direct,1,,D003035,"<span class=""chemical"">cobalt</span>",D064420,"<span class=""disease"">toxicity</span>","The environmental impact associated with resource depletion and human <span class=""disease"">toxicity</span> is mainly associated with <span class=""chemical"">cobalt</span>, copper, nickel, thallium, and silver, whereas the ecotoxicity potential is primarily associated with <span class=""chemical"">cobalt</span>, copper, nickel, thallium, and silver.",,23638841,23638841_D003035_D064420,23638841_7,bcv_sentence_task_befree_4695,,770960627,FALSE,finalized,5,8/15/15 0:46,"



",yes_direct,0.806,,D012834,"<span class=""chemical"">silver</span>",D064420,"<span class=""disease"">toxicity</span>","The environmental impact associated with resource depletion and human <span class=""disease"">toxicity</span> is mainly associated with cobalt, copper, nickel, thallium, and <span class=""chemical"">silver</span>, whereas the ecotoxicity potential is primarily associated with cobalt, copper, nickel, thallium, and <span class=""chemical"">silver</span>.",,23638841,23638841_D012834_D064420,23638841_7,bcv_sentence_task_befree_4696,,770960628,FALSE,finalized,5,8/15/15 0:08,"



Nickel is not a chemical.",yes_direct,0.8045,,D009532,"<span class=""chemical"">nickel</span>",D064420,"<span class=""disease"">toxicity</span>","The environmental impact associated with resource depletion and human <span class=""disease"">toxicity</span> is mainly associated with cobalt, copper, <span class=""chemical"">nickel</span>, thallium, and silver, whereas the ecotoxicity potential is primarily associated with cobalt, copper, <span class=""chemical"">nickel</span>, thallium, and silver.",,23638841,23638841_D009532_D064420,23638841_7,bcv_sentence_task_befree_4697,,770960629,FALSE,finalized,5,8/14/15 22:36,"



",yes_direct,0.788,,D003300,"<span class=""chemical"">copper</span>",D064420,"<span class=""disease"">toxicity</span>","The environmental impact associated with resource depletion and human <span class=""disease"">toxicity</span> is mainly associated with cobalt, <span class=""chemical"">copper</span>, nickel, thallium, and silver, whereas the ecotoxicity potential is primarily associated with cobalt, <span class=""chemical"">copper</span>, nickel, thallium, and silver.",,23638841,23638841_D003300_D064420,23638841_7,bcv_sentence_task_befree_4698,,770960630,FALSE,finalized,5,8/15/15 0:48,"



",yes_direct,0.8019,,D013793,"<span class=""chemical"">thallium</span>",D064420,"<span class=""disease"">toxicity</span>","The environmental impact associated with resource depletion and human <span class=""disease"">toxicity</span> is mainly associated with cobalt, copper, nickel, <span class=""chemical"">thallium</span>, and silver, whereas the ecotoxicity potential is primarily associated with cobalt, copper, nickel, <span class=""chemical"">thallium</span>, and silver.",,23638841,23638841_D013793_D064420,23638841_7,bcv_sentence_task_befree_4699,,770960631,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,0.6184,,D000535,"<span class=""chemical"">aluminum</span>",D064420,"<span class=""disease"">toxicity</span>","However, the relative contribution of <span class=""chemical"">aluminum</span> and lithium to human <span class=""disease"">toxicity</span> and ecotoxicity could not be estimated due to insufficient <span class=""disease"">toxicity</span> data in the models.",,23638841,23638841_D000535_D064420,23638841_8,bcv_sentence_task_befree_4700,,770960632,FALSE,finalized,5,8/14/15 22:43,"



",yes_direct,0.6213,,D008094,"<span class=""chemical"">lithium</span>",D064420,"<span class=""disease"">toxicity</span>","However, the relative contribution of aluminum and <span class=""chemical"">lithium</span> to human <span class=""disease"">toxicity</span> and ecotoxicity could not be estimated due to insufficient <span class=""disease"">toxicity</span> data in the models.",,23638841,23638841_D008094_D064420,23638841_8,bcv_sentence_task_befree_4701,,770960633,FALSE,finalized,5,8/14/15 22:51,"



",no_relation,1,,D002248,"<span class=""chemical"">Co</span>",D008545,"<span class=""disease"">melanoma</span>","<span class=""chemical"">Co</span>-injection of <span class=""disease"">melanoma</span> cells with 12(S)-HETE increased the lung homing activity of B16F10 <span class=""disease"">melanoma</span> cells.",,23664097,23664097_D002248_D008545,23664097_5,bcv_sentence_task_befree_4702,,770960634,FALSE,finalized,5,8/14/15 23:37,"



",yes_direct,0.5868,,D019377,"<span class=""chemical"">12(S)-HETE</span>",D008545,"<span class=""disease"">melanoma</span>","Co-injection of <span class=""disease"">melanoma</span> cells with <span class=""chemical"">12(S)-HETE</span> increased the lung homing activity of B16F10 <span class=""disease"">melanoma</span> cells.",,23664097,23664097_D019377_D008545,23664097_5,bcv_sentence_task_befree_4703,,770960635,FALSE,finalized,5,8/15/15 0:36,"



",yes_direct,0.5809,,D019377,"<span class=""chemical"">12(S)-HETE</span>",D000267,"<span class=""disease"">adhesion</span>","In vitro studies showed that <span class=""chemical"">12(S)-HETE</span> and 15(S)-HETE treatment resulted in a concentration-dependent increase of <span class=""disease"">adhesion</span> of B16F10 cells on collagen or fibronectin.",,23664097,23664097_D019377_D000267,23664097_6,bcv_sentence_task_befree_4704,,770960636,FALSE,finalized,5,8/14/15 22:41,"



",no_relation,0.3976,,D019377,"<span class=""chemical"">12(S)-HETE</span>",D008545,"<span class=""disease"">melanoma</span>","Treatment of <span class=""chemical"">12(S)-HETE</span> increased the pFAK in <span class=""disease"">melanoma</span> cells adhering on collagen-coated slide.",,23664097,23664097_D019377_D008545,23664097_9,bcv_sentence_task_befree_4705,,770960637,FALSE,finalized,5,8/14/15 22:31,"



There's literally no disease in this sentence. :-)",no_relation,0.8007,,D019377,"<span class=""chemical"">12(S)-HETE</span>",D000267,"<span class=""disease"">adhesion</span>","The enhancement of adherence elicited by <span class=""chemical"">12(S)-HETE</span> in B16F10 cells could be antagonised by focal <span class=""disease"">adhesion</span> kinase (FAK) inhibitor 14 (FAK inhibitor) or PD98059 (extracellular signal-regulated kinase (ERK) inhibitor).",,23664097,23664097_D019377_D000267,23664097_10,bcv_sentence_task_befree_4706,,770960638,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,0.7958,,C093973,"<span class=""chemical"">PD98059</span>",D000267,"<span class=""disease"">adhesion</span>","The enhancement of adherence elicited by 12(S)-HETE in B16F10 cells could be antagonised by focal <span class=""disease"">adhesion</span> kinase (FAK) inhibitor 14 (FAK inhibitor) or <span class=""chemical"">PD98059</span> (extracellular signal-regulated kinase (ERK) inhibitor).",,23664097,23664097_C093973_D000267,23664097_10,bcv_sentence_task_befree_4707,,770960639,FALSE,finalized,5,8/14/15 22:42,"



",no_relation,0.5848,,D019377,"<span class=""chemical"">12(S)-HETE</span>",D008545,"<span class=""disease"">melanoma</span>","<span class=""chemical"">12(S)-HETE</span> increased the phosphorylation of FAK and ERK in adhering <span class=""disease"">melanoma</span> cells.",,23664097,23664097_D019377_D008545,23664097_11,bcv_sentence_task_befree_4708,,770960640,FALSE,finalized,5,8/15/15 1:03,"



",yes_direct,0.6133,,D019377,"<span class=""chemical"">12(S)-HETE</span>",D008545,"<span class=""disease"">melanoma</span>","The adhesion and lung metastasis of human <span class=""disease"">melanoma</span> cells of C32 in NOD/SCID mice were also potentiated by co-treatment with <span class=""chemical"">12(S)-HETE</span>.",,23664097,23664097_D019377_D008545,23664097_13,bcv_sentence_task_befree_4709,,770960641,FALSE,finalized,5,8/15/15 0:45,"



",no_relation,0.588,,D019377,"<span class=""chemical"">12(S)-HETE</span>",D000267,"<span class=""disease"">adhesion</span>","The <span class=""disease"">adhesion</span> and lung metastasis of human melanoma cells of C32 in NOD/SCID mice were also potentiated by co-treatment with <span class=""chemical"">12(S)-HETE</span>.",,23664097,23664097_D019377_D000267,23664097_13,bcv_sentence_task_befree_4710,,770960642,FALSE,finalized,5,8/14/15 22:43,"



",yes_direct,0.6074,,D019377,"<span class=""chemical"">12(S)-HETE</span>",D053632,"<span class=""disease"">SCID</span>","The adhesion and lung metastasis of human melanoma cells of C32 in NOD/<span class=""disease"">SCID</span> mice were also potentiated by co-treatment with <span class=""chemical"">12(S)-HETE</span>.",,23664097,23664097_D019377_D053632,23664097_13,bcv_sentence_task_befree_4711,,770960643,FALSE,finalized,5,8/14/15 22:47,"



",yes_direct,0.6206,,D019377,"<span class=""chemical"">12(S)-HETE</span>",D009362,"<span class=""disease"">metastasis</span>","The adhesion and lung <span class=""disease"">metastasis</span> of human melanoma cells of C32 in NOD/SCID mice were also potentiated by co-treatment with <span class=""chemical"">12(S)-HETE</span>.",,23664097,23664097_D019377_D009362,23664097_13,bcv_sentence_task_befree_4712,,770960644,FALSE,finalized,5,8/14/15 23:26,"



",yes_direct,0.6452,,D019377,"<span class=""chemical"">12(S)-HETE</span>",D008545,"<span class=""disease"">melanoma</span>","These results demonstrate that <span class=""chemical"">12(S)-HETE</span>/15(S)-HETE activates ERK and FAK signalling pathways, thereby upregulates the adhesion and metastatic potential of <span class=""disease"">melanoma</span> cells.",,23664097,23664097_D019377_D008545,23664097_14,bcv_sentence_task_befree_4713,,770960645,FALSE,finalized,5,8/15/15 2:13,"



",yes_direct,0.4048,,D019377,"<span class=""chemical"">12(S)-HETE</span>",D000267,"<span class=""disease"">adhesion</span>","These results demonstrate that <span class=""chemical"">12(S)-HETE</span>/15(S)-HETE activates ERK and FAK signalling pathways, thereby upregulates the <span class=""disease"">adhesion</span> and metastatic potential of melanoma cells.",,23664097,23664097_D019377_D000267,23664097_14,bcv_sentence_task_befree_4714,,770960646,FALSE,finalized,5,8/15/15 0:58,"



",yes_direct,0.6079,,D019377,"<span class=""chemical"">12(S)-HETE</span>",D008545,"<span class=""disease"">melanoma</span>","The endogenous release of <span class=""chemical"">12(S)-HETE</span>/15(S)-HETE in the host organ may affect the metastatic potential of <span class=""disease"">melanoma</span>.",,23664097,23664097_D019377_D008545,23664097_15,bcv_sentence_task_befree_4715,,770960647,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,0.8064,,D000622,"<span class=""chemical"">aminolevulinic acid/ALA</span>",D009456,"<span class=""disease"">von Recklinghausen disease</span>","We present the case of a 54-year-old male patient with <span class=""disease"">von Recklinghausen disease</span> who had a diffuse contrast-enhancing cerebellar mass that was resected guided by <span class=""chemical"">aminolevulinic acid</span> (<span class=""chemical"">ALA</span>)-fluorescence.",,23670807,23670807_D000622_D009456,23670807_5,bcv_sentence_task_befree_4716,,770960648,FALSE,finalized,5,8/14/15 22:57,"



",no_relation,1,,C047246,"<span class=""chemical"">temozolomide</span>",D009369,"<span class=""disease"">tumor</span>","Due to the proximity of the <span class=""disease"">tumor</span> to the brainstem, adjuvant <span class=""chemical"">temozolomide</span> chemotherapy was administered rather than first-line radiotherapy.",,23670807,23670807_C047246_D009369,23670807_7,bcv_sentence_task_befree_4717,,770960649,FALSE,finalized,5,8/14/15 22:55,"



",no_relation,1,,C047246,"<span class=""chemical"">temozolomide</span>",D009369,"<span class=""disease"">Tumor</span>","<span class=""disease"">Tumor</span> control after resection was achieved in both patients; however, the patient in the mentioned report received radiation instead of <span class=""chemical"">temozolomide</span>.",,23670807,23670807_C047246_D009369,23670807_12,bcv_sentence_task_befree_4718,,770960650,FALSE,finalized,5,8/15/15 2:10,"



",no_relation,0.7974,,D008140,"<span class=""chemical"">Lorazepam</span>",D002389,"<span class=""disease"">catatonia</span>","<span class=""chemical"">Lorazepam</span> achieved full resolution of <span class=""disease"">catatonia</span> in 50% of patients.",,23684045,23684045_D008140_D002389,23684045_9,bcv_sentence_task_befree_4719,,770960651,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,D017374,"<span class=""chemical"">paroxetine</span>",D011537,"<span class=""disease"">pruritus</span>","Therefore, identifying the underlying cause of <span class=""disease"">pruritus</span> is of prime importance in order to develop tailored treatment plans, even if in palliative care the treatment is focused towards the symptom and not necessarily the underlying disease.Results show that in palliative care patients with <span class=""disease"">pruritus</span> of different natures, treatment with the drug <span class=""chemical"">paroxetine</span>, a selective serotonin reuptake inhibitor, may be beneficial.",,23749733,23749733_D017374_D011537,23749733_20,bcv_sentence_task_befree_4720,,770960652,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,D012701,"<span class=""chemical"">serotonin</span>",D011537,"<span class=""disease"">pruritus</span>","Therefore, identifying the underlying cause of <span class=""disease"">pruritus</span> is of prime importance in order to develop tailored treatment plans, even if in palliative care the treatment is focused towards the symptom and not necessarily the underlying disease.Results show that in palliative care patients with <span class=""disease"">pruritus</span> of different natures, treatment with the drug paroxetine, a selective <span class=""chemical"">serotonin</span> reuptake inhibitor, may be beneficial.",,23749733,23749733_D012701_D011537,23749733_20,bcv_sentence_task_befree_4721,,770960653,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,1,,D007213,"<span class=""chemical"">indomethacin</span>",D011537,"<span class=""disease"">pruritus</span>","For patients suffering from <span class=""disease"">pruritus</span> associated with HIV infection, <span class=""chemical"">indomethacin</span> was described as the most effective drug, although the evidence was weak.",,23749733,23749733_D007213_D011537,23749733_21,bcv_sentence_task_befree_4722,,770960654,FALSE,finalized,5,8/14/15 22:36,"



",no_relation,1,,D007213,"<span class=""chemical"">indomethacin</span>",D015658,"<span class=""disease"">HIV infection</span>","For patients suffering from pruritus associated with <span class=""disease"">HIV infection</span>, <span class=""chemical"">indomethacin</span> was described as the most effective drug, although the evidence was weak.",,23749733,23749733_D007213_D015658,23749733_21,bcv_sentence_task_befree_4723,,770960655,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,C040029,"<span class=""chemical"">gabapentin</span>",D011537,"<span class=""disease"">pruritus</span>","For patients suffering from chronic kidney disease-associated <span class=""disease"">pruritus</span>, <span class=""chemical"">gabapentin</span> may be an option.",,23749733,23749733_C040029_D011537,23749733_22,bcv_sentence_task_befree_4724,,770960656,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,1,,C040029,"<span class=""chemical"">gabapentin</span>",D051436,"<span class=""disease"">chronic kidney disease</span>","For patients suffering from <span class=""disease"">chronic kidney disease</span>-associated pruritus, <span class=""chemical"">gabapentin</span> may be an option.",,23749733,23749733_C040029_D051436,23749733_22,bcv_sentence_task_befree_4725,,770960657,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D012293,"<span class=""chemical"">rifampicin</span>",D011537,"<span class=""disease"">pruritus</span>","As they have exhibited a low incidence of adverse effects, <span class=""chemical"">rifampicin</span> and flumecinolmay be recommended for patients with cholestatic <span class=""disease"">pruritus</span>.",,23749733,23749733_D012293_D011537,23749733_24,bcv_sentence_task_befree_4726,,770960658,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,1,,C016914,"<span class=""chemical"">flumecinol</span>",D011537,"<span class=""disease"">pruritus</span>","As they have exhibited a low incidence of adverse effects, rifampicin and <span class=""chemical"">flumecinol</span>may be recommended for patients with cholestatic <span class=""disease"">pruritus</span>.",,23749733,23749733_C016914_D011537,23749733_24,bcv_sentence_task_befree_4727,,770960659,FALSE,finalized,5,8/14/15 22:35,"



",no_relation,1,,D009271,"<span class=""chemical"">naltrexone</span>",D011537,"<span class=""disease"">pruritus</span>","The opioid antagonist <span class=""chemical"">naltrexone</span> has been shown to offer a therapeutic alternative for patients suffering from uraemic or cholestatic <span class=""disease"">pruritus</span>.",,23749733,23749733_D009271_D011537,23749733_25,bcv_sentence_task_befree_4728,,770960660,FALSE,finalized,5,8/14/15 22:29,"



",yes_direct,0.8109,,D002244,"<span class=""chemical"">carbon</span>",D064420,"<span class=""disease"">toxicity</span>","Understanding the <span class=""disease"">toxicity</span> of <span class=""chemical"">carbon</span> nanotubes in the environment is crucial to the control of nanomaterials in producing and processing and the assessment of health risk for human: a review.",,23770455,23770455_D002244_D064420,23770455_0,bcv_sentence_task_befree_4729,,770960661,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,1,,D005045,"<span class=""chemical"">etomidate</span>",D003866,"<span class=""disease"">depressed</span>","A retrospective comparison of the effects of propofol and <span class=""chemical"">etomidate</span> on stimulus variables and efficacy of electroconvulsive therapy in <span class=""disease"">depressed</span> inpatients.",,23774194,23774194_D005045_D003866,23774194_0,bcv_sentence_task_befree_4730,,770960662,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D003866,"<span class=""disease"">depressed</span>","A retrospective comparison of the effects of <span class=""chemical"">propofol</span> and etomidate on stimulus variables and efficacy of electroconvulsive therapy in <span class=""disease"">depressed</span> inpatients.",,23774194,23774194_D015742_D003866,23774194_0,bcv_sentence_task_befree_4731,,770960663,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D005045,"<span class=""chemical"">etomidate</span>",D003866,"<span class=""disease"">depressed</span>","To compare the effects of propofol and <span class=""chemical"">etomidate</span> on the stimulus variables and efficacy of electroconvulsive therapy (ECT) in <span class=""disease"">depressed</span> inpatients.",,23774194,23774194_D005045_D003866,23774194_1,bcv_sentence_task_befree_4732,,770960664,FALSE,finalized,5,8/14/15 22:42,"


Used as treatment.
",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D003866,"<span class=""disease"">depressed</span>","To compare the effects of <span class=""chemical"">propofol</span> and etomidate on the stimulus variables and efficacy of electroconvulsive therapy (ECT) in <span class=""disease"">depressed</span> inpatients.",,23774194,23774194_D015742_D003866,23774194_1,bcv_sentence_task_befree_4733,,770960665,FALSE,finalized,5,8/14/15 22:42,"



",no_relation,0.7989,,D005045,"<span class=""chemical"">etomidate</span>",D012640,"<span class=""disease"">seizures/seizure</span>","The propofol group had shorter mean electroencephalogram (<span class=""chemical"">etomidate</span> = 69.41  22.50, propofol = 42.95  22.26, p<0.001) <span class=""disease"">seizure</span> duration and motor (etomidate = 46.11  14.38, propofol = 22.89  7.13, p<0.001) <span class=""disease"">seizure</span> duration and a higher mean number of inadequate <span class=""disease"">seizures</span> (etomidate = 0.12  0.15, propofol = 0.47  0.26, p<0.001).",,23774194,23774194_D005045_D012640,23774194_6,bcv_sentence_task_befree_4734,,770960666,FALSE,finalized,5,8/15/15 1:12,"



",no_relation,0.7867,,D015742,"<span class=""chemical"">propofol</span>",D012640,"<span class=""disease"">seizures/seizure</span>","The <span class=""chemical"">propofol</span> group had shorter mean electroencephalogram (etomidate = 69.41  22.50, <span class=""chemical"">propofol</span> = 42.95  22.26, p<0.001) <span class=""disease"">seizure</span> duration and motor (etomidate = 46.11  14.38, <span class=""chemical"">propofol</span> = 22.89  7.13, p<0.001) <span class=""disease"">seizure</span> duration and a higher mean number of inadequate <span class=""disease"">seizures</span> (etomidate = 0.12  0.15, <span class=""chemical"">propofol</span> = 0.47  0.26, p<0.001).",,23774194,23774194_D015742_D012640,23774194_6,bcv_sentence_task_befree_4735,,770960667,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,D015742,"<span class=""chemical"">propofol</span>",D012640,"<span class=""disease"">seizures/seizure</span>","Anesthesia with <span class=""chemical"">propofol</span> has a significant reducing effect on <span class=""disease"">seizure</span> duration during the course of ECT which results in more inadequate <span class=""disease"">seizures</span>, despite the use of a higher mean stimulus charge.",,23774194,23774194_D015742_D012640,23774194_9,bcv_sentence_task_befree_4736,,770960668,FALSE,finalized,5,8/14/15 22:54,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D014652,"<span class=""disease"">vascular diseases</span>","Accumulating evidence has demonstrated that EPCs have therapeutic potential in reactive <span class=""chemical"">oxygen</span> species (ROS)-mediated <span class=""disease"">vascular diseases</span>.",,23778534,23778534_D010100_D014652,23778534_2,bcv_sentence_task_befree_4737,,770960669,FALSE,finalized,5,8/15/15 1:14,"



",no_relation,0.8023,,D006861,"<span class=""chemical"">H2O2</span>",D014085,"<span class=""disease"">migration</span>","In this study, to investigate the effects of oxidative stress on EPCs, EPCs were treated with <span class=""chemical"">H2O2</span> at different final concentrations for 3 h. MTT assay, scratch-wound assay and Matrigel invasion assay revealed that cell proliferation, <span class=""disease"">migration</span> and tubule formation and function, respectively, were impaired under <span class=""chemical"">H2O2</span> stress in a concentration-dependent manner.",,23778534,23778534_D006861_D014085,23778534_3,bcv_sentence_task_befree_4738,,770960670,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D008175,"<span class=""disease"">lung cancer</span>","Activation of ERK1/2 and Akt is associated with <span class=""chemical"">cisplatin</span> resistance in human <span class=""disease"">lung cancer</span> cells.",,23783141,23783141_D002945_D008175,23783141_0,bcv_sentence_task_befree_4739,,770960671,FALSE,finalized,5,8/15/15 1:45,"



",no_relation,1,,D002945,"<span class=""chemical"">Cisplatin</span>",D055752,"<span class=""disease"">small cell lung cancers</span>","<span class=""chemical"">Cisplatin</span> is widely used for the treatment of solid tumours including <span class=""disease"">small cell lung cancers</span>, but its success is often compromised by relapse and resistance to further treatment.",,23783141,23783141_D002945_D055752,23783141_1,bcv_sentence_task_befree_4740,,770960672,FALSE,finalized,5,8/15/15 0:19,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D008175,"<span class=""disease"">lung cancer</span>","Although individually targeting the ERK1/2 or Akt pathway has been reported to sensitize cancer cells to therapy, the effect of concurrently blocking these two pathways on the sensitivity of <span class=""disease"">lung cancer</span> cells to <span class=""chemical"">cisplatin</span> has not been investigated.",,23783141,23783141_D002945_D008175,23783141_4,bcv_sentence_task_befree_4741,,770960673,FALSE,finalized,5,8/14/15 22:37,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D009369,"<span class=""disease"">cancer</span>","Although individually targeting the ERK1/2 or Akt pathway has been reported to sensitize <span class=""disease"">cancer</span> cells to therapy, the effect of concurrently blocking these two pathways on the sensitivity of lung cancer cells to <span class=""chemical"">cisplatin</span> has not been investigated.",,23783141,23783141_D002945_D009369,23783141_4,bcv_sentence_task_befree_4742,,770960674,FALSE,finalized,5,8/15/15 0:16,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D055752,"<span class=""disease"">small cell lung cancer</span>","In the present study, we aimed to determine whether the ERK1/2 and Akt pathways contribute to <span class=""chemical"">cisplatin</span> resistance in human <span class=""disease"">small cell lung cancer</span> A549 cells.",,23783141,23783141_D002945_D055752,23783141_5,bcv_sentence_task_befree_4743,,770960675,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,0.61,,D002945,"<span class=""chemical"">cisplatin</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Strikingly, concurrent inhibition of p-ERK1/2 and p-Akt significantly potentiated <span class=""chemical"">cisplatin</span> <span class=""disease"">cytotoxicity</span> in vitro and in vivo.",,23783141,23783141_D002945_D004487,23783141_8,bcv_sentence_task_befree_4744,,770960676,FALSE,finalized,5,8/15/15 0:05,"



",yes_direct,0.606,,D002945,"<span class=""chemical"">cisplatin</span>",D004487,"<span class=""disease"">cytotoxicity</span>","The sensitization of A549 cells to <span class=""chemical"">cisplatin</span> <span class=""disease"">cytotoxicity</span> induced by p-Akt inhibition was mediated by the upregulation of PUMA, whereas that induced by p-ERK1/2 inhibition occurred by Bcl-2 downregulation.",,23783141,23783141_D002945_D004487,23783141_9,bcv_sentence_task_befree_4745,,770960677,FALSE,finalized,5,8/15/15 2:03,"



",no_relation,0.5686,,D002945,"<span class=""chemical"">cisplatin</span>",D004487,"<span class=""disease"">cytotoxicity</span>","These data indicate that the cooperative effects of p-ERK1/2 and p-Akt on attenuating <span class=""chemical"">cisplatin</span> <span class=""disease"">cytotoxicity</span> are mediated by PUMA and Bcl-2 regulation, and concurrently blocking these pathways may be an effective strategy for improving the efficacy of <span class=""chemical"">cisplatin</span> as anticancer treatment.",,23783141,23783141_D002945_D004487,23783141_10,bcv_sentence_task_befree_4746,,770960678,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,1,,C067311,"<span class=""chemical"">docetaxel</span>",D009369,"<span class=""disease"">breast cancer</span>","Predictive value of PET-CT for pathological response in stages II and III <span class=""disease"">breast cancer</span> patients following neoadjuvant chemotherapy with <span class=""chemical"">docetaxel</span>.",,23809513,23809513_C067311_D009369,23809513_0,bcv_sentence_task_befree_4747,,770960679,FALSE,finalized,5,8/15/15 0:57,"



",no_relation,1,,D019788,"<span class=""chemical"">fluorine-18 fluorodeoxyglucose</span>",D009369,"<span class=""disease"">breast cancer</span>","To prospectively study the value of PET-CT with <span class=""chemical"">fluorine-18 fluorodeoxyglucose</span> (FDG) to predict neoadjuvant chemotherapy (NAC) response of locoregional disease of stages II and III <span class=""disease"">breast cancer</span> patients.",,23809513,23809513_D019788_D009369,23809513_1,bcv_sentence_task_befree_4748,,770960680,FALSE,finalized,5,8/14/15 23:51,"



",no_relation,1,,C453980,"<span class=""chemical"">sugammadex</span>",D006261,"<span class=""disease"">headache</span>","Does rocuronium-<span class=""chemical"">sugammadex</span> reduce myalgia and <span class=""disease"">headache</span> after electroconvulsive therapy in patients with major depression?",,23812022,23812022_C453980_D006261,23812022_0,bcv_sentence_task_befree_4749,,770960681,FALSE,finalized,5,8/15/15 1:00,"



",no_relation,1,,C453980,"<span class=""chemical"">sugammadex</span>",D063806,"<span class=""disease"">myalgia</span>","Does rocuronium-<span class=""chemical"">sugammadex</span> reduce <span class=""disease"">myalgia</span> and headache after electroconvulsive therapy in patients with major depression?",,23812022,23812022_C453980_D063806,23812022_0,bcv_sentence_task_befree_4750,,770960682,FALSE,finalized,5,8/14/15 22:31,"



",no_relation,1,,C061870,"<span class=""chemical"">rocuronium</span>",D063806,"<span class=""disease"">myalgia</span>","Does <span class=""chemical"">rocuronium</span>-sugammadex reduce <span class=""disease"">myalgia</span> and headache after electroconvulsive therapy in patients with major depression?",,23812022,23812022_C061870_D063806,23812022_0,bcv_sentence_task_befree_4751,,770960683,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,C061870,"<span class=""chemical"">rocuronium</span>",D006261,"<span class=""disease"">headache</span>","Does <span class=""chemical"">rocuronium</span>-sugammadex reduce myalgia and <span class=""disease"">headache</span> after electroconvulsive therapy in patients with major depression?",,23812022,23812022_C061870_D006261,23812022_0,bcv_sentence_task_befree_4752,,770960684,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,C061870,"<span class=""chemical"">rocuronium</span>",D003865,"<span class=""disease"">major depression</span>","Does <span class=""chemical"">rocuronium</span>-sugammadex reduce myalgia and headache after electroconvulsive therapy in patients with <span class=""disease"">major depression</span>?",,23812022,23812022_C061870_D003865,23812022_0,bcv_sentence_task_befree_4753,,770960685,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,C453980,"<span class=""chemical"">sugammadex</span>",D003865,"<span class=""disease"">major depression</span>","Does rocuronium-<span class=""chemical"">sugammadex</span> reduce myalgia and headache after electroconvulsive therapy in patients with <span class=""disease"">major depression</span>?",,23812022,23812022_C453980_D003865,23812022_0,bcv_sentence_task_befree_4754,,770960686,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,0.6147,,C453980,"<span class=""chemical"">sugammadex</span>",D006261,"<span class=""disease"">headache</span>","We aimed to compare the effects of succinylcholine and rocuronium-<span class=""chemical"">sugammadex</span> on development of myalgia and <span class=""disease"">headache</span> after electroconvulsive therapy (ECT).",,23812022,23812022_C453980_D006261,23812022_1,bcv_sentence_task_befree_4755,,770960687,FALSE,finalized,5,8/15/15 1:39,"



",no_relation,0.595,,C453980,"<span class=""chemical"">sugammadex</span>",D063806,"<span class=""disease"">myalgia</span>","We aimed to compare the effects of succinylcholine and rocuronium-<span class=""chemical"">sugammadex</span> on development of <span class=""disease"">myalgia</span> and headache after electroconvulsive therapy (ECT).",,23812022,23812022_C453980_D063806,23812022_1,bcv_sentence_task_befree_4756,,770960688,FALSE,finalized,5,8/14/15 22:56,"



",no_relation,1,,C061870,"<span class=""chemical"">rocuronium</span>",D063806,"<span class=""disease"">myalgia</span>","We aimed to compare the effects of succinylcholine and <span class=""chemical"">rocuronium</span>-sugammadex on development of <span class=""disease"">myalgia</span> and headache after electroconvulsive therapy (ECT).",,23812022,23812022_C061870_D063806,23812022_1,bcv_sentence_task_befree_4757,,770960689,FALSE,finalized,5,8/15/15 1:20,"



",no_relation,0.8117,,C061870,"<span class=""chemical"">rocuronium</span>",D006261,"<span class=""disease"">headache</span>","We aimed to compare the effects of succinylcholine and <span class=""chemical"">rocuronium</span>-sugammadex on development of myalgia and <span class=""disease"">headache</span> after electroconvulsive therapy (ECT).",,23812022,23812022_C061870_D006261,23812022_1,bcv_sentence_task_befree_4758,,770960690,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,0.8017,,D013390,"<span class=""chemical"">succinylcholine</span>",D006261,"<span class=""disease"">headache</span>","We aimed to compare the effects of <span class=""chemical"">succinylcholine</span> and rocuronium-sugammadex on development of myalgia and <span class=""disease"">headache</span> after electroconvulsive therapy (ECT).",,23812022,23812022_D013390_D006261,23812022_1,bcv_sentence_task_befree_4759,,770960691,FALSE,finalized,5,8/15/15 1:14,"



",no_relation,1,,D013390,"<span class=""chemical"">succinylcholine</span>",D063806,"<span class=""disease"">myalgia</span>","We aimed to compare the effects of <span class=""chemical"">succinylcholine</span> and rocuronium-sugammadex on development of <span class=""disease"">myalgia</span> and headache after electroconvulsive therapy (ECT).",,23812022,23812022_D013390_D063806,23812022_1,bcv_sentence_task_befree_4760,,770960692,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,C453980,"<span class=""chemical"">Sugammadex</span>",D012640,"<span class=""disease"">seizure</span>","<span class=""chemical"">Sugammadex</span> 4 mg/kg IV was administered to group R after the motor <span class=""disease"">seizure</span>.",,23812022,23812022_C453980_D012640,23812022_4,bcv_sentence_task_befree_4761,,770960693,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,1,,C471405,"<span class=""chemical"">sorafenib</span>",D009369,"<span class=""disease"">breast cancer</span>","A phase II study of combined VEGF inhibitor (bevacizumab+<span class=""chemical"">sorafenib</span>) in patients with metastatic <span class=""disease"">breast cancer</span>: Hoosier Oncology Group Study BRE06-109.",,23812905,23812905_C471405_D009369,23812905_0,bcv_sentence_task_befree_4762,,770960694,FALSE,finalized,5,8/15/15 1:31,"



",no_relation,1,,C471405,"<span class=""chemical"">sorafenib</span>",D009369,"<span class=""disease"">breast cancer</span>","We evaluated the efficacy and safety of dual angiogenesis blockade with bevacizumab and <span class=""chemical"">sorafenib</span> in patients with metastatic <span class=""disease"">breast cancer</span>.",,23812905,23812905_C471405_D009369,23812905_2,bcv_sentence_task_befree_4763,,770960695,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,0.8062,,C471405,"<span class=""chemical"">sorafenib</span>",D009369,"<span class=""disease"">breast cancer</span>","The combination of <span class=""chemical"">sorafenib</span> and bevacizumab has substantial toxicity and minimal efficacy in patients with previously treated metastatic <span class=""disease"">breast cancer</span>.",,23812905,23812905_C471405_D009369,23812905_13,bcv_sentence_task_befree_4764,,770960696,FALSE,finalized,5,8/14/15 22:49,"



",yes_direct,0.6274,,C471405,"<span class=""chemical"">sorafenib</span>",D064420,"<span class=""disease"">toxicity</span>","The combination of <span class=""chemical"">sorafenib</span> and bevacizumab has substantial <span class=""disease"">toxicity</span> and minimal efficacy in patients with previously treated metastatic breast cancer.",,23812905,23812905_C471405_D064420,23812905_13,bcv_sentence_task_befree_4765,,770960697,FALSE,finalized,5,8/15/15 0:11,"



",no_relation,1,,C080625,"<span class=""chemical"">Taxane</span>",D006258,"<span class=""disease"">head and neck cancers/head and neck cancer</span>","<span class=""chemical"">Taxane</span>-cisplatin-fluorouracil as induction chemotherapy in locally advanced <span class=""disease"">head and neck cancers</span>: an individual patient data meta-analysis of the meta-analysis of chemotherapy in <span class=""disease"">head and neck cancer</span> group.",,23835714,23835714_C080625_D006258,23835714_0,bcv_sentence_task_befree_4766,,770960698,FALSE,finalized,5,8/14/15 23:37,"

Used as treatment.

",no_relation,1,,C067311,"<span class=""chemical"">docetaxel</span>",D006258,"<span class=""disease"">head and neck cancers</span>","PURPOSE Cisplatin plus fluorouracil (PF) induction chemotherapy has been compared with taxane (<span class=""chemical"">docetaxel</span> or paclitaxel), cisplatin, and fluorouracil (Tax-PF) in randomized trials in locoregionally advanced <span class=""disease"">head and neck cancers</span> (LAHNCs).",,23835714,23835714_C067311_D006258,23835714_1,bcv_sentence_task_befree_4767,,770960699,FALSE,finalized,5,8/14/15 23:20,"



",no_relation,1,,D002945,"<span class=""chemical"">Cisplatin</span>",D006258,"<span class=""disease"">head and neck cancers</span>","PURPOSE <span class=""chemical"">Cisplatin</span> plus fluorouracil (PF) induction chemotherapy has been compared with taxane (docetaxel or paclitaxel), <span class=""chemical"">cisplatin</span>, and fluorouracil (Tax-PF) in randomized trials in locoregionally advanced <span class=""disease"">head and neck cancers</span> (LAHNCs).",,23835714,23835714_D002945_D006258,23835714_1,bcv_sentence_task_befree_4768,,770960700,FALSE,finalized,5,8/14/15 23:31,"



",no_relation,1,,D005472,"<span class=""chemical"">fluorouracil</span>",D006258,"<span class=""disease"">head and neck cancers</span>","PURPOSE Cisplatin plus <span class=""chemical"">fluorouracil</span> (PF) induction chemotherapy has been compared with taxane (docetaxel or paclitaxel), cisplatin, and <span class=""chemical"">fluorouracil</span> (Tax-PF) in randomized trials in locoregionally advanced <span class=""disease"">head and neck cancers</span> (LAHNCs).",,23835714,23835714_D005472_D006258,23835714_1,bcv_sentence_task_befree_4769,,770960701,FALSE,finalized,5,8/14/15 22:53,"



",no_relation,1,,C080625,"<span class=""chemical"">taxane</span>",D006258,"<span class=""disease"">head and neck cancers</span>","PURPOSE Cisplatin plus fluorouracil (PF) induction chemotherapy has been compared with <span class=""chemical"">taxane</span> (docetaxel or paclitaxel), cisplatin, and fluorouracil (Tax-PF) in randomized trials in locoregionally advanced <span class=""disease"">head and neck cancers</span> (LAHNCs).",,23835714,23835714_C080625_D006258,23835714_1,bcv_sentence_task_befree_4770,,770960702,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,1,,D017239,"<span class=""chemical"">paclitaxel</span>",D006258,"<span class=""disease"">head and neck cancers</span>","PURPOSE Cisplatin plus fluorouracil (PF) induction chemotherapy has been compared with taxane (docetaxel or <span class=""chemical"">paclitaxel</span>), cisplatin, and fluorouracil (Tax-PF) in randomized trials in locoregionally advanced <span class=""disease"">head and neck cancers</span> (LAHNCs).",,23835714,23835714_D017239_D006258,23835714_1,bcv_sentence_task_befree_4771,,770960703,FALSE,finalized,5,8/15/15 0:50,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D018365,"<span class=""disease"">MRD</span>","Detection of <span class=""disease"">MRD</span> may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with <span class=""chemical"">tyrosine</span> kinase inhibitors plus chemotherapy.",,23836561,23836561_D014443_D018365,23836561_0,bcv_sentence_task_befree_4772,,770960704,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D010677,"<span class=""disease"">Philadelphia</span>","Detection of MRD may predict the outcome of patients with <span class=""disease"">Philadelphia</span> chromosome-positive ALL treated with <span class=""chemical"">tyrosine</span> kinase inhibitors plus chemotherapy.",,23836561,23836561_D014443_D010677,23836561_0,bcv_sentence_task_befree_4773,,770960705,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D054198,"<span class=""disease"">ALL</span>","Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive <span class=""disease"">ALL</span> treated with <span class=""chemical"">tyrosine</span> kinase inhibitors plus chemotherapy.",,23836561,23836561_D014443_D054198,23836561_0,bcv_sentence_task_befree_4774,,770960706,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,0.8237,,C097613,"<span class=""chemical"">imatinib</span>",D010677,"<span class=""disease"">Philadelphia</span>","From 2001 to 2011, 122 patients with newly diagnosed <span class=""disease"">Philadelphia</span> chromosome-positive acute lymphoblastic leukemia were treated with chemotherapy + <span class=""chemical"">imatinib</span> (n = 54) or + dasatinib (n = 68).",,23836561,23836561_C097613_D010677,23836561_1,bcv_sentence_task_befree_4775,,770960707,FALSE,finalized,5,8/15/15 1:52,"



",no_relation,1,,C488369,"<span class=""chemical"">dasatinib</span>",D054198,"<span class=""disease"">acute lymphoblastic leukemia</span>","From 2001 to 2011, 122 patients with newly diagnosed Philadelphia chromosome-positive <span class=""disease"">acute lymphoblastic leukemia</span> were treated with chemotherapy + imatinib (n = 54) or + <span class=""chemical"">dasatinib</span> (n = 68).",,23836561,23836561_C488369_D054198,23836561_1,bcv_sentence_task_befree_4776,,770960708,FALSE,finalized,5,8/14/15 23:17,"



",no_relation,1,,C097613,"<span class=""chemical"">imatinib</span>",D054198,"<span class=""disease"">acute lymphoblastic leukemia</span>","From 2001 to 2011, 122 patients with newly diagnosed Philadelphia chromosome-positive <span class=""disease"">acute lymphoblastic leukemia</span> were treated with chemotherapy + <span class=""chemical"">imatinib</span> (n = 54) or + dasatinib (n = 68).",,23836561,23836561_C097613_D054198,23836561_1,bcv_sentence_task_befree_4777,,770960709,FALSE,finalized,5,8/15/15 1:18,"



",no_relation,0.791,,C488369,"<span class=""chemical"">dasatinib</span>",D010677,"<span class=""disease"">Philadelphia</span>","From 2001 to 2011, 122 patients with newly diagnosed <span class=""disease"">Philadelphia</span> chromosome-positive acute lymphoblastic leukemia were treated with chemotherapy + imatinib (n = 54) or + <span class=""chemical"">dasatinib</span> (n = 68).",,23836561,23836561_C488369_D010677,23836561_1,bcv_sentence_task_befree_4778,,770960710,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,1,,D001599,"<span class=""chemical"">Berberine</span>",D009369,"<span class=""disease"">Cancer Cell Growth</span>","<span class=""chemical"">Berberine</span> Targets AP-2/hTERT, NF-B/COX-2, HIF-1/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human <span class=""disease"">Cancer Cell Growth</span>.",,23869238,23869238_D001599_D009369,23869238_0,bcv_sentence_task_befree_4779,,770960711,FALSE,finalized,5,8/15/15 0:02,"



",no_relation,1,,D001599,"<span class=""chemical"">Berberine</span>",D009369,"<span class=""disease"">cancers</span>","<span class=""chemical"">Berberine</span> (BBR), an isoquinoline derivative alkaloid isolated from Chinese herbs, has a long history of uses for the treatment of multiple diseases, including <span class=""disease"">cancers</span>.",,23869238,23869238_D001599_D009369,23869238_1,bcv_sentence_task_befree_4780,,770960712,FALSE,finalized,5,8/14/15 22:51,"



",no_relation,1,,C039109,"<span class=""chemical"">isoquinoline</span>",D000015,"<span class=""disease"">multiple diseases</span>","Berberine (BBR), an <span class=""chemical"">isoquinoline</span> derivative alkaloid isolated from Chinese herbs, has a long history of uses for the treatment of <span class=""disease"">multiple diseases</span>, including cancers.",,23869238,23869238_C039109_D000015,23869238_1,bcv_sentence_task_befree_4781,,770960713,FALSE,finalized,5,8/15/15 2:30,"



",no_relation,0.8255,,D001599,"<span class=""chemical"">Berberine</span>",D000015,"<span class=""disease"">multiple diseases</span>","<span class=""chemical"">Berberine</span> (BBR), an isoquinoline derivative alkaloid isolated from Chinese herbs, has a long history of uses for the treatment of <span class=""disease"">multiple diseases</span>, including cancers.",,23869238,23869238_D001599_D000015,23869238_1,bcv_sentence_task_befree_4782,,770960714,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,C039109,"<span class=""chemical"">isoquinoline</span>",D009369,"<span class=""disease"">cancers</span>","Berberine (BBR), an <span class=""chemical"">isoquinoline</span> derivative alkaloid isolated from Chinese herbs, has a long history of uses for the treatment of multiple diseases, including <span class=""disease"">cancers</span>.",,23869238,23869238_C039109_D009369,23869238_1,bcv_sentence_task_befree_4783,,770960715,FALSE,finalized,5,8/15/15 0:30,"



",no_relation,1,,C000499,"<span class=""chemical"">iron oxide</span>",D009369,"<span class=""disease"">cancer</span>","In particular, the advancements of polymeric nanomaterials in the past decades have paved the way for the development of <span class=""disease"">cancer</span> nanotheranostics that are primarily comprised of polymers or conjugates of polymer and other types of nanomaterials such as gold nanoparticles, quantum dots, carbon nanotubes, and magnetic <span class=""chemical"">iron oxide</span> nanoparticles.",,23869810,23869810_C000499_D009369,23869810_4,bcv_sentence_task_befree_4784,,770960716,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,0.7934,,D002244,"<span class=""chemical"">carbon</span>",D009369,"<span class=""disease"">cancer</span>","In particular, the advancements of polymeric nanomaterials in the past decades have paved the way for the development of <span class=""disease"">cancer</span> nanotheranostics that are primarily comprised of polymers or conjugates of polymer and other types of nanomaterials such as gold nanoparticles, quantum dots, <span class=""chemical"">carbon</span> nanotubes, and magnetic iron oxide nanoparticles.",,23869810,23869810_D002244_D009369,23869810_4,bcv_sentence_task_befree_4785,,770960717,FALSE,finalized,5,8/14/15 22:36,"



",no_relation,1,,D005947,"<span class=""chemical"">dextrose</span>",D036981,"<span class=""disease"">plantar fasciitis</span>","Autologous platelet-rich plasma versus <span class=""chemical"">dextrose</span> prolotherapy for the treatment of chronic recalcitrant <span class=""disease"">plantar fasciitis</span>.",,23876935,23876935_D005947_D036981,23876935_0,bcv_sentence_task_befree_4786,,770960718,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,1,,D005947,"<span class=""chemical"">dextrose</span>",D036981,"<span class=""disease"">PF/plantar fasciitis</span>","To determine the efficacy of autologous platelet-rich plasma (PRP) compared with <span class=""chemical"">dextrose</span> prolotherapy (DP) in patients with chronic recalcitrant <span class=""disease"">plantar fasciitis</span> (<span class=""disease"">PF</span>) DESIGN: A single-blinded, randomized, controlled study.",,23876935,23876935_D005947_D036981,23876935_1,bcv_sentence_task_befree_4787,,770960719,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,0.7935,,D001241,"<span class=""chemical"">aspirin</span>",D010195,"<span class=""disease"">pancreatic disorders</span>","Antiplatelet therapy with <span class=""chemical"">aspirin</span> is prevalent among patients presenting for operative treatment of <span class=""disease"">pancreatic disorders</span>.",,23890963,23890963_D001241_D010195,23890963_1,bcv_sentence_task_befree_4788,,770960720,FALSE,finalized,5,8/14/15 22:49,"



",yes_direct,0.5943,,D001241,"<span class=""chemical"">aspirin</span>",D006470,"<span class=""disease"">bleeding</span>","Operative practice has called for the cessation of <span class=""chemical"">aspirin</span> 7-10 days before elective procedures because of the perceived increased risk of procedure-related <span class=""disease"">bleeding</span>.",,23890963,23890963_D001241_D006470,23890963_2,bcv_sentence_task_befree_4789,,770960721,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,0.8252,,D001241,"<span class=""chemical"">aspirin</span>",D019106,"<span class=""disease"">blood loss</span>","The estimated intraoperative <span class=""disease"">blood loss</span> was similar between the two groups, <span class=""chemical"">aspirin</span> versus no <span class=""chemical"">aspirin</span> (median 400 mL vs 400 mL, P = .661), as was the rate of blood transfusion anytime during the index admission (29% vs 26%, P = 0.37) and the postoperative duration of hospital stay (median 7 days vs 6 days, P = .103).",,23890963,23890963_D001241_D019106,23890963_8,bcv_sentence_task_befree_4790,,770960722,FALSE,finalized,5,8/15/15 1:45,"



",yes_direct,0.8025,,D001241,"<span class=""chemical"">aspirin</span>",D002318,"<span class=""disease"">cardiovascular complications</span>","The <span class=""chemical"">aspirin</span> group had a slightly increased rate of <span class=""disease"">cardiovascular complications</span> (10.1% vs 7.0%, P=.107), likely reflecting their increased cardiovascular comorbidities that led to their physicians recommending aspirin therapy.",,23890963,23890963_D001241_D002318,23890963_9,bcv_sentence_task_befree_4791,,770960723,FALSE,finalized,5,8/14/15 22:36,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D006470,"<span class=""disease"">bleeding</span>","This is the first study to report that <span class=""chemical"">aspirin</span> therapy is not associated with increased rates of perioperative <span class=""disease"">bleeding</span>, transfusion requirement, or major procedure related complications after elective pancreatic surgery.",,23890963,23890963_D001241_D006470,23890963_11,bcv_sentence_task_befree_4792,,770960724,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D019698,"<span class=""disease"">chronic hepatitis C</span>","Liver histology of <span class=""disease"">chronic hepatitis C</span> patients who relapsed or not responded to conventional interferon and <span class=""chemical"">ribavirin</span> therapy.",,23894901,23894901_D012254_D019698,23894901_0,bcv_sentence_task_befree_4793,,770960725,FALSE,finalized,5,8/15/15 1:53,"



",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D006526,"<span class=""disease"">hepatitis C</span>","The study had 109 <span class=""disease"">hepatitis C</span> patients who had relapsed or not responded to the conventional interferon and <span class=""chemical"">ribavirin</span> for at least 24 weeks.",,23894901,23894901_D012254_D006526,23894901_3,bcv_sentence_task_befree_4794,,770960726,FALSE,finalized,5,8/14/15 23:23,"



",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D005355,"<span class=""disease"">fibrosis</span>","Results suggested that even if it failed to eradicate hepatitis C virus, the conventional interferon and <span class=""chemical"">ribavirin</span> therapy was able to halt the progress of necroinflammation and <span class=""disease"">fibrosis</span>.",,23894901,23894901_D012254_D005355,23894901_13,bcv_sentence_task_befree_4795,,770960727,FALSE,finalized,5,8/14/15 22:39,"



",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D006526,"<span class=""disease"">hepatitis C virus</span>","Results suggested that even if it failed to eradicate <span class=""disease"">hepatitis C virus</span>, the conventional interferon and <span class=""chemical"">ribavirin</span> therapy was able to halt the progress of necroinflammation and fibrosis.",,23894901,23894901_D012254_D006526,23894901_13,bcv_sentence_task_befree_4796,,770960728,FALSE,finalized,5,8/15/15 1:02,"



",no_relation,0.6045,,D011084,"<span class=""chemical"">polycyclic aromatic hydrocarbons</span>",D064420,"<span class=""disease"">toxicity</span>","Bioaccessibility of <span class=""chemical"">polycyclic aromatic hydrocarbons</span>: relevance to <span class=""disease"">toxicity</span> and carcinogenesis.",,23898780,23898780_D011084_D064420,23898780_0,bcv_sentence_task_befree_4797,,770960729,FALSE,finalized,5,8/14/15 23:22,"



",no_relation,0.593,,D011084,"<span class=""chemical"">polycyclic aromatic hydrocarbons</span>",D063646,"<span class=""disease"">carcinogenesis</span>","Bioaccessibility of <span class=""chemical"">polycyclic aromatic hydrocarbons</span>: relevance to toxicity and <span class=""disease"">carcinogenesis</span>.",,23898780,23898780_D011084_D063646,23898780_0,bcv_sentence_task_befree_4798,,770960730,FALSE,finalized,5,8/14/15 23:21,"



",yes_direct,0.7912,,D011084,"<span class=""chemical"">PAHs</span>",D009369,"<span class=""disease"">cancer</span>","As polycyclic aromatic hydrocarbons (<span class=""chemical"">PAHs</span>) are ubiquitous environmental pollutants, they are the toxicants of focus to establish <span class=""disease"">cancer</span> risks in humans.",,23898780,23898780_D011084_D009369,23898780_2,bcv_sentence_task_befree_4799,,770960731,FALSE,finalized,5,8/14/15 22:49,"



",yes_direct,1,,D011084,"<span class=""chemical"">PAHs</span>",D064420,"<span class=""disease"">toxicity</span>","Orally ingested <span class=""chemical"">PAHs</span> also cause <span class=""disease"">toxicity</span> and even affect the pharmacokinetic behavior of some therapeutic agents.",,23898780,23898780_D011084_D064420,23898780_3,bcv_sentence_task_befree_4800,,770960732,FALSE,finalized,5,8/15/15 0:47,"



",no_relation,1,,D010130,"<span class=""chemical"">PAH</span>",D010661,"<span class=""disease"">PAH</span>","This review also considers the factors that influence bioaccessibility and debates the merits and limitations of using a bioaccessibility concept for estimating risk from ingestion of <span class=""chemical""></span><span class=""disease"">PAH</span>-contaminated soil and food.",,23898780,23898780_D010130_D010661,23898780_6,bcv_sentence_task_befree_4801,,770960733,FALSE,finalized,5,8/15/15 0:31,"



",yes_direct,0.8125,,D010130,"<span class=""chemical"">PAH</span>",D064420,"<span class=""disease"">toxicity</span>","Finally, the authors discuss the implications of bioaccessibility for <span class=""chemical"">PAH</span>-induced <span class=""disease"">toxicity</span> and cancers in the context of risk assessment.",,23898780,23898780_D010130_D064420,23898780_7,bcv_sentence_task_befree_4802,,770960734,FALSE,finalized,5,8/14/15 23:50,"



",yes_direct,0.5988,,D010130,"<span class=""chemical"">PAH</span>",D009369,"<span class=""disease"">cancers</span>","Finally, the authors discuss the implications of bioaccessibility for <span class=""chemical"">PAH</span>-induced toxicity and <span class=""disease"">cancers</span> in the context of risk assessment.",,23898780,23898780_D010130_D009369,23898780_7,bcv_sentence_task_befree_4803,,770960735,FALSE,finalized,5,8/14/15 23:46,"



",no_relation,1,,D010130,"<span class=""chemical"">PAH</span>",D010661,"<span class=""disease"">PAH</span>","Finally, the authors discuss the implications of bioaccessibility for <span class=""chemical""></span><span class=""disease"">PAH</span>-induced toxicity and cancers in the context of risk assessment.",,23898780,23898780_D010130_D010661,23898780_7,bcv_sentence_task_befree_4804,,770960736,FALSE,finalized,5,8/14/15 23:05,"


No proper highlighting for the chemical.
",no_relation,1,,D010130,"<span class=""chemical"">PAH</span>",D010661,"<span class=""disease"">PAH</span>","So far, much of the focus on <span class=""chemical""></span><span class=""disease"">PAH</span> bioaccessibility is centered on soil as a preferential matrix.",,23898780,23898780_D010130_D010661,23898780_8,bcv_sentence_task_befree_4805,,770960737,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,D013748,"<span class=""chemical"">tetracaine</span>",D004427,"<span class=""disease"">ear infection</span>","The use of extemporaneously compounded 1% <span class=""chemical"">tetracaine</span> to improve adherence with clotrimazole 1% topical solution in the treatment of <span class=""disease"">ear infection</span>: a case report.",,23932769,23932769_D013748_D004427,23932769_0,bcv_sentence_task_befree_4806,,770960738,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,D003022,"<span class=""chemical"">clotrimazole</span>",D004427,"<span class=""disease"">ear infection</span>","The use of extemporaneously compounded 1% tetracaine to improve adherence with <span class=""chemical"">clotrimazole</span> 1% topical solution in the treatment of <span class=""disease"">ear infection</span>: a case report.",,23932769,23932769_D003022_D004427,23932769_0,bcv_sentence_task_befree_4807,,770960739,FALSE,finalized,5,8/15/15 0:51,"



",yes_direct,1,,D003022,"<span class=""chemical"">clotrimazole</span>",D010146,"<span class=""disease"">pain</span>","We report a case of non-adherence due to severe <span class=""disease"">pain</span> associated with the topical use of <span class=""chemical"">clotrimazole</span> 1% solution in the ear.",,23932769,23932769_D003022_D010146,23932769_3,bcv_sentence_task_befree_4808,,770960740,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D013748,"<span class=""chemical"">tetracaine</span>",D010146,"<span class=""disease"">pain</span>","Instillation of <span class=""chemical"">tetracaine</span> 1% solution prior to the administration of the clotrimazole blocked the <span class=""disease"">pain</span> sensation allowing the patient to successfully complete the antifungal therapy.",,23932769,23932769_D013748_D010146,23932769_4,bcv_sentence_task_befree_4809,,770960741,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,1,,D003022,"<span class=""chemical"">clotrimazole</span>",D010146,"<span class=""disease"">pain</span>","Instillation of tetracaine 1% solution prior to the administration of the <span class=""chemical"">clotrimazole</span> blocked the <span class=""disease"">pain</span> sensation allowing the patient to successfully complete the antifungal therapy.",,23932769,23932769_D003022_D010146,23932769_4,bcv_sentence_task_befree_4810,,770960742,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,D014025,"<span class=""chemical"">titanium</span>",D006547,"<span class=""disease"">hernia</span>","Repair of symptomatic perineal <span class=""disease"">hernia</span> with a <span class=""chemical"">titanium</span> mesh.",,23934356,23934356_D014025_D006547,23934356_0,bcv_sentence_task_befree_4811,,770960743,FALSE,finalized,5,8/14/15 23:45,"



",no_relation,1,,D014025,"<span class=""chemical"">titanium</span>",D009437,"<span class=""disease"">perineal hernia repair</span>","Here, we describe the application of a <span class=""chemical"">titanium</span> mesh for <span class=""disease"">perineal hernia repair</span>.",,23934356,23934356_D014025_D009437,23934356_3,bcv_sentence_task_befree_4812,,770960744,FALSE,finalized,5,8/14/15 22:54,"



",no_relation,1,,D014025,"<span class=""chemical"">titanium</span>",D006547,"<span class=""disease"">hernia</span>","We performed <span class=""disease"">hernia</span> repair with a thin <span class=""chemical"">titanium</span> mesh via a perineal approach in three patients who developed secondary perineal <span class=""disease"">hernia</span> following abdominoperineal resection.",,23934356,23934356_D014025_D006547,23934356_4,bcv_sentence_task_befree_4813,,770960745,FALSE,finalized,5,8/14/15 22:30,"



",no_relation,1,,D014025,"<span class=""chemical"">titanium</span>",D006547,"<span class=""disease"">hernia sac</span>","After the <span class=""disease"">hernia sac</span> was isolated and dissected, the <span class=""chemical"">titanium</span> mesh was molded and placed over the ischium and coccyx to support the pelvic floor.",,23934356,23934356_D014025_D006547,23934356_5,bcv_sentence_task_befree_4814,,770960746,FALSE,finalized,5,8/14/15 22:44,"



",no_relation,1,,D014025,"<span class=""chemical"">titanium</span>",D009437,"<span class=""disease"">perineal hernia repair</span>","Our successful preliminary results indicate that a <span class=""chemical"">titanium</span> mesh is useful for <span class=""disease"">perineal hernia repair</span> by the perineal approach, as it can provide rigid support for the pelvic floor by its entire surface while ensuring stability without any fixation.",,23934356,23934356_D014025_D009437,23934356_8,bcv_sentence_task_befree_4815,,770960747,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,0.5736,,D000450,"<span class=""chemical"">aldosterone</span>",D006333,"<span class=""disease"">heart failure</span>","The heart is one important target tissue for damage due to excess <span class=""chemical"">aldosterone</span>, and the role of natriuretic peptides is well recognized in diagnosing <span class=""disease"">heart failure</span>.",,23943252,23943252_D000450_D006333,23943252_2,bcv_sentence_task_befree_4816,,770960748,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,1,,D000450,"<span class=""chemical"">aldosterone</span>",D006929,"<span class=""disease"">PA</span>","We hypothesized that measuring the NT-proBNP could improve the diagnostic evaluation of <span class=""disease"">PA</span>. We enrolled 132 hypertensive patients, who underwent <span class=""chemical"">aldosterone</span> to renin ratio (ARR) screening, and 81 underwent an intravenous saline loading test (ivSLT) because of a high ARR.",,23943252,23943252_D000450_D006929,23943252_3,bcv_sentence_task_befree_4817,,770960749,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D000450,"<span class=""chemical"">aldosterone</span>",D006973,"<span class=""disease"">hypertensive</span>","We hypothesized that measuring the NT-proBNP could improve the diagnostic evaluation of PA. We enrolled 132 <span class=""disease"">hypertensive</span> patients, who underwent <span class=""chemical"">aldosterone</span> to renin ratio (ARR) screening, and 81 underwent an intravenous saline loading test (ivSLT) because of a high ARR.",,23943252,23943252_D000450_D006973,23943252_3,bcv_sentence_task_befree_4818,,770960750,FALSE,finalized,5,8/14/15 22:46,"



",no_relation,1,,D003000,"<span class=""chemical"">clonidine</span>",D012852,"<span class=""disease"">sinusitis</span>","A group of 44 patients undergoing FESS for chronic <span class=""disease"">sinusitis</span> and polyp removal were enrolled and randomly assigned to receive either oral <span class=""chemical"">clonidine</span> or midazolam as preoperative premedication.",,23943734,23943734_D003000_D012852,23943734_5,bcv_sentence_task_befree_4819,,770960751,FALSE,finalized,5,8/14/15 22:50,"



",no_relation,1,,D008874,"<span class=""chemical"">midazolam</span>",D012852,"<span class=""disease"">sinusitis</span>","A group of 44 patients undergoing FESS for chronic <span class=""disease"">sinusitis</span> and polyp removal were enrolled and randomly assigned to receive either oral clonidine or <span class=""chemical"">midazolam</span> as preoperative premedication.",,23943734,23943734_D008874_D012852,23943734_5,bcv_sentence_task_befree_4820,,770960752,FALSE,finalized,5,8/14/15 23:23,"



",no_relation,1,,D002118,"<span class=""chemical"">calcium</span>",D015875,"<span class=""disease"">MDD</span>","All admixtures were within the specifications set by the USP with respect to the <span class=""disease"">MDD</span> at 0, 24, and 48 hours, but only those batches lacking <span class=""chemical"">calcium</span> met the benchmarks set by the pharmacopoeia, with respect to PFAT5, on the day of preparation.",,23976766,23976766_D002118_D015875,23976766_7,bcv_sentence_task_befree_4821,,770960753,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,1,,C031327,"<span class=""chemical"">artemisinin</span>",D008288,"<span class=""disease"">malaria</span>","The <span class=""disease"">malaria</span> treatment recommended by the World Health Organization involves medicines derived from <span class=""chemical"">artemisinin</span>, an active compound extracted from the plant Artemisia annua, and some of its derivatives, such as artesunate.",,23979886,23979886_C031327_D008288,23979886_1,bcv_sentence_task_befree_4822,,770960754,FALSE,finalized,5,8/15/15 2:23,"



",no_relation,1,,C039726,"<span class=""chemical"">artesunate</span>",D008288,"<span class=""disease"">malaria</span>","The <span class=""disease"">malaria</span> treatment recommended by the World Health Organization involves medicines derived from artemisinin, an active compound extracted from the plant Artemisia annua, and some of its derivatives, such as <span class=""chemical"">artesunate</span>.",,23979886,23979886_C039726_D008288,23979886_1,bcv_sentence_task_befree_4823,,770960755,FALSE,finalized,5,8/14/15 22:36,"



",no_relation,1,,C031327,"<span class=""chemical"">artemisinin</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Considering the lack of data regarding the genotoxic effects of these compounds in human cells, the objective of this study was to evaluate the <span class=""disease"">cytotoxicity</span> and genotoxicity, and expressions of the CASP3 and SOD1 genes in a cultured human hepatocellular liver carcinoma cell line (HepG2 cells) treated with <span class=""chemical"">artemisinin</span> and artesunate.",,23979886,23979886_C031327_D004487,23979886_2,bcv_sentence_task_befree_4824,,770960756,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,1,,C039726,"<span class=""chemical"">artesunate</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Considering the lack of data regarding the genotoxic effects of these compounds in human cells, the objective of this study was to evaluate the <span class=""disease"">cytotoxicity</span> and genotoxicity, and expressions of the CASP3 and SOD1 genes in a cultured human hepatocellular liver carcinoma cell line (HepG2 cells) treated with artemisinin and <span class=""chemical"">artesunate</span>.",,23979886,23979886_C039726_D004487,23979886_2,bcv_sentence_task_befree_4825,,770960757,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,C031327,"<span class=""chemical"">artemisinin</span>",D002277,"<span class=""disease"">carcinoma</span>","Considering the lack of data regarding the genotoxic effects of these compounds in human cells, the objective of this study was to evaluate the cytotoxicity and genotoxicity, and expressions of the CASP3 and SOD1 genes in a cultured human hepatocellular liver <span class=""disease"">carcinoma</span> cell line (HepG2 cells) treated with <span class=""chemical"">artemisinin</span> and artesunate.",,23979886,23979886_C031327_D002277,23979886_2,bcv_sentence_task_befree_4826,,770960758,FALSE,finalized,5,8/14/15 22:49,"



",no_relation,1,,C039726,"<span class=""chemical"">artesunate</span>",D002277,"<span class=""disease"">carcinoma</span>","Considering the lack of data regarding the genotoxic effects of these compounds in human cells, the objective of this study was to evaluate the cytotoxicity and genotoxicity, and expressions of the CASP3 and SOD1 genes in a cultured human hepatocellular liver <span class=""disease"">carcinoma</span> cell line (HepG2 cells) treated with artemisinin and <span class=""chemical"">artesunate</span>.",,23979886,23979886_C039726_D002277,23979886_2,bcv_sentence_task_befree_4827,,770960759,FALSE,finalized,5,8/14/15 23:08,"



",no_relation,0.608,,C005843,"<span class=""chemical"">resazurin</span>",D004487,"<span class=""disease"">cytotoxicity</span>","We tested concentrations of 2.5, 5, 7.5, 10, and 20 _g/mL of both substances with a <span class=""chemical"">resazurin</span> <span class=""disease"">cytotoxicity</span> assay, and the concentrations used in the genotoxicity experiments (2.5, 5, and 10 _g/mL) and gene expression analysis (5 _g/mL) were determined.",,23979886,23979886_C005843_D004487,23979886_3,bcv_sentence_task_befree_4828,,770960760,FALSE,finalized,5,8/15/15 0:05,"



Ambiguous, sir. Is B19 the same as curcumin? If so then curcumin causes ovarian cancer. Since it is only ""analogue"" I guess the answer is ""no"" or ""don't know.""",no_relation,0.6131,,D003474,"<span class=""chemical"">curcumin</span>",D009369,"<span class=""disease"">ovarian cancer</span>","B19, a novel monocarbonyl analogue of <span class=""chemical"">curcumin</span>, induces human <span class=""disease"">ovarian cancer</span> cell apoptosis via activation of endoplasmic reticulum stress and the autophagy signaling pathway.",,23983610,23983610_D003474_D009369,23983610_0,bcv_sentence_task_befree_4829,,770960761,FALSE,finalized,5,8/15/15 1:33,"



",no_relation,1,,D003474,"<span class=""chemical"">Curcumin</span>",D009369,"<span class=""disease"">ovarian cancer/cancers</span>","<span class=""chemical"">Curcumin</span> has been used to treat several different <span class=""disease"">cancers</span>, including <span class=""disease"">ovarian cancer</span>, in clinical trials and research; however, the role of ER stress and autophagy in the therapeutic effects of <span class=""chemical"">curcumin</span> and new <span class=""chemical"">curcumin</span> analogues remains unclear.",,23983610,23983610_D003474_D009369,23983610_2,bcv_sentence_task_befree_4830,,770960762,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,0.817,,C025946,"<span class=""chemical"">3-methyladenine/3-MA</span>",D009369,"<span class=""disease"">ovarian cancer</span>","The inhibition of autophagy using <span class=""chemical"">3-methyladenine</span> (<span class=""chemical"">3-MA</span>) increased levels of intracellular misfolded proteins, which enhanced <span class=""disease"">ovarian cancer</span> apoptosis.",,23983610,23983610_C025946_D009369,23983610_10,bcv_sentence_task_befree_4831,,770960763,FALSE,finalized,5,8/15/15 0:32,"



",no_relation,0.7939,,D003474,"<span class=""chemical"">curcumin</span>",D009369,"<span class=""disease"">ovarian cancer</span>","Our data indicate that ER stress and autophagy may play a role in the apoptosis that is induced by the <span class=""chemical"">curcumin</span> analogue B19 in an epithelial <span class=""disease"">ovarian cancer</span> cell line and that autophagy inhibition can increase <span class=""chemical"">curcumin</span> analogue-induced apoptosis by inducing severe ER stress.",,23983610,23983610_D003474_D009369,23983610_11,bcv_sentence_task_befree_4832,,770960764,FALSE,finalized,5,8/14/15 22:31,"



",no_relation,1,,C522181,"<span class=""chemical"">apixaban</span>",D006470,"<span class=""disease"">bleeding</span>","In ARISTOTLE, <span class=""chemical"">apixaban</span> resulted in a 21% reduction in stroke, a 31% reduction in major <span class=""disease"">bleeding</span>, and an 11% reduction in death.",,24016507,24016507_C522181_D006470,24016507_1,bcv_sentence_task_befree_4833,,770960765,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,1,,C522181,"<span class=""chemical"">apixaban</span>",D003643,"<span class=""disease"">death</span>","In ARISTOTLE, <span class=""chemical"">apixaban</span> resulted in a 21% reduction in stroke, a 31% reduction in major bleeding, and an 11% reduction in <span class=""disease"">death</span>.",,24016507,24016507_C522181_D003643,24016507_1,bcv_sentence_task_befree_4834,,770960766,FALSE,finalized,5,8/14/15 22:52,"



",no_relation,1,,C522181,"<span class=""chemical"">apixaban</span>",D020521,"<span class=""disease"">stroke</span>","In ARISTOTLE, <span class=""chemical"">apixaban</span> resulted in a 21% reduction in <span class=""disease"">stroke</span>, a 31% reduction in major bleeding, and an 11% reduction in death.",,24016507,24016507_C522181_D020521,24016507_1,bcv_sentence_task_befree_4835,,770960767,FALSE,finalized,5,8/14/15 23:45,"



",no_relation,1,,C486464,"<span class=""chemical"">telaprevir</span>",D006526,"<span class=""disease"">hepatitis C genotype 1 infected</span>","The advent of first-generation direct antiviral agents such as boceprevir and <span class=""chemical"">telaprevir</span> has changed the concept of treatment of adult chronic <span class=""disease"">hepatitis C genotype 1 infected</span> patients.",,24038567,24038567_C486464_D006526,24038567_3,bcv_sentence_task_befree_4836,,770960768,FALSE,finalized,5,8/15/15 0:34,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D014657,"<span class=""disease"">vasculitis</span>","Follow-up data from the RAVE trial have shown that rituximab is as effective as immunosuppression with <span class=""chemical"">cyclophosphamide</span> followed by azathioprine in antineutrophil cytoplasmic antibody (ANCA) associated <span class=""disease"">vasculitis</span>.",,24080801,24080801_D003520_D014657,24080801_1,bcv_sentence_task_befree_4837,,770960769,FALSE,finalized,5,8/15/15 1:31,"



",no_relation,1,,D001379,"<span class=""chemical"">azathioprine</span>",D014657,"<span class=""disease"">vasculitis</span>","Follow-up data from the RAVE trial have shown that rituximab is as effective as immunosuppression with cyclophosphamide followed by <span class=""chemical"">azathioprine</span> in antineutrophil cytoplasmic antibody (ANCA) associated <span class=""disease"">vasculitis</span>.",,24080801,24080801_D001379_D014657,24080801_1,bcv_sentence_task_befree_4838,,770960770,FALSE,finalized,5,8/14/15 22:33,"



",yes_direct,0.5903,,C400082,"<span class=""chemical"">Bortezomib</span>",D015470,"<span class=""disease"">AML</span>","<span class=""chemical"">Bortezomib</span> exerted a dose-dependent increase in miR-29b expression in <span class=""disease"">AML</span> blasts ex vivo, followed by decreased Dnmts, reduced proliferation, and increased apoptosis.",,24085765,24085765_C400082_D015470,24085765_4,bcv_sentence_task_befree_4839,,770960771,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,C400082,"<span class=""chemical"">bortezomib</span>",D015470,"<span class=""disease"">AML</span>","In vivo, <span class=""chemical"">bortezomib</span> was not active against dKI <span class=""disease"">AML</span>, yet liposomal-encapsulated <span class=""chemical"">bortezomib</span>, as a single agent, reversed downregulation of miR-29b in vivo and induced a long-term (90-day) disease-free remission in 80% of dKI <span class=""disease"">AML</span> mice that exhibited high leukemic burden at the start of therapy, yet showed no signs of relapse at autopsy.",,24085765,24085765_C400082_D015470,24085765_5,bcv_sentence_task_befree_4840,,770960772,FALSE,finalized,5,8/14/15 23:50,"



",no_relation,1,,C400082,"<span class=""chemical"">bortezomib</span>",D009886,"<span class=""disease"">ITD</span>","Taken together, these data support that liposomal <span class=""chemical"">bortezomib</span>, as a single agent, eradicates Mll(PTD/wt):Flt3(<span class=""disease"">ITD</span>/wt) AML in mouse and may represent a powerful and potentially curative approach to high-risk human disease.",,24085765,24085765_C400082_D009886,24085765_6,bcv_sentence_task_befree_4841,,770960773,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,1,,C400082,"<span class=""chemical"">bortezomib</span>",D015470,"<span class=""disease"">AML</span>","Taken together, these data support that liposomal <span class=""chemical"">bortezomib</span>, as a single agent, eradicates Mll(PTD/wt):Flt3(ITD/wt) <span class=""disease"">AML</span> in mouse and may represent a powerful and potentially curative approach to high-risk human disease.",,24085765,24085765_C400082_D015470,24085765_6,bcv_sentence_task_befree_4842,,770960774,FALSE,finalized,5,8/14/15 22:42,"


WHAT!? I have to read about that. *Googles it* XD
",yes_direct,1,,D001241,"<span class=""chemical"">aspirin</span>",D014947,"<span class=""disease"">Unusual burn injury</span>","<span class=""disease"">Unusual burn injury</span> due to application of white vinegar and <span class=""chemical"">aspirin</span> mixture.",,24102713,24102713_D001241_D014947,24102713_0,bcv_sentence_task_befree_4843,,770960775,FALSE,finalized,5,8/14/15 22:57,"



",no_relation,1,,D001241,"<span class=""chemical"">aspirin</span>",D010146,"<span class=""disease"">pain</span>","Here, we describe a patient who suffered from a split-thickness leg burn after applying a self-inflicted mixture consisting of white vinegar and <span class=""chemical"">aspirin</span> prepared for knee <span class=""disease"">pain</span>.",,24102713,24102713_D001241_D010146,24102713_2,bcv_sentence_task_befree_4844,,770960776,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,1,,D000728,"<span class=""chemical"">androgen</span>",D003922,"<span class=""disease"">T1D</span>","At the beginning of puberty, the <span class=""disease"">T1D</span> group had higher levels of SHBG (p=0.003) and similar <span class=""chemical"">androgen</span> levels than the Control group.",,24118936,24118936_D000728_D003922,24118936_6,bcv_sentence_task_befree_4845,,770960777,FALSE,finalized,5,8/14/15 22:52,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D003922,"<span class=""disease"">T1D</span>","Higher HbA1c had a negative effect on total <span class=""chemical"">testosterone</span> and cFT and a positive effect on SHBG levels in <span class=""disease"">T1D</span> boys.",,24118936,24118936_D013739_D003922,24118936_11,bcv_sentence_task_befree_4846,,770960778,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D007006,"<span class=""disease"">hypogonadism</span>","Adolescents with T1D do not exhibit <span class=""disease"">hypogonadism</span>, as shown by normal gonadotropin, <span class=""chemical"">testosterone</span>, inhibin B, and AMH levels.",,24118936,24118936_D013739_D007006,24118936_12,bcv_sentence_task_befree_4847,,770960779,FALSE,finalized,5,8/15/15 0:05,"



",no_relation,1,,D013739,"<span class=""chemical"">testosterone</span>",D003922,"<span class=""disease"">T1D</span>","Adolescents with <span class=""disease"">T1D</span> do not exhibit hypogonadism, as shown by normal gonadotropin, <span class=""chemical"">testosterone</span>, inhibin B, and AMH levels.",,24118936,24118936_D013739_D003922,24118936_12,bcv_sentence_task_befree_4848,,770960780,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,0.8168,,D013739,"<span class=""chemical"">testosterone</span>",D003922,"<span class=""disease"">T1D</span>","However, in <span class=""disease"">T1D</span> boys, HbA1c and BMI-SDS had a negative association with <span class=""chemical"">testosterone</span> levels.",,24118936,24118936_D013739_D003922,24118936_13,bcv_sentence_task_befree_4849,,770960781,FALSE,finalized,5,8/14/15 23:54,"



",yes_direct,0.5727,,C005692,"<span class=""chemical"">triphosphate</span>",D054537,"<span class=""disease"">atrioventricular block</span>","Syncope associated with documented paroxysmal <span class=""disease"">atrioventricular block</span> reproduced by adenosine 5' <span class=""chemical"">triphosphate</span> injection.",,24128810,24128810_C005692_D054537,24128810_0,bcv_sentence_task_befree_4850,,770960782,FALSE,finalized,5,8/14/15 23:02,"



",yes_direct,0.5861,,C005692,"<span class=""chemical"">triphosphate</span>",D013575,"<span class=""disease"">Syncope</span>","<span class=""disease"">Syncope</span> associated with documented paroxysmal atrioventricular block reproduced by adenosine 5' <span class=""chemical"">triphosphate</span> injection.",,24128810,24128810_C005692_D013575,24128810_0,bcv_sentence_task_befree_4851,,770960783,FALSE,finalized,5,8/14/15 22:36,"



",yes_direct,0.5843,,D000241,"<span class=""chemical"">adenosine</span>",D054537,"<span class=""disease"">atrioventricular block</span>","Syncope associated with documented paroxysmal <span class=""disease"">atrioventricular block</span> reproduced by <span class=""chemical"">adenosine</span> 5' triphosphate injection.",,24128810,24128810_D000241_D054537,24128810_0,bcv_sentence_task_befree_4852,,770960784,FALSE,finalized,5,8/14/15 22:34,"



",yes_indirect,0.6025,,D000241,"<span class=""chemical"">adenosine</span>",D013575,"<span class=""disease"">Syncope</span>","<span class=""disease"">Syncope</span> associated with documented paroxysmal atrioventricular block reproduced by <span class=""chemical"">adenosine</span> 5' triphosphate injection.",,24128810,24128810_D000241_D013575,24128810_0,bcv_sentence_task_befree_4853,,770960785,FALSE,finalized,5,8/14/15 23:13,"



",no_relation,0.7839,,D000255,"<span class=""chemical"">ATP/adenosine triphosphate</span>",D013575,"<span class=""disease"">syncope</span>","We sought to investigate in patients with <span class=""disease"">syncope</span> the relationship between documented paroxysmal atrioventricular block (AVB) of unknown mechanism and AVB induced by <span class=""chemical"">adenosine triphosphate</span> (<span class=""chemical"">ATP</span>) injection.",,24128810,24128810_D000255_D013575,24128810_1,bcv_sentence_task_befree_4854,,770960786,FALSE,finalized,5,8/15/15 1:59,"



",yes_direct,0.8093,,D000255,"<span class=""chemical"">ATP/adenosine triphosphate</span>",D054537,"<span class=""disease"">atrioventricular block/AVB</span>","We sought to investigate in patients with syncope the relationship between documented paroxysmal <span class=""disease"">atrioventricular block</span> (<span class=""disease"">AVB</span>) of unknown mechanism and <span class=""disease"">AVB</span> induced by <span class=""chemical"">adenosine triphosphate</span> (<span class=""chemical"">ATP</span>) injection.",,24128810,24128810_D000255_D054537,24128810_1,bcv_sentence_task_befree_4855,,770960787,FALSE,finalized,5,8/14/15 22:56,"



",yes_direct,0.6014,,D000255,"<span class=""chemical"">ATP</span>",D054537,"<span class=""disease"">AVB</span>","In all patients, <span class=""chemical"">ATP</span> induced a long ventricular pause related to <span class=""disease"">AVB</span> (mean duration 13.2 s; range from 7 to 56 s).",,24128810,24128810_D000255_D054537,24128810_6,bcv_sentence_task_befree_4856,,770960788,FALSE,finalized,5,8/14/15 23:22,"

It's 'ATP test' and not just 'ATP'

",yes_direct,0.4044,,D000255,"<span class=""chemical"">ATP</span>",D013575,"<span class=""disease"">syncope</span>","Some patients, predominantly older females, with 'normal' heart and ECG, have <span class=""disease"">syncope</span> associated with spontaneous AVB of unknown origin reproduced during the <span class=""chemical"">ATP</span> test.",,24128810,24128810_D000255_D013575,24128810_8,bcv_sentence_task_befree_4857,,770960789,FALSE,finalized,5,8/14/15 22:37,"



",yes_direct,0.5903,,D000255,"<span class=""chemical"">ATP</span>",D054537,"<span class=""disease"">AVB</span>","Some patients, predominantly older females, with 'normal' heart and ECG, have syncope associated with spontaneous <span class=""disease"">AVB</span> of unknown origin reproduced during the <span class=""chemical"">ATP</span> test.",,24128810,24128810_D000255_D054537,24128810_8,bcv_sentence_task_befree_4858,,770960790,FALSE,finalized,5,8/14/15 23:14,"



",yes_direct,0.6298,,D000255,"<span class=""chemical"">ATP</span>",D054537,"<span class=""disease"">AVB</span>","This unusual behaviour could be interpreted as an abnormal susceptibility to <span class=""chemical"">ATP</span> and these patients could be considered to have '<span class=""chemical"">ATP</span>-sensitive <span class=""disease"">AVB</span>'.",,24128810,24128810_D000255_D054537,24128810_10,bcv_sentence_task_befree_4859,,770960791,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,1,,C424423,"<span class=""chemical"">Roflumilast</span>",D029424,"<span class=""disease"">COPD</span>","<span class=""chemical"">Roflumilast</span> for the treatment of <span class=""disease"">COPD</span> in an Asian population: a randomized, double-blind, parallel-group study.",,24135893,24135893_C424423_D029424,24135893_0,bcv_sentence_task_befree_4860,,770960792,FALSE,finalized,5,8/14/15 23:32,"

Used as treatment.

",no_relation,1,,C424423,"<span class=""chemical"">Roflumilast</span>",D029424,"<span class=""disease"">COPD</span>","<span class=""chemical"">Roflumilast</span> is the only oral phosphodiesterase 4 inhibitor indicated for use in the treatment of <span class=""disease"">COPD</span>.",,24135893,24135893_C424423_D029424,24135893_1,bcv_sentence_task_befree_4861,,770960793,FALSE,finalized,5,8/14/15 23:09,"



",no_relation,0.8174,,C424423,"<span class=""chemical"">roflumilast</span>",D029424,"<span class=""disease"">COPD</span>","In a placebo-controlled, double-blind, parallel-group, multicenter, phase 3 study, patients of Chinese, Malay, and Indian ethnicity (N = 626) with severe to very severe <span class=""disease"">COPD</span> were randomized 1:1 to receive either <span class=""chemical"">roflumilast</span> 500 _g once daily or placebo for 24 weeks.",,24135893,24135893_C424423_D029424,24135893_4,bcv_sentence_task_befree_4862,,770960794,FALSE,finalized,5,8/14/15 22:32,"



",yes_direct,1,,C424423,"<span class=""chemical"">roflumilast</span>",D003967,"<span class=""disease"">diarrhea</span>","The most frequently reported treatment-related adverse event was <span class=""disease"">diarrhea</span> (6.0% and 1.0% of patients in the <span class=""chemical"">roflumilast</span> and placebo groups, respectively).",,24135893,24135893_C424423_D003967,24135893_10,bcv_sentence_task_befree_4863,,770960795,FALSE,finalized,5,8/15/15 1:18,"



",no_relation,1,,D005492,"<span class=""chemical"">folate</span>",C562799,"<span class=""disease"">folate deficiency</span>","The prevalence of biochemical <span class=""chemical""></span><span class=""disease"">folate</span> deficiency, defined as plasma folate <6.8 nmol/L or erythrocyte <span class=""chemical"">folate</span> <305 nmol/L, was 2%.",,24174623,24174623_D005492_C562799,24174623_8,bcv_sentence_task_befree_4864,,770960796,FALSE,finalized,5,8/14/15 22:35,"



",no_relation,1,,D005492,"<span class=""chemical"">folate</span>",C562799,"<span class=""disease"">folate deficiency</span>","The prevalence of biochemical <span class=""chemical""></span><span class=""disease"">folate</span> deficiency in New Zealand adults is low.",,24174623,24174623_D005492_C562799,24174623_10,bcv_sentence_task_befree_4865,,770960797,FALSE,finalized,5,8/14/15 22:37,"



",yes_direct,1,,D020058,"<span class=""chemical"">styrene</span>",C564013,"<span class=""disease"">ototoxic</span>","The <span class=""disease"">ototoxic</span> effect of the exposure to <span class=""chemical"">styrene</span> is evaluated, also in the presence of simultaneous exposure to noise, using otoacoustic emissions as biomarkers of mild cochlear damage.",,24180784,24180784_D020058_C564013,24180784_1,bcv_sentence_task_befree_4866,,770960798,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,0.8074,,D020058,"<span class=""chemical"">styrene</span>",D006177,"<span class=""disease"">cochlear damage</span>","The ototoxic effect of the exposure to <span class=""chemical"">styrene</span> is evaluated, also in the presence of simultaneous exposure to noise, using otoacoustic emissions as biomarkers of mild <span class=""disease"">cochlear damage</span>.",,24180784,24180784_D020058_D006177,24180784_1,bcv_sentence_task_befree_4867,,770960799,FALSE,finalized,5,8/15/15 1:58,"



",no_relation,1,,C417083,"<span class=""chemical"">pegylated-interferon</span>",D006526,"<span class=""disease"">hepatitis C</span>","Our aims were to evaluate the association between myxovirus resistance protein, osteopontin and suppressor of cytokine signaling 3 gene polymorphisms in combination with IL28B and to assess the therapy response in <span class=""disease"">hepatitis C</span> patients treated with <span class=""chemical"">pegylated-interferon</span> plus ribavirin.",,24212839,24212839_C417083_D006526,24212839_2,bcv_sentence_task_befree_4868,,770960800,FALSE,finalized,5,8/14/15 23:01,"



",no_relation,1,,D012254,"<span class=""chemical"">ribavirin</span>",D006526,"<span class=""disease"">hepatitis C</span>","Our aims were to evaluate the association between myxovirus resistance protein, osteopontin and suppressor of cytokine signaling 3 gene polymorphisms in combination with IL28B and to assess the therapy response in <span class=""disease"">hepatitis C</span> patients treated with pegylated-interferon plus <span class=""chemical"">ribavirin</span>.",,24212839,24212839_D012254_D006526,24212839_2,bcv_sentence_task_befree_4869,,770960801,FALSE,finalized,5,8/15/15 0:35,"



",yes_direct,0.5735,,D044242,"<span class=""chemical"">Trans fatty acids</span>",D007249,"<span class=""disease"">inflammation</span>","<span class=""chemical"">Trans fatty acids</span> in diets act as a precipitating factor for gut <span class=""disease"">inflammation</span>?",,24251700,24251700_D044242_D007249,24251700_0,bcv_sentence_task_befree_4870,,770960802,FALSE,finalized,5,8/14/15 23:01,"



",no_relation,0.5893,,D044242,"<span class=""chemical"">TFAs</span>",D003920,"<span class=""disease"">diabetes mellitus</span>","Although an increased report in the effects of the diet containing <span class=""chemical"">TFAs</span> on a risk factor of metabolic syndrome, <span class=""disease"">diabetes mellitus</span>, and coronary heart disease has been observed in the recent years, influence on intestinal inflammation remains unknown.",,24251700,24251700_D044242_D003920,24251700_4,bcv_sentence_task_befree_4871,,770960803,FALSE,finalized,5,8/14/15 23:14,"



",yes_direct,1,,D044242,"<span class=""chemical"">TFAs</span>",D003327,"<span class=""disease"">coronary heart disease</span>","Although an increased report in the effects of the diet containing <span class=""chemical"">TFAs</span> on a risk factor of metabolic syndrome, diabetes mellitus, and <span class=""disease"">coronary heart disease</span> has been observed in the recent years, influence on intestinal inflammation remains unknown.",,24251700,24251700_D044242_D003327,24251700_4,bcv_sentence_task_befree_4872,,770960804,FALSE,finalized,5,8/14/15 23:35,"



",yes_direct,0.8031,,D044242,"<span class=""chemical"">TFAs</span>",D008659,"<span class=""disease"">metabolic syndrome</span>","Although an increased report in the effects of the diet containing <span class=""chemical"">TFAs</span> on a risk factor of <span class=""disease"">metabolic syndrome</span>, diabetes mellitus, and coronary heart disease has been observed in the recent years, influence on intestinal inflammation remains unknown.",,24251700,24251700_D044242_D008659,24251700_4,bcv_sentence_task_befree_4873,,770960805,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,1,,D044242,"<span class=""chemical"">TFAs</span>",D007249,"<span class=""disease"">inflammation</span>","Although an increased report in the effects of the diet containing <span class=""chemical"">TFAs</span> on a risk factor of metabolic syndrome, diabetes mellitus, and coronary heart disease has been observed in the recent years, influence on intestinal <span class=""disease"">inflammation</span> remains unknown.",,24251700,24251700_D044242_D007249,24251700_4,bcv_sentence_task_befree_4874,,770960806,FALSE,finalized,5,8/14/15 22:59,"



",no_relation,0.5865,,D044242,"<span class=""chemical"">TFAs</span>",D009422,"<span class=""disease"">systemic disorders</span>","This review describes pro-inflammatory effects of <span class=""chemical"">TFAs</span> in our diary diet on various <span class=""disease"">systemic disorders</span> and also discusses a possible role of <span class=""chemical"">TFAs</span> on gut inflammation.",,24251700,24251700_D044242_D009422,24251700_5,bcv_sentence_task_befree_4875,,770960807,FALSE,finalized,5,8/15/15 2:49,"



",yes_direct,0.8043,,D044242,"<span class=""chemical"">TFAs</span>",D007249,"<span class=""disease"">inflammation</span>","This review describes pro-inflammatory effects of <span class=""chemical"">TFAs</span> in our diary diet on various systemic disorders and also discusses a possible role of <span class=""chemical"">TFAs</span> on gut <span class=""disease"">inflammation</span>.",,24251700,24251700_D044242_D007249,24251700_5,bcv_sentence_task_befree_4876,,770960808,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,C551994,"<span class=""chemical"">crizotinib</span>",D002289,"<span class=""disease"">non-small cell lung cancer</span>","Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive <span class=""disease"">non-small cell lung cancer</span> treated with the ALK inhibitor <span class=""chemical"">crizotinib</span>.",,24258622,24258622_C551994_D002289,24258622_0,bcv_sentence_task_befree_4877,,770960809,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,0.8055,,C551994,"<span class=""chemical"">crizotinib</span>",D008223,"<span class=""disease"">anaplastic lymphoma</span>","A total of 38 patients with stage IV <span class=""disease"">anaplastic lymphoma</span> kinase (ALK)-positive non-small cell lung cancer who were treated with <span class=""chemical"">crizotinib</span> were identified.",,24258622,24258622_C551994_D008223,24258622_3,bcv_sentence_task_befree_4878,,770960810,FALSE,finalized,5,8/14/15 22:40,"



",no_relation,1,,C551994,"<span class=""chemical"">crizotinib</span>",D002289,"<span class=""disease"">non-small cell lung cancer</span>","A total of 38 patients with stage IV anaplastic lymphoma kinase (ALK)-positive <span class=""disease"">non-small cell lung cancer</span> who were treated with <span class=""chemical"">crizotinib</span> were identified.",,24258622,24258622_C551994_D002289,24258622_3,bcv_sentence_task_befree_4879,,770960811,FALSE,finalized,5,8/14/15 22:59,"



",no_relation,1,,C107135,"<span class=""chemical"">everolimus</span>",D009362,"<span class=""disease"">spinal cord metastasis</span>","Response of subependymal giant cell astrocytoma with <span class=""disease"">spinal cord metastasis</span> to <span class=""chemical"">everolimus</span>.",,24276039,24276039_C107135_D009362,24276039_0,bcv_sentence_task_befree_4880,,770960812,FALSE,finalized,5,8/15/15 0:15,"



",no_relation,0.5955,,C107135,"<span class=""chemical"">everolimus</span>",D001254,"<span class=""disease"">Response of subependymal giant cell astrocytoma</span>","<span class=""disease"">Response of subependymal giant cell astrocytoma</span> with spinal cord metastasis to <span class=""chemical"">everolimus</span>.",,24276039,24276039_C107135_D001254,24276039_0,bcv_sentence_task_befree_4881,,770960813,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,C107135,"<span class=""chemical"">everolimus</span>",D014402,"<span class=""disease"">tuberous sclerosis</span>","Brain subependymal giant cell astrocytomas (SEGAs) in patients with <span class=""disease"">tuberous sclerosis</span> have been reported to respond to <span class=""chemical"">everolimus</span>.",,24276039,24276039_C107135_D014402,24276039_1,bcv_sentence_task_befree_4882,,770960814,FALSE,finalized,5,8/14/15 23:19,"


Used as possible treatment.
",no_relation,0.8008,,C081309,"<span class=""chemical"">irbesartan</span>",D008382,"<span class=""disease"">Marfan syndrome</span>","A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of <span class=""chemical"">irbesartan</span> on aortic dilatation in <span class=""disease"">Marfan syndrome</span> (AIMS trial): study protocol.",,24289736,24289736_C081309_D008382,24289736_0,bcv_sentence_task_befree_4883,,770960815,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,C081309,"<span class=""chemical"">irbesartan</span>",D001018,"<span class=""disease"">aortic dilatation</span>","A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of <span class=""chemical"">irbesartan</span> on <span class=""disease"">aortic dilatation</span> in Marfan syndrome (AIMS trial): study protocol.",,24289736,24289736_C081309_D001018,24289736_0,bcv_sentence_task_befree_4884,,770960816,FALSE,finalized,5,8/15/15 0:01,"



",no_relation,0.7962,,C081309,"<span class=""chemical"">irbesartan</span>",D008382,"<span class=""disease"">Marfan syndrome</span>","This trial will investigate the effects of <span class=""chemical"">irbesartan</span> on aortic dilatation in <span class=""disease"">Marfan syndrome</span>.",,24289736,24289736_C081309_D008382,24289736_5,bcv_sentence_task_befree_4885,,770960817,FALSE,finalized,5,8/14/15 23:24,"



",no_relation,0.8187,,C081309,"<span class=""chemical"">irbesartan</span>",D001018,"<span class=""disease"">aortic dilatation</span>","This trial will investigate the effects of <span class=""chemical"">irbesartan</span> on <span class=""disease"">aortic dilatation</span> in Marfan syndrome.",,24289736,24289736_C081309_D001018,24289736_5,bcv_sentence_task_befree_4886,,770960818,FALSE,finalized,5,8/15/15 0:08,"



",no_relation,1,,C081309,"<span class=""chemical"">irbesartan</span>",D008382,"<span class=""disease"">MFS</span>","This is the first clinical trial to evaluate the ARB <span class=""chemical"">irbesartan</span> versus placebo in reducing the rate of aortic root dilatation in <span class=""disease"">MFS</span>.",,24289736,24289736_C081309_D008382,24289736_12,bcv_sentence_task_befree_4887,,770960819,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,1,,C081309,"<span class=""chemical"">irbesartan</span>",D001018,"<span class=""disease"">aortic root dilatation</span>","This is the first clinical trial to evaluate the ARB <span class=""chemical"">irbesartan</span> versus placebo in reducing the rate of <span class=""disease"">aortic root dilatation</span> in MFS.",,24289736,24289736_C081309_D001018,24289736_12,bcv_sentence_task_befree_4888,,770960820,FALSE,finalized,5,8/14/15 22:52,"



",no_relation,1,,D019808,"<span class=""chemical"">losartan</span>",D020521,"<span class=""disease"">hypertensive stroke</span>","Comparison of the effects of amlodipine and <span class=""chemical"">losartan</span> on blood pressure and diurnal variation in <span class=""disease"">hypertensive stroke</span> patients: a prospective, randomized, double-blind, comparative parallel study.",,24296324,24296324_D019808_D020521,24296324_0,bcv_sentence_task_befree_4889,,770960821,FALSE,finalized,5,8/14/15 22:37,"



",no_relation,0.8207,,D017311,"<span class=""chemical"">amlodipine</span>",D020521,"<span class=""disease"">hypertensive stroke</span>","Comparison of the effects of <span class=""chemical"">amlodipine</span> and losartan on blood pressure and diurnal variation in <span class=""disease"">hypertensive stroke</span> patients: a prospective, randomized, double-blind, comparative parallel study.",,24296324,24296324_D017311_D020521,24296324_0,bcv_sentence_task_befree_4890,,770960822,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,0.6058,,D019808,"<span class=""chemical"">losartan</span>",D020521,"<span class=""disease"">acute stroke</span>","This study was conducted to compare the BP-lowering and diurnal BP variation effects of amlodipine and <span class=""chemical"">losartan</span> on <span class=""disease"">acute stroke</span> patients.",,24296324,24296324_D019808_D020521,24296324_2,bcv_sentence_task_befree_4891,,770960823,FALSE,finalized,5,8/14/15 23:34,"



",no_relation,0.8121,,D017311,"<span class=""chemical"">amlodipine</span>",D020521,"<span class=""disease"">acute stroke</span>","This study was conducted to compare the BP-lowering and diurnal BP variation effects of <span class=""chemical"">amlodipine</span> and losartan on <span class=""disease"">acute stroke</span> patients.",,24296324,24296324_D017311_D020521,24296324_2,bcv_sentence_task_befree_4892,,770960824,FALSE,finalized,5,8/14/15 23:14,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D004828,"<span class=""disease"">local or systemic corticosteroids</span>","Patients received no treatment, short-term (_1 year) treatment including <span class=""disease"">local or systemic </span><span class=""chemical"">corticosteroids</span>, or long-term (>1 year) treatment including systemic <span class=""chemical"">corticosteroids</span> and second-line immunosuppressive agents.",,24336967,24336967_D000305_D004828,24336967_5,bcv_sentence_task_befree_4893,,770960825,FALSE,finalized,5,8/14/15 22:37,"



",no_relation,1,,D019793,"<span class=""chemical"">fluorescein</span>",D002386,"<span class=""disease"">cataract</span>","Some clinical indices correlated with transient worse best-corrected visual acuity, including presence of <span class=""disease"">cataract</span> (P=.05), foveal leakage on <span class=""chemical"">fluorescein</span> angiography (P=.04), and increased central retinal thickness (P=.02).",,24336967,24336967_D019793_D002386,24336967_9,bcv_sentence_task_befree_4894,,770960826,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D004317,"<span class=""chemical"">doxorubicin</span>",D000860,"<span class=""disease"">hypoxic</span>","Here we characterize the spatial distribution and ability of TH-302 to selectively target <span class=""disease"">hypoxic</span> regions and complement the effect of <span class=""chemical"">doxorubicin</span> and docetaxel by modifying biomarker distribution.",,24338277,24338277_D004317_D000860,24338277_3,bcv_sentence_task_befree_4895,,770960827,FALSE,finalized,5,8/14/15 23:42,"



",no_relation,1,,C067311,"<span class=""chemical"">docetaxel</span>",D000860,"<span class=""disease"">hypoxic</span>","Here we characterize the spatial distribution and ability of TH-302 to selectively target <span class=""disease"">hypoxic</span> regions and complement the effect of doxorubicin and <span class=""chemical"">docetaxel</span> by modifying biomarker distribution.",,24338277,24338277_C067311_D000860,24338277_3,bcv_sentence_task_befree_4896,,770960828,FALSE,finalized,5,8/15/15 0:43,"



",no_relation,1,,D004317,"<span class=""chemical"">doxorubicin</span>",D009369,"<span class=""disease"">tumors</span>","Athymic nude mice bearing human breast MCF-7 or prostate PC-3 <span class=""disease"">tumors</span> were treated with <span class=""chemical"">doxorubicin</span> or docetaxel respectively and TH-302 alone or in combination.",,24338277,24338277_D004317_D009369,24338277_4,bcv_sentence_task_befree_4897,,770960829,FALSE,finalized,5,8/15/15 0:58,"



",no_relation,1,,C067311,"<span class=""chemical"">docetaxel</span>",D009369,"<span class=""disease"">tumors</span>","Athymic nude mice bearing human breast MCF-7 or prostate PC-3 <span class=""disease"">tumors</span> were treated with doxorubicin or <span class=""chemical"">docetaxel</span> respectively and TH-302 alone or in combination.",,24338277,24338277_C067311_D009369,24338277_4,bcv_sentence_task_befree_4898,,770960830,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,1,,C029652,"<span class=""chemical"">DiOC7</span>",D009369,"<span class=""disease"">tumor</span>","Biomarkers of drug effect including _H2aX (a marker of DNA damage), cleaved caspase-3 or -6 (markers of apoptosis) and reduction in Ki-67 (a marker of cell proliferation) were quantified in <span class=""disease"">tumor</span> sections in relation to functional blood vessels (recognized by <span class=""chemical"">DiOC7</span>) and hypoxia (recognized by EF5) using immunohistochemistry.",,24338277,24338277_C029652_D009369,24338277_5,bcv_sentence_task_befree_4899,,770960831,FALSE,finalized,5,8/14/15 22:42,"



",no_relation,1,,C029652,"<span class=""chemical"">DiOC7</span>",D000860,"<span class=""disease"">hypoxia</span>","Biomarkers of drug effect including _H2aX (a marker of DNA damage), cleaved caspase-3 or -6 (markers of apoptosis) and reduction in Ki-67 (a marker of cell proliferation) were quantified in tumor sections in relation to functional blood vessels (recognized by <span class=""chemical"">DiOC7</span>) and <span class=""disease"">hypoxia</span> (recognized by EF5) using immunohistochemistry.",,24338277,24338277_C029652_D000860,24338277_5,bcv_sentence_task_befree_4900,,770960832,FALSE,finalized,5,8/15/15 2:06,"



",no_relation,1,,D004317,"<span class=""chemical"">doxorubicin</span>",D000860,"<span class=""disease"">hypoxic</span>","_H2aX expression at 10 min and cleaved caspase-3 or -6 at 24 hr after <span class=""chemical"">doxorubicin</span> or docetaxel decreased with increasing distance from tumor blood vessels, with minimal expression in <span class=""disease"">hypoxic</span> regions; maximum reduction in Ki67 levels was observed in regions closest to vasculature at 24 hr.",,24338277,24338277_D004317_D000860,24338277_6,bcv_sentence_task_befree_4901,,770960833,FALSE,finalized,5,8/15/15 1:41,"



",no_relation,1,,C067311,"<span class=""chemical"">docetaxel</span>",D000860,"<span class=""disease"">hypoxic</span>","_H2aX expression at 10 min and cleaved caspase-3 or -6 at 24 hr after doxorubicin or <span class=""chemical"">docetaxel</span> decreased with increasing distance from tumor blood vessels, with minimal expression in <span class=""disease"">hypoxic</span> regions; maximum reduction in Ki67 levels was observed in regions closest to vasculature at 24 hr.",,24338277,24338277_C067311_D000860,24338277_6,bcv_sentence_task_befree_4902,,770960834,FALSE,finalized,5,8/15/15 1:10,"



",no_relation,1,,D004317,"<span class=""chemical"">doxorubicin</span>",D009369,"<span class=""disease"">tumor</span>","_H2aX expression at 10 min and cleaved caspase-3 or -6 at 24 hr after <span class=""chemical"">doxorubicin</span> or docetaxel decreased with increasing distance from <span class=""disease"">tumor</span> blood vessels, with minimal expression in hypoxic regions; maximum reduction in Ki67 levels was observed in regions closest to vasculature at 24 hr.",,24338277,24338277_D004317_D009369,24338277_6,bcv_sentence_task_befree_4903,,770960835,FALSE,finalized,5,8/14/15 22:54,"



",no_relation,1,,C067311,"<span class=""chemical"">docetaxel</span>",D009369,"<span class=""disease"">tumor</span>","_H2aX expression at 10 min and cleaved caspase-3 or -6 at 24 hr after doxorubicin or <span class=""chemical"">docetaxel</span> decreased with increasing distance from <span class=""disease"">tumor</span> blood vessels, with minimal expression in hypoxic regions; maximum reduction in Ki67 levels was observed in regions closest to vasculature at 24 hr.",,24338277,24338277_C067311_D009369,24338277_6,bcv_sentence_task_befree_4904,,770960836,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,1,,D004317,"<span class=""chemical"">doxorubicin</span>",D009369,"<span class=""disease"">tumor</span>","TH-302 given 4 hr before <span class=""chemical"">doxorubicin</span> or docetaxel increased DNA damage and apoptosis throughout the <span class=""disease"">tumor</span> compared to chemotherapy alone.",,24338277,24338277_D004317_D009369,24338277_8,bcv_sentence_task_befree_4905,,770960837,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,0.8017,,C067311,"<span class=""chemical"">docetaxel</span>",D009369,"<span class=""disease"">tumor</span>","TH-302 given 4 hr before doxorubicin or <span class=""chemical"">docetaxel</span> increased DNA damage and apoptosis throughout the <span class=""disease"">tumor</span> compared to chemotherapy alone.",,24338277,24338277_C067311_D009369,24338277_8,bcv_sentence_task_befree_4906,,770960838,FALSE,finalized,5,8/14/15 23:57,"



",no_relation,1,,D004317,"<span class=""chemical"">doxorubicin</span>",D000860,"<span class=""disease"">hypoxic</span>","When given with <span class=""chemical"">doxorubicin</span> or docetaxel, TH-302 complements and enhances anticancer effects in both perivascular and <span class=""disease"">hypoxic</span> regions but also increases toxicity.",,24338277,24338277_D004317_D000860,24338277_9,bcv_sentence_task_befree_4907,,770960839,FALSE,finalized,5,8/15/15 0:04,"



",yes_direct,1,,C067311,"<span class=""chemical"">docetaxel</span>",D064420,"<span class=""disease"">toxicity</span>","When given with doxorubicin or <span class=""chemical"">docetaxel</span>, TH-302 complements and enhances anticancer effects in both perivascular and hypoxic regions but also increases <span class=""disease"">toxicity</span>.",,24338277,24338277_C067311_D064420,24338277_9,bcv_sentence_task_befree_4908,,770960840,FALSE,finalized,5,8/14/15 22:42,"


Only when given with TH-302, making the third answer the best and the first answer the second-best.
",yes_direct,0.8028,,D004317,"<span class=""chemical"">doxorubicin</span>",D064420,"<span class=""disease"">toxicity</span>","When given with <span class=""chemical"">doxorubicin</span> or docetaxel, TH-302 complements and enhances anticancer effects in both perivascular and hypoxic regions but also increases <span class=""disease"">toxicity</span>.",,24338277,24338277_D004317_D064420,24338277_9,bcv_sentence_task_befree_4909,,770960841,FALSE,finalized,5,8/14/15 22:57,"



",no_relation,1,,C067311,"<span class=""chemical"">docetaxel</span>",D000860,"<span class=""disease"">hypoxic</span>","When given with doxorubicin or <span class=""chemical"">docetaxel</span>, TH-302 complements and enhances anticancer effects in both perivascular and <span class=""disease"">hypoxic</span> regions but also increases toxicity.",,24338277,24338277_C067311_D000860,24338277_9,bcv_sentence_task_befree_4910,,770960842,FALSE,finalized,5,8/14/15 23:05,"



",no_relation,1,,D004837,"<span class=""chemical"">epinephrine</span>",D011471,"<span class=""disease"">prostate cancer</span>","Recent reports show that stress inhibits apoptosis in <span class=""disease"">prostate cancer</span> cells via <span class=""chemical"">epinephrine</span>/beta2 adrenergic receptor/PKA/BAD pathway.",,24339759,24339759_D004837_D011471,24339759_2,bcv_sentence_task_befree_4911,,770960843,FALSE,finalized,5,8/15/15 2:30,"



",no_relation,1,,C018511,"<span class=""chemical"">paradichlorobenzene</span>",D009103,"<span class=""disease"">Multiple sclerosis</span>","<span class=""disease"">Multiple sclerosis</span> disease progression and <span class=""chemical"">paradichlorobenzene</span>: a tale of mothballs and toilet cleaner.",,24343157,24343157_C018511_D009103,24343157_0,bcv_sentence_task_befree_4912,,770960844,FALSE,finalized,5,8/15/15 1:00,"



",no_relation,1,,D004317,"<span class=""chemical"">adriamycin</span>",D013274,"<span class=""disease"">gastric cancer</span>","Knockdown of MDR1 increases the sensitivity to <span class=""chemical"">adriamycin</span> in drug resistant <span class=""disease"">gastric cancer</span> cells.",,24377601,24377601_D004317_D013274,24377601_0,bcv_sentence_task_befree_4913,,770960845,FALSE,finalized,5,8/14/15 22:49,"



",no_relation,1,,D000255,"<span class=""chemical"">ATP</span>",D013274,"<span class=""disease"">gastric cancer</span>","Multiple drug resistance 1/P-glycoprotein (MDR1/p-gp) contributes to drug resistance via <span class=""chemical"">ATP</span>-dependent drug efflux pumps and is overexpressed in many solid tumors including <span class=""disease"">gastric cancer</span>.",,24377601,24377601_D000255_D013274,24377601_3,bcv_sentence_task_befree_4914,,770960846,FALSE,finalized,5,8/15/15 1:25,"



",no_relation,1,,D004317,"<span class=""chemical"">ADR/adriamycin</span>",D013274,"<span class=""disease"">gastric cancer</span>","To investigate the role of MDR1 knockdown on drug resistance reversal, we knocked down MDR1 expression using shRNA in drug resistant <span class=""disease"">gastric cancer</span> cells and examined the consequences with regard to <span class=""chemical"">adriamycin</span> (<span class=""chemical"">ADR</span>) accumulation and drug- sensitivity.",,24377601,24377601_D004317_D013274,24377601_4,bcv_sentence_task_befree_4915,,770960847,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,D012293,"<span class=""chemical"">Rifampicin</span>",D014376,"<span class=""disease"">tuberculosis</span>","<span class=""chemical"">Rifampicin</span> mono-resistant <span class=""disease"">tuberculosis</span> in France: a 2005-2010 retrospective cohort analysis.",,24410906,24410906_D012293_D014376,24410906_0,bcv_sentence_task_befree_4916,,770960848,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,0.8181,,D012293,"<span class=""chemical"">Rifampicin</span>",D014376,"<span class=""disease"">tuberculosis</span>","<span class=""chemical"">Rifampicin</span> resistance is a risk factor for poor outcome in <span class=""disease"">tuberculosis</span>.",,24410906,24410906_D012293_D014376,24410906_1,bcv_sentence_task_befree_4917,,770960849,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,1,,D012293,"<span class=""chemical"">Rifampicin</span>",D014376,"<span class=""disease"">TB/tuberculosis</span>","Therefore, we sought to describe the characteristics and management of <span class=""chemical"">Rifampicin</span> monoresistant (RMR) <span class=""disease"">tuberculosis</span> (<span class=""disease"">TB</span>) in France.",,24410906,24410906_D012293_D014376,24410906_2,bcv_sentence_task_befree_4918,,770960850,FALSE,finalized,5,8/15/15 0:09,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D060085,"<span class=""disease"">HIV-coinfection</span>","A standardized questionnaire was used to collect basic demographic data, region of birth, history of TB, <span class=""disease"">HIV-coinfection</span>, <span class=""chemical"">alcohol</span> use, and antituberculosis treatment.",,24410906,24410906_D000431_D060085,24410906_4,bcv_sentence_task_befree_4919,,770960851,FALSE,finalized,5,8/15/15 0:02,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D014376,"<span class=""disease"">TB</span>","A standardized questionnaire was used to collect basic demographic data, region of birth, history of <span class=""disease"">TB</span>, HIV-coinfection, <span class=""chemical"">alcohol</span> use, and antituberculosis treatment.",,24410906,24410906_D000431_D014376,24410906_4,bcv_sentence_task_befree_4920,,770960852,FALSE,finalized,5,8/14/15 23:09,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D060085,"<span class=""disease"">HIV-coinfection</span>","Patient with secondary RMR were more likely to have <span class=""chemical"">alcohol</span> abuse (P = 0.04) and <span class=""disease"">HIV-coinfection</span> (p = 0.04).",,24410906,24410906_D000431_D060085,24410906_8,bcv_sentence_task_befree_4921,,770960853,FALSE,finalized,5,8/15/15 1:49,"



",no_relation,1,,D000431,"<span class=""chemical"">alcohol</span>",D000437,"<span class=""disease"">alcohol abuse</span>","Patient with secondary RMR were more likely to have <span class=""chemical""></span><span class=""disease"">alcohol</span> abuse (P = 0.04) and HIV-coinfection (p = 0.04).",,24410906,24410906_D000431_D000437,24410906_8,bcv_sentence_task_befree_4922,,770960854,FALSE,finalized,5,8/15/15 2:33,"



",no_relation,1,,D014975,"<span class=""chemical"">lutein</span>",D064420,"<span class=""disease"">toxicity</span>","A new dye for vitreoretinal surgery comprised of soluble <span class=""chemical"">lutein</span>/zeaxanthin 1 % and brilliant blue 0.025 % is advantageous compared with other dyes currently used for chromovitrectomy, and showed no signs of <span class=""disease"">toxicity</span> at 1 month of follow-up.",,24441951,24441951_D014975_D064420,24441951_1,bcv_sentence_task_befree_4923,,770960855,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,1,,D014975,"<span class=""chemical"">lutein</span>",D019773,"<span class=""disease"">epiretinal membranes/ERM</span>","To evaluate the feasibility and safety of a dye [soluble <span class=""chemical"">lutein</span>/zeaxanthin (LZ) 1 % and brilliant blue (BB) 0.025 %] for improving removal of vitreous, <span class=""disease"">epiretinal membranes</span> (<span class=""disease"">ERM</span>), and internal limiting membranes (ILM) in humans.",,24441951,24441951_D014975_D019773,24441951_2,bcv_sentence_task_befree_4924,,770960856,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,1,,C006796,"<span class=""chemical"">brilliant blue</span>",D019773,"<span class=""disease"">epiretinal membranes/ERM</span>","To evaluate the feasibility and safety of a dye [soluble lutein/zeaxanthin (LZ) 1 % and <span class=""chemical"">brilliant blue</span> (BB) 0.025 %] for improving removal of vitreous, <span class=""disease"">epiretinal membranes</span> (<span class=""disease"">ERM</span>), and internal limiting membranes (ILM) in humans.",,24441951,24441951_C006796_D019773,24441951_2,bcv_sentence_task_befree_4925,,770960857,FALSE,finalized,5,8/14/15 22:52,"



",no_relation,1,,C005881,"<span class=""chemical"">zeaxanthin</span>",D019773,"<span class=""disease"">epiretinal membranes/ERM</span>","To evaluate the feasibility and safety of a dye [soluble lutein/<span class=""chemical"">zeaxanthin</span> (LZ) 1 % and brilliant blue (BB) 0.025 %] for improving removal of vitreous, <span class=""disease"">epiretinal membranes</span> (<span class=""disease"">ERM</span>), and internal limiting membranes (ILM) in humans.",,24441951,24441951_C005881_D019773,24441951_2,bcv_sentence_task_befree_4926,,770960858,FALSE,finalized,5,8/15/15 1:08,"



",yes_direct,0.5965,,D019438,"<span class=""chemical"">ritonavir</span>",D014082,"<span class=""disease"">fracture</span>","Tenofovir, particularly when given with a <span class=""chemical"">ritonavir</span>-boosted protease inhibitor (rPI), reduces bone mineral density (BMD) and increases bone turnover markers (BTMs), both of which are associated with increased <span class=""disease"">fracture</span> risk.",,24460797,24460797_D019438_D014082,24460797_1,bcv_sentence_task_befree_4927,,770960859,FALSE,finalized,5,8/15/15 1:16,"



",yes_direct,0.4136,,C096918,"<span class=""chemical"">Tenofovir</span>",D014082,"<span class=""disease"">fracture</span>","<span class=""chemical"">Tenofovir</span>, particularly when given with a ritonavir-boosted protease inhibitor (rPI), reduces bone mineral density (BMD) and increases bone turnover markers (BTMs), both of which are associated with increased <span class=""disease"">fracture</span> risk.",,24460797,24460797_C096918_D014082,24460797_1,bcv_sentence_task_befree_4928,,770960860,FALSE,finalized,5,8/14/15 22:41,"



",no_relation,1,,C096918,"<span class=""chemical"">tenofovir</span>",D015658,"<span class=""disease"">HIV-infected</span>","Switching virologically suppressed <span class=""disease"">HIV-infected</span> adults with low BMD taking an rPI from <span class=""chemical"">tenofovir</span> to raltegravir was safe and significantly improved hip and spine BMD and reduced markers of bone turnover over 48 weeks.",,24460797,24460797_C096918_D015658,24460797_13,bcv_sentence_task_befree_4929,,770960861,FALSE,finalized,5,8/15/15 0:08,"



",no_relation,0.6004,,D005680,"<span class=""chemical"">GABA</span>",D003643,"<span class=""disease"">neuronal death</span>","<span class=""chemical"">GABA</span>(A) receptor dephosphorylation followed by internalization is coupled to <span class=""disease"">neuronal death</span> in in vitro ischemia.",,24513087,24513087_D005680_D003643,24513087_0,bcv_sentence_task_befree_4930,,770960862,FALSE,finalized,5,8/14/15 22:49,"



",no_relation,0.8175,,D005680,"<span class=""chemical"">GABA</span>",D007511,"<span class=""disease"">ischemia</span>","<span class=""chemical"">GABA</span>(A) receptor dephosphorylation followed by internalization is coupled to neuronal death in in vitro <span class=""disease"">ischemia</span>.",,24513087,24513087_D005680_D007511,24513087_0,bcv_sentence_task_befree_4931,,770960863,FALSE,finalized,5,8/14/15 22:30,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D000860,"<span class=""disease"">oxygen-glucose deprivation/OGD</span>","Here we report a downregulation of GABA(A) receptor (GABA(A)R) expression, affecting both mRNA and protein levels of GABA(A)R subunits, in hippocampal neurons subjected to <span class=""chemical""></span><span class=""disease"">oxygen</span>-glucose deprivation (<span class=""disease"">OGD</span>), an in vitro model of ischemia.",,24513087,24513087_D010100_D000860,24513087_2,bcv_sentence_task_befree_4932,,770960864,FALSE,finalized,5,8/15/15 0:18,"



",no_relation,1,,D005680,"<span class=""chemical"">GABA</span>",D007511,"<span class=""disease"">ischemia</span>","Here we report a downregulation of <span class=""chemical"">GABA</span>(A) receptor (<span class=""chemical"">GABA</span>(A)R) expression, affecting both mRNA and protein levels of <span class=""chemical"">GABA</span>(A)R subunits, in hippocampal neurons subjected to oxygen-glucose deprivation (OGD), an in vitro model of <span class=""disease"">ischemia</span>.",,24513087,24513087_D005680_D007511,24513087_2,bcv_sentence_task_befree_4933,,770960865,FALSE,finalized,5,8/14/15 23:12,"



",no_relation,1,,D005680,"<span class=""chemical"">GABA</span>",D000860,"<span class=""disease"">oxygen-glucose deprivation/OGD</span>","Here we report a downregulation of <span class=""chemical"">GABA</span>(A) receptor (<span class=""chemical"">GABA</span>(A)R) expression, affecting both mRNA and protein levels of <span class=""chemical"">GABA</span>(A)R subunits, in hippocampal neurons subjected to <span class=""disease"">oxygen-glucose deprivation</span> (<span class=""disease"">OGD</span>), an in vitro model of ischemia.",,24513087,24513087_D005680_D000860,24513087_2,bcv_sentence_task_befree_4934,,770960866,FALSE,finalized,5,8/15/15 2:01,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D000860,"<span class=""disease"">oxygen-glucose deprivation/OGD</span>","Here we report a downregulation of GABA(A) receptor (GABA(A)R) expression, affecting both mRNA and protein levels of GABA(A)R subunits, in hippocampal neurons subjected to <span class=""disease"">oxygen-</span><span class=""chemical"">glucose</span> deprivation (<span class=""disease"">OGD</span>), an in vitro model of ischemia.",,24513087,24513087_D005947_D000860,24513087_2,bcv_sentence_task_befree_4935,,770960867,FALSE,finalized,5,8/14/15 23:25,"


It's 'oxygen-glucose deprivation' and not just 'Glucose'
",no_relation,0.8006,,D005947,"<span class=""chemical"">glucose</span>",D007511,"<span class=""disease"">ischemia</span>","Here we report a downregulation of GABA(A) receptor (GABA(A)R) expression, affecting both mRNA and protein levels of GABA(A)R subunits, in hippocampal neurons subjected to oxygen-<span class=""chemical"">glucose</span> deprivation (OGD), an in vitro model of <span class=""disease"">ischemia</span>.",,24513087,24513087_D005947_D007511,24513087_2,bcv_sentence_task_befree_4936,,770960868,FALSE,finalized,5,8/15/15 1:54,"



",no_relation,1,,D010100,"<span class=""chemical"">oxygen</span>",D007511,"<span class=""disease"">ischemia</span>","Here we report a downregulation of GABA(A) receptor (GABA(A)R) expression, affecting both mRNA and protein levels of GABA(A)R subunits, in hippocampal neurons subjected to <span class=""chemical"">oxygen</span>-glucose deprivation (OGD), an in vitro model of <span class=""disease"">ischemia</span>.",,24513087,24513087_D010100_D007511,24513087_2,bcv_sentence_task_befree_4937,,770960869,FALSE,finalized,5,8/14/15 23:17,"



",no_relation,1,,D005680,"<span class=""chemical"">GABA</span>",D002545,"<span class=""disease"">brain ischemia</span>","Similar alterations in the abundance of <span class=""chemical"">GABA</span>(A)R subunits were observed in in vivo <span class=""disease"">brain ischemia</span>.",,24513087,24513087_D005680_D002545,24513087_3,bcv_sentence_task_befree_4938,,770960870,FALSE,finalized,5,8/15/15 0:03,"



",no_relation,1,,D005680,"<span class=""chemical"">GABA</span>",D000860,"<span class=""disease"">OGD</span>","<span class=""disease"">OGD</span> reduced the interaction of surface <span class=""chemical"">GABA</span>(A)R with the scaffold protein gephyrin, followed by clathrin-dependent receptor internalization.",,24513087,24513087_D005680_D000860,24513087_4,bcv_sentence_task_befree_4939,,770960871,FALSE,finalized,5,8/15/15 1:40,"



",no_relation,1,,D005680,"<span class=""chemical"">GABA</span>",D007511,"<span class=""disease"">ischemic</span>","Expression of phospho-mimetic mutant <span class=""chemical"">GABA</span>(A)R _3 subunits prevented receptor internalization and protected hippocampal neurons from <span class=""disease"">ischemic</span> cell death.",,24513087,24513087_D005680_D007511,24513087_6,bcv_sentence_task_befree_4940,,770960872,FALSE,finalized,5,8/15/15 1:15,"



",yes_direct,0.5932,,D005680,"<span class=""chemical"">GABA</span>",D003643,"<span class=""disease"">neuronal death</span>","The results show a key role for _3 <span class=""chemical"">GABA</span>(A)R subunit dephosphorylation in the downregulation of GABAergic synaptic transmission in brain ischemia, contributing to <span class=""disease"">neuronal death</span>.",,24513087,24513087_D005680_D003643,24513087_7,bcv_sentence_task_befree_4941,,770960873,FALSE,finalized,5,8/14/15 23:13,"


'_3 GABA(A)R subunit' and not just 'GABA'
",no_relation,0.5885,,D005680,"<span class=""chemical"">GABA</span>",D002545,"<span class=""disease"">brain ischemia</span>","The results show a key role for _3 <span class=""chemical"">GABA</span>(A)R subunit dephosphorylation in the downregulation of GABAergic synaptic transmission in <span class=""disease"">brain ischemia</span>, contributing to neuronal death.",,24513087,24513087_D005680_D002545,24513087_7,bcv_sentence_task_befree_4942,,770960874,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,D005680,"<span class=""chemical"">GABA</span>",D002545,"<span class=""disease"">brain ischemia</span>","<span class=""chemical"">GABA</span>(A)R phosphorylation might be a therapeutic target to preserve synaptic inhibition in <span class=""disease"">brain ischemia</span>.",,24513087,24513087_D005680_D002545,24513087_8,bcv_sentence_task_befree_4943,,770960875,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,C045645,"<span class=""chemical"">cilostazol</span>",D008209,"<span class=""disease"">lymphedema</span>","In this study, we investigated whether <span class=""chemical"">cilostazol</span> has the potential to proliferate lymphatic vessels and to improve lymphatic function using human lymphatic endothelial cells (LECs) and mouse <span class=""disease"">lymphedema</span> models.",,24517869,24517869_C045645_D008209,24517869_3,bcv_sentence_task_befree_4944,,770960876,FALSE,finalized,5,8/14/15 22:36,"



",no_relation,0.6165,,C045645,"<span class=""chemical"">cilostazol</span>",D008209,"<span class=""disease"">lymphedema</span>","After oral administration of <span class=""chemical"">cilostazol</span>, tail <span class=""disease"">lymphedema</span> was examined in this mouse model.",,24517869,24517869_C045645_D008209,24517869_7,bcv_sentence_task_befree_4945,,770960877,FALSE,finalized,5,8/15/15 0:25,"



",no_relation,1,,C045645,"<span class=""chemical"">cilostazol</span>",D008209,"<span class=""disease"">lymphedema</span>","Oral administration of <span class=""chemical"">cilostazol</span> also decreased <span class=""disease"">lymphedema</span> in a tail of wild type mice.",,24517869,24517869_C045645_D008209,24517869_11,bcv_sentence_task_befree_4946,,770960878,FALSE,finalized,5,8/14/15 23:05,"



",no_relation,0.8069,,C045645,"<span class=""chemical"">Cilostazol</span>",D008209,"<span class=""disease"">lymphedema</span>","<span class=""chemical"">Cilostazol</span> promoted growth of human LECs and improved lymph flow and <span class=""disease"">lymphedema</span> in two different mouse <span class=""disease"">lymphedema</span> models.",,24517869,24517869_C045645_D008209,24517869_12,bcv_sentence_task_befree_4947,,770960879,FALSE,finalized,5,8/14/15 23:40,"



",no_relation,1,,C045645,"<span class=""chemical"">cilostazol</span>",D008209,"<span class=""disease"">lymphedema</span>","These results suggest that <span class=""chemical"">cilostazol</span> would be a promising agent for the treatment of <span class=""disease"">lymphedema</span>.",,24517869,24517869_C045645_D008209,24517869_13,bcv_sentence_task_befree_4948,,770960880,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,0.8002,,C445361,"<span class=""chemical"">Restylane</span>",D004342,"<span class=""disease"">hypersensitivity</span>","No inflammatory or <span class=""disease"">hypersensitivity</span> reactions to <span class=""chemical"">Restylane</span> occurred.",,24529939,24529939_C445361_D004342,24529939_9,bcv_sentence_task_befree_4949,,770960881,FALSE,finalized,5,8/14/15 22:56,"



",no_relation,1,,C445361,"<span class=""chemical"">Restylane</span>",D004342,"<span class=""disease"">hypersensitivity</span>","This represents the largest series to date using <span class=""chemical"">Restylane</span> and no <span class=""disease"">hypersensitivity</span> or granulomatous reactions were observed.",,24529939,24529939_C445361_D004342,24529939_12,bcv_sentence_task_befree_4950,,770960882,FALSE,finalized,5,8/14/15 22:49,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D008659,"<span class=""disease"">metabolic syndrome</span>","The broad-ranging effects of FXE may be due to a unique compositional profile that could be useful to prevent the <span class=""disease"">metabolic syndrome</span>, characterized by obesity, insulin resistance, <span class=""chemical"">glucose</span> intolerance, hypertriglyceridemia and elevated blood pressure.",,24573510,24573510_D005947_D008659,24573510_7,bcv_sentence_task_befree_4951,,770960883,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D009765,"<span class=""disease"">obesity</span>","The broad-ranging effects of FXE may be due to a unique compositional profile that could be useful to prevent the metabolic syndrome, characterized by <span class=""disease"">obesity</span>, insulin resistance, <span class=""chemical"">glucose</span> intolerance, hypertriglyceridemia and elevated blood pressure.",,24573510,24573510_D005947_D009765,24573510_7,bcv_sentence_task_befree_4952,,770960884,FALSE,finalized,5,8/14/15 22:44,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D015228,"<span class=""disease"">hypertriglyceridemia</span>","The broad-ranging effects of FXE may be due to a unique compositional profile that could be useful to prevent the metabolic syndrome, characterized by obesity, insulin resistance, <span class=""chemical"">glucose</span> intolerance, <span class=""disease"">hypertriglyceridemia</span> and elevated blood pressure.",,24573510,24573510_D005947_D015228,24573510_7,bcv_sentence_task_befree_4953,,770960885,FALSE,finalized,5,8/14/15 23:54,"



",no_relation,0.8205,,D005947,"<span class=""chemical"">glucose</span>",D018149,"<span class=""disease"">glucose intolerance</span>","The broad-ranging effects of FXE may be due to a unique compositional profile that could be useful to prevent the metabolic syndrome, characterized by obesity, insulin resistance, <span class=""chemical""></span><span class=""disease"">glucose</span> intolerance, hypertriglyceridemia and elevated blood pressure.",,24573510,24573510_D005947_D018149,24573510_7,bcv_sentence_task_befree_4954,,770960886,FALSE,finalized,5,8/14/15 22:47,"



",no_relation,1,,D003907,"<span class=""chemical"">dexamethasone</span>",D020434,"<span class=""disease"">alveolar nerve</span>","A solution of <span class=""chemical"">dexamethasone</span> 4 mg/1 mL was drawn into a syringe and poured directly on the distal segment of the exposed inferior <span class=""disease"">alveolar nerve</span> during splitting and 1 mL was poured on the same nerve immediately before the start of fixation.",,24576440,24576440_D003907_D020434,24576440_6,bcv_sentence_task_befree_4955,,770960887,FALSE,finalized,5,8/15/15 2:42,"



",no_relation,1,,D003907,"<span class=""chemical"">dexamethasone</span>",D020434,"<span class=""disease"">alveolar nerve</span>","Local application of <span class=""chemical"">dexamethasone</span> on the exposed inferior <span class=""disease"">alveolar nerve</span> during BSSO is not recommended.",,24576440,24576440_D003907_D020434,24576440_10,bcv_sentence_task_befree_4956,,770960888,FALSE,finalized,5,8/14/15 22:43,"



",yes_direct,1,,D001241,"<span class=""chemical"">aspirin</span>",D012141,"<span class=""disease"">respiratory disease</span>","Clinical course of patients with <span class=""chemical"">aspirin</span>-exacerbated <span class=""disease"">respiratory disease</span>: can we predict the prognosis?",,24624912,24624912_D001241_D012141,24624912_0,bcv_sentence_task_befree_4957,,770960889,FALSE,finalized,5,8/14/15 23:33,"



",no_relation,0.6079,,D001241,"<span class=""chemical"">aspirin</span>",D012141,"<span class=""disease"">respiratory disease</span>","This study aimed to identify prognostic factors of <span class=""chemical"">aspirin</span>-exacerbated <span class=""disease"">respiratory disease</span> by comparing clinical and genetic data with the clinical course.",,24624912,24624912_D001241_D012141,24624912_1,bcv_sentence_task_befree_4958,,770960890,FALSE,finalized,5,8/15/15 1:06,"



",yes_direct,0.7883,,D001241,"<span class=""chemical"">aspirin</span>",D012141,"<span class=""disease"">respiratory disease</span>","Baseline FEV and lower lung function after treatment were clinical factors indicating a poor prognosis of <span class=""chemical"">aspirin</span>-exacerbated <span class=""disease"">respiratory disease</span>.",,24624912,24624912_D001241_D012141,24624912_6,bcv_sentence_task_befree_4959,,770960891,FALSE,finalized,5,8/14/15 23:30,"



",yes_direct,0.6118,,D001241,"<span class=""chemical"">aspirin</span>",D008171,"<span class=""disease"">lower lung function</span>","Baseline FEV and <span class=""disease"">lower lung function</span> after treatment were clinical factors indicating a poor prognosis of <span class=""chemical"">aspirin</span>-exacerbated respiratory disease.",,24624912,24624912_D001241_D008171,24624912_6,bcv_sentence_task_befree_4960,,770960892,FALSE,finalized,5,8/15/15 2:14,"



",yes_direct,0.8137,,D001241,"<span class=""chemical"">aspirin</span>",D004342,"<span class=""disease"">bronchial hypersensitivity</span>","The G allele of CCR3 -520T>G was associated with persistent <span class=""disease"">bronchial hypersensitivity</span> to <span class=""chemical"">aspirin</span>.",,24624912,24624912_D001241_D004342,24624912_7,bcv_sentence_task_befree_4961,,770960893,FALSE,finalized,5,8/14/15 22:42,"



",no_relation,0.7963,,C055162,"<span class=""chemical"">clopidogrel</span>",D034381,"<span class=""disease"">Decreased MAADP</span>","<span class=""disease"">Decreased MAADP</span> (odds ratio [OR] 0.94), increased percent inhibition of platelets by <span class=""chemical"">clopidogrel</span> (OR 1.03), and lower body mass index (BMI) (OR 0.78) were significantly associated with elevated CTD.",,24630471,24630471_C055162_D034381,24630471_10,bcv_sentence_task_befree_4962,,770960894,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D015282,"<span class=""chemical"">octreotide</span>",D002915,"<span class=""disease"">Chylous ascites</span>","<span class=""disease"">Chylous ascites</span> after a living-donor liver graft, effectively treated in a child with <span class=""chemical"">octreotide</span>.",,24635821,24635821_D015282_D002915,24635821_0,bcv_sentence_task_befree_4963,,770960895,FALSE,finalized,5,8/15/15 1:47,"



",no_relation,1,,D004164,"<span class=""chemical"">bisphosphonates</span>",D009362,"<span class=""disease"">metastasis</span>","Medical treatment of breast cancer bone <span class=""disease"">metastasis</span>: from <span class=""chemical"">bisphosphonates</span> to targeted drugs.",,24641358,24641358_D004164_D009362,24641358_0,bcv_sentence_task_befree_4964,,770960896,FALSE,finalized,5,8/14/15 22:40,"



",no_relation,1,,D004164,"<span class=""chemical"">bisphosphonates</span>",D009369,"<span class=""disease"">breast cancer</span>","Medical treatment of <span class=""disease"">breast cancer</span> bone metastasis: from <span class=""chemical"">bisphosphonates</span> to targeted drugs.",,24641358,24641358_D004164_D009369,24641358_0,bcv_sentence_task_befree_4965,,770960897,FALSE,finalized,5,8/14/15 22:52,"



",yes_direct,0.8138,,D002945,"<span class=""chemical"">cisplatin</span>",D004487,"<span class=""disease"">apoptotic cytotoxicity</span>","In lung cancer cells, knockdown of RIP1 substantially increased <span class=""chemical"">cisplatin</span>-induced <span class=""disease"">apoptotic cytotoxicity</span>, which was associated with robust JNK activation.",,24675421,24675421_D002945_D004487,24675421_3,bcv_sentence_task_befree_4966,,770960898,FALSE,finalized,5,8/15/15 0:02,"



",no_relation,0.6242,,D002945,"<span class=""chemical"">cisplatin</span>",D008175,"<span class=""disease"">lung cancer</span>","In <span class=""disease"">lung cancer</span> cells, knockdown of RIP1 substantially increased <span class=""chemical"">cisplatin</span>-induced apoptotic cytotoxicity, which was associated with robust JNK activation.",,24675421,24675421_D002945_D008175,24675421_3,bcv_sentence_task_befree_4967,,770960899,FALSE,finalized,5,8/14/15 23:05,"



",yes_direct,0.5937,,D002945,"<span class=""chemical"">cisplatin</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Knockdown of miR-940 restored MKP1 expression and attenuated <span class=""chemical"">cisplatin</span>-induced JNK activation and <span class=""disease"">cytotoxicity</span>.",,24675421,24675421_D002945_D004487,24675421_7,bcv_sentence_task_befree_4968,,770960900,FALSE,finalized,5,8/14/15 22:32,"



",yes_direct,0.607,,D002945,"<span class=""chemical"">cisplatin</span>",D004487,"<span class=""disease"">cytotoxicity</span>","Importantly, ectopic expression of MKP1 effectively attenuated <span class=""chemical"">cisplatin</span>-induced JNK activation and <span class=""disease"">cytotoxicity</span>.",,24675421,24675421_D002945_D004487,24675421_8,bcv_sentence_task_befree_4969,,770960901,FALSE,finalized,5,8/15/15 2:23,"



",no_relation,1,,D000111,"<span class=""chemical"">NAC/N-acetylcysteine</span>",D019966,"<span class=""disease"">substance abuse disorders</span>","To conduct the first systematic literature review of clinical trials of <span class=""chemical"">N-acetylcysteine</span> (<span class=""chemical"">NAC</span>) for the treatment of <span class=""disease"">substance abuse disorders</span> and addictive behaviors.",,24676047,24676047_D000111_D019966,24676047_1,bcv_sentence_task_befree_4970,,770960902,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D000111,"<span class=""chemical"">NAC/N-acetylcysteine</span>",D001523,"<span class=""disease"">addictive behaviors</span>","To conduct the first systematic literature review of clinical trials of <span class=""chemical"">N-acetylcysteine</span> (<span class=""chemical"">NAC</span>) for the treatment of substance abuse disorders and <span class=""disease"">addictive behaviors</span>.",,24676047,24676047_D000111_D001523,24676047_1,bcv_sentence_task_befree_4971,,770960903,FALSE,finalized,5,8/15/15 1:11,"



",no_relation,1,,D000111,"<span class=""chemical"">NAC</span>",D001523,"<span class=""disease"">addictive behaviors</span>","The inclusion criteria for the review were clinical trials that used <span class=""chemical"">NAC</span> in the treatment of a disorder related to substance use and/or <span class=""disease"">addictive behaviors</span>, limited to texts in English, Spanish, or French.",,24676047,24676047_D000111_D001523,24676047_3,bcv_sentence_task_befree_4972,,770960904,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,1,,D003042,"<span class=""chemical"">cocaine</span>",D002189,"<span class=""disease"">cannabis dependence</span>","These studies evaluated the role of NAC in <span class=""chemical"">cocaine</span> dependence (three studies), <span class=""disease"">cannabis dependence</span> (two studies), nicotine dependence (two studies), methamphetamine addiction (one study), and pathological gambling (one study).",,24676047,24676047_D003042_D002189,24676047_6,bcv_sentence_task_befree_4973,,770960905,FALSE,finalized,5,8/15/15 2:57,"



",no_relation,1,,D000111,"<span class=""chemical"">NAC</span>",D009293,"<span class=""disease"">addiction</span>","These studies evaluated the role of <span class=""chemical"">NAC</span> in cocaine dependence (three studies), cannabis dependence (two studies), nicotine dependence (two studies), methamphetamine <span class=""disease"">addiction</span> (one study), and pathological gambling (one study).",,24676047,24676047_D000111_D009293,24676047_6,bcv_sentence_task_befree_4974,,770960906,FALSE,finalized,5,8/14/15 23:37,"

Both terms being part of different diseases

",no_relation,1,,D008694,"<span class=""chemical"">methamphetamine</span>",D005715,"<span class=""disease"">pathological gambling</span>","These studies evaluated the role of NAC in cocaine dependence (three studies), cannabis dependence (two studies), nicotine dependence (two studies), <span class=""chemical"">methamphetamine</span> addiction (one study), and <span class=""disease"">pathological gambling</span> (one study).",,24676047,24676047_D008694_D005715,24676047_6,bcv_sentence_task_befree_4975,,770960907,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,1,,D008694,"<span class=""chemical"">methamphetamine</span>",D002189,"<span class=""disease"">cannabis dependence</span>","These studies evaluated the role of NAC in cocaine dependence (three studies), <span class=""disease"">cannabis dependence</span> (two studies), nicotine dependence (two studies), <span class=""chemical"">methamphetamine</span> addiction (one study), and pathological gambling (one study).",,24676047,24676047_D008694_D002189,24676047_6,bcv_sentence_task_befree_4976,,770960908,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,0.8045,,D009538,"<span class=""chemical"">nicotine</span>",D019966,"<span class=""disease"">dependence</span>","These studies evaluated the role of NAC in cocaine <span class=""disease"">dependence</span> (three studies), cannabis dependence (two studies), <span class=""chemical"">nicotine</span> <span class=""disease"">dependence</span> (two studies), methamphetamine addiction (one study), and pathological gambling (one study).",,24676047,24676047_D009538_D019966,24676047_6,bcv_sentence_task_befree_4977,,770960909,FALSE,finalized,5,8/14/15 23:42,"



There might be a connection, abstract is suspenseful.",no_relation,0.6092,,D000111,"<span class=""chemical"">NAC</span>",D005715,"<span class=""disease"">pathological gambling</span>","These studies evaluated the role of <span class=""chemical"">NAC</span> in cocaine dependence (three studies), cannabis dependence (two studies), nicotine dependence (two studies), methamphetamine addiction (one study), and <span class=""disease"">pathological gambling</span> (one study).",,24676047,24676047_D000111_D005715,24676047_6,bcv_sentence_task_befree_4978,,770960910,FALSE,finalized,5,8/15/15 2:29,"



",no_relation,1,,D003042,"<span class=""chemical"">cocaine</span>",D005715,"<span class=""disease"">pathological gambling</span>","These studies evaluated the role of NAC in <span class=""chemical"">cocaine</span> dependence (three studies), cannabis dependence (two studies), nicotine dependence (two studies), methamphetamine addiction (one study), and <span class=""disease"">pathological gambling</span> (one study).",,24676047,24676047_D003042_D005715,24676047_6,bcv_sentence_task_befree_4979,,770960911,FALSE,finalized,5,8/14/15 23:53,"



",no_relation,0.8096,,D000111,"<span class=""chemical"">NAC</span>",D019966,"<span class=""disease"">dependence</span>","These studies evaluated the role of <span class=""chemical"">NAC</span> in cocaine <span class=""disease"">dependence</span> (three studies), cannabis dependence (two studies), nicotine <span class=""disease"">dependence</span> (two studies), methamphetamine addiction (one study), and pathological gambling (one study).",,24676047,24676047_D000111_D019966,24676047_6,bcv_sentence_task_befree_4980,,770960912,FALSE,finalized,5,8/15/15 1:58,"



",no_relation,1,,D009538,"<span class=""chemical"">nicotine</span>",D002189,"<span class=""disease"">cannabis dependence</span>","These studies evaluated the role of NAC in cocaine dependence (three studies), <span class=""disease"">cannabis dependence</span> (two studies), <span class=""chemical"">nicotine</span> dependence (two studies), methamphetamine addiction (one study), and pathological gambling (one study).",,24676047,24676047_D009538_D002189,24676047_6,bcv_sentence_task_befree_4981,,770960913,FALSE,finalized,5,8/14/15 23:15,"



",no_relation,1,,D003042,"<span class=""chemical"">cocaine</span>",D009293,"<span class=""disease"">addiction</span>","These studies evaluated the role of NAC in <span class=""chemical"">cocaine</span> dependence (three studies), cannabis dependence (two studies), nicotine dependence (two studies), methamphetamine <span class=""disease"">addiction</span> (one study), and pathological gambling (one study).",,24676047,24676047_D003042_D009293,24676047_6,bcv_sentence_task_befree_4982,,770960914,FALSE,finalized,5,8/15/15 0:59,"



",no_relation,0.8102,,D000111,"<span class=""chemical"">NAC</span>",D002189,"<span class=""disease"">cannabis dependence</span>","These studies evaluated the role of <span class=""chemical"">NAC</span> in cocaine dependence (three studies), <span class=""disease"">cannabis dependence</span> (two studies), nicotine dependence (two studies), methamphetamine addiction (one study), and pathological gambling (one study).",,24676047,24676047_D000111_D002189,24676047_6,bcv_sentence_task_befree_4983,,770960915,FALSE,finalized,5,8/14/15 23:37,"



",no_relation,0.8105,,D008694,"<span class=""chemical"">methamphetamine</span>",D019966,"<span class=""disease"">dependence</span>","These studies evaluated the role of NAC in cocaine <span class=""disease"">dependence</span> (three studies), cannabis dependence (two studies), nicotine <span class=""disease"">dependence</span> (two studies), <span class=""chemical"">methamphetamine</span> addiction (one study), and pathological gambling (one study).",,24676047,24676047_D008694_D019966,24676047_6,bcv_sentence_task_befree_4984,,770960916,FALSE,finalized,5,8/14/15 23:35,"



",no_relation,1,,D009538,"<span class=""chemical"">nicotine</span>",D005715,"<span class=""disease"">pathological gambling</span>","These studies evaluated the role of NAC in cocaine dependence (three studies), cannabis dependence (two studies), <span class=""chemical"">nicotine</span> dependence (two studies), methamphetamine addiction (one study), and <span class=""disease"">pathological gambling</span> (one study).",,24676047,24676047_D009538_D005715,24676047_6,bcv_sentence_task_befree_4985,,770960917,FALSE,finalized,5,8/14/15 22:31,"



",no_relation,0.6048,,D009538,"<span class=""chemical"">nicotine</span>",D009293,"<span class=""disease"">addiction</span>","These studies evaluated the role of NAC in cocaine dependence (three studies), cannabis dependence (two studies), <span class=""chemical"">nicotine</span> dependence (two studies), methamphetamine <span class=""disease"">addiction</span> (one study), and pathological gambling (one study).",,24676047,24676047_D009538_D009293,24676047_6,bcv_sentence_task_befree_4986,,770960918,FALSE,finalized,5,8/14/15 23:17,"



",yes_direct,0.781,,D003042,"<span class=""chemical"">cocaine</span>",D019966,"<span class=""disease"">dependence</span>","These studies evaluated the role of NAC in <span class=""chemical"">cocaine</span> <span class=""disease"">dependence</span> (three studies), cannabis dependence (two studies), nicotine <span class=""disease"">dependence</span> (two studies), methamphetamine addiction (one study), and pathological gambling (one study).",,24676047,24676047_D003042_D019966,24676047_6,bcv_sentence_task_befree_4987,,770960919,FALSE,finalized,5,8/14/15 23:03,"



",yes_direct,0.7896,,D008694,"<span class=""chemical"">methamphetamine</span>",D009293,"<span class=""disease"">addiction</span>","These studies evaluated the role of NAC in cocaine dependence (three studies), cannabis dependence (two studies), nicotine dependence (two studies), <span class=""chemical"">methamphetamine</span> <span class=""disease"">addiction</span> (one study), and pathological gambling (one study).",,24676047,24676047_D008694_D009293,24676047_6,bcv_sentence_task_befree_4988,,770960920,FALSE,finalized,5,8/15/15 2:13,"



",no_relation,1,,D000111,"<span class=""chemical"">NAC</span>",D002189,"<span class=""disease"">cannabis dependence</span>","The studies analyzed suggest a potential role for <span class=""chemical"">NAC</span> in the treatment of addiction, especially of cocaine and <span class=""disease"">cannabis dependence</span>.",,24676047,24676047_D000111_D002189,24676047_8,bcv_sentence_task_befree_4989,,770960921,FALSE,finalized,5,8/14/15 22:43,"



",no_relation,1,,D003042,"<span class=""chemical"">cocaine</span>",D002189,"<span class=""disease"">cannabis dependence</span>","The studies analyzed suggest a potential role for NAC in the treatment of addiction, especially of <span class=""chemical"">cocaine</span> and <span class=""disease"">cannabis dependence</span>.",,24676047,24676047_D003042_D002189,24676047_8,bcv_sentence_task_befree_4990,,770960922,FALSE,finalized,5,8/15/15 1:45,"



",no_relation,1,,D000111,"<span class=""chemical"">NAC</span>",D009293,"<span class=""disease"">addiction</span>","The studies analyzed suggest a potential role for <span class=""chemical"">NAC</span> in the treatment of <span class=""disease"">addiction</span>, especially of cocaine and cannabis dependence.",,24676047,24676047_D000111_D009293,24676047_8,bcv_sentence_task_befree_4991,,770960923,FALSE,finalized,5,8/14/15 23:51,"



",yes_direct,0.6075,,D003042,"<span class=""chemical"">cocaine</span>",D009293,"<span class=""disease"">addiction</span>","The studies analyzed suggest a potential role for NAC in the treatment of <span class=""disease"">addiction</span>, especially of <span class=""chemical"">cocaine</span> and cannabis dependence.",,24676047,24676047_D003042_D009293,24676047_8,bcv_sentence_task_befree_4992,,770960924,FALSE,finalized,5,8/15/15 1:11,"



",no_relation,1,,D014640,"<span class=""chemical"">vancomycin</span>",D016470,"<span class=""disease"">bacteremia</span>","Identification of temporal clusters and risk factors of <span class=""disease"">bacteremia</span> by nosocomial <span class=""chemical"">vancomycin</span>-resistant enterococci.",,24679566,24679566_D014640_D016470,24679566_0,bcv_sentence_task_befree_4993,,770960925,FALSE,finalized,5,8/15/15 1:34,"



",no_relation,1,,D014640,"<span class=""chemical"">vancomycin</span>",D016470,"<span class=""disease"">bacteremia</span>","This study aimed to evaluate a different methodology for addressing the evolution of nosocomial <span class=""disease"">bacteremia</span> by <span class=""chemical"">vancomycin</span>-resistant enterococci (VRE) in a hospital setting.",,24679566,24679566_D014640_D016470,24679566_1,bcv_sentence_task_befree_4994,,770960926,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,0.58,,D014640,"<span class=""chemical"">vancomycin</span>",D016470,"<span class=""disease"">bacteremia</span>","Thirty cases of VRE <span class=""disease"">bacteremia</span> and 274 cases of <span class=""chemical"">vancomycin</span>-susceptible enterococci (VSE) <span class=""disease"">bacteremia</span> were identified.",,24679566,24679566_D014640_D016470,24679566_3,bcv_sentence_task_befree_4995,,770960927,FALSE,finalized,5,8/15/15 1:18,"



",no_relation,1,,C548956,"<span class=""chemical"">paliperidone palmitate</span>",D006212,"<span class=""disease"">hallucinations</span>","Our study suggests that risperidone long-acting injection and <span class=""chemical"">paliperidone palmitate</span> long-acting injection may be useful in the treatment of DD patients, specifically those with nonprominent <span class=""disease"">hallucinations</span>.",,24681811,24681811_C548956_D006212,24681811_11,bcv_sentence_task_befree_4996,,770960928,FALSE,finalized,5,8/15/15 1:14,"



",no_relation,1,,D018967,"<span class=""chemical"">risperidone</span>",D006212,"<span class=""disease"">hallucinations</span>","Our study suggests that <span class=""chemical"">risperidone</span> long-acting injection and paliperidone palmitate long-acting injection may be useful in the treatment of DD patients, specifically those with nonprominent <span class=""disease"">hallucinations</span>.",,24681811,24681811_D018967_D006212,24681811_11,bcv_sentence_task_befree_4997,,770960929,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,0.7869,,D005947,"<span class=""chemical"">glucose</span>",D003929,"<span class=""disease"">diabetes</span>","We assessed the impact of using an automated bolus advisor integrated into a blood <span class=""chemical"">glucose</span> meter on the timing and frequency of adjusting insulin therapy parameter settings and whether the availability of this technology would increase blood <span class=""chemical"">glucose</span> test strip utilization in <span class=""disease"">diabetes</span> patients treated with multiple daily insulin injection (MDI) therapy.",,24716820,24716820_D005947_D003929,24716820_1,bcv_sentence_task_befree_4998,,770960930,FALSE,finalized,5,8/15/15 1:43,"



",no_relation,1,,D005947,"<span class=""chemical"">glucose</span>",D020773,"<span class=""disease"">multiple daily insulin injection/MDI</span>","We assessed the impact of using an automated bolus advisor integrated into a blood <span class=""chemical"">glucose</span> meter on the timing and frequency of adjusting insulin therapy parameter settings and whether the availability of this technology would increase blood <span class=""chemical"">glucose</span> test strip utilization in diabetes patients treated with <span class=""disease"">multiple daily insulin injection</span> (<span class=""disease"">MDI</span>) therapy.",,24716820,24716820_D005947_D020773,24716820_1,bcv_sentence_task_befree_4999,,770960931,FALSE,finalized,5,8/14/15 23:13,"


Used as treatment.
",no_relation,1,,C056493,"<span class=""chemical"">imiquimod</span>",D018327,"<span class=""disease"">LM</span>","Reflectance confocal microscopy (RCM) is a noninvasive method that has not been validated for monitoring the treatment of <span class=""disease"">LM</span> with <span class=""chemical"">imiquimod</span>.",,24725478,24725478_C056493_D018327,24725478_2,bcv_sentence_task_befree_5000,,770960932,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,1,,C056493,"<span class=""chemical"">imiquimod</span>",D018327,"<span class=""disease"">LM</span>","We sought to evaluate the use of invivo RCM to accurately monitor the response of <span class=""disease"">LM</span> to nonsurgical treatment with topical <span class=""chemical"">imiquimod</span>.",,24725478,24725478_C056493_D018327,24725478_3,bcv_sentence_task_befree_5001,,770960933,FALSE,finalized,5,8/14/15 22:53,"



",no_relation,1,,C056493,"<span class=""chemical"">imiquimod</span>",D018327,"<span class=""disease"">LM</span>","Invivo RCM evaluation was useful in accurately monitoring the response of <span class=""disease"">LM</span> to nonsurgical treatment with topical <span class=""chemical"">imiquimod</span> in patients when surgery is contraindicated.",,24725478,24725478_C056493_D018327,24725478_11,bcv_sentence_task_befree_5002,,770960934,FALSE,finalized,5,8/15/15 0:46,"



",no_relation,1,,C097613,"<span class=""chemical"">imatinib</span>",D046152,"<span class=""disease"">Gastrointestinal stromal tumor</span>","A PubMed search using the phrases '<span class=""disease"">Gastrointestinal stromal tumor</span>', '<span class=""chemical"">imatinib</span>', 'c-kit'.",,24749828,24749828_C097613_D046152,24749828_3,bcv_sentence_task_befree_5003,,770960935,FALSE,finalized,5,8/15/15 1:23,"



",no_relation,1,,D014859,"<span class=""chemical"">warfarin</span>",D011183,"<span class=""disease"">postoperative complications</span>","Three groups: continuation (CW), discontinuation (DW) and case-matched control (C) not on <span class=""chemical"">warfarin</span> therapy were compared for operative details and <span class=""disease"">postoperative complications</span>.",,24756918,24756918_D014859_D011183,24756918_5,bcv_sentence_task_befree_5004,,770960936,FALSE,finalized,5,8/14/15 22:58,"

Used theraputically.

",no_relation,0.5918,,D014859,"<span class=""chemical"">warfarin</span>",D011183,"<span class=""disease"">postoperative complications</span>","Maintenance of <span class=""chemical"">warfarin</span> therapy during the perioperative period for open inguinal herniorrhaphy results in equivalent operative times and <span class=""disease"">postoperative complications</span> as discontinuation.",,24756918,24756918_D014859_D011183,24756918_12,bcv_sentence_task_befree_5005,,770960937,FALSE,finalized,5,8/15/15 0:01,"



",no_relation,1,,C076946,"<span class=""chemical"">donepezil</span>",D000544,"<span class=""disease"">Alzheimer's disease</span>","Drugs that are used to treat <span class=""disease"">Alzheimer's disease</span> include the acetyl cholinesterase inhibitors (ACHIs) <span class=""chemical"">donepezil</span>, rivastigmine and galantamine and the NMDA receptor antagonist memantine.",,24777654,24777654_C076946_D000544,24777654_1,bcv_sentence_task_befree_5006,,770960938,FALSE,finalized,5,8/15/15 1:43,"



",no_relation,1,,D005702,"<span class=""chemical"">galantamine</span>",D000544,"<span class=""disease"">Alzheimer's disease</span>","Drugs that are used to treat <span class=""disease"">Alzheimer's disease</span> include the acetyl cholinesterase inhibitors (ACHIs) donepezil, rivastigmine and <span class=""chemical"">galantamine</span> and the NMDA receptor antagonist memantine.",,24777654,24777654_D005702_D000544,24777654_1,bcv_sentence_task_befree_5007,,770960939,FALSE,finalized,5,8/15/15 1:15,"



",no_relation,1,,D008559,"<span class=""chemical"">memantine</span>",D000544,"<span class=""disease"">Alzheimer's disease</span>","Drugs that are used to treat <span class=""disease"">Alzheimer's disease</span> include the acetyl cholinesterase inhibitors (ACHIs) donepezil, rivastigmine and galantamine and the NMDA receptor antagonist <span class=""chemical"">memantine</span>.",,24777654,24777654_D008559_D000544,24777654_1,bcv_sentence_task_befree_5008,,770960940,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,C072506,"<span class=""chemical"">rivastigmine</span>",D000544,"<span class=""disease"">Alzheimer's disease</span>","Drugs that are used to treat <span class=""disease"">Alzheimer's disease</span> include the acetyl cholinesterase inhibitors (ACHIs) donepezil, <span class=""chemical"">rivastigmine</span> and galantamine and the NMDA receptor antagonist memantine.",,24777654,24777654_C072506_D000544,24777654_1,bcv_sentence_task_befree_5009,,770960941,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,D016202,"<span class=""chemical"">NMDA</span>",D000544,"<span class=""disease"">Alzheimer's disease</span>","Drugs that are used to treat <span class=""disease"">Alzheimer's disease</span> include the acetyl cholinesterase inhibitors (ACHIs) donepezil, rivastigmine and galantamine and the <span class=""chemical"">NMDA</span> receptor antagonist memantine.",,24777654,24777654_D016202_D000544,24777654_1,bcv_sentence_task_befree_5010,,770960942,FALSE,finalized,5,8/14/15 22:51,"



",yes_direct,0.6221,,D008559,"<span class=""chemical"">memantine</span>",D001919,"<span class=""disease"">bradycardia</span>","Little is known about the cardiovascular effects of <span class=""chemical"">memantine</span> but there have been reports of <span class=""disease"">bradycardia</span> and reduced cardiovascular survival associated with its use.",,24777654,24777654_D008559_D001919,24777654_8,bcv_sentence_task_befree_5011,,770960943,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D012459,"<span class=""chemical"">salicylate</span>",D001249,"<span class=""disease"">bronchial asthma</span>","It is the drug of choice in patients that cannot be treated with non-steroidal anti-inflammatory drugs (NSAID), such as people with <span class=""disease"">bronchial asthma</span>, peptic ulcer disease, hemophilia, <span class=""chemical"">salicylate</span>-sensitized people, children under 12 years of age, pregnant or breastfeeding women.",,24779190,24779190_D012459_D001249,24779190_2,bcv_sentence_task_befree_5012,,770960944,FALSE,finalized,5,8/14/15 22:36,"



",no_relation,1,,D012459,"<span class=""chemical"">salicylate</span>",D014456,"<span class=""disease"">ulcer disease</span>","It is the drug of choice in patients that cannot be treated with non-steroidal anti-inflammatory drugs (NSAID), such as people with bronchial asthma, peptic <span class=""disease"">ulcer disease</span>, hemophilia, <span class=""chemical"">salicylate</span>-sensitized people, children under 12 years of age, pregnant or breastfeeding women.",,24779190,24779190_D012459_D014456,24779190_2,bcv_sentence_task_befree_5013,,770960945,FALSE,finalized,5,8/14/15 22:36,"



",no_relation,1,,D012459,"<span class=""chemical"">salicylate</span>",D006467,"<span class=""disease"">hemophilia</span>","It is the drug of choice in patients that cannot be treated with non-steroidal anti-inflammatory drugs (NSAID), such as people with bronchial asthma, peptic ulcer disease, <span class=""disease"">hemophilia</span>, <span class=""chemical"">salicylate</span>-sensitized people, children under 12 years of age, pregnant or breastfeeding women.",,24779190,24779190_D012459_D006467,24779190_2,bcv_sentence_task_befree_5014,,770960946,FALSE,finalized,5,8/15/15 2:29,"



",no_relation,1,,C115070,"<span class=""chemical"">ranirestat</span>",D003929,"<span class=""disease"">diabetic neuropathy</span>","Evaluation of <span class=""chemical"">ranirestat</span> for the treatment of <span class=""disease"">diabetic neuropathy</span>.",,24785785,24785785_C115070_D003929,24785785_0,bcv_sentence_task_befree_5015,,770960947,FALSE,finalized,5,8/15/15 2:02,"



",no_relation,0.7877,,C115070,"<span class=""chemical"">ranirestat</span>",D003929,"<span class=""disease"">diabetic</span>","The objective of this evaluation is to summarize and provide expert opinion on the status of <span class=""chemical"">ranirestat</span> with an emphasis on its pharmacokinetics in the context of its potential effects to prevent/treat <span class=""disease"">diabetic</span> complications.",,24785785,24785785_C115070_D003929,24785785_5,bcv_sentence_task_befree_5016,,770960948,FALSE,finalized,5,8/14/15 23:19,"


No connection is implied between the terms.
",no_relation,1,,C115070,"<span class=""chemical"">ranirestat</span>",D003929,"<span class=""disease"">diabetic neuropathy/diabetic</span>","A qualitative systematic literature search of PubMed through November 2013 using MeSH terms - aldose reductase inhibitors, <span class=""disease"">diabetic neuropathy</span>, AS-3201, <span class=""chemical"">ranirestat</span>, <span class=""disease"">diabetic</span> complications and pharmacokinetics/pharmacodynamics - identified relevant publications limited to human and rodent (mouse and rat) and English-language studies.",,24785785,24785785_C115070_D003929,24785785_6,bcv_sentence_task_befree_5017,,770960949,FALSE,finalized,5,8/15/15 2:05,"



",no_relation,1,,C115070,"<span class=""chemical"">ranirestat</span>",D001167,"<span class=""disease"">neuropathy</span>","Trials in subjects with newly diagnosed <span class=""disease"">neuropathy</span> along with the identification of objective biomarkers/measurements of efficacy will be critical in identifying the real value and effect of <span class=""chemical"">ranirestat</span>.",,24785785,24785785_C115070_D001167,24785785_10,bcv_sentence_task_befree_5018,,770960950,FALSE,finalized,5,8/14/15 23:30,"



",no_relation,0.7797,,D006854,"<span class=""chemical"">hydrocortisone</span>",D003480,"<span class=""disease"">Cushing's syndrome</span>","A high prevalence of psychological morbidity and maladaptive personality as well as impaired quality of life (QoL) is observed in patients with and without <span class=""chemical"">hydrocortisone</span> dependency following (cured) <span class=""disease"">Cushing's syndrome</span>.",,24801589,24801589_D006854_D003480,24801589_1,bcv_sentence_task_befree_5019,,770960951,FALSE,finalized,5,8/14/15 23:05,"



",yes_direct,0.6096,,D006854,"<span class=""chemical"">hydrocortisone</span>",D009771,"<span class=""disease"">compulsivity</span>","However, there was a strong and consistent positive association between the daily <span class=""chemical"">hydrocortisone</span> dose and prevalence of maladaptive personality traits (i.e. identity problems, cognitive distortion, <span class=""disease"">compulsivity</span>, restricted expression, callousness, oppositionality, rejection, conduct problems, social avoidance, narcissism, and insecure attachment, all P<0.05).",,24801589,24801589_D006854_D009771,24801589_8,bcv_sentence_task_befree_5020,,770960952,FALSE,finalized,5,8/15/15 0:53,"



",yes_direct,0.622,,D006854,"<span class=""chemical"">hydrocortisone</span>",D003072,"<span class=""disease"">cognitive distortion</span>","However, there was a strong and consistent positive association between the daily <span class=""chemical"">hydrocortisone</span> dose and prevalence of maladaptive personality traits (i.e. identity problems, <span class=""disease"">cognitive distortion</span>, compulsivity, restricted expression, callousness, oppositionality, rejection, conduct problems, social avoidance, narcissism, and insecure attachment, all P<0.05).",,24801589,24801589_D006854_D003072,24801589_8,bcv_sentence_task_befree_5021,,770960953,FALSE,finalized,5,8/14/15 22:51,"



",yes_direct,0.8061,,D006854,"<span class=""chemical"">hydrocortisone</span>",D003866,"<span class=""disease"">depression</span>","There was also a strong relation between the mean daily <span class=""chemical"">hydrocortisone</span> dose and both psychological morbidity (i.e. <span class=""disease"">depression</span>, P<0.05) and QoL impairments (i.e. general health perception, several measures of physical functioning, and vitality, all P<0.05).",,24801589,24801589_D006854_D003866,24801589_9,bcv_sentence_task_befree_5022,,770960954,FALSE,finalized,5,8/15/15 2:05,"



",yes_direct,0.5914,,D006854,"<span class=""chemical"">hydrocortisone</span>",D034381,"<span class=""disease"">QoL impairments</span>","There was also a strong relation between the mean daily <span class=""chemical"">hydrocortisone</span> dose and both psychological morbidity (i.e. depression, P<0.05) and <span class=""disease"">QoL impairments</span> (i.e. general health perception, several measures of physical functioning, and vitality, all P<0.05).",,24801589,24801589_D006854_D034381,24801589_9,bcv_sentence_task_befree_5023,,770960955,FALSE,finalized,5,8/15/15 2:33,"



",yes_direct,1,,D011078,"<span class=""chemical"">Polychlorinated biphenyls/PCBs</span>",D065626,"<span class=""disease"">NAFLD/non-alcoholic fatty liver disease</span>","<span class=""chemical"">Polychlorinated biphenyls</span> (<span class=""chemical"">PCBs</span>) are persistent environmental toxicants, present in 100% ofU.S. adults and dose-dependently associated with obesity and <span class=""disease"">non-alcoholic fatty liver disease</span> (<span class=""disease"">NAFLD</span>).",,24812009,24812009_D011078_D065626,24812009_1,bcv_sentence_task_befree_5024,,770960956,FALSE,finalized,5,8/15/15 0:21,"



",yes_direct,1,,D011078,"<span class=""chemical"">Polychlorinated biphenyls/PCBs</span>",D009765,"<span class=""disease"">obesity</span>","<span class=""chemical"">Polychlorinated biphenyls</span> (<span class=""chemical"">PCBs</span>) are persistent environmental toxicants, present in 100% ofU.S. adults and dose-dependently associated with <span class=""disease"">obesity</span> and non-alcoholic fatty liver disease (NAFLD).",,24812009,24812009_D011078_D009765,24812009_1,bcv_sentence_task_befree_5025,,770960957,FALSE,finalized,5,8/14/15 23:15,"



",no_relation,0.7974,,D011078,"<span class=""chemical"">PCBs</span>",D065626,"<span class=""disease"">NAFLD</span>","<span class=""chemical"">PCBs</span> are predicted to interact with receptors previously implicated in xenobiotic/energy metabolism and <span class=""disease"">NAFLD</span>.",,24812009,24812009_D011078_D065626,24812009_2,bcv_sentence_task_befree_5026,,770960958,FALSE,finalized,5,8/14/15 22:53,"



",no_relation,1,,C026987,"<span class=""chemical"">Aroclor 1260</span>",D006528,"<span class=""disease"">hepatoma</span>","This study evaluates <span class=""chemical"">Aroclor 1260</span>, a PCB mixture with congener composition mimicking that of human adipose tissue, and selected congeners, as potential ligands for these receptors utilizing human <span class=""disease"">hepatoma</span>-derived (HepG2) and primate-derived (COS-1) cell lines, and primary human hepatocytes.",,24812009,24812009_C026987_D006528,24812009_4,bcv_sentence_task_befree_5027,,770960959,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,0.8024,,C511514,"<span class=""chemical"">Poly-SNO-HSA</span>",D009369,"<span class=""disease"">tumors</span>","We have previously demonstrated that poly-nitric oxide (NO) conjugated human serum albumin (<span class=""chemical"">Poly-SNO-HSA</span>) has the potential to be a DDS carrier capable of accumulating NO in <span class=""disease"">tumors</span>.",,24846171,24846171_C511514_D009369,24846171_2,bcv_sentence_task_befree_5028,,770960960,FALSE,finalized,5,8/15/15 2:21,"



",no_relation,1,,C511514,"<span class=""chemical"">Poly-SNO-HSA</span>",D009369,"<span class=""disease"">tumor</span>","We observed that pegylation enhanced the stability of <span class=""chemical"">Poly-SNO-HSA</span> both in vitro and in vivo, and that dimerization of <span class=""chemical"">Poly-SNO-HSA</span> enhanced the antitumor activity via more efficient delivery of NO in Colon 26 <span class=""disease"">tumor</span>-bearing mice.",,24846171,24846171_C511514_D009369,24846171_5,bcv_sentence_task_befree_5029,,770960961,FALSE,finalized,5,8/14/15 23:05,"



",no_relation,1,,C511514,"<span class=""chemical"">Poly-SNO-HSA</span>",D009369,"<span class=""disease"">tumors</span>","These data suggest that pegylation and dimerization of <span class=""chemical"">Poly-SNO-HSA</span> are very important tuners to optimize NO stability and accumulation, and thereby effect, in <span class=""disease"">tumors</span>.",,24846171,24846171_C511514_D009369,24846171_7,bcv_sentence_task_befree_5030,,770960962,FALSE,finalized,5,8/14/15 22:31,"



",no_relation,1,,D011092,"<span class=""chemical"">polyethylene glycol</span>",D009369,"<span class=""disease"">cancer</span>","Thus, <span class=""chemical"">polyethylene glycol</span>-Poly-SNO-HSA dimer seems to be a very appealing and safe NO carrier and thereby a strong candidate as an antitumor drug in future development of <span class=""disease"">cancer</span> therapeutics.",,24846171,24846171_D011092_D009369,24846171_8,bcv_sentence_task_befree_5031,,770960963,FALSE,finalized,5,8/14/15 23:11,"



",no_relation,1,,C511514,"<span class=""chemical"">Poly-SNO-HSA</span>",D009369,"<span class=""disease"">cancer</span>","Thus, polyethylene glycol-<span class=""chemical"">Poly-SNO-HSA</span> dimer seems to be a very appealing and safe NO carrier and thereby a strong candidate as an antitumor drug in future development of <span class=""disease"">cancer</span> therapeutics.",,24846171,24846171_C511514_D009369,24846171_8,bcv_sentence_task_befree_5032,,770960964,FALSE,finalized,5,8/15/15 0:38,"



",no_relation,1,,D005231,"<span class=""chemical"">PUFAs</span>",D050197,"<span class=""disease"">atherosclerosis</span>","The beneficial effects of fish and n-3 polyunsaturated fatty acids (<span class=""chemical"">PUFAs</span>) consumption on <span class=""disease"">atherosclerosis</span> have been reported in numerous epidemiological studies.",,24850465,24850465_D005231_D050197,24850465_1,bcv_sentence_task_befree_5033,,770960965,FALSE,finalized,5,8/14/15 23:01,"



",no_relation,0.8154,,D005231,"<span class=""chemical"">PUFAs</span>",D003920,"<span class=""disease"">T2DM</span>","Twenty-three postmenopausal women with <span class=""disease"">T2DM</span> were assigned to two four-week periods of either a fish-based diet (n-3 <span class=""chemical"">PUFAs</span>  3.0 g/day) or a control diet in a randomized crossover design.",,24850465,24850465_D005231_D003920,24850465_4,bcv_sentence_task_befree_5034,,770960966,FALSE,finalized,5,8/14/15 23:48,"



",no_relation,1,,D005227,"<span class=""chemical"">fatty acids</span>",D006940,"<span class=""disease"">hyperemia</span>","Endothelial function was measured with reactive <span class=""disease"">hyperemia</span> using strain-gauge plethysmography and compared with the serum levels of <span class=""chemical"">fatty acids</span> and their metabolites.",,24850465,24850465_D005227_D006940,24850465_5,bcv_sentence_task_befree_5035,,770960967,FALSE,finalized,5,8/14/15 23:53,"



",no_relation,0.6106,,D018943,"<span class=""chemical"">Anthracyclines</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","<span class=""chemical"">Anthracyclines</span> are important anticancer drugs, but their use is limited by acute and chronic <span class=""disease"">cardiotoxicity</span>.",,24862616,24862616_D018943_D066126,24862616_1,bcv_sentence_task_befree_5036,,770960968,FALSE,finalized,5,8/14/15 22:57,"



",yes_direct,0.4128,,D018943,"<span class=""chemical"">anthracycline</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","We assessed whether early 3D-strain analysis could predict later <span class=""chemical"">anthracycline</span>-induced <span class=""disease"">cardiotoxicity</span>.",,24862616,24862616_D018943_D066126,24862616_5,bcv_sentence_task_befree_5037,,770960969,FALSE,finalized,5,8/15/15 0:23,"



",yes_direct,1,,D018943,"<span class=""chemical"">anthracycline</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","Cumulative <span class=""chemical"">anthracycline</span> dose at 12 weeks, LVEF, 3DGLS and TnT were predictors of the later development of <span class=""disease"">cardiotoxicity</span> on univariate logistic regression.",,24862616,24862616_D018943_D066126,24862616_11,bcv_sentence_task_befree_5038,,770960970,FALSE,finalized,5,8/15/15 1:27,"



",yes_direct,1,,D018943,"<span class=""chemical"">anthracycline</span>",D066126,"<span class=""disease"">cardiotoxicity</span>","3DGLS seems to be a good predictor of the future development of <span class=""chemical"">anthracycline</span>-induced <span class=""disease"">cardiotoxicity</span>.",,24862616,24862616_D018943_D066126,24862616_14,bcv_sentence_task_befree_5039,,770960971,FALSE,finalized,5,8/15/15 2:49,"



",no_relation,1,,C540278,"<span class=""chemical"">enzalutamide</span>",D011471,"<span class=""disease"">prostate cancer</span>","The FDA approvals of <span class=""chemical"">enzalutamide</span> and abiraterone have rapidly changed the clinical landscape of <span class=""disease"">prostate cancer</span> treatment.",,25048254,25048254_C540278_D011471,25048254_1,bcv_sentence_task_befree_5040,,770960972,FALSE,finalized,5,8/14/15 22:41,"



",no_relation,1,,C089740,"<span class=""chemical"">abiraterone</span>",D011471,"<span class=""disease"">prostate cancer</span>","The FDA approvals of enzalutamide and <span class=""chemical"">abiraterone</span> have rapidly changed the clinical landscape of <span class=""disease"">prostate cancer</span> treatment.",,25048254,25048254_C089740_D011471,25048254_1,bcv_sentence_task_befree_5041,,770960973,FALSE,finalized,5,8/15/15 2:33,"



",no_relation,1,,D000728,"<span class=""chemical"">androgen</span>",D013734,"<span class=""disease"">AR/androgen receptor</span>","Both drugs were designed to further suppress <span class=""chemical""></span><span class=""disease"">androgen</span> receptor (<span class=""disease"">AR</span>) signaling, which is restored following first-line <span class=""chemical"">androgen</span> deprivation therapies.",,25048254,25048254_D000728_D013734,25048254_2,bcv_sentence_task_befree_5042,,770960974,FALSE,finalized,5,8/15/15 1:53,"



",no_relation,0.8037,,C540278,"<span class=""chemical"">enzalutamide</span>",D013734,"<span class=""disease"">AR</span>","Resistance to <span class=""chemical"">enzalutamide</span> and abiraterone, however, is again marked by a return of <span class=""disease"">AR</span> signaling, indicating a remarkable ""addiction"" of prostate cancer cells to the <span class=""disease"">AR</span> pathway.",,25048254,25048254_C540278_D013734,25048254_3,bcv_sentence_task_befree_5043,,770960975,FALSE,finalized,5,8/14/15 23:15,"



",no_relation,0.6144,,C089740,"<span class=""chemical"">abiraterone</span>",D013734,"<span class=""disease"">AR</span>","Resistance to enzalutamide and <span class=""chemical"">abiraterone</span>, however, is again marked by a return of <span class=""disease"">AR</span> signaling, indicating a remarkable ""addiction"" of prostate cancer cells to the <span class=""disease"">AR</span> pathway.",,25048254,25048254_C089740_D013734,25048254_3,bcv_sentence_task_befree_5044,,770960976,FALSE,finalized,5,8/14/15 22:51,"



",no_relation,1,,C540278,"<span class=""chemical"">enzalutamide</span>",D011471,"<span class=""disease"">prostate cancer</span>","Resistance to <span class=""chemical"">enzalutamide</span> and abiraterone, however, is again marked by a return of AR signaling, indicating a remarkable ""addiction"" of <span class=""disease"">prostate cancer</span> cells to the AR pathway.",,25048254,25048254_C540278_D011471,25048254_3,bcv_sentence_task_befree_5045,,770960977,FALSE,finalized,5,8/15/15 1:56,"



",no_relation,1,,C089740,"<span class=""chemical"">abiraterone</span>",D011471,"<span class=""disease"">prostate cancer</span>","Resistance to enzalutamide and <span class=""chemical"">abiraterone</span>, however, is again marked by a return of AR signaling, indicating a remarkable ""addiction"" of <span class=""disease"">prostate cancer</span> cells to the AR pathway.",,25048254,25048254_C089740_D011471,25048254_3,bcv_sentence_task_befree_5046,,770960978,FALSE,finalized,5,8/14/15 23:58,"



",no_relation,1,,C540278,"<span class=""chemical"">enzalutamide</span>",D013734,"<span class=""disease"">AR/androgen receptor</span>","Among these, the <span class=""disease"">androgen receptor</span> splice variants (<span class=""disease"">AR</span>-Vs), particularly variant 7 (<span class=""disease"">AR</span>-V7), have been implicated in resistance to <span class=""chemical"">enzalutamide</span> and abiraterone in preclinical studies, and they cannot be targeted by currently available <span class=""disease"">AR</span>-directed drugs.",,25048254,25048254_C540278_D013734,25048254_5,bcv_sentence_task_befree_5047,,770960979,FALSE,finalized,5,8/15/15 0:17,"



",no_relation,1,,C089740,"<span class=""chemical"">abiraterone</span>",D013734,"<span class=""disease"">AR/androgen receptor</span>","Among these, the <span class=""disease"">androgen receptor</span> splice variants (<span class=""disease"">AR</span>-Vs), particularly variant 7 (<span class=""disease"">AR</span>-V7), have been implicated in resistance to enzalutamide and <span class=""chemical"">abiraterone</span> in preclinical studies, and they cannot be targeted by currently available <span class=""disease"">AR</span>-directed drugs.",,25048254,25048254_C089740_D013734,25048254_5,bcv_sentence_task_befree_5048,,770960980,FALSE,finalized,5,8/15/15 0:21,"



",no_relation,1,,D000728,"<span class=""chemical"">androgen</span>",D013734,"<span class=""disease"">AR/androgen receptor</span>","Among these, the <span class=""chemical""></span><span class=""disease"">androgen</span> receptor splice variants (<span class=""disease"">AR</span>-Vs), particularly variant 7 (<span class=""disease"">AR</span>-V7), have been implicated in resistance to enzalutamide and abiraterone in preclinical studies, and they cannot be targeted by currently available <span class=""disease"">AR</span>-directed drugs.",,25048254,25048254_D000728_D013734,25048254_5,bcv_sentence_task_befree_5049,,770960981,FALSE,finalized,5,8/14/15 23:00,"



",no_relation,1,,C089740,"<span class=""chemical"">abiraterone</span>",D013734,"<span class=""disease"">AR/androgen receptor</span>","In this mini-review, we will discuss general mechanisms of resistance to <span class=""disease"">AR</span>-directed therapies, with a focus on the role of <span class=""disease"">androgen receptor</span> splice variants in the new era of treating advanced prostate cancer with enzalutamide and <span class=""chemical"">abiraterone</span>.",,25048254,25048254_C089740_D013734,25048254_7,bcv_sentence_task_befree_5050,,770960982,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,1,,D000728,"<span class=""chemical"">androgen</span>",D011471,"<span class=""disease"">prostate cancer</span>","In this mini-review, we will discuss general mechanisms of resistance to AR-directed therapies, with a focus on the role of <span class=""chemical"">androgen</span> receptor splice variants in the new era of treating advanced <span class=""disease"">prostate cancer</span> with enzalutamide and abiraterone.",,25048254,25048254_D000728_D011471,25048254_7,bcv_sentence_task_befree_5051,,770960983,FALSE,finalized,5,8/14/15 23:22,"



",no_relation,1,,C540278,"<span class=""chemical"">enzalutamide</span>",D011471,"<span class=""disease"">prostate cancer</span>","In this mini-review, we will discuss general mechanisms of resistance to AR-directed therapies, with a focus on the role of androgen receptor splice variants in the new era of treating advanced <span class=""disease"">prostate cancer</span> with <span class=""chemical"">enzalutamide</span> and abiraterone.",,25048254,25048254_C540278_D011471,25048254_7,bcv_sentence_task_befree_5052,,770960984,FALSE,finalized,5,8/14/15 23:34,"



",no_relation,1,,C540278,"<span class=""chemical"">enzalutamide</span>",D013734,"<span class=""disease"">AR/androgen receptor</span>","In this mini-review, we will discuss general mechanisms of resistance to <span class=""disease"">AR</span>-directed therapies, with a focus on the role of <span class=""disease"">androgen receptor</span> splice variants in the new era of treating advanced prostate cancer with <span class=""chemical"">enzalutamide</span> and abiraterone.",,25048254,25048254_C540278_D013734,25048254_7,bcv_sentence_task_befree_5053,,770960985,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,C089740,"<span class=""chemical"">abiraterone</span>",D011471,"<span class=""disease"">prostate cancer</span>","In this mini-review, we will discuss general mechanisms of resistance to AR-directed therapies, with a focus on the role of androgen receptor splice variants in the new era of treating advanced <span class=""disease"">prostate cancer</span> with enzalutamide and <span class=""chemical"">abiraterone</span>.",,25048254,25048254_C089740_D011471,25048254_7,bcv_sentence_task_befree_5054,,770960986,FALSE,finalized,5,8/15/15 1:50,"



",no_relation,1,,D000728,"<span class=""chemical"">androgen</span>",D013734,"<span class=""disease"">AR/androgen receptor</span>","In this mini-review, we will discuss general mechanisms of resistance to <span class=""disease"">AR</span>-directed therapies, with a focus on the role of <span class=""chemical""></span><span class=""disease"">androgen</span> receptor splice variants in the new era of treating advanced prostate cancer with enzalutamide and abiraterone.",,25048254,25048254_D000728_D013734,25048254_7,bcv_sentence_task_befree_5055,,770960987,FALSE,finalized,5,8/15/15 0:46,"



",no_relation,0.8048,,D015725,"<span class=""chemical"">fluconazole</span>",D058387,"<span class=""disease"">candidemia</span>","Prior exposure to <span class=""chemical"">fluconazole</span> before <span class=""disease"">candidemia</span> (22.3 vs. 11.6 %, p < 0.001) and fungemia due to Candida glabrata (13.1 vs. 7.8 %, p = 0.03) were more frequent in period 2, as was the proportion of patients receiving an echinocandin as primary therapy (18.0 vs. 5.9 %, p < 0.001).",,25082359,25082359_D015725_D058387,25082359_5,bcv_sentence_task_befree_5056,,770960988,FALSE,finalized,5,8/14/15 22:36,"



",no_relation,1,,D015725,"<span class=""chemical"">fluconazole</span>",D016469,"<span class=""disease"">fungemia</span>","Prior exposure to <span class=""chemical"">fluconazole</span> before candidemia (22.3 vs. 11.6 %, p < 0.001) and <span class=""disease"">fungemia</span> due to Candida glabrata (13.1 vs. 7.8 %, p = 0.03) were more frequent in period 2, as was the proportion of patients receiving an echinocandin as primary therapy (18.0 vs. 5.9 %, p < 0.001).",,25082359,25082359_D015725_D016469,25082359_5,bcv_sentence_task_befree_5057,,770960989,FALSE,finalized,5,8/14/15 23:17,"



",no_relation,1,,D054714,"<span class=""chemical"">echinocandins</span>",D058387,"<span class=""disease"">candidemia</span>","The use of <span class=""chemical"">echinocandins</span> as primary therapy for <span class=""disease"">candidemia</span> appears to be associated with better outcomes.",,25082359,25082359_D054714_D058387,25082359_9,bcv_sentence_task_befree_5058,,770960990,FALSE,finalized,5,8/15/15 0:13,"



",no_relation,1,,C504072,"<span class=""chemical"">carbosilane</span>",D015658,"<span class=""disease"">HIV</span>","Enhanced activity of <span class=""chemical"">carbosilane</span> dendrimers against <span class=""disease"">HIV</span> when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides.",,25114528,25114528_C504072_D015658,25114528_0,bcv_sentence_task_befree_5059,,770960991,FALSE,finalized,5,8/15/15 1:20,"



",no_relation,1,,C504072,"<span class=""chemical"">carbosilane</span>",D015658,"<span class=""disease"">HIV</span>","Thereby, new nanosystems, such as <span class=""chemical"">carbosilane</span> dendrimers, have been shown to be safe and effective compounds against <span class=""disease"">HIV</span> with great potential as topical microbicides.",,25114528,25114528_C504072_D015658,25114528_5,bcv_sentence_task_befree_5060,,770960992,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,1,,C504072,"<span class=""chemical"">carbosilane</span>",D015658,"<span class=""disease"">HIV-1 infection</span>","We evaluated various combinations of anionic <span class=""chemical"">carbosilane</span> dendrimers with sulfated (G3-S16) and naphthyl sulfonated (G2-NF16) ended groups with different ARVs against <span class=""disease"">HIV-1 infection</span>.",,25114528,25114528_C504072_D015658,25114528_7,bcv_sentence_task_befree_5061,,770960993,FALSE,finalized,5,8/14/15 23:33,"



",no_relation,1,,C096918,"<span class=""chemical"">tenofovir</span>",D015658,"<span class=""disease"">HIV</span>","The G3-S16 and G2-NF16 dendrimers showed a synergistic or additive activity profile with zidovudine, efavirenz, and <span class=""chemical"">tenofovir</span> in the majority of the combinations tested against the X4 and R5 tropic <span class=""disease"">HIV</span>-1 in cell lines, as well as in human primary cells.",,25114528,25114528_C096918_D015658,25114528_8,bcv_sentence_task_befree_5062,,770960994,FALSE,finalized,5,8/14/15 22:54,"



",no_relation,1,,D015215,"<span class=""chemical"">zidovudine</span>",D015658,"<span class=""disease"">HIV</span>","The G3-S16 and G2-NF16 dendrimers showed a synergistic or additive activity profile with <span class=""chemical"">zidovudine</span>, efavirenz, and tenofovir in the majority of the combinations tested against the X4 and R5 tropic <span class=""disease"">HIV</span>-1 in cell lines, as well as in human primary cells.",,25114528,25114528_D015215_D015658,25114528_8,bcv_sentence_task_befree_5063,,770960995,FALSE,finalized,5,8/15/15 0:48,"



",no_relation,1,,C098320,"<span class=""chemical"">efavirenz</span>",D015658,"<span class=""disease"">HIV</span>","The G3-S16 and G2-NF16 dendrimers showed a synergistic or additive activity profile with zidovudine, <span class=""chemical"">efavirenz</span>, and tenofovir in the majority of the combinations tested against the X4 and R5 tropic <span class=""disease"">HIV</span>-1 in cell lines, as well as in human primary cells.",,25114528,25114528_C098320_D015658,25114528_8,bcv_sentence_task_befree_5064,,770960996,FALSE,finalized,5,8/14/15 22:49,"



",no_relation,1,,C504072,"<span class=""chemical"">carbosilane</span>",D015658,"<span class=""disease"">HIV</span>","Therefore, the combination of ARVs and polyanionic <span class=""chemical"">carbosilane</span> dendrimers enhances the antiviral potency of the individual compounds, and our findings support further clinical research on combinational approaches as potential microbicides to block the sexual transmission of <span class=""disease"">HIV</span>-1.",,25114528,25114528_C504072_D015658,25114528_9,bcv_sentence_task_befree_5065,,770960997,FALSE,finalized,5,8/14/15 22:47,"



",yes_direct,0.8049,,C400082,"<span class=""chemical"">Bortezomib</span>",D001925,"<span class=""disease"">encephalopathy</span>","<span class=""chemical"">Bortezomib</span>-induced posterior reversible <span class=""disease"">encephalopathy</span> syndrome: clinical and imaging features.",,25130124,25130124_C400082_D001925,25130124_0,bcv_sentence_task_befree_5066,,770960998,FALSE,finalized,5,8/15/15 0:06,"



",yes_direct,1,,C400082,"<span class=""chemical"">bortezomib</span>",D054038,"<span class=""disease"">PRES</span>","We herein present a case of <span class=""disease"">PRES</span> that occurred after 33 days of high-dose <span class=""chemical"">bortezomib</span> treatment and propose both overwhelmed cerebral autoregulation and toxin-mediated blood-brain barrier damage as the underlying mechanisms based on the imaging findings.",,25130124,25130124_C400082_D054038,25130124_2,bcv_sentence_task_befree_5067,,770960999,FALSE,finalized,5,8/15/15 0:40,"



",no_relation,1,,C400082,"<span class=""chemical"">bortezomib</span>",D006973,"<span class=""disease"">hypertension</span>","A favorable recovery was observed two days after achieving stringent <span class=""disease"">hypertension</span> control and withholding <span class=""chemical"">bortezomib</span>.",,25130124,25130124_C400082_D006973,25130124_3,bcv_sentence_task_befree_5068,,770961000,FALSE,finalized,5,8/14/15 22:50,"



",no_relation,0.6069,,C400082,"<span class=""chemical"">bortezomib</span>",D054038,"<span class=""disease"">PRES</span>","With explicit clinical and imaging features, this case highlights the need for early recognition of <span class=""disease"">PRES</span> during the clinical course of <span class=""chemical"">bortezomib</span> therapy.",,25130124,25130124_C400082_D054038,25130124_5,bcv_sentence_task_befree_5069,,770961001,FALSE,finalized,5,8/15/15 0:31,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D006086,"<span class=""disease"">graft-versus-host disease</span>","Multi-institutional study of post-transplantation <span class=""chemical"">cyclophosphamide</span> as single-agent <span class=""disease"">graft-versus-host disease</span> prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning.",,25267759,25267759_D003520_D006086,25267759_0,bcv_sentence_task_befree_5070,,770961002,FALSE,finalized,5,8/15/15 1:46,"



",no_relation,0.7904,,C024352,"<span class=""chemical"">fludarabine</span>",D006086,"<span class=""disease"">graft-versus-host disease</span>","Multi-institutional study of post-transplantation cyclophosphamide as single-agent <span class=""disease"">graft-versus-host disease</span> prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and <span class=""chemical"">fludarabine</span> conditioning.",,25267759,25267759_C024352_D006086,25267759_0,bcv_sentence_task_befree_5071,,770961003,FALSE,finalized,5,8/14/15 22:40,"



",no_relation,1,,D002066,"<span class=""chemical"">busulfan</span>",D006086,"<span class=""disease"">graft-versus-host disease</span>","Multi-institutional study of post-transplantation cyclophosphamide as single-agent <span class=""disease"">graft-versus-host disease</span> prophylaxis after allogeneic bone marrow transplantation using myeloablative <span class=""chemical"">busulfan</span> and fludarabine conditioning.",,25267759,25267759_D002066_D006086,25267759_0,bcv_sentence_task_befree_5072,,770961004,FALSE,finalized,5,8/14/15 22:34,"



",no_relation,0.7946,,D002066,"<span class=""chemical"">busulfan</span>",D006086,"<span class=""disease"">graft-versus-host disease/GVHD</span>","The clinical safety and efficacy of intravenous <span class=""chemical"">busulfan</span> and fludarabine (IV Bu/Flu) myeloablative conditioning as well as <span class=""disease"">graft-versus-host disease</span> (<span class=""disease"">GVHD</span>) prophylaxis with high-dose, post-transplantation cyclophosphamide (PTCy) have been demonstrated independently in several single-institutional studies.",,25267759,25267759_D002066_D006086,25267759_1,bcv_sentence_task_befree_5073,,770961005,FALSE,finalized,5,8/15/15 0:26,"



",no_relation,1,,C024352,"<span class=""chemical"">fludarabine</span>",D006086,"<span class=""disease"">graft-versus-host disease/GVHD</span>","The clinical safety and efficacy of intravenous busulfan and <span class=""chemical"">fludarabine</span> (IV Bu/Flu) myeloablative conditioning as well as <span class=""disease"">graft-versus-host disease</span> (<span class=""disease"">GVHD</span>) prophylaxis with high-dose, post-transplantation cyclophosphamide (PTCy) have been demonstrated independently in several single-institutional studies.",,25267759,25267759_C024352_D006086,25267759_1,bcv_sentence_task_befree_5074,,770961006,FALSE,finalized,5,8/14/15 22:53,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D006086,"<span class=""disease"">graft-versus-host disease/GVHD</span>","The clinical safety and efficacy of intravenous busulfan and fludarabine (IV Bu/Flu) myeloablative conditioning as well as <span class=""disease"">graft-versus-host disease</span> (<span class=""disease"">GVHD</span>) prophylaxis with high-dose, post-transplantation <span class=""chemical"">cyclophosphamide</span> (PTCy) have been demonstrated independently in several single-institutional studies.",,25267759,25267759_D003520_D006086,25267759_1,bcv_sentence_task_befree_5075,,770961007,FALSE,finalized,5,8/15/15 1:13,"



",yes_direct,0.7943,,C009250,"<span class=""chemical"">sevoflurane</span>",D014474,"<span class=""disease"">unconsciousness</span>","Neurophysiological correlates of <span class=""chemical"">sevoflurane</span>-induced <span class=""disease"">unconsciousness</span>.",,25296108,25296108_C009250_D014474,25296108_0,bcv_sentence_task_befree_5076,,770961008,FALSE,finalized,5,8/15/15 1:44,"



",yes_direct,1,,D015742,"<span class=""chemical"">propofol</span>",D014474,"<span class=""disease"">unconsciousness</span>","Recent studies of anesthetic-induced <span class=""disease"">unconsciousness</span> in humans have focused predominantly on the intravenous drug <span class=""chemical"">propofol</span> and have identified anterior dominance of alpha rhythms and frontal phase-amplitude coupling patterns as neurophysiological markers.",,25296108,25296108_D015742_D014474,25296108_1,bcv_sentence_task_befree_5077,,770961009,FALSE,finalized,5,8/15/15 0:01,"



",yes_direct,1,,D015742,"<span class=""chemical"">propofol</span>",D014474,"<span class=""disease"">unconsciousness</span>","However, it is unclear whether the correlates of <span class=""chemical"">propofol</span>-induced <span class=""disease"">unconsciousness</span> are generalizable to inhaled anesthetics, which have distinct molecular targets and which are used more commonly in clinical practice.",,25296108,25296108_D015742_D014474,25296108_2,bcv_sentence_task_befree_5078,,770961010,FALSE,finalized,5,8/14/15 22:37,"



",yes_direct,0.6106,,C009250,"<span class=""chemical"">sevoflurane</span>",D014474,"<span class=""disease"">unconsciousness</span>","The authors recorded 64-channel electroencephalograms in healthy human participants during consciousness, <span class=""chemical"">sevoflurane</span>-induced <span class=""disease"">unconsciousness</span>, and recovery (n = 10; n = 7 suitable for analysis).",,25296108,25296108_C009250_D014474,25296108_3,bcv_sentence_task_befree_5079,,770961011,FALSE,finalized,5,8/15/15 0:44,"



",yes_direct,0.5975,,C009250,"<span class=""chemical"">sevoflurane</span>",D014474,"<span class=""disease"">unconsciousness</span>","At concentrations sufficient for <span class=""disease"">unconsciousness</span>, <span class=""chemical"">sevoflurane</span> did not result in a consistent anteriorization of alpha power; the relationship between low-frequency phase and alpha amplitude in the frontal cortex did not undergo characteristic transitions.",,25296108,25296108_C009250_D014474,25296108_6,bcv_sentence_task_befree_5080,,770961012,FALSE,finalized,5,8/14/15 22:42,"



",yes_direct,0.6055,,C009250,"<span class=""chemical"">sevoflurane</span>",D014474,"<span class=""disease"">unconsciousness</span>","Furthermore, a reversible disruption of anterior-posterior phase relationships in the alpha bandwidth was identified as a correlate of <span class=""chemical"">sevoflurane</span>-induced <span class=""disease"">unconsciousness</span>.",,25296108,25296108_C009250_D014474,25296108_8,bcv_sentence_task_befree_5081,,770961013,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,1,,C009250,"<span class=""chemical"">sevoflurane</span>",D006316,"<span class=""disease"">cross-frequency patterns</span>","In humans, <span class=""chemical"">sevoflurane</span>-induced unconsciousness is not correlated with anteriorization of alpha and related <span class=""disease"">cross-frequency patterns</span>, but rather by a disruption of phase-amplitude coupling in the parietal region and phase-phase relationships across the cortex.",,25296108,25296108_C009250_D006316,25296108_9,bcv_sentence_task_befree_5082,,770961014,FALSE,finalized,5,8/15/15 2:01,"



",yes_direct,0.6064,,C009250,"<span class=""chemical"">sevoflurane</span>",D014474,"<span class=""disease"">unconsciousness</span>","In humans, <span class=""chemical"">sevoflurane</span>-induced <span class=""disease"">unconsciousness</span> is not correlated with anteriorization of alpha and related cross-frequency patterns, but rather by a disruption of phase-amplitude coupling in the parietal region and phase-phase relationships across the cortex.",,25296108,25296108_C009250_D014474,25296108_9,bcv_sentence_task_befree_5083,,770961015,FALSE,finalized,5,8/14/15 22:46,"



",yes_direct,0.8042,,D024505,"<span class=""chemical"">tocopherol</span>",D007249,"<span class=""disease"">inflammation</span>","Patterns of dietary intake and serum carotenoid and <span class=""chemical"">tocopherol</span> status are associated with biomarkers of chronic low-grade systemic <span class=""disease"">inflammation</span> and cardiovascular risk.",,25313576,25313576_D024505_D007249,25313576_0,bcv_sentence_task_befree_5084,,770961016,FALSE,finalized,5,8/14/15 22:56,"



",no_relation,0.7894,,D024505,"<span class=""chemical"">tocopherol</span>",D007249,"<span class=""disease"">inflammation</span>","In the present study, we examined the relationship between dietary patterns, circulating carotenoid and <span class=""chemical"">tocopherol</span> concentrations, and biomarkers of chronic low-grade systemic <span class=""disease"">inflammation</span> in a 10-year longitudinal study of Scottish postmenopausal women.",,25313576,25313576_D024505_D007249,25313576_2,bcv_sentence_task_befree_5085,,770961017,FALSE,finalized,5,8/15/15 1:03,"



",no_relation,1,,D024505,"<span class=""chemical"">tocopherols</span>",C567296,"<span class=""disease"">carotenoids</span>","Diet was assessed by FFQ (n 1682) and blood was collected for the analysis of serum high-sensitivity C-reactive protein (hs-CRP), IL-6, serum amyloid A, E-selectin, lipid profile and dietary biomarkers (<span class=""disease"">carotenoids</span>, <span class=""chemical"">tocopherols</span> and retinol).",,25313576,25313576_D024505_C567296,25313576_5,bcv_sentence_task_befree_5086,,770961018,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,1,,D014801,"<span class=""chemical"">retinol</span>",C567296,"<span class=""disease"">carotenoids</span>","Diet was assessed by FFQ (n 1682) and blood was collected for the analysis of serum high-sensitivity C-reactive protein (hs-CRP), IL-6, serum amyloid A, E-selectin, lipid profile and dietary biomarkers (<span class=""disease"">carotenoids</span>, tocopherols and <span class=""chemical"">retinol</span>).",,25313576,25313576_D014801_C567296,25313576_5,bcv_sentence_task_befree_5087,,770961019,FALSE,finalized,5,8/15/15 1:56,"



",yes_direct,0.5808,,D016202,"<span class=""chemical"">N-methyl-D-aspartate</span>",D003072,"<span class=""disease"">cognitive impairment</span>","Severe <span class=""disease"">cognitive impairment</span> associated with intrathecal antibodies to the NR1 subunit of the <span class=""chemical"">N-methyl-D-aspartate</span> receptor in a patient with multiple sclerosis.",,25384024,25384024_D016202_D003072,25384024_0,bcv_sentence_task_befree_5088,,770961020,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,D016202,"<span class=""chemical"">N-methyl-D-aspartate</span>",D009103,"<span class=""disease"">multiple sclerosis</span>","Severe cognitive impairment associated with intrathecal antibodies to the NR1 subunit of the <span class=""chemical"">N-methyl-D-aspartate</span> receptor in a patient with <span class=""disease"">multiple sclerosis</span>.",,25384024,25384024_D016202_D009103,25384024_0,bcv_sentence_task_befree_5089,,770961021,FALSE,finalized,5,8/14/15 23:08,"



",no_relation,1,,D003520,"<span class=""chemical"">cyclophosphamide</span>",D003072,"<span class=""disease"">cognitive deficits</span>","Treatment with different immunotherapies, including <span class=""chemical"">cyclophosphamide</span> and natalizumab, did not improve her <span class=""disease"">cognitive deficits</span>, necessitating admission to a nursing home at age 39 years.",,25384024,25384024_D003520_D003072,25384024_4,bcv_sentence_task_befree_5090,,770961022,FALSE,finalized,5,8/14/15 22:42,"



",no_relation,1,,D016202,"<span class=""chemical"">N-methyl-D-aspartate</span>",D004660,"<span class=""disease"">encephalitis</span>","During a thorough reevaluation at age 43 years, analysis of current and stored cerebrospinal fluid and serum samples demonstrated an intrathecal synthesis of IgG antibodies to the NR1 subunit of the <span class=""chemical"">N-methyl-D-aspartate</span> receptor, that is, the characteristic laboratory finding of anti-<span class=""chemical"">N-methyl-D-aspartate</span> receptor <span class=""disease"">encephalitis</span>.",,25384024,25384024_D016202_D004660,25384024_5,bcv_sentence_task_befree_5091,,770961023,FALSE,finalized,5,8/14/15 23:23,"



",no_relation,1,,D008942,"<span class=""chemical"">mitoxantrone</span>",D003072,"<span class=""disease"">cognitive impairment</span>","Although the patient initially stabilized under therapy with corticosteroids, plasma exchange, and <span class=""chemical"">mitoxantrone</span>, severe <span class=""disease"">cognitive impairment</span> persisted and she eventually died from the sequelae of her disease.",,25384024,25384024_D008942_D003072,25384024_6,bcv_sentence_task_befree_5092,,770961024,FALSE,finalized,5,8/14/15 23:05,"



",no_relation,1,,D008942,"<span class=""chemical"">mitoxantrone</span>",D006013,"<span class=""disease"">her disease</span>","Although the patient initially stabilized under therapy with corticosteroids, plasma exchange, and <span class=""chemical"">mitoxantrone</span>, severe cognitive impairment persisted and she eventually died from the sequelae of <span class=""disease"">her disease</span>.",,25384024,25384024_D008942_D006013,25384024_6,bcv_sentence_task_befree_5093,,770961025,FALSE,finalized,5,8/14/15 22:48,"



",no_relation,0.7942,,D000305,"<span class=""chemical"">corticosteroids</span>",D003072,"<span class=""disease"">cognitive impairment</span>","Although the patient initially stabilized under therapy with <span class=""chemical"">corticosteroids</span>, plasma exchange, and mitoxantrone, severe <span class=""disease"">cognitive impairment</span> persisted and she eventually died from the sequelae of her disease.",,25384024,25384024_D000305_D003072,25384024_6,bcv_sentence_task_befree_5094,,770961026,FALSE,finalized,5,8/15/15 1:35,"



",no_relation,1,,D000305,"<span class=""chemical"">corticosteroids</span>",D006013,"<span class=""disease"">her disease</span>","Although the patient initially stabilized under therapy with <span class=""chemical"">corticosteroids</span>, plasma exchange, and mitoxantrone, severe cognitive impairment persisted and she eventually died from the sequelae of <span class=""disease"">her disease</span>.",,25384024,25384024_D000305_D006013,25384024_6,bcv_sentence_task_befree_5095,,770961027,FALSE,finalized,5,8/15/15 1:45,"



",no_relation,1,,D017294,"<span class=""chemical"">ondansetron</span>",D004630,"<span class=""disease"">ED/emergency department</span>","To assess the hypothesis that <span class=""chemical"">ondansetron</span> administration to children with type 1 diabetes mellitus (T1DM) presenting for <span class=""disease"">emergency department</span> (<span class=""disease"">ED</span>) care with intercurrent illness and vomiting improves clinical outcomes by reducing hospitalization rates (primary), length of <span class=""disease"">ED</span> stay, intravenous fluid (IVF) administration, and revisits (secondary outcomes).",,25454931,25454931_D017294_D004630,25454931_1,bcv_sentence_task_befree_5096,,770961028,FALSE,finalized,5,8/15/15 0:20,"



",no_relation,1,,D017294,"<span class=""chemical"">ondansetron</span>",D003922,"<span class=""disease"">T1DM/type 1 diabetes mellitus</span>","To assess the hypothesis that <span class=""chemical"">ondansetron</span> administration to children with <span class=""disease"">type 1 diabetes mellitus</span> (<span class=""disease"">T1DM</span>) presenting for emergency department (ED) care with intercurrent illness and vomiting improves clinical outcomes by reducing hospitalization rates (primary), length of ED stay, intravenous fluid (IVF) administration, and revisits (secondary outcomes).",,25454931,25454931_D017294_D003922,25454931_1,bcv_sentence_task_befree_5097,,770961029,FALSE,finalized,5,8/14/15 23:03,"



",no_relation,1,,D017294,"<span class=""chemical"">ondansetron</span>",D005067,"<span class=""disease"">illness</span>","To assess the hypothesis that <span class=""chemical"">ondansetron</span> administration to children with type 1 diabetes mellitus (T1DM) presenting for emergency department (ED) care with intercurrent <span class=""disease"">illness</span> and vomiting improves clinical outcomes by reducing hospitalization rates (primary), length of ED stay, intravenous fluid (IVF) administration, and revisits (secondary outcomes).",,25454931,25454931_D017294_D005067,25454931_1,bcv_sentence_task_befree_5098,,770961030,FALSE,finalized,5,8/15/15 1:51,"



",no_relation,0.8098,,D017294,"<span class=""chemical"">ondansetron</span>",D014839,"<span class=""disease"">vomiting</span>","To assess the hypothesis that <span class=""chemical"">ondansetron</span> administration to children with type 1 diabetes mellitus (T1DM) presenting for emergency department (ED) care with intercurrent illness and <span class=""disease"">vomiting</span> improves clinical outcomes by reducing hospitalization rates (primary), length of ED stay, intravenous fluid (IVF) administration, and revisits (secondary outcomes).",,25454931,25454931_D017294_D014839,25454931_1,bcv_sentence_task_befree_5099,,770961031,FALSE,finalized,5,8/14/15 22:37,"



ED stands for Emergency Department and therefore shouldn't be a disease. :-)",no_relation,0.802,,D017294,"<span class=""chemical"">Ondansetron</span>",D004630,"<span class=""disease"">ED</span>","<span class=""chemical"">Ondansetron</span> usage increased from 0% to 67% of <span class=""disease"">ED</span> encounters between 2002 and 2011.",,25454931,25454931_D017294_D004630,25454931_5,bcv_sentence_task_befree_5100,,770961032,FALSE,finalized,5,8/14/15 22:38,"



",no_relation,1,,D017294,"<span class=""chemical"">ondansetron</span>",D003922,"<span class=""disease"">T1DM</span>","Over time, along with increasing <span class=""chemical"">ondansetron</span> use, there have been reductions in admissions, length of stay, and IVF administration in children with <span class=""disease"">T1DM</span>.",,25454931,25454931_D017294_D003922,25454931_12,bcv_sentence_task_befree_5101,,770961033,FALSE,finalized,5,8/15/15 0:36,"



",no_relation,1,,D007213,"<span class=""chemical"">indomethacin</span>",D010195,"<span class=""disease"">pancreatitis</span>","Does rectal <span class=""chemical"">indomethacin</span> given for prevention of post-ERCP <span class=""disease"">pancreatitis</span> increase bleeding after biliary endoscopic sphincterotomy or cardiovascular mortality?.",,25474427,25474427_D007213_D010195,25474427_0,bcv_sentence_task_befree_5102,,770961034,FALSE,finalized,5,8/15/15 1:59,"



",no_relation,1,,D007213,"<span class=""chemical"">indomethacin</span>",D006470,"<span class=""disease"">bleeding</span>","Does rectal <span class=""chemical"">indomethacin</span> given for prevention of post-ERCP pancreatitis increase <span class=""disease"">bleeding</span> after biliary endoscopic sphincterotomy or cardiovascular mortality?.",,25474427,25474427_D007213_D006470,25474427_0,bcv_sentence_task_befree_5103,,770961035,FALSE,finalized,5,8/15/15 1:16,"



",no_relation,1,,D007213,"<span class=""chemical"">indomethacin</span>",D010195,"<span class=""disease"">pancreatitis</span>","Rectal <span class=""chemical"">indomethacin</span> has been proven to be effective for prevention of post-ERCP <span class=""disease"">pancreatitis</span> (PEP) but its impact on bleeding after biliary sphincterotomy (BABES) and cardiovascular mortality has not been extensively studied.",,25474427,25474427_D007213_D010195,25474427_2,bcv_sentence_task_befree_5104,,770961036,FALSE,finalized,5,8/14/15 23:40,"



",no_relation,0.8137,,D007213,"<span class=""chemical"">indomethacin</span>",D006470,"<span class=""disease"">bleeding</span>","Rectal <span class=""chemical"">indomethacin</span> has been proven to be effective for prevention of post-ERCP pancreatitis (PEP) but its impact on <span class=""disease"">bleeding</span> after biliary sphincterotomy (BABES) and cardiovascular mortality has not been extensively studied.",,25474427,25474427_D007213_D006470,25474427_2,bcv_sentence_task_befree_5105,,770961037,FALSE,finalized,5,8/14/15 23:35,"



",yes_direct,0.5759,,D003474,"<span class=""chemical"">curcumin</span>",D012509,"<span class=""disease"">Ras</span>","<span class=""disease"">Ras</span>/ERK signaling pathway is involved in <span class=""chemical"">curcumin</span>-induced cell cycle arrest and apoptosis in human gastric carcinoma AGS cells.",,25492214,25492214_D003474_D012509,25492214_0,bcv_sentence_task_befree_5106,,770961038,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,0.5932,,D003474,"<span class=""chemical"">curcumin</span>",C535607,"<span class=""disease"">AGS</span>","Ras/ERK signaling pathway is involved in <span class=""chemical"">curcumin</span>-induced cell cycle arrest and apoptosis in human gastric carcinoma <span class=""disease"">AGS</span> cells.",,25492214,25492214_D003474_C535607,25492214_0,bcv_sentence_task_befree_5107,,770961039,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,1,,D003474,"<span class=""chemical"">curcumin</span>",D013272,"<span class=""disease"">gastric carcinoma</span>","Ras/ERK signaling pathway is involved in <span class=""chemical"">curcumin</span>-induced cell cycle arrest and apoptosis in human <span class=""disease"">gastric carcinoma</span> AGS cells.",,25492214,25492214_D003474_D013272,25492214_0,bcv_sentence_task_befree_5108,,770961040,FALSE,finalized,5,8/15/15 1:04,"



",no_relation,0.6214,,D003474,"<span class=""chemical"">Curcumin</span>",D013272,"<span class=""disease"">gastric carcinoma</span>","<span class=""chemical"">Curcumin</span>, the biologically active compound from the rhizome of Curcuma longa, could inhibit cell growth and induce apoptosis in <span class=""disease"">gastric carcinoma</span>.",,25492214,25492214_D003474_D013272,25492214_1,bcv_sentence_task_befree_5109,,770961041,FALSE,finalized,5,8/14/15 23:02,"



",no_relation,1,,D003474,"<span class=""chemical"">curcumin</span>",D013272,"<span class=""disease"">gastric carcinoma</span>","However, the underlying mechanism of <span class=""chemical"">curcumin</span> on <span class=""disease"">gastric carcinoma</span> cells still needs further investigation.",,25492214,25492214_D003474_D013272,25492214_2,bcv_sentence_task_befree_5110,,770961042,FALSE,finalized,5,8/15/15 0:00,"



",no_relation,0.7843,,D003474,"<span class=""chemical"">curcumin</span>",C535607,"<span class=""disease"">AGS</span>","In this study, morphological observation indicated that <span class=""chemical"">curcumin</span> inhibited the proliferation of <span class=""disease"">AGS</span> cells in a dose-dependent manner.",,25492214,25492214_D003474_C535607,25492214_3,bcv_sentence_task_befree_5111,,770961043,FALSE,finalized,5,8/14/15 22:59,"



",no_relation,0.7989,,D003474,"<span class=""chemical"">curcumin</span>",C535607,"<span class=""disease"">AGS</span>","According to the flow cytometric analysis, <span class=""chemical"">curcumin</span> treatment resulted in G2/M arrest in <span class=""disease"">AGS</span> cells, accompanied with an increased expression of cyclin B1 and a decreased expression of cyclin D1.",,25492214,25492214_D003474_C535607,25492214_4,bcv_sentence_task_befree_5112,,770961044,FALSE,finalized,5,8/15/15 0:41,"



",no_relation,1,,D003474,"<span class=""chemical"">curcumin</span>",C535607,"<span class=""disease"">AGS</span>","Meanwhile, the activities of caspase-3, -8, and -9 were also enhanced in <span class=""chemical"">curcumin</span>-treated <span class=""disease"">AGS</span> cells.",,25492214,25492214_D003474_C535607,25492214_6,bcv_sentence_task_befree_5113,,770961045,FALSE,finalized,5,8/15/15 0:48,"



",yes_direct,0.5885,,D003474,"<span class=""chemical"">curcumin</span>",D012509,"<span class=""disease"">rat sarcoma/Ras</span>","Furthermore, downregulation of <span class=""disease"">rat sarcoma</span> (<span class=""disease"">Ras</span>) and upregulation of extracellular-signal-regulated kinase (ERK) were also observed in AGS cells treated with <span class=""chemical"">curcumin</span> by Western blot.",,25492214,25492214_D003474_D012509,25492214_8,bcv_sentence_task_befree_5114,,770961046,FALSE,finalized,5,8/15/15 1:42,"



",no_relation,1,,D003474,"<span class=""chemical"">curcumin</span>",C535607,"<span class=""disease"">AGS</span>","Furthermore, downregulation of rat sarcoma (Ras) and upregulation of extracellular-signal-regulated kinase (ERK) were also observed in <span class=""disease"">AGS</span> cells treated with <span class=""chemical"">curcumin</span> by Western blot.",,25492214,25492214_D003474_C535607,25492214_8,bcv_sentence_task_befree_5115,,770961047,FALSE,finalized,5,8/14/15 22:54,"



",no_relation,0.801,,D003474,"<span class=""chemical"">curcumin</span>",D012509,"<span class=""disease"">Ras</span>","The results suggested that <span class=""chemical"">curcumin</span> inhibited the growth of the AGS cells and induced apoptosis through the activation of <span class=""disease"">Ras</span>/ERK signaling pathway and downstream caspase cascade, and <span class=""chemical"">curcumin</span> might be a potential target for the treatment of gastric carcinoma.",,25492214,25492214_D003474_D012509,25492214_10,bcv_sentence_task_befree_5116,,770961048,FALSE,finalized,5,8/15/15 0:34,"



",no_relation,1,,D003474,"<span class=""chemical"">curcumin</span>",C535607,"<span class=""disease"">AGS</span>","The results suggested that <span class=""chemical"">curcumin</span> inhibited the growth of the <span class=""disease"">AGS</span> cells and induced apoptosis through the activation of Ras/ERK signaling pathway and downstream caspase cascade, and <span class=""chemical"">curcumin</span> might be a potential target for the treatment of gastric carcinoma.",,25492214,25492214_D003474_C535607,25492214_10,bcv_sentence_task_befree_5117,,770961049,FALSE,finalized,5,8/14/15 23:10,"


Not sure on this one, there is connection, but i lack medical knowledge to determine is it cause of cure.
",no_relation,0.7812,,D003474,"<span class=""chemical"">curcumin</span>",D013272,"<span class=""disease"">gastric carcinoma</span>","The results suggested that <span class=""chemical"">curcumin</span> inhibited the growth of the AGS cells and induced apoptosis through the activation of Ras/ERK signaling pathway and downstream caspase cascade, and <span class=""chemical"">curcumin</span> might be a potential target for the treatment of <span class=""disease"">gastric carcinoma</span>.",,25492214,25492214_D003474_D013272,25492214_10,bcv_sentence_task_befree_5118,,770961050,FALSE,finalized,5,8/15/15 0:00,"



",no_relation,1,,D000666,"<span class=""chemical"">amphotericin B</span>",D007898,"<span class=""disease"">Indian visceral leishmaniasis</span>","Single-dose indigenous liposomal <span class=""chemical"">amphotericin B</span> in the treatment of <span class=""disease"">Indian visceral leishmaniasis</span>: a phase 2 study.",,25510715,25510715_D000666_D007898,25510715_0,bcv_sentence_task_befree_5119,,770961051,FALSE,finalized,5,8/15/15 2:18,"



",no_relation,1,,D000666,"<span class=""chemical"">amphotericin B</span>",D007898,"<span class=""disease"">visceral leishmaniasis</span>","Liposomal <span class=""chemical"">amphotericin B</span> is an effective and safe alternative for the treatment of <span class=""disease"">visceral leishmaniasis</span> in the Indian subcontinent.",,25510715,25510715_D000666_D007898,25510715_1,bcv_sentence_task_befree_5120,,770961052,FALSE,finalized,5,8/15/15 1:22,"



",no_relation,1,,C060506,"<span class=""chemical"">sphingosine-1-phosphate</span>",D011695,"<span class=""disease"">allergic</span>","The <span class=""chemical"">sphingosine-1-phosphate</span>/<span class=""chemical"">sphingosine-1-phosphate</span> receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute <span class=""disease"">allergic</span> responses.",,25512083,25512083_C060506_D011695,25512083_0,bcv_sentence_task_befree_5121,,770961053,FALSE,finalized,5,8/14/15 22:55,"



",no_relation,0.8042,,C060506,"<span class=""chemical"">sphingosine-1-phosphate</span>",D011695,"<span class=""disease"">allergic</span>","We used a highly specific neutralizing anti-S1P antibody (mAb) and the <span class=""chemical"">sphingosine-1-phosphate</span> receptor 2 (S1PR2) antagonist JTE-013 to study the signaling contributions of S1P and S1PR2 to MC- and IgE-dependent airway <span class=""disease"">allergic</span> responses in mice within minutes after antigen challenge.",,25512083,25512083_C060506_D011695,25512083_3,bcv_sentence_task_befree_5122,,770961054,FALSE,finalized,5,8/14/15 22:56,"



",no_relation,1,,C471998,"<span class=""chemical"">JTE-013</span>",D011695,"<span class=""disease"">allergic</span>","We used a highly specific neutralizing anti-S1P antibody (mAb) and the sphingosine-1-phosphate receptor 2 (S1PR2) antagonist <span class=""chemical"">JTE-013</span> to study the signaling contributions of S1P and S1PR2 to MC- and IgE-dependent airway <span class=""disease"">allergic</span> responses in mice within minutes after antigen challenge.",,25512083,25512083_C471998_D011695,25512083_3,bcv_sentence_task_befree_5123,,770961055,FALSE,finalized,5,8/14/15 23:13,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D006560,"<span class=""disease"">labial adhesions</span>","Comparison of <span class=""chemical"">estrogen</span> and betamethasone in the topical treatment of <span class=""disease"">labial adhesions</span> in prepubertal girls.",,25552168,25552168_D004967_D006560,25552168_0,bcv_sentence_task_befree_5124,,770961056,FALSE,finalized,5,8/14/15 23:37,"



",no_relation,1,,D001623,"<span class=""chemical"">betamethasone</span>",D006560,"<span class=""disease"">labial adhesions</span>","Comparison of estrogen and <span class=""chemical"">betamethasone</span> in the topical treatment of <span class=""disease"">labial adhesions</span> in prepubertal girls.",,25552168,25552168_D001623_D006560,25552168_0,bcv_sentence_task_befree_5125,,770961057,FALSE,finalized,5,8/14/15 22:55,"



",no_relation,1,,D004967,"<span class=""chemical"">estrogen</span>",D006560,"<span class=""disease"">labial adhesions</span>","To compare <span class=""chemical"">estrogen</span> and betamethasone in the topical treatment of <span class=""disease"">labial adhesions</span> in prepubertal girls.",,25552168,25552168_D004967_D006560,25552168_1,bcv_sentence_task_befree_5126,,770961058,FALSE,finalized,5,8/14/15 22:51,"



",no_relation,1,,D001623,"<span class=""chemical"">betamethasone</span>",D006560,"<span class=""disease"">labial adhesions</span>","To compare estrogen and <span class=""chemical"">betamethasone</span> in the topical treatment of <span class=""disease"">labial adhesions</span> in prepubertal girls.",,25552168,25552168_D001623_D006560,25552168_1,bcv_sentence_task_befree_5127,,770961059,FALSE,finalized,5,8/14/15 22:42,"



",no_relation,1,,D001623,"<span class=""chemical"">Betamethasone</span>",D006560,"<span class=""disease"">labial adhesions</span>","<span class=""chemical"">Betamethasone</span> cream with petroleum ointment is a safe and effective primary therapy for prepubertal <span class=""disease"">labial adhesions</span>.",,25552168,25552168_D001623_D006560,25552168_9,bcv_sentence_task_befree_5128,,770961060,FALSE,finalized,5,8/14/15 22:59,"



",no_relation,1,,C065179,"<span class=""chemical"">atorvastatin</span>",D058729,"<span class=""disease"">peripheral arterial disease</span>","High-dose <span class=""chemical"">atorvastatin</span> is superior to moderate-dose simvastatin in preventing <span class=""disease"">peripheral arterial disease</span>.",,25595417,25595417_C065179_D058729,25595417_0,bcv_sentence_task_befree_5129,,770961061,FALSE,finalized,5,8/15/15 1:48,"



",no_relation,1,,D019821,"<span class=""chemical"">simvastatin</span>",D058729,"<span class=""disease"">peripheral arterial disease</span>","High-dose atorvastatin is superior to moderate-dose <span class=""chemical"">simvastatin</span> in preventing <span class=""disease"">peripheral arterial disease</span>.",,25595417,25595417_D019821_D058729,25595417_0,bcv_sentence_task_befree_5130,,770961062,FALSE,finalized,5,8/14/15 23:37,"



",no_relation,1,,C065179,"<span class=""chemical"">atorvastatin</span>",D009203,"<span class=""disease"">myocardial infarction</span>","In the Incremental Decrease in End Points Through Aggressive Lipid Lowering trial, 8888 post-<span class=""disease"">myocardial infarction</span> patients were randomised to high-dose or usual-dose statin therapy (<span class=""chemical"">atorvastatin</span> 80mg/day vs simvastatin 20-40mg/day).",,25595417,25595417_C065179_D009203,25595417_2,bcv_sentence_task_befree_5131,,770961063,FALSE,finalized,5,8/14/15 23:05,"



",no_relation,1,,D019821,"<span class=""chemical"">simvastatin</span>",D009203,"<span class=""disease"">myocardial infarction</span>","In the Incremental Decrease in End Points Through Aggressive Lipid Lowering trial, 8888 post-<span class=""disease"">myocardial infarction</span> patients were randomised to high-dose or usual-dose statin therapy (atorvastatin 80mg/day vs <span class=""chemical"">simvastatin</span> 20-40mg/day).",,25595417,25595417_D019821_D009203,25595417_2,bcv_sentence_task_befree_5132,,770961064,FALSE,finalized,5,8/15/15 1:57,"



",no_relation,1,,D019821,"<span class=""chemical"">statins</span>",D058729,"<span class=""disease"">PAD</span>","We investigated the effect of high-dose versus usual-dose <span class=""chemical"">statins</span> on the pre-specified outcome <span class=""disease"">PAD</span> incidence, and additionally performed a posthoc analysis of the efficacy of high-dose <span class=""chemical"">statins</span> in reducing CVD risk among patients with <span class=""disease"">PAD</span>.",,25595417,25595417_D019821_D058729,25595417_3,bcv_sentence_task_befree_5133,,770961065,FALSE,finalized,5,8/14/15 23:34,"



",no_relation,1,,D019821,"<span class=""chemical"">statins</span>",D002318,"<span class=""disease"">CVD</span>","We investigated the effect of high-dose versus usual-dose <span class=""chemical"">statins</span> on the pre-specified outcome PAD incidence, and additionally performed a posthoc analysis of the efficacy of high-dose <span class=""chemical"">statins</span> in reducing <span class=""disease"">CVD</span> risk among patients with PAD.",,25595417,25595417_D019821_D002318,25595417_3,bcv_sentence_task_befree_5134,,770961066,FALSE,finalized,5,8/15/15 0:14,"



",no_relation,0.5882,,C065179,"<span class=""chemical"">atorvastatin</span>",D058729,"<span class=""disease"">PAD</span>","During a median follow-up of 4.8years, 94 patients (2.2%) receiving <span class=""chemical"">atorvastatin</span> and 135 patients (3.2%) receiving simvastatin developed <span class=""disease"">PAD</span> (HR=0.70, 95% CI 0.53 to 0.91; p=0.007).",,25595417,25595417_C065179_D058729,25595417_4,bcv_sentence_task_befree_5135,,770961067,FALSE,finalized,5,8/15/15 1:18,"



",yes_direct,1,,D019821,"<span class=""chemical"">simvastatin</span>",D058729,"<span class=""disease"">PAD</span>","During a median follow-up of 4.8years, 94 patients (2.2%) receiving atorvastatin and 135 patients (3.2%) receiving <span class=""chemical"">simvastatin</span> developed <span class=""disease"">PAD</span> (HR=0.70, 95% CI 0.53 to 0.91; p=0.007).",,25595417,25595417_D019821_D058729,25595417_4,bcv_sentence_task_befree_5136,,770961068,FALSE,finalized,5,8/14/15 23:36,"



",no_relation,1,,C065179,"<span class=""chemical"">atorvastatin</span>",D058729,"<span class=""disease"">PAD</span>","In <span class=""disease"">PAD</span> patients, major coronary events occurred in fewer patients in the <span class=""chemical"">atorvastatin</span> group (14.4%) than in the simvastatin group (20.1%), but the difference did not reach statistical significance.",,25595417,25595417_C065179_D058729,25595417_6,bcv_sentence_task_befree_5137,,770961069,FALSE,finalized,5,8/14/15 22:49,"



",no_relation,1,,D019821,"<span class=""chemical"">simvastatin</span>",D058729,"<span class=""disease"">PAD</span>","In <span class=""disease"">PAD</span> patients, major coronary events occurred in fewer patients in the atorvastatin group (14.4%) than in the <span class=""chemical"">simvastatin</span> group (20.1%), but the difference did not reach statistical significance.",,25595417,25595417_D019821_D058729,25595417_6,bcv_sentence_task_befree_5138,,770961070,FALSE,finalized,5,8/15/15 2:15,"



",no_relation,1,,C065179,"<span class=""chemical"">atorvastatin</span>",D058729,"<span class=""disease"">PAD</span>","High-dose statin therapy with <span class=""chemical"">atorvastatin</span> significantly reduced the incidence of <span class=""disease"">PAD</span> compared with usual-dose statin therapy with simvastatin.",,25595417,25595417_C065179_D058729,25595417_9,bcv_sentence_task_befree_5139,,770961071,FALSE,finalized,5,8/14/15 22:59,"



",no_relation,1,,D019821,"<span class=""chemical"">simvastatin</span>",D058729,"<span class=""disease"">PAD</span>","High-dose statin therapy with atorvastatin significantly reduced the incidence of <span class=""disease"">PAD</span> compared with usual-dose statin therapy with <span class=""chemical"">simvastatin</span>.",,25595417,25595417_D019821_D058729,25595417_9,bcv_sentence_task_befree_5140,,770961072,FALSE,finalized,5,8/14/15 23:51,"



",no_relation,1,,C065179,"<span class=""chemical"">atorvastatin</span>",D058729,"<span class=""disease"">PAD</span>","Patients with a history of <span class=""disease"">PAD</span> at baseline were at higher risk of future coronary events and this risk was reduced by high-dose <span class=""chemical"">atorvastatin</span> treatment.",,25595417,25595417_C065179_D058729,25595417_10,bcv_sentence_task_befree_5141,,770961073,FALSE,finalized,5,8/14/15 23:15,"



",no_relation,0.8151,,D008691,"<span class=""chemical"">methadone</span>",D010146,"<span class=""disease"">pain</span>","Out-of-hospital mortality among patients receiving <span class=""chemical"">methadone</span> for noncancer <span class=""disease"">pain</span>.",,25599329,25599329_D008691_D010146,25599329_0,bcv_sentence_task_befree_5142,,770961074,FALSE,finalized,5,8/14/15 23:43,"



",no_relation,1,,D008691,"<span class=""chemical"">methadone</span>",D010146,"<span class=""disease"">pain</span>","Growing <span class=""chemical"">methadone</span> use in <span class=""disease"">pain</span> management has raised concerns regarding its safety relative to other long-acting opioids.",,25599329,25599329_D008691_D010146,25599329_1,bcv_sentence_task_befree_5143,,770961075,FALSE,finalized,5,8/15/15 2:19,"



",yes_direct,0.7835,,D008691,"<span class=""chemical"">Methadone hydrochloride</span>",D001145,"<span class=""disease"">ventricular arrhythmias</span>","<span class=""chemical"">Methadone hydrochloride</span> may increase the risk for lethal respiratory depression related to accidental overdose and life-threatening <span class=""disease"">ventricular arrhythmias</span>.",,25599329,25599329_D008691_D001145,25599329_2,bcv_sentence_task_befree_5144,,770961076,FALSE,finalized,5,8/15/15 1:48,"



",no_relation,0.6184,,D008691,"<span class=""chemical"">Methadone hydrochloride</span>",D062787,"<span class=""disease"">overdose</span>","<span class=""chemical"">Methadone hydrochloride</span> may increase the risk for lethal respiratory depression related to accidental <span class=""disease"">overdose</span> and life-threatening ventricular arrhythmias.",,25599329,25599329_D008691_D062787,25599329_2,bcv_sentence_task_befree_5145,,770961077,FALSE,finalized,5,8/15/15 0:04,"



",yes_direct,1,,D008691,"<span class=""chemical"">Methadone hydrochloride</span>",D012131,"<span class=""disease"">respiratory depression</span>","<span class=""chemical"">Methadone hydrochloride</span> may increase the risk for lethal <span class=""disease"">respiratory depression</span> related to accidental overdose and life-threatening ventricular arrhythmias.",,25599329,25599329_D008691_D012131,25599329_2,bcv_sentence_task_befree_5146,,770961078,FALSE,finalized,5,8/15/15 1:14,"



",no_relation,1,,D008691,"<span class=""chemical"">methadone</span>",D010146,"<span class=""disease"">pain</span>","To compare the risk of out-of-hospital death in patients receiving <span class=""chemical"">methadone</span> for noncancer <span class=""disease"">pain</span> with that in comparable patients receiving sustained-release (SR) morphine sulfate.",,25599329,25599329_D008691_D010146,25599329_3,bcv_sentence_task_befree_5147,,770961079,FALSE,finalized,5,8/15/15 1:53,"



",no_relation,0.6142,,D008691,"<span class=""chemical"">methadone</span>",D003643,"<span class=""disease"">death</span>","To compare the risk of out-of-hospital <span class=""disease"">death</span> in patients receiving <span class=""chemical"">methadone</span> for noncancer pain with that in comparable patients receiving sustained-release (SR) morphine sulfate.",,25599329,25599329_D008691_D003643,25599329_3,bcv_sentence_task_befree_5148,,770961080,FALSE,finalized,5,8/14/15 23:45,"



",no_relation,1,,D008691,"<span class=""chemical"">methadone</span>",D009369,"<span class=""disease"">cancer</span>","The cohort included patients receiving morphine SR or <span class=""chemical"">methadone</span> who were aged 30 to 74 years, did not have <span class=""disease"">cancer</span> or another life-threatening illness, and were not in a hospital or nursing home.",,25599329,25599329_D008691_D009369,25599329_5,bcv_sentence_task_befree_5149,,770961081,FALSE,finalized,5,8/14/15 23:13,"


'Did not' being the key term.
",no_relation,1,,D009020,"<span class=""chemical"">morphine</span>",D009369,"<span class=""disease"">cancer</span>","The cohort included patients receiving <span class=""chemical"">morphine</span> SR or methadone who were aged 30 to 74 years, did not have <span class=""disease"">cancer</span> or another life-threatening illness, and were not in a hospital or nursing home.",,25599329,25599329_D009020_D009369,25599329_5,bcv_sentence_task_befree_5150,,770961082,FALSE,finalized,5,8/14/15 23:03,"



",yes_direct,1,,D008691,"<span class=""chemical"">methadone</span>",D003643,"<span class=""disease"">death</span>","After control for study covariates, patients receiving <span class=""chemical"">methadone</span> had a 46% increased risk of <span class=""disease"">death</span> during the follow-up period, with an adjusted hazard ratio (HR) of 1.46 (95% CI, 1.17-1.83; P<.001), resulting in 72 (95% CI, 27-130) excess deaths per 10000 person-years of follow-up.",,25599329,25599329_D008691_D003643,25599329_12,bcv_sentence_task_befree_5151,,770961083,FALSE,finalized,5,8/14/15 22:55,"



",no_relation,0.8046,,D009020,"<span class=""chemical"">morphine</span>",D003643,"<span class=""disease"">death</span>","Methadone doses of 20 mg/d or less, the lowest dose quartile, were associated with an increased risk of <span class=""disease"">death</span> (HR,1.59; 95% CI, 1.01-2.51, P=.046) relative to a comparable dose of <span class=""chemical"">morphine</span> SR (<60 mg/d).",,25599329,25599329_D009020_D003643,25599329_13,bcv_sentence_task_befree_5152,,770961084,FALSE,finalized,5,8/15/15 0:34,"



",yes_direct,1,,D008691,"<span class=""chemical"">Methadone</span>",D003643,"<span class=""disease"">death</span>","<span class=""chemical"">Methadone</span> doses of 20 mg/d or less, the lowest dose quartile, were associated with an increased risk of <span class=""disease"">death</span> (HR,1.59; 95% CI, 1.01-2.51, P=.046) relative to a comparable dose of morphine SR (<60 mg/d).",,25599329,25599329_D008691_D003643,25599329_13,bcv_sentence_task_befree_5153,,770961085,FALSE,finalized,5,8/14/15 22:40,"



",no_relation,0.7974,,D008691,"<span class=""chemical"">methadone</span>",D010146,"<span class=""disease"">pain</span>","The increased risk of death observed for patients receiving <span class=""chemical"">methadone</span> in this retrospective cohort study, even for low doses, supports recommendations that it should not be a drug of first choice for noncancer <span class=""disease"">pain</span>.",,25599329,25599329_D008691_D010146,25599329_14,bcv_sentence_task_befree_5154,,770961086,FALSE,finalized,5,8/15/15 1:49,"



",yes_direct,1,,D008691,"<span class=""chemical"">methadone</span>",D003643,"<span class=""disease"">death</span>","The increased risk of <span class=""disease"">death</span> observed for patients receiving <span class=""chemical"">methadone</span> in this retrospective cohort study, even for low doses, supports recommendations that it should not be a drug of first choice for noncancer pain.",,25599329,25599329_D008691_D003643,25599329_14,bcv_sentence_task_befree_5155,,770961087,FALSE,finalized,5,8/15/15 2:12,"



",no_relation,1,,D014443,"<span class=""chemical"">tyrosine</span>",D008175,"<span class=""disease"">lung cancer</span>","Role of <span class=""chemical"">tyrosine</span> kinase-independent phosphorylation of EGFR with activating mutation in cisplatin-treated <span class=""disease"">lung cancer</span> cells.",,25701783,25701783_D014443_D008175,25701783_0,bcv_sentence_task_befree_5156,,770961088,FALSE,finalized,5,8/14/15 22:35,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D008175,"<span class=""disease"">lung cancer</span>","Role of tyrosine kinase-independent phosphorylation of EGFR with activating mutation in <span class=""chemical"">cisplatin</span>-treated <span class=""disease"">lung cancer</span> cells.",,25701783,25701783_D002945_D008175,25701783_0,bcv_sentence_task_befree_5157,,770961089,FALSE,finalized,5,8/14/15 22:33,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D009369,"<span class=""disease"">cancer</span>","We therefore introduce a potential combinatorial therapy composed of p38 inhibition and <span class=""chemical"">cisplatin</span> to block the activation of EGFR, therefore inducing <span class=""disease"">cancer</span> cell death and apoptosis.",,25701783,25701783_D002945_D009369,25701783_6,bcv_sentence_task_befree_5158,,770961090,FALSE,finalized,5,8/15/15 0:55,"



",no_relation,1,,D002945,"<span class=""chemical"">cisplatin</span>",D003643,"<span class=""disease"">death</span>","We therefore introduce a potential combinatorial therapy composed of p38 inhibition and <span class=""chemical"">cisplatin</span> to block the activation of EGFR, therefore inducing cancer cell <span class=""disease"">death</span> and apoptosis.",,25701783,25701783_D002945_D003643,25701783_6,bcv_sentence_task_befree_5159,,